PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Purcell, S; Neale, B; Todd-Brown, K; Thomas, L; Ferreira, MAR; Bender, D; Maller, J; Sklar, P; de Bakker, PIW; Daly, MJ; Sham, PC				Purcell, Shaun; Neale, Benjamin; Todd-Brown, Kathe; Thomas, Lori; Ferreira, Manuel A. R.; Bender, David; Maller, Julian; Sklar, Pamela; de Bakker, Paul I. W.; Daly, Mark J.; Sham, Pak C.			PLINK: A tool set for whole-genome association and population-based linkage analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRATIFICATION; SCALE; VARIANTS; SEGMENTS; HISTORY	Whole-genome association studies (WGAS) bring new computational, as well as analytic, challenges to researchers. Many existing genetic-analysis tools are not designed to handle such large data sets in a convenient manner and do not necessarily exploit the new opportunities that whole-genome data bring. To address these issues, we developed PLINK, an open-source C/C++ WGAS tool set. With PLINK, large data sets comprising hundreds of thousands of markers genotyped for thousands of individuals can be rapidly manipulated and analyzed in their entirety. As well as providing tools to make the basic analytic steps computationally efficient, PLINK also supports some novel approaches to whole-genome data that take advantage of whole-genome coverage. We introduce PLINK and describe the five main domains of function: data management, summary statistics, population stratification, association analysis, and identity-by-descent estimation. In particular, we focus on the estimation and use of identity-by-state and identity-by-descent information in the context of population-based whole-genome studies. This information can be used to detect and correct for population stratification and to identify extended chromosomal segments that are shared identical by descent between very distantly related individuals. Analysis of the patterns of segmental sharing has the potential to map disease loci that contain multiple rare variants in a population-based linkage analysis.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA USA; Univ London, Inst Psychiat, London, England; Univ Hong Kong, Ctr Gene Res, Hong Kong, Hong Kong, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; King's College London; University of Hong Kong	Purcell, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Room 6-254,CPZ N,185 Cambridge St, Boston, MA 02114 USA.	Shaun@pngu.mgh.harvard.edu	Daly, Mark J/B-2453-2017; de Bakker, Paul IW/B-8730-2009; maller, julian B/A-9323-2009; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Ganesh, Dunna Sai/AGX-5170-2022; Ferreira, Manuel A R/D-3609-2013	Daly, Mark J/0000-0002-0949-8752; de Bakker, Paul IW/0000-0001-7735-7858; Ferreira, Manuel A R/0000-0001-9059-1825; Sai Ganesh, Dunna/0000-0002-3570-7466; Maller, Julian/0000-0002-1565-9559; Todd-Brown, Katherine/0000-0002-3109-8130	NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH073806] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012562, EY-12562] Funding Source: Medline; NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; NIMH NIH HHS [R03 MH73806-01A1, R03 MH073806] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Agresti A, 1990, CATEGORICAL DATA ANA, P100; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beckmann L, 2005, HUM HERED, V59, P67, DOI 10.1159/000085221; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESAG J, 1991, BIOMETRIKA, V78, P301; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doerge RW, 1996, GENETICS, V142, P285; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Ferreira MAR, 2007, BEHAV GENET, V37, P631, DOI 10.1007/s10519-007-9149-0; Fleiss JL, 1981, STAT METHODS RATES P; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lee WC, 2003, INT J EPIDEMIOL, V32, P1120, DOI 10.1093/ije/dyg301; Milligan BG, 2003, GENETICS, V163, P1153; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886; Purcell S, 2004, HUM HERED, V58, P93, DOI 10.1159/000083030; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; Wang Y, 2006, AM J HUM GENET, V78, P615, DOI 10.1086/502632; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	39	19003	19418	52	957	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					559	575		10.1086/519795	http://dx.doi.org/10.1086/519795			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701901	Green Published, Bronze			2022-12-18	WOS:000249128200012
J	Stephens, M; Smith, NJ; Donnelly, P				Stephens, M; Smith, NJ; Donnelly, P			A new statistical method for haplotype reconstruction from population data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; INFERENCE	Current routine genotyping methods typically do not provide haplotype information, which is essential for many analyses of fine-scale molecular-genetics data. Haplotypes can be obtained, at considerable cost, experimentally or (partially) through genotyping of additional family members. Alternatively, a statistical method can be used to infer phase and to reconstruct haplotypes. We present a new statistical method, applicable to genotype data at linked loci from a population sample, that improves substantially on current algorithms; often, error rates are reduced by >50%, relative to its nearest competitor. Furthermore, our algorithm performs well in absolute terms, suggesting that reconstructing haplotypes experimentally or by genotyping additional family members may be an inefficient use of resources.	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Oxford, Dept Stat, Oxford OX1 2JD, England; Univ Oxford, Dept Biochem, Oxford OX1 2JD, England	University of Washington; University of Washington Seattle; University of Oxford; University of Oxford	Stephens, M (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.	stephens@stat.washington.edu		Donnelly, Peter/0000-0001-9495-3408				CLARK AG, 1990, MOL BIOL EVOL, V7, P111; DONNELLY P, 1986, THEOR POPUL BIOL, V30, P271, DOI 10.1016/0040-5809(86)90037-7; Excoffier L, 1998, AM J HUM GENET, V62, P171, DOI 10.1086/301674; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilks WR, 1996, MARKOV CHAIN MONTE C; Harding RM, 1997, AM J HUM GENET, V60, P772; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Heckerman D, 2001, J MACH LEARN RES, V1, P49, DOI 10.1162/153244301753344614; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Kimmel M, 1998, GENETICS, V148, P1921; Kuhner MK, 2000, GENET EPIDEMIOL, V19, pS15, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI3>3.0.CO;2-V; Kuhner MK, 2000, GENETICS, V156, P1393; Little RJ, 1987, STAT ANAL MISSING DA; LONG JC, 1995, AM J HUM GENET, V56, P799; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; WATTERSON GA, 1977, THEOR POPUL BIOL, V12, P179, DOI 10.1016/0040-5809(77)90041-7	24	6306	6458	0	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					978	989		10.1086/319501	http://dx.doi.org/10.1086/319501			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254454	Bronze, Green Published			2022-12-18	WOS:000167666000019
J	BOTSTEIN, D; WHITE, RL; SKOLNICK, M; DAVIS, RW				BOTSTEIN, D; WHITE, RL; SKOLNICK, M; DAVIS, RW			CONSTRUCTION OF A GENETIC-LINKAGE MAP IN MAN USING RESTRICTION FRAGMENT LENGTH POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MASSACHUSETTS, SCH MED, DEPT MICROBIOL, WORCESTER, MA 01605 USA; UNIV UTAH, COLL MED, DEPT MED BIOPHYS & COMP, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, LATTER DAY ST HOSP, SALT LAKE CITY, UT 84143 USA; STANFORD UNIV, SCH MED, DEPT BIOCHEM, STANFORD, CA 94305 USA	University of Massachusetts System; University of Massachusetts Worcester; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Stanford University	BOTSTEIN, D (corresponding author), MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA.							ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; [Anonymous], 1974, GENETIC BASIS EVOLUT; BIRD AP, 1978, J MOL BIOL, V118, P49, DOI 10.1016/0022-2836(78)90243-7; BISHOP DT, 1980, 1979 P C HUM HLTH DA; BISSBORT S, 1973, HUMANGENETIK, V18, P93; BRITTEN R, 1977, CELL, V10, P509; CAMERON JR, 1979, CELL, V16, P739, DOI 10.1016/0092-8674(79)90090-4; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1976, COMPUT BIOMED RES, V9, P393, DOI 10.1016/0010-4809(76)90058-6; CARTER ND, 1968, ACTA GENET STAT MED, V18, P109; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; CHAKRABORTY R, 1979, GENETIC ANAL COMMON, P297; CHEN SH, 1972, ANN HUM GENET, V35, P401; CLEGHORN TE, 1960, NATURE, V187, P701, DOI 10.1038/187701a0; CLEGHORN TE, 1961, THESIS U SHEFFIELD; DAIGER SP, 1978, AM J HUM GENET, V30, P202; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GIBLETT ER, 1974, AM J HUM GENET, V26, P627; GIBLETT ER, 1969, GENETIC MARKER HUMAN; GOODMAN HM, 1977, P NATL ACAD SCI USA, V74, P5453, DOI 10.1073/pnas.74.12.5453; GRODZICKER T, 1974, COLD SPRING HARB SYM, V39, P439, DOI 10.1101/SQB.1974.039.01.056; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; HIRSCHFELD J, 1962, PROG ALLERGY, V6, P155, DOI 10.1159/000313799; HOPKINSON DA, 1966, ANN HUM GENET, V30, P167, DOI 10.1111/j.1469-1809.1966.tb00016.x; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; HOPKINSON DA, 1968, ANN HUM GENET, V31, P359, DOI 10.1111/j.1469-1809.1968.tb00567.x; HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEFFREYS AJ, 1977, CELL, V12, P429, DOI 10.1016/0092-8674(77)90119-2; KAN YW, 1978, LANCET, V2, P910; KOMPF J, 1975, HUMANGENETIK, V27, P141; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MERRITT AD, 1973, AM J HUM GENET, V25, P510; Morton N. E., 1978, GENETIC EPIDEMIOLOGY; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; Mourant A., 1954, DISTRIBUTION HUMAN B; NATHANS D, 1975, ANNU REV BIOCHEM, V44, P273, DOI 10.1146/annurev.bi.44.070175.001421; OLSON MV, 1979, J MOL BIOL, V127, P285, DOI 10.1016/0022-2836(79)90330-9; ORKIN SH, 1978, NEW ENGL J MED, V299, P166, DOI 10.1056/NEJM197807272990403; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; POTTER SS, 1975, P NATL ACAD SCI USA, V72, P4496, DOI 10.1073/pnas.72.11.4496; Race RR, 1944, NATURE, V153, P52, DOI 10.1038/153052a0; RACE RR, 1951, HEREDITY, V5, P103, DOI 10.1038/hdy.1951.6; RAPLEY S, 1968, ANN HUM GENET, V31, P237, DOI 10.1111/j.1469-1809.1968.tb00554.x; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; ROBSON EB, 1967, ANN HUM GENET, V30, P219, DOI 10.1111/j.1469-1809.1967.tb00023.x; ROSBASH M, 1975, NATURE, V258, P682, DOI 10.1038/258682a0; RUBIN GM, 1977, COLD SPRING HARB SYM, V42, P1041; RUDDLE F, 1977, SCIENCE, V196, P390; SAMLOFF IM, 1970, SCIENCE, V168, P144, DOI 10.1126/science.168.3927.144; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; SING CF, 1978, GENETIC ANAL COMMON; SKOLNICK MH, 1977, GENETICS HUMAN CANC, P19; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TEISBERG P, 1970, VOX SANG, V19, P47, DOI 10.1111/j.1423-0410.1970.tb01494.x; TENG YS, 1975, AM J HUM GENET, V27, P492; Thompson E. A., 1978, GENETIC EPIDEMIOLOGY, P247; THOMSON G, 1976, POPULATION GENETICS, P465; TUAN D, 1979, NUCLEIC ACIDS RES, V6, P2519, DOI 10.1093/nar/6.7.2519; UPHOLT WB, 1977, NUCLEIC ACIDS RES, V4, P1257, DOI 10.1093/nar/4.5.1257; WYMAN A, UNPUBLISHED; [No title captured]	65	6230	7790	9	412	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					314	331						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	6247908				2022-12-18	WOS:A1980JX05900002
J	SPIELMAN, RS; MCGINNIS, RE; EWENS, WJ				SPIELMAN, RS; MCGINNIS, RE; EWENS, WJ			TRANSMISSION TEST FOR LINKAGE DISEQUILIBRIUM - THE INSULIN GENE REGION AND INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-DISEASE ASSOCIATIONS; HAPLOTYPE RELATIVE RISK; RECEPTOR LOCUS; SUSCEPTIBILITY; CHROMOSOME-11; DISORDERS	A population association has consistently been observed between insulin-dependent diabetes mellitus (IDDM) and the ''class 1'' alleles of the region of tandem-repeat DNA (5' flanking polymorphism [5'FP]) adjacent to the insulin gene on chromosome 11p. This finding suggests that the insulin gene region contains a gene or genes contributing to IDDM susceptibility. However, several studies that have sought to show linkage with IDDM by testing for cosegregation in affected sib pairs have failed to find evidence for linkage. As means for identifying genes for complex diseases, both the association and the affected-sib-pairs approaches have limitations. It is well known that population association between a disease and a genetic marker can arise as an artifact of population structure, even in the absence of linkage. On the other hand, linkage studies with modest numbers of affected sib pairs may fail to detect linkage, especially if there is linkage heterogeneity. We consider an alternative method to test for linkage with a genetic marker when population association has been found. Using data from families with at least one affected child, we evaluate the transmission of the associated marker allele from a heterozygous parent to an affected offspring. This approach has been used by several investigators, but the statistical properties of the method as a test for linkage have not been investigated. In the present paper we describe the statistical basis for this ''transmission test for linkage disequilibrium'' (transmission/disequilibrium test [TDT]). We then show the relationship of this test to tests of cosegregation that are based on the proportion of haplotypes or genes identical by descent in affected sibs. The TDT provides strong evidence for linkage between the 5'FP and susceptibility to IDDM. The conclusions from this analysis apply in general to the study of disease associations, where genetic markers are usually closely linked to candidate genes. When a disease is found to be associated with such a marker, the TDT may detect linkage even when haplotype-sharing tests do not.	UNIV PENN,DEPT BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania	SPIELMAN, RS (corresponding author), UNIV PENN,SCH MED,DEPT GENET,422 CURIE BLVD,PHILADELPHIA,PA 19104, USA.			McGinnis, Ralph/0000-0003-4540-9857	NIDDK NIH HHS [DK35047] Funding Source: Medline; NIGMS NIH HHS [GM21135] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021135] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUR MP, 1989, GENET EPIDEMIOL, V6, P15, DOI 10.1002/gepi.1370060105; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; COX NJ, 1989, DIABETES, V38, P947, DOI 10.2337/diabetes.38.8.947; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; COX NJ, 1988, AM J HUM GENET, V42, P167; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FERNS GAA, 1986, J MED GENET, V23, P210, DOI 10.1136/jmg.23.3.210; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; FIELD LL, 1986, GENET EPIDEMIOL S, V1, P323; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; HOOVER ML, 1986, COLD SPRING HARB SYM, V51, P803, DOI 10.1101/SQB.1986.051.01.093; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LI SR, 1988, LANCET, V2, P368; MCGINNIS RE, 1991, AM J HUM GENET S, V49, pA476; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; OWERBACH D, 1990, DIABETES, V39, P1504, DOI 10.2337/diabetes.39.12.1504; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; Sokal Robert R., 1969, BIOMETRY; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1988, ANNU REV GENET, V22, P31	27	3174	3302	0	54	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					506	516						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447318				2022-12-18	WOS:A1993KR72000008
J	Yang, JA; Lee, SH; Goddard, ME; Visscher, PM				Yang, Jian; Lee, S. Hong; Goddard, Michael E.; Visscher, Peter M.			GCTA: A Tool for Genome-wide Complex Trait Analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; STRATIFICATION; ASSOCIATION; LOCI; PREDICTIONS; INFORMATION; SELECTION; DISEASES	For most human complex diseases and traits, SNPs identified by genome-wide association studies (GWAS) explain only a small fraction of the heritability. Here we report a user-friendly software tool called genome-wide complex trait analysis (GCTA), which was developed based on a method we recently developed to address the "missing heritability" problem. GCTA estimates the variance explained by all the SNPs on a chromosome or on the whole genome for a complex trait rather than testing the association of any particular SNP to the trait. We introduce GCTA's five main functions: data management, estimation of the genetic relationships from SNPs, mixed linear model analysis of variance explained by the SNPs, estimation of the linkage disequilibrium structure, and GWAS simulation. We focus on the function of estimating the variance explained by all the SNPs on the X chromosome and testing-the hypotheses of dosage compensation. The GCTA software is a versatile tool to estimate and partition complex trait variation with large GWAS data sets.	[Yang, Jian; Lee, S. Hong; Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic 3086, Australia	QIMR Berghofer Medical Research Institute; University of Melbourne	Yang, JA (corresponding author), Queensland Inst Med Res, Queensland Stat Genet Lab, 300 Herston Rd, Brisbane, Qld 4006, Australia.	jian.yang@qimr.edu.au	Lee, Sang Hong/A-2569-2011; Visscher, Peter/ABB-6151-2020; Yang, Jian/A-5852-2010	Lee, Sang Hong/0000-0001-9701-2718; Visscher, Peter/0000-0002-2143-8760; Yang, Jian/0000-0003-2001-2474	Australian National Health and Medical Research Council [389892, 613672]; Australian Research Council [DP0770096, DP1093900]; Medical Research Council [G0700704B] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Bruce Weir for discussions on the sampling variance of estimators of inbreeding coefficients. We thank Allan McRae and David Duffy for discussions and Anna Vinkhuyzen for software testing. We acknowledge funding from the Australian National Health and Medical Research Council (grants 389892 and 613672) and the Australian Research Council (grants DP0770096 and DP1093900).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; DEMPSTER ER, 1950, GENETICS, V35, P212; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Falush D, 2003, GENETICS, V164, P1567; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gilmour AR., 2006, ASREML USER GUIDE RE; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2007, GENETICS, V177, P1725, DOI 10.1534/genetics.106.069088; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Kent JW, 2005, GENET EPIDEMIOL, V29, P377, DOI 10.1002/gepi.20093; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Lynch M, 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; ROBERTSON A, 1949, GENETICS, V34, P395; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	35	3128	3183	31	334	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					76	82		10.1016/j.ajhg.2010.11.011	http://dx.doi.org/10.1016/j.ajhg.2010.11.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ		Bronze, Green Published			2022-12-18	WOS:000286501500007
J	WEBER, JL; MAY, PE				WEBER, JL; MAY, PE			ABUNDANT CLASS OF HUMAN DNA POLYMORPHISMS WHICH CAN BE TYPED USING THE POLYMERASE CHAIN-REACTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WEBER, JL (corresponding author), MARSHFIELD MED FDN INC,510 N ST JOSEPH AVE,MARSHFIELD,WI 54449, USA.			Marquardt, Paula E./0000-0001-8854-0172				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRAATEN DC, 1988, NUCLEIC ACIDS RES, V16, P865, DOI 10.1093/nar/16.3.865; DAS HK, 1987, J BIOL CHEM, V262, P4787; GILLIAM TC, 1987, NUCLEIC ACIDS RES, V15, P1445, DOI 10.1093/nar/15.4.1445; GROSS DS, 1986, MOL CELL BIOL, V6, P3010, DOI 10.1128/MCB.6.8.3010; GROSS DS, 1985, J MOL BIOL, V183, P251, DOI 10.1016/0022-2836(85)90218-9; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; HAMADA H, 1984, MOL CELL BIOL, V4, P2622, DOI 10.1128/MCB.4.12.2622; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; HAMADA H, 1984, MOL CELL BIOL, V4, P2610, DOI 10.1128/MCB.4.12.2610; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; MOTULSKY AG, 1988, AM J HUM GENET, V42, P405; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NICKLAS JA, 1987, MUTAGENESIS, V2, P341, DOI 10.1093/mutage/2.5.341; NORDHEIM A, 1983, P NATL ACAD SCI-BIOL, V80, P1821, DOI 10.1073/pnas.80.7.1821; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; PARDUE ML, 1987, EMBO J, V6, P1781, DOI 10.1002/j.1460-2075.1987.tb02431.x; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHUMM JW, 1988, AM J HUM GENET, V42, P43; SHEN LP, 1984, SCIENCE, V224, P168, DOI 10.1126/science.6142531; Skolnick MH, 1988, GENOMICS, V2, P273, DOI 10.1016/0888-7543(88)90014-6; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SUN L, 1984, NUCLEIC ACIDS RES, V12, P2669, DOI 10.1093/nar/12.6.2669; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; WAYE J S, 1987, Genomics, V1, P43, DOI 10.1016/0888-7543(87)90103-0; WEBER JL, 1988, EXP PARASITOL, V66, P143, DOI 10.1016/0014-4894(88)90087-2; WEBER JL, 1988, J BIOL CHEM, V263, P11421	37	2978	3213	0	66	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					388	396						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2916582				2022-12-18	WOS:A1989T353500012
J	Stephens, M; Donnelly, P				Stephens, M; Donnelly, P			A comparison of Bayesian methods for haplotype reconstruction from population genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFERENCE; SAMPLES	In this report, we compare and contrast three previously published Bayesian methods for inferring haplotypes from genotype data in a population sample. We review the methods, emphasizing the differences between them in terms of both the models ("priors") they use and the computational strategies they employ. We introduce a new algorithm that combines the modeling strategy of one method with the computational strategies of another. In comparisons using real and simulated data, this new algorithm outperforms all three existing methods. The new algorithm is included in the software package PHASE, version 2.0, available online( http://www.stat.washington.edu/stephens/software.html).	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Washington; University of Washington Seattle; University of Oxford	Stephens, M (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.			Donnelly, Peter/0000-0001-9495-3408	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01HG/LM02585-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Behrends E., 2000, INTRO MARKOV CHAINS, VVolume 228; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M, 2001, AM J HUM GENET, V69, P912, DOI 10.1086/323623; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254	13	2971	3076	0	72	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1162	1169		10.1086/379378	http://dx.doi.org/10.1086/379378			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14574645	Green Published, Bronze			2022-12-18	WOS:000186493400017
J	Almasy, L; Blangero, J				Almasy, L; Blangero, J			Multipoint quantitative-trait linkage analysis in general pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; SIB-PAIR ANALYSIS; VARIANCE-COMPONENTS; DESCENT; IDENTITY; MODELS; SIMULATION; STATISTICS; EXTENSIONS; MAPS	Multipoint linkage analysis of quantitative-trait loci (QTLs) has previously been restricted to sibships and small pedigrees. In this article, we show how variance-component linkage methods can be used in pedigrees of arbitrary size and complexity, and we develop a general framework for multipoint identity-by-descent (IBD) probability calculations. We extend the sib-pair multipoint mapping approach of Fulker et al. to general relative pairs. This multipoint IBD method uses the proportion of alleles shared identical by descent at genotyped loci to estimate IBD sharing at arbitrary points along a chromosome for each relative pair. We have derived correlations in IBD sharing as a function of chromosomal distance for relative pairs in general pedigrees and provide a simple framework whereby these correlations can be easily obtained for any relative pair related by a single line of descent or by multiple independent lines of descent. Once calculated, the multipoint relative-pair IBDs can be utilized in variance-component linkage analysis, which considers the likelihood of the entire pedigree jointly. Examples are given that use simulated data, demonstrating both the accuracy of QTL localization and the increase in power provided by multipoint analysis with 5-, 10-, and 20-cM marker maps. The general pedigree variance component and IBD estimation methods have been implemented in the SOLAR (Sequential Oligogenic Linkage Analysis Routines) computer package.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA	Texas Biomedical Research Institute	Almasy, L (corresponding author), SW Fdn Biomed Res, Dept Genet, 7620 NW Loop 410,POB 760549, San Antonio, TX 78245 USA.		Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018897, R01GM031575] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45522] Funding Source: Medline; NIGMS NIH HHS [GM31575, GM18897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1997, AM J MED GENET, V74, P595; Almasy L, 1997, ATHEROSCLEROSIS, V134, P76, DOI 10.1016/S0021-9150(97)88463-8; AMOS CI, 1994, AM J HUM GENET, V54, P535; AMOS CI, 1990, AM J HUM GENET, V47, P842; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; AMOS CI, 1988, THESIS LOUISIANA STA; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BEGLEITER H, IN PRESS ELECTROENCE; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; BLANGERO J, 1993, HUM BIOL, V65, P941; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Cotterman C.W., 1940, THESIS OHIO STATE U; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Davis S, 1996, AM J HUM GENET, V58, P867; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Heath SC, 1997, GENET EPIDEMIOL, V14, P1011, DOI 10.1002/(SICI)1098-2272(1997)14:6<1011::AID-GEPI75>3.3.CO;2-E; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MAMELKA PM, 1988, PEDIGREE DRAW APPLE; Mitchell BD, 1997, GENET EPIDEMIOL, V14, P1017, DOI 10.1002/(SICI)1098-2272(1997)14:6<1017::AID-GEPI76>3.0.CO;2-L; Porjesz B, 1997, AM J MED GENET, V74, P573; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sobel E, 1996, AM J HUM GENET, V58, P1323; Speer M., 1992, American Journal of Human Genetics, V51, pA202; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Todorov AA, 1997, GENET EPIDEMIOL, V14, P909, DOI 10.1002/(SICI)1098-2272(1997)14:6<909::AID-GEPI58>3.0.CO;2-Q; Towne B, 1997, GENET EPIDEMIOL, V14, P1053, DOI 10.1002/(SICI)1098-2272(1997)14:6<1053::AID-GEPI82>3.0.CO;2-G; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F	46	2554	2592	0	66	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1198	1211		10.1086/301844	http://dx.doi.org/10.1086/301844			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545414	Green Published, Bronze			2022-12-18	WOS:000073487000025
J	Kruglyak, L; Daly, MJ; ReeveDaly, MP; Lander, ES				Kruglyak, L; Daly, MJ; ReeveDaly, MP; Lander, ES			Parametric and nonparametric linkage analysis: A unified multipoint approach	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE-MEMBER METHOD; LIKELIHOOD CALCULATIONS; COMPLEX PEDIGREES; CONSTRUCTION; HUMANS; MAPS	In complex disease studies, it is crucial to perform multipoint linkage analysis with many markers and to use robust nonparametric methods that take account of all pedigree information. Currently available methods fall short in both regards. In this paper, we describe how to extract complete multipoint inheritance information from general pedigrees of moderate size. This information is captured in the multipoint inheritance distribution, which provides a framework for a unified approach to both parametric and nonparametric methods of linkage analysis. Specifically, the approach includes the following: (1) Rapid exact computation of multipoint LOD scores involving dozens of highly polymorphic markers, even in the presence of loops and missing data. (2) Nonparametric linkage (NPL) analysis, a powerful new approach to pedigree analysis. We show that NPL is robust to uncertainty about mode of inheritance, is much more powerful than commonly used nonparametric methods, and loses little power relative to parametric linkage analysis. NPL thus appears to be the method of choice for pedigree studies of complex traits. (3) Information-content mapping, which measures the fraction of the total inheritance information extracted by the available marker data and points out the regions in which typing additional markers is most useful. (4) Maximum-likelihood reconstruction of many-marker haplotypes, even in pedigrees with missing data. We have implemented NPL analysis, LOD-score computation, information-content mapping, and haplotype reconstruction in a new computer package, GENEHUNTER. The package allows efficient multipoint analysis of pedigree data to be performed rapidly in a single user-friendly environment.	WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, ENGLAND	Massachusetts Institute of Technology (MIT); Whitehead Institute			Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752	NHGRI NIH HHS [HG00017, HG00098] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; CURTIS D, 1995, AM J HUM GENET, V57, P703; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GUO SW, 1995, AM J HUM GENET, V56, P1468; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; MORTON NE, 1955, AM J HUM GENET, V7, P277; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Royden H. L., 1968, REAL ANAL, V2nd; SANDKUIJL LA, 1989, MULTIPOINT MAPPING L; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sobel E, 1993, Stat Methods Med Res, V2, P263, DOI 10.1177/096228029300200305; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Terwilliger J., 1994, HDB HUMAN GENETIC LI; THOMAS A, 1994, IMA J MATH APPL MED, V11, P1; Thompson E. A., 1994, American Journal of Human Genetics, V55, pA167; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WEEKS DE, 1995, HUM HERED, V45, P13, DOI 10.1159/000154250; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	33	2539	2605	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1347	1363						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651312				2022-12-18	WOS:A1996UM27100028
J	Antoniou, A; Pharoah, PDP; Narod, S; Risch, HA; Eyfjord, JE; Hopper, JL; Loman, N; Olsson, H; Johannsson, O; Borg, A; Pasini, B; Radice, P; Manoukian, S; Eccles, DM; Tang, N; Olah, E; Anton-Culver, H; Warner, E; Lubinski, J; Gronwald, J; Gorski, B; Tulinius, H; Thorlacius, S; Eerola, H; Nevanlinna, H; Syrjakoski, K; Kallioniemi, OP; Thompson, D; Evans, C; Peto, J; Lalloo, F; Evans, DG; Easton, DF				Antoniou, A; Pharoah, PDP; Narod, S; Risch, HA; Eyfjord, JE; Hopper, JL; Loman, N; Olsson, H; Johannsson, O; Borg, A; Pasini, B; Radice, P; Manoukian, S; Eccles, DM; Tang, N; Olah, E; Anton-Culver, H; Warner, E; Lubinski, J; Gronwald, J; Gorski, B; Tulinius, H; Thorlacius, S; Eerola, H; Nevanlinna, H; Syrjakoski, K; Kallioniemi, OP; Thompson, D; Evans, C; Peto, J; Lalloo, F; Evans, DG; Easton, DF			Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWISH WOMEN; GERMLINE MUTATIONS; GENE-MUTATIONS; POPULATION; CARRIERS; PREVALENCE; PENETRANCE; GENOTYPE; POSITION; REPEAT	Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context. Estimates based on multiple-case families may be enriched for mutations of higher risk and/or other familial risk factors, whereas risk estimates from studies based on cases unselected for family history have been imprecise. We pooled pedigree data from 22 studies involving 8,139 index case patients unselected for family history with female (86%) or male (2%) breast cancer or epithelial ovarian cancer (12%), 500 of whom had been found to carry a germline mutation in BRCA1 or BRCA2. Breast and ovarian cancer incidence rates for mutation carriers were estimated using a modified segregation analysis, based on the occurrence of these cancers in the relatives of mutation-carrying index case patients. The average cumulative risks in BRCA1-mutation carriers by age 70 years were 65% (95% confidence interval 44%-78%) for breast cancer and 39% (18%-54%) for ovarian cancer. The corresponding estimates for BRCA2 were 45% (31%-56%) and 11% (2.4%-19%). Relative risks of breast cancer declined significantly with age for BRCA1-mutation carriers ( P trend .0012) but not for BRCA2-mutation carriers. Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age. We found some evidence for a reduction in risk in women from earlier birth cohorts and for variation in risk by mutation position for both genes. The pattern of cancer risks was similar to those found in multiple-case families, but their absolute magnitudes were lower, particularly for BRCA2. The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers.	Univ Cambridge, Canc Res UK Human Canc Genet Grp, Dept Oncol, Strangeways Res Labs, Cambridge CB1 8RN, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Dept Publ Hlth, Cambridge CB1 8RN, England; Univ Toronto, Ctr Res Womens Hlth, Toronto, ON, Canada; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Iceland Canc Soc, Reykjavik, Iceland; Univ Iceland, Reykjavik, Iceland; Univ Melbourne, Ctr Genet Epidemiol, Dept Publ Hlth, Melbourne, Vic, Australia; Univ Lund Hosp, Dept Oncol, Jubileum Inst, S-22185 Lund, Sweden; Natl Canc Inst, I-20133 Milan, Italy; FIRC Inst Mol Oncol, Milan, Italy; Princess Anne Hosp, Western Clin Genet Serv, Southampton, Hants, England; Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; Natl Inst Oncol, Budapest, Hungary; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA; Pomeranian Acad Med, Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; Tampere Univ, Canc Genet Lab, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; London Sch Hyg & Trop Med, London WC1, England; St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England	Cancer Research UK; University of Cambridge; Cancer Research UK; University of Cambridge; University of Toronto; Yale University; University of Iceland; University of Melbourne; Lund University; Skane University Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Chinese University of Hong Kong; National Institute of Oncology Hungary; University of California System; University of California Irvine; Pomeranian Medical University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Manchester; University of Manchester	Pharoah, PDP (corresponding author), Univ Cambridge, Canc Res UK Human Canc Genet Grp, Dept Oncol, Strangeways Res Labs, Worts Causeway, Cambridge CB1 8RN, England.		Gronwald, Jacek/A-4576-2017; Eccles, Diana/K-6327-2019; Pasini, Barbara/AHI-2004-2022; manoukian, siranoush/E-7132-2017; Tang, Nelson L/P-5018-2017; Kallioniemi, Olli P/H-5111-2011; Radice, Paolo/O-3119-2013; Narod, Steven A/AAA-6112-2022; Kleibl, Zdenek/A-2009-2008; Pharoah, Paul/V-6658-2019; Evans, D Gareth/AAB-4308-2022	Gronwald, Jacek/0000-0002-3643-2871; Eccles, Diana/0000-0002-9935-3169; Pasini, Barbara/0000-0002-4373-1212; manoukian, siranoush/0000-0002-6034-7562; Tang, Nelson L/0000-0002-3607-5819; Kallioniemi, Olli P/0000-0002-3231-0332; Radice, Paolo/0000-0001-6298-4111; Kleibl, Zdenek/0000-0003-2050-9667; Pharoah, Paul/0000-0001-8494-732X; Evans, D Gareth/0000-0002-8482-5784; Olsson, Hakan/0000-0002-8794-9635; Acquah, Ronald/0000-0002-5375-6106; Nevanlinna, Heli/0000-0002-0916-2976	NCI NIH HHS [R01 CA063682, 1R01 CA81203, R01 CA63682] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081203, R01CA063682] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anton-Culver H, 2000, EUR J CANCER, V36, P1200, DOI 10.1016/S0959-8049(00)00110-6; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; BASHAM VM, 2002, BREAST CANC RES, V4; Begg CB, 2002, J NATL CANCER I, V94, P1221; Claus EB, 1998, J NATL CANCER I, V90, P1824, DOI 10.1093/jnci/90.23.1824; Clerget-Darpoux F, 2001, ADV GENET, V42, P115, DOI 10.1016/S0065-2660(01)42018-9; De Benedetti V M, 1998, Hum Mutat, V12, P215; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; ECCLES D, 1994, J MED GENET, V31, P944, DOI 10.1136/jmg.31.12.944; Eccles DM, 1998, BRIT J CANCER, V77, P2199, DOI 10.1038/bjc.1998.366; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levy-Lahad E, 2001, P NATL ACAD SCI USA, V98, P3232, DOI 10.1073/pnas.051624098; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; MUIR C, 1987, CANC INCIDENCE 5 CON, V5; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; Parkin DM, 1992, CANC INCIDENCE 5 CON, VVI; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Phelan CM, 1996, NAT GENET, V12, P309, DOI 10.1038/ng0396-309; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rebbeck TR, 1999, AM J HUM GENET, V64, P1371, DOI 10.1086/302366; Rebbeck TR, 2001, CANCER RES, V61, P5420; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Runnebaum IB, 2001, PHARMACOGENETICS, V11, P635, DOI 10.1097/00008571-200110000-00010; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tang NLS, 1999, J NATL CANCER I, V91, P882, DOI 10.1093/jnci/91.10.882; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thompson D, 2002, CANCER EPIDEM BIOMAR, V11, P329; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Van der Looij M, 2000, INT J CANCER, V86, P737, DOI 10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; Waterhouse JAH, 1982, CANC INCIDENCE 5 CON, VIV; Waterhouse JAH, 1976, CANC INCIDENCE 5 CON, VIII; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	48	2478	2539	3	206	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1117	1130		10.1086/375033	http://dx.doi.org/10.1086/375033			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12677558	Bronze, Green Published			2022-12-18	WOS:000182474400005
J	CAVALLISFORZA, LL; EDWARDS, AWF				CAVALLISFORZA, LL; EDWARDS, AWF			PHYLOGENETIC ANALYSIS MODELS AND ESTIMATION PROCEDURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																		CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; CAVALLI-SFORZA L. L., 1960, ATTI ASS GENET ITAL, V5, P333; CAVALLIS.LL, 1964, COLD SPRING HARB SYM, V29, P9, DOI 10.1101/SQB.1964.029.01.006; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1964, 11 P INT C GEN HAG, V3, P923; CAVALLISFORZA LL, IN PRESS; Cayley A., 1857, PHILOS MAG, V13, P172, DOI [10.1080/14786445708642275, DOI 10.1080/14786445708642275]; CAYLEY A, 1859, PHILOS MAG, V18, P374; CHOWN B, 1959, AM J PHYS ANTHROPOL, V17, P13, DOI 10.1002/ajpa.1330170103; COURANT R, 1961, WHAT MATHEMATICS; Edwards A. W. F., 1964, PHENETIC PHYLOGENETI, P67; EDWARDS AJ, IN PRESS; EDWARDS AWF, 1964, BIOMETRICS, V20, P383; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; Edwards AWF, 1963, 5 INT BIOM C; EDWARDS AWF, HEREDITY, V18, P553; FISHER RA, 1958, STATISTICAL METHODS; Harding E., IN PRESS; KENDALL MG, 1961, ADV THEORY STAT, V2, pCH19; KIMURA M, 1955, EVOLUTION, V9, P419, DOI 10.2307/2405476; KIMURA M, 1954, GENETICS, V39, P280; LEWIS M, 1957, AM J HUM GENET, V9, P274; Polya G, 1937, ACTA MATH-DJURSHOLM, V68, P145, DOI 10.1007/BF02546665; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; RACE RR, 1959, BLOOD GROUPS MAN; Rao C.R., 1952, ADV STAT METHODS BIO; SIMPSON GG, 1965, SCIENCE, V148, P1078, DOI 10.1126/science.148.3673.1078; Sokal R, 1963, PRINCIPLES NUMERICAL; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WON CD, 1960, AM J PHYS ANTHROPOL, V18, P115, DOI 10.1002/ajpa.1330180208; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21; Zoutendyk A, 1955, AM J PHYS ANTHROP-NE, V13, P691, DOI 10.1002/ajpa.1330130410; ZUCKERKANDL E, 1965, SCI AM, V212, P110, DOI 10.1038/scientificamerican0565-110; [No title captured]	34	2471	2535	1	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P1					233	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96073	6026583				2022-12-18	WOS:A19679607300004
J	Ford, D; Easton, DF; Stratton, M; Narod, S; Goldgar, D; Devilee, P; Bishop, DT; Weber, B; Lenoir, G; Chang-Claude, J; Sobol, H; Teare, MD; Struewing, J; Arason, A; Scherneck, S; Peto, J; Rebbeck, TR; Tonin, P; Neuhausen, S; Barkardottir, R; Eyfjord, J; Lynch, H; Ponder, BAJ; Gayther, SA; Birch, JM; Lindblom, A; Stoppa-Lyonnet, D; Bignon, Y; Borg, A; Hamann, U; Haites, N; Scott, RJ; Maugard, CM; Vasen, H				Ford, D; Easton, DF; Stratton, M; Narod, S; Goldgar, D; Devilee, P; Bishop, DT; Weber, B; Lenoir, G; Chang-Claude, J; Sobol, H; Teare, MD; Struewing, J; Arason, A; Scherneck, S; Peto, J; Rebbeck, TR; Tonin, P; Neuhausen, S; Barkardottir, R; Eyfjord, J; Lynch, H; Ponder, BAJ; Gayther, SA; Birch, JM; Lindblom, A; Stoppa-Lyonnet, D; Bignon, Y; Borg, A; Hamann, U; Haites, N; Scott, RJ; Maugard, CM; Vasen, H		Breast Cancer Linkage Consortium	Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; RAPID DETECTION; MUTATIONS; CHROMOSOME-17Q21; CARRIERS	The contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage and mutation analysis in 237 families, each with at least four cases of breast cancer, collected by the Breast Cancer Linkage Consortium. Families were included without regard to the occurrence of ovarian or other cancers, Overall, disease was linked to BRCA1 in an estimated 52% of families, to BRCA2 in 32% of families, and to neither gene in 16% (95% confidence interval [CI] 6%-28%), suggesting other predisposition genes, The majority (81%) of the breast-ovarian cancer families were due to BRCA1, with most others (14%) due To BRCA2. Conversely, the majority of families with male and female breast cancer were due to BRCA2 (76%). The largest proportion (67%) of families due to other genes tvas found in families with four or five cases of female breast cancer only, These estimates were not substantially affected either by changing the assumed penetrance model for BRCA1 or by including or excluding BRCA1 mutation data. Among those families with disease due to BRCA1 that were tested by one of the standard screening methods, mutations were detected in the coding sequence or splice sites in an estimated 63% (95% CI 51%-77%). The estimated sensitivity was identical for direct sequencing and other techniques. The penetrance of BRCA2 was estimated bg maximizing the LOD score in BRCA2-mutation families, over all possible penetrance functions, The estimated cumulative risk of breast cancer reached 28% (95% CI 9%-44%) by age 50 years and 84% (95% CI 43%-95%) by age 70 pears. The corresponding ovarian cancer risks were 0.4% (95% CI 0%-1%) by age 50 years and 27% (95% CI 0%-47%) by age 70 years, The lifetime risk of breast cancer appears similar to the risk in BRCA1 carriers, but there was some suggestion of a lower risk in BRCA2 carriers <50 years of age.	Inst Publ Hlth, CRC, Genet Epidemiol Unit, Strangeways Res Labs, Cambridge CB1 4RN, England; Canc Res Inst, Epidemiol Sect, Sutton, Surrey, England; Canc Res Inst, Sect Mol Carcinogenesis, Sutton, Surrey, England; Univ Cambridge, CRC, Human Canc Genet Res Grp, Cambridge CB2 1TN, England; Ctr Res Womens Hlth, Toronto, ON, Canada; Int Agcy Res Canc, F-69372 Lyon, France; Leiden Univ, Dept Pathol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Imperial Canc Res Fund, Genet Epidemiol Lab, Leeds, W Yorkshire, England; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; Inst J Paoli I Calmettes, Dept Oncol Genet, INSERM CRI9703, F-13009 Marseille, France; NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA; Univ Hosp, Cell Biol Lab, Reykjavik, Iceland; Iceland Canc Soc, Reykjavik, Iceland; Max Delbruck Ctr Mol Med, Berlin, Germany; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Univ Utah, Genet Epidemiol Grp, Salt Lake City, UT 84112 USA; Creighton Univ, Sch Med, Dept Preventat Med & Publ Hlth, Omaha, NE USA; Christie Hosp & Holt Radium Inst, CRC, Paediat & Familial Canc Res Grp, Manchester M20 9BX, Lancs, England; Karolinska Inst, Dept Clin Genet, Stockholm, Sweden; Inst Curie, Unite Genet Oncol, Paris, France; Ctr Jean Perrin, Mol Oncol Lab, Clermont Ferrand, France; Univ Hosp, Dept Oncol, Lund, Sweden; Univ Aberdeen, Aberdeen AB9 1FX, Scotland; Kantonsspital, CH-4031 Basel, Switzerland; Ctr Rene Gauducheau, F-44035 Nantes, France; Fdn Detect Hereditary Tumors, Leiden, Netherlands	University of Cambridge; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Pennsylvania; University of Pennsylvania; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Landspitali National University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; McGill University; McGill University; Utah System of Higher Education; University of Utah; Creighton University; Christie NHS Foundation Trust; Christie Hospital; Karolinska Institutet; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Jean Perrin; Lund University; Skane University Hospital; University of Aberdeen; Kantonsspital Aarau AG (KSA); University of Basel; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Easton, DF (corresponding author), Inst Publ Hlth, CRC, Genet Epidemiol Unit, Strangeways Res Labs, Worts Causeway, Cambridge CB1 4RN, England.		, bignon/Y-3243-2019; DEVILEE, PETER/ABR-2140-2022; Narod, Steven A/AAA-6112-2022; Struewing, Jeffery P/C-3221-2008; Struewing, Jeffery P/I-7502-2013; Rebbeck, Timothy/GLU-8348-2022; Scott, Rodney J/B-2827-2013	Struewing, Jeffery P/0000-0002-4848-3334; Rebbeck, Timothy/0000-0002-4799-1900; Scott, Rodney J/0000-0001-7724-3404; albright, lisa/0000-0003-2602-3668; Bishop, Tim/0000-0002-8752-8785; Teare, Marion Dawn/0000-0003-3994-0051	NATIONAL CANCER INSTITUTE [R01CA055914] Funding Source: NIH RePORTER; NCI NIH HHS [CA55914] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1993, AM J HUM GENET, V53, P787; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELSTON RC, 1995, AM J HUM GENET, V56, P15; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hakansson S, 1997, AM J HUM GENET, V60, P1068; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; KERANGUEVEN F, 1995, ONCOGENE, V10, P1023; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD S, 1995, AM J HUM GENET, V57, P957; NAROD SA, 1995, AM J HUM GENET, V56, P254; Peelen T, 1997, AM J HUM GENET, V60, P1041; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Schubert EK, 1997, AM J HUM GENET, V60, P1031; Seitz S, 1997, ONCOGENE, V14, P741, DOI 10.1038/sj.onc.1200881; Serova OM, 1997, AM J HUM GENET, V60, P486; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; WEBER JM, 1990, NUCLEIC ACIDS RES, V128, P464; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	39	2207	2251	1	193	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					676	689		10.1086/301749	http://dx.doi.org/10.1086/301749			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497246	Bronze, Green Published			2022-12-18	WOS:000072894400022
J	NEEL, JV				NEEL, JV			DIABETES MELLITUS - A THRIFTY GENOTYPE RENDERED DETRIMENTAL BY PROGRESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allan W, 1933, ANN INTERN MED, V6, P1272, DOI 10.7326/0003-4819-6-10-1272; Allen E, 1939, AM J OBSTET GYNECOL, V38, P982, DOI 10.1016/S0002-9378(39)90641-1; ALLISON A. C., 1957, EXPTL PARASITOL, V6, P418, DOI 10.1016/0014-4894(57)90032-2; ALLISON AC, 1955, S QUANT BIOL, V20, P239; ANTONIADES HN, 1958, METABOLISM, V7, P266; ANTONIADES HN, 1960, P SOC EXP BIOL MED, V103, P677; ANTONIADES HN, 1958, SCIENCE, V127, P593, DOI 10.1126/science.127.3298.593; ARDUINO F., 1958, ARQ BRASIL ENDOCRINOL, V7, P77; ASCHNER BM, 1957, ACTA GENET BASEL, V6, P362; BAIRD CW, 1957, LANCET, V1, P1111; BAIRD JD, 1962, LANCET, V1, P71; Bix H, 1933, MED KLIN, V29, P50; BORNSTEIN J, 1951, BRIT MED J, V2, P1541, DOI 10.1136/bmj.2.4747.1541; Bowcock HM, 1928, J AMER MED ASSOC, V90, P502, DOI 10.1001/jama.1928.02690340004002; BROSSET A, 1950, NORD MED, V44, P1710; CONN JW, 1961, AM J MED, V31, P839, DOI 10.1016/0002-9343(61)90023-7; FAJANS SS, 1961, DIABETES, V10, P63, DOI 10.2337/diab.10.1.63; FAJANS SS, 1961, METABOLISM, V10, P951; FAJANS SS, 1954, DIABETES, V3, P296, DOI 10.2337/diab.3.4.296; FAJANS SS, 1961, 4 C FED INT DIAB, V1, P167; GILBERT JAL, 1949, BRIT MED J, V1, P702, DOI 10.1136/bmj.1.4607.702; GONCE J E Jr, 1949, Nebr State Med J, V34, P12; GUNDERSEN K, 1960, P SOC EXP BIOL MED, V104, P411; HARRIS H, 1950, ANN EUGENIC, V15, P95; HSIA DYY, 1957, ANN HUM GENET, V22, P80, DOI 10.1111/j.1469-1809.1957.tb01303.x; JACKSON WPU, 1952, BMJ-BRIT MED J, V2, P690, DOI 10.1136/bmj.2.4786.690; KRISS JP, 1948, J CLIN ENDOCRINOL, V8, P380, DOI 10.1210/jcem-8-5-380; LAMY M, 1957, EXTR REV FRANC ETUDE, V2, P907; LAZAROW A, 1960, DIABETES, V9, P114, DOI 10.2337/diab.9.2.114; LOWY C, 1961, LANCET, V1, P802; MILLER HC, 1945, NEW ENGL J MED, V233, P376, DOI 10.1056/NEJM194509272331302; MILLER HC, 1947, ENDOCRINOLOGY, V40, P251, DOI 10.1210/endo-40-4-251; MILLER HC, 1956, ADV PEDIATR, V7, P137; MOSS JM, 1951, ANN INTERN MED, V34, P678, DOI 10.7326/0003-4819-34-3-678; NILSSON SE, 1962, ACTA MED SCAND  S375, P96; Pincus G, 1933, AM J MED SCI, V186, P1; Pincus G, 1934, AM J MED SCI, V188, P159, DOI 10.1097/00000441-193408000-00002; PIRART J, 1955, ACTA ENDOCRINOL-COP, V20, P192, DOI 10.1530/acta.0.0200192; POST RH, 1962, DIABETES, V11, P287; POST RH, 1962, DIABETES, V11, P56; POST RH, 1958, DIABETES, V7, P27, DOI 10.2337/diab.7.1.27; PYKE DA, 1961, 4 C INT DIAB FED, V1, P276; Rucknagel D. L., 1961, PROGR MED GENETICS, P158; SELTZER H S, 1959, Diabetes, V8, P417; SELTZER HS, 1956, DIABETES, V5, P437, DOI 10.2337/diab.5.6.437; SHELDON JH, 1949, LANCET, V2, P869; SIEGELER K, 1960, MED WELT, V51, P2693; STEINBERG AG, 1952, AM J HUM GENET, V4, P113; STEINBERG AG, 1959, ANN NY ACAD SCI, V82, P197, DOI 10.1111/j.1749-6632.1959.tb44900.x; STEINKE J, 1961, LANCET, V1, P30; STEINKE J, 1961, METABOLISM, V10, P707; VALLANCEOWEN J, 1961, LANCET, V1, P804; VALLANCEOWEN J, 1955, LANCET, V2, P583; VALLANCEOWEN J, 1961, LANCET, V1, P806; VALLANCEOWEN J, 1958, LANCET, V2, P336; Wagner R, 1942, AM J DIS CHILD, V63, P667; White P, 1939, ARCH INTERN MED, V63, P39, DOI 10.1001/archinte.1939.00180180049003; WHITE P, 1960, DIABETES, V9, P345, DOI 10.2337/diab.9.5.345; WRIGHT PH, 1957, LANCET, V2, P621; YALOW RS, 1961, DIABETES, V10, P339, DOI 10.2337/diab.10.5.339; YALOW RS, 1960, DIABETES, V9, P254, DOI 10.2337/diab.9.4.254	61	2165	2232	1	119	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					353	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13937884				2022-12-18	WOS:A19622965A00006
J	Browning, SR; Browning, BL				Browning, Sharon R.; Browning, Brian L.			Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE DATA; RECONSTRUCTION; ALGORITHM; RESOLUTION; EFFICIENT	Whole-genome association studies present many new statistical and computational challenges due to the large quantity of data obtained. One of these challenges is haplotype inference; methods for haplotype inference designed for small data sets from candidate-gene studies do not scale well to the large number of individuals genotyped in whole-genome association studies. We present a new method and software for inference of haplotype phase and missing data that can accurately phase data from whole-genome association studies, and we present the first comparison of haplotype-inference methods for real and simulated data sets with thousands of genotyped individuals. We find that our method outperforms existing methods in terms of both speed and accuracy for large data sets with thousands of individuals and densely spaced genetic markers, and we use our method to phase a real data set of 3,002 individuals genotyped for 490,032 markers in 3.1 days of computing time, with 99% of masked alleles imputed correctly. Our method is implemented in the Beagle software package, which is freely available.	Univ Auckland, Dept Stat, Auckland 1, New Zealand; Univ Auckland, Discipline Nutr, Auckland 1, New Zealand	University of Auckland; University of Auckland	Browning, SR (corresponding author), Univ Auckland, Dept Stat, Private Bag 92019, Auckland 1, New Zealand.	s.browning@auckland.ac.nz	Browning, Brian L/A-1178-2010; Browning, Sharon/B-1530-2008	Browning, Brian L/0000-0001-6454-6633; Browning, Sharon/0000-0001-7251-9715	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM075091, 3R01GM075091-02S1] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Brinza D, 2006, BIOINFORMATICS, V22, P371, DOI 10.1093/bioinformatics/bti785; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Celeux G., 1986, COMPUT STAT Q, V2, P73; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier Laurent, 2003, Human Genomics, V1, P7; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lin DY, 2007, AM J HUM GENET, V80, P577, DOI 10.1086/512201; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; LONG JC, 1995, AM J HUM GENET, V56, P799; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ron D, 1998, J COMPUT SYST SCI, V56, P133, DOI 10.1006/jcss.1997.1555; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; THOMPSON EA, 2000, STAT INFERENCE GENET, V6; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x	32	1934	1994	5	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1084	1097		10.1086/521987	http://dx.doi.org/10.1086/521987			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924348	Green Published, Bronze			2022-12-18	WOS:000250480900018
J	O'Connell, JR; Weeks, DE				O'Connell, JR; Weeks, DE			PedCheck: A program for identification of genotype incompatibilities in linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORES; ELIMINATION; ALGORITHM; ERROR	Prior to performance of linkage analysis, elimination of all Mendelian inconsistencies in the pedigree data is essential. Often, identification of erroneous genotypes by visual inspection can be very difficult and time consuming. In fact, sometimes the errors are not recognized until the stage of running linkage-analysis software. The effort then required to find the erroneous genotypes and to cross-reference pedigree and marker data that may have been recoded and renumbered can be not only tedious but also quite daunting, in the case of very large pedigrees. We have implemented four error-checking algorithms in a new computer program, PedCheck, which will assist researchers in identifying all Mendelian inconsistencies in pedigree data and will provide them with useful and detailed diagnostic information to help resolve the errors. Our program, which uses many of the algorithms implemented in VITESSE, handles large data sets quickly and efficiently, accepts a variety of input formats, and offers various error-checking algorithms that match the subtlety of the pedigree error. These algorithms range from simple parent-offspring-compatibility checks to a single-locus likelihood-based statistic that identifies and ranks the individuals most likely to be in error. We use various real data sets to illustrate the power and effectiveness of our program.	Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics	O'Connell, JR (corresponding author), Univ Pittsburgh, Dept Human Genet, 130 DeSoto St, Pittsburgh, PA 15261 USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000932] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00932] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; *CAS W RES U DEP E, 1994, STAT AN GEN EP SAGE; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; Ehm MG, 1996, AM J HUM GENET, V58, P225; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LANGE K, 1987, AM J HUM GENET, V40, P250; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LATHROP GM, 1983, HUM HERED, V33, P377; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; SOBEL E, 1995, GENETIC MAPPING DNA, P1; Stivers D. N., 1996, American Journal of Human Genetics, V59, pA190; Stringham HM, 1996, AM J HUM GENET, V59, P946	18	1803	1827	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					259	266		10.1086/301904	http://dx.doi.org/10.1086/301904			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634505	Green Published, Bronze			2022-12-18	WOS:000074761000034
J	Miller, DT; Adam, MP; Aradhya, S; Biesecker, LG; Brothman, AR; Carter, NP; Church, DM; Crolla, JA; Eichler, EE; Epstein, CJ; Faucett, WA; Feuk, L; Friedman, JM; Hamosh, A; Jackson, L; Kaminsky, EB; Kok, K; Krantz, ID; Kuhn, RM; Lee, C; Ostell, JM; Rosenberg, C; Scherer, SW; Spinner, NB; Stavropoulos, DJ; Tepperberg, JH; Thorland, EC; Vermeesch, JR; Waggoner, DJ; Watson, MS; Martin, CL; Ledbetter, DH				Miller, David T.; Adam, Margaret P.; Aradhya, Swaroop; Biesecker, Leslie G.; Brothman, Arthur R.; Carter, Nigel P.; Church, Deanna M.; Crolla, John A.; Eichler, Evan E.; Epstein, Charles J.; Faucett, W. Andrew; Feuk, Lars; Friedman, Jan M.; Hamosh, Ada; Jackson, Laird; Kaminsky, Erin B.; Kok, Klaas; Krantz, Ian D.; Kuhn, Robert M.; Lee, Charles; Ostell, James M.; Rosenberg, Carla; Scherer, Stephen W.; Spinner, Nancy B.; Stavropoulos, Dimitri J.; Tepperberg, James H.; Thorland, Erik C.; Vermeesch, Joris R.; Waggoner, Darrel J.; Watson, Michael S.; Martin, Christa Lese; Ledbetter, David H.			Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER VARIATIONS; IDIOPATHIC MENTAL-RETARDATION; ARRAY-BASED TECHNOLOGY; LOW-LEVEL MOSAICISM; MICRODELETION SYNDROME; STRUCTURAL VARIATION; CYTOGENETIC SURVEY; RECURRENT MICRODELETIONS; MARKER CHROMOSOMES	Chromosomal microarray (CMA) is increasingly utilized for genetic testing of individuals with unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders (ASD), or multiple congenital anomalies (MCA). Performing CMA and G-banded karyotyping on every patient substantially increases the total cost of genetic testing. The International Standard Cytogenomic Array (ISCA) Consortium held two international workshops and conducted a literature review of 33 studies, including 21,698 patients tested by CMA. We provide an evidence-based summary of clinical cytogenetic testing comparing CMA to G-banded karyotyping with respect to technical advantages and limitations, diagnostic yield for various types of chromosomal aberrations, and issues that affect test interpretation. CMA offers a much higher diagnostic yield (15%-20%) for genetic testing of individuals with unexplained DD/ID, ASD, or MCA than a G-banded karyotype (similar to 3%, excluding Down syndrome and other recognizable chromosomal syndromes), primarily because of its higher sensitivity for submicroscopic deletions and duplications. Truly balanced rearrangements and low-level mosaicism are generally not detectable by arrays, but these are relatively infrequent causes of abnormal phenotypes in this population (<1%). Available evidence strongly supports the use of CMA in place of G-banded karyotyping as the first-tier cytogenetic diagnostic test for patients with DD/ID, ASD, or MCA. G-banded karyotype analysis should be reserved for patients with obvious chromosomal syndromes (e.g., Down syndrome), a family history of chromosomal rearrangement, or a history of multiple miscarriages.	[Miller, David T.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Miller, David T.] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Miller, David T.] Harvard Univ, Sch Med, Boston, MA USA; [Adam, Margaret P.; Faucett, W. Andrew; Kaminsky, Erin B.; Martin, Christa Lese; Ledbetter, David H.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Adam, Margaret P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Aradhya, Swaroop] GeneDx, Gaithersburg, MD USA; [Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pediat, Human Genet Lab, Salt Lake City, UT USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pediat, Pathol Lab, Salt Lake City, UT USA; [Brothman, Arthur R.] Univ Utah, Sch Med, Dept Pediat, ARUP Lab, Salt Lake City, UT USA; [Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge, England; [Church, Deanna M.; Ostell, James M.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Crolla, John A.] Natl Genet Reference Lab Wessex, Salisbury, Wilts, England; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Sch Med, Seattle, WA 98195 USA; [Epstein, Charles J.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Epstein, Charles J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Feuk, Lars] Uppsala Univ, Rudbeck Lab, Uppsala, Sweden; [Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Friedman, Jan M.] Child & Family Res Inst, Vancouver, BC, Canada; [Hamosh, Ada] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Hamosh, Ada] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Jackson, Laird] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Kok, Klaas] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Krantz, Ian D.; Spinner, Nancy B.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat Human Genet, Philadelphia, PA 19104 USA; [Kuhn, Robert M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Lee, Charles] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rosenberg, Carla] Univ Sao Paulo, Dept Genet & Evolutionary Biol, BR-05508 Sao Paulo, Brazil; [Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Program Genet & Genet Biol, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Stavropoulos, Dimitri J.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Tepperberg, James H.] Lab Corp Amer, Res Triangle Pk, NC USA; [Thorland, Erik C.] Mayo Clin, Rochester, MN USA; [Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Waggoner, Darrel J.] Univ Chicago, Dept Human Genet & Pediat, Chicago, IL 60637 USA; [Watson, Michael S.] Amer Coll Med Genet, Bethesda, MI USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Emory University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Uppsala University; University of British Columbia; Child & Family Research Institute; Johns Hopkins University; Johns Hopkins University; Drexel University; University of Groningen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California Santa Cruz; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade de Sao Paulo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Mayo Clinic; KU Leuven; University of Chicago	Miller, DT (corresponding author), Childrens Hosp, Div Genet, 300 Longwood Ave, Boston, MA 02115 USA.	david.miller2@childrens.harvard.edu; david.ledbetter@emory.edu	rosenberg, carla/N-4148-2015; Cetgen, Inct/I-2412-2013; Scherer, Stephen W./B-3785-2013	rosenberg, carla/0000-0003-3253-4448; Scherer, Stephen W./0000-0002-8326-1999; Friedman, Jan/0000-0002-7482-9570; Vermeesch, Joris/0000-0002-3071-1191; ARADHYA, SWAROOP/0000-0001-6219-2931	National Institutes of Health [RC2FID064525, MH074090]; Simons Foundation [137578]; ACMG Foundation; Luminex; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC2HD064525] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; ACMG Foundation; Luminex; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Workshops and conference calls related to the ISCA Consortium were funded through a grant from the ACMG Foundation and Luminex to D.H.L. and C.L.M., and ongoing standards and database development are funded in part by grants from the National Institutes of Health (RC2FID064525 and MH074090 to D.H.L. and C.L.M.). This work was also supported by Simons Foundation grant 137578 (to FEE.). E.E.E. is an investigator of the Howard Hughes Medical Institute. The opinions expressed here are those of the authors and the ISCA Consortium and do not necessarily reflect the views of the institutions to which the authors are affiliated, the ACMG, or the American Society of Human Genetics (ASHG). The authors would like to thank Dr. Omer Gokcumen for his assistance with summary of population CNV data. Regarding conflict of interest, the majority of authors are involved in CMA testing and/or cytogenetic testing, either as clinicians who order the testing, laboratory professionals who perform the testing, or researchers in the genomics field. S.A. is a director of clinical cytogenetics at GeneDx, a subsidiary of BioReference Laboratories; A.R.B. is a director of clinical cytogenetics and molecular cytogenetics at ARUP Laboratories; E.E.E. is a member of the Pacific Biosciences Scientific Advisory Board. S.W.S. is on the Scientific Advisory Board of Combimatrix Diagnostics and the Scientific Advisory Committee of Autism Speaks. J.T. is a director of clinical cytogenetics at Laboratory Corporation of America. J.V. is on the board of directors of Cartagenia. M.W. raises funds from industry to support the educational activities of the ACMG Foundation.	[Anonymous], 2009, Obstet Gynecol, V114, P1161, DOI 10.1097/AOG.0b013e3181c33cad; Aradhya S, 2007, GENET MED, V9, P553, DOI 10.1097/GIM.0b013e318149e354; Aradhya S, 2007, AM J MED GENET A, V143A, P1431, DOI 10.1002/ajmg.a.31773; Aston E, 2008, J MED GENET, V45, P268, DOI 10.1136/jmg.2007.055319; Baldwin EL, 2008, GENET MED, V10, P415, DOI 10.1097/GIM.0b013e318177015c; Ballif BC, 2007, AM J MED GENET A, V143A, P1850, DOI 10.1002/ajmg.a.31842; Ballif BC, 2007, GENET MED, V9, P150, DOI 10.1097/GIM.0b013e3180312087; Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Baptista J, 2005, EUR J HUM GENET, V13, P1205, DOI 10.1038/sj.ejhg.5201488; Baptista J, 2008, AM J HUM GENET, V82, P927, DOI 10.1016/j.ajhg.2008.02.012; Baris HN, 2007, AM J MED GENET A, V143A, P2523, DOI 10.1002/ajmg.a.31988; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Curry CJ, 2008, AM J MED GENET A, V146A, P1903, DOI 10.1002/ajmg.a.32450; De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Derbent M, 2006, AM J MED GENET A, V140A, P659, DOI 10.1002/ajmg.a.31120; Engels H, 2007, NEUROLOGY, V68, P743, DOI 10.1212/01.wnl.0000256367.70365.e0; FAED MJW, 1979, CLIN GENET, V16, P191; Fan YS, 2007, HUM MUTAT, V28, P1124, DOI 10.1002/humu.20581; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; Grati FR, 2009, AM J MED GENET A, V149A, P906, DOI 10.1002/ajmg.a.32754; Green NS, 2007, GENET MED, V9, P792, DOI 10.1097/GIM.0b013e318159a38e; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; Hochstenbach R, 2006, EUR J HUM GENET, V14, P262, DOI 10.1038/sj.ejhg.5201553; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; HOOK EB, 1977, AM J HUM GENET, V29, P94; Hoyer J, 2007, J MED GENET, V44, P629, DOI 10.1136/jmg.2007.050914; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; JACOBS PA, 1978, CLIN GENET, V13, P37; KONDO I, 1980, CLIN GENET, V17, P177; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Krepischi-Santos ACV, 2006, CYTOGENET GENOME RES, V115, P254, DOI 10.1159/000095922; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Manning M, 2007, GENET MED, V9, P650, DOI 10.1097/GIM.0b013e31814cec3a; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Ming JRE, 2006, HUM MUTAT, V27, P467, DOI 10.1002/humu.20322; Miyake N, 2006, AM J MED GENET A, V140A, P205, DOI 10.1002/ajmg.a.31098; Moeschler JB, 2006, PEDIATRICS, V117, P2304, DOI 10.1542/peds.2006-1006; *NAT NEWB SCREEN G, 2009, NAT NEWB SCREEN STAT; Newman WG, 2007, CLIN GENET, V71, P254, DOI 10.1111/j.1399-0004.2007.00756.x; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nowakowska B, 2008, AM J MED GENET A, V146A, P2361, DOI 10.1002/ajmg.a.32475; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pickering DL, 2008, GENET MED, V10, P262, DOI 10.1097/GIM.0b013e31816b64ad; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; Rodriguez-Revenga L, 2007, GENET MED, V9, P600, DOI 10.1097/GIM.0b013e318149e1e3; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Schoumans J, 2005, J MED GENET, V42, P699, DOI 10.1136/jmg.2004.029637; Scott SA, 2010, GENET MED, V12, P85, DOI 10.1097/GIM.0b013e3181cc75d0; Shaffer LG, 2009, ISCN INT SYSTEM HUMA; Shaffer LG, 2007, AM J MED GENET C, V145C, P335, DOI 10.1002/ajmg.c.30152; Shaffer LG, 2007, GENET MED, V9, P607, DOI 10.1097/GIM.0b013e3181484b49; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shafter LG, 2007, GENET MED, V9, P654, DOI 10.1097/GIM.0b013e31814ce3d9; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P2770, DOI 10.1093/hmg/ddm234; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shen YP, 2007, CLIN CHEM, V53, P2051, DOI 10.1373/clinchem.2007.090290; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Shevell MI, 2008, AM J MED GENET B, V147B, P1101, DOI 10.1002/ajmg.b.30730; Shevell M, 2008, PEDIATR CLIN N AM, V55, P1071, DOI 10.1016/j.pcl.2008.07.010; South ST, 2008, J MED GENET, V45, P391, DOI 10.1136/jmg.2008.057315; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; SUTHERLAND GR, 1976, HUM GENET, V34, P231, DOI 10.1007/BF00295286; Theisen A, 2009, AM J MED GENET A, V149A, P914, DOI 10.1002/ajmg.a.32767; Thuresson AC, 2007, CYTOGENET GENOME RES, V118, P1, DOI 10.1159/000106434; Tsuchiya KD, 2009, GENET MED, V11, P866, DOI 10.1097/GIM.0b013e3181c0c3b0; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; Vermeesch JR, 2007, EUR J HUM GENET, V15, P1105, DOI 10.1038/sj.ejhg.5201896; Vermeesch JR, 2006, EUR J HUM GENET, V14, P1063, DOI 10.1038/sj.ejhg.5201663; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vos J, 2009, GENET MED, V11, P742, DOI 10.1097/GIM.0b013e3181b2e608; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Wong A, 2005, GENET MED, V7, P264, DOI 10.1097/01.GIM.0000160076.14102.EC; Xiang BX, 2008, AM J MED GENET A, V146A, P1942, DOI 10.1002/ajmg.a.32411; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	107	1706	1865	2	135	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					749	764		10.1016/j.ajhg.2010.04.006	http://dx.doi.org/10.1016/j.ajhg.2010.04.006			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20466091	Green Published, hybrid			2022-12-18	WOS:000278045300011
J	LATHROP, GM; LALOUEL, JM				LATHROP, GM; LALOUEL, JM			EASY CALCULATIONS OF LOD SCORES AND GENETIC RISKS ON SMALL COMPUTERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									MUSEE LHOMME,ANTHROPOL LAB,PARIS,FRANCE	Museum National d'Histoire Naturelle (MNHN)	LATHROP, GM (corresponding author), UNIV PARIS 07,ANTHROPOBIOL LAB,F-75221 PARIS 05,FRANCE.							BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; COTTERMAN CW, 1953, AM J HUM GENET, V5, P193; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HASSTEDT SJ, 1979, 13 U UT DEP MED BIOP; KAPLAN EB, 1975, UNPUB GENPED GENERAL; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; MAYNARDSMITH S, 1961, MATH TABLES RES WORK; Morton N E, 1979, Birth Defects Orig Artic Ser, V15, P9; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1981, HUM HERED, V31, P3, DOI 10.1159/000153168; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; OTT J, 1974, AM J HUM GENET, V26, P588; SMITH CAB, 1953, J R STAT SOC B, V15, P153; VOGEL F, 1981, HUMAN GENETICS PROBL; [No title captured]	18	1553	1566	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					460	465						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	SM324	6585139				2022-12-18	WOS:A1984SM32400020
J	ALLEN, RC; ZOGHBI, HY; MOSELEY, AB; ROSENBLATT, HM; BELMONT, JW				ALLEN, RC; ZOGHBI, HY; MOSELEY, AB; ROSENBLATT, HM; BELMONT, JW			METHYLATION OF HPAII AND HHAI SITES NEAR THE POLYMORPHIC CAG REPEAT IN THE HUMAN ANDROGEN-RECEPTOR GENE CORRELATES WITH X-CHROMOSOME INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LINKED AGAMMAGLOBULINEMIA LOCUS; CARRIER DETECTION; DIFFERENTIAL METHYLATION; PHOSPHOGLYCERATE KINASE; CLONAL ANALYSIS; DNA; EXPRESSION; PATTERNS; DXS255	The human androgen-receptor gene (HUMARA; GenBank) contains a highly polymorphic trinucleotide repeat in the first exon. We have found that the methylation of HpaII and HhaI sites less than 100 bp away from this polymorphic short tandem repeat (STR) correlates with X inactivation. The close proximity of the restriction-enzyme sites to the STR allows the development of a PCR assay that distinguishes between the maternal and paternal alleles and identifies their methylation status. The accuracy of this assay was tested on (a) DNA from hamster/human hybrid cell lines containing either an active or inactive human X chromosome; (b) DNA from normal males and females; and (c) DNA from females showing nonrandom patterns of X inactivation. Data obtained using this assay correlated substantially with those obtained using the PGK, HPRT, and M27beta probes, which detect X inactivation patterns by Southern blot analysis. In order to demonstrate one application of this assay, we examined X inactivation patterns in the B lymphocytes of potential and obligate carriers of X-linked agammaglobulinemia.	BAYLOR COLL MED, INST MOLEC GENET, 1 BAYLOR PLAZA, T828, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	BELMONT, JW (corresponding author), BAYLOR COLL MED, INST MOLEC GENET, 1 BAYLOR PLAZA, T828, HOUSTON, TX 77030 USA.		Belmont, John/AAH-6084-2021; Belmont, John W/AAI-2494-2019	Belmont, John W/0000-0001-7409-3578; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD022880] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 24234, R29 HD22880] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RC, 1992, HUM MOL GENET, V1, P216, DOI 10.1093/hmg/1.3.216; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1990, AM J HUM GENET, V46, P273; BROWN RM, 1990, GENOMICS, V7, P215, DOI 10.1016/0888-7543(90)90543-4; BRUTON OC, 1952, PEDIATRICS, V9, P722; CONLEY ME, 1988, J PEDIATR-US, V112, P688, DOI 10.1016/S0022-3476(88)80683-8; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRASER NJ, 1987, NUCLEIC ACIDS RES, V15, P9616, DOI 10.1093/nar/15.22.9616; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GILLILAND DG, 1991, P NATL ACAD SCI USA, V88, P6848, DOI 10.1073/pnas.88.15.6848; GOMEZ MR, 1977, NEUROLOGY, V27, P537, DOI 10.1212/WNL.27.6.537; GOODSHIP J, 1988, LANCET, V1, P729; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; GREER WL, 1989, GENOMICS, V4, P60, DOI 10.1016/0888-7543(89)90315-7; HANSEN RS, 1988, MOL CELL BIOL, V8, P4692, DOI 10.1128/MCB.8.11.4692; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KUIPER GGJM, 1989, J MOL ENDOCRINOL, V2, pR1, DOI 10.1677/jme.0.002R001; KWAN SP, 1986, J CLIN INVEST, V77, P649, DOI 10.1172/JCI112351; KWAN SP, 1990, GENOMICS, V6, P238, DOI 10.1016/0888-7543(90)90562-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LYON MF, 1989, PROG NUCLEIC ACID RE, V36, P119; LYON MF, 1972, BIOL REV, V47, P1; MALCOLM S, 1987, HUM GENET, V77, P172, DOI 10.1007/BF00272387; Maniatis T., 1982, MOL CLONING; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MOSELEY AB, 1991, J IMMUNOL, V146, P826; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; ROSEN FS, 1984, NEW ENGL J MED, V311, P235, DOI 10.1056/NEJM198407263110406; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P687, DOI 10.1093/nar/18.3.687; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; TONIOLO D, 1988, EMBO J, V7, P401, DOI 10.1002/j.1460-2075.1988.tb02827.x; VOGELSTEIN B, 1985, SCIENCE, V227, P642, DOI 10.1126/science.2982210; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759	41	1550	1601	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1229	1239						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1281384				2022-12-18	WOS:A1992KC99500006
J	Schaid, DJ; Rowland, CM; Tines, DE; Jacobson, RM; Poland, GA				Schaid, DJ; Rowland, CM; Tines, DE; Jacobson, RM; Poland, GA			Score tests for association between traits and haplotypes when linkage phase is ambiguous	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREQUENCY ESTIMATION; DISEQUILIBRIUM; LIKELIHOOD; RECONSTRUCTION; INDIVIDUALS; ALGORITHM; ACCURACY; SEQUENCE; GENES; LOCI	A key step toward the discovery of a gene related to a trait is the finding of an association between the trait and one or more haplotypes. Haplotype analyses can also provide critical information regarding the function of a gene; however, when unrelated subjects are sampled, haplotypes are often ambiguous because of unknown linkage phase of the measured sites along a chromosome. A popular method of accounting for this ambiguity in case-control studies uses a likelihood that depends on haplotype frequencies, so that the haplotype frequencies can be compared between the cases and controls; however, this traditional method is limited to a binary trait (case vs. control), and it does not provide a method of testing the statistical significance of specific haplotypes. To address these limitations, we developed new methods of testing the statistical association between haplotypes and a wide variety of traits, including binary, ordinal, and quantitative traits. Our methods allow adjustment for nongenetic covariates, which may be critical when analyzing genetically complex traits. Furthermore, our methods provide several different global tests for association, as well as haplotype-specific tests, which give a meaningful advantage in attempts to understand the roles of many different haplotypes. The statistics can be computed rapidly, making it feasible to evaluate the associations between many haplotypes and a trait. To illustrate the use of our new methods, they are applied to a study of the association of haplotypes (composed of genes from the human-leukocyte-antigen complex) with humoral immune response to measles vaccination. Limited simulations are also presented to demonstrate the validity of our methods, as well as to provide guidelines on how our methods could be used.	Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Biostat Sect, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pediat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Biostat Sect, Harwick 775, Rochester, MN 55905 USA.	schaid@mayo.edu	de cid, rafael/Q-2952-2016	de cid, rafael/0000-0003-3579-6777; Jacobson, Robert/0000-0002-6355-8752	NIAID NIH HHS [R01 2AI33144, R01 AI033144, N01 AI45240] Funding Source: Medline; NIDCR NIH HHS [R01 DE13276] Funding Source: Medline; NIGMS NIH HHS [R01 GM065450] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045240, R01AI033144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013276] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Guo SW, 1997, HUM HERED, V47, P301, DOI 10.1159/000154430; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; LONG JC, 1995, AM J HUM GENET, V56, P799; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; McCullagh P, 1989, GEN LINEAR MODELS, V2nd, DOI [10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; McKeigue PM, 2000, AM J HUM GENET, V67, P1626, DOI 10.1086/316912; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Poland GA, 2001, VACCINE, V20, P430, DOI 10.1016/S0264-410X(01)00346-2; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; SCHNEIDER S, 2000, ARLEQUIN GENETICS BI; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Zhang SL, 2001, AM J HUM GENET, V69, P906, DOI 10.1086/323622	40	1533	1577	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					425	434		10.1086/338688	http://dx.doi.org/10.1086/338688			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791212	Bronze, Green Published			2022-12-18	WOS:000173254300014
J	Visscher, PM; Wray, NR; Zhang, Q; Sklar, P; McCarthy, MI; Brown, MA; Yang, J				Visscher, Peter M.; Wray, Naomi R.; Zhang, Qian; Sklar, Pamela; McCarthy, Mark I.; Brown, Matthew A.; Yang, Jian			10 Years of GWAS Discovery: Biology, Function, and Translation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE ASSOCIATION; MIXED-MODEL ANALYSIS; LD SCORE REGRESSION; DE-NOVO MUTATIONS; GENETIC ARCHITECTURE; MENDELIAN RANDOMIZATION; ANKYLOSING-SPONDYLITIS; RISK VARIANTS; LOW-FREQUENCY; PARTITIONING HERITABILITY	Application of the experimental design of genome-wide association studies (GWASs) is now 10 years old (young), and here we review the remarkable range of discoveries it has facilitated in population and complex-trait genetics, the biology of diseases, and translation toward new therapeutics. We predict the likely discoveries in the next 10 years, when GWASs will be based on millions of samples with array data imputed to a large fully sequenced reference panel and on hundreds of thousands of samples with whole-genome sequencing data.	[Visscher, Peter M.; Wray, Naomi R.; Zhang, Qian; Yang, Jian] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Visscher, Peter M.; Wray, Naomi R.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Genet, New York, NY 10029 USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Genom Sci, New York, NY 10029 USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Old Rd, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Old Rd, Oxford OX3 7LJ, England; [Brown, Matthew A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Translat Res Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia	University of Queensland; University of Queensland; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Queensland University of Technology (QUT)	Visscher, PM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.; Visscher, PM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	peter.visscher@uq.edu.au	Zhang, Qian/AAA-2144-2022; Yang, Jian/A-5852-2010; Wray, Naomi/C-8639-2015; Brown, Matthew A/E-5749-2010; Visscher, Peter/ABB-6151-2020; Zhang, Qian/D-6735-2017; McCarthy, Mark/M-3763-2015	Yang, Jian/0000-0003-2001-2474; Wray, Naomi/0000-0001-7421-3357; Brown, Matthew A/0000-0003-0538-8211; Visscher, Peter/0000-0002-2143-8760; Zhang, Qian/0000-0002-0769-1057; McCarthy, Mark/0000-0002-4393-0510	Australian National Health and Medical Research Council [1107258, 1078901, 1078037, 1056929, 1048853, 1113400]; gs2:Sylvia and Charles Viertel Charitable Foundation; NIH [GM099568, MH100141-01, MH095034, MH109897, DK098032, DK085545, MH101814, DKD105535]; Wellcome Trust [090532, 090367, 098381, 106130]; UK Medical Research Council [L020149, 004422, J010642]; Innovative Medicines Initiative; Accelerating Medicines Partnership (via the Foundation for the NIH); MRC [MR/L020149/1, MR/J010642/1, MR/M004422/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085545, R01DK098032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141, R01MH095034, R01MH101814, R01MH109897] Funding Source: NIH RePORTER; Medical Research Council [MR/L020149/1, MR/M004422/1, MR/J010642/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); gs2:Sylvia and Charles Viertel Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Innovative Medicines Initiative; Accelerating Medicines Partnership (via the Foundation for the NIH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the Australian National Health and Medical Research Council (1107258, 1078901, 1078037, 1056929, 1048853, and 1113400), the gs2:Sylvia and Charles Viertel Charitable Foundation, the NIH (GM099568, MH100141-01, MH095034, MH109897, DK098032, DK085545, MH101814, and DKD105535), the Wellcome Trust (090532, 090367, 098381, and 106130), the UK Medical Research Council (L020149, 004422, and J010642), the Innovative Medicines Initiative, and the Accelerating Medicines Partnership (via the Foundation for the NIH). M.I.M. is a Wellcome Trust Senior Investigator. We thank the reviewers for their many helpful comments, which improved the paper. Because of space limitations, we were unable to do full justice to all relevant and important GWAS articles that have been published in the last 10 years. We apologize to many of our colleagues whose work is not cited.	Agrawal N, 2014, GENES IMMUN, V15, P521, DOI 10.1038/gene.2014.46; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ayub Q, 2014, AM J HUM GENET, V94, P176, DOI 10.1016/j.ajhg.2013.12.010; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; de Jong S, 2016, J PSYCHOPHARMACOL, V30, P826, DOI 10.1177/0269881116653109; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Evans DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003919; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fall T, 2015, DIABETES, V64, P2676, DOI 10.2337/db14-1710; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Georgieva L, 2014, HUM MOL GENET, V23, P6677, DOI 10.1093/hmg/ddu379; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Heap GA, 2014, NAT GENET, V46, P1131, DOI 10.1038/ng.3093; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Jiang L, 2014, ARTHRITIS RHEUMATOL, V66, P1121, DOI 10.1002/art.38353; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kawalkowska J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26430; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9442; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Lotta LA, 2016, JAMA-J AM MED ASSOC, V316, P1383, DOI 10.1001/jama.2016.14568; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Lynch M, 1998, GENETICS ANAL QUANTI; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marigorta UM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003566; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McDonald TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rafiq S, 2008, DIABETOLOGIA, V51, P2205, DOI 10.1007/s00125-008-1160-3; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shah S, 2015, AM J HUM GENET, V97, P75, DOI 10.1016/j.ajhg.2015.05.014; Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114; Sieper J, 2017, ANN RHEUM DIS, V76, P571, DOI 10.1136/annrheumdis-2016-210023; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Subramanian V, 2015, J MED CHEM, V58, P1337, DOI 10.1021/jm501636x; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2016, NAT GENET, V48, P707, DOI 10.1038/ng.3604; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456; Ye Z, 2015, LANCET DIABETES ENDO, V3, P35, DOI 10.1016/S2213-8587(14)70184-6; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou KX, 2016, NAT GENET, V48, P1055, DOI 10.1038/ng.3632; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	145	1509	1537	29	387	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					5	22		10.1016/j.ajhg.2017.06.005	http://dx.doi.org/10.1016/j.ajhg.2017.06.005			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28686856	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000404886800001
J	Visscher, PM; Brown, MA; McCarthy, MI; Yang, J				Visscher, Peter M.; Brown, Matthew A.; McCarthy, Mark I.; Yang, Jian			Five Years of GWAS Discovery	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; DIABETES SUSCEPTIBILITY LOCI; REACTIVE PROTEIN-LEVELS; GENETIC-VARIATION; FASTING GLUCOSE; RARE VARIANTS; FTO GENE; ANKYLOSING-SPONDYLITIS; POPULATION-GENETICS	The past five years have seen many scientific and biological discoveries made through the experimental design of genome-wide association studies (GWASs). These studies were aimed at detecting variants at genomic loci that are associated with complex traits in the population and, in particular, at detecting associations between common single-nucleotide polymorphisms (SNPs) and common diseases such as heart disease, diabetes, auto-immune diseases, and psychiatric disorders. We start by giving a number of quotes from scientists and journalists about perceived problems with GWASs. We will then briefly give the history of GWASs and focus on the discoveries made through this experimental design, what those discoveries tell us and do not tell us about the genetics and biology of complex traits, and what immediate utility has come out of these studies. Rather than giving an exhaustive review of all reported findings for all diseases and other complex traits, we focus on the results for auto-immune diseases and metabolic diseases. We return to the perceived failure or disappointment about GWASs in the concluding section.	[Visscher, Peter M.; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Yang, Jian] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; QIMR Berghofer Medical Research Institute	Visscher, PM (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	peter.visscher@uq.edu.au	Yang, Jian/A-5852-2010; Visscher, Peter/ABB-6151-2020; Brown, Matthew A/E-5749-2010; McCarthy, Mark/M-3763-2015	Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760; Brown, Matthew A/0000-0003-0538-8211; McCarthy, Mark/0000-0002-4393-0510	Australian National Health and Medical Research Council (NHMRC) [389892, 496667, 613672, 613601, 1011506]; Australian Research Council (ARC) [DP1093502]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC grants 389892, 496667, 613672, 613601, and 1011506) and the Australian Research Council (ARC grant DP1093502). P.M.V. and M.A.B. are funded by NHMRC Senior Principal Research Fellowships. We thank two referees for many helpful comments.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Brown MA, 2011, BRIEF FUNCT GENOMICS, V10, P249, DOI 10.1093/bfgp/elr023; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Crow TJ, 2011, MOL PSYCHIATR, V16, P362, DOI 10.1038/mp.2010.92; Dalageorgou C, 2008, J CARDIOVASC ELECTR, V19, P386, DOI 10.1111/j.1540-8167.2007.01030.x; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hartl DL, 1997, PRINCIPLES POPULATIO; Hawkes CH, 2009, MULT SCLER J, V15, P661, DOI 10.1177/1352458509104592; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; HILL WG, 1968, GENETICS, V60, P615; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mihaescu Raluca, 2011, PLoS Curr, V3, pRRN1208, DOI 10.1371/currents.RRN1208; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; Shah SH, 2009, NAT GENET, V41, P388, DOI 10.1038/ng0409-388; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Slatkin M, 2008, GENETICS, V179, P2253, DOI 10.1534/genetics.107.077719; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thanabalasingham G, 2011, DIABETOLOGIA, V54, P2801, DOI 10.1007/s00125-011-2261-y; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2010, CELL, V142, P351, DOI 10.1016/j.cell.2010.07.025; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	123	1461	1505	9	495	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					7	24		10.1016/j.ajhg.2011.11.029	http://dx.doi.org/10.1016/j.ajhg.2011.11.029			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22243964	Green Published, Bronze			2022-12-18	WOS:000299409100001
J	Wu, MC; Lee, S; Cai, TX; Li, Y; Boehnke, M; Lin, XH				Wu, Michael C.; Lee, Seunggeun; Cai, Tianxi; Li, Yun; Boehnke, Michael; Lin, Xihong			Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON DISEASES; GENETIC PATHWAY; MIXED MODELS; TRAITS; SNPS; STRATEGIES; REGRESSION	Sequencing studies are increasingly being conducted to identify rare variants associated with complex traits. The limited power of classical single-marker association analysis for rare variants poses a central challenge in such studies. We propose the sequence kernel association test (SKAT), a supervised, flexible, computationally efficient regression method to test for association between genetic variants (common and rare) in a region and a continuous or dichotomous trait while easily adjusting for covariates. As a score-based variance-component test, SKAT can quickly calculate p values analytically by fitting the null model containing only the covariates, and so can easily be applied to genome-wide data. Using SKAT to analyze a genome-wide sequencing study of 1000 individuals, by segmenting the whole genome into 30 kb regions, requires only 7 hr on a laptop. Through analysis of simulated data across a wide range of practical scenarios and triglyceride data from the Dallas Heart Study, we show that SKAT can substantially outperform several alternative rare-variant association tests. We also provide analytic power and sample-size calculations to help design candidate-gene, whole-exome, and whole-genome sequence association studies.	[Lee, Seunggeun; Cai, Tianxi; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wu, Michael C.; Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, XH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xlin@hsph.harvard.edu	Wu, Michael/X-5084-2019	Wu, Michael/0000-0002-3357-6570	 [P30 ES010126];  [DMS 0854970];  [R01 GM079330];  [R01 HG000376];  [R37 CA076404];  [P01 CA134294]; NATIONAL CANCER INSTITUTE [P01CA134294, R37CA076404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292, R01HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079330] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants P30 ES010126 (to M.C.W.), DMS 0854970 and R01 GM079330 (to T.C.), R01 HG000376 (to M.B.), and R37 CA076404 and P01 CA134294 (to S.L. and X.L.). We thank Jonathan Cohen, Alkes Price, and Shamil Sunyaev for providing the Dallas Heart Study data and Larisa Miropolsky for help with the software development.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Carvajal-Carmona LG, 2010, CURR OPIN GENET DEV, V20, P277, DOI 10.1016/j.gde.2010.05.005; Cristianini N., 2000, INTRO SUPPORT VECTOR; DAVIES R. B., 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fleuret F., 2003, 3 INT WORKSH STAT CO; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu H, 2009, COMPUT STAT DATA AN, V53, P853, DOI 10.1016/j.csda.2008.11.025; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; SKATSOFTWARE	39	1461	1504	3	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					82	93		10.1016/j.ajhg.2011.05.029	http://dx.doi.org/10.1016/j.ajhg.2011.05.029			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21737059	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000293041700007
J	Ritchie, MD; Hahn, LW; Roodi, N; Bailey, LR; Dupont, WD; Parl, FF; Moore, JH				Ritchie, MD; Hahn, LW; Roodi, N; Bailey, LR; Dupont, WD; Parl, FF; Moore, JH			Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATECHOL-O-METHYLTRANSFERASE; CYTOCHROME P4501B1; MENOPAUSAL STATUS; HUMAN CYP1A1; RISK; POLYMORPHISMS; ASSOCIATION; POPULATION; PHARMACOGENETICS; SUSCEPTIBILITY	One of the greatest challenges facing human geneticists is the identification and characterization of susceptibility genes for common complex multifactorial human diseases. This challenge is partly due to the limitations of parametric-statistical methods for detection of gene effects that are dependent solely or partially on interactions with other genes and with environmental exposures. We introduce multifactor-dimensionality reduction (MDR) as a method for reducing the dimensionality of multilocus information, to improve the identification of polymorphism combinations associated with disease risk. The MDR method is nonparametric (i.e., no hypothesis about the value of a statistical parameter is made), is model-free (i.e., it assumes no particular inheritance model), and is directly applicable to case-control and discordant-sib-pair studies. Using simulated case-control data, we demonstrate that MDR has reasonable power to identify interactions among two or more loci in relatively small samples. When it was applied to a sporadic breast cancer case-control data set, in the absence of any statistically significant independent main effects, MDR identified a statistically significant high-order interaction among four polymorphisms from three different estrogen-metabolism genes. To our knowledge, this is the first report of a four-locus interaction associated with a common complex multifactorial disease.	Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Moore, JH (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Program Human Genet, 519 Light Hall, Nashville, TN 37232 USA.		Ritchie, Marylyn/C-1114-2012; Dupont, William D./I-4430-2012; Moore, Jason H./AAV-9645-2021	Moore, Jason H./0000-0002-5015-1099	NATIONAL CANCER INSTITUTE [R01CA083752, T32CA078136] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA078136, T32 CA78136, R01 CA/ES 83752] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMBROSONE CB, 1995, CANCER RES, V55, P3483; Bailey LR, 1998, CANCER RES, V58, P5038; Bailey LR, 1998, CANCER RES, V58, P65; Bailey LR, 1999, CANCER RES, V59, P1388; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; CANTUPAZ E, 2000, EFFICIENT ACCURATE P; Cascorbi I, 1996, CANCER RES, V56, P4965; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; DUPONT WD, 1989, CANCER-AM CANCER SOC, V63, P948, DOI 10.1002/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-U; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Hanna IH, 2000, CANCER RES, V60, P3440; HARRIS JR, 1992, NEW ENGL J MED, V327, P319, DOI 10.1056/NEJM199207303270505; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P407, DOI 10.1093/oxfordjournals.jbchem.a123594; Hosmer D. W., 2000, APPL LOGISTIC REGRES, V2nd; KELSEY JL, 1988, CANCER RES, V48, P5615; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lavigne JA, 1997, CANCER RES, V57, P5493; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; MACDONALD PC, 1978, AM J OBSTET GYNECOL, V130, P448, DOI 10.1016/0002-9378(78)90287-9; Millikan RC, 1998, CARCINOGENESIS, V19, P1943, DOI 10.1093/carcin/19.11.1943; MOORE JW, 1987, BRIT J CANCER, V56, P661, DOI 10.1038/bjc.1987.262; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Parl F.F., 2000, ESTROGENS ESTROGEN R; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Persson I, 1997, BIOCHEM BIOPH RES CO, V231, P227, DOI 10.1006/bbrc.1997.6051; Potischman N, 1996, JNCI-J NATL CANCER I, V88, P756, DOI 10.1093/jnci/88.11.756; REBBECK TR, 1994, CANCER EPIDEM BIOMAR, V3, P511; Ripley B.D., 1996, PATTERN RECOGN, DOI 10.1017/CBO9780511812651; Schlichting CD., 1998, PHENOTYPIC EVOLUTION, DOI 10.1038/sj.hdy.688535; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Syvanen AC, 1997, PHARMACOGENETICS, V7, P65; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Thompson PA, 1998, CANCER RES, V58, P2107; Wade Michael J., 2000, P213; WIENCKE JK, 1995, CANCER EPIDEM BIOMAR, V4, P253; Wilson A. F., 1996, American Journal of Human Genetics, V59, pA193; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Yong LC, 1996, AM J EPIDEMIOL, V143, P985, DOI 10.1093/oxfordjournals.aje.a008681	43	1414	1490	2	69	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					138	147		10.1086/321276	http://dx.doi.org/10.1086/321276			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11404819	Green Published, Bronze			2022-12-18	WOS:000170108100014
J	Pritchard, JK; Stephens, M; Rosenberg, NA; Donnelly, P				Pritchard, JK; Stephens, M; Rosenberg, NA; Donnelly, P			Association mapping in structured populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMANS; TRANSMISSION/DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; ETHNIC-DIFFERENCES; DISEASE RISK; ADMIXTURE; ALLELES; MARKERS; HISTORY; GENES	The use, in association studies, of the forthcoming dense genomewide collection of single-nucleotide polymorphism (SNPs) has been heralded as a potential breakthrough in the study of the genetic basis of common complex disorders. A serious problem with association mapping is that population structure can lead to spurious associations between a candidate marker and a phenotype. One common solution has been to abandon case-control studies in favor of family-based tests of association, such as the transmission/disequilibrium test (TDT), but this comes at a considerable cost in the need to collect DNA from close relatives of affected individuals. In this article we describe a novel, statistically valid, method for ease-control association studies in structured populations. Our method uses a set of unlinked genetic markers to infer details of population structure, and to estimate the ancestry of sampled individuals, before using this information to test for associations within subpopulations. It provides power comparable with the TDT in many settings and may substantially outperform it if there are conflicting associations in different subpopulations.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Oxford; Stanford University	Pritchard, JK (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Rosenberg, Noah/0000-0002-1829-8664				Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Cooper G, 1999, AM J HUM GENET, V65, P1125, DOI 10.1086/302574; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Feldman M.W., 1999, MICROSATELLITES EVOL, P98; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; PRITCHARD JK, 2000, IN PRESS GENETICS; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; [No title captured]	21	1404	1483	8	135	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					170	181		10.1086/302959	http://dx.doi.org/10.1086/302959			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10827107	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000088926900019
J	LITT, M; LUTY, JA				LITT, M; LUTY, JA			A HYPERVARIABLE MICROSATELLITE REVEALED BY INVITRO AMPLIFICATION OF A DINUCLEOTIDE REPEAT WITHIN THE CARDIAC-MUSCLE ACTIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LITT, M (corresponding author), OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201, USA.				NIGMS NIH HHS [R01-GM32500] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032500] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; GOLDIN LR, 1988, GENET EPIDEMIOL, V5, P35, DOI 10.1002/gepi.1370050104; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P961; GUNNING P, 1984, P NATL ACAD SCI-BIOL, V81, P1813, DOI 10.1073/pnas.81.6.1813; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P5901, DOI 10.1073/pnas.79.19.5901; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kornberg A., 1980, DNA REPLICATION; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; Maniatis T., 1982, MOL CLONING; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; PENROSE LS, 1953, ANN EUGENIC, V18, P120; ROYLE NJ, 1987, CYTOGENET CELL GENET, V46, P685; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEN LP, 1984, SCIENCE, V224, P168, DOI 10.1126/science.6142531; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; WEBER J L, 1988, American Journal of Human Genetics, V43, pA161; WEEKS DE, 1988, AM J HUM GENET, V42, P315	22	1387	1578	1	60	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					397	401						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2563634				2022-12-18	WOS:A1989T353500013
J	Scheet, P; Stephens, M				Scheet, P; Stephens, M			A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; INFERENCE; RECONSTRUCTION; LOCI	We present a statistical model for patterns of genetic variation in samples of unrelated individuals from natural populations. This model is based on the idea that, over short regions, haplotypes in a population tend to cluster into groups of similar haplotypes. To capture the fact that, because of recombination, this clustering tends to be local in nature, our model allows cluster memberships to change continuously along the chromosome according to a hidden Markov model. This approach is flexible, allowing for both "block-like" patterns of linkage disequilibrium ( LD) and gradual decline in LD with distance. The resulting model is also fast and, as a result, is practicable for large data sets ( e. g., thousands of individuals typed at hundreds of thousands of markers). We illustrate the utility of the model by applying it to dense single-nucleotide-polymorphism genotype data for the tasks of imputing missing genotypes and estimating haplotypic phase. For imputing missing genotypes, methods based on this model are as accurate or more accurate than existing methods. For haplotype estimation, the point estimates are slightly less accurate than those from the best existing methods ( e. g., for unrelated Centre d'Etude du Polymorphisme Humain individuals from the HapMap project, switch error was 0.055 for our method vs. 0.051 for PHASE) but require a small fraction of the computational cost. In addition, we demonstrate that the model accurately reflects uncertainty in its estimates, in that probabilities computed using the model are approximately well calibrated. The methods described in this article are implemented in a software package, fastPHASE, which is available from the Stephens Lab Web site.	Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Scheet, P (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.	pscheet@alum.wustl.edu			NHGRI NIH HHS [1R01HG/LM02585-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BATES JM, 1969, OPER RES QUART, V20, P451, DOI 10.2307/3008764; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Falush D, 2003, GENETICS, V164, P1567; Freund Y., 1996, P 13 INT C INT C MAC, P148, DOI DOI 10.5555/3091696.3091715; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Kimmel G, 2005, J COMPUT BIOL, V12, P1243, DOI 10.1089/cmb.2005.12.1243; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Koivisto M, 2003, Pac Symp Biocomput, P502; Li N, 2003, GENETICS, V165, P2213; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Pritchard JK, 2000, GENETICS, V155, P945; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rastas P, 2005, LECT NOTES COMPUT SC, V3692, P140; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMOUSE PE, 1990, CAN J FISH AQUAT SCI, V47, P620, DOI 10.1139/f90-070; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SUN S, 2004, P ABSTR AM SOC HUM G; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	28	1367	1422	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					629	644		10.1086/502802	http://dx.doi.org/10.1086/502802			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532393	Green Published, Bronze			2022-12-18	WOS:000236755900009
J	Nyholt, DR				Nyholt, DR			A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE GENES; HAPLOTYPE ANALYSIS; COMPLEX DISEASE; ASSOCIATION; MARKERS; POWER; POPULATION; TRAITS; LOCI	In this report, we describe a simple correction for multiple testing of single-nucleotide polymorphisms ( SNPs) in linkage disequilibrium (LD) with each other, on the basis of the spectral decomposition (SpD) of matrices of pairwise LD between SNPs. This method provides a useful alternative to more computationally intensive permutation tests. A user-friendly interface (SNPSpD) for performing this correction is available online (http://genepi.qimr.edu.au/ general/daleN/SNPSpD/). Additionally, output from SNPSpD includes eigenvalues, principal-component coefficients, and factor "loadings" after varimax rotation, enabling the selection of a subset of SNPs that optimize the information in a genomic region.	Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Nyholt, DR (corresponding author), Queensland Inst Med Res, Post Off Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.	daleN@qimr.edu.au	Nyholt, Dale Robert/J-3174-2017	Nyholt, Dale Robert/0000-0001-7159-3040				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; CHEVERUD JM, 1983, EVOLUTION, V37, P895, DOI [10.2307/2408405, 10.1111/j.1558-5646.1983.tb05619.x]; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Escamilla MA, 1999, AM J HUM GENET, V64, P1670, DOI 10.1086/302400; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; HOLM S, 1979, SCAND J STAT, V6, P65; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.1093/biomet/75.2.383; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Long AD, 1999, GENOME RES, V9, P720; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Meng ZL, 2003, AM J HUM GENET, V73, P115, DOI 10.1086/376561; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; R Development Core Team, 2003, R LANG ENV STAT COMP; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; SIDAK Z, 1968, ANN MATH STAT, V39, P1425, DOI 10.1214/aoms/1177698122; SIDAK Z, 1971, ANN MATH STAT, V41, P169; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Westfall P.H., 1993, RESAMPLING BASED MUL; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	29	1365	1378	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					765	769		10.1086/383251	http://dx.doi.org/10.1086/383251			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	14997420	Green Published, Bronze			2022-12-18	WOS:000220280800017
J	MORTON, NE				MORTON, NE			SEQUENTIAL TESTS FOR THE DETECTION OF LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAILEY NTJ, 1951, ANN EUGENIC, V16, P223, DOI 10.1111/j.1469-1809.1951.tb02474.x; BERNSTEIN F, 1931, Z INDUKT ABSTAMM VER, V57, P113; BRIDGES CB, 1944, 552 CARN I WASH PUBL; BROSS I, 1952, BIOMETRICS, V8, P188, DOI 10.2307/3001547; CARTER T. C., 1955, JOUR GENETICS, V53, P21, DOI 10.1007/BF02981505; Crew FAE, 1932, J GENET, V26, P359, DOI 10.1007/BF02984496; Finney DJ, 1943, ANN EUGENIC, V12, P31, DOI 10.1111/j.1469-1809.1943.tb02309.x; Finney DJ, 1941, ANN EUGENIC, V11, P10, DOI 10.1111/j.1469-1809.1941.tb02267.x; Finney DJ, 1941, ANN EUGENIC, V11, P115, DOI 10.1111/j.1469-1809.1941.tb02279.x; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; Finney DJ, 1941, ANN EUGENIC, V11, P233, DOI 10.1111/j.1469-1809.1941.tb02287.x; Fisher RA, 1935, ANN EUGENIC, V4, P187; HALDANE JBS, 1946, ANN EUGENIC, V13, P122, DOI 10.1111/j.1469-1809.1946.tb02348.x; Haldane JBS, 1934, ANN EUGENIC, V6, P26, DOI 10.1111/j.1469-1809.1934.tb02106.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; Harris H, 1948, EUGEN REV, V40, P70; Hogben L, 1934, P R SOC LOND B-CONTA, V114, P340, DOI 10.1098/rspb.1934.0011; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; MOHR J, 1954, OP DOM BIOL HERED, V33, P1; NEEL JV, 1949, AM J HUM GENET, V1, P19; PENROSE LS, 1953, ANN EUGENIC, V18, P120; RHOADES MM, 1950, J HERED, V41, P58, DOI 10.1093/oxfordjournals.jhered.a106089; SLIZYNSKI BM, 1949, J GENET, V49, P242, DOI 10.1007/BF02986078; SMITH CAB, 1953, J R STAT SOC B, V15, P153; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; Wald A., 1947, SEQUENTIAL ANAL	26	1334	1368	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1955	7	3					277	318						42	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA212	13258560				2022-12-18	WOS:A1955WA21200004
J	Marshall, CR; Noor, A; Vincent, JB; Lionel, AC; Feuk, L; Skaug, J; Shago, M; Moessner, R; Pinto, D; Ren, Y; Thiruvahindrapduram, B; Fiebig, A; Schreiber, S; Friedman, J; Ketelaars, CEJ; Vos, YJ; Ficicioglu, C; Kirkpatrick, S; Nicolson, R; Sloman, L; Surnmers, A; Gibbons, CA; Teebi, A; Chitayat, D; Weksberg, R; Thompson, A; Vardy, C; Crosbie, V; Luscombe, S; Baatjes, R; Zwaigenbaum, L; Roberts, W; Fernandez, B; Szatmari, P; Scherer, SW				Marshall, Christian R.; Noor, Abdul; Vincent, John B.; Lionel, Anath C.; Feuk, Lars; Skaug, Jennifer; Shago, Mary; Moessner, Rainald; Pinto, Dalila; Ren, Yan; Thiruvahindrapduram, Bhoorna; Fiebig, Andreas; Schreiber, Stefan; Friedman, Jan; Ketelaars, Cees E. J.; Vos, Yvonne J.; Ficicioglu, Can; Kirkpatrick, Susan; Nicolson, Rob; Sloman, Leon; Surnmers, Anne; Gibbons, Clare A.; Teebi, Ahmad; Chitayat, David; Weksberg, Rosanna; Thompson, Ann; Vardy, Cathy; Crosbie, Vicki; Luscombe, Sandra; Baatjes, Rebecca; Zwaigenbaum, Lonnie; Roberts, Wendy; Fernandez, Bridget; Szatmari, Peter; Scherer, Stephen W.			Structural variation of chromosomes in autism spectrum disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; HIGH-FREQUENCY; MICRODELETION; NUCLEOTIDE; MUTATIONS; REARRANGEMENTS; NEUROLIGINS; DUPLICATION; DISCOVERY; DELETIONS	Structural variation (copy number variation [CNV] including deletion and duplication, translocation, inversion) of chromosomes has been identified in some individuals with autism spectrum disorder (ASD), but the full etiologic role is unknown. We performed genome-wide assessment for structural abnormalities in 427 unrelated ASD cases via single-nucleotide polymorphism microarrays and karyotyping. With microarrays, we discovered 277 unbalanced CNVs in 44% of ASD families not present in 500 controls (and re-examined in another 1152 controls). Karyotyping detected additional balanced changes. Although most variants were inherited, we found a total of 27 cases with de novo alterations, and in three (11%) of these individuals, two or more new variants were observed. De novo CNVs were found in similar to 7% and similar to 2% of idiopathic families having one child, or two or more ASD siblings, respectively. We also detected 13 loci with recurrent/overlapping CNV in unrelated cases, and at these sites, deletions and duplications affecting the same gene(s) in different individuals and sometimes in asymptomatic carriers were also found. Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility. Our most compelling result discovered CNV at 16p11.2 (p = 0.002) (with characteristics of a genomic disorder) at similar to 1% frequency. Some of the ASD regions were also common to mental retardation loci. Structural variants were found in sufficiently high frequency influencing ASD to suggest that cytogenetic and microarray analyses be considered in routine clinical workup.	[Marshall, Christian R.; Lionel, Anath C.; Feuk, Lars; Skaug, Jennifer; Moessner, Rainald; Pinto, Dalila; Ren, Yan; Thiruvahindrapduram, Bhoorna; Scherer, Stephen W.] Univ Toronto, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Marshall, Christian R.; Lionel, Anath C.; Feuk, Lars; Skaug, Jennifer; Moessner, Rainald; Pinto, Dalila; Ren, Yan; Thiruvahindrapduram, Bhoorna; Baatjes, Rebecca; Scherer, Stephen W.] Univ Toronto, Program Genet & Genom Biol, Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Marshall, Christian R.; Lionel, Anath C.; Feuk, Lars; Skaug, Jennifer; Moessner, Rainald; Pinto, Dalila; Ren, Yan; Thiruvahindrapduram, Bhoorna; Baatjes, Rebecca; Scherer, Stephen W.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; [Noor, Abdul; Vincent, John B.; Sloman, Leon] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Noor, Abdul; Vincent, John B.; Sloman, Leon] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Teebi, Ahmad; Chitayat, David; Weksberg, Rosanna] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Shago, Mary] Hosp Sick Children, Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Fiebig, Andreas; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Friedman, Jan] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Ketelaars, Cees E. J.; Vos, Yvonne J.] Univ Groningen, Dept Child Psychiat, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Ficicioglu, Can] Childrens Hosp Philadelphia, Div Metab, Philadelphia, PA 19104 USA; [Kirkpatrick, Susan] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Nicolson, Rob] Univ Western Ontario, Dept Psychiat, London, ON N6A 4GS, Canada; [Surnmers, Anne; Gibbons, Clare A.] N York Gen Hosp, Dept Genet, Toronto, ON M2K 1E1, Canada; [Thompson, Ann; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8P 3B6, Canada; [Vardy, Cathy; Crosbie, Vicki; Luscombe, Sandra; Fernandez, Bridget] Mem Univ Newfoundland, Discipline Genet & Med, St John, NF A1B 3V6, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2J3, Canada; [Roberts, Wendy] Univ Toronto, Bloorview Kids Rehab, Toronto, ON M4G 1R8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Kiel; University of British Columbia; University of Groningen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Wisconsin System; University of Wisconsin Madison; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; North York General Hospital; McMaster University; Memorial University Newfoundland; University of Alberta; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Scherer, SW (corresponding author), Univ Toronto, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Ficicioglu, Can/AAQ-8002-2020; Nicolson, Robert/E-4797-2011; Scherer, Stephen W./B-3785-2013; Pinto, Dalila/C-4218-2016; Noor, Abdul/J-2345-2016	Nicolson, Robert/0000-0001-7086-7038; Scherer, Stephen W./0000-0002-8326-1999; Pinto, Dalila/0000-0002-8769-0846; Friedman, Jan/0000-0002-7482-9570; Ficicioglu, Can/0000-0002-8331-9804	Autism Speaks [AS2077] Funding Source: Medline	Autism Speaks		BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bonnet C, 2006, J HUM GENET, V51, P815, DOI 10.1007/s10038-006-0023-3; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Falush D, 2003, GENETICS, V164, P1567; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; FEUK L, 2006, TRENDS GENET, V23, P387; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JONES MB, 1988, J AUTISM DEV DISORD, V18, P31, DOI 10.1007/BF02211816; Kohler JR, 2007, AM J HUM GENET, V81, P684, DOI 10.1086/520823; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Mitchell KJ, 2007, PLOS BIOL, V5, P690, DOI 10.1371/journal.pbio.0050113; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RISI S, 2006, PSYCHIATRY, V45, P1094; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Xu Jie, 2004, Current Genomics, V5, P347, DOI 10.2174/1389202043349246; Yu CE, 2002, AM J HUM GENET, V71, P100, DOI 10.1086/341291; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	41	1303	1357	4	255	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					477	488		10.1016/j.ajhg.2007.12.009	http://dx.doi.org/10.1016/j.ajhg.2007.12.009			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252227	Bronze, Green Published			2022-12-18	WOS:000253223900019
J	Stefansson, H; Sigurdsson, E; Steinthorsdottir, V; Bjornsdottir, S; Sigmundsson, T; Ghosh, S; Brynjolfsson, J; Gunnarsdottir, S; Ivarsson, O; Chou, TT; Hjaltason, O; Birgisdottir, B; Jonsson, H; Gudnadottir, VG; Gudmundsdottir, E; Bjornsson, A; Ingvarsson, B; Ingason, A; Sigfusson, S; Hardardottir, H; Harvey, RP; Lai, D; Zhou, MD; Brunner, D; Mutel, V; Gonzalo, A; Lemke, G; Sainz, J; Johannesson, G; Andresson, T; Gudbjartsson, D; Manolescu, A; Frigge, ML; Gurney, ME; Kong, A; Gulcher, JR; Petursson, H; Stefansson, K				Stefansson, H; Sigurdsson, E; Steinthorsdottir, V; Bjornsdottir, S; Sigmundsson, T; Ghosh, S; Brynjolfsson, J; Gunnarsdottir, S; Ivarsson, O; Chou, TT; Hjaltason, O; Birgisdottir, B; Jonsson, H; Gudnadottir, VG; Gudmundsdottir, E; Bjornsson, A; Ingvarsson, B; Ingason, A; Sigfusson, S; Hardardottir, H; Harvey, RP; Lai, D; Zhou, MD; Brunner, D; Mutel, V; Gonzalo, A; Lemke, G; Sainz, J; Johannesson, G; Andresson, T; Gudbjartsson, D; Manolescu, A; Frigge, ML; Gurney, ME; Kong, A; Gulcher, JR; Petursson, H; Stefansson, K			Neuregulin 1 and susceptibility to schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPARTATE RECEPTOR SUBUNITS; LINKAGE ANALYSIS; CARDIAC DEVELOPMENT; MAXIMUM-LIKELIHOOD; DIABETES-MELLITUS; MICE; EXPRESSION; GENE; HAPLOTYPES; GLUTAMATE	The cause of schizophrenia is unknown, but it has a significant genetic component. Pharmacologic studies, studies of gene expression in man, and studies of mouse mutants suggest involvement of glutamate and dopamine neurotransmitter systems. However, so far, strong association has not been found between schizophrenia and variants of the genes encoding components of these systems. Here, we report the results of a genomewide scan of schizophrenia families in Iceland; these results support previous work, done in five populations, showing that schizophrenia maps to chromosome 8p. Extensive fine-mapping of the 8p locus and haplotype-association analysis, supplemented by a transmission/disequilibrium test, identifies neuregulin 1 (NRG1) as a candidate gene for schizophrenia. NRG1 is expressed at central nervous system synapses and has a clear role in the expression and activation of neurotransmitter receptors, including glutamate receptors. Mutant mice heterozygous for either NRG1 or its receptor, ErbB4, show a behavioral phenotype that overlaps with mouse models for schizophrenia. Furthermore, NRG1 hypomorphs have fewer functional NMDA receptors than wild-type mice. We also demonstrate that the behavioral phenotypes of the NRG1 hypomorphs are partially reversible with clozapine, an atypical antipsychotic drug used to treat schizophrenia.	Natl Univ Hosp Reykjavik, DeCODE Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Dept Psychiat, IS-101 Reykjavik, Iceland; Akureyri Hosp, Dept Psychiat, Akureyri, Iceland; Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; Univ New S Wales, Fac Med, Sydney, NSW, Australia; Univ New S Wales, Fac Life Sci, Sydney, NSW, Australia; Zensun Sci & Tech, Shanghai, Peoples R China; PsychoGenics, New York, NY USA; F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Landspitali National University Hospital; Landspitali National University Hospital; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; Roche Holding; Salk Institute	Stefansson, H (corresponding author), Natl Univ Hosp Reykjavik, DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019; Manolescu, Andrei/G-4565-2014; Sigurdsson, Engilbert/D-2486-2014	Manolescu, Andrei/0000-0002-0713-4664; Harvey, Richard/0000-0002-9950-9792; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Gudbjartsson, Daniel/0000-0002-5222-9857; Sigurdsson, Engilbert/0000-0001-9404-7982; Stefansson, Hreinn/0000-0002-9331-6666				Bilder RM, 1996, CURR OPIN PSYCHIATR, V9, P57, DOI 10.1097/00001504-199601000-00011; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cameron JS, 2001, P NATL ACAD SCI USA, V98, P2832, DOI 10.1073/pnas.041394098; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Chen XN, 1999, GENOME RES, V9, P492; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Erickson SL, 1997, DEVELOPMENT, V124, P4999; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gerber DJ, 2001, P NATL ACAD SCI USA, V98, P15312, DOI 10.1073/pnas.261583798; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Glickstein SB, 2001, PHARMACOL THERAPEUT, V91, P63, DOI 10.1016/S0163-7258(01)00145-0; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Holt DJ, 1999, NEUROSCIENCE, V94, P21, DOI 10.1016/S0306-4522(99)00279-1; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ibrahim HM, 2000, AM J PSYCHIAT, V157, P1811, DOI 10.1176/appi.ajp.157.11.1811; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Levinson DF, 1996, AM J MED GENET, V67, P580; LIDDLE P, 1994, BRIT J PSYCHIAT, V165, P721, DOI 10.1192/bjp.165.6.721; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; LONG JC, 1995, AM J HUM GENET, V56, P799; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; O'Donovan MC, 1999, AM J HUM GENET, V65, P587, DOI 10.1086/302560; O'Neill MF, 1999, PSYCHOPHARMACOLOGY, V145, P237, DOI 10.1007/s002130051055; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; RISCH N, 1990, AM J HUM GENET, V46, P222; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Steiger B, 1999, J PORPHYR PHTHALOCYA, V3, P159; Tsuang M. T., 2001, BRIT J PSYCHIAT, V40, ps18, DOI [DOI 10.1192/BJP.178.40.S18, 10.1192/bjp.178.40.s18]; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200	57	1282	1337	1	105	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					877	892		10.1086/342734	http://dx.doi.org/10.1086/342734			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12145742	Green Published, Bronze			2022-12-18	WOS:000178613800015
J	LATHROP, GM; LALOUEL, JM; JULIER, C; OTT, J				LATHROP, GM; LALOUEL, JM; JULIER, C; OTT, J			MULTILOCUS LINKAGE ANALYSIS IN HUMANS - DETECTION OF LINKAGE AND ESTIMATION OF RECOMBINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHU COCHIN,INST PATHOL MOLEC,INSERM,U129,F-75014 PARIS,FRANCE; CITY STAT OFF,NAPFGASSE 6,CH-8001 ZURICH,SWITZERLAND	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	LATHROP, GM (corresponding author), UNIV PARIS 07,ANTHROPOL BIOL LAB,2 PL JUSSIEU,F-75005 PARIS,FRANCE.		JULIER, Cécile/M-9824-2017	JULIER, Cécile/0000-0002-1538-0240				ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; BAILEY NTJ, 1961, INTRO MATH THEORY LI; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; Conneally P M, 1980, Adv Hum Genet, V10, P209; COTTERMAN CW, 1953, AM J HUM GENET, V5, P193; CRAMER H, 1946, MATH METHODS STATIST; EDWARDS JH, 1982, CYTOGENET CELL GENET, V32, P43, DOI 10.1159/000131685; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; ELSTON RC, 1971, HUM HERED, V21, P533; FELSENSTEIN J, 1979, GENETICS, V91, P769; Haldane JBS, 1919, J GENET, V8, P299; KARLIN S, 1978, P NATL ACAD SCI USA, V75, P6332, DOI 10.1073/pnas.75.12.6332; KARLIN S, 1979, ADV APPL PROB, V2, P479; KENDALL MG, 1979, ADV THEORY STATISTIC, V2; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Meyers D. A., 1976, BIRTH DEFECTS-ORIG, P335; OTT J, 1984, ANAL HUMAN GENETIC L; OWEN ARG, 1949, PROC R SOC SER B-BIO, V136, P67, DOI 10.1098/rspb.1949.0006; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RISCH N, 1979, ANN HUM GENET, V43, P61, DOI 10.1111/j.1469-1809.1979.tb01549.x; RISCH N, 1983, BIOMETRICS, V39, P949, DOI 10.2307/2531330; STURT E, 1976, ANN HUM GENET, V40, P147, DOI 10.1111/j.1469-1809.1976.tb00175.x; 1984, CYTOGENET CELL GENET, V37, P1	27	1277	1294	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					482	498						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	3859205				2022-12-18	WOS:A1985AKE0700005
J	Chen, JS; Lipska, BK; Halim, N; Ma, QD; Matsumoto, M; Melhem, S; Kolachana, BS; Hyde, TM; Herman, MM; Apud, J; Egan, MF; Kleinman, JE; Weinberger, DR				Chen, JS; Lipska, BK; Halim, N; Ma, QD; Matsumoto, M; Melhem, S; Kolachana, BS; Hyde, TM; Herman, MM; Apud, J; Egan, MF; Kleinman, JE; Weinberger, DR			Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DORSOLATERAL PREFRONTAL CORTEX; DOPAMINE TRANSPORTER; BIOCHEMICAL GENETICS; THERMAL-STABILITY; BIPOLAR DISORDER; SCHIZOPHRENIA; EXPRESSION; GENOTYPE; MICE; IMMUNOREACTIVITY	Catechol-O-methyltransferase (COMT) is a key enzyme in the elimination of dopamine in the prefrontal cortex of the human brain. Genetic variation in the COMT gene (MIM 116790) has been associated with altered prefrontal cortex function and higher risk for schizophrenia, but the specific alleles and their functional implications have been controversial. We analyzed the effects of several single-nucleotide polymorphisms (SNPs) within COMT on mRNA expression levels (using reverse-transcriptase polymerase chain reaction analysis), protein levels (using Western blot analysis), and enzyme activity (using catechol methylation) in a large sample (n = 108) of postmortem human prefrontal cortex tissue, which predominantly expresses the -membrane-bound isoform. A common coding SNP, Val158Met (rs4680), significantly affected protein abundance and enzyme activity but not mRNA expression levels, suggesting that differences in protein integrity account for the difference in enzyme activity between alleles. A SNP in intron 1 (rs737865) and a SNP in the 3' flanking region (rs165599) - both of which have been reported to contribute to allelic expression differences and to be associated with schizophrenia as part of a haplotype with Val - had no effect on mRNA expression levels, protein immunoreactivity, or enzyme activity. In lymphocytes from 47 subjects, we confirmed a similar effect on enzyme activity in samples with the Val/Met genotype but no effect in samples with the intron 1 or 3 a SNPs. Separate analyses revealed that the subject's sex, as well as the presence of a SNP in the P2 promoter region (rs2097603), had small effects on COMT enzyme activity. Using site-directed mutagenesis of mouse COMT cDNA, followed by in vitro translation, we found that the conversion of Leu at the homologous position into Met or Val progressively and significantly diminished enzyme activity. Thus, although we cannot exclude a more complex genetic basis for functional effects of COMT, Val is a predominant factor that determines higher COMT activity in the prefrontal cortex, which presumably leads to lower synaptic dopamine levels and relatively deleterious prefrontal function.	NIMH, NIH, Genes Cognit & Psychosis Program, Clin Brain Disorders Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Weinberger, DR (corresponding author), NIMH, NIH, Genes Cognit & Psychosis Program, Clin Brain Disorders Branch, Room 42-235,10 Center Dr, Bethesda, MD 20892 USA.	daniel.weinberger@mail.nih.gov	Lipska, Barbara K/E-4569-2017; Matsumoto, Mitsuyuki/G-3207-2012	Matsumoto, Mitsuyuki/0000-0002-1172-2354	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002734, Z01MH002399, Z01MH002734, ZIAMH002399] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahsan H, 2004, BREAST CANCER RES TR, V85, P121, DOI 10.1023/B:BREA.0000025401.60794.68; Ailenberg M, 1997, BIOTECHNIQUES, V22, P624, DOI 10.2144/97224bm11; AXELROD J, 1958, J BIOL CHEM, V233, P702; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; BOUDIKOVA B, 1990, CLIN PHARMACOL THER, V48, P381, DOI 10.1038/clpt.1990.166; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; DeMille MMC, 2002, HUM GENET, V111, P521, DOI 10.1007/s00439-002-0809-0; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; GARRIS PA, 1993, J NEUROCHEM, V61, P637; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; Halim ND, 2003, MOL PSYCHIATR, V8, P797, DOI 10.1038/sj.mp.4001319; HARRISON PJ, 2004, MOL PSYCHIAT; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Huotari M, 2002, J PHARMACOL EXP THER, V303, P1309, DOI 10.1124/jpet.102.043042; Kleinman Joel E., 1995, P859; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Liu HL, 2003, PROTEIN ENG, V16, P19, DOI 10.1093/proeng/gzg007; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; LUNDSTROM K, 1995, BBA-PROTEIN STRUCT M, V1251, P1, DOI 10.1016/0167-4838(95)00071-2; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Matsumoto M, 2003, NEUROPSYCHOPHARMACOL, V28, P1521, DOI 10.1038/sj.npp.1300218; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Palmatier MA, 2004, MOL PSYCHIATR, V9, P859, DOI 10.1038/sj.mp.4001496; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shield AJ, 2004, MOL PSYCHIATR, V9, P151, DOI 10.1038/sj.mp.4001386; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SLADEKCHELGREN S, 1981, BIOCHEM GENET, V19, P1037, DOI 10.1007/BF00484563; SPIELMAN RS, 1981, AM J MED GENET, V10, P279, DOI 10.1002/ajmg.1320100311; TENHUNEN J, 1993, DNA CELL BIOL, V12, P253, DOI 10.1089/dna.1993.12.253; Tunbridge E, 2004, SYNAPSE, V51, P112, DOI 10.1002/syn.10286; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; WEINSHILBOUM R, 1981, CLIN GENET, V19, P426; WEINSHILBOUM RM, 1977, AM J HUM GENET, V29, P125; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029; ZURCHER G, 1982, J NEUROCHEM, V38, P191, DOI 10.1111/j.1471-4159.1982.tb10871.x	45	1268	1314	1	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					807	821		10.1086/425589	http://dx.doi.org/10.1086/425589			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15457404	Green Published, Bronze			2022-12-18	WOS:000224303500006
J	van der Put, NMJ; Gabreels, F; Stevens, EMB; Smeitink, JAM; Trijbels, FJM; Eskes, TKAB; van den Heuvel, LP; Blom, HJ				van der Put, NMJ; Gabreels, F; Stevens, EMB; Smeitink, JAM; Trijbels, FJM; Eskes, TKAB; van den Heuvel, LP; Blom, HJ			A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERHOMOCYSTEINEMIA	Recently, we showed that homozygosity for the common 677(C-->T) mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, causing thermolability of the enzyme, is a risk factor for neural-tube defects (NTDs). We now report on another mutation in the same gene, the 1298(A-->C) mutation, which changes a glutamate into an alanine residue. This mutation destroys an MboII recognition site and has an allele frequency of .33. This 1298(A-->C) mutation results in decreased MTHFR activity tone-way analysis of variance [ANOVA] P < .0001), which is more pronounced in the homozygous than heterozygous state. Neither the homozygous nor the heterozygous state is associated with higher plasma homocysteine (Hcy) or a lower plasma folate concentration-phenomena that are evident with homozygosity for the 677(C-->T) mutation. However, there appears to be an interaction between these two common mutations. When compared with heterozygosity for either the 677(C-->T) or 1298(A-->C) mutations, the combined heterozygosity for the 1298(A-->C) and 677(C-->T) mutations was associated with reduced MTHFR specific activity (ANOVA P < .0001), higher Hey, and decreased plasma folate levels (ANOVA P < .03). Thus, combined heterozygosity for both MTHFR mutations results in similar features as observed in homozygotes for the 677(C-->T) mutation. This combined heterozygosity was observed in 28% (n = 86) of the NTD patients compared with 20% (n = 403) among controls, resulting in an odds ratio of 2.04 (95% confidence interval:.9-4.7). These data suggest that the combined heterozygosity for the two MTHFR common mutations accounts for a proportion of folate-related NTDs, which is not explained by homozygosity for the 677(C-->T) mutation, and can be an additional genetic risk factor for NTDs.	Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Child Neurol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Blom, HJ (corresponding author), Univ Nijmegen Hosp, Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.	H.Blom@ckslkn.azn.nl	van den Heuvel, L.P.W.J./H-8044-2014; Smeitink, Jan A.M./D-6064-2011; van den Heuvel, Lambertus/AAM-1772-2021; Smeitink, Jan/C-1351-2013	van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Blom, Henk/0000-0001-5202-9241				COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; KANG SS, 1988, AM J HUM GENET, V43, P414; KIRKE PN, 1993, Q J MED, V86, P703; Malinow MR, 1997, ARTERIOSCL THROM VAS, V17, P1157, DOI 10.1161/01.ATV.17.6.1157; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Molloy AM, 1998, CLIN CHEM, V44, P186; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; MORRIS JA, 1989, STAT CONFIDENCE, P50; Ou C.-Y., 1995, American Journal of Human Genetics, V57, pA223; Ramsbottom D, 1997, CLIN GENET, V51, P39; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Te Poele-Pothoff M. T. W. B., 1995, Annals of Clinical Biochemistry, V32, P218; van der Put NMJ, 1996, P 3 WORKSH METH MET, P186; vanderPut NMJ, 1997, QJM-INT J MED, V90, P511, DOI 10.1093/qjmed/90.8.511; vanderPut NMJ, 1997, QJM-INT J MED, V90, P505, DOI 10.1093/qjmed/90.8.505; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; VANDERPUT NMJ, 1995, LANCET, V346, P1071; VERHOEF P, 1996, THESIS WAGENINGEN AG; Viel A, 1997, BRIT J CANCER, V75, P1105, DOI 10.1038/bjc.1997.191; WALD N, 1991, LANCET, V338, P131; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763	26	1267	1314	3	50	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1044	1051		10.1086/301825	http://dx.doi.org/10.1086/301825			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545395	Bronze, Green Published			2022-12-18	WOS:000073487000007
J	COTTINGHAM, RW; IDURY, RM; SCHAFFER, AA				COTTINGHAM, RW; IDURY, RM; SCHAFFER, AA			FASTER SEQUENTIAL GENETIC-LINKAGE COMPUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIKELIHOOD CALCULATIONS; PEDIGREES	Linkage analysis using maximum-likelihood estimation is a powerful tool for locating genes. As available data sets have grown, the computation required for analysis has grown exponentially and become a significant impediment. Others have previously shown that parallel computation is applicable to linkage analysis and can yield order-of-magnitude improvements in speed. In this paper, we demonstrate that algorithmic modifications can also yield order-of-magnitude improvements, and sometimes much more. Using the software package LINKAGE, we describe a variety of algorithmic improvements that we have implemented, demonstrating both how these techniques are applied and their power. Experiments show that these improvements speed up the programs by an order of magnitude, on problems of moderate and large size. All improvements were made only in the combinatorial part of the code, without resorting to parallel computers. These improvements synthesize biological principles with computer science techniques, to effectively restructure the time-consuming computations in genetic linkage analysis.	RICE UNIV,DEPT COMP SCI,HOUSTON,TX 77251	Rice University	COTTINGHAM, RW (corresponding author), BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030, USA.		Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Cottingham, Robert/D-2628-2014	Cottingham, Robert/0000-0002-2775-3905				BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GORADIA TM, 1992, HUM HERED, V42, P42, DOI 10.1159/000154045; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LANGE K, 1987, AM J HUM GENET, V40, P250; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LAW A, 1992, HUM GENET, V88, P562, DOI 10.1007/BF00219345; MILLER PL, 1991, COMPUT BIOMED RES, V24, P234, DOI 10.1016/0010-4809(91)90046-Y; OTT J, 1974, AM J HUM GENET, V26, P588; Ott J., 1991, ANAL HUMAN GENETIC L; STALLMAN R, 1992, USING PORTING GNU CC; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356; 1991, HUM GENOME NEWS, V3, P1	18	1267	1278	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					252	263						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317490				2022-12-18	WOS:A1993LJ38500028
J	Carlson, CS; Eberle, MA; Rieder, MJ; Yi, Q; Kruglyak, L; Nickerson, DA				Carlson, CS; Eberle, MA; Rieder, MJ; Yi, Q; Kruglyak, L; Nickerson, DA			Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; HUMAN GENOME; CANDIDATE GENES; TAGGING SNPS; DIVERSITY; IDENTIFICATION; RECOMBINATION; POPULATIONS; DISEASE; COMPLEX	Common genetic polymorphisms may explain a portion of the heritable risk for common diseases. Within candidate genes, the number of common polymorphisms is finite, but direct assay of all existing common polymorphism is inefficient, because genotypes at many of these sites are strongly correlated. Thus, it is not necessary to assay all common variants if the patterns of allelic association between common variants can be described. We have developed an algorithm to select the maximally informative set of common single-nucleotide polymorphisms (tagSNPs) to assay in candidate-gene association studies, such that all known common polymorphisms either are directly assayed or exceed a threshold level of association with a tagSNP. The algorithm is based on the r(2) linkage disequilibrium (LD) statistic, because r(2) is directly related to statistical power to detect disease associations with unassayed sites. We show that, at a relatively stringent r(2) threshold (r(2) > 0.8), the LD-selected tagSNPs resolve >80% of all haplotypes across a set of 100 candidate genes, regardless of recombination, and tag specific haplotypes and clades of related haplotypes in nonrecombinant regions. Thus, if the patterns of common variation are described for a candidate gene, analysis of the tagSNP set can comprehensively interrogate for main effects from common functional variation. We demonstrate that, although common variation tends to be shared between populations, tagSNPs should be selected separately for populations with different ancestries.	Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Carlson, CS (corresponding author), Univ Washington, Med Ctr, Dept Genome Sci, 1705 NE Pacific St,Room K-322, Seattle, WA 98195 USA.	csc47@u.washington.edu		Eberle, Michael/0000-0001-8965-1253	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066642, U01HL066682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES15478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059520, R37MH059520] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66682, HL66642, U01 HL066682, U01 HL066642] Funding Source: Medline; NIEHS NIH HHS [N01ES15478] Funding Source: Medline; NIMH NIH HHS [R37 MH059520, MH59520, R01 MH059520] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackerman H, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r24; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Ewens W.J., 1979, MATH POPULATION GENE; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1968, GENETICS, V60, P615; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Meng ZL, 2003, AM J HUM GENET, V73, P115, DOI 10.1086/376561; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wright S, 1931, GENETICS, V16, P0097; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	41	1261	1318	0	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					106	120		10.1086/381000	http://dx.doi.org/10.1086/381000			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681826	Green Published, Bronze			2022-12-18	WOS:000187723500010
J	EASTON, DF; FORD, D; BISHOP, DT; HAITES, N; MILNER, B; ALLAN, L; EASTON, DF; PONDER, BAJ; PETO, J; SMITH, S; FORD, D; STRATTON, M; NAROD, SA; LENOIR, GM; FEUNTEUN, J; LYNCH, H; ARASON, A; BARKDARDOTTIR, R; EGILSSON, DV; BISHOP, DT; BLACK, DM; KELSELL, D; SPURR, NK; DEVILEE, P; CORNELISSE, CJ; VARSEN, H; BIRCH, JM; SANTIBANEZKOREF, MS; TEARE, MD; STEEL, M; PORTER, D; COHEN, BB; CAROTHERS, A; SMYTH, E; WEBER, B; BOEHNKE, M; COLLINS, FS; CANNONALBRIGHT, LA; GOLDGAR, D; SKOLNICK, M				EASTON, DF; FORD, D; BISHOP, DT; HAITES, N; MILNER, B; ALLAN, L; EASTON, DF; PONDER, BAJ; PETO, J; SMITH, S; FORD, D; STRATTON, M; NAROD, SA; LENOIR, GM; FEUNTEUN, J; LYNCH, H; ARASON, A; BARKDARDOTTIR, R; EGILSSON, DV; BISHOP, DT; BLACK, DM; KELSELL, D; SPURR, NK; DEVILEE, P; CORNELISSE, CJ; VARSEN, H; BIRCH, JM; SANTIBANEZKOREF, MS; TEARE, MD; STEEL, M; PORTER, D; COHEN, BB; CAROTHERS, A; SMYTH, E; WEBER, B; BOEHNKE, M; COLLINS, FS; CANNONALBRIGHT, LA; GOLDGAR, D; SKOLNICK, M			BREAST AND OVARIAN-CANCER INCIDENCE IN BRCAI-MUTATION CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL BREAST; LINKAGE ANALYSIS; CHROMOSOME-17Q21; GENE; LOCUS; MAPS	Dominant predisposition to early-onset breast cancer and/or ovarian cancer in many families is known to be the result of germ-line mutations in a gene on chromosome 17q, known as BRCA1, In this paper we use data from families with evidence of linkage to BRCA1 to estimate the age-specific risks of breast and ovarian cancer in BRCA1-mutation carriers and to examine the variation in risk between and within families, Under the assumption of no heterogeneity of risk between families, BRCA1 is estimated to confer a breast cancer risk of 54% by age 60 years (95% confidence interval [CI] 27%-71%) and an ovarian cancer risk of 30% by age 60 years (95% CI 8%-47%). Similar lifetime-risk estimates are obtained by examining the risks of contralateral breast cancer and of ovarian cancer, in breast cancer cases in linked families. However, there is significant evidence of heterogeneity of risk between families; a much better fit to the data is obtained by assuming two BRCA1 alleles, one conferring a breast cancer risk of 62% and an ovarian cancer risk of 11% by age 60 years, the other conferring a breast cancer risk of 39% and an ovarian cancer risk of 42%, with the first allele representing 71% of all mutations (95% CI 55%-87%), There is no evidence of clustering of breast and ovarian cancer cases within families.	ST JAMES HOSP,IMPERIAL CANC RES FUND,GENET EPIDEMIOL LAB,LEEDS,W YORKSHIRE,ENGLAND; UNIV ABERDEEN,ABERDEEN,SCOTLAND; CANC RES CAMPAIGN,LONDON,ENGLAND; CANC RES CAMPAIGN,CAMBRIDGE,ENGLAND; INST CANC RES,LONDON,ENGLAND; INST CANC RES,CAMBRIDGE,ENGLAND; INT AGCY RES CANC,LYON,FRANCE; UNIV ICELAND,REYKJAVIK,ICELAND; IMPERIAL CANC RES FUND,LEEDS,W YORKSHIRE,ENGLAND; IMPERIAL CANC RES FUND,LONDON,ENGLAND; LEIDEN UNIV,LEIDEN,NETHERLANDS; FDN DETECT HEREDITARY TUMOURS,LEIDEN,NETHERLANDS; CHRISTIE HOSP & HOLT RADIUM INST,MANCHESTER,LANCS,ENGLAND; MRC,HUMAN GENET UNIT,EDINBURGH,MIDLOTHIAN,SCOTLAND; UNIV MICHIGAN,ANN ARBOR,MI; UNIV UTAH,SALT LAKE CITY,UT	Saint James's University Hospital; University of Aberdeen; CRUK Cambridge Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; World Health Organization; International Agency for Research on Cancer (IARC); University of Iceland; Cancer Research UK; Leiden University; Leiden University - Excl LUMC; Christie NHS Foundation Trust; Christie Hospital; University of Edinburgh; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah	EASTON, DF (corresponding author), INST CANC RES,EPIDEMIOL SECT,BLOCK D,15 COTSWOLD RD,SUTTON SM2 5NG,SURREY,ENGLAND.		DEVILEE, PETER/ABR-2140-2022; Feunteun, Jean/AAZ-1267-2020; Narod, Steven A/AAA-6112-2022; Kelsell, David P/F-8767-2011	Bishop, Tim/0000-0002-8752-8785; Feunteun, Jean/0000-0003-1212-9189	NATIONAL CANCER INSTITUTE [R01CA057601] Funding Source: NIH RePORTER; NCI NIH HHS [CA57601] Funding Source: Medline; NHGRI NIH HHS [HG00209] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CLAUS EB, 1993, AM J HUM GENET S, V53, pA787; EASTON DF, 1993, AM J HUM GENET, V52, P678; EASTON DF, 1992, THESIS U LONDON LOND; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUIR C, 1987, CANCER INCIDENCE 5 C, V5; NAROD SA, 1991, LANCET, V338, P82; NAROD SA, 1994, AM J HUM GENET, V56, P254; RISCH N, 1984, AM J HUM GENET, V36, P363; STEICHENGERSDOR.E, 1994, AM J HUM GENET, V55, P870; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	19	1259	1281	1	50	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					265	271						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825587				2022-12-18	WOS:A1995QC10100034
J	Lo, YMD; Tein, MSC; Lau, TK; Haines, CJ; Leung, TN; Poon, PMK; Wainscoat, JS; Johnson, PJ; Chang, AMZ; Hjelm, NM				Lo, YMD; Tein, MSC; Lau, TK; Haines, CJ; Leung, TN; Poon, PMK; Wainscoat, JS; Johnson, PJ; Chang, AMZ; Hjelm, NM			Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; PERIPHERAL-BLOOD; MICROSATELLITE ALTERATIONS; CANCER PATIENTS; CELLS; PCR; PRODUCT	We have developed a real-time quantitative PCR assay to measure the concentration of fetal DNA in maternal plasma and serum. Our results show that fetal DNA is present in high concentrations in maternal plasma, reaching a mean of 25.4 genome equivalents/ml (range 3.3-69.4) in early pregnancy and 292.2 genome equivalents/ml (range 76.9-769) in late pregnancy. These concentrations correspond to 3.4% (range 0.39%-11.9%) and 6.2% (range 2.33%-11.4%) of the total plasma DNA in early and late pregnancy, respectively. Sequential follow-up study of women who conceived by in vitro fertilization shows that fetal DNA can be detected in maternal serum as early as the 7th wk of gestation and that it then increases in concentration as pregnancy progresses. These data suggest that fetal DNA can be readily detected in maternal plasma and serum and may be a valuable source of material for noninvasive prenatal diagnosis.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, New Territories, Hong Kong; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynecol, Shatin, New Territories, Hong Kong; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, New Territories, Hong Kong; John Radcliffe Hosp, Dept Hematol, Oxford OX3 9DU, England	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Oxford	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, New Territories, Hong Kong.		Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410				Anker P, 1997, GASTROENTEROLOGY, V112, P1114, DOI 10.1016/S0016-5085(97)70121-5; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1994, AM J OBSTET GYNECOL, V171, P922, DOI 10.1016/S0002-9378(94)70059-1; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Bianchi DW, 1997, AM J HUM GENET, V61, P822, DOI 10.1086/514885; Boland CR, 1996, NAT MED, V2, P972, DOI 10.1038/nm0996-972; CAMASCHELLA C, 1990, BLOOD, V75, P2102; Chen XQ, 1996, NAT MED, V2, P1033; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; HAMADA H, 1993, HUM GENET, V91, P427; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Lo YMD, 1996, BLOOD, V88, P4390; LO YMD, 1993, LANCET, V341, P1147, DOI 10.1016/0140-6736(93)93161-S; LO YMD, 1989, LANCET, V2, P1363; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; LO YMD, 1994, ANN NY ACAD SCI, V731, P204, DOI 10.1111/j.1749-6632.1994.tb55772.x; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; Sohda S, 1997, PRENATAL DIAG, V17, P743, DOI 10.1002/(SICI)1097-0223(199708)17:8<743::AID-PD144>3.3.CO;2-V; WALKNOWSKA J, 1969, LANCET, V1, P1119	26	1224	1511	2	82	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					768	775		10.1086/301800	http://dx.doi.org/10.1086/301800			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529358	Green Published, Bronze			2022-12-18	WOS:000073514400006
J	EASTON, DF; BISHOP, DT; FORD, D; CROCKFORD, GP				EASTON, DF; BISHOP, DT; FORD, D; CROCKFORD, GP			GENETIC-LINKAGE ANALYSIS IN FAMILIAL BREAST AND OVARIAN-CANCER - RESULTS FROM 214 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; ONSET; LOCUS; RISK; AGE; SEGREGATION; POPULATION; PEDIGREES; HORMONE; HUMANS	Breast cancer is known to have an inherited component, consistent in some families with autosomal dominant inheritance; in such families the disease often occurs in association with ovarian cancer. Previous genetic linkage studies have established that in some such families disease occurrence is linked to markers on chromosome 17q. This paper reports the results of a collaborative linkage study involving 214 breast cancer families, including 57 breast-ovarian cancer families; this represents almost all the known families with 17q linkage data. Six markers on 17q, spanning approximately 30 cM, were typed in the families. The aims of the study were to define more precisely the localization of the disease gene, the extent of genetic heterogeneity and the characteristics of linked families and to estimate the penetrance of the 17q gene. Under the assumption of no genetic heterogeneity, the strongest linkage evidence was obtained with D17S588 (maximum LOD score [Z(max)] = 21.68 at female recombination fraction [theta(f)] = .13) and D17S579 (Z(max) = 13.02 at theta(f) = .16). Multipoint linkage analysis allowing for genetic heterogeneity provided evidence that the predisposing gene lies between the markers D17S588 and D17S250, an interval whose genetic length is estimated to be 8.3 cM in males and 18.0 cM in females. This position was supported over other intervals by odds of 66:1. The location of the gene with respect to D17S579 could not be determined unequivocally. Under the genetic model used in the analysis, the best estimate of the proportion of linked breast-ovarian cancer families was 1.0 (lower LOD - 1 limit 0.79). In contrast, there was significant evidence of genetic heterogeneity among the families without ovarian cancer, with an estimated 45% being linked. These results suggest that a gene(s) on chromosome 17q accounts for the majority of families in which both early-onset breast cancer and ovarian cancer occur but that other genes predisposing to breast cancer exist. By examining the fit of the linkage data to different penetrance functions, the cumulative risk associated with the 17q gene was estimated to be 59% by age 50 years and 82% by age 70 years. The corresponding estimates for the breast-ovary families were 67% and 76%, and those for the families without ovarian cancer were 49% and 90%; these penetrance functions did not differ significantly from one another.	ST JAMES HOSP, GENET EPIDEMIOL LAB,IMPERIAL CANC RES FUND, ASHLEY WING,BECKETT ST, LEEDS LS9 7TF, ENGLAND; CANC RES CAMPAIGN, BELMONT, SURREY, ENGLAND; INST CANC RES, EPIDEMIOL SECT, BELMONT, SURREY, ENGLAND	Saint James's University Hospital; University of London; Institute of Cancer Research - UK				Bishop, Tim/0000-0002-8752-8785; Bowcock, Anne/0000-0001-8691-9090				ADAMI HO, 1980, BRIT J CANCER, V42, P71, DOI 10.1038/bjc.1980.204; ARASON A, 1993, AM J HUM GENET, V52, P711; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; BLACK DM, 1993, AM J HUM GENET, V52, P702; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; COHEN BB, 1993, AM J HUM GENET, V52, P723; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; FAIN PR, 1991, CYTOGENET CELL GENET, V57, P66; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FRAUMENI JF, 1975, CANCER-AM CANCER SOC, V36, P364, DOI 10.1002/1097-0142(197508)36:2<364::AID-CNCR2820360211>3.0.CO;2-C; GARDNER EJ, 1950, AM J HUM GENET, V2, P30; GOLDGAR DE, 1993, AM J HUM GENET, V52, P743; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; ISELIUS L, 1991, ANN HUM GENET, V55, P151, DOI 10.1111/j.1469-1809.1991.tb00408.x; Kelsey J L, 1979, Epidemiol Rev, V1, P74; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LYNCH HT, 1978, CANCER-AM CANCER SOC, V41, P1543, DOI 10.1002/1097-0142(197804)41:4<1543::AID-CNCR2820410444>3.0.CO;2-Y; MACKAY K, 1990, NUCLEIC ACIDS RES, V18, P5926, DOI 10.1093/nar/18.19.5926; MARGARITTE P, 1992, AM J HUM GENET, V50, P1231; MERETTE C, 1992, AM J HUM GENET, V50, P515; METTLIN C, 1990, AM J EPIDEMIOL, V131, P973, DOI 10.1093/oxfordjournals.aje.a115617; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1992, AM J HUM GENET, V51, P283; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; RISCH N, 1984, AM J HUM GENET, V36, P363; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; SCHILDKRAUT JM, 1988, AM J EPIDEMIOL, V128, P456, DOI 10.1093/oxfordjournals.aje.a114994; SMITH SA, 1993, AM J HUM GENET, V52, P767; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P1, DOI 10.1159/000133157; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P686, DOI 10.1159/000133177; SPURR NK, 1993, AM J HUM GENET, V52, P777; VARESCO L, 1992, GENE CHROMOSOME CANC, V4, P84, DOI 10.1002/gcc.2870040113; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104	42	1170	1198	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					678	701						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460634				2022-12-18	WOS:A1993KY05900005
J	RISCH, N				RISCH, N			LINKAGE STRATEGIES FOR GENETICALLY COMPLEX TRAITS .1. MULTILOCUS MODELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHS [GM39812] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANTOR R M, 1987, American Journal of Human Genetics, V41, pA252; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DEMPSTER ER, 1950, GENETICS, V35, P212; HODGE SE, 1981, AM J HUM GENET, V33, P381; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; MCGUE M, 1983, AM J HUM GENET, V35, P1161; RISCH N, 1983, BEHAV GENET, V13, P441, DOI 10.1007/BF01065920; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; THOMSON G, 1986, AM J HUM GENET, V39, P207; WEEKS DE, 1988, AM J HUM GENET, V42, P315	11	1160	1181	0	22	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					222	228						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301392				2022-12-18	WOS:A1990CM93800002
J	Browning, BL; Browning, SR				Browning, Brian L.; Browning, Sharon R.			A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated Individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LARGE-SCALE; SUSCEPTIBILITY LOCI; METAANALYSIS; MODELS; POWER; MAP	We present methods for imputing data for ungenotyped markers and for inferring haplotype phase in large data sets of unrelated individuals and parent-offspring trios. Our methods make use of known haplotype phase when it is available, and our methods are computationally efficient so that the full information in large reference panels with thousands of individuals is utilized. We demonstrate that substantial gains in imputation accuracy accrue with increasingly large reference panel sizes, particularly when imputing low-frequency A variants, and that unphased reference panels can provide highly accurate genotype imputation. We place our methodology in a unified framework that enables the simultaneous use of unphased and phased data from trios and unrelated individuals in a single analysis. For unrelated individuals, our imputation methods produce well-calibrated posterior genotype probabilities and highly accurate allele frequency estimates. For trios, our haplotype-inference method is four orders of magnitude faster than the gold-standard PHASE program 14 and has excellent accuracy. Our methods enable genotype imputation to be performed with unphased trio or unrelated reference panels, thus accounting for haplotype-phase uncertainty in the reference panel. We present a useful measure of imputation accuracy, allelic R-2, and show that this measure can be estimated accurately from posterior genotype probabilities. Our methods are implemented in version 3.0 of the BEAGLE software package.	[Browning, Brian L.; Browning, Sharon R.] Univ Auckland, Dept Stat, Auckland 1142, New Zealand	University of Auckland	Browning, BL (corresponding author), Univ Auckland, Dept Stat, Auckland 1142, New Zealand.	b.browning@auckland.ac.nz	Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010	Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633	Wellcome Trust [076113]; National Institutes of Health [3R01GM075091-02S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from the Wellcome Trust Case Control Consortium (see Web Resources). Funding for the Wellcome Trust Case Control Consortium project was provided by the Wellcome Trust under award 076113. We gratefully acknowledge the use of Illumina 550K genotype data for individuals in the British 1958 Birth Cohort generated by the Wellcome Trust Sanger Institute. We thank Benjamin Neale and the GAIN Imputation Workgroup for suggesting the allelefrequency correlation metric for measuring imputation accuracy. This work was supported by National Institutes of Health grant 3R01GM075091-02S1.	Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grice JA, 1997, COMPUT APPL BIOSCI, V13, P45; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wheeler R, 2000, BIOINFORMATICS, V16, P1082, DOI 10.1093/bioinformatics/16.12.1082; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	29	1153	1198	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					210	223		10.1016/j.ajhg.2009.01.005	http://dx.doi.org/10.1016/j.ajhg.2009.01.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200528	Green Published, Bronze			2022-12-18	WOS:000263799700011
J	TIRET, L; RIGAT, B; VISVIKIS, S; BREDA, C; CORVOL, P; CAMBIEN, F; SOUBRIER, F				TIRET, L; RIGAT, B; VISVIKIS, S; BREDA, C; CORVOL, P; CAMBIEN, F; SOUBRIER, F			EVIDENCE, FROM COMBINED SEGREGATION AND LINKAGE ANALYSIS, THAT A VARIANT OF THE ANGIOTENSIN-I-CONVERTING ENZYME (ACE) GENE CONTROLS PLASMA ACE LEVELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION; UNIFIED MODEL; SERUM; RESEMBLANCE; ADULTS	The hypothesis of a genetic control of plasma angiotensin 1-converting enzyme (ACE) level has been suggested both by segregation analysis and by the identification of an insertion/deletion (I/D) polymorphism of the ACE gene, a polymorphism contributing much to the variability of ACE level. To elucidate whether the I/D polymorphism was directly involved in the genetic regulation, plasma ACE activity and genotype for the I/D polymorphism were both measured in a sample of 98 healthy nuclear families. The pattern of familial correlations of ACE level was compatible with a zero correlation between spouses and equal parent-offspring and sib-sib correlations (.24 +/- .04). A segregation analysis indicated that this familial resemblance could be entirely explained by the transmission of a codominant major gene. The I/D polymorphism was associated with marked differences of ACE levels, although these differences were less pronounced than those observed in the segregation analysis. After adjustment for the polymorphism effects, the residual heritability (.280 +/- .096) was significant. Finally, a combined segregation and linkage analysis provided evidence that the major-gene effect was due to a variant of the ACE gene, in strong linkage disequilibrium with the I/D polymorphism. The marker allele I appeared always associated with the major-gene allele s characterized by lower ACE levels. The frequency of allele I was .431 +/- .025, and that of major allele s was .557 +/- .041. The major gene had codominant effects equal to 1.3 residual SDs and accounted for 44% of the total variability of ACE level, as compared with 28% for the I/D polymorphism. The I/D polymorphism should constitute a powerful tool for identifying the ACE gene variant involved in the regulation of ACE level.	COLL FRANCE, INSERM, U36, 3 RUE ULM, F-75231 PARIS 05, FRANCE; INSERM, U258, F-75005 PARIS, FRANCE; INSERM, SC7, F-75005 PARIS, FRANCE; CTR MED PREVENT, F-54500 Vandoeuvre Les Nancy, FRANCE; CNRS, URA 597, VANDOEUVRE LES NANCY, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine			Cambien, Francois/AAP-9751-2020; Visvikis-Siest, Sophie/H-2324-2014	Visvikis-Siest, Sophie/0000-0001-8104-8425				ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; BENETEAU B, 1986, CLIN CHEM, V32, P884; BENETEAUBURNAT B, 1990, CLIN CHEM, V36, P344; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BONNEY GE, 1988, AM J HUM GENET, V43, P29; CAMBIEN F, 1988, AM J HUM GENET, V43, P774; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DESCHAMPS JP, 1987, MAINTAINING HLTH STA, P3; DONNER A, 1981, AM J EPIDEMIOL, V114, P149, DOI 10.1093/oxfordjournals.aje.a113162; DUX S, 1984, ISRAEL J MED SCI, V20, P1138; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ERDOS EG, 1987, LAB INVEST, V56, P345; HASSTEDT SJ, 1989, PEDIGREE ANAL PACKAG; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HUBERT C, 1991, J BIOL CHEM, V266, P15377; JACOB HJ, 1991, GENE, V67, P213; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; MARCADET A, 1986, HISTOCOMPATIBILITY T, V1, P553; MATTEI MG, 1989, CYTOGENET CELL GENET, V51, P1041; MORTON NE, 1974, AM J HUM GENET, V26, P489; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; WEI L, 1991, J BIOL CHEM, V266, P5540	24	1119	1185	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					197	205						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1319114				2022-12-18	WOS:A1992JA46700021
J	Firth, HV; Richards, SM; Bevan, AP; Clayton, S; Corpas, M; Rajan, D; Van Vooren, S; Moreau, Y; Pettett, RM; Carter, NP				Firth, Helen V.; Richards, Shola M.; Bevan, A. Paul; Clayton, Stephen; Corpas, Manuel; Rajan, Diana; Van Vooren, Steven; Moreau, Yves; Pettett, Roger M.; Carter, Nigel P.			DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DELAY; COPY NUMBER; ARRAY-CGH; MICRODELETION; MUTATIONS; DELETIONS; GENE; DUPLICATIONS; REARRANGEMENTS	Many patients suffering from developmental disorders harbor submicroscopic deletions or duplications that, by affecting the copy number of dosage-sensitive genes or disrupting normal gene expression, lead to disease. However, many aberrations are novel or extremely rare, making clinical interpretation problematic and genotype-phenotype correlations uncertain. Identification of patients sharing a genomic rearrangement and having phenotypic features in common leads to greater certainty in the pathogenic nature of the rearrangement and enables new syndromes to be defined. To facilitate the analysis of these rare events, we have developed an interactive web-based database called DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources) which incorporates a suite of tools designed to aid the interpretation of submicroscopic chromosomal imbalance, inversions, and trans-locations. DECIPHER catalogs common copy-number changes in normal populations and thus, by exclusion, enables changes that are novel and potentially pathogenic to be identified. DECIPHER enhances genetic counseling by retrieving relevant information from a variety of bioinformatics resources. Known and predicted genes within an aberration are listed in the DECIPHER patient report, and genes of recognized clinical importance are highlighted and prioritized. DECIPHER enables clinical scientists worldwide to maintain records of phenotype and chromosome rearrangement for their patients and, with informed consent, share this information with the wider clinical research community through display in the genome browser Ensembl. By sharing cases worldwide, clusters of rare cases having phenotype and structural rearrangement in common can be identified, leading to the delineation of new syndromes and furthering understanding of gene function.	[Firth, Helen V.] Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; [Richards, Shola M.; Bevan, A. Paul; Clayton, Stephen; Corpas, Manuel; Rajan, Diana; Pettett, Roger M.; Carter, Nigel P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Van Vooren, Steven; Moreau, Yves] Katholieke Univ Leuven, ESAT SCD, B-3001 Louvain, Belgium	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; KU Leuven	Firth, HV (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England.	hvf21@cam.ac.uk; npc@sanger.ac.uk	Corpas, Manuel/AAE-7869-2020	Corpas, Manuel/0000-0002-4417-1018; Bevan, Paul/0000-0002-0656-9164; Moreau, Yves/0000-0002-4647-6560; Van Vooren, Steven/0000-0001-8437-957X	Wellcome Trust [WT077008]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant number WT077008). We thank the patients and their families for permission to include their details in this paper. We thank Jim Lupski and Martin Bobrow for their helpful comments on the draft manuscript, Anthony V. Cox for his bioinformatics expertise, and Lionel Willatt for conducting the FISH studies. We wish to thank all of the DECIPHER Syndrome Expert advisors together with the members of the DECIPHER Advisory Board for giving so generously of their expertise. Finally, we would like to thank all of the DECIPHER Consortium members, a list of whom can be found on the DECIPHER website.	Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; Brown Lesley, 1993, NEW SHORTER OXFORD E; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MALAN V, 2009, J MED GENET IN PRESS; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Michils G, 2005, HUM MUTAT, V25, P125, DOI 10.1002/humu.20122; NELLIST M, 1993, CELL, V75, P1305; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Rebholz-Schuhmann D, 2007, BIOINFORMATICS, V23, pE237, DOI 10.1093/bioinformatics/btl302; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Van Vooren S, 2007, NUCLEIC ACIDS RES, V35, P2533, DOI 10.1093/nar/gkm054; Veltman JA, 2006, CURR OPIN PEDIATR, V18, P598, DOI 10.1097/MOP.0b013e3280105417; Vermeesch JR, 2007, EUR J HUM GENET, V15, P1105, DOI 10.1038/sj.ejhg.5201896; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823	42	1108	1123	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					524	533		10.1016/j.ajhg.2009.03.010	http://dx.doi.org/10.1016/j.ajhg.2009.03.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19344873	Green Published, Bronze			2022-12-18	WOS:000265232800013
J	Stephens, M; Scheet, P				Stephens, M; Scheet, P			Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPECTATION-MAXIMIZATION ALGORITHM; GENOTYPE DATA; HUMAN GENOME; POPULATION-GENETICS; RECOMBINATION RATES; RECONSTRUCTION; SAMPLES	Although many algorithms exist for estimating haplotypes from genotype data, none of them take full account of both the decay of linkage disequilibrium (LD) with distance and the order and spacing of genotyped markers. Here, we describe an algorithm that does take these factors into account, using a flexible model for the decay of LD with distance that can handle both "blocklike" and "nonblocklike" patterns of LD. We compare the accuracy of this approach with a range of other available algorithms in three ways: for reconstruction of randomly paired, molecularly determined male X chromosome haplotypes; for reconstruction of haplotypes obtained from trios in an autosomal region; and for estimation of missing genotypes in 50 autosomal genes that have been completely resequenced in 24 African Americans and 23 individuals of European descent. For the autosomal data sets, our new approach clearly outperforms the best available methods, whereas its accuracy in inferring the X chromosome haplotypes is only slightly superior. For estimation of missing genotypes, our method performed slightly better when the two subsamples were combined than when they were analyzed separately, which illustrates its robustness to population stratification. Our method is implemented in the software package PHASE (v2.1.1), available from the Stephens Lab Web site.	Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Stephens, M (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.	stephens@stat.washington.edu			NHGRI NIH HHS [T32 HG00035, 1R01HG/LM02585-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585, T32HG000035] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Besag J. E., 1994, J R STAT SOC B, V56, P591; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; ESKIN E, 2003, P 7 ANN INT C RES CO, P104; Eskin Eleazar, 2003, J Bioinform Comput Biol, V1, P1, DOI 10.1142/S0219720003000174; Evans G., 1993, PRACTICAL NUMERICAL; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier Laurent, 2003, Human Genomics, V1, P7; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fearnhead P, 2001, GENETICS, V159, P1299; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Heckerman D, 2001, J MACH LEARN RES, V1, P49, DOI 10.1162/153244301753344614; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kimmel G, 2004, P 8 ANN INT C RES CO, P2, DOI [10.1145/974614.974616, DOI 10.1145/974614.974616]; Li N, 2003, GENETICS, V165, P2213; Lin S, 2004, GENOME RES, V14, P1624, DOI 10.1101/gr.2204604; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; LONG JC, 1995, AM J HUM GENET, V56, P799; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254	33	1094	1123	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					449	462		10.1086/428594	http://dx.doi.org/10.1086/428594			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15700229	Bronze, Green Published			2022-12-18	WOS:000226851900008
J	Begovich, AB; Carlton, VEH; Honigberg, LA; Schrodi, SJ; Chokkalingam, AP; Alexander, HC; Ardlie, KG; Huang, QQ; Smith, AM; Spoerke, JM; Conn, MT; Chang, M; Chang, SYP; Saiki, RK; Catanese, JJ; Leong, DU; Garcia, VE; McAllister, LB; Jeffery, DA; Lee, AT; Batliwalla, F; Remmers, E; Criswell, LA; Seldin, MF; Kastner, DL; Amos, CI; Sninsky, JJ; Gregersen, PK				Begovich, AB; Carlton, VEH; Honigberg, LA; Schrodi, SJ; Chokkalingam, AP; Alexander, HC; Ardlie, KG; Huang, QQ; Smith, AM; Spoerke, JM; Conn, MT; Chang, M; Chang, SYP; Saiki, RK; Catanese, JJ; Leong, DU; Garcia, VE; McAllister, LB; Jeffery, DA; Lee, AT; Batliwalla, F; Remmers, E; Criswell, LA; Seldin, MF; Kastner, DL; Amos, CI; Sninsky, JJ; Gregersen, PK			A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE LINKAGE; AUTOIMMUNE-DISEASES; T-CELLS; SUSCEPTIBILITY LOCUS; KINASE P50(CSK); COMPLEX; PEP; LYP; FREQUENCY; FAMILIES	Rheumatoid arthritis (RA) is the most common systemic autoimmune disease, affecting similar to1% of the adult population worldwide, with an estimated heritability of 60%. To identify genes involved in RA susceptibility, we investigated the association between putative functional single-nucleotide polymorphisms (SNPs) and RA among white individuals by use of a case-control study design; a second sample was tested for replication. Here we report the association of RA susceptibility with the minor allele of a missense SNP in PTPN22 (discovery-study allelic P = 6.6 x 10(-4); replication-study allelic P = 5.6 x 10(-8)), which encodes a hematopoietic-specific protein tyrosine phosphatase also known as "Lyp." We show that the risk allele, which is present in similar to17% of white individuals from the general population and in similar to28% of white individuals with RA, disrupts the P1 proline-rich motif that is important for interaction with Csk, potentially altering these proteins' normal function as negative regulators of T-cell activation. The minor allele of this SNP recently was implicated in type 1 diabetes, suggesting that the variant phosphatase may increase overall reactivity of the immune system and may heighten an individual carrier's risk for autoimmune disease.	Celera Diagnost, Alameda, CA 94502 USA; Celera Genom, San Francisco, CA USA; Genom Collaborat Inc, Cambridge, MA USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; N Shore LIJ Res Inst, Ctr Genom & Human Genet, Manhasset, NY USA; NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; Univ Calif Davis, Dept Med, Rowe Program Human Genet, Davis, CA 95616 USA	University of Texas System; UTMD Anderson Cancer Center; Northwell Health; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of California System; University of California San Francisco; University of California System; University of California Davis	Begovich, AB (corresponding author), Celera Diagnost, 1401 Harbor Bay Pkwy, Alameda, CA 94502 USA.	Ann.Begovich@celeradiagnostics.com	Schrodi, Steven J./O-4288-2019; Peng, Bo/A-6920-2009	Schrodi, Steven J./0000-0003-2304-8528; Peng, Bo/0000-0001-8225-2284; Remmers, Elaine F/0000-0002-9522-1249; Morelli, Maria Paula/0000-0001-7157-486X	NCRR NIH HHS [5 M01 RR-00079, M01 RR000079] Funding Source: Medline; NHGRI NIH HHS [HG 02275, R01 HG002275] Funding Source: Medline; NIAMS NIH HHS [N01-AR-7-2232, R01-AR44222] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041139, N01AR072232] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Breslow NE., 1980, IARC SCI PUBL, P5; Chien WW, 2003, J BIOL CHEM, V278, P27413, DOI 10.1074/jbc.M304575200; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fisher SA, 2003, ARTHRITIS RHEUM-US, V48, P1200, DOI 10.1002/art.10945; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hill RJ, 2002, EXP HEMATOL, V30, P237, DOI 10.1016/S0301-472X(01)00794-9; Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.3.CO;2-L; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kojo S, 2001, ARTHRITIS RHEUM-US, V44, P1127, DOI 10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Lin JP, 1998, HUM GENET, V103, P475, DOI 10.1007/s004390050853; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Schlesselman James J., 1982, CASE CONTROL STUDIES; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Yang QH, 2003, EPIDEMIOLOGY, V14, P161, DOI 10.1097/00001648-200303000-00009	37	1092	1142	1	58	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					330	337		10.1086/422827	http://dx.doi.org/10.1086/422827			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15208781	Bronze, Green Published			2022-12-18	WOS:000222702000018
J	WORKMAN, PL; NISWANDER, JD				WORKMAN, PL; NISWANDER, JD			POPULATION STUDIES ON SOUTHWESTERN INDIAN TRIBES .2. LOCAL GENETIC DIFFERENTIATION IN PAPAGO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; BODMER WF, 1968, GENETICS, V59, P565; BROWN KS, 1958, AM J HUM GENET, V10, P175; HOWELLS WW, 1966, CURR ANTHROPOL, V7, P531, DOI 10.1086/200769; JONES RD, 1969, THESIS U ARIZONA; KENDALL MG, 1961, ADVANCED THEORY STAT, V2; KIMURA M, 1964, GENETICS, V49, P461; LI CC, 1953, AM J HUM GENET, V5, P107; MALECOT G, 1966, PROBABILITES HEREDIT; Mark A., 1960, THESIS U ARIZONA; MORTON NE, 1968, AM J HUM GENET, V20, P411; NEEL JV, 1967, AM J HUM GENET, V19, P554; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEI M, 1966, HEREDITY, V21, P461, DOI 10.1038/hdy.1966.45; NEI M, 1965, EVOLUTION, V19, P256, DOI 10.2307/2406379; NEI M, 1966, HEREDITY, V21, P183, DOI 10.1038/hdy.1966.17; NEI M, 1966, HEREDITY, V21, P9, DOI 10.1038/hdy.1966.2; NISWANDER JD, 1970, AM J HUM GENET, V22, P7; PERSSON I, 1968, ACTA GENET STAT MED, V18, P261; ROBERTS D. F., 1965, EUGEN REV, V56, P185; SALZANO FM, 1961, HUM BIOL, V33, P110; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SALZANO FM, 1968, AM J PHYS ANTHROPOL, V28, P183, DOI 10.1002/ajpa.1330280215; Sanghvi LD, 1953, AM J PHYS ANTHROP-NE, V11, P385, DOI 10.1002/ajpa.1330110313; SCHULL WJ, 1962, HUM BIOL, V34, P271; SNEDECOR GEORGE W., 1933, IOWA STATE COLL JOUR SCI, V8, P75; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WORKMAN PL, 1969, HUM BIOL, V41, P97; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Wright S, 1943, GENETICS, V28, P139; YASUDA N, 1967, 3RD P INT C HUM GEN, P249	33	1074	1089	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	1					24	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F4294	5411647				2022-12-18	WOS:A1970F429400003
J	MUDD, SH; SKOVBY, F; LEVY, HL; PETTIGREW, KD; WILCKEN, B; PYERITZ, RE; ANDRIA, G; BOERS, GHJ; BROMBERG, IL; CERONE, R; FOWLER, B; GROBE, H; SCHMIDT, H; SCHWEITZER, L				MUDD, SH; SKOVBY, F; LEVY, HL; PETTIGREW, KD; WILCKEN, B; PYERITZ, RE; ANDRIA, G; BOERS, GHJ; BROMBERG, IL; CERONE, R; FOWLER, B; GROBE, H; SCHMIDT, H; SCHWEITZER, L			THE NATURAL-HISTORY OF HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIMH, THEORET STUFF & MATH, BETHESDA, MD 20205 USA; HARVARD UNIV, MASSACHUSETTS GEN HOSP, JOSEPH P KENNEDY LABS, BOSTON, MA 02114 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; CATHOLIC UNIV NIJMEGEN, DEPT MED, NIJMEGEN, NETHERLANDS; HOSP SICK CHILDREN, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV GENOA, PEDIAT CLIN R, I-16126 GENOA, ITALY; ROYAL MANCHESTER CHILDRENS HOSP, WILLINK BIOCHEM GENET UNIT, MANCHESTER M27 1HA, LANCS, ENGLAND; UNIV MUNSTER, KINDERKLIN, D-4400 MUNSTER, FED REP GER; UNIV HEIDELBERG, KINDERKLIN, D-6900 HEIDELBERG, FED REP GER; NEW YORK STATE INST BASIC RES DEV DISABIL, STATEN ISL, NY 10314 USA; FAC MED & CHIRURG 2, PEDIAT CLIN, NAPOLI, ITALY; NEW S WALES DEPT HLTH, N RYDE 2113, AUSTRALIA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Radboud University Nijmegen; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Genoa; Royal Manchester Children's Hospital; University of Munster; Ruprecht Karls University Heidelberg; Institute for Basic Research in Developmental Disabilities	MUDD, SH (corresponding author), NIMH, GEN & COMPARAT BIOCHEM LAB, BLDG 32, ROOM 101, 9000 ROCKVILLE, BETHESDA, MD 20205 USA.		andria, generoso/V-7172-2019; Pyeritz, Reed/A-1364-2010; Melis, Daniela/AAD-3623-2019	Melis, Daniela/0000-0002-9458-3926				ALMGREN B, 1978, ACTA CHIR SCAND, V144, P545; ANDLAUER AC, 1978, PEDIATRIE, V33, P669; AUTRET E, 1982, ANN PEDIATR-PARIS, V29, P203; BARBER GW, 1969, J PEDIATR, V75, P463, DOI 10.1016/S0022-3476(69)80274-X; BARBER GW, 1967, LANCET, V1, P337; BOERS GHJ, 1983, METABOLISM, V32, P390, DOI 10.1016/0026-0495(83)90049-5; BRENTON DP, 1966, Q J MED, V35, P325; BRENTON DP, 1977, ANN CLIN BIOCHEM, V14, P161, DOI 10.1177/000456327701400136; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.1093/biomet/57.3.579; CAREY MC, 1968, AM J MED, V45, P7, DOI 10.1016/0002-9343(68)90003-X; Carson N. A. J., 1982, INBORN ERRORS METABO, P53; CARSON NAJ, 1965, J PEDIATR-US, V66, P565, DOI 10.1016/S0022-3476(65)80121-4; CARSON NAJ, 1962, ARCH DIS CHILD, V37, P505, DOI 10.1136/adc.37.195.505; CARSON NAJ, 1971, INHERITED DISORDERS, P284; CHOU SM, 1965, ARCH PATHOL, V79, P357; CRITCHLE.M, 1966, P ROY SOC MED, V59, P484, DOI 10.1177/003591576605900604; CROOKE JW, 1971, BRIT J ANAESTH, V43, P96, DOI 10.1093/bja/43.1.96; DRAYER JIM, 1980, NETH J MED, V23, P89; DUNN HG, 1966, NEUROLOGY, V16, P407, DOI 10.1212/WNL.16.4.407; Finkelstein J D, 1969, Clin Proc Child Hosp Dist Columbia, V25, P291; FOWLER B, 1984, AMINOACIDOPATIE CLIN; FROST PM, 1980, ANAESTHESIA, V35, P918, DOI 10.1111/j.1365-2044.1980.tb03955.x; FUKS AB, 1980, J DENT CHILD     SEP, P340; GARSTON JB, 1970, BRIT J OPHTHALMOL, V54, P248, DOI 10.1136/bjo.54.4.248; GAUDIER B, 1969, ARCH FR PEDIATR, V26, P963; GAUDIER B, 1968, ARCH FR PEDIATR, V25, P541; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203; GERRITSEN T, 1962, BIOCHEM BIOPH RES CO, V9, P493, DOI 10.1016/0006-291X(62)90114-6; Girard P F, 1967, Lyon Med, V218, P1369; GRIFFITHS R, 1976, CLIN CHIM ACTA, V73, P157, DOI 10.1016/0009-8981(76)90317-X; GROBE H, 1980, EUR J PEDIATR, V135, P199, DOI 10.1007/BF00441642; GROVER VK, 1979, ANAESTHESIA, V34, P913, DOI 10.1111/j.1365-2044.1979.tb08563.x; HAGBERG B, 1968, DEV MED CHILD NEUROL, V10, P479; HAMBRAEUS L, 1974, UPSALA J MED SCI, V15, P3; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; HILLZOBEL RL, 1982, NEW ENGL J MED, V307, P781, DOI 10.1056/NEJM198209233071303; HOLMGREN G, 1973, HUM HERED, V23, P548, DOI 10.1159/000152622; HOLMGREN G, 1974, NEUROPADIATRIE, V5, P402, DOI 10.1055/s-0028-1091720; HUBERT JP, 1973, PATHOL EUR, V8, P113; KAESER AC, 1969, J NEUROL NEUROSUR PS, V32, P88, DOI 10.1136/jnnp.32.2.88; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOMROWER GM, 1966, ARCH DIS CHILD, V41, P666, DOI 10.1136/adc.41.220.666; KOMROWER GM, 1963, P ROY SOC MED, V56, P996, DOI 10.1177/003591576305601127; KOMROWER GM, 1971, INHERITED DISORDERS, P254; KOSSOWICZ H, 1977, METAB PEDIATR SYST O, V1, P121; LAMON JM, 1981, GENETIC DISEASES PRE, P1; LENKE RR, 1980, NEW ENGL J MED, V303, P1202, DOI 10.1056/NEJM198011203032104; Levy H.L., 1971, INHERITED DISORDERS, P235; MCCURDY RS, 1984, NEWSLETTER MOUNTAIN, V6; McKusick VA, 1971, INHERITED DISORDERS, P179; MEYNADIER J, 1981, DERMATOLOGICA, V163, P34, DOI 10.1159/000250138; MORROW G, 1972, J PEDIATR-US, V81, P946, DOI 10.1016/S0022-3476(72)80548-1; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; MUDD SH, 1981, AM J HUM GENET, V33, P883; MUDD SH, 1974, HERITABLE DISORDERS, P429; MUDD SH, 1983, METABOLIC BASIS INHE, P522; NEWMAN G, 1984, Q J MED, V53, P251; PARKINSON MS, 1969, P ROY SOC MED, V62, P909, DOI 10.1177/003591576906200923; PARRIS WCV, 1982, ANESTH ANALG, V61, P708; PERRY TL, 1968, LANCET, V2, P474; Price J, 1968, J Ment Defic Res, V12, P111; PULLON DHH, 1980, NEONATAL SCREENING I, P29; RAHMAN M, 1971, BRIT J OPHTHALMOL, V55, P338, DOI 10.1136/bjo.55.5.338; REGENBOGEN L, 1980, METAB PEDIATR SYST O, V4, P209; RITCHIE JWK, 1973, J OBSTET GYN BR COMM, V80, P664; SCHLESSELMAN JJ, 1979, AM J OBSTET GYNECOL, V135, P135; SCHUH S, 1984, NEW ENGL J MED, V310, P686, DOI 10.1056/NEJM198403153101104; SKOVBY F, 1984, AM J HUM GENET, V36, P452; SKOVBY F, 1982, AM J HUM GENET, V34, P73; SMOLIN LA, 1981, J PEDIATR-US, V99, P467, DOI 10.1016/S0022-3476(81)80352-6; Tancredi F, 1967, Minerva Pediatr, V19, P642; TURNBULL BW, 1974, J AM STAT ASSOC, V69, P74, DOI 10.2307/2285502; VANDRESSE JH, 1978, NEURORADIOLOGY, V17, P57, DOI 10.1007/BF00345271; VERGER P, 1968, LILLE MED, V13, P450; VERGER P, 1973, BORDEAUX MED, V16, P1893; WILCKEN B, 1978, ARCH DIS CHILD, V53, P242, DOI 10.1136/adc.53.3.242; WILCKEN DEL, 1983, NEW ENGL J MED, V309, P448, DOI 10.1056/NEJM198308253090802; YOSHIDA T, 1968, TOHOKU J EXP MED, V96, P235, DOI 10.1620/tjem.96.235; YOSHIDA T, 1966, RINSHO SHONIIGAKU JA, V14, P402; 1982, STATISTICAL ABSTRACT, P27	80	1047	1080	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					1	31						31	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	3872065				2022-12-18	WOS:A1985AGY5700001
J	Wigginton, JE; Cutler, DJ; Abecasis, GR				Wigginton, JE; Cutler, DJ; Abecasis, GR			A note on exact tests of Hardy-Weinberg equilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION	Deviations from Hardy-Weinberg equilibrium (HWE) can indicate inbreeding, population stratification, and even problems in genotyping. In samples of affected individuals, these deviations can also provide evidence for association. Tests of HWE are commonly performed using a simple chi(2) goodness-of-fit test. We show that this chi(2) test can have inflated type I error rates, even in relatively large samples (e.g., samples of 1,000 individuals that include similar to 100 copies of the minor allele). On the basis of previous work, we describe exact tests of HWE together with efficient computational methods for their implementation. Our methods adequately control type I error in large and small samples and are computationally efficient. They have been implemented in freely available code that will be useful for quality assessment of genotype data and for the detection of genetic association or population stratification in very large data sets.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA	University of Michigan System; University of Michigan; Johns Hopkins University	Wigginton, JE (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	goncalo@umich.edu	Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; CROW JF, 1988, GENETICS, V119, P473; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Vithayasai C, 1973, COMMUN STATISTICS, V1, P229; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Weinberg W., 1908, PAPERS HUMAN GENETIC; Weir B., 1996, GENETIC DATA ANAL; Wellek S, 2004, BIOMETRICS, V60, P694, DOI 10.1111/j.0006-341X.2004.00219.x	16	1037	1063	1	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					887	893		10.1086/429864	http://dx.doi.org/10.1086/429864			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15789306	Green Published, Bronze			2022-12-18	WOS:000228198300016
J	LYON, MF				LYON, MF			SEX CHROMATIN AND GENE ACTION IN MAMMALIAN X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1959, BLOOD, V14, P103, DOI 10.1182/blood.V14.2.103.103; BIGGS R, 1958, BRIT J HAEMATOL, V4, P1, DOI 10.1111/j.1365-2141.1958.tb03830.x; BOWEN R, 1957, South Med J, V50, P1018; BRINKHOUS KM, 1954, BLOOD, V9, P254, DOI 10.1182/blood.V9.3.254.254; BRINKHOUS KM, 1950, SCIENCE, V111, P723, DOI 10.1126/science.111.2896.723; CATTANACH B, 1961, GENET RES, V2, P156, DOI 10.1017/S001667230000063X; CHILDS B, 1958, B JOHNS HOPKINS HOSP, V102, P21; CUENDET J F, 1957, Acta Genet Stat Med, V7, P75; DICKIE MM, 1954, J HERED, V45, P158, DOI 10.1093/oxfordjournals.jhered.a106466; DOUGLAS AS, 1957, LANCET, V2, P616; Dunn LC, 1934, J GENET, V29, P317, DOI 10.1007/BF02982230; FALCONER DS, 1953, Z INDUKT ABSTAMM VER, V85, P210, DOI 10.1007/BF00309836; FALCONER DS, 1954, Z INDUKT ABSTAMM VER, V86, P263, DOI 10.1007/BF00444792; FALLS HF, 1948, ARCH OPHTHALMOL-CHIC, V40, P685, DOI 10.1001/archopht.1948.00900030700009; FALLS HF, 1951, AM J OPHTHALMOL, V34, P41, DOI 10.1016/0002-9394(51)90007-4; FANTL P, 1955, BMJ-BRIT MED J, V1, P640, DOI 10.1136/bmj.1.4914.640; FERGUSONSMITH MA, 1960, LANCET, V2, P184; FORD CE, 1959, LANCET, V1, P711; FORSSMAN H, 1955, AM J HUM GENET, V7, P21; FRACCARO M, 1960, LANCET, V2, P1303; FRANCESCHETTI A, 1961, ARCH JULIUS KLAUSSTI, V35, P322; FRANCOIS J, 1953, OPHTHALMOLOGICA, V126, P209, DOI 10.1159/000301877; FRASER AS, 1953, J GENET, V51, P217, DOI 10.1007/BF03023293; GARBER ED, 1952, P NATL ACAD SCI USA, V38, P876, DOI 10.1073/pnas.38.10.876; Gates Reginald Ruggles, 1946, HUMAN GENETICS; Goedbloed J., 1942, OPHTHALMOLOGICA, V104, P308; GRAHAM JB, 1953, AM J MED SCI, V225, P46; GRAHAM JB, 1959, AM J HUM GENET, V11, P311; GRUNEBERG H, 1952, GENETICS MOUSE; GRUNEBERG HANS, 1955, JOUR GENETICS, V53, P551, DOI 10.1007/BF02981674; HAMERTON JL, 1958, S NUCLEAR SEX; HARDISTY RM, 1957, BRIT MED J, V1, P1039, DOI 10.1136/bmj.1.5026.1039; JACOBS PA, 1959, LANCET, V2, P423; JACOBS PA, 1961, LANCET, V1, P1183; JAEGER W, 1952, GRAEFE ARCH OPHTH, V152, P379; JAEGER W, 1951, GRAEFES ARCH OPHTHAL, V151, P229; Kryschowa N, 1934, Z GESAMTE NEUROL PSY, V150, P421, DOI 10.1007/BF02890922; Levit SG, 1936, J GENET, V33, P411, DOI 10.1007/BF02982897; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; LINDSTEN J, 1961, LANCET, V1, P1228; LYON M. F., 1960, JOUR HEREDITY, V51, P116; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, PRIVATE COMMUNICATIO; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; MELLMAN WJ, 1961, BLOOD, V17, P719, DOI 10.1182/blood.V17.6.719.719; MERSKEY C, 1951, LANCET, V260, P487; MILLER OJ, 1961, LANCET, V2, P78; MILLER OJ, 1960, ADVANCES HUMAN GENET; NILSSON IM, 1959, LANCET, V2, P264; OHNO S, 1961, LANCET, V1, P78; OHNO S, 1959, EXP CELL RES, V18, P415, DOI 10.1016/0014-4827(59)90031-X; OHNO S, 1960, CANCER RES, V20, P541; OHNO S., 1960, PROC AMER ASSOC CANCER RES, V3, P139; OHNO S, 1960, EXP CELL RES, V19, P417, DOI 10.1016/0014-4827(60)90023-9; PARK WW, 1957, J ANAT, V91, P369; PHILLIPS RJ, 1961, GENET RES, V2, P290, DOI 10.1017/S0016672300000768; PITNEY WR, 1955, BRIT MED BULL, V11, P11, DOI 10.1093/oxfordjournals.bmb.a069438; POLANI PE, 1961, MOLECULAR GENETICS H; RAMOT B, 1955, J LAB CLIN MED, V46, P80; ROBERTS ELMER, 1929, JOUR AMER MED ASSOC, V93, P277; RUNDLES RW, 1946, AM J MED SCI, V211, P641, DOI 10.1097/00000441-194606000-00001; RUSSELL LB, 1961, GENETICS, V46, P509; RUSSELL LB, 1957, GENETICS, V42, P161; RUSSELL LB, 1960, GENETICS, V45, P1008; RUSSELL LB, 1961, SCIENCE, V133, P1795, DOI 10.1126/science.133.3467.1795; RUSSELL LB, 1959, GENETICS, V44, P532; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; SEAGLE JB, 1954, J PEDIATR-US, V45, P688, DOI 10.1016/S0022-3476(54)80264-2; SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P152; SORSBY A, 1951, CLINICAL GENETICS; SORSBY A, 1951, GENETICS OPTHTHALMOL; Stern C., 1960, PRINCIPLES HUMAN GEN; STEWART JS, 1961, LANCET, V2, P104; TAYLOR K, 1957, BRIT MED J, V1, P1494, DOI 10.1136/bmj.1.5034.1494; WAARDENBURG PJ, 1956, ANN HUM GENET, V21, P101, DOI 10.1111/j.1469-1809.1971.tb00270.x; Walls G. L., 1952, U CALIF PUBL PSYCHOL, V7, P1; WALLS GL, 1959, ARCH OPHTHALMOL-CHIC, V62, P13; WALTON J N, 1957, Acta Genet Stat Med, V7, P318; WELSHONS W. J., 1959, PROC NATL ACAD SCI, V45, P560, DOI 10.1073/pnas.45.4.560; WILKINSON JF, 1957, BRIT MED J, V2, P1528, DOI 10.1136/bmj.2.5060.1528; ZYBINA EV, 1930, DOKL AKAD NAUK SSSR, V130, P66	81	1027	1032	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					135	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	14467629				2022-12-18	WOS:A19622963A00006
J	Li, BS; Leal, SM				Li, Bingshan; Leal, Suzanne M.			Methods for detecting associations with rare variants for common diseases: Application to analysis of sequence data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; MACULAR DEGENERATION; LOGISTIC-REGRESSION; HDL CHOLESTEROL; PLASMA-LEVELS; GENE; SUSCEPTIBILITY; CONTRIBUTE	Although whole-genome association studies using tagSNPs are a powerful approach for detecting common variants, they are underpowered for detecting associations with rare variants. Recent studies have demonstrated that common diseases can be due to functional variants with a wide spectrum of allele frequencies, ranging from rare to common. An effective way to identify rare variants is through direct sequencing. The development of cost-effective sequencing technologies enables association studies to use sequence data from candidate genes and, in the future, from the entire genome. Although methods used for analysis of common variants are applicable to sequence data, their performance might not be optimal. In this study, it is shown that the collapsing method, which involves collapsing genotypes across variants and applying a univariate test, is powerful for analyzing rare variants, whereas multivariate analysis is robust against inclusion of noncausal variants. Both methods are superior to analyzing each variant individually with univariate tests. In order to unify the advantages of both collapsing and multiple-marker tests, we developed the Combined Multivariate and Collapsing (CMC) method and demonstrated that the CMC method is both powerful and robust. The CMC method can be applied to either candidate-gene or whole-genome sequence data.	[Li, Bingshan; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	sleal@bcm.edu	Li, Bingshan/H-1944-2011		National Institutes of Health [R01 DC03594, R01-NS049130]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was funded by National Institutes of Health grants R01 DC03594 and R01-NS049130. The authors would like to thank Andrew DeWan and Michael Nothnagel for their useful comments and suggestions.	Agresti A., 2003, CATEGORICAL DATA ANA; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; [Anonymous], 1932, STAT METHODS RES WOR; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Brunham LR, 2006, ANNU REV NUTR, V26, P105, DOI 10.1146/annurev.nutr.26.061505.111214; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Mooney S, 2005, BRIEF BIOINFORM, V6, P44, DOI 10.1093/bib/6.1.44; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Slatter TL, 2008, CLIN GENET, V73, P179, DOI 10.1111/j.1399-0004.2007.00940.x; Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455; Spirin V, 2007, AM J HUM GENET, V81, P1298, DOI 10.1086/522497; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	37	1007	1042	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					311	321		10.1016/j.ajhg.2008.06.024	http://dx.doi.org/10.1016/j.ajhg.2008.06.024			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18691683	Green Published, Bronze			2022-12-18	WOS:000259307200003
J	Sobel, E; Lange, K				Sobel, E; Lange, K			Descent graphs in pedigree analysis: Applications to haplotyping, location scores, and marker-sharing statistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS	The introduction of stochastic methods in pedigree analysis has enabled geneticists to tackle computations intractable by standard deterministic methods. Until now these stochastic techniques have worked by running a Markov chain on the set of genetic descent states of a pedigree. Each descent state specifies the paths of gene now in the pedigree and the founder alleles dropped down each path. The current paper follows up on a suggestion by Elizabeth Thompson that genetic descent graphs offer a more appropriate space for executing a Markov chain. A descent graph specifies the paths of gene flow but not the particular founder alleles traveling down the paths. This paper explores algorithms for implementing Thompson's suggestion for codominant markers in the context of automatic haplotyping, estimating location scores, and computing gene-clustering statistics for robust linkage analysis. Realistic numerical examples demonstrate the feasibility of the algorithms.	UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT MATH,ANN ARBOR,MI 48109; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University				Sobel, Eric/0000-0002-1718-0031	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-53275] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GUO SW, 1991, IMA J MATH APPL MED, V8, P171; GUO SW, 1994, BIOMETRICS, V50, P417, DOI 10.2307/2533385; GUO SW, 1992, AM J HUM GENET, V51, P1111; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; LANGE E, 1995, AM J HUM GENET, V57, P112; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1989, AM J HUM GENET, V45, P959; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1994, AM J HUM GENET, V55, P702; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Press W. H., 1992, NUMERICAL RECIPES FO; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sobel E, 1993, Stat Methods Med Res, V2, P263, DOI 10.1177/096228029300200305; SOBEL E, 1995, IMA VOLUMES MATH ITS, V81, P89; TANNER MA, 1991, TOOLS STAT INFERENCE; THOMAS DC, 1992, HUM HERED, V42, P63, DOI 10.1159/000154046; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; THOMPSON EA, IN PRESS ANN STAT; THOMPSON EA, 1994, P 1994 INT C SAS CAR; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; ZIV Y, 1992, HUM GENET, V88, P619, DOI 10.1007/BF02265285	27	1005	1026	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1323	1337						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651310				2022-12-18	WOS:A1996UM27100026
J	WEINSHILBOUM, RM; SLADEK, SL				WEINSHILBOUM, RM; SLADEK, SL			MERCAPTOPURINE PHARMACOGENETICS - MONOGENIC INHERITANCE OF ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN,SCH MED,DEPT INTERNAL MED,ROCHESTER,MN 55901	Mayo Clinic	WEINSHILBOUM, RM (corresponding author), MAYO CLIN & MAYO FDN,SCH MED,DEPT PHARMACOL,CLIN PHARMACOL SERV,ROCHESTER,MN 55901, USA.				NHLBI NIH HHS [HL-17487] Funding Source: Medline; NINDS NIH HHS [NS-11014] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BREMER J, 1961, BIOCHIM BIOPHYS ACTA, V46, P217, DOI 10.1016/0006-3002(61)90746-6; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P45; DRAYER DE, 1974, DRUG METAB DISPOS, V2, P499; EINHORN N, 1964, J AM MED ASS, V188, P102; ELION GB, 1967, FED PROC, V26, P898; FREIREICH EJ, 1967, CANCER RES, V27, P2573; GORNALL AG, 1949, J BIOL CHEM, V177, P751; LINDSAY RH, 1975, BIOCHEM PHARMACOL, V24, P463, DOI 10.1016/0006-2952(75)90129-X; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; PATERSON ARP, 1975, 6 THIOPURINES ANTI 2, P384; PAZMINO PA, 1978, CLIN CHIM ACTA, V89, P317, DOI 10.1016/0009-8981(78)90331-5; PERRY HM, 1973, AM J MED, V54, P58, DOI 10.1016/0002-9343(73)90084-3; REILLY DK, 1978, PHARMACOLOGIST, V20, P156; REMY CN, 1963, J BIOL CHEM, V238, P1078; ROYBURMAN P, 1970, RECENT RES CANCER, V25, P1; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Tay B. S., 1969, BIOCHEM PHARMACOL, V18, P936; WEINSHILBOUM RM, 1977, AM J HUM GENET, V29, P125; WEINSHILBOUM RM, 1974, NATURE, V252, P490, DOI 10.1038/252490a0; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; WEINSHILBOUM RM, 1979, CLIN CHIM ACTA, V97, P59, DOI 10.1016/0009-8981(79)90025-1; WEINSHILBOUM RM, 1978, LIFE SCI, V22, P625, DOI 10.1016/0024-3205(78)90343-0; 1963, BLOOD, V21, P699; 1976, BIRTH DEFECTS OAS, V12, P65	25	1004	1043	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					651	662						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	7191632				2022-12-18	WOS:A1980KJ79500003
J	OTT, J				OTT, J			ESTIMATION OF RECOMBINATION FRACTION IN HUMAN PEDIGREES - EFFICIENT COMPUTATION OF LIKELIHOOD FOR HUMAN LINKAGE STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle								CHASE G A, 1971, Clinical Genetics, V2, P141; COOK PJL, 1972, ANN HUM GENET, V35, P239, DOI 10.1111/j.1469-1809.1957.tb01397.x; EDWARDS JH, 1972, PERSPECTIVES CYTOGEN; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, GENETICS, V73, P695; FALK CT, 1970, GENETICS, V64, pS18; FRASER GR, 1968, ANN HUM GENET, V32, P65, DOI 10.1111/j.1469-1809.1968.tb00050.x; GEDDEDAHL T, 1972, ANN HUM GENET, V35, P393; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HEUCH I, 1972, CLIN GENET, V3, P501, DOI 10.1111/j.1399-0004.1972.tb01488.x; HILDEN J, 1970, Clinical Genetics, V1, P319; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURPHY EA, 1970, ANN HUM GENET, V34, P73, DOI 10.1111/j.1469-1809.1970.tb00221.x; OTT J, 1974, AM J HUM GENET, V26, P598; OTT J, 1973, GENETICS, V74, pS206; PENROSE LS, 1935, ANN EUGEN, V6, P133; Renwick J. H., 1961, EXCERPTA MED INT C S, V32, pE145; RENWICK JH, 1971, J MED GENET, V8, P407, DOI 10.1136/jmg.8.4.407; SCHROTT HG, 1973, CLIN GENET, V4, P38; SIMPSON HR, 1958, ANN HUM GENET, V22, P356, DOI 10.1111/j.1469-1809.1958.tb01429.x; SMITH CAB, 1968, ANN HUM GENET, V32, P127, DOI 10.1111/j.1469-1809.1968.tb00058.x; SMITH CAB, 1953, J R STAT SOC B, V15, P153; VOGEL F, 1972, HUMANGENETIK KURZES, V1, P307	24	988	994	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	5					588	597						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U0241	4422075				2022-12-18	WOS:A1974U024100006
J	Little, RD; Carulli, JP; Del Mastro, RG; Dupuis, J; Osborne, M; Folz, C; Manning, SP; Swain, PM; Zhao, SC; Eustace, B; Lappe, MM; Spitzer, L; Zweier, S; Braunschweiger, K; Benchekroun, Y; Hu, XT; Adair, R; Chee, L; FitzGerald, MG; Tulig, C; Caruso, A; Tzellas, N; Bawa, A; Franklin, B; McGuire, S; Nogues, X; Gong, G; Allen, KM; Anisowicz, A; Morales, AJ; Lomedico, PT; Recker, SM; Van Eerdewegh, P; Recker, RR; Johnson, ML				Little, RD; Carulli, JP; Del Mastro, RG; Dupuis, J; Osborne, M; Folz, C; Manning, SP; Swain, PM; Zhao, SC; Eustace, B; Lappe, MM; Spitzer, L; Zweier, S; Braunschweiger, K; Benchekroun, Y; Hu, XT; Adair, R; Chee, L; FitzGerald, MG; Tulig, C; Caruso, A; Tzellas, N; Bawa, A; Franklin, B; McGuire, S; Nogues, X; Gong, G; Allen, KM; Anisowicz, A; Morales, AJ; Lomedico, PT; Recker, SM; Van Eerdewegh, P; Recker, RR; Johnson, ML			A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY; IDENTIFICATION; STRENGTH; SEQUENCE; SUBUNIT; REGIONS; LINKAGE; CLONING; LRP5	Osteoporosis is a complex disease that affects >10 million people in the United States and results in 1.5 million fractures annually. In addition, the high prevalence of osteopenia (low bone mass) in the general population places a large number of people at risk for developing the disease. In an effort to identify genetic factors influencing bone density, we characterized a family that includes individuals who possess exceptionally dense bones but are otherwise phenotypically normal. This high-bone-mass trait (HBM) was originally localized by linkage analysis to chromosome 11q12-13. We refined the interval by extending the pedigree and genotyping additional markers. A systematic search for mutations that segregated with the HBM phenotype uncovered an amino acid change, in a predicted beta -propeller module of the low-density lipoprotein receptor-related protein 5 (LRP5), that results in the HBM phenotype. During analysis of > 1,000 individuals, this mutation was observed only in affected individuals from the HBM kindred. By use of in situ hybridization to rat tibia, expression of LRP5 was detected in areas of bone involved in remodeling. Our findings suggest that the HBM mutation confers a unique osteogenic activity in bone remodeling, and this understanding may facilitate the development of novel therapies for the treatment of osteoporosis.	Genome Therapeut Corp, Dept Human Genet, Waltham, MA 02453 USA; Genome Therapeut Corp, Dept Genom Serv, Waltham, MA 02453 USA; Genome Therapeut Corp, Dept Bioinformat, Waltham, MA 02453 USA; Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA	Creighton University	Little, RD (corresponding author), Genome Therapeut Corp, Dept Human Genet, 100 Beaver St, Waltham, MA 02453 USA.	rlittle@genomecorp.com	Little, Randall/O-7172-2014	Nogues, Xavier/0000-0002-5537-1859; Dupuis, Josee/0000-0003-2871-3603; Nogues, Xavier/0000-0001-8201-9933				Blank RD, 2001, J BONE MINER RES, V16, P1207, DOI 10.1359/jbmr.2001.16.7.1207; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Del Mastro R G, 1997, Methods Mol Biol, V68, P183; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Heaney C, 1998, HUM MOL GENET, V7, P1407, DOI 10.1093/hmg/7.9.1407; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; Levasseur R, 2001, J BONE MINER RES, V16, pS152; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Marks Sandy C. Jr., 1996, P3; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soares M. B., 1994, AUTOMATED DNA SEQUEN, P110; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Twells RCJ, 2001, GENOMICS, V72, P231, DOI 10.1006/geno.2000.6492; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565	32	968	1058	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					11	19		10.1086/338450	http://dx.doi.org/10.1086/338450			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11741193	Bronze, Green Published			2022-12-18	WOS:000172571900002
J	Abecasis, GR; Cardon, LR; Cookson, WOC				Abecasis, GR; Cardon, LR; Cookson, WOC			A general test of association for quantitative traits in nuclear families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; LINKAGE; MARKERS; PARENT	High-resolution mapping is an important step in the identification of complex disease genes. In outbred populations, linkage disequilibrium is expected to operate over short distances and could provide a powerful fine-mapping tool. Here we build on recently developed methods for linkage-disequilibrium mapping of quantitative traits to construct a general approach that can accommodate nuclear families of any size, with or without parental information. Variance components are used to construct a test that utilizes information from all available offspring but that is not biased in the presence of linkage or familiality. A permutation test is described for situations in which maximum-likelihood estimates of the variance components are biased. Simulation studies are used to investigate power and error rates of this approach and to highlight situations in which violations of multivariate normality assumptions warrant the permutation test: The relationship between power and the level of linkage disequilibrium for this test suggests that the method is well suited to the analysis of dense maps. The relationship between power and family structure is investigated, and these results are applicable to study design in complex disease, especially for late-onset conditions for which parents are usually not available. When parental genotypes are available, power does not depend greatly on the number of offspring in each family. Power decreases when parental genotypes are not available, but the loss in power is negligible when four or more offspring per family are genotyped. Finally, it is shown that, when siblings are available, the total number of genotypes required in order to achieve comparable power is smaller if parents are not genotyped.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Abecasis, GR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022	Abecasis, Goncalo/0000-0003-1509-1825				Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Allison DB, 1997, AM J HUM GENET, V60, P676; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; CARDON LR, IN PRESS HUM HERED; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Falconer D. S., 1989, Introduction to quantitative genetics.; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; LEWONTIN RC, 1960, EVOLUTION, V14, P450; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Searle S., 1992, WILEY SERIES PROBABI; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wan Y, 1997, ANN HUM GENET, V61, P79; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Whittaker JC, 1999, AM J HUM GENET, V64, P910, DOI 10.1086/302277	24	926	949	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					279	292		10.1086/302698	http://dx.doi.org/10.1086/302698			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631157	Bronze, Green Published			2022-12-18	WOS:000085033600028
J	Hu, XZ; Lipsky, RH; Zhu, GS; Akhtar, LA; Taubman, J; Greenberg, BD; Xu, K; Arnold, PD; Richter, MA; Kennedy, JL; Murphy, DL; Goldman, D				Hu, XZ; Lipsky, RH; Zhu, GS; Akhtar, LA; Taubman, J; Greenberg, BD; Xu, K; Arnold, PD; Richter, MA; Kennedy, JL; Murphy, DL; Goldman, D			Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA LEVELS; SYMPTOM PROVOCATION; GENETIC-VARIATION; POLYMORPHISM 5-HTTLPR; TRANSCRIPTION FACTOR; ALLELIC VARIANTS; BINDING-SITES; IN-VIVO; ASSOCIATION; AMYGDALA	A functional serotonin transporter promoter polymorphism, HTTLPR, alters the risk of disease as well as brain morphometry and function. Here, we show that HTTLPR is functionally triallelic. The L-G allele, which is the L allele with a common G substitution, creates a functional AP2 transcription-factor binding site. Expression assays in 62 lymphoblastoid cell lines representing the six genotypes and in transfected raphe-derived cells showed co-dominant allele action and low, nearly equivalent expression for the S and L-G alleles, accounting for more variation in HTT expression than previously recognized. The gain-of-function LALA genotype was approximately twice as common in 169 whites with obsessive-compulsive disorder (OCD) than in 253 ethnically matched controls. We performed a replication study in 175 trios consisting of probands with OCD and their parents. The L-A allele was twofold overtransmitted to the patients with OCD. The HTTLPR LALA genotype exerts a moderate (1.8-fold) effect on risk of OCD, which crystallizes the evidence that the HTT gene has a role in OCD.	NIAAA, Neurogenet Lab, Rockville, MD 20852 USA; Brown Univ, Sch Med, Butler Hosp, Providence, RI 02912 USA; Brown Univ, Sch Med, Dept Psychiat, Providence, RI 02912 USA; Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Toronto, ON, Canada; NIMH, Clin Sci Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Brown University; Butler Hospital Rhode Island; Brown University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Goldman, D (corresponding author), NIAAA, Neurogenet Lab, Rockville, MD 20852 USA.	dgneuro@box-d.nih.gov	Goldman, David/F-9772-2010; Kennedy, James Lowery/AAZ-6947-2020; Majid, Salma/AAT-2616-2020; Xu, Ke/V-5941-2019	Goldman, David/0000-0002-1724-5405; Kennedy, James Lowery/0000-0002-8733-3806; Majid, Salma/0000-0002-1724-5405; Xu, Ke/0000-0002-6472-7052; Lipsky, Robert/0000-0001-7753-1473	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH000336, Z01MH000336, ZIAMH000332, Z01MH000332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000303, Z01AA000301, Z01AA000326, ZIAAA000301, Z01AA000302, Z01AA000290, Z01AA000304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adler CM, 2000, J PSYCHIATR RES, V34, P317, DOI 10.1016/S0022-3956(00)00022-4; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Carey PD, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-30; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Delbruck SJW, 1997, CYTOGENET CELL GENET, V79, P214, DOI 10.1159/000134726; EATON MJ, 1995, J NEUROBIOL, V28, P465, DOI 10.1002/neu.480280407; Eloranta JJ, 2002, J BIOL CHEM, V277, P30798, DOI 10.1074/jbc.M202780200; Ewens WJ, 2004, HUM HERED, V58, P59, DOI 10.1159/000081458; Fiskerstrand CE, 1999, FEBS LETT, V458, P171, DOI 10.1016/S0014-5793(99)01150-3; Glatt CE, 2002, TRENDS GENET, V18, P307, DOI 10.1016/S0168-9525(02)02670-7; Goldman D, 1996, SCIENCE, V274, P1483, DOI 10.1126/science.274.5292.1483; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Heils A, 1996, J NEUROCHEM, V66, P2621; Heils A, 1995, J NEURAL TRANSM-GEN, V102, P247, DOI 10.1007/BF01281159; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; Hollander E, 2002, J CLIN PSYCHIAT, V63, P20; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Jenike MA, 2004, NEW ENGL J MED, V350, P259, DOI 10.1056/NEJMcp031002; Jiang JG, 2000, BIOCHEM BIOPH RES CO, V272, P882, DOI 10.1006/bbrc.2000.2848; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Kraft JB, 2005, BIOL PSYCHIAT, V58, P374, DOI 10.1016/j.biopsych.2005.04.048; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Little KY, 1997, BIOL PSYCHIAT, V41, P1156, DOI 10.1016/S0006-3223(96)00301-0; Little KY, 1998, AM J PSYCHIAT, V155, P207; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; Mortensen OV, 1999, MOL BRAIN RES, V68, P141, DOI 10.1016/S0169-328X(99)00083-2; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pogarell O, 2003, BIOL PSYCHIAT, V54, P1406, DOI 10.1016/S0006-3223(03)00183-5; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Rosenberg DR, 1998, BIOL PSYCHIAT, V43, P623, DOI 10.1016/S0006-3223(97)00443-5; Sakai K, 2002, NEUROSCI LETT, V327, P13, DOI 10.1016/S0304-3940(02)00348-8; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Serretti A, 1999, MOL PSYCHIATR, V4, P280, DOI 10.1038/sj.mp.4000485; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; SWEDO SE, 1992, ARCH GEN PSYCHIAT, V49, P690; Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782; Szeszko PR, 2004, NEUROPSYCHOPHARMACOL, V29, P826, DOI 10.1038/sj.npp.1300399; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Yen FC, 2003, NEUROPSYCHOBIOLOGY, V48, P5, DOI 10.1159/000071821	46	919	955	1	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					815	826		10.1086/503850	http://dx.doi.org/10.1086/503850			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642437	Green Published, Bronze			2022-12-18	WOS:000236756200008
J	Lewis, CM; Levinson, DF; Wise, LH; DeLisi, LE; Straub, RE; Hovatta, I; Williams, NM; Schwab, SG; Pulver, AE; Faraone, SV; Brzustowicz, LM; Kaufmann, CA; Garver, DL; Gurling, HMD; Lindholm, E; Coon, H; Moises, HW; Byerley, W; Shaw, SH; Mesen, A; Sherrington, R; O'Neill, FA; Walsh, D; Kendler, KS; Ekelund, J; Paunio, T; Lonnqvist, J; Peltonen, L; O'Donovan, MC; Owen, MJ; Wildenauer, DB; Maier, W; Nestadt, G; Blouin, JL; Antonarakis, SE; Mowry, BJ; Silverman, JM; Crowe, RR; Cloninger, CR; Tsuang, MT; Malaspina, D; Harkavy-Friedman, JM; Svrakic, DM; Bassett, AS; Holcomb, J; Kalsi, G; McQuillin, A; Brynjolfson, J; Sigmundsson, T; Petursson, H; Jazin, E; Zoega, T; Helgason, T				Lewis, CM; Levinson, DF; Wise, LH; DeLisi, LE; Straub, RE; Hovatta, I; Williams, NM; Schwab, SG; Pulver, AE; Faraone, SV; Brzustowicz, LM; Kaufmann, CA; Garver, DL; Gurling, HMD; Lindholm, E; Coon, H; Moises, HW; Byerley, W; Shaw, SH; Mesen, A; Sherrington, R; O'Neill, FA; Walsh, D; Kendler, KS; Ekelund, J; Paunio, T; Lonnqvist, J; Peltonen, L; O'Donovan, MC; Owen, MJ; Wildenauer, DB; Maier, W; Nestadt, G; Blouin, JL; Antonarakis, SE; Mowry, BJ; Silverman, JM; Crowe, RR; Cloninger, CR; Tsuang, MT; Malaspina, D; Harkavy-Friedman, JM; Svrakic, DM; Bassett, AS; Holcomb, J; Kalsi, G; McQuillin, A; Brynjolfson, J; Sigmundsson, T; Petursson, H; Jazin, E; Zoega, T; Helgason, T			Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; WIDE SCAN; VULNERABILITY LOCUS; GENETIC-LINKAGE; SIBLING PAIRS; SCHIZOAFFECTIVE DISORDER; CHROMOSOME 8P; FOLLOW-UP; FAMILIES	Schizophrenia is a common disorder with high heritability and a 10-fold increase in risk to siblings of probands. Replication has been inconsistent for reports of significant genetic linkage. To assess evidence for linkage across studies, rank-based genome scan meta-analysis (GSMA) was applied to data from 20 schizophrenia genome scans. Each marker for each scan was assigned to 1 of 120 30-cM bins, with the bins ranked by linkage scores (1 = most significant) and the ranks averaged across studies (R-avg) and then weighted for sample size (rootN[affected cases]). A permutation test was used to compute the probability of observing, by chance, each bin's average rank (P-AvgRnk) or of observing it for a bin with the same place (first, second, etc.) in the order of average ranks in each permutation (P-ord). The GSMA produced significant genomewide evidence for linkage on chromosome 2q (P-AvgRnk <.000417). Two aggregate criteria for linkage were also met ( clusters of nominally significant P values that did not occur in 1,000 replicates of the entire data set with no linkage present): 12 consecutive bins with both P-AvgRnk and P-ord <.05, including regions of chromosomes 5q, 3p, 11q, 6p, 1q, 22q, 8p, 20q, and 14p, and 19 consecutive bins with, additionally including regions of chromosomes 16q, 18q, 10p, 15q, 6q, and 17q. There is greater consistency of linkage results across studies than has been previously recognized. The results suggest that some or all of these regions contain loci that increase susceptibility to schizophrenia in diverse populations.	Univ Penn, Sch Med, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; Guys Kings & St Thomas Sch Med, Div Genet & Dev, London, England; UCL, Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London WC1E 6BT, England; NYU, Med Ctr, New York, NY 10016 USA; Columbia Univ, Dept Psychiat, New York, NY USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; NIMH, Clin Brain Disorders Branch, Intramural Res Program, Bethesda, MD 20892 USA; Natl Publ Hlth Inst, Biomedicum, Dept Mol Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Biomedicum, Helsinki, Finland; Cardiff Univ, Dept Psychol Med, Cardiff CF4 4XN, S Glam, Wales; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA; Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr, Dept Psychiat, Boston, MA USA; Rutgers State Univ, Dept Genet, Piscataway, NJ USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA; Univ Louisville, Sch Med, Dept Psychiat & Behav Sci, Louisville, KY 40292 USA; Louisville Vet Affairs Med Ctr, Louisville, KY USA; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Univ Utah, Salt Lake City, UT USA; Univ Hosp Schleswig Holstein, Dept Psychiat & Psychotherapy, Genet Mol Lab, Kiel, Germany; Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; DNA Sci, Fremont, CA USA; Hosp Nacl Psiquitr, San Jose, Costa Rica; Xenon Genet, Burnaby, BC, Canada; Queens Univ Belfast, Belfast, Antrim, North Ireland; Hlth Res Board, Dublin, Ireland; Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Geneva, Sch Med, Ctr Med Univ Geneva, Dept Med Genet, CH-1211 Geneva, Switzerland; Wolston Pk Hosp, Queensland Ctr Schizophrenia Res, Wacol, Australia; Univ Queensland, Dept Psychiat, Brisbane, Qld, Australia; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Mental Hlth Clin Res Ctr, Iowa City, IA 52242 USA; Washington Univ, Dept Psychiat, St Louis, MO USA; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Gen Hosp, Dept Psychiat, Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland	University of Pennsylvania; Pennsylvania Medicine; University of London; King's College London; University of London; University College London; New York University; Columbia University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Cardiff University; University of Bonn; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Louisville; Uppsala University; Utah System of Higher Education; University of Utah; University of Kiel; Schleswig Holstein University Hospital; University of California System; University of California Irvine; Queens University Belfast; Health Research Board - Ireland; Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California Los Angeles; University of Geneva; University of Queensland; University of Iowa; University of Iowa; Washington University (WUSTL); University of Toronto; Landspitali National University Hospital	Levinson, DF (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Ctr Neurobiol & Behav, 3535 Market St,Room 4006, Philadelphia, PA 19104 USA.	DFL@mail.med.upenn.edu	Silverman, Jeremy M./AAO-4268-2020; Gurling, Hugh M/A-5029-2010; Faraone, Stephen V/O-7239-2018; Lewis, Cathryn M/A-5225-2010; O'Donovan, Michael C/P-7005-2018; Faraone, Stephen/AAE-7334-2019; Cloninger, Claude/F-5357-2012; Kendler, Kenneth/AAF-2876-2019; Antonarakis, Stylianos E/N-8866-2014; Lewis, Cathryn/M-8766-2019; O'Neill, Francis A/C-5582-2008; Ekelund, Jesper/D-6655-2013; McQuillin, Andrew/C-1623-2008; Hovatta, Iiris/D-6871-2012; Mowry, Bryan/G-5046-2010	Faraone, Stephen V/0000-0002-9217-3982; Lewis, Cathryn M/0000-0002-8249-8476; O'Donovan, Michael C/0000-0001-7073-2379; Faraone, Stephen/0000-0002-9217-3982; Cloninger, Claude/0000-0003-3096-4807; Antonarakis, Stylianos E/0000-0001-8907-5823; Lewis, Cathryn/0000-0002-8249-8476; O'Neill, Francis A/0000-0002-7531-7657; McQuillin, Andrew/0000-0003-1567-2240; Hovatta, Iiris/0000-0002-5990-7892; Harkavy-Friedman, Jill/0000-0002-1449-0667; Jazin, Elena/0000-0002-0363-3466; Moises, Hans/0000-0003-1522-3226; Mowry, Bryan/0000-0002-4115-5645	MRC [G9309834, G9810900] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042643, U01MH046276, R01MH041953, R01MH041874, R01MH044245, K02MH001089, U01MH046289, R01MH056098, U01MH046318, R37MH044292, K08MH001392, R01MH045097, R01MH052537, R37MH043518, R01MH045390, R01MH062440, K24MH064197, R01MH044292] Funding Source: NIH RePORTER; Medical Research Council [G9810900, G9309834] Funding Source: Medline; NIMH NIH HHS [R01 MH 62440, U01 MH 44292, U01 MH046276, K08 MH 01392, 1R01 MH 41874-01, R01 MH 4558, 5U01 MH 46318, K02 MH 01089, U01 MH046318, R01 MH 52537, R01 MH 44245, K24 MH064197, U01 MH 46289, R01 MH044292, R01 MH 61602, R01 MH 42643, R37 MH043518, R01 MH062440, K24 MH 64197, R01 MH 45390, R01 MH041953, 1R37 MH 43518, R01 MH 56098, U01 MH046289, R01 MH 41953, R01 MH 45097, U01 MH 46276] Funding Source: Medline; PHS HHS [K02 01207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bailer U, 2002, BIOL PSYCHIAT, V52, P40, DOI 10.1016/S0006-3223(02)01320-3; BARR CL, 1994, AM J MED GENET, V54, P51, DOI 10.1002/ajmg.1320540110; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Chiu YF, 2002, MOL PSYCHIATR, V7, P658, DOI 10.1038/sj.mp.4001045; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Coon H, 1998, MOL PSYCHIATR, V3, P521, DOI 10.1038/sj.mp.4000453; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; DeLisi LE, 2000, AM J MED GENET, V96, P335, DOI 10.1002/1096-8628(20000612)96:3<335::AID-AJMG20>3.0.CO;2-E; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; Faraone SV, 1996, PSYCHOL MED, V26, P401, DOI 10.1017/S0033291700034796; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Freedman R, 2001, AM J MED GENET, V105, P794, DOI 10.1002/ajmg.10100; Freedman R, 2001, AM J MED GENET, V105, P20, DOI 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C; Garver DL, 2001, SCHIZOPHR RES, V52, P145, DOI 10.1016/S0920-9964(01)00157-8; Gejman PV, 2001, AM J MED GENET, V105, P789, DOI 10.1002/ajmg.1552; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson D.F., 2000, GENETIC INFLUENCES N, P47; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; Maziade M, 2001, MOL PSYCHIATR, V6, P684, DOI 10.1038/sj.mp.4000915; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Murphy KC, 1998, BRIT J PSYCHIAT, V172, P180, DOI 10.1192/bjp.172.2.180; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Rees MI, 1999, MOL PSYCHIATR, V4, P353, DOI 10.1038/sj.mp.4000521; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; Rybicki BA, 2000, AM J HUM GENET, V66, P593, DOI 10.1086/302778; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stober G, 2000, AM J HUM GENET, V67, P1201, DOI 10.1086/321183; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Tsuang DW, 2001, AM J MED GENET, V105, P662, DOI 10.1002/ajmg.1550; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; WISE LH, 2000, THESIS U LONDON LOND	62	916	952	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					34	48		10.1086/376549	http://dx.doi.org/10.1086/376549			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12802786	Bronze, Green Published			2022-12-18	WOS:000183904900004
J	Broman, KW; Murray, JC; Sheffield, VC; White, RL; Weber, JL				Broman, KW; Murray, JC; Sheffield, VC; White, RL; Weber, JL			Comprehensive human genetic maps: Individual and sex-specific variation in recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT TANDEM REPEATS; LINKAGE MAP; HUMAN GENOME; CONSTRUCTION; CEPH; POLYMORPHISMS; CHROMOSOME; MUTATION; TRINUCLEOTIDE; INTERFERENCE	Comprehensive human genetic maps were constructed on the basis of nearly 1 million genotypes from eight CEPH families; they incorporated >8,000 short tandem-repeat polymorphisms (STRPs), primarily from Gene-thon, the Cooperative Human Linkage Center,the Utah Marker Development Group, and the Marshfield Medical Research Foundation. As part of the map budding process, 0.08% of the genotypes that resulted in tight double recombinants and that largely, if not entirely, represent genotyping errors, mutations, or gene-conversion events were removed. The total female, male, and sex-averaged lengths of the final maps were 44, 27, and 35 morgans, respectively. Numerous (267) sets of STRPs were identified that represented the exact same loci yet were developed independently and had different primer pairs. The distributions of the total number of recombination events per gamete, among the eight mothers of the CEPH families, were significantly different, and this variation was not due to maternal age. The female:male ratio of genetic distance varied across individual chromosomes in a remarkably consistent fashion, with peaks at the centromeres of all metacentric chromosomes. The new linkage maps plus much additional information, including a query system for use in the construction of reliably ordered maps for selected subsets of markers, are available from the Marshfield Website.	Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Utah System of Higher Education; University of Utah	Broman, KW (corresponding author), Marshfield Med Res Fdn, Ctr Med Genet, 1000 N Oak Ave, Marshfield, WI 54449 USA.	BromanK@cmg.mfldclin.edu		Broman, Karl/0000-0002-4914-6671; Sheffield, Val/0000-0002-6282-0835	DIVISION OF HEART AND VASCULAR DISEASES [N01HV048141] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-48141] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; BUETOW KH, 1991, AM J HUM GENET, V49, P985; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; Choo KHA, 1998, NAT GENET, V18, P3; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; duSart D, 1997, NAT GENET, V16, P144; Fain PR, 1996, HUM MOL GENET, V5, P1631, DOI 10.1093/hmg/5.10.1631; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Manly B. F., 1997, RANDOMIZATION BOOTST; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OCONNELL P, 1994, GENOMICS, V24, P557, DOI 10.1006/geno.1994.1666; Robinson WP, 1996, AM J HUM GENET, V59, P1175; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; Sunden SLF, 1996, GENOMICS, V32, P15, DOI 10.1006/geno.1996.0071; TOMFOHRDE J, 1992, GENOMICS, V14, P144, DOI 10.1016/S0888-7543(05)80297-6; Venables W.N., 2013, MODERN APPL STAT S; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Yu J, 1996, AM J HUM GENET, V59, P1186; ZAHN LM, 1995, GENOMICS, V28, P140, DOI 10.1006/geno.1995.1124	37	900	920	0	34	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					861	869		10.1086/302011	http://dx.doi.org/10.1086/302011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718341	Green Published, Bronze			2022-12-18	WOS:000075919000025
J	Claes, L; Del-Favero, J; Ceulemans, B; Lagae, L; Van Broeckhoven, C; De Jonghe, P				Claes, L; Del-Favero, J; Ceulemans, B; Lagae, L; Van Broeckhoven, C; De Jonghe, P			De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FEBRILE SEIZURES PLUS; GENERALIZED EPILEPSY; POLYMORPHISMS	Severe myoclonic epilepsy of infancy (SMEI) is a rare disorder that occurs in isolated patients. The disease is characterized by generalized tonic, clonic, and tonic-clonic seizures that are initially induced by fever and begin during the first year of life. Later, patients also manifest other seizure types, including absence, myoclonic, and simple and complex partial seizures. Psychomotor development stagnates around the second year of life. Missense mutations in the gene that codes for a neuronal voltage-gated sodium-channel alpha -subunit (SCN1A) were identified in families with generalized epilepsy with febrile seizures plus (GEFS+). GEFS+ is a mild type of epilepsy associated with febrile and afebrile seizures. Because both GEFS+ and SMEI involve fever-associated seizures, we screened seven unrelated patients with SMEI for mutations in SCN1A. We identified a mutation in each patient: four had frameshift mutations, one had a nonsense mutation, one had a splice-donor mutation, and one had a missense mutation. All mutations are de novo mutations and were not observed in 184 control chromosomes.	Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; Epilepsy Ctr Children & Youth, Pulderbos, Belgium; Univ Hosp Gasthuisberg, Dept Child Neurol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; KU Leuven; University Hospital Leuven	De Jonghe, P (corresponding author), Univ Instelling Antwerp, Dept Biochem, Mol Genet Lab, Univ Splein 1, B-2610 Antwerp, Belgium.	dejonghe@uia.ua.ac.be	Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Del Favero, jurgen/0000-0002-7427-7489				Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dravet C., 1978, VIE ME, V8, P543, DOI DOI 10.1016/S0370-4475(78)80126-9; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9; SCHALLER KL, 1992, J NEUROSCI, V12, P1370; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wang SY, 1999, GENOME RES, V9, P1059, DOI 10.1101/gr.9.11.1059	14	898	939	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1327	1332		10.1086/320609	http://dx.doi.org/10.1086/320609			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11359211	Bronze, Green Published			2022-12-18	WOS:000169094600003
J	BUDOWLE, B; CHAKRABORTY, R; GIUSTI, AM; EISENBERG, AJ; ALLEN, RC				BUDOWLE, B; CHAKRABORTY, R; GIUSTI, AM; EISENBERG, AJ; ALLEN, RC			ANALYSIS OF THE VNTR LOCUS DIS80 BY THE PCR FOLLOWED BY HIGH-RESOLUTION PAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HYPERVARIABLE REGION; POLYACRYLAMIDE GELS; AMPLIFICATION; POPULATIONS; FRAGMENTS; SEQUENCES; SILVER	Allelic data for the D1S80 locus was obtained by using the PCR and subsequent analysis with a high-resolution, horizontal PAGE technique and silver staining. Compared with RFLP analysis of VNTR loci by Southern blotting, the approach described in this paper offers certain advantages: (1) discrete allele resolution, (2) minimal measurement error, (3) correct genotyping of single-band VNTR patterns, (4) a nonisotopic assay, (5) a permanent record of the electrophoretic separation, and (6) reduced assay time. In a sample of 99 unrelated Caucasians, the D1S80 locus demonstrated a heterozygosity of 80.8% with 37 phenotypes and 16 alleles. The distribution of genotypes is in agreement with expected values according to the Hardy-Weinberg equilibrium. Furthermore, the observed number of alleles and the level of heterozygosity, obtained through the protocol described here, were congruent with each other in accordance with the expectation of a mutation-drift equilibrium model for a single, homogeneous, random-mating population. Therefore, the analysis of D1S80 and similar VNTR loci by amplified fragment length polymorphism (AMP-FLP) may prove useful as models for population genetic issues for VNTR loci analyzed by RFLP typing via Southern blotting.	UNIV TEXAS,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025; TEXAS COLL OSTEOPATH MED,DEPT PATHOL,DNA INDENT LAB,FT WORTH,TX 76107; MED UNIV S CAROLINA,DEPT PATHOL,CHARLESTON,SC 29425	University of Texas System; Medical University of South Carolina	BUDOWLE, B (corresponding author), FED BUR INVEST ACAD,DIV LAB,CTR FORENS SCI RES & TRAINING,QUANTICO,VA 22135, USA.				NIGMS NIH HHS [GM41399] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen R.C., 1980, ELECTROPHORESIS, V1, P32, DOI [10.1002/elps.1150010107, DOI 10.1002/ELPS.1150010107]; ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181; BUDOWLE B, IN PRESS METHODS MOL, V7; BUDOWLE B, IN PRESS AM J HUM GE; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; CHAKRABORTY R, 1990, AM J HUM GENET, V47, P87; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOODMAN LA, 1965, TECHNOMETRICS, V7, P247, DOI 10.2307/1266673; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; KASAI K, IN PRESS P INT S FOR; LUDWIG EH, 1989, AM J HUM GENET, V45, P458; Maniatis T, 1982, MOL CLONING LABORATO, P438; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9364, DOI 10.1093/nar/16.19.9364; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WARD RH, 1970, AM NAT, V104, P355, DOI 10.1086/282669	21	896	930	0	67	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					137	144						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1670750				2022-12-18	WOS:A1991ET18800019
J	EDWARDS, A; CIVITELLO, A; HAMMOND, HA; CASKEY, CT				EDWARDS, A; CIVITELLO, A; HAMMOND, HA; CASKEY, CT			DNA TYPING AND GENETIC-MAPPING WITH TRIMERIC AND TETRAMERIC TANDEM REPEATS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; REPEATED SEQUENCES; VARIABLE NUMBER; HUMAN GENOME; POLYMORPHISMS; LOCUS; AMPLIFICATION; APOLIPOPROTEIN(A); HETEROGENEITY; EVOLUTION	Tandemly reiterated sequences represent a rich source of highly polymorphic markers for genetic linkage, mapping, and personal identification. Human trimeric and tetrameric short tandem repeats (STRs) were studied for informativeness, frequency, distribution, and suitability for DNA typing and genetic mapping. The STRs were highly polymorphic and inherited stably. A STR-based multiplex PCR for personal identification is described. It features fluorescent detection of amplified products on sequencing gels, specific allele identification, simultaneous detection of independent loci, and internal size standards. Variation in allele frequencies were explored for four U.S. populations. The three STR loci (chromosomes 4, 11, and X) used in the fluorescent multiplex PCR have a combined average individualization potential of 1/500 individuals. STR loci appear common, being found every 300-500 kb on the X chromosome. The combined frequency of polymorphic trimeric and tetrameric STRs could be as high as 1 locus/20 kb. The markers should be useful for genetic mapping, as they are sequence based, and can be multiplexed with the PCR. A method enabling rapid localization of STRs and determination of their flanking DNA sequences was developed, thus simplifying the identification of polymorphic STR loci. The ease by which STRs may be identified, as well as their genetic and physical mapping utility, give them the properties of useful sequence tagged sites (STSs) for the human genome initiative.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute	EDWARDS, A (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Civitello, Andrew/L-9755-2019	Civitello, Andrew/0000-0003-0731-1891				BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; CHAKRABORTY R, 1990, AM J HUM GENET, V47, P87; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; DAVIS LG, 1986, BASIC METHODS MOL BI, P75; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; EDWARDS A, 1989, T ASSOC AM PHYSICIAN, V102, P185; EDWARDS A, UNPUB POPULATION GEN; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; HUANG THM, UNPUB LINKAGE GENE X; KOSCHINSKY ML, 1990, BIOCHEMISTRY-US, V29, P640, DOI 10.1021/bi00455a007; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; LINDAHL G, 1990, HUM GENET, V84, P563; LITT M, 1989, AM J HUM GENET, V44, P397; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NANDA I, 1990, HUM GENET, V85, P187, DOI 10.1007/BF00193194; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SAVATIER P, 1985, J MOL BIOL, V182, P21, DOI 10.1016/0022-2836(85)90024-5; Sensabaugh G.F., 1982, FORENSIC SCI HDB, P338; SINNETT D, 1990, GENOMICS, V7, P331, DOI 10.1016/0888-7543(90)90166-R; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SWALLOW DM, 1987, NATURE, V328, P82, DOI 10.1038/328082a0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; ZULIANI G, 1990, AM J HUM GENET, V46, P963	35	893	1024	0	60	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					746	756						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897522				2022-12-18	WOS:A1991GG66500006
J	Pritchard, JK; Rosenberg, NA				Pritchard, JK; Rosenberg, NA			Use of unlinked genetic markers to detect population stratification in association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMANS; TRANSMISSION/DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; POLYMORPHISMS; ADMIXTURE; HISTORY; RISK; IDDM	We examine the issue of population stratification in association-mapping studies. In case-control studies of association, population subdivision or recent admixture of populations can lead to spurious associations between a phenotype and unlinked candidate loci. Using a model of sampling from a structured population, we show that if population stratification exists, it can be detected by use of unlinked marker loci. We show that the case-control-study design, using unrelated control individuals, is a valid approach for association mapping, provided that marker loci unlinked to the candidate locus are included in the study, to test for stratification. We suggest guidelines as to the number of unlinked marker loci to use.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Oxford; Stanford University	Pritchard, JK (corresponding author), Univ Oxford, Dept Stat, 1 S Pk Rd, Oxford OX1 3TG, England.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Rosenberg, Noah/0000-0002-1829-8664	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428, F32GM019634] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28428, GM19634] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FELDMAN MW, 1999, MICROSATELLITES EVOL; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rohlf F.J., 1995, STAT TABLES; Shriver MD, 1997, AM J HUM GENET, V60, P957; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WOKAL RR, 1995, BIOMETRY; WRIGHT S, 1951, ANN EUGENIC, V15, P323	24	865	917	1	27	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					220	228		10.1086/302449	http://dx.doi.org/10.1086/302449			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364535	Bronze, Green Published			2022-12-18	WOS:000081224300027
J	Pritchard, JK; Przeworski, M				Pritchard, JK; Przeworski, M			Linkage disequilibrium in humans: Models and data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON DISEASE GENES; HUMAN GENOME; RECOMBINATION RATES; POPULATION-SIZE; REGIONS; LOCUS; DNA; INVERSION; SEGMENTS	In this review, we describe recent empirical and theoretical work on the extent of linkage disequilibrium (LD) in the human genome, comparing the predictions of simple population-genetic models to available data. Several studies report significant LD over distances longer than those predicted by standard models, whereas some data from short, intergenic regions show less LD than would be expected. The apparent discrepancies between theory and data present a challenge-both to modelers and to human geneticists-to identify which important features are missing from our understanding of the biological processes that give rise to LD. Salient features may include demographic complications such as recent admixture, as well as genetic factors such as local variation in recombination rates, gene conversion, and the potential segregation of inversions. We also outline some implications that the emerging patterns of LD have for association-mapping strategies. In particular, we discuss what marker densities might be necessary for genomewide association scans.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	Przeworski, M (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Andolfatto P, 1998, GENETICS, V148, P1397; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Clark AG, 1999, AM J HUM GENET, V65, P1489, DOI 10.1086/302668; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eaves IA, 2000, NAT GENET, V25, P320; Eisenbarth I, 2000, AM J HUM GENET, V67, P873, DOI 10.1086/303085; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Harding RM, 1997, AM J HUM GENET, V60, P772; Hartl DL, 1997, PRINCIPLES POPULATIO; Hey J, 1999, TRENDS ECOL EVOL, V14, P35, DOI 10.1016/S0169-5347(98)01497-9; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; HUDSON RR, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P23; HUDSON RR, 2001, HDB STAT GENETICS, P309; Huttley GA, 1999, GENETICS, V152, P1711; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; KAPLAN NL, 1989, GENETICS, V123, P887; Kelly JK, 2000, J THEOR BIOL, V204, P83, DOI 10.1006/jtbi.2000.2003; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuhner MK, 2000, GENETICS, V156, P1393; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LEWONTIN RC, 1964, GENETICS, V49, P49; LI WH, 1991, GENETICS, V129, P513; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Long AD, 1999, GENOME RES, V9, P720; Martin RH, 1999, AM J HUM GENET, V64, P1480, DOI 10.1086/302363; McKeigue PM, 1997, AM J HUM GENET, V60, P188; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; Nachman MW, 2000, GENETICS, V156, P297; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Nielsen R, 2000, GENETICS, V154, P931; Nordborg M, 2000, GENETICS, V154, P923; Nordborg M., 2001, HDB STAT GENETICS, P179; Payseur BA, 2000, GENETICS, V156, P1285; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROBERTS PA, 1976, GENETICS BIOL DROS A, V1, P67; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Service SK, 2001, HUM MOL GENET, V10, P545, DOI 10.1093/hmg/10.5.545; SLATKIN M, 1994, GENETICS, V137, P331; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Stephens M., 2001, HDB STAT GENETICS; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1989, GENETICS, V123, P597; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Wall JD, 2000, MOL BIOL EVOL, V17, P156, DOI 10.1093/oxfordjournals.molbev.a026228; Wall JD, 2000, GENETICS, V155, P1865; Weir B., 1996, GENETIC DATA ANAL; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	72	857	919	4	79	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					1	14		10.1086/321275	http://dx.doi.org/10.1086/321275			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11410837	Green Published, Bronze			2022-12-18	WOS:000170108100001
J	Kohler, S; Bauer, S; Horn, D; Robinson, PN				Koehler, Sebastian; Bauer, Sebastian; Horn, Denise; Robinson, Peter N.			Walking the interactome for prioritization of candidate disease genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERACTION NETWORK; PROTEIN; MUTATIONS; DATABASE; SEQUENCE; IDENTIFICATION; INTEGRATION; PREDICTION; DISCOVERY; RESOURCE	The identification of genes associated with hereditary disorders has contributed to improving medical care and to a better understanding of gene functions, interactions, and pathways. However, there are well over 1500 Mendelian disorders whose molecular basis remains unknown. At present, methods such as linkage analysis can identify the chromosomal region in which unknown disease genes are located, but the regions could contain up to hundreds of candidate genes. In this work, we present a method for prioritization of candidate genes by use of a global network distance measure, random walk analysis, for definition of similarities in protein-protein interaction networks. We tested our method on 110 disease-gene families with a total of 783 genes and achieved an area under the ROC curve of up to 98% on simulated linkage intervals of 100 genes surrounding the disease gene, significantly outperforming previous methods based on local distance measures. Our results not only provide an improved tool for positional-cloning projects but also add weight to the assumption that phenotypically similar diseases are associated with disturbances of subnetworks within the larger protein interactome that extend beyond the disease proteins themselves.	[Koehler, Sebastian; Bauer, Sebastian; Horn, Denise; Robinson, Peter N.] Charite, Inst Med Genet, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Robinson, PN (corresponding author), Charite, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.robinson@charite.de	Köhler, Sebastian/H-3301-2019; Köhler, Sebastian/A-2029-2012	Köhler, Sebastian/0000-0002-5316-1399; Köhler, Sebastian/0000-0002-5316-1399; Robinson, Peter/0000-0002-0736-9199				Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Can T, 2005, BIOKDD 05 P 5 INT WO, P61; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; George RA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl707; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kondor R. I., 2002, P 19 INT C MACHINE L, P315; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pagel P, 2004, TRENDS GENET, V20, P72, DOI 10.1016/j.tig.2003.12.007; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2006, CURR OPIN CHEM BIOL, V10, P551, DOI 10.1016/j.cbpa.2006.10.005; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Turner FS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r75; van Driel MA, 2003, EUR J HUM GENET, V11, P57, DOI 10.1038/sj.ejhg.5200918; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825	44	842	857	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					949	958		10.1016/j.ajhg.2008.02.013	http://dx.doi.org/10.1016/j.ajhg.2008.02.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18371930	Bronze, Green Published			2022-12-18	WOS:000255103900013
J	Cargill, M; Schrodi, SJ; Chang, M; Garcia, VE; Brandon, R; Callis, KP; Matsunami, N; Ardlie, KG; Civello, D; Catanese, JJ; Leong, DU; Panko, JM; McAllister, LB; Hansen, CB; Papenfuss, J; Prescott, SM; White, TJ; Leppert, MF; Krueger, GG; Begovich, AB				Cargill, Michele; Schrodi, Steven J.; Chang, Monica; Garcia, Veronica E.; Brandon, Rhonda; Callis, Kristina P.; Matsunami, Nori; Ardlie, Kristin G.; Civello, Daniel; Catanese, Joseph J.; Leong, Diane U.; Panko, Jackie M.; McAllister, Linda B.; Hansen, Christopher B.; Papenfuss, Jason; Prescott, Stephen M.; White, Thomas J.; Leppert, Mark F.; Krueger, Gerald G.; Begovich, Ann B.			A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; INHERITED INTERLEUKIN-12 DEFICIENCY; GENOME-WIDE ASSOCIATION; IL-12 P40 GENE; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; ALZHEIMERS-DISEASE; HLA-C; VARIANTS; IL-23	We performed a multitiered, case-control association study of psoriasis in three independent sample sets of white North American individuals (1,446 cases and 1,432 controls) with 25,215 genecentric single-nucleotide polymorphisms (SNPs) and found a highly significant association with an IL12B 3'-untranslated-region SNP (rs3212227), confirming the results of a small Japanese study. This SNP was significant in all three sample sets (odds ratio [OR](common) 0.64, combined P [P-comb] = 7.85 x 10(-10)). A Monte Carlo simulation to address multiple testing suggests that this association is not a type comb I error. The coding regions of IL12B were resequenced in 96 individuals with psoriasis, and 30 additional IL12B-region SNPs were genotyped. Haplotypes were estimated, and genotype-conditioned analyses identified a second risk allele (rs6887695) located similar to 60 kb upstream of the IL12B coding region that exhibited association with psoriasis after adjustment for rs3212227. Together, these two SNPs mark a common IL12B risk haplotype (ORcommon 1.40, P-comb = 8.11 x 10(-9)) and comb a less frequent protective haplotype (ORcommon 0.58, P-comb = 5.65 x 10(-12)), which were statistically significant in all three comb studies. Since IL12B encodes the common IL-12p40 subunit of IL-12 and IL-23, we individually genotyped 17 SNPs in the genes encoding the other chains of these cytokines (IL12A and IL23A) and their receptors (IL12RB1, IL12RB2, and IL23R). Haplotype analyses identified two IL23R missense SNPs that together mark a common psoriasis-associated haplotype in all three studies (ORcommon 1.44, P-comb = 3.13 x 10-(6)). Individuals homozygous for both the IL12B and the IL23R comb predisposing haplotypes have an increased risk of disease (ORcommon 1.66, P-comb = 1.33 x 10(-8)). These data, and the comb previous observation that administration of an antibody specific for the IL-12p40 subunit to patients with psoriasis is highly efficacious, suggest that these genes play a fundamental role in psoriasis pathogenesis.	Celera, Alameda, CA 94502 USA; Univ Utah, Dept Dermatol, Salt Lake City, UT USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; LineaGen Res Corp, Salt Lake City, UT USA; SeraCare Life Sci, Genom Collaborat Div, Cambridge, MA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Begovich, AB (corresponding author), Celera, 1401 Harbor Bay Pkwy, Alameda, CA 94502 USA.	ann.begovich@celera.com	Schrodi, Steven J./O-4288-2019	Schrodi, Steven J./0000-0003-2304-8528; Morelli, Maria Paula/0000-0001-7157-486X	NCRR NIH HHS [M01 RR000064] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Bowman EP, 2006, CURR OPIN INFECT DIS, V19, P245, DOI 10.1097/01.qco.0000224818.42729.67; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fisher R., 1954, OLIVER BOYD, DOI DOI 10.1007/BF01603396; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Hall MA, 2000, GENES IMMUN, V1, P219, DOI 10.1038/sj.gene.6363661; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hewett D, 2002, GENOMICS, V79, P305, DOI 10.1006/geno.2002.6720; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hong K, 1999, J IMMUNOL, V162, P7480; Hu XL, 2004, HUM HERED, V57, P156, DOI 10.1159/000079246; Huang D, 2000, GENES IMMUN, V1, P515, DOI 10.1038/sj.gene.6363720; Huang HJ, 2006, GASTROENTEROLOGY, V130, P1679, DOI 10.1053/j.gastro.2006.02.032; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jeffreys H, 1935, P CAMB PHILOS SOC, V31, P203, DOI 10.1017/S030500410001330X; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li YH, 2004, NEUROSCI LETT, V366, P268, DOI 10.1016/j.neulet.2004.05.047; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Litjens NHR, 2004, J INVEST DERMATOL, V122, P923, DOI 10.1111/j.0022-202X.2004.22427.x; Long AD, 1999, GENOME RES, V9, P720; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Mueller T, 2004, J HEPATOL, V41, P652, DOI 10.1016/j.jhep.2004.06.021; Muller-Berghaus J, 2004, GENES IMMUN, V5, P431, DOI 10.1038/sj.gene.6364102; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nielsen DM, 2004, GENETICS, V168, P1029, DOI 10.1534/genetics.103.022335; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Orozco G, 2005, HUM IMMUNOL, V66, P711, DOI 10.1016/j.humimm.2005.02.004; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez E, 2005, RHEUMATOLOGY, V44, P1136, DOI 10.1093/rheumatology/keh697; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schlesselman James J., 1982, CASE CONTROL STUDIES; Schrodi SJ, 2005, STAT APPL GENET MOL, V4; Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Sokal R. R., 1995, BIOMETRY; Stanilova S, 2005, GENES IMMUN, V6, P364, DOI 10.1038/sj.gene.6364213; THOMSON G, 1988, AM J HUM GENET, V43, P799; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Valdes AM, 1997, AM J HUM GENET, V60, P703; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; WALTER SD, 1975, BIOMETRIKA, V62, P371, DOI 10.2307/2335374; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Weir B., 1996, GENETIC DATA ANAL; Winterfield LS, 2005, ANN RHEUM DIS, V64, P87, DOI 10.1136/ard.2004.032276; Yilmaz V, 2005, CYTOKINE, V30, P188, DOI 10.1016/j.cyto.2005.01.006; YIP SY, 1984, J AM ACAD DERMATOL, V10, P965, DOI 10.1016/S0190-9622(84)80314-X; Yoo JH, 2005, NUCLEIC ACIDS RES, V33, pW483, DOI 10.1093/nar/gki428; Zwiers A, 2004, GENES IMMUN, V5, P675, DOI 10.1038/sj.gene.6364131	76	837	883	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					273	290		10.1086/511051	http://dx.doi.org/10.1086/511051			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236132	Bronze, Green Published			2022-12-18	WOS:000243729500007
J	KRUGLYAK, L; LANDER, ES				KRUGLYAK, L; LANDER, ES			COMPLETE MULTIPOINT SIB-PAIR ANALYSIS OF QUALITATIVE AND QUANTITATIVE TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFFECTED RELATIVE PAIRS; LINKAGE ANALYSIS; POWER; STRATEGIES; MAPS	Sib-pair analysis is an increasingly important tool for genetic dissection of complex traits. Current methods for sib-pair analysis are primarily based on studying individual genetic markers one at a time and thus fail to use the full inheritance information provided by multipoint linkage analysis. In this paper, we describe how to extract the complete multipoint inheritance information for each sib pair. We then describe methods that use this information to map loci affecting traits, thereby providing a unified approach to both qualitative and quantitative traits. Specifically, complete multipoint approaches are presented for (1) exclusion mapping of qualitative traits; (2) maximum-likelihood mapping of qualitative traits; (3) information-content mapping, showing the extent to which all inheritance information has been extracted at each location in the genome; and (4) quantitative-trait mapping, by two parametric methods and one nonparametric method. In addition, we explore the effects of marker density, marker polymorphism, and availability of parents on the information content of a study. We have implemented the analysis methods in a new computer package, MAPMAKER/SIBS. With this computer package, complete multipoint analysis with dozens of markers in hundreds of sib pairs can be carried out in minutes.	MIT,DEPT BIOL,CAMBRIDGE,MA	Massachusetts Institute of Technology (MIT)	KRUGLYAK, L (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.							BISHOP DT, 1990, AM J HUM GENET, V46, P254; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FULKER DW, 1995, AM J HUM GENET, V56, P1224; FULKER DW, 1994, AM J HUM GENET, V54, P1092; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GUO SW, 1994, AM J HUM GENET, V54, P1104; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; KRUGLYAK L, 1995, GENETICS, V139, P1421; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LITTLE R, 1987, STATISTICAL ANAL MIS; OLSON JM, 1995, AM J HUM GENET, V56, P788; Penrose LS, 1938, ANN EUGENIC, V8, P233, DOI 10.1111/j.1469-1809.1938.tb02176.x; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; SANDKUIJL LA, 1989, MULTIPOINT MAPPING L; TERWILLIGR JD, 1994, HDB HUMAN GENETIC LI	26	832	843	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					439	454						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668271				2022-12-18	WOS:A1995RL77100028
J	HOLT, IJ; HARDING, AE; PETTY, RKH; MORGANHUGHES, JA				HOLT, IJ; HARDING, AE; PETTY, RKH; MORGANHUGHES, JA			A NEW MITOCHONDRIAL DISEASE ASSOCIATED WITH MITOCHONDRIAL-DNA HETEROPLASMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND	University of London; University College London				holt, ian/0000-0001-5468-0193				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anderson S, 1982, MITOCHONDRIAL GENES, P5; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CHOMYN A, 1985, ACHIEVEMENTS PERSPEC, V2, P259; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1988, HUM GENET, V79, P53, DOI 10.1007/BF00291710; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOLT IJ, 1988, LANCET, V1, P1462; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020; Old JM, 1986, HUMAN GENETIC DISEAS, P1; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; POULTON J, 1989, LANCET, V1, P236; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VANERVEN PMM, 1987, ARCH NEUROL-CHICAGO, V44, P775, DOI 10.1001/archneur.1987.00520190079019; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YATSCOFF RW, 1978, SOMAT CELL GENET, V4, P633, DOI 10.1007/BF01543155; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	34	832	847	0	23	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					428	433						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2137962				2022-12-18	WOS:A1990CT66800004
J	Kong, A; Cox, NJ				Kong, A; Cox, NJ			Allele-sharing models: LOD scores and accurate linkage tests	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS	Starting with a test statistic for linkage analysis based on allele sharing, we propose an associated one-parameter model. Under general missing-data patterns, this model allows exact calculation of likelihood ratios and LOD scores and has been implemented by a simple modification of existing software. Most important, accurate linkage tests can be performed. Using an example, we show that some previously suggested approaches to handling less than perfectly informative data can be unacceptably conservative. Situations in which this model may not perform well are discussed, and an alternative model that requires additional computations is suggested.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; DECODE GENET,REYKJAVIK,ICELAND	University of Chicago	Kong, A (corresponding author), UNIV CHICAGO,DEPT STAT,CHICAGO,IL 60637, USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Kong, Augustine/0000-0001-8193-5438	NIDDK NIH HHS [DK-20595, DK-47481] Funding Source: Medline; NIGMS NIH HHS [R01-GM46800] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, P30DK020595, R01DK047481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046800] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COX DR, 1994, THEORETICAL STATISTI; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; RISCH N, 1990, AM J HUM GENET, V46, P222; *SAGE, 1994, STAT ANAL GEN EP REL; Teng J, 1997, AM J HUM GENET, V60, P979; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 1996, AM J HUM GENET, V59, P704	11	831	841	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1179	1188		10.1086/301592	http://dx.doi.org/10.1086/301592			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345087	Bronze, Green Published			2022-12-18	WOS:A1997YH01700025
J	Sachse, C; Brockmoller, J; Bauer, S; Roots, I				Sachse, C; Brockmoller, J; Bauer, S; Roots, I			Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POOR METABOLIZER PHENOTYPE; CYP2D6 ALLELE; DEBRISOQUINE; GENE; IDENTIFICATION; HYDROXYLATION; DELETION; SPARTEINE; LOCUS; DEXTROMETHORPHAN	Cytochrome P450 2DG (CYP2DG) metabolizes many important drugs. CYP2DG activity ranges from complete deficiency to ultrafast metabolism, depending on at least 16 different known alleles. Their frequencies were determined in 589 unrelated German volunteers and correlated with enzyme activity measured by phenotyping with dextromethorphan or debrisoquine. For genotyping, nested PCR-RFLP tests from a PCR amplificate of the entire CYP2D6 gene were developed. The frequency of the CYP2DG6*1 allele coding for extensive metabolizer (EM) phenotype was .364. The alleles coding for slightly (CYP2D6*2) or moderately (*9 and *10) reduced activity (intermediate metabolizer phenotype [IM]) showed frequencies of .324, .018, and .015, respectively. By use of novel PCR tests for discrimination, CYP2D6 gene duplication alleles were found with frequencies of .005 (*1x2), .013 (*2x2), and .001 (*4x2). Frequencies of alleles with complete deficiency (poor metabolizer phenotype [PM]) were .207 (*4), .020 (*3 and *5), .009 (*6), and .001 (*7, *15, and *16). The defective CYP2D6 alleles *8, *11, *12, *13, and *14 were not found. All 41 PMs (7.0%) in this sample were explained by five mutations detected by four PCR-RFLP tests, which may suffice, together with the gene duplication test, for clinical prediction of CYP2D6 capacity. Three novel variants of known CYP2D6 alleles were discovered: *1C(T1957C), *2B (additional C2558T), and *4E (additional C2938T) Analysis of variance showed significant differences in enzymatic activity measured by the dextromethorphan metabolic ratio (MR) between carriers of EM/PM (mean MR = .006) and IM/PM (mean MR = .014) alleles and between carriers of one (mean MR = .009) and two (mean MR = .003) functional alleles. The results of this study provide a solid basis for prediction of CYP2D6 capacity, as required in drug research and routine drug treatment.	HUMBOLDT UNIV BERLIN,UNIV KLIN CHARITE,INST KLIN PHARMAKOL,D-10098 BERLIN,GERMANY	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin								AGUNDEZ JAG, 1995, CLIN PHARMACOL THER, V57, P265, DOI 10.1016/0009-9236(95)90151-5; Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; Appanna G, 1996, DRUG METAB DISPOS, V24, P303; BERTILSSON L, 1995, CLIN PHARMACOKINET, V29, P192, DOI 10.2165/00003088-199529030-00005; BROCKMOLLER J, 1994, CLIN PHARMACOKINET, V27, P216, DOI 10.2165/00003088-199427030-00005; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; CHEN ZR, 1990, THER DRUG MONIT, V12, P97, DOI 10.1097/00007691-199001000-00018; DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516; DALY AK, 1991, PHARMACOGENETICS, V1, P33, DOI 10.1097/00008571-199110000-00006; Daly AK, 1996, PHARMACOGENETICS, V6, P319, DOI 10.1097/00008571-199608000-00005; DALY AK, 1995, HUM GENET, V95, P337; Daly AK, 1996, PHARMACOGENETICS, V6, P193, DOI 10.1097/00008571-199606000-00001; DIXON WJ, 1992, BMDP STATISTICAL SOF; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; EVERT B, 1994, N-S ARCH PHARMACOL, V350, P434; EVERT B, 1994, PHARMACOGENETICS, V4, P271, DOI 10.1097/00008571-199410000-00005; Goodman Gilman G, 1996, GOODMAN GILMANS PHAR, V9th, P3; GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; Johansson I, 1996, PHARMACOGENETICS, V6, P351, DOI 10.1097/00008571-199608000-00008; JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825; KIMURA S, 1989, AM J HUM GENET, V45, P889; LENNARD MS, 1977, J CHROMATOGR, V133, P161, DOI 10.1016/S0021-9673(00)89216-X; Lovlie R, 1996, FEBS LETT, V392, P30, DOI 10.1016/0014-5793(96)00779-X; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MASIMIREMBWA CM, 1993, PHARMACOGENETICS, V3, P275, DOI 10.1097/00008571-199312000-00001; PANSERAT S, 1995, BRIT J CLIN PHARMACO, V40, P361, DOI 10.1111/j.1365-2125.1995.tb04558.x; Sachse C, 1996, PHARMACOGENETICS, V6, P269, DOI 10.1097/00008571-199606000-00012; Sambrook J, 1989, MOL CLONING LAB MANU; SAXENA R, 1994, HUM MOL GENET, V3, P923, DOI 10.1093/hmg/3.6.923; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; STEEN VM, 1995, PHARMACOGENETICS, V5, P215, DOI 10.1097/00008571-199508000-00005; TEFRE T, 1994, PHARMACOGENETICS, V4, P47; TYNDALE R, 1991, PHARMACOGENETICS, V1, P26, DOI 10.1097/00008571-199110000-00005	35	830	873	0	31	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					284	295						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012401				2022-12-18	WOS:A1997WE93100007
J	Pritchard, JK				Pritchard, JK			Are rare variants responsible for susceptibility to complex diseases?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; MUTATION-RATES; POPULATION-GENETICS; HEMOPHILIA-B; HUMANS; TRAITS; GENES; STRATEGIES; SELECTION	Little is known about the nature of genetic variation underlying complex diseases in humans. One popular view proposes that mapping efforts should focus on identification of susceptibility mutations that are relatively old and at high frequency. It is generally assumed-at least for modeling purposes-that selection against complex disease mutations is so weak that it can be ignored. In this article, I propose an explicit model for the evolution of complex disease loci, incorporating mutation, random genetic drift, and the possibility of purifying selection against susceptibility mutations. I show that, for the most plausible range of mutation rates, neutral susceptibility alleles are unlikely to be at intermediate frequencies and contribute little to the overall genetic variance for the disease. Instead, it seems likely that the bulk of genetic variance underlying diseases is due to loci where susceptibility mutations are mildly deleterious and where there is a high overall mutation rate to the susceptible class. At such loci, the total frequency of susceptibility mutations may be quite high, but there is likely to be extensive allelic heterogeneity at many of these loci. I discuss some practical implications of these results for gene mapping efforts.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	Pritchard, JK (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.							Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Ewens W.J., 1979, MATH POPULATION GENE; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; FEARNHEAD P, 2001, IN PRESS THEOR POP B; Friedman JM, 1999, AM J MED GENET, V89, P1; Giannelli F, 1999, AM J HUM GENET, V65, P1580, DOI 10.1086/302652; Gilks WR, 1996, MARKOV CHAIN MONTE C; Green PM, 1999, AM J HUM GENET, V65, P1572, DOI 10.1086/302651; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Levin BR, 2000, GENETICS, V154, P985; LI WH, 1991, GENETICS, V129, P513; Long AD, 1999, GENOME RES, V9, P720; Nachman MW, 2000, GENETICS, V156, P297; Neuhauser C, 1997, GENETICS, V145, P519; Peters AD, 2000, GENETICS, V156, P1635; Przeworski M, 1999, MOL BIOL EVOL, V16, P246, DOI 10.1093/oxfordjournals.molbev.a026106; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Slatkin M, 1997, GENETICS, V147, P1855; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Tolarova MM, 1997, AM J MED GENET, V72, P394, DOI 10.1002/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R; Wall JD, 2000, GENETICS, V155, P1865; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; Wright S., 1949, P365; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766; Zwick ME, 2000, ANNU REV GENOM HUM G, V1, P387, DOI 10.1146/annurev.genom.1.1.387	39	827	856	1	34	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					124	137		10.1086/321272	http://dx.doi.org/10.1086/321272			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11404818	Green Published, Bronze			2022-12-18	WOS:000170108100013
J	KOENIG, M; BEGGS, AH; MOYER, M; SCHERPF, S; HEINDRICH, K; BETTECKEN, T; MENG, G; MULLER, CR; LINDLOF, M; KAARIAINEN, H; DELACHAPELLE, A; KIURU, A; SAVONTAUS, ML; GILGENKRANTZ, H; RECAN, D; CHELLY, J; KAPLAN, JC; COVONE, AE; ARCHIDIACONO, N; ROMEO, G; LIECHTIGALLATI, S; SCHNEIDER, V; BRAGA, S; MOSER, H; DARRAS, BT; MURPHY, P; FRANCKE, U; CHEN, JD; MORGAN, G; DENTON, M; GREENBERG, CR; WROGEMANN, K; BLONDEN, LAJ; VANPAASSEN, HMB; VANOMMEN, GJB; KUNKEL, LM				KOENIG, M; BEGGS, AH; MOYER, M; SCHERPF, S; HEINDRICH, K; BETTECKEN, T; MENG, G; MULLER, CR; LINDLOF, M; KAARIAINEN, H; DELACHAPELLE, A; KIURU, A; SAVONTAUS, ML; GILGENKRANTZ, H; RECAN, D; CHELLY, J; KAPLAN, JC; COVONE, AE; ARCHIDIACONO, N; ROMEO, G; LIECHTIGALLATI, S; SCHNEIDER, V; BRAGA, S; MOSER, H; DARRAS, BT; MURPHY, P; FRANCKE, U; CHEN, JD; MORGAN, G; DENTON, M; GREENBERG, CR; WROGEMANN, K; BLONDEN, LAJ; VANPAASSEN, HMB; VANOMMEN, GJB; KUNKEL, LM			THE MOLECULAR-BASIS FOR DUCHENNE VERSUS BECKER MUSCULAR-DYSTROPHY - CORRELATION OF SEVERITY WITH TYPE OF DELETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SYLVIUS LABS,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,DIV GENET,BOSTON,MA 02115; HOP COCHIN,INST PATHOL MOLEC,INSERM,F-75674 PARIS 14,FRANCE; IST GIANNINA GASLINI,MOLEC GENET LAB,I-16148 GENOA,ITALY; PRINCE WALES HOSP,DEPT PATHOL,SYDNEY,NSW,AUSTRALIA; UNIV WURZBURG,INST HUMAN GENET,D-8700 WURZBURG,FED REP GER; UNIV HELSINKI,DEPT MED GENET,SF-00100 HELSINKI 10,FINLAND; UNIV TURKU,DEPT MED GENET,SF-20500 TURKU 50,FINLAND; UNIV BERN,INSELSPITAL,DEPT PEDIAT,CH-3010 BERN,SWITZERLAND; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV MANITOBA,DEPT BIOCHEM,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT HUMAN GENET,WINNIPEG R3T 2N2,MANITOBA,CANADA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Wurzburg; University of Helsinki; University of Turku; University of Bern; University Hospital of Bern; Yale University; University of Manitoba; University of Manitoba			Covone, Angela/AAA-7859-2020; Gilgenkrantz, Helene/G-5534-2017	Covone, Angela/0000-0002-7669-5270; gilgenkrantz, helene/0000-0001-6770-4561; Beggs, Alan/0000-0001-8818-0568; archidiacono, nicoletta/0000-0002-1439-9521				BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1988, AM J HUM GENET, V43, P126; DARRAS BT, 1988, AM J HUM GENET, V43, P612; DENDUNNEN JT, IN PRESS TOPOGRAPHY; ENGEL AG, 1986, MYOLOGY BASIC CLIN, V2; FORREST SM, 1987, LANCET, V2, P1294; GILGENKRANTZ H, IN PRESS GENOMICS; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEMAIRE C, 1988, EMBO J, V7, P4157, DOI 10.1002/j.1460-2075.1988.tb03311.x; LIECHTIGALLATI S, 1989, HUM GENET, V81, P343, DOI 10.1007/BF00283688; LINDLOF M, 1989, AM J HUM GENET, V44, P496; MALHOTRA SB, 1988, SCIENCE, V242, P756; MCCABE ERB, 1989, J CLIN INVEST, V83, P95, DOI 10.1172/JCI113890; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0	24	820	845	0	49	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					498	506						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491009				2022-12-18	WOS:A1989AW39500003
J	Astuti, D; Latif, F; Dallol, A; Dahia, PLM; Douglas, F; George, E; Skoldberg, F; Husebye, ES; Eng, C; Maher, ER				Astuti, D; Latif, F; Dallol, A; Dahia, PLM; Douglas, F; George, E; Skoldberg, F; Husebye, ES; Eng, C; Maher, ER			Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU-DISEASE; COMPLEX-II; VHL; RET; MITOCHONDRIA; INVOLVEMENT; APOPTOSIS; BINDING	The pheochromocytomas are an important cause of secondary hypertension. Although pheochromocytoma susceptibility may be associated with germline mutations in the tumor-suppressor genes VHL and NF1 and in the proto-oncogene RET, the genetic basis for most cases of nonsyndromic familial pheochromocytoma is unknown. Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations. Germline SDHD mutations were originally described in hereditary paraganglioma, a dominantly inherited disorder characterized by vascular tumors in the head and the neck, most frequently at the carotid bifurcation. The gene products of two components of succinate dehydrogenase, SDHC and SDHD, anchor the gene products of two other components, SDHA and SDHB, which form the catalytic core, to the inner-mitochondrial membrane. Although mutations in SDHC and in SDHD may cause hereditary paraganglioma, germline SDHA mutations are associated with juvenile encephalopathy, and the phenotypic consequences of SDHB mutations have not been defined. To investigate the genetic causes of pheochromocytoma, we analyzed SDHB and SDHC, in familial and in sporadic cases. Inactivating SDHB mutations were detected in two of the five kindreds with familial pheochromocytoma, two of the three kindreds with pheochromocytoma and paraganglioma susceptibility, and 1 of the 24 cases of sporadic pheochromocytoma. These findings extend the link between mitochondrial dysfunction and tumorigenesis and suggest that germline SDHB mutations are an important cause of pheochromocytoma susceptibility.	Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Royal Victoria Infirm, No Reg Genet Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Kings Lynn Hosp, Dept Med, Norfolk, England; Uppsala Univ, Dept Med Sci, Uppsala, Sweden; Ohio State Univ, Ctr Comprehens Canc, Clin Canc Genet Programs, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Univ Cambridge, CRC, Human Canc Genet Res Grp, Cambridge, England	University of Birmingham; Harvard University; Dana-Farber Cancer Institute; Newcastle University - UK; Uppsala University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Cambridge	Maher, ER (corresponding author), Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.		MAHER, EAMONN R/A-9507-2008; Dallol, Ashraf/H-8661-2012	MAHER, EAMONN R/0000-0002-6226-6918; Dallol, Ashraf/0000-0002-8803-228X; Astuti, Dewi/0000-0003-4205-6160	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, P30 CA16058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUIAR RCT, IN PRESS J CLIN ENDO; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2000, CANCER RES, V60, P7048; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cavalli LR, 1998, MUTAT RES-FUND MOL M, V398, P19, DOI 10.1016/S0027-5107(97)00223-6; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1995, J MED GENET, V32, P885, DOI 10.1136/jmg.32.11.885; Gimm O, 2000, CANCER RES, V60, P6822; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hofstra RMW, 1996, J CLIN ENDOCR METAB, V81, P2881, DOI 10.1210/jc.81.8.2881; JENSEN JC, 1991, J UROLOGY, V145, P1040, DOI 10.1016/S0022-5347(17)38524-5; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; MAHER ER, 2000, GENETICS ENDOCRINE M; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; NEUMANN HPH, 1995, JAMA-J AM MED ASSOC, V274, P1149; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; PRITCHETT JW, 1982, CANCER, V49, P2578, DOI 10.1002/1097-0142(19820615)49:12<2578::AID-CNCR2820491227>3.0.CO;2-M; Skoldberg F, 1998, CLIN ENDOCRINOL, V48, P11; Woodward ER, 1997, HUM MOL GENET, V6, P1051, DOI 10.1093/hmg/6.7.1051	26	818	849	0	30	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					49	54		10.1086/321282	http://dx.doi.org/10.1086/321282			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11404820	Green Published, Bronze			2022-12-18	WOS:000170108100005
J	Deng, ZM; Morse, JH; Slager, SL; Cuervo, N; Moore, KJ; Venetos, G; Kalachikov, S; Cayanis, E; Fischer, SG; Barst, RJ; Hodge, SE; Knowles, JA				Deng, ZM; Morse, JH; Slager, SL; Cuervo, N; Moore, KJ; Venetos, G; Kalachikov, S; Cayanis, E; Fischer, SG; Barst, RJ; Hodge, SE; Knowles, JA			Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TGF-BETA; CLONING; DOMAINS; TOOL	Familial primary pulmonary hypertension is a rare autosomal dominant disorder that has reduced penetrance and that has been mapped to a 3-cM region on chromosome 2q33 (locus PPH1). The phenotype is characterized by monoclonal plexiform lesions of proliferating endothelial cells in pulmonary arterioles. These lesions lead to elevated pulmonary-artery pressures, right-ventricular failure, and death. Although primary pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs, including phentermine-fenfluramine. We genotyped 35 multiplex families with the disorder, using 27 microsatellite markers; we constructed disease haplotypes; and we looked for evidence of haplotype sharing across families, using the program TRANSMIT. Suggestive evidence of sharing was observed with markers GGAA19e07 and D2S307, and three nearby candidate genes were examined by denaturing high-performance liquid chromatography on individuals from 19 families. One of these genes (BMPR2), which encodes bone morphogenetic protein receptor type II, was found to contain five mutations that predict premature termination of the protein product and two missense mutations. These mutations were not observed in 196 control chromosomes. These findings indicate that the bone morphogenetic protein-signaling pathway is defective in patients with primary pulmonary hypertension and may implicate the pathway in the nonfamilial forms of the disease.	Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Med, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Sch Publ Hlth, Div Biostat, New York, NY USA; Taub Inst Res Alzheimers Dis Aging Brain, New York, NY USA	Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Knowles, JA (corresponding author), Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Columbia Genome Ctr, 1051 Riverside Dr,Room 5916,Unit 28, New York, NY 10032 USA.		Slager, Susan L./B-6756-2009		NHLBI NIH HHS [R01 HL060056, HL60056-1] Funding Source: Medline; NIDDK NIH HHS [R01 DK031813, DK31813] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK031813, R01DK031813] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; BRAND T, 1995, J BIOL CHEM, V270, P8274, DOI 10.1074/jbc.270.14.8274; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J RESP CRIT CARE, V161, P1055, DOI 10.1164/ajrccm.161.3.9906051; DOUGLAS JG, 1981, BMJ-BRIT MED J, V283, P881, DOI 10.1136/bmj.283.6296.881; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; MORSE JH, 1994, SEMIN RESP CRIT CARE, V15, P222, DOI 10.1055/s-2007-1006366; MORSE JH, 1996, CIRCULATION, V94, P1; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; PASQUE MK, 1995, CIRCULATION, V92, P2252, DOI 10.1161/01.CIR.92.8.2252; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Soda H, 1998, ANTI-CANCER DRUG, V9, P327, DOI 10.1097/00001813-199804000-00006; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239	37	816	860	2	34	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					737	744		10.1086/303059	http://dx.doi.org/10.1086/303059			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10903931	Green Published, Bronze			2022-12-18	WOS:000089002300019
J	COOK, EH; STEIN, MA; KRASOWSKI, MD; COX, NJ; OLKON, DM; KIEFFER, JE; LEVENTHAL, BL				COOK, EH; STEIN, MA; KRASOWSKI, MD; COX, NJ; OLKON, DM; KIEFFER, JE; LEVENTHAL, BL			ASSOCIATION OF ATTENTION-DEFICIT DISORDER AND THE DOPAMINE TRANSPORTER GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D2-DOPAMINE RECEPTOR GENE; HAPLOTYPE RELATIVE RISK; HYPERACTIVITY DISORDER; POINT MUTATIONS; CHILDREN; ALCOHOLISM; POLYMORPHISMS; ALLELE	Attention-deficit hyperactivity disorder (ADHD) has been shown to be familial and heritable, in previous studies. As with most psychiatric disorders, examination of pedigrees has not revealed a consistent Mendelian mode of transmission. The response of ADHD patients to medications that inhibit the dopamine transporter, including methylphenidate, amphetamine, pemoline, and bupropion, led us to consider the dopamine transporter as a primary candidate gene for ADHD. To avoid effects of population stratification and to avoid the problem of classification of relatives with other psychiatric disorders as affected or unaffected, we used the haplotype-based haplotype relative risk (HHRR) method to test for association between a VNTR polymorphism at the dopamine transporter locus (DAT1) and DSM-III-R-diagnosed ADHD (N = 49) and undifferentiated attention-deficit disorder (UADD) (N = 8) in trios composed of father, mother, and affected offspring. HHRR analysis revealed significant association between ADHD/UADD and the 480-bp DAT1 allele (chi(2) 7.51, 1 df, P = .006). When cases of UADD were dropped from the analysis, similar results were found (chi(2) 7.29, 1 df, P = .007). If these findings are replicated, molecular analysis of the dopamine transporter gene may identify mutations that increase susceptibility to ADHD/UADD. Biochemical analysis of such mutations may lead to development of more effective therapeutic interventions.	UNIV CHICAGO,DEPT PSYCHIAT,CHICAGO,IL 60637; UNIV CHICAGO,HARRIS CTR DEV STUDIES,DEV NEUROSCI LAB,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	University of Chicago; University of Chicago; University of Chicago; University of Chicago			Krasowski, Matthew D/ABA-8590-2020	Krasowski, Matthew D/0000-0003-0856-8402	NIMH NIH HHS [K07 MH00822] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K07MH000822] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ALBERTSCORUSH J, 1986, AM J ORTHOPSYCHIAT, V56, P413, DOI 10.1111/j.1939-0025.1986.tb03473.x; ASKEW GR, 1993, MOL CELL BIOL, V13, P4115, DOI 10.1128/MCB.13.7.4115; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BIEDERMAN J, 1990, J AM ACAD CHILD PSY, V29, P526, DOI 10.1097/00004583-199007000-00004; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BYERLEY W, 1993, HUM HERED, V43, P319, DOI 10.1159/000154151; CANTWELL DP, 1972, ARCH GEN PSYCHIAT, V27, P414; CASAT CD, 1987, PSYCHOPHARMACOL BULL, V23, P120; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; GELERNTER J, 1991, JAMA-J AM MED ASSOC, V266, P1801, DOI 10.1001/jama.266.13.1801; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; GREENHILL LL, 1992, PSYCHIAT CLIN N AM, V15, P1; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; HECHTMAN L, 1994, J PSYCHIATR NEUROSCI, V19, P193; HECHTMAN L, 1993, CAN J PSYCHIAT, V38, P458, DOI 10.1177/070674379303800614; Hollingshead AB., 1965, 2 FACTOR INDEX SOCIA; IALONGO NS, 1993, J AM ACAD CHILD PSY, V32, P182, DOI 10.1097/00004583-199301000-00026; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PERSICO AM, 1993, BIOL PSYCHIAT, V34, P265, DOI 10.1016/0006-3223(93)90081-N; RAPPORT MD, 1994, J AM ACAD CHILD PSY, V33, P882, DOI 10.1097/00004583-199407000-00015; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; STEVENSON J, 1992, BEHAV GENET, V22, P337, DOI 10.1007/BF01066665; ULLMANN RK, 1984, PSYCHOPHARMACOL BULL, V20, P160; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Wechsler D., 2008, WECHSLER PRESCHOOL P, V3rd; Wechsler D., 1997, WECHSLER INTELLIGENC; WEISS RE, 1994, J CLIN ENDOCR METAB, V78, P1525, DOI 10.1210/jc.78.6.1525; WEISS RE, 1993, J PEDIATR-US, V123, P539, DOI 10.1016/S0022-3476(05)80947-3; ZAMETKIN AJ, 1987, J AM ACAD CHILD PSY, V26, P676, DOI 10.1097/00004583-198709000-00011; 1994, DIAGNOSTIC STATISTIC	36	804	830	0	73	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					993	998						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	QP663	7717410				2022-12-18	WOS:A1995QP66300021
J	Lo, YMD; Zhang, J; Leung, TN; Lau, TK; Chang, AMZ; Hjelm, NM				Lo, YMD; Zhang, J; Leung, TN; Lau, TK; Chang, AMZ; Hjelm, NM			Rapid clearance of fetal DNA from maternal plasma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL SEX DETERMINATION; MICROSATELLITE ALTERATIONS; DEOXYRIBONUCLEIC-ACID; PERIPHERAL-BLOOD; CELLS; AMPLIFICATION; LOCALIZATION; PRODUCT; SERUM; TIME	Fetal DNA has been detected in maternal plasma during pregnancy. We investigated the clearance of circulating fetal DNA after delivery, using quantitative PCR analysis of the sex-determining region Y gene as a marker for male fetuses. We analyzed plasma samples from 12 women 1-42 d after delivery of male babies and found that circulating fetal DNA was undetectable by day 1 after delivery. To obtain a higher time-resolution picture of fetal DNA clearance, we performed serial sampling of eight women, which indicated that most women (seven) had undetectable levels of circulating fetal DNA by 2 h postpartum. The mean half-life for circulating fetal DNA was 16.3 min (range 4-30 min). Plasma nucleases were found to account for only part of the clearance of plasma fetal DNA, The rapid turnover of circulating DNA suggests that plasma DNA analysis may be less susceptible to false-positive results, which result from carryover from previous pregnancies, than is the detection of fetal cells in maternal blood; also, rapid turnover may be useful for the monitoring of fete-maternal events with rapid dynamics. These results also may have implications for the study of other types of nonhost DNA in plasma, such as circulating tumor-derived and graft-derived DNA in oncology and transplant patients, respectively.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, New Territories, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynecol, Shatin, New Territories, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, New Territories, Peoples R China.	loym@cuhk.edu.hk	Chang, Allan M/B-1882-2009; Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410				Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 1998, AM J HUM GENET, V62, P763, DOI 10.1086/301809; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Chen XQ, 1996, NAT MED, V2, P1033; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; CHUSED TM, 1972, CLIN EXP IMMUNOL, V12, P465; EMLEN W, 1984, CLIN EXP IMMUNOL, V56, P185; EMLEN W, 1978, J EXP MED, V147, P684, DOI 10.1084/jem.147.3.684; FROST P. G., 1968, CLIN EXP IMMUNOL, V3, P447; GOSSE C, 1965, CANCER RES, V25, P877; HAMADA H, 1994, AM J OBSTET GYNECOL, V170, P1188, DOI 10.1016/S0002-9378(94)70120-2; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HERRIOTT RM, 1961, NATURE, V189, P817, DOI 10.1038/189817a0; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HSIEH TT, 1993, HUM GENET, V92, P204; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lo YMD, 1996, BLOOD, V88, P4390; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; LO YMD, 1989, LANCET, V2, P1363; LO YMD, 1993, HUM GENET, V90, P483; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; PAOLETTI C, 1963, BIOCHEMISTRY-US, V28, P531; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Simpson JL, 1995, HUM REPROD UPDATE, V1, P409, DOI 10.1093/humupd/1.4.409; THOMAS MR, 1995, PRENATAL DIAG, V15, P641, DOI 10.1002/pd.1970150709; TSUMITA T, 1963, NATURE, V198, P1088, DOI 10.1038/1981088a0; WALKNOWSKA J, 1969, LANCET, V1, P1119	34	797	935	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					218	224		10.1086/302205	http://dx.doi.org/10.1086/302205			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915961	Bronze, Green Published			2022-12-18	WOS:000078477400027
J	RISCH, N				RISCH, N			LINKAGE STRATEGIES FOR GENETICALLY COMPLEX TRAITS .2. THE POWER OF AFFECTED RELATIVE PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHS [GM39812] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; CLAUS EB, IN PRESS AM J EPIDEM; CLAUS EB, UNPUB AUTOSOMAL DOMI; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KAPLAN EB, 1972, I STATISTICS MIMEO, V823; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; PAYAMI H, 1988, ANN HUM GENET, V49, P303; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; SCHWARTZ AG, 1985, JNCI-J NATL CANCER I, V75, P665; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; Thompson EA, 1986, PEDIGREE ANAL HUMAN; WAGENER DK, 1982, DIABETES, V31, P225; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104	21	796	806	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					229	241						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301393				2022-12-18	WOS:A1990CM93800003
J	Ioannidis, NM; Rothstein, JH; Pejaver, V; Middha, S; McDonnell, SK; Baheti, S; Musolf, A; Li, Q; Holzinger, E; Karyadi, D; Cannon-Albright, LA; Teerlink, CC; Stanford, JL; Isaacs, WB; Xu, JF; Cooney, KA; Lange, EM; Schleutker, J; Carpten, JD; Powell, IJ; Cussenot, O; Cancel-Tassin, G; Giles, GG; MacInnis, RJ; Maier, C; Hsieh, CL; Wiklund, F; Catalona, WJ; Foulkes, WD; Mandal, D; Eeles, RA; Kote-Jarai, Z; Bustamante, CD; Schaid, DJ; Hastie, T; Ostrander, EA; Bailey-Wilson, JE; Radivojac, P; Thibodeau, SN; Whittemore, AS; Sieh, W				Ioannidis, Nilah M.; Rothstein, Joseph H.; Pejaver, Vikas; Middha, Sumit; McDonnell, Shannon K.; Baheti, Saurabh; Musolf, Anthony; Li, Qing; Holzinger, Emily; Karyadi, Danielle; Cannon-Albright, Lisa A.; Teerlink, Craig C.; Stanford, Janet L.; Isaacs, William B.; Xu, Jianfeng; Cooney, Kathleen A.; Lange, Ethan M.; Schleutker, Johanna; Carpten, John D.; Powell, Isaac J.; Cussenot, Olivier; Cancel-Tassin, Geraldine; Giles, Graham G.; MacInnis, Robert J.; Maier, Christiane; Hsieh, Chih-Lin; Wiklund, Fredrik; Catalona, William J.; Foulkes, William D.; Mandal, Diptasri; Eeles, Rosalind A.; Kote-Jarai, Zsofia; Bustamante, Carlos D.; Schaid, Daniel J.; Hastie, Trevor; Ostrander, Elaine A.; Bailey-Wilson, Joan E.; Radivojac, Predrag; Thibodeau, Stephen N.; Whittemore, Alice S.; Sieh, Weiva			REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINVAR PUBLIC ARCHIVE; NONSYNONYMOUS SNVS; FUNCTIONAL IMPACT; SEQUENCE VARIANTS; DISEASE; CONSENSUS; FRAMEWORK; CONSEQUENCES; ANNOTATION; MUTATIONS	The vast majority of coding variants are rare, and assessment of the contribution of rare variants to complex traits is hampered by low statistical power and limited functional data. Improved methods for predicting the pathogenicity of rare coding variants are needed to facilitate the discovery of disease variants from exome sequencing studies. We developed REVEL (rare exome variant ensemble learner), an ensemble method for predicting the pathogenicity of missense variants on the basis of individual tools: MutPred, FATHMM, VEST, PolyPhen, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP, SiPhy, phyloP, and phastCons. REVEL was trained with recently discovered pathogenic and rare neutral missense variants, excluding those previously used to train its constituent tools. When applied to two independent test sets, REVEL had the best overall performance (p < 10(-12)) as compared to any individual tool and seven ensemble methods: MetaSVM, MetaLR, KGGSeq, Condel, CADD, DANN, and Eigen. Importantly, REVEL also had the best performance for distinguishing pathogenic from rare neutral variants with allele frequencies <0.5%. The area under the receiver operating characteristic curve (AUC) for REVEL was 0.046-0.182 higher in an independent test set of 935 recent SwissVar disease variants and 123,935 putatively neutral exome sequencing variants and 0.027-0.143 higher in an independent test set of 1,953 pathogenic and 2,406 benign variants recently reported in ClinVar than the AUCs for other ensemble methods. We provide pre-computed REVEL scores for all possible human missense variants to facilitate the identification of pathogenic variants in the sea of rare variants discovered as sequencing studies expand in scale.	[Ioannidis, Nilah M.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ioannidis, Nilah M.; Rothstein, Joseph H.; Whittemore, Alice S.; Sieh, Weiva] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Rothstein, Joseph H.; Sieh, Weiva] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Rothstein, Joseph H.; Sieh, Weiva] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Pejaver, Vikas; Radivojac, Predrag] Indiana Univ, Dept Comp Sci & Informat, Bloomington, IN 47405 USA; [Middha, Sumit] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [McDonnell, Shannon K.; Baheti, Saurabh; Schaid, Daniel J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Musolf, Anthony; Li, Qing; Holzinger, Emily; Bailey-Wilson, Joan E.] NHGRI, Computat & Stat Genom Branch, Baltimore, MD 21224 USA; [Karyadi, Danielle; Ostrander, Elaine A.] NHGRI, Canc Genet & Comparat Genom Branch, Bethesda, MD 20892 USA; [Cannon-Albright, Lisa A.; Teerlink, Craig C.; Cooney, Kathleen A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84108 USA; [Stanford, Janet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Isaacs, William B.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Xu, Jianfeng] NorthShore Univ HealthSyst Res Inst, Evanston, IL 60201 USA; [Cooney, Kathleen A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cooney, Kathleen A.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Lange, Ethan M.] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA; [Schleutker, Johanna] Univ Turku, Dept Med Biochem & Genet, Turku 20014, Finland; [Schleutker, Johanna] Turku Univ Hosp, Dept Med Genet Tyks Microbiol & Genet, FIN-20520 Turku, Finland; [Carpten, John D.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA; [Powell, Isaac J.] Wayne State Univ, Dept Urol, Detroit, MI 48201 USA; [Cussenot, Olivier; Cancel-Tassin, Geraldine] Univ Paris, Ctr Rech Pathol Prostat & Urol, F-75013 Paris, France; [Giles, Graham G.; MacInnis, Robert J.] Canc Council Victoria, Cancer Epidemiol Ctr, Melbourne, Vic 3004, Australia; [Giles, Graham G.; MacInnis, Robert J.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Maier, Christiane] Univ Hosp Ulm, Inst Human Genet, D-89075 Ulm, Germany; [Maier, Christiane] Univ Hosp Ulm, Dept Urol, D-89075 Ulm, Germany; [Hsieh, Chih-Lin] Univ Southern Calif, Dept Urol, Los Angeles, CA 90033 USA; [Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Catalona, William J.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Foulkes, William D.] Montreal Gen Hosp, Dept Oncol, Montreal, PQ H3G 1A4, Canada; [Foulkes, William D.] Montreal Gen Hosp, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Mandal, Diptasri] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA; [Eeles, Rosalind A.; Kote-Jarai, Zsofia] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Bustamante, Carlos D.; Hastie, Trevor; Whittemore, Alice S.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Hastie, Trevor] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Stanford University; Stanford University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University Bloomington; Memorial Sloan Kettering Cancer Center; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; NorthShore University Health System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Turku; University of Turku; Translational Genomics Research Institute; Wayne State University; UDICE-French Research Universities; Universite Paris Cite; Cancer Council Victoria; University of Melbourne; Ulm University; Ulm University; University of Southern California; Karolinska Institutet; Northwestern University; Feinberg School of Medicine; McGill University; McGill University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of London; Institute of Cancer Research - UK; Stanford University; Stanford University; Mayo Clinic	Sieh, W (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.; Sieh, W (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Sieh, W (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.	weiva.sieh@mssm.edu	Foulkes, William D./AAR-9586-2021	Foulkes, William D./0000-0001-7427-4651; Karyadi, Danielle/0000-0003-4164-5625; Middha, Sumit/0000-0003-4135-6268; Dichgans, Martin/0000-0002-0654-387X; McDonnell, Shannon/0000-0001-6201-369X; Hastie, Trevor/0000-0002-0164-3142; Eeles, Rosalind/0000-0002-3698-6241; Schleutker, Johanna/0000-0002-1863-0305; Ioannidis, Nilah/0000-0001-9628-8229; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Cooney, Kathleen/0000-0003-3831-6943; Bustamante, Carlos D./0000-0002-4187-7920; Ostrander, Elaine/0000-0001-6075-9738; Bailey-Wilson, Joan/0000-0002-9153-2920; MacInnis, Robert/0000-0002-1627-5047; cussenot, olivier/0000-0002-9912-0533	NIH [U01CA089600, R01CA094069, R01LM009722, R01MH105524, K07CA143047, F32HG008330]; Intramural Research Program of the National Human Genome Research Institute, NIH; NATIONAL CANCER INSTITUTE [R01CA094069, U01CA089600, P50CA180995, K07CA143047, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, ZIAHG000153, F32HG008330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105524] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was funded by NIH grants U01CA089600, R01CA094069, R01LM009722, R01MH105524, K07CA143047, and F32HG008330 and by the Intramural Research Program of the National Human Genome Research Institute, NIH.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Crockett DK, 2012, GENOME MED, V4, DOI 10.1186/gm347; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Frousios K, 2013, GENOMICS, V102, P223, DOI 10.1016/j.ygeno.2013.06.005; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Hodgkinson A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-495; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Niroula A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117380; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Peterson TA, 2013, J MOL BIOL, V425, P4047, DOI 10.1016/j.jmb.2013.08.008; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	53	785	792	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					877	885		10.1016/j.ajhg.2016.08.016	http://dx.doi.org/10.1016/j.ajhg.2016.08.016			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27666373	Green Published, Bronze			2022-12-18	WOS:000385333700007
J	CLAUS, EB; RISCH, N; THOMPSON, WD				CLAUS, EB; RISCH, N; THOMPSON, WD			GENETIC-ANALYSIS OF BREAST-CANCER IN THE CANCER AND STEROID-HORMONE STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGREGATION ANALYSIS; FAMILY HISTORY; RISK; HETEROGENEITY	The familial risk of breast cancer is investigated in a large population-based, case-control study conducted by the Centers for Disease Control. The data set is based on 4,730 histologically confirmed breast cancer cases aged 20 to 54 years and on 4,688 controls who were frequency matched to the basis of both geographic region and 5-year categories of age, and it includes family histories, obtained through interviews of cases and controls, of breast cancer in mothers and sisters. Segregation analysis and goodness-of-fit tests of genetic models provide evidence for the existence of a rare autosomal dominant allele (q = .0033) leading to increased susceptibility to breast cancer. The effect of genotype on the risk of breast cancer is shown to be a function of a woman's age. Although, compared with noncarriers, carriers of the allele appear to be at greater risk at all ages, the ratio of age-specific risks is greatest at young ages and declines steadily thereafter. The proportion of cases predicted to carry the allele is highest (36%) among cases aged 20-29 years. This proportion gradually decreases to 1% among cases aged 80 years or older. The cumulative lifetime risk of breast cancer for women who carry the susceptibility allele is predicted to be high, approximately 92%, while the cumulative lifetime risk for noncarriers is estimated to be approximately 10%.	YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV SO MAINE,PORTLAND,ME 04103	Yale University; University of Maine System; University of Southern Maine	CLAUS, EB (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,NEW HAVEN,CT 06510, USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007085] Funding Source: NIH RePORTER; NICHD NIH HHS [3-Y01-HD-8-1037] Funding Source: Medline; NIEHS NIH HHS [2-T32-ES07085] Funding Source: Medline; NIGMS NIH HHS [GM39812] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; CLAUS EB, 1990, ANN HUM GENET, V54, P169, DOI 10.1111/j.1469-1809.1990.tb00373.x; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; DIXON WJ, 1983, BMDP STATISTICAL SOF; GO RCP, 1983, J NATL CANCER I, V71, P455; GOLDSTEIN AM, 1987, JNCI-J NATL CANCER I, V78, P911; GOLDSTEIN AM, 1988, GENET EPIDEMIOL, V5, P121, DOI 10.1002/gepi.1370050207; KAPLAN EB, 1972, I STAT MIMEO SER, V823; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1980, 3 POP GEN LAB TECH R; LYNCH HT, 1988, BREAST CANCER RES TR, V12, P275, DOI 10.1007/BF01811240; LYNCH HT, 1988, BREAST CANCER RES TR, V11, P263, DOI 10.1007/BF01807285; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; SATTIN RW, 1985, JAMA-J AM MED ASSOC, V253, P1908, DOI 10.1001/jama.253.13.1908; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; SCHWARTZ AG, 1985, JNCI-J NATL CANCER I, V75, P665; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; WINGO PA, 1988, AM J EPIDEMIOL, V128, P206, DOI 10.1093/oxfordjournals.aje.a114942	18	785	803	0	26	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					232	242						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990835				2022-12-18	WOS:A1991EV74400008
J	Spielman, RS; Ewens, WJ				Spielman, RS; Ewens, WJ			The TDT and other family-based tests for linkage disequilibrium and association	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DEPENDENT DIABETES-MELLITUS; GENETIC DISSECTION; COMPLEX TRAITS; MARKER LOCI; IDDM; RISK		UNIV PENN, DEPT BIOL, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	Spielman, RS (corresponding author), UNIV PENN, SCH MED, DEPT GENET, 415 CURIE BLVD, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046618, R01DK047481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021135] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46618, DK47481] Funding Source: Medline; NIGMS NIH HHS [GM21135] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COX NJ, 1988, AM J HUM GENET, V42, P167; CURTIS D, 1995, AM J HUM GENET, V56, P811; Duffy DL, 1995, GENET EPIDEMIOL, V12, P595, DOI 10.1002/gepi.1370120612; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Feller W., 1968, INTRO PROBABILITY TH, V3; FIELD LL, 1986, GENET EPIDEMIOL, P323; GOLDIN LR, 1995, GENET EPIDEMIOL, V12, P545; Harley JB, 1995, GENET EPIDEMIOL, V12, P607, DOI 10.1002/gepi.1370120614; KENDALL MG, 1979, ADV THEORY STATISTIC, V2; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; Rice JP, 1995, GENET EPIDEMIOL, V12, P659, DOI 10.1002/gepi.1370120623; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1995, AM J HUM GENET, V57, P487	22	782	820	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					983	989						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900224				2022-12-18	WOS:A1996VN90000003
J	Lesage, S; Zouali, H; Cezard, JP; Colombel, JF; Belaiche, J; Almer, S; Tysk, C; O'Morain, C; Gassull, M; Binder, V; Finkel, Y; Modigliani, R; Gower-Rousseau, C; Macry, J; Merlin, F; Chamaillard, M; Jannot, AS; Thomas, G; Hugot, JP				Lesage, S; Zouali, H; Cezard, JP; Colombel, JF; Belaiche, J; Almer, S; Tysk, C; O'Morain, C; Gassull, M; Binder, V; Finkel, Y; Modigliani, R; Gower-Rousseau, C; Macry, J; Merlin, F; Chamaillard, M; Jannot, AS; Thomas, G; Hugot, JP		EPWG-IBD Grp; EPIMAD Grp; GETAID Grp	CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; CIGARETTE-SMOKING; PROVIDES EVIDENCE; KAPPA-B; FAMILIES; ETIOLOGY; PROTEIN; LINKAGE	CARD15/NOD2 encodes a protein involved in bacterial recognition by monocytes. Mutations in CARD15 have recently been found in patients with Crohn disease (CD), a chronic inflammatory condition of the digestive tract. Here, we report the mutational analyses of CARD15 in 453 patients with CD, including 166 sporadic and 287 familial cases, 159 patients with ulcerative colitis (UC), and 103 healthy control subjects. Of 67 sequence variations identified, 9 had an allele frequency >5% in patients with CD. Six of them were considered to be polymorphisms, and three (R702W, G908R, and 1007fs) were confirmed to be independently associated with susceptibility to CD. Also considered as potential disease-causing mutations (DCMs) were 27 rare additional mutations. The three main variants (R702W, G908R, and 1007fs) represented 32%, 18%, and 31%, respectively, of the total CD mutations, whereas the total of the 27 rare mutations represented 19% of DCMs. Altogether, 93% of the mutations were located in the distal third of the gene. No mutations were found to be associated with UC. In contrast, 50% of patients with CD carried at least one DCM, including 17% who had a double mutation. This observation confirmed the gene-dosage effect in CD. The patients with double-dose mutations were characterized by a younger age at onset (16.9 years vs. 19.8 years;), a more frequent stricturing phenotype (53% vs. 28%; P = .00003; odds ratio 2.92), and a less frequent colonic involvement (43% vs. 62%; odds ratio 0.44) than were seen in those patients who had no mutation. The severity of the disease and extraintestinal manifestations were not different for any of the CARD15 genotypes. The proportion of familial and sporadic cases and the proportion of patients with smoking habits were similar in the groups of patients with CD with or without mutation. These findings provide tools for a DNA-based test of susceptibility and for genetic counseling in inflammatory bowel disease.	Fdn Jean Dausset, CEPH, F-75010 Paris, France; Hop Robert Debre, Dept Paediat Gastroenterol, European Paediat Working Grp Genet Inflammatory B, F-75019 Paris, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France; Hop St Louis, Dept Gastroenterol, Paris, France; Hop Calmette, Serv Epidemiol & Sante Publ, Registre EPIMAD, Lille, France; CHU Liege, Dept Gastroenterol, Grp Etud Therapeut Affect Inflammatoires Digest, Liege, Belgium; Linkoping Univ, Inst Mol Klin Med, Div Gastroenterol & Hepatol, Linkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, S-70185 Orebro, Sweden; Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona, Spain; Adelaide & Meath Hosp, Dept Gastroenterol, Dublin, Ireland; Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; Karolinska Childrens Hosp, Dept Gastroenterol, Stockholm, Sweden; INSERM, U535, F-94275 Le Kremlin Bicetre, France	Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Liege; Linkoping University; Hospital Germans Trias i Pujol; Trinity College Dublin; University of Copenhagen; Herlev & Gentofte Hospital; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hugot, JP (corresponding author), Fdn Jean Dausset, CEPH, 27 Rue Juliette Dodu, F-75010 Paris, France.	jean-pierre.hugot@cephb.fr	Hugot, Jean-Pierre/F-6594-2012; Gower, Corinne/I-2553-2018	Almer, Sven/0000-0001-9334-1821; Gower, Corinne/0000-0002-3925-5364; Hugot, Jean-Pierre/0000-0002-8446-6056; Jannot, Anne-Sophie/0000-0002-8001-8539				Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Brant SR, 2000, GASTROENTEROLOGY, V119, P1483, DOI 10.1053/gast.2000.20245; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; Cooper DN, 1995, METABOLIC MOL BASES, P259; Cosnes J, 1996, GASTROENTEROLOGY, V110, P424, DOI 10.1053/gast.1996.v110.pm8566589; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1999, INT J COLORECTAL DIS, V14, P2, DOI 10.1007/s003840050175; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Lee JCW, 1996, GASTROENTEROLOGY, V111, P587, DOI 10.1053/gast.1996.v111.pm8780561; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; TOBIN MV, 1987, GASTROENTEROLOGY, V93, P316, DOI 10.1016/0016-5085(87)91021-3; Vermeire S, 2001, GASTROENTEROLOGY, V120, P834, DOI 10.1053/gast.2001.22453; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	30	765	803	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					845	857		10.1086/339432	http://dx.doi.org/10.1086/339432			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11875755	Bronze, Green Published			2022-12-18	WOS:000174252100002
J	Risch, HA; McLaughlin, JR; Cole, DEC; Rosen, B; Bradley, L; Kwan, E; Jack, E; Vesprini, DJ; Kuperstein, G; Abrahamson, JLA; Fan, I; Wong, B; Narod, SA				Risch, HA; McLaughlin, JR; Cole, DEC; Rosen, B; Bradley, L; Kwan, E; Jack, E; Vesprini, DJ; Kuperstein, G; Abrahamson, JLA; Fan, I; Wong, B; Narod, SA			Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; 185DELAG MUTATION; FOUNDER BRCA1; GENETIC-HETEROGENEITY; JEWISH WOMEN; FREQUENCY; RISK; FAMILIES; FEATURES	A population-based series of 649 unselected incident cases of ovarian cancer diagnosed in Ontario, Canada, during 1995-96 was screened for germline mutations in BRCA1 and BRCA2. We specifically tested for 11 of the most commonly reported mutations in the two genes. Then, cases were assessed with the protein-truncation test (PTT) for exon 11 of BRCA1, with denaturing gradient gel electrophoresis for the remainder of BRCA1, and with PTT for exons 10 and 11 of BRCA2. No mutations were found in all 134 women with tumors of borderline histology. Among the 515 women with invasive cancers, we identified 60 mutations, 39 in BRCA1 and 21 in BRCA2. The total mutation frequency among women with invasive cancers, 11.7% (95% confidence interval [95% CI] 9.2%-14.8%), is higher than previous estimates. Hereditary ovarian cancers diagnosed at age <50 years were mostly (83%) due to BRCA1, whereas the majority (60%) of those diagnosed at age >60 years were due to BRCA2. Mutations were found in 19% of women reporting first-degree relatives with breast or ovarian cancer and in 6.5% of women with no affected first-degree relatives. Risks of ovarian, breast, and stomach cancers and leukemias/ lymphomas were increased nine-, five-, six- and threefold, respectively, among first-degree relatives of cases carrying BRCA1 mutations, compared with relatives of noncarriers, and risk of colorectal cancer was increased threefold for relatives of cases carrying BRCA2 mutations. For carriers of BRCA1 mutations, the estimated penetrance by age 80 years was 36% for ovarian cancer and 68% for breast cancer. In breast-cancer risk for first-degree relatives, there was a strong trend according to mutation location along the coding sequence of BRCA1, with little evidence of increased risk for mutations in the 5' fifth, but 8.8-fold increased risk for mutations in the 3' fifth (95% CI 3.6-22.0), corresponding to a carrier penetrance of essentially 100%. Ovarian, colorectal, stomach, pancreatic, and prostate cancer occurred among first-degree relatives of carriers of BRCA2 mutations only when mutations were in the ovarian cancer-cluster region (OCCR) of exon 11, whereas an excess of breast cancer was seen when mutations were outside the OCCR. For cancers of all sites combined, the estimated penetrance of BRCA2 mutations was greater for males than for females, 53% versus 38%. Past studies may have underestimated the contribution of BRCA2 to ovarian cancer, because mutations in this gene cause predominantly late-onset cancer, and previous work has focused more on early-onset disease. If confirmed in future studies, the trend in breast-cancer penetrance, according to mutation location along the BRCA1 coding sequence, may have significant impact on treatment decisions for carriers of BRCA1-mutations. As well, BRCA2 mutations may prove to be a greater cause of cancer in male carriers than previously has been thought.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Dept Clin Biochem, Toronto, ON, Canada; Toronto Hosp, Dept Gynecol, Toronto, ON M5T 2S8, Canada; Womens Coll Hosp, Dept Med, Toronto, ON M5S 1B2, Canada	Yale University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Risch, HA (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St,POB 208034, New Haven, CT 06520 USA.	harvey.risch@yale.edu	McLaughlin, John R/E-4577-2013; Narod, Steven A/AAA-6112-2022		NATIONAL CANCER INSTITUTE [R01CA063678, R01CA063682] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 63678, R01 CA063678, R01 CA063682, R01 CA 63682] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foster KA, 1996, CANCER RES, V56, P3622; Frank LS, 1998, ASYMPTOTIC ANAL, V16, P1; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gotlieb WH, 1998, JNCI-J NATL CANCER I, V90, P995, DOI 10.1093/jnci/90.13.995; Janezic SA, 1999, HUM MOL GENET, V8, P889, DOI 10.1093/hmg/8.5.889; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Khoo U S, 2000, Hum Mutat, V16, P88, DOI 10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G; Kuperstein G, 2000, CLIN GENET, V57, P213, DOI 10.1034/j.1399-0004.2000.570307.x; Lehrer S, 1998, BRIT J CANCER, V78, P771, DOI 10.1038/bjc.1998.576; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; MATSUSHIMA M, 1995, HUM MOL GENET, V4, P1953, DOI 10.1093/hmg/4.10.1953; Mazoyer S, 2000, AM J HUM GENET, V67, P207, DOI 10.1086/302974; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Muto MG, 1996, CANCER RES, V56, P1250; NAROD S, 1995, AM J HUM GENET, V57, P957; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Ries LAG, 1994, NIH PUBL; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Sinclair CS, 2000, CANCER RES, V60, P1371; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Stratton JF, 1999, AM J HUM GENET, V65, P1725, DOI 10.1086/302671; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Takahashi H, 1996, CANCER RES, V56, P2738; TAKAHASHI H, 1995, CANCER RES, V55, P2998; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Van der Looij M, 2000, INT J CANCER, V86, P737, DOI 10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1; Wacholder S, 1998, AM J EPIDEMIOL, V148, P623, DOI 10.1093/aje/148.7.623; Whittemore AS, 1997, AM J HUM GENET, V60, P496	40	743	760	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					700	710		10.1086/318787	http://dx.doi.org/10.1086/318787			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179017	Green Published, Bronze			2022-12-18	WOS:000166994200014
J	Brunkow, ME; Gardner, JC; Van Ness, J; Paeper, BW; Kovacevich, BR; Proll, S; Skonier, JE; Zhao, L; Sabo, PJ; Fu, YH; Alisch, RS; Gillett, L; Colbert, T; Tacconi, P; Galas, D; Hamersma, H; Beighton, P; Mulligan, JT				Brunkow, ME; Gardner, JC; Van Ness, J; Paeper, BW; Kovacevich, BR; Proll, S; Skonier, JE; Zhao, L; Sabo, PJ; Fu, YH; Alisch, RS; Gillett, L; Colbert, T; Tacconi, P; Galas, D; Hamersma, H; Beighton, P; Mulligan, JT			Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MORPHOGENETIC PROTEINS; CHROMOSOME 17Q12-Q21; DISEASE; DNA; HOMOZYGOSITY; FAMILY; DECAY; MAPS	Sclerosteosis is an autosomal recessive sclerosing bone dysplasia characterized by progressive skeletal overgrowth. The majority of affected individuals have been reported in the Afrikaner population of South Africa, where a high incidence of the disorder occurs as a result of a founder effect. Homozygosity mapping in Afrikaner families along with analysis of historical recombinants localized sclerosteosis to an interval of similar to2 cM between the loci D17S1787 and D17S930 on chromosome 17q12-q21. Here we report two independent mutations in a novel gene, termed "SOST." Affected Afrikaners carry a nonsense mutation near the amino terminus of the encoded protein, whereas an unrelated affected person of Senegalese origin carries a splicing mutation within the single intron of the gene. The SOST gene encodes a protein that shares similarity with a class of cystine knot-containing factors including dan, cerberus, gremlin, prdc, and caronte. The specific and progressive effect on bone formation observed in individuals affected with sclerosteosis, along with the data presented in this study, together suggest that the SOST gene encodes an important new regulator of bone homeostasis.	Celltech Inc, Bothell, WA 98021 USA; Univ Cape Town, Sch Med, Observatory, ZA-7700 Rondebosch, South Africa; Univ Cagliari, Ist Neurol, Cagliari, Italy	University of Cape Town; University of Cagliari	Brunkow, ME (corresponding author), Celltech Inc, 1631 220th St SE, Bothell, WA 98021 USA.	mary.brunkow@sea.celltechgroup.com						ALVES AFD, 1982, REV BRAS GENET, V5, P825; Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; BEIGHTON P, 1976, ANN INTERN MED, V84, P393, DOI 10.7326/0003-4819-84-4-393; BEIGHTON P, 1977, CLIN GENET, V11, P1; BEIGHTON P, 1988, J MED GENET, V25, P200, DOI 10.1136/jmg.25.3.200; BEIGHTON P, 1979, S AFR MED J, V55, P783; BEIGHTON P, 1984, CLIN GENET, V25, P175; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; BUENO M, 1994, J MED GENET, V31, P976, DOI 10.1136/jmg.31.12.976; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox LA, 1998, J LIPID RES, V39, P1319; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIXON JM, 1982, J NEUROL NEUROSUR PS, V45, P913, DOI 10.1136/jnnp.45.10.913; EPSTEIN S, 1979, S AFR MED J, V55, P1105; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; FRYNS JP, 1988, EUR J PEDIATR, V147, P99, DOI 10.1007/BF00442624; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hausen H, 1967, HDB KINDERHEILKUNDE, V6, P351; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Higinbotham N., 1941, AM J SURG, V53, P444; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lunetta KL, 1996, AM J HUM GENET, V59, P717; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MEITINGER T, 1993, NAT GENET, V5, P376, DOI 10.1038/ng1293-376; Nakamura Y, 1997, EUR J CANCER, V33, P1986, DOI 10.1016/S0959-8049(97)00333-X; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Peitrushka G., 1958, KLIN MONATSBL AUGENK, V132, P509; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; STEIN SA, 1983, NEUROLOGY, V33, P267, DOI 10.1212/WNL.33.3.267; SUGIURA Y, 1975, J BONE JOINT SURG AM, VA 57, P273, DOI 10.2106/00004623-197557020-00026; Tacconi P, 1998, CLIN GENET, V53, P497; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Van Buchem FSPP, 1976, HYPEROSTOSIS CORTICA; Van Hul W, 1998, AM J HUM GENET, V62, P391, DOI 10.1086/301721; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755; [No title captured]; [No title captured]	51	723	815	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					577	589		10.1086/318811	http://dx.doi.org/10.1086/318811			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179006	Bronze, Green Published			2022-12-18	WOS:000166994200003
J	Nishimura, AL; Mitne-Neto, M; Silva, HCA; Richieri-Costa, A; Middleton, S; Cascio, D; Kok, F; Oliveira, JRM; Gillingwater, T; Webb, J; Skehel, P; Zatz, M				Nishimura, AL; Mitne-Neto, M; Silva, HCA; Richieri-Costa, A; Middleton, S; Cascio, D; Kok, F; Oliveira, JRM; Gillingwater, T; Webb, J; Skehel, P; Zatz, M			A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; BINDING PROTEIN; 3 FAMILIES; GENE; DYSTROPHY; VAMP; PHENOTYPES; HELICASE; HOMOLOG	Motor neuron diseases (MNDs) are a group of neurodegenerative disorders with involvement of upper and/or lower motor neurons, such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), progressive bulbar palsy, and primary lateral sclerosis. Recently, we have mapped a new locus for an atypical form of ALS/MND ( atypical amyotrophic lateral sclerosis [ALS8]) at 20q13.3 in a large white Brazilian family. Here, we report the finding of a novel missense mutation in the vesicle-associated membrane protein/synaptobrevin-associated membrane protein B (VAPB) gene in patients from this family. Subsequently, the same mutation was identified in patients from six additional kindreds but with different clinical courses, such as ALS8, late-onset SMA, and typical severe ALS with rapid progression. Although it was not possible to link all these families, haplotype analysis suggests a founder effect. Members of the vesicle-associated proteins are intracellular membrane proteins that can associate with microtubules and that have been shown to have a function in membrane transport. These data suggest that clinically variable MNDs may be caused by a dysfunction in intracellular membrane trafficking.	Univ Sao Paulo, Inst Biociencias, Dept Biol, Human Genome Res Ctr, Sao Paulo, Brazil; Univ Fed Sao Paulo, Sch Med, Anesthesiol Pain & Intens Care Dept, Sao Paulo, Brazil; Univ Sao Paulo, Hosp Rehabil Craniofacial Anomalies, Genet Serv, Bauru, Brazil; Univ Edinburgh, Dept Neurosci, Edinburgh, Midlothian, Scotland; Univ Calif Los Angeles, Dept Energy, Inst Mol Biol, Inst Genom & Proteom, Los Angeles, CA USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; University of Edinburgh; University of California System; University of California Los Angeles	Zatz, M (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Biol, Human Genome Res Ctr, Rua Matao 277, Sao Paulo, Brazil.	mayazatz@usp.br	Kok, Fernando/E-7865-2016; Silva, Helga C/D-8959-2012; Richieri-Costa, Antonio/B-2514-2013; Zatz, Mayana/M-5338-2015; Nishimura, Agnes L/B-2905-2011	Silva, Helga C/0000-0002-9372-7019; Zatz, Mayana/0000-0003-3970-8025; Gillingwater, Thomas/0000-0002-0306-5577; Nishimura, Agnes/0000-0001-5295-797X				BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bullock TL, 1996, J MOL BIOL, V263, P284, DOI 10.1006/jmbi.1996.0575; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Corcia P, 2002, NEUROLOGY, V59, P1464, DOI 10.1212/01.WNL.0000032500.73621.C5; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Illarioshkin SN, 1996, BRAIN, V119, P1895, DOI 10.1093/brain/119.6.1895; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mallick P, 2002, P NATL ACAD SCI USA, V99, P16041, DOI 10.1073/pnas.252626399; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; RICHIERICOSTA A, 1981, AM J MED GENET, V9, P119, DOI 10.1002/ajmg.1320090206; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Takata RI, 2004, J MED GENET, V41, P224, DOI 10.1136/jmg.2003.013201; Weiler T, 1996, AM J HUM GENET, V59, P872; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zatz M, 2003, NEUROMUSCULAR DISORD, V13, P532, DOI 10.1016/S0960-8966(03)00100-7; Zatz M, 2000, CURR OPIN NEUROL, V13, P511, DOI 10.1097/00019052-200010000-00002	31	713	739	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					822	831		10.1086/425287	http://dx.doi.org/10.1086/425287			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15372378	Green Published, Bronze			2022-12-18	WOS:000224303500007
J	Richards, M; Macaulay, V; Hickey, E; Vega, E; Sykes, B; Guida, V; Rengo, C; Sellitto, D; Cruciani, F; Kivisild, T; Villems, R; Thomas, M; Rychkov, S; Rychkov, O; Rychkov, Y; Golge, M; Dimitrov, D; Hill, E; Bradley, D; Romano, V; Cali, F; Vona, G; Demaine, A; Papiha, S; Triantaphyllidis, C; Stefanescu, G; Hatina, J; Belledi, M; Di Rienzo, A; Novelletto, A; Oppenheim, A; Norby, S; Al-Zaheri, N; Santachiara-Benerecetti, S; Scozzari, R; Torroni, A; Bandelt, HJ				Richards, M; Macaulay, V; Hickey, E; Vega, E; Sykes, B; Guida, V; Rengo, C; Sellitto, D; Cruciani, F; Kivisild, T; Villems, R; Thomas, M; Rychkov, S; Rychkov, O; Rychkov, Y; Golge, M; Dimitrov, D; Hill, E; Bradley, D; Romano, V; Cali, F; Vona, G; Demaine, A; Papiha, S; Triantaphyllidis, C; Stefanescu, G; Hatina, J; Belledi, M; Di Rienzo, A; Novelletto, A; Oppenheim, A; Norby, S; Al-Zaheri, N; Santachiara-Benerecetti, S; Scozzari, R; Torroni, A; Bandelt, HJ			Tracing European founder lineages in the near eastern mtDNA pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; AFRICAN POPULATIONS REVEALS; Y-CHROMOSOME POLYMORPHISMS; HUMAN-GENE-FREQUENCIES; D-LOOP; CONTROL-REGION; GEOGRAPHIC-VARIATION; NEOLITHIC LINEAGES; IBERIAN PENINSULA; SEQUENCE-ANALYSIS	Founder analysis is a method for analysis of nonrecombining DNA sequence data, with the aim of identification and dating of migrations into new territory. The method picks out founder sequence types in potential source populations and dates lineage clusters deriving from them in the settlement zone of interest. Here, using mtDNA, we apply the approach to the colonization of Europe, to estimate the proportion of modern lineages whose ancestors arrived during each major phase of settlement. To estimate the Palaeolithic and Neolithic contributions to European mtDNA diversity more accurately than was previously achievable, we have now extended the Near Eastern, European, and northern-Caucasus databases to 1,234, 2,804, and 208 samples, respectively. Both back-migration into the source population and recurrent mutation in the source and derived populations represent major obstacles to this approach. We have developed phylogenetic criteria to take account of both these factors, and we suggest a way to account for multiple dispersals of common sequence types. We conclude that (i) there has been substantial back-migration into the Near East, (ii) the majority of extant mtDNA lineages entered Europe in several waves during the Upper Palaeolithic, (iii) there was a founder effect or bottleneck associated with the Last Glacial Maximum, 20,000 years ago, from which derives the largest fraction of surviving lineages, and (iv) the immigrant Neolithic component is likely to comprise less than one-quarter of the mtDNA pool of modern Europeans.	Univ Oxford, Inst Mol Med, Oxford, England; Univ Oxford, Dept Stat, Oxford, England; UCL, Dept Biol, London, England; UCL, Ctr Genet Anthropol, Dept Anthropol, London, England; UCL, Dept Biol, London, England; Linnaean Soc London, London, England; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Med Legale, Rome, Italy; Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; Russian Acad Sci, Inst Gen Genet, Human Genet Lab, Moscow V71, Russia; Univ Kiel, Dept Physiol, Kiel, Germany; Trinity Coll Dublin, Dept Genet, Dublin, Ireland; Assoc Oasi Maria SS, Ist Ricovero & Cura, Carattere Sci Studio Ritardo Mentale & Involuzion, Troina, Italy; Univ Palermo, Dipartimento Biopatol & Metodol Biomed, Palermo, Italy; Univ Cagliari, Dipartimento Biol Sperimentale, Sezione Antropol, Cagliari, Italy; Univ Plymouth, Postgrad Med Sch, Plymouth PL4 8AA, Devon, England; Newcastle Univ, Dept Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; Inst Cercetari Biol, Iasi, Romania; Univ Pilsen, Fac Med, Inst Biol, Pilsen, Italy; Dipartimento Biol Evolut, Sezione Biol Umana, Parma, Italy; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel; Univ Copenhagen, Inst Forens Med, Lab Biol Anthropol, Copenhagen, Denmark; Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad, Iraq; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Urbino, Ist Biochim, I-61029 Urbino, Italy; Univ Hamburg, Fachbereich Math, Hamburg, Germany	University of Oxford; University of Oxford; University of London; University College London; University of London; University College London; University of London; University College London; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Tartu; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; University of Kiel; Trinity College Dublin; IRCCS Oasi Maria SS; University of Palermo; University of Cagliari; University of Plymouth; Newcastle University - UK; Aristotle University of Thessaloniki; University of West Bohemia Pilsen; University of Chicago; University of Calabria; Hebrew University of Jerusalem; University of Copenhagen; University of Baghdad; University of Pavia; University of Urbino; University of Hamburg	Richards, M (corresponding author), Univ Huddersfield, Dept Chem & Biol Sci, Queensgate, Huddersfield HD1 3DH, W Yorkshire, England.	M.B.Richards@hud.ac.uk	Calì, Francesco/D-9178-2017; Al-Zahery, Nadia/AAV-5878-2020; Cruciani, Fulvio/G-6105-2012; Guida, Valentina/K-4517-2015; Kivisild, Toomas/P-5889-2017; Torroni, Antonio/E-1557-2011; Thomas, Mark G/A-2219-2012; Bradley, Daniel G/A-3240-2012	Calì, Francesco/0000-0001-8667-8223; Guida, Valentina/0000-0003-3946-645X; Kivisild, Toomas/0000-0002-6297-7808; Torroni, Antonio/0000-0002-4163-4478; Thomas, Mark G/0000-0002-2452-981X; 				Adams J, 1999, CURR ANTHROPOL, V40, P73, DOI 10.1086/515804; Ammerman A.J., 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BALLINGER SW, 1992, GENETICS, V130, P139; BANDELT HJ, 1995, GENETICS, V141, P743; Bar-Yosef O, 1998, CAMB ARCHAEOL J, V8, P141, DOI 10.1017/S0959774300001815; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; Barker G., 1985, PREHISTORIC FARMING; Belledi M, 2000, EUR J HUM GENET, V8, P480, DOI 10.1038/sj.ejhg.5200443; Berger JO., 1985, STAT DECISION THEORY; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BIETTI A, 1990, J WORLD PREHIST, V4, P95, DOI 10.1007/BF00974820; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; CHEN YS, 1995, AM J HUM GENET, V57, P133; Chikhi L, 1998, HUM BIOL, V70, P643; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DENNELL R, 1983, EUROPEAN ECONOMIC PR; Diamond JM, 1997, NATURE, V389, P544, DOI 10.1038/39184; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DOLUKHANOV P, 1994, ENV ETHNICITY ANCIEN; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Gamble C.S., 1999, PALAEOLITHIC SOC EUR; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; GILEAD I, 1991, J WORLD PREHIST, V5, P105, DOI 10.1007/BF00974677; Harris D. R, 1996, ORIGINS SPREAD AGR P; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Henry DO., 1989, FORAGING AGR LEVANT; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Jochim M., 1987, PLEISTOCENE OLD WORL, P317, DOI DOI 10.1007/978-1-4613-1817-020; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; KUHRT A, 1995, ANCIENT NEAR E, V1, P3000; Leighton R., 1999, SICILY HIST; LEWIS B, 1998, MULTIPLE IDENTIES MI; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Malyarchuk BA, 1999, ANN HUM GENET, V63, P489, DOI 10.1017/S0003480099007794; MELLARS PA, 1992, PHILOS T ROY SOC B, V337, P225, DOI 10.1098/rstb.1992.0100; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; OLSZEWSKI DI, 1994, CURR ANTHROPOL, V35, P68, DOI 10.1086/204242; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Passarino G, 1996, AM J HUM GENET, V59, P927; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Passarino G, 1992, Gene Geogr, V6, P139; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; REDGATE AE, 1998, ARMENIANS; Renfrew C, 1998, MEM CALIF ACAD SCI, P171; Richards M, 1998, AM J HUM GENET, V62, P491, DOI 10.1086/301733; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; SAILLARD J, IN PRESS HUM BIOL; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Semino O, 1996, AM J HUM GENET, V59, P964; SHERRATT A, 1994, OXFORD ILLUSTRATED P; Soffer O., 1987, PLEISTOCENE OLD WORL, P333; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Straus Lawrence Guy, 1995, Evolutionary Anthropology, V4, P4, DOI 10.1002/evan.1360040103; SYKES B, 1995, AM J HUM GENET, V57, P1463; TEMPLETON AR, 1995, GENETICS, V140, P767; TERRELL JE, 1986, PREHISTORY PACIFIC H; Thorpe I.J.N., 1996, ORIGINS AGR EUROPE; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Tubb Jonathan N, 1998, CANAANITES; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Whittle A., 1996, EUROPE NEOLITHIC; Zilhao J, 1998, CURR ANTHROPOL, V39, P690, DOI 10.1086/204791; Zilhao J., 1993, J MEDITERR ARCHAEOL, V6, P5, DOI DOI 10.1558/JMEA.V6I1.5; ZVELEBIL M, 1989, ANTIQUITY, V63, P379, DOI 10.1017/S0003598X00076110; Zvelebil M, 1986, HUNTERS TRANSITION M, P5	102	704	731	4	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1251	1276		10.1016/S0002-9297(07)62954-1	http://dx.doi.org/10.1016/S0002-9297(07)62954-1			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW		Green Published, Bronze			2022-12-18	WOS:000165091600021
J	Sharp, AJ; Locke, DP; McGrath, SD; Cheng, Z; Bailey, JA; Vallente, RU; Pertz, LM; Clark, RA; Schwartz, S; Segraves, R; Oseroff, VV; Albertson, DG; Pinkel, D; Eichler, EE				Sharp, AJ; Locke, DP; McGrath, SD; Cheng, Z; Bailey, JA; Vallente, RU; Pertz, LM; Clark, RA; Schwartz, S; Segraves, R; Oseroff, VV; Albertson, DG; Pinkel, D; Eichler, EE			Segmental duplications and copy-number variation in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; CHROMOSOME; SEQUENCE; DELETION; REARRANGEMENTS; POLYMORPHISM; HYBRIDIZATION; MICROARRAY; RECOMBINATION; EVOLUTION	The human genome contains numerous blocks of highly homologous duplicated sequence. This higher- order architecture provides a substrate for recombination and recurrent chromosomal rearrangement associated with genomic disease. However, an assessment of the role of segmental duplications in normal variation has not yet been made. On the basis of the duplication architecture of the human genome, we defined a set of 130 potential rearrangement hotspots and constructed a targeted bacterial artificial chromosome ( BAC) microarray ( with 2,194 BACs) to assess copy- number variation in these regions by array comparative genomic hybridization. Using our segmental duplication BAC microarray, we screened a panel of 47 normal individuals, who represented populations from four continents, and we identified 119 regions of copy- number polymorphism ( CNP), 73 of which were previously unreported. We observed an equal frequency of duplications and deletions, as well as a 4- fold enrichment of CNPs within hotspot regions, compared with control BACs ( P <.000001), which suggests that segmental duplications are a major catalyst of large- scale variation in the human genome. Importantly, segmental duplications themselves were also significantly enriched > 4- fold within regions of CNP. Almost without exception, CNPs were not confined to a single population, suggesting that these either are recurrent events, having occurred independently in multiple founders, or were present in early human populations. Our study demonstrates that segmental duplications define hotspots of chromosomal rearrangement, likely acting as mediators of normal variation as well as genomic disease, and it suggests that the consideration of genomic architecture can significantly improve the ascertainment of large- scale rearrangements. Our specialized segmental duplication BAC microarray and associated database of structural polymorphisms will provide an important resource for the future characterization of human genomic disorders.	Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Case Western Reserve University; Case Western Reserve University; Washington State University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	McGrath, Sean David/AAT-3540-2020; Sharp, Andrew/A-5783-2008	McGrath, Sean David/0000-0001-9064-8449; Locke, Devin/0000-0002-2527-0475; Vallente, Rhea/0000-0002-1573-4782	NICHD NIH HHS [R01 HD043569, HD043569] Funding Source: Medline; NIGMS NIH HHS [T32 GM007250] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barber JCK, 1999, HUM GENET, V104, P211, DOI 10.1007/s004390050938; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Dalen P, 1998, CLIN PHARMACOL THER, V63, P444, DOI 10.1016/S0009-9236(98)90040-6; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Fantes JA, 2002, J MED GENET, V39, P170, DOI 10.1136/jmg.39.3.170; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; McLellan RA, 1997, MOL PHARMACOL, V52, P958, DOI 10.1124/mol.52.6.958; Mehan Michael R., 2004, Human Genomics, V1, P335; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Rao YS, 2000, MOL PHARMACOL, V58, P747, DOI 10.1124/mol.58.4.747; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SASSO EH, 1995, J CLIN INVEST, V96, P1591, DOI 10.1172/JCI118198; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Siniscalco M, 2000, TRENDS GENET, V16, P435, DOI 10.1016/S0168-9525(00)02101-6; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Snijders Antoine M, 2004, Methods Mol Biol, V256, P39; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; TUZUN E, 2005, NAT GENET       0515; van der Burg M, 2002, J IMMUNOL, V169, P271, DOI 10.4049/jimmunol.169.1.271; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350	54	693	720	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					78	88		10.1086/431652	http://dx.doi.org/10.1086/431652			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15918152	Bronze, Green Published			2022-12-18	WOS:000229794500007
J	Feldkotter, M; Schwarzer, V; Wirth, R; Wienker, TF; Wirth, B				Feldkotter, M; Schwarzer, V; Wirth, R; Wienker, TF; Wirth, B			Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE COPY NUMBER; SINGLE NUCLEOTIDE; SURVIVAL; SMA; IDENTIFICATION; PROTEIN; CLASSIFICATION; PHENOTYPE; DELETION; GENOTYPE	Spinal muscular atrophy (SMA) is a common autosomal recessive disorder in humans, caused by homozygous absence of the survival motor neuron gene 1 (SMN1). SMN2, a copy gene, influences the severity of SMA and may be used in somatic gene therapy of patients with SMA in the future. We present a new, fast, and highly reliable quantitative test, based on real-time LightCycler PCR that amplifies either SMN1 or SMN2. The SMN1 copies were determined and validated in 329 carriers and controls. The specificity of the test is 100%, whereas the sensitivity is 96.2%. The quantitative analysis of SMN2 copies in 375 patients with type I, type II, or type III SMA showed a significant correlation between SMN2 copy number and type of SMA as well as duration of survival. Thus, 80% of patients with type I SMA carry one or two SMN2 copies, and 82% of patients with type II SMA carry three SMN2 copies, whereas 96% of patients with type III SMA carry three or four SMN2 copies. Among 113 patients with type I SMA, 9 with one SMN2 copy lived <11 mo, 88/ 94 with two SMN2 copies lived <21 mo, and 8/10 with three SMN2 copies lived 33-66 mo. On the basis of SMN2 copy number, we calculated the posterior probability that a child with homozygous absence of SMN1 will develop type I, type II, or type III SMA.	Univ Bonn, Univ Clin, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Univ Clin, Dept Surg, D-53111 Bonn, Germany; Univ Bonn, Univ Clin, Inst Med Biometry Informat & Epidemiol, D-53111 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Wirth, B (corresponding author), Univ Bonn, Univ Clin, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Wirth, Brunhilde/H-3192-2019	Wirth, Brunhilde/0000-0003-4051-5191				Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; HAUSMANOWAPETRUSEWICZ I, 1985, J MED GENET, V22, P350, DOI 10.1136/jmg.22.5.350; Helmken C, 2000, EUR J HUM GENET, V8, P493, DOI 10.1038/sj.ejhg.5200479; Helmken C, 2000, HUM GENET, V107, P554, DOI 10.1007/s004390000409; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hosmer D. W., 2000, APPL LOGISTIC REGRES, V2nd; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; PEARN J, 1980, LANCET, V1, P919; SAS Institute, 1996, SAS STAT SOFTW CHANG; Scheffer H, 2001, EUR J HUM GENET, V9, P484, DOI 10.1038/sj.ejhg.5200667; Scheffer H, 2000, EUR J HUM GENET, V8, P79, DOI 10.1038/sj.ejhg.5200404; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.3.CO;2-0; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	29	693	736	1	31	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					358	368		10.1086/338627	http://dx.doi.org/10.1086/338627			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791208	Green Published, Bronze			2022-12-18	WOS:000173254300009
J	Bersaglieri, T; Sabeti, PC; Patterson, N; Vanderploeg, T; Schaffner, SF; Drake, JA; Rhodes, M; Reich, DE; Hirschhorn, JN				Bersaglieri, T; Sabeti, PC; Patterson, N; Vanderploeg, T; Schaffner, SF; Drake, JA; Rhodes, M; Reich, DE; Hirschhorn, JN			Genetic signatures of strong recent positive selection at the lactase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADULT LACTOSE INTOLERANCE; LINKAGE DISEQUILIBRIUM; HUMAN GENOME; NATURAL-SELECTION; CULTURAL INTERRELATIONS; HAPLOTYPE DIVERSITY; DNA POLYMORPHISMS; MILKING HABIT; POPULATION; ORIGIN	In most human populations, the ability to digest lactose contained in milk usually disappears in childhood, but in European-derived populations, lactase activity frequently persists into adulthood (Scrimshaw and Murray 1988). It has been suggested (Cavalli-Sforza 1973; Hollox et al. 2001; Enattah et al. 2002; Poulter et al. 2003) that a selective advantage based on additional nutrition from dairy explains these genetically determined population differences (Simoons 1970; Kretchmer 1971; Scrimshaw and Murray 1988; Enattah et al. 2002), but formal population-genetics-based evidence of selection has not yet been provided. To assess the population-genetics evidence for selection, we typed 101 single-nucleotide polymorphisms covering 3.2 Mb around the lactase gene. In northern European-derived populations, two alleles that are tightly associated with lactase persistence ( Enattah et al. 2002) uniquely mark a common (similar to77%) haplotype that extends largely undisrupted for >1 Mb. We provide two new lines of genetic evidence that this long, common haplotype arose rapidly due to recent selection: ( 1) by use of the traditional F-ST measure and a novel test based on p(excess), we demonstrate large frequency differences among populations for the persistence-associated markers and for flanking markers throughout the haplotype, and ( 2) we show that the haplotype is unusually long, given its high frequency-a hallmark of recent selection. We estimate that strong selection occurred within the past 5,000-10,000 years, consistent with an advantage to lactase persistence in the setting of dairy farming; the signals of selection we observe are among the strongest yet seen for any gene in the genome.	Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Whitehead MIT Ctr Genome Res, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Hirschhorn, JN (corresponding author), Childrens Hosp, Div Genet, Enders 561,300 Longwood Ave, Boston, MA 02115 USA.	joel.hirschhorn@childrens.harvard.edu	Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011	Schaffner, Stephen/0000-0001-6699-3568				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BAYLESS TM, 1966, J AMER MED ASSOC, V197, P968, DOI 10.1001/jama.197.12.968; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; CAVALLISFORZA LL, 1973, AM J HUM GENET, V25, P82; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grand RJ, 2003, GUT, V52, P617, DOI 10.1136/gut.52.5.617; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hartl DL, 1997, PRINCIPLES POPULATIO; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRETCHMER N, 1971, GASTROENTEROLOGY, V61, P805; LEWONTIN RC, 1973, GENETICS, V74, P175; LI WH, 1975, AM J HUM GENET, V27, P274; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; REICH DE, 1998, MICROSATELLITES EVOL; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosner B, 1982, FUNDAMENTALS BIOSTAT; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SCRIMSHAW N S, 1988, American Journal of Clinical Nutrition, V48, P1083; SIMOONS FJ, 1969, AM J DIG DIS, V14, P819, DOI 10.1007/BF02233204; SIMOONS FJ, 1970, AM J DIG DIS, V15, P695, DOI 10.1007/BF02235991; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Toomajian C, 2003, GENETICS, V165, P287; Wiuf C, 2001, GENET RES, V78, P41, DOI 10.1017/S0016672301005195; [No title captured]	40	688	705	3	236	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1111	1120		10.1086/421051	http://dx.doi.org/10.1086/421051			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15114531	Bronze, Green Published			2022-12-18	WOS:000221651900004
J	PERICAKVANCE, MA; BEBOUT, JL; GASKELL, PC; YAMAOKA, LH; HUNG, WY; ALBERTS, MJ; WALKER, AP; BARTLETT, RJ; HAYNES, CA; WELSH, KA; EARL, NL; HEYMAN, A; CLARK, CM; ROSES, AD				PERICAKVANCE, MA; BEBOUT, JL; GASKELL, PC; YAMAOKA, LH; HUNG, WY; ALBERTS, MJ; WALKER, AP; BARTLETT, RJ; HAYNES, CA; WELSH, KA; EARL, NL; HEYMAN, A; CLARK, CM; ROSES, AD			LINKAGE STUDIES IN FAMILIAL ALZHEIMER-DISEASE - EVIDENCE FOR CHROMOSOME-19 LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY; TIGHT LINKAGE; RELATIVES; COMMITTEE; RISK	A genetic component in the etiology of Alzheimer disease (AD) has been supported by indirect evidence for several years, with autosomal dominant inheritance with age-dependent penetrance being suggested to explain the familial aggregation of affecteds. St. George Hyslop et al. reported linkage of familial AD (FAD) in four early-onset families (mean age at onset [M] < 50 years). Subsequent studies have been inconsistent in their results; Goate et al. also reported positive lod scores. However, both Pericak-Vance et al.'s study of a series of mainly late-onset FAD families (M > 60 years) and Schellenberg et al.'s study failed to confirm linkage to chromosome 21 (CH21). These various studies suggest the possibility of genetic heterogeneity, with some families linked to CH21 and others unlocalized. Recently, St. George Hyslop et al. extended their analysis to include additional families. The extended analyses supported their earlier finding of linkage to CH21, while showing strong evidence of heterogeneity between early-onset (M < 65 years) and late-onset (M > 60 years) FAD families. Because our families did not show linkage to CH21, we undertook a genomic search for an additional locus for FAD. Because of both the confounding factor of late age at onset of FAD and the lack of clear evidence of Mendelian transmission in some of our families, we employed the affected-pedigree-member (APM) method of linkage analysis as an initial screen for possible linkage. Using this method, we identified two regions suggesting linkage: the proximal long arm of chromosome 19 (CH19) and the CH21 region of FAD linkage reported by St. George Hyslop et al. Application of standard likelihood (LOD score) analysis to these data support the possibility of an FAD gene located on CH19, particularly in the late-onset FAD families. These data further suggest genetic heterogeneity and delineate this region of CH19 as an area needing additional investigation in FAD.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT PSYCHIAT, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, JOSEPH & KATHLEEN BRYAN ALZHEIMER & DIS RES CTR, DURHAM, NC 27710 USA	Duke University; Duke University; Duke University	PERICAKVANCE, MA (corresponding author), DUKE UNIV, MED CTR, DEPT MED NEUROL, DIV NEUROL, BOX 2900, DURHAM, NC 27710 USA.		Walker, Ann P/C-1628-2008		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG007922] Funding Source: NIH RePORTER; NIA NIH HHS [AG07922, AG05128] Funding Source: Medline; NINDS NIH HHS [P01-NS-26630] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876; BREITNER JCS, 1988, NEUROLOGY, V38, P207; Elston RC, 1987, ESSENTIALS BIOSTATIS; FARRER L A, 1988, American Journal of Human Genetics, V43, pA213; George Hyslop P. St., 1990, NATURE, V347, P194; GOATE AM, 1989, LANCET, V1, P352; HAINES J L, 1988, American Journal of Human Genetics, V43, pA145; HAYNES C, 1986, GENET EPIDEMIOL, P235; HAYNES C S, 1988, American Journal of Human Genetics, V43, pA146; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HYSLOP PHS, 1987, SCIENCE, V235, P885; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LANGE K, 1990, WORLD REV NUTR DIET, V63, P236; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1956, AM J HUM GENET, V8, P80; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PERICAKVANCE MA, 1988, AUST PAEDIATR J, V24, P87; PERICAKVANCE MA, 1986, NEUROLOGY, V36, P1418, DOI 10.1212/WNL.36.11.1418; PERICAKVANCE MA, 1986, GENET EPIDEMIOL, P197; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PERICAKVANCE MA, 1989, FAMILIAL ALZHEIMERS, P85; PERICAKVANCE MA, IN PRESS P INT S DEM; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1990, AM J HUM GENET S, V47, pA198; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WEEKS DE, 1988, AM J HUM GENET, V42, P315; YAMAOKA LH, 1990, NEUROLOGY, V40, P222, DOI 10.1212/WNL.40.2.222	33	682	715	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1034	1050						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035524				2022-12-18	WOS:A1991FP09200003
J	Lee, SH; Wray, NR; Goddard, ME; Visscher, PM				Lee, Sang Hong; Wray, Naomi R.; Goddard, Michael E.; Visscher, Peter M.			Estimating Missing Heritability for Disease from Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON SNPS EXPLAIN; LARGE PROPORTION; INFORMATION; LIABILITY; VARIANCE	Genome-wide association studies are designed to discover SNPs that are associated with a complex trait. Employing strict significance thresholds when testing individual SNPs avoids false positives at the expense of increasing false negatives. Recently, we developed a method for quantitative traits that estimates the variation accounted for when fitting all SNPs simultaneously. Here we develop this method further for case-control studies. We use a linear mixed model for analysis of binary traits and transform the estimates to a liability scale by adjusting both for scale and for ascertainment of the case samples. We show by theory and simulation that the method is unbiased. We apply the method to data from the Wellcome Trust Case Control Consortium and show that a substantial proportion of variation in liability for Crohn disease, bipolar disorder, and type I diabetes is tagged by common SNPs.	[Lee, Sang Hong; Wray, Naomi R.; Visscher, Peter M.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic 3086, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic 3010, Australia	QIMR Berghofer Medical Research Institute; University of Melbourne	Visscher, PM (corresponding author), Queensland Inst Med Res, 300 Herston Rd, Herston, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Wray, Naomi/C-8639-2015; Lee, Sang Hong/A-2569-2011; Visscher, Peter/ABB-6151-2020; Austin, Eric Douglas/A-6070-2013	Wray, Naomi/0000-0001-7421-3357; Lee, Sang Hong/0000-0001-9701-2718; Visscher, Peter/0000-0002-2143-8760; Austin, Eric Douglas/0000-0002-1709-9022; Goddard, Michael/0000-0001-9917-7946	Australian National Health and Medical Research Council [389892, 442915, 496688, 613672, 613601]; Australian Research Council [DP0770096, DP1093900]; Wellcome Trust [076113]; Netherlands Scientific Organization [NWO 480-05-003]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Scientific Organization	We acknowledge funding from the Australian National Health and Medical Research Council (Grants 389892, 442915, 496688, 613672, and 613601) and the Australian Research Council (Grants DP0770096 and DP1093900 and Future Fellowship to N.R.W.). This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the WTCCC data is available from www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. We thank Stuart Macgregor for useful discussions and suggestions. S.H.L. acknowledges the use of the Genetic Cluster Computer for carrying out simulations. The cluster is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). We thank the referees for many helpful comments and suggestions.	Barr DR, 1999, AM STAT, V53, P357, DOI 10.2307/2686057; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; DEMPSTER ER, 1950, GENETICS, V35, P212; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Falconer DS, 1996, INTRO QUANTITATIVE G; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; GILMOUR AR, 1985, BIOMETRIKA, V72, P593, DOI 10.1093/biomet/72.3.593; Gilmour AR., 2006, ASREML USER GUIDE RE; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Gottesman II, 2010, ARCH GEN PSYCHIAT, V67, P252, DOI 10.1001/archgenpsychiatry.2010.1; Henderson C. R., 1984, APPL LINEAR MODELS A; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Lee SH, 2010, GENET EPIDEMIOL, V34, P854, DOI 10.1002/gepi.20541; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lynch M, 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; SCHALL R, 1991, BIOMETRIKA, V78, P719; VANVLECK LD, 1972, J DAIRY SCI, V55, P218, DOI 10.3168/jds.S0022-0302(72)85463-8; VENABLES WN, 2010, INTRO R VERSION 2 11; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	31	680	692	2	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					294	305		10.1016/j.ajhg.2011.02.002	http://dx.doi.org/10.1016/j.ajhg.2011.02.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21376301	Green Published, Bronze			2022-12-18	WOS:000288589000007
J	DeBaun, MR; Niemitz, EL; Feinberg, AP				DeBaun, MR; Niemitz, EL; Feinberg, AP			Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILMS-TUMOR; DISRUPTION; EXPRESSION; CULTURE; INSTABILITY; TRANSCRIPT; CHILDREN; EMBRYOS; CANCER; LOCUS	Recent data in humans and animals suggest that assisted reproductive technology (ART) might affect the epigenetics of early embryogenesis and might cause birth defects. We report the first evidence, to our knowledge, that ART is associated with a human overgrowth syndrome-namely, Beckwith-Wiedemann syndrome (BWS). In a prospective study, the prevalence of ART was 4.6% (3 of 65), versus the background rate of 0.8% in the United States. A total of seven children with BWS were born after ART-five of whom were conceived after intracytoplasmic sperm injection. Molecular studies of six of the children indicate that five of the six have specific epigenetic alterations associated with BWS-four at LIT1 and one at both LIT1 and H19. We discuss the implications of our finding that ART is associated with human overgrowth, similar to the large offspring syndrome reported in ruminants.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Washington Univ, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63130 USA	Johns Hopkins University; Washington University (WUSTL)	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 1064 Ross,720 Rutland Ave, Baltimore, MD 21205 USA.		Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [R37 CA054358-13, R37 CA054358, R01 CA054358, CA54358] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Sutcliffe AG, 1995, HUM REPROD, V10, P3332, DOI 10.1093/oxfordjournals.humrep.a135915; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/ror.0.0030155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	22	676	711	1	62	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					156	160		10.1086/346031	http://dx.doi.org/10.1086/346031			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12439823	Green Published, Bronze			2022-12-18	WOS:000180186800015
J	Spada, M; Pagliardini, S; Yasuda, M; Tukel, T; Thiagarajan, G; Sakuraba, H; Ponzone, A; Desnick, RJ				Spada, Marco; Pagliardini, Severo; Yasuda, Makiko; Tukel, Turgut; Thiagarajan, Geetha; Sakuraba, Hitoshi; Ponzone, Alberto; Desnick, Robert J.			High incidence of later-onset Fabry disease revealed by newborn screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	55th Annual Meeting of the American-Society-of-Human-Genetics	OCT 25-29, 2005	Salt Lake City, UT	Amer Soc Human Genet			LYSOSOMAL STORAGE DISORDERS; ENZYME REPLACEMENT THERAPY; HUMAN ALPHA-GALACTOSIDASE; TANDEM MASS-SPECTROMETRY; ATYPICAL VARIANT; INBORN-ERRORS; A GENE; MUTATIONS; PREVALENCE; DIAGNOSIS	The classic phenotype of Fabry disease, X-linked alpha-galactosidase A ( alpha-Gal A) deficiency, has an estimated incidence of similar to 1 in 50,000 males. The recent recognition of later-onset variants suggested that this treatable lysosomal disease is more frequent. To determine the disease incidence, we undertook newborn screening by assaying the alpha-Gal A activity in blood spots from 37,104 consecutive Italian male neonates. Enzyme-deficient infants were retested, and "doubly screened-positive" infants and their relatives were diagnostically confirmed by enzyme and mutation analyses. Twelve ( 0.03%) neonates had deficient alpha-Gal A activities and specific mutations, including four novel missense mutations ( M51I, E66G, A73V, and R118C), three missense mutations ( F113L, A143T, and N215S) identified previously in later-onset patients, and one splicing defect ( IVS5(+1G -> T)) reported in a patient with the classic phenotype. Molecular modeling and in vitro overexpression of the missense mutations demonstrated structures and residual activities, which were rescued/enhanced by an alpha-Gal A-specific pharmacologic chaperone, consistent with mutations that cause the later-onset phenotype. Family studies revealed undiagnosed Fabry disease in affected individuals. In this population, the incidence of alpha-Gal A deficiency was 1 in similar to 3,100, with an 11.1 ratio of patients with the later-onset: classic phenotypes. If only known disease-causing mutations were included, the incidence would be 1 in similar to 4,600, with a 7: 1 ratio of patients with the later-onset: classic phenotypes. These results suggest that the later-onset phenotype of Fabry disease is underdiagnosed among males with cardiac, cerebrovascular, and/or renal disease. Recognition of these patients would permit family screening and earlier therapeutic intervention. However, the higher incidence of the later-onset phenotype in patients raises ethical issues related to when screening should be performed - in the neonatal period or at early maturity, perhaps in conjunction with screening for other treatable adult-onset disorders.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Regina Margherita Childrens Hosp, Newborn Screening Unit, Turin, Italy; Univ Turin, Dept Pediat, Turin, Italy; Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Tokyo 113, Japan	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Tokyo Metropolitan Institute of Medical Science	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave 100th St, New York, NY 10029 USA.	robert.desnick@mssm.edu		Spada, Marco/0000-0002-8894-350X	NCRR NIH HHS [5 M01 RR00071, M01 RR000071] Funding Source: Medline; NIDDK NIH HHS [R37 DK034045, R37 DK34045] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; [Anonymous], 2014, METABOLIC MOL BASES; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Desnick RJ, 2002, J INHERIT METAB DIS, V25, pS116; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; ENG CM, 1993, AM J HUM GENET, V53, P1186; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Froissart R, 2003, MOL GENET METAB, V80, P307, DOI 10.1016/S1096-7192(03)00136-7; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Henthorn JS, 2004, BRIT J HAEMATOL, V124, P259, DOI 10.1046/j.1365-2141.2003.04775.x; Ishii S, 2000, ARCH BIOCHEM BIOPHYS, V377, P228, DOI 10.1006/abbi.2000.1743; Kaback MM, 2001, ADV GENET, V44, P253; Kotanko P, 2004, J AM SOC NEPHROL, V15, P1323, DOI 10.1097/01.ASN.0000124671.61963.1E; Li YJ, 2004, CLIN CHEM, V50, P1785, DOI 10.1373/clinchem.2004.035907; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; McCabe LL, 2004, ANNU REV GENOM HUM G, V5, P57, DOI 10.1146/annurev.genom.5.061903.175941; Meikle PJ, 2004, PEDIATRICS, V114, P909, DOI 10.1542/peds.2004-0583; Meikle PJ, 2003, EUR J PEDIATR, V162, pS34, DOI 10.1007/s00431-003-1348-y; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; OKUMIYA T, 1995, HUM GENET, V95, P557; OKUMIYA T, 1995, BIOCHEM BIOPH RES CO, V214, P1219, DOI 10.1006/bbrc.1995.2416; Pagliardini S., 2003, J INHERIT METAB DIS, V26, pS1; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Spada M., 2003, Journal of Inherited Metabolic Disease, V26, P171; Spada M., 2002, Journal of Inherited Metabolic Disease, V25, P113; Utsumi K, 2000, CLIN EXP NEPHROL, V4, P49, DOI 10.1007/s101570050061; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Yasuda M, 2003, HUM MUTAT, V22, P486, DOI 10.1002/humu.10275	44	674	718	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					31	40		10.1086/504601	http://dx.doi.org/10.1086/504601			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Genetics & Heredity	053YD	16773563	Green Published, Bronze			2022-12-18	WOS:000238341200004
J	Kwiatkowski, DP				Kwiatkowski, DP			How malaria has affected the human genome and what human genetics can teach us about malaria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							PLASMODIUM-FALCIPARUM MALARIA; BLOOD INFECTION LEVELS; NITRIC-OXIDE PRODUCTION; GAMMA RECEPTOR-IIA; INTERCELLULAR-ADHESION MOLECULE-1; MAJOR HISTOCOMPATIBILITY COMPLEX; EXPERIMENTAL CEREBRAL MALARIA; PYRUVATE-KINASE DEFICIENCY; SYMPATRIC ETHNIC-GROUPS; NECROSIS-FACTOR-ALPHA	Malaria is a major killer of children worldwide and the strongest known force for evolutionary selection in the recent history of the human genome. The past decade has seen growing evidence of ethnic differences in susceptibility to malaria and of the diverse genetic adaptations to malaria that have arisen in different populations: epidemiological confirmation of the hypotheses that G6PD deficiency, alpha(+) thalassemia, and hemoglobin C protect against malaria mortality; the application of novel haplotype-based techniques demonstrating that malaria-protective genes have been subject to recent positive selection; the first genetic linkage maps of resistance to malaria in experimental murine models; and a growing number of reported associations with resistance and susceptibility to human malaria, particularly in genes involved in immunity, inflammation, and cell adhesion. The challenge for the next decade is to build the global epidemiological infrastructure required for statistically robust genomewide association analysis, as a way of discovering novel mechanisms of protective immunity that can be used in the development of an effective malaria vaccine.	Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Paediat, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Kwiatkowski, DP (corresponding author), Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	dominic@well.ox.ac.uk		Kwiatkowski, Dominic/0000-0002-5023-0176				ABEL L, 1992, AM J HUM GENET, V50, P1308; Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; ACKERMAN H, 2005, ANN HUM GENET; Ackerman HC, 2003, GENES IMMUN, V4, P476, DOI 10.1038/sj.gene.6364008; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLEN SJ, 1909, T R SOC TROP MED HYG, V86, P494; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Amani V, 1998, INFECT IMMUN, V66, P4093; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Aucan C, 2002, T ROY SOC TROP MED H, V96, P327, DOI 10.1016/S0035-9203(02)90114-8; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Bagot S, 2002, INFECT IMMUN, V70, P2049, DOI 10.1128/IAI.70.4.2049-2056.2002; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Bellamy R, 1998, QJM-INT J MED, V91, P13, DOI 10.1093/qjmed/91.1.13; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; BENNETT S, 1993, T ROY SOC TROP MED H, V87, P286, DOI 10.1016/0035-9203(93)90130-I; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BIENZLE U, 1972, LANCET, V1, P107; BRITTENHAM GM, 1985, BLOOD, V65, P183; Burgner D, 2003, HUM GENET, V112, P379, DOI 10.1007/s00439-002-0882-4; Burgner D, 1998, LANCET, V352, P1193, DOI 10.1016/S0140-6736(05)60531-4; Burt RA, 2002, INFECT IMMUN, V70, P4750, DOI 10.1128/IAI.70.8.4750-4753.2002; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; CAMPINO S, 2005, GENES IMMUN; Casals-Pascual C, 2001, AM J TROP MED HYG, V65, P736, DOI 10.4269/ajtmh.2001.65.736; CATTANI JA, 1987, T ROY SOC TROP MED H, V81, P705, DOI 10.1016/0035-9203(87)90001-0; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Conway DJ, 2003, TRENDS GENET, V19, P671, DOI 10.1016/j.tig.2003.10.007; Cooke GS, 2003, AM J TROP MED HYG, V69, P565, DOI 10.4269/ajtmh.2003.69.565; COT M, 1993, AM J TROP MED HYG, V48, P358, DOI 10.4269/ajtmh.1993.48.358; Diallo DA, 2004, ACTA TROP, V90, P295, DOI 10.1016/j.actatropica.2004.02.005; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Elagib AA, 1998, T ROY SOC TROP MED H, V92, P309, DOI 10.1016/S0035-9203(98)91025-2; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; FACER CA, 1983, B SOC PATHOL EXOT, V76, P463; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Farouk SE, 2005, MICROBES INFECT, V7, P110, DOI 10.1016/j.micinf.2004.09.012; Feng ZL, 2004, MATH BIOSCI, V189, P1, DOI 10.1016/j.mbs.2004.01.005; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Flori L, 2003, HUM MOL GENET, V12, P375, DOI 10.1093/hmg/ddg033; FLORI L, 2005, GENES IMMUN; FOO LC, 1992, AM J TROP MED HYG, V47, P271, DOI 10.4269/ajtmh.1992.47.271; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; GILLES HM, 1967, LANCET, V1, P138; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GRAU GE, 1987, IMMUNOLOGY, V61, P521; GREENBERG J, 1954, J INFECT DIS, V95, P114, DOI 10.1093/infdis/95.1.114; GREENBERG J, 1959, J PARASITOL, V45, P263, DOI 10.2307/3274494; HADLEY TJ, 1987, J CLIN INVEST, V80, P1190, DOI 10.1172/JCI113178; Haldane J. B. S, 1949, RICERCA SCIENTIFIC S, V19, P3; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hartl DL, 2004, NAT REV MICROBIOL, V2, P15, DOI 10.1038/nrmicro795; Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Hernandez-Valladares M, 2004, IMMUNOGENETICS, V56, P115, DOI 10.1007/s00251-004-0667-0; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; Hobbs MR, 2002, LANCET, V360, P1468, DOI 10.1016/S0140-6736(02)11474-7; Hunt NH, 2001, REDOX REP, V6, P389, DOI 10.1179/135100001101536508; HUNT NH, 1993, PARASITOLOGY, V107, P471, DOI 10.1017/S0031182000068049; Imrie H, 2004, MOL BIOCHEM PARASIT, V133, P93, DOI 10.1016/j.molbiopara.2003.07.007; Jepson A, 1997, BRIT MED J, V315, P96, DOI 10.1136/bmj.315.7100.96; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Juliger S, 2003, IMMUNOGENETICS, V54, P675, DOI 10.1007/s00251-002-0516-y; Kikuchi M, 2001, PARASITOL INT, V50, P235, DOI 10.1016/S1383-5769(01)00082-4; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Koch O, 2005, GENES IMMUN, V6, P312, DOI 10.1038/sj.gene.6364214; KREMSNER PG, 1991, J INFECT DIS, V164, P605, DOI 10.1093/infdis/164.3.605; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Kun JFJ, 1998, LANCET, V351, P265, DOI 10.1016/S0140-6736(05)78273-8; KWIATKOWSKI D, 1995, PARASITOL TODAY, V11, P206, DOI 10.1016/0169-4758(95)80079-4; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; Levesque MC, 1999, J INFECT DIS, V180, P1994, DOI 10.1086/315140; Luoni G, 2001, GENES IMMUN, V2, P411, DOI 10.1038/sj.gene.6363797; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Meyer CG, 2002, TISSUE ANTIGENS, V59, P287, DOI 10.1034/j.1399-0039.2002.590406.x; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Min-Oo G, 2004, GENES IMMUN, V5, P168, DOI 10.1038/sj.gene.6364069; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1999, AM J TROP MED HYG, V61, P663, DOI 10.4269/ajtmh.1999.61.663; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MODIANO G, 1991, AM J HUM GENET, V48, P390; Morahan G, 2002, GENES IMMUN, V3, P414, DOI 10.1038/sj.gene.6363909; Nagayasu E, 2002, INFECT IMMUN, V70, P512, DOI 10.1128/IAI.70.2.512-516.2002; Nagayasu Eiji, 2001, American Journal of Tropical Medicine and Hygiene, V64, P1; NAGEL RL, 1990, SEMIN HEMATOL, V27, P342; NEILL AL, 1992, PARASITOLOGY, V105, P165, DOI 10.1017/S0031182000074072; NEILL AL, 1993, PARASITOLOGY, V107, P477, DOI 10.1017/S0031182000068050; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Omi K, 2002, PARASITOL INT, V51, P361, DOI 10.1016/S1383-5769(02)00040-5; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Patel SS, 2004, AM J HEMATOL, V75, P1, DOI 10.1002/ajh.10448; Patel SS, 2001, BLOOD, V98, P3489, DOI 10.1182/blood.V98.12.3489; Pattanapanyasat K, 1999, BLOOD, V93, P3116; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Quaye IKE, 2000, T ROY SOC TROP MED H, V94, P216, DOI 10.1016/S0035-9203(00)90281-5; Ranque S, 2005, J INFECT DIS, V191, P799, DOI 10.1086/427238; REST JR, 1982, T ROY SOC TROP MED H, V76, P410, DOI 10.1016/0035-9203(82)90203-6; Rihet P, 2004, HUM MOL GENET, V13, P1, DOI 10.1093/hmg/ddh002; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SAYLES PC, 1988, J IMMUNOL, V141, P241; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Sengupta S, 2004, ANN HUM GENET, V68, P574, DOI 10.1046/j.1529-8817.2003.00126.x; SHEAR HL, 1993, BLOOD, V81, P222; Shi YP, 2001, J INFECT DIS, V184, P107, DOI 10.1086/320999; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SJOBERG K, 1992, P NATL ACAD SCI USA, V89, P2101, DOI 10.1073/pnas.89.6.2101; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; STEVENSON MM, 1985, INFECT IMMUN, V47, P452, DOI 10.1128/IAI.47.2.452-456.1985; Stirnadel HA, 2000, INT J EPIDEMIOL, V29, P579, DOI 10.1093/ije/29.3.579; Stirnadel HA, 1999, GENET EPIDEMIOL, V17, P16, DOI 10.1002/(SICI)1098-2272(1999)17:1<16::AID-GEPI2>3.0.CO;2-7; Stirnadel HA, 1999, TROP MED INT HEALTH, V4, P187, DOI 10.1046/j.1365-3156.1999.43381.x; Stirnadel HA, 2000, EPIDEMIOL INFECT, V124, P153, DOI 10.1017/S0950268899003325; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TERRENATO L, 1988, ANN TROP MED PARASIT, V82, P1; THUMWOOD CM, 1988, PARASITOLOGY, V96, P579, DOI 10.1017/S0031182000080203; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; Vigario AM, 2001, BLOOD, V97, P3966, DOI 10.1182/blood.V97.12.3966; Walley AJ, 2004, EUR J HUM GENET, V12, P132, DOI 10.1038/sj.ejhg.5201084; Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2002, BRIT J HAEMATOL, V118, P663, DOI 10.1046/j.1365-2141.2002.03610.x; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0; WILSON J, 2005, ANAL IL10 HAPOTYPIC; Yazdani SS, 2004, VACCINE, V22, P3727, DOI 10.1016/j.vaccine.2004.03.030; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973; Zimmerman PA, 2003, GENES IMMUN, V4, P368, DOI 10.1038/sj.gene.6363980	198	671	695	3	145	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					171	192		10.1086/432519	http://dx.doi.org/10.1086/432519			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	16001361	Green Published, Bronze			2022-12-18	WOS:000230387200001
J	ECKERSON, HW; WYTE, CM; LADU, BN				ECKERSON, HW; WYTE, CM; LADU, BN			THE HUMAN-SERUM PARAOXONASE ARYLESTERASE POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ECKERSON, HW (corresponding author), UNIV MICHIGAN,DEPT PHARMACOL,ANN ARBOR,MI 48109, USA.				NIGMS NIH HHS [GM27028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM027028] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; ALDRIDGE WN, 1975, ENZYME INHIBITORS SU, P176; AUGUSTINSSON K, 1958, NATURE, V181, P1786, DOI 10.1038/1811786a0; AUGUSTINSSON K, 1961, ANN NY ACAD SCI, V94, P844, DOI 10.1111/j.1749-6632.1961.tb35578.x; AUGUSTINSSON KB, 1962, ACTA CHEM SCAND, V16, P240, DOI 10.3891/acta.chem.scand.16-0240; AUGUSTINSSON KB, 1964, J HISTOCHEM CYTOCHEM, V12, P744, DOI 10.1177/12.10.744; BACHORIK PS, 1976, CLIN CHEM, V22, P1828; BLANCO A, 1966, B JOHNS HOPKINS HOSP, V118, P27; BURLINA A, 1977, EUR J CLIN INVEST, V7, P17, DOI 10.1111/j.1365-2362.1977.tb01564.x; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; CHOI SS, 1967, J DAIRY SCI, V50, P1088, DOI 10.3168/jds.S0022-0302(67)87570-2; CHOI SS, 1967, J DAIRY SCI, V50, P837, DOI 10.3168/jds.S0022-0302(67)87532-5; DON MM, 1975, BIOCHEM J, V151, P625, DOI 10.1042/bj1510625; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1982, AM J HUM GENET, V34, pA50; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; ERDOES EG, 1961, NATURE, V190, P716, DOI 10.1038/190716a0; ERDOS EG, 1960, BIOCHEM PHARMACOL, V5, P173, DOI 10.1016/0006-2952(60)90061-7; FLUGEL M, 1978, KLIN WOCHENSCHR, V56, P911, DOI 10.1007/BF01489217; Geldermacher-Von M.M, 1978, HUM GENET S, V1, P65; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; HEIN DW, 1982, J PHARMACOL EXP THER, V220, P1; HUGGINS C, 1947, J BIOL CHEM, V170, P467; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; LADU BN, 1971, HDB EXPTL PHARMACOLO, V28, P477; MAIN AR, 1960, BIOCHEM J, V74, P10, DOI 10.1042/bj0740010; MAIN AR, 1960, BIOCHEM J, V75, P188, DOI 10.1042/bj0750188; MARTON AV, 1962, CAN J BIOCHEM PHYS, V40, P319; MENDOZA CE, 1976, COMP BIOCHEM PHYS C, V55, P23, DOI 10.1016/0306-4492(76)90006-X; MOUNTER LA, 1953, BIOCHEM J, V54, P551, DOI 10.1042/bj0540551; PATTERSON E, 1980, MOL PHARMACOL, V17, P367; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SIMPSON NE, 1971, AM J HUM GENET, V23, P375; SMOLEN A, 1982, AM J HUM GENET, V34, pA63; WILLE LE, 1976, CLIN CHIM ACTA, V71, P355, DOI 10.1016/0009-8981(76)90554-4; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6; ZELLER EA, 1956, ARCH BIOCHEM BIOPHYS, V61, P231, DOI 10.1016/0003-9861(56)90335-6	39	666	682	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1126	1138						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6316781				2022-12-18	WOS:A1983RU70500008
J	SING, CF; DAVIGNON, J				SING, CF; DAVIGNON, J			ROLE OF THE APOLIPOPROTEIN-E POLYMORPHISM IN DETERMINING NORMAL PLASMA-LIPID AND LIPOPROTEIN VARIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CLIN RES INST MONTREAL, DEPT LIPID METAB & ATHEROSCLEROSIS RES, MONTREAL H2W 1R7, QUEBEC, CANADA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	SING, CF (corresponding author), UNIV NANCY 1, SCH MED, DEPT HUMAN GENET, F-54506 VANDOEUVRE LES NANCY, FRANCE.			Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [HL-24489] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; BASU SK, 1983, SCIENCE, V219, P871, DOI 10.1126/science.6823554; BASU SK, 1982, J BIOL CHEM, V257, P9788; BILHEIMER DW, 1971, CIRCULATION, V44, P41; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; BOUTHILLIER D, 1983, J LIPID RES, V24, P1060; BRESLOW JL, 1982, J LIPID RES, V23, P1224; Brewer GJ, 1983, GENETICS; CAVALLI L, 1971, GENETICS HUMAN POPUL; CONNOR SL, 1982, CIRCULATION, V65, P1290, DOI 10.1161/01.CIR.65.7.1290; CUMMING AM, 1984, CLIN GENET, V25, P310; DAVIGNON J, 1983, ANN MED INTERNE, V134, P483; DAVIGNON J, 1984, LATENT DYSLIPOPROTEI, P213; EGUSA G, 1982, CIRCULATION, V66, P240; EISENBERG S, 1976, ATHEROSCLER REV, V1, P23; GHISELLI G, 1982, LANCET, V2, P405; GHISELLI G, 1982, J CLIN INVEST, V70, P474, DOI 10.1172/JCI110638; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; GREGG RE, 1983, J CLIN ENDOCR METAB, V57, P969, DOI 10.1210/jcem-57-5-969; GREGG RE, 1982, CIRCULATION, V66, P160; Hartl D L, 1980, PRINCIPLES POPULATIO, P488; HAVEL RJ, 1980, P NATL ACAD SCI-BIOL, V77, P4349, DOI 10.1073/pnas.77.7.4349; HAVEL RJ, 1982, MED CLIN N AM, V66, P441, DOI 10.1016/S0025-7125(16)31429-8; HAZZARD WR, 1981, METABOLISM, V30, P79, DOI 10.1016/0026-0495(81)90223-7; HEWITT D, 1977, CAN MED ASSOC J, V117, P1020; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; JAIN RS, 1979, LIFE SCI, V25, P1315, DOI 10.1016/0024-3205(79)90397-7; JONES GJL, 1980, CAN MED ASSOC J, V122, P37; KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85; MAHLEY RW, 1982, MED CLIN N AM, V66, P375, DOI 10.1016/S0025-7125(16)31426-2; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; MAHLEY RW, 1981, J CLIN INVEST, V68, P1197, DOI 10.1172/JCI110365; MCLEAN JW, 1983, ARTERIOSCLEROSIS, V3, pA514; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; Mourant AE, 1976, DISTRIBUTION HUMAN B; MULLER DPR, 1978, BRIT J OBSTET GYNAEC, V85, P127, DOI 10.1111/j.1471-0528.1978.tb10466.x; NETER J, 1978, APPLIED STATISTICS, P743; NEVO E, 1978, THEOR POPUL BIOL, V13, P121, DOI 10.1016/0040-5809(78)90039-4; Powell JR, 1975, EVOL BIOL, V8, P79; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1983, J CLIN INVEST, V71, P1023, DOI 10.1172/JCI110829; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; REARDON MF, 1981, CLIN CHEM, V27, P892; ROHEIM PS, 1979, P NATL ACAD SCI USA, V76, P4646, DOI 10.1073/pnas.76.9.4646; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; ROSENBLUM BB, 1983, BIOL PROSPECTIVE, V1, P85; ROSSENEU M, 1981, ANAL BIOCHEM, V116, P204, DOI 10.1016/0003-2697(81)90345-6; SAMPSON EJ, 1975, CLIN CHEM, V21, P1983; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; SING CF, 1978, AM J HUM GENET, V30, P491; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1975, AM J HUM GENET, V27, P333; UTERMANN G, 1982, HUM GENET, V60, P344, DOI 10.1007/BF00569216; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, CLIN GENET, V15, P63; WARDELL MR, 1982, J LIPID RES, V23, P1174; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059; ZANNIS VI, 1982, J LIPID RES, V23, P911; 1974, NIH75628 DHEW PUBL, P1	61	664	683	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					268	285						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	3985008				2022-12-18	WOS:A1985AGY5900003
J	Kleinjan, DA; van Heyningen, V				Kleinjan, DA; van Heyningen, V			Long-range control of gene expression: Emerging mechanisms and disruption in disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							BETA-GLOBIN LOCUS; FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SONIC-HEDGEHOG GENE; LYMPHEDEMA-DISTICHIASIS SYNDROME; POSITION-EFFECT VARIEGATION; SISTER-CHROMATID COHESION; BZIP TRANSCRIPTION FACTOR; AUTOSOMAL SEX REVERSAL; CIS-ACTING REGULATOR; DE-LANGE-SYNDROME	Transcriptional control is a major mechanism for regulating gene expression. The complex machinery required to effect this control is still emerging from functional and evolutionary analysis of genomic architecture. In addition to the promoter, many other regulatory elements are required for spatiotemporally and quantitatively correct gene expression. Enhancer and repressor elements may reside in introns or up- and downstream of the transcription unit. For some genes with highly complex expression patterns - often those that function as key developmental control genes - the cis-regulatory domain can extend long distances outside the transcription unit. Some of the earliest hints of this came from disease-associated chromosomal breaks positioned well outside the relevant gene. With the availability of wide-ranging genome sequence comparisons, strong conservation of many noncoding regions became obvious. Functional studies have shown many of these conserved sites to be transcriptional regulatory elements that sometimes reside inside unrelated neighboring genes. Such sequence-conserved elements generally harbor sites for tissue-specific DNA-binding proteins. Developmentally variable chromatin conformation can control protein access to these sites and can regulate transcription. Disruption of these finely tuned mechanisms can cause disease. Some regulatory element mutations will be associated with phenotypes distinct from any identified for coding-region mutations.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	van Heyningen, V (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	v.vanheyningen@hgu.mrc.ac.uk	VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008	van Heyningen, Veronica/0000-0003-0359-0141	Medical Research Council [MC_U127527199] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; BAKKER E, 1995, MUSCLE NERVE, pS39; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Bulger M, 1999, P NATL ACAD SCI USA, V96, P5129, DOI 10.1073/pnas.96.9.5129; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Cai JL, 2003, HUM GENET, V114, P68, DOI 10.1007/s00439-003-1012-7; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Chun K, 2002, AM J MED GENET, V110, P136, DOI 10.1002/ajmg.10400; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; CREMERS FP, 2004, INBORN ERRORS DEV MO; Crisponi L, 2004, GENOMICS, V83, P757, DOI 10.1016/j.ygeno.2003.11.010; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Davies AF, 1999, J MED GENET, V36, P708; De Baere E, 2003, AM J HUM GENET, V72, P478, DOI 10.1086/346118; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; DiLeone RJ, 2000, P NATL ACAD SCI USA, V97, P1612, DOI 10.1073/pnas.97.4.1612; Dillon N, 2000, BIOESSAYS, V22, P657, DOI 10.1002/1521-1878(200007)22:7<657::AID-BIES8>3.3.CO;2-U; Dillon N, 2003, NATURE, V425, P457, DOI 10.1038/425457a; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Dubchak I, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-122; Duboule D, 1998, TRENDS GENET, V14, P54, DOI 10.1016/S0168-9525(97)01358-9; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Finegold DN, 2001, HUM MOL GENET, V10, P1185, DOI 10.1093/hmg/10.11.1185; Flint J, 2001, HUM MOL GENET, V10, P371, DOI 10.1093/hmg/10.4.371; Flomen RH, 1998, GENOMICS, V47, P409, DOI 10.1006/geno.1997.5127; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gaffney DJ, 2004, TRENDS GENET, V20, P332, DOI 10.1016/j.tig.2004.06.011; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Herault Y, 1997, DEVELOPMENT, V124, P3493; Heydemann A, 2001, DEV BRAIN RES, V128, P83, DOI 10.1016/S0165-3806(01)00137-7; Hill RE, 2003, J ANAT, V202, P13, DOI 10.1046/j.1469-7580.2003.00148.x; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Ianakiev P, 2001, AM J HUM GENET, V68, P38, DOI 10.1086/316955; Ignatius J, 1996, J MED GENET, V33, P507, DOI 10.1136/jmg.33.6.507; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; KLEINES M, 2002, RRD MICROBIOL 1, V6, P107; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Knight JC, 2003, CLIN SCI, V104, P493, DOI 10.1042/CS20020304; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lyon MF, 2003, HUM MOL GENET, V12, P585, DOI 10.1093/hmg/ddg063; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Paige AJW, 2000, CANCER RES, V60, P1690; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Phippard D, 2000, HUM MOL GENET, V9, P79, DOI 10.1093/hmg/9.1.79; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Qin YJ, 2003, HUM MOL GENET, V12, P509, DOI 10.1093/hmg/ddg045; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 1997, HUM GENET, V100, P172, DOI 10.1007/s004390050486; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Santagati F, 2003, GENETICS, V165, P235; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; Schramke V, 2004, CURR OPIN GENET DEV, V14, P174, DOI 10.1016/j.gde.2004.02.006; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sharpe J, 1999, CURR BIOL, V9, P97, DOI 10.1016/S0960-9822(99)80022-0; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2002, GENOMICS, V79, P493, DOI 10.1006/geno.2002.6735; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Treisman Jessica, 2002, Mechanisms of Development, V112, P3, DOI 10.1016/S0925-4773(01)00619-0; Trembath DG, 2004, BIRTH DEFECTS RES A, V70, P82, DOI 10.1002/bdra.10154; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Valle D, 2004, AM J HUM GENET, V74, P374, DOI 10.1086/382790; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; VANDERHOEVEN F, 1993, MAMM GENOME, V4, P276, DOI 10.1007/BF00417435; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; VYAS P, 1995, GENOMICS, V29, P679, DOI 10.1006/geno.1995.9951; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Walter J, 2003, SEMIN CELL DEV BIOL, V14, P101, DOI 10.1016/S1084-9521(02)00142-8; Wang CC, 1997, GENOMICS, V39, P303, DOI 10.1006/geno.1996.4519; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	167	663	701	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					8	32		10.1086/426833	http://dx.doi.org/10.1086/426833			25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15549674	Green Published, Bronze			2022-12-18	WOS:000225643600002
J	McQuillan, R; Leutenegger, AL; Abdel-Rahman, R; Franklin, CS; Pericic, M; Barac-Lauc, L; Smolej-Narancic, N; Janicijevic, B; Polasek, O; Tenesa, A; MacLeod, AK; Farrington, SM; Rudan, P; Hayward, C; Vitart, V; Rudan, I; Wild, SH; Dunlop, MG; Wright, AF; Campbell, H; Wilson, JF				McQuillan, Ruth; Leutenegger, Anne-Louise; Abdel-Rahman, Rehab; Franklin, Christopher S.; Pericic, Marijana; Barac-Lauc, Lovorka; Smolej-Narancic, Nina; Janicijevic, Branka; Polasek, Ozren; Tenesa, Albert; MacLeod, Andrew K.; Farrington, Susan M.; Rudan, Pavao; Hayward, Caroline; Vitart, Veronique; Rudan, Igor; Wild, Sarah H.; Dunlop, Malcolm G.; Wright, Alan F.; Campbell, Harry; Wilson, James F.			Runs of homozygosity in European populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COPY NUMBER VARIATION; LINKAGE DISEQUILIBRIUM; INBREEDING COEFFICIENT; EXTENDED HOMOZYGOSITY; REPRODUCTIVE SUCCESS; ASSOCIATION; DISEASE; LOCI; HETEROZYGOSITY	Estimating individual genome-wide autozygosity is important both in the identification of recessive disease variants via homozygosity mapping and in the investigation of the effects of genome-wide homozygosity on traits of biomedical importance. Approaches have tended to involve either single-point estimates or rather complex multipoint methods of inferring individual autozygosity, all on the basis of limited marker data. Now, with the availability of high-density genome scans, a multipoint, observational method of estimating individual autozygosity is possible. Using data from a 300,000 SNP panel in 2618 individuals from two isolated and two more-cosmopolitan populations of European origin, we explore the potential of estimating individual autozygosity from data on runs of homozygosity (ROHs). Termed F-roh, this is defined as the proportion of the autosomal genome in runs of homozygosity above a specified length. Mean F-roh distinguishes clearly between subpopulations classified in terms of grandparental endogamy and population size. With the use of good pedigree data for one of the populations (Orkney), F-roh was found to correlate strongly with the inbreeding coefficient estimated from pedigrees (r = 0.86). Using pedigrees to identify individuals with no shared maternal and paternal ancestors in five, and probably at least ten, generations, we show that ROHs measuring up to 4 Mb are common in demonstrably outbred individuals. Given the stochastic variation in ROH number, length, and location and the fact that ROHs are important whether ancient or recent in origin, approaches such as this will provide a more useful description of genomic autozygosity than has hitherto been possible.	[McQuillan, Ruth; Abdel-Rahman, Rehab; Franklin, Christopher S.; Polasek, Ozren; Rudan, Igor; Wild, Sarah H.; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Leutenegger, Anne-Louise] INSERM, Unite Rech Genet Epidemiol & Struct Populat Humai, U535, F-94817 Villejuif, France; [Pericic, Marijana; Barac-Lauc, Lovorka; Smolej-Narancic, Nina; Janicijevic, Branka; Rudan, Pavao] Inst Anthropol Res, Zagreb 10000, Croatia; [Polasek, Ozren] Univ Zagreb, Fac Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia; [Tenesa, Albert; Farrington, Susan M.; Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Farrington, Susan M.; Dunlop, Malcolm G.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [MacLeod, Andrew K.] Univ Edinburgh, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Abdel-Rahman, Rehab; Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Rudan, Igor] Univ Zagreb, Univ Hosp Sestre Milosrdnice, Inst Clin Med Res, HR-10000 Zagreb, Croatia	University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); Institute for Anthropological Research Zagreb; University of Zagreb; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Split; University of Zagreb	Wilson, JF (corresponding author), Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland.	jim.wilson@hgu.mrc.ac.uk	Rudan, Igor/I-1467-2012; Farrington, Susan M/Q-2710-2019; Leutenegger, Anne-Louise/B-5597-2009; Campbell, Harry/E-2959-2010; Polasek, Ozren/B-6002-2011; Wilson, James F/A-5704-2009; Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/C-7319-2013; Hayward, Caroline/M-8818-2016; MacLeod, Andrew/Q-8655-2016	Rudan, Igor/0000-0001-6993-6884; Farrington, Susan M/0000-0001-5955-7389; Leutenegger, Anne-Louise/0000-0002-1302-4357; Campbell, Harry/0000-0002-6169-6262; Polasek, Ozren/0000-0002-5765-1862; Wilson, James F/0000-0001-5751-9178; Dunlop, Malcolm G/0000-0002-3033-5851; Hayward, Caroline/0000-0002-9405-9550; Tenesa, Albert/0000-0003-4884-4475; MacLeod, Andrew/0000-0003-3298-5193	Chief Scientist Office of the Scottish Executive; the MRC Human Genetics Unit; the Royal Society; the Edinburgh Wellcome Trust Clinical Research Facility; the European Union Framework Program 6; University of Edinburgh College of Medicine and Veterinary Medicine Ph.D. studentship; Supreme Council of Egyptian Universities; Croatian Ministry of Science, Education and Sport [196-1962766-2751];  [10810803 15-0302];  [196-1962766-2763];  [196-1962766-2747]; MRC [MC_U127527198, MC_U127561128] Funding Source: UKRI; Medical Research Council [MC_U127561128, MC_U127527198] Funding Source: researchfish; Chief Scientist Office [CZB/4/449] Funding Source: researchfish	Chief Scientist Office of the Scottish Executive; the MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); the Royal Society(Royal Society of London); the Edinburgh Wellcome Trust Clinical Research Facility(Wellcome Trust); the European Union Framework Program 6(European Commission); University of Edinburgh College of Medicine and Veterinary Medicine Ph.D. studentship; Supreme Council of Egyptian Universities; Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank the people of Orkney; Lorraine Anderson and the research nurse team in Orkney; Rosa Bisset, Kay Lindsay, Gail Crosbie, and the administrative team at Public Health Sciences, University of Edinburgh; Ruby McMenemy, Sam Harcus, George Gray, Orkney Library and Archive, and the Orkney Family History Society for help with reconstructing pedigrees; Graeme Grimes, Colin Semple, Sarfraz Mohammed, Dave du Feu, Craig Nicol, and Lesley McGoohan for IT support; and Evi Theodoratu for advice relating to the Scottish data set. ORCADES is supported by the Chief Scientist Office of the Scottish Executive, the MRC Human Genetics Unit, the Royal Society, the Edinburgh Wellcome Trust Clinical Research Facility and the European Union Framework Program 6. Ruth McQuillan is supported by a University of Edinburgh College of Medicine and Veterinary Medicine Ph.D. studentship. Rehab Abdel-Rahman is supported by a fund from the Supreme Council of Egyptian Universities. Igor Rudan is supported by grant no. 10810803 15-0302, Branka Janicijevic by grant no. 196-1962766-2763, Nina Smolej-Narancic by grant no. 196-1962766-2747, and Pavao Rudan by grant no. 196-1962766-2751 of the Croatian Ministry of Science, Education and Sport.	Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2005, HUM HERED, V59, P118, DOI 10.1159/000085226; Badaruddoza, 2004, COLLEGIUM ANTROPOL, V28, P311; Bittles AH, 2003, DEV MED CHILD NEUROL, V45, P571; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BOYCE AJ, 1973, GENETIC VARIATION BR; BRENNAN ER, 1983, ANN HUM BIOL, V10, P265, DOI 10.1080/03014468300006431; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carothers AD, 2006, ANN HUM GENET, V70, P666, DOI 10.1111/j.1469-1809.2006.00263.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charpentier M, 2005, P NATL ACAD SCI USA, V102, P16723, DOI 10.1073/pnas.0507205102; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; *DEP RA, 2004, SCOTT EX URB RUR CLA; Ewald H, 2005, AM J MED GENET B, V133B, P25, DOI 10.1002/ajmg.b.30106; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Halberstein RA, 1999, HUM BIOL, V71, P659; Hartl DL, 1997, PRINCIPLES POPULATIO; Hoffman JI, 2004, EVOLUTION, V58, P2087; HURWICH BJ, 1978, ISRAEL J MED SCI, V14, P962; *INT HAPMAP PROJ, NATURE, V426, P789; Ismail J, 2004, HEART, V90, P259, DOI 10.1136/hrt.2003.013631; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHLAT M, 1991, EPIDEMIOL REV, V13, P28, DOI 10.1093/oxfordjournals.epirev.a036072; KRIEGER H, 1969, AM J HUM GENET, V21, P537; LEBEL RR, 1989, AM J MED GENET, V33, P1, DOI 10.1002/ajmg.1320330102; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; Liu F, 2006, ANN HUM GENET, V70, P965, DOI 10.1111/j.1469-1809.2006.00279.x; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; MARTIN AO, 1973, AM J HUM GENET, V25, P581; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Modell B, 2002, NAT REV GENET, V3, P225, DOI 10.1038/nrg754; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puzyrev V P, 1992, Arctic Med Res, V51, P136; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rudan I, 2003, GENETICS, V163, P1011; Rudan I, 1999, HUM BIOL, V71, P173; Saleh E A, 2000, East Mediterr Health J, V6, P333; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; SIMPSON JL, 1981, AM J OBSTET GYNECOL, V141, P629, DOI 10.1016/S0002-9378(15)33302-0; SMITH CAB, 1953, J R STAT SOC B, V15, P153; STAM P, 1980, GENET RES, V35, P131, DOI 10.1017/S0016672300014002; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; Vitart V, 2005, AM J HUM GENET, V76, P763, DOI 10.1086/429840; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Wright A, 2003, TRENDS GENET, V19, P97, DOI 10.1016/S0168-9525(02)00033-1; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	62	662	676	5	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					359	372		10.1016/j.ajhg.2008.08.007	http://dx.doi.org/10.1016/j.ajhg.2008.08.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18760389	Green Published, Bronze			2022-12-18	WOS:000259307200007
J	Dabora, SL; Jozwiak, S; Franz, DN; Roberts, PS; Nieto, A; Chung, J; Choy, YS; Reeve, MP; Thiele, E; Egelhoff, JC; Kasprzyk-Obara, J; Domanska-Pakiela, D; Kwiatkowski, DJ				Dabora, SL; Jozwiak, S; Franz, DN; Roberts, PS; Nieto, A; Chung, J; Choy, YS; Reeve, MP; Thiele, E; Egelhoff, JC; Kasprzyk-Obara, J; Domanska-Pakiela, D; Kwiatkowski, DJ			Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRUNCATION TEST PTT; GERMLINE MUTATIONS; UNRELATED PATIENTS; GENE; COMPLEX; HAMARTOMAS; MOSAICISM; DIAGNOSIS; FREQUENCY; DELETIONS	Tuberous sclerosis (TSC) is a relatively common hamartoma syndrome caused by mutations in either of two genes, TSC1 and TSC2. Here we report comprehensive mutation analysis in 224 index patients with TSC and correlate mutation findings with clinical features, Denaturing high-performance liquid chromatography, long-range polymerase chain reaction (PCR), and quantitative PCR were used for mutation detection. Mutations were identified in 186 (83%) of 224 of cases, comprising 138 small TSC2 mutations, 20 large TSC2 mutations, and 28 small TSC1 mutations. A standardized clinical assessment instrument covering 16 TSC manifestations was used. Sporadic patients with TSC1 mutations had, on average, milder disease in comparison with patients with TSC2 mutations, despite being of similar age. They had a lower frequency of seizures and moderate-to-severe mental retardation, fewer subependymal nodules and cortical tubers, less-severe kidney involvement, no retinal hamartomas, and less-severe facial angiofibroma. Patients in whom no mutation was found also had disease that was milder, on average, than that in patients with TSC2 mutations and was somewhat distinct from patients with TSC1 mutations. Although there was overlap in the spectrum of many clinical features of patients with TSC1 versus TSC2 mutations, some features (grade 2-4 kidney cysts or angiomyolipomas, forehead plaques, retinal hamartomas, and liver angiomyolipomas) were very rare or not seen at all in TSC1 patients. Thus both germline and somatic mutations appear to be less common in TSC1 than in TSC2. The reduced severity of disease in patients without defined mutations suggests that many of these patients are mosaic for a TSC2 mutation and/or have TSC because of mutations in an as-yet-unidentified locus with a relatively mild clinical phenotype.	Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Neurol, Boston, MA 02115 USA; Childrens Hosp, Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; Childrens Mem Hosp, Dept Child Neurol, Warsaw, Poland	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; Children's Memorial Health Institute	Dabora, SL (corresponding author), Brigham & Womens Hosp, Div Hematol, Genet Lab, 221 Longwood Ave,LMRC 301, Boston, MA 02115 USA.	sdabora@rics.bwh.harvard.edu; dk@zk.bwh.harvard.edu	/AAD-2267-2020	/0000-0003-4810-4434	NCI NIH HHS [R21 CA086248, CA86248, R33 CA086248, CA71445] Funding Source: Medline; NINDS NIH HHS [NS31535, R37 NS031535, R01 NS031535] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA086248, R33CA086248, K08CA071445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031535, R37NS031535] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Beauchamp RL, 1998, HUM MUTAT, V12, P408, DOI 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.3.CO;2-G; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Choy YS, 1999, ANN HUM GENET, V63, P383, DOI 10.1046/j.1469-1809.1999.6350383.x; Dabora SL, 1998, ANN HUM GENET, V62, P491, DOI 10.1046/j.1469-1809.1998.6260491.x; Dabora SL, 2000, J MED GENET, V37, P877, DOI 10.1136/jmg.37.11.877; Eussen BHJ, 2000, J MED GENET, V37, P287, DOI 10.1136/jmg.37.4.287; Ewalt DH, 1998, J UROLOGY, V160, P141, DOI 10.1016/S0022-5347(01)63072-6; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; Goodman M, 1997, J CHILD NEUROL, V12, P85, DOI 10.1177/088307389701200203; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Jones AC, 2000, HUM GENET, V106, P663, DOI 10.1007/s004390050040; JOZWIAK S, 1994, EUR J PEDIATR, V153, P155, DOI 10.1007/s004310050110; Jozwiak S, 1998, INT J DERMATOL, V37, P911; JOZWIAK S, 1992, ARCH DIS CHILD, V67, P1363, DOI 10.1136/adc.67.11.1363; Kim KK, 1995, CELL MOL BIOL RES, V41, P515; KOBAYASHI T, 1995, NUCLEIC ACIDS RES, V23, P2608, DOI 10.1093/nar/23.14.2608; Kwiatkowska J, 1998, ANN HUM GENET, V62, P277, DOI 10.1046/j.1469-1809.1998.6240277.x; Kwiatkowska J, 1999, NEW ENGL J MED, V340, P703, DOI 10.1056/NEJM199903043400905; KWIATKOWSKI DJ, 1994, ARCH DERMATOL, V130, P348, DOI 10.1001/archderm.130.3.348; Maheshwar MM, 1996, HUM MOL GENET, V5, P131, DOI 10.1093/hmg/5.1.131; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Mayer K, 1999, HUM MUTAT, V14, P401, DOI 10.1002/(SICI)1098-1004(199911)14:5<401::AID-HUMU6>3.0.CO;2-R; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; O'Callaghan FJK, 2000, J MED GENET, V37, P156, DOI 10.1136/jmg.37.2.156; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; van Slegtenhorst M, 1999, J MED GENET, V36, P285; vanBakel I, 1997, HUM MOL GENET, V6, P1409, DOI 10.1093/hmg/6.9.1409; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verhoef S, 1999, AM J HUM GENET, V64, P1632, DOI 10.1086/302412; Webb DW, 1996, BRIT J DERMATOL, V135, P1; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550; Young JM, 1998, ANN HUM GENET, V62, P203, DOI 10.1046/j.1469-1809.1998.6230203.x	45	660	703	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					64	80		10.1086/316951	http://dx.doi.org/10.1086/316951			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112665	Green Published, Bronze			2022-12-18	WOS:000166399900006
J	VAZIRI, H; SCHACHTER, F; UCHIDA, I; WEI, L; ZHU, XM; EFFROS, R; COHEN, D; HARLEY, CB				VAZIRI, H; SCHACHTER, F; UCHIDA, I; WEI, L; ZHU, XM; EFFROS, R; COHEN, D; HARLEY, CB			LOSS OF TELOMERIC DNA DURING AGING OF NORMAL AND TRISOMY-21 HUMAN-LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOWNS-SYNDROME; DENSITY GRADIENT; PERCOLL; YEAST; CELLS	The telomere hypothesis of cellular aging proposes that loss of telomeric DNA (TTAGGG) from human chromosomes may ultimately cause cell-cycle exit during replicative senescence. Since lymphocytes have. a limited replicative capacity and since blood cells were previously shown to lose telomeric DNA during aging in vivo, we wished to determine (a) whether accelerated telomere loss is associated with the premature immunosenescence of lymphocytes in individuals with Down syndrome (DS) and (b) whether telomeric DNA is also lost during aging of lymphocytes in vitro. To investigate the effects of aging and trisomy 21 on telomere loss in vivo, genomic DNA was isolated from peripheral blood lymphocytes of 140 individuals (age 0-107 years), including 21 DS patients (age 0-45 years). Digestion with restriction enzymes HinfI and RsaI generated terminal restriction fragments (TRFs), which were detected by Southern analysis using a telomere-specific probe (P-32-(C3TA2)3). The rate of telomere loss was calculated from the decrease in mean TRF length, as a function of donor age. DS patients showed a significantly higher rate of telomere loss with donor age (133 +/- 15 bp/year) compared with age-matched controls (41 +/- 7.7 bp/year) (P < .0005), suggesting that accelerated telomere loss is a biomarker of premature immunosenescence of DS patients and that it may play a role in this process. Telomere loss during aging in vitro was calculated for lymphocytes from four normal individuals, grown in culture for 10-30 population doublings. The rate of telomere loss was approximately 120 bp/cell doubling, comparable to that seen in other somatic cells. Moreover, telomere lengths of lymphocytes from centenarians and from older DS patients were similar to those of senescent lymphocytes in culture, which suggests that replicative senescence could partially account for aging of the immune system in DS patients and in elderly individuals.	MCMASTER UNIV, DEPT BIOCHEM, HAMILTON L8N 3Z5, ONTARIO, CANADA; MCMASTER UNIV, DEPT PEDIAT, HAMILTON L8N 3Z5, ONTARIO, CANADA; CTR ETUD POLYMORPHISM HUMAIN, PARIS, FRANCE; UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90024 USA	McMaster University; McMaster University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NIA NIH HHS [AG09383A, AG05309] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009383, R37AG009383, R01AG005309] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BENDER MA, 1989, MUTAT RES, V212, P149, DOI 10.1016/0027-5107(89)90065-1; BENN PA, 1976, AM J HUM GENET, V28, P465; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COSSARIZZA A, 1991, BLOOD, V77, P1263; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DOOLEY DC, 1982, EXP HEMATOL, V10, P591; EFFROS RB, 1990, UCLA SYM BI, V123, P265; FRANCESCHI C, 1991, ANN NY ACAD SCI, V621, P428; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUTIERREZ C, 1979, J IMMUNOL METHODS, V29, P57, DOI 10.1016/0022-1759(79)90125-X; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Murasko D M, 1990, Annu Rev Gerontol Geriatr, V10, P71; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; RABINOWE SL, 1989, J AUTOIMMUN, V2, P25, DOI 10.1016/0896-8411(89)90105-4; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; THOMAN ML, 1989, ADV IMMUNOL, V46, P221, DOI 10.1016/S0065-2776(08)60655-0; UGAZIO AG, 1990, AM J MED GENET, P204; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0	31	657	684	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					661	667						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460632				2022-12-18	WOS:A1993KY05900002
J	MULLER, HJ				MULLER, HJ			OUR LOAD OF MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Altenburg E, 1920, GENETICS, V5, P1; Bedichek S, 1938, ANN EUGENIC, V8, P245, DOI 10.1111/j.1469-1809.1938.tb02178.x; Bell J, 1940, ANN EUGENIC, V10, P370; Berg RL, 1942, CR ACAD SCI URSS, V36, P212; DAHLBERG G, 1947, MATH METHODS POPULAT; DAHLBERG G, 1949, HEREDITAS S, V35, P555; DANFORTH CH, 1923, 2 INT C EUG, V1, P120; Dobzhansky T., 1927, Zeitschrift fuer Induktive Abstammungs und Vererbungslehre Berlin, V43, P330, DOI 10.1007/BF01741014; Dobzhansky T, 1941, GENETICS, V26, P23; DUBININ NP, 1946, GENETICS, V31, P21; Fisher R., 1930, GENETICAL THEORY NAT; Fisher RA, 1928, AM NAT, V62, P571, DOI 10.1086/280234; Fisher RA, 1928, AM NAT, V62, P115, DOI 10.1086/280193; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FISHER RA, 1921, 2ND INT C EUG N Y, V1, P115; Gunther M, 1935, J GENET, V31, P413, DOI 10.1007/BF02982409; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Haldane JBS, 1940, ANN EUGENIC, V10, P417, DOI 10.1111/j.1469-1809.1940.tb02263.x; Haldane JBS, 1939, ANN EUGENIC, V9, P400, DOI 10.1111/j.1469-1809.1939.tb02220.x; Haldane JBS, 1930, AM NAT, V64, P87, DOI 10.1086/280299; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Haldane JBS, 1939, ANN EUGENIC, V9, P232, DOI 10.1111/j.1469-1809.1939.tb02210.x; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P35, DOI 10.1111/j.1469-1809.1947.tb02377.x; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; HALDANE JBS, 1938, ANN EUGEN CAMBR, V8, P262; Halperin SL, 1945, AM J MENT DEF, V50, P8; HAMAN J O, 1947, West J Surg Obstet Gynecol, V55, P107; Hogben LT, 1946, INTRO MATH GENETICS; KERKIS JJ, 1938, IAN SSSR, P75; KERKIS JJ, 1935, 15 INT PHYSL C LEN, P198; Levit SG, 1936, J GENET, V33, P411, DOI 10.1007/BF02982897; LEVIT SG, 1936, P MAXIM GORKY MED GE, V4, P17; LEVIT SG, 1935, C R ACAD SCI U R S S, V2, P428; LEVIT SG, 1936, P MAXIM GORKY MEDICO, V4, P149; LEVIT SG, 1935, C R ACAD SCI URSS, V2, P499; LEVIT SG, 1934, P MAXIM GORKY MED BI, V3, P132; Li C.C., 1948, INTRO POPULATION GEN; MARTIN JH, 1947, BRIT J RADIOL, V20, P279, DOI 10.1259/0007-1285-20-235-279; MAZING RA, 1939, CR ACAD SCI URSS, V23, P835; MAZING RA, 1938, CR ACAD SCI URSS, V20, P173; MEYER HU, 1949, GENETICS, V35, P123; MEYER HU, 1949, REC GENET SOC AM, V18, P103; MORCH ET, 1941, OPERA DOMO BIOL HERE, V3, P1; MORGAN TH, 1915, MECHANISM MENDELIAN; MULLER H. J., 1950, AMER SCIENTIST, V38, P399; MULLER H. J., 1950, AMER SCIENTIST, V38, P33; MULLER H. J., 1928, ZEITSCHR INDUKT ABSTAM U VERERBUNGSL SUPPL, V1, P234; MULLER H. J., 1936, Strahlenthempie, V55, P72; Muller H. J., 1943, GENETICS, V28, P83; Muller H J, 1941, SCIENCE, V93, P438; Muller H.J., 1950, HARVEY LECT, V43, P165; Muller H.J., 1919, EXP BIOL MED, V17, P10; Muller H. J., 1940, NEW SYSTEMATICS, P185; Muller HJ, 1918, GENETICS, V3, P422; MULLER HJ, 1947, PROC R SOC SER B-BIO, V134, P1, DOI 10.1098/rspb.1947.0001; Muller HJ, 1928, GENETICS, V13, P279; MULLER HJ, 1948, B NEW YORK ACAD MED, V24, P447; MULLER HJ, 1950, GENETICS, V35, P126; Muller HJ, 1935, AM NAT, V69, P405, DOI 10.1086/280615; MULLER HJ, 1950, J CELL COMPAR PHYSL, V35, P9, DOI 10.1002/jcp.1030350404; Muller HJ, 1935, J GENET, V30, P407, DOI 10.1007/BF02982249; MULLER HJ, 1949, REC GENET SOC AM, V18, P106; MULLER HJ, 1949, SCI NEWS LETT, V55, P379; MULLER HJ, 1949, REC GEN SOC AM, V18, P105; MULLER HJ, 1927, 5 INT K VER; MULLER HJ, 1934, 4TH VERH INT K RAD Z, V2, P100; Muller HJ, 1946, YB 1945, P150; MULLER HJ, 1942, REC GENET SOC AM, V11, P83; MULLER HJ, 1949, GENETICS, V35, P125; MULLER HJ, 1923, 2 P INT C EUG NEW YO, V1, P106; MULLER HJ, 1950, IN PRESS FURTHER EVI; MULLER HJ, 1949, SCI NEWS LETT, V55, P374; Muller HJ, 1950, AM SCI, V38, P126; MULLER HJ, 1933, P 6 INT C GEN, V1, P213; NEEL JV, 1947, GENETICS, V32, P38; NEEL JV, 1949, AM J HUM GENET, V1, P19; Penrose L.S., 1934, INFLUENCE HEREDITY D; Penrose Lionel, 1949, BIOL MENTAL DEFECT; PLUNKETT CR, 1933, 6 P INT C GEN ITH, V2, P158; PLUNKETT CR, 1933, AM NAT, V67, P84; Soper HE, 1914, BIOMETRIKA, V10, P25, DOI 10.1093/biomet/10.1.25; TIMOFEEFF-RESSOVSKY N. W., 1934, STRAHLENTHERAPIE, V51, P658; Timoleeff-Ressovsky N. W., 1935, Nachrichten von der Gesellschaft der Wissenschaften zu Gottingen Berlin Biol (NF), V1, P163; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; WRIGHT S, 1935, J GENET CAMBR, V30, P357; [No title captured]	90	652	661	0	32	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	2					111	176						66	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS389	14771033				2022-12-18	WOS:A1950XS38900001
J	Wang, K; Li, MY; Bucan, M				Wang, Kai; Li, Mingyao; Bucan, Maja			Pathway-based approaches for analysis of genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSONS-DISEASE; STATISTICS; EXPRESSION; GLUTAMATE; FALSE; TESTS; SCANS; POWER	Published genomewide association (GWA) studies typically analyze and report single-nucleotide polymorphisms (SNPs) and their neighboring genes with the strongest evidence of association (the "most-significant SNPs/genes" approach), while paying little attention to the rest. Borrowing ideas from microarray data analysis, we demonstrate that pathway-based approaches, which jointly consider multiple contributing factors in the same pathway, might complement the most-significant SNPs/genes approach and provide additional insights into interpretation of GWA data on complex diseases.	Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wang, K (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	kai@mail.med.upenn.edu			NIMH NIH HHS [R01-MH604687] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Espinosa B, 2001, J NEUROPATH EXP NEUR, V60, P441, DOI 10.1093/jnen/60.5.441; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hollander M., 1999, NONPARAMETRIC STAT M; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lee G, 2004, PHARM RES-DORDR, V21, P1313, DOI 10.1023/B:PHAM.0000036905.82914.8e; Lefebvre T, 2005, EXPERT REV PROTEOMIC, V2, P265, DOI 10.1586/14789450.2.2.265; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Marino MJ, 2003, DRUG AGING, V20, P377, DOI 10.2165/00002512-200320050-00006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wille A, 2003, GENET EPIDEMIOL, V25, P350, DOI 10.1002/gepi.10263; Zaykin DV, 2005, GENETICS, V171, P813, DOI 10.1534/genetics.105.044206	29	644	674	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1278	1283		10.1086/522374	http://dx.doi.org/10.1086/522374			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17966091	Bronze, Green Published			2022-12-18	WOS:000251098800013
J	Straub, RE; Jiang, YX; MacLean, CJ; Ma, YL; Webb, BT; Myakishev, MV; Harris-Kerr, C; Wormley, B; Sadek, H; Kadambi, B; Cesare, AJ; Gibberman, A; Wang, X; O'Neill, FA; Walsh, D; Kendler, KS				Straub, RE; Jiang, YX; MacLean, CJ; Ma, YL; Webb, BT; Myakishev, MV; Harris-Kerr, C; Wormley, B; Sadek, H; Kadambi, B; Cesare, AJ; Gibberman, A; Wang, X; O'Neill, FA; Walsh, D; Kendler, KS			Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SINGLE-NUCLEOTIDE POLYMORPHISMS; TYPE-2 DIABETES-MELLITUS; CHROMOSOME 6P; SUSCEPTIBILITY LOCUS; ROSCOMMON FAMILY; LINKAGE ANALYSIS; TRANSMISSION/DISEQUILIBRIUM TEST; COGNITIVE IMPAIRMENT; BRAIN DYSTROPHIN	Prior evidence has supported the existence of multiple susceptibility genes for schizophrenia. Multipoint linkage analysis of the 270 Irish high-density pedigrees that we have studied, as well as results from several other samples, suggest that at least one such gene is located in region 6p24-21. In the present study, family-based association analysis of 36 simple sequence-length-polymorphism markers and of 17 SNP markers implicated two regions, separated by (7similar to) Mb. The first region, and the focus of this report, is 6p22.3. In this region, single-nucleotide polymorphisms within the 140-kb gene DTNBP1 ((d) under bar ys (t) under bar robrevi (n) under bar -binding (p) under bar rotein (1) under bar, or dysbindin) are strongly associated with schizophrenia. Uncorrected, empirical P values produced by the program TRANSMIT were significant (P<.01) for a number of individual SNP markers, and most remained significant when the data were restricted to include only one affected offspring per nuclear family per extended pedigree; multiple three-marker haplotypes were highly significant (P=.008-.0001) under the restricted conditions. The pattern of linkage disequilibrium is consistent with the presence of more than one susceptibility allele, but this important issue is unresolved. The number of markers tested in the adjacent genes, all of which are negative, is not sufficient to rule out the possibility that the dysbindin gene is not the actual susceptibility gene, but this possibility appears to be very unlikely. We conclude that further investigation of dysbindin is warranted.	Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; Queens Univ Belfast, Dept Psychiat, Belfast, Antrim, North Ireland; Hlth Res Board, Dublin, Ireland	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Queens University Belfast; Health Research Board - Ireland	Straub, RE (corresponding author), NIMH, Clin Brain Disorders Branch, IRP, NIH, Bldg 10,Room 4N-311,MSC 1385, Bethesda, MD 20892 USA.	straubr@intra.nimh.nih.gov	Cesare, Anthony J/F-4691-2010; O'Neill, Francis A/C-5582-2008; Kendler, Kenneth/AAF-2876-2019; Cesare, Anthony/N-7415-2019; Webb, Bradley T/B-1459-2009	Cesare, Anthony J/0000-0002-0864-1254; O'Neill, Francis A/0000-0002-7531-7657; Cesare, Anthony/0000-0002-0864-1254; Webb, Bradley T/0000-0002-0576-5366	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045390, R01MH052537, R01MH041953] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH041953, MH 45390, MH 52537, MH 41953] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; Arolt V, 1996, AM J MED GENET, V67, P564, DOI 10.1002/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; Benes FM, 2000, BRAIN RES REV, V31, P251, DOI 10.1016/S0165-0173(99)00041-7; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2000, TRENDS NEUROSCI, V23, P92, DOI 10.1016/S0166-2236(99)01510-6; Bray NJ, 2001, TRENDS MOL MED, V7, P169, DOI 10.1016/S1471-4914(01)01950-5; Bredt DS, 1999, NAT CELL BIOL, V1, pE89, DOI 10.1038/12085; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; Chen XN, 1999, GENET ANAL-BIOMOL E, V14, P157, DOI 10.1016/S1050-3862(98)00016-3; Chen XN, 1999, GENOME RES, V9, P492; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Daly MJ, 1998, JAMA-J AM MED ASSOC, V280, P652, DOI 10.1001/jama.280.7.652; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Glantz LA, 2001, ARCH GEN PSYCHIAT, V58, P203, DOI 10.1001/archpsyc.58.2.203; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443; Hwu HG, 2000, AM J MED GENET, V96, P74, DOI 10.1002/(SICI)1096-8628(20000207)96:1<74::AID-AJMG15>3.0.CO;2-G; Imai K, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-1; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Joo EJ, 1999, PSYCHIATR GENET, V9, P7, DOI 10.1097/00041444-199903000-00002; Karayiorgou M, 1997, MOL PSYCHIATR, V2, P211, DOI 10.1038/sj.mp.4000271; Kendler K. S., 2000, COMPREHENSIVE TXB PS, V1, P1147; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Levinson DF, 1996, AM J MED GENET, V67, P580; LEWONTIN RC, 1988, GENETICS, V120, P849; Lindholm E, 1999, AM J MED GENET, V88, P369, DOI 10.1002/(SICI)1096-8628(19990820)88:4<369::AID-AJMG14>3.0.CO;2-9; LINDOR NM, 1994, AM J MED GENET, V54, P1, DOI 10.1002/ajmg.1320540102; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.3.CO;2-C; Maziade M, 2001, MOL PSYCHIATR, V6, P684, DOI 10.1038/sj.mp.4000915; McGinnis RE, 2001, NAT GENET, V28, P128, DOI 10.1038/88839; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; MELO M, 1993, BRIT J PSYCHIAT, V162, P711, DOI 10.1192/bjp.162.5.711b; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Moukhles H, 2001, J NEUROCHEM, V78, P824, DOI 10.1046/j.1471-4159.2001.00466.x; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Mukhopadhyay N, 1999, AM J HUM GENET, V65, pA436; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Pearlson GD, 2000, ANN NEUROL, V48, P556, DOI 10.1002/1531-8249(200010)48:4<556::AID-ANA2>3.3.CO;2-U; Pujana MA, 1997, HUM GENET, V99, P772, DOI 10.1007/s004390050446; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Riley BP, 2000, AM J MED GENET, V97, P23, DOI 10.1002/(SICI)1096-8628(200021)97:1<23::AID-AJMG5>3.0.CO;2-K; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roberts RG, 2001, GENOME BIOL, V2; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Sklar P, 2001, NAT GENET, V28, P126, DOI 10.1038/88836; Sobel E, 1996, AM J HUM GENET, V58, P1323; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Straub RE, 1996, MOL PSYCHIATR, V1, P89; Sullivan PF, 2001, AM J MED GENET, V105, P479, DOI 10.1002/ajmg.1433; Tsuang MT, 1999, HARVARD REV PSYCHIAT, V7, P185, DOI 10.1093/hrp/7.4.185; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Ujike H, 2001, NEUROSCI LETT, V301, P41, DOI 10.1016/S0304-3940(01)01602-0; Vieland VJ, 2001, NAT GENET, V29, P244, DOI 10.1038/ng1101-244; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Wang SB, 1996, AM J HUM GENET, V59, P731; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weinberger DR, 1999, BIOL PSYCHIAT, V45, P395, DOI 10.1016/S0006-3223(98)00331-X; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wright P, 2001, SCHIZOPHR RES, V47, P1, DOI 10.1016/S0920-9964(00)00022-0; ZATZ M, 1993, J MED GENET, V30, P131, DOI 10.1136/jmg.30.2.131	92	638	669	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					337	348		10.1086/341750	http://dx.doi.org/10.1086/341750			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12098102	Green Published, Bronze			2022-12-18	WOS:000176977700012
J	GARDNER, EJ; RICHARDS, RC				GARDNER, EJ; RICHARDS, RC			MULTIPLE CUTANEOUS AND SUBCUTANEOUS LESIONS OCCURRING SIMULTANEOUSLY WITH HEREDITARY POLYPOSIS AND OSTEOMATOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GARDNER EJ, 1952, AM J HUM GENET, V4, P31	2	635	643	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					139	147						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	13065261				2022-12-18	WOS:A1953XW63000003
J	Tassone, F; Hagerman, RJ; Taylor, AK; Gane, LW; Godfrey, TE; Hagerman, PJ				Tassone, F; Hagerman, RJ; Taylor, AK; Gane, LW; Godfrey, TE; Hagerman, PJ			Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAPID ANTIBODY-TEST; FEMALE CARRIERS; CGG REPEAT; GENE-EXPRESSION; PREMUTATION; PHENOTYPE; MUTATION; PCR; EXPANSION; METHYLATION	Fragile-X syndrome is a trinucleotide-repeat-expansion disorder in which the clinical phenotype is believed to result from transcriptional silencing of the fragile-X mental retardation 1 (FMR1) gene as the number of CGG repeats exceeds similar to 200. For premutation alleles (similar to 55-200 repeats), no abnormalities in FMR1-gene expression have been described, despite growing evidence of clinical involvement in premutation carriers. To address this (apparent) paradox, we have determined, for 16 carrier males (55-192 repeats), the relative levels of leukocyte FMR1 mRNA, by use of automated fluorescence-detection reverse transcriptase-PCR, and the percent of lymphocytes that are immunoreactive for FMR1 protein (FMRP). For some alleles with >100 repeats, there was a reduction in the number of FMRP-positive cells. Unexpectedly, FMR1 mRNA levels were elevated at least fivefold within this same range. No significant increase in FMR1 mRNA stability was observed in a lymphoblastoid cell line (160 repeats) derived from one of the carrier males, suggesting that the increased message levels are due to an increased rate of transcription. Current results support a mechanism of involvement in premutation carriers, in which reduced translational efficiency is at least partially compensated through increased transcriptional activity. Thus, diminished translational efficiency may be important throughout much of the premutation range, with a mechanistic switch occurring in the full-mutation range as the FMR1 gene is silenced.	Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA; Childrens Hosp, Child Dev Unit, Denver, CO 80218 USA; Childrens Hosp, Fragile Treatment & Res Ctr X, Denver, CO 80218 USA; Univ Calif San Francisco, Ctr Canc, San Francisco, CA USA; Kimball Genet Inc, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; Children's Hospital Colorado; University of California System; University of California San Francisco	Hagerman, PJ (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, B-121,4200 E 9th Ave, Denver, CO 80262 USA.	paul.hagerman@uchsc.edu	Godfrey, Tony/A-5572-2013	Godfrey, Tony/0000-0002-3283-6983	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035305] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD036071, HD36071] Funding Source: Medline; NIGMS NIH HHS [GM35305] Funding Source: Medline; PHS HHS [MCJ-089413] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; BAEYENS DA, 1993, J CELL PHYSIOL, V157, P70, DOI 10.1002/jcp.1041570109; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; deVries BBA, 1996, J MED GENET, V33, P1007, DOI 10.1136/jmg.33.12.1007; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DORN MB, 1994, J AM ACAD CHILD PSY, V33, P256, DOI 10.1097/00004583-199402000-00015; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FENG Y, 1995, AM J HUM GENET, V56, P106; Franke P, 1998, PSYCHIAT RES, V80, P113, DOI 10.1016/S0165-1781(98)00055-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Hagerman R J, 1999, NEURODEVELOPMENTAL D, P61; Hagerman RJ, 1996, PEDIATRICS, V97, P122; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hmadcha A, 1998, J LAB CLIN MED, V131, P170, DOI 10.1016/S0022-2143(98)90160-3; Kaufmann WE, 1999, AM J MED GENET, V83, P286, DOI 10.1002/(SICI)1096-8628(19990402)83:4<286::AID-AJMG10>3.3.CO;2-8; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LOESCH DZ, 1994, AM J MED GENET, V51, P392, DOI 10.1002/ajmg.1320510418; LOESCH DZ, 1987, AM J MED GENET, V27, P401, DOI 10.1002/ajmg.1320270219; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1993, AM J HUM GENET, V52, P884; Riddle JE, 1998, AM J MENT RETARD, V102, P590; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SMEETS HJM, 1995, HUM MOL GENET, V4, P2103, DOI 10.1093/hmg/4.11.2103; SMITS A, 1994, AM J MED GENET, V51, P497, DOI 10.1002/ajmg.1320510440; Steyaert J, 1996, AM J MED GENET, V64, P274, DOI 10.1002/(SICI)1096-8628(19960809)64:2<274::AID-AJMG8>3.0.CO;2-U; Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4; TASSONE F, IN PRESS AM J MED GE; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; TURNER G, 1994, LANCET, V344, P1500, DOI 10.1016/S0140-6736(94)90313-1; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Waring JD, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P131; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; Willemsen R, 1997, HUM GENET, V99, P308, DOI 10.1007/s004390050363	40	629	638	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					6	15		10.1086/302720	http://dx.doi.org/10.1086/302720			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	279FK	10631132	Green Published, Bronze			2022-12-18	WOS:000085033600003
J	AMOS, CI				AMOS, CI			ROBUST VARIANCE-COMPONENTS APPROACH FOR ASSESSING GENETIC-LINKAGE IN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; LINEAR-MODELS; MARKER LOCUS; IDENTITY	To assess evidence for genetic linkage from pedigrees, I developed a limited variance-components approach. In this method, variability among trait observations from individuals within pedigrees is expressed in terms of fixed effects from covariates and effects due to an unobservable trait-affecting major locus, random polygenic effects, and residual nongenetic variance. The effect attributable to a locus linked to a marker is a function of the additive and dominance components of variance of the locus, the recombination fraction, and the proportion of genes identical by descent at the marker locus for each pair of sibs. For unlinked loci, the polygenic variance component depends only on the relationship between the relative pair. Parameters can be estimated by either maximum-likelihood methods or quasi-likelihood methods. The forms of quasi-likelihood estimators are provided. Hypothesis tests derived from the maximum-likelihood approach are constructed by appeal to asymptotic theory. A simulation study showed that the size of likelihood-ratio tests was appropriate but that the monogenic component of variance was generally underestimated by the likelihood approach.	NIAMS,GENET STUDIES SECT,BETHESDA,MD	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	AMOS, CI (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EPIDEMIOL,1515 HOLCOMBE BLVD,BOX 189,HOUSTON,TX 77030, USA.							AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; AMOS CI, 1990, AM J HUM GENET, V47, P842; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AMOS CI, IN PRESS GENET EPIDE; BRUES AM, 1950, AM J HUM GENET, V2, P215; CAREY G, 1991, AM J HUM GENET, V49, P786; CARROLL RJ, 1982, ANN STAT, V10, P429, DOI 10.1214/aos/1176345784; CHEVALET C, 1984, GENET SEL EVOL, V16, P431, DOI 10.1186/1297-9686-16-4-431; CORBEIL RR, 1976, BIOMETRICS, V32, P779, DOI 10.2307/2529264; DEMENAIS FM, 1989, PROG CLIN BIOL RES, V329, P201; ELSTON RC, 1986, 7TH INT C HUM GEN BE; FISHER RT, 1918, T R SOC EDINB, P399; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; JAYAKAR SD, 1970, BIOMETRICS, V26, P451, DOI 10.2307/2529101; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAMMERER CM, 1985, HUM HERED, V35, P319, DOI 10.1159/000153570; LANDER ES, 1989, GENETICS, V121, P185; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MACCLUER JW, 1989, MONOGR HUM GENET, V12, P50; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; PENROSE LS, 1935, ANN EUGEN, V6, P133; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306	27	619	633	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					535	543						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116623				2022-12-18	WOS:A1994MZ15800017
J	Liu, JZ; Mcrae, AF; Nyholt, DR; Medland, SE; Wray, NR; Brown, KM; Hayward, NK; Montgomery, GW; Visscher, PM; Martin, NG; Macgregor, S				Liu, Jimmy Z.; Mcrae, Allan F.; Nyholt, Dale R.; Medland, Sarah E.; Wray, Naomi R.; Brown, Kevin M.; Hayward, Nicholas K.; Montgomery, Grant W.; Visscher, Peter M.; Martin, Nicholas G.; Macgregor, Stuart		AMFS Investigators	A Versatile Gene-Based Test for Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; SEQUENCE VARIANTS; LINKAGE; PATHWAY; HEIGHT; LOCI	We have derived a versatile gene-based test for genome-wide association studies (GWAS). Our approach, called VEGAS (versatile gene-based association study), is applicable to all GWAS designs, including family-based GWAS, meta-analyses of GWAS on the basis of summary data, and DNA-pooling-based GWAS, where existing approaches based on permutation are not possible, as well as singleton data, where they are. The test incorporates information from a full set of markers (or a defined subset) within a gene and accounts for linkage disequilibrium between markers by using simulations from the multivariate normal distribution. We show that for an association study using singletons, our approach produces results equivalent to those obtained via permutation in a fraction of the computation time. We demonstrate proof-of-principle by using the gene-based test to replicate several genes known to be associated on the basis of results from a family-based GWAS for height in 11,536 individuals and a DNA-pooling-based GWAS for melanoma in similar to 1300 cases and controls. Our method has the potential to identify novel associated genes; provide a basis for selecting SNPs for replication; and be directly used in network (pathway) approaches that require per-gene association test statistics. We have implemented the approach in both an easy-to-use web interface, which only requires the uploading of markers with their association p-values, and a separate downloadable application.	[Liu, Jimmy Z.; Mcrae, Allan F.; Nyholt, Dale R.; Medland, Sarah E.; Wray, Naomi R.; Hayward, Nicholas K.; Montgomery, Grant W.; Visscher, Peter M.; Martin, Nicholas G.; Macgregor, Stuart] Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia; [Brown, Kevin M.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85028 USA	QIMR Berghofer Medical Research Institute; Translational Genomics Research Institute	Liu, JZ (corresponding author), Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia.	jimmy.liu@uqconnect.edu.au; stuart.macgregor@qimr.edu.au	Medland, Sarah E/C-7630-2013; hayward, nick/AAV-8802-2020; Wray, Naomi/C-8639-2015; Nyholt, Dale Robert/J-3174-2017; hayward, nicholas k/C-1367-2015; McRae, Allan F/J-2644-2014; Medland, Sarah/AAT-7595-2020; Macgregor, Stuart/C-6442-2009; Mann, Graham J/G-4758-2014; Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020	Medland, Sarah E/0000-0003-1382-380X; Wray, Naomi/0000-0001-7421-3357; Nyholt, Dale Robert/0000-0001-7159-3040; hayward, nicholas k/0000-0003-4760-1033; McRae, Allan F/0000-0001-5286-5485; Medland, Sarah/0000-0003-1382-380X; Macgregor, Stuart/0000-0001-6731-8142; Mann, Graham J/0000-0003-1301-405X; Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760; Kefford, Richard/0000-0001-9251-9229; Aitken, Joanne Frances/0000-0001-6859-2186; Martin, Nicholas/0000-0003-4069-8020	National Health and Medical Research Council (NHMRC) [496675]; Australian Research Council; Melanoma Research Foundation; National Cancer Institute, National Institutes of Health [CA109544, CA083115]; NATIONAL CANCER INSTITUTE [R01CA083115, R01CA109544] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Melanoma Research Foundation; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Australian Melanoma Family Study Investigators: Graham J. Mann and Richard F. Kefford (Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, PO Box 412, Westmead, NSW 2145, Australia); John L. Hopper (Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, School of Population Health, Level 2, 723 Swanston Street, University of Melbourne, VIC 3052, Australia); Joanne E Aitken (Viertel Centre for Research in Cancer Control, The Queensland Cancer Council Queensland, PO Box 201, Spring Hill, QLD 4004, Australia); Graham G. Giles (Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, VIC 3053, Australia); and Bruce K. Armstrong (School of Public Health, A27, University of Sydney, NSW 2006, Australia). J.Z.L. is supported by National Health and Medical Research Council (NHMRC) project grant 496675. S.M., N.K.H., G.W.M., P.M.V., ARM., and S.E.M. are supported by the NHMRC Fellowships scheme. N.R.W. and D.R.N. are supported by Australian Research Council Fellowships. K.M.B. is a recipient of a Career Development Award from the Melanoma Research Foundation and is supported by the National Cancer Institute, National Institutes of Health (CA109544, CA083115). We thank Joseph Powell for suggesting the name VEGAS. Additional acknowledgements are provided in the Supplemental Data.	Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Benyamin B, 2008, EUR J HUM GENET, V16, P516, DOI 10.1038/sj.ejhg.5201992; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Cornes BK, 2005, TWIN RES HUM GENET, V8, P616; Cui YH, 2008, GENETICS, V179, P637, DOI 10.1534/genetics.107.082370; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; FARACO J, 1995, GENOMICS, V25, P630, DOI 10.1016/0888-7543(95)80004-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Genz A, 2009, MVTNORM MULTIVARIATE; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; HIGHAM NJ, 1988, LINEAR ALGEBRA APPL, V103, P103, DOI 10.1016/0024-3795(88)90223-6; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; SCHAEFER J, 2009, EFFICIENT ESTIMATION; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	26	618	626	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					139	145		10.1016/j.ajhg.2010.06.009	http://dx.doi.org/10.1016/j.ajhg.2010.06.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598278	Green Published, Bronze			2022-12-18	WOS:000280029200015
J	SLAGBOOM, PE; DROOG, S; BOOMSMA, DI				SLAGBOOM, PE; DROOG, S; BOOMSMA, DI			GENETIC DETERMINATION OF TELOMERE SIZE IN HUMANS - A TWIN STUDY OF 3 AGE-GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN FIBROBLASTS; PEDIGREE ANALYSIS; DNA; LYMPHOCYTES; CHROMOSOMES; ELONGATION; YEAST	Reduction of telomere length has been postulated to be a causal factor in cellular aging. Human telomeres terminate in tandemly arranged repeat arrays consisting of the (TTAGGG) motif. The length of these arrays in cells from human mitotic tissues is inversely related to the age of the donor, indicating telomere reduction with age. In addition to telomere length differences between different age cohorts, considerable variation is present among individuals of the same age. To investigate whether this variation can be ascribed to genetic influences, we have measured the size of terminal restriction fragments (TRFs) in HaeIII-digested genomic DNA from 123 human MZ and DZ twin pairs 2-95 years of age. The average rate of telomere shortening was 31 bp/year, which is similar to that observed by others. Statistical analysis in 115 pairs 2-63 years of age indicates a 78% heritability for mean TRF length in this age cohort. The individual differences in mean TRF length in blood, therefore, seem to a large extent to be genetically determined.	FREE UNIV AMSTERDAM,DEPT PSYCHOL,AMSTERDAM,NETHERLANDS	Vrije Universiteit Amsterdam	SLAGBOOM, PE (corresponding author), TNO PG,DEPT VASC & CONNECT TISSUE RES,ZERNIKEDREEF 9,POB 430,2300 AK LEIDEN,NETHERLANDS.		Slagboom, P. Eline/R-4790-2016; Boomsma, Dorret I/AAX-4470-2020	Slagboom, P. Eline/0000-0002-2875-4723; 				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BENDER MA, 1989, MUTAT RES, V212, P149, DOI 10.1016/0027-5107(89)90065-1; BIESSMANN H, 1992, ADV GENET, V30, P185, DOI 10.1016/S0065-2660(08)60321-1; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOOMSMA DI, 1993, ATHEROSCLEROSIS, V99, P23, DOI 10.1016/0021-9150(93)90047-X; BOOMSMA DI, 1992, BEHAV GENET, V22, P247, DOI 10.1007/BF01067004; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SNIEDER H, IN PRESS BEHAVIOR GE; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; VANDEHOFSTEDE JW, 1993, 1993 MED INF C P, P149; VAZIRI H, 1993, AM J HUM GENET, V52, P661	24	609	636	0	38	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					876	882						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977349				2022-12-18	WOS:A1994QB68200005
J	Pinto, D; Delaby, E; Merico, D; Barbosa, M; Merikangas, A; Klei, L; Thiruvahindrapuram, B; Xu, X; Ziman, R; Wang, ZZ; Vorstman, JAS; Thompson, A; Regan, R; Pilorge, M; Pellecchia, G; Pagnamenta, AT; Oliveira, B; Marshall, CR; Magalhaes, TR; Lowe, JK; Howe, JL; Griswold, AJ; Gilbert, J; Duketis, E; Dombroski, BA; De Jonge, MV; Cuccaro, M; Crawford, EL; Correia, CT; Conroy, J; Conceicao, IC; Chiocchetti, AG; Casey, JP; Cai, G; Cabrol, C; Bolshakova, N; Bacchelli, E; Anney, R; Gallinger, S; Cotterchio, M; Casey, G; Zwaigenbaum, L; Wittemeyer, K; Wing, K; Wallace, S; van Engeland, H; Tryfon, A; Thomson, S; Soorya, L; Roge, B; Roberts, W; Poustka, F; Mouga, S; Minshew, N; McInnes, LA; McGrew, SG; Lord, C; Leboyer, M; Le Couteur, AS; Kolevzon, A; Gonzalez, PJ; Jacob, S; Holt, R; Guter, S; Green, J; Green, A; Gillberg, C; Fernandez, BA; Duque, F; Delorme, R; Dawson, G; Chaste, P; Cafe, C; Brennan, S; Bourgeron, T; Bolton, PF; Bolte, S; Bernier, R; Baird, G; Bailey, AJ; Anagnostou, E; Almeida, J; Wijsman, EM; Vieland, VJ; Vicente, AM; Schellenberg, GD; Pericak-Vance, M; Paterson, AD; Parr, JR; Oliveira, G; Nurnberger, JI; Monaco, AP; Maestrini, E; Klauck, SM; Hakonarson, H; Haines, JL; Geschwind, DH; Freitag, CM; Folstein, SE; Ennis, S; Coon, H; Battaglia, A; Szatmari, P; Sutcliffe, JS; Hallmayer, J; Gill, M; Cook, EH; Buxbaum, JD; Devlin, B; Gallagher, L; Betancur, C; Scherer, SW				Pinto, Dalila; Delaby, Elsa; Merico, Daniele; Barbosa, Mafalda; Merikangas, Alison; Klei, Lambertus; Thiruvahindrapuram, Bhooma; Xu, Xiao; Ziman, Robert; Wang, Zhuozhi; Vorstman, Jacob A. S.; Thompson, Ann; Regan, Regina; Pilorge, Marion; Pellecchia, Giovanna; Pagnamenta, Alistair T.; Oliveira, Barbara; Marshall, Christian R.; Magalhaes, Tiago R.; Lowe, Jennifer K.; Howe, Jennifer L.; Griswold, Anthony J.; Gilbert, John; Duketis, Eftichia; Dombroski, Beth A.; De Jonge, Maretha V.; Cuccaro, Michael; Crawford, Emily L.; Correia, Catarina T.; Conroy, Judith; Conceicao, Ines C.; Chiocchetti, Andreas G.; Casey, Jillian P.; Cai, Guiqing; Cabrol, Christelle; Bolshakova, Nadia; Bacchelli, Elena; Anney, Richard; Gallinger, Steven; Cotterchio, Michelle; Casey, Graham; Zwaigenbaum, Lonnie; Wittemeyer, Kerstin; Wing, Kirsty; Wallace, Simon; van Engeland, Herman; Tryfon, Ana; Thomson, Susanne; Soorya, Latha; Roge, Bernadette; Roberts, Wendy; Poustka, Fritz; Mouga, Susana; Minshew, Nancy; McInnes, L. Alison; McGrew, Susan G.; Lord, Catherine; Leboyer, Marion; Le Couteur, Ann S.; Kolevzon, Alexander; Gonzalez, Patricia Jimenez; Jacob, Suma; Holt, Richard; Guter, Stephen; Green, Jonathan; Green, Andrew; Gillberg, Christopher; Fernandez, Bridget A.; Duque, Frederico; Delorme, Richard; Dawson, Geraldine; Chaste, Pauline; Cafe, Catia; Brennan, Sean; Bourgeron, Thomas; Bolton, Patrick F.; Boelte, Sven; Bernier, Raphael; Baird, Gillian; Bailey, Anthony J.; Anagnostou, Evdokia; Almeida, Joana; Wijsman, Ellen M.; Vieland, Veronica J.; Vicente, Astrid M.; Schellenberg, Gerard D.; Pericak-Vance, Margaret; Paterson, Andrew D.; Parr, Jeremy R.; Oliveira, Guiomar; Nurnberger, John I.; Monaco, Anthony P.; Maestrini, Elena; Klauck, Sabine M.; Hakonarson, Hakon; Haines, Jonathan L.; Geschwind, Daniel H.; Freitag, Christine M.; Folstein, Susan E.; Ennis, Sean; Coon, Hilary; Battaglia, Agatino; Szatmari, Peter; Sutcliffe, James S.; Hallmayer, Joachim; Gill, Michael; Cook, Edwin H.; Buxbaum, Joseph D.; Devlin, Bernie; Gallagher, Louise; Betancur, Catalina; Scherer, Stephen W.			Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; INTELLECTUAL DISABILITY; STRUCTURAL VARIATION; PHENOTYPE ONTOLOGY; DELETIONS; VARIANTS; DUPLICATIONS; RISK; INFORMATION	Rare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 x 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability (odds ratio = 12.62, p = 2.7 x 10(-15), similar to 3% of ASD subjects). Pathogenic CNVs, often showing variable expressivity, included rare de novo and inherited events at 36 loci, implicating ASD-associated genes (CHD2, HDAC4, and GDI1) previously linked to other neurodevelopmental disorders, as well as other genes such as SETD5, MIR137, and HDAC9. Consistent with hypothesized gender-specific modulators, females with ASD were more likely to have highly penetrant CNVs (p = 0.017) and were also overrepresented among subjects with fragile X syndrome protein targets (p = 0.02). Genes affected by de novo CNVs and/or loss-of-function single-nucleotide variants converged on networks related to neuronal signaling and development, synapse function, and chromatin regulation.	[Pinto, Dalila; Barbosa, Mafalda; Cai, Guiqing; Tryfon, Ana; Soorya, Latha; McInnes, L. Alison; Kolevzon, Alexander; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Pinto, Dalila; Barbosa, Mafalda; Xu, Xiao; Cai, Guiqing; Tryfon, Ana; Soorya, Latha; McInnes, L. Alison; Kolevzon, Alexander; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Pinto, Dalila; Barbosa, Mafalda; Cai, Guiqing; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Pinto, Dalila; Barbosa, Mafalda; Xu, Xiao; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Pinto, Dalila; Xu, Xiao] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Pinto, Dalila; Kolevzon, Alexander; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Delaby, Elsa; Pilorge, Marion; Cabrol, Christelle; Betancur, Catalina] Inst Natl Sante & Rech Med U1130, F-75005 Paris, France; [Delaby, Elsa; Pilorge, Marion; Cabrol, Christelle; Betancur, Catalina] CNRS, UMR 8246, F-75005 Paris, France; [Delaby, Elsa; Pilorge, Marion; Cabrol, Christelle; Betancur, Catalina] Sorbonne Univ, Univ Paris 06, Neurosci Paris Seine, F-75005 Paris, France; [Merico, Daniele; Thiruvahindrapuram, Bhooma; Ziman, Robert; Wang, Zhuozhi; Pellecchia, Giovanna; Marshall, Christian R.; Howe, Jennifer L.; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Gen, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Merikangas, Alison; Bolshakova, Nadia; Anney, Richard; Brennan, Sean; Gill, Michael; Gallagher, Louise] Univ Dublin Trinity Coll, Sch Med, Discipline Psychiat, Dublin 8, Ireland; [Klei, Lambertus; Minshew, Nancy; Chaste, Pauline; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Vorstman, Jacob A. S.; De Jonge, Maretha V.; van Engeland, Herman] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NL-3584 CX Utrecht, Netherlands; [Thompson, Ann; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4K1, Canada; [Regan, Regina; Magalhaes, Tiago R.; Casey, Jillian P.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin 12, Ireland; [Regan, Regina; Magalhaes, Tiago R.; Conroy, Judith; Casey, Jillian P.; Green, Andrew; Ennis, Sean] Univ Coll Dublin, Sch Med & Med Sci, Acad Ctr Rare Dis, Dublin 4, Ireland; [Pagnamenta, Alistair T.; Wing, Kirsty; Holt, Richard; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Oliveira, Barbara; Correia, Catarina T.; Conceicao, Ines C.; Vicente, Astrid M.] Inst Nacl Saude Doutor Ricardo Jorge, P-1649016 Lisbon, Portugal; [Oliveira, Barbara; Correia, Catarina T.; Conceicao, Ines C.; Vicente, Astrid M.] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Griswold, Anthony J.; Gilbert, John; Cuccaro, Michael; Pericak-Vance, Margaret] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Griswold, Anthony J.; Gilbert, John; Cuccaro, Michael; Pericak-Vance, Margaret] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miller Sch Med, Miami, FL 33136 USA; [Duketis, Eftichia; Chiocchetti, Andreas G.; Poustka, Fritz; Freitag, Christine M.] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60528 Frankfurt, Germany; [Dombroski, Beth A.; Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Crawford, Emily L.; Thomson, Susanne; Haines, Jonathan L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Human Genet Res, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Crawford, Emily L.; Thomson, Susanne; Haines, Jonathan L.; Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Conroy, Judith] Childrens Univ Hosp Temple St, Dublin 1, Ireland; [Bacchelli, Elena; Maestrini, Elena] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Cotterchio, Michelle] Canc Care Ontario, Toronto, ON M5G 2L7, Canada; [Casey, Graham] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T6B 2H3, Canada; [Wittemeyer, Kerstin] Univ Birmingham, Sch Educ, Birmingham B15 2TT, W Midlands, England; [Wallace, Simon; Bailey, Anthony J.] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Wallace, Simon; Bailey, Anthony J.] Warneford Hosp, Oxford OX3 7JX, England; [Roge, Bernadette] Univ Toulouse 2, Unite Rech Interdisciplinaire Octogone, Ctr Etud & Rech Psychopathol, F-31058 Toulouse, France; [Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Mouga, Susana; Duque, Frederico; Cafe, Catia; Almeida, Joana; Oliveira, Guiomar] Ctr Hosp Coimbra, Pediat Hosp, Unidade Neurodesenvolvimento & Autismo Serv, Ctr Desenvolvimento Crianca, P-3000602 Coimbra, Portugal; [Mouga, Susana; Duque, Frederico; Cafe, Catia; Almeida, Joana; Oliveira, Guiomar] Ctr Hosp Coimbra, Ctr Invest & Formacao Clin, Pediat Hosp, P-3000602 Coimbra, Portugal; [Mouga, Susana; Duque, Frederico; Cafe, Catia; Almeida, Joana; Oliveira, Guiomar] Univ Coimbra, P-3000602 Coimbra, Portugal; [Mouga, Susana; Duque, Frederico; Cafe, Catia; Almeida, Joana; Oliveira, Guiomar] Univ Coimbra, P-3000354 Coimbra, Portugal; [Mouga, Susana; Duque, Frederico; Oliveira, Guiomar] Univ Coimbra, Univ Clin Pediat, P-3000354 Coimbra, Portugal; [Mouga, Susana; Duque, Frederico; Oliveira, Guiomar] Univ Coimbra, Inst Biomed Imaging & Life Sci, Fac Med, P-3000354 Coimbra, Portugal; [McGrew, Susan G.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Lord, Catherine] NewYorkPresbyterian Weill Cornell Med Ctr, New York, NY 10065 USA; [Leboyer, Marion; Delorme, Richard; Chaste, Pauline; Bourgeron, Thomas] FondaMental Fdn, F-94010 Creteil, France; [Leboyer, Marion] Inst Natl Sante & Rech U955, F-94010 Creteil, France; [Leboyer, Marion] Univ Paris Est, Fac Med, F-94010 Creteil, France; [Leboyer, Marion] Henri Mondor Albert Chenevier Hosp, AP HP, Dept Psychiat, F-94010 Creteil, France; [Le Couteur, Ann S.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gonzalez, Patricia Jimenez] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Child Dev & Behav Unit, Caja Costarricense Seguro Social, San Jose, Costa Rica; [Jacob, Suma; Guter, Stephen; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60608 USA; [Jacob, Suma] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Jacob, Suma] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Green, Jonathan] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester M13 9PL, Lancs, England; [Green, Jonathan] Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Green, Andrew; Ennis, Sean] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Gillberg, Christopher] Univ Gothenburg, Gillberg Neuropsychiat Ctr, S-41119 Gothenburg, Sweden; [Fernandez, Bridget A.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF A1B 3V6, Canada; [Delorme, Richard; Bourgeron, Thomas] Inst Pasteur, Human Genet & Cognit Funct Unit, F-75015 Paris, France; [Delorme, Richard; Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, F-75015 Paris, France; [Delorme, Richard] Robert Debre Hosp, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France; [Dawson, Geraldine] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Bourgeron, Thomas] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Bolton, Patrick F.] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Bolton, Patrick F.] South London & Maudsley Biomed Res Ctr Mental Hlt, London SES 8AF, England; [Boelte, Sven] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60528 Frankfurt, Germany; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Baird, Gillian] Kings Coll London, Kings Hlth Partners, London WC2R 2L5, England; [Anagnostou, Evdokia] Univ Toronto, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Wijsman, Ellen M.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Vieland, Veronica J.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Paterson, Andrew D.] Dalla Lana Sch Publ Hlth, Toronto, ON MST 3M7, Canada; [Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Nurnberger, John I.] Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN 46202 USA; [Nurnberger, John I.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Nurnberger, John I.] Indiana Univ Sch Med, Program Med Neurosci, Indianapolis, IN 46202 USA; [Monaco, Anthony P.] Tufts Univ, Off President, Medford, MA 02155 USA; [Klauck, Sabine M.] Deutsch Krebsforschungszentrum, German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Folstein, Susan E.] Univ Miami, Dept Psychiat, Miller Sch Med, Div Child & Adolescent Psychiat, Miami, FL 33136 USA; [Coon, Hilary] Univ Utah, Sch Med, Dept Psychiat, Utah Autism Res Program, Salt Lake City, UT 84108 USA; [Battaglia, Agatino] Stella Maris Clin Res Inst Child & Adolescent Neu, I-56128 Pisa, Italy; [Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Trinity College Dublin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utrecht University; Utrecht University Medical Center; McMaster University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; University of Oxford; Wellcome Centre for Human Genetics; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Miami; University of Miami; Goethe University Frankfurt; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Vanderbilt University; Childrens University Hospital - Temple Street; University of Bologna; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cancer Care Ontario; University of Southern California; University of Alberta; University of Birmingham; University of Oxford; Universite de Toulouse; Universite de Toulouse - Jean Jaures; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Vanderbilt University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Newcastle University - UK; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Manchester; University of Manchester; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Gothenburg; Memorial University Newfoundland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Duke University; UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; Goethe University Frankfurt; University of Washington; University of Washington Seattle; University of Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Toronto; Newcastle University - UK; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Tufts University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Miami; Utah System of Higher Education; University of Utah; IRCCS Fondazione Stella Maris; Stanford University; Icahn School of Medicine at Mount Sinai	Betancur, C (corresponding author), Inst Natl Sante & Rech Med U1130, F-75005 Paris, France.	catalina.betancur@inserm.fr; stephen.scherer@sickkids.ca	Bölte, Sven/AAH-8675-2019; Jacob, Suma/J-7941-2013; bacchelli, elena/R-3675-2016; Paterson, Andrew D/A-4088-2011; Mouga, Susana/AAE-3497-2022; Battaglia, Agatino/AAG-1406-2020; Duque, Frederico/H-3692-2014; Paterson, Andrew/AAQ-7511-2020; Mouga, Susana/AAF-6690-2020; Oliveira, Guiomar/AAF-3911-2021; Gallinger, Steven/E-4575-2013; Conceiçao, Ines/ABC-6167-2021; Sutcliffe, James S/C-1348-2012; Scherer, Stephen W./B-3785-2013; Betancur, Catalina/K-3791-2017; Haines, Jonathan/C-3374-2012; Buxbaum, Joseph D/G-6001-2010; Vicente, Astrid/F-8692-2014; Pinto, Dalila/C-4218-2016; Bailey, Anthony/J-2860-2014; Leboyer, Marion/AAW-3648-2021; Monaco, Anthony P/A-4495-2010	Bölte, Sven/0000-0002-4579-4970; Jacob, Suma/0000-0001-7434-7398; bacchelli, elena/0000-0001-8800-9568; Paterson, Andrew D/0000-0002-9169-118X; Battaglia, Agatino/0000-0002-7128-7606; Duque, Frederico/0000-0001-5684-1472; Paterson, Andrew/0000-0002-9169-118X; Mouga, Susana/0000-0003-1072-4208; Oliveira, Guiomar/0000-0002-7049-1277; Sutcliffe, James S/0000-0001-5200-6007; Scherer, Stephen W./0000-0002-8326-1999; Betancur, Catalina/0000-0002-3327-4804; Haines, Jonathan/0000-0002-4351-4728; Vicente, Astrid/0000-0001-7134-8037; Pinto, Dalila/0000-0002-8769-0846; Bailey, Anthony/0000-0003-4257-972X; Leboyer, Marion/0000-0001-5473-3697; Monaco, Anthony P/0000-0001-7480-3197; Nurnberger, John/0000-0002-7674-1767; Green, Andrew/0000-0002-1077-7417; Chiocchetti, Andreas G/0000-0002-7329-9985; Merikangas, Alison/0000-0003-2253-839X; Conceicao, Ines/0000-0002-1246-3761; Bourgeron, Thomas/0000-0001-8164-9220; Buxbaum, Joseph/0000-0001-8898-8313; Gallagher, Louise/0000-0001-9462-2836; Guter, Stephen/0000-0002-4476-2045; Anney, Richard/0000-0002-6083-407X; MAESTRINI, ELENA/0000-0001-5924-3179; Freitag, Christine Margarete/0000-0001-9676-4782; Bolshakova, Nadia/0000-0003-2173-6562; Green, Jonathan/0000-0002-0143-181X; McNeil, Kirsty/0000-0003-0437-3608; Ennis, Sean/0000-0002-4330-1386; Gill, Michael/0000-0003-0206-5337; R Magalhaes, Tiago/0000-0002-5528-2119; Correia, Catarina/0000-0001-5481-2010; Merico, Daniele/0000-0002-3728-4401; Oliveira, Barbara/0000-0002-3270-5780; Dawson, Geraldine/0000-0003-1410-2764; Delorme, Richard/0000-0002-5614-3663	Autism Speaks (USA); Health Research Board (Ireland) [AUT/2006/1, AUT/2006/2, PD/2006/48]; Medical Research Council (UK); Hilibrand Foundation (USA); Genome Canada; Canadian Institutes of Health Research (CIHR); Brain & Behavior Research Foundation; Ontario Genomics Institute; Autistica [7267] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094382, R01MH094400, R01MH094714, R01MH094293] Funding Source: NIH RePORTER	Autism Speaks (USA); Health Research Board (Ireland); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hilibrand Foundation (USA); Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Brain & Behavior Research Foundation(NARSAD); Ontario Genomics Institute; Autistica(Autistica); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the main funders of the Autism Genome Project: Autism Speaks (USA), the Health Research Board (Ireland; AUT/2006/1, AUT/2006/2, PD/2006/48), the Medical Research Council (UK), the Hilibrand Foundation (USA), Genome Canada, the Ontario Genomics Institute, and the Canadian Institutes of Health Research (CIHR). Additional support for individual groups is shown in the Supplemental Acknowledgments. D.P. is the Abraham & Mildred Goldstein Seaver Center Faculty Fellow, J.D.B. holds the G. Harold and Leila Y. Mathers Professorship, C.B. is the recipient of a NARSAD Independent Investigator Grant from the Brain & Behavior Research Foundation, and S.W.S. holds the GlaxoSmithKline-CIHR Pathfinder Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children. E.H.C. is an advisor of Seaside Therapeutics, G.D. is a member of the Scientific Advisory Board at Integragen Inc., and S.W.S. is an advisor to Population Diagnostics and advisor and founder of YouNique Genomics. D.P., P.S J.S.S., J.H., M.G., E.H.C., J.D.B., B.D., L.G., C.B., and S.W.S were leading contributors to the design and analysis of this study, and D.P., E. Delaby, D.M., M.B., J.D.B., B.D., L.G., C.B., and S.W.S wrote the manuscript.	Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Carter MT, 2011, CLIN GENET, V80, P435, DOI 10.1111/j.1399-0004.2010.01578.x; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Sparrow S.S., 2005, VINELAND ADAPTIVE BE, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Stankiewicz P, 2012, HUM MUTAT, V33, P165, DOI 10.1002/humu.21614; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tropeano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061365; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Vandewalle J, 2009, AM J HUM GENET, V85, P809, DOI 10.1016/j.ajhg.2009.10.019; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	64	608	621	3	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					677	694		10.1016/j.ajhg.2014.03.018	http://dx.doi.org/10.1016/j.ajhg.2014.03.018			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24768552	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-18	WOS:000335485700003
J	Parra, EJ; Marcini, A; Akey, L; Martinson, J; Batzer, MA; Cooper, R; Forrester, T; Allison, DB; Deka, R; Ferrell, RE; Shriver, MD				Parra, EJ; Marcini, A; Akey, L; Martinson, J; Batzer, MA; Cooper, R; Forrester, T; Allison, DB; Deka, R; Ferrell, RE; Shriver, MD			Estimating African American admixture proportions by use of population-specific alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ADMIXED POPULATIONS; GENE; REGION; MTDNA; DNA; IDENTIFICATION; MITOCHONDRIAL; HAPLOGROUPS; SEQUENCE	We analyzed the European genetic contribution to 10 populations of African descent in the United States (Maywood, Illinois; Detroit; New York; Philadelphia; Pittsburgh; Baltimore; Charleston, South Carolina; New Orleans; and Houston) and in Jamaica, using nine autosomal DNA markers. These markers either are population-specific or show frequency differences >45 % between the parental populations and are thus especially informative for admixture. European genetic ancestry ranged from 6.8% (Jamaica) to 22.5% (New Orleans). The unique utility of these markers is reflected in the low variance associated with these admixture estimates (SEM 1.3%-2.7%). We also estimated the male and female European contribution to African Americans, on the basis of informative mtDNA (haplogroups H and L) and Y Alu polymorphic markers. Results indicate a sex-biased gene flow from Europeans, the male contribution being substantially greater than the female contribution. mtDNA haplogroups analysis shows no evidence of a significant maternal Amerindian contribution to any of the 10 populations. We detected significant nonrandom association between two markers located 22 cM apart (FY-null and AT3), most likely due to admixture linkage disequilibrium created in the interbreeding off the two parental populations. The strength of this association and the substantial genetic distance between FY and AT3 emphasize the importance of admired populations as a useful resource for mapping traits with different prevalence in two parental populations.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Allegheny Univ Hlth Sci, Dept Human Genet, Philadelphia, PA USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; Louisiana State Univ, Med Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA; Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ W Indies, Trop Metab Res Unit, Mona, Jamaica; Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp, New York, NY USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Loyola University Chicago; University West Indies Mona Jamaica; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University System of Ohio; University of Cincinnati	Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, 409 Carpenter Bldg, University Pk, PA 16802 USA.	mds17@psu.edu	Parra, Esteban J/A-4957-2008	Martinson, Jeremy/0000-0003-4673-7238; Allison, David/0000-0003-3566-9399; Akey, Joshua/0000-0002-4411-1330; parra, esteban J/0000-0002-2057-8577; Shriver, Mark/0000-0003-0006-0479	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045861] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45861] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; Allison DB, 1997, AM J HUM GENET, V60, P676; Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4; Batzer MA, 1996, J MOL EVOL, V42, P22, DOI 10.1007/BF00163207; BOOKSTEIN R, 1990, NUCLEIC ACIDS RES, V18, P1666, DOI 10.1093/nar/18.6.1666; BRISCOE D, 1994, J HERED, V85, P59; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CHAKRABORTY R, 1975, AM J PHYS ANTHROPOL, V42, P507, DOI 10.1002/ajpa.1330420319; CHEN YS, 1995, AM J HUM GENET, V57, P133; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; GOTODA T, 1992, J LIPID RES, V33, P1067; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Herskovits Melville, 1930, ANTHROPOMETRY AM NEG; HSIEH CL, 1992, ANN HUM GENET, V56, P105, DOI 10.1111/j.1469-1809.1992.tb01137.x; Johnson D.M., 1981, BLACK MIGRATION AM S; Kaplan NL, 1997, AM J HUM GENET, V61, pA202; Katz William Loren, 1986, BLACK INDIANS HIDDEN; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; LIU Y, 1995, HUM HERED, V45, P192, DOI 10.1159/000154288; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1995, AM J HUM GENET, V56, P799; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Meier A, 1949, AM J PHYS ANTHROP-NE, V7, P227, DOI 10.1002/ajpa.1330070206; PIERSEN WD, 1996, AFRICA AM; RAYMOND M, 1995, GENEPOP VERSION 2 0; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; Schneider S, 1997, ARLEQUIN SOFTWARE PO; Shriver MD, 1997, AM J HUM GENET, V60, P957; Soodyall H, 1996, AM J HUM GENET, V58, P595; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; WALLACE DC, 1992, HUM BIOL, V64, P403; Wilkinson Doris Y., 1975, BLACK MALE WHITE FEM; Williamson J., 1995, NEW PEOPLE MISCEGENA; WORKMAN PL, 1968, HUM BIOL, V40, P260; [No title captured]	50	608	630	0	28	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1839	1851		10.1086/302148	http://dx.doi.org/10.1086/302148			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	151EL	9837836	Green Submitted, hybrid, Green Published			2022-12-18	WOS:000077707700029
J	Kluijtmans, LAJ; vandenHeuvel, LPWJ; Boers, GHJ; Frosst, P; Stevens, EMB; vanOost, BA; denHeijer, M; Trijbels, FJM; Rozen, R; Blom, HJ				Kluijtmans, LAJ; vandenHeuvel, LPWJ; Boers, GHJ; Frosst, P; Stevens, EMB; vanOost, BA; denHeijer, M; Trijbels, FJM; Rozen, R; Blom, HJ			Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; CULTURED FIBROBLASTS; VASCULAR-DISEASE; HOMOCYSTINURIA; HOMOCYSTEINEMIA; HETEROZYGOTES; DEFICIENCY; METABOLISM; CELLS	Mild hyperhomocysteinemia is an established risk factor for cardiovascular disease. Genetic aberrations in the cystathionine beta-synthase (CBS) and methylenetetrahydrofolate reductase (MTHFR) genes may account for reduced enzyme activities and elevated plasma homocysteine levels. In 15 unrelated Dutch patients with homozygous CBS deficiency, we observed the 833T-->C (I278T) mutation in 50% of the alleles. Very recently, we identified a common mutation (677C-->T; A-->V) in the MTHFR gene, which, in homozygous state, is responsible for the thermolabile phenotype and which is associated with decreased specific MTHFR activity and elevated homocysteine levels. We screened 60 cardiovascular patients and 111 controls for these two mutations, to determine whether these mutations are risk factors for premature cardiovascular disease. Heterozygosity for the 833T-->C mutation in the CBS gene was observed in one individual of the control group but was absent in patients with premature cardiovascular disease. Homozygosity for the 677C-->T mutation in the MTHFR gene was found in 9 (15%) of 60 cardiovascular patients and in only 6 (similar to 5%) of 111 control individuals (odds ratio 3.1 [95% confidence interval 1.0-9.2]). Because of both the high prevalence of the 833T-->C mutation among homozygotes for CBS deficiency and its absence in 60 cardiovascular patients, we may conclude that heterozygosity for CBS deficiency does not appear to be involved in premature cardiovascular disease. However, a frequent homozygous mutation in the MTHFR gene is associated with a threefold increase in risk for premature cardiovascular disease.	UNIV NIJMEGEN HOSP,DEPT PEDIAT,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT HUMAN GENET,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT PEDIAT,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT BIOL,MONTREAL,PQ H3H 1P3,CANADA; MUNICIPAL HOSP LEYENBURG,DEPT HEMATOL,THE HAGUE,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; McGill University; McGill University; McGill University			Rozen, Rima/AAE-9294-2020; Kluijtmans, Leo A/L-4437-2015; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Blom, Henk/0000-0001-5202-9241				BOERS GHJ, 1985, HUM GENET, V69, P164, DOI 10.1007/BF00293290; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BOERS GHJ, 1986, CLIN RES SERIES, V3; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DALY L, 1993, Q J MED, V86, P685, DOI 10.1093/qjmed/86.10.685; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FINKELSTEIN JD, 1964, SCIENCE, V146, P785, DOI 10.1126/science.146.3645.785; FOWLER B, 1978, J CLIN INVEST, V61, P645, DOI 10.1172/JCI108976; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GOYETTE P, 1995, AM J HUM GENET, V56, P1052; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; GUTTORMSEN AB, 1994, J NUTR, V124, P1934, DOI 10.1093/jn/124.10.1934; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1993, CIRCULATION, V88, P1463, DOI 10.1161/01.CIR.88.4.1463; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; KLUIJTMANS LAJ, 1995, HUM GENET, V96, P249, DOI 10.1007/BF00207394; KOZICH V, 1995, HUM MOL GENET, V4, P623, DOI 10.1093/hmg/4.4.623; KRAUS JP, 1993, HUM MOL GENET, V2, P1633, DOI 10.1093/hmg/2.10.1633; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALINOW MR, 1994, J INTERN MED, V236, P603, DOI 10.1111/j.1365-2796.1994.tb00854.x; MILLER JW, 1992, AM J CLIN NUTR, V55, P1154, DOI 10.1093/ajcn/55.6.1154; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORRIS JA, 1989, STAT CONFIDENCE, P50; MUDD SH, 1981, AM J HUM GENET, V33, P883; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Te Poele-Pothoff M. T. W. B., 1995, Annals of Clinical Biochemistry, V32, P218; WHITEHEAD AS, 1994, METHIONINE METABOLIS, P79; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350	35	597	619	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					35	41						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554066				2022-12-18	WOS:A1996TL69700007
J	Vilhjalmsson, BJ; Yang, J; Finucane, HK; Gusev, A; Lindstrom, S; Ripke, S; Genovese, G; Loh, PR; Bhatia, G; Do, R; Hayeck, T; Won, HH; Kathiresan, S; Pato, M; Pato, C; Tamimi, R; Stahl, E; Zaitlen, N; Pasaniuc, B; Belbin, G; Kenny, EE; Schierup, MH; De Jager, P; Patsopouos, NA; Mc Carroll, S; Daly, M; Purce, S; Chasman, D; Neale, B; Goddard, M; Visscher, PM; Kraft, P; Patterson, N; Price, AL				Vilhjalmsson, Bjarni J.; Yang, Jian; Finucane, Hilary K.; Gusev, Alexander; Lindstrom, Sara; Ripke, Stephan; Genovese, Giulio; Loh, Po-Ru; Bhatia, Gaurav; Do, Ron; Hayeck, Tristan; Won, Hong-Hee; Kathiresan, Sekar; Pato, Michele; Pato, Carlos; Tamimi, Rulla; Stahl, Eli; Zaitlen, Noah; Pasaniuc, Bogdan; Belbin, Gillian; Kenny, Eimear E.; Schierup, Mikkel H.; De Jager, Philip; Patsopouos, Nikolaos A.; Mc Carroll, Steve; Daly, Mark; Purce, Shaun; Chasman, Daniel; Neale, Benjamin; Goddard, Michael; Visscher, Peter M.; Kraft, Peter; Patterson, Nick; Price, Alkes L.		Psychiat Genomics Consortium; Discovery Biol Risk Inherited	Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ANALYSIS IDENTIFIES 13; GENETIC-RISK; SUSCEPTIBILITY LOCI; COMPLEX TRAITS; MIXED-MODEL; PREDICTION; BREAST; ARCHITECTURE; REGRESSION	Polygenic risk scores have shown great promise in predicting complex disease risk and will become more accurate as training sample sizes increase. The standard approach for calculating risk scores involves linkage disequilibrium (LD)-based marker pruning and applying a p value threshold to association statistics, but this discards information and can reduce predictive accuracy. We introduce LDpred, a method that infers the posterior mean effect size of each marker by using a prior on effect sizes and LD information from an external reference panel. Theory and simulations show that LDpred outperforms the approach of pruning followed by thresholding, particularly at large sample sizes. Accordingly, predicted R-2 increased from 20.1% to 25.3% in a large schizophrenia dataset and from 9.8% to 12.0% in a large multiple sclerosis dataset. A similar relative improvement in accuracy was observed for three additional large disease datasets and for non-European schizophrenia samples. The advantage of LDpred over existing methods will grow as sample sizes increase.	[Vilhjalmsson, Bjarni J.; Yang, Jian; Finucane, Hilary K.; Lindstrom, Sara; Loh, Po-Ru; Bhatia, Gaurav; Hayeck, Tristan; Tamimi, Rulla; Kraft, Peter; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Vilhjalmsson, Bjarni J.; Finucane, Hilary K.; Gusev, Alexander; Lindstrom, Sara; Loh, Po-Ru; Bhatia, Gaurav; Hayeck, Tristan; Tamimi, Rulla; Kraft, Peter; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Vilhjalmsson, Bjarni J.; Finucane, Hilary K.; Gusev, Alexander; Genovese, Giulio; Loh, Po-Ru; Bhatia, Gaurav; Hayeck, Tristan; Won, Hong-Hee; Kathiresan, Sekar; Stahl, Eli; De Jager, Philip; Patsopouos, Nikolaos A.; Mc Carroll, Steve; Daly, Mark; Purce, Shaun; Neale, Benjamin; Kraft, Peter; Patterson, Nick; Price, Alkes L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Finucane, Hilary K.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Yang, Jian; Finucane, Hilary K.; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4101, Australia; [Ripke, Stephan; Genovese, Giulio; Mc Carroll, Steve; Daly, Mark; Neale, Benjamin] MIT, Dept Math, Cambridge, MA 02139 USA; [Ripke, Stephan; Genovese, Giulio; Mc Carroll, Steve; Daly, Mark] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Genovese, Giulio; Mc Carroll, Steve] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Do, Ron; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Stahl, Eli; Kenny, Eimear E.; Purce, Shaun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Won, Hong-Hee; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Won, Hong-Hee; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Pato, Michele; Pato, Carlos] Univ So Calif, Dept Psychiat & Behav Sci, Keck Sch Med, Los Angeles, CA 90089 USA; [Tamimi, Rulla] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Stahl, Eli; Purce, Shaun] Icahn Sch Med Mt Sinai, Div Psychiat Genom, New York, NY 10029 USA; [Stahl, Eli; Kenny, Eimear E.; Purce, Shaun] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Zaitlen, Noah] Univ Calif San Francisco, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [De Jager, Philip; Patsopouos, Nikolaos A.; Chasman, Daniel] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [De Jager, Philip; Patsopouos, Nikolaos A.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Ann Romney Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; [Chasman, Daniel] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Goddard, Michael] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3010, Australia; [Goddard, Michael] Dept Primary Ind, Biosci Res Div, Bundoora, Vic 3083, Australia; [Kraft, Peter; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Aarhus University; University of Queensland; University of Queensland; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Southern California; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Melbourne; Harvard University; Harvard T.H. Chan School of Public Health	Vilhjalmsson, BJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bjami.vilhjalmsson@gmail.com; aprice@hsph.harvard.edu	Konte, Bettina/AAT-1142-2021; Mortensen, Preben B/D-2358-2015; Domenici, Enrico/K-8194-2016; Andreassen, Ole A./AAY-7531-2020; Meier, Sandra/AAB-1242-2021; Daly, Mark J/B-2453-2017; Lee, Jimmy/ABB-2919-2020; Garcia-Closas, Montserrat/AAZ-6930-2021; Won, Hong-Hee/D-2672-2011; McQuillin, Andrew/C-1623-2008; Wu, Jingqin/V-9319-2019; Schierup, Mikkel Heide/AAM-4997-2020; Hammer, Christian/C-5827-2014; Bramon, Elvira/HHC-3809-2022; Ripke, Stephan/AAK-5486-2021; Fanous, Ayman H/O-1263-2017; Hansen, Thomas Folkmann/O-5965-2014; van Os, Jim/C-2113-2014; KUČINSKAS, Vaidutis/A-4798-2013; Golimbet, V/E-2328-2016; O'Donovan, Michael C/P-7005-2018; Reichenberg, Abraham/GQB-1227-2022; Zimprich, Fritz/O-1406-2019; Vilhjálmsson, Bjarni/ABC-1369-2020; Kraft, Peter/GQH-8448-2022; Roffman, Joshua/G-8228-2012; Mattheisen, Manuel/S-3725-2019; Hartmann, Annette/AAS-6331-2021; Schierup, Mikkel H/F-1675-2010; Melle, Ingrid S/B-4858-2011; Pantelis, Christos/H-7722-2014; Mattingsdal, Morten/Q-9367-2016; Crisponi, Laura/AAC-2642-2019; Liu, Jianjun/AAK-4989-2020; Milani, Lili/N-1097-2019; McIntosh, Andrew M/B-9379-2008; Visscher, Peter/ABB-6151-2020; Lee, Sang Hong/A-2569-2011; Myin-Germeys, Inez/L-5106-2014; Stroup, Thomas/AAB-7780-2019; Collier, David A/D-1649-2011; Agerbo, Esben/A-2645-2012; Yang, Jian/A-5852-2010; Slominsky, Petr A/B-4640-2016; Mattheisen, Manuel/B-4949-2012; Webb, Bradley T/B-1459-2009; Degenhardt, Franziska/H-4169-2017; Zimprich, Fritz/W-1738-2017; Bergen, Sarah/I-8313-2012; O'Neill, Francis A/C-5582-2008; Slominsky, Petr/AAO-1852-2020; Figueroa, Jonine/AFK-2752-2022; Ruderfer, Douglas M/M-5795-2016; Figueroa, Jonine/GWD-1322-2022; Kelly, Brian/G-7755-2013; Grove, Jakob/K-8112-2015; Scott, Rodney/B-2827-2013; Mowry, Bryan/G-5046-2010; Ptackova, Hana/M-9763-2017; Franke, Lude/P-7036-2016; Sigurdsson, Engilbert/D-2486-2014; murray, robin/F-8658-2012	Konte, Bettina/0000-0001-5287-308X; Mortensen, Preben B/0000-0002-5230-9865; Domenici, Enrico/0000-0001-7436-6919; Daly, Mark J/0000-0002-0949-8752; Lee, Jimmy/0000-0002-7724-7445; Garcia-Closas, Montserrat/0000-0003-1033-2650; Won, Hong-Hee/0000-0001-5719-0552; McQuillin, Andrew/0000-0003-1567-2240; Wu, Jingqin/0000-0002-2052-3875; Schierup, Mikkel Heide/0000-0002-5028-1790; Hammer, Christian/0000-0003-4548-7548; Bramon, Elvira/0000-0003-1369-5983; Hansen, Thomas Folkmann/0000-0001-6703-7762; Golimbet, V/0000-0002-9960-7114; O'Donovan, Michael C/0000-0001-7073-2379; Zimprich, Fritz/0000-0002-6998-5480; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Roffman, Joshua/0000-0003-4073-532X; Mattheisen, Manuel/0000-0002-8442-493X; Schierup, Mikkel H/0000-0002-5028-1790; Melle, Ingrid S/0000-0002-9783-548X; Pantelis, Christos/0000-0002-9565-0238; Mattingsdal, Morten/0000-0003-4440-0324; Crisponi, Laura/0000-0001-9128-8537; Liu, Jianjun/0000-0002-3255-3019; Milani, Lili/0000-0002-5323-3102; McIntosh, Andrew M/0000-0002-0198-4588; Visscher, Peter/0000-0002-2143-8760; Lee, Sang Hong/0000-0001-9701-2718; Stroup, Thomas/0000-0002-3123-0672; Collier, David A/0000-0003-4087-1559; Agerbo, Esben/0000-0002-2849-524X; Yang, Jian/0000-0003-2001-2474; Slominsky, Petr A/0000-0003-3530-0655; Mattheisen, Manuel/0000-0002-8442-493X; Webb, Bradley T/0000-0002-0576-5366; Zimprich, Fritz/0000-0002-6998-5480; Bergen, Sarah/0000-0002-5888-0034; O'Neill, Francis A/0000-0002-7531-7657; Slominsky, Petr/0000-0003-3530-0655; Figueroa, Jonine/0000-0002-5100-623X; Ruderfer, Douglas M/0000-0002-2365-386X; Figueroa, Jonine/0000-0002-5100-623X; Knight, Joanne/0000-0002-7148-1660; Johansson, Mattias/0000-0002-3116-5081; Kraft, Peter/0000-0002-4472-8103; Goddard, Michael/0000-0001-9917-7946; Stogmann, Elisabeth/0000-0003-4688-8482; TOSATO, Sarah/0000-0002-9665-7538; Toncheva, Draga/0000-0002-7451-6363; Djurovic, Srdjan/0000-0002-8140-8061; Schall, Ulrich/0000-0001-9041-4562; Buccola, Nancy/0000-0003-1378-4636; Buxbaum, Joseph/0000-0001-8898-8313; Freedman, Robert/0000-0002-2181-2898; van der Luijt, Rob/0000-0002-0018-1089; Kelly, Brian/0000-0003-4460-1134; Walters, James/0000-0002-6980-4053; Klovins, Janis/0000-0001-8362-5505; Grove, Jakob/0000-0003-2284-5744; Dinan, Timothy/0000-0002-2316-7220; Curtis, David/0000-0002-4089-9183; Roth, Rebecca/0000-0002-2841-4921; Bruggeman, Richard/0000-0002-3238-8471; Borglum, Anders/0000-0001-8627-7219; Myin-Germeys, Inez/0000-0002-3731-4930; Scott, Rodney/0000-0001-7724-3404; Suvisaari, Jaana/0000-0001-7167-0990; Milovancevic, Milos/0000-0002-7891-1010; Legge, Sophie/0000-0001-6617-0289; Gill, Michael/0000-0003-0206-5337; Escott-Price, Valentina/0000-0003-1784-5483; Mowry, Bryan/0000-0002-4115-5645; Waisfisz, Quinten/0000-0002-7384-9182; Kirov, George/0000-0002-3427-3950; ripke, stephan/0000-0003-3622-835X; Black, Donald/0000-0001-8038-1971; Pocklington, Andrew/0000-0002-2137-0452; Sim, Kang/0000-0003-3209-9626; Perkins, Diana/0000-0001-9396-2206; IWATA, Nakao/0000-0003-3189-6076; Chen, Eric/0000-0002-5247-3593; Patsopoulos, Nikolaos/0000-0003-3757-8941; dos Santos Silva, Isabel/0000-0002-6596-8798; Ptackova, Hana/0000-0002-5694-3695; Makalic, Enes/0000-0003-3017-0871; /0000-0002-8114-7615; Turnbull, Clare/0000-0002-1734-5772; Franke, Lude/0000-0002-5159-8802; Ehrenreich, Hannelore/0000-0001-8371-5711; Lund, Eiliv/0000-0002-8071-8711; Murphy, Kieran/0000-0003-2930-4465; Bacanu, Silviu-Alin/0000-0002-4364-1583; Sigurdsson, Engilbert/0000-0001-9404-7982; Papiol, Sergi/0000-0001-9366-8728; Tooney, Paul/0000-0003-3745-4367; Canzian, Federico/0000-0002-4261-4583; Pers, Tune/0000-0003-0207-4831; Crowley, James/0000-0001-9051-1557; Adolfsson, Rolf/0000-0001-9785-8473; Joa, Inge/0000-0002-5516-2336; So, Hon-Cheong/0000-0002-7102-833X; Moran, Jennifer/0000-0002-5664-4716; Eliassen, A Heather/0000-0002-3961-6609; Demontis, Ditte/0000-0001-9124-2766; Quested, Digby/0000-0001-6155-3336; Golimbet, Vera/0000-0002-0114-4300; Julia Cano, Antonio/0000-0001-6064-3620; marsal, sara/0000-0001-5515-3854; Gopal, Srihari/0000-0001-5254-2192; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Donohoe, Gary/0000-0003-3037-7426; Baglietto, Laura/0000-0002-8193-7529; Posthuma, Danielle/0000-0001-7582-2365; Agartz, Ingrid/0000-0002-9839-5391; murray, robin/0000-0003-0829-0519; Pasaniuc, Bogdan/0000-0002-0227-2056; Petryshen, Tracey/0000-0002-7972-4612; Southey, Melissa/0000-0002-6313-9005; Mors, Ole/0000-0002-5660-0393; Corvin, Aiden/0000-0001-6717-4089	NIH [R01 GM105857, R03 CA173785, U19 CA148065-01]; Danish Council for Independent Research [DFF-1325-0014]; Fannie and John Hertz Foundation; Wellcome Trust [076113]; NATIONAL CANCER INSTITUTE [P01CA134294, R35CA197449, U19CA148065, R03CA173785] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL121295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, R01GM105857] Funding Source: NIH RePORTER; MRC [MR/L023784/2, G0801418] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MR/L010305/1, MR/L023784/2, G0801418, G0801418B] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Fannie and John Hertz Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Shamil Sunayev, Brendan Bulik-Sullivan, Liming Liang, Naomi Wray, Daniel Sorensen, and Esben Agerbo for useful discussions. We would also like to thank Toni Clarke for useful comments on the software. This research was supported by NIH grants R01 GM105857, R03 CA173785, and U19 CA148065-01. B.J.V. was supported by Danish Council for Independent Research grant DFF-1325-0014. H.K.F. was supported by the Fannie and John Hertz Foundation. This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) and the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the WTCCC data is available at www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113.	Abraham G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-88; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Chen CY, 2015, GENET EPIDEMIOL, V39, P427, DOI 10.1002/gepi.21906; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Finucane H.K., 2015, BIORXIV; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Golan D, 2014, AM J HUM GENET, V95, P383, DOI 10.1016/j.ajhg.2014.09.007; Grimmett G. R., 2001, PROBABILITY RANDOM P; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hastie T., 2009, SPRINGER, V2nd, DOI DOI 10.1007/978-0-387-21606-5; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Legarra A, 2008, J DAIRY SCI, V91, P360, DOI 10.3168/jds.2007-0403; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Logsdon BA, 2012, BIOINFORMATICS, V28, P1738, DOI 10.1093/bioinformatics/bts261; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Machiela MJ, 2011, GENET EPIDEMIOL, V35, P506, DOI 10.1002/gepi.20600; Maier R, 2015, AM J HUM GENET, V96, P283, DOI 10.1016/j.ajhg.2014.12.006; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Visscher PM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000628; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	64	595	602	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					576	592		10.1016/j.ajhg.2015.09.001	http://dx.doi.org/10.1016/j.ajhg.2015.09.001			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26430803	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000362617300008
J	Lee, S; Emond, MJ; Bamshad, MJ; Barnes, KC; Rieder, MJ; Nickerson, DA; Christiani, DC; Wurfel, MM; Lin, XH				Lee, Seunggeun; Emond, Mary J.; Bamshad, Michael J.; Barnes, Kathleen C.; Rieder, Mark J.; Nickerson, Deborah A.; Christiani, David C.; Wurfel, Mark M.; Lin, Xihong		NHLBI GO Exome Sequencing Project; ESP Lung Project Team	Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAIN-KINASE GENE; ACUTE LUNG INJURY; COMMON DISEASES; STRATEGIES; FRAMEWORK; RISK	We propose in this paper a unified approach for testing the association between rare variants and phenotypes in sequencing association studies. This approach maximizes power by adaptively using the data to optimally combine the burden test and the nonburden sequence kernel association test (SKAT). Burden tests are more powerful when most variants in a region are causal and the effects are in the same direction, whereas SKAT is more powerful when a large fraction of the variants in a region are noncausal or the effects of causal variants are in different directions. The proposed unified test maintains the power in both scenarios. We show that the unified test corresponds to the optimal test in an extended family of SKAT tests, which we refer to as SKAT-O. The second goal of this paper is to develop a small-sample adjustment procedure for the proposed methods for the correction of conservative type I error rates of SKAT family tests when the trait of interest is dichotomous and the sample size is small. Both small-sample-adjusted SKAT and the optimal unified test (SKAT-O) are computationally efficient and can easily be applied to genome-wide sequencing association studies. We evaluate the finite sample performance of the proposed methods using extensive simulation studies and illustrate their application using the acute-lung-injury exome-sequencing data of the National Heart, Lung, and Blood Institute Exome Sequencing Project.	[Lee, Seunggeun; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Emond, Mary J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Barnes, Kathleen C.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA; [Bamshad, Michael J.; Rieder, Mark J.; Nickerson, Deborah A.] Univ Washington, Dept Genom Sci, Seattle, WA 98195 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wurfel, Mark M.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98104 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle	Lin, XH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 665 Huntington Ave, Boston, MA 02115 USA.	xlin@hsph.harvard.edu			Mary Beryl Patch Turnbull Scholar Program; NHLBI; NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926];  [R37 CA076404];  [PO1 CA134294];  [RC2 HL101779];  [R01HL060710];  [UC2HL102923]; NATIONAL CANCER INSTITUTE [R37CA076404, P01CA134294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102925, RC2HL102924, RC2HL102926, R01HL060710, RC2HL102923, UC2HL102923, RC2HL101779, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Mary Beryl Patch Turnbull Scholar Program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants R37 CA076404 and PO1 CA134294 (S.L. and XL.), RC2 HL101779 (D.C.C., S.L., XL., and M.M.W.), R01HL060710 (D.C.C.), and UC2HL102923 (M.J.B., K.C.B., M.J.E., and M.M.W.). K.C.B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The authors wish to acknowledge the support of the NHLBI and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO), and RC2 HL-102924 (Women's Health Initiative Sequencing Project [WHISP]). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Artigas A, 1998, AM J RESP CRIT CARE, V157, P1332, DOI 10.1164/ajrccm.157.4.ats2-98; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Davies R. B., 1980, APPLIED STATISTICS, V29, P323, DOI DOI 10.2307/2346911; Davison A.C., 1999, BOOTSTRAP METHODS TH; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Emond M.J., 2012, NAT GENET       0527; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Lee S, 2012, BIOSTATISTICS; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu H, 2009, COMPUT STAT DATA AN, V53, P853, DOI 10.1016/j.csda.2008.11.025; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012	37	591	603	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					224	237		10.1016/j.ajhg.2012.06.007	http://dx.doi.org/10.1016/j.ajhg.2012.06.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22863193	Green Published, Bronze			2022-12-18	WOS:000307608700002
J	Brinkmann, B; Klintschar, M; Neuhuber, F; Huhne, J; Rolf, B				Brinkmann, B; Klintschar, M; Neuhuber, F; Huhne, J; Rolf, B			Mutation rate in human microsatellites: Influence of the structure and length of the tandem repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; LOCUS; POLYMORPHISM; DNA; SEQUENCES; EVOLUTION; ACTBP2; CELLS; STRS	In 10,844 parent/child allelic transfers at nine short-tandem-repeat (STR) loci, 23 isolated STR mismatches were observed. The parenthood in each of these cases was highly validated (probability >99.97%). The event was always repeal related, owing to either a single-step mutation (n = 22) or a double-step mutation (n = 1). The mutation rate was between 0 and 7 x 10(-3) per locus per gamete per generation. No mutations were observed in three of the nine Loci. Mutation events in the male germ line were five to six times more frequent than in the female germ line. A positive exponential correlation between the geometric mean of the number of uninterrupted repeats and the mutation rate was observed. Our data demonstrate that mutation rates of different loci can differ by several orders of magnitude and that different alleles at one locus exhibit different mutation rates.	Univ Munster, Inst Rechtsmed, D-48129 Munster, Germany; Gerichtlich Med Inst, Graz, Austria; Inst Gerichtliche Med, Salzburg, Austria	University of Munster	Brinkmann, B (corresponding author), Univ Munster, Inst Rechtsmed, von Esmarch Str 62, D-48129 Munster, Germany.		Schneider, Peter M./A-6661-2011					ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; ALPER B, 1995, INT J LEGAL MED, V108, P93, DOI 10.1007/BF01369912; Barber MD, 1996, INT J LEGAL MED, V108, P180, DOI 10.1007/BF01369788; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brinkmann B, 1996, EUR J HUM GENET, V4, P175; Brinkmann B, 1998, HUM MUTAT, V11, P135, DOI 10.1002/(SICI)1098-1004(1998)11:2<135::AID-HUMU6>3.3.CO;2-L; Brinkmann B, 1996, HUM GENET, V98, P60, DOI 10.1007/s004390050160; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; EDWARDS A, 1991, AM J HUM GENET, V49, P746; EDWARDS MC, 1991, NUCLEIC ACIDS RES, V19, P4791, DOI 10.1093/nar/19.17.4791-a; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; EVBETT IW, 1997, INT J LEGAL MED, V110, P5; Fimmers R, 1992, ADV FORENSIC HAEMOGE, V4, P285; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; Klintschar M, 1998, INT J LEGAL MED, V111, P107, DOI 10.1007/s004140050128; KODAIRA M, 1995, AM J HUM GENET, V57, P1275; Lareu MV, 1996, INT J LEGAL MED, V109, P134, DOI 10.1007/BF01369673; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MEYER E, 1995, INT J LEGAL MED, V107, P314, DOI 10.1007/BF01246881; MEYER E, 1995, J MOL EVOL, V41, P10; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLLER A, 1994, INT J LEGAL MED, V106, P319, DOI 10.1007/BF01224779; MOLLER A, 1994, INT J LEGAL MED, V106, P262, DOI 10.1007/BF01225417; NISHIMURA DY, 1992, NUCLEIC ACIDS RES, V20, P1167, DOI 10.1093/nar/20.5.1167; Petes TD, 1997, GENETICS, V146, P491; POLYMEROPOULOS MH, 1992, NUCLEIC ACIDS RES, V20, P1432, DOI 10.1093/nar/20.6.1432; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018-a; Richards RI, 1996, HUM MUTAT, V8, P1; Rolf B, 1997, INT J LEGAL MED, V110, P69, DOI 10.1007/s004140050033; Rolf B., 1997, RECHTSMEDIZIN, V7, P157; SHARMA V, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67-a; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Shriver MD, 1997, AM J HUM GENET, V60, P957; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; VALDES AM, 1993, GENETICS, V133, P737; Vogel F., 1997, HUMAN GENETICS PROBL; WAYE JS, 1989, BIOTECHNIQUES, V7, P852; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WIEGAND P, 1993, INT J LEGAL MED, V105, P315, DOI 10.1007/BF01222114; Wierdl M, 1997, GENETICS, V146, P769	46	590	645	0	26	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1408	1415		10.1086/301869	http://dx.doi.org/10.1086/301869			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585597	Green Published, Bronze			2022-12-18	WOS:000074174700017
J	Zimprich, A; Benet-Pages, A; Struhal, W; Graf, E; Eck, SH; Offman, MN; Haubenberger, D; Spielberger, S; Schulte, EC; Lichtner, P; Rossle, SC; Klopp, N; Wolf, E; Seppi, K; Pirker, W; Presslauer, S; Mollenhauer, B; Katzenschlager, R; Foki, T; Hotzy, C; Reinthaler, E; Harutyunyan, A; Kralovics, R; Peters, A; Zimprich, F; Bruecke, T; Poewe, W; Auff, E; Trenkwalder, C; Rost, B; Ransmayr, G; Winkelmann, J; Meitinger, T; Strom, TM				Zimprich, Alexander; Benet-Pages, Anna; Struhal, Walter; Graf, Elisabeth; Eck, Sebastian H.; Offman, Marc N.; Haubenberger, Dietrich; Spielberger, Sabine; Schulte, Eva C.; Lichtner, Peter; Rossle, Shaila C.; Klopp, Norman; Wolf, Elisabeth; Seppi, Klaus; Pirker, Walter; Presslauer, Stefan; Mollenhauer, Brit; Katzenschlager, Regina; Foki, Thomas; Hotzy, Christoph; Reinthaler, Eva; Harutyunyan, Ashot; Kralovics, Robert; Peters, Annette; Zimprich, Fritz; Bruecke, Thomas; Poewe, Werner; Auff, Eduard; Trenkwalder, Claudia; Rost, Burkhard; Ransmayr, Gerhard; Winkelmann, Juliane; Meitinger, Thomas; Strom, Tim M.			A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON LRRK2 MUTATION; GENE; ASSOCIATION; ENDOSOMES; VARIANTS; SERVER; RISK	To identify rare causal variants in late-onset Parkinson disease (PD), we investigated an Austrian family with 16 affected individuals by exome sequencing. We found a missense mutation, c.1858G>A (p.Asp620Asn), in the VPS35 gene in all seven affected family members who are alive. By screening additional PI) cases, we saw the same variant cosegregating with the disease in an autosomal-dominant mode with high but incomplete penetrance in two further families with five and ten affected members, respectively. The mean age of onset in the affected individuals was 53 years. Genotyping showed that the shared haplotype extends across 65 kilobases around VPS35. Screening the entire VPS35 coding sequence in an additional 860 cases and 1014 controls revealed six further nonsynonymous missense variants. Three were only present in cases, two were only present in controls, and one was present in cases and controls. The familial mutation p.Asp620Asn and a further variant, c.1570C>T (p.Arg524Trp), detected in a sporadic PD case were predicted to be damaging by sequence-based and molecular-dynamics analyses. VPS35 is a component of the retromer complex and mediates retrograde transport between endosomes and the trans-Golgi network, and it has recently been found to be involved in Alzheimer disease.	[Zimprich, Alexander; Haubenberger, Dietrich; Pirker, Walter; Foki, Thomas; Hotzy, Christoph; Reinthaler, Eva; Zimprich, Fritz; Auff, Eduard] Med Univ Wien, Dept Neurol, A-1090 Vienna, Austria; [Benet-Pages, Anna; Graf, Elisabeth; Eck, Sebastian H.; Schulte, Eva C.; Lichtner, Peter; Winkelmann, Juliane; Meitinger, Thomas; Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Struhal, Walter; Ransmayr, Gerhard] Allgemeines Krankenhaus, Dept Neurol & Psychiat, A-4021 Linz, Austria; [Offman, Marc N.; Rossle, Shaila C.; Rost, Burkhard] Tech Univ Munich, Inst Bioinformat, D-85748 Garching, Germany; [Spielberger, Sabine; Wolf, Elisabeth; Seppi, Klaus; Poewe, Werner] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Schulte, Eva C.; Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, D-81675 Munich, Germany; [Klopp, Norman; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Presslauer, Stefan; Bruecke, Thomas] Wilhelminenspital Stadt Wien, Dept Neurol, A-1160 Vienna, Austria; [Mollenhauer, Brit; Trenkwalder, Claudia] Paracelsus Elena Klin, D-34128 Kassel, Germany; [Katzenschlager, Regina] Ost Donauspital, Dept Neurol, Sozialmed Zentrum, A-1220 Vienna, Austria; [Harutyunyan, Ashot; Kralovics, Robert] Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; [Trenkwalder, Claudia] Univ Gottingen, Dept Clin Neurophysiol, D-37079 Gottingen, Germany; [Winkelmann, Juliane; Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany	Medical University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kepler University Hospital; Technical University of Munich; Medical University of Innsbruck; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wilhelminenspital; Donauspital; Austrian Academy of Sciences; University of Gottingen; Technical University of Munich	Zimprich, A (corresponding author), Med Univ Wien, Dept Neurol, A-1090 Vienna, Austria.	alexander.zimprich@meduniwien.ac.at; timstrom@helmholtz-muenchen.de	Schulte, Eva C./AAT-2410-2021; Pirker, Walter/P-2966-2019; Zimprich, Fritz/W-1738-2017; Meitinger, Thomas/O-1318-2015; Zimprich, Fritz/O-1406-2019; Peters, Annette/A-6117-2011; Harutyunyan, Ashot S/M-3528-2014; Zimprich, Alexander/A-5232-2017; Mollenhauer, Brit/F-8863-2010; Trenkwalder, Claudia/ABD-6559-2021; Rost, Burkhard/A-1908-2016; Trenkwalder, Claudia/AHD-1232-2022	Zimprich, Fritz/0000-0002-6998-5480; Zimprich, Fritz/0000-0002-6998-5480; Peters, Annette/0000-0001-6645-0985; Harutyunyan, Ashot S/0000-0002-9050-9315; Zimprich, Alexander/0000-0002-1668-5177; Rost, Burkhard/0000-0003-0179-8424; Trenkwalder, Claudia/0000-0001-6407-1199; Foki, Thomas/0000-0002-1411-8048; Schulte, Eva Christina/0000-0003-3105-5672; Seppi, Klaus/0000-0001-6503-1455; Winkelmann, Juliane/0000-0003-2667-9691; Meitinger, Thomas/0000-0002-8838-8403; Haubenberger, Dietrich/0000-0002-6233-8168; Kralovics, Robert/0000-0002-6997-8539	German Ministry for Education and Research [01GR0804-4]; Helmholtz Zentrum Munchen; German Federal Ministry of Education and Research; State of Bavaria; German National Genome Research Network [NGFNplus: 01GS0823]; Munich Center of Health Sciences (MCHealth); Alexander von Humboldt Foundation	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German National Genome Research Network; Munich Center of Health Sciences (MCHealth); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank all patients and their families for participating in this study. We also thank C. Fischer and B. Schmick for technical assistance and S. Schmidegg, S. Hoedl, and M. Guger for clinical examination of family A. This work was supported by a grant from the German Ministry for Education and Research (01GR0804-4). The KORA study was financed by the Helmholtz Zentrum Munchen, the German Federal Ministry of Education and Research, the State of Bavaria, the German National Genome Research Network (NGFNplus: 01GS0823), and the Munich Center of Health Sciences (MCHealth) as part of LMUinnovativ. M.N.O., S.C.R., and B.R. were supported by the Alexander von Humboldt Foundation.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; [Anonymous], EXONPRIMER; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; BONIFATI V, 1995, CAN J NEUROL SCI, V22, P272, DOI 10.1017/S0317167100039469; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; Di Fonzo A, 2005, LANCET, V365, P412; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Johnson J, 2004, NEUROLOGY, V63, P554, DOI 10.1212/01.WNL.0000133401.09043.44; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	37	589	607	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					168	175		10.1016/j.ajhg.2011.06.008	http://dx.doi.org/10.1016/j.ajhg.2011.06.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763483	Bronze, Green Published			2022-12-18	WOS:000293041700016
J	Vilarino-Guell, C; Wider, C; Ross, OA; Dachsel, JC; Kachergus, JM; Lincoln, SJ; Soto-Ortolaza, AI; Cobb, SA; Wilhoite, GJ; Bacon, JA; Behrouz, B; Melrose, HL; Hentati, E; Puschmann, A; Evans, DM; Conibear, E; Wasserman, WW; Aasly, JO; Burkhard, PR; Djaldetti, R; Ghika, J; Hentati, F; Krygowska-Wajs, A; Lynch, T; Melamed, E; Rajput, A; Rajput, AH; Solida, A; Wu, RM; Uitti, RJ; Wszolek, ZK; Vingerhoets, F; Farrer, MJ				Vilarino-Gueell, Carles; Wider, Christian; Ross, Owen A.; Dachsel, Justus C.; Kachergus, Jennifer M.; Lincoln, Sarah J.; Soto-Ortolaza, Alexandra I.; Cobb, Stephanie A.; Wilhoite, Greggory J.; Bacon, Justin A.; Behrouz, Bahareh; Melrose, Heather L.; Hentati, Emna; Puschmann, Andreas; Evans, Daniel M.; Conibear, Elizabeth; Wasserman, Wyeth W.; Aasly, Jan O.; Burkhard, Pierre R.; Djaldetti, Ruth; Ghika, Joseph; Hentati, Faycal; Krygowska-Wajs, Anna; Lynch, Tim; Melamed, Eldad; Rajput, Alex; Rajput, Ali H.; Solida, Alessandra; Wu, Ruey-Meei; Uitti, Ryan J.; Wszolek, Zbigniew K.; Vingerhoets, Francois; Farrer, Matthew J.			VPS35 Mutations in Parkinson Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETROMER; ASSOCIATION; COMPLEX; VARIANTS; RAB7	The identification of genetic causes for Mendelian disorders has been based on the collection of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals. This study describes the application of next-generation sequencing technologies to a Swiss kindred presenting with autosomal-dominant, late-onset Parkinson disease (PD). The family has tremor-predominant dopa-responsive parkinsonism with a mean onset of 50.6 +/- 7.3 years. Exome analysis suggests that an aspartic-acid-to-asparagine mutation within vacuolar protein sorting 35 (VPS35 c.1858G>A; p.Asp620Asn) is the genetic determinant of disease. VPS35 is a central component of the retromer cargo-recognition complex, is critical for endosome-trans-golgi trafficking and membrane-protein recycling, and is evolutionarily highly conserved. VPS35 c.1858G>A was found in all affected members of the Swiss kindred and in three more families and one patient with sporadic PD, but it was not observed in 3,309 controls. Further sequencing of familial affected probands revealed only one other missense variant, VPS35 c.946C>T; (p.Pro316Ser), in a pedigree with one unaffected and two affected carriers, and thus the pathogenicity of this mutation remains uncertain. Retromer-mediated sorting and transport is best characterized for acid hydrolase receptors. However, the complex has many types of cargo and is involved in a diverse array of biologic pathways from developmental Wnt signaling to lysosome biogenesis. Our study implicates disruption of VPS35 and retromer-mediated trans-membrane protein sorting, rescue, and recycling in the neurodegenerative process leading to PD.	[Vilarino-Gueell, Carles; Evans, Daniel M.; Conibear, Elizabeth; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Wider, Christian; Ghika, Joseph; Solida, Alessandra; Vingerhoets, Francois] CHU Vaudois, Dept Neurol, CH-1011 Lausanne, Switzerland; [Ross, Owen A.; Dachsel, Justus C.; Kachergus, Jennifer M.; Lincoln, Sarah J.; Soto-Ortolaza, Alexandra I.; Cobb, Stephanie A.; Wilhoite, Greggory J.; Bacon, Justin A.; Behrouz, Bahareh; Melrose, Heather L.; Hentati, Emna; Puschmann, Andreas; Farrer, Matthew J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Puschmann, Andreas] Lund Univ, Sect Geriatr Psychiat, Dept Clin Sci, S-22100 Lund, Sweden; [Aasly, Jan O.] St Olavs Hosp, Dept Neurol, N-7006 Trondheim, Norway; [Burkhard, Pierre R.] Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland; [Burkhard, Pierre R.] Fac Med, CH-1211 Geneva, Switzerland; [Djaldetti, Ruth; Melamed, Eldad] Tel Aviv Univ, Rabin Med Ctr, Dept Neurol, Movement Disorders Units, IL-49100 Tel Aviv, Israel; [Hentati, Faycal] Inst Natl Neurol, Serv Neurol, Tunis 1007, Tunisia; [Krygowska-Wajs, Anna] Jagiellonian Univ, Coll Med, Dept Neurol, PL-31358 Krakow, Poland; [Lynch, Tim] Mater Misericordiae Univ Hosp, Dublin Neurol Inst, Dublin 7, Ireland; [Lynch, Tim] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Rajput, Alex; Rajput, Ali H.] Univ Saskatchewan, Div Neurol, Saskatoon, SK S7N 0W8, Canada; [Rajput, Alex; Rajput, Ali H.] Saskatoon Hlth Reg, Saskatoon, SK S7N 0W8, Canada; [Wu, Ruey-Meei] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10617, Taiwan; [Uitti, Ryan J.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	University of British Columbia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Mayo Clinic; Lund University; Norwegian University of Science & Technology (NTNU); University of Geneva; University of Geneva; Rabin Medical Center; Tel Aviv University; Universite de Tunis-El-Manar; Institut National de Neurologie; Jagiellonian University; Collegium Medicum Jagiellonian University; Mater Misericordiae University Hospital; University College Dublin; University College Dublin; University of Saskatchewan; University of Saskatchewan; National Taiwan University; National Taiwan University Hospital; Mayo Clinic	Vilarino-Guell, C (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada.	carles@can.ubc.ca	Wszolek, Zbigniew K./AAB-1431-2019; Ross, Owen/D-7573-2013; Vilarino-Guell, Carles/D-8628-2011; Wasserman, Wyeth/I-4866-2015; Lynch, Timothy/M-1316-2019; Conibear, Elizabeth/G-5297-2010	Vilarino-Guell, Carles/0000-0002-5612-5940; Wu, Ruey-Meei/0000-0002-4947-5467; Puschmann, Andreas/0000-0002-3201-8198; Wasserman, Wyeth/0000-0001-6098-6412; Conibear, Elizabeth/0000-0001-5129-0499; Ross, Owen/0000-0003-4813-756X; Farrer, Matthew/0000-0003-1159-5321	Parkinson Disease Foundation; National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS/NIH) [P50NS040256]; Swiss Parkinson's Disease Foundation; Michael J. Fox Foundation; NINDS/NIH [P50NS072187]; Canada Excellence Research Chairs program; Province of British Columbia; LifeLabs; Genome BC; Medical Research Council [G0600705, G0800582] Funding Source: researchfish; MRC [G0800582, G0600705] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, P50NS040256] Funding Source: NIH RePORTER	Parkinson Disease Foundation; National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss Parkinson's Disease Foundation; Michael J. Fox Foundation; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Excellence Research Chairs program(Canada Research Chairs); Province of British Columbia; LifeLabs; Genome BC; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all individuals who generously participated in this study. We thank the Greenberg family for their 2011 AD/PD Conference Award generously donated by Evelyn Greenberg, in memory of Moshe Greenberg. C.V.-G. and exome sequencing were financed by the Parkinson Disease Foundation. Additional funding for clinical, genetic, and functional studies was provided by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS/NIH) (Morris K. Udall Parkinson's Disease Research Center of Excellence; P50NS040256), the Swiss Parkinson's Disease Foundation, and the Michael J. Fox Foundation. Z.K.W. was partially supported by NINDS/NIH grant P50NS072187 and a gift from Carl Edward Bolch, Jr., and Susan Bass Bolch (MCF #90052031/PAU #90052). This research was undertaken, in part, thanks to funding from the Canada Excellence Research Chairs program (to M.J.F. and C.V.-G.). Leading Edge Endowment Funds provided by the Province of British Columbia, LifeLabs, and Genome BC support the Dr. Donald Rix BC Leadership Chair (M.J.F.).	[Anonymous], DBGAP; [Anonymous], DBSNP; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Dachsel JC, 2010, PARKINSONISM RELAT D, V16, P650, DOI 10.1016/j.parkreldis.2010.08.018; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; McDonnell SK, 2006, ANN NEUROL, V59, P788, DOI 10.1002/ana.20844; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Ross OA, 2008, PARKINSONISM RELAT D, V14, P539, DOI 10.1016/j.parkreldis.2008.08.003; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Wider C, 2008, PARKINSONISM RELAT D, V14, P465, DOI 10.1016/j.parkreldis.2007.11.013; DATABASE GENOMIC VAR	27	582	595	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					162	167		10.1016/j.ajhg.2011.06.001	http://dx.doi.org/10.1016/j.ajhg.2011.06.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763482	Green Published, Bronze			2022-12-18	WOS:000293041700015
J	Alarcon, M; Abrahams, BS; Stone, JL; Duvall, JA; Perederiy, JV; Bomar, JM; Sebat, J; Wigler, M; Martin, CL; Ledbetter, DH; Nelson, SE; Cantor, RM; Geschwind, DH				Alarcon, Maricela; Abrahams, Brett S.; Stone, Jennifer L.; Duvall, Jacqueline A.; Perederiy, Julia V.; Bomar, Jamee M.; Sebat, Jonathan; Wigler, Michael; Martin, Christa L.; Ledbetter, David H.; Nelson, Stanley E.; Cantor, Rita M.; Geschwind, Daniel H.			Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; JOINT ATTENTION; FRONTAL-CORTEX; LANGUAGE; BRAIN; SEX; POLYMORPHISM; REPLICATION; DISORDER; NEUREXIN	Autism is a genetically complex neurodevelopmental syndrome in which language deficits are a core feature. We describe results from two complimentary approaches used to identify risk variants on chromosome 7 that likely contribute to the etiology of autism. A two-stage association study tested 2758 SNPs across a 10 Mb 7q35 language-related autism QTL in AGRE (Autism Genetic Resource Exchange) trios(1,2) and found significant association with Contactin Associated Protein-Like 2 (CNTNAP2), a strong a priori candidate. Male-only containing families were identified as primarily responsible for this association signal, consistent with the strong male affection bias in ASD and other language-based disorders. Gene-expression analyses in developing human brain further identified CATTNAP2 as enriched in circuits important for language development. Together, these results provide convergent evidence for involvement of CNTNAP2, a Neurexin family member, in autism, and demonstrate a connection between genetic risk for autism and specific brain structures.	[Alarcon, Maricela; Duvall, Jacqueline A.; Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ctr Autism Res & Treatment, Semel Inst Neurosci, Los Angeles, CA 90095 USA; [Alarcon, Maricela; Abrahams, Brett S.; Duvall, Jacqueline A.; Perederiy, Julia V.; Bomar, Jamee M.; Nelson, Stanley E.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Stone, Jennifer L.; Duvall, Jacqueline A.; Nelson, Stanley E.; Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cantor, Rita M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Sebat, Jonathan; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Martin, Christa L.; Ledbetter, David H.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cold Spring Harbor Laboratory; Emory University	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ctr Autism Res & Treatment, Semel Inst Neurosci, Los Angeles, CA 90095 USA.	dhg@ucla.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Sebat, Jonathan/0000-0002-9087-526X; Wigler, Michael/0000-0003-4396-1971	NIMH NIH HHS [R01 MH064547, R01 MH076431, R01 MH64547] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH076431] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Bailey A, 1998, HUM MOL GENET, V7, P571; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett S, 1999, AM J MED GENET, V88, P609; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Dawson G, 2002, DEV PSYCHOPATHOL, V14, P581, DOI 10.1017/S0954579402003103; Duvall JA, 2007, AM J PSYCHIAT, V164, P656, DOI 10.1176/appi.ajp.164.4.656; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Lee S, 2004, BIOINFORMATICS, V20, P581, DOI 10.1093/bioinformatics/btg458; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LOVELAND KA, 1986, J AUTISM DEV DISORD, V16, P335, DOI 10.1007/BF01531663; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; Oliphant A, 2002, BIOTECHNIQUES, P56; Palferman S, 2001, AM J HUM GENET, V69, P570; Paterson SJ, 2006, NEUROSCI BIOBEHAV R, V30, P1087, DOI 10.1016/j.neubiorev.2006.05.001; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Piven J, 1997, J CHILD PSYCHOL PSYC, V38, P1011, DOI 10.1111/j.1469-7610.1997.tb01618.x; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; Scherer SW, 2004, HUM MOL GENET, V13, pR303, DOI 10.1093/hmg/ddh231; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Song YS, 2007, THEOR POPUL BIOL, V71, P49, DOI 10.1016/j.tpb.2006.09.001; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Viding E, 2004, J CHILD PSYCHOL PSYC, V45, P315, DOI 10.1111/j.1469-7610.2004.00223.x; Walt DR, 2000, SCIENCE, V287, P451, DOI 10.1126/science.287.5452.451; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Weir B., 1996, GENETIC DATA ANAL; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; [No title captured], DOI DOI 10.1002/AJPA.10171	64	582	605	3	186	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					150	159		10.1016/j.ajhg.2007.09.005	http://dx.doi.org/10.1016/j.ajhg.2007.09.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179893	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000253223800015
J	Martin, AR; Gignoux, CR; Walters, RK; Wojcik, GL; Neale, BM; Gravel, S; Daly, MJ; Bustamante, CD; Kenny, EE				Martin, Alicia R.; Gignoux, Christopher R.; Walters, Raymond K.; Wojcik, Genevieve L.; Neale, Benjamin M.; Gravel, Simon; Daly, Mark J.; Bustamante, Carlos D.; Kenny, Eimear E.			Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES SUSCEPTIBILITY; AFRICAN-ANCESTRY; LOCAL-ANCESTRY; BREAST-CANCER; HISPANIC/LATINO POPULATIONS; POLYGENIC INHERITANCE; POSITIVE SELECTION; INCREASES ACCURACY; CODING VARIATION	The vast majority of genome-wide association studies (GWASs) are performed in Europeans, and their transferability to other populations is dependent on many factors (e.g., linkage disequilibrium, allele frequencies, genetic architecture). As medical genomics studies become increasingly large and diverse, gaining insights into population history and consequently the transferability of disease risk measurement is critical. Here, we disentangle recent population history in the widely used 1000 Genomes Project reference panel, with an emphasis on populations underrepresented in medical studies. To examine the transferability of single-ancestry GWASs, we used published summary statistics to calculate polygenic risk scores for eight well-studied phenotypes. We identify directional inconsistencies in all scores; for example, height is predicted to decrease with genetic distance from Europeans, despite robust anthropological evidence that West Africans are as tall as Europeans on average. To gain deeper quantitative insights into GWAS transferability, we developed a complex trait coalescent-based simulation framework considering effects of polygenicity, causal allele frequency divergence, and heritability. As expected, correlations between true and inferred risk are typically highest in the population from which summary statistics were derived. We demonstrate that scores inferred from European GWASs are biased by genetic drift in other populations even when choosing the same causal variants and that biases in any direction are possible and unpredictable. This work cautions that summarizing findings from large-scale GWASs may have limited portability to other populations using standard approaches and highlights the need for generalized risk prediction methods and the inclusion of more diverse individuals in medical genomics.	[Martin, Alicia R.; Walters, Raymond K.; Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Martin, Alicia R.; Walters, Raymond K.; Neale, Benjamin M.; Daly, Mark J.] Harvard Med Sch, Boston, MA 02114 USA; [Martin, Alicia R.; Walters, Raymond K.; Neale, Benjamin M.; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Martin, Alicia R.; Walters, Raymond K.; Neale, Benjamin M.; Daly, Mark J.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Martin, Alicia R.; Gignoux, Christopher R.; Wojcik, Genevieve L.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Gravel, Simon] McGill Univ, Dept Human Genet, Montreal H3A 0G1, PQ, Canada; [Gravel, Simon] McGill Univ, Montreal H3A 0G1, PQ, Canada; [Gravel, Simon] Genome Quebec Innovat Ctr, Montreal H3A 0G1, PQ, Canada; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; McGill University; McGill University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, York, NY 10029 USA.; Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA.; Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.	eimear.kenny@mssm.edu	Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Martin, Alicia/0000-0003-0241-3522; Bustamante, Carlos D./0000-0002-4187-7920	National Human Genome Research Institute [U01HG009080, U01HG007419, U01HG007417, U01HG005208, T32HG000044, R01GM083606]; National Institute of General Medical Sciences [T32GM007790]; National Institute of Health, the National Institute for Mental Health [5U01MH094432-02]; Directorate of Mathematical and Physical Sciences award at the National Science Foundation [1201234]; Canadian Institutes of Health Research through Canada Research Chair program; Sloan Research Fellowship;  [MOP-136855]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007419, U01HG007417, U01HG005208, T32HG000044, U01HG009080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606, T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH094432] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health, the National Institute for Mental Health; Directorate of Mathematical and Physical Sciences award at the National Science Foundation; Canadian Institutes of Health Research through Canada Research Chair program; Sloan Research Fellowship(Alfred P. Sloan Foundation); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Suyash Shringarpure, Brian Maples, Andres MorenoEstrada, Danny Park, Noah Zaitlen, Alexander Gusev, and Alkes Price for helpful discussions/feedback. We thank Verneri Antilla for providingGWAS summary statistics. We thank Jerome Kelleher for several conversations about msprime, providing example scripts, and implementing new simulation capabilities. This work was supported by funds from several grants: the National Human Genome Research Institute under award numbers U01HG009080 (E.E.K., C.D.B., C.R.G.), U01HG007419 (C.D.B., C.R.G., G.L.W.), U01HG007417 (E.E.K.), U01HG005208 (M.J.D.), T32HG000044 (C.R.G.), and R01GM083606 (C.D.B.), the National Institute of General Medical Sciences under award number T32GM007790 (A.R.M.) at the National Institute of Health, the National Institute for Mental Health 5U01MH094432-02 (R.G.W., M.J.D.), the Directorate of Mathematical and Physical Sciences award 1201234 (S.G., C.D.B.) at the National Science Foundation, the Canadian Institutes of Health Research through the Canada Research Chair program and operating grant MOP-136855 (S.G.), and a Sloan Research Fellowship (S.G.).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baharian S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006059; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chan YL, 2014, AM J HUM GENET, V94, P437, DOI 10.1016/j.ajhg.2014.02.006; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Chen H, 2015, THEOR POPUL BIOL, V99, P18, DOI 10.1016/j.tpb.2014.11.001; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; de Candia TR, 2013, AM J HUM GENET, V93, P463, DOI 10.1016/j.ajhg.2013.07.007; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Dudbridge F, 2016, GENET EPIDEMIOL, V40, P268, DOI 10.1002/gepi.21966; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fejerman L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6260; Fejerman L, 2012, HUM MOL GENET, V21, P1907, DOI 10.1093/hmg/ddr617; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Fu WQ, 2014, AM J HUM GENET, V95, P421, DOI 10.1016/j.ajhg.2014.09.006; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Genovese G, 2013, AM J HUM GENET, V93, P411, DOI 10.1016/j.ajhg.2013.07.002; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gustafsson A, 2004, J HUM EVOL, V47, P253, DOI 10.1016/j.jhevol.2004.07.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Kessler MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12521; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li YR, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0091-5; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maier R, 2015, AM J HUM GENET, V96, P283, DOI 10.1016/j.ajhg.2014.12.006; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; Mathieson I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004528; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; O'Connor TD, 2015, MOL BIOL EVOL, V32, P653, DOI 10.1093/molbev/msu326; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Petrovski S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1016-y; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Scutari M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006288; Shi JX, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006493; Shringarpure S.S., 2016, BIORXIV; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; So HC, 2017, BIOINFORMATICS, V33, P886, DOI 10.1093/bioinformatics/btw745; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Szulc P., 2016, BIORXIV; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141	96	579	580	4	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					635	649		10.1016/j.ajhg.2017.03.004	http://dx.doi.org/10.1016/j.ajhg.2017.03.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	EQ9FK	28366442	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000398389600006
J	Gonzalez-Perez, A; Lopez-Bigas, N				Gonzalez-Perez, Abel; Lopez-Bigas, Nuria			Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN FUNCTION; MUTATIONS; SEQUENCE; CANCER; CONSTRAINT; ANNOTATION; JIGSAW; SIFT; TOOL	Several large ongoing initiatives that profit from next-generation sequencing technologies have driven and in coming years will continue to drive the emergence of long catalogs of missense single-nucleotide variants (SNVs) in the human genome. As a consequence, researchers have developed various methods and their related computational tools to classify these missense SNVs as probably deleterious or probably neutral polymorphisms. The outputs produced by each of these computational tools are of different natures and thus difficult to compare and integrate. Taking advantage of the possible complementarity between different tools might allow more accurate classifications. Here we propose an effective approach to integrating the output of some of these tools into a unified classification; this approach is based on a weighted average of the normalized scores of the individual methods (WAS). (In this paper, the approach is illustrated for the integration of five tools.) We show that this WAS outperforms each individual method in the task of classifying missense SNVs as deleterious or neutral. Furthermore, we demonstrate that this WAS can be used not only for classification purposes (deleterious versus neutral mutation) but also as an indicator of the impact of the mutation on the functionality of the mutant protein. In other words, it may be used as a deleteriousness score of missense SNVs. Therefore, we recommend the use of this WAS as a consensus deleteriousness score of missense mutations (Condel).	[Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Res Programme Biomed Informat, E-08003 Barcelona, Spain	Pompeu Fabra University	Gonzalez-Perez, A (corresponding author), Univ Pompeu Fabra, Res Programme Biomed Informat, Parc Recerca Biomed Barcelona,C Dr Aiguader 88, E-08003 Barcelona, Spain.	abel.gonzalez@upf.edu; nuria.lopez@upf.edu	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	Lopez-Bigas, Nuria/0000-0003-4925-8988; Gonzalez-Perez, Abel/0000-0002-8582-4660	Spanish Ministerio de Educacion y Ciencia [SAF2009-06954]; Spanish National Institute of Bioinformatics (INB)	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Spanish National Institute of Bioinformatics (INB)	We would like to thank Xavier Rafael, Sophia Derdak and the useful suggestions and feedback provided by anonymous reviewers, and Jordi Deu-Pons for maintenance of condel website. We acknowledge funding from the Spanish Ministerio de Educacion y Ciencia, grant number SAF2009-06954 and the Spanish National Institute of Bioinformatics (INB).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen JE, 2005, BIOINFORMATICS, V21, P3596, DOI 10.1093/bioinformatics/bti609; Allen JE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s9; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Brazdova M, 2002, NUCLEIC ACIDS RES, V30, P4966, DOI 10.1093/nar/gkf616; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Coghlan A, 2007, BIOINFORMATICS, V23, P1468, DOI 10.1093/bioinformatics/btm133; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Olivier M, 2009, CANCER GENE THER, V16, P1, DOI 10.1038/cgt.2008.69; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107	37	577	586	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					440	449		10.1016/j.ajhg.2011.03.004	http://dx.doi.org/10.1016/j.ajhg.2011.03.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21457909	Green Published, Bronze			2022-12-18	WOS:000289664300004
J	Mill, J; Tang, T; Kaminsky, Z; Khare, T; Yazdanpanah, S; Bouchard, L; Jia, P; Assadzadeh, A; Flanagan, J; Schumacher, A; Wang, SC; Petronis, A				Mill, Jonathan; Tang, Thomas; Kaminsky, Zachary; Khare, Tarang; Yazdanpanah, Simin; Bouchard, Luigi; Jia, Peixin; Assadzadeh, Abbas; Flanagan, James; Schumacher, Axel; Wang, Sun-Chong; Petronis, Arturas			Epigenomic profiling reveals DNA-Methylation changes associated with major psychosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR DISORDER; MESSENGER-RNA; INCREASED EXPRESSION; EPIGENETIC VARIATION; GENDER-DIFFERENCES; PREFRONTAL CORTEX; SCHIZOPHRENIA; PROMOTER; GENE; BRAIN	Epigenetic misregulation is consistent with various non-Mendelian features of schizophrenia and bipolar disorder. To date, however, few studies have investigated the role of DNA methylation in major psychosis, and none have taken a genome-wide epigenomic approach. In this study we used CpG-island microarrays to identify DNA-methylation changes in the frontal cortex and germline associated with schizophrenia and bipolar disorder. In the frontal cortex we find evidence for psychosis-associated DNA-methylation differences in numerous loci, including several involved in glutamatergic and GABAergic neurotransmission, brain development, and other processes functionally linked to disease etiology. DNA-methylation changes in a significant proportion of these loci correspond to reported changes of steady-state mRNA level associated with psychosis. Gene-ontology analysis highlighted epigenetic disruption to loci involved in mitochondrial function, brain development, and stress response. Methylome network analysis uncovered decreased epigenetic modularity in both the brain and the germline of affected individuals, suggesting that systemic epigenetic dysfunction may be associated with major psychosis. We also report evidence for a strong correlation between DNA methylation in the MEK1 gene promoter region and lifetime antipsychotic use in schizophrenia patients. Finally, we observe that frontal-cortex DNA methylation in the BDNF gene is correlated with genotype at a nearby nonsynonymous SNP that has been previously associated with major psychosis. Our data are consistent with the epigenetic theory of major psychosis and suggest that DNA-methylation changes are important to the etiology of schizophrenia and bipolar disorder.	[Mill, Jonathan; Tang, Thomas; Kaminsky, Zachary; Khare, Tarang; Yazdanpanah, Simin; Bouchard, Luigi; Jia, Peixin; Assadzadeh, Abbas; Flanagan, James; Schumacher, Axel; Wang, Sun-Chong; Petronis, Arturas] Ctr Addict & Mental Hlth, Krembil Family Epigenet lab, Toronto, ON M5T 1R8, Canada; [Mill, Jonathan] Kings Coll London, Inst Psychiat, SGDP Res Ctr, London SE5 8AF, England; [Bouchard, Luigi] Univ Laval, Lipid Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Bouchard, Luigi] Univ Laval, Laval Univ Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Flanagan, James] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Schumacher, Axel] Tech Univ Munich, D-80333 Munich, Germany; [Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli 32001, Taiwan	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of London; King's College London; Laval University; Laval University; University of London; University College London; Technical University of Munich; National Central University	Petronis, A (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet lab, 250 Coll St, Toronto, ON M5T 1R8, Canada.	arturas_petronis@camh.net	Schumacher, Axel/C-6612-2008; Mill, Jonathan S/B-3276-2010; Petronis, Art/AAD-4491-2019; Mill, Jonathan/B-5678-2014	Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Flanagan, James/0000-0003-4955-1383; Doyon, Myriam/0000-0001-9787-7367	NIMH NIH HHS [R01 MH088413, R01 MH074127, R01 MH074127-01] Funding Source: Medline; Medical Research Council [G9817803B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088413, R01MH074127] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Arnold LM, 2003, PSYCHIAT CLIN N AM, V26, P595, DOI 10.1016/S0193-953X(03)00036-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning JL, 2005, BIOL PSYCHIAT, V57, P617, DOI 10.1016/j.biopsych.2004.12.002; Bruneau EG, 2005, SCHIZOPHR RES, V75, P27, DOI 10.1016/j.schres.2004.12.012; Couve A, 2004, J BIOL CHEM, V279, P13934, DOI 10.1074/jbc.M311737200; Cowled P, 2005, NEOPLASIA, V7, P1091, DOI 10.1593/neo.05364; Coyle JT, 2004, BIOCHEM PHARMACOL, V68, P1507, DOI 10.1016/j.bcp.2004.07.034; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; Dempster EL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-10; Eastwood SL, 2005, SCHIZOPHR RES, V73, P159, DOI 10.1016/j.schres.2004.05.010; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Gupta DS, 2005, SYNAPSE, V57, P123, DOI 10.1002/syn.20164; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; HORROBIN DF, 1994, SCHIZOPHR RES, V13, P195, DOI 10.1016/0920-9964(94)90043-4; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Jung HH, 2004, J CLIN PSYCHIAT, V65, P722; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; KLEMPNAUER KH, 1993, ONCOGENE, V8, P111; Kontkanen O, 2002, NEUROPSYCHOPHARMACOL, V27, P152, DOI 10.1016/S0893-133X(02)00289-0; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mann H, 2003, MOL CELL, V12, P925, DOI 10.1016/S1097-2765(03)00357-5; Marksteiner J, 2001, NEUROSCIENCE, V104, P325, DOI 10.1016/S0306-4522(01)00081-1; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; MCQUILLIN A, 2007, GENOMICS, V17, P605; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Petronis A, 2004, BIOL PSYCHIAT, V55, P965, DOI 10.1016/j.biopsych.2004.02.005; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; RIGGS AD, 1998, NOVART FDN SYMP, V214, P225; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; SALUZ HP, 1986, P NATL ACAD SCI USA, V83, P7167, DOI 10.1073/pnas.83.19.7167; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Smith RE, 2001, NEUROREPORT, V12, P2885, DOI 10.1097/00001756-200109170-00026; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Westhoff C M, 2004, Immunohematology, V20, P37; Xing GQ, 2006, SCHIZOPHR RES, V84, P36, DOI 10.1016/j.schres.2005.11.006; YOKOMORI N, 1995, P NATL ACAD SCI USA, V92, P1302, DOI 10.1073/pnas.92.5.1302	63	576	601	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					696	711		10.1016/j.ajhg.2008.01.008	http://dx.doi.org/10.1016/j.ajhg.2008.01.008			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319075	Bronze, Green Published			2022-12-18	WOS:000254067800014
J	Chen, YZ; Bennett, CL; Huynh, HM; Blair, IP; Puls, I; Irobi, J; Dierick, I; Abel, A; Kennerson, ML; Rabin, BA; Nicholson, GA; Auer-Grumbach, M; Wagner, K; De Jonghe, P; Griffin, JW; Fischbeck, KH; Timmerman, V; Cornblath, DR; Chance, PF				Chen, YZ; Bennett, CL; Huynh, HM; Blair, IP; Puls, I; Irobi, J; Dierick, I; Abel, A; Kennerson, ML; Rabin, BA; Nicholson, GA; Auer-Grumbach, M; Wagner, K; De Jonghe, P; Griffin, JW; Fischbeck, KH; Timmerman, V; Cornblath, DR; Chance, PF			DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 9Q34; MOTOR-NEURON; RNA HELICASE; PROTEIN; COMPLEX; ATAXIA; DISORDERS; SURVIVAL; ATROPHY; DECAY	Juvenile amyotrophic lateral sclerosis (ALS4) is a rare autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS) characterized by distal muscle weakness and atrophy, normal sensation, and pyramidal signs. Individuals affected with ALS4 usually have an onset of symptoms at age <25 years, a slow rate of progression, and a normal life span. The ALS4 locus maps to a 1.7-Mb interval on chromosome 9q34 flanked by D9S64 and D9S1198. To identify the molecular basis of ALS4, we tested 19 genes within the ALS4 interval and detected missense mutations (T3I, L389S, and R2136H) in the Senataxin gene (SETX). The SETX gene encodes a novel 302.8-kD protein. Although its function remains unknown, SETX contains a DNA/RNA helicase domain with strong homology to human RENT1 and IGHMBP2, two genes encoding proteins known to have roles in RNA processing. These observations of ALS4 suggest that mutations in SETX may cause neuronal degeneration through dysfunction of the helicase activity or other steps in RNA processing.	Univ Washington, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; NINDS, Neurogenet Branch, Bethesda, MD 20892 USA; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; Univ Sydney, ANZAC Res Inst, Neurobiol Lab, Sydney, NSW 2006, Australia; Concord Hosp, Sydney, NSW, Australia; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Karl Franzens Univ Graz, Inst Med Biol & Human Genet, Graz, Austria	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Johns Hopkins University; University of Graz	Chance, PF (corresponding author), Univ Washington, Dept Pediat, Div Genet & Dev Med, Box 356320,Room RR247, Seattle, WA 98195 USA.	pchance@u.washington.edu	Research Institute, ANZAC/CAE-9030-2022; Kennerson, Marina L/B-5058-2014; Chance, Phillip/AAX-5826-2020; Timmerman, Vincent/O-7283-2019	Timmerman, Vincent/0000-0002-2162-0933; Bennett, CRAIG/0000-0002-5847-1687; Blair, Ian/0000-0003-3083-0075; Kennerson, Marina/0000-0003-3332-5074; Nicholson, Garth/0000-0001-9694-066X	NINDS NIH HHS [NS42810, R01 NS042810] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974, ZIANS002974, R01NS042810] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blair IP, 2000, NEUROGENETICS, V3, P1; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; De Jonghe P, 2002, BRAIN, V125, P1320, DOI 10.1093/brain/awf127; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Majoor-Krakauer D, 2003, CLIN GENET, V63, P83, DOI 10.1046/j.0009-9163.2002.00001.x; Marra G, 2001, CANCER RES, V61, P7719; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Molnar GM, 1997, P NATL ACAD SCI USA, V94, P7831, DOI 10.1073/pnas.94.15.7831; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; MORRISON KE, 1994, BAILLIERE CLIN NEUR, V3, P431; MYRIANTHOPOULOS NC, 1964, BRAIN, V87, P589, DOI 10.1093/brain/87.4.589; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Rabin BA, 1999, BRAIN, V122, P1539, DOI 10.1093/brain/122.8.1539; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; STRONG MJ, 1991, CAN J NEUROL SCI, V18, P45, DOI 10.1017/S0317167100031280; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Valente EM, 2002, ANN NEUROL, V51, P681, DOI 10.1002/ana.10204; Watanabe M, 1998, ANN NEUROL, V44, P265, DOI 10.1002/ana.410440220; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	26	574	602	2	35	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1128	1135		10.1086/421054	http://dx.doi.org/10.1086/421054			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15106121	Green Published, Bronze			2022-12-18	WOS:000221651900006
J	TORRONI, A; SCHURR, TG; CABELL, MF; BROWN, MD; NEEL, JV; LARSEN, M; SMITH, DG; VULLO, CM; WALLACE, DC				TORRONI, A; SCHURR, TG; CABELL, MF; BROWN, MD; NEEL, JV; LARSEN, M; SMITH, DG; VULLO, CM; WALLACE, DC			ASIAN AFFINITIES AND CONTINENTAL RADIATION OF THE 4 FOUNDING NATIVE-AMERICAN MTDNAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; PAPUA-NEW-GUINEA; PRIVATE POLYMORPHISMS; GENETIC-VARIATION; LENGTH MUTATIONS; YANOMAMA INDIANS; AMERINDIAN TRIBE; POPULATION; MIGRATIONS	The mtDNA variation of 321 individuals from 17 Native American populations was examined by high-resolution restriction endonuclease analysis. All mtDNAs were amplified from a variety of sources by using PCR. The mtDNA of a subset of 38 of these individuals was also analyzed by D-loop sequencing. The resulting data were combined with previous mtDNA data from five other Native American tribes, as well as with data from a variety of Asian populations, and were used to deduce the phylogenetic relationships between mtDNAs and to estimate sequence divergences. This analysis revealed the presence of four haplotype groups (haplogroups A, B, C, and D) in the Amerind, but only one haplogroup (A) in the Na-Dene, and confirmed the independent origins of the Amerinds and the Na-Dene. Further, each haplogroup appeared to have been founded by a single mtDNA haplotype, a result which is consistent with a hypothesized founder effect. Most of the variation within haplogroups was tribal specific, that is, it occurred as tribal private polymorphisms. These observations suggest that the process of tribalization began early in the history of the Amerinds, with relatively little intertribal genetic exchange occurring subsequently. The sequencing of 341 nucleotides in the mtDNA D-loop revealed that the D-loop sequence variation correlated strongly with the four haplogroups defined by restriction analysis, and it indicated that the D-loop variation, like the haplotype variation, arose predominantly after the migration of the ancestral Amerinds across the Bering land bridge.	EMORY UNIV, DEPT GENET & MOLEC MED, ATLANTA, GA 30322 USA; EMORY UNIV, DEPT ANTHROPOL, ATLANTA, GA 30322 USA; UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA; UNIV CALIF DAVIS, DEPT ANTHROPOL, DAVIS, CA 95616 USA; UNIV NACL CORDOBA, HOP NACL CLIN, FAC CIENCIAS MED, CORDOBA, ARGENTINA	Emory University; Emory University; University of Michigan System; University of Michigan; University of California System; University of California Davis; National University of Cordoba			Torroni, Antonio/E-1557-2011; Schurr, Theodore G/A-1336-2007	Torroni, Antonio/0000-0002-4163-4478; VULLO, CARLOS/0000-0002-1950-7667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 46915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BASSO KH, 1983, HDB N AM INDIANS, P462; Bernstein F., 1931, COMITATO ITALIANO ST; BROWN MD, 1992, GENETICS, V130, P163; Campbell L. R., 1979, LANGUAGES NATIVE AM; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; FIELD LL, 1988, AM J PHYS ANTHROPOL, V76, P155, DOI 10.1002/ajpa.1330760203; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOFTON JP, 1975, J RHEUMATOL, V2, P314; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GREENBERG JP, 1987, J RHEUMATOL; Haskell J. Loring, 1987, SO ATHAPASKAN MIGRAT; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KRAUSS ME, 1964, INT J AM LINGUIST, V30, P118, DOI 10.1086/464766; LEVINE RD, 1979, INT J AM LINGUIST, V45, P157, DOI 10.1086/465587; MADDISON WP, 1992, MAC CLADE ANAL PHYLO; MOHRENWEISER H, 1979, AM J PHYS ANTHROPOL, V50, P237, DOI 10.1002/ajpa.1330500212; NEEL JV, 1978, P NATL ACAD SCI USA, V75, P1904, DOI 10.1073/pnas.75.4.1904; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; NEEL JV, 1980, POPULATION STRUCTURE, P173; NEI M, 1983, GENETICS, V105, P207; NICHOLS J, 1990, LANGUAGE, V66, P475, DOI 10.2307/414609; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214; SCHELL LM, 1978, AM J PHYS ANTHROPOL, V49, P111, DOI 10.1002/ajpa.1330490117; SCHELL LM, 1988, YEARB PHYS ANTHROPOL, V31, P1; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, IN PRESS GENOMICS; SOKAL RR, 1981, SYST ZOOL, V30, P309, DOI 10.2307/2413252; SPENCER RF, 1977, NATIVE AM, P39; SPIELMAN RS, 1979, CURR ANTHROPOL, V20, P377, DOI 10.1086/202275; STEWART CB, 1993, NATURE, V361, P603, DOI 10.1038/361603a0; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; SZATHMARY E J E, 1984, Acta Anthropogenetica, V8, P79; SZATHMARY EJ, 1974, AM J PHYS ANTHROPOL, V40, P49, DOI 10.1002/ajpa.1330400106; SZATHMARY EJE, 1983, ANN HUM BIOL, V10, P147, DOI 10.1080/03014468300006291; SZATHMARY EJE, 1987, SOC SCI MED, V24, P791, DOI 10.1016/0277-9536(87)90181-X; TANIS RJ, 1973, AM J HUM GENET, V25, P655; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TROUP GM, 1982, TISSUE ANTIGENS, V20, P339; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VULLO CM, 1984, TISSUE ANTIGENS, V23, P33; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1992, HUM BIOL, V64, P403; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; WARD RH, 1975, AM J HUM GENET, V27, P1; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WILLIAMS RC, 1981, AM J PHYS ANTHROPOL, V56, P291, DOI 10.1002/ajpa.1330560309; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	75	574	593	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					563	590						28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	7688932				2022-12-18	WOS:A1993LU55900002
J	HALL, JG				HALL, JG			GENOMIC IMPRINTING - REVIEW AND RELEVANCE TO HUMAN-DISEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									UNIV BRITISH COLUMBIA, CLIN GENET UNIT, VANCOUVER V6T 1W5, BC, CANADA; UNIV OXFORD, DEPT BIOCHEM, OXFORD, ENGLAND	University of British Columbia; University of Oxford				Hall, Judith G./0000-0001-5062-491X				AGULNIK AI, 1988, MOUSE NEWS LETT, V81, P77; ALECK KA, 1989, AM J MED GENET, V33, P155, DOI 10.1002/ajmg.1320330202; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; BANDER SAA, IN PRESS GENET RES; Beatty R. A., 1957, PARTHENOGENESIS POLY; BEECHEY CV, 1987, MOUSE NEWS LETT, V77, P126; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1988, MOUSE NEWSLETTER, V82, P93; CATTANACH BM, 1989, MOUSE NEWSLETTER, V83, P161; CHAKRABORTY R, 1989, GENETICS, V122, P713; CHANDLEY AC, 1989, Q J BRIT MULE SOC, V43, P7; CROUSE HV, 1960, GENETICS, V45, P1429; DONLON TA, 1988, HUM GENET, V80, P322, DOI 10.1007/BF00273644; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; Eldridge R, 1981, Adv Neurol, V29, P57; EPSTEIN CJ, 1985, TRENDS GENET, V1, P129, DOI 10.1016/0168-9525(85)90054-X; FENNELL SJ, 1989, J MED GENET, V26, P167, DOI 10.1136/jmg.26.3.167; GAL A, 1989, CLIN GENET, V35, P13; GESSLER M, 1989, AM J HUM GENET, V44, P486; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HAAN EA, 1989, AM J MED GENET, V32, P490, DOI 10.1002/ajmg.1320320412; HADCHOUEL M, 1987, NATURE, V329, P454, DOI 10.1038/329454a0; HARDING AE, 1981, J MED GENET, V18, P436, DOI 10.1136/jmg.18.6.436; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HOLLIDAY R, 1989, SCI AM           JUN, P60; HUEBNER K, 1989, CANCER RES, V49, P4071; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HULTEN MA, IN PRESS CHROMOSOME; JACOBS PA, 1982, ANN HUM GENET, V46, P223, DOI 10.1111/j.1469-1809.1982.tb00714.x; KALOUSEK DK, 1988, GROWTH, V4, P1; KELLEY SE, 1988, NATURE, V331, P714, DOI 10.1038/331714a0; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; KIRK KM, 1988, CYTOGENETICS MAMMALI, P739; KITZIS A, 1988, NATURE, V336, P316, DOI 10.1038/336316a0; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; LAIRD CD, 1987, GENETICS, V117, P587; LAWLER SD, 1982, ANN HUM GENET, V46, P209, DOI 10.1111/j.1469-1809.1982.tb00713.x; LAWLER SD, 1984, ADV EXP MED BIOL, V176, P147; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; LITZ CE, 1988, AM J MED GENET, V30, P821, DOI 10.1002/ajmg.1320300316; LORENZ K, 1974, LANCET, V1, P983; LUDECKE HJ, 1989, HUM GENET, V82, P327; LYON MF, 1988, AM J HUM GENET, V42, P8; LYON MF, 1989, PROG NUCLEIC ACID RE, V36, P119; LYON MF, 1977, GENET RES, V29, P83, DOI 10.1017/S0016672300017134; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MARX JL, 1988, SCIENCE, V239, P352, DOI 10.1126/science.3336789; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MIGEON BR, 1985, AM J HUM GENET, V37, P608; MILLER M, 1978, LANCET, V2, P1071; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1988, GENE DEV, V2, P921, DOI 10.1101/gad.2.8.921; MONK M, 1987, NATURE, V328, P203, DOI 10.1038/328203a0; MONK M, 1987, DEVELOPMENT, V99, P371; MYERS RH, 1989, AM J HUM GENET, V45, P615; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; OLNEY AH, 1988, AM J MED GENET, V29, P491, DOI 10.1002/ajmg.1320290304; OTTMAN R, 1988, AM J HUM GENET, V43, P257; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; PING AJ, 1989, AM J HUM GENET, V44, P720; PONDER B, 1989, NATURE, V340, P264, DOI 10.1038/340264a0; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; REIK W, 1989, NATURE, V338, P112, DOI 10.1038/338112a0; REIK W, 1989, HUM GENET DIS, V5, P331; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SAPIENZA C, 1989, ANN NY ACAD SCI, V564, P24, DOI 10.1111/j.1749-6632.1989.tb25885.x; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SCHEFFER H, 1989, AM J HUM GENET, V45, P252; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SEARLE AG, 1978, CYTOGENET CELL GENET, V20, P282, DOI 10.1159/000130859; SEARLE AG, 1985, ANEUPLOIDY ETIOLOGY, P363; SOLTER D, 1987, TRENDS GENET, V3, P23, DOI 10.1016/0168-9525(87)90157-0; SOLTER D, 1988, ANNU REV GENET, V22, P127; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPRANGER M, 1988, EUR J PEDIATR, V147, P202, DOI 10.1007/BF00442225; SULZMAN AE, 1984, HUMAN TROPHOBLAST NE, P135; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; SURANI MAH, 1986, EXPT APPROACHES MAMM, P401; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VANDERMEY AGL, 1989, LANCET, V2, P1291; VANHEIM CM, 1986, NEW ENGL J MED, V315, P1314; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; VOSS R, 1989, AM J HUM GENET, V45, P373; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304; WEITKAMP LR, 1985, NEW ENGL J MED, V313, P925, DOI 10.1056/NEJM198510103131505; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WILKINS RJ, 1988, LANCET, V1, P329; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	106	573	578	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					857	873						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2187341				2022-12-18	WOS:A1990DD89600001
J	Vionnet, N; Hani, E; Dupont, S; Gallina, S; Francke, S; Dotte, S; De Matos, F; Durand, E; Lepretre, F; Lecoeur, C; Gallina, P; Zekiri, L; Dina, C; Froguel, P				Vionnet, N; Hani, E; Dupont, S; Gallina, S; Francke, S; Dotte, S; De Matos, F; Durand, E; Lepretre, F; Lecoeur, C; Gallina, P; Zekiri, L; Dina, C; Froguel, P			Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; AUTOSOMAL GENOMIC SCAN; SERUM LEPTIN LEVELS; AFFECTED SIB PAIRS; LINKAGE ANALYSIS; PIMA-INDIANS; MEXICAN-AMERICANS; HUMAN OBESITY; WIDE SEARCH; MELLITUS	Despite recent advances in the molecular genetics of type 2 diabetes, the majority of susceptibility genes in humans remain to be identified. We therefore conducted a 10-cM genomewide search (401 microsatellite markers) for type 2 diabetes-related traits in 637 members of 143 French pedigrees ascertained through multiple diabetic siblings, to map such genes in the white population. Nonparametric two-point and multipoint linkage analyzes-using the MAPMAXER-SIBS (MLS) and MAXIMUM-BINOMIAL-LIKELIHOOD (MLB) programs for autosomal markers and the ASPEX program for chromosome X markers-were performed with six diabetic phenotypes: diabetes and diabetes or glucose intolerance (GI), as well as with each of the two phenotypes associated with normal body weight (body-mass index<27 kg/m(2)) or early age at diagnosis (<45 years). In a second step, high-resolution genetic mapping (similar to2 cM) was performed in regions on chromosomes 1 and 3 loci showing the strongest linkage to diabetic traits. We found evidence for linkage with diabetes or GI diagnosed at age <45 years in 92 affected sib pairs from 55 families at the D3S1580 locus on chromosome 3q27-qter using MAPMAKER-SIBS (MLS = 4.67, P = .000004), supported by the MLB statistic (MLB-LOD = 3.43, P = .00003). We also found suggestive linkage between the lean diabetic status and markers APOA2-D1S484 (MLS = 3.04, P = .00018; MLB-LOD = 2.99, P = .00010) on chromosome 1q21-q24. Several other chromosomal regions showed indication of linkage with diabetic traits, including markers on chromosome 2p21-p16, 10q26, 20p, and 20q. These results (a) showed evidence for a novel susceptibility locus for type 2 diabetes in French whites on chromosome 3q27-qter and (b) confirmed the previously reported diabetes-susceptibility locus on chromosome 1q21-q24. Saturation on both chromosomes narrowed the regions of interest down to an interval of <7 cM.	CNRS, Inst Biol, Inst Pasteur, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Froguel, P (corresponding author), CNRS, Inst Biol, Inst Pasteur, 1 Rue Pr Calmette, F-59000 Lille, France.		Dina, Christian R/D-3535-2015; FROGUEL, Philippe/O-6799-2017; Vionnet, Nathalie/N-6302-2017	Dina, Christian R/0000-0002-7722-7348; FROGUEL, Philippe/0000-0003-2972-0784; Gallina, Sophie/0000-0002-6194-3649; lepretre, frederic/0000-0002-5249-3930				Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Baier L, 1998, DIABETES, V47, pA171; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; BOEHNKE M, 1998, 48 ANN M AM SOC HUM; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; DESTEFANO AL, 1998, 7 ANN M INT GEN EP S; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Elbein SC, 1997, J NUTR, V127, pS1891, DOI 10.1093/jn/127.9.1891S; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hani EH, 1996, DIABETES METAB, V22, P451; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hegele RA, 1999, J HUM GENET, V44, P10, DOI 10.1007/s100380050097; HITMAN GA, 1992, ANN MED, V24, P491, DOI 10.3109/07853899209167001; Holmans P, 1997, AM J HUM GENET, V60, P657; Hopper JL, 1999, DIABETOLOGIA, V42, P125, DOI 10.1007/s001250051129; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Rao DC, 1998, GENET EPIDEMIOL, V15, P1; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rotimi CN, 1999, DIABETES, V48, P643, DOI 10.2337/diabetes.48.3.643; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; St Jean PL, 1999, DIABETES, V48, pA46; STJEAN PL, 1999, 2 RES S GEN DIAB SAN; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VIJAYARAGHAVAN S, 1994, J CLIN ENDOCR METAB, V79, P568, DOI 10.1210/jc.79.2.568; Vionnet N, 1997, DIABETES, V46, P1062, DOI 10.2337/diabetes.46.6.1062; Wolford JK, 1999, DIABETES, V48, pA47; WOLFORD JK, 1999, 2 ADA RES S GEN DIAB; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401	54	570	610	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1470	1480		10.1086/316887	http://dx.doi.org/10.1086/316887			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11067779	Green Published, Bronze			2022-12-18	WOS:000165607600012
J	WAARDENBURG, PJ				WAARDENBURG, PJ			A NEW SYNDROME COMBINING DEVELOPMENTAL ANOMALIES OF THE EYELIDS, EYEBROWS AND NOSE ROOT WITH PIGMENTARY DEFECTS OF THE IRIS AND HEAD HAIR AND WITH CONGENITAL DEAFNESS - DYSTOPIA-CANTHI MEDIALIS ET PUNCTORUM LACRIMALIUM LATEROVERSA, HYPERPLASIA SUPERCILII MEDIALIS ET RADICIS NASI, HETEROCHROMIA IRIDUM TOTALIS SIVE PARTIALIS, ALBINISMUS CIRCUMSCRIPTUS (LEUCISMUS, POLIOSIS), ET SURDITAS CONGENITA (SURDIMUTITAS)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABELSDORFF G, 1904, ARCH OPHTH BERL, V59, P376; Albrecht W., 1923, ARCHIV OHRENNASENUND, V110, P15; ALBRECHT W, 1926, Z LARYNG, V14, P1; ALEXANDER G, 1900, ARCH OHRENH, V51, P159; ALEXANDER G, 1905, ARCH OHRENHEILK, V66, P161; BELLECCI P, 1946, ANN MED NAV ROMA, V1, P1; Bond CJ, 1912, J GENET, V2, P99, DOI 10.1007/BF02984338; BOONACKER, 1915, NED TSCHR GENEESK, V59, P1843; BRAENDSTRUP P, 1941, ACTA OPHTHALMOL, V19, P281; BROUWER B, 1909, THESIS U AMSTERDAM; CLOUDMAN AM, 1945, J HERED, V36, P258, DOI 10.1093/oxfordjournals.jhered.a105514; COTTERMAN CW, 1951, AM J HUM GENET, V3, P254; COTTERMAN CW, 1949, AM J HUM GENET, V1, P203; CSORSZ K, 1934, MSCHR OHRENH WIEN, V68, P42; DARWIN C, 1885, ORIGIN SPECIES; DEKLEYN A, 1915, NED TSCHR GENEESK, V59, P1843; DEWILDE PA, 1913, NED TSCHR GENEESK, V57, P1287; DEWILDE PA, 1919, THESIS U AMSTERDAM; DIEHL K, 1933, ZWILLINGSTUBERKULOSE, P109; ELLIS R. W. B., 1931, PROC ROY SOC MED, V24, P1057; Fay E.A., 1898, MARRIAGES DEAF AM; Gossage AM, 1907, Q J MED, V1, P331; GROHMANN H, 1939, ERBARZT, V7, P12; Gruneberg H, 1947, ANIMAL GENETICS MED; HALBERTSMA KTA, 1939, NED TIJDSCHR GENEES, V83, P4985; HALBERTSMA KTA, 1929, NED TSCHR GENEESK, V73, P1647; HALBERTSMA KTA, 1929, B OCUL, V8, P3; HAMMERSCHLAG V, 1907, Z OHRENHEILKD, V54, P18; HAMMERSCHLAG V, 1910, Z MENSCHL VERERB, V21, P609; HAMMERSCHLAG V, 1908, Z OHRENHEILKD, V56, P126; JANCKE G, 1941, ARCH OPHTH BERL, V142, P113; JOHN I, 1934, ARCH OPHTH BERL, V133, P60; KAMERBEEK AEH, 1949, THESIS U LEIDEN LEID; KLEIN D, 1947, Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg, V22, P336; Klein D, 1950, HELV PAEDIATR ACTA, V5, P38; KLEMOLA V, 1931, Z ZUCHTG B, V20, P24; KLING J, 1932, HYGIEA STOCKH, V94, P743; KRANZ H. W., 1926, ALBR V GRAEFE S ARCH OPHTHALMOL, V117, P554, DOI 10.1007/BF01853530; KUIPER T, 1913, THESIS U AMSTERDAM; LAUBER H, 1906, Z AUGENHEILKD, V16, P326; LEHMANN WOLFGANG, 1950, ZEITSCHRIFT MENSCHL VERERBUNGS U KONSTITUTIONSLEHRE, V29, P825; LEONARDI E, 1931, B OCUL, V10, P165; LINDENOV H, 1945, ETIOLOGY DEAF MUTISM, P268; LISCH K, 1937, KLIN MBL AUGENH, V99, P264; LOEBELL H, 1938, HALS ARZT, V29, P1; LURIE M. H., 1941, ANN OTOL RHINOL AND LARYNGOL, V50, P113; LURIE MH, 1939, LARYNGOSCOPE, V49, P558; MALATESTA C, 1948, Boll Ocul, V27, P88; MATIEGKA J, 1924, ANTHROPOLOGIE PRAHA, V2, P98; MAZZINI G, 1924, RIV BIOL, V6, P413; MENDE IRMGARD, 1926, ARCH KINDERHEILK, V79, P214; MORGANTI G, 1948, ATTI C SOC OFT ITAL, V10; MUHLMANN WE, 1929, ARCH RASSENB, V22, P181; MULLER E, 1936, ARCH OHR NAS KEHLKOP, V142, P156; MULLER E, 1937, ARCH OHR HEILK, V143, P376; NACHTSHEIM H, 1935, HUND, V36, P206; NACHTSHEIM H, 1940, HDB ERBBIOLOGIE MENS, V3, P543; NOWAK H, 1932, DEUT MED WOCHENSCHR, V58, P94; OREL H, 1931, EUGENIK, V2, P10; PASSOW A, 1933, ARCH AUGENHEILKD, V107, P1; Przibram H, 1907, ARCH ENTWICKLUNG ORG, V25, P260, DOI 10.1007/BF02292168; QUIX FH, 1910, ANATOMIE TAUBSTUMMHE; RAWITZ B, 1896, MORPHOLOGISCHE ARBEI; RIZZOLI, 1877, NOTA B SOC MED CHIR, V23; SCHNEIDER KW, 1937, Z HALS NASEN OHRENH, V42, P314; TIMMER C, 1948, TSCHR DOOFSTOMMENOND, P129; TIRELLI G, 1932, RASS ITAL OTTALMOL, V1, P236; URBANTSCHITSCH E, 1910, VERH DTSCH OTOL GES, V350, P153; Van der Hoeve J, 1913, KLIN MBL AUGENKD, V51, P461; van Gilse P. H. G., 1942, BIBLIOGR GENETICA [GRAVENHAGE], V13, P301; VANDERBREGGEN FA, 1915, NED TSCHR GENEESK, V59, P1874; VANDERHOEVE J, 1941, NED TSCHR GENEESK, V85, P4020; VANDERHOEVE J, 1916, KLIN MBL AUGENHEILK, V56, P232; VANDERHOEVE J, 1939, NED TSCHR GENEESK, V83, P5003; VANDERHOEVE J, 1929, B SOC FR OPHT, V42, P210; VANDERHOEVE J, 1944, NED TSCHR GENEESK, V87, P1926; VANDERHOEVE J, 1934, NED TSCHR GENEESK, V78, P3741; VANDERHOEVE J, 1930, NED TSCHR GENEESK, V74, P4730; VANDERHOEVE J, 1928, NED TSCHR GENEESK, V72, P4319; VANDISHOECK HAE, 1949, ENCY ENSIE, V6, P539; VANGILSE PHG, 1926, NED TIJDSCHR GENEES, V70, P479; VANLENNEP ECC, 1910, THESIS U UTRECHT; VOGELSANG, 1937, HALS ARZT, V28, P35; VONVERSCHUER O, 1931, VERH GES PHYS ANTHR, V6, P1; WAARDENBURG P J, 1948, Ned Tijdschr Geneeskd, V92, P3463; WAARDENBURG PJ, 1938, FORTSCH ERBPATH, V2, P162; WAARDENBURG PJ, 1930, ARCH OPHTHALMOL-CHIC, V124, P221; WAARDENBURG PJ, 1932, MENSCHLICHE AUGE SEI; WAARDENBURG PJ, 1934, NED T GENEESK, V78, P1700; WAARDENBURG PJ, 1938, FORTSCH ERBPATH, V2, P1; WALSH FB, 1947, CLIN NEUROOPHTHALMOL; Winkler C, 1908, P K AKAD WET-AMSTERD, V11, P225; ZIMMERMANN K, 1935, ERBARZT, V8, P119	93	570	595	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1951	3	3					195	253						59	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS394	14902764				2022-12-18	WOS:A1951XS39400001
J	MORTON, NE; MACLEAN, CJ				MORTON, NE; MACLEAN, CJ			ANALYSIS OF FAMILY RESEMBLANCE .3. COMPLEX SEGREGATION OF QUANTITATIVE TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System								CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Falconer D.S., 1960, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Householder A., 1953, PRINCIPLES NUMERICAL; MACLEAN CJ, IN PRESS; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1974, AM J HUM GENET, V26, P318; RAO DC, 1974, AM J HUM GENET, V26, P331; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wright S, 1921, J AGR RES, V7, P557	14	569	571	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	4					489	503						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T5051	4842773				2022-12-18	WOS:A1974T505100007
J	Lee, S; Abecasis, GR; Boehnke, M; Lin, XH				Lee, Seunggeung; Abecasis, Goncalo R.; Boehnke, Michael; Lin, Xihong			Rare-Variant Association Analysis: Study Designs and Statistical Tests	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE ASSOCIATION; LINEAR MIXED MODELS; FAST-LMM-SELECT; POPULATION STRATIFICATION; MISSING HERITABILITY; GENOTYPE IMPUTATION; QUANTITATIVE TRAITS; LOW-FREQUENCY; PRINCIPAL-COMPONENTS; NONCODING SEQUENCE	Despite the extensive discovery of trait- and disease-associated common variants, much of the genetic contribution to complex traits remains unexplained. Rare variants can explain additional disease risk or trait variability. An increasing number of studies are underway to identify trait- and disease-associated rare variants. In this review, we provide an overview of statistical issues in rare-variant association studies with a focus on study designs and statistical tests. We present the design and analysis pipeline of rare-variant studies and review cost-effective sequencing designs and genotyping platforms. We compare various gene- or region-based association tests, including burden tests, variance-component tests, and combined omnibus tests, in terms of their assumptions and performance. Also discussed are the related topics of meta-analysis, population-stratification adjustment, genotype imputation, follow-up studies, and heritability due to rare variants. We provide guidelines for analysis and discuss some of the challenges inherent in these studies and future research directions.	[Lee, Seunggeung; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48105 USA; [Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health	Lin, XH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xlin@hsph.harvard.edu		Dichgans, Martin/0000-0002-0654-387X	 [R00 HL113164];  [HG006513];  [HG007022];  [HG000376];  [R37 CA076404];  [P01 CA134294];  [P42 ES016454]; NATIONAL CANCER INSTITUTE [R37CA076404, P01CA134294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626, R00HL113164] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376, U01HG006513, R01HG000376, R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, P42ES016454] Funding Source: NIH RePORTER	; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants R00 HL113164 (S.L.), HG006513 and HG007022 (G.R.A.), HG000376 (M.B.), and R37 CA076404, P01 CA134294, and P42 ES016454 (X.L.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Asimit JL, 2012, HUM HERED, V73, P84, DOI 10.1159/000336982; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Babron MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046519; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barnett IJ, 2013, GENET EPIDEMIOL, V37, P142, DOI 10.1002/gepi.21699; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chen LS, 2012, AM J HUM GENET, V91, P977, DOI 10.1016/j.ajhg.2012.09.017; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DAVIES R. B., 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Fisher R. A., 1946, Statistical methods for research workers.; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; He ZX, 2014, AM J HUM GENET, V94, P33, DOI 10.1016/j.ajhg.2013.11.021; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hu YJ, 2013, AM J HUM GENET, V93, P236, DOI 10.1016/j.ajhg.2013.06.011; Hu YN, 2013, AM J HUM GENET, V93, P891, DOI 10.1016/j.ajhg.2013.10.008; Huang YT, 2014, ANN APPL STAT, V8, P352, DOI 10.1214/13-AOAS690; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jolliffe I, 2002, PRINCIPAL COMPONENT; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lambert CG, 2012, BIOSTATISTICS, V13, P195, DOI 10.1093/biostatistics/kxr055; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Lee JC, 2011, BRIEF FUNCT GENOMICS, V10, P71, DOI 10.1093/bfgp/elr009; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2011, BIOMETRICS, V67, P967, DOI 10.1111/j.1541-0420.2010.01520.x; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li DL, 2011, GENET EPIDEMIOL, V35, P790, DOI 10.1002/gepi.20628; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024945; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Lin DY, 2013, P NATL ACAD SCI USA, V110, P12247, DOI 10.1073/pnas.1221713110; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Liu D.J., 2010, PLOS GENET, V6; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Liu QY, 2013, GENET EPIDEMIOL, V37, P286, DOI 10.1002/gepi.21714; Logsdon BA, 2014, GENET EPIDEMIOL, V38, P21, DOI 10.1002/gepi.21772; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacCullagh P., 1989, GEN LINEAR MODELS; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mathieson I, 2013, NAT GENET, V45, P471, DOI 10.1038/ng.2619; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quintana MA, 2011, GENET EPIDEMIOL, V35, P638, DOI 10.1002/gepi.20613; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Sebastiani P, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-a; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Stouffer SA, 1949, AM SOLDIER ADJUSTMEN; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Sunyaev SR, 2012, HUM MOL GENET, V21, pR10, DOI 10.1093/hmg/dds385; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tang ZZ, 2013, BIOINFORMATICS, V29, P1803, DOI 10.1093/bioinformatics/btt280; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Tyekucheva S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r105; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang XF, 2013, GENET EPIDEMIOL, V37, P778, DOI 10.1002/gepi.21763; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xiong Q, 2012, GENOME RES, V22, P386, DOI 10.1101/gr.124370.111; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zhang YW, 2013, GENET EPIDEMIOL, V37, P787, DOI 10.1002/gepi.21764; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	147	568	582	12	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					5	23		10.1016/j.ajhg.2014.06.009	http://dx.doi.org/10.1016/j.ajhg.2014.06.009			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24995866	Bronze, Green Published			2022-12-18	WOS:000338904100001
J	Blackwood, DHR; Fordyce, A; Walker, MT; St Clair, DM; Porteous, DJ; Muir, WJ				Blackwood, DHR; Fordyce, A; Walker, MT; St Clair, DM; Porteous, DJ; Muir, WJ			Schizophrenia and affective disorders - Cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EVENT-RELATED POTENTIALS; BIPOLAR-DISORDER; SUSCEPTIBILITY LOCUS; LINKAGE; LATENCY; SCAN	A family with a (1;11)(q42;q14.3) translocation significantly linked to a clinical phenotype that includes schizophrenia and affective disorders is described. This translocation generates a LOD score of 3.6 when the disease phenotype is restricted to schizophrenia, of 4.5 when the disease phenotype is restricted to affective disorders, of 7.1 when relatives with recurrent major depression, with bipolar disorder, or with schizophrenia are all classed as affected. This evidence for linkage is among the strongest reported for a psychiatric disorder. Family members showed no distinctive features by which the psychiatric phenotype could be distinguished from unrelated cases of either schizophrenia or affective disorders, and no physical, neurological, or dysmorphic conditions co-occurred with psychiatric symptoms. Translocation carriers and noncarriers had the same mean intelligence quotient. Translocation carriers were similar to subjects with schizophrenia and different from noncarriers and controls, in showing a significant reduction in the amplitude of the P300 event-related potential (ERP). Furthermore, P300 amplitude reduction and latency prolongation were measured in some carriers of the translocation who had no psychiatric symptoms-a pattern found in other families with multiple members with schizophrenia, in which amplitude of and latency of P300 appear to be trait markers of risk. The results of karyotypic, clinical, and ERP investigations of this family suggest that the recently described genes DISC1 and DISC2, which are directly disrupted by the breakpoint on chromosome 1, may have a role in the development of a disease phenotype that includes schizophrenia as well as unipolar and bipolar affective disorders.	Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; Univ Edinburgh, Med Genet Sect, Mol Med Ctr, Edinburgh, Midlothian, Scotland; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen	Blackwood, DHR (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland.		Porteous, David/AAA-3446-2021; blackwood, douglas/AIB-8874-2022; Porteous, David J/C-7289-2013; St Clair, David/AAN-2412-2021	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; 				Berrettini WH, 2000, BIOL PSYCHIAT, V47, P245, DOI 10.1016/S0006-3223(99)00226-7; Blackwood D, 2000, LANCET, V355, P771, DOI 10.1016/S0140-6736(99)00261-5; BLACKWOOD DHR, 1991, ARCH GEN PSYCHIAT, V48, P899; Blackwood DHR, 1999, BRIT J PSYCHIAT, V175, P357, DOI 10.1192/bjp.175.4.357; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GEJMAN PV, 1993, NEUROPSYCHOPHARMACOL, V9, P31, DOI 10.1038/npp.1993.40; GLABUS MF, 1994, ELECTROEN CLIN NEURO, V90, P123, DOI 10.1016/0013-4694(94)90004-3; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; JACOBS PA, 1970, ANN HUM GENET, V33, P325, DOI 10.1111/j.1469-1809.1970.tb01658.x; LaBuda MC, 1996, AM J HUM GENET, V59, P1343; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; MUIR WJ, 1991, PSYCHOL MED, V21, P867, DOI 10.1017/S003329170002986X; O'Donnell BF, 1999, PSYCHOPHYSIOLOGY, V36, P388, DOI 10.1017/S0048577299971688; Potash JB, 2000, BIPOLAR DISORD, V2, P8, DOI 10.1034/j.1399-5618.2000.020103.x; Riley BP, 2000, AM J MED GENET, V97, P23, DOI 10.1002/(SICI)1096-8628(200021)97:1<23::AID-AJMG5>3.0.CO;2-K; Salisbury DF, 1999, BIOL PSYCHIAT, V45, P98, DOI 10.1016/S0006-3223(98)00208-X; SCHREIBER H, 1992, BIOL PSYCHIAT, V32, P634, DOI 10.1016/0006-3223(92)90294-A; SHAM PC, 1994, PSYCHIATR GENET, V4, P29, DOI 10.1097/00041444-199421000-00005; SOUZA VBN, 1995, BIOL PSYCHIAT, V37, P300, DOI 10.1016/0006-3223(94)00131-L; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; STCLAIR D, 1989, NATURE, V339, P305; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Weisbrod M, 1999, BIOL PSYCHIAT, V46, P721, DOI 10.1016/S0006-3223(99)00022-0; Wildenauer DB, 1999, SCHIZOPHR RES, V39, P107, DOI 10.1016/S0920-9964(99)00108-5	30	567	588	0	53	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					428	433		10.1086/321969	http://dx.doi.org/10.1086/321969			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443544	Bronze, Green Published			2022-12-18	WOS:000170108200017
J	Shifman, S; Bronstein, M; Sternfeld, M; Pisante-Shalom, A; Lev-Lehman, E; Weizman, A; Reznik, I; Spivak, B; Grisaru, N; Karp, L; Schiffer, R; Kotler, M; Strous, RD; Swartz-Vanetik, M; Knobler, HY; Shinar, E; Beckmann, JS; Yakir, B; Risch, N; Zak, NB; Darvasi, A				Shifman, S; Bronstein, M; Sternfeld, M; Pisante-Shalom, A; Lev-Lehman, E; Weizman, A; Reznik, I; Spivak, B; Grisaru, N; Karp, L; Schiffer, R; Kotler, M; Strous, RD; Swartz-Vanetik, M; Knobler, HY; Shinar, E; Beckmann, JS; Yakir, B; Risch, N; Zak, NB; Darvasi, A			A highly significant association between a COMT haplotype and schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							O-METHYLTRANSFERASE PHARMACOGENETICS; TRANSMISSION-RATIO DISTORTION; OBSESSIVE-COMPULSIVE DISORDER; NON-MENDELIAN INHERITANCE; LINKAGE DISEQUILIBRIUM; FREQUENCIES; POPULATIONS; CHROMOSOME; GENOTYPE; DISEASES	Several lines of evidence have placed the catechol-O-methyltransferase (COMT) gene in the limelight as a candidate gene for schizophrenia. One of these is its biochemical function in metabolism of catecholamine neurotransmitters; another is the microdeletion, on chromosome 22q11, that includes the COMT gene and causes velocardiofacial syndrome, a syndrome associated with a high rate of psychosis, particularly schizophrenia. The interest in the COMT gene as a candidate risk factor for schizophrenia has led to numerous linkage and association analyses. These, however, have failed to produce any conclusive result. Here we report an efficient approach to gene discovery. The approach consists of (i) a large sample size-to our knowledge, the present study is the largest case-control study performed to date in schizophrenia; (ii) the use of Ashkenazi Jews, a well defined homogeneous population; and (iii) a stepwise procedure in which several single nucleotide polymorphisms (SNPs) are scanned in DNA pools, followed by individual genotyping and haplotype analysis of the relevant SNPs. We found a highly significant association between schizophrenia and a COMT haplotype (P = 9.5 x 10(-8)). The approach presented can be widely implemented for the genetic dissection of other common diseases.	IDgene Pharmaceut Ltd, IL-91344 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Stat, IL-91905 Jerusalem, Israel; Kfar Shaul Hosp, Jerusalem Mental Hlth Ctr, Jerusalem, Israel; Beilinson Med Ctr, Geha Psychiat Hosp, IL-49100 Petah Tiqwa, Israel; Ness Ziona Med Ctr, Ness Ziona, Israel; Ben Gurion Univ Negev, Mental Hlth Ctr, IL-84105 Beer Sheva, Israel; Lev Hasharon Community Mental Hlth Clin, Pardesia, Israel; Mental Hlth Res Ctr, Beer Yaagov, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Abarbanel Mental Hlth Ctr, Bat Yam, Israel; Magen David Adom Natl Blood Serv, Ramat Gan, Israel; Weizmann Inst Sci, Dept Mol Genet & Crown Genome Ctr, IL-76100 Rehovot, Israel; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Herzog Medical Center; Jerusalem Mental Health Center; Rabin Medical Center; Tel Aviv University; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Stanford University	Darvasi, A (corresponding author), IDgene Pharmaceut Ltd, POB 34478, IL-91344 Jerusalem, Israel.	reprints@idgene.com	Shifman, Sagiv/D-8749-2017; Beckmann, Jacques S/A-9772-2008; Weizman, Abraham/AAK-6450-2020	Shifman, Sagiv/0000-0003-4071-5361; Beckmann, Jacques S/0000-0002-9741-1900; Weizman, Abraham/0000-0002-9765-8938				AXELROD J, 1958, J BIOL CHEM, V233, P702; BOUDIKOVA B, 1990, CLIN PHARMACOL THER, V48, P381, DOI 10.1038/clpt.1990.166; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; CASAS M, 1986, ACTA PSYCHIAT SCAND, V73, P221, DOI 10.1111/j.1600-0447.1986.tb10591.x; de la Casa-Esperon E, 2000, GENETICS, V154, P343; de Villena FPM, 2000, GENETICS, V154, P351; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Escamilla MA, 2001, BIPOLAR DISORD, V3, P299, DOI 10.1034/j.1399-5618.2001.30605.x; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KHOURY MJ, 1993, MONOGRAPHS EPIDEMIOL; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; Naumova AK, 1998, AM J HUM GENET, V62, P1493, DOI 10.1086/301860; NEZIROGLU F, 1992, AM J PSYCHIAT, V149, P947; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; PARVEZ S, 1978, J NEURAL TRANSM, V42, P305, DOI 10.1007/BF01673554; Pulver AE, 2000, BIOL PSYCHIAT, V47, P221; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Salem JE, 1998, CLIN PSYCHOL REV, V18, P795, DOI 10.1016/S0272-7358(98)00008-7; Shendure J, 1998, MAMM GENOME, V9, P812, DOI 10.1007/s003359900872; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Silva F, 1999, ELECTROPHORESIS, V20, P1697, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1697::AID-ELPS1697>3.0.CO;2-3; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Usiskin SI, 1999, J AM ACAD CHILD PSY, V38, P1536, DOI 10.1097/00004583-199912000-00015; Wasson J, 2002, BIOTECHNIQUES, V32, P1144, DOI 10.2144/02325dd04; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; WIJSMAN EM, 1984, HUM GENET, V67, P441, DOI 10.1007/BF00291407; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Zak NB, 2001, DRUG DISCOV TODAY, V6, P1111, DOI 10.1016/S1359-6446(01)02007-4; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	39	565	595	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1296	1302		10.1086/344514	http://dx.doi.org/10.1086/344514			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12402217	Green Published, Bronze			2022-12-18	WOS:000179586800004
J	LUBS, HA				LUBS, HA			A MARKER X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLAN W, 1944, AMER J MENT DEFIC, V68, P325; Allant W, 1944, J HERED, V35, P41, DOI 10.1093/oxfordjournals.jhered.a105347; BISHOP A, 1965, J Med Genet, V2, P107, DOI 10.1136/jmg.2.2.107; BROWN WMC, 1966, CHROMOSOME STUDIES A; DAY EJ, 1967, LANCET, V2, P1307; GERMAN J, 1964, CYTOGENETICS CELLS C, P191; HARRIS RJC, 1964, CYTOGENETICS CELL ED, P191; HUNGERFORD DA, 1965, STAIN TECHNOL, V40, P333, DOI 10.3109/10520296509116440; KOHN G, 1968, J NATL CANCER I, V41, P795; KOHN G, 1967, J NATL CANCER I, V38, P209; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LUBS H, IN PRESS; MARTIN J, 1943, ARCH NEUROL PSYCHIAT, V6, P154; MILES CP, 1967, CANCER RES, V27, P392; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682	15	564	575	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	3					231	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D4606	5794013				2022-12-18	WOS:A1969D460600001
J	Browning, BL; Browning, SR				Browning, Brian L.; Browning, Sharon R.			Genotype Imputation with Millions of Reference Samples	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEQUENCE; IDENTITY	We present a genotype imputation method that scales to millions of reference samples. The imputation method, based on the Li and Stephens model and implemented in Beagle v.4.1, is parallelized and memory efficient, making it well suited to multi-core computer processors. It achieves fast, accurate, and memory-efficient genotype imputation by restricting the probability model to markers that are genotyped in the target samples and by performing linear interpolation to impute ungenotyped variants. We compare Beagle v.4.1 with Impute2 and Minimac3 by using 1000 Genomes Project data, UK10K Project data, and simulated data. All three methods have similar accuracy but different memory requirements and different computation times. When imputing 10 Mb of sequence data from 50,000 reference samples, Beagle's throughput was more than 100x greater than Impute2's throughput on our computer servers. When imputing 10 Mb of sequence data from 200,000 reference samples in VCF format, Minimac3 consumed 26x more memory per computational thread and 15x more CPU time than Beagle. We demonstrate that Beagle v.4.1 scales to much larger reference panels-by performing imputation from a simulated reference panel having 5 million samples and a mean marker density of one marker per four base pairs.	[Browning, Brian L.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Browning, Brian L.; Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, BL (corresponding author), Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA.	browning@uw.edu	Browning, Brian/ABC-4543-2021; Browning, Brian L/A-1178-2010; Browning, Sharon/B-1530-2008	Browning, Brian L/0000-0001-6454-6633; Browning, Sharon/0000-0001-7251-9715	NIH [HG004960, HG008359, GM099568]; Wellcome Trust [WT091310]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960, R01HG008359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_15018] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by research grants HG004960, HG008359, and GM099568 from the NIH. This study makes use of data generated by the UK10K Consortium, derived from samples from the UK10K_COHORTS_TWINSUK and UK10K_COHORT_ALSPAC cohorts. A full list of the investigators who contributed to the generation of the data is available at http://www.UK10K.org. Funding for the UK10K Consortium was provided by the Wellcome Trust under award WT091310.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning BL, 2013, AM J HUM GENET, V93, P840, DOI 10.1016/j.ajhg.2013.09.014; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Grice JA, 1997, COMPUT APPL BIOSCI, V13, P45; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Lappalainen I, 2015, NAT GENET, V47, P692, DOI 10.1038/ng.3312; Li N, 2003, GENETICS, V165, P2213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Wheeler R, 2000, BIOINFORMATICS, V16, P1082, DOI 10.1093/bioinformatics/16.12.1082; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	28	561	576	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					116	126		10.1016/j.ajhg.2015.11.020	http://dx.doi.org/10.1016/j.ajhg.2015.11.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748515	Bronze, Green Published			2022-12-18	WOS:000368050800009
J	Clayton, D				Clayton, D			A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-MARKERS; ASSOCIATION; LINKAGE; DISEASE; DISEQUILIBRIUM; LIKELIHOOD; PARENTS	A new transmission/disequilibrium-test statistic is proposed for situations in which transmission is uncertain. Such situations arise when transmission of a multilocus marker haplotype is considered, since haplotype phase is often unknown in a substantial number of instances. Even for single-locus markers, transmission is uncertain if one or both parents are missing. In both these situations, uncertainty may be reduced by the typing of further siblings, whose disease status may be unaffected or unknown. The proposed test is a score test based on a partial score function that omits the terms most influenced by hidden population stratification.	Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	MRC Biostatistics Unit; University of Cambridge	Clayton, D (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Univ Forvie Site,Robinson Way, Cambridge CB2 2SR, England.							Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Little RJ, 1987, STAT ANAL MISSING DA; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MAXWELL AE, 1970, BRIT J PSYCHIAT, V116, P651, DOI 10.1192/bjp.116.535.651; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; Morris AP, 1997, ANN HUM GENET, V61, P335, DOI 10.1017/S0003480097006349; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STUART A, 1955, BIOMETRIKA, V42, P412, DOI 10.2307/2333387; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; [No title captured]	21	559	576	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1170	1177		10.1086/302577	http://dx.doi.org/10.1086/302577			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486336	Green Published, Bronze			2022-12-18	WOS:000082910000026
J	Forster, P; Harding, R; Torroni, A; Bandelt, HJ				Forster, P; Harding, R; Torroni, A; Bandelt, HJ			Origin and evolution of native American mtDNA variation: A reappraisal	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; DIVERSITY; POLYMORPHISM; POPULATIONS; SEQUENCE; AMERINDS; HAPLOTYPES; AFFINITIES; REVEALS; ANCIENT	The timing and number of prehistoric migrations involved in the settlement of the American continent is subject to intense debate. Here, we reanalyze Native American control region mtDNA data and demonstrate that only an appropriate phylogenetic analysis accompanied by an appreciation of demographic factors allows us to discern different migrations and to estimate their ages. Reappraising 574 mtDNA control region sequences from aboriginal Siberians and Native Americans, we confirm in agreement with linguistic, archaeological and climatic evidence that (i) the major wave of migration brought one population, ancestral to the Amerinds, from northeastern Siberia to America 20,000-25,000 years ago and (ii) a rapid expansion of a Beringian source population took place at the end of the Younger Dryas glacial phase similar to 11,300 years ago, ancestral to present Eskimo and Na-Dene populations.	UNIV HAMBURG, MATH SEMINAR, D-20146 HAMBURG, GERMANY; UNIV HAMBURG, HEINRICH PETTE INST EXPT VIROL & IMMUNOL, D-2000 HAMBURG, GERMANY; JOHN RADCLIFFE HOSP, INST MOL MED, OXFORD, ENGLAND; UNIV ROMA LA SAPIENZA, DIPARTIMENTO GENET & BIOL MOL, I-00185 ROME, ITALY	University of Hamburg; Heinrich Pette Institute; University of Hamburg; University of Oxford; Sapienza University Rome			Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BANDELT HJ, 1995, GENETICS, V141, P743; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Bianchi NO, 1995, BRAZ J GENET, V18, P661; CHEN YS, 1995, AM J HUM GENET, V57, P133; DILLEHAY TD, 1988, NATURE, V332, P150, DOI 10.1038/332150a0; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; GINTHER C, 1993, EXS, V67, P211; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HARDING RM, IN PRESS MOL BIOL HU, P63; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1994, EXPERIENTIA, V50, P585, DOI 10.1007/BF01921729; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; IVANOVA AV, 1993, THESIS U NOVOSIBIRSK; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; KUNZ ML, 1994, SCIENCE, V263, P660, DOI 10.1126/science.263.5147.660; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; MORELL V, 1990, SCIENCE, V248, P439, DOI 10.1126/science.248.4954.439; MORELL V, 1995, SCIENCE, V268, P1279, DOI 10.1126/science.268.5215.1279; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; OOTA H, 1995, AM J PHYS ANTHROPOL, V98, P133, DOI 10.1002/ajpa.1330980204; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; RICHARDS M, 1995, N W EUROPEAN LANGU S, V12, P141; SANTOS M, 1994, HUM BIOL, V66, P963; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1990, THESIS U CALIFORNIA; VOEVODA MI, 1994, SIBIRSKY EKOL ZH, V2, P149; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720	42	559	576	1	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					935	945						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808611				2022-12-18	WOS:A1996VL28300025
J	CALLEN, DF; THOMPSON, AD; SHEN, Y; PHILLIPS, HA; RICHARDS, RI; MULLEY, JC; SUTHERLAND, GR				CALLEN, DF; THOMPSON, AD; SHEN, Y; PHILLIPS, HA; RICHARDS, RI; MULLEY, JC; SUTHERLAND, GR			INCIDENCE AND ORIGIN OF NULL ALLELES IN THE (AC)N MICROSATELLITE MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISMS	Twenty-three (AC)n repeat markers from chromosome 16 were typed in the parents of the 40 CEPH (Centre d'Etude du Polymorphisme Humain) families. Where parents were informative, the entire families were then typed. There were seven markers in which null alleles were demonstrated, as recognized by the apparent noninheritance, by a sib, of a parental allele. Four of these markers showed a null allele in a single sibship, while in the other three at least 30% of the CEPH sibships were shown to have a null allele segregating. One null allele was sequenced and shown to be the result of an 8-bp deletion occurring within the priming sequence for PCR amplification of the (AC)n repeats. In gene mapping or in application to diagnosis, the presence of a segregating null allele will not corrupt the linkage data but could result in loss of information. In isolated instances a segregating null allele may be interpreted as nonpaternity. The presence of a null allele may generate misleading data when individuals are haplotyped to determine the presence of linkage disequilibrium with a disease gene.			CALLEN, DF (corresponding author), WOMENS & CHILDRENS HOSP,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012; Callen, David F/G-1975-2012; Richards, Robert/ABE-6423-2020	Richards, Robert Ian/0000-0002-5978-6453; Callen, David/0000-0002-6189-9991				AKSENTIJEVICH I, UNPUB REFINED PHYSIC; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; PHILLIPS HA, 1991, NUCLEIC ACIDS RES, V19, P6664, DOI 10.1093/nar/19.23.6664; PHILLIPS HA, 1991, NUCLEIC ACIDS RES, V19, P6964, DOI 10.1093/nar/19.24.6964; Shen Y., 1992, Human Molecular Genetics, V1, P773, DOI 10.1093/hmg/1.9.773; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4034, DOI 10.1093/nar/18.13.4034; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R	10	559	606	0	23	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					922	927						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488841				2022-12-18	WOS:A1993LB88900009
J	Laumonnier, F; Bonnet-Brilhault, F; Gomot, M; Blanc, R; David, A; Moizard, MP; Raynaud, M; Ronce, N; Lemonnier, E; Calvas, P; Laudier, B; Chelly, J; Fryns, JP; Ropers, HH; Hamel, BCJ; Andres, C; Barthelemy, C; Moraine, C; Briault, S				Laumonnier, F; Bonnet-Brilhault, F; Gomot, M; Blanc, R; David, A; Moizard, MP; Raynaud, M; Ronce, N; Lemonnier, E; Calvas, P; Laudier, B; Chelly, J; Fryns, JP; Ropers, HH; Hamel, BCJ; Andres, C; Barthelemy, C; Moraine, C; Briault, S			X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISORDERS; SCREEN	A large French family including members affected by nonspecific X-linked mental retardation, with or without autism or pervasive developmental disorder in affected male patients, has been found to have a 2-base-pair deletion in the Neuroligin 4 gene (NLGN4) located at Xp22.33. This mutation leads to a premature stop codon in the middle of the sequence of the normal protein and is thought to suppress the transmembrane domain and sequences important for the dimerization of neuroligins that are required for proper cell-cell interaction through binding to beta-neurexins. As the neuroligins are mostly enriched at excitatory synapses, these results suggest that a defect in synaptogenesis may lead to deficits in cognitive development and communication processes. The fact that the deletion was present in both autistic and nonautistic mentally retarded males suggests that the NLGN4 gene is not only involved in autism, as previously described, but also in mental retardation, indicating that some types of autistic disorder and mental retardation may have common genetic origins.	CHU Bretonneau, INSERM, U619, Serv Genet, F-37044 Tours, France; CHU Bretonneau, INSERM, U619, Serv Explorat Fonct & Neurophysiol Pedopsychiat, F-37044 Tours, France; CHU Hotel Dieu, Inst Biol, Serv Genet Med, Nantes, France; Ctr Inter Reg Etud & Ressource Autisme, Brest, France; CHU Hop Purpan, Serv Genet, Toulouse, France; CHU Cochin, ICGM, INSERM, U129, Paris, France; Ctr Human Genet, Louvain, Belgium; Max Planck Inst Mol Genet, Berlin, Germany; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; Max Planck Society; Radboud University Nijmegen	Briault, S (corresponding author), CHU Bretonneau, INSERM, U619, Serv Genet, 2 Bd Tonnelle, F-37044 Tours, France.	briault@med.univ-tours.fr	Chelly, Jamel/J-7528-2015; Laumonnier, Frederic/N-1165-2016; BLANC, Romuald/GYA-0704-2022; lemonnier, eric/K-1084-2016; Gomot, Marie/N-3135-2016; Bonnet-Brilhault, Frédérique/P-5815-2016; Raynaud, Martine/R-9811-2019	Chelly, Jamel/0000-0002-0939-8719; Laumonnier, Frederic/0000-0003-2567-0708; Gomot, Marie/0000-0003-1747-5806; Bonnet-Brilhault, Frédérique/0000-0003-4763-9066; Raynaud, Martine/0000-0002-6888-6480; Andres, Christian/0000-0002-5062-3156				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chiurazzi P, 2001, EUR J HUM GENET, V9, P71, DOI 10.1038/sj.ejhg.5200603; Claes S, 1997, AM J MED GENET, V73, P474; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Fukami M, 2000, AM J HUM GENET, V67, P563, DOI 10.1086/303047; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Rao A, 2000, NAT NEUROSCI, V3, P747, DOI 10.1038/77636; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SPARROW SS, 1985, VINELAND ADAPTATIVE; Stevenson RE, 2002, CYTOGENET GENOME RES, V99, P265, DOI 10.1159/000071603; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Thomas NS, 1999, HUM GENET, V104, P43, DOI 10.1007/s004390050908; Wechsler D., 1989, MANUAL WECHSLER PRES; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; Wechsler D, 1997, WECHSLER ADULT INTEL	29	555	582	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					552	557		10.1086/382137	http://dx.doi.org/10.1086/382137			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14963808	Green Published, Bronze			2022-12-18	WOS:000220118500021
J	Price, AL; Kryukov, GV; de Bakker, PIW; Purcell, SM; Staples, J; Wei, LJ; Sunyaev, SR				Price, Alkes L.; Kryukov, Gregory V.; de Bakker, Paul I. W.; Purcell, Shaun M.; Staples, Jeff; Wei, Lee-Jen; Sunyaev, Shamil R.			Pooled Association Tests for Rare Variants in Exon-Resequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTRIBUTE; ALLELES; CAPTURE; SERVER	Deep sequencing will soon generate comprehensive sequence information in large disease samples. Although the power to detect association with an individual rare variant is limited, pooling variants by gene or pathway into a composite test provides an alternative strategy for identifying susceptibility genes. We describe a statistical method for detecting association of multiple rare variants in protein-coding genes with a quantitative or dichotomous trait. The approach is based on the regression of phenotypic values on individuals' genotype scores subject to a variable allele-frequency threshold, incorporating computational predictions of the functional effects of missense variants. Statistical significance is assessed by permutation testing with variable thresholds. We used a rigorous population-genetics simulation framework to evaluate the power of the method, and we applied the method to empirical sequencing data from three disease studies.	[Price, Alkes L.; Kryukov, Gregory V.; de Bakker, Paul I. W.; Purcell, Shaun M.; Staples, Jeff; Sunyaev, Shamil R.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.; Wei, Lee-Jen] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kryukov, Gregory V.; de Bakker, Paul I. W.; Staples, Jeff; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Purcell, Shaun M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sunyaev, SR (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.	ssunyaev@rics.bwh.harvard.edu	Wei, Lee-Jen/CAI-0175-2022; de Bakker, Paul IW/B-8730-2009; Kryukov, Gregory V/A-9592-2008	de Bakker, Paul IW/0000-0001-7735-7858; Kryukov, Gregory/0000-0002-6131-9483	NIH [R01 MH084676, R01 GM078598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to J. Cohen for sharing data from <SUP>14</SUP> and to L. Pennacchio for sharing data from <SUP>11</SUP>. This work was funded by NIH grants R01 MH084676 and R01 GM078598.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248	19	553	567	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					832	838		10.1016/j.ajhg.2010.04.005	http://dx.doi.org/10.1016/j.ajhg.2010.04.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20471002	Green Published, Bronze			2022-12-18	WOS:000278948900001
J	Robinson, PN; Kohler, S; Bauer, S; Seelow, D; Horn, D; Mundlos, S				Robinson, Peter N.; Koehler, Sebastian; Bauer, Sebastian; Seelow, Dominik; Horn, Denise; Mundlos, Stefan			The Human Phenotype Ontology: A Tool for Annotating and Analyzing Human Hereditary Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONLINE MENDELIAN INHERITANCE; GENE-ONTOLOGY; MAN OMIM; PROTEIN; INTERACTOME; NETWORK	There are many thousands of hereditary diseases in humans, each of which has a specific combination of phenotypic features, but computational analysis of phenotypic data has been hampered by lack of adequate computational data structures. Therefore, we have developed a Human Phenotype Ontology (HPO) with over 8000 terms representing individual phenotypic anomalies and have annotated all clinical entries in Online Mendelian Inheritance in Man with the terms of the HPO. We show that the HPO is able to Capture phenotypic similarities between diseases in a useful and highly significant fashion.	[Robinson, Peter N.; Koehler, Sebastian; Bauer, Sebastian; Seelow, Dominik; Horn, Denise; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Robinson, Peter N.; Koehler, Sebastian; Mundlos, Stefan] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Seelow, Dominik] Charite Univ Med Berlin, Dept Neuropaediat, D-13353 Berlin, Germany; [Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Robinson, PN (corresponding author), Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de	Seelow, Dominik/HGB-3124-2022; Köhler, Sebastian/A-2029-2012; Köhler, Sebastian/H-3301-2019; Mundlos, Stefan/ABH-9585-2020	Seelow, Dominik/0000-0002-9746-4412; Köhler, Sebastian/0000-0002-5316-1399; Köhler, Sebastian/0000-0002-5316-1399; Mundlos, Stefan/0000-0002-9788-3166; Robinson, Peter/0000-0002-0736-9199	Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Bundesministerium fur Bildung und Forschung [0313911]; Deutsche Forschungsgemeinschaft [SFB 760]	Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) (Bundesministerium fur Bildung und Forschung, project number 0313911) and the Deutsche Forschungsgemeinschaft (SFB 760).	Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bajdik CD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-78; Bodenreider O, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P61; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lu Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn434; Lussier Yves A, 2007, Proc Am Thorac Soc, V4, P18, DOI 10.1513/pats.200607-142JG; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masseroli M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S18; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585	28	552	566	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					610	615		10.1016/j.ajhg.2008.09.017	http://dx.doi.org/10.1016/j.ajhg.2008.09.017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18950739	Green Published, Bronze			2022-12-18	WOS:000261006900007
J	Yang, N; MacArthur, DG; Gulbin, JP; Hahn, AG; Beggs, AH; Easteal, S; North, K				Yang, N; MacArthur, DG; Gulbin, JP; Hahn, AG; Beggs, AH; Easteal, S; North, K			ACTN3 genotype is associated with human elite athletic performance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANGIOTENSIN-CONVERTING ENZYME; SKELETAL-MUSCLE; LINKAGE DISEQUILIBRIUM; I/D POLYMORPHISM; ALPHA-ACTININ; HUMAN GENOME; CATHEPSIN-F; HUMAN GENE; POPULATION; LOCALIZATION	There is increasing evidence for strong genetic influences on athletic performance and for an evolutionary "tradeoff" between performance traits for speed and endurance activities. We have recently demonstrated that the skeletal-muscle actin-binding protein alpha-actinin-3 is absent in 18% of healthy white individuals because of homozygosity for a common stop-codon polymorphism in the ACTN3 gene, R577X. alpha-Actinin-3 is specifically expressed in fast-twitch myofibers responsible for generating force at high velocity. The absence of a disease phenotype secondary to alpha-actinin-3 deficiency is likely due to compensation by the homologous protein, alpha-actinin-2. However, the high degree of evolutionary conservation of ACTN3 suggests function(s) independent of ACTN2. Here, we demonstrate highly significant associations between ACTN3 genotype and athletic performance. Both male and female elite sprint athletes have significantly higher frequencies of the 577R allele than do controls. This suggests that the presence of alpha-actinin-3 has a beneficial effect on the function of skeletal muscle in generating forceful contractions at high velocity, and provides an evolutionary advantage because of increased sprint performance. There is also a genotype effect in female sprint and endurance athletes, with higher than expected numbers of 577RX heterozygotes among sprint athletes and lower than expected numbers among endurance athletes. The lack of a similar effect in males suggests that the ACTN3 genotype affects athletic performance differently in males and females. The differential effects in sprint and endurance athletes suggests that the R577X polymorphism may have been maintained in the human population by balancing natural selection.	Childrens Hosp Westmead, Inst Neuromuscular Res, Westmead, NSW 2145, Australia; Univ Sydney, Discipline Paediat & Child Hlth, Fac Med, Sydney, NSW 2006, Australia; Australian Natl Univ, Australian Inst Sport, Canberra, ACT, Australia; Australian Natl Univ, John Curtin Sch Med Res, Human Genet Grp, Canberra, ACT 2601, Australia; Childrens Hosp, Div Genet, Boston, MA 02115 USA	University of Sydney; University of Sydney; Australian Institute of Sport; Australian National University; Australian National University; John Curtin School of Medical Research; Harvard University; Boston Children's Hospital	North, K (corresponding author), Childrens Hosp Westmead, Inst Neuromuscular Res, Locked Bag 4001, Westmead, NSW 2145, Australia.		MacArthur, Daniel/E-3275-2010; North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Easteal, Simon/0000-0002-0462-502X; Beggs, Alan/0000-0001-8818-0568; MacArthur, Daniel/0000-0002-5771-2290				Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Chowrashi P, 2002, CELL MOTIL CYTOSKEL, V53, P125, DOI 10.1002/cm.10059; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; GARLAND T, 1990, EXPERIENTIA, V46, P530, DOI 10.1007/BF01954257; Gayagay G, 1998, HUM GENET, V103, P48, DOI 10.1007/s004390050781; Gizak A, 2003, HISTOL HISTOPATHOL, V18, P135, DOI 10.14670/HH-18.135; Huttley GA, 2000, GENETICS, V156, P2127; KAPLAN NL, 1989, GENETICS, V123, P887; Miller RG, 2001, AMYOTROPH LATERAL SC, V2, P3, DOI 10.1080/146608201300079355; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Myerson S, 1999, J APPL PHYSIOL, V87, P1313, DOI 10.1152/jappl.1999.87.4.1313; Nazarov IB, 2001, EUR J HUM GENET, V9, P797, DOI 10.1038/sj.ejhg.5200711; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Rankinen T, 2002, MED SCI SPORT EXER, V34, P1219, DOI 10.1097/00005768-200208000-00001; Rankinen T, 2000, J APPL PHYSIOL, V88, P1571, DOI 10.1152/jappl.2000.88.5.1571; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; SIMONEAU JA, 1995, FASEB J, V9, P1091, DOI 10.1096/fasebj.9.11.7649409; Taylor RR, 1999, J APPL PHYSIOL, V87, P1035, DOI 10.1152/jappl.1999.87.3.1035; Van Damme R, 2002, NATURE, V415, P755, DOI 10.1038/415755b; Wang B, 1998, J BIOL CHEM, V273, P32000, DOI 10.1074/jbc.273.48.32000; Woods D, 2001, HUM GENET, V108, P230, DOI 10.1007/s004390100466	27	546	586	4	116	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					627	631		10.1086/377590	http://dx.doi.org/10.1086/377590			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12879365	Bronze, Green Published			2022-12-18	WOS:000185134000014
J	Jacquemont, S; Hagerman, RJ; Leehey, M; Grigsby, J; Zhang, L; Brunberg, JA; Greco, C; Des Portes, V; Jardini, T; Levine, R; Berry-Kravis, E; Brown, WT; Schaeffer, S; Kissel, J; Tassone, F; Hagerman, PJ				Jacquemont, S; Hagerman, RJ; Leehey, M; Grigsby, J; Zhang, L; Brunberg, JA; Greco, C; Des Portes, V; Jardini, T; Levine, R; Berry-Kravis, E; Brown, WT; Schaeffer, S; Kissel, J; Tassone, F; Hagerman, PJ			Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-SYSTEM ATROPHY; RAPID ANTIBODY-TEST; FEMALE CARRIERS; FMR1 GENE; INVOLVEMENT; TRANSCRIPTION; CEREBELLAR; POPULATION; EXPRESSION; PHENOTYPE	We present a series of 26 patients, all >50 years of age, who are carriers of the fragile X premutation and are affected by a multisystem, progressive neurological disorder. The two main clinical features of this new syndrome are cerebellar ataxia and/or intention tremor, which were chosen as clinical inclusion criteria for this series. Other documented symptoms were short-term memory loss, executive function deficits, cognitive decline, parkinsonism, peripheral neuropathy, lower limb proximal muscle weakness, and autonomic dysfunction. Symmetrical regions of increased T2 signal intensity in the middle cerebellar peduncles and adjacent cerebellar white matter are thought to be highly sensitive for this neurologic condition, and their presence is the radiological inclusion criterion for this series. Molecular findings include elevated mRNA and low-normal or mildly decreased levels of fragile X mental retardation 1 protein. The clinical presentation of these patients, coupled with a specific lesion visible on magnetic resonance imaging and with neuropathological findings, affords a more complete delineation of this fragile X premutation-associated tremor/ataxia syndrome and distinguishes it from other movement disorders.	Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Rush Presbyterian St Lukes Med Ctr, Dept Pediat, Chicago, IL 60612 USA; New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; Ohio State Univ, Med Ctr, Dept Neurol, Columbus, OH 43210 USA; CHU Caen, Serv Neurol, F-14000 Caen, France; San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rush University; Institute for Basic Research in Developmental Disabilities; University System of Ohio; Ohio State University; CHU de Caen NORMANDIE; Universite de Caen Normandie; California State University System; San Diego State University	Hagerman, RJ (corresponding author), Univ Calif Davis, Med Ctr, MIND Inst, 4860 Y St,Suite 3020, Sacramento, CA 95817 USA.	randi.hagerman@ucdmc.udavis.edu	Brown, William/GXN-2777-2022; Jacquemont, Sebastien/AAS-5060-2021	Jacquemont, Sebastien/0000-0001-6838-8767	NICHD NIH HHS [HD 36071, R01 HD036071] Funding Source: Medline; NINDS NIH HHS [NS 43532, R01 NS043532] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043532] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Bhattacharya K, 2002, ARCH NEUROL-CHICAGO, V59, P835, DOI 10.1001/archneur.59.5.835; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371; DORN MB, 1994, J AM ACAD CHILD PSY, V33, P256, DOI 10.1097/00004583-199402000-00015; Fahn S., 1987, RECENT DEV PARKINSON, P153; FAHN S, 1998, PARKINSONS DIS MOVEM, P225; Franke P, 1996, AM J MED GENET, V64, P334, DOI 10.1002/(SICI)1096-8628(19960809)64:2<334::AID-AJMG20>3.0.CO;2-F; Franke P, 1998, PSYCHIAT RES, V80, P113, DOI 10.1016/S0165-1781(98)00055-9; Goodglass H., 1983, ASSESSMENT APHASIA R, V2; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Grigsby J, 1998, J AM GERIATR SOC, V46, P590, DOI 10.1111/j.1532-5415.1998.tb01075.x; HAGERMAN PJ, 2002, AM J HUM GENET S, V71, pA508; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Leehey MA, 2003, ARCH NEUROL-CHICAGO, V60, P117, DOI 10.1001/archneur.60.1.117; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Naka H, 2002, NEURORADIOLOGY, V44, P204, DOI 10.1007/s00234-001-0713-7; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Riddle JE, 1998, AM J MENT RETARD, V102, P590; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; SOBESKY WE, 1996, FRAGILE X SYNDROME D, P332; Spreen O., 1977, NEUROSENSORY CTR COM; Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2000, AM J MED GENET, V97, P195, DOI 10.1002/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; Willemsen R, 1997, HUM GENET, V99, P308, DOI 10.1007/s004390050363	36	546	559	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					869	878		10.1086/374321	http://dx.doi.org/10.1086/374321			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	662WT	12638084	Green Published, Bronze			2022-12-18	WOS:000181972600008
J	WARBURTON, D				WARBURTON, D			DENOVO BALANCED CHROMOSOME REARRANGEMENTS AND EXTRA MARKER CHROMOSOMES IDENTIFIED AT PRENATAL-DIAGNOSIS - CLINICAL-SIGNIFICANCE AND DISTRIBUTION OF BREAKPOINTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURAL CYTOGENETIC ABNORMALITIES; FRAGILE SITES; CONSTITUTIONAL REARRANGEMENTS; RECIPROCAL TRANSLOCATIONS; ANTENATAL DIAGNOSIS; MENTAL-RETARDATION; FOLLOW-UP; AMNIOCENTESIS; ASSOCIATION; AUTOSOMES	A questionnaire sent to major cytogenetics laboratories in the United States and Canada over a 10-year period collected data on the frequency and outcome of cases with either apparently balanced de novo rearrangements or de novo supernumerary marker chromosomes detected at amniocentesis. Of 377,357 reported amniocenteses, approximately 1/2,000 had a de novo reciprocal translocation, 1/9,000 a Robertsonian translocation, 1/10,000 a de novo inversion, and 1/2,500 an extra structurally abnormal chromosome of unidentifiable origin. The risk of a serious congenital anomaly was estimated to be 6.1% (n = 163) for de novo reciprocal translocations, 3.7% (n = 51) for Robertsonian translocations, and 9.4% (n = 32) for inversions. The combined risk for reciprocal translocations and inversions was 6.7% (95% confidence limits 3.1%-10.3%). The risk of abnormality for extra nonsatellited marker chromosomes was 14.7% (n = 68), and that for satellited marker chromosomes was 10.9% (n = 55). In non-Robertsonian rearrangements, distribution of breakpoints among chromosomes was not as would be expected strictly on the basis of length. Most breaks were stated to occur within G-negative bands, but there was little evidence of particular hot spots among these bands. Nevertheless, there did appear to be a correlation between those bands in which breakage was observed most often and those bands where common or rare fragile sites have been described.	COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10027	Columbia University; Columbia University								AURIAS A, 1978, HUM GENET, V45, P259, DOI 10.1007/BF00278725; BENN PA, 1984, AM J HUM GENET, V36, P1092; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BOGART MH, 1986, J MED GENET, V23, P180, DOI 10.1136/jmg.23.2.180; BOUE A, 1984, PRENATAL DIAG, V4, P45, DOI 10.1002/pd.1970040705; BREG WR, 1972, AM J DIS CHILD, V123, P561, DOI 10.1001/archpedi.1972.02110120085007; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; BUDARF M, 1989, AM J HUM GENET, V45, P128; CALLEN DF, 1990, AM J HUM GENET, V47, P493; CHEUNG SW, 1990, PRENATAL DIAG, V10, P717, DOI 10.1002/pd.1970101105; DANIEL A, 1986, PRENATAL DIAG, V6, P315, DOI 10.1002/pd.1970060502; DONNAI D, 1989, J MED GENET, V26, P545, DOI 10.1136/jmg.26.9.545; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; FRYNS JP, 1986, HUM GENET, V72, P1, DOI 10.1007/BF00278808; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; GARDNER JS, 1989, CHROMOSOME ABNORMALI; GRASS FS, 1987, PRENATAL DIAG, V7, P1, DOI 10.1002/pd.1970070102; HANSEN H, 1980, MENTAL RETARDATION D, V11, P21; HECHT F, 1984, CLIN GENET, V26, P174; HECHT F, 1984, CLIN GENET, V26, P169; HOOK EB, 1989, ANN HUM GENET, V53, P237, DOI 10.1111/j.1469-1809.1989.tb01790.x; HOOK EB, 1987, AM J HUM GENET, V40, P83; HOOK EB, 1987, ANN HUM GENET, V51, P27; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; JACOBS PA, 1974, J MED GENET, V11, P50, DOI 10.1136/jmg.11.1.50; KLECZKOWSKA A, 1989, CLIN GENET, V36, P65; KNIGHT LA, 1984, AM J MED GENET, V17, P649, DOI 10.1002/ajmg.1320170315; KODURU P, 1988, CYTOGENET CELL GENET, V49, P269, DOI 10.1159/000132675; MACGREGOR DJ, 1989, J MED GENET, V26, P590, DOI 10.1136/jmg.26.9.590; MINY P, 1986, PRENATAL DIAG, V6, P303, DOI 10.1002/pd.1970060411; MOHANDAS T, 1985, AM J MED GENET, V20, P361, DOI 10.1002/ajmg.1320200220; PHILIP N, 1988, Journal de Genetique Humaine, V36, P37; PUISSANT H, 1988, HUM GENET, V79, P280, DOI 10.1007/BF00366252; SACHS ES, 1987, PRENATAL DIAG, V7, P81, DOI 10.1002/pd.1970070204; SUTHERLAND GR, 1988, CANCER GENET CYTOGEN, V31, P9, DOI 10.1016/0165-4608(88)90004-0; SUTHERLAND GR, 1989, CYTOGENET CELL GENET, V51, P452, DOI 10.1159/000132804; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; TIERNEY I, 1984, J MED GENET, V21, P45, DOI 10.1136/jmg.21.1.45; TRENT JM, 1989, CYTOGENET CELL GENET, V51, P533, DOI 10.1159/000132807; VANDYKE DL, 1983, AM J HUM GENET, V35, P301; WARBURTON D, 1984, PRENATAL DIAG, V4, P69, DOI 10.1002/pd.1970040706; WARBURTON D, 1987, American Journal of Human Genetics, V41, pA145; Warburton D, 1982, CLIN GENETICS PROBLE, P63; WASSMAN ER, 1989, AM J OBSTET GYNECOL, V161, P698; WOLFF F, 1986, GEBURTSH FRAUENHEILK, V46, P359, DOI 10.1055/s-2008-1035931	45	546	575	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					995	1013						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928105				2022-12-18	WOS:A1991GM87300011
J	MORAES, CT; SHANSKE, S; TRITSCHLER, HJ; APRILLE, JR; ANDREETTA, F; BONILLA, E; SCHON, EA; DIMAURO, S				MORAES, CT; SHANSKE, S; TRITSCHLER, HJ; APRILLE, JR; ANDREETTA, F; BONILLA, E; SCHON, EA; DIMAURO, S			MTDNA DEPLETION WITH VARIABLE TISSUE EXPRESSION - A NOVEL GENETIC ABNORMALITY IN MITOCHONDRIAL DISEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								We studied two related infants with a fatal mitochondrial disease, affecting muscle in one and liver in the other. Quantitative analysis revealed a severe depletion of mtDNA in affected tissues. This genetic abnormality was also observed in muscle of an unrelated infant with myopathy and in muscle and kidney of a fourth child with myopathy and nephropathy. Biochemistry, immunohistochemistry, and in situ hybridization showed that the depletion of mtDNA in muscle fibers was correlated with a respiratory chain defect and with lack of mitochondrially translated proteins. Although the differential tissue involvement in these infants suggests mtDNA heteroplasmy, sequence analysis of mtDNA replication origins did not reveal any abnormality that could account for the low copy number.	COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; TUFTS UNIV, DEPT BIOL, MEDFORD, MA 02155 USA	Columbia University; Columbia University; Tufts University			Andreetta, Francesca/J-9957-2018; Moraes, Carlos/AAT-3818-2021	Andreetta, Francesca/0000-0001-8239-8830; 	NINDS NIH HHS [NS 11766] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; APRILLE JR, 1985, ACHIEVEMENTS PERSPEC, P465; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; BOUSTANY RN, 1983, ANN NEUROL, V14, P462, DOI 10.1002/ana.410140411; BROSS K, 1972, HUMANGENETIK, V14, P137, DOI 10.1007/BF00273298; CASCIO SM, 1981, DEV BIOL, V83, P166, DOI 10.1016/S0012-1606(81)80019-X; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DESJARDINS P, 1986, SOMAT CELL MOLEC GEN, V12, P133, DOI 10.1007/BF01560660; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOLT IJ, 1990, AM J HUM GENET, V46, P428; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117; PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; PIKO L, 1970, DEV BIOL, V21, P257, DOI 10.1016/0012-1606(70)90071-0; POULTON J, 1989, LANCET, V1, P236; REIS RJS, 1983, J BIOL CHEM, V258, P9078; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; ROTIG A, 1989, LANCET, V1, P902; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMICKEL RD, 1977, PEDIATR RES, V11, P929, DOI 10.1203/00006450-197708000-00015; SCHMICKEL RD, 1973, PEDIATR RES, V7, P5, DOI 10.1203/00006450-197301000-00002; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Tzagoloff A, 1982, MITOCHONDRIA; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367; YOUNG BD, 1976, BIOCHIM BIOPHYS ACTA, V454, P539, DOI 10.1016/0005-2787(76)90279-3; YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	47	544	548	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					492	501						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998336				2022-12-18	WOS:A1991FK47000009
J	Feldmann, J; Prieur, AM; Quartier, P; Berquin, P; Certain, S; Cortis, E; Teillac-Hamel, D; Fischer, A; de Saint Basile, G				Feldmann, J; Prieur, AM; Quartier, P; Berquin, P; Certain, S; Cortis, E; Teillac-Hamel, D; Fischer, A; de Saint Basile, G			Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENCODING MEVALONATE KINASE; FAMILY; APOPTOSIS; PROTEIN; ACTIVATION; DOMAIN; MEMBER; CED-4; RASH	Chronic infantile neurological cutaneous and articular (CINCA) syndrome is a severe chronic inflammatory disease of early onset, characterized by cutaneous symptoms, central-nervous-system involvement, and arthropathy. In the present study, we report, in seven unrelated patients with CINCA syndrome, distinct missense mutations within the nucleotide-binding site of CIAS1, a gene encoding cryopyrin and previously shown to cause Muckle-Wells syndrome and familial cold urticaria. Because of the severe cartilage overgrowth observed in some patients with CINCA syndrome and the implications of polymorphonuclear cell infiltration in the cutaneous and neurological manifestations of this syndrome, the tissue-specific expression of CIAS1 was evaluated. A high level of expression of CIAS1 was found to be restricted to polymorphonuclear cells and chondrocytes. These findings demonstrate that CIAS1 missense mutations can result in distinct phenotypes with only a few overlapping symptoms and suggest that this gene may function as a potential inducer of apoptosis.	INSERM, U429, Unit Rech Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Hop Necker Enfants Malad, Unite Immunohematol & Rhumatol Pediat, Paris, France; Hop Necker Enfants Malad, Dermatol Serv, Paris, France; Hosp Univ Nord, Neuropediat Ctr, Amiens, France; Ospidale Pediat Bambino Gesu, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; IRCCS Bambino Gesu	de Saint Basile, G (corresponding author), INSERM, U429, Unit Rech Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France.	sbasile@necker.fr	de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269; Quartier, Pierre/0000-0002-1769-549X; DOGNIAUX, Stephanie/0000-0003-3309-1204				Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; Cuisset L, 1999, AM J HUM GENET, V65, P1054, DOI 10.1086/302589; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Falcon-Perez JM, 2001, J BACTERIOL, V183, P4761, DOI 10.1128/JB.183.16.4761-4770.2001; HASSINK SG, 1983, ARTHRITIS RHEUM, V26, P668, DOI 10.1002/art.1780260515; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Martin Seamus J., 2001, Trends in Cell Biology, V11, P188, DOI 10.1016/S0962-8924(01)01971-7; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; MUCKLE TJ, 1979, BRIT J DERMATOL, V100, P87, DOI 10.1111/j.1365-2133.1979.tb03572.x; Prieur A M, 1987, Scand J Rheumatol Suppl, V66, P57; Prieur AM, 2001, CLIN EXP RHEUMATOL, V19, P103; PRIEUR AM, 1981, J PEDIATR-US, V99, P79, DOI 10.1016/S0022-3476(81)80961-4; TORBIAK RP, 1989, SKELETAL RADIOL, V18, P359, DOI 10.1007/BF00361425; ZIP CM, 1993, CLIN EXP DERMATOL, V18, P338, DOI 10.1111/j.1365-2230.1993.tb02212.x; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	24	542	572	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					198	203		10.1086/341357	http://dx.doi.org/10.1086/341357			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12032915	Bronze, Green Published			2022-12-18	WOS:000176307700023
J	Browning, BL; Zhou, Y; Browning, SR				Browning, Brian L.; Zhou, Ying; Browning, Sharon R.			A One-Penny Imputed Genome from Next-Generation Reference Panels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE IMPUTATION; WIDE ASSOCIATION; GENETIC-VARIATION; HAPLOTYPE MAP; POPULATIONS	Genotype imputation is commonly performed in genome-wide association studies because it greatly increases the number of markers that can be tested for association with a trait. In general, one should perform genotype imputation using the largest reference panel that is available because the number of accurately imputed variants increases with reference panel size. However, one impediment to using larger reference panels is the increased computational cost of imputation. We present a new genotype imputation method, Beagle 5.0, which greatly reduces the computational cost of imputation from large reference panels. We compare Beagle 5.0 with Beagle 4.1, Impute4, Minimac3, and Minimac4 using 1000 Genomes Project data, Haplotype Reference Consortium data, and simulated data for 10k, 100k, 1M, and 10M reference samples. All methods produce nearly identical accuracy, but Beagle 5.0 has the lowest computation time and the best scaling of computation time with increasing reference panel size. For 10k, 100k, 1M, and 10M reference samples and 1,000 phased target samples, Beagle 5.0' s computation time is 33 (10k), 123 (100k), 433 (1M), and 5333 (10M) faster than the fastest alternative method. Cost data from the Amazon Elastic Compute Cloud show that Beagle 5.0 can perform genome-wide imputation from 10M reference samples into 1,000 phased target samples at a cost of less than one US cent per sample.	[Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Browning, Brian L.; Zhou, Ying; Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, BL (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.; Browning, BL (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	browning@uw.edu	Browning, Brian/ABC-4543-2021; Zhou, Ying/AAT-2949-2020; Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010	Zhou, Ying/0000-0002-8107-3927; Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633	National Human Genome Research Institute of the National Institutes of Health [R01HG008359]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008359] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under award number R01HG008359. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Brody JA, 2017, NAT GENET, V49, P1560, DOI 10.1038/ng.3968; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Lappalainen I, 2015, NAT GENET, V47, P692, DOI 10.1038/ng.3312; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li N, 2003, GENETICS, V165, P2213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McClure Matthew, 2012, Frontiers in Genetics, V3, P140, DOI 10.3389/fgene.2012.00140; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	32	529	542	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					338	348		10.1016/j.ajhg.2018.07.015	http://dx.doi.org/10.1016/j.ajhg.2018.07.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30100085	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000443819500003
J	Spielman, RS; Ewens, WJ				Spielman, RS; Ewens, WJ			A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; DEPENDENT DIABETES-MELLITUS; INSULIN GENE; DISEASE; TDT; SUSCEPTIBILITY; REGION; IDDM	Linkage analysis with genetic markers has been successful in the localization of genes for many monogenic human diseases. In studies of complex diseases, however, tests that rely on linkage disequilibrium (the simultaneous presence of linkage and association) are often more powerful than those that rely on linkage alone. This advantage is illustrated by the transmission/disequilibrium test (TDT). The TDT requires data (marker genotypes) for affected individuals and their parents; for some diseases, however, data from parents may be difficult or impossible to obtain. In this article, we describe a method, called the "sib TDT" (or "S-TDT"), that overcomes this problem by use of marker data from unaffected sibs instead of from parents, thus allowing application of the principle of the TDT to sibships without parental data. In a single collection of families, there might be some that can be analyzed only by the TDT and others that are suitable for analysis by the S-TDT. We show how all the data may be used jointly in one overall TDT-type procedure that tests for linkage in the presence of association, These extensions of the TDT will be valuable for the study of diseases of late onset, such as non-insulin-dependent diabetes, cardiovascular diseases, and other diseases associated with aging.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ewens, WJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.				NIDDK NIH HHS [DK46618, DK47481] Funding Source: Medline; NIGMS NIH HHS [GM21135] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046618, R01DK047481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021135] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; CURTIS D, 1995, AM J HUM GENET, V56, P811; Duffy DL, 1995, GENET EPIDEMIOL, V12, P595, DOI 10.1002/gepi.1370120612; EWENS WJ, 1995, AM J HUM GENET, V57, P455; EWENS WJ, 1997, CURRENT PROTOCOLS S, V15; Harley JB, 1995, GENET EPIDEMIOL, V12, P607, DOI 10.1002/gepi.1370120614; Hodge SE, 1995, GENET EPIDEMIOL, V12, P545, DOI 10.1002/gepi.1370120604; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; McGinnis RE, 1995, GENET EPIDEMIOL, V12, P637, DOI 10.1002/gepi.1370120619; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	16	528	562	0	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					450	458		10.1086/301714	http://dx.doi.org/10.1086/301714			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463321	Green Published, hybrid			2022-12-18	WOS:000072416000028
J	Risch, N; Spiker, D; Lotspeich, L; Nouri, N; Hinds, D; Hallmayer, J; Kalaydjieva, L; McCague, P; Dimiceli, S; Pitts, T; Nguyen, L; Yang, J; Harper, C; Thorpe, D; Vermeer, S; Young, H; Hebert, J; Lin, A; Ferguson, J; Chiotti, C; Wiese-Slater, S; Rogers, T; Salmon, B; Nicholas, P; Petersen, PB; Pingree, C; McMahon, W; Wong, DL; Cavalli-Sforza, LL; Kraemer, HC; Myers, RM				Risch, N; Spiker, D; Lotspeich, L; Nouri, N; Hinds, D; Hallmayer, J; Kalaydjieva, L; McCague, P; Dimiceli, S; Pitts, T; Nguyen, L; Yang, J; Harper, C; Thorpe, D; Vermeer, S; Young, H; Hebert, J; Lin, A; Ferguson, J; Chiotti, C; Wiese-Slater, S; Rogers, T; Salmon, B; Nicholas, P; Petersen, PB; Pingree, C; McMahon, W; Wong, DL; Cavalli-Sforza, LL; Kraemer, HC; Myers, RM			A genomic screen of autism: Evidence for a multilocus etiology	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAGNOSTIC INTERVIEW; FAMILY HISTORY; COMPLEX TRAITS; LINKAGE; TWIN; GENETICS; CHROMOSOME; DISORDERS	We have conducted a genome screen of autism, by linkage analysis in an initial set of 90 multiplex sibships, with parents, containing 97 independent affected sib pairs (ASPs), with follow-up in 49 additional multiplex sibships, containing 50 ASPs. In total, 519 markers were genotyped, including 362 for the initial screen, and an additional 157 were genotyped in the follow-up. As a control, we also included in the analysis unaffected sibs, which provided 51 discordant sib pairs (DSPs) for the initial screen and 29 for the follow-up. In the initial phase of the work, we observed increased identity by descent (IBD) in the ASPs (sharing of 51.6%) compared with the DSPs (sharing of 50.8%). The excess sharing in the ASPs could not be attributed to the effect of a small number of loci but, rather, was due to the modest increase in the entire distribution of IBD. These results are most compatible with a model specifying a large number of loci (perhaps greater than or equal to 15) and are less compatible with models specifying less than or equal to 10 loci. The largest LOD score obtained in the initial scan was for a marker on chromosome 1p; this region also showed positive sharing in the replication family set, giving a maximum multipoint LOD score of 2.15 for both sets combined. Thus, there may exist a gene of moderate effect in this region. We had only modestly positive or negative linkage evidence in candidate regions identified in other studies. Our results suggest that positional cloning of susceptibility loci by linkage analysis may be a formidable task and that other approaches may be necessary.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Univ Western Australia, Graylands Hosp, Ctr Clin Res Neuropsychiat, Perth, WA 6009, Australia; Edith Cowan Univ, Ctr Human Genet, Perth, WA 6009, Australia; Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA	Stanford University; Stanford University; University of Western Australia; Edith Cowan University; Utah System of Higher Education; University of Utah	Risch, N (corresponding author), Stanford Univ, Sch Med, Dept Genet, M322, Stanford, CA 94305 USA.		Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880	NIMH NIH HHS [MH39437, MH52708, MH00219] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH039437, R01MH052708] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Cook EH, 1997, AM J HUM GENET, V60, P928; Feinstein C, 1998, J AUTISM DEV DISORD, V28, P393, DOI 10.1023/A:1026000404855; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; GILLBERG C, 1991, J AM ACAD CHILD PSY, V30, P489, DOI 10.1097/00004583-199105000-00022; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Hallmayer J, 1996, ARCH GEN PSYCHIAT, V53, P985; HANSON DR, 1976, J AUTISM CHILD SCHIZ, V6, P209, DOI 10.1007/BF01543463; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; JORDE LB, 1990, AM J MED GENET, V36, P85, DOI 10.1002/ajmg.1320360116; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kanner L, 1943, NERV CHILD, V2, P217; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Pericak-Vance MA, 1997, AM J HUM GENET, V61, pA40; PICKLES A, 1995, AM J HUM GENET, V57, P717; RISCH N, 1990, AM J HUM GENET, V46, P222; ROGERS T, IN PRESS J AUTISM DE; SALMON B, IN PRESS AM J MED GE; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; Smalley SL, 1998, J AUTISM DEV DISORD, V28, P407, DOI 10.1023/A:1026052421693; SPENCE MA, 1985, BEHAV GENET, V15, P1; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; VIELAND V, 1998, AM J HUM GENET, V63, pA16	36	526	550	0	28	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					493	507		10.1086/302497	http://dx.doi.org/10.1086/302497			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	223JA	10417292	Green Published, Bronze			2022-12-18	WOS:000081836900025
J	Chen, FC; Li, WH				Chen, FC; Li, WH			Genomic divergences between humans and other hominoids and the effective population size of the common ancestor of humans and chimpanzees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCE VARIATION; NUCLEOTIDE SUBSTITUTION; NONCODING REGION; MUTATION-RATE; EVOLUTION; PHYLOGENY; RATES; TIME; CLASSIFICATION; POLYMORPHISM	To study the genomic divergences among hominoids and to estimate the effective population size of the common ancestor of humans and chimpanzees, we selected 53 autosomal intergenic nonrepetitive DNA segments from the human genome and sequenced them in a human, a chimpanzee, a gorilla, and an orangutan. The average sequence divergence was only 1.24% +/- 0.07% for the human-chimpanzee pair, 1.62% +/- 0.08% for the human-gorilla pair, and 1.63% +/- 0.08% for the chimpanzee-gorilla pair. These estimates, which were confirmed by additional data from GenBank, are substantially lower than previous ones, which included repetitive sequences and might have been based on less-accurate sequence data. The average sequence divergences between orangutans and humans, chimpanzees, and gorillas were 3.08% +/- 0.11%, 3.12% +/- 0.11%, and 3.09% +/- 0.11%, respectively, which also are substantially lower than previous estimates. The sequence divergences in other regions between hominoids were estimated from extensive data in GenBank and the literature, and Alus showed the highest divergence, followed in order by Y-linked noncoding regions, pseudogenes, autosomal intergenic regions, X-linked noncoding regions, synonymous sites, introns, and nonsynonymous sites. The neighbor-joining tree derived from the concatenated sequence of the 53 segments-24,234 bp in length-supports the Homo-Pan clade with a 100% bootstrap value. However, when each segment is analyzed separately, 22 of the 53 segments (similar to 42%) give a tree that is incongruent with the species tree, suggesting a large effective population size (Ne) of the common ancestor of Homo and Pan. Indeed, a parsimony analysis of the 53 segments and 37 protein-coding genes leads to an estimate of N-e = 52,000 to 96,000. As this estimate is 5 to 9 times larger than the long-term effective population size of humans (similar to 10,000) estimated from various genetic polymorphism data, the human lineage apparently had experienced a large reduction in effective population size after its separation from the chimpanzee lineage. Our analysis assumes a molecular clock, which is in fact supported by the sequence data used. Taking the orangutan speciation date as 12 to 16 million years ago, we obtain an estimate of 4.6 to 6.2 million years for the Homo-Pan divergence and an estimate of 6.2 to 8.4 million years for the gorilla speciation date, suggesting that the gorilla lineage branched off 1.6 to 2.2 million years earlier than did the human-chimpanzee divergence.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	whli@uchicago.edu	Chen, Feng-Chi/E-3841-2010	Li, Wen-Hsiung/0000-0003-1086-1456	NIGMS NIH HHS [GM55759, R01 GM030998, GM30998, R37 GM030998] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055759, R01GM030998, R37GM030998] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY WJ, 1991, MOL BIOL EVOL, V8, P155; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; DURET L, 1994, NUCLEIC ACIDS RES, V22, P2360, DOI 10.1093/nar/22.12.2360; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GOODMAN M, 1990, J MOL EVOL, V30, P260, DOI 10.1007/BF02099995; GOODMAN M, 1961, HUM BIOL, V33, P131; Graur D, 2000, FUNDAMENTALS MOL EVO; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; Jaruzelska J, 1999, MOL BIOL EVOL, V16, P1633, DOI 10.1093/oxfordjournals.molbev.a026076; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Li W.H., 1997, MOL EVOLUTION; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; MARUYAMA T, 1980, P NATL ACAD SCI-BIOL, V77, P6710, DOI 10.1073/pnas.77.11.6710; Nachman MW, 2000, GENETICS, V156, P297; NEI M, 1984, EVOL BIOL, V17, P73; Nei M., 1986, Progress in Clinical and Biological Research, V218, P133; Nowak R.M., 1983, WALKERS MAMMALS WORL, VI; Reynolds V., 1965, pUnpaginated; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; SIBLEY CG, 1987, J MOL EVOL, V26, P99, DOI 10.1007/BF02111285; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; WU CI, 1991, GENETICS, V127, P429; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; XIA X, 2000, DATA ANAL MOL BIOL E; YU N, IN PRESS MOL BIOL EV; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	41	525	542	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					444	456		10.1086/318206	http://dx.doi.org/10.1086/318206			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170892	Green Published, Bronze			2022-12-18	WOS:000166524800014
J	Parmigiani, G; Berry, DA; Aguilar, O				Parmigiani, G; Berry, DA; Aguilar, O			Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; MUTATIONS	Breast cancer-susceptibility genes BRCA1 and BRCA2 have recently been identified on the human genome. Women who carry a mutation of one of these genes have a greatly increased chance of developing breast and ovarian cancer, and they usually develop the disease at a much younger age, compared with normal individuals. Women can be tested to see whether they are carriers. A woman who undergoes genetic counseling before testing can be told the probabilities that she is a carrier, given her family history. In this paper we develop a model for evaluating the probabilities that a woman is a carrier of a mutation of BRCA1 and BRCA2, on the basis of her family history of breast and ovarian cancer in first- and second-degree relatives. Of special importance are the relationships of the family members with cancer, the ages at onset of the diseases, and the ages of family members who do not have the diseases. This information can be elicited during genetic counseling and prior to genetic testing. The carrier probabilities are obtained from Bayes's rule, by use of family history as the evidence and by use of the mutation prevalences as the prior distribution, In addressing an individual's carrier probabilities, we incorporate uncertainty about some of the key inputs of the model, such as the age-specific incidence of diseases and the overall prevalence of mutations. There is some evidence that other, undiscovered genes may be important in explaining familial breast cancer. Users of the current version of the model should be aware of this limitation. The methodology that we describe can be extended to more than two genes, should data become available about other genes.	Duke Univ, Inst Stat & Decis Sci, Durham, NC 27708 USA	Duke University	Parmigiani, G (corresponding author), Duke Univ, Inst Stat & Decis Sci, Durham, NC 27708 USA.	gp@isds.duke.edu						Andersen TI, 1996, ACTA ONCOL, V35, P407, DOI 10.3109/02841869609109913; BERRY DA, 1997, J NATL CANCER I, V89, P9; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; Falconer DS, 1996, QUANTITATIVE GENETIC; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Hakansson S, 1997, AM J HUM GENET, V60, P1068; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; HOUWINGDUISTERM.JJ, 1997, GENET EPIDEMIOL, V14, P530; LEAL SM, 1994, AM J HUM GENET, V54, P913; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOOLGAVKAR SH, 1979, J NATL CANCER I, V62, P493, DOI 10.1093/jnci/62.3.493; MURPHY EA, 1969, HUM HERED, V19, P126, DOI 10.1159/000152210; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Szolovits P., 1992, MEDINFO 92. Proceedings of the Seventh World Congress on Medical Informatics, P679; THOMPSON EA, 1991, IMA J MATH APPL MED, V8, P149; Thompson EA, 1986, PEDIGREE ANAL HUMAN; Vehmanen P, 1997, AM J HUM GENET, V60, P1050; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; YANCIK R, 1993, CANCER, V71, P517	29	524	534	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					145	158		10.1086/301670	http://dx.doi.org/10.1086/301670			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443863	Bronze, Green Published			2022-12-18	WOS:000072127900020
J	Tartaglia, M; Kalidas, K; Shaw, A; Song, XL; Musat, DL; van der Burgt, I; Brunner, HG; Bertola, DR; Crosby, A; Ion, A; Kucherlapati, RS; Jeffery, S; Patton, MA; Gelb, BD				Tartaglia, M; Kalidas, K; Shaw, A; Song, XL; Musat, DL; van der Burgt, I; Brunner, HG; Bertola, DR; Crosby, A; Ion, A; Kucherlapati, RS; Jeffery, S; Patton, MA; Gelb, BD			PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINE-PHOSPHATASE SHP-2; CELL LESION SYNDROME; TERMINAL SH2 DOMAIN; MOTH-EATEN MICE; RECEPTOR; KINASE; STIMULATION; MUTANT; SYP; EXPRESSION	Noonan syndrome (NS) is a developmental disorder characterized by facial dysmorphia, short stature, cardiac defects, and skeletal malformations. We recently demonstrated that mutations in PTPN11, the gene encoding the non-receptor-type protein tyrosine phosphatase SHP-2 (src homology region 2-domain phosphatase-2), cause NS, accounting for 50% of cases of this genetically heterogeneous disorder in a small cohort. All mutations were missense changes and clustered at the interacting portions of the amino-terminal src-homology 2 (N-SH2) and protein tyrosine phosphatase (PTP) domains. A gain of function was postulated as a mechanism for the disease. Here, we report the spectrum and distribution of PTPN11 mutations in a large, well-characterized cohort with NS. Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS. There was a significantly higher prevalence of mutations among familial cases than among sporadic ones. All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains, but defects also affected residues in the C-SH2 domain, as well as in the peptide linking the N-SH2 and C-SH2 domains. Genotype-phenotype analysis revealed that pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P < .01), whereas hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P < .005). The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups. A PTPN11 mutation was identified in a family inheriting Noonan-like/multiple giant-cell lesion syndrome, extending the phenotypic range of disease associated with this gene.	CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Ist Super Sanita, Lab Metab & Biochim Patol, I-00161 Rome, Italy; Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Univ Sao Paulo, Dept Pediat, Sao Paulo, Brazil; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Istituto Superiore di Sanita (ISS); St Georges University London; Radboud University Nijmegen; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard Medical School	Gelb, BD (corresponding author), CUNY Mt Sinai Sch Med, Dept Pediat, 1 Gustave Levy Pl,Box 1498, New York, NY 10029 USA.		Kucherlapati, Raju/ABC-8807-2021; Brunner, Han/C-9928-2013; Tartaglia, Marco/K-2955-2018; Bertola, Débora/I-5120-2016; Crosby, Andrew H/E-2218-2015	Tartaglia, Marco/0000-0001-7736-9672; Bertola, Débora/0000-0002-4701-6777; Crosby, Andrew H/0000-0003-3667-9054	NICHD NIH HHS [K24 HD001294, 5P30 HD 28822, 5K24 HD 001294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822, K24HD001294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Bertola D R, 2000, Arq Bras Cardiol, V75, P409, DOI 10.1590/S0066-782X2000001100005; Bertola DR, 2001, AM J MED GENET, V98, P230, DOI 10.1002/1096-8628(20010122)98:3<230::AID-AJMG1080>3.0.CO;2-K; Bradford T, 1997, ART CRITICISM, V12, P5; BURCH M, 1993, J AM COLL CARDIOL, V22, P1189, DOI 10.1016/0735-1097(93)90436-5; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Cohen M.M., 1974, SYNDR IDENT, V2, P14; COHEN MM, 1991, AM J MED GENET, V40, P159, DOI 10.1002/ajmg.1320400208; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Huyer G, 1998, BIOCHEMISTRY-US, V37, P2741, DOI 10.1021/bi9722913; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Legius E, 1998, EUR J HUM GENET, V6, P32, DOI 10.1038/sj.ejhg.5200150; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; NORA JJ, 1974, AM J DIS CHILD, V127, P48, DOI 10.1001/archpedi.1974.02110200050007; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SHAPIRO LM, 1983, J AM COLL CARDIOL, V2, P437, DOI 10.1016/S0735-1097(83)80269-1; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Stein-Gerlach M, 1998, INT J BIOCHEM CELL B, V30, P559, DOI 10.1016/S1357-2725(98)00002-8; Stofega MR, 2000, MOL ENDOCRINOL, V14, P1338, DOI 10.1210/me.14.9.1338; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; van der Burgt I, 2000, AM J MED GENET, V94, P46, DOI 10.1002/1096-8628(20000904)94:1<46::AID-AJMG10>3.0.CO;2-I; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs	41	522	559	2	26	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1555	1563		10.1086/340847	http://dx.doi.org/10.1086/340847			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992261	Green Published, Bronze			2022-12-18	WOS:000175445700016
J	Campion, D; Dumanchin, C; Hannequin, D; Dubois, B; Belliard, S; Puel, M; Thomas-Anterion, C; Michon, A; Martin, C; Charbonnier, F; Raux, G; Camuzat, A; Penet, C; Mesnage, V; Martinez, M; Clerget-Darpoux, F; Brice, A; Frebourg, T				Campion, D; Dumanchin, C; Hannequin, D; Dubois, B; Belliard, S; Puel, M; Thomas-Anterion, C; Michon, A; Martin, C; Charbonnier, F; Raux, G; Camuzat, A; Penet, C; Mesnage, V; Martinez, M; Clerget-Darpoux, F; Brice, A; Frebourg, T			Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNITED-STATES POPULATION; PRESENILIN-1 GENE; APOLIPOPROTEIN-E; FAMILIAL AGGREGATION; MISSENSE MUTATIONS; SEVERE DEMENTIA; PEDIGREE; AGE; IDENTIFICATION; ASSOCIATION	To determine the prevalence of early-onset Alzheimer disease (EOAD) and of autosomal dominant forms of EOAD (ADEOAD), we performed a population-based study in the city of Rouen (426,710 residents). EOAD was defined as onset of disease at age <61 years, and ADEOAD was defined as the occurrence of at least three EOAD cases in three generations. Using these stringent criteria, we calculated that the EOAD and ADEOAD prevalences per 100,000 persons at risk were 41.2 and 5.3, respectively. We then performed a mutational analysis of the genes for amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) in 34 families with ADEOAD ascertained in France. In 19 (56%) of these families, we identified 16 distinct PSEN1 missense mutations, including 4 (Thr147Ile, Trp165Cys, Leu173Trp, and Ser390Ile) not reported elsewhere; APP mutations, including a novel mutation located at codon 715, were identified in 5 (15%) of the families. In the 10 remaining ADEOAD families and in 9 additional autosomal dominant Alzheimer disease families that did not fulfill the strict criteria for ADEOAD, no PSEN1, PSEN2, or APP mutation was identified. These results show that (1) PSEN1 and APP mutations account for 71% of ADEOAD families and (2) nonpenetrance at age <61 years is probably infrequent for PSEN1 or APP mutations.	Inst Federatif Rech Multidisciplinaires Peptides, INSERM EPI 9906, Fac Med & Pharm, Rouen, France; Hop La Pitie Salpetriere, INSERM U289 & Federat Neurol, Paris, France; INSERM U358, Paris, France; INSERM U155, Paris, France; CHU Rennes, Hop Pontchaillou, Rennes, France; CHU Toulouse, Hop Purpan, Toulouse, France; Hop Bellevue, CHU St Etienne, St Etienne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU de Toulouse; CHU de St Etienne	Frebourg, T (corresponding author), Fac Med, INSERM EPI 9906, 22 Blvd Gambetta, F-76183 Rouen, France.	frebourg@chu-rouen.fr	Frebourg, Thierry/AAK-8390-2020; Martinez, Maria/B-3111-2013; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019; Clerget-Darpoux, Francoise/I-4825-2017	Martinez, Maria/0000-0003-2180-4537; brice, alexis/0000-0002-0941-3990; Clerget-Darpoux, Francoise/0000-0003-4816-6619; CHARBONNIER, Francoise/0000-0002-4875-2506				Aldudo J, 1998, NEUROSCI LETT, V240, P174, DOI 10.1016/S0304-3940(97)00950-6; Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Aoki M, 1997, NEUROLOGY, V48, P1118, DOI 10.1212/WNL.48.4.1118; Axelman K, 1998, ARCH NEUROL-CHICAGO, V55, P698, DOI 10.1001/archneur.55.5.698; CAMPION D, 1995, AM J MED GENET, V60, P221, DOI 10.1002/ajmg.1320600310; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; Campion D, 1996, J MED GENET, V33, P661, DOI 10.1136/jmg.33.8.661; CAMPION D, 1995, NEUROLOGY, V45, P80, DOI 10.1212/WNL.45.1.80; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Crook R, 1997, ANN NEUROL, V42, P124, DOI 10.1002/ana.410420121; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Dermaut B, 1999, AM J HUM GENET, V64, P290, DOI 10.1086/302200; Dumanchin C, 1998, J MED GENET, V35, P672, DOI 10.1136/jmg.35.8.672; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FIDANI L, 1992, HUM MOL GENET, V1, P165, DOI 10.1093/hmg/1.3.165; Forsell C, 1997, NEUROSCI LETT, V234, P3, DOI 10.1016/S0304-3940(97)00603-4; Fox NC, 1997, BRAIN, V120, P491, DOI 10.1093/brain/120.3.491; GomezIsla T, 1997, ANN NEUROL, V41, P809, DOI 10.1002/ana.410410618; Harvey RJ, 1998, J NEUROL NEUROSUR PS, V64, P44, DOI 10.1136/jnnp.64.1.44; HIXSON JE, 1990, J LIPID RES, V31, P545; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; KOKMEN E, 1989, NEUROLOGY, V39, P773, DOI 10.1212/WNL.39.6.773; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; Lendon CL, 1997, HUM MUTAT, V10, P186; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Martinez M, 1998, ARCH NEUROL-CHICAGO, V55, P810, DOI 10.1001/archneur.55.6.810; Mattila KM, 1998, ANN NEUROL, V44, P965, DOI 10.1002/ana.410440617; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; PerezTur J, 1995, AM J MED GENET, V60, P550, DOI 10.1002/ajmg.1320600613; PerezTur J, 1995, NEUROREPORT, V7, P297; Poorkaj P, 1998, HUM MUTAT, V11, P216, DOI 10.1002/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.3.CO;2-O; ROHAN DHA, 1997, NEUROREPORT, V8, pR1; Rossor MN, 1996, LANCET, V347, P1560, DOI 10.1016/S0140-6736(96)90715-1; Sandbrink R, 1996, ANN NEUROL, V40, P265, DOI 10.1002/ana.410400225; SCHOENBERG BS, 1985, ARCH NEUROL-CHICAGO, V42, P740, DOI 10.1001/archneur.1985.04210090004002; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; SULKAVA R, 1985, NEUROLOGY, V35, P1025, DOI 10.1212/WNL.35.7.1025; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; Wisniewski T, 1998, NEUROREPORT, V9, P217, DOI 10.1097/00001756-199801260-00008; Yasuda M, 1997, NEUROSCI LETT, V232, P29, DOI 10.1016/S0304-3940(97)00569-7	42	521	544	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					664	670		10.1086/302553	http://dx.doi.org/10.1086/302553			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441572	Green Published, Bronze			2022-12-18	WOS:000082426400010
J	Cox, GF; Burger, J; Lip, V; Mau, UA; Sperling, K; Wu, BL; Horsthemke, B				Cox, GF; Burger, J; Lip, V; Mau, UA; Sperling, K; Wu, BL; Horsthemke, B			Intracytoplasmic sperm injection may increase the risk of imprinting defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; ANGELMAN	In germ cells and the early embryo, the mammalian genome undergoes widespread epigenetic reprogramming. Animal studies suggest that this process is vulnerable to external factors. We report two children who were conceived by intracytoplasmic sperm injection (ICSI) and who developed Angelman syndrome. Molecular studies, including DNA methylation and microsatellite and quantitative Southern blot analysis, revealed a sporadic imprinting defect in both patients. We discuss the possibility that ICSI may interfere with the establishment of the maternal imprint in the oocyte or pre-embryo.	Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Humboldt Univ, Charite, Inst Humangenet, Berlin, Germany; Univ Tubingen, Inst Humangenet, Tubingen, Germany; Univ Essen Gesamthsch, Inst Humangenet, Essen, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; University of Duisburg Essen	Wu, BL (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	bai-lin.wu@tch.harvard.edu; b.horsthemke@uni-essen.de						Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Koulischer L, 1997, Early Pregnancy, V3, P164; Manning M, 2000, MOL HUM REPROD, V6, P1049, DOI 10.1093/molehr/6.11.1049; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Schumacher A, 1998, NAT GENET, V19, P324, DOI 10.1038/1211; Sutcliffe AG, 2001, LANCET, V357, P2080, DOI 10.1016/S0140-6736(00)05180-1; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zeschnigk M, 1997, EUR J HUM GENET, V5, P94, DOI 10.1159/000484740	11	520	549	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					162	164		10.1086/341096	http://dx.doi.org/10.1086/341096			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12016591	Green Published, Bronze			2022-12-18	WOS:000176307700016
J	KANG, SS; ZHOU, J; WONG, PWK; KOWALISYN, J; STROKOSCH, G				KANG, SS; ZHOU, J; WONG, PWK; KOWALISYN, J; STROKOSCH, G			INTERMEDIATE HOMOCYSTEINEMIA - A THERMOLABILE VARIANT OF METHYLENETETRAHYDROFOLATE REDUCTASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612	Rush University	KANG, SS (corresponding author), RUSH MED COLL,DEPT PEDIAT,1750 W HARRISON ST,CHICAGO,IL 60612, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036135] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36135] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COOPER BA, 1987, ANNU REV NUTR, V7, P291, DOI 10.1146/annurev.nu.07.070187.001451; DUNN RT, 1973, CLIN CHEM, V19, P1101; ERBE RW, 1986, FOLATE PTERINE, V3, P413; ERBE RW, 1979, ADV HUM GENET, P293; FABBRO D, 1987, AM J HUM GENET, V40, P15; HERBERT V, 1966, BLOOD-J HEMATOL, V28, P130; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; KANG SS, 1982, PEDIATR RES, V16, P370, DOI 10.1203/00006450-198205000-00010; KANG SS, 1979, PEDIATR RES, V13, P1141, DOI 10.1203/00006450-197910000-00012; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1986, J CLIN INVEST, V77, P1482, DOI 10.1172/JCI112461; KANG SS, 1987, METABOLISM, V36, P458, DOI 10.1016/0026-0495(87)90043-6; KANWAR YS, 1976, PEDIATR RES, V10, P598, DOI 10.1203/00006450-197606000-00008; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LOU K, 1965, BLOOD, V26, P202; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MUDD SH, 1972, BIOCHEM BIOPH RES CO, V46, P905; MUDD SH, 1983, METABOLIC BASIS INHE, P522; ROSENBERG LE, 1983, METABOLIC BASIS INHE, P474; ROSENBLATT DS, 1977, PEDIATR RES, V11, P1141, DOI 10.1203/00006450-197711000-00005; ROSENBLATT DS, 1977, PEDIATR RES, V11, P1137, DOI 10.1203/00006450-197711000-00004; Rowe PB, 1983, METABOLIC BASIS INHE, P498; RUDZKI Z, 1976, J LAB CLIN MED, V87, P859; SARDHARWALLA IB, 1974, ARCH DIS CHILD, V49, P553, DOI 10.1136/adc.49.7.553; SMOLIN LA, 1982, J NUTR, V112, P1264, DOI 10.1093/jn/112.7.1264; WONG PWK, 1977, PEDIATRICS, V59, P749; WONG PWK, 1977, J LAB CLIN MED, V90, P283	27	518	538	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					414	421						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177384				2022-12-18	WOS:A1988Q473600007
J	SUTHERLAND, GR				SUTHERLAND, GR			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .1. FACTORS AFFECTING EXPRESSION IN LYMPHOCYTE CULTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE 5006,S AUSTRALIA,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					BUHLER EM, 1970, HUMANGENETIK, V9, P97, DOI 10.1007/BF00696019; CECCARINI C, 1975, IN VITRO CELL DEV B, V11, P78; CHAUDHURI JP, 1972, CHROMOSOMES TODAY, V3, P147; DEKABAN A, 1965, J NUCL MED, V6, P740; EAGLE H, 1973, J CELL PHYSIOL, V82, P1, DOI 10.1002/jcp.1040820102; ERBE RW, 1975, NEW ENGL J MED, V293, P753, DOI 10.1056/NEJM197510092931506; FRACCARO M, 1972, CHROMOSOMES TODAY, V3, P138; KALLEN RG, 1966, J BIOL CHEM, V241, P5845; LITTLEFIELD JW, 1966, NATURE, V211, P250, DOI 10.1038/211250a0; MCDOUGALL JK, 1971, J GEN VIROL, V12, P43, DOI 10.1099/0022-1317-12-1-43; MCDOUGALL JK, 1973, NATURE-NEW BIOL, V245, P172, DOI 10.1038/newbio245172a0; NOEL B, 1977, EXP CELL RES, V104, P423, DOI 10.1016/0014-4827(77)90107-0; ODONOVAN GA, 1970, BACTERIOL REV, V34, P278, DOI 10.1128/MMBR.34.3.278-343.1970; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; ZUR HAUSEN HARALD, 1967, J VIROL, V1, P1174; 1975, BIRTH DEFECTS OAS, V11	17	518	521	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					125	135						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	36752				2022-12-18	WOS:A1979GZ38600004
J	Kyogoku, C; Langefeld, CD; Ortmann, WA; Lee, A; Selby, S; Carlton, VEH; Chang, M; Ramos, P; Baechler, EC; Batliwalla, FM; Novitzke, J; Williams, AH; Gillett, C; Rodine, P; Graham, RR; Ardlie, KG; Gaffney, PM; Moser, KL; Petri, M; Begovich, AB; Gregersen, PK; Behrens, TW				Kyogoku, C; Langefeld, CD; Ortmann, WA; Lee, A; Selby, S; Carlton, VEH; Chang, M; Ramos, P; Baechler, EC; Batliwalla, FM; Novitzke, J; Williams, AH; Gillett, C; Rodine, P; Graham, RR; Ardlie, KG; Gaffney, PM; Moser, KL; Petri, M; Begovich, AB; Gregersen, PK; Behrens, TW			Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELL SIGNAL-TRANSDUCTION; RHEUMATOID-ARTHRITIS; T-CELLS; KINASE; COHORT; MICE; PEP	We genotyped 525 independent North American white individuals with systemic lupus erythematosus (SLE) for the PTPN22 R620W polymorphism and compared the results with data generated from 1,961 white control individuals. The R620W SNP was associated with SLE (genotypic P=.00009), with estimated minor (T) allele frequencies of 12.67% in SLE cases and 8.64% in controls. A single copy of the T allele (W620) increases risk of SLE (odds ratio [OR]=1.37; 95% confidence interval [CI] 1.07-1.75), and two copies of the allele more than double this risk (OR=4.37; 95% CI 1.98-9.65). Together with recent evidence showing association of this SNP with type 1 diabetes and rheumatoid arthritis, these data provide compelling evidence that PTPN22 plays a fundamental role in regulating the immune system and the development of autoimmunity.	Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Wake Forest Univ, Bowman Gray Sch Med, Biostat Sect, Winston Salem, NC USA; N Shore Long Isl Jewish Res Inst, Robert S Boas Ctr Genom & Genet, Manhasset, NY USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Genom Collaborat Inc, Cambridge, MA USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; Northwell Health; Harvard University; Massachusetts General Hospital; Johns Hopkins University	Behrens, TW (corresponding author), Univ Minnesota, Sch Med, Dept Med, 6-126 Basic Sci Biomed Engn Bldg,312 Church St SE, Minneapolis, MN 55455 USA.	behre001@umn.edu	Gillespie, Emily/N-1265-2013	Gillespie, Emily/0000-0001-5261-3931; Gaffney, Patrick/0000-0002-1580-869X; Ramos, Paula/0000-0002-9433-6634	NCRR NIH HHS [M01 RR000052, M01-RR00052] Funding Source: Medline; NIAMS NIH HHS [R01 AR043727, R01 AR43727, R01 AR32274] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Kammer GM, 2002, ARTHRITIS RHEUM-US, V46, P1139, DOI 10.1002/art.10192; Khan Islam U, 2003, Curr Dir Autoimmun, V6, P89; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Petri M, 2000, RHEUM DIS CLIN N AM, V26, P199, DOI 10.1016/S0889-857X(05)70135-6; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Schultz Leonard D., 1993, Cell, V73, P1445; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1	15	514	531	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					504	507		10.1086/423790	http://dx.doi.org/10.1086/423790			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15273934	Green Published, Bronze			2022-12-18	WOS:000223272200015
J	THOMASSON, HR; EDENBERG, HJ; CRABB, DW; MAI, XL; JEROME, RE; LI, TK; WANG, SP; LIN, YT; LU, RB; YIN, SJ				THOMASSON, HR; EDENBERG, HJ; CRABB, DW; MAI, XL; JEROME, RE; LI, TK; WANG, SP; LIN, YT; LU, RB; YIN, SJ			ALCOHOL AND ALDEHYDE DEHYDROGENASE GENOTYPES AND ALCOHOLISM IN CHINESE MEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIVER ALCOHOL; CHROMOSOMAL ASSIGNMENT; METABOLISM; BLOOD; ETHANOL; POLYMORPHISM; ELIMINATION; JAPANESE; INDIANS; HYBRIDIZATION	The liver enzymes alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), which are responsible for the oxidative metabolism of ethanol, are polymorphic in humans. An allele encoding an inactive form of the mitochondrial ALDH2 is known to reduce the likelihood of alcoholism in Japanese. We hypothesized that the polymorphisms of both ALDH and ADH modify the predisposition to development of alcoholism. Therefore, we determined the genotypes of the ADH2, ADH3, and ALDH2 loci of alcoholic and nonalcoholic Chinese men living in Taiwan, using leukocyte DNA amplified by the PCR and allele-specific oligonucleotides. The alcoholics had significantly lower frequencies of the ADH2*2, ADH3*1, and ALDH2*2 alleles than did the nonalcoholics, suggesting that genetic variation in both ADH and ALDH, by modulating the rate of metabolism of ethanol and acetaldehyde, influences drinking behavior and the risk of developing alcoholism.	INDIANA UNIV, SCH MED, DEPT MED GENET, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, INDIANAPOLIS, IN 46202 USA; NATL DEF MED CTR, TRI SERV GEN HOSP, DEPT PSYCHIAT, TAIPEI, TAIWAN; NATL DEF MED CTR, TRI SERV GEN HOSP, DEPT BIOCHEM, TAIPEI, TAIWAN	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	THOMASSON, HR (corresponding author), INDIANA UNIV, SCH MED, DEPT MED, 975 W WALNUT ST, IB 424, INDIANAPOLIS, IN 46202 USA.			Edenberg, Howard/0000-0003-0344-9690	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006460, R37AA002342, R01AA006434, R37AA006434, R01AA002342, R37AA006460] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA02342, AA06460, AA06434] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BENNION LJ, 1976, NEW ENGL J MED, V294, P9, DOI 10.1056/NEJM197601012940103; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BOSRON WF, 1988, INT CONGR SER, V805, P31; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; GOEDDE HW, 1989, HUM GENET, V81, P305, DOI 10.1007/BF00283679; GOEDDE HW, 1979, HUM GENET, V51, P331; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; HARADA S, 1980, AM J HUM GENET, V32, P8; HARADA S, 1985, ALCOHOL, V2, P391, DOI 10.1016/0741-8329(85)90100-4; HARADA S, 1983, PHARMACOL BIOCHEM BE, V18, P151, DOI 10.1016/0091-3057(83)90163-6; HSU LC, 1986, AM J HUM GENET, V38, P641; Hsu LC, 1988, GENOMICS, V2, P57, DOI 10.1016/0888-7543(88)90109-7; KLATSKIN G, 1961, GASTROENTEROLOGY, V41, P443; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; KOPUN M, 1977, EUR J CLIN PHARMACOL, V11, P337, DOI 10.1007/BF00566530; LEE SC, 1989, J FORMOS MED ASSOC, V88, P437; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MARTIN NG, 1985, BEHAV GENET, V15, P93, DOI 10.1007/BF01065891; MIZOI Y, 1979, PHARMACOL BIOCHEM BE, V10, P303, DOI 10.1016/0091-3057(79)90105-9; MIZOI Y, 1985, ALCOHOL, V2, P393, DOI 10.1016/0741-8329(85)90101-6; RITCHIE JM, 1980, PHARMACOL BASIS THER, P376; SHIBUYA A, 1988, AM J HUM GENET, V43, P744; SHIBUYA A, 1989, HUM GENET, V82, P14, DOI 10.1007/BF00288263; SMITH M, 1986, ADV HUM GENET, V15, P249; SORENSEN TIA, 1984, LANCET, V2, P241, DOI 10.1016/S0140-6736(84)90295-2; TENG YS, 1979, HUM GENET, V53, P87, DOI 10.1007/BF00289455; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; TSUKAHARA M, 1989, GENOMICS, V4, P218, DOI 10.1016/0888-7543(89)90304-2; TSUKAMOTO S, 1989, ALCOHOL ALCOHOLISM, V24, P101, DOI 10.1093/oxfordjournals.alcalc.a044872; WAGNER JG, 1976, J PHARM SCI, V65, P152, DOI 10.1002/jps.2600650142; WOLFF PH, 1972, SCIENCE, V175, P449, DOI 10.1126/science.175.4020.449; XU Y, 1988, Genomics, V2, P209, DOI 10.1016/0888-7543(88)90004-3; YASUNAMI M, 1990, GENOMICS, V7, P152, DOI 10.1016/0888-7543(90)90535-3; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; YOSHIHARA H, 1983, PHARMACOL BIOCHEM BE, V18, P425, DOI 10.1016/0091-3057(83)90211-3; 1980, DIAGNOSTIC STATISTIC, P169	38	512	527	2	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					677	681						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014795				2022-12-18	WOS:A1991FK47800005
J	Martin, ER; Monks, SA; Warren, LL; Kaplan, NL				Martin, ER; Monks, SA; Warren, LL; Kaplan, NL			A test for linkage and association in general pedigrees: The pedigree disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; SIBSHIP TEST	Family-based tests of linkage disequilibrium typically are based on nuclear-family data including affected individuals and their parents or their unaffected siblings. A limitation of such tests is that they generally are not valid tests of association when data from related nuclear families from larger pedigrees are used. Standard methods require selection of a single nuclear family from any extended pedigrees when testing for linkage disequilibrium. Often data are available for larger pedigrees, and it would be desirable to have a valid test of linkage disequilibrium that can use all potentially informative data. In this study, we present the pedigree disequilibrium test (PDT) for analysis of linkage disequilibrium in general pedigrees. The PDT can use data from related nuclear families from extended pedigrees and is valid even when there is population substructure. Using computer simulations, we demonstrated validity of the test when the asymptotic distribution is used to assess the significance, and examined statistical power. Power simulations demonstrate that, when extended pedigree data are available, substantial gains in power can be attained by use of the PDT rather than existing methods that use only a subset of the data. Furthermore, the PDT remains more powerful even when there is misclassification of unaffected individuals. Our simulations suggest that there may be advantages to using the PDT even if the data consist of independent families without extended family information. Thus, the PDT provides a general test of linkage disequilibrium that can be widely applied to different data structures.	Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC 27710 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	Duke University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Martin, ER (corresponding author), Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Box 3468, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES044004] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Martin ER, 1999, AM J HUM GENET, V65, pA434; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Wilson A. F., 1996, American Journal of Human Genetics, V59, pA193	13	506	517	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					146	154		10.1086/302957	http://dx.doi.org/10.1086/302957			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10825280	Green Published, Bronze			2022-12-18	WOS:000088926900017
J	Soares, P; Ermini, L; Thomson, N; Mormina, M; Rito, T; Rohl, A; Salas, A; Oppenheimer, S; Macaulay, V; Richards, MB				Soares, Pedro; Ermini, Luca; Thomson, Noel; Mormina, Maru; Rito, Teresa; Roehl, Arne; Salas, Antonio; Oppenheimer, Stephen; Macaulay, Vincent; Richards, Martin B.			Correcting for Purifying Selection: An Improved Human Mitochondrial Molecular Clock	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							RIBOSOMAL-RNA GENES; TIME DEPENDENCY; GENOME VARIATION; MTDNA VARIATION; PHYLOGENETIC NETWORK; MACROHAPLOGROUP-M; MUTATION-RATES; CLIMATE-CHANGE; DNA-SEQUENCES; UPPER MIOCENE	There is currently no calibration available for the whole human mtDNA genome, incorporating both coding and control regions. Furthermore, as several authors have pointed out recently, linear molecular clocks that incorporate selectable characters are in any case problematic. We here confirm a modest effect of purifying selection on the mtDNA coding region and propose an improved molecular clock for dating human mtDNA, based on a worldwide phylogeny of > 2000 complete mtDNA genomes and calibrating against recent evidence for the divergence time of humans and chimpanzees. We focus on a time-dependent mutation rate based on the entire mtDNA genome and supported by a neutral clock based on synonymous mutations alone. We show that the corrected rate is further corroborated by archaeological dating for the settlement of the Canary Islands and Remote Oceania and also, given certain phylogeographic assumptions, by the timing of the first modern human settlement of Europe and resettlement after the Last Glacial Maximum. The corrected rate yields an age of modern human expansion in the Americas at similar to 15 kya that-unlike the uncorrected clock matches the archaeological evidence, but continues to indicate an out-of-Africa dispersal at around 55-70 kya, 5-20 ky before any clear archaeological record, suggesting the need for archaeological research efforts focusing on this time window. We also present improved rates for the mtDNA control region, and the first comprehensive estimates of positional mutation rates for human mtDNA, which are essential for defining mutation models in phylogenetic analyses.	[Soares, Pedro; Ermini, Luca; Mormina, Maru; Richards, Martin B.] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; [Ermini, Luca] Univ Camerino, Lab Archeoantropol Mol DNA Ant, I-62032 Camerino, Italy; [Thomson, Noel; Macaulay, Vincent] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland; [Mormina, Maru] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Rito, Teresa] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Roehl, Arne] Fluxus Technol, Clare CO10 8NN, Suffolk, England; [Salas, Antonio] Univ Santiago de Compostela, Unidad Xenet, Inst Med Legal, Fac Med, Santiago De Compostela 15782, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patol & Ciencias Forenses, Fac Med, Santiago De Compostela 15782, Galicia, Spain; [Oppenheimer, Stephen] Univ Oxford, Sch Anthropol, Oxford OX2 6PN, England	University of Leeds; University of Camerino; University of Glasgow; University of Cambridge; Liverpool School of Tropical Medicine; University of Liverpool; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Oxford	Richards, MB (corresponding author), Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England.	m.b.richards@leeds.ac.uk	Salas, Antonio/U-2029-2019; Rito, Teresa/AAC-9041-2019; Mormina, Maru/HGC-2853-2022; Ermini, Luca/O-4813-2016; Rito, Teresa/O-7726-2014; Salas, Antonio/E-3977-2012; Soares, Pedro A/G-9422-2011	Salas, Antonio/0000-0002-2336-702X; Rito, Teresa/0000-0002-8374-6347; Ermini, Luca/0000-0001-8109-6021; Rito, Teresa/0000-0002-8374-6347; Salas, Antonio/0000-0002-2336-702X; Soares, Pedro A/0000-0002-2807-690X; Macaulay, Vincent/0000-0001-9084-2700; Mormina, Maru/0000-0002-5836-8989; RICHARDS, MARTIN/0000-0003-3118-0967	Marie Curie Early Stage Training Grant; European Union; Bradshaw Foundation	Marie Curie Early Stage Training Grant(European Commission); European Union(European Commission); Bradshaw Foundation	We thank Toomas Kivisild, Hans-Jurgen Bandelt, Matthew Spriggs, Jacob Morales, Colin Groves, Stanley Ambrose, Yan Wong, and Marie-Anne Shaw for invaluable advice and suggestions and Sturla Ellingvag (of Explico) for the Canarian samples. P.S. was supported by a Marie Curie Early Stage Training Grant, and we thank the European Union and the Bradshaw Foundation for financial Support. Arne Rohl is a founder of Genetic Ancestor Ltd. and a member of its scientific advisory board.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; AMORIM A, 1999, J IBERIAN ARCHAEOL, V1, P15; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 1984, AM NAT; Arnason U, 1996, J MOL EVOL, V42, P145, DOI 10.1007/BF02198840; Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; Bandelt HJ, 2008, HEREDITY, V100, P1, DOI 10.1038/sj.hdy.6801054; Bandelt Hans-Jurgen, 2002, WHAT MOL CANT TELL S, P99; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BANDELT HJ, 1995, GENETICS, V141, P743; BANDELT HJ, 2006, MITOCHONDRIAL DNA EV, P47; Begun DR, 2004, SCIENCE, V303, P1478, DOI 10.1126/science.1095516; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Cela-Conde CJ, 2003, P NATL ACAD SCI USA, V100, P7684, DOI 10.1073/pnas.0832372100; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Davies W., 2001, P PREHIST SOC, V67, P195, DOI [10.1017/S0079497X00001663, DOI 10.1017/S0079497X00001663]; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000081; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Forster P, 1996, AM J HUM GENET, V59, P935; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; Galipaud JC, 2007, TERRA AUSTRALIS, V26, P151; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-124; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; HIXSON JE, 1986, MOL BIOL EVOL, V3, P1; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; James HVA, 2005, CURR ANTHROPOL, V46, pS3, DOI 10.1086/444365; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Klein R.G., 1999, HUMAN CAREER; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MACAULAY V, 2008, MITOCHONDRIAL GENOME; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nachman MW, 1996, GENETICS, V142, P953; Nikolaev SI, 2007, P NATL ACAD SCI USA, V104, P20443, DOI 10.1073/pnas.0705658104; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Oppenheimer S., 2003, OUT EDEN; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pesole G, 2001, GENETICS, V157, P859; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Pickford M, 2005, ANTHROPOL SCI, V113, P95, DOI 10.1537/ase.04S014; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Pilbeam D, 2004, CR PALEVOL, V3, P305, DOI 10.1016/j.crpv.2004.01.006; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; RICHARDS M, 2002, EXAMINING FARMING LA, P459; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; ROBERTS MB, 1994, NATURE, V369, P311, DOI 10.1038/369311a0; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rossett S, 2008, GENETICS, V180, P1511, DOI 10.1534/genetics.108.091116; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SANTOS BG, 1999, INVESTIGACIONES ARQU, V6, P9; SAWYER GJ, 2007, LAST HUMAN; Scholz CA, 2007, P NATL ACAD SCI USA, V104, P16416, DOI 10.1073/pnas.0703874104; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Team RC., 2022, R LANG ENV STAT COMP; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Trinkaus E, 1996, J HUM EVOL, V30, P299, DOI 10.1006/jhev.1996.0025; Pellekaan SMV, 2006, AM J PHYS ANTHROPOL, V131, P282, DOI 10.1002/ajpa.20426; Waguespack NM, 2007, EVOL ANTHROPOL, V16, P63, DOI 10.1002/evan.20124; Wood B, 2002, NATURE, V418, P133, DOI 10.1038/418133a; Xu XF, 1996, MOL BIOL EVOL, V13, P691, DOI 10.1093/oxfordjournals.molbev.a025630; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238	130	502	516	2	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					740	759		10.1016/j.ajhg.2009.05.001	http://dx.doi.org/10.1016/j.ajhg.2009.05.001			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	458SC	19500773	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000267042800005
J	KANG, SS; WONG, PWK; SUSMANO, A; SORA, J; NORUSIS, M; RUGGIE, N				KANG, SS; WONG, PWK; SUSMANO, A; SORA, J; NORUSIS, M; RUGGIE, N			THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE - AN INHERITED RISK FACTOR FOR CORONARY-ARTERY DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEART-DISEASE; DEFICIENCY; HOMOCYSTEINEMIA; LIPOPROTEIN; HOMOCYSTINURIA; HOMOCYST(E)INE; CHOLESTEROL; FRAMINGHAM; INFARCTION; LP(A)	Severe methylenetetrahydrofolate reductase (MTHFR) deficiency with less than 2% of normal enzyme activity is characterized by neurological abnormalities, atherosclerotic changes, and thromboembolism. We have discovered a "new" variant of MTHFR deficiency which is characterized by the absence of neurological abnormalities, an enzyme activity of about 50% of the normal value, and distinctive thermolability under specific conditions of heat inactivation. In this study, lymphocyte MTHFR specific activities in the thermolabile variant and control groups were 5.58 +/- 0.91 and 10.33 +/- 2.89 nmol formaldehyde formed/mg protein/h, respectively. The difference was significant (P < .01). However, there was overlap among the individual values from the two groups. On the other hand, residual MTHFR activity after heat inactivation was 11.2 +/- 1.43% in the thermolabile variant and 36.3 +/- 5.18% in the controls. There was no overlap. Enzyme studies in 10 subjects with thermolabile MTHFR and their family members support the hypothesis that thermolabile MTHFR is inherited as an autosomal recessive trait. To elucidate the association of thermolabile MTHFR with the development of coronary artery disease, we determined the thermostability of lymphocyte MTHFR in 212 patients with proven coronary artery disease and in 202 controls without clinical evidence of atherosclerotic vascular disease. Thermolabile MTHFR was found in 36 (17.0%) cardiac patients and 10 (5.0%) controls. The difference in incidence between the two groups was statistically significant (P < .01). The average age at onset of clinical coronary artery disease in 36 patients with thermolabile MTHFR was 57.3 +/- 7.6 years (35-72 years). The mean total plasma homocysteine concentration in patients with thermolabile MTHFR was 13.19 +/- 5.32 nmol/ml and was significantly different from the normal mean of 8.50 +/- 2.80 nmol/ml (P < .05). There was no association between thermolabile MTHFR and other major risk factors. We conclude that thermolabile MTHFR is a variant(s) of MTHFR deficiency which is inherited as an autosomal recessive trait. In addition, it is positively associated with the development of coronary artery disease. Determination of in vitro thermostability of lymphocyte MTHFR is a reliable method for identifying subjects with this abnormality.	RUSH MED COLL,DEPT PEDIAT,CHICAGO,IL 60612; RUSH MED COLL,DEPT INTERNAL MED,CHICAGO,IL 60612; RUSH MED COLL,DEPT PREVENT MED,CHICAGO,IL 60612	Rush University; Rush University; Rush University	KANG, SS (corresponding author), RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT PEDIAT,GENET SECT,1753 W CONGRESS PKWY,CHICAGO,IL 60612, USA.				NHLBI NIH HHS [HL 36135] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036135] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baumgartner R, 1980, J Inherit Metab Dis, V3, P101, DOI 10.1007/BF02312541; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BRATTSTROM LE, 1984, STROKE, V15, P1012, DOI 10.1161/01.STR.15.6.1012; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; ERBE RW, 1986, FOLATE PTERINE, V3, P413; GIBSON JB, 1964, J CLIN PATHOL, V17, P427, DOI 10.1136/jcp.17.4.427; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GORDON T, 1974, J CHRON DIS, V27, P329, DOI 10.1016/0021-9681(74)90013-7; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1986, J CLIN INVEST, V77, P1482, DOI 10.1172/JCI112461; KANG SS, 1987, METABOLISM, V36, P458, DOI 10.1016/0026-0495(87)90043-6; KANG SS, 1991, AM J HUM GENET, V48, P546; KANWAR YS, 1976, PEDIATR RES, V10, P598, DOI 10.1203/00006450-197606000-00008; KOSTNER GM, 1981, ATHEROSCLEROSIS, V38, P51, DOI 10.1016/0021-9150(81)90103-9; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; MALINOW MR, 1989, CIRCULATION, V79, P1180, DOI 10.1161/01.CIR.79.6.1180; MCCULLY KS, 1969, AM J PATHOL, V56, P111; MCGILL JJ, 1990, AM J MED GENET, V36, P45, DOI 10.1002/ajmg.1320360111; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; MURAI A, 1986, ATHEROSCLEROSIS, V59, P199, DOI 10.1016/0021-9150(86)90048-1; MURPHYCHUTORIAN DR, 1985, J AM COLL CARDIOL, V6, P725, DOI 10.1016/S0735-1097(85)80473-3; ROSENBLATT DS, 1977, PEDIATR RES, V11, P1141, DOI 10.1203/00006450-197711000-00005; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; SARTORIO R, 1986, J INHERIT METAB DIS, V9, P25, DOI 10.1007/BF01813897; SMITH CAB, 1956, ANN HUM GENET, V20, P257; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; WILCKEN DEL, 1983, METABOLISM, V32, P363, DOI 10.1016/0026-0495(83)90045-8; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350; 1988, ARCH INTERN MED, V148, P36; 1979, PREV MED, V8, P715	33	497	514	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					536	545						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998339				2022-12-18	WOS:A1991FK47000014
J	Beltran-Valero de Bernabe, D; Currier, S; Steinbrecher, A; Celli, J; van Beusekom, E; van der Zwaag, B; Kayserili, H; Merlini, L; Chitayat, D; Dobyns, WB; Cormand, B; Lehesjoki, AE; Cruces, J; Voit, T; Walsh, CA; van Bokhoven, H; Brunner, HG				Beltran-Valero de Bernabe, D; Currier, S; Steinbrecher, A; Celli, J; van Beusekom, E; van der Zwaag, B; Kayserili, H; Merlini, L; Chitayat, D; Dobyns, WB; Cormand, B; Lehesjoki, AE; Cruces, J; Voit, T; Walsh, CA; van Bokhoven, H; Brunner, HG			Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; ALPHA-DYSTROGLYCAN; SKELETAL-MUSCLE; PROTEIN FAMILY; BRAIN; DEFICIENCY; LAMININ; MICE; GLYCOSYLATION; INTEGRIN	Walker-Warburg syndrome (WWS) is an autosomal recessive developmental disorder characterized by congenital muscular dystrophy and complex brain and eye abnormalities. A similar combination of symptoms is presented by two other human diseases, muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD). Although the genes underlying FCMD (Fukutin) and MEB (POMGnT1) have been cloned, loci for WWS have remained elusive. The protein products of POMGnT1 and Fukutin have both been implicated in protein glycosylation. To unravel the genetic basis of WWS, we first performed a genomewide linkage analysis in 10 consanguineous families with WWS. The results indicated the existence of at least three WWS loci. Subsequently, we adopted a candidate-gene approach in combination with homozygosity mapping in 15 consanguineous families with WWS. Candidate genes were selected on the basis of the role of the FCMD and MEB genes. Since POMGnT1 encodes an O-mannoside N-acetylglucosaminyltransferase, we analyzed the possible implication of O-mannosyl glycan synthesis in WWS. Analysis of the locus for O-mannosyltransferase 1 (POMT1) revealed homozygosity in 5 of 15 families. Sequencing of the POMT1 gene revealed mutations in 6 of the 30 unrelated patients with WWS. Of the five mutations identified, two are nonsense mutations, two are frameshift mutations, and one is a missense mutation. Immunohistochemical analysis of muscle from patients with POMT1 mutations corroborated the O-mannosylation defect, as judged by the absence of glycosylation of alpha-dystroglycan. The implication of O-mannosylation in MEB and WWS suggests new lines of study in understanding the molecular basis of neuronal migration.	Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Pathol, Nijmegen, Netherlands; Beth Israel Deaconess Med Ctr, Div Neurogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Free Univ Berlin, Inst Neuropathol, D-1000 Berlin, Germany; Univ Hosp Essen, Dept Pediat & Pediat Neurol, Essen, Germany; Istanbul Univ, Istanbul Fac Med, Div Med Genet, Dept Neurol, Istanbul, Turkey; Ist Ortoped Rizzoli, Lab Neuromuscular Pathol, Bologna, Italy; Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Barcelona, Dept Genet, Barcelona, Spain; Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Autonoma Madrid, Fac Med, Dept Biochem, Madrid, Spain	Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Free University of Berlin; University of Duisburg Essen; Istanbul University; IRCCS Istituto Ortopedico Rizzoli; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Chicago; University of Chicago; University of Chicago; University of Barcelona; University of Helsinki; University of Helsinki; Autonomous University of Madrid	Brunner, HG (corresponding author), 417 Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	h.brunner@antrg.azn.nl	van Bokhoven, Hans/D-8764-2012; van Beusekom, Ellen/AAF-2687-2019; Brunner, Han/C-9928-2013; Dobyns, William Brian/ABC-6525-2021; Bokhoven, J.H.L.M. van van/H-8015-2014; Dobyns, William/AAI-2768-2020; Cormand, Bru/H-5338-2015; Merlini, Luciano/N-6478-2019	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Dobyns, William/0000-0002-7681-2844; Cormand, Bru/0000-0001-5318-4382; Merlini, Luciano/0000-0002-1108-1198	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035129, R01 NS 35129] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Barresi R, 1997, ACTA NEUROPATHOL, V94, P28, DOI 10.1007/s004010050668; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown SC, 1999, J CELL SCI, V112, P209; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hung NA, 1998, PEDIATR DEVEL PATHOL, V1, P393, DOI 10.1007/s100249900054; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kanoff RJ, 1998, PEDIATR NEUROL, V18, P76, DOI 10.1016/S0887-8994(97)00137-9; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lammens M, 2000, EUR J MORPHOL, V38, P327, DOI 10.1076/ejom.38.5.327.7358; LOCHTER A, 1991, J CELL BIOL, V113, P1159, DOI 10.1083/jcb.113.5.1159; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Villanova M, 1998, ACTA NEUROPATHOL, V96, P651, DOI 10.1007/s004010050947; WEWER UM, 1995, NEUROLOGY, V45, P2099, DOI 10.1212/WNL.45.11.2099; WING DR, 1992, BIOCHEM SOC T, V20, P386, DOI 10.1042/bst0200386; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yuen CT, 1997, J BIOL CHEM, V272, P8924	46	496	504	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1033	1043		10.1086/342975	http://dx.doi.org/10.1086/342975			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12369018	Green Published, Bronze			2022-12-18	WOS:000178884300003
J	LI, CC; HORVITZ, DG				LI, CC; HORVITZ, DG			SOME METHODS OF ESTIMATING THE INBREEDING COEFFICIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Haldane JBS, 1938, J GENET, V36, P213, DOI 10.1007/BF02982415; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; LI CC, 1948, CHINESE J AGR, V1, P43; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; Wright S., 1949, P365; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Wright S, 1948, ENCY BRITANNICA, V10; WRIGHT S, 1922, US DEP AGR B, V1121, P59	8	491	500	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					107	117						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	13065259				2022-12-18	WOS:A1953XW63000001
J	Rosenberg, NA; Li, LM; Ward, R; Pritchard, JK				Rosenberg, NA; Li, LM; Ward, R; Pritchard, JK			Informativeness of genetic markers for inference of ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-STRUCTURE; MULTILOCUS GENOTYPES; STOCK IDENTIFICATION; HUMAN GENOME; ADMIXTURE; ASSIGNMENT; LOCI; INDIVIDUALS; LINKAGE; ASSOCIATION	Inference of individual ancestry is useful in various applications, such as admixture mapping and structured-association mapping. Using information-theoretic principles, we introduce a general measure, the informativeness for assignment (I-n), applicable to any number of potential source populations, for determining the amount of information that multiallelic markers provide about individual ancestry. In a worldwide human microsatellite data set, we identify markers of highest informativeness for inference of regional ancestry and for inference of population ancestry within regions; these markers, which are listed in online-only tables in our article, can be useful both in testing for and in controlling the influence of ancestry on case-control genetic association studies. Markers that are informative in one collection of source populations are generally informative in others. Informativeness of random dinucleotides, the most informative class of microsatellites, is five to eight times that of random single-nucleotide polymorphisms (SNPs), but 2%-12% of SNPs have higher informativeness than the median for dinucleotides. Our results can aid in decisions about the type, quantity, and specific choice of markers for use in studies of ancestry.	Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; Univ Oxford, Inst Biol Anthropol, Oxford, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Southern California; University of Oxford; University of Chicago	Rosenberg, NA (corresponding author), Univ So Calif, Program Mol & Computat Biol, 1042 W 36th Pl,DRB 289, Los Angeles, CA 90089 USA.	noahr@usc.edu	Li, Lei M/C-7196-2009	Li, Lei M/0000-0002-6571-1079; Rosenberg, Noah/0000-0002-1829-8664				ABRAMOWITZ M., 1965, HDB MATH FUNCTIONS; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Anderson EC, 2002, GENETICS, V160, P1217; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Banks MA, 2003, BIOINFORMATICS, V19, P1436, DOI 10.1093/bioinformatics/btg172; Barron A, 1998, IEEE T INFORM THEORY, V44, P2743, DOI 10.1109/18.720554; Brenner CH, 1998, AM J HUM GENET, V62, P1558, DOI 10.1086/301856; BUCHANAN FC, 1994, GENOMICS, V22, P397, DOI 10.1006/geno.1994.1401; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; Cann HM, 2002, SCIENCE, V296, P261; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Cornuet JM, 1999, GENETICS, V153, P1989; Cover T.M., 2006, ELEMENTS INFORMATION, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Davies N, 1999, TRENDS ECOL EVOL, V14, P17, DOI 10.1016/S0169-5347(98)01530-4; DEAN M, 1994, AM J HUM GENET, V55, P788; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; Excoffier L, 2001, HDB STAT GENETICS, P271; Falush D, 2003, GENETICS, V164, P1567; Ghebranious N, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-6; GIBBONS JD, 1985, NONPARAMETRIC STAT I; GOMULKIEWICZ R, 1990, CAN J FISH AQUAT SCI, V47, P611, DOI 10.1139/f90-069; Guinand B, 2002, J HERED, V93, P260, DOI 10.1093/jhered/93.4.260; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; KULLBACK S, 1959, INFORMATION THEORY S; LINARES AR, 1999, MICROSATELLITES EVOL, P183; Lowe AL, 2001, FORENSIC SCI INT, V119, P17, DOI 10.1016/S0379-0738(00)00387-X; Manel S, 2002, CONSERV BIOL, V16, P650, DOI 10.1046/j.1523-1739.2002.00576.x; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; MILLAR RB, 1991, CAN J FISH AQUAT SCI, V48, P2173, DOI 10.1139/f91-256; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Primmer CR, 2000, P ROY SOC B-BIOL SCI, V267, P1699; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; RAMACHANDRAN S, IN PRESS HUM GENOMIC; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Risch N., 2002, GENOME BIOL, V3; ROSENBERG N, 2003, AM MATH MONTHLY, V110, P743; Rosenberg NA, 2003, SCIENCE, V300; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2001, GENETICS, V159, P699; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; SMOUSE PE, 1982, AM NAT, V119, P445, DOI 10.1086/283925; Sokal R. R., 1995, BIOMETRY; STEPHENS JC, 1999, MICROSATELLITES EVOL, P211; Weir B., 1996, GENETIC DATA ANAL; Weiss L., 1961, STAT DECISION THEORY; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	52	488	502	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1402	1422		10.1086/380416	http://dx.doi.org/10.1086/380416			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14631557	Green Published, Bronze			2022-12-18	WOS:000187491100015
J	Joubert, BR; Felix, JF; Yousefi, P; Bakulski, KM; Just, AC; Breton, C; Reese, SE; Markunas, CA; Richmond, RC; Xu, CJ; Kupers, LK; Oh, SS; Hoyo, C; Gruzieva, O; Soderhal, C; Salas, LA; Baiz, N; Zhang, HM; Lepeule, J; Ruiz, C; Ligthart, S; Wang, TY; Taylor, JA; Duijts, L; Sharp, GC; Jankipersadsing, SA; Nilsen, RM; Vaez, A; Fallin, MD; Hu, DL; Litonjua, AA; Fuemmeler, BF; Huen, K; Kere, J; Kull, I; Munthe-Kaas, MC; Gehring, U; Bustamante, M; Saurel-Coubizolles, MJ; Quraishi, BM; Ren, J; Tost, J; Gonzalez, JR; Peters, MJ; Haberg, SE; Xu, ZL; van Meurs, JB; Gaunt, TR; Kerkhof, M; Corpeleijn, E; Feinberg, AP; Eng, C; Baccarelli, AA; Neelon, SEB; Bradman, A; Merid, SK; Bergstrom, A; Herceg, Z; Hernandez-Vargas, H; Brunekreef, B; Pinart, M; Heude, B; Ewart, S; Yao, J; Lemonnier, N; Franco, OH; Wu, MC; Hofman, A; McArdle, W; Van der Vlies, P; Falahi, F; Gillman, MW; Barcellos, LF; Kumar, A; Wickman, M; Guerra, S; Charles, MA; Holloway, J; Auffray, C; Tiemeier, HW; Smith, GD; Postma, D; Hivert, MF; Eskenazi, B; Vrijheid, M; Arshad, H; Anto, JM; Dehghan, A; Karmaus, W; Annesi-Maesano, I; Sunyer, J; Ghantous, A; Pershagen, G; Hollands, N; Murphy, SK; DeMeo, DL; Burchard, EG; Ladd-Acosta, C; Snieder, H; Nystad, W; Koppelman, GH; Relton, CL; Jaddoe, VWV; Wilcox, A; Melen, E; London, SJ				Joubert, Bonnie R.; Felix, Janine F.; Yousefi, Paul; Bakulski, Kelly M.; Just, Allan C.; Breton, Carrie; Reese, Sarah E.; Markunas, Christina A.; Richmond, Rebecca C.; Xu, Cheng-Jian; Kupers, Leanne K.; Oh, Sam S.; Hoyo, Cathrine; Gruzieva, Olena; Soderhal, Cilla; Salas, Lucas A.; Baiz, Nour; Zhang, Hongmei; Lepeule, Johanna; Ruiz, Carlos; Ligthart, Symen; Wang, Tianyuan; Taylor, Jack A.; Duijts, Liesbeth; Sharp, Gemma C.; Jankipersadsing, Soesma A.; Nilsen, Roy M.; Vaez, Ahmad; Fallin, M. Daniele; Hu, Donglei; Litonjua, Augusto A.; Fuemmeler, Bernard F.; Huen, Karen; Kere, Juha; Kull, Inger; Munthe-Kaas, Monica Cheng; Gehring, Ulrike; Bustamante, Mariona; Saurel-Coubizolles, Marie Jose; Quraishi, Bilal M.; Ren, Jie; Tost, Jorg; Gonzalez, Juan R.; Peters, Marjolein J.; Haberg, Siri E.; Xu, Zongli; van Meurs, Joyce B.; Gaunt, Tom R.; Kerkhof, Marjan; Corpeleijn, Eva; Feinberg, Andrew P.; Eng, Celeste; Baccarelli, Andrea A.; Neelon, Sara E. Benjamin; Bradman, Asa; Merid, Simon Kebede; Bergstrom, Anna; Herceg, Zdenko; Hernandez-Vargas, Hector; Brunekreef, Bert; Pinart, Mariona; Heude, Barbara; Ewart, Susan; Yao, Jin; Lemonnier, Nathanael; Franco, Oscar H.; Wu, Michael C.; Hofman, Albert; McArdle, Wendy; Van der Vlies, Pieter; Falahi, Fahimeh; Gillman, Matthew W.; Barcellos, Lisa F.; Kumar, Ashish; Wickman, Magnus; Guerra, Stefano; Charles, Marie-Aline; Holloway, John; Auffray, Charles; Tiemeier, Henning W.; Smith, George Davey; Postma, Dirkje; Hivert, Marie-France; Eskenazi, Brenda; Vrijheid, Martine; Arshad, Hasan; Anto, Josep M.; Dehghan, Abbas; Karmaus, Wilfried; Annesi-Maesano, Isabella; Sunyer, Jordi; Ghantous, Akram; Pershagen, Goran; Hollands, Nina; Murphy, Susan K.; DeMeo, Dawn L.; Burchard, Esteban G.; Ladd-Acosta, Christine; Snieder, Harold; Nystad, Wenche; Koppelman, Gerard H.; Relton, Caroline L.; Jaddoe, Vincent W. V.; Wilcox, Allen; Melen, Erik; London, Stephanie J.			DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPH-NODE METASTASIS; LUNG-FUNCTION DECLINE; CIGARETTE-SMOKING; NEUROPILIN-2 EXPRESSION; PRENATAL EXPOSURE; TOBACCO-SMOKING; ASSOCIATION; GENE; CANCER; DISCOVERY	Epigenetic modifications, including DNA methylation, represent a potential mechanism for environmental impacts on human disease. Maternal smoking in pregnancy remains an important public health problem that impacts child health in a myriad of ways and has potential lifelong consequences. The mechanisms are largely unknown, but epigenetics most likely plays a role. We formed the Pregnancy And Childhood Epigenetics (PACE) consortium and meta-analyzed, across 13 cohorts (n = 6,685), the association between maternal smoking in pregnancy and newborn blood DNA methylation at over 450,000 CpG sites (CpGs) by using the Illumina 450K BeadChip. Over 6,000 CpGs were differentially methylated in relation to maternal smoking at genome-wide statistical significance (false discovery rate, 5%), including 2,965 CpGs corresponding to 2,017 genes not previously related to smoking and methylation in either newborns or adults. Several genes are relevant to diseases that can be caused by maternal smoking (e.g., orofacial clefts and asthma) or adult smoking (e.g., certain cancers). A number of differentially methylated CpGs were associated with gene expression. We observed enrichment in pathways and processes critical to development. In older children (5 cohorts, n = 3,187), 100% of CpGs gave at least nominal levels of significance, far more than expected by chance (p value < 2.2 x 10(-16)). Results were robust to different normalization methods used across studies and cell type adjustment. In this large scale meta-analysis of methylation data, we identified numerous loci involved in response to maternal smoking in pregnancy with persistence into later childhood and provide insights into mechanisms underlying effects of this important exposure.	[Joubert, Bonnie R.; Reese, Sarah E.; Markunas, Christina A.; Wang, Tianyuan; Taylor, Jack A.; Xu, Zongli] NIEHS, NIH, US Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA; [Felix, Janine F.; Ligthart, Symen; Duijts, Liesbeth; Franco, Oscar H.; Dehghan, Abbas] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Felix, Janine F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, NL-3000 CA Rotterdam, Netherlands; [Felix, Janine F.; Duijts, Liesbeth; Tiemeier, Henning W.] Univ Med Ctr Rotterdam, Erasmus MC, Generat Study Grp R, NL-3000 CA Rotterdam, Netherlands; [Yousefi, Paul; Huen, Karen; Bradman, Asa; Barcellos, Lisa F.; Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, CERCH, Berkeley, CA 94720 USA; [Bakulski, Kelly M.; Fallin, M. Daniele; Neelon, Sara E. Benjamin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Just, Allan C.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Breton, Carrie; Ren, Jie; Yao, Jin] Univ So Calif, Los Angeles, CA 90032 USA; [Markunas, Christina A.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Richmond, Rebecca C.; Sharp, Gemma C.; Gaunt, Tom R.; Smith, George Davey; Relton, Caroline L.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Xu, Cheng-Jian; Jankipersadsing, Soesma A.; Van der Vlies, Pieter] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Xu, Cheng-Jian; Jankipersadsing, Soesma A.; Postma, Dirkje] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, NL-9700 RB Groningen, Netherlands; [Xu, Cheng-Jian; Kerkhof, Marjan; Postma, Dirkje; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst Groningen, NL-9700 RB Groningen, Netherlands; [Kupers, Leanne K.; Vaez, Ahmad; Corpeleijn, Eva; Falahi, Fahimeh; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Oh, Sam S.; Hu, Donglei; Eng, Celeste; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hoyo, Cathrine] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Hoyo, Cathrine] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Gruzieva, Olena; Kull, Inger; Merid, Simon Kebede; Bergstrom, Anna; Kumar, Ashish; Wickman, Magnus; Pershagen, Goran; Melen, Erik] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Soderhal, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, S-14183 Stockholm, Sweden; [Salas, Lucas A.; Ruiz, Carlos; Bustamante, Mariona; Gonzalez, Juan R.; Pinart, Mariona; Guerra, Stefano; Vrijheid, Martine; Anto, Josep M.; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain; [Salas, Lucas A.; Ruiz, Carlos; Bustamante, Mariona; Gonzalez, Juan R.; Pinart, Mariona; Vrijheid, Martine; Anto, Josep M.; Sunyer, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona 08003, Spain; [Salas, Lucas A.; Ruiz, Carlos; Bustamante, Mariona; Gonzalez, Juan R.; Pinart, Mariona; Vrijheid, Martine; Anto, Josep M.; Sunyer, Jordi] UPF, Barcelona 08003, Spain; [Baiz, Nour; Annesi-Maesano, Isabella] Univ Paris 06, Sorbonne Univ,St Antoine Med Sch, INSERM,Epidemiol Allerg & Resp Dis Dept EPAR, Pierre Louis Inst Epidemiol & Publ Hlth IPLESP UM, F-75012 Paris, France; [Zhang, Hongmei; Quraishi, Bilal M.; Karmaus, Wilfried] Univ Memphis, Sch Publ Hlth, Div Epidemiol Biostat & Environm Hlth, Memphis, TN 38152 USA; [Lepeule, Johanna] Ctr Hosp Univ Grenoble, Inst Natl Sante & Rech Med,Inst Albert Bonniot, Univ Grenoble Alpes, Team Environm Epidemiol Appl, F-38000 Grenoble, France; [Duijts, Liesbeth] Univ Med Ctr Rotterdam, Erasmus MC, Div Neonatol, Dept Pediat, NL-3000 CA Rotterdam, Netherlands; [Duijts, Liesbeth] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Div Resp Med, NL-3000 CA Rotterdam, Netherlands; [Nilsen, Roy M.] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5018 Bergen, Norway; [Vaez, Ahmad] Isfahan Univ Med Sci, Sch Med, Esfahan 8174673461, Iran; [Litonjua, Augusto A.; DeMeo, Dawn L.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Fuemmeler, Bernard F.] Duke Univ, Sch Med, Dept Community & Family Med, Durham, NC 27710 USA; [Munthe-Kaas, Monica Cheng] Oslo Univ Hosp, Dept Pediat, N-424 Oslo, Norway; [Gehring, Ulrike; Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands; [Bustamante, Mariona] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Saurel-Coubizolles, Marie Jose] INSERM, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, F-75654 Paris, France; [Tost, Jorg] CEA, Inst Genom, Ctr Natl Genotypage, Lab Epigenet & Environm, F-91000 Evry, France; [Peters, Marjolein J.; van Meurs, Joyce B.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Haberg, Siri E.; Nystad, Wenche] Norwegian Inst Publ Hlth, Div Mental & Phys Hlth, N-0403 Oslo, Norway; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Baccarelli, Andrea A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Herceg, Zdenko; Hernandez-Vargas, Hector; Ghantous, Akram] IARC, Epigenet Grp, F-69008 Lyon, France; [Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 TD Utrecht, Netherlands; [Pinart, Mariona; Anto, Josep M.; Sunyer, Jordi] Hosp Mar Med Res Inst IMIM, Barcelona 08003, Spain; [Heude, Barbara; Charles, Marie-Aline] Univ Paris 05, INSERM, UMR 1153,Ctr Rech Epidemiol & Stat Sorbonne Paris, Early Origin Childs Hlth & Dev ORCHAD Team, F-94807 Villejuif, France; [Ewart, Susan] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Lemonnier, Nathanael; Auffray, Charles] Univ Lyon 1, Ctr Natl Rech Sci, Ecole Normale Super, European Inst Syst Biol & Med, F-69007 Lyon, France; [Wu, Michael C.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Hofman, Albert] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [McArdle, Wendy] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Gillman, Matthew W.; Hivert, Marie-France] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02215 USA; [Gillman, Matthew W.; Hivert, Marie-France] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Kumar, Ashish] Swiss Trop & Publ Hlth Inst, Unit Chron Dis Epidemiol, Dept Publ Hlth Epidemiol, CH-4051 Basel, Switzerland; [Kumar, Ashish] Univ Basel, CH-4001 Basel, Switzerland; [Wickman, Magnus; Melen, Erik] Stockholm Cty Council, Sachs Childrens Hosp, S-17177 Stockholm, Sweden; [Wickman, Magnus; Melen, Erik] Stockholm Cty Council, Ctr Occupat & Environm Med, S-17177 Stockholm, Sweden; [Holloway, John; Arshad, Hasan] Univ Southampton, Fac Med Clin & Expt Sci, Southampton SO16 6YD, Hants, England; [Holloway, John] Univ Southampton, Fac Med Human Dev & Hlth, Southampton SO16 6YD, Hants, England; [Murphy, Susan K.] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Murphy, Susan K.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, NL-9700 RB Groningen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Icahn School of Medicine at Mount Sinai; University of Southern California; Duke University; University of Bristol; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of California System; University of California San Francisco; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Karolinska Institutet; Karolinska Institutet; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Memphis; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Bergen; Isfahan University Medical Science; Harvard University; Brigham & Women's Hospital; Duke University; Utrecht University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; Norwegian Institute of Public Health (NIPH); Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; International Agency for Research on Cancer (IARC); Utrecht University; Utrecht University Medical Center; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Michigan State University; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Bristol; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Stockholm County Council; Stockholm County Council; University of Southampton; University of Southampton; Duke University; Duke University; University of California System; University of California San Francisco; University of Groningen	London, SJ (corresponding author), NIEHS, NIH, US Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	london2@niehs.nih.gov	Annesi-Maesano, Isabella/D-9173-2016; Gaunt, Tom R/O-3918-2014; Pinart Gilberga, Mariona/GLS-8842-2022; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Charles, Marie Aline/F-8567-2017; Bustamante, Mariona/ABB-9142-2021; Davey Smith, George/A-7407-2013; Wilcox, Allen J/C-7723-2019; Vaez, Ahmad/B-4336-2018; Haghjooy Javanmard, Shaghayegh/W-5060-2017; GHANTOUS, Akram/C-1689-2017; Wu, Michael/X-5084-2019; Gonzalez, Juan R/B-7860-2018; Franco, Óscar H/ABE-2305-2020; Feinberg, Andrew/AAY-7666-2020; Tost, Joerg/H-7129-2019; Tiemeier, Henning/H-6534-2019; Dehghan, Abbas/ABE-7377-2020; Lepeule, Johanna/N-2579-2013; Anto, J M/H-2676-2014; Pinart, Mariona/L-1931-2015; Charles, Marie Aline/S-1866-2019; Hivert, Marie-France/GWN-0455-2022; Holloway, John W/B-5424-2009; Vrijheid, Martine/H-2702-2014; Heude, Barbara/G-3095-2016; Relton, Caroline/AAC-5904-2019; Koppelman, Gerard/AAG-9187-2020; Lemonnier, Nathanael/K-5393-2016; Heude, Barbara/GLU-9626-2022; Sharp, Gemma/U-1294-2019; Xu, Cheng-Jian/G-9144-2018; Ligthart, Symen/AAF-7185-2020; Sunyer, Jordi/G-6909-2014; Salas, Lucas A/U-2217-2019; London, Stephanie/C-3734-2019; taylor, jack a/C-7154-2019; Murphy, Susan/R-3903-2019; Dehghan, Abbas/B-9896-2008	Annesi-Maesano, Isabella/0000-0002-6340-9300; Gaunt, Tom R/0000-0003-0924-3247; Pinart Gilberga, Mariona/0000-0002-8223-1325; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Charles, Marie Aline/0000-0003-4025-4390; Bustamante, Mariona/0000-0003-0127-2860; Davey Smith, George/0000-0002-1407-8314; Wilcox, Allen J/0000-0002-3376-1311; Vaez, Ahmad/0000-0001-9048-3795; Haghjooy Javanmard, Shaghayegh/0000-0002-3853-5006; GHANTOUS, Akram/0000-0002-2582-6402; Wu, Michael/0000-0002-3357-6570; Gonzalez, Juan R/0000-0003-3267-2146; Franco, Óscar H/0000-0002-4606-4929; Tost, Joerg/0000-0002-2683-0817; Tiemeier, Henning/0000-0002-4395-1397; Lepeule, Johanna/0000-0001-8907-197X; Anto, J M/0000-0002-4736-8529; Pinart, Mariona/0000-0002-8223-1325; Charles, Marie Aline/0000-0003-4025-4390; Holloway, John W/0000-0001-9998-0464; Vrijheid, Martine/0000-0002-7090-1758; Heude, Barbara/0000-0002-1565-1629; Lemonnier, Nathanael/0000-0002-3994-8697; Heude, Barbara/0000-0002-1565-1629; Sharp, Gemma/0000-0003-2906-4035; Xu, Cheng-Jian/0000-0003-1586-4672; Sunyer, Jordi/0000-0002-2602-4110; Salas, Lucas A/0000-0002-2279-4097; London, Stephanie/0000-0003-4911-5290; taylor, jack a/0000-0001-5303-6398; Murphy, Susan/0000-0001-8298-7272; Kumar, Ashish/0000-0002-7075-5930; BAIZ, Nour/0000-0001-6165-3935; Jankipersadsing, Soesma/0000-0001-9225-9236; Fuemmeler, Bernard/0000-0002-3550-0107; Joubert, Bonnie/0000-0001-7952-1180; Just, Allan/0000-0003-4312-5957; Kebede Merid, Simon/0000-0001-5974-7676; Reese, Sarah/0000-0002-2127-1454; Dehghan, Abbas/0000-0001-6403-016X; Feinberg, Andrew/0000-0002-8364-1991; Venkatasubramanian, Siddharth/0000-0002-5860-0768; xu, zongli/0000-0002-9034-8902; Nilsen, Roy Miodini/0000-0002-6340-4593; s, hema/0000-0002-3440-9475; Kupers, Leanne/0000-0001-9850-5215; Gruzieva, Olena/0000-0003-4147-5654; Huen, Karen/0000-0003-3604-2096; Relton, Caroline/0000-0003-2052-4840; Kull, Inger/0000-0001-6096-3771; Hernandez-Vargas, Hector/0000-0001-6045-2103; Richmond, Rebecca/0000-0003-0574-5071; Corpeleijn, Eva/0000-0002-2974-3305; van Meurs, Joyce/0000-0001-6245-2123; Gehring, Ulrike/0000-0003-3612-5780; Ruiz-Arenas, Carlos/0000-0002-6014-3498; Koppelman, Gerard/0000-0001-8567-3252	BBSRC [BB/I025263/1, BB/I025751/1] Funding Source: UKRI; MRC [MC_UU_12013/1, MC_UU_12013/2, MC_UU_12013/8] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025263/1, BB/I025751/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019, R01ES021369, R01ES022216, R01ES016772, P30ES007048, P30ES023515, ZIAES049032, R21ES014947, R00ES023450, ZIAES049033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013945] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER; Medical Research Council [G9815508, MC_UU_12013/8, MC_UU_12013/2, MC_UU_12013/1, MC_PC_15018] Funding Source: Medline; NHLBI NIH HHS [R01 HL078885, K23 HL004464, R01 HL088133, R01 HL117004, R01 HL104608] Funding Source: Medline; NIAID NIH HHS [R01 AI091905, R01 AI121226] Funding Source: Medline; NIDDK NIH HHS [R01 DK085173] Funding Source: Medline; NIEHS NIH HHS [R01 ES015794, R00 ES023450, R01 ES022216, R21 ES014947, P30 ES007048, R01 ES016772, K01 ES017801, P30 ES023515, R01 ES021369] Funding Source: Medline; NIMHD NIH HHS [P60 MD006902] Funding Source: Medline; NINR NIH HHS [R01 NR013945] Funding Source: Medline; Wellcome Trust [102215] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Wellcome Trust(Wellcome Trust)		Alexa A., 2020, TOPGO ENRICHMENT ANA, DOI [10.18129/B9.bioc.topGO, DOI 10.18129/B9.BIOC.TOPGO]; Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besingi W, 2014, HUM MOL GENET, V23, P2290, DOI 10.1093/hmg/ddt621; Boimel PJ, 2011, GENOMICS, V98, P164, DOI 10.1016/j.ygeno.2011.05.011; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099716; Broad Institute TCGA Genome Data Analysis Center, 2015, CORR GEN METH STAT C; Burdett T, 2015, NHGRI EBI CATALOG PU; Chen QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109038; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chertkow-Deutsher Y, 2010, INT J NEUROPSYCHOPH, V13, P347, DOI 10.1017/S146114570999071X; Chhabra D, 2014, EPIGENETICS-US, V9, P1473, DOI 10.4161/15592294.2014.971593; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-26; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Dai BH, 2014, EXP BIOL MED, V239, P883, DOI 10.1177/1535370214536651; DeMille D, 2013, IUBMB LIFE, V65, P921, DOI 10.1002/iub.1219; Dijkstra A, 2006, J ALLERGY CLIN IMMUN, V117, P604, DOI 10.1016/j.jaci.2005.11.023; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Flanagan JM, 2015, CANCER EPIDEM BIOMAR, V24, P221, DOI 10.1158/1055-9965.EPI-14-0767; Flom JD, 2011, CANCER EPIDEM BIOMAR, V20, P2518, DOI 10.1158/1055-9965.EPI-11-0553; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P3036, DOI 10.1158/1055-9965.EPI-09-0678; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hindorff LA, 2015, CATALOG PUBLISHED GE; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086356; Ivanova E, 2012, EPIGENETICS-US, V7, P1200, DOI 10.4161/epi.22141; Ivorra C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0384-5; Joosten LAB, 2013, CELL MOL LIFE SCI, V70, P3883, DOI 10.1007/s00018-013-1301-9; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Jubb AM, 2012, HISTOPATHOLOGY, V61, P340, DOI 10.1111/j.1365-2559.2012.04224.x; Komai T, 2009, GENE EXPR PATTERNS, V9, P503, DOI 10.1016/j.gep.2009.07.005; Koppelman GH, 2011, J ALLERGY CLIN IMMUN, V128, P479, DOI 10.1016/j.jaci.2011.05.036; Kupers LK, 2015, INT J EPIDEMIOL, V44, P1224, DOI 10.1093/ije/dyv048; Lee KWK, 2015, ENVIRON HEALTH PERSP, V123, P193, DOI 10.1289/ehp.1408614; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085373; Maccani JZJ, 2013, EPIGENOMICS-UK, V5, P619, DOI 10.2217/epi.13.63; Maden CH, 2012, DEV BIOL, V369, P277, DOI 10.1016/j.ydbio.2012.06.026; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Martin TC, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0568-2; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Moritsugu KP, 2007, AM J PREV MED, V32, P542, DOI 10.1016/j.amepre.2007.02.026; Mostowska A, 2010, EUR J ORAL SCI, V118, P325, DOI 10.1111/j.1600-0722.2010.00757.x; Nasarre P, 2013, CANCER RES, V73, P7111, DOI 10.1158/0008-5472.CAN-13-1755; Neufeld G, 2002, ADV EXP MED BIOL, V515, P81; Ozolins TRS, 1996, J PHARMACOL EXP THER, V277, P945; Philibert RA, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-19; Philibert RA, 2012, EPIGENETICS-US, V7, P1331, DOI 10.4161/epi.22520; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; R Core Team, 2019, R LANG ENV STAT COMP; Ranta S, 2000, EUR J HUM GENET, V8, P381, DOI 10.1038/sj.ejhg.5200440; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Samuel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023208; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Siedlinski M, 2012, EPIGENETICS-US, V7, P720, DOI 10.4161/epi.20319; Sun YV, 2013, HUM GENET, V132, P1027, DOI 10.1007/s00439-013-1311-6; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1; Triche T, 2014, ILLUMINAHUMANMETHYLA; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; Tumpel S, 2002, DEV BIOL, V246, P45, DOI 10.1006/dbio.2002.0665; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Vaez A, 2015, CIRC-CARDIOVASC GENE, V8, P487, DOI 10.1161/CIRCGENETICS.114.000714; Wan ES, 2015, AM J RESP CELL MOL, V53, P246, DOI 10.1165/rcmb.2014-0103OC; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu SP, 2007, AM J MED GENET B, V144B, P492, DOI 10.1002/ajmg.b.30495; Yasuoka H, 2011, J CLIN ENDOCR METAB, V96, pE1857, DOI 10.1210/jc.2011-1180; Yasuoka H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-220; Zaghlool SB, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-014-0040-6; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang HP, 2014, HUM GENET, V133, P1093, DOI 10.1007/s00439-014-1452-2; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	92	487	496	3	152	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					680	696		10.1016/j.ajhg.2016.02.019	http://dx.doi.org/10.1016/j.ajhg.2016.02.019			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27040690	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000374203800007
J	Moessner, R; Marshall, CR; Sutcliffe, JS; Skaug, J; Pinto, D; Vincent, J; Zwaigenbaum, L; Fernandez, B; Roberts, W; Szatmari, P; Scherer, SW				Moessner, Rainald; Marshall, Christian R.; Sutcliffe, James S.; Skaug, Jennifer; Pinto, Dalila; Vincent, John; Zwaigenbaum, Lonnie; Fernandez, Bridget; Roberts, Wendy; Szatmari, Peter; Scherer, Stephen W.			Contribution of SHANK3 mutations to autism spectrum disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; MULTILOCUS GENOTYPE DATA; 22Q13 DELETION SYNDROME; HUMAN GENOME; COPY NUMBER; CHROMOSOMAL REARRANGEMENTS; POSTSYNAPTIC DENSITY; STRUCTURAL VARIANTS; GENETIC DISORDER; HIGH-FREQUENCY	Mutations in SHANK3, which encodes a synaptic scaffolding protein, have been described in subjects with an autism spectrum disorder (ASD). To assess the quantitative contribution of SHANK3 to the pathogenesis of autism, we determined the frequency of DNA sequence and copy-number variants in this gene in 400 ASD-affected subjects ascertained in Canada. One de novo mutation and two gene deletions were discovered, indicating a contribution of 0.75% in this cohort. One additional SHANK3 deletion was characterized in two ASD-affected siblings from another collection, which brings the total number of published mutations in unrelated ASD-affected families to seven. The combined data provide support that haploinsufficiency of SHANK3 can cause a monogenic form of autism in sufficient frequency to warrant consideration in clinical diagnostic testing.	Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; Program Genet & Genome Biol, Toronto, ON, Canada; Autism Res Unit, Toronto, ON, Canada; Univ Toronto, Clark Inst, Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; Vanderbilt Univ, Vanderbilt Kennedy Ctr, Ctr Mol Neurosci, Nashville, TN USA; Univ Alberta, Dept Pediat, Edmonton, AB, Canada; Mem Univ Newfoundland, St John, NF, Canada; McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Vanderbilt University; University of Alberta; Memorial University Newfoundland; McMaster University	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, 14th Flr Med Discovery Tower,101 Coll St,Rm 14-70, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Pinto, Dalila/C-4218-2016; Scherer, Stephen W./B-3785-2013; Sutcliffe, James S/C-1348-2012	Pinto, Dalila/0000-0002-8769-0846; Scherer, Stephen W./0000-0002-8326-1999; Sutcliffe, James S/0000-0001-5200-6007	NIMH NIH HHS [MH061009, R01 MH061009] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061009] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; De Haan GJ, 2006, EPILEPSIA, V47, P851, DOI 10.1111/j.1528-1167.2006.00552.x; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Falush D, 2003, GENETICS, V164, P1567; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Prasad C, 2000, CLIN GENET, V57, P103, DOI 10.1034/j.1399-0004.2000.570203.x; Pritchard JK, 2000, GENETICS, V155, P945; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Steinlein OK, 2007, EPILEPSY RES, V73, P245, DOI 10.1016/j.eplepsyres.2006.10.010; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Xu Jie, 2004, Current Genomics, V5, P347, DOI 10.2174/1389202043349246	38	484	502	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1289	1297		10.1086/522590	http://dx.doi.org/10.1086/522590			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999366	Green Published, Bronze			2022-12-18	WOS:000251098800015
J	Neale, BM; Sham, PC				Neale, BM; Sham, PC			The future of association studies: Gene-based analysis and replication	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; DYSBINDIN GENE; POPULATION STRATIFICATION; DISEASE ASSOCIATIONS; HAPLOTYPE DIVERSITY; CONTINUOUS TRAITS; CANDIDATE GENES; BLOCK STRUCTURE; 6P22.3 GENE; SCHIZOPHRENIA	Historically, association tests were limited to single variants, so that the allele was considered the basic unit for association testing. As marker density increases and indirect approaches are used to assess association through linkage disequilibrium, association is now frequently considered at the haplotypic level. We suggest that there are difficulties in replicating association findings at the single-nucleotide-polymorphism (SNP) or the haplotype level, and we propose a shift toward a gene-based approach in which all common variation within a candidate gene is considered jointly. Inconsistencies arising from population differences are more readily resolved by use of a gene-based approach rather than either a SNP-based or a haplotype-based approach. A gene-based approach captures all of the potential risk-conferring variations; thus, negative findings are subject only to the issue of power. In addition, chance findings due to multiple testing can be readily accounted for by use of a genewide-significance level. Meta-analysis procedures can be formalized for gene-based methods through the combination of P values. It is only a matter of time before all variation within genes is mapped, at which point the gene-based approach will become the natural end point for association analysis and will inform our search for functional variants relevant to disease etiology.	Univ Hong Kong, Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; Univ Hong Kong, Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Fac Med, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of London; King's College London; University of Hong Kong; University of Hong Kong	Sham, PC (corresponding author), Univ Hong Kong, Fac Med, Dept Psychiat, Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	pcsham@hku.hk			NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NEI NIH HHS [EY-12562, R01 EY012562] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allison DB, 1998, GENETICS, V148, P859; Altshuler D, 1998, NEW ENGL J MED, V338, P1626, DOI 10.1056/NEJM199805283382214; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Byng MC, 2003, ANN HUM GENET, V67, P543, DOI 10.1046/j.1529-8817.2003.00055.x; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fisher R., 1954, OLIVER BOYD, DOI DOI 10.1007/BF01603396; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GADBURY GL, IN PRESS STAT METH M; GOEDDE HW, 1992, HUM GENET, V88, P344; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; HARADA S, 1981, LANCET, V2, P982; Helmuth L, 2001, SCIENCE, V293, P583; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Morris DW, 2003, SCHIZOPHR RES, V60, P167, DOI 10.1016/S0920-9964(02)00527-3; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; MORTON NE, 1955, AM J HUM GENET, V7, P277; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; North BV, 2003, ANN HUM GENET, V67, P348, DOI 10.1046/j.1469-1809.2003.00030.x; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peterson RJ, 1999, HUM GENET, V104, P177, DOI 10.1007/s004390050932; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Seltman H, 2003, GENET EPIDEMIOL, V25, P48, DOI 10.1002/gepi.10246; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Sham PC, 2000, ANN HUM GENET, V64, P161, DOI [10.1046/j.1469-1809.2000.6420161.x, 10.1017/S0003480000008046]; Sham PC, 2004, BEHAV GENET, V34, P207, DOI 10.1023/B:BEGE.0000013734.39266.a3; SHIBUYA A, 1988, AM J HUM GENET, V43, P741; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Stumpf MPH, 2003, CURR BIOL, V13, P1, DOI 10.1016/S0960-9822(02)01404-5; Tanck MWT, 2003, ANN HUM GENET, V67, P175, DOI 10.1046/j.1469-1809.2003.00021.x; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Thomas DC, 2003, HUM HERED, V56, P32, DOI 10.1159/000073730; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2004, MOL PSYCHIATR, V9, P227, DOI 10.1038/sj.mp.4001449; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404; Zhang SL, 2003, AM J HUM GENET, V73, P566, DOI 10.1086/378205; Zhang W, 2002, ANN HUM GENET, V66, P211, DOI 10.1017/S0003480002001112; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	77	484	496	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					353	362		10.1086/423901	http://dx.doi.org/10.1086/423901			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15272419	Green Published, Bronze			2022-12-18	WOS:000223272200001
J	Cook, EH; Lindgren, V; Leventhal, BL; Courchesne, R; Lincoln, A; Shulman, C; Lord, C; Courchesne, E				Cook, EH; Lindgren, V; Leventhal, BL; Courchesne, R; Lincoln, A; Shulman, C; Lord, C; Courchesne, E			Autism or atypical autism in maternally but not paternally derived proximal 15q duplication	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INDIVIDUALS; CHROMOSOME; DISORDERS; TWIN; 15Q11-Q13; REGION	Duplications of proximal 15q have been found in individuals with autistic disorder (AD) and varying degrees of mental retardation. Often these abnormalities take the form of a supernumerary inverted duplicated chromosome 15, more properly described as an isodicentric chromosome 15, or idic(15). However, intrachromosomal duplications also have been reported. In a few cases, unaffected mothers, as well as their affected children, carry the same duplications. During the course of the genotyping of trios of affected probands with AD and their parents, at the positional candidate locus D15S122, an intrachromosomal duplication of proximal 15q was detected by microsatellite analysis in a phenotypically normal mother. Microsatellite and methylation analyses of the pedigree in the following report show that, among three children, the two with autism or atypical autism have maternal inheritance of a 15q11-q13 duplication whereas the third child, who is unaffected, did not inherit this duplication. Their mother's 15q11-q13 duplication arose de novo from her father's chromosomes 15. This finding documents, for the first time, the significance of parental origin for duplications of 15q11-q13. In this family, paternal inheritance leads to a normal phenotype, and maternal inheritance leads to autism or atypical autism.	UNIV CHICAGO, LAB DEV NEUROSCI, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT PEDIAT, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT OBSTET & GYNECOL, CHICAGO, IL 60637 USA; UNIV CALIF SAN DIEGO, CHILDRENS HOSP,RES CTR,AUTISM & BRAIN DEV RES LAB, SCH MED, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, SCH MED, DEPT NEUROSCI, LA JOLLA, CA 92093 USA	University of Chicago; University of Chicago; University of Chicago; Children's Hospital Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego	Cook, EH (corresponding author), UNIV CHICAGO, DEPT PSYCHIAT, MC 3077, 5841 S MARYLAND AVE, CHICAGO, IL 60637 USA.		Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880	NIMH NIH HHS [R01 MH52223, K95 MH01196] Funding Source: Medline; NINDS NIH HHS [5-R01-NS-19855] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052223, K05MH001196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019855] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAKER P, 1994, J AUTISM DEV DISORD, V24, P529, DOI 10.1007/BF02172133; BRYSON SE, 1988, J CHILD PSYCHOL PSYC, V29, P433, DOI 10.1111/j.1469-7610.1988.tb00735.x; BUNDEY S, 1994, DEV MED CHILD NEUROL, V36, P736; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; Dunn L. M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; Flejter WL, 1996, AM J MED GENET, V61, P182, DOI 10.1002/(SICI)1096-8628(19960111)61:2<182::AID-AJMG17>3.3.CO;2-K; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; GILLBERG C, 1991, J AM ACAD CHILD PSY, V30, P489, DOI 10.1097/00004583-199105000-00022; GLATT K, 1994, GENOMICS, V19, P157, DOI 10.1006/geno.1994.1027; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hirsch B., 1995, American Journal of Human Genetics, V57, pA116; HOTOPF M, 1995, J AUTISM DEV DISORD, V25, P41, DOI 10.1007/BF02178166; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; JORDE LB, 1991, AM J HUM GENET, V49, P932; LEANACOX J, 1994, AM J HUM GENET, V54, P748; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mignon C, 1996, EUR J HUM GENET, V4, P88; PICKLES A, 1995, AM J HUM GENET, V57, P717; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; Raven J., 1993, COLOURED PROGR MATRI; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; SCHINZEL AA, 1994, J MED GENET, V31, P798, DOI 10.1136/jmg.31.10.798; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SMALLEY SL, 1995, AM J MED GENET, V60, P19, DOI 10.1002/ajmg.1320600105; Sparrow SS., 1984, VINELAND ADAPTIVE BE; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; STERGIANOU K, 1992, HUM GENET, V88, P364	31	484	499	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					928	934						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WT614	9106540				2022-12-18	WOS:A1997WT61400023
J	Edwards, SL; Beesley, J; French, JD; Dunning, AM				Edwards, Stacey L.; Beesley, Jonathan; French, Juliet D.; Dunning, Alison M.			Beyond GWASs: Illuminating the Dark Road from Association to Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; LINKAGE DISEQUILIBRIUM; DNA METHYLATION; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; SNP RS6983267; HLA-C; CANCER; BREAST	Genome-wide association studies (GWASs) have enabled the discovery of common genetic variation contributing to normal and pathological traits and clinical drug responses, but recognizing the precise targets of these associations is now the major challenge. Here, we review recent approaches to the functional follow-up of GWAS loci, including fine mapping of GWAS signal(s), prioritization of putative functional SNPs by the integration of genetic epidemiological and bioinformatic methods, and in vitro and in vivo experimental verification of predicted molecular mechanisms for identifying the targeted genes. The majority of GWAS-identified variants fall in noncoding regions of the genome. Therefore, this review focuses on strategies for assessing likely mechanisms affected by noncoding variants; such mechanisms include transcriptional regulation, noncoding RNA function, and epigenetic regulation. These approaches have already accelerated progress from genetic studies to biological knowledge and might ultimately guide the development of prognostic, preventive, and therapeutic measures.	[Edwards, Stacey L.; Beesley, Jonathan; French, Juliet D.] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld 4029, Australia; [Edwards, Stacey L.; French, Juliet D.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England	QIMR Berghofer Medical Research Institute; University of Queensland; University of Cambridge	Edwards, SL (corresponding author), QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld 4029, Australia.	stacey.edwards@qimrberghofer.edu.au	Edwards, Stacey/A-4980-2011; French, Juliet/AAV-4435-2020; French, Juliet D/A-4982-2011	French, Juliet/0000-0002-9770-0198; Beesley, Jonathan/0000-0003-1942-325X; Dunning, Alison Margaret/0000-0001-6651-7166	Australian National Health and Medical Research Council [1021731, 1012023]; National Breast Cancer Foundation Australia; Cancer Research UK [C8197/A10865, C1287/A10118, C8197/A10123]; Joseph Mitchell trust; European Commission; Cancer Research UK [16565] Funding Source: researchfish; National Breast Cancer Foundation [ECF-12-04] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation Australia; Cancer Research UK(Cancer Research UK); Joseph Mitchell trust; European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); National Breast Cancer Foundation	We would like to thank Georgia Chenevix-Trench, Dylan Glubb, and Karen McCue for critical reading of the manuscript. This work was supported by Australian National Health and Medical Research Council grants 1021731 (to S.L.E. and J.D.F.) and 1012023 (to J.B.). S.L.E. and J.D.F. were supported by fellowships from the National Breast Cancer Foundation Australia. A.M.D. was funded by Cancer Research UK (C8197/A10865) and the Joseph Mitchell trust. Fine-scale mapping in her laboratory was funded by Cancer Research UK grants (C1287/A10118) and (C8197/A10123) and European Commission Seventh Framework Programme Health-F2-2009-223175 "COGS" WP4 "Genomic Locus Mapping." The funders had no role in study design, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Berndt SI, 2011, HUM MOL GENET, V20, P3322, DOI 10.1093/hmg/ddr213; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Butter F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002982; Chakravarti A, 2013, CELL, V155, P21, DOI 10.1016/j.cell.2013.09.001; Chatterjee N, 2009, STAT SCI, V24, P489, DOI 10.1214/09-STS297; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ermann J, 2012, CURR OPIN IMMUNOL, V24, P564, DOI 10.1016/j.coi.2012.09.005; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Flandez M, 2013, GUT; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; Gamazon ER, 2012, AM J HUM GENET, V90, P1046, DOI 10.1016/j.ajhg.2012.04.023; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Nguyen HH, 2012, HUM MOL GENET, V21, P2076, DOI 10.1093/hmg/dds025; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hein R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042380; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt435; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Olshavsky NA, 2010, CANCER RES, V70, P3975, DOI 10.1158/0008-5472.CAN-09-3468; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Patel B., 2013, LEUKEMIA, DOI 10.1038/leu.2013.158; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rhie SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063925; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Udler MS, 2010, GENET EPIDEMIOL, V34, P463, DOI 10.1002/gepi.20504; Udler MS, 2010, HUM MOL GENET, V19, P2507, DOI 10.1093/hmg/ddq122; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Dijk M., 2012, HELLP BABIES LINK NO, P4003; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; von Figura G., 2013, GUT; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	122	483	488	5	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					779	797		10.1016/j.ajhg.2013.10.012	http://dx.doi.org/10.1016/j.ajhg.2013.10.012			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24210251	Green Published, Bronze			2022-12-18	WOS:000326996600001
J	Neves-Pereira, M; Mundo, E; Muglia, P; King, N; Macciardi, F; Kennedy, JL				Neves-Pereira, M; Mundo, E; Muglia, P; King, N; Macciardi, F; Kennedy, JL			The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECURRENT MAJOR DEPRESSION; MOOD DISORDERS; RAT-BRAIN; LINKAGE DISEQUILIBRIUM; BDNF; SCHIZOPHRENIA; SURVIVAL; NEURONS; STRESS; FUTURE	Bipolar disorder (BP) is a severe psychiatric disease, with a strong genetic component, that affects 1% of the population worldwide and is characterized by recurrent episodes of mania and depression. Brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of mood disorders, and the aim of the present study was to test for the presence of linkage disequilibrium between two polymorphisms in the BDNF gene and BP in 283 nuclear families. Family-based association test (FBAT) results for the dinucleotide repeat (GT)(N) polymorphism at position -1040 bp showed that allele A3 was preferentially transmitted to the affected individuals (Z = 2.035 and P = .042). FBAT results for the val66met SNP showed a significant association for allele G (Z = 3.415 and P = .00064). Transmission/disequilibrium test (TDT) haplotype analysis showed a significant result for the 3-G allele combination (P = .000394), suggesting that a DNA variant in the vicinity of the BDNF locus confers susceptibility to BP. Given that there is no direct evidence that either of the polymorphisms we examined alters function, it is unlikely that the actual risk-conferring allele is from these two sites. Rather, the causative site is likely nearby and in linkage disequilibrium with the 3-G haplotype that we have identified.	Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Kennedy, JL (corresponding author), CAMH, Neurosci Res Dept, R-31,250 Coll St, Toronto, ON M5T 1R8, Canada.		anand, amit/A-7222-2009; Muglia, Pierandrea/ABD-9235-2020; Macciardi, Fabio/N-3768-2014; Kennedy, James Lowery/AAZ-6947-2020	Muglia, Pierandrea/0000-0002-3973-8606; Macciardi, Fabio/0000-0003-0537-4266; Kennedy, James Lowery/0000-0002-8733-3806	NIMH NIH HHS [MH59585, MH59561] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; DREVETS WC, 1999, NEUROBIOLOGY MENTAL, P394; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Duman RS, 1998, J ECT, V14, P181; DUMAN RS, 1999, NEUROBIOLOGY MENTAL, P333; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Gershon Elliot S., 1990, MANIC DEPRESSIVE ILL, P373; HANSON IM, 1992, GENOMICS, V13, P1331, DOI 10.1016/0888-7543(92)90060-6; Hawi Z, 1998, PSYCHIAT RES, V81, P111, DOI 10.1016/S0165-1781(98)00076-6; IP NY, 1993, J NEUROSCI, V13, P3394; KING N, 2001, AM J HUM GENET, V69, pA2112; KLITZ W, 1995, AM J HUM GENET, V57, P1436; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Krebs MO, 2000, MOL PSYCHIATR, V5, P558, DOI 10.1038/sj.mp.4000749; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Mamounas LA, 1995, J NEUROSCI, V15, P7929; McGinnis R, 2000, AM J HUM GENET, V67, P1340; MCGUFFIN P, 1989, BRIT J PSYCHIAT, V155, P294, DOI 10.1192/bjp.155.3.294; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; MUGLIA P, IN PRESS MOL PSYCHIA; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; NIBUYA M, 1995, J NEUROSCI, V15, P7539; OZCSLIC T, 1991, GENOMICS, V10, P569; Proschel M, 1992, Hum Mol Genet, V1, P353, DOI 10.1093/hmg/1.5.353-a; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sasaki T, 1997, AM J MED GENET, V74, P443, DOI 10.1002/(SICI)1096-8628(19970725)74:4<443::AID-AJMG17>3.0.CO;2-I; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 1999, J NEUROSCI, V19, P5034; Siuciak JA, 1996, BRAIN RES, V710, P11, DOI 10.1016/0006-8993(95)01289-3; SIUCIAK JA, 1994, BRAIN RES, V633, P326, DOI 10.1016/0006-8993(94)91556-3; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Steffens DC, 1998, BIOL PSYCHIAT, V43, P705, DOI 10.1016/S0006-3223(98)00084-5; Virgos C, 2001, SCHIZOPHR RES, V49, P65, DOI 10.1016/S0920-9964(00)00106-7; Wassink TH, 1999, AM J MED GENET, V88, P724, DOI 10.1002/(SICI)1096-8628(19991215)88:6<724::AID-AJMG25>3.0.CO;2-7	42	483	500	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					651	655		10.1086/342288	http://dx.doi.org/10.1086/342288			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12161822	Bronze, Green Published			2022-12-18	WOS:000177489600020
J	Breitling, LP; Yang, RX; Korn, B; Burwinkel, B; Brenner, H				Breitling, Lutz P.; Yang, Rongxi; Korn, Bernhard; Burwinkel, Barbara; Brenner, Hermann			Tobacco-Smoking-Related Differential DNA Methylation: 27K Discovery and Replication	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-DISEASE; PROMOTER METHYLATION; CARDIOVASCULAR RISK; MULTIPLE GENES; CANCER; HYPERMETHYLATION; SMOKERS; EPIGENETICS; MECHANISMS	Tobacco smoking is responsible for substantial morbidity and mortality worldwide, in particular through cardiovascular, pulmonary, and malignant pathology. CpG methylation might plausibly play a role in a variety of smoking-related phenomena, as suggested by candidate gene promoter or global methylation studies. Arrays allowing hypothesis-free searches on a scale resembling genome-wide studies of SNPs have become available only very recently. Methylation extents in peripheral-blood DNA were assessed at 27,578 sites in more than 14,000 gene promoter regions in 177 current smokers, former smokers, and those who had never smoked, with the use of the Illumina Human Methylation 27K Bead Chip. This revealed a single locus, cg03636183, located in F2RL3, with genome-wide significance for lower methylation in smokers (p = 2.68 x 10(-31)). This was similarly significant in 316 independent replication samples analyzed by mass spectrometry and Sequenom EpiTyper (p = 6.33 x 10(-34)). Our results, which were based on a rigorous replication approach, show that the gene coding for a potential drug target of cardiovascular importance features altered methylation patterns in smokers. To date, this gene had not attracted attention in the literature on smoking.	[Breitling, Lutz P.; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res C070, D-69120 Heidelberg, Germany; [Korn, Bernhard] German Canc Res Ctr, Genom Facil, D-69120 Heidelberg, Germany; [Korn, Bernhard] German Canc Res Ctr, Prote Core Facil, D-69120 Heidelberg, Germany; [Yang, Rongxi; Burwinkel, Barbara] Univ Heidelberg, Dept Obstet & Gynecol, D-69115 Heidelberg, Germany; [Korn, Bernhard] Inst Mol Biol, Core Facil & Technol, D-55128 Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institute of Molecular Biology (IMB)	Breitling, LP (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res C070, D-69120 Heidelberg, Germany.	l.breitling@dkfz.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572	German Research Foundation [Br1704/11-1]; Eaden Wurttemberg Ministry of Research, Science and Arts; Marsilius Kolleg, University of Heidelberg; Helmholtz Society; Dietmar-Hopp Foundation; BMBF [PB13358]; Boehringer Ingelheim Foundation	German Research Foundation(German Research Foundation (DFG)); Eaden Wurttemberg Ministry of Research, Science and Arts; Marsilius Kolleg, University of Heidelberg; Helmholtz Society(Helmholtz Association); Dietmar-Hopp Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	This work was funded by the German Research Foundation (Br1704/11-1); Eaden Wurttemberg Ministry of Research, Science and Arts; Marsilius Kolleg, University of Heidelberg; Helmholtz Society; the Dietmar-Hopp Foundation; and BMBF (PB13358). The Institute of Molecular Biology Mainz is funded by the Boehringer Ingelheim Foundation.	AMMERPOHL O, 2008, APPL NOTE GENOME WID; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Enokida H, 2006, CANCER-AM CANCER SOC, V106, P79, DOI 10.1002/cncr.21577; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Leone A, 2007, CURR PHARM DESIGN, V13, P1661, DOI 10.2174/138161207780831347; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Morita H, 2005, J AM COLL CARDIOL, V45, P589, DOI 10.1016/j.jacc.2004.10.061; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Rahman MM, 2007, CURR VASC PHARMACOL, V5, P276, DOI 10.2174/157016107782023406; Raum E, 2007, EUR J CARDIOV PREV R, V14, P809, DOI 10.1097/HJR.0b013e3282eeb308; Rebagliato M, 2002, J EPIDEMIOL COMMUN H, V56, P163, DOI 10.1136/jech.56.3.163; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; van der Maarel SM, 2008, ANN RHEUM DIS, V67, P97, DOI 10.1136/ard.2008.098392; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Wu CC, 2006, EUR J PHARMACOL, V546, P142, DOI 10.1016/j.ejphar.2006.07.004; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Zochbauer-Muller S, 2003, INT J CANCER, V107, P612, DOI 10.1002/ijc.11458	38	481	495	0	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					450	457		10.1016/j.ajhg.2011.03.003	http://dx.doi.org/10.1016/j.ajhg.2011.03.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21457905	Green Published, Bronze			2022-12-18	WOS:000289664300005
J	Zhao, ZZ; Tuakli-Wosornu, Y; Lagace, TA; Kinch, L; Grishin, NV; Horton, JD; Cohen, JC; Hobbs, HH				Zhao, Zhenze; Tuakli-Wosornu, Yetsa; Lagace, Thomas A.; Kinch, Lisa; Grishin, Nicholas V.; Horton, Jay D.; Cohen, Jonathan C.; Hobbs, Helen H.			Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; MISSENSE MUTATIONS; APOLIPOPROTEIN-B; CULTURED-CELLS; TARGET GENES; CHOLESTEROL; RECEPTOR; LIVER; MICE; PROTEIN	Elevated levels of circulating low-density lipoprotein cholesterol (LDL-C) play a central role in the development of atherosclerosis. Mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9) that are associated with lower plasma levels of LDL-C confer protection from coronary heart disease. Here, we show that four severe loss-of-function mutations prevent the secretion of PCSK9 by disrupting synthesis or trafficking of the protein. In contrast to recombinant wildtype PCSK9, which was secreted from cells into the medium within 2 hours, the severe loss-of-function mutations in PCSK9 largely abolished PCSK9 secretion. This finding predicted that circulating levels of PCSK9 would be lower in individuals with the loss-of-function mutations. Immunoprecipitation and immunoblotting of plasma for PCSK9 provided direct evidence that the serine protease is present in the circulation and identified the first known individual who has no immunodetectable circulating PCSK9. This healthy, fertile college graduate, who was a compound heterozygote for two inactivating mutations in PCSK9, had a strikingly low plasma level of LDL-C ( 14 mg/dL). The very low plasma level of LDL-C and apparent good health of this individual demonstrate that PCSK9 plays a major role in determining plasma levels of LDL-C and provides an attractive target for LDL-lowering therapy.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovacs Clin Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.hobbs@utsouthwestern.edu	Zhao, Zhenze/AAW-5870-2020	Kinch, Lisa/0000-0003-3041-2615	NHLBI NIH HHS [P01 HL020948, P01 HL20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Ginalski K, 2004, NUCLEIC ACIDS RES, V32, pW576, DOI 10.1093/nar/gkh370; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; HERZ J, 1990, J BIOL CHEM, V265, P21355; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kane J, 2001, METAB MOL BASES INHE, P2717; Kim JS, 2004, J MOL BIOL, V335, P787, DOI 10.1016/j.jmb.2003.11.006; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ouguerram K, 2004, ARTERIOSCL THROM VAS, V24, P1448, DOI 10.1161/01.ATV.0000133684.77013.88; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 1999, ANN NY ACAD SCI, V885, P57; SELDAH NG, 2003, P NATL ACAD SCI USA, V100, P928; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Tarugi P, 1996, GASTROENTEROLOGY, V111, P1125, DOI 10.1016/S0016-5085(96)70082-3; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058	30	478	518	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					514	523		10.1086/507488	http://dx.doi.org/10.1086/507488			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909389	Bronze, Green Published			2022-12-18	WOS:000239830700013
J	Niu, TH; Qin, ZHS; Xu, XP; Liu, JS				Niu, TH; Qin, ZHS; Xu, XP; Liu, JS			Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA(2)-ADRENERGIC RECEPTOR; MAXIMUM-LIKELIHOOD; CYSTIC-FIBROSIS; DNA; ALGORITHM; LOCUS; GENE; AMPLIFICATION; FREQUENCIES; ALBUTEROL	Haplotypes have gained increasing attention in the mapping of complex-disease genes, because of the abundance of single-nucleotide polymorphisms (SNPs) and the limited power of conventional single-locus analyses. It has been shown that haplotype-inference methods such as Clark's algorithm, the expectation-maximization algorithm, and a coalescence-based iterative-sampling algorithm are fairly effective and economical alternatives to molecular-haplotyping methods. To contend with some weaknesses of the existing algorithms, we propose a new Monte Carlo approach. In particular, we first partition the whole haplotype into smaller segments. Then, we use the Gibbs sampler both to construct the partial haplotypes of each segment and to assemble all the segments together. Our algorithm can accurately and rapidly infer haplotypes for a large number of linked SNPs. By using a wide variety of real and simulated data sets, we demonstrate the advantages of our Bayesian algorithm, and we show that it is robust to the violation of Hardy-Weinberg equilibrium, to the presence of missing data, and to occurrences of recombination hotspots.	Harvard Univ, Sci Ctr 610, Dept Stat, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Northeastern Univ, Coll Comp Sci, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liu, JS (corresponding author), Harvard Univ, Sci Ctr 610, Dept Stat, 1 Oxford St, Cambridge, MA 02138 USA.		Qin, Zhaohui/Q-3133-2019; Qin, Zhaohui S/E-8196-2011	Qin, Zhaohui/0000-0002-1583-146X; Qin, Zhaohui S/0000-0002-1583-146X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056371] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R01 HL/AI56371-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Beaudet L, 2001, GENOME RES, V11, P600, DOI 10.1101/gr.172501; Bradshaw MS, 1995, NUCLEIC ACIDS RES, V23, P4850, DOI 10.1093/nar/23.23.4850; Chen R, 1996, J ROY STAT SOC B MET, V58, P397; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Cox DG, 2001, HUM MUTAT, V17, P141, DOI 10.1002/1098-1004(200102)17:2<141::AID-HUMU6>3.0.CO;2-1; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; GELMAN A, 1993, J ROY STAT SOC B MET, V55, P185; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Heng C. K., 2000, Annals Academy of Medicine Singapore, V29, P313; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Judson R, 2001, PHARMACOGENOMICS, V2, P7, DOI 10.1517/14622416.2.1.7; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; LIU JS, 1994, J AM STAT ASSOC, V89, P958, DOI 10.2307/2290921; Liu JS., 2001, MONTE CARLO STRATEGI, DOI DOI 10.1007/978-0-387-76371-2; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; LONG JC, 1995, AM J HUM GENET, V56, P799; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; NIU T, IN PRESS DRUGS; Niu TH, 2001, HUM BIOL, V73, P429, DOI 10.1353/hub.2001.0039; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ranade K, 2001, GENOME RES, V11, P1262; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; RUANO G, 1990, P NATL ACAD SCI USA, V87, P6296, DOI 10.1073/pnas.87.16.6296; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TEMPLETON AR, 1995, GENETICS, V140, P403; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Wallenstein S, 1998, GENET EPIDEMIOL, V15, P173, DOI 10.1002/(SICI)1098-2272(1998)15:2<173::AID-GEPI5>3.0.CO;2-7; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Zhang SL, 2001, AM J HUM GENET, V69, P906, DOI 10.1086/323622; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	55	478	513	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					157	169		10.1086/338446	http://dx.doi.org/10.1086/338446			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11741196	Green Published, Bronze			2022-12-18	WOS:000172571900014
J	HALLMAN, DM; BOERWINKLE, E; SAHA, N; SANDHOLZER, C; MENZEL, HJ; CSAZAR, A; UTERMANN, G				HALLMAN, DM; BOERWINKLE, E; SAHA, N; SANDHOLZER, C; MENZEL, HJ; CSAZAR, A; UTERMANN, G			THE APOLIPOPROTEIN-E POLYMORPHISM - A COMPARISON OF ALLELE FREQUENCIES AND EFFECTS IN 9 POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEASURED GENOTYPE INFORMATION; RECEPTOR-RELATED PROTEIN; APOPROTEIN-E; QUANTITATIVE PHENOTYPES; CHOLESTEROL-METABOLISM; GENETIC-VARIATION; LIPOPROTEINS; BINDING; SERUM; GEL	Application of uniform methods for measuring the apolipoprotein (apo) E polymorphism and plasma cholesterol levels in nine populations (Tyrolean, Sudanese, Indian, Chinese, Japanese, Hungarian, Icelandic, Finnish, and Malay) revealed significant heterogeneity among them in apo E type frequencies and mean cholesterol levels. The major apo E types in all populations were E3/2 (frequency range from 7.0% in Indians to 16.9% in Malays), E3/3 (frequency range from 39.8% in Sudanese to 72.1% in Japanese), and E3/4 (frequency range from 11.3% in Japanese to 35.9% in Sudanese). Mean cholesterol levels ranged from 144.2 mg/dl in the Sudanese to 228.5 mg/dl in the Icelandics. Two-way analysis of variance of the effect of population and apo E type on cholesterol levels showed no significant interaction effect, indicating that the effects of apo E type on cholesterol levels do not differ significantly among the populations. The overall average excess for the epsilon-2 allele was - 14.12 mg/dl (range - 31.63 to - 8.82 mg/dl); for the epsilon-3 allele, 0.04 mg/dl (range - 1.87 to 1.58 mg/dl; and for the epsilon-4 allele, 8.14 mg/dl (range - 1.71 to 13.31 mg/dl). Despite the apparent heterogeneity in these values, especially for the epsilon-4 allele, comparison of the average excesses by a method of repeated sampling with random permutations revealed no significant difference in effects among populations. These data indicate that a given apo E allele acts in a relatively uniform manner in different populations despite differences in genetic background and environmental factors.	UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225; NATL UNIV SINGAPORE HOSP,DIV GENET,SINGAPORE,SINGAPORE; UNIV INNSBRUCK,INST MED BIOL & HUMAN GENET,A-6020 INNSBRUCK,AUSTRIA	University of Texas System; University of Texas Health Science Center Houston; National University of Singapore; University of Innsbruck					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040613] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-40613] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1960, CONTRIBUTIONS PROBAB; ASAKAWA J, 1985, HUM GENET, V70, P222; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BOERWINKLE E, 1987, ANN HUM GENET, V51, P211, DOI 10.1111/j.1469-1809.1987.tb00874.x; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BOUTHILLIER D, 1983, J LIPID RES, V24, P1060; BROWN MB, 1974, TECHNOMETRICS, V16, P129, DOI 10.2307/1267501; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Efron B, 1982, JACKKNIFE BOOTSTRAP; EHNHOLM C, 1986, J LIPID RES, V27, P227; ETO M, 1986, CLIN GENET, V29, P477; FALASE AO, 1972, TROP GEOGR MED, V25, P147; FALCONER DS, 1985, GENET RES, V46, P337, DOI 10.1017/S0016672300022825; Freeman DH, 1987, APPLIED CATEGORICAL; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; GREGORIUS HR, 1986, THEOR APPL GENET, V72, P413, DOI 10.1007/BF00288581; HARDING RM, 1988, P NATL ACAD SCI USA, V85, P9370, DOI 10.1073/pnas.85.23.9370; HERR DG, 1986, AM STAT, V40, P265, DOI 10.2307/2684597; HUI DY, 1984, J BIOL CHEM, V259, P860; Keys A, 1980, 7 COUNTRIES MULTIVAR, P121; KOBORI S, 1988, ATHEROSCLEROSIS, V69, P81, DOI 10.1016/0021-9150(88)90291-2; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KUTNER MH, 1974, AM STAT, V28, P98, DOI 10.2307/2683034; LEHTIMAKI T, 1990, J LIPID RES, V31, P487; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MENZEL HJ, 1986, ELECTROPHORESIS, V7, P492, DOI 10.1002/elps.1150071103; PALMER RH, 1986, J LIPID RES, V27, P637; PEARSON ES, 1951, BIOMETRIKA, V38, P112, DOI 10.2307/2332321; RALL SC, 1982, J BIOL CHEM, V257, P4171; ROBERTSON FW, 1985, ARTERIOSCLEROSIS, V5, P283, DOI 10.1161/01.ATV.5.3.283; Ruhlen M., 1987, GUIDE WORLDS LANGUAG, V1; Scheffe H., 1959, ANAL VARIANCE; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; SEPEHRNIA B, 1989, AM J HUM GENET, V45, P586; SHAPER AG, 1974, CORONARY HEART DIS, P148; SHRIVER MD, 1991, DIABETES, V40, P334, DOI 10.2337/diabetes.40.3.334; SING CF, 1989, INT J EPIDEMIOL, V18, pS183; SING CF, 1985, AM J HUM GENET, V37, P268; SPEED FM, 1976, AM STAT, V30, P30, DOI 10.2307/2682884; TAN PY, 1984, GENET RES, V43, pA135; TEMPLETON AR, 1988, GENETICS, V120, P1145; TIKKANEN MJ, 1990, ARTERIOSCLEROSIS, V10, P285, DOI 10.1161/01.ATV.10.2.285; TSUCHIYA S, 1985, JPN J HUM GENET, V30, P271, DOI 10.1007/BF01907964; UTERMANN G, 1984, J LIPID RES, V25, P378; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, CLIN GENET, V15, P63; WANG K, 1986, ACTA ACAD MED SINICA, V8, P18; WILLIAMS AO, 1971, BRIT HEART J, V33, P95; XU CF, 1990, GENET EPIDEMIOL, V7, P261, DOI 10.1002/gepi.1370070405; ZANNIS VI, 1982, J LIPID RES, V23, P911; 1983, REV FOOD CONSUMPTION; 1988, WORLD HLTH STAT Q, V41, P115; 1987, 5TH WORLD FOOD SURVE; 1984, FOOD BALANCE SHEETS; 1986, LANCET, V2, P991	56	478	494	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					338	349						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867194				2022-12-18	WOS:A1991GA86600010
J	Edenberg, HJ; Dick, DM; Xuei, XL; Tian, HJ; Almasy, L; Bauer, LO; Crowe, RR; Goate, A; Hesselbrock, V; Jones, K; Kwon, J; Li, TK; Nurnberger, JI; O'Connor, SJ; Reich, T; Rice, J; Schuckit, MA; Porjesz, B; Foroud, T; Begleiter, H				Edenberg, HJ; Dick, DM; Xuei, XL; Tian, HJ; Almasy, L; Bauer, LO; Crowe, RR; Goate, A; Hesselbrock, V; Jones, K; Kwon, J; Li, TK; Nurnberger, JI; O'Connor, SJ; Reich, T; Rice, J; Schuckit, MA; Porjesz, B; Foroud, T; Begleiter, H			Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENERAL PEDIGREES; GENETIC-LINKAGE; BETA-FREQUENCY; ETHANOL INTAKE; HUMAN GENOME; IN-VITRO; EEG; RISK; SUSCEPTIBILITY	Alcoholism is a complex disease with both genetic and environmental risk factors. To identify genes that affect the risk for alcoholism, we systematically ascertained and carefully assessed individuals in families with multiple alcoholics. Linkage and association analyses suggested that a region of chromosome 4p contained genes affecting a quantitative endophenotype, brain oscillations in the beta frequency range (13 - 28 Hz), and the risk for alcoholism. To identify the individual genes that affect these phenotypes, we performed linkage disequilibrium analyses of 69 single-nucleotide polymorphism (SNPs) within a cluster of four GABA(A) receptor genes, GABRG1, GABRA2, GABRA4, and GABRB1, at the center of the linked region. GABA(A) receptors mediate important effects of alcohol and also modulate beta frequencies. Thirty-one SNPs in GABRA2, but only 1 of the 20 SNPs in the flanking genes, showed significant association with alcoholism. Twenty-five of the GABRA2 SNPs, but only one of the SNPs in the flanking genes, were associated with the brain oscillations in the beta frequency. The region of strongest association with alcohol dependence extended from intron 3 past the 3' end of GABRA2; all 43 of the consecutive three-SNP haplotypes in this region of GABRA2 were highly significant. A three-SNP haplotype was associated with alcoholism, with P = .00000022. No coding differences were found between the high-risk and low-risk haplotypes, suggesting that the effect is mediated through gene regulation. The very strong association of GABRA2 with both alcohol dependence and the beta frequency of the electroencephalogram, combined with biological evidence for a role of this gene in both phenotypes, suggest that GABRA2 might influence susceptibility to alcohol dependence by modulating the level of neural excitation.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; SW Fdn Biomed Res, San Antonio, TX 78284 USA; Univ Connecticut, Farmington, CT USA; Univ Iowa, Carver Coll Med, Iowa City, IA USA; Washington Univ, Sch Med, St Louis, MO USA; Univ Calif San Diego, San Diego, CA 92103 USA; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Texas Biomedical Research Institute; University of Connecticut; University of Iowa; Washington University (WUSTL); University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Edenberg, HJ (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,Med Sci 4063, Indianapolis, IN 46202 USA.	edenberg@iupui.edu	anand, amit/A-7222-2009; Xuei, Xiaoling/L-8564-2019; Almasy, Laura/V-3156-2019	Goate, Alison/0000-0002-0576-2472; Nurnberger, John/0000-0002-7674-1767; Edenberg, Howard/0000-0003-0344-9690	NIAAA NIH HHS [U10AA08403] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008403] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Almasy L, 1999, GENET EPIDEMIOL, V17, pS31; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barnard EA, 1998, PHARMACOL REV, V50, P291; Bauer LO, 2001, NEUROPSYCHOPHARMACOL, V25, P332, DOI 10.1016/S0893-133X(01)00236-6; BAUER LO, 1993, J STUD ALCOHOL, V54, P577, DOI 10.15288/jsa.1993.54.577; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; Begleiter H, 1999, ALCOHOL CLIN EXP RES, V23, P1125, DOI 10.1111/j.1530-0277.1999.tb04269.x; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOYLE AE, 1993, PHARMACOL BIOCHEM BE, V46, P179, DOI 10.1016/0091-3057(93)90338-T; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Buck KJ, 1998, MAMM GENOME, V9, P975, DOI 10.1007/s003359900909; Buck KJ, 1996, ALCOHOL CLIN EXP RES, V20, pA198, DOI 10.1111/j.1530-0277.1996.tb01776.x; Buck KJ, 2001, ADDICTION, V96, P139, DOI 10.1046/j.1360-0443.2001.96113910.x; Costa L, 1997, DRUG ALCOHOL DEPEN, V46, P87, DOI 10.1016/S0376-8716(97)00058-6; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Edenberg HJ, 2002, ALCOHOL RES HEALTH, V26, P214; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghosh S, 2003, AM J MED GENET B, V118B, P66, DOI 10.1002/ajmg.b.10057; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; GOODWIN DW, 1979, BRIT J ADDICT, V74, P161; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Haenschel C, 2000, P NATL ACAD SCI USA, V97, P7645, DOI 10.1073/pnas.120162397; Harris RA, 1998, DRUG ALCOHOL DEPEN, V51, P155, DOI 10.1016/S0376-8716(98)00073-8; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hood HM, 2000, ALCOHOL CLIN EXP RES, V24, P1327, DOI 10.1111/j.1530-0277.2000.tb02100.x; Jurinke C, 2001, Methods Mol Biol, V170, P103; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Korpi ER, 1998, NEWS PHYSIOL SCI, V13, P164; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Nowak KL, 1998, PSYCHOPHARMACOLOGY, V139, P108, DOI 10.1007/s002130050695; PICKENS RW, 1991, ARCH GEN PSYCHIAT, V48, P19; Porjesz B, 2002, P NATL ACAD SCI USA, V99, P3729, DOI 10.1073/pnas.052716399; Porjesz B, 2002, BIOL PSYCHOL, V61, P229, DOI 10.1016/S0301-0511(02)00060-1; Rangaswamy M, 2004, INT J PSYCHOPHYSIOL, V51, P239, DOI 10.1016/j.ijpsycho.2003.09.003; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Song JZ, 2003, AM J MED GENET B, V117B, P39, DOI 10.1002/ajmg.b.10022; Spielman RS, 1996, AM J HUM GENET, V59, P983; Tobler I, 2001, P NATL ACAD SCI USA, V98, P6464, DOI 10.1073/pnas.111055398; Tomkins DM, 1996, BEHAV PHARMACOL, V7, P85; Traub RD, 1999, FAST OSCILLATIONS CO; Ueno S, 2001, ALCOHOL CLIN EXP RES, V25, p76S, DOI 10.1097/00000374-200105051-00014; Wang KM, 2000, BRAIN TOPOGR, V12, P263, DOI 10.1023/A:1023455404934; Whittington MA, 1996, BRIT J PHARMACOL, V118, P1977, DOI 10.1111/j.1476-5381.1996.tb15633.x; *WHO, 1993, INT CLASS DIS	54	476	484	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					705	714		10.1086/383283	http://dx.doi.org/10.1086/383283			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	804EA	15024690	Green Published, Bronze			2022-12-18	WOS:000220280800009
J	Paloneva, J; Manninen, T; Christman, G; Hovanes, K; Mandelin, J; Adolfsson, R; Bianchin, M; Bird, T; Miranda, R; Salmaggi, A; Tranebjaerg, L; Konttinen, Y; Peltonen, L				Paloneva, J; Manninen, T; Christman, G; Hovanes, K; Mandelin, J; Adolfsson, R; Bianchin, M; Bird, T; Miranda, R; Salmaggi, A; Tranebjaerg, L; Konttinen, Y; Peltonen, L			Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; NATURAL-KILLER-CELLS; SCLEROSING LEUKOENCEPHALOPATHY; PRESENILE-DEMENTIA; CUTTING EDGE; BONE-CYSTS; MYELOID CELLS; PLO-SL; DAP12; ACTIVATION	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as "Nasu-Hakola disease," is a globally distributed recessively inherited disease leading to death during the 5th decade of life and is characterized by early-onset progressive dementia and bone cysts. Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP. Here we complete the molecular pathology of PLOSL by identifying TREM2 as the second PLOSL gene. TREM2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells. Patients with PLOSL have no defects in cell-mediated immunity, suggesting a remarkable capacity of the human immune system to compensate for the inactive TYROBP-mediated activation pathway. Our data imply that the TYROBP-mediated signaling pathway plays a significant role in human brain and bone tissue and provide an interesting example of how mutations in two different subunits of a multisubunit receptor complex result in an identical human disease phenotype.	Univ Calif Los Angeles, UCLS Sch Med, Dept Human Genet, Gonda Ctr, Los Angeles, CA 90095 USA; Univ Helsinki, Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Biomed Anat, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Invalid Fdn, ORTON Res Inst, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Med Invartes Med, Helsinki, Finland; Umea Univ, Dept Psychiat, Umea, Sweden; Hosp Reg Sao Jose, Div Neurol, Santa Catarina, Brazil; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Vet Affairs Med Ctr, Seattle, WA 98108 USA; CBES, Clin Modelo, Dept Internal Med, La Paz, Bolivia; Inst Nazl Neurol C Besta, Dept Clin Neurosci, Milan, Italy; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Bispebjerg Hosp, Dept Audiol, DK-2400 Copenhagen, Denmark; Inst Med Biochem & Genet, Copenhagen, Denmark	University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Umea University; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); IRCCS Istituto Neurologico Besta; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Copenhagen; Bispebjerg Hospital	Peltonen, L (corresponding author), Univ Calif Los Angeles, UCLS Sch Med, Dept Human Genet, Gonda Ctr, 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	lpeltonen@mednet.ucla.edu	Mandelin, Jami/A-7943-2008; Bianchin, Marino/V-5956-2019; Paloneva, Juha/K-2419-2019; Salmaggi, Andrea/S-7154-2017	Paloneva, Juha/0000-0003-3340-9390; Salmaggi, Andrea/0000-0001-6925-3434; Adolfsson, Rolf/0000-0001-9785-8473				Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; BIRD TD, 1983, NEUROLOGY, V33, P81, DOI 10.1212/WNL.33.1.81; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Campbell CJ, 1999, REV FINANC STUD, V12, P631, DOI 10.1093/rfs/12.3.631; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; EDVARDSEN P, 1983, INT ORTHOP, V7, P99; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; HAKOLA HPA, 1983, J NEUROL NEUROSUR PS, V46, P515, DOI 10.1136/jnnp.46.6.515; HAKOLA HPA, 1993, ACTA NEUROL SCAND, V88, P370, DOI 10.1111/j.1600-0404.1993.tb05360.x; Hakola P., 1990, MONOGRAPHS PSYCHIAT, V17, P1; Kim KJ, 2001, J BIOMED MATER RES, V58, P393, DOI 10.1002/jbm.1033; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Nylander PO, 1996, CLIN GENET, V50, P353; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pekkarinen P, 1998, AM J HUM GENET, V62, P362, DOI 10.1086/301722; Pekkarinen P, 1998, GENOMICS, V54, P307, DOI 10.1006/geno.1998.5591; Smith KM, 1998, J IMMUNOL, V161, P7; Tranebjaerg L, 2000, Tidsskr Nor Laegeforen, V120, P3196; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078	29	475	488	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					656	662		10.1086/342259	http://dx.doi.org/10.1086/342259			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12080485	Bronze, Green Published			2022-12-18	WOS:000177489600021
J	Macaulay, V; Richards, M; Hickey, E; Vega, E; Cruciani, F; Guida, V; Scozzari, R; Bonne-Tamir, B; Sykes, B; Torroni, A				Macaulay, V; Richards, M; Hickey, E; Vega, E; Cruciani, F; Guida, V; Scozzari, R; Bonne-Tamir, B; Sykes, B; Torroni, A			The emerging tree of west Eurasian mtDNAs: A synthesis of control-region sequences and RFLPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; HEREDITARY OPTIC NEUROPATHY; EUROPEAN POPULATIONS; ORIGIN; HAPLOGROUPS; AFRICAN; DIVERSITY; MUTATIONS; HAPLOTYPE; ANCIENT	Variation in the human mitochondrial genome (mtDNA) is now routinely described and used to infer the histories of peoples, by means of one of two procedures, namely, the assaying of RFLPs throughout the genome and the sequencing of parts of the control region (CR). Using 95 samples from the Near East and northwest Caucasus, we present an analysis based on both systems, demonstrate their concordance, and, using additional available information, present the most refined phylogeny to date of west Eurasian mtDNA. We describe and apply a nomenclature for mtDNA clusters. Hypervariable nucleotides are identified, and the relative mutation rates of the two systems are evaluated. We point out where ambiguities remain, The identification of signature mutations for each cluster leads us to apply a hierarchical scheme for determining the cluster composition of a sample of Berber speakers, previously analyzed only for CR variation. We show that the main indigenous North African cluster is a sister group to the most ancient cluster of European mtDNAs, hom which it diverged similar to 50,000 years ago.	Univ Oxford, Inst Mol Med, Oxford, England; Univ Rome La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Sackler Fac Med, Dept Human Genet, Ramat Aviv, Israel; Univ Urbino, Ist Biochim, I-61029 Urbino, Italy	University of Oxford; Sapienza University Rome; Tel Aviv University; Sackler Faculty of Medicine; University of Urbino	Macaulay, V (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.		Cruciani, Fulvio/G-6105-2012; Torroni, Antonio/E-1557-2011; Guida, Valentina/K-4517-2015	Torroni, Antonio/0000-0002-4163-4478; Guida, Valentina/0000-0003-3946-645X; RICHARDS, MARTIN/0000-0003-3118-0967; Cruciani, Fulvio/0000-0002-6900-024X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Berger JO., 1985, STAT DECISION THEORY; Bertranpetit J, 1996, MOL BIOL HUMAN DIVER, p[112, 129]; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; CHEN YS, 1995, AM J HUM GENET, V57, P133; Close A. E., 1990, WORLD 18000 BP, V2, P41; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Fentress Elizabeth, 1996, BERBERS; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; HOWELL N, 1995, GENETICS, V140, P285; Jeffreys H, 1983, THEORY PROBABILITY; Kolman CJ, 1996, GENETICS, V142, P1321; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777; Lindholm E, 1997, EUR J HUM GENET, V5, P406, DOI 10.1159/000484799; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; Richards M, 1997, AM J HUM GENET, V61, P251; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rohl A., 1997, MATH SEM U HAMB HAMB; STONEKING M, 1991, AM J HUM GENET, V48, P370; Swofford David L., 1990, P411; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P563; WAKELEY J, 1993, J MOL EVOL, V37, P613; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WilkinsonHerbots HM, 1996, ANN HUM GENET, V60, P499, DOI 10.1111/j.1469-1809.1996.tb01616.x	43	474	495	0	33	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					232	249		10.1086/302204	http://dx.doi.org/10.1086/302204			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915963	Green Published, Bronze			2022-12-18	WOS:000078477400029
J	SPEISER, PW; DUPONT, B; RUBINSTEIN, P; PIAZZA, A; KASTELAN, A; NEW, MI				SPEISER, PW; DUPONT, B; RUBINSTEIN, P; PIAZZA, A; KASTELAN, A; NEW, MI			HIGH-FREQUENCY OF NONCLASSICAL STEROID 21-HYDROXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MEM SLOAN KETTERING CANC CTR, TISSUE TYPING LAB, NEW YORK, NY 10021 USA; NEW YORK BLOOD CTR, HUMAN IMMUNOGENET LAB, NEW YORK, NY 10021 USA; STANFORD UNIV, MED CTR, DEPT GENET, STANFORD, CA 94305 USA; TISSUE TYPING CTR, YU-41000 Zagreb, YUGOSLAVIA; UNIV TORINO, INST GENET MED, I-10126 Turin, ITALY	Memorial Sloan Kettering Cancer Center; New York Blood Center; Stanford University; University of Turin	SPEISER, PW (corresponding author), CORNELL UNIV, MED CTR, NEW YORK HOSP, DEPT PEDIAT, DIV PEDIAT ENDOCRINOL, NEW YORK, NY 10021 USA.			Piazza, Alberto/0000-0002-2355-4183	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000072, R37HD000072] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA022507] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUR MP, 1980, HISTOCOMPATIBILITY T; BEHRMAN RE, 1983, NELSON TXB PEDIATRIC, P284; BLANKSTEIN J, 1980, AM J MED, V68, P441, DOI 10.1016/0002-9343(80)90117-5; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P235, DOI 10.1111/j.1399-0039.1978.tb01255.x; BRKLJACIC LJ, 1983, OCT INT S AD FEM END; CACCIARI E, 1983, ARCH DIS CHILD, V58, P803, DOI 10.1136/adc.58.10.803; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHILDS B, 1956, J CLIN INVEST, V35, P213, DOI 10.1172/JCI103266; DANILOVS JA, 1980, HISTOCOMPATIBILITY T; DECOURT J, 1957, Ann Endocrinol (Paris), V18, P416; DUPONT B, 1977, LANCET, V2, P1309; DUPONT B, 1984, EXCERPTA MED, V652, P543; DUPONT B, 1980, HISTOCOMPATIBILITY T, P643; GILES CM, 1976, TISSUE ANTIGENS, V8, P143; Ingelfinger JA, 1983, BIOSTATISTICS CLIN M; JONES GES, 1953, FERTIL STERIL, V4, P49; KIDD KK, 1977, HLA DISEASE; KLOUDA PT, 1978, LANCET, V2, P1046; KOHN B, 1982, J CLIN ENDOCR METAB, V55, P817, DOI 10.1210/jcem-55-5-817; KORTHSCHUTZ S, 1978, J CLIN ENDOCR METAB, V46, P452, DOI 10.1210/jcem-46-3-452; LARON Z, 1980, HUM IMMUNOL, V1, P55, DOI 10.1016/0198-8859(80)90009-9; LEVINE LS, 1980, J CLIN ENDOCR METAB, V51, P1316, DOI 10.1210/jcem-51-6-1316; LEVINE LS, 1981, J CLIN ENDOCR METAB, V53, P1193, DOI 10.1210/jcem-53-6-1193; LEVINE LS, 1978, NEW ENGL J MED, V299, P911, DOI 10.1056/NEJM197810262991702; LORENZEN F, 1979, PEDIATR RES, V13, P1356, DOI 10.1203/00006450-197912000-00011; LORENZEN F, 1980, J CLIN ENDOCR METAB, V50, P572, DOI 10.1210/jcem-50-3-572; MIDDLETON J, 1974, TISSUE ANTIGENS, V4, P366; MIGEON CJ, 1980, J CLIN ENDOCR METAB, V51, P647, DOI 10.1210/jcem-51-3-647; NEW MI, 1983, J CLIN ENDOCR METAB, V57, P320, DOI 10.1210/jcem-57-2-320; NEW MI, 1984, ANNU REV MED, V35, P649, DOI 10.1146/annurev.me.35.020184.003245; ONEILL GJ, 1979, TRANSPL P, V11, P1713; ONEILL GJ, 1978, TRANSPLANT P, V10, P749; PANG S, 1977, J CLIN ENDOCR METAB, V45, P1003, DOI 10.1210/jcem-45-5-1003; PANG S, 1985, ANN NY ACAD SCI; POLLACK MS, 1981, HUM GENET, V58, P331, DOI 10.1007/BF00294933; POLLACK MS, 1981, AM J HUM GENET, V33, P540; POLLACK MS, 1979, TRANSPLANT P, V11, P1315; POLLACK MS, 1979, LANCET, V1, P1107; PUCHOLT V, 1978, LANCET, V2, P1046; RAUH W, 1978, KLIN WOCHENSCHR, V56, P161, DOI 10.1007/BF01477468; RUBINSTEIN P, 1982, THEORETICAL ASPECTS, P107; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; THOMSON G, 1977, HLA DISEASE; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; YANG SY, 1978, TRANSPLANT P, V10, P753; Zar JH, 1974, BIOSTATISTICAL ANAL	48	473	493	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					650	667						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556656				2022-12-18	WOS:A1985APR1800004
J	Alves-Silva, J; Santos, MD; Guimaraes, PEM; Ferreira, ACS; Bandelt, HJ; Pena, SDJ; Prado, VF				Alves-Silva, J; Santos, MD; Guimaraes, PEM; Ferreira, ACS; Bandelt, HJ; Pena, SDJ; Prado, VF			The ancestry of Brazilian mtDNA lineages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; AFRICAN POPULATIONS REVEALS; CONTROL-REGION SEQUENCES; NATIVE-AMERICAN; SOUTH-AMERICAN; NEW-WORLD; FOUNDING LINEAGES; ETHNIC ADMIXTURE; MODERN HUMANS; HAPLOGROUP-X	We have analyzed 247 Brazilian mtDNAs for hypervariable segment (HVS)-I and selected restriction fragment-length-polymorphism sites, to assess their ancestry in different continents. The total sample showed nearly equal amounts of Native American, African, and European matrilineal genetic contribution but with regional differences within Brazil. The mtDNA pool of present-day Brazilians clearly reflects the imprints of the early portuguese colonization process (involving directional mating), as well as the recent immigrant waves (from Europe) of the last century. The subset of 99 mtDNAs from the southeastern region encompasses nearly all mtDNA haplogroups observed in the total Brazilian sample; for this regional subset, HVS-II was analyzed, providing, in particular, some novel details of the African mtDNA phylogeny.	Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-30161970 Belo Horizonte, MG, Brazil; Univ Hamburg, Fachbereich Math, Hamburg, Germany	Universidade Federal de Minas Gerais; University of Hamburg	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Caixa Postal 486, BR-30161970 Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	santos, magda s/J-4509-2015; Guimaraes, Pedro/A-9715-2008; Silva, Juliana A/C-4299-2019; Prado, Vania Ferreira/K-7630-2013	santos, magda s/0000-0003-0626-3015; Guimaraes, Pedro/0000-0002-7530-600X; Prado, Vania Ferreira/0000-0003-4994-6393; Silva, Juliana/0000-0002-7627-3000				Alves-Silva J, 1999, HUM HERED, V49, P56, DOI 10.1159/000022842; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arpini-Sampaio Z, 1999, HUM BIOL, V71, P69; BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bandelt HJ, 1997, AM J HUM GENET, V61, P980, DOI 10.1086/514878; BETHELL L, 1997, AM LATINA COLONIAL, P129; Bianchi NO, 1995, BRAZ J GENET, V18, P661; Bortolini M C, 1992, Gene Geogr, V6, P1; Bortolini MC, 1997, HUM BIOL, V69, P141; Bortolini MC, 1997, AM J PHYS ANTHROPOL, V103, P147, DOI 10.1002/(SICI)1096-8644(199706)103:2<147::AID-AJPA1>3.0.CO;2-R; BORTOLINI MC, 1995, HUM BIOL, V67, P547; Bortolini MC, 1998, ANN HUM GENET, V62, P133, DOI 10.1046/j.1469-1809.1998.6220133.x; Bortolini MC, 1996, BRAZ J GENET, V19, P527; Bortolini MC, 1998, HUM BIOL, V70, P443; Bravi CM, 1997, HUM BIOL, V69, P641; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Callegari-Jacques Sidia M., 1999, Ciencia e Cultura (Sao Paulo), V51, P166; CHEN YS, 1995, AM J HUM GENET, V57, P133; CONCEICAO MM, 1987, REV BRAS GENET, V10, P313; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; Dornelles CL, 1999, GENET MOL BIOL, V22, P151, DOI 10.1590/S1415-47571999000200003; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Easton RD, 1996, AM J HUM GENET, V59, P213; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; FRANCO MHLP, 1982, AM J PHYS ANTHROPOL, V58, P127, DOI 10.1002/ajpa.1330580204; GINTHER C, 1993, EXS, V67, P211; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; Guerreiro JF, 1999, GENET MOL BIOL, V22, P163, DOI 10.1590/S1415-47571999000200004; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kolman CJ, 1997, GENETICS, V147, P1289; Kolman CJ, 1996, GENETICS, V142, P1321; KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lee SD, 1997, FORENSIC SCI INT, V87, P99, DOI 10.1016/S0379-0738(97)02114-2; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; Metspalu E, 1999, GENOMIC DIVERSITY, P121; Meyer S, 1999, GENETICS, V152, P1103; Monteiro John Manuel, 1994, NEGROS TERRA INDIOS; MORAES ME, 1993, TISSUE ANTIGENS, V41, P238, DOI 10.1111/j.1399-0039.1993.tb02012.x; Morner Magnus, 1967, RACE MIXTURE HIST LA; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Ribeiro D., 1995, POVO BRASILEIRO FORM; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; ROSA VL, 1984, BRAZ J GENET, V75, P69; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Salzano F. M., 1970, PROBLEMS HUMAN BIOL; Salzano FM, 1997, INTERCIENCIA, V22, P221; Salzano FM, 1967, POPULACOES BRASILEIR; SANTOS EJM, 1996, BRAZ J GENET, V19, P511; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; SANTOS SEB, 1995, BRAZ J GENET, V18, P311; Santos Sidney E. B., 1999, Ciencia e Cultura (Sao Paulo), V51, P181; SCHNEIDER H, 1987, REV BRAS GENET, V10, P565; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSRA; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; STONEKING M, 1991, AM J HUM GENET, V48, P370; TORRONI A, 1995, HUM MUTAT, V5, P310, DOI 10.1002/humu.1380050407; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALIFORNIA; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	86	469	525	4	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					444	461		10.1086/303004	http://dx.doi.org/10.1086/303004			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10873790	Green Published, Bronze			2022-12-18	WOS:000089357800019
J	LEWONTIN, RC				LEWONTIN, RC			ANALYSIS OF VARIANCE AND ANALYSIS OF CAUSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,MUSEUM COMP ZOOL,CAMBRIDGE,MA 02138	Harvard University								CLAUSEN J, 1940, 520 CARN I WASH PUBL, P1; Dobzhansky T, 1944, GENETICS, V29, P270; JENSEN AR, 1969, HARVARD EDUC REV, V39, P1; MORTON NE, 1974, AM J HUM GENET, V26, P318; RAO DC, 1974, AM J HUM GENET, V26, P331; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.2307/2406126; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747	7	469	477	2	36	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					400	411						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	T0991	4827368				2022-12-18	WOS:A1974T099100010
J	EWENS, WJ; SPIELMAN, RS				EWENS, WJ; SPIELMAN, RS			THE TRANSMISSION DISEQUILIBRIUM TEST - HISTORY, SUBDIVISION AND ADMIXTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; HAPLOTYPE RELATIVE RISK; HLA-DISEASE ASSOCIATIONS; INSULIN GENE REGION; IDDM; SUSCEPTIBILITY; LINKAGE	Disease association with a genetic marker is often taken as a preliminary indication of linkage with disease susceptibility. However, population subdivision and admixture may lead to disease association even in the absence of linkage. In a previous paper, we described a test for linkage (and linkage disequilibrium) between a genetic marker and disease susceptibility; linkage is detected by this test only if association is also present. This transmission/disequilibrium test (TDT) is carried out with data on transmission of marker alleles from parents heterozygous for the marker to affected offspring. The TDT is a valid test for linkage and association, even when the association is caused by population subdivision and admixture. In the previous paper, we did not explicitly consider the effect of recent history on population structure. Here we extend the previous results by examining in detail the effects of subdivision and admixture, viewed as processes in population history. We describe two models for these processes. For both models, we analyze the properties of (a) the TDT as a test for linkage (and association) between marker and disease and (b) the conventional contingency statistic used with family data to test for population association. We show that the contingency test statistic does not have a chi(2) distribution if subdivision or admixture is present. In contrast, the TDT remains a valid chi(2) statistic for the linkage hypothesis, regardless of population history.	UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA	University of Pennsylvania	EWENS, WJ (corresponding author), UNIV PENN,DEPT BIOL,PHILADELPHIA,PA 19104, USA.				NIDDK NIH HHS [DK46618, DK47481] Funding Source: Medline; NIGMS NIH HHS [GM21135] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046618, R01DK047481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021135] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BICKEBOLLER H, 1994, IN PRESS GENET EPIDE; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; COX NJ, 1988, AM J HUM GENET, V42, P167; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FALK CT, 1991, BAILLIERES CLIN ENDO, V5, P413; FIELD LL, 1986, GENET EPIDEMIOL S, V1, P323; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LEWONTIN RC, 1988, GENETICS, V120, P849; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; RICE JP, 1994, IN PRESS GENET EPIDE; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1995, AM J HUM GENET, V57, P487	20	467	485	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					455	464						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668272				2022-12-18	WOS:A1995RL77100029
J	McDaniell, R; Warthen, DM; Sanchez-Lara, PA; Pai, A; Krantz, ID; Piccoli, DA; Spinner, NB				McDaniell, Ryan; Warthen, Daniel M.; Sanchez-Lara, Pedro A.; Pai, Athma; Krantz, Ian D.; Piccoli, David A.; Spinner, Nancy B.			NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIOHEPATIC DYSPLASIA; HUMAN JAGGED1; EXPRESSION; RECEPTOR; DEFECTS; LIGAND; HEART; GENE	Alagille syndrome ( AGS) is caused by mutations in the gene for the Notch signaling pathway ligand Jagged1 ( JAG1), which are found in 94% of patients. To identify the cause of disease in patients without JAG1 mutations, we screened 11 JAG1 mutation-negative probands with AGS for alterations in the gene for the Notch2 receptor ( NOTCH2). We found NOTCH2 mutations segregating in two families and identified five affected individuals. Renal manifestations, a minor feature in AGS, were present in all the affected individuals. This demonstrates that AGS is a heterogeneous disorder and implicates NOTCH2 mutations in human disease.	Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Spinner, NB (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, 1007A Abramson Res Ctr,3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	spinner@mail.med.upenn.edu	Sanchez, Pedro/P-1377-2018; Sanchez-Lara, Pedro A./AAP-5644-2021; Sanchez, Pedro/HHM-5713-2022; Sanchez-Lara, Pedro/F-6352-2012	Sanchez-Lara, Pedro A./0000-0003-1181-7828; Sanchez, Pedro/0000-0003-1181-7828; Sanchez-Lara, Pedro/0000-0002-8027-177X; Pai, Athma/0000-0002-7995-9948	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053104] Funding Source: NIH RePORTER; NCRR NIH HHS [U54RR019455, U54 RR019455] Funding Source: Medline; NIDDK NIH HHS [R01 DK053104, DK53104] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; HABIB R, 1987, PEDIATR NEPHROL, V1, P455, DOI 10.1007/BF00849254; Harendza S, 2005, J NEPHROL, V18, P312; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; McCright B, 2001, DEVELOPMENT, V128, P491; McCright B, 2002, DEVELOPMENT, V129, P1075; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	22	466	494	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					169	173		10.1086/505332	http://dx.doi.org/10.1086/505332			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773578	Green Published, Bronze			2022-12-18	WOS:000238341200019
J	Yamada, N; Yamaya, M; Okinaga, S; Nakayama, K; Sekizawa, K; Shibahara, S; Sasaki, H				Yamada, N; Yamaya, M; Okinaga, S; Nakayama, K; Sekizawa, K; Shibahara, S; Sasaki, H			Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CIGARETTE-SMOKING; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; INDUCTION; ALPHA-1-ANTITRYPSIN; UPSTREAM; DISEASE; ELEMENT; STRESS	Cigarette smoke, containing reactive oxygen species, is the most important risk factor for chronic pulmonary emphysema (CPE). Heme oxygenase-1 (HO-1) plays a protective role as an antioxidant in the lung. A (GT)(n) dinucleotide repeat in the 5'-flanking region of human HO-1 gene-shows length polymorphism and could modulate the level of gene transcription. To investigate the correlation between the length of the (GT), repeat and susceptibility to the development of CPE, we screened the frequencies of alleles with varying numbers of (GT)(n) repeats in the HO-1 gene in 101 smokers with CPE and in 100 smokers without CPE. Polymorphisms of the (GT)(n) repeat were grouped into three classes: class S alleles (<25 repeats), class M alleles (25-29 repeats), and class L alleles (greater than or equal to 30 repeats). The proportion of allele frequencies in class L, as well as the proportion of genotypic frequencies in the group with class L alleles (L/L, L/M, and L/S), was significantly higher in the smokers with CPE than in smokers without CPE. Moreover, we analyzed the promoter activities of the HO-1 gene carrying different (GT())n repeats (n = 16, 20, 29, and 38), by transient-transfection assay in cultured cell lines. H2O2 exposure up-regulated the transcriptional activity of the HO-1 promoter/luciferase fusion genes with (GT)(16) or (GT)(20) but did not do so with (GT)(29) or (GT)(38). These findings suggest that the large size of a (GT), repeat in the HO-1 gene promoter may reduce HO-1 inducibility by reactive oxygen species in cigarette smoke, thereby resulting in the development of CPE.	Tohoku Univ, Sch Med, Dept Geriatr & Resp Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; Tohoku Univ, Sch Med, Dept Mol Biol & Appl Physiol, Aoba Ku, Sendai, Miyagi 9808574, Japan; Univ Tsukuba, Inst Clin Med, Dept Pulm Med, Tsukuba, Ibaraki 305, Japan	Tohoku University; Tohoku University; University of Tsukuba	Sasaki, H (corresponding author), Tohoku Univ, Sch Med, Dept Geriatr & Resp Med, Aoba Ku, Seiryo Machi 1-1, Sendai, Miyagi 9808574, Japan.		Shibahara, Shigeki/M-3644-2014; Nakayama, Katsutoshi/AAT-4536-2021	Nakayama, Katsutoshi/0000-0002-0141-7081				ALAM J, 1995, J BIOL CHEM, V270, P11977, DOI 10.1074/jbc.270.20.11977; CELLI BR, 1995, J RESP CRIT CARE M S, V152, pS77; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; FARBER JL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432207; GARVER RI, 1986, NEW ENGL J MED, V314, P762, DOI 10.1056/NEJM198603203141207; Hanrahan JP, 1996, AM J RESP CRIT CARE, V153, P861, DOI 10.1164/ajrccm.153.2.8564146; HOIDAL JR, 1983, CHEST, V83, P679, DOI 10.1378/chest.83.4.679; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; KUPERMAN AS, 1973, CHEST, V63, P655, DOI 10.1378/chest.63.5.655; Lu TH, 1997, BBA-GENE STRUCT EXPR, V1352, P293, DOI 10.1016/S0167-4781(97)00028-6; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MCGINNIS RE, 1995, DIABETES, V44, P1296, DOI 10.2337/diabetes.44.11.1296; MURAOSA Y, 1993, MOL CELL BIOL, V13, P7881, DOI 10.1128/MCB.13.12.7881; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; OGUSHI F, 1991, J CLIN INVEST, V87, P1060, DOI 10.1172/JCI115066; Okinaga S, 1996, BLOOD, V87, P5074, DOI 10.1182/blood.V87.12.5074.bloodjournal87125074; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; OTTERBEIN LE, 1997, P NATL ACAD SCI USA, V94, P10925; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; SHIBAHARA S, 1989, EUR J BIOCHEM, V179, P557, DOI 10.1111/j.1432-1033.1989.tb14583.x; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TAKEDA K, 1994, J BIOL CHEM, V269, P22858; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1970, BIOCHEMISTRY-US, V9, P298, DOI 10.1021/bi00804a016; THOM TJ, 1989, AM REV RESPIR DIS, V140, pS27, DOI 10.1164/ajrccm/140.3_Pt_2.S27; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x	33	466	495	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					187	195		10.1086/302729	http://dx.doi.org/10.1086/302729			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631150	Green Published, Bronze			2022-12-18	WOS:000085033600021
J	Paznekas, WA; Boyadjiev, SA; Shapiro, RE; Daniels, O; Wollnik, B; Keegan, CE; Innis, JW; Dinulos, MB; Christian, C; Hannibal, MC; Jabs, EW				Paznekas, WA; Boyadjiev, SA; Shapiro, RE; Daniels, O; Wollnik, B; Keegan, CE; Innis, JW; Dinulos, MB; Christian, C; Hannibal, MC; Jabs, EW			Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAP-JUNCTION GENE; MARIE-TOOTH-DISEASE; MISSENSE MUTATION; ERYTHROKERATODERMIA VARIABILIS; CONGENITAL CATARACT; MULTIPLE CONNEXINS; CARDIAC CONDUCTION; MICE; EXPRESSION; DEFECTS	Gap junctions are assemblies of intercellular channels that regulate a variety of physiologic and developmental processes through the exchange of small ions and signaling molecules. These channels consist of connexin family proteins that allow for diversity of channel composition and conductance properties. The human connexin 43 gene, or GJA1, is located at human chromosome 6q22-q23 within the candidate region for the oculodentodigital dysplasia locus. This autosomal dominant syndrome presents with craniofacial (ocular, nasal, and dental) and limb dysmorphisms, spastic paraplegia, and neurodegeneration. Syndactyly type III and conductive deafness can occur in some cases, and cardiac abnormalities are observed in rare instances. We found mutations in the GJA1 gene in all 17 families with oculodentodigital dysplasia that we screened. Sixteen different missense mutations and one codon duplication were detected. These mutations may cause misassembly of channels or alter channel conduction properties. Expression patterns and phenotypic features of gja1 animal mutants, reported elsewhere, are compatible with the pleiotropic clinical presentation of oculodentodigital dysplasia.	Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Kaiser Permanente, Dept Genet, San Francisco, CA USA; Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Istanbul Univ, Inst Child Hlth, Div Med Genet, Istanbul, Turkey; UMCN St Radboud, Childrens Heart Ctr, Nijmegen, Netherlands; Univ Vermont, Coll Med, Dept Neurol, Burlington, VT USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Dept Pediat, Ctr Craniofacial Dev & Disorders,Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Dept Med & Plast Surg, Ctr Craniofacial Dev & Disorders,Sch Med, Baltimore, MD 21205 USA	University of Washington; University of Washington Seattle; Kaiser Permanente; Dartmouth College; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Istanbul University; Radboud University Nijmegen; University of Vermont; Johns Hopkins University; Johns Hopkins University	Jabs, EW (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,CMSC 1004, Baltimore, MD 21287 USA.		Wollnik, Bernd/GRY-6062-2022	Wollnik, Bernd/0000-0003-2589-0364; Hannibal, Mark/0000-0002-9077-3837; Jabs, Ethylin/0000-0001-8983-5466	NCRR NIH HHS [M01 RR000052, M01 RR0052] Funding Source: Medline; NICHD NIH HHS [P30 HD024061, R01 HD24061] Funding Source: Medline; NIDCR NIH HHS [R01 DE13849, R01 DE013849] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013849] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Boyadjiev SA, 1999, GENOMICS, V58, P34, DOI 10.1006/geno.1999.5814; BOYADJIEV SA, IN PRESS CYTOGENET G; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Dasgupta C, 2001, MUTAT RES-FUND MOL M, V479, P173, DOI 10.1016/S0027-5107(01)00160-9; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dermietzel R, 1997, GLIA, V20, P101, DOI 10.1002/(SICI)1098-1136(199706)20:2<101::AID-GLIA2>3.0.CO;2-C; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Ewart JL, 1997, DEVELOPMENT, V124, P1281; Fried KAJ, 1996, INT J DEV BIOL, V40, P985; GELLIS SS, 1974, AM J DIS CHILD, V128, P81, DOI 10.1001/archpedi.1974.02110260083015; Gladwin A, 1997, HUM MOL GENET, V6, P123, DOI 10.1093/hmg/6.1.123; GORLIN RJ, 1963, J PEDIATR-US, V63, P69, DOI 10.1016/S0022-3476(63)80304-2; GORLIN RJ, 2001, SYNDROMES HEAD NECK, P290; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; JUDISCH GF, 1979, ARCH OPHTHALMOL-CHIC, V97, P878, DOI 10.1001/archopht.1979.01020010436007; KANTER HL, 1993, CIRC RES, V73, P344, DOI 10.1161/01.RES.73.2.344; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kirchhoff S, 2000, CIRC RES, V87, P399; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; LEE SH, 1995, GLIA, V15, P195, DOI 10.1002/glia.440150212; Liu XZ, 2001, HUM MOL GENET, V10, P2945, DOI 10.1093/hmg/10.25.2945; Loddenkemper T, 2002, J NEUROL, V249, P584, DOI 10.1007/s004150200068; Macari F, 2000, AM J HUM GENET, V67, P1296; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Meyer RA, 1997, DEV GENET, V21, P290; Mohr OL, 1939, HEREDITAS, V25, P193; Murakami K, 2001, COAST ENG J, V43, P203, DOI 10.1142/S0578563401000347; NORTON KK, 1995, AM J MED GENET, V57, P458, DOI 10.1002/ajmg.1320570320; OPJORDSMOEN S, 1980, ACTA NEUROL SCAND, V61, P35; Pal JD, 1999, AM J PHYSIOL-CELL PH, V276, pC1443, DOI 10.1152/ajpcell.1999.276.6.C1443; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I; RAJIC DS, 1966, ANN RADIOL, V9, P224; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Ressot C, 2000, BRAIN RES REV, V32, P192, DOI 10.1016/S0165-0173(99)00081-8; Richard G, 2002, AM J HUM GENET, V70, P1341, DOI 10.1086/339986; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rouan F, 2001, J CELL SCI, V114, P2105; RUANGVORAVAT CP, 1992, DEV DYNAM, V194, P261, DOI 10.1002/aja.1001940403; Schneider J A, 1977, Va Med, V104, P262; Schrander-Stumpel C.t.r.m., 1993, Genetic Counseling, V4, P271; Shapiro RE, 1997, AM J MED GENET, V71, P36, DOI 10.1002/(SICI)1096-8628(19970711)71:1<36::AID-AJMG7>3.0.CO;2-O; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Stanislaw C.L., 1998, P GREENWOOD GENET CT, V17, P20; TRABOULSI EI, 1990, AM J OPHTHALMOL, V109, P310, DOI 10.1016/S0002-9394(14)74556-8; van der Heyden MAG, 2001, MECH DEVELOP, V108, P217, DOI 10.1016/S0925-4773(01)00490-7; Vaney DI, 2000, BRAIN RES REV, V32, P115, DOI 10.1016/S0165-0173(99)00070-3; WEINTRAUB DM, 1975, CLEFT PALATE J, V12, P323; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; WOOLDRIDGE WE, 1977, MO MED, V74, P379; WOOLDRIDGE WE, 1993, CLIN DERMATOL, P1; ZACH GA, 1975, ORAL SURG ORAL MED O, V40, P122, DOI 10.1016/0030-4220(75)90354-0; ZELLWEGER H, 1974, AM J HUM GENET, V26, pA97	62	465	483	1	16	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					408	418		10.1086/346090	http://dx.doi.org/10.1086/346090			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12457340	Bronze, Green Published			2022-12-18	WOS:000180680000020
J	HUNGERFORD, DA; DONNELLY, AJ; NOWELL, PC; BECK, S				HUNGERFORD, DA; DONNELLY, AJ; NOWELL, PC; BECK, S			THE CHROMOSOME CONSTITUTION OF A HUMAN PHENOTYPIC INTERSEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BLOOM W, 1938, HDB HAEMATOLOGY, P1471; BOND VP, 1958, SCIENCE, V128, P202, DOI 10.1126/science.128.3317.202; CHU EHY, 1959, AM J HUM GENET, V11, P63; DANON M, 1957, LANCET, V2, P20; DAVIDSON WM, 1954, BRIT MED J, V2, P6, DOI 10.1136/bmj.2.4878.6; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; FORD CE, 1959, LANCET, V1, P711; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FORD CE, 1959, LANCET, V1, P709; FRACCARO M, 1959, LANCET, V1, P886; GRAHAM MA, 1952, ANAT REC, V112, P709, DOI 10.1002/ar.1091120402; GRUMBACH MM, 1958, RECENT PROG HORM RES, V14, P255; HUNGERFORD DA, 1958, J BIOPHYS BIOCHEM CY, V4, P391, DOI 10.1083/jcb.4.4.391; HUNGERFORD DAVID ALDEN, 1955, J MORPH, V97, P497, DOI 10.1002/jmor.1050970305; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; JACOBS PA, 1959, LANCET, V1, P710; JOST A, 1953, RECENT PROG HORM RES, V8, P379; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; LEVAN A, 1953, J NATL CANCER I, V14, P1; MOORE KL, 1953, SURG GYNECOL OBSTET, V96, P641; MOORE KL, 1957, J EXP ZOOL, V135, P101, DOI 10.1002/jez.1401350109; NOWELL PC, 1958, P AM ASSOC CANC RES, V2, P331; OSGOOD EE, 1955, BLOOD, V10, P1010, DOI 10.1182/blood.V10.10.1010.1010; OSGOOD EE, 1955, EXP CELL RES, V9, P116, DOI 10.1016/0014-4827(55)90165-8; REITALU J, 1957, Acta Genet Med Gemellol (Roma), V6, P393; SACHS LEO, 1956, GENETICA, V28, P201; STURTEVANT AH, 1945, GENETICS, V30, P297; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229; WELSHONS W. J., 1959, PROC NATL ACAD SCI, V45, P560, DOI 10.1073/pnas.45.4.560	31	465	465	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	3					215	236						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF075	13848459				2022-12-18	WOS:A1959WF07500001
J	LONG, JC; WILLIAMS, RC; URBANEK, M				LONG, JC; WILLIAMS, RC; URBANEK, M			AN E-M ALGORITHM AND TESTING STRATEGY FOR MULTIPLE-LOCUS HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RANDOMLY MATING POPULATIONS; LINKAGE DISEQUILIBRIUM; ALLELES	This paper gives an expectation maximization (EM) algorithm to obtain allele frequencies, haplotype frequencies, and gametic disequilibrium coefficients for multiple-locus systems. It permits high polymorphism and null alleles at all loci. This approach effectively deals with the primary estimation problems associated with such systems; that is, there is not a one-to-one correspondence between phenotypic and genotypic categories, and sample sizes tend to be much smaller than the number of phenotypic categories. The EM method provides maximum-likelihood estimates and therefore allows hypothesis tests using likelihood ratio statistics that have chi(2) distributions with large sample sizes. We also suggest a data resampling approach to estimate test statistic sampling distributions. The resampling approach is more computer intensive, but it is applicable to all sample sizes. A strategy to test hypotheses about aggregate groups of gametic disequilibrium coefficients is recommended. This strategy minimizes the number of necessary hypothesis tests while at the same time describing the structure of disequilibrium. These methods are applied to three unlinked dinucleotide repeat loci in Navajo Indians and to three linked HLA loci in Gila River (Pima) Indians. The likelihood functions of both data sets are shown to be maximized by the EM estimates, and the testing strategy provides a useful description of the structure of gametic disequilibrium. Following these applications, a number of simulation experiments are performed to test how well the likelihood-ratio statistic distributions are approximated by chi(2) distributions. In most circumstances the chi(2) grossly underestimated the probability of type I errors. However, at times they also overestimated the type 1 error probability. Accordingly, we recommend hypothesis tests that use the resampling method.	ARIZONA STATE UNIV,DEPT ANTHROPOL,TEMPE,AZ 85287	Arizona State University; Arizona State University-Tempe	LONG, JC (corresponding author), NIAAA,NEUROGENET LAB,12501 WASHINGTON AVE,ROCKVILLE,MD 20852, USA.			Urbanek, Margrit/0000-0001-6994-7110				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; BAUR MP, 1980, HISTOCOMPATIBILITY T; BENNETT JH, 1954, ANN EUGENIC, V18, P311; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROWN AHD, 1980, GENETICS, V96, P523; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; CHAKRABORTY R, 1994, AM J HUM GENET, V55, P391; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CLARK AG, 1990, MOL BIOL EVOL, V2, P111; Deming WE, 1940, ANN MATH STAT, V11, P427, DOI 10.1214/aoms/1177731829; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Efron B., 1993, INTRO BOOTSTRAP; GART JJ, 1984, BIOMETRICS, V40, P887, DOI 10.2307/2531140; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hartl D. L., 1989, PRINCIPLES POPULATIO; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEDRICK PW, 1987, GENETICS, V117, P331; HEDRICK PW, 1986, GENETICS, V112, P135; HILL WG, 1994, AM J HUM GENET, V54, P705; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; JORDE LB, 1993, AM J HUM GENET, V53, P1038; KAPLAN N, 1992, AM J HUM GENET, V51, P333; MICHELINI S, IN PRESS NEUROPSYCHI; NAM JM, 1987, AM J HUM GENET, V41, P70; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; OTT J, 1992, AM J HUM GENET, V51, P283; Piazza A., 1975, Histocompatibility testing 1975., P923; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; Sokal R.R., 1981, BIOMETRY, V2nd ed.; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEIR BS, 1978, GENETICS, V88, P633; WEIR BS, 1992, GENETICS, V130, P873; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Weir BS, 1990, GENETIC DATA ANAL; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLIAMS RC, 1992, HUM IMMUNOL, V33, P39, DOI 10.1016/0198-8859(92)90050-W; YASUDA N, 1968, ANN HUM GENET, V13, P409	41	464	489	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					799	810						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887436				2022-12-18	WOS:A1995QK91800031
J	FELSENSTEIN, J				FELSENSTEIN, J			MAXIMUM-LIKELIHOOD ESTIMATION OF EVOLUTIONARY TREES FROM CONTINUOUS CHARACTERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle			Rohlf, F J/A-8710-2008					BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; Cavalli-Sforza LL, 1965, GENETICS TODAY, V3, P923; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; EDWARDS AWF, 1970, J ROY STAT SOC B, V32, P155; Edwards AWF, 1972, ASSESSMENT POPULATIO; EDWARDS AWF, 1964, 6 SYST ASS PUBL; KALBFLEI.JD, 1970, J ROY STAT SOC B, V32, P175; KIDD KK, 1971, AM J HUM GENET, V23, P235; KURCZYNSKI TW, 1970, BIOMETRICS, V26, P525, DOI 10.2307/2529106; MALYUTOV MB, 1972, ASSESSMENT POPULATIO; MORTON N E, 1971, Theoretical Population Biology, V2, P507, DOI 10.1016/0040-5809(71)90038-4; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771	14	464	469	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	5					471	492						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7858	4741844				2022-12-18	WOS:A1973Q785800002
J	Lou, XY; Chen, GB; Yan, L; Ma, JZ; Zhu, J; Elston, RC; Li, MD				Lou, Xiang-Yang; Chen, Guo-Bo; Yan, Lei; Ma, Jennie Z.; Zhu, Jun; Elston, Robert C.; Li, Ming D.			A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIOLOGICAL COMPLEXITY; MOLECULAR-BIOLOGY; SYSTEMS BIOLOGY; TRAIT VARIATION; HUMAN-DISEASES; EPISTASIS; EVOLUTION; ASSOCIATION; ROBUSTNESS; SUSCEPTIBILITY	The determination of gene-by-gene and gene-by-environment interactions has long been one of the greatest challenges in genetics. The traditional methods are typically inadequate because of the problem referred to as the "curse of dimensionality." Recent combinatorial approaches, such as the multifactor dimensionality reduction (MDR) method, the combinatorial partitioning method, and the restricted partition method, have a straightforward correspondence to the concept of the phenotypic landscape that unifies biological, statistical genetics, and evolutionary theories. However, the existing approaches have several limitations, such as not allowing for covariates, that restrict their practical use. In this study, we report a generalized MDR (GMDR) method that permits adjustment for discrete and quantitative covariates and is applicable to both dichotomous and continuous phenotypes in various population-based study designs. Computer simulations indicated that the GMDR method has superior performance in its ability to identify epistatic loci, compared with current methods in the literature. We applied our proposed method to a genetics study of four genes that were reported to be associated with nicotine dependence and found significant joint action between CHRNB4 and NTRK2. Moreover, our example illustrates that the newly proposed GMDR approach can increase prediction ability, suggesting that its use is justified in practice. In summary, GMDR serves the purpose of identifying contributors to population variation better than do the other existing methods.	Univ Virginia, Neurobiol Sect, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22911 USA; Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22911 USA; Zhejiang Univ, Inst Bioinformat, Hangzhou 310027, Peoples R China; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Virginia; University of Virginia; Zhejiang University; Case Western Reserve University	Li, MD (corresponding author), Univ Virginia, Neurobiol Sect, Dept Psychiat & Neurobehav Sci, 1670 Discovery Dr,Suite 110, Charlottesville, VA 22911 USA.	ml2km@virginia.edu	Zhu, Jun/B-9945-2009; Lou, Xiang-Yang/B-6291-2013; Chen, Guo-Bo/C-2435-2009	Chen, Guo-Bo/0000-0001-5475-8237	NIDA NIH HHS [DA12844, R01 DA012844] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, R37 GM028356, GM28356] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Beuten J, 2007, BIOL PSYCHIAT, V61, P48, DOI 10.1016/j.biopsych.2006.02.023; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elston R C, 1981, Adv Hum Genet, V11, P63; Elston R.C., 1981, ADV HUM GENET, V11, P372; ELSTON RC, 1961, BIOMETRICS, V17, P209, DOI 10.2307/2527987; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Gibson G, 1996, THEOR POPUL BIOL, V49, P58, DOI 10.1006/tpbi.1996.0003; Hahn Lance W, 2004, In Silico Biol, V4, P183; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Hermisson J, 2003, AM NAT, V161, P708, DOI 10.1086/374204; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; KACSER H, 1981, GENETICS, V97, P639; KELETI T, 1989, PROG BIOPHYS MOL BIO, V53, P105, DOI 10.1016/0079-6107(89)90016-3; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Nijhout HF, 2003, DEVELOPMENT, V130, P5863, DOI 10.1242/dev.00902; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; Phillips PC, 1998, GENETICS, V149, P1167; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Rice SH, 2002, P NATL ACAD SCI USA, V99, P15518, DOI 10.1073/pnas.202620999; Rice SH, 1998, EVOLUTION, V52, P647, DOI [10.2307/2411260, 10.1111/j.1558-5646.1998.tb03690.x]; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schork NJ, 1997, AM J RESP CRIT CARE, V156, pS103, DOI 10.1164/ajrccm.156.4.12-tac-5; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Stephanopoulos G, 2004, NAT BIOTECHNOL, V22, P1261, DOI 10.1038/nbt1016; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938; Valent A, 1997, EUR J HUM GENET, V5, P102, DOI 10.1159/000484742; VELEZ DR, 2007, GENET EPIDEMIOL; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Wolf JB, 2002, P NATL ACAD SCI USA, V99, P15849, DOI 10.1073/pnas.012686699	58	460	505	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1125	1137		10.1086/518312	http://dx.doi.org/10.1086/518312			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503330	Green Published, Bronze			2022-12-18	WOS:000246553800011
J	den Hollander, AI; Koenekoop, RK; Yzer, S; Lopez, I; Arends, ML; Voesenek, KEJ; Zonneveld, MN; Strom, TM; Meitinger, T; Brunner, HG; Hoyng, CB; van den Born, LI; Rohrschneider, K; Cremers, FPM				den Hollander, Anneke I.; Koenekoop, Robert K.; Yzer, Suzanne; Lopez, Irma; Arends, Maarten L.; Voesenek, Krysta E. J.; Zonneveld, Marijke N.; Strom, Tim M.; Meitinger, Thomas; Brunner, Han G.; Hoyng, Carel B.; van den Born, L. Ingeborgh; Rohrschneider, Klaus; Cremers, Frans P. M.			Mutations in the CEP290 (NPHP6) gene are a frequent cause of leber congenital amaurosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; DYSTROPHY	Leber congenital amaurosis (LCA) is one of the main causes of childhood blindness. To date, mutations in eight genes have been described, which together account for similar to 45% of LCA cases. We localized the genetic defect in a consanguineous LCA-affected family from Quebec and identified a splice defect in a gene encoding a centrosomal protein (CEP290). The defect is caused by an intronic mutation ( c. 2991+ 1655A -> G) that creates a strong splice-donor site and inserts a cryptic exon in the CEP290 messenger RNA. This mutation was detected in 16 (21%) of 76 unrelated patients with LCA, either homozygously or in combination with a second deleterious mutation on the other allele. CEP290 mutations therefore represent one of the most frequent causes of LCA identified so far.	Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; McGill Univ, Ctr Hlth, McGill Ocular Genet Ctr, Montreal, PQ, Canada; Rotterdam Eye Hosp, Rotterdam, Netherlands; Natl Res Ctr Environm & Hlth, German Sci Fdn, Inst Human Genet, Munich, Germany; Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; McGill University; Rotterdam Eye Hospital; University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	a.denhollander@antrg.umcn.nl	Meitinger, Thomas/O-1318-2015; Koenekoop, Robert/AAT-6676-2021; Yzer, Suzanne/ABB-6929-2020; Hoyng, C.B./H-8050-2014; Cremers, Frans/A-5625-2014; Hollander, Anneke den/N-4911-2014; Brunner, Han/C-9928-2013	Cremers, Frans/0000-0002-4954-5592; Rohrschneider, Klaus/0000-0003-1996-7935; Meitinger, Thomas/0000-0002-8838-8403				Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cremers FPM, 2002, HUM MOL GENET, V11, P1169, DOI 10.1093/hmg/11.10.1169; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; LITTLE S, 2000, CURRENT PROTOCOLS HU; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111	18	460	475	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					556	561		10.1086/507318	http://dx.doi.org/10.1086/507318			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909394	Green Published, Bronze			2022-12-18	WOS:000239830700018
J	Dumitrescu, AM; Liao, XH; Best, TB; Brockmann, K; Refetoff, S				Dumitrescu, AM; Liao, XH; Best, TB; Brockmann, K; Refetoff, S			A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							XPCT GENE; HORMONE; IDENTIFICATION; EXPRESSION; FAMILY; CHAIN; BRAIN	Thyroid hormones are iodothyronines that control growth and development, as well as brain function and metabolism. Although thyroid hormone deficiency can be caused by defects of hormone synthesis and action, it has not been linked to a defect in cellular hormone transport. In fact, the physiological role of the several classes of membrane transporters remains unknown. We now report, for the first time, mutations in the monocarboxylate transporter 8 (MCT8) gene, located on the X chromosome, that encodes a 613 - amino acid protein with 12 predicted transmembrane domains. The propositi of two unrelated families are males with abnormal relative concentrations of three circulating iodothyronines, as well as neurological abnormalities, including global developmental delay, central hypotonia, spastic quadriplegia, dystonic movements, rotary nystagmus, and impaired gaze and hearing. Heterozygous females had a milder thyroid phenotype and no neurological defects. These findings establish the physiological importance of MCT8 as a thyroid hormone transporter.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Gottingen, Dept Pediat & Neuropediat, D-3400 Gottingen, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Gottingen	Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC3090,5841 S Maryland Ave, Chicago, IL 60637 USA.		Refetoff, Samuel/ABB-1263-2021	Refetoff, Samuel/0000-0003-0164-8231	NCRR NIH HHS [RR00055, M01 RR000055] Funding Source: Medline; NIDDK NIH HHS [DK17050] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe T, 2002, TRENDS ENDOCRIN MET, V13, P215, DOI 10.1016/S1043-2760(02)00599-4; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; de Escobar GM, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI 10.1210/jc.85.11.3975; Debrand E, 1998, GENOMICS, V48, P296, DOI 10.1006/geno.1997.5173; DELANGE FM, 2000, WERNER INGBARS THYRO, P743; EKINS R, 1992, CLIN CHEM, V38, P1289; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; HAGENBUCH B, 2003, SODIUM BILE SALT COT; HALESTRAP AP, 2003, SLC16 GENE FAMILY MO; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; LAFRENIERE RG, 1994, HUM MOL GENET, V3, P1133, DOI 10.1093/hmg/3.7.1133; LARSEN PR, 1981, ENDOCR REV, V2, P87, DOI 10.1210/edrv-2-1-87; Mac M, 2003, NEUROCHEM INT, V43, P305, DOI 10.1016/S0197-0186(03)00016-0; MORLEY JE, 1981, ENDOCR REV, V2, P396, DOI 10.1210/edrv-2-4-396; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; REFETOFF S, 2001, METABOLIC MOL BASIS, V2, P4029; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; StGermain DL, 1997, THYROID, V7, P655	22	460	477	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					168	175		10.1086/380999	http://dx.doi.org/10.1086/380999			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14661163	Green Published, Bronze			2022-12-18	WOS:000187723500016
J	Lahat, H; Pras, E; Olender, T; Avidan, N; Ben-Asher, E; Man, O; Levy-Nissenbaum, E; Khoury, A; Lorber, A; Goldman, B; Lancet, D; Eldar, M				Lahat, H; Pras, E; Olender, T; Avidan, N; Ben-Asher, E; Man, O; Levy-Nissenbaum, E; Khoury, A; Lorber, A; Goldman, B; Lancet, D; Eldar, M			A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; OVEREXPRESSING CALSEQUESTRIN; RYANODINE RECEPTOR; AFTERDEPOLARIZATIONS; PROTEINS; HEARTS	Catecholamine-induced polymorphic ventricular tachycardia (PVT) is characterized by episodes of syncope, seizures, or sudden death, in response to physical activity or emotional stress. Two modes of inheritance have been described: autosomal dominant and autosomal recessive. Mutations in the ryanodine receptor 2 gene (RYR2), which encodes a cardiac sarcoplasmic reticulum (SR) Ca2+-release channel, were recently shown to cause the autosomal dominant form of the disease. In the present report, we describe a missense mutation in a highly conserved region of the calsequestrin 2 gene (CASQ2) as the potential cause of the autosomal recessive form. The CASQ2 protein serves as the major Ca2+ reservoir within the SR of cardiac myocytes and is part of a protein complex that contains the ryanodine receptor. The mutation, which is in full segregation in seven Bedouin families affected by the disorder, converts a negatively charged aspartic acid into a positively charged histidine, in a highly negatively charged domain, and is likely to exert its deleterious effect by disrupting Ca2+ binding.	Chaim Sheba Med Ctr, Danek Gartner Inst Human Genet, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Inst Heart, IL-52621 Tel Hashomer, Israel; Weizmann Inst Sci, Dept Mol Genet, Crown Human Genome Ctr, IL-76100 Rehovot, Israel; Rambam Med Ctr, Inst Pediat Cardiol, Haifa, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Weizmann Institute of Science; Rambam Health Care Campus; Technion Israel Institute of Technology	Pras, E (corresponding author), Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel.	epras@post.tau.ac.il						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Lahat H, 2001, CIRCULATION, V103, P2822; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; Marban E, 1995, CARDIAC ELECTROPHYSI, P11; OTSU K, 1993, GENOMICS, V17, P507, DOI 10.1006/geno.1993.1357; Priori SG, 2001, CIRCULATION, V103, P196; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; Puglisi JL, 1996, AM J PHYSIOL-HEART C, V270, pH1772, DOI 10.1152/ajpheart.1996.270.5.H1772; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; RUBART M, 2001, HEART DIS TXB CARDIO, P680; Stokes DL, 2000, EUR J BIOCHEM, V267, P5274, DOI 10.1046/j.1432-1327.2000.01569.x; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Viskin S, 1998, PROG CARDIOVASC DIS, V41, P17, DOI 10.1016/S0033-0620(98)80020-0; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	25	460	481	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1378	1384		10.1086/324565	http://dx.doi.org/10.1086/324565			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704930	Bronze, Green Published			2022-12-18	WOS:000172086900021
J	Van Esch, H; Bauters, M; Ignatius, J; Jansen, M; Raynaud, M; Hollanders, K; Lugtenberg, D; Bienvenu, T; Jensen, LR; Gecz, J; Moraine, C; Marynen, P; Fryns, JP; Froyen, G				Van Esch, H; Bauters, M; Ignatius, J; Jansen, M; Raynaud, M; Hollanders, K; Lugtenberg, D; Bienvenu, T; Jensen, LR; Gecz, J; Moraine, C; Marynen, P; Fryns, JP; Froyen, G			Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CPG-BINDING PROTEIN-2; RETT-SYNDROME; FUNCTIONAL DISOMY; INHERITED DUPLICATION; MOLECULE L1; DISTAL XQ; GENE; EXPRESSION; MUTATIONS	Loss-of-function mutations of the MECP2 gene at Xq28 are associated with Rett syndrome in females and with syndromic and nonsyndromic forms of mental retardation (MR) in males. By array comparative genomic hybridization (array-CGH), we identified a small duplication at Xq28 in a large family with a severe form of MR associated with progressive spasticity. Screening by real-time quantitation of 17 additional patients with MR who have similar phenotypes revealed three more duplications. The duplications in the four patients vary in size from 0.4 to 0.8 Mb and harbor several genes, which, for each duplication, include the MR-related L1CAM and MECP2 genes. The proximal breakpoints are located within a 250-kb region centromeric of L1CAM, whereas the distal breakpoints are located in a 300-kb interval telomeric of MECP2. The precise size and location of each duplication is different in the four patients. The duplications segregate with the disease in the families, and asymptomatic carrier females show complete skewing of X inactivation. Comparison of the clinical features in these patients and in a previously reported patient enables refinement of the genotype-phenotype correlation and strongly suggests that increased dosage of MECP2 results in the MR phenotype. Our findings demonstrate that, in humans, not only impaired or abolished gene function but also increased MeCP2 dosage causes a distinct phenotype. Moreover, duplication of the MECP2 region occurs frequently in male patients with a severe form of MR, which justifies quantitative screening of MECP2 in this group of patients.	Univ Hosp Gasthuisberg, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; Oulu Univ Hosp, Dept Clin Genet, Oulu, Finland; Oulu Univ, Oulu, Finland; Ctr Hosp Univ Tours, Serv Genet, Tours, France; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Univ Paris 05, Ctr Natl Rech Sci, INSERM, Fac Med,Inst Cochin, F-75014 Paris, France; Max Planck Inst Mol Genet, Berlin, Germany; Univ Adelaide, Dept Med Genet, Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Dept Pediat, Adelaide, SA, Australia	KU Leuven; University Hospital Leuven; University of Oulu; University of Oulu; CHU Tours; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide	Van Esch, H (corresponding author), Univ Hosp Gasthuisberg, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Hilde.VanEsch@med.kuleuven.ac.be	Raynaud, Martine/R-9811-2019; Van+Esch, Hilde/AAU-5688-2020; Lugtenberg, Dorien/B-6338-2018; Gecz, Jozef/X-3469-2019	Raynaud, Martine/0000-0002-6888-6480; Gecz, Jozef/0000-0002-7884-6861; Van Esch, Hilde/0000-0002-9604-5726				Akiyama M, 2001, AM J MED GENET, V99, P111, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1150>3.0.CO;2-C; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 2000, AM J MED GENET, V97, P147, DOI 10.1002/1096-8628(200022)97:2<147::AID-AJMG6>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; BAUTERS M, 2005, IN PRESS EUR J MED G; Ben Zeev B, 2002, J CHILD NEUROL, V17, P20, DOI 10.1177/088307380201700105; Bourdon Violaine, 2003, Mol Diagn, V7, P3, DOI 10.2165/00066982-200307010-00002; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Goodman BK, 1998, AM J MED GENET, V80, P377, DOI 10.1002/(SICI)1096-8628(19981204)80:4<377::AID-AJMG14>3.0.CO;2-7; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Kammoun F, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014480; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kokalj-Vokac N, 2004, EUR J PEDIATR, V163, P658, DOI 10.1007/s00431-004-1519-5; Lachlan KL, 2004, HUM GENET, V115, P399, DOI 10.1007/s00439-004-1175-x; LAHN BT, 1994, NAT GENET, V8, P243, DOI 10.1038/ng1194-243; Lammer EJ, 2001, CLIN DYSMORPHOL, V10, P141, DOI 10.1097/00019605-200104000-00012; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Novelli A, 2004, AM J MED GENET A, V128A, P165, DOI 10.1002/ajmg.a.30088; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Ravn K, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9320; Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063; Sanlaville D, 2005, EUR J HUM GENET, V13, P579, DOI 10.1038/sj.ejhg.5201384; Schollen E, 2003, HUM MUTAT, V22, P116, DOI 10.1002/humu.10242; TEEK ROK, 2004, EUR J HUM GENET, V12, P129; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; VASQUEZ AI, 1995, J MED GENET, V32, P891, DOI 10.1136/jmg.32.11.891; Veltman JA, 2004, J MED GENET, V41, P425, DOI 10.1136/jmg.2004.018531; ZOGHBI H, 1988, J CHILD NEUROL, V3, pS76, DOI 10.1177/0883073888003001S15	37	459	470	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					442	453		10.1086/444549	http://dx.doi.org/10.1086/444549			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080119	Green Published, Bronze			2022-12-18	WOS:000231314100010
J	Li, Q; Wang, K				Li, Quan; Wang, Kai			InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; INCIDENTAL FINDINGS; NONSYNONYMOUS SNVS; SEQUENCE VARIANTS; GENOME; EXOME; DATABASE; RECOMMENDATIONS; PREDICTION; STANDARDS	In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published updated standards and guidelines for the clinical interpretation of sequence variants with respect to human diseases on the basis of 28 criteria. However, variability between individual interpreters can be extensive because of reasons such as the different understandings of these guidelines and the lack of standard algorithms for implementing them, yet computational tools for semi-automated variant interpretation are not available. To address these problems, we propose a suite of methods for implementing these criteria and have developed a tool called InterVar to help human reviewers interpret the clinical significance of variants. InterVar can take a pre-annotated or VCF file as input and generate automated interpretation on 18 criteria. Furthermore, we have developed a companion web server, wInterVar, to enable user-friendly variant interpretation with an automated interpretation step and a manual adjustment step. These tools are especially useful for addressing severe congenital or very early-onset developmental disorders with high penetrance. Using results from a few published sequencing studies, we demonstrate the utility of InterVar in significantly reducing the time to interpret the clinical significance of sequence variants.	[Li, Quan; Wang, Kai] Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Kai] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Wang, Kai] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Li, Quan] Mem Univ Newfoundland, Fac Med, St John, NF A1B 3V6, Canada	University of Southern California; Columbia University; Columbia University; Memorial University Newfoundland	Wang, K (corresponding author), Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.; Wang, K (corresponding author), Columbia Univ, Inst Genom Med, New York, NY 10032 USA.; Wang, K (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA.	kw2701@cumc.columbia.edu	Li, Quan/B-3605-2009		NIH [HG006465, MH108728]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Fan Xia (Baylor College of Medicine) and Dr. Rong Mao (AAUP Laboratories) for reading the manuscripts and offering valuable suggestions on the web server. We thank three anonymous reviewers for their valuable comments, which helped improve the manuscript substantially. We also want to thank members of the K.W. lab for testing the InterVar and wInterVar tools and providing feedback. This study was supported by NIH grants HG006465 and MH108728. K.W. was previously a board member and stock holder of Tute Genomics, a bioinformatics software company.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; [Anonymous], 2016, NAT METHODS, V13, P103, DOI 10.1038/nmeth.3762; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Kazazian HA, 2000, GENET MED, V2, P302; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li MJ, 2016, NUCLEIC ACIDS RES, V44, pD869, DOI 10.1093/nar/gkv1317; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lyon GJ, 2012, GENOME MED, V4, DOI 10.1186/gm359; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Malcolmson J, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001073; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McPherson JD, 2009, NAT METHODS, V6, pS2, DOI [10.1038/NMETH.F.268, 10.1038/nmeth.f.268]; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Quintans B, 2014, APPL TRANSL GENOM, V3, P60, DOI 10.1016/j.atg.2014.06.001; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Shi LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12065; Shihab HA, 2013, BIOINFORMATICS, V29, P1504, DOI 10.1093/bioinformatics/btt182; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; Thompson BA, 2013, HUM MUTAT, V34, P255, DOI 10.1002/humu.22214; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	59	458	468	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					267	280		10.1016/j.ajhg.2017.01.004	http://dx.doi.org/10.1016/j.ajhg.2017.01.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132688	Bronze, Green Published			2022-12-18	WOS:000393352000008
J	Sigurdsson, S; Nordmark, G; Goring, HHH; Lindroos, K; Wiman, AC; Sturfelt, G; Jonsen, A; Rantapaa-Dahlqvist, S; Moller, B; Kere, J; Koskenmies, S; Widen, E; Eloranta, ML; Julkunen, H; Kristjansdottir, H; Steinsson, K; Alm, G; Ronnblom, L; Syvanen, AC				Sigurdsson, S; Nordmark, G; Goring, HHH; Lindroos, K; Wiman, AC; Sturfelt, G; Jonsen, A; Rantapaa-Dahlqvist, S; Moller, B; Kere, J; Koskenmies, S; Widen, E; Eloranta, ML; Julkunen, H; Kristjansdottir, H; Steinsson, K; Alm, G; Ronnblom, L; Syvanen, AC			Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMACYTOID DENDRITIC CELLS; FC-GAMMA-RIIA; GENOME SCAN; ALPHA; EXPRESSION; SUSCEPTIBILITY; TYK2; INDUCTION; LINKAGE; INNATE	Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease caused by both genetic and environmental factors. Genome scans in families with SLE point to multiple potential chromosomal regions that harbor SLE susceptibility genes, and association studies in different populations have suggested several susceptibility alleles for SLE. Increased production of type I interferon (IFN) and expression of IFN-inducible genes is commonly observed in SLE and may be pivotal in the molecular pathogenesis of the disease. We analyzed 44 single-nucleotide polymorphisms ( SNPs) in 13 genes from the type I IFN pathway in 679 Swedish, Finnish, and Icelandic patients with SLE, in 798 unaffected family members, and in 438 unrelated control individuals for joint linkage and association with SLE. In two of the genes - the tyrosine kinase 2 (TYK2) and IFN regulatory factor 5 (IRF5) genes - we identified SNPs that displayed strong signals in joint analysis of linkage and association (unadjusted P < 10(-7)) with SLE. TYK2 binds to the type I IFN receptor complex and IRF5 is a regulator of type I IFN gene expression. Thus, our results support a disease mechanism in SLE that involves key components of the type I IFN system.	Landspitalinn Univ Hosp, Ctr Rheumatol Res, Dept Rheumatol, Reykjavik, Iceland; Helsinki Univ Hosp, Helsinki, Finland; Peijas Hosp, Dept Med, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Umea Univ Hosp, Div Rheumatol, S-90185 Umea, Sweden; Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biosci, Uppsala, Sweden; Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden	Landspitali National University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Umea University; Lund University; Skane University Hospital; Texas Biomedical Research Institute; Swedish University of Agricultural Sciences; Uppsala University	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci, Acad Hosp, Res Dept 2, Entrance 70,3rd Floor,, S-75185 Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Sigurdsson, Snaevar/0000-0003-4860-6311				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bave U, 2000, J IMMUNOL, V165, P3519, DOI 10.4049/jimmunol.165.6.3519; Bell PA, 2002, BIOTECHNIQUES, P70; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Cantor RM, 2004, ARTHRITIS RHEUM, V50, P3203, DOI 10.1002/art.20511; Chong WP, 2004, GENES IMMUN, V5, P484, DOI 10.1038/sj.gene.6364119; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; David M, 2002, BIOTECHNIQUES, P58; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; HOCHBERG MC, 1987, J RHEUMATOL, V14, P867; Hsu TM, 2001, BIOTECHNIQUES, V31, P560, DOI 10.2144/01313rr01; Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kaplan MJ, 2004, CLIN IMMUNOL, V112, P210, DOI 10.1016/j.clim.2004.04.007; Karassa FB, 2002, ARTHRITIS RHEUM-US, V46, P1563, DOI 10.1002/art.10306; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Koskenmies S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009977; Kristjansdottir H, 2000, J RHEUMATOL, V27, P2590; LANGE K, 2001, AM J HUM GENET S, V69, P212; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Lindroos K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf069; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Magnusson V, 2004, GENES IMMUN, V5, P130, DOI 10.1038/sj.gene.6364052; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Namjou B, 2002, GENES IMMUN, V3, pS35, DOI 10.1038/sj.gene.6363905; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Sanghera DK, 2004, HUM GENET, V115, P393, DOI 10.1007/s00439-004-1172-0; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Stewart TA, 2003, CYTOKINE GROWTH F R, V14, P139, DOI 10.1016/S1359-6101(02)00088-6; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsao BP, 2004, CURR OPIN RHEUMATOL, V16, P513, DOI 10.1097/01.bor.0000132648.62680.81; WALLACE DJ, 2002, DUBOIS LUPUS ERYTHEM; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	50	458	498	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					528	537		10.1086/428480	http://dx.doi.org/10.1086/428480			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15657875	Bronze, Green Published			2022-12-18	WOS:000226851900016
J	RISCH, N				RISCH, N			ASSESSING THE ROLE OF HLA-LINKED AND UNLINKED DETERMINANTS OF DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NICHD NIH HHS [HD00648] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000648] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARBOSA J, 1982, CLIN GENET, V21, P25; BARBOSA J, 1979, J CLIN INVEST, V65, P592; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; CLERGETDARPOUX F, 1980, CLIN GENET, V18, P51; EBERS G C, 1984, American Journal of Human Genetics, V36, p49S; GREENBERG DA, 1982, AM J HUM GENET, V34, P263; HAILE RWC, 1985, HUM HERED, V35, P43, DOI 10.1159/000153514; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; HO HZ, 1982, IMMUNOGENETICS, V15, P509, DOI 10.1007/BF00345910; HODGE SE, 1981, AM J HUM GENET, V33, P381; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; KUWERT EK, 1977, ACTA NEUROL SCAND, V55, P23; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; MACLEAN CJ, 1984, COMPUT BIOMED RES, V17, P471, DOI 10.1016/0010-4809(84)90013-2; PAYAMI H, 1985, ANN HUM GENET, V49, P303, DOI 10.1111/j.1469-1809.1985.tb01706.x; RAFFEL LJ, 1985, PEDIATR RES, V19, pA252, DOI 10.1203/00006450-198504000-00879; RISCH N, 1984, AM J HUM GENET, V36, P363; RISCH N, 1983, AM J MED GENET, V16, P243, DOI 10.1002/ajmg.1320160214; Risch N, 1984, Genet Epidemiol, V1, P207, DOI 10.1002/gepi.1370010216; RISCH N, IN PRESS GENET EPIDE; SPIELMAN RS, 1982, EPIDEMIOL REV, V4, P45, DOI 10.1093/oxfordjournals.epirev.a036251; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; STEWART GJ, 1981, HUM IMMUNOL, V3, P13, DOI 10.1016/0198-8859(81)90040-9; SUAREZ B, 1982, AM J MED GENET, V12, P309, DOI 10.1002/ajmg.1320120309; SVEJGAARD A, 1981, ANN HUM GENET, V45, P293, DOI 10.1111/j.1469-1809.1981.tb00340.x; THOMSON G, 1981, THEOR POPUL BIOL, V20, P168, DOI 10.1016/0040-5809(81)90009-5; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84; THOMSON G, IN PRESS GENET EPIDE; TIWARI J L, 1984, Genetic Epidemiology, V1, P37, DOI 10.1002/gepi.1370010106; WAGENER DK, 1982, DIABETES, V31, P136, DOI 10.2337/diabetes.31.2.136	35	458	463	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1987	40	1					1	14						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G0618	3468804				2022-12-18	WOS:A1987G061800001
J	McKusick, VA				McKusick, Victor A.			Mendelian inheritance in man and its online version, OMIM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							BINDING PROTEIN ABP-280; GENETIC-DISORDERS; PEJORATIVE TERMINOLOGY; ALZHEIMERS-DISEASE; HUMAN HYPERTENSION; CHROMOSOME MAPS; X-CHROMOSOME; COPY NUMBER; MUTATIONS; NOMENCLATURE		Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA	Johns Hopkins University	McKusick, VA (corresponding author), Johns Hopkins Univ Hosp, 1007 Blalock Bldg,600 N Wolfe St, Baltimore, MD 21287 USA.	mckusick@peas.welch.jhu.edu						Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; [Anonymous], 1931, INBORN FACTORS DIS E; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Antonarakis SE, 2000, NAT GENET, V25, P11, DOI 10.1038/75497; Antonarakis SE, 1998, HUM MUTAT, V11, P1; BASS EB, 1983, ANN INTERN MED, V99, P192, DOI 10.7326/0003-4819-99-2-192; Becker KG, 2004, MED HYPOTHESES, V62, P309, DOI 10.1016/S0306-9877(03)00332-3; BERGSMA D, 1969, Birth Defects Original Article Series, V5, P1; BUCKLE VJ, 1984, CLIN GENET, V26, P1, DOI 10.1111/j.1399-0004.1984.tb00780.x; Burchfield R., 1991, UNLOCKING ENGLISH LA; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Childs B., 1999, GENETIC MED LOGIC DI; Chung EK, 2002, AM J HUM GENET, V71, P823, DOI 10.1086/342777; Cohen MM, 2006, AM J MED GENET A, V140A, P1483, DOI 10.1002/ajmg.a.31264; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; den Dunnen JT, 2000, HUM MUTAT, V15, P7; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Dipple KM, 2001, HUM GENET, V109, P55, DOI 10.1007/s004390100545; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; FABER K, 1930, NOSOGRAPHY; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feingold M, 2006, AM J MED GENET A, V140A, P410, DOI 10.1002/ajmg.a.31108; FERGUSONSMITH MA, 1976, HUM GENET, V34, P35, DOI 10.1007/BF00284432; Garrod A, 1928, LANCET, V1, P1055; Garrod AE, 1902, LANCET, V2, P1616; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goodfellow P, 1997, NAT GENET, V16, P209, DOI 10.1038/ng0797-209; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; GORLIN JB, 1993, GENOMICS, V17, P496, DOI 10.1006/geno.1993.1354; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harada K, 2002, ONCOGENE, V21, P4345, DOI 10.1038/sj.onc.1205446; HARMAN D, 1988, P RIAO 88 C US OR CO; JONES PA, 2002, NAT REV CANCER, V3, P414; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; KIMBERLING WJ, 1975, AM J HUM GENET, V27, P586; KLMBERLING WJ, 1978, BLOOD, V52, P859; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LUBS HA, 1969, AM J HUM GENET, V21, P231; Ludman MD, 2006, AM J MED GENET A, V140A, P1485, DOI 10.1002/ajmg.a.31263; Lupski J.R., 2006, GENOMIC DISORDERS TH; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; MCKUSICK V A, 1969, Birth Defects Original Article Series, V5, P23; McKusick V.A., 1998, MENDELIAN INHERITANC; McKusick V.A., 1956, HERITABLE DISORDERS; McKusick V.A., 1992, MENDELIAN INHERITANC; MCKUSICK VA, 1964, CIRCULATION, V30, P326, DOI 10.1161/01.CIR.30.3.326; MCKUSICK VA, 1964, COLD SPRING HARB SYM, V29, P99, DOI 10.1101/SQB.1964.029.01.015; MCKUSICK VA, 1969, PERSPECT BIOL MED, V12, P298; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; MCKUSICK VA, 1962, Q REV BIOL, V37, P69, DOI 10.1086/403631; MCKUSICK VA, 1965, MED GENETICS 1961 19; MCKUSICK VA, 1961, MED GENETICS 1958 19; MCKUSICK VA, 1993, MED GENETICS SELF IN; McKusick VA, 1992, DNA TECHN FOR SCI; McKusick VA, 2006, ANNU REV GENOM HUM G, V7, P1, DOI 10.1146/annurev.genom.7.080505.115749; MIGEON BR, 1968, SCIENCE, V162, P1005, DOI 10.1126/science.162.3857.1005; MILLER OJ, 1971, SCIENCE, V173, P244, DOI 10.1126/science.173.3993.244; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; MITELMAN F, 1998, CATALOG CHROMOSOME A; Murray K. M. E, 1977, CAUGHT WEB WORDS JAH; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCRIVER CR, 1989, GARRODS INBORN FACTO; SEARLE A G, 1987, Genomics, V1, P3, DOI 10.1016/0888-7543(87)90099-1; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Slaney SF, 1996, AM J HUM GENET, V58, P923; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844	81	457	480	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					588	604		10.1086/514346	http://dx.doi.org/10.1086/514346			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357067	Bronze, Green Published			2022-12-18	WOS:000245465200002
J	Heath, SC				Heath, SC			Markov chain Monte Carlo segregation and linkage analysis for oligogenic models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-ANALYSIS; PEDIGREE DATA; IRREDUCIBILITY; SIMULATION; LIKELIHOOD; TRAITS	A new method for segregation and linkage analysis, with pedigree data, is described. Reversible jump Markov chain Monte Carlo methods are used to implement a sampling scheme in which the Markov chain can jump between parameter subspaces corresponding to models with different numbers of quantitative-trait loci (QTL's). Joint estimation of QTL number, position, and effects is possible, avoiding the problems that can arise from misspecification of the number of QTL's in a linkage analysis. The method is illustrated by use of a data set simulated for the 9th Genetic Analysis Workshop; this data set had several oligogenic traits, generated by use of a 1,497-member pedigree. The mixing characteristics of the method appear to be good, and the method correctly recovers the simulated model from the test data set. The approach appears to have great potential both for robust linkage analysis and for the answering of more general questions regarding the genetic control of complex traits.	UNIV WASHINGTON,DEPT STAT,SEATTLE,WA 98195	University of Washington; University of Washington Seattle			Heath, Simon C/J-4138-2012	Heath, Simon C/0000-0002-9550-0897	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255, R01GM031575, R01GM046255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31575, GM46255] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BESAG J, 1993, STAT SCI, V10, P3; Blangero J, 1995, GENET EPIDEMIOL, V12, P689, DOI 10.1002/gepi.1370120628; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; DIZIER MH, 1993, AM J HUM GENET, V53, P1338; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Falconer D. S., 1989, Introduction to quantitative genetics.; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; GREEN PJ, 1994, J R STATIST SOC B, V56, P589; GUO SW, 1992, AM J HUM GENET, V51, P1111; Haldane JBS, 1919, J GENET, V8, P299; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HEATH SC, 1994, P 5 WORLD C GEN APPL, V18, P398; HEATH WK, 1995, THESIS EDINBURGH U E; HOESCHELE I, 1994, P 5 WORLD C GEN APPL, V21, P241; KONG A, 1991, COMPUTING SCIENCE AND STATISTICS, P379; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LIN SL, 1994, AM J HUM GENET, V54, P695; LIN SL, 1993, IMA J MATH APPL MED, V10, P1; MacCluer JW, 1995, GENET EPIDEMIOL, V12, P707, DOI 10.1002/gepi.1370120629; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Phillips DV, 1996, MARKOV CHAIN MONTE C, P215; RICHARDSON S, J R STAT SOC B, V59, P731; SATAGOPAN JM, 1996, GENETICS, V144, P905; SHEEHAN N, 1993, BIOMETRICS, V49, P163, DOI 10.2307/2532611; STEPHENS DA, 1993, ANN HUM GENET, V57, P65, DOI 10.1111/j.1469-1809.1993.tb00887.x; THOMAS A, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P157; THOMPSON EA, 1994, PHILOS T ROY SOC B, V344, P345, DOI 10.1098/rstb.1994.0073; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; TIERNEY L, 1994, ANN STAT, V22, P1721; WANG CS, 1993, GENET SEL EVOL, V25, P41, DOI 10.1051/gse:19930103	35	456	468	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					748	760		10.1086/515506	http://dx.doi.org/10.1086/515506			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326339	Green Published, Bronze			2022-12-18	WOS:A1997XY52300031
J	FORD, D; EASTON, DF; PETO, J				FORD, D; EASTON, DF; PETO, J			ESTIMATES OF THE GENE-FREQUENCY OF BRCA1 AND ITS CONTRIBUTION TO BREAST AND OVARIAN-CANCER INCIDENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOMETRIAL CANCER; FAMILIAL BREAST; HISTORY; RISK; RELATIVES; LINKAGE	The majority of multiple-case families that segregate both breast and ovarian cancer in a dominant fashion are due to mutations in the BRCA1 gene on chromosome 17q. In this paper, we have combined penetrance estimates for BRCA1 with the results of two population-based genetic epidemiological studies to estimate the gene frequency of BRCA1. On the assumption that the excess risk of ovarian cancer in first degree relatives of breast cancer patients and the breast cancer excess in relatives of ovarian cancer patients are both entirely accounted for by BRCA1, we estimate that the BRCA1 gene frequency is 0.0006 (95% confidence interval [0.0002-0.001]) and that the proportion of breast cancer cases in the general population due to BRCA1 is 5.3% below age 40 years, 2.2% between ages 40 and 49 years, and 1.1% between ages 50 and 70 years. The corresponding estimates for ovarian cancer are 5.7%, 4.6%, and 2.1%, respectively. Our results suggest that the majority of breast cancer families with less than four cases and no ovarian cancer are not due to rare highly penetrant genes such as BRCA1 but are more likely to be due either to chance or to more common genes of lower penetrance.			FORD, D (corresponding author), CANC RES INST,EPIDEMIOL SECT,BLOCK D,15 COTSWOLD RD,BELMONT SM2 5NG,SURREY,ENGLAND.							ANDERSON KE, 1992, BRIT J CANCER, V66, P599, DOI 10.1038/bjc.1992.321; CLAUS EB, 1991, AM J HUM GENET, V48, P232; COLEMAN M, 1986, INT J EPIDEMIOL, V15, P134, DOI 10.1093/ije/15.1.134; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; EASTON DF, IN PRESS INT J CANCE; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KOCH M, 1989, INT J EPIDEMIOL, V18, P782, DOI 10.1093/ije/18.4.782; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; NAROD SA, 1991, LANCET, V338, P82; PARAZZINI F, 1993, INT J EPIDEMIOL, V22, P614, DOI 10.1093/ije/22.4.614; PETO J, IN PRESS INT J CANCE; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; SCOTT D, 1994, LANCET, V344, P1444, DOI 10.1016/S0140-6736(94)90615-7; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; TEARE MD, 1994, BRIT J CANCER, V70, P102, DOI 10.1038/bjc.1994.257; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; TZONOU A, 1984, EUR J CANCER CLIN ON, V20, P1045, DOI 10.1016/0277-5379(84)90107-X; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	22	452	458	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1457	1462						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533776				2022-12-18	WOS:A1995TE65500024
J	Lammi, L; Arte, S; Somer, M; Jarvinen, H; Lahermo, P; Thesleff, I; Pirinen, S; Nieminen, P				Lammi, L; Arte, S; Somer, M; Jarvinen, H; Lahermo, P; Thesleff, I; Pirinen, S; Nieminen, P			Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; MISSENSE MUTATION; ADENOMATOSIS-COLI; IDENTIFICATION; OLIGODONTIA; GENE; NONSENSE; PAX9; MORPHOGENESIS	Wnt signaling regulates embryonic pattern formation and morphogenesis of most organs. Aberrations of regulation of Wnt signaling may lead to cancer. Here, we have used positional cloning to identify the causative mutation in a Finnish family in which severe permanent tooth agenesis ( oligodontia) and colorectal neoplasia segregate with dominant inheritance. Eleven members of the family lacked at least eight permanent teeth, two of whom developed only three permanent teeth. Colorectal cancer or precancerous lesions of variable types were found in eight of the patients with oligodontia. We show that oligodontia and predisposition to cancer are caused by a nonsense mutation, Arg656Stop, in the Wnt-signaling regulator AXIN2. In addition, we identified a de novo frameshift mutation 1994-1995insG in AXIN2 in an unrelated young patient with severe tooth agenesis. Both mutations are expected to activate Wnt signaling. The results provide the first evidence of the importance of Wnt signaling for the development of dentition in humans and suggest that an intricate control of Wnt-signal activity is necessary for normal tooth development, since both inhibition and stimulation of Wnt signaling may lead to tooth agenesis. Our findings introduce a new gene for hereditary colorectal cancer and suggest that tooth agenesis may be an indicator of cancer susceptibility.	Univ Helsinki, Biomedicum, Inst Dent, FIN-00014 Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; Family Federat Finland, Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Family Federation of Finland; University of Helsinki	Nieminen, P (corresponding author), Univ Helsinki, Biomedicum, Inst Dent, POB 63, FIN-00014 Helsinki, Finland.	pekka.nieminen@helsinki.fi						Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Arte S., 2001, THESIS U HELSINKI HE; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; FITZGERALD GM, 1943, J AM DENT ASSOC, V30, P1408; GARDNER EJ, 1962, AM J HUM GENET, V14, P376; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; IDA M, 1981, ORAL SURG ORAL MED O, V52, P2, DOI 10.1016/0030-4220(81)90164-X; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kiecker C, 2001, DEVELOPMENT, V128, P4189; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Knudsen Anne Lyster, 2003, Fam Cancer, V2, P43, DOI 10.1023/A:1023286520725; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MAI YW, 1999, POLYM BLENDS FORMULA, V2, P17; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Nieminen P, 2003, J DENT RES, V82, P1013, DOI 10.1177/154405910308201215; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Petersen J, 1998, INTERNET WORLD, V9, P12; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; van de Water S, 2001, DEVELOPMENT, V128, P3877; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1016/S0889-5406(00)70173-9; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; Wilusz CJ, 2001, GENE DEV, V15, P2781; WOLF J, 1986, BRIT J ORAL MAX SURG, V24, P410, DOI 10.1016/0266-4356(86)90054-9; Wu R, 2001, CANCER RES, V61, P8247; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	50	447	521	0	24	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1043	1050		10.1086/386293	http://dx.doi.org/10.1086/386293			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15042511	Green Published, Bronze			2022-12-18	WOS:000220926100022
J	WILFOND, BS; PELIAS, MZ; KNOPPERS, BM; REILLY, PR; WERTZ, DC; BILLINGS, P; FLEISHER, LD; ROWLEY, P; STROM, C; ZINBERG, R; BOYD, P; CLAYTON, EW; FANOS, J; MARKEL, D; SCHNEIDER, K				WILFOND, BS; PELIAS, MZ; KNOPPERS, BM; REILLY, PR; WERTZ, DC; BILLINGS, P; FLEISHER, LD; ROWLEY, P; STROM, C; ZINBERG, R; BOYD, P; CLAYTON, EW; FANOS, J; MARKEL, D; SCHNEIDER, K			POINTS TO CONSIDER - ETHICAL, LEGAL, AND PSYCHOSOCIAL IMPLICATIONS OF GENETIC TESTING IN CHILDREN AND ADOLESCENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DISCRIMINATION; DISEASE; MUTATIONS; INSURANCE; CANCER				WILFOND, BS (corresponding author), AMER SOC HUMAN GENET,BOARD DIRECTORS,EXECUT OFF,9650 ROCKVILLE PIKE,SUITE 3500,BETHESDA,MD 20814, USA.							ALPER JS, 1993, AM J HUM GENET, V53, P26; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLOCH M, 1990, AM J HUM GENET, V46, P1; BRETT AS, 1986, NEW ENGL J MED, V315, P1347, DOI 10.1056/NEJM198611203152109; Buchanan AE., 1989, DECIDING OTHERS ETHI; CARANDANG MLA, 1979, AM J ORTHOPSYCHIAT, V49, P474, DOI 10.1111/j.1939-0025.1979.tb02630.x; CORTNER JA, 1993, J PEDIATR-US, V123, P177, DOI 10.1016/S0022-3476(05)81686-5; FANOS JH, 1993, AM J HUM GENET, V53, P51; FARRELL PM, 1992, ADV PEDIATR, V39, P36; GALLIE BL, 1991, PEDIATR CLIN N AM, V38, P299; GARBER JE, 1994, CURR OPIN PEDIATR, V5, P712; GARDNER RA, 1969, AM J PSYCHIAT, V126, P636, DOI 10.1176/ajp.126.5.636; GLENN GM, 1992, JAMA-J AM MED ASSOC, V267, P1226, DOI 10.1001/jama.267.9.1226; GREENM, 1964, PEDIATRICS, P53; Grodin M. A., 1994, CHILDREN RES SUBJECT, pvii; HARPER PS, 1990, LANCET, V335, P1205, DOI 10.1016/0140-6736(90)92713-R; HOFMAN KJ, 1992, J PEDIATR-US, V120, P394, DOI 10.1016/S0022-3476(05)80903-5; Holder A R, 1988, Law Med Health Care, V16, P219; KOOCHER G P, 1986, Cancer, V58, P468, DOI 10.1002/1097-0142(19860715)58:2+<468::AID-CNCR2820581310>3.0.CO;2-Q; LABERGE CM, 1990, GENETIC SCREENING NE, P379; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; MARON BJ, 1987, NEW ENGL J MED, V316, P884; MARTEAU T, 1994, J MED GENET, V31, P785; MCEWEN JE, 1993, AM J HUM GENET, V53, P33; MELTON GB, 1983, CHILDRENS COMPETENCE, P1; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; OSTRER H, 1993, AM J HUM GENET, V52, P565; PELIAS MZ, 1991, AM J MED GENET, V39, P347, DOI 10.1002/ajmg.1320390320; PERRIN EC, 1981, PEDIATRICS, V67, P841; PETERSEN BM, IN PRESS J NATL CANC; Revo, 2022, SURG SOLUTION; SUTHERLAND GR, 1993, J MED GENET, V30, P978, DOI 10.1136/jmg.30.12.978; TARLETON JC, 1993, J PEDIATR-US, V122, P169, DOI 10.1016/S0022-3476(06)80110-1; WADLINGTON WJ, 1983, CHILDRENS COMPETENCE, P57; Weithorn L. A., 1983, CHILDRENS COMPETENCE, P235; WERTZ DC, 1988, AM J HUM GENET, V42, P592; WERTZ DC, 1994, JAMA-J AM MED ASSOC, V272, P875, DOI 10.1001/jama.272.11.875; Wexler N S, 1985, Prog Med Genet, V6, P277; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; WILFOND BS, 1993, JAMA-J AM MED ASSOC, V270, P2948, DOI 10.1001/jama.270.24.2948; YOUNGER SJ, 1988, JAMA-J AM MED ASSOC, V260, P2094, DOI 10.1001/jama.260.14.2094; 1994, FED REGISTER, V48, P9818; 1994, J MED GENET, V31, P785; 1983, SCREENING COUNSELING; 1988, PEDIATRICS, V81, P169	46	447	453	1	27	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1233	1241						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	TA449	7485175				2022-12-18	WOS:A1995TA44900031
J	DENDUNNEN, JT; GROOTSCHOLTEN, PM; BAKKER, E; BLONDEN, LAJ; GINJAAR, HB; WAPENAAR, MC; VANPAASSEN, HMB; VANBROECKHOVEN, C; PEARSON, PL; VANOMMEN, GJB				DENDUNNEN, JT; GROOTSCHOLTEN, PM; BAKKER, E; BLONDEN, LAJ; GINJAAR, HB; WAPENAAR, MC; VANPAASSEN, HMB; VANBROECKHOVEN, C; PEARSON, PL; VANOMMEN, GJB			TOPOGRAPHY OF THE DUCHENNE MUSCULAR-DYSTROPHY (DMD) GENE - FIGE AND CDNA ANALYSIS OF 194 CASES REVEALS 115 DELETIONS AND 13 DUPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									LEIDEN STATE UNIV,DEPT HUMAN GENET,WASSENAARSEWEG 72,2333 AL LEIDEN,NETHERLANDS; UNIV ANTWERP,DEPT BIOCHEM,ANTWERP,BELGIUM	Leiden University; Leiden University - Excl LUMC; University of Antwerp			dunnen, johan den/ABH-4228-2020; Bakker, Egbert/D-3525-2009; Van Broeckhoven, Christine/M-7853-2019	dunnen, johan den/0000-0002-6304-1710; Bakker, Egbert/0000-0002-2843-7357; Van Broeckhoven, Christine/0000-0003-0183-7665				ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BAKKER E, 1989, J INHERIT METAB DIS, V12, P174, DOI 10.1007/BF01799293; BAKKER E, 1985, LANCET, V1, P655; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BLONDEN LAJ, 1989, NUCLEIC ACIDS RES, V17, P5611, DOI 10.1093/nar/17.14.5611; BONILLA E, 1988, AM J PATHOL, V133, P440; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER H, 1986, NATURE, V324, P482; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHEN JD, 1988, AM J HUM GENET, V42, P777; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1988, AM J HUM GENET, V43, P126; DARRAS BT, 1988, AM J HUM GENET, V43, P612; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DENDUNNEN JT, 1989, BRIT MED BULL, V45, P644, DOI 10.1093/oxfordjournals.bmb.a072350; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; EMERY AEH, 1988, OXFORD MONOGRAPHS ME, V15; FEENER GA, 1989, NATURE, V338, P509; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; FRANCKE U, 1985, AM J HUM GENET, V37, P250; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; HU X, 1989, J MED GENET, V44, P855; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KONINGS RNH, 1986, GENE, V46, P269, DOI 10.1016/0378-1119(86)90411-7; LEVINSON B, 1988, American Journal of Human Genetics, V43, pA192; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MCCABE ERB, 1989, J CLIN INVEST, V83, P95, DOI 10.1172/JCI113890; MEITINGER T, 1988, GENOMICS, V3, P315, DOI 10.1016/0888-7543(88)90122-X; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NUDLE U, 1989, NATURE, V337, P76; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; WIEACKER P, 1983, LANCET, V2, P1325; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	43	447	455	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					835	847						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2573997				2022-12-18	WOS:A1989CF40300002
J	Rosser, ZH; Zerjal, T; Hurles, ME; Adojaan, M; Alavantic, D; Amorim, A; Amos, W; Armenteros, M; Arroyo, E; Barbujani, G; Beckman, G; Beckman, L; Bertranpetit, J; Bosch, E; Bradley, DG; Brede, G; Cooper, G; Corte-Real, HBSM; de Knijff, P; Decorte, R; Dubrova, YE; Evgrafov, O; Gilissen, A; Glisic, S; Golge, M; Hill, EW; Jeziorowska, A; Kalaydjieva, L; Kayser, M; Kivisild, T; Kravchenko, SA; Krumina, A; Kucinskas, V; Lavinha, J; Livshits, LA; Malaspina, P; Maria, S; McElreavey, K; Meitinger, TA; Mikelsaar, AV; Mitchell, RJ; Nafa, K; Nicholson, J; Norby, S; Pandya, A; Parik, J; Patsalis, PC; Pereira, L; Peterlin, B; Pielberg, G; Prata, ML; Previdere, C; Roewer, L; Rootsi, S; Rubinsztein, DC; Saillard, J; Santos, FR; Stefanescu, G; Sykes, BC; Tolun, A; Villems, R; Tyler-Smith, C; Jobling, MA				Rosser, ZH; Zerjal, T; Hurles, ME; Adojaan, M; Alavantic, D; Amorim, A; Amos, W; Armenteros, M; Arroyo, E; Barbujani, G; Beckman, G; Beckman, L; Bertranpetit, J; Bosch, E; Bradley, DG; Brede, G; Cooper, G; Corte-Real, HBSM; de Knijff, P; Decorte, R; Dubrova, YE; Evgrafov, O; Gilissen, A; Glisic, S; Golge, M; Hill, EW; Jeziorowska, A; Kalaydjieva, L; Kayser, M; Kivisild, T; Kravchenko, SA; Krumina, A; Kucinskas, V; Lavinha, J; Livshits, LA; Malaspina, P; Maria, S; McElreavey, K; Meitinger, TA; Mikelsaar, AV; Mitchell, RJ; Nafa, K; Nicholson, J; Norby, S; Pandya, A; Parik, J; Patsalis, PC; Pereira, L; Peterlin, B; Pielberg, G; Prata, ML; Previdere, C; Roewer, L; Rootsi, S; Rubinsztein, DC; Saillard, J; Santos, FR; Stefanescu, G; Sykes, BC; Tolun, A; Villems, R; Tyler-Smith, C; Jobling, MA			Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEOLITHIC DEMIC DIFFUSION; HUMAN-GENE-FREQUENCIES; DNA VARIATION; SPATIAL AUTOCORRELATION; SEQUENCE VARIATION; MITOCHONDRIAL-DNA; NUCLEAR-DNA; HAPLOTYPES; PATTERNS; POPULATION	Clinal patterns of autosomal genetic diversity within Europe have been interpreted in previous studies in terms of a Neolithic demic diffusion model for the spread of agriculture; in contrast, studies using mtDNA have traced many founding lineages to the Paleolithic and have not shown strongly clinal variation. We have used 11 human Y-chromosomal biallelic polymorphisms, defining 10 haplogroups, to analyze a sample of 3,616 Y chromosomes belonging to 47 European and circum-European populations. Patterns of geographic differentiation are highly nonrandom, and, when they are assessed using spatial autocorrelation analysis, they show significant dines for five of six haplogroups analyzed. Clines for two haplogroups, representing 45% of the chromosomes, are continentwide and consistent with the demic diffusion hypothesis. Clines for three other haplogroups each have different foci and are more regionally restricted and are likely to reflect distinct population movements, including one from north of the Black Sea. principal-components analysis suggests that populations are related primarily on the basis of geography, rather than on the basis of linguistic affinity. This is confirmed in Mantel tests, which show a strong and highly significant partial correlation between genetics and geography but a low nonsignificant partial correlation between genetics and language. Genetic-barrier analysis also indicates the primacy of geography in the shaping of patterns of variation. These patterns retain a strong signal of expansion from the Near East but also suggest that the demographic history of Europe has been complex and influenced by other major population movements, as well as by linguistic and geographic heterogeneities and the effects of drift.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Biochem, CRC, Chromosome Mol Biol Grp, Oxford OX1 3QU, England; Univ Oxford, Inst Mol Med, Oxford OX1 3QU, England; Univ Tartu, Inst Gen & Mol Pathol, EE-50090 Tartu, Estonia; Estonian Bioctr, Tartu, Estonia; Inst Nucl Sci Vinca, Lab Radiol & Mol Genet, Belgrade, Yugoslavia; Univ Porto, IPATIMUP 5, P-4100 Porto, Portugal; Univ Porto, Fac Ciencias, P-4100 Porto, Portugal; Univ Cambridge, Dept Zool, Cambridge, England; Univ Complutense Madrid, Ctr Invest & Criminalist, Lab ADN, Madrid, Spain; Univ Complutense Madrid, Lab Biol Forense, Dept Toxicol & Legislac Sanitaria, Madrid, Spain; Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy; Umea Univ, Dept Med Genet, Umea, Sweden; Univ Pompeu Fabra, Unitat Biol Evolut, Fac Ciecies Salut & Vida, Barcelona, Spain; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Oslo, Ctr Biotechnol, N-0316 Oslo, Norway; Inst Nacl Saude Dr Ricardo Jorge, Lisbon, Portugal; Leiden Univ, Med Ctr, Forens Lab DNA Res, MGC,Dept Human & Clin Genet, Leiden, Netherlands; Katholieke Univ Leuven, Lab Forens Genet & Mol Archaeol, Ctr Human Genet, Louvain, Belgium; Russian Acad Med Sci, Med Genet Res Ctr, UFA Sci Ctr, Dept Biochem & Cytochem, Moscow, Russia; Univ Kiel, Dept Physiol, Kiel, Germany; Med Univ Lodz, Dept Med Genet, Inst Endocrinol, PL-90131 Lodz, Poland; Edith Cowan Univ, Dept Human Biol, Perth, WA, Australia; Royal Perth Hosp, Western Australian Inst Med Res, Perth, WA, Australia; Humboldt Univ, Fac Med Charite, Genet Res Lab, Inst Legal Med, D-10098 Berlin, Germany; Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-252143 Kiev, Ukraine; Med Acad Latvia, Dept Med Biol & Genet, Riga, Latvia; Vilnius State Univ, Ctr Human Genet, Vilnius, Lithuania; Univ Roma Tor Vergata, Dept Biol, Rome, Italy; Cyprus Inst Neurol & Genet, Nicosia, Cyprus; Inst Pasteur, Unite Immunogenet Humaine, Paris, France; Kinderpoliklin, Dept Med Genet, Munich, Germany; La Trobe Univ, Sch Genet & Human Variat, Bundoora, Vic 3083, Australia; Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Univ Copenhagen, Lab Biol Anthropol, Inst Forens Med, Copenhagen, Denmark; Dept Obstet & Gynaecol, Div Med Genet, Ljubljana, Slovenia; Dipartimento Med Legale & Sanita Pubbl, Pavia, Italy; IC Biol, Iasi, Romania; Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey	University of Leicester; University of Oxford; University of Oxford; University of Tartu; Estonian Biocentre; University of Belgrade; Universidade do Porto; Universidade do Porto; University of Cambridge; Complutense University of Madrid; Complutense University of Madrid; University of Ferrara; Umea University; Pompeu Fabra University; Trinity College Dublin; University of Oslo; Instituto Nacional de Saude Dr. Ricardo Jorge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; University of Kiel; Medical University Lodz; Edith Cowan University; Royal Perth Hospital; University of Western Australia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Riga Stradins University; Vilnius University; University of Rome Tor Vergata; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; La Trobe University; Memorial Sloan Kettering Cancer Center; University of Copenhagen; Bogazici University	Jobling, MA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	maj4@leicester.ac.uk	Bosch, Elena/D-8681-2014; Alavantic, Dragan/A-7974-2011; Livshits, Ludmila/J-4421-2013; KUČINSKAS, Vaidutis/A-4798-2013; Kivisild, Toomas/P-5889-2017; Decorte, Ronny/AAG-1365-2021; Rubinsztein, David C/C-3472-2011; Santos, Fabrício Rodrigues/H-2370-2011; Tolun, Aslihan/AAS-2250-2020; Peterlin, Borut/C-6086-2011; Bradley, Daniel G/A-3240-2012; de Knijff, Peter/Y-2519-2018; Meitinger, Thomas/O-1318-2015; zerjal, tatiana/AAO-9473-2020; Pardo, Eduardo Arroyo/L-2240-2014; Pereira, Luisa/H-3050-2011; Prata, Maria João/A-6945-2010; Dubrova, Yuri/ABA-7148-2020; Bertranpetit, Jaume/F-8550-2012; Amorim, Antonio/A-7938-2008; Bosch, Elena/N-7603-2019; Barbujani, Guido/ABE-9998-2020; Malaspina, Patrizia/G-7772-2017	Bosch, Elena/0000-0003-2848-103X; Livshits, Ludmila/0000-0001-5444-3964; Kivisild, Toomas/0000-0002-6297-7808; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Tolun, Aslihan/0000-0002-0328-6046; Peterlin, Borut/0000-0001-7824-4978; de Knijff, Peter/0000-0002-0899-771X; Pardo, Eduardo Arroyo/0000-0003-1851-0589; Pereira, Luisa/0000-0002-4271-1527; Prata, Maria João/0000-0002-0583-1028; Bertranpetit, Jaume/0000-0003-0100-0590; Amorim, Antonio/0000-0002-7518-6247; Bosch, Elena/0000-0003-2848-103X; Barbujani, Guido/0000-0001-7854-6669; Decorte, Ronny/0000-0002-0001-386X; Sergey, Kravchenko/0000-0002-1923-5702; Lavinha, Joao/0000-0002-7474-6871; Roewer, Lutz/0000-0001-9383-4941; Hill, Emmeline/0000-0002-1805-2250; Meitinger, Thomas/0000-0002-8838-8403; Stefanescu, Gheorghe/0000-0002-6200-0992; Malaspina, Patrizia/0000-0002-0067-369X; Bradley, Daniel G/0000-0001-7335-7092; Jobling, Mark/0000-0002-8061-1308; Alavantic, Dragan/0000-0001-5353-213X				Adams J, 1999, CURR ANTHROPOL, V40, P73, DOI 10.1086/515804; Ammerman A.J., 1984, NEOLITHIC TRANSITION; Barbujani G, 1997, AM J HUM GENET, V61, P1011, DOI 10.1086/301620; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; BARBUJANI G, 1991, TRENDS ECOL EVOL, V6, P151, DOI 10.1016/0169-5347(91)90056-4; BARBUJANI G, 1989, SYST ZOOL, V38, P376, DOI 10.2307/2992403; BERTORELLE G, 1995, GENETICS, V140, P811; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; BOYD R, 1997, HUMANS EVOLVED; BRASSEL KE, 1979, GEOGR ANAL, V11, P289; Bravi CM, 1997, HUM BIOL, V69, P641; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Chikhi L, 1998, HUM BIOL, V70, P643; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Collins R., 1986, BASQUES; Comas D, 1997, HUM GENET, V99, P443, DOI 10.1007/s004390050386; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Dennell R., 1983, EUROPEAN EC PREHISTO; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Gimbutas M., 1970, INDOEUROPEAN INDOEUR, P155; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; HASSAN FA, 1973, CURR ANTHROPOL, V14, P535, DOI 10.1086/201380; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; HURLES ME, 1999, MUTATION VARIABILITY; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kwok C, 1996, J MED GENET, V33, P465, DOI 10.1136/jmg.33.6.465; LANDERS J, 1992, CAMBRIDGE ENCY HUMAN, P402; LANGANEY A, 1992, HUM EVOL, V7, P47; Lucotte G, 1999, HUM BIOL, V71, P431; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; MANTEL N, 1967, CANCER RES, V27, P209; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; McKeigue PM, 1997, AM J HUM GENET, V60, P188; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; NGO KY, 1986, AM J HUM GENET, V38, P407; PIAZZA A, 1995, P NATL ACAD SCI USA, V92, P5836, DOI 10.1073/pnas.92.13.5836; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Quintana-Murci L, 1999, EUR J HUM GENET, V7, P603, DOI 10.1038/sj.ejhg.5200347; RENFREW C, 1989, SCI AM, V261, P106, DOI 10.1038/scientificamerican1089-106; Renfrew C, 2000, CAMB ARCHAEOL J, V10, P7, DOI 10.1017/S0959774300000019; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1998, AM J HUM GENET, V62, P491, DOI 10.1086/301733; Richards M, 1996, AM J HUM GENET, V59, P185; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; Santos FR, 1996, BRAZ J GENET, V19, P665, DOI 10.1590/S0100-84551996000400025; SANTOS FR, 1999, METHODS TOOLS BIOSCI, P133; Schneider S., 2000, ARLEQUIN VER 2 0 SOF; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Simoni L, 1999, HUM BIOL, V71, P399; Simoni L, 2000, AM J HUM GENET, V66, P1177, DOI 10.1086/302790; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; SOKAL RR, 1990, AM NAT, V135, P157, DOI 10.1086/285037; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; Sokal RR, 1997, BIOL J LINN SOC, V60, P73, DOI 10.1111/j.1095-8312.1997.tb01484.x; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Swadesh Morris, 1952, P AM PHILOS SOC, V96, DOI DOI 10.2307/3143802; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Veitia R, 1997, HUM GENET, V99, P648, DOI 10.1007/s004390050422; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1999, GENOMIC DIVERSITY, P91; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZVELEBIL M, 1988, ANTIQUITY, V62, P574, DOI 10.1017/S0003598X00074743	84	445	469	1	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1526	1543		10.1086/316890	http://dx.doi.org/10.1086/316890			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	378WE	11078479	Green Published, Bronze			2022-12-18	WOS:000165607600017
J	CHAKRAVARTI, A; BUETOW, KH; ANTONARAKIS, SE; WABER, PG; BOEHM, CD; KAZAZIAN, HH				CHAKRAVARTI, A; BUETOW, KH; ANTONARAKIS, SE; WABER, PG; BOEHM, CD; KAZAZIAN, HH			NONUNIFORM RECOMBINATION WITHIN THE HUMAN BETA-GLOBIN GENE-CLUSTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA	Johns Hopkins University	CHAKRAVARTI, A (corresponding author), UNIV PITTSBURGH, DEPT BIOSTAT, PITTSBURGH, PA 15261 USA.		Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM013983] Funding Source: NIH RePORTER; NIADDK NIH HHS [1R0IAM13983-14] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONARAKIS SE, 1982, J PEDIATR-US, V100, P845, DOI 10.1016/S0022-3476(82)80500-3; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; CHAKRAVARTI A, 1982, AM J HUM GENET, V34, P531; CHAKRAVARTI A, 1981, AM J HUM GENET, V33, pA134; CHAKRAVARTI A, 1984, P NATL ACAD SCI US; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DIXON WJ, 1981, BMDP STATISTICAL SOF, P237; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; GERHARD DS, 1984, P NATL ACAD SCI US; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; KAZAZIAN HH, 1983, EVOLUTION GENES PROT, P137; KENTER AL, 1981, NATURE, V293, P402, DOI 10.1038/293402a0; Kimura M., 1971, THEORETICAL ASPECTS; KOBAYASHI I, 1983, GENETICS, V104, P549; KOBORI JA, 1984, J MOL CELL IMMUNOL, V1, P125; KURNIT DM, 1979, ANNU REV GENET, V13, P235, DOI 10.1146/annurev.ge.13.120179.001315; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; MAEDA N, 1983, P NATL ACAD SCI-BIOL, V80, P5012, DOI 10.1073/pnas.80.16.5012; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; Morton N. E., 1982, OUTLINE GENETIC EPID; MOSCHONAS N, 1982, NUCLEIC ACIDS RES, V10, P2109; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; NEI M, 1982, EVOL BIOL, V14, P1; NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RAO CR, 1965, LINEAR STATISTICAL I; SPRITZ RA, 1981, NUCLEIC ACIDS RES, V9, P5037, DOI 10.1093/nar/9.19.5037; STAHL FW, 1979, ANNU REV GENET, V13, P7, DOI 10.1146/annurev.ge.13.120179.000255; STEINMETZ M, 1982, NATURE, V300, P35, DOI 10.1038/300035a0; TUAN D, 1979, NUCLEIC ACIDS RES, V6, P2519, DOI 10.1093/nar/6.7.2519; TUAN D, 1983, P NATL ACAD SCI-BIOL, V80, P6937, DOI 10.1073/pnas.80.22.6937; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631	39	445	451	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1239	1258						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6097112				2022-12-18	WOS:A1984TZ59000008
J	de Vries, BBA; Pfundt, R; Leisink, M; Koolen, DA; Vissers, LELM; Janssen, IM; van Reijmersdal, S; Nillesen, WM; Huys, EHLPG; de Leeuw, N; Smeets, D; Sistermans, EA; Feuth, T; van Ravenswaaij-Arts, CMA; van Kessel, AG; Schoenmakers, EFPM; Brunner, HG; Veltman, JA				de Vries, BBA; Pfundt, R; Leisink, M; Koolen, DA; Vissers, LELM; Janssen, IM; van Reijmersdal, S; Nillesen, WM; Huys, EHLPG; de Leeuw, N; Smeets, D; Sistermans, EA; Feuth, T; van Ravenswaaij-Arts, CMA; van Kessel, AG; Schoenmakers, EFPM; Brunner, HG; Veltman, JA			Diagnostic genome profiling in mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT PROBE AMPLIFICATION; COPY NUMBER VARIATION; SUBTELOMERIC REARRANGEMENTS; CHROMOSOMAL REARRANGEMENTS; HYBRIDIZATION; MICROARRAY; DNA; ABERRATIONS; SEQUENCES; TUTORIAL	Mental retardation (MR) occurs in 2%-3% of the general population. Conventional karyotyping has a resolution of 5-10 million bases and detects chromosomal alterations in similar to 5% of individuals with unexplained MR. The frequency of smaller submicroscopic chromosomal alterations in these patients is unknown. Novel molecular karyotyping methods, such as array-based comparative genomic hybridization (array CGH), can detect submicroscopic chromosome alterations at a resolution of 100 kb. In this study, 100 patients with unexplained MR were analyzed using array CGH for DNA copy-number changes by use of a novel tiling-resolution genomewide microarray containing 32,447 bacterial artificial clones. Alterations were validated by fluorescence in situ hybridization and/or multiplex ligation-dependent probe amplification, and parents were tested to determine de novo occurrence. Reproducible DNA copy-number changes were present in 97% of patients. The majority of these alterations were inherited from phenotypically normal parents, which reflects normal large-scale copy-number variation. In 10% of the patients, de novo alterations considered to be clinically relevant were found: seven deletions and three duplications. These alterations varied in size from 540 kb to 12 Mb and were scattered throughout the genome. Our results indicate that the diagnostic yield of this approach in the general population of patients with MR is at least twice as high as that of standard GTG-banded karyotyping.	Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Biophys, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	b.devries@antrg.umcn.nl	Janssen, Irene M/V-3667-2018; Sistermans, Erik/B-1109-2009; Vissers, Lisenka/A-2598-2015; Veltman, Joris/F-5128-2010	Sistermans, Erik/0000-0001-7187-4563; Vissers, Lisenka/0000-0001-6470-5497; Veltman, Joris/0000-0002-3218-8250				Baralle D, 2001, LANCET, V358, P7, DOI 10.1016/S0140-6736(00)05300-9; Biesecker LG, 2002, AM J MED GENET, V107, P263, DOI 10.1002/ajmg.10160.abs; de Vries BBA, 2003, J MED GENET, V40, P385, DOI 10.1136/jmg.40.6.385; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; Koolen DA, 2004, CLIN GENET, V65, P429, DOI 10.1111/j.0009-9163.2004.00245.x; Krzywinski M, 2004, NUCLEIC ACIDS RES, V32, P3651, DOI 10.1093/nar/gkh700; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; PHELAN MC, 1996, P GREENW GEN CTR GR, P45; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ried T, 2004, NEW ENGL J MED, V350, P1597, DOI 10.1056/NEJMp038242; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; ROSENBERG C, 2005, J MED GENET; Schinzel A., 2001, CATALOGUE UNBALANCED; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Veltman JA, 2004, J MED GENET, V41, P425, DOI 10.1136/jmg.2004.018531; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142; Yin L, 1996, IEEE T CIRCUITS-II, V43, P157, DOI 10.1109/82.486465	36	444	476	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					606	616		10.1086/491719	http://dx.doi.org/10.1086/491719			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175506	Green Published, Bronze			2022-12-18	WOS:000232106900008
J	Stefansson, H; Sarginson, J; Kong, A; Yates, P; Steinthorsdottir, V; Gudfinnsson, E; Gunnarsdottir, S; Walker, N; Petursson, H; Crombie, C; Ingason, A; Gulcher, JR; Stefansson, K; St Clair, D				Stefansson, H; Sarginson, J; Kong, A; Yates, P; Steinthorsdottir, V; Gudfinnsson, E; Gunnarsdottir, S; Walker, N; Petursson, H; Crombie, C; Ingason, A; Gulcher, JR; Stefansson, K; St Clair, D			Association of neuregulin 1 with schizophrenia confirmed in a Scottish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENES; MAXIMUM-LIKELIHOOD; RECEPTOR SUBUNIT; LINKAGE; HAPLOTYPES; EXPRESSION; ALGORITHM; 13Q32; LOCUS; 8P	Recently, we identified neuregulin 1 (NRG1) as a susceptibility gene for schizophrenia in the Icelandic population, by a combined linkage and association approach. Here, we report the first study evaluating the relevance of NRG1 to schizophrenia in a population outside Iceland. Markers representing a core at-risk haplotype found in Icelanders at the 5' end of the NRG1 gene were genotyped in 609 unrelated Scottish patients and 618 unrelated Scottish control individuals. This haplotype consisted of five SNP markers and two microsatellites, which all appear to be in strong linkage disequilibrium. For the Scottish patients and control subjects, haplotype frequencies were estimated by maximum likelihood, using the expectation-maximization algorithm. The frequency of the seven-marker haplotype among the Scottish patients was significantly greater than that among the control subjects (10.2% vs. 5.9%, P = .00031). The estimated risk ratio was 1.8, which is in keeping with our report of unrelated Icelandic patients (2.1). Three of the seven markers in the haplotype gave single-point P values ranging from .000064 to.0021 for the allele contributing to the at-risk haplotype. This direct replication of haplotype association in a second population further implicates NRG1 as a factor that contributes to the etiology of schizophrenia.	DeCODE Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland; Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland; Aberdeen Royal Infirm, Aberdeen, Scotland; Ravenscraig Hosp, Greenock, Scotland	Landspitali National University Hospital; University of Aberdeen; University of Aberdeen	Stefansson, H (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.		St Clair, David/AAN-2412-2021; Stefansson, Kari/AAE-7187-2019	Stefansson, Hreinn/0000-0002-9331-6666				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cameron JS, 2001, P NATL ACAD SCI USA, V98, P2832, DOI 10.1073/pnas.041394098; Chen XN, 1999, GENOME RES, V9, P492; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Levinson DF, 1996, AM J MED GENET, V67, P580; LONG JC, 1995, AM J HUM GENET, V56, P799; O'Donovan MC, 1999, AM J HUM GENET, V65, P587, DOI 10.1086/302560; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; PuYlsson H., 1972, BOOK SETTLEMENTS LAN; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steffensen J., 1975, MENNING MEINSEMDIR R; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Yu CE, 2002, AM J HUM GENET, V71, P100, DOI 10.1086/341291	32	443	465	0	20	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					83	87		10.1086/345442	http://dx.doi.org/10.1086/345442			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12478479	Green Published, Bronze			2022-12-18	WOS:000180186800008
J	WEEKS, DE; LANGE, K				WEEKS, DE; LANGE, K			THE AFFECTED-PEDIGREE-MEMBER METHOD OF LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WEEKS, DE (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOMATH, LOS ANGELES, CA 90024 USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NIADDK NIH HHS [AM 33329] Funding Source: Medline; NIGMS NIH HHS [GM-08185, GM-07104] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM033329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008185] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DEVRIES RRP, 1976, LANCET, V2, P1328; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; GRENNAN DM, 1983, J RHEUMATOL, V10, P584; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Jacquard A., 1974, GENETIC STRUCTURE PO; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; KARIGL G, 1982, THEOR POPUL BIOL, V21, P379, DOI 10.1016/0040-5809(82)90025-9; LANGE K, 1986, AM J HUM GENET, V39, P148; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; Lange K., 1987, PROGRAMS PEDIGREE AN; MICHALSKI JP, 1982, J RHEUMATOL, V9, P451; Penrose LS, 1935, ANN EUGENIC, V4, P133; Renyi A., 1970, PROBABILITY THEORY; ROSSEN RD, 1982, HUM IMMUNOL, V4, P183, DOI 10.1016/0198-8859(82)90034-9; STROM H, 1981, TISSUE ANTIGENS, V18, P92, DOI 10.1111/j.1399-0039.1981.tb01370.x; SUAREZ BK, 1979, CLIN GENET, V15, P126; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; THOMPSON EA, 1974, BIOMETRICS, V30, P667, DOI 10.2307/2529231; Thomson G, 1977, HLA DISEASE, P84; YOUNGMAN S, 1986, HUM GENET, V73, P333, DOI 10.1007/BF00279096	24	443	454	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					315	326						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3422543				2022-12-18	WOS:A1988M313300014
J	Itsara, A; Cooper, GM; Baker, C; Girirajan, S; Li, J; Absher, D; Krauss, RM; Myers, RM; Ridker, PM; Chasman, DI; Mefford, H; Ying, P; Nickerson, DA; Eichler, EE				Itsara, Andy; Cooper, Gregory M.; Baker, Carl; Girirajan, Santhosh; Li, Jun; Absher, Devin; Krauss, Ronald M.; Myers, Richard M.; Ridker, Paul M.; Chasman, Daniel I.; Mefford, Heather; Ying, Phyllis; Nickerson, Deborah A.; Eichler, Evan E.			Population Analysis of Large Copy Number Variants and Hotspots of Human Genetic Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURAL VARIATION; SEGMENTAL DUPLICATIONS; MICRODELETION SYNDROME; POLYMORPHISM; REARRANGEMENTS; DELETION; PREDISPOSES; ASSOCIATION; DISORDERS; THERAPY	Copy number variants (CNVs) contribute to human genetic and phenotypic diversity. However, the distribution of larger CNVs in the general population remains largely unexplored. We identify large variants in similar to 2500 individuals by using Illumina SNP data, with an emphasis on "hotspots" prone to recurrent mutations. We find variants larger than 500 kb in 5%-10% of individuals and variants greater than 1 Mb in 1%-2%. In contrast to previous studies, we find limited evidence for stratification of CNVs in geographically distinct human populations. Importantly, our sample size permits a robust distinction between truly rare and polymorphic but low-frequency copy number variation. We find that a significant fraction of individual CNVs larger than 100 kb are rare and that both gene density and size are strongly anticorrelated with allele frequency. Thus, although large CNVs commonly exist in normal individuals, which suggests that size alone can not be used as a predictor of pathogenicity such variation is generally deleterious. Considering these observations, we combine our data with published CNVs from more than 12,000 individuals contrasting control and neurological disease collections. This analysis identifies known disease loci and highlights additional CNVs (e.g., 3q29, 16p12, and 15q25.2) for further investigation. This study provides one of the first analyses of large, rare (0.1%-1%) CNVs in the general population, with insights relevant to future analyses of genetic disease.	[Itsara, Andy; Cooper, Gregory M.; Baker, Carl; Girirajan, Santhosh; Mefford, Heather; Ying, Phyllis; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Absher, Devin; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Ctr Cardiovasc Dis Prevent,Med Sch, Boston, MA 02115 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@ags.washington.edu	Girirajan, Santhosh/A-5280-2010; Cooper, Gregory/D-6914-2011; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Cooper, Gregory/0000-0001-5509-9923; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Li, Jun/0000-0001-6727-0812	Intramural NIH HHS [Z01 AG000932] Funding Source: Medline; NHGRI NIH HHS [P01 HG004120, T32 HG000035, T32 HG00035, HG004120] Funding Source: Medline; NHLBI NIH HHS [HL01069757] Funding Source: Medline; NICHD NIH HHS [HD043569, R01 HD043569] Funding Source: Medline; NIGMS NIH HHS [T32 GM007266] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120, T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000932] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Cann HM, 2002, SCIENCE, V296, P261; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; HANNES ED, 2008, J MED GENET IN PRESS, DOI DOI 10.1136/JMG.2007.055202; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Slavotinek AM, 2008, HUM GENET, V124, P1, DOI 10.1007/s00439-008-0513-9; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	56	440	469	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					148	161		10.1016/j.ajhg.2008.12.014	http://dx.doi.org/10.1016/j.ajhg.2008.12.014			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19166990	Green Published, Bronze			2022-12-18	WOS:000263799700006
J	Jakobsdottir, J; Conley, YP; Weeks, DE; Mah, TS; Ferrell, RE; Gorin, MB				Jakobsdottir, J; Conley, YP; Weeks, DE; Mah, TS; Ferrell, RE; Gorin, MB			Susceptibility genes for age-related maculopathy on chromosome 10q26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; GENOMEWIDE-SCAN; LINKAGE ANALYSIS; ASSOCIATION; PROTEINS; DRUSEN; IDENTIFICATION; EXPRESSION; HAPLOTYPE	On the basis of genomewide linkage studies of families affected with age-related maculopathy ( ARM), we previously identified a significant linkage peak on 10q26, which has been independently replicated by several groups. We performed a focused SNP genotyping study of our families and an additional control cohort. We identified a strong association signal overlying three genes, PLEKHA1, LOC387715, and PRSS11. All nonsynonymous SNPs in this critical region were genotyped, yielding a highly significant association (P <.00001) between PLEKHA1/LOC387715 and ARM. Although it is difficult to determine statistically which of these two genes is most important, SNPs in PLEKHA1 are more likely to account for the linkage signal in this region than are SNPs in LOC387715; thus, this gene and its alleles are implicated as an important risk factor for ARM. We also found weaker evidence supporting the possible involvement of the GRK5/RGS10 locus in ARM. These associations appear to be independent of the association of ARM with the Y402H allele of complement factor H, which has previously been reported as a major susceptibility factor for ARM. The combination of our analyses strongly implicates PLEKHA1/LOC387715 as primarily responsible for the evidence of linkage of ARM to the 10q26 locus and as a major contributor to ARM susceptibility. The association of either a single or a double copy of the high-risk allele within the PLEKHA1/LOC387715 locus accounts for an odds ratio of 5.0 (95% confidence interval 3.2-7.9) for ARM and a population attributable risk as high as 57%.	Univ Pittsburgh, Sch Med, Dept Ophthalmol, UPMC,Eye Ctr, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Biostat, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Hlth Promot & Dev, Sch Nursing, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gorin, MB (corresponding author), Eye & Ear Inst Pittsburgh, Dept Ophthalmol, Bldg 203 Lothrop St,Room 1027, Pittsburgh, PA 15213 USA.	gorinmb@upmc.edu	Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Jakobsdottir, Johanna/0000-0002-8019-9683; Mah-Fraser, Tammy/0000-0003-1795-8031	NEI NIH HHS [R01EY009859, R01 EY009859] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009859] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning SR, 2005, GENET EPIDEMIOL, V28, P110, DOI 10.1002/gepi.20051; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; De Luca A, 2004, J HISTOCHEM CYTOCHEM, V52, P1609, DOI 10.1369/jhc.4A6330.2004; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARIBABU B, 1993, P NATL ACAD SCI USA, V90, P9398, DOI 10.1073/pnas.90.20.9398; Hollborn M, 2004, CURR EYE RES, V28, P215, DOI 10.1076/ceyr.28.3.215.26250; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kenealy SJ, 2004, MOL VIS, V10, P57; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Lange K., 2001, AM J HUM GENET S, V69, pA1886; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Moratz C, 2004, METHOD ENZYMOL, V389, P15; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Mukhopadhyay N, 2004, HUM HERED, V58, P175, DOI 10.1159/000083545; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; R Development Core Team, 2004, R LANG ENV STAT COMP; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Santangelo Susan L, 2005, Ophthalmic Genet, V26, P61, DOI 10.1080/13816810490967944; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schmidt S, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-18; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	49	440	470	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					389	407		10.1086/444437	http://dx.doi.org/10.1086/444437			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080115	Green Published, Bronze			2022-12-18	WOS:000231314100006
J	Criswell, LA; Pfeiffer, KA; Lum, RF; Gonzales, B; Novitzke, J; Moser, KL; Begovich, AB; Carlton, VEH; Li, W; Lee, AT; Ortmann, W; Behrens, TW; Gregersen, PK				Criswell, LA; Pfeiffer, KA; Lum, RF; Gonzales, B; Novitzke, J; Moser, KL; Begovich, AB; Carlton, VEH; Li, W; Lee, AT; Ortmann, W; Behrens, TW; Gregersen, PK			Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LYMPHOID TYROSINE PHOSPHATASE; RHEUMATOID-ARTHRITIS; RISK-FACTORS; REGULATORY POLYMORPHISM; R620W POLYMORPHISM; THYROID-DISORDERS; SUSCEPTIBILITY; SMOKING; AUTOANTIBODIES	Autoimmune disorders constitute a diverse group of phenotypes with overlapping features and a tendency toward familial aggregation. It is likely that common underlying genes are involved in these disorders. Until very recently, no specific alleles - aside from a few common human leukocyte antigen class II genes - had been identified that clearly associate with multiple different autoimmune diseases. In this study, we describe a unique collection of 265 multiplex families assembled by the Multiple Autoimmune Disease Genetics Consortium ( MADGC). At least two of nine "core" autoimmune diseases are present in each of these families. These core diseases include rheumatoid arthritis ( RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis ( MS), autoimmune thyroid disease ( Hashimoto thyroiditis or Graves disease), juvenile RA, inflammatory bowel disease ( Crohn disease or ulcerative colitis), psoriasis, and primary Sjogren syndrome. We report that a recently described functional single-nucleotide polymorphism (rs2476601, encoding R620W) in the intracellular tyrosine phosphatase (PTPN22) confers risk of four separate autoimmune phenotypes in these families: T1D, RA, SLE, and Hashimoto thyroiditis. MS did not show association with the PTPN22 risk allele. These findings suggest a common underlying etiologic pathway for some, but not all, autoimmune disorders, and they suggest that MS may have a pathogenesis that is distinct from RA, SLE, and T1D. DNA and clinical data for the MADGC families are available to the scientific community; these data will provide a valuable resource for the dissection of the complex genetic factors that underlie the various autoimmune phenotypes.	N Shore Long Isl Jewish Res Inst, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA; Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; Univ Minnesota, Sch Med, Dept Med, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA; Celera Diagnost, Alameda, CA USA	Northwell Health; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities	Gregersen, PK (corresponding author), N Shore Long Isl Jewish Res Inst, Robert S Boas Ctr Genom & Human Genet, 350 Community Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu		Li, Wentian/0000-0003-1155-110X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095386] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI95386, N01AI95386] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Becker KG, 2001, CURR OPIN ALLERGY CL, V1, P399, DOI 10.1097/01.all.0000011052.77127.a6; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Begovich AB, 2005, AM J HUM GENET, V76, P184, DOI 10.1086/427244; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bengtsson AA, 2002, RHEUMATOLOGY, V41, P563, DOI 10.1093/rheumatology/41.5.563; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; GABRIEL S, 2000, KELLYS TXB RHEUMATOL; Ginn LR, 1998, ARTHRITIS RHEUM, V41, P400, DOI 10.1002/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hall FC, 1996, QJM-MON J ASSOC PHYS, V89, P821, DOI 10.1093/qjmed/89.11.821; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Hardy CJ, 1998, ANN RHEUM DIS, V57, P451, DOI 10.1136/ard.57.8.451; Harley JB, 1999, ARTHRITIS RHEUM, V42, P1782, DOI 10.1002/1529-0131(199908)42:8<1782::AID-ANR36>3.0.CO;2-X; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HELIOVAARA M, 1993, J RHEUMATOL, V20, P1830; Hoppu S, 2004, CLIN EXP IMMUNOL, V136, P120, DOI 10.1111/j.1365-2249.2004.02416.x; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; LEE AT, IN PRESS GENES IMMUN; Lin JP, 1998, HUM GENET, V103, P475, DOI 10.1007/s004390050853; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Mustelin T, 2004, MOL IMMUNOL, V41, P687, DOI 10.1016/j.molimm.2004.04.015; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Prokunina L, 2004, ARTHRITIS RHEUM-US, V50, P1770, DOI 10.1002/art.20280; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; STEENLAND K, 1995, AM J IND MED, V28, P603, DOI 10.1002/ajim.4700280505; Strieder TGA, 2003, CLIN ENDOCRINOL, V59, P396, DOI 10.1046/j.1365-2265.2003.01862.x; Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106; Tan Filemon K., 1998, Current Opinion in Rheumatology, V10, P399, DOI 10.1097/00002281-199809000-00002; TODD JA, 1988, TRENDS GENET, V4, P129, DOI 10.1016/0168-9525(88)90135-7; TORFS CP, 1986, AM J HUM GENET, V38, P170; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Uhlig T, 1999, J RHEUMATOL, V26, P47; Vandiedonck C, 2004, P NATL ACAD SCI USA, V101, P15464, DOI 10.1073/pnas.0406756101; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Vestergaard P, 2002, EUR J ENDOCRINOL, V146, P153, DOI 10.1530/eje.0.1460153; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8	55	439	457	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					561	571		10.1086/429096	http://dx.doi.org/10.1086/429096			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15719322	Bronze, Green Published			2022-12-18	WOS:000227516000003
J	Brockington, M; Blake, DJ; Prandini, P; Brown, SC; Torelli, S; Benson, MA; Ponting, CP; Estournet, B; Romero, NB; Mercuri, E; Voit, T; Sewry, CA; Guicheney, P; Muntoni, F				Brockington, M; Blake, DJ; Prandini, P; Brown, SC; Torelli, S; Benson, MA; Ponting, CP; Estournet, B; Romero, NB; Mercuri, E; Voit, T; Sewry, CA; Guicheney, P; Muntoni, F			Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha 2 deficiency and abnormal glycosylation of alpha-dystroglycan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENMC SPONSORED WORKSHOP; EXTRACELLULAR-MATRIX; MEROSIN DEFICIENCY; FUKUYAMA-TYPE; MENTAL-RETARDATION; NETHERLANDS; MUSCLE; LOCALIZATION; BIOSYNTHESIS; FAMILIES	The congenital muscular dystrophies (CMD) are a heterogeneous group of autosomal recessive disorders presenting in infancy with muscle weakness, contractures, and dystrophic changes on skeletal-muscle biopsy. Structural brain defects, with or without mental retardation, are additional features of several CMD syndromes. Approximately 40% of patients with CMD have a primary deficiency (MDC1A) of the laminin alpha2 chain of merosin (laminin-2) due to mutations in the LAMA2 gene. In addition, a secondary deficiency of laminin a 2 is apparent in some CMD syndromes, including MDC1B, which is mapped to chromosome 1q42, and both muscle-eye-brain disease (MEB) and Fukuyama CMD (FCMD), two forms with severe brain involvement. The FCMD gene encodes a protein of unknown function, fukutin, though sequence analysis predicts it to be a phosphoryl-ligand transferase. Here we identify the gene for a new member of the fukutin protein family (fukutin related protein [FKRP]), mapping to human chromosome 19q13.3. We report the genomic organization of the FKRP gene and its pattern of tissue expression. Mutations in the FKRP gene have been identified in seven families with CMD characterized by disease onset in the first weeks of life and a severe phenotype with inability to walk, muscle hypertrophy, marked elevation of serum creatine kinase, and normal brain structure and function. Affected individuals had a secondary deficiency of laminin a 2 expression. In addition, they had both a marked decrease in immunostaining of muscle alpha -dystroglycan and a reduction in its molecular weight on western blot analysis. We suggest these abnormalities of alpha -dystroglycan are caused by its defective glycosylation and are integral to the pathology seen in MDC1C.	Imperial Coll Sch Med, Dept Paediat, Dubowitz Neuromuscular Ctr, London, England; Univ Oxford, MRC, Funct Genet Unit, Oxford, England; Univ Oxford, Dept Human Anat & Genet, Oxford, England; Univ Cagliari, Dept Cytomorphol, Cagliari, Italy; Hop Raymond Poincare, Serv Pediat Reanimat Infantile & Reeduc Neuroresp, Garches, France; Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U523, F-75634 Paris, France; Univ Essen Gesamthsch, Dept Paediat & Paediat Neurol, Essen, Germany; Robert Jones & Agnes Hunt Orthopaed Hosp, Dept Histopathol, Oswestry SY10 7AG, Shrops, England	Imperial College London; University of London; University College London; University of Oxford; University of Oxford; University of Cagliari; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Duisburg Essen; Keele University	Muntoni, F (corresponding author), Imperial Coll Sch Med, Dept Paediat, Dubowitz Neuromuscular Ctr, Hammersmith Hosp Campus, London, England.	f.muntoni@ic.ac.uk	Guicheney, Pascale/D-1034-2017; Ponting, Chris/AAV-2621-2021	Guicheney, Pascale/0000-0002-7663-2050; Ponting, Chris/0000-0003-0202-7816; Benson, Matthew/0000-0003-4459-0439; Brown, Sue/0000-0001-8112-933X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Brockington M, 2000, AM J HUM GENET, V66, P428, DOI 10.1086/302775; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Corman B, 1999, AM J HUM GENET, V64, P126, DOI 10.1086/302206; Dubowitz V, 1997, NEUROMUSCULAR DISORD, V7, P539; Dubowitz V, 1999, Neuromuscul Disord, V9, P446; DUBOWITZ V, 1994, NEUROMUSCULAR DISORD, V4, P75, DOI 10.1016/0960-8966(94)90051-5; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P253, DOI 10.1016/0960-8966(95)90011-X; DUBOWITZ V, 1995, MUSLCE DISORDERS CHI; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ishii H, 1997, NEUROMUSCULAR DISORD, V7, P191, DOI 10.1016/S0960-8966(97)00462-8; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Leschziner A, 2000, J NEUROCHEM, V74, P70, DOI 10.1046/j.1471-4159.2000.0740070.x; MATHEWS KD, 1995, J NEUROPATH EXP NEUR, V54, P601, DOI 10.1093/whq/54.4.601; Mercuri E, 2000, NEUROPEDIATRICS, V31, P186, DOI 10.1055/s-2000-7460; Moghadaszadeh B, 1998, AM J HUM GENET, V62, P1439, DOI 10.1086/301882; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Mostacciuolo ML, 1996, HUM GENET, V97, P277, DOI 10.1007/BF02185752; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; Muntoni F, 1998, Eur J Paediatr Neurol, V2, P19; MUNTONI F, 2000, IN PRESS NEUROMUSCUL; Talim B, 2000, NEUROMUSCULAR DISORD, V10, P548, DOI 10.1016/S0960-8966(00)00140-1; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Villanova M, 2000, NEUROMUSCULAR DISORD, V10, P541, DOI 10.1016/S0960-8966(00)00139-5	39	439	456	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1198	1209		10.1086/324412	http://dx.doi.org/10.1086/324412			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11592034	Green Published, Bronze			2022-12-18	WOS:000172086900004
J	Kryukov, GV; Pennacchio, LA; Sunyaev, SR				Kryukov, Gregory V.; Pennacchio, Len A.; Sunyaev, Shamil R.			Most rare missense alleles are deleterious in humans: Implications for complex disease and association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PURIFYING SELECTION; GENETIC-VARIABILITY; SYNONYMOUS MUTATIONS; COMMON DISEASES; CODING REGIONS; PATTERNS; SUBSTITUTION; RATES; DATABASE	The accumulation of mildly deleterious missense mutations in individual human genomes has been proposed to be a genetic basis for complex diseases. The plausibility of this hypothesis depends on quantitative estimates of the prevalence of mildly deleterious de novo mutations and polymorphic variants in humans and on the intensity of selective pressure against them. We combined analysis of mutations causing human Mendelian diseases, of human-chimpanzee divergence, and of systematic data on human genetic variation and found that similar to 20% of new missense mutations in humans result in a loss of function, whereas similar to 27% are effectively neutral. Thus, the remaining 53% of new missense mutations have mildly deleterious effects. These mutations give rise to many low-frequency deleterious allelic variants in the human population, as is evident from a new data set of 37 genes sequenced in 11,500 individual human chromosomes. Surprisingly, up to 70% of low-frequency missense alleles are mildly deleterious and are associated with a heterozygous fitness loss in the range 0.001-0.003. Thus, the low allele frequency of an amino acid variant can, by itself, serve as a predictor of its functional significance. Several recent studies have reported a significant excess of rare missense variants in candidate genes or pathways in individuals with extreme values of quantitative phenotypes. These studies would be unlikely to yield results if most rare variants were neutral or if rare variants were not a significant contributor to the genetic component of phenotypic inheritance. Our results provide a justification for these types of candidate-gene (pathway) association studies and imply that mutation-selection balance may be a feasible evolutionary mechanism underlying some common diseases.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02125 USA; Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA USA; US Dept Energy Joint Genome Inst, Walnut Creek, CA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Sunyaev, SR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02125 USA.	ssunyaev@rics.bwh.harvard.edu	Kryukov, Gregory V/A-9592-2008; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Pennacchio, Len/0000-0002-8748-3732; Kryukov, Gregory/0000-0002-6131-9483	NIGMS NIH HHS [R01 GM071852, 1R01GM071852] Funding Source: Medline; NLM NIH HHS [U54LM008748, U54 LM008748] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071852] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Arndt PF, 2005, BIOINFORMATICS, V21, P2322, DOI 10.1093/bioinformatics/bti376; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Bustamante CD, 2003, THEOR POPUL BIOL, V63, P91, DOI 10.1016/S0040-5809(02)00050-3; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Crawford DC, 2005, ANNU REV GENOM HUM G, V6, P287, DOI 10.1146/annurev.genom.6.080604.162309; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Fay JC, 2001, GENETICS, V158, P1227; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gorlov IP, 2006, HUM MOL GENET, V15, P1143, DOI 10.1093/hmg/ddl029; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; KIMURA M, 1965, P NATL ACAD SCI USA, V54, P731, DOI 10.1073/pnas.54.3.731; KIMURA M, 1983, NEUTRAL THEORY MOL E, P236; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LI WH, 1997, MOL EVOLUTION, P80; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Loewe L, 2006, GENETICS, V172, P1079, DOI 10.1534/genetics.105.047217; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; NEEL JV, 1962, AM J HUM GENET, V14, P353; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Subramanian S, 2006, MOL BIOL EVOL, V23, P2283, DOI 10.1093/molbev/msl123; Sunyaev S, 2003, HUM MOL GENET, V12, P3325, DOI 10.1093/hmg/ddg359; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; VOET D, 2004, BIOCHEMISTRY-US, P183; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Zhang XS, 2005, TRENDS ECOL EVOL, V20, P468, DOI 10.1016/j.tree.2005.06.010; Zhang XS, 2004, GENETICS, V166, P597, DOI 10.1534/genetics.166.1.597	69	438	451	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					727	739		10.1086/513473	http://dx.doi.org/10.1086/513473			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357078	Bronze, Green Published			2022-12-18	WOS:000245465200013
J	MORTON, NE				MORTON, NE			THE DETECTION AND ESTIMATION OF LINKAGE BETWEEN THE GENES FOR ELLIPTOCYTOSIS AND THE RH-BLOOD TYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANSCOMBE FJ, 1952, P CAMB PHILOS SOC, V48, P600, DOI 10.1017/S0305004100076386; CHALMERS JNM, 1953, ANN EUGENIC, V17, P267; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; DISCOMBE G, 1948, J PATHOL BACTERIOL, V60, P315, DOI 10.1002/path.1700600219; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; FISHER RA, 1950, BIOMETRICS, V6, P17, DOI 10.2307/3001420; FUJII T, 1955, AM J HUM GENET, V7, P72; GOODALL HB, 1954, ANN EUGENIC, V18, P325; GOODALL HB, 1953, ANN EUGENIC, V17, P272; HALDANE JBS, 1946, ANN EUGENIC, V13, P122, DOI 10.1111/j.1469-1809.1946.tb02348.x; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HOLLANDER L, 1954, SCHWEIZ MED WSCHR, V84, P1119; LAWLER SD, 1954, ANN EUGENIC, V18, P328; MARSHALL RA, 1954, J CLIN INVEST, V33, P790, DOI 10.1172/JCI102949; MORTON NE, 1955, AM J HUM GENET, V7, P277; MOTULSKY AG, 1954, BLOOD, V9, P57, DOI 10.1182/blood.V9.1.57.57; Mourant A., 1954, DISTRIBUTION HUMAN B; NEEL JV, 1949, AM J HUM GENET, V1, P19; NEEL JV, 1953, CLIN GENETICS; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; VANDEPITTE J, 1955, Rev Hematol, V10, P19; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; Wald A., 1947, SEQUENTIAL ANAL; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; White MJD., 1954, ANIMAL CYTOLOGY EVOL, V2; Wyandt H, 1941, ARCH INTERN MED, V68, P1043, DOI 10.1001/archinte.1941.00200120002001	27	438	440	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	2					80	96						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF069	13313518				2022-12-18	WOS:A1956WF06900002
J	KOUFOS, A; GRUNDY, P; MORGAN, K; ALECK, KA; HADRO, T; LAMPKIN, BC; KALBAKJI, A; CAVENEE, WK				KOUFOS, A; GRUNDY, P; MORGAN, K; ALECK, KA; HADRO, T; LAMPKIN, BC; KALBAKJI, A; CAVENEE, WK			FAMILIAL WIEDEMANN-BECKWITH SYNDROME AND A 2ND WILMS TUMOR LOCUS BOTH MAP TO 11P15.5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SO ILLINOIS UNIV,SCH MED,DEPT PEDIAT,SPRINGFIELD,IL 62708; CHILDRENS HOSP MED CTR,DIV HEMATOL & ONCOL,CINCINNATI,OH 45229; ROYAL VICTORIA HOSP,LUDWIG INST CANC RES,MONTREAL H3A 1A1,QUEBEC,CANADA; MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,MONTREAL H3A 2T5,QUEBEC,CANADA; VIVIGEN INC,SANTA FE,NM	Southern Illinois University System; Southern Illinois University; Cincinnati Children's Hospital Medical Center; Ludwig Institute for Cancer Research; McGill University; Royal Victoria Hospital; McGill University								ALECK KA, IN PRESS AM J MED GE; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BARKER D, 1984, AM J HUM GENET, V36, P1159; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BECKWITH J B, 1969, Birth Defects Original Article Series, V5, P188; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BEST LG, 1981, AM J MED GENET, V9, P291, DOI 10.1002/ajmg.1320090405; DAO DD, 1987, AM J HUM GENET, V41, P202; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEDER J, 1985, AM J HUM GENET, V37, P635; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; GLASER TM, 1987, CYTOGENET CELL GENET, V40, P620; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; GRZESCHIK KH, 1985, CYTOGENET CELL GENET, V40, P179, DOI 10.1159/000132174; HAAS OA, 1986, CANCER GENET CYTOGEN, V23, P95, DOI 10.1016/0165-4608(86)90409-7; HADRO T, 1985, American Journal of Human Genetics, V37, pA56; HAYWARD NK, 1988, CANCER GENET CYTOGEN, V30, P127, DOI 10.1016/0165-4608(88)90100-8; HOPPENER JWM, 1984, HUM GENET, V66, P309, DOI 10.1007/BF00287635; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; JEANPIERRE M, 1985, CYTOGENET CELL GENET, V40, P661; KAZAZIAN HH, 1987, CYTOGENET CELL GENET, V46, P188, DOI 10.1159/000132477; KOSSEFF AL, 1976, EUR J PEDIATR, V123, P139, DOI 10.1007/BF00452093; KOSSEFF AL, 1972, LANCET, V1, P844; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; LITTLE MH, 1988, HUM GENET, V79, P186, DOI 10.1007/BF00280564; LUBINSKY M, 1974, LANCET, V1, P932; MEADOWS AT, 1974, NEW ENGL J MED, V291, P123; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; RAIZIS AM, 1985, HUM GENET, V70, P344, DOI 10.1007/BF00295375; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SAAL H, 1984, American Journal of Human Genetics, V36, p110S; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SCHMIDTKE J, 1984, HUM GENET, V67, P428, DOI 10.1007/BF00291404; SCHMUTZ SM, 1986, CLIN GENET, V30, P154; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; Sotelo-Avila C, 1976, Perspect Pediatr Pathol, V3, P255; THORBURN MJ, 1970, AM J DIS CHILD, V119, P316, DOI 10.1001/archpedi.1970.02100050318006; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; WILKINS RJ, 1988, LANCET, V1, P329; 1987, CYTOGENET CELL GENET, V46, P1	52	436	440	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					711	719						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2539717				2022-12-18	WOS:A1989U333800012
J	Yao, YG; Kong, QP; Bandelt, HJ; Kivisild, T; Zhang, YP				Yao, YG; Kong, QP; Bandelt, HJ; Kivisild, T; Zhang, YP			Phylogeographic differentiation of mitochondrial DNA in Han Chinese	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSONS-DISEASE; GENETIC-ANALYSIS; HUMAN-POPULATION; POINT MUTATIONS; MTDNA VARIATION; EAST-ASIA; ORIGIN; REGION; POLYMORPHISM; RELEVANCE	To characterize the mitochondrial DNA (mtDNA) variation in Han Chinese from several provinces of China, we have sequenced the two hypervariable segments of the control region and the segment spanning nucleotide positions 10171-10659 of the coding region, and we have identified a number of specific coding-region mutations by direct sequencing or restriction-fragment-length-polymorphism tests. This allows us to define new haplogroups (clades of the mtDNA phylogeny) and to dissect the Han mtDNA pool on a phylogenetic basis, which is a prerequisite for any fine-grained phylogeographic analysis, the interpretation of ancient mtDNA, or future complete mtDNA sequencing efforts. Some of the haplogroups under study differ considerably in frequencies across different provinces. The southernmost provinces show more pronounced contrasts in their regional Han mtDNA pools than the central and northern provinces. These and other features of the geographical distribution of the mtDNA haplogroups observed in the Han Chinese make an initial Paleolithic colonization from south to north plausible but would suggest subsequent migration events in China that mainly proceeded from north to south and east to west. Lumping together all regional Han mtDNA pools into one fictive general mtDNA pool or choosing one or two regional Han populations to represent all Han Chinese is inappropriate for prehistoric considerations as well as for forensic purposes or medical disease studies.	Chinese Acad Sci, Kunming Inst Zool, Lab Mol Evolut & Genome Divers, Kunming 650223, Yunnan, Peoples R China; Univ Hamburg, Fachbereich Math, Hamburg, Germany; Univ Tartu, Inst Mol & Cell Biol, Dept Evolut Biol, EE-50090 Tartu, Estonia; Estonian Bioctr, Tartu, Estonia	Chinese Academy of Sciences; Kunming Institute of Zoology; University of Hamburg; University of Tartu; Estonian Biocentre	Zhang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Lab Mol Evolut & Genome Divers, Kunming 650223, Yunnan, Peoples R China.		Yao, Yong-Gang/AAH-2303-2021; Kivisild, Toomas/P-5889-2017	Yao, Yong-Gang/0000-0002-2955-0693; Kivisild, Toomas/0000-0002-6297-7808				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Betty DJ, 1996, AM J HUM GENET, V58, P428; Chen Renbiao, 1993, Acta Genetica Sinica, V20, P389; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; DU R, 1998, SCI CHINA SER C, V28, P83; Du R., 1993, ETHNIC GROUPS CHINA; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 1996, AM J HUM GENET, V59, P935; Fucharoen G, 2001, J HUM GENET, V46, P115, DOI 10.1007/s100380170098; Horai S, 1996, AM J HUM GENET, V59, P579; Hou YP, 2001, FORENSIC SCI INT, V118, P147, DOI 10.1016/S0379-0738(01)00383-8; IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Nachman MW, 1996, GENETICS, V142, P953; Nishimaki Y, 1999, Leg Med (Tokyo), V1, P238, DOI 10.1016/S1344-6223(99)80044-3; Oota H, 1999, AM J HUM GENET, V64, P250, DOI 10.1086/302197; OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1; Qian YP, 2001, J HUM GENET, V46, P211, DOI 10.1007/s100380170091; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Shinoda K, 1999, ANTHROPOL SCI, V107, P129, DOI 10.1537/ase.107.129; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Tsai LC, 2001, FORENSIC SCI INT, V119, P239, DOI 10.1016/S0379-0738(00)00439-4; Wang L, 2000, MOL BIOL EVOL, V17, P1396, DOI 10.1093/oxfordjournals.molbev.a026422; WU R, 1989, EARLY HUMANKIND CHIN; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Yao YG, 2000, HUM GENET, V107, P504, DOI 10.1007/s004390000403; Yao YG, 2000, GENES GENET SYST, V75, P173, DOI 10.1266/ggs.75.173; Zhang Hai-Guo, 1998, Acta Genetica Sinica, V25, P381; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	43	435	499	4	59	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					635	651		10.1086/338999	http://dx.doi.org/10.1086/338999			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11836649	Bronze, Green Published			2022-12-18	WOS:000173880000008
J	Slaugenhaupt, SA; Blumenfeld, A; Gill, SP; Leyne, M; Mull, J; Cuajungco, MP; Liebert, CB; Chadwick, B; Idelson, M; Reznik, L; Robbins, CM; Makalowska, I; Brownstein, MJ; Krappmann, D; Scheidereit, C; Maayan, C; Axelrod, FB; Gusella, JF				Slaugenhaupt, SA; Blumenfeld, A; Gill, SP; Leyne, M; Mull, J; Cuajungco, MP; Liebert, CB; Chadwick, B; Idelson, M; Reznik, L; Robbins, CM; Makalowska, I; Brownstein, MJ; Krappmann, D; Scheidereit, C; Maayan, C; Axelrod, FB; Gusella, JF			Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; LOCALIZATION; CLONING; 9Q31	Familial dysautonomia (FD; also known as "Riley-Day syndrome"), an Ashkenazi Jewish disorder, is the best known and most frequent of a group of congenital sensory neuropathies and is characterized by widespread sensory and variable autonomic dysfunction. Previously, we had mapped the FD gene, DYS, to a 0.5-cM region on chromosome 9q31 and had shown that the ethnic bias is due to a founder effect, with >99.5% of disease alleles sharing a common ancestral haplotype. To investigate the molecular basis of FD, we sequenced the minimal candidate region and cloned and characterized its five genes. One of these, IKBKAP, harbors two mutations that can cause FD. The major haplotype mutation is located in the donor splice site of intron 20. This mutation can result in skipping of exon 20 in the mRNA of patients with FD, although they continue to express varying levels of wild-type message in a tissue-specific manner. RNA isolated from lymphoblasts of patients is primarily wild-type, whereas only the deleted message is seen in RNA isolated from brain. The mutation associated with the minor haplotype in four patients is a missense (R696P) mutation in exon 19, which is predicted to disrupt a potential phosphorylation site. Our findings indicate that almost all cases of FD are caused by an unusual splice defect that displays tissue-specific expression; and they also provide the basis for rapid carrier screening in the Ashkenazi Jewish population.	Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Harvard Inst Human Genet, Boston, MA USA; Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel; NIMH, Genet Lab, NIH, Bethesda, MD 20892 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; NINDS, NIH, Bethesda, MD 20892 USA; Max Delbruck Ctr Mol Med, Berlin, Germany; NYU Med Ctr, Dept Pediat, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University	Gusella, JF (corresponding author), Massachusetts Gen Hosp E, Room 6214,149 13th St, Charlestown, MA 02129 USA.		Makalowska, Izabela/AAF-4967-2021; Krappmann, Daniel/AAT-4354-2021; Brownstein, Michael/B-8609-2009; Krappmann, Daniel/ABF-4038-2021; Cuajungco, Math/B-2647-2008; Makalowska, Izabela/AAU-2682-2021	Makalowska, Izabela/0000-0002-8144-5671; Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; Cuajungco, Math/0000-0003-0749-9564; Chadwick, Brian/0000-0001-5272-8384	NINDS NIH HHS [NS 36326] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036326] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Axelrod F B, 1974, Adv Pediatr, V21, P75; AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; Axelrod FB, 1984, CELL MOL BIOL NEURON, P331; Axelrod FB, 1996, PRIMER AUTONOMIC NER, P242; Axelrod FP, 1995, DISORDERS AUTONOMIC, P217; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blumenfeld A, 1999, AM J HUM GENET, V64, P1110, DOI 10.1086/302339; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; Chadwick BP, 1999, GENE, V240, P67, DOI 10.1016/S0378-1119(99)00432-1; Chadwick BP, 1999, GENOMICS, V58, P302, DOI 10.1006/geno.1999.5848; Chadwick BP, 2000, MAMM GENOME, V11, P81, DOI 10.1007/s003350010017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; MAAYAN C, 1987, CLIN GENET, V32, P106; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; PEARSON J, 1978, J NEUROL SCI, V39, P123, DOI 10.1016/0022-510X(78)90193-4; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; RILEY CM, 1949, PEDIATRICS, V3, P468; Shimizu K, 2000, GENOMICS, V65, P113, DOI 10.1006/geno.2000.6154; Zhang JS, 1998, GENOMICS, V54, P149, DOI 10.1006/geno.1998.5458	21	435	447	0	20	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					598	605		10.1086/318810	http://dx.doi.org/10.1086/318810			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179008	Bronze, Green Published			2022-12-18	WOS:000166994200005
J	Rampazzo, A; Nava, A; Malacrida, S; Beffagna, G; Bauce, B; Rossi, V; Zimbello, R; Simionati, B; Basso, C; Thiene, G; Towbin, JA; Danieli, GA				Rampazzo, A; Nava, A; Malacrida, S; Beffagna, G; Bauce, B; Rossi, V; Zimbello, R; Simionati, B; Basso, C; Thiene, G; Towbin, JA; Danieli, GA			Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PALMOPLANTAR KERATODERMA; INTERMEDIATE FILAMENTS; WOOLLY HAIR; DILATED CARDIOMYOPATHY; SUDDEN-DEATH; LONG ARM; DYSPLASIA; LOCUS; GENE; MAPS	Arrhythmogenic right ventricular cardiomyopathy (ARVD/C) is a genetically heterogeneous disease characterized by progressive degeneration of the right ventricular myocardium and increased risk of sudden death. Here, we report on a genome scan in one Italian family in which the disease appeared unlinked to any of the six different ARVD loci reported so far; we identify a mutation (S299R) in exon 7 of desmoplakin (DSP), which modifies a putative phosphorylation site in the N-terminal domain binding plakoglobin. It is interesting that a nonsense DSP mutation was reported elsewhere in the literature, inherited as a recessive trait and causing a biventricular dilative cardiomyopathy associated with palmoplantar keratoderma and woolly hairs. Therefore, different DSP mutations might produce different clinical phenotypes, with different modes of inheritance.	Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ Padua, Dept Cardiol, I-35131 Padua, Italy; Univ Padua, Dept Pathol, I-35131 Padua, Italy; Univ Padua, CRIBI, I-35131 Padua, Italy; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	University of Padua; University of Padua; University of Padua; University of Padua; Baylor College of Medicine	Danieli, GA (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; basso, cristina/0000-0002-0195-9753; simionati, barbara/0000-0002-0522-0737; Malacrida, Sandro/0000-0002-4775-3857	NHLBI NIH HHS [U01 HL065652, 1 U01 HL 65652] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065652] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983; Carvajal-Huerta L, 1998, J AM ACAD DERMATOL, V39, P418, DOI 10.1016/S0190-9622(98)70317-2; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; GALLO P, 1992, HUM PATHOL, V23, P948, DOI 10.1016/0046-8177(92)90410-5; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Li DX, 2000, AM J HUM GENET, V66, P148, DOI 10.1086/302713; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Melberg A, 1999, ANN NEUROL, V46, P684, DOI 10.1002/1531-8249(199911)46:5<684::AID-ANA2>3.0.CO;2-#; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Nava A, 2000, J AM COLL CARDIOL, V36, P2226, DOI 10.1016/S0735-1097(00)00997-9; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; OKEEFE EJ, 1989, J BIOL CHEM, V264, P8310; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; PINAMONTI B, 1992, AM HEART J, V123, P711, DOI 10.1016/0002-8703(92)90511-S; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Severini GM, 1996, GENOMICS, V31, P193, DOI 10.1006/geno.1996.0031; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; VIRATA MLA, 1992, P NATL ACAD SCI USA, V89, P544, DOI 10.1073/pnas.89.2.544; Whittock NV, 1999, J INVEST DERMATOL, V113, P940, DOI 10.1046/j.1523-1747.1999.00783.x; Whittock NV, 2002, J INVEST DERMATOL, V118, P232, DOI 10.1046/j.0022-202x.2001.01664.x	35	432	449	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1200	1206		10.1086/344208	http://dx.doi.org/10.1086/344208			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12373648	Green Published, Bronze			2022-12-18	WOS:000178884300019
J	ADKINS, S; GAN, KN; MODY, M; LADU, BN				ADKINS, S; GAN, KN; MODY, M; LADU, BN			MOLECULAR-BASIS FOR THE POLYMORPHIC FORMS OF HUMAN SERUM PARAOXONASE ARYLESTERASE - GLUTAMINE OR ARGININE AT POSITION 191, FOR THE RESPECTIVE A-ALLOZYMES OR B-ALLOZYMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID SEQUENCE; PHENYLALANINE-HYDROXYLASE; GENETIC-POLYMORPHISM; CDNA CLONES; DNA; IDENTIFICATION; CHOLINESTERASE; PURIFICATION; PROBES; RABBIT	The paraoxonase/arylesterase gene is located close to the cystic fibrosis gene on chromosome 7. Human serum contains two paraoxonase/arylesterase allozymes, A and B, which differ in their substrate specificities and kinetic properties. Purified A, AB, and B esterases were digested with trypsin, and the resultant peptides were compared by high-performance liquid chromatography. The elution profiles were very similar for all three samples, except for (1) one peptide (i.e., peptide A) seen only in the A and AB profiles and (2) another peptide (i.e., peptide B) seen only in the B and AB profiles. Sequencing revealed that peptide A had glutamine at amino acid position 191, whereas peptide B was generated by cleavage on the carboxy side of position 191, presumably because there was a basic (trypsin-specific) amino acid at that position. Working independently, our laboratory and one other laboratory have sequenced the coding region for paraoxonase from human liver cDNA libraries and have identified two polymorphic sites: Arg/Gln at position 191 and Leu/Met at position 54. Using PCR amplification and direct sequencing of nucleotides in both polymorphic regions with genomic DNA, we have estimated the allelic frequencies and have determined their concordance with the serum paraoxonase allozyme phenotypes in 27 unrelated adults and in 16 members of a three-generation pedigree. Among unrelated individuals, the Met/Leu polymorphism at position 54 did not correlate with the serum esterase phenotype. In contrast, the particular amino acid at position 191 correlated perfectly with serum phenotypes: A-type individuals had Gln at position 191, and B-type individuals had Arg at position 191; AB-type serum was found only with the heterozygous (Arg/Gln) combination. Pedigree analysis showed both polymorphisms to be inherited in the expected Mendelian manner and confirmed that only the 191 polymorphism showed concordance with the serum paraoxonase/arylesterase phenotypes.	UNIV MICHIGAN,SCH MED,DEPT ANAESTHESIOL,KRESGE 2,BOX 0572,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH PUBL HLTH,DEPT ENVIRONM & IND HLTH,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Adkins, Stephen W/G-2050-2014		NIEHS NIH HHS [ES 07062] Funding Source: Medline; NIGMS NIH HHS [GM46979, GM27028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM027028, R01GM046979] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BLACK SD, 1982, ANAL BIOCHEM, V121, P281, DOI 10.1016/0003-2697(82)90480-8; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FURLONG CE, 1988, AM J HUM GENET, V43, P230; FURLONG CE, 1991, BIOCHEMISTRY-US, V30, P10133, DOI 10.1021/bi00106a009; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; HAMILTON BA, 1991, NUCLEIC ACIDS RES, V19, P1951, DOI 10.1093/nar/19.8.1951; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; HUMBERT R, IN PRESS NATURE GENE; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; La Du BN, 1992, PHARMACOGENETICS DRU, P51; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; MACKNESS MI, 1987, BIOCHEM J, V245, P293, DOI 10.1042/bj2450293; MANIATIS T, 1982, MOL CLONING LABORATO, P320; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; MERCER JFB, 1986, BIOCHEM J, V236, P679, DOI 10.1042/bj2360679; MULLENBACH R, 1989, TRENDS GENET, V5, P391; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SMOLEN A, 1991, DRUG METAB DISPOS, V19, P107; TARR GE, 1982, METHODS PROTEIN SEQU, P223; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931	25	431	456	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					598	608						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	7916578				2022-12-18	WOS:A1993KR72000017
J	Szabo, CI; King, MC				Szabo, CI; King, MC			Population genetics of BRCA1 and BRCA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							OVARIAN-CANCER FAMILIES; MALE BREAST-CANCER; GERMLINE MUTATIONS; SUSCEPTIBILITY GENE		UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				King, Mary-Claire/0000-0001-9426-1743				ABELIOVICH D, 1997, J HUM GENET, V60, P505; Anderson TI, 1996, AM J HUM GENET, V59, P486; Arena J. F., 1996, American Journal of Human Genetics, V59, pA34; BOYD M, 1995, NATURE, V375, P541, DOI 10.1038/375541b0; Caligo M. A, 1996, BRCA1 GERMLINE MUTAT; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRPAHY HUMAN; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; DeBenedetti VMG, 1996, ONCOGENE, V13, P1353; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gao Q, 1997, AM J HUM GENET, V60, P1233; Gayther SA, 1997, AM J HUM GENET, V60, P1239; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; Gudmundsson J, 1996, AM J HUM GENET, V58, P749; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Hamann U, 1997, GENE CHROMOSOME CANC, V18, P126, DOI 10.1002/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.3.CO;2-O; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; INOUE R, 1995, CANCER RES, V55, P3521; Jandrig B, 1996, INT J CANCER, V68, P188, DOI 10.1002/(SICI)1097-0215(19961009)68:2<188::AID-IJC8>3.0.CO;2-U; Johannesdottir G, 1996, CANCER RES, V56, P3663; Johannsson O, 1996, AM J HUM GENET, V58, P441; Katagiri T, 1996, HUM MUTAT, V7, P334, DOI 10.1002/(SICI)1098-1004(1996)7:4<334::AID-HUMU7>3.0.CO;2-8; LAVECCHIA C, 1992, INT J CANCER, V51, P62, DOI 10.1002/ijc.2910510113; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; MATSUSHIMA M, 1995, HUM MOL GENET, V4, P1953, DOI 10.1093/hmg/4.10.1953; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Montagna M, 1996, CANCER RES, V56, P5466; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Peelen T, 1997, AM J HUM GENET, V60, P1041; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Ramus SJ, 1997, AM J HUM GENET, V60, P1242; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Schubert EK, 1997, AM J HUM GENET, V60, P1031; Serova O, 1996, AM J HUM GENET, V58, P42; Serova OM, 1997, AM J HUM GENET, V60, P486; SerovaSinilnikova OM, 1997, AM J HUM GENET, V60, P1236; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STEINITZ R, 1989, IARC SCI PUBLICATION, V98; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; Vehmanen P, 1997, AM J HUM GENET, V60, P1050; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	55	429	440	0	16	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1013	1020						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150148				2022-12-18	WOS:A1997WX76000001
J	HOOK, EB				HOOK, EB			EXCLUSION OF CHROMOSOMAL MOSAICISM - TABLES OF 90PERCENT, 95PERCENT, AND 99PERCENT CONFIDENCE-LIMITS AND COMMENTS ON USE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE DEPT HLTH,INST BIRTH DEFECTS,EPIDEMIOL & HUMAN ECOL SECT,ALBANY,NY 12201; UNION UNIV,ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	State University of New York (SUNY) System; Albany Medical College; Union College								Beyer WH, 1968, CRC HDB PROBABILITY, P219; BOCHKOV NP, 1974, HUMANGENETIK, V22, P139; DIEM K, 1962, DOCUMENTA GEIGY SCI, P85; HATCHER NH, 1976, AM J HUM GENET, V28, P290; HOOK EB, 1975, HUMANGENETIK, V30, P251, DOI 10.1007/BF00279190	5	429	440	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	1					94	97						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CU441	835578				2022-12-18	WOS:A1977CU44100010
J	van der Walt, JM; Nicodemus, KK; Martin, ER; Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Haines, JL; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Mastaglia, F; Stajich, JM; McLaurin, AC; Middleton, LT; Scott, BL; Schmechel, DE; Pericak-Vance, MA; Vance, JM				van der Walt, JM; Nicodemus, KK; Martin, ER; Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Haines, JL; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Mastaglia, F; Stajich, JM; McLaurin, AC; Middleton, LT; Scott, BL; Schmechel, DE; Pericak-Vance, MA; Vance, JM			Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX I DEFICIENCY; CODING-REGION; DNA MUTATIONS; MTDNA; SEQUENCES; ORIGIN; HAPLOGROUPS; POPULATIONS; EXPRESSION; LONGEVITY	Mitochondrial (mt) impairment, particularly within complex I of the electron transport system, has been implicated in the pathogenesis of Parkinson disease (PD). More than half of mitochondrially encoded polypeptides form part of the reduced nicotinamide adenine dinucleotide dehydrogenase (NADH) complex I enzyme. To test the hypothesis that mtDNA variation contributes to PD expression, we genotyped 10 single-nucleotide polymorphisms (SNPs) that define the European mtDNA haplogroups in 609 white patients with PD and 340 unaffected white control subjects. Overall, individuals classified as haplogroup J (odds ratio [OR] 0.55; 95% confidence interval [CI] 0.34-0.91; P = .02) or K (OR 0.52; 95% CI 0.30-0.90; P = .02) demonstrated a significant decrease in risk of PD versus individuals carrying the most common haplogroup, H. Furthermore, a specific SNP that defines these two haplogroups, 10398G, is strongly associated with this protective effect (OR 0.53; 95% CI 0.39-0.73; P = .0001). SNP 10398G causes a nonconservative amino acid change from threonine to alanine within the NADH dehydrogenase 3 (ND3) of complex I. After stratification by sex, this decrease in risk appeared stronger in women than in men (OR 0.43; 95% CI 0.27-0.71; P = .0009). In addition, SNP 9055A of ATP6 demonstrated a protective effect for women (OR 0.45; 95% CI 0.22-0.93; P = .03). Our results suggest that ND3 is an important factor in PD susceptibility among white individuals and could help explain the role of complex I in PD expression.	Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Struthers Parkinson Ctr, Golden Valley, MN USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA; Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Carolina Neurol Clin, Charlotte, NC USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; GlaxoSmithKline Res & Dev Ltd, Greenford, Middx, England	Duke University; Duke University; Emory University; University System of Ohio; Ohio State University; Vanderbilt University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Marshfield Clinic; Baylor College of Medicine; Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Western Australia; GlaxoSmithKline	Vance, JM (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Box 2903, Durham, NC 27710 USA.	jeff@chg.duhs.duke.edu	Scott, Burton/L-3951-2019; Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Vance, Jeffery/0000-0003-3815-8199; Scott, William/0000-0001-9336-6404	NIA NIH HHS [R01 AG020135, 1R01-AG-20135-01] Funding Source: Medline; NINDS NIH HHS [P01 NS026630, P50 NS039764, 2 P50 NS39764-02, P01 NS26630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Arnason U, 1996, J MOL EVOL, V42, P145, DOI 10.1007/BF02198840; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; De Benedictis G, 2000, EXP GERONTOL, V35, P795, DOI 10.1016/S0531-5565(00)00169-8; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Muthane U, 2001, MED HYPOTHESES, V57, P51, DOI 10.1054/mehy.2001.1289; Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Sherer TB, 2002, J NEUROSCI, V22, P7006; Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Swerdlow RH, 2001, PARKINSONISM RELAT D, V7, P129, DOI 10.1016/S1353-8020(00)00029-8; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1994, AM J HUM GENET, V55, P760; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Veech GA, 2000, J NEUROSCI RES, V61, P693; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4	35	427	449	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					804	811		10.1086/373937	http://dx.doi.org/10.1086/373937			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12618962	Bronze, Green Published			2022-12-18	WOS:000181972600003
J	Arking, DE; Cutler, DJ; Brune, CW; Teslovich, TM; West, K; Ikeda, M; Rea, A; Guy, M; Lin, S; Cook, EH; Chakravarti, A				Arking, Dan E.; Cutler, David J.; Brune, Camille W.; Teslovich, Tanya M.; West, Kristen; Ikeda, Morna; Rea, Alexis; Guy, Moltu; Lin, Shin; Cook, Edwin H., Jr.; Chakravarti, Aravinda			A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELINATED AXONS; CASPR2	Autism is a childhood neuropsychiatric disorder that, despite exhibiting high heritability, has largely eluded efforts to identify specific genetic variants underlying its etiology. We performed a two-stage genetic study in which genome-wide linkage and family-based association mapping was followed up by association and replication studies in an independent sample. We identified a common polymorphism in contactin-associated protein-like 2 (CNTNAP2), a member of the neurexin superfamily, that is significantly associated with autism susceptibility. Importantly, the genetic variant displays a parent-of-origin and gender effect recapitulating the inheritance of autism.	[Arking, Dan E.; Cutler, David J.; Teslovich, Tanya M.; West, Kristen; Ikeda, Morna; Rea, Alexis; Guy, Moltu; Lin, Shin; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Brune, Camille W.; Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA	Johns Hopkins University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Cook, Edwin/0000-0002-5848-5114; Lin, Shin/0000-0003-0118-0413	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, P01MH039437, R01MH060007, R10MH055135, R01MH055284, R01MH061009, R01MH064547, R10MH055284, R01MH055135] Funding Source: NIH RePORTER; NIMH NIH HHS [MH61009, MH55284, MH60007, MH00219, MH52708, MH39437, MH55135, MH00980, R01 MH064547, R01 MH055284, R01 MH060007, MH64547, R01 MH061009] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Kanner L, 1943, NERV CHILD, V2, P217; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; MORTON NE, 1974, AM J HUM GENET, V26, P318; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1	18	426	438	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					160	164		10.1016/j.ajhg.2007.09.015	http://dx.doi.org/10.1016/j.ajhg.2007.09.015			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179894	Green Published, Bronze			2022-12-18	WOS:000253223800016
J	Fang, JM; Dagenais, SL; Erickson, RP; Arlt, MF; Glynn, MW; Gorski, JL; Seaver, LH; Glover, TW				Fang, JM; Dagenais, SL; Erickson, RP; Arlt, MF; Glynn, MW; Gorski, JL; Seaver, LH; Glover, TW			Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE FAMILY; HEAD; BREAKPOINT; DISEASE; DEFECTS; PROTEIN; MAPS	Lymphedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphedema of the limbs, with variable age at onset, and double rows of eyelashes (distichiasis). Other complications may include cardiac defects, cleft palate, extradural cysts, and photophobia, suggesting a defect in a gene with pleiotrophic effects acting during development. We previously reported neonatal lymphedema, similar to that in Turner syndrome, associated with a t(Y;16)(q12;q24.3) translocation. A candidate gene was not found on the Y chromosome, and we directed our efforts toward the chromosome 16 breakpoint. Subsequently, a gene for LD was mapped, by linkage studies, to a 16-cM region at 16q24.3. By FISH, we determined that the translocation breakpoint was within this critical region and further narrowed the breakpoint to a 20-kb interval. Because the translocation did not appear to interrupt a gene,,ve considered candidate genes in the immediate region that might be inactivated by position effect. In two additional unrelated families with LD, we identified inactivating mutations-a nonsense mutation and a frameshift mutation-in the FOXC2 (MFH-1) gene. FOXC2 is a member of the forkhead/winged-helix family of transcription factors, whose members are involved in diverse developmental pathways. FOXC2 knockout mice display cardiovascular, craniofacial, and vertebral abnormalities similar to those seen in LD syndrome. Our findings show that FOXC2 haploinsufficiency results in LD. FOXC2 represents the second known gene to result in hereditary lymphedema, and LD is only the second hereditary disorder known to be caused by a mutation in a forkhead-family gene.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Arizona, Dept Pediat, Steele Mem Childrens Res Ctr, Tucson, AZ 85721 USA; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Arizona; Greenwood Genetic Center	Glover, TW (corresponding author), Univ Michigan, Dept Human Genet, 4909 Buhl,Box 0618, Ann Arbor, MI 48109 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NCI NIH HHS [R01 CA043222, CA43222] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; CORBETT CRR, 1982, LYMPHOLOGY, V15, P85; Dagenais SL, 1999, MAMM GENOME, V10, P753, DOI 10.1007/s003359901085; Drury SS, 1998, CYTOGENET CELL GENET, V80, P199, DOI 10.1159/000014980; ERICKSON RP, 1995, CYTOGENET CELL GENET, V71, P163, DOI 10.1159/000134099; FALLS H F, 1964, Trans Am Ophthalmol Soc, V62, P248; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GOLDSTEIN S, 1985, AM J MED GENET, V20, P283, DOI 10.1002/ajmg.1320200212; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Iida K, 1997, DEVELOPMENT, V124, P4627; KAESTNER KH, 1993, P NATL ACAD SCI USA, V90, P7628, DOI 10.1073/pnas.90.16.7628; Kaestner KH, 1996, DEVELOPMENT, V122, P1751; Kaestner KH, 2000, GENE DEV, V14, P142; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; LEHMANN OJ, 2000, AM J HUM GENET, P67; Mangion J, 1999, AM J HUM GENET, V65, P427, DOI 10.1086/302500; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; Miura N, 1997, GENOMICS, V41, P489, DOI 10.1006/geno.1997.4695; Neel J., 1954, HUM HERED, P41; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; ROBINOW M, 1970, AM J DIS CHILD, V119, P343, DOI 10.1001/archpedi.1970.02100050345013; SCHWARTZ JF, 1980, ANN NEUROL, V7, P340, DOI 10.1002/ana.410070410; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Yanga XL, 2000, FEBS LETT, V470, P29, DOI 10.1016/S0014-5793(00)01285-0	28	426	441	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1382	1388		10.1086/316915	http://dx.doi.org/10.1086/316915			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078474	Green Published, Bronze			2022-12-18	WOS:000165607600003
J	McAndrew, PE; Parsons, DW; Simard, LR; Rochette, C; Ray, PN; Mendell, JR; Prior, TW; Burghes, AHM				McAndrew, PE; Parsons, DW; Simard, LR; Rochette, C; Ray, PN; Mendell, JR; Prior, TW; Burghes, AHM			Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON GENE; POLYMERASE CHAIN-REACTION; DELETIONS; SMA; REGION; 5Q13; PCR; LINKAGE; CONTIG; AMPLIFICATION	The survival motor neuron (SMN) transcript is encoded by two genes, SMNT and SMNC. The autosomal recessive proximal spinal muscular atrophy that maps to 5q12 is caused by mutations in the SMNT gene. The SMNT gene can be distinguished from the SMNC gene by base-pair changes in exons 7 and 8. SMNT exon 7 is not detected in similar to 95% of SMA cases due to either deletion or sequence-conversion events. Small mutations in SMNT now have been identified in some of the remaining nondeletion patients. However, there is no reliable quantitative assay for SMNT, to distinguish SMA compound heterozygotes from non-5q SMA-like cases (phenocopies) and to accurately determine carrier status. We have developed a quantitative PCR assay for the determination of SMNT and SMNC gene-copy number. This report demonstrates how risk estimates for the diagnosis and detection of SMA carriers can be modified by the accurate determination of SMNT copy number.	OHIO STATE UNIV,DEPT PATHOL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT MED BIOCHEM,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT MOL GENET,COLUMBUS,OH 43210; HOP ST JUSTINE,MONTREAL,PQ H3T 1C5,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)				Simard, Louise/0000-0003-0391-8821; Parsons, Donald/0000-0002-8775-3501; Burghes, Arthur/0000-0001-9031-1555				Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; BRAHE C, 1994, HUM GENET, V93, P494, DOI 10.1007/BF00202811; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; CARPTEN JD, 1994, GENOMICS, V24, P351, DOI 10.1006/geno.1994.1626; CELI FS, 1994, GENOMICS, V21, P304, DOI 10.1006/geno.1994.1270; CELI FS, 1993, NUCLEIC ACIDS RES, V21, P1047, DOI 10.1093/nar/21.4.1047; COBBEN JM, 1995, AM J HUM GENET, V57, P805; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Matthijs G, 1996, J MED GENET, V33, P469, DOI 10.1136/jmg.33.6.469; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLER B, 1992, AM J HUM GENET, V50, P892; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; PEARN J, 1980, LANCET, V1, P919; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; RUDNIKSCHONEBOR.S, 1994, AM J MED GENET, V51, P7; Sambrook J, 1989, MOL CLONING LAB MANU; Schwartz M, 1997, HUM MOL GENET, V6, P99, DOI 10.1093/hmg/6.1.99; SESTINI R, 1994, CLIN CHEM, V40, P630; SESTINI R, 1995, CLIN CHEM, V41, P826; SIMARD LR, 1992, GENOMICS, V14, P188, DOI 10.1016/S0888-7543(05)80305-2; SIMARD LR, IN PRESS AM J MED GE; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; THOMPSON TG, 1995, NAT GENET, V9, P56, DOI 10.1038/ng0195-56; vanderSteege G, 1996, AM J HUM GENET, V59, P834; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Viollet L, 1997, GENOMICS, V40, P185, DOI 10.1006/geno.1996.4551; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; WIRTH B, 1995, EUR J HUM GENET, V3, P56; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8	48	426	444	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1411	1422		10.1086/515465	http://dx.doi.org/10.1086/515465			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199562	Green Published, Bronze			2022-12-18	WOS:A1997XE29400019
J	Landi, MT; Chatterjee, N; Yu, K; Goldin, LR; Goldstein, AM; Rotunno, M; Mirabello, L; Jacobs, K; Wheeler, W; Yeager, M; Bergen, AW; Li, QZ; Consonni, D; Pesatori, AC; Wacholder, S; Thun, M; Diver, R; Oken, M; Virtamo, J; Albanes, D; Wang, ZM; Burdette, L; Doheny, KF; Pugh, EW; Laurie, C; Brennan, P; Hung, R; Gaborieau, V; McKay, JD; Lathrop, M; McLaughlin, J; Wang, Y; Tsao, MS; Spitz, MR; Wang, YF; Krokan, H; Vatten, L; Skorpen, F; Arnesen, E; Benhamou, S; Bouchard, C; Metsapalu, A; Vooder, T; Nelis, M; Valk, K; Field, JK; Chen, C; Goodman, G; Sulem, P; Thorleifsson, G; Rafnar, T; Eisen, T; Sauter, W; Rosenberger, A; Bickeboller, H; Risch, A; Chang-Claude, J; Wichmann, HE; Stefansson, K; Houlston, R; Amos, CI; Fraumeni, JF; Savage, SA; Bertazzi, PA; Tucker, MA; Chanock, S; Caporaso, NE				Landi, Maria Teresa; Chatterjee, Nilanjan; Yu, Kai; Goldin, Lynn R.; Goldstein, Alisa M.; Rotunno, Melissa; Mirabello, Lisa; Jacobs, Kevin; Wheeler, William; Yeager, Meredith; Bergen, Andrew W.; Li, Qizhai; Consonni, Dario; Pesatori, Angela C.; Wacholder, Sholom; Thun, Michael; Diver, Ryan; Oken, Martin; Virtamo, Jarmo; Albanes, Demetrius; Wang, Zhaoming; Burdette, Laurie; Doheny, Kimberly F.; Pugh, Elizabeth W.; Laurie, Cathy; Brennan, Paul; Hung, Rayjean; Gaborieau, Valerie; McKay, James D.; Lathrop, Mark; McLaughlin, John; Wang, Ying; Tsao, Ming-Sound; Spitz, Margaret R.; Wang, Yufei; Krokan, Hans; Vatten, Lars; Skorpen, Frank; Arnesen, Egil; Benhamou, Simone; Bouchard, Christine; Metsapalu, Andres; Vooder, Tonu; Nelis, Mari; Vaelk, Kristian; Field, John K.; Chen, Chu; Goodman, Gary; Sulem, Patrick; Thorleifsson, Gudmar; Rafnar, Thorunn; Eisen, Timothy; Sauter, Wiebke; Rosenberger, Albert; Bickeboeller, Heike; Risch, Angela; Chang-Claude, Jenny; Wichmann, H. Erich; Stefansson, Kari; Houlston, Richard; Amos, Christopher I.; Fraumeni, Joseph F., Jr.; Savage, Sharon A.; Bertazzi, Pier Alberto; Tucker, Margaret A.; Chanock, Stephen; Caporaso, Neil E.			A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; SUSCEPTIBILITY LOCUS; FAMILY-HISTORY; MUTATIONS; VARIANTS; EXPRESSION; TERT; SMOKERS; IMPACT; COHORT	Three genetic loci for lung cancer risk have been identified by genome-wide association studies (GWAS), but inherited susceptibility to specific histologic types of king cancer is not well established. We conducted a GWAS of lung cancer and its major histologic types, genotyping 515,922 single-nucleotide polymorphisms (SNPs) in 5739 lung cancer cases and 5848 controls from one population-based case-control study and three cohort studies. Results were combined with summary data from ten additional studies, for a total of 13,300 cases and 19,666 controls of European descent. Four Studies also provided histology data for replication, resulting in 3333 adenocarcinomas (AD), 2589 squamous cell carcinomas (SQ), and 1418 small cell carcinomas (SQ. In analyses by histology, rs2736100 (TERT), on chromosome 5p15.33, was associated with risk of adenocarcinoma (odds ratio [OR] = 1.23, 95% confidence interval [CI] = 1.13-1.33, p = 3.02 x 10(-7)), but not with other histologic types (OR = 1.01, p = 0.84 and OR = 1.00, p = 0.93 for SQ and SC, respectively). This finding was confirmed in each replication study and overall meta-analysis (OR = 1.24, 95% CI = 1.17-1.31, p = 3.74 x 10(-14) for AD; OR = 0.99, p = 0.69 and OR = 0.97, p = 0.48 for SQ and SC, respectively). Other previously reported association signals on 15q25 and 6p21 were also refined, but no additional loci reached genome-wide significance. In conclusion, a lung cancer GWAS identified a distinct hereditary contribution to adenocarcinoma.	[Landi, Maria Teresa; Chatterjee, Nilanjan; Yu, Kai; Goldin, Lynn R.; Goldstein, Alisa M.; Rotunno, Melissa; Mirabello, Lisa; Jacobs, Kevin; Yeager, Meredith; Li, Qizhai; Wacholder, Sholom; Albanes, Demetrius; Wang, Zhaoming; Burdette, Laurie; Fraumeni, Joseph F., Jr.; Savage, Sharon A.; Tucker, Margaret A.; Chanock, Stephen; Caporaso, Neil E.] NCI, Div Canc Epidemiol, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Wheeler, William] Informat Management Serv Inc, Rockville, MD 20852 USA; [Bergen, Andrew W.] SRI Int, Ctr Hlth Sci, Mol Genet program, Menlo Pk, CA 94025 USA; [Li, Qizhai] Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Syst & Control, Beijing 100190, Peoples R China; [Consonni, Dario; Pesatori, Angela C.; Bertazzi, Pier Alberto] Osped Maggiore Policlin Mangiagalli & Regina Elen, Fdn Ist Ricevero & Cura Carattere Sci, Epidemiol Unit, I-20122 Milan, Italy; [Consonni, Dario; Pesatori, Angela C.; Bertazzi, Pier Alberto] Univ Milan, Dept Occupat & Environm Hlth, I-20122 Milan, Italy; [Thun, Michael; Diver, Ryan] Amer Canc Soc Epidemiol & Surveillance Res, Atlanta, GA 30301 USA; [Oken, Martin] Univ Minnesota, Hubert H Humphrey Canc Ctr, Minneapolis, MN 55455 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki 00280, Finland; [Doheny, Kimberly F.; Pugh, Elizabeth W.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; [Laurie, Cathy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Brennan, Paul; Gaborieau, Valerie; McKay, James D.] Int Agcy Res Canc, F-69372 Lyon, France; [Hung, Rayjean; McLaughlin, John; Wang, Ying] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Lathrop, Mark; Benhamou, Simone] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Dept Pathol, Toronto, ON M5T 3L9, Canada; [Spitz, Margaret R.; Amos, Christopher I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wang, Yufei; Houlston, Richard] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Krokan, Hans; Vatten, Lars; Skorpen, Frank] Norwegian Univ Sci & Technol, Fac Med, N-7489 Trondheim, Norway; [Arnesen, Egil] Univ Tromso, Dept Community Med, N-9037 Tromso, Norway; [Benhamou, Simone] INSERM, F-75010 Paris, France; [Bouchard, Christine] Geneva Canc Registry, CH-1205 Geneva, Switzerland; [Metsapalu, Andres; Vooder, Tonu; Nelis, Mari; Vaelk, Kristian] Univ Tartu, Inst Mol & Cell Biol, Estonian Bioctr, EE-51010 Tartu, Estonia; [Metsapalu, Andres; Vooder, Tonu; Nelis, Mari; Vaelk, Kristian] Univ Tartu, Estonian Genome Project, Estonian Bioctr, EE-51010 Tartu, Estonia; [Field, John K.] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Program, Liverpool L3 97A, Merseyside, England; [Chen, Chu; Goodman, Gary] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA; [Sulem, Patrick; Thorleifsson, Gudmar; Rafnar, Thorunn; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge CB2 2RE, England; [Sauter, Wiebke; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-81377 Munich, Germany; [Rosenberger, Albert; Bickeboeller, Heike] Univ Gottingen, Dept Genet Epidemiol, Sch Med, D-37073 Gottingen, Germany; [Risch, Angela; Chang-Claude, Jenny] German Canc Res Ctr, Div Epigenom & Canc Risk Factors, D-69120 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; SRI International; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; American Cancer Society; University of Minnesota System; University of Minnesota Twin Cities; Finland National Institute for Health & Welfare; Johns Hopkins University; University of Washington; University of Washington Seattle; World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Foundation Jean Dausset-CEPH; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of London; Institute of Cancer Research - UK; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; Estonian Biocentre; University of Tartu; Estonian Biocentre; University of Tartu; University of Liverpool; Fred Hutchinson Cancer Center; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Gottingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Landi, MT (corresponding author), NCI, Div Canc Epidemiol, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Savage, Sharon A/B-9747-2015; Risch, Angela/H-2669-2013; Wichmann, Heinz Erich/AAA-5695-2022; bertazzi, pietro alberto/D-5039-2017; McLaughlin, John R/E-4577-2013; Benhamou, Simone/ABD-2590-2020; Mirabello, Lisa/H-5594-2018; Nelis, Mari/ABG-7775-2020; Vatten, Lars/AFK-2073-2022; Bickeböller, Heike/V-2318-2018; Albanes, Demetrius/B-9749-2015; Wang, Zhaoming/R-5527-2018; Yeager, Meredith/AAA-5322-2020; Consonni, Dario/AAM-2947-2020; Tucker, Margaret A/B-4297-2015; Diver, Ryan/AAG-3469-2019; Field, John K./AAD-5674-2020; Savage, Sharon/AAB-5160-2019; Stefansson, Kari/AAE-7187-2019; Benhamou, Simone/K-6554-2015; Hung, Rayjean J/A-7439-2013; Tsao, Ming-Sound/M-3503-2017; Vatten, Lars/AAF-9380-2022; Tsao, Ming Sound/AFQ-7332-2022; pesatori, angela/K-5742-2016	Savage, Sharon A/0000-0001-6006-0740; Risch, Angela/0000-0002-8026-5505; bertazzi, pietro alberto/0000-0003-3475-2449; Nelis, Mari/0000-0001-9748-1020; Bickeböller, Heike/0000-0002-3361-5488; Wang, Zhaoming/0000-0001-7556-3869; Consonni, Dario/0000-0002-8935-3843; Diver, Ryan/0000-0002-5418-9000; Field, John K./0000-0003-3951-6365; Savage, Sharon/0000-0001-6006-0740; Tsao, Ming Sound/0000-0002-9160-5405; pesatori, angela/0000-0002-0261-3252; Houlston, Richard/0000-0002-5268-0242; Skorpen, Frank/0000-0001-7093-8000; Hung, Rayjean/0000-0002-4486-7496; BENHAMOU, Simone/0000-0001-5853-8047; Bergen, Andrew/0000-0002-1237-7644	MRC [G9900432] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIACP005804, R01CA127219] Funding Source: NIH RePORTER; Medical Research Council [G9900432] Funding Source: Medline; NCI NIH HHS [R01 CA127219-04, R01 CA127219, R01 CA127219-02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMBROSONE CB, 1993, CANCER, V72, P1192, DOI 10.1002/1097-0142(19930815)72:4<1192::AID-CNCR2820720410>3.0.CO;2-S; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970.abs; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Fernandez-Garcia I, 2008, J THORAC ONCOL, V3, P1085, DOI 10.1097/JTO.0b013e3181886713; Feyler A, 2002, CANCER EPIDEM BIOMAR, V11, P1550; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabrielson E, 2006, RESPIROLOGY, V11, P533, DOI 10.1111/j.1440-1843.2006.00909.x; Gao Y, 2009, INT J CANCER, V125, P146, DOI 10.1002/ijc.24283; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann D, 1997, PREV MED, V26, P427, DOI 10.1006/pmed.1997.0183; HOLMEN J, 2003, J EPIDEMIOL, V13, P19; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Lantuejoul S, 2007, INT J CANCER, V120, P1835, DOI 10.1002/ijc.22473; Le Marchand L, 1998, CANCER RES, V58, P4858; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; OMENN GS, 1994, CANCER RES, V54, pS2038; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; SELLERS TA, 1992, CANCER, V69, P86, DOI 10.1002/1097-0142(19920101)69:1<86::AID-CNCR2820690116>3.0.CO;2-S; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Sweet-Cordero A, 2006, GENE CHROMOSOME CANC, V45, P338, DOI 10.1002/gcc.20296; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; VIELRONEN S, 2008, P NATL ACAD SCI USA, V105, P10155; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Wang LQ, 2009, TRIBOL T, V52, P59, DOI 10.1080/10402000802105422; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	54	423	429	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					679	691		10.1016/j.ajhg.2009.09.012	http://dx.doi.org/10.1016/j.ajhg.2009.09.012			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19836008	Green Published, Bronze			2022-12-18	WOS:000271916500014
J	Van Wesenbeeck, L; Cleiren, E; Gram, J; Beals, RK; Benichou, O; Scopelliti, D; Key, L; Renton, T; Bartels, C; Gong, YQ; Warman, ML; de Vernejoul, MC; Bollerslev, J; Van Hul, W				Van Wesenbeeck, L; Cleiren, E; Gram, J; Beals, RK; Benichou, O; Scopelliti, D; Key, L; Renton, T; Bartels, C; Gong, YQ; Warman, ML; de Vernejoul, MC; Bollerslev, J; Van Hul, W			Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAMURATI-ENGELMANN-DISEASE; CRANIOMETAPHYSEAL DYSPLASIA; OSTEOPETROSIS; SCLEROSTEOSIS; SUBUNIT; SOST	Bone is a dynamic tissue that is subject to the balanced processes of bone formation and bone resorption. Imbalance can give rise to skeletal pathologies with increased bone density. In recent years, several genes underlying such sclerosing bone disorders have been identified. The LDL receptor-related protein 5 (LRP5) gene has been shown to be involved in both osteoporosis-pseudoglioma syndrome and the high-bone-mass phenotype and turned out to be an important regulator of peak bone mass in vertebrates. We performed mutation analysis of the LRP5 gene in 10 families or isolated patients with different conditions with an increased bone density, including endosteal hyperostosis, Van Buchem disease, autosomal dominant osteosclerosis, and osteopetrosis type I. Direct sequencing of the LRP5 gene revealed 19 sequence variants. Thirteen of these were confirmed as polymorphisms, but six novel missense mutations (D111Y, G171R, A214T, A214V, A242T, and T253I) are most likely disease causing. Like the previously reported mutation (G171V) that causes the high-bone-mass phenotype, all mutations are located in the aminoterminal part of the gene, before the first epidermal growth factor-like domain. These results indicate that, despite the different diagnoses that can be made, conditions with an increased bone density affecting mainly the cortices of the long bones and the skull are often caused by mutations in the LRP5 gene. Functional analysis of the effects of the various mutations will be of interest, to evaluate whether all the mutations give rise to the same pathogenic mechanism.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Ribe Cty Hosp, Dept Med, Esbjerg, Denmark; Oregon Hlth Sci Univ, Dept Orthoped & Rehabil, Portland, OR 97201 USA; Hop Lariboisiere, INSERM, U349, F-75475 Paris, France; Santo Spirito Hosp, Dept Maxillofacial Surg, Rome, Italy; Univ S Carolina, Dept Pediat Endocrinol, Charleston, SC USA; Guys Dent Inst, Dept Oral & Maxillofacial Surg, London, England; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Oslo, Rikshosp, Dept Endocrinol, N-0027 Oslo, Norway	University of Antwerp; Oregon Health & Science University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of South Carolina; University of London; King's College London; Case Western Reserve University; University of Oslo; National Hospital Norway	Van Hul, W (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Antwerp, Belgium.			Gram, Jeppe/0000-0003-2584-1132; Van Hul, Wim/0000-0002-5065-7858				Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BEALS RK, 1976, J BONE JOINT SURG AM, V58, P1172, DOI 10.2106/00004623-197658080-00028; Beals RK, 2001, J BONE JOINT SURG AM, V83A, P1643, DOI 10.2106/00004623-200111000-00004; BOLLERSLEV J, 1988, BONE, V9, P7, DOI 10.1016/8756-3282(88)90021-X; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/88236; Okubo Minoru, 2002, Hum Mutat, V19, P186, DOI 10.1002/humu.9012; Reichenberger E, 2001, AM J HUM GENET, V68, P1321, DOI 10.1086/320612; Renton T, 2002, BRIT J ORAL MAX SURG, V40, P55, DOI 10.1054/bjom.2001.0719; Scopelliti D, 1999, Minerva Stomatol, V48, P227; Van Hul E, 2002, J BONE MINER RES, V17, P1111, DOI 10.1359/jbmr.2002.17.6.1111; VANGAAL L, 1978, TIJDSCHR GENEESKUNDE, V24, P1597; Whyte M. P., 1999, PRIMER METABOLIC BON, P367	26	422	449	2	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					763	771		10.1086/368277	http://dx.doi.org/10.1086/368277			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12579474	Bronze, Green Published			2022-12-18	WOS:000181152600028
J	TATUCH, Y; CHRISTODOULOU, J; FEIGENBAUM, A; CLARKE, JTR; WHERRET, J; SMITH, C; RUDD, N; PETROVABENEDICT, R; ROBINSON, BH				TATUCH, Y; CHRISTODOULOU, J; FEIGENBAUM, A; CLARKE, JTR; WHERRET, J; SMITH, C; RUDD, N; PETROVABENEDICT, R; ROBINSON, BH			HETEROPLASMIC MTDNA MUTATION (T-]) AT 8993 CAN CAUSE LEIGH DISEASE WHEN THE PERCENTAGE OF ABNORMAL MTDNA IS HIGH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; ATP SYNTHASE; MITOCHONDRIAL; DNA; DEFICIENCY; COMPLEX; MECHANISM; SUBUNIT; PROTEIN	A female infant showing lacticacidemia, hypotonia, and neurodegenerative disease died at 7 mo of age. Autopsy revealed lesions typical of Leigh disease, both in the basal ganglia and in the brain stem. A maternal aunt and uncle died 1 year and 5 mo, respectively, after following a similar clinical course, while another uncle, presently 33 years of age, has retinitis pigmentosa and ataxia and is mentally retarded. PCR restriction-digest analysis of mtDNA isolated from the proband revealed a T-to-G change at position 8993, creating a new AvaI restriction site. The mutation present in the ATP 6 gene results in the substitution of an arginine residue for a leucine. The indexed patient had > 95% abnormal mtDNA in her skin fibroblasts, brain, kidney, and liver tissues, as measured by laser densitometry. The maternal aunt who died at age 1 year had > 95% abnormal mtDNA in her lymphoblasts. The uncle with retinitis pigmentosa had 78% and 79% abnormal mtDNA in his skin fibroblasts and lymphoblasts, respectively, while an asymptomatic maternal aunt and her son had no trace of this mutation. The mother of the index case had 71% and 39% abnormal mtDNA in her skin fibroblasts and lymphoblasts, respectively, showing that the heteroplasmy can be variable, on a tissue-specific basis, within one individual. This shows that mtDNA mutations at 8993 can produce the clinical phenotype of Leigh disease in addition to the phenotype of ataxia and retinitis pigmentosa described by Holt et al. The insertion of an arginine in the hydrophobic sequence at ATPase 6 probably interferes with the H+ channel formed by subunits 6 and 9 of the ATPase, thus causing failure of ATP synthesis.	HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PATHOL,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV CALGARY,DEPT GENET,CALGARY T2N 1N4,ALBERTA,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Calgary			Christodoulou, John/E-5866-2015; Christodoulou, John/M-3628-2019	Christodoulou, John/0000-0002-8431-0641				BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; FARRELL LB, 1987, BIOCHEM BIOPH RES CO, V144, P1257, DOI 10.1016/0006-291X(87)91446-X; FUJII T, 1990, J PEDIATR-US, V116, P84, DOI 10.1016/S0022-3476(05)81650-6; GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; JOSHI S, 1989, J BIOL CHEM, V264, P15548; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; Old JM, 1986, HUMAN GENETIC DISEAS, P1; PAPA S, 1990, FEBS LETT, V272, P117, DOI 10.1016/0014-5793(90)80462-R; PETROVABENEDICT R, IN PRESS J INHERITED; PINCUS JH, 1976, ARCH NEUROL-CHICAGO, V33, P759, DOI 10.1001/archneur.1976.00500110027005; POULTON J, 1988, J MED GENET, V25, P600, DOI 10.1136/jmg.25.9.600; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SODEBERG K, 1988, J CELL PHYSL, V103, P169; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336	22	422	464	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					852	858						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550128				2022-12-18	WOS:A1992HL84800022
J	LALOUEL, JM; RAO, DC; MORTON, NE; ELSTON, RC				LALOUEL, JM; RAO, DC; MORTON, NE; ELSTON, RC			A UNIFIED MODEL FOR COMPLEX SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT PREVENT MED,DIV BIOSTAT,ST LOUIS,MO 63110; UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822; LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY,NEW ORLEANS,LA 70112	Washington University (WUSTL); University of Hawaii System; Louisiana State University System	LALOUEL, JM (corresponding author), UNIV PARIS 07,ANTHROPOL BIOL LAB,F-75221 PARIS 05,FRANCE.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719, R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-17173, GM-28356, GM-28719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOYLE CR, 1979, BIOMETRICS, V35, P55, DOI 10.2307/2529936; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CLONINGER CR, 1979, AM J HUM GENET, V31, P366; CLONINGER CR, 1979, AM J HUM GENET, V31, P176; DARLU P, 1982, AM J HUM GENET, V34, P874; DEMENAIS F, 1981, AM J HUM GENET, V33, P300; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1978, ANNU REV BIOPHYS BIO, V7, P253, DOI 10.1146/annurev.bb.07.060178.001345; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; GERRARD JW, 1978, AM J HUM GENET, V30, P46; GLUECK CJ, 1973, METABOLISM, V22, P1403, DOI 10.1016/0026-0495(73)90256-4; GO RCP, 1978, AM J HUM GENET, V30, P28; HALDANE JBS, 1949, ANN EUGENIC, V14, P339; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; LALOUEL JM, 1983, AM J HUM GENET, V35, P938; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, UNPUB COMBINED HYPER; LALOUEL JM, 1981, GENETIQUE MED ACQUIS, P161; LAMY M, 1961, JOURNEES ANN DIABETO, P5; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; Morton N.E., 1983, METHODS GENETIC EPID; Morton N. E., 1978, GENETIC EPIDEMIOLOGY; MORTON NE, 1958, SCIENCE, V127, P79, DOI 10.1126/science.127.3289.79; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1974, AM J HUM GENET, V26, P489; RAO DC, 1980, AM J HUM GENET, V32, P620; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1975, AM J HUM GENET, V27, P509; RAO DC, 1978, GENETIC EPIDEMIOLOGY, P145; RICE J, 1978, AM J HUM GENET, V30, P618; SING CF, 1979, GENETIC ANAL COMMON	33	422	427	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					816	826						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6614001				2022-12-18	WOS:A1983RK60400002
J	Herrnstadt, C; Elson, JL; Fahy, E; Preston, G; Turnbull, DM; Anderson, C; Ghosh, SS; Olefsky, JM; Beal, MF; Davis, RE; Howell, N				Herrnstadt, C; Elson, JL; Fahy, E; Preston, G; Turnbull, DM; Anderson, C; Ghosh, SS; Olefsky, JM; Beal, MF; Davis, RE; Howell, N			Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; HUMAN MTDNA; LINKAGE DISEQUILIBRIUM; HUMAN-POPULATIONS; HUMAN-EVOLUTION; NEAR-EASTERN; RECOMBINATION; MUTATIONS; LINEAGES; ORIGIN	The evolution of the human mitochondrial genome is characterized by the emergence of ethnically distinct lineages or haplogroups. Nine European, seven Asian (including Native American), and three African mitochondrial DNA (mtDNA) haplogroups have been identified previously on the basis of the presence or absence of a relatively small number of restriction-enzyme recognition sites or on the basis of nucleotide sequences of the D-loop region. We have used reduced-median-network approaches to analyze 560 complete European, Asian, and African mtDNA coding-region sequences from unrelated individuals to develop a more complete understanding of sequence diversity both within and between haplogroups. A total of 497 haplogroup-associated polymorphisms were identified, 323 (65%) of which were associated with one haplogroup and 174 (35%) of which were associated with two or more haplogroups. Approximately one-half of these polymorphisms are reported for the first time here. Our results confirm and substantially extend the phylogenetic relationships among mitochondrial genomes described elsewhere from the major human ethnic groups. Another important result is that there were numerous instances both of parallel mutations at the same site and of reversion (i.e., homoplasy). It is likely that homoplasy in the coding region will confound evolutionary analysis of small sequence sets. By a linkage-disequilibrium approach, additional evidence for the absence of human mtDNA recombination is presented here.	MitoKor, San Diego, CA 92121 USA; Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Vet Adm Med Ctr, San Diego, CA 92161 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA	Newcastle University - UK; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Medical Branch Galveston	Herrnstadt, C (corresponding author), MitoKor, 11494 Sorrento Valley Rd, San Diego, CA 92121 USA.	herrnstadtc@mitokor.com		/0000-0002-3551-5624				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; BANDELT HJ, 1995, GENETICS, V141, P743; Brown MD, 1997, AM J HUM GENET, V60, P381; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Eyre-Walker A, 2001, J MOL EVOL, V53, P430, DOI 10.1007/s002390010232; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Hedges SB, 2000, NATURE, V408, P652, DOI 10.1038/35047193; HERRNSTADT C, IN PRESS MUTAT RES; Hoehe MR, 2000, HUM MOL GENET, V9, P2895, DOI 10.1093/hmg/9.19.2895; Howell N, 1996, AM J HUM GENET, V59, P501; Howell N, 1999, INT REV CYTOL, V186, P49; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Meinila M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372; Meunier J, 2001, MOL BIOL EVOL, V18, P2132, DOI 10.1093/oxfordjournals.molbev.a003756; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Saillard J, 2000, HUM BIOL, V72, P1065; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; WALLACE DC, 1992, HUM BIOL, V64, P403; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wiuf C, 2001, GENETICS, V159, P749; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928	54	421	433	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1152	1171		10.1086/339933	http://dx.doi.org/10.1086/339933			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11938495	Green Published, Bronze			2022-12-18	WOS:000175012400007
J	Kim, HG; Kishikawa, S; Higgins, AW; Seong, IS; Donovan, DJ; Shen, Y; Lally, E; Weiss, LA; Najm, J; Kutsche, K; Descartes, M; Holt, L; Braddock, S; Troxell, R; Kaplan, L; Volkmar, F; Klin, A; Tsatsanis, K; Harris, DJ; Noens, I; Pauls, DL; Daly, MJ; MacDonald, ME; Morton, CC; Quade, BJ; Gusella, JE				Kim, Hyung-Goo; Kishikawa, Shotaro; Higgins, Anne W.; Seong, Ihn-Sik; Donovan, Diana J.; Shen, Yiping; Lally, Eric; Weiss, Lauren A.; Najm, Juliane; Kutsche, Kerstin; Descartes, Maria; Holt, Lynn; Braddock, Stephen; Troxell, Robin; Kaplan, Lee; Volkmar, Fred; Klin, Ami; Tsatsanis, Katherine; Harris, David J.; Noens, Ilse; Pauls, David L.; Daly, Mark J.; MacDonald, Marcy E.; Morton, Cynthia C.; Quade, Bradley J.; Gusella, James E.			Disruption of neurexin 1 associated with autism spectrum disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-NEUREXINS; HIGH-FREQUENCY; CELL-ADHESION; CLEFT-LIP; GENES; NEUROLIGIN; MUTATION; HAPLOINSUFFICIENCY; BINDING; NLGN4	Autism is a neurodevelopmental disorder of complex etiology in which genetic factors play a major role. We have implicated the neurexin 1 (NRXN1) gene in two independent subjects who display an autism spectrum disorder (ASD) in association with a balanced chromosomal abnormality involving 2p16.3. In the first, with karyotype 46,XX,ins(16;2)(q22.1;p16.1p16.3)pat, NRXN1 is directly disrupted within intron 5. Importantly, the father possesses the same chromosomal abnormality in the absence of ASD, indicating that the interruption of alpha-NRXN1 is not fully penetrant and must interact with other factors to produce ASD. The breakpoint in the second subject, with 46,XY,t(1;2)(q31.3;p16.3)dn, occurs similar to 750 kb 5' to NRXN1 within a 2.6 Mb genomic segment that harbors no currently annotated genes. A scan of the NRXN1 coding sequence in a cohort of ASD subjects, relative to non-ASD controls, revealed that amino acid alterations in neurexin 1 are not present at high frequency in ASD. However, a number of rare sequence variants in the coding region, including two missense changes in conserved residues of the alpha-neurexin 1 leader sequence and of an epidermal growth factor (EGF)-like domain, respectively, suggest that even subtle changes in NRXN1 might contribute to susceptibility to ASD.	[Kim, Hyung-Goo; Kishikawa, Shotaro; Seong, Ihn-Sik; Shen, Yiping; Kaplan, Lee; MacDonald, Marcy E.; Gusella, James E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Mol Neurogenet Unit, Boston, MA 02114 USA; [Kim, Hyung-Goo; Kishikawa, Shotaro; Seong, Ihn-Sik; Shen, Yiping; Kaplan, Lee; MacDonald, Marcy E.; Gusella, James E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Higgins, Anne W.; Donovan, Diana J.; Lally, Eric; Morton, Cynthia C.; Quade, Bradley J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Weiss, Lauren A.; Pauls, David L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Psychiat & Neurodev Genet Uni, Boston, MA 02114 USA; [Weiss, Lauren A.; Pauls, David L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02114 USA; [Weiss, Lauren A.; Daly, Mark J.; MacDonald, Marcy E.; Morton, Cynthia C.; Gusella, James E.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Weiss, Lauren A.; Daly, Mark J.; MacDonald, Marcy E.; Morton, Cynthia C.; Gusella, James E.] MIT, Cambridge, MA 02142 USA; [Najm, Juliane; Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Descartes, Maria; Holt, Lynn] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Braddock, Stephen] Univ Virginia Hlth Syst, Dept Pediat, Div Med Genet, Charlottesville, VA 22908 USA; [Troxell, Robin] Univ Missouri, Dept Child Hlth, Div Med Genet, Columbia, MO 65212 USA; [Volkmar, Fred; Klin, Ami; Tsatsanis, Katherine] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06520 USA; [Harris, David J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; [Noens, Ilse] Leiden Univ, NL-2300 RA Leiden, Netherlands; [Pauls, David L.; Daly, Mark J.; Gusella, James E.] Autism Consortium, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Morton, Cynthia C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Gusella, James E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Alabama System; University of Alabama Birmingham; University of Virginia; University of Missouri System; University of Missouri Columbia; Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School; Leiden University; Leiden University - Excl LUMC; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Gusella, JE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Mol Neurogenet Unit, Boston, MA 02114 USA.	gusella@helix.mgh.harvard.edu	Daly, Mark J/B-2453-2017; Warfield, Simon/B-3352-2009; Volkmar, Fred/AEB-0666-2022; Donovan, Diana J./A-1256-2010; Holt, R. Lynn/CAF-1547-2022; Sandor, Paul/I-7211-2016; Braddock, Stephen/AAL-1667-2021	Daly, Mark J/0000-0002-0949-8752; Warfield, Simon/0000-0002-7659-3880; Sandor, Paul/0000-0003-2397-0758; Noens, Ilse/0000-0003-3353-4423	NICHD NIH HHS [U19-HD35482, P01-HD00300838, U19 HD035482] Funding Source: Medline; NIGMS NIH HHS [P01-GM061354, P01 GM061354] Funding Source: Medline; NIMH NIH HHS [R01 MH064547, MH64547] Funding Source: Medline; NINDS NIH HHS [R01-NS16648, R01 NS016648] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016648] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Geppert M, 1998, J BIOL CHEM, V273, P1705, DOI 10.1074/jbc.273.3.1705; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grice DE, 2006, NEUROMOL MED, V8, P451, DOI 10.1385/NMM:8:4:451; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharma S, 2006, NEURON, V52, P574, DOI 10.1016/j.neuron.2006.11.005; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Xu Jie, 2004, Current Genomics, V5, P347, DOI 10.2174/1389202043349246; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629	41	419	445	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					199	207		10.1016/j.ajhg.2007.09.011	http://dx.doi.org/10.1016/j.ajhg.2007.09.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179900	Green Published, Bronze			2022-12-18	WOS:000253223800022
J	Kotowski, IK; Pertsemlidis, A; Luke, A; Cooper, RS; Vega, GL; Cohen, JC; Hobbs, HH				Kotowski, IK; Pertsemlidis, A; Luke, A; Cooper, RS; Vega, GL; Cohen, JC; Hobbs, HH			A spectrum of PCSK9 Alleles contributes to plasma levels of low-density lipoprotein cholesterol	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; HEPATIC STEATOSIS; APOLIPOPROTEIN-B; TARGET GENES; LDL RECEPTOR; PROTEIN; MUTATIONS; LIVER; MICE; HAPLOTYPE	Selected missense mutations in the proprotein convertase subtilisin/kexin type 9 serine protease gene (PCSK9) cause autosomal dominant hypercholesterolemia, whereas nonsense mutations in the same gene are associated with low plasma levels of low-density lipoprotein cholesterol (LDL-C). Here, DNA sequencing and chip-based oligonucleotide hybridization were used to determine whether other sequence variations in PCSK9 contribute to differences in LDLC levels. The coding regions of PCSK9 were sequenced in the blacks and whites from the Dallas Heart Study (n=3,543) who had the lowest (< 5th percentile) and highest (> 195th percentile) plasma levels of LDL-C. Of the 17 missense variants identified, 3 (R46L, L253F, and A443T) were significantly and reproducibly associated with lower plasma levels of LDL-C (reductions ranging from 3.5% to 30%). None of the low-LDL-C variants were associated with increased hepatic triglyceride content, as measured by proton magnetic resonance spectroscopy. This finding is most consistent with the reduction in LDL-C being caused primarily by accelerating LDL clearance, rather than by reduced lipoprotein production. Association studies with 93 noncoding single-nucleotide polymorphisms (SNPs) at the PCSK9 locus identified 3 SNPs associated with modest differences in plasma LDL-C levels. Thus, a spectrum of sequence variations ranging in frequency (from 0.2% to 34%) and magnitude of effect (from a 3% increase to a 49% decrease) contribute to interindividual differences in LDL-C levels. These findings reveal that PCSK9 activity is a major determinant of plasma levels of LDL-C in humans and make it an attractive therapeutic target for LDL-C lowering.	Univ Texas, SW Med Ctr, Dept Mol Genet, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX USA; Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Loyola University Chicago	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Donald W Reynolds Cardiovasc Clin Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.hobbs@utsouthwestern.edu	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL020948, HL 20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chen SN, 2005, J AM COLL CARDIOL, V45, P1611, DOI 10.1016/j.jacc.2005.01.051; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ouguerram K, 2004, ARTERIOSCL THROM VAS, V24, P1448, DOI 10.1161/01.ATV.0000133684.77013.88; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; R Development Core Team, 2004, R LANG ENV STAT COMP; RAO DC, 1982, AM J HUM GENET, V34, P888; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shioji K, 2004, J HUM GENET, V49, P109, DOI 10.1007/s10038-003-0114-3; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058	37	419	458	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					410	422		10.1086/500615	http://dx.doi.org/10.1086/500615			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465619	Green Published, Bronze			2022-12-18	WOS:000236747500009
J	Wu, MC; Kraft, P; Epstein, MP; Taylor, DM; Chanock, SJ; Hunter, DJ; Lin, XH				Wu, Michael C.; Kraft, Peter; Epstein, Michael P.; Taylor, Deanne M.; Chanock, Stephen J.; Hunter, David J.; Lin, Xihong			Powerful SNP-Set Analysis for Case-Control Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-TESTING CORRECTION; SCORE TESTS; REGRESSION; LOCI; RISK; HAPLOTYPES; SIMILARITY; TRAITS; MODELS; GENES	GWAS have emerged as popular tools for identifying genetic variants that are associated with disease risk. Standard analysis of a case-control GWAS involves assessing the association between each individual genotyped SNP and disease risk. However, this approach suffers from limited reproducibility and difficulties in detecting multi-SNP and epistatic effects. As an alternative analytical strategy, we propose grouping SNPs together into SNP sets on the basis of proximity to genomic features such as genes or haplotype blocks, then testing the joint effect of each SNP set. Testing of each SNP set proceeds via the logistic kernel-machine-based test, which is based on a statistical framework that allows for flexible modeling of epistatic and nonlinear SNP effects. This flexibility and the ability to naturally adjust for covariate effects are important features of our test that make it appealing in comparison to individual SNP tests and existing multimarker tests. Using simulated data based on the International HapMap Project, we show that SNP-set testing can have improved power over standard individual-SNP analysis under a wide range of settings. In particular, we find that our approach has higher power than individual-SNP analysis when the median correlation between the disease-susceptibility variant and the genotyped SNPs is moderate to high. When the correlation is low, both individual-SNP analysis and the SNP-set analysis tend to have low power. We apply SNP-set analysis to analyze the Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer GWAS discovery-phase data.	[Kraft, Peter; Taylor, Deanne M.; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wu, Michael C.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Epstein, Michael P.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lin, XH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xlin@hsph.harvard.edu	Taylor, Deanne/AAY-6296-2020; Taylor, Deanne M/Q-4777-2017; Wu, Michael/X-5084-2019	Taylor, Deanne/0000-0002-3302-4610; Taylor, Deanne M/0000-0002-3302-4610; Wu, Michael/0000-0002-3357-6570	National Institutes of Health [CA76404, CA134294, HG003618]; NATIONAL CANCER INSTITUTE [P01CA134294, R01CA076404, R29CA076404, R37CA076404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was sponsored by National Institutes of Health grants CA76404 and CA134294 (to XL.) and HG003618 (to M.P.E.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Cristianini M., 2000, INTRO SUPPORT VECTOR; Croiseau Pascal, 2009, BMC Proc, V3 Suppl 7, pS61; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Kraft P, 2008, ADV GENET, V60, P465, DOI 10.1016/S0065-2660(07)00417-8; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Li CM, 1999, GENOMICS, V62, P223, DOI 10.1006/geno.1999.5940; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin WY, 2009, GENET EPIDEMIOL, V33, P183, DOI 10.1002/gepi.20364; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McAuliffe JD, 2004, BIOINFORMATICS, V20, P1850, DOI 10.1093/bioinformatics/bth153; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Mukhopadhyay I, 2010, GENET EPIDEMIOL, V34, P213, DOI 10.1002/gepi.20451; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Saad AF, 2007, CANCER BIOL THER, V6, P1455; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Szymczak S, 2009, GENET EPIDEMIOL, V33, pS51, DOI 10.1002/gepi.20473; Tachmazidou I, 2007, PLOS GENET, V3, P1163, DOI 10.1371/journal.pgen.0030111; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57	49	416	431	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					929	942		10.1016/j.ajhg.2010.05.002	http://dx.doi.org/10.1016/j.ajhg.2010.05.002			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20560208	Green Published, Bronze			2022-12-18	WOS:000278948900010
J	Nair, RP; Stuart, PE; Nistor, I; Hiremagalore, R; Chia, NVC; Jenisch, S; Weichenthal, M; Abecasis, GR; Lim, HW; Christophers, E; Voorhees, JJ; Elder, JT				Nair, RP; Stuart, PE; Nistor, I; Hiremagalore, R; Chia, NVC; Jenisch, S; Weichenthal, M; Abecasis, GR; Lim, HW; Christophers, E; Voorhees, JJ; Elder, JT			Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEDIGREE DISEQUILIBRIUM TEST; FAMILY-BASED TESTS; CORNEODESMOSIN GENE; LINKAGE DISEQUILIBRIUM; SWEDISH POPULATION; S-GENE; TRANSMISSION/DISEQUILIBRIUM TEST; ASSOCIATION ANALYSIS; JAPANESE PATIENTS	Previous studies have narrowed the interval containing PSORS1, the psoriasis-susceptibility locus in the major histocompatibility complex (MHC), to an similar to 300-kb region containing HLA-C and at least 10 other genes. In an effort to identify the PSORS1 gene, we cloned and completely sequenced this region from both chromosomes of five individuals. Two of the sequenced haplotypes were associated with psoriasis (risk), and the other eight were clearly unassociated (nonrisk). Comparison of sequence of the two risk haplotypes identified a 298-kb region of homology, extending from just telomeric of HLA-B to the HCG22 gene, which was flanked by clearly nonhomologous regions. Similar haplotypes cloned from unrelated individuals had nearly identical sequence. Combinatorial analysis of exonic variations in the known genes of the candidate interval revealed that HCG27, PSORS1C3, OTF3, TCF19, HCR, STG, and HCG22 bore no alleles unique to risk haplotypes among the 10 sequenced haplotypes. SPR1 and SEEK1 both had messenger RNA alleles specific to risk haplotypes, but only HLA-C and CDSN yielded protein alleles unique to risk. The risk alleles of HLA-C and CDSN (HLA-Cw6 and CDSN*TTC) were genotyped in 678 families with early-onset psoriasis; 620 of these families were also typed for 34 microsatellite markers spanning the PSORS1 interval. Recombinant haplotypes retaining HLA-Cw6 but lacking CDSN*TTC were significantly associated with psoriasis, whereas recombinants retaining CDSN*TTC but lacking HLA-Cw6 were not associated, despite good statistical power. By grouping recombinants with similar breakpoints, the most telomeric quarter of the 298-kb candidate interval could be excluded with high confidence. These results strongly suggest that HLA-Cw6 is the PSORS1 risk allele that confers susceptibility to early-onset psoriasis.	Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Radiat Oncol Canc Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Hosp, Dept Dermatol, Ann Arbor, MI USA; Univ Kiel, Dept Immunol, D-2300 Kiel, Germany; Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany; Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Kiel; Henry Ford Health System; Henry Ford Hospital	Elder, JT (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, 3312 CCGC,Box 0932, Ann Arbor, MI 48109 USA.	jelder@umich.edu	Weichenthal, Michael/A-5692-2009; Lim, HW/GRY-3517-2022; Abecasis, Goncalo R/B-7840-2010; Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X; Abecasis, Goncalo/0000-0003-1509-1825	NCRR NIH HHS [M01 RR00042, M01 RR000042] Funding Source: Medline; NIAMS NIH HHS [R01 AR042742, R01 AR050511] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050511, R01AR042742] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abecasis G, 2005, J INVEST DERMATOL, V124, P921, DOI 10.1111/j.0022-202X.2005.23729.x; Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahnini RT, 1999, HUM MOL GENET, V8, P1135, DOI 10.1093/hmg/8.6.1135; Allen M, 2001, LAB INVEST, V81, P969, DOI 10.1038/labinvest.3780309; Allen MH, 1999, LANCET, V353, P1589, DOI 10.1016/S0140-6736(99)01618-9; Ameen M, 2005, CLIN EXP DERMATOL, V30, P414, DOI 10.1111/j.1365-2230.2005.01789.x; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Capon F, 2004, DERMATOL CLIN, V22, P339, DOI 10.1016/S0733-8635(03)00125-6; Capon F, 2003, J MED GENET, V40, P447, DOI 10.1136/jmg.40.6.447; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHANG SF, 1995, IEEE J SEL AREA COMM, V13, P1, DOI 10.1109/49.363151; Chang YT, 2005, BRIT J DERMATOL, V153, P90, DOI 10.1111/j.1365-2133.2005.06570.x; Chang YT, 2004, BRIT J DERMATOL, V150, P1104, DOI 10.1111/j.1365-2133.2004.05972.x; Chang YT, 2003, BRIT J DERMATOL, V148, P418, DOI 10.1046/j.1365-2133.2003.05166.x; Chang YT, 2003, EXP DERMATOL, V12, P307, DOI 10.1034/j.1600-0625.2003.00039.x; Chia NVC, 2001, J INVEST DERMATOL, V116, P823, DOI 10.1046/j.1523-1747.2001.01245-2.x; Choonhakarn C, 2002, INT J DERMATOL, V41, P330, DOI 10.1046/j.1365-4362.2002.01496.x; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; CURTIS D, 1995, AM J HUM GENET, V56, P811; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Enerback C, 2000, J INVEST DERMATOL, V114, P1158, DOI 10.1046/j.1523-1747.2000.00002.x; ESPINOZA LR, 1982, SEMIN ARTHRITIS RHEU, V11, P375, DOI 10.1016/0049-0172(82)90058-0; Fischer G, 2000, IMMUNOGENETICS, V51, P591, DOI 10.1007/s002510000179; Foerster J, 2005, J INVEST DERMATOL, V124, P99, DOI 10.1111/j.0022-202X.2004.23504.x; Gaudieri S, 2000, GENOME RES, V10, P1579, DOI 10.1101/gr.127200; GLADMAN DD, 1994, BAILLIERE CLIN RHEUM, V8, P379, DOI 10.1016/S0950-3579(94)80024-3; GLADMAN DD, 1986, J RHEUMATOL, V13, P586; Gonzalez S, 2000, J INVEST DERMATOL, V115, P824, DOI 10.1046/j.1523-1747.2000.00133.x; Goon ATJ, 2004, SKIN RES TECHNOL, V10, P10, DOI 10.1111/j.1600-0846.2004.00046.x; Gudjonsson JE, 2004, CLIN EXP IMMUNOL, V135, P1, DOI 10.1111/j.1365-2249.2004.02310.x; Guerrin M, 2001, TISSUE ANTIGENS, V57, P32, DOI 10.1034/j.1399-0039.2001.057001032.x; GUPTA MA, 1993, INT J DERMATOL, V32, P188, DOI 10.1111/j.1365-4362.1993.tb02790.x; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Holm SJ, 2005, ACTA DERM-VENEREOL, V85, P2, DOI 10.1080/00015550410023527; Holm SJ, 2003, EXP DERMATOL, V12, P435, DOI 10.1034/j.1600-0625.2003.00048.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hui J, 2002, TISSUE ANTIGENS, V60, P77, DOI 10.1034/j.1399-0039.2002.600110.x; Ishihara M, 1996, TISSUE ANTIGENS, V48, P182, DOI 10.1111/j.1399-0039.1996.tb02626.x; Jenisch S, 1999, TISSUE ANTIGENS, V54, P439, DOI 10.1034/j.1399-0039.1999.540501.x; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; KOIZUMI H, 1988, Acta Dermatologica (Kyoto), V83, P483; Korendowych E, 2006, BRIT J DERMATOL, V154; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lin WJ, 2001, J INVEST DERMATOL, V117, P1546, DOI 10.1046/j.0022-202x.2001.01548.x; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Mallon E, 1999, J INVEST DERMATOL, V113, P693, DOI 10.1046/j.1523-1747.1999.00724.x; MANLY BFJ, 1986, BRIT J MATH STAT PSY, V39, P183, DOI 10.1111/j.2044-8317.1986.tb00855.x; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; MURRAY C, 1980, J CLIN INVEST, V66, P670, DOI 10.1172/JCI109903; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; NAIR RP, 1995, HUM HERED, V45, P219, DOI 10.1159/000154293; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; NAKAGAWA H, 1990, TISSUE ANTIGENS, V36, P241, DOI 10.1111/j.1399-0039.1990.tb01835.x; O'Brien KP, 2001, J INVEST DERMATOL, V116, P750, DOI 10.1046/j.0022-202x.2001.01323.x; Orru S, 2005, AM J HUM GENET, V76, P164, DOI 10.1086/426948; Orru S, 2002, TISSUE ANTIGENS, V60, P292, DOI 10.1034/j.1399-0039.2002.600403.x; Ozawa Akira, 1998, Journal of Dermatology (Tokyo), V25, P573; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI 10.1093/nar/GKG070; Romphruk AV, 2003, TISSUE ANTIGENS, V62, P217, DOI 10.1034/j.1399-0039.2003.00056.x; RUSSELL TJ, 1972, NEW ENGL J MED, V287, P738, DOI 10.1056/NEJM197210122871503; Sagoo GS, 2004, J INVEST DERMATOL, V122, P1401, DOI 10.1111/j.0022-202X.2004.22607.x; Salamon H, 1996, J COMPUT BIOL, V3, P407, DOI 10.1089/cmb.1996.3.407; Sanchez F, 2004, EXP DERMATOL, V13, P413, DOI 10.1111/j.0906-6705.2004.00170.x; Schmitt-Egenolf M, 2001, TISSUE ANTIGENS, V57, P440, DOI 10.1034/j.1399-0039.2001.057005440.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1999, AM J HUM GENET, V64, P668, DOI 10.1086/302265; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Stuart P, 2006, J MED GENET, V43, P12, DOI 10.1136/jmg.2005.032193; Suomela S, 2003, J INVEST DERMATOL, V121, P1360, DOI 10.1046/j.1523-1747.2003.12642.x; Suzuki Y, 2004, J INVEST DERMATOL, V122, P1133, DOI 10.1111/j.0022-202X.2004.22517.x; Tazi-Ahnini R, 1999, LANCET, V354, P597, DOI 10.1016/S0140-6736(05)77950-2; Teraoka Y, 2000, TISSUE ANTIGENS, V55, P206, DOI 10.1034/j.1399-0039.2000.550303.x; TRABACE S, 1994, ACTA DERM-VENEREOL, V74, P69; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Vejbaesya S, 1998, TISSUE ANTIGENS, V52, P389, DOI 10.1111/j.1399-0039.1998.tb03061.x; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Williams F, 2005, HUM IMMUNOL, V66, P836, DOI 10.1016/j.humimm.2005.04.005	98	416	434	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					827	851		10.1086/503821	http://dx.doi.org/10.1086/503821			25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642438	Green Published, Bronze			2022-12-18	WOS:000236756200009
J	Toro, JR; Nickerson, ML; Wei, MH; Warren, MB; Glenn, GM; Turner, ML; Stewart, L; Duray, P; Tourre, O; Sharma, N; Choyke, P; Stratton, P; Merino, M; Walther, MM; Linehan, WM; Schmidt, LS; Zbar, B				Toro, JR; Nickerson, ML; Wei, MH; Warren, MB; Glenn, GM; Turner, ML; Stewart, L; Duray, P; Tourre, O; Sharma, N; Choyke, P; Stratton, P; Merino, M; Walther, MM; Linehan, WM; Schmidt, LS; Zbar, B			Mutations in the Fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLECTING DUCT CARCINOMA; HOGG-DUBE-SYNDROME; UTERINE FIBROIDS; SPONTANEOUS PNEUMOTHORAX; CUTANEOUS LEIOMYOMATA; DEFICIENCY; ENCEPHALOPATHY; MITOCHONDRIAL; PREVALENCE; PARENCHYMA	Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant disorder characterized by smooth-muscle tumors of the skin and uterus and/or renal cancer. Although the identification of germline mutations in the fumarate hydratase (FH) gene in European families supports it as the susceptibility gene for HLRCC, its role in families in North America has not been studied. We screened for germline mutations in FH in 35 families with cutaneous leiomyomas. Sequence analysis revealed mutations in FH in 31 families (89%). Twenty different mutations in FH were identified, of which 18 were novel. Of these 20 mutations, 2 were insertions, 5 were small deletions that caused frameshifts leading to premature truncation of the protein, and 13 were missense mutations. Eleven unrelated families shared a common mutation: R190H. Eighty-one individuals ( 47 women and 34 men) had cutaneous leiomyomas. Ninety-eight percent (46/47) of women with cutaneous leiomyomas also had uterine leiomyomas. Eighty-nine percent (41/46) of women with cutaneous and uterine leiomyomas had a total hysterectomy, 44% at age less than or equal to 30 years. We identified 13 individuals in 5 families with unilateral and solitary renal tumors. Seven individuals from four families had papillary type II renal cell carcinoma, and another individual from one of these families had collecting duct carcinoma of the kidney. The present study shows that mutations in FH are associated with HLRCC in North America. HLRCC is associated with clinically significant uterine fibroids and aggressive renal tumors. The present study also expands the histologic spectrum of renal tumors and FH mutations associated with HLRCC.	NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; NCI, Immunobiol Lab, Ctr Canc Res, Frederick, MD 21701 USA; NCI, Basic Res Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA; NICHHD, Dermatol Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Pathol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Diagnost Radiol Serv, NIH, Bethesda, MD 20892 USA; NICHHD, Gynecol Consultat Serv, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Toro, JR (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,Execut Plaza S,Room 7012, Rockville, MD 20892 USA.	torojo@exchange.nih.gov			NCI NIH HHS [N01CO12400, N01 CO 12400] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008728] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC006659] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIBA T, 1984, J BIOCHEM-TOKYO, V96, P189, DOI 10.1093/oxfordjournals.jbchem.a134812; Alam NA, 2001, AM J HUM GENET, V68, P1264, DOI 10.1086/320124; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Choyke PL, 1997, J COMPUT ASSIST TOMO, V21, P737, DOI 10.1097/00004728-199709000-00014; Coughlin EM, 1998, MOL GENET METAB, V63, P254, DOI 10.1006/mgme.1998.2684; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; EDWARDS YH, 1979, ANN HUM GENET, V42, P303, DOI 10.1111/j.1469-1809.1979.tb00664.x; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; FUZESI L, 1992, HISTOPATHOLOGY, V21, P155, DOI 10.1111/j.1365-2559.1992.tb00364.x; GELLERA C, 1990, NEUROLOGY, V40, P495, DOI 10.1212/WNL.40.3_Part_1.495; KENNEDY SM, 1990, HUM PATHOL, V21, P449, DOI 10.1016/0046-8177(90)90209-N; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Keshavarz Homa, 2002, Morbidity and Mortality Weekly Report, V51, P1; Kiuru M, 2001, AM J PATHOL, V159, P825, DOI 10.1016/S0002-9440(10)61757-9; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; McKeeby JL, 2001, AM J PATHOL, V159, P1121, DOI 10.1016/S0002-9440(10)61788-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ornstein DK, 2000, J UROLOGY, V163, P431, DOI 10.1016/S0022-5347(05)67893-7; REED WB, 1973, ACTA DERM-VENEREOL, V53, P409; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Steiner G, 1996, CANCER RES, V56, P5044; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Tatusova TA, 1999, FEMS MICROBIOL LETT, V177, P187, DOI 10.1111/j.1574-6968.1999.tb13730.x; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; WALTHER MM, 1995, J UROLOGY, V154, P2010, DOI 10.1016/S0022-5347(01)66674-6; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393	32	416	424	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					95	106		10.1086/376435	http://dx.doi.org/10.1086/376435			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12772087	Green Published, Bronze			2022-12-18	WOS:000183904900009
J	KIMURA, S; UMENO, M; SKODA, RC; MEYER, UA; GONZALEZ, FJ				KIMURA, S; UMENO, M; SKODA, RC; MEYER, UA; GONZALEZ, FJ			THE HUMAN DEBRISOQUINE 4-HYDROXYLASE (CYP2D) LOCUS - SEQUENCE AND IDENTIFICATION OF THE POLYMORPHIC CYP2D6 GENE, A RELATED GENE, AND A PSEUDOGENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NCI,MOLEC CARCINOGENESIS LAB,BLDG 37,ROOM 3E-24,BETHESDA,MD 20892; UNIV BASEL,DEPT PHARMACOL,CH-4051 BASEL,SWITZERLAND	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Basel								DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057; Eichelbaum M, 1986, Prog Clin Biol Res, V214, P157; GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0; GONZALEZ FJ, 1987, DNA-J MOLEC CELL BIO, V6, P149, DOI 10.1089/dna.1987.6.149; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; GUT J, 1986, J BIOL CHEM, V261, P1734; IDLE JR, 1979, DRUG METAB REV, V9, P301, DOI 10.3109/03602537908993896; KAISER K, 1985, DNA CLONING PRACTICA, V1, P1; LARREY D, 1984, BIOCHEMISTRY-US, V23, P2787, DOI 10.1021/bi00307a039; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MILLER WL, 1988, AM J HUM GENET, V42, P4; NEBERT DW, 1985, TRENDS PHARMACOL SCI, V6, P160, DOI 10.1016/0165-6147(85)90075-6; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240	19	414	433	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					889	904						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2574001				2022-12-18	WOS:A1989CF40300008
J	Filla, A; DeMichele, G; Cavalcanti, F; Pianese, L; Monticelli, A; Campanella, G; Cocozza, S				Filla, A; DeMichele, G; Cavalcanti, F; Pianese, L; Monticelli, A; Campanella, G; Cocozza, S			The relationship between trinucleotide (GAA) repeat length and clinical features in friedreich ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE; CHROMOSOME-9; LOCUS; MUTATION; REGION	Friedreich ataxia (FA) is associated with the expansion of a GAA trinucleotide repeat in the first intron of the X25 gene. We found both alleles expanded in 67 FA patients from 48 Italian families. Five patients from three families were compound heterozygotes with expansion on one allele and an isoleucine-->phenylalanine change at position 154 on the other one. We found neither expansions nor point mutations in three patients. The length of FA alleles ranged from 201 to 1,186 repeat units, with no overlap with the normal range, and showed a negatively skewed distribution with a peak between 800 and 1,000 repeats. The FA repeat showed meiotic instability with a median variation of 150 repeats. The lengths of both larger and smaller alleles in each patient inversely correlated with age at onset of the disorder. Smaller alleles showed the best correlation, accounting for similar to 50% of the variation of age at onset. Mean allele length was significantly higher in patients with diabetes and in those with cardiomyopathy.	UNIV NAPLES FEDERICO II,DEPT MOL & CELLULAR BIOL,I-80131 NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT PATHOL,I-80131 NAPLES,ITALY; UNIV NAPLES FEDERICO II,CEOS,I-80131 NAPLES,ITALY; MEDITERRANEAN INST NEUROSCI,POZZILLI,ITALY	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II			Cocozza, Sergio/F-6488-2010; CAVALCANTI, FRANCESCA/I-3651-2014; Cavalcanti, Francesca/N-3901-2019	CAVALCANTI, FRANCESCA/0000-0001-5769-4582; Cavalcanti, Francesca/0000-0001-5769-4582	Telethon [722] Funding Source: Medline	Telethon(Fondazione Telethon)		BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; DEMICHELE G, 1994, J NEUROL NEUROSUR PS, V57, P977, DOI 10.1136/jnnp.57.8.977; DEMICHELE G, 1989, J NEUROL NEUROSUR PS, V52, P1398, DOI 10.1136/jnnp.52.12.1398; FILLA A, 1992, J NEUROL, V239, P351, DOI 10.1007/BF00867594; FILLA A, 1990, J NEUROL, V237, P345, DOI 10.1007/BF00315657; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; MONTERMINI L, 1995, AM J HUM GENET, V57, P1061; PALAU F, 1995, ANN NEUROL, V37, P359, DOI 10.1002/ana.410370312; PENTLAND B, 1983, J NEUROL NEUROSUR PS, V46, P1138, DOI 10.1136/jnnp.46.12.1138; WALLIS J, 1989, AM J MED GENET, V34, P458, DOI 10.1002/ajmg.1320340327; WINTER RM, 1981, CLIN GENET, V20, P419	16	413	427	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					554	560						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751856				2022-12-18	WOS:A1996VN62500009
J	FRANCKE, U; OCHS, HD; DEMARTINVILLE, B; GIACALONE, J; LINDGREN, V; DISTECHE, C; PAGON, RA; HOFKER, MH; VANOMMEN, GJB; PEARSON, PL; WEDGWOOD, RJ				FRANCKE, U; OCHS, HD; DEMARTINVILLE, B; GIACALONE, J; LINDGREN, V; DISTECHE, C; PAGON, RA; HOFKER, MH; VANOMMEN, GJB; PEARSON, PL; WEDGWOOD, RJ			MINOR XP21 CHROMOSOME DELETION IN A MALE ASSOCIATED WITH EXPRESSION OF DUCHENNE MUSCULAR-DYSTROPHY, CHRONIC GRANULOMATOUS-DISEASE, RETINITIS PIGMENTOSA, AND MCLEOD SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; LEIDEN STATE UNIV,INST ANTHROPOGENET,2312 AV LEIDEN,NETHERLANDS	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University - Excl LUMC	FRANCKE, U (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHS [GM32156, GM26105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032156, R01GM026105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BENNETT D, 1975, CELL, V6, P441, DOI 10.1016/0092-8674(75)90033-1; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; BORREGAARD N, 1984, J BIOL CHEM, V259, P47; BRUNS G, 1982, ADV EXP MED BIOL, V154, P60; CONLON T, 1983, CLIN CHIM ACTA, V130, P139, DOI 10.1016/0009-8981(83)90110-9; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DENSEN P, 1981, BLOOD, V58, P34; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; DUCOS J, 1971, LANCET, V2, P219; DUTRILLAUX B, 1973, CR ACAD SCI D NAT, V276, P3179; EMANUEL BS, 1983, J MED GENET, V20, P461, DOI 10.1136/jmg.20.6.461; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P273; FERGUSONSMITH MA, 1973, NATURE-NEW BIOL, V243, P271, DOI 10.1038/newbio243271a0; FISHMAN GA, 1978, ARCH OPHTHALMOL-CHIC, V96, P1185, DOI 10.1001/archopht.1978.03910060019004; FRANCKE U, 1976, AM J HUM GENET, V28, P357; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FRANCKE U, 1977, CYTOGENET CELL GENET, V19, P197, DOI 10.1159/000130809; GIBLETT ER, 1971, LANCET, V1, P1235; GLUECKSOHNWAELSCH S, 1979, CELL, V16, P225, DOI 10.1016/0092-8674(79)90001-1; GRUTZNER P, 1972, HUMANGENETIK, V14, P155, DOI 10.1007/BF00273301; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HECKENLIVELY J, 1983, PRINCIPLES PRACTICE, P522; HITZIG WH, 1983, HUM GENET, V64, P207, DOI 10.1007/BF00279395; HOFKER MH, 1985, HUM GENET; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; JACOBS PA, 1981, AM J HUM GENET, V33, P513; JUDD BH, 1972, GENETICS, V71, P139; JUNIEN C, 1980, ANN GENET-PARIS, V23, P165; KHAN PM, 1971, ARCH BIOCHEM BIOPHYS, V145, P470, DOI 10.1016/S0003-9861(71)80007-3; KINGSTON HM, 1984, HUM GENET, V67, P6, DOI 10.1007/BF00270551; KOUSSEFF B, 1981, LANCET, V1, P1149; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; LINDSLEY DL, 1972, GENETICS, V71, P157; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; Marsh W L, 1978, Birth Defects Orig Artic Ser, V14, P9; MARSH WL, 1981, VOX SANG, V40, P403, DOI 10.1111/j.1423-0410.1981.tb00728.x; MARSH WL, 1978, CYTOGENET CELL GENET, V22, P531, DOI 10.1159/000131017; MILLER OJ, 1984, CYTOGENET CELL GENET, V37, P176, DOI 10.1159/000132009; MUNKE M, 1984, SOMAT CELL MOLEC GEN, V10, P589, DOI 10.1007/BF01535224; NUSSBAUM RL, 1985, HUM GENET; OCHS HD, 1973, J PEDIATR-US, V83, P77, DOI 10.1016/S0022-3476(73)80316-6; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PINCUS SH, 1971, NEW ENGL J MED, V284, P744, DOI 10.1056/NEJM197104082841402; ROZEN R, 1985, NATURE; SARFARAZI M, 1983, HUM GENET, V65, P169, DOI 10.1007/BF00286656; SCHOTLAND DL, 1977, SCIENCE, V196, P1005, DOI 10.1126/science.860127; SEGAL AW, 1978, LANCET, V2, P446; SEGAL AW, 1983, NEW ENGL J MED, V308, P245, DOI 10.1056/NEJM198302033080503; SHERMAN F, 1975, GENETICS, V81, P51; SPARKES RS, 1979, CYTOGENET CELL GENET, V25, P209; SWASH M, 1983, BRAIN, V106, P717, DOI 10.1093/brain/106.3.717; VERELLENDUMOULIN C, 1984, HUM GENET, V67, P115, DOI 10.1007/BF00270570; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111; WOLFF G, 1980, HUM GENET, V54, P269, DOI 10.1007/BF00278983; 1981, CYTOGENET CELL GENET, V31, P1	64	413	418	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					250	267						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	4039107				2022-12-18	WOS:A1985AGY5900002
J	Eerola, I; Boon, LM; Mulliken, JB; Burrows, PE; Dompmartin, A; Watanabe, S; Vanwijck, R; Vikkula, M				Eerola, I; Boon, LM; Mulliken, JB; Burrows, PE; Dompmartin, A; Watanabe, S; Vanwijck, R; Vikkula, M			Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTPASE-ACTIVATING PROTEIN; NEUROFIBROMATOSIS TYPE-1 GENE; PORT-WINE STAINS; CEREBRAL CAVERNOMAS; BINDING-PROTEIN; ENCODING KRIT1; RAS-P21 GTPASE; GAP; INTEGRIN; DOMAIN	Capillary malformation (CM), or "port-wine stain," is a common cutaneous vascular anomaly that initially appears as a red macular stain that darkens over years. CM also occurs in several combined vascular anomalies that exhibit hypertrophy, such as Sturge-Weber syndrome, Klippel-Trenaunay syndrome, and Parkes Weber syndrome. Occasional familial segregation of CM suggests that there is genetic susceptibility, underscored by the identification of a large locus, CMC1, on chromosome 5q. We used genetic fine mapping with polymorphic markers to reduce the, size of the CMC1 locus. A positional candidate gene, RASA1, encoding p120-RasGAP, was screened for mutations in 17 families. Heterozygous inactivating RASA1 mutations were detected in six families manifesting atypical CMs that were multiple, small, round to oval in shape, and pinkish red in color. In addition to CM, either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome was documented in all the families with a mutation. We named this newly identified association caused by RASA1 mutations "CM-AVM," for capillary malformation-arteriovenous malformation. The phenotypic variability can be explained by the involvement of p120-RasGAP in signaling for various growth factor receptors that control proliferation, migration, and survival of several cell types, including vascular endothelial cells.	Catholic Univ Louvain, Christian du Duve Inst Cellular Pathol, Lab Human Mol Genet, B-1200 Brussels, Belgium; Catholic Univ Louvain, Clin Univ St Luc, Div Plast Surg, Ctr Vasc Anomalies, B-1200 Brussels, Belgium; Harvard Univ, Sch Med, Childrens Hosp, Vasc Anomalies Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Plast Surg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Intervent Radiol, Boston, MA 02114 USA; CHU Caen, Div Dermatol, Caen, France; Showa Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 142, Japan	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; CHU de Caen NORMANDIE; Universite de Caen Normandie; Showa University	Vikkula, M (corresponding author), Catholic Univ Louvain, Christian du Duve Inst Cellular Pathol, Lab Human Mol Genet, Ave Hippocrate 74 5,BP 75-39, B-1200 Brussels, Belgium.	vikkula@bchm.ucl.ac.be	Vikkula, Miikka/Q-1038-2018; Boon, Laurence/HCI-3629-2022	Vikkula, Miikka/0000-0002-6236-338X; 				BALLAUN C, 1995, J INVEST DERMATOL, V104, P7, DOI 10.1111/1523-1747.ep12613450; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARSKY SH, 1980, J INVEST DERMATOL, V74, P154, DOI 10.1111/1523-1747.ep12535052; BOS JL, 1989, CANCER RES, V49, P4682; Brouillard P, 2002, AM J HUM GENET, V70, P866, DOI 10.1086/339492; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; CLARK GJ, 1993, P NATL ACAD SCI USA, V90, P4887, DOI 10.1073/pnas.90.11.4887; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Drugan JK, 2000, J BIOL CHEM, V275, P35021, DOI 10.1074/jbc.M004386200; Eerola I, 2002, EUR J HUM GENET, V10, P375, DOI 10.1038/sj.ejhg.5200817; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; FRIEDMAN E, 1993, NAT GENET, V5, P242, DOI 10.1038/ng1193-242; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; Glanzer JG, 2002, GENE, V285, P149, DOI 10.1016/S0378-1119(02)00415-8; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; HATA Y, 1990, J BIOL CHEM, V265, P7104; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; JACOBS AH, 1976, PEDIATRICS, V58, P218; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kim I, 2002, FASEB J, V16, P1126, DOI 10.1096/fj.01-0805fje; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Labauge P, 2001, NEUROLOGY, V57, P1825, DOI 10.1212/WNL.57.10.1825; Labauge P, 2000, NEURORADIOLOGY, V42, P327, DOI 10.1007/s002340050893; Labauge P, 1999, ANN NEUROL, V45, P250, DOI 10.1002/1531-8249(199902)45:2<250::AID-ANA17>3.0.CO;2-V; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879, DOI 10.1128/MCB.14.10.6879; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Notelet L, 1997, SURG NEUROL, V47, P364, DOI 10.1016/S0090-3019(96)00248-0; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; RYDH M, 1991, PLAST RECONSTR SURG, V87, P419, DOI 10.1097/00006534-199103000-00003; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SMOLLER BR, 1986, ARCH DERMATOL, V122, P177, DOI 10.1001/archderm.122.2.177; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Young AE, 1988, VASCULAR BIRTHMARKS, P24; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953	49	412	430	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1240	1249		10.1086/379793	http://dx.doi.org/10.1086/379793			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14639529	Green Published, Bronze			2022-12-18	WOS:000187491100002
J	Fellermann, K; Stange, DE; Schaeffeler, E; Schmalzl, H; Wehkamp, J; Bevins, CL; Reinisch, W; Teml, A; Schwab, M; Lichter, P; Radlwimmer, B; Stange, EF				Fellermann, Klaus; Stange, Daniel E.; Schaeffeler, Elke; Schmalzl, Hartmut; Wehkamp, Jan; Bevins, Charles L.; Reinisch, Walter; Teml, Alexander; Schwab, Matthias; Lichter, Peter; Radlwimmer, Bernhard; Stange, Eduard F.			A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; RESIDENT INTESTINAL FLORA; HUMAN GENOME; SEGMENTAL DUPLICATIONS; ULCERATIVE-COLITIS; DEFENSIN DEFICIENCY; ALPHA-DEFENSIN; PANETH CELLS; DNA-SEQUENCE; NOD2	Defensins are endogenous antimicrobial peptides that protect the intestinal mucosa against bacterial invasion. It has been suggested that deficient defensin expression may underlie the chronic inflammation of Crohn disease ( CD). The DNA copy number of the beta-defensin gene cluster on chromosome 8p23.1 is highly polymorphic within the healthy population, which suggests that the defective beta-defensin induction in colonic CD could be due to low beta-defensin gene copy number. Here, we tested this hypothesis, using genomewide DNA copy number profiling by array-based comparative genomic hybridization and quantitative polymerase-chain-reaction analysis of the human beta-defensin 2 (HBD-2) gene. We showed that healthy individuals, as well as patients with ulcerative colitis, have a median of 4 ( range 2 - 10) HBD-2 gene copies per genome. In a surgical cohort with ileal or colonic CD and in a second large cohort with inflammatory bowel diseases, those with ileal resections/disease exhibited a normal median HBD-2 copy number of 4, whereas those with colonic CD had a median of only 3 copies per genome ( for the surgical cohort; P = .008 P = .032 for the second cohort). Overall, the copy number distribution in colonic CD was shifted to lower numbers compared with controls ( for both the surgical cohort and the cohort with inflammatory bowel diseases). Individuals with P = .002 <= 3 copies have a significantly higher risk of developing colonic CD than did individuals with >= 4 copies ( odds ratio 3.06; 95% confidence interval 1.46 - 6.45). An HBD-2 gene copy number of < 4 was associated with diminished mucosal HBD-2 mRNA expression (P = 0.033). In conclusion, a lower HBD-2 gene copy number in the beta-defensin locus predisposes to colonic CD, most likely through diminished beta-defensin expression.	Robert Bosch Krankenhaus, Dept Internal Med 1, D-70376 Stuttgart, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; German Canc Res Ctr, Div Mol Genet, D-6900 Heidelberg, Germany; Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; Med Univ Vienna, Dept Internal Med 4, Vienna, Austria	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California Davis; Medical University of Vienna	Fellermann, K (corresponding author), Robert Bosch Krankenhaus, Dept Internal Med 1, Auerbachstr 110, D-70376 Stuttgart, Germany.	klaus.fellermann@rbk.de	Schwab, Matthias/ABH-7449-2020; Wehkamp, Jan/B-7319-2011; Bevins, Charles L/P-4438-2015; Stange, Daniel E/O-1837-2015; Radlwimmer, Bernhard F/I-3229-2013	Bevins, Charles L/0000-0003-2725-2622; Stange, Daniel E/0000-0003-4246-2230; Radlwimmer, Bernhard F/0000-0002-4553-7800; Wehkamp, Jan/0000-0001-6788-841X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032738] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI032738, R01 AI032738, AI32738] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bridger S, 2002, GUT, V51, P21, DOI 10.1136/gut.51.1.21; Chen QX, 2006, J IMMUNOL METHODS, V308, P231, DOI 10.1016/j.jim.2005.11.001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hollox EJ, 2005, J NEGAT RESULTS BIOM, V4, DOI 10.1186/1477-5751-4-9; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1999, PEDIATR RES, V45, P159, DOI 10.1203/00006450-199902000-00001; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Mendrzyk F, 2006, GENE CHROMOSOME CANC, V45, P401, DOI 10.1002/gcc.20304; Nusbaum C, 2006, NATURE, V439, P331, DOI 10.1038/nature04406; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaeffeler E, 2003, HUM MUTAT, V22, P476, DOI 10.1002/humu.10280; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; TOBIN MV, 1987, GASTROENTEROLOGY, V93, P316, DOI 10.1016/0016-5085(87)91021-3; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265	51	410	429	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					439	448		10.1086/505915	http://dx.doi.org/10.1086/505915			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909382	Green Published, Bronze			2022-12-18	WOS:000239830700006
J	Laurin, N; Brown, JP; Morissette, J; Raymond, V				Laurin, N; Brown, JP; Morissette, J; Raymond, V			Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; FAMILIAL EXPANSILE OSTEOLYSIS; CHROMOSOME 18Q; UBA DOMAIN; LINKAGE; HETEROGENEITY; LOCI; ACTIVATION; IDENTIFICATION; TRANSITIONS	Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to similar to300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.	CHU Laval, Mol Endocrinol & Oncol Res Ctr, Res Ctr, Quebec City, PQ G1V 4G2, Canada; CHU Laval, Grp Rech Mald Osseuses Rhumatol Immunol, Res Ctr, Quebec City, PQ G1V 4G2, Canada; CHU Laval, Ctr Genom Est Quebec, Res Ctr, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University; Laval University	Raymond, V (corresponding author), CHU Laval, Mol Endocrinol & Oncol Res Ctr, Res Ctr, 2705 Laurier Blvd,Room T3-67, Quebec City, PQ G1V 4G2, Canada.			Brown, Jacques/0000-0003-1910-788X				Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Cody JD, 1997, AM J HUM GENET, V61, P1117, DOI 10.1086/301601; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FOTINO M, 1977, TRANSPLANT P, V9, P1867; Glaser B, 1999, HUM MUTAT, V14, P23, DOI 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-#; Good D, 2001, J BONE MINER RES, V16, P33, DOI 10.1359/jbmr.2001.16.1.33; Good DA, 2002, AM J HUM GENET, V70, P517, DOI 10.1086/338658; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; HAMDY RC, 1995, ENDOCRIN METAB CLIN, V24, P421, DOI 10.1016/S0889-8529(18)30047-1; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; Hocking L, 2000, BONE, V26, P577, DOI 10.1016/S8756-3282(00)00278-7; Hocking LJ, 2001, AM J HUM GENET, V69, P1055, DOI 10.1086/323798; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; HOWATSON AF, 1982, INTERVIROLOGY, V18, P150, DOI 10.1159/000149318; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Kanis J., 1998, PATHOPHYSIOLOGY TREA, VSecond; KLEIN RM, 1995, ENDOCRIN METAB CLIN, V24, P437, DOI 10.1016/S0889-8529(18)30048-3; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; Laurin N, 2001, AM J HUM GENET, V69, P528, DOI 10.1086/322975; Leach RJ, 2001, J CLIN ENDOCR METAB, V86, P24, DOI 10.1210/jc.86.1.24; Lund A, 2001, EUR J HUM GENET, V9, P431, DOI 10.1038/sj.ejhg.5200656; McLean W, 2001, Trends Genet, V17, pS38, DOI 10.1016/S0168-9525(01)02458-1; MILLS BG, 1976, SCIENCE, V194, P201, DOI 10.1126/science.959849; MOORE SB, 1988, TISSUE ANTIGENS, V31, P69, DOI 10.1111/j.1399-0039.1988.tb02065.x; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nance MA, 2000, AM J MED GENET, V92, P303, DOI 10.1002/1096-8628(20000619)92:5<303::AID-AJMG2>3.0.CO;2-E; REBEL A, 1974, REV RHUM, V41, P767; Rizzo WB, 1999, AM J HUM GENET, V65, P1547, DOI 10.1086/302681; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; SIRIS ES, 1990, PRINCIPLES PRACTICE, P504; Sobel E, 1996, AM J HUM GENET, V58, P1323; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; TILYARD MW, 1982, AUST NZ J MED, V12, P498, DOI 10.1111/j.1445-5994.1982.tb03830.x; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939	41	410	426	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1582	1588		10.1086/340731	http://dx.doi.org/10.1086/340731			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992264	Bronze, Green Published			2022-12-18	WOS:000175445700020
J	Antonellis, A; Ellsworth, RE; Sambuughin, N; Puls, I; Abel, A; Lee-Lin, SQ; Jordanova, A; Kremensky, I; Christodoulou, K; Middleton, LT; Sivakumar, K; Ionasescu, V; Funalot, B; Vance, JM; Goldfarb, LG; Fischbeck, KH; Green, ED				Antonellis, A; Ellsworth, RE; Sambuughin, N; Puls, I; Abel, A; Lee-Lin, SQ; Jordanova, A; Kremensky, I; Christodoulou, K; Middleton, LT; Sivakumar, K; Ionasescu, V; Funalot, B; Vance, JM; Goldfarb, LG; Fischbeck, KH; Green, ED			Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 7P; CMT2D	Charcot-Marie-Tooth disease type 2D (CMT2D) and distal spinal muscular atrophy type V (dSMA-V) are axonal peripheral neuropathies inherited in an autosomal dominant fashion. Our previous genetic and physical mapping efforts localized the responsible gene(s) to a well-defined region on human chromosome 7p. Here, we report the identification of four disease-associated missense mutations in the glycyl tRNA synthetase gene in families with CMT2D and dSMA-V. This is the first example of an aminoacyl tRNA synthetase being implicated in a human genetic disease, which makes genes that encode these enzymes relevant candidates for other inherited neuropathies and motor neuron diseases.	NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; NINDS, Clin Neurogenet Unit, NIH, Bethesda, MD 20892 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Barrow Neurol Inst, Phoenix, AZ 85013 USA; George Washington Univ, Grad Program Genet, Washington, DC USA; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Cyprus Inst Neurol & Genet, Mol Genet Dept D, Nicosia, Cyprus; Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Hop St Anne, INSERM, U573, F-75674 Paris, France; Hop St Anne, Dept Neurol, F-75674 Paris, France; Duke Univ, Ctr Human Genet, Inst Genome Sci & Policy, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Barrow Neurological Institute; George Washington University; Medical University Sofia; University of Iowa; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Duke University	Green, ED (corresponding author), Bldg 50,Room 5222,50 South Dr,MSC 8002, Bethesda, MD 20892 USA.		Jordanova, Albena/H-8323-2015	Jordanova, Albena/0000-0002-3833-3754; Christodoulou, Kyproula/0000-0002-0622-7594; Vance, Jeffery/0000-0003-3815-8199	NINDS NIH HHS [P01 NS026630, NS 26630] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000060, Z01HG000196, ZIAHG000060, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974, Z01NS002973, ZIANS002974, ZIANS002973, P01NS026630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRYANT SH, 1993, PROTEINS, V16, P92, DOI 10.1002/prot.340160110; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; Ellsworth RE, 1999, GENOME RES, V9, P568; Freist W, 1996, BIOL CHEM H-S, V377, P343; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Murakami T, 1996, MEDICINE, V75, P233, DOI 10.1097/00005792-199609000-00001; Pericak-Vance MA, 1997, NEUROGENETICS, V1, P89, DOI 10.1007/s100480050013; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; SKRE H, 1974, CLIN GENET, V6, P98; Sternbach G, 1999, J EMERG MED, V17, P519, DOI 10.1016/S0736-4679(99)00030-X; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	16	409	435	1	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1293	1299		10.1086/375039	http://dx.doi.org/10.1086/375039			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12690580	Green Published, Bronze			2022-12-18	WOS:000182474400022
J	Machado, RD; Pauciulo, MW; Thomson, JR; Lane, KB; Morgan, NV; Wheeler, L; Phillips, JA; Newman, J; Williams, D; Galie, N; Manes, A; McNeil, K; Yacoub, M; Mikhail, G; Rogers, P; Corris, P; Humbert, M; Donnai, D; Martensson, G; Tranebjaerg, L; Loyd, JE; Trembath, RC; Nichols, WC				Machado, RD; Pauciulo, MW; Thomson, JR; Lane, KB; Morgan, NV; Wheeler, L; Phillips, JA; Newman, J; Williams, D; Galie, N; Manes, A; McNeil, K; Yacoub, M; Mikhail, G; Rogers, P; Corris, P; Humbert, M; Donnai, D; Martensson, G; Tranebjaerg, L; Loyd, JE; Trembath, RC; Nichols, WC			BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; RECEPTOR; ACTIVIN; PROTEIN; CELLS; BETA	Primary pulmonary hypertension (PPH) is a potentially lethal disorder, because the elevation of the pulmonary arterial pressure may result in right-heart failure. Histologically, the disorder is characterized by proliferation of pulmonary-artery smooth muscle and endothelial cells, by intimal hyperplasia, and by in situ thrombus formation. Heterozygous mutations within the bone morphogenetic protein type II receptor (BMPR-II) gene (BMPR2), of the transforming growth factor beta (TGF-beta) cell-signaling superfamily, have been identified in familial and sporadic cases of PPH. We report the molecular spectrum of BMPR2 mutations in 47 additional families with PPH and in three patients with sporadic PPH. Among the cohort of patients, we have identified 22 novel mutations, including 4 partial deletions, distributed throughout the BMPR2 gene. The majority (58%) of mutations are predicted to lead to a premature termination codon. We have also investigated the functional impact and genotype-phenotype relationships, to elucidate the mechanisms contributing to pathogenesis of this important vascular disease. In vitro expression analysis demonstrated loss of BMPR-II function for a number of the identified mutations. These data support the suggestion that haploinsufficiency represents the common molecular mechanism in PPH. Marked variability of the age at onset of disease was observed both within and between families. Taken together, these studies illustrate the considerable heterogeneity of BMPR2 mutations that cause PPH, and they strongly suggest that additional factors, genetic and/or environmental, may be required for the development of the clinical phenotype.	Univ Leicester, Div Med Genet, Dept Med, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA; Univ Bologna, Ist Cardiol, Bologna, Italy; Papworth Hosp, Pulm Vasc Dis Unit, Cambridge CB3 8RE, England; Royal Brompton Hosp, Natl Heart & Lung Inst, Harefield, Middx, England; Harefield Hosp, Natl Heart & Lung Inst, Harefield UB9 6JH, Middx, England; Royal Freeman Hosp, William Leech Ctr Lung Res, Newcastle Upon Tyne, Tyne & Wear, England; Hop Antoine Beclere, Serv Pneumol & Reanimat Resp, Clamart, France; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Sahlgrens Univ Hosp, Div Heart & Lung Transplant, S-41345 Gothenburg, Sweden; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway	University of Leicester; University of Leicester; Cincinnati Children's Hospital Medical Center; Vanderbilt University; University of Bologna; Papworth Hospital; Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Newcastle Freeman Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; University of Manchester; Sahlgrenska University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway	Trembath, RC (corresponding author), Univ Leicester, Div Med Genet, Dept Med, Adrian Bldg, Leicester LE1 7RH, Leics, England.		Morgan, Neil V/A-5475-2009; Machado, Rajiv D./AAD-7813-2019; Galie, Nazzareno/F-7004-2014	Morgan, Neil V/0000-0001-6433-5692; Machado, Rajiv D./0000-0001-9247-0744; Galie, Nazzareno/0000-0003-4271-8670; Trembath, Richard/0000-0003-0550-3400; Humbert, Marc/0000-0003-0703-2892	NHLBI NIH HHS [HL61997, R01 HL061997, HL48164] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061997, R01HL048164] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Deng ZM, 2000, AM J RESP CRIT CARE, V161, P1055, DOI 10.1164/ajrccm.161.3.9906051; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; GOMEZSANCHEZ MA, 1991, J AM COLL CARDIOL, V18, P1539, DOI 10.1016/0735-1097(91)90688-6; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; Machado RD, 2000, GENOMICS, V68, P220, DOI 10.1006/geno.2000.6291; MAQUAT LE, 1995, RNA, V1, P453; Marchuk D A, 1998, Curr Opin Hematol, V5, P332, DOI 10.1097/00062752-199809000-00005; Massague J, 2000, GENE DEV, V14, P627; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; Mesa RA, 1998, MAYO CLIN PROC, V73, P37; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; Piek E, 1999, J CELL SCI, V112, P4557; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Thomson JR, 2000, J CLIN PATHOL, V53, P899, DOI 10.1136/jcp.53.12.899; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741	27	409	436	1	24	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					92	102		10.1086/316947	http://dx.doi.org/10.1086/316947			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11115378	Bronze, Green Published			2022-12-18	WOS:000166399900008
J	SAKAI, T; TOGUCHIDA, J; OHTANI, N; YANDELL, DW; RAPAPORT, JM; DRYJA, TP				SAKAI, T; TOGUCHIDA, J; OHTANI, N; YANDELL, DW; RAPAPORT, JM; DRYJA, TP			ALLELE-SPECIFIC HYPERMETHYLATION OF THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE; HEREDITARY RETINOBLASTOMA; DNA METHYLATION; OSTEO-SARCOMA; DETERMINES METHYLATION; LINKAGE ANALYSIS; RB GENE; EXPRESSION; MUTATION; POLYMORPHISMS	Inactivation of the retinoblastoma gene appears to have a fundamental role in the genesis of retinoblastoma, osteosarcoma, and other malignant tumors. The gene is generally inactivated because of loss-of-function mutations, although epigenetic phenomena, such as hypermethylation of the promoter region, could possibly have the same effect. We investigated the methylation pattern at the 5' end of the retinoblastoma gene, including its promoter region and exon 1, in DNA purified from 56 primary retinoblastomas. We found five tumors with evidence for hypermethylation, all from unilateral, simplex patients. No methylation abnormalities were detected in DNA purified from the leukocytes from these patients. It is interesting that in one of these tumors the hypermethylation was confined to one allele. There were no mutations in a 1,306-bp sequence including the hypermethylated region that might account for the allele-specific hypermethylation. We believe that the hypermethylation of the retinoblastoma gene that we found in these tumors corresponds to the allelic inactivation of the gene, and we speculate that erroneous hypermethylation without alteration of nucleotide sequence occasionally plays a role in the genesis of this cancer. If this is true, then retinoblastomas with hypermethylation might be treatable with chemotherapeutic agents that interfere with methylation of DNA.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,HOWE LAB OPHTHALMOL,243 CHARLES ST,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary					NEI NIH HHS [EY07573, EY05321] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY007573, R01EY005321] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; FREIND SH, 1987, P NATL ACAD SCI USA, V84, P9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; GREGER V, 1988, J MED GENET, V25, P217, DOI 10.1136/jmg.25.4.217; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; JONES PA, 1986, CANCER RES, V46, P461; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SCHEFFER H, 1989, AM J HUM GENET, V45, P252; STRATTON MR, 1989, BRIT J CANCER, V60, P202, DOI 10.1038/bjc.1989.251; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; VOGEL F, 1979, HUM GENET, V52, P1; WEICHSELBAUM RR, 1988, P NATL ACAD SCI USA, V85, P2106, DOI 10.1073/pnas.85.7.2106; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305	36	408	433	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					880	888						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673287				2022-12-18	WOS:A1991FK89700007
J	De Sandre-Giovannoli, A; Chaouch, M; Kozlov, S; Vallat, JM; Tazir, M; Kassouri, N; Szepetowski, P; Hammadouche, T; Vandenberghe, A; Stewart, CL; Grid, D; Levy, N				De Sandre-Giovannoli, A; Chaouch, M; Kozlov, S; Vallat, JM; Tazir, M; Kassouri, N; Szepetowski, P; Hammadouche, T; Vandenberghe, A; Stewart, CL; Grid, D; Levy, N			Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE TYPE 1A; A-TYPE LAMIN; GENE; MUTATIONS; FORM; IDENTIFICATION; EXPRESSION; DOMINANT; FAMILY; LOCUS	The Charcot-Marie-Tooth (CMT) disorders comprise a group of clinically and genetically heterogeneous hereditary motor and sensory neuropathies, which are mainly characterized by muscle weakness and wasting, foot deformities, and electrophysiological, as well as histological, changes. A subtype, CMT2, is defined by a slight or absent reduction of nerve-conduction velocities together with the loss of large myelinated fibers and axonal degeneration. CMT2 phenotypes are also characterized by a large genetic heterogeneity, although only two genes-NF-L and KIF1Bbeta-have been identified to date. Homozygosity mapping in inbred Algerian families with autosomal recessive CMT2 (AR-CMT2) provided evidence of linkage to chromosome 1q21.2-q21.3 in two families (Z(max) = 4.14). All patients shared a common homozygous ancestral haplotype that was suggestive of a founder mutation as the cause of the phenotype. A unique homozygous mutation in LMNA (which encodes lamin A/C, a component of the nuclear envelope) was identified in all affected members and in additional patients with CMT2 from a third, unrelated family. Ultrastructural exploration of sciatic nerves of LMNA null (i.e., -/-) mice was performed and revealed a strong reduction of axon density, axonal enlargement, and the presence of nonmyelinated axons, all of which were highly similar to the phenotypes of human peripheral axonopathies. The finding of site-specific amino acid substitutions in limb-girdle muscular dystrophy type 1B, autosomal dominant Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy type 1A, autosomal dominant partial lipodystrophy, and, now, AR-CMT2 suggests the existence of distinct functional domains in lamin A/C that are essential for the maintenance and integrity of different cell lineages. To our knowledge, this report constitutes the first evidence of the recessive inheritance of a mutation that causes CMT2; additionally, we suggest that mutations in LMNA may also be the cause of the genetically overlapping disorder CMT2B1.	Fac Med de la Timone, INSERM, U491, Unite Genet Med & Dev, F-13385 Marseille 5, France; Hop Enfants La Timone, Dept Med Genet, Marseille, France; Inst Pasteur, Algiers, Algeria; NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; Ctr Hosp Univ Dupuytren, Serv Neuropathol, Limoges, France; Hop Antiquaille, Neurogenet Lab, Lyon, France; Genethon 3, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CHU Limoges; CHU Lyon	Levy, N (corresponding author), Fac Med de la Timone, INSERM, U491, Unite Genet Med & Dev, F-13385 Marseille 5, France.	Nicolas.Levy@medecine.univ-mrs.fr	De Sandre-Giovannoli, Annachiara/AAJ-6992-2020; De Sandre-Giovannoli, Annachiara/L-5759-2016; LEVY, Nicolas/J-1632-2014	De Sandre-Giovannoli, Annachiara/0000-0002-2324-2462; De Sandre-Giovannoli, Annachiara/0000-0002-2324-2462; LEVY, Nicolas/0000-0001-5171-6365				Barhoumi C, 2001, NEUROMUSCULAR DISORD, V11, P27, DOI 10.1016/S0960-8966(00)00162-0; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bouhouche A, 1999, AM J HUM GENET, V65, P722, DOI 10.1086/302542; Brown CA, 2001, AM J MED GENET, V102, P359, DOI 10.1002/ajmg.1463; CANCE WG, 1992, J EXP CLIN CANC RES, V11, P233; Chapon F, 1999, J NEUROL NEUROSUR PS, V66, P779, DOI 10.1136/jnnp.66.6.779; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FURUKAWA K, 1994, EXP CELL RES, V212, P426, DOI 10.1006/excr.1994.1164; Garcia CA, 1999, ANN NY ACAD SCI, V883, P69, DOI 10.1111/j.1749-6632.1999.tb08570.x; Gemignani F, 2001, J NEUROL SCI, V184, P1, DOI 10.1016/S0022-510X(00)00497-4; Hahn AF, 2001, ACTA NEUROPATHOL, V101, P129; Huxley C, 1996, HUM MOL GENET, V5, P563, DOI 10.1093/hmg/5.5.563; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Laporte J, 2001, TRENDS GENET, V17, P221, DOI 10.1016/S0168-9525(01)02245-4; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Leal A, 2001, AM J HUM GENET, V68, P269, DOI 10.1086/316934; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Misu K, 2000, J NEUROL NEUROSUR PS, V69, P806, DOI 10.1136/jnnp.69.6.806; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Norreel JC, 2001, EUR J NEUROSCI, V13, P1625, DOI 10.1046/j.0953-816x.2001.01535.x; Pierce T, 1999, EXP NEUROL, V157, P241, DOI 10.1006/exnr.1999.7060; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Reilly MM, 2000, CURR OPIN NEUROL, V13, P561, DOI 10.1097/00019052-200010000-00009; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; SKRE H, 1974, CLIN GENET, V6, P98; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Villard L, 2001, J MED GENET, V38, P435, DOI 10.1136/jmg.38.7.435; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	37	406	424	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					726	736		10.1086/339274	http://dx.doi.org/10.1086/339274			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11799477	Bronze, Green Published			2022-12-18	WOS:000173880000015
J	Kachergus, J; Mata, IF; Hulihan, M; Taylor, JP; Lincoln, S; Aasly, J; Gibson, JM; Ross, OA; Lynch, T; Wiley, J; Payami, H; Nutt, J; Maraganore, DM; Czyzewski, K; Styczynska, M; Wszolek, ZK; Farrer, MJ; Toft, M				Kachergus, J; Mata, IF; Hulihan, M; Taylor, JP; Lincoln, S; Aasly, J; Gibson, JM; Ross, OA; Lynch, T; Wiley, J; Payami, H; Nutt, J; Maraganore, DM; Czyzewski, K; Styczynska, M; Wszolek, ZK; Farrer, MJ; Toft, M			Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: Evidence of a common founder across European populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY-ONSET PARKINSONISM; ALPHA-SYNUCLEIN; PROTEIN-KINASES; DISEASE; GENE; LOCUS; LINKAGE; PATHOLOGY; TRAITS; PINK1	Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucine-rich repeat kinase 2 (LRRK2). By sequencing multiplex families consistent with a PARK8 assignment, we identified a novel heterozygous LRRK2 mutation. A referral sample of 248 affected probands from families with autosomal dominant parkinsonism was subsequently assessed; 7 (2.8%) were found to carry a heterozygous LRRK2 6055G-->A transition (G2019S). These seven patients originate from the United States, Norway, Ireland, and Poland. In samples of patients with idiopathic Parkinson disease (PD) from the same populations, further screening identified six more patients with LRRK2 G2019S; no mutations were found in matched control individuals. Subsequently, 42 family members of the 13 probands were examined; 22 have an LRRK2 G2019S substitution, 7 with a diagnosis of PD. Of note, all patients share an ancestral haplotype indicative of a common founder, and, within families, LRRK2 G2019S segregates with disease (multipoint LOD score 2.41). Penetrance is age dependent, increasing from 17% at age 50 years to 85% at age 70 years. In summary, our study demonstrates that LRRK2 G2019S accounts for parkinsonism in several families within Europe and North America. Our work highlights the fact that a proportion of clinically typical, late-onset PD cases have a genetic basis.	Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; St Olavs Hosp, Dept Neurol, Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland; Queens Univ Belfast, Sch Biol & Biochem, Belfast BT7 1NN, Antrim, North Ireland; Mater Misericordiae Univ Hosp, Dept Neurol, Dublin, Ireland; Conway Inst Biomol & Biomed Res, Dublin, Ireland; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA; Mayo Clin, Dept Neurol, Rochester, MN USA; Polish Acad Sci, Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; Minist Spraw Wewnetrznych & Adm Hosp, Dept Neurol, Warsaw, Poland	Mayo Clinic; Mayo Clinic; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Queens University Belfast; Mater Misericordiae University Hospital; University College Dublin; University College Dublin; State University of New York (SUNY) System; Wadsworth Center; Oregon Health & Science University; Mayo Clinic; Polish Academy of Sciences	Farrer, MJ (corresponding author), Mayo Clin, Dept Neurosci, Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	farrer.matthew@mayo.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Payami, Haydeh/ABE-1944-2020; Wszolek, Zbigniew K./AAB-1431-2019; Toft, Mathias/AAY-5212-2021; Ross, Owen/D-7573-2013	Farrer, Matthew/0000-0003-1159-5321; Ross, Owen/0000-0003-4813-756X; Fernandez Mata, Ignacio/0000-0003-1198-0633; Toft, Mathias/0000-0002-6723-6865	NIA NIH HHS [R01 AG022579] Funding Source: Medline; NINDS NIH HHS [R01 NS36960, P01 NS040256, P01 NS40256, R01 NS036960] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040256, R01NS036960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022579] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Mata IF, 2004, HUM MOL GENET, V13, pR127, DOI 10.1093/hmg/ddh089; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Simon DK, 2002, J NEUROL NEUROSUR PS, V72, P686, DOI 10.1136/jnnp.72.6.686; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wirdefeldt K, 2004, NEUROLOGY, V63, P305, DOI 10.1212/01.WNL.0000129841.30587.9D; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	36	405	415	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					672	680		10.1086/429256	http://dx.doi.org/10.1086/429256			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15726496	Green Published, Bronze			2022-12-18	WOS:000227516000013
J	HUOPONEN, K; VILKKI, J; AULA, P; NIKOSKELAINEN, EK; SAVONTAUS, ML				HUOPONEN, K; VILKKI, J; AULA, P; NIKOSKELAINEN, EK; SAVONTAUS, ML			A NEW MTDNA MUTATION ASSOCIATED WITH LEBER HEREDITARY OPTIC NEURORETINOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISM; COMPLETE NUCLEOTIDE-SEQUENCE; GENETIC-HETEROGENEITY; NADH DEHYDROGENASE; FINNISH FAMILIES; NEUROPATHY; GENOME; ORGANIZATION	A single base mutation at nucleotide position 3460 (nt 3460) in the ND1 gene in human mtDNA was found to be associated with Leber hereditary optic neuroretinopathy (LHON). The G-to-A mutation converts an alanine to a threonine at the 52d codon of the gene. The mutation also abolishes an AhaII restriction site and thus can be detected easily by RFLP analysis. The mutation was found in three independent Finnish LHON families but in none of the 60 controls. None of the families with the nt 3460 mutation in ND1 had the previously reported nt 11778 mutation in the ND4 gene. The G-to-A change at nt 3460 is the second mutation so far detected in LHON.	UNIV TURKU,DEPT BIOL,SF-20500 TURKU 50,FINLAND; UNIV TURKU,CENT HOSP,DEPT OPHTHALMOL,SF-20520 TURKU 52,FINLAND	University of Turku; University of Turku	HUOPONEN, K (corresponding author), UNIV TURKU,DEPT MED GENET,KIINAMYLLYNKATU 10,SF-20520 TURKU 52,FINLAND.							ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ANDERSON S, 1981, NATURE, V290, P451; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; FRIEDRICH T, 1990, FEBS LETT, V265, P37, DOI 10.1016/0014-5793(90)80878-M; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HUOPONEN K, 1990, GENOMICS, V8, P583, DOI 10.1016/0888-7543(90)90049-Z; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VILKKI J, 1989, HUM GENET, V82, P208, DOI 10.1007/BF00291155; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	17	405	419	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1147	1153						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	1674640				2022-12-18	WOS:A1991FP09200017
J	Cantor, RM; Lange, K; Sinsheimer, JS				Cantor, Rita M.; Lange, Kenneth; Sinsheimer, Janet S.			Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their Application	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE ASSOCIATION; DETECTING GENE-GENE; HIGH-ORDER INTERACTIONS; COMPLEX DISEASES; COMMON VARIANTS; CELIAC-DISEASE; ENVIRONMENT INTERACTIONS; EPISTATIC INTERACTIONS; QUANTITATIVE TRAITS; SUSCEPTIBILITY LOCI	Genome-wide association studies (GWAS) have rapidly become a standard method for disease gene discovery. A substantial number of recent GWAS indicate that for most disorders, only a few common variants are implicated and the associated SNPs explain only a small fraction of the genetic risk. This review is written from the viewpoint that findings from the GWAS provide preliminary genetic information that is available for additional analysis by statistical procedures that accumulate evidence, and that these secondary analyses are very likely to provide valuable information that will help Prioritize the strongest constellations of results. We review and discuss three analytic methods to combine preliminary GWAS statistics to identify genes, alleles, and pathways for deeper investigations. Meta-analysis seeks to pool informatin from Multiple GWAS to increase the chances of finding true positives among the false positives and provides a way to combine associations across GWAS, even when the original data are unavailable. Testing for epistasis within a single GWAS study can identify the stronger results that are revealed when genes interact. Pathway analysis of GWAS results is used to prioritize genes and pathways within a biological context. Following a GWAS, association results can be assigned to pathways and tested in aggregate with Computational tools and pathway databases. Reviews of published methods with recommendations for their application are provided within the framework for each approach.	[Cantor, Rita M.; Lange, Kenneth; Sinsheimer, Janet S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lange, Kenneth; Sinsheimer, Janet S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cantor, RM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	rcantor@mednet.ucla.edu			Database and Statistics Core of National Institutes of Health (NIH) [HL28481]; NIH [MH59490, GM53275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	Database and Statistics Core of National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was provided by the Database and Statistics Core of National Institutes of Health (NIH) grant HL28481 and NIH grants MH59490 and GM53275. We thank Jeonglim Yoon for technical assistance and Karen Reue for critical reading and comments. We also appreciate critical input from three anonymous reviewers.	Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Chen L, 2009, BIOINFORMATICS, V25, P237, DOI 10.1093/bioinformatics/btn613; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; CLAERBOUT JF, 1973, GEOPHYSICS, V38, P826, DOI 10.1190/1.1440378; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Craddock N, 2009, BRIT J PSYCHIAT, V195, P97, DOI 10.1192/bjp.bp.108.063156; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dempfle A, 2004, ANN HUM GENET, V68, P69, DOI 10.1046/j.1529-8817.2003.00061.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; Dong CZ, 2008, EUR J HUM GENET, V16, P229, DOI 10.1038/sj.ejhg.5201921; Eddy DM, 1991, METAANALYSIS CONFIDE; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Falconer DS, 1996, INTRO QUANTITATIVE G; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Fisher RA., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Fu WJJ, 1998, J COMPUT GRAPH STAT, V7, P397, DOI 10.2307/1390712; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; HASTIE R, 2009, ELEMENTS STAT LEARNI, P13; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kang GL, 2008, J THEOR BIOL, V250, P362, DOI 10.1016/j.jtbi.2007.10.001; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Lange K, 2001, AM J HUM GENET, V69, P504; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewinger JP, 2007, GENET EPIDEMIOL, V31, P871, DOI 10.1002/gepi.20248; LI Z, 2007, BMC P S1, V1; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Long Q, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S75; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKinney BA, 2007, BIOINFORMATICS, V23, P2113, DOI 10.1093/bioinformatics/btm317; Mechanic LE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-146; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Newcombe PJ, 2009, AM J HUM GENET, V84, P567, DOI 10.1016/j.ajhg.2009.04.001; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nunkesser R, 2007, BIOINFORMATICS, V23, P3280, DOI 10.1093/bioinformatics/btm522; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; SANTOSA F, 1986, SIAM J SCI STAT COMP, V7, P1307, DOI 10.1137/0907087; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schwarz DF, 2008, GENET EPIDEMIOL, V32, P671; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; TAYLOR HL, 1979, GEOPHYSICS, V44, P39, DOI 10.1190/1.1440921; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wu TT, 2008, ANN APPL STAT, V2, P224, DOI 10.1214/07-AOAS147; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yesupriya A, 2008, GENET MED, V10, P633, DOI 10.1097GIM.0b013e3181815360; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	112	404	419	4	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					6	22		10.1016/j.ajhg.2009.11.017	http://dx.doi.org/10.1016/j.ajhg.2009.11.017			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20074509	Bronze, Green Published			2022-12-18	WOS:000274471200001
J	Wong, KK; deLeeuw, RJ; Dosanjh, NS; Kimm, LR; Cheng, Z; Horsman, DE; MacAulay, C; Ng, RT; Brown, CJ; Eichler, EE; Lam, WL				Wong, Kendy K.; deLeeuw, Ronald J.; Dosanjh, Nirpjit S.; Kimm, Lindsey R.; Cheng, Ze; Horsman, Douglas E.; MacAulay, Calum; Ng, Raymond T.; Brown, Carolyn J.; Eichler, Evan E.; Lam, Wan L.			A comprehensive analysis of common copy-number variations in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; LINKAGE DISEQUILIBRIUM; ANIMAL DEVELOPMENT; POLYMORPHISMS; HYBRIDIZATION; SEQUENCE; CLUSTER	Segmental copy-number variations (CNVs) in the human genome are associated with developmental disorders and susceptibility to diseases. More importantly, CNVs may represent a major genetic component of our phenotypic diversity. In this study, using a whole-genome array comparative genomic hybridization assay, we identified 3,654 autosomal segmental CNVs, 800 of which appeared at a frequency of at least 3%. Of these frequent CNVs, 77% are novel. In the 95 individuals analyzed, the two most diverse genomes differed by at least 9 Mb in size or varied by at least 266 loci in content. Approximately 68% of the 800 polymorphic regions overlap with genes, which may reflect human diversity in senses (smell, hearing, taste, and sight), rhesus phenotype, metabolism, and disease susceptibility. Intriguingly, 14 polymorphic regions harbor 21 of the known human microRNAs, raising the possibility of the contribution of microRNAs to phenotypic diversity in humans. This in-depth survey of CNVs across the human genome provides a valuable baseline for studies involving human genetics.	Univ British Columbia, Dept Canc Genet & Dev Biol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Canc Imaging, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, British Columbia Canc Res Ctr, Dept Pathol, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Comp Sci, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA USA	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Wong, KK (corresponding author), 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	kwong@bccrc.ca	Brown, Carolyn J/A-5159-2014; MacAulay, Calum/K-1795-2016	Brown, Carolyn J/0000-0002-8959-0101; MacAulay, Calum/0000-0003-4440-2792				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Chi B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-13; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Lee C, 2005, NAT GENET, V37, P660, DOI 10.1038/ng0705-660; Lerman MI, 2000, CANCER RES, V60, P6116; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Rozen S, 2000, Methods Mol Biol, V132, P365; SEABRIGH.M, 1971, LANCET, V2, P971; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070	33	404	428	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					91	104		10.1086/510560	http://dx.doi.org/10.1086/510560			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160897	Bronze, Green Published			2022-12-18	WOS:000243102500009
J	Plenge, RM; Padyukov, L; Remmers, EF; Purcell, S; Lee, AT; Karlson, EW; Wolfe, F; Kastner, DL; Alfredsson, L; Altshuler, D; Gregersen, PK; Klareskog, L; Rioux, JD				Plenge, RM; Padyukov, L; Remmers, EF; Purcell, S; Lee, AT; Karlson, EW; Wolfe, F; Kastner, DL; Alfredsson, L; Altshuler, D; Gregersen, PK; Klareskog, L; Rioux, JD			Replication of putative candidate-gene associations with rheumatoid arthritis in > 4,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; JUVENILE IDIOPATHIC ARTHRITIS; CYCLIC CITRULLINATED PEPTIDE; GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; FACTOR RECEPTOR-II; CROHNS-DISEASE; AUTOIMMUNE-DISEASES; SHARED EPITOPE; FUNCTIONAL VARIANT	Candidate-gene association studies in rheumatoid arthritis (RA) have lead to encouraging yet apparently inconsistent results. One explanation for the inconsistency is insufficient power to detect modest effects in the context of a low prior probability of a true effect. To overcome this limitation, we selected alleles with an increased probability of a disease association, on the basis of a review of the literature on RA and other autoimmune diseases, and tested them for association with RA susceptibility in a sample collection powered to detect modest genetic effects. We tested 17 alleles from 14 genes in 2,370 RA cases and 1,757 controls from the North American Rheumatoid Arthritis Consortium (NARAC) and the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) collections. We found strong evidence of an association of PTPN22 with the development of anti-citrulline antibody positive RA (odds ratio [OR] 1.49; P = .001), using previously untested EIRA samples. We provide support for an association of CTLA4 (CT60 allele, OR 1.23; P = .001) and PADI4 (PADI4_94, OR 1.24; P = .001) with the development of RA, but only in the NARAC cohort. The CTLA4 association is stronger in patients with RA from both cohorts who are seropositive for anti-citrulline antibodies (P = .006). Exploration of our data set with clinically relevant subsets of RA reveals that PTPN22 is associated with an earlier age at disease onset (P = .004) and that PTPN22 has a stronger effect in males than in females (P = .03). A meta-analysis failed to demonstrate an association of the remaining alleles with RA susceptibility, suggesting that the previously published associations may represent false-positive results. Given the strong statistical power to replicate a true-positive association in this study, our results provide support for PTPN22, CTLA4, and PADI4 as RA susceptibility genes and demonstrate novel associations with clinically relevant subsets of RA.	Univ Montreal, Broad Inst MIT & Harvard, Montreal, PQ H1T 1C8, Canada; Montreal Heart Inst, Inst Cardiol Montreal, Montreal, PQ H1T 1C8, Canada; Program Med & Populat Genet, Cambridge, MA USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, England; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Karolinska Inst, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; N Shore LIJ Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; Natl Data Bank Rheumat Dis, Wichita, KS USA	Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwell Health; National Data Bank for Rheumatic Diseases	Rioux, JD (corresponding author), Univ Montreal, Broad Inst MIT & Harvard, 5000 Belanger, Montreal, PQ H1T 1C8, Canada.	rioux@broad.mit.edu	Rioux, John D/A-9599-2015; Altshuler, David M/A-4476-2009; Alfredsson, Lars/AAC-9007-2019; Padyukov, Leonid/A-4890-2009	Rioux, John D/0000-0001-7560-8326; Altshuler, David M/0000-0002-7250-4107; Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186; Wolfe, Frederick/0000-0002-2801-6413; Remmers, Elaine F/0000-0002-9522-1249	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [K08 AI055314, K08 AI 55314] Funding Source: Medline; NIAMS NIH HHS [P60 AR047782, K24 AR0524-01, N01-AR-2-2263, P60 AR47782-05, R01-AR44222, R01 AR049880, R01 AR49880-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049880, Z01AR041139, P60AR047782, N01AR022263] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adarichev VA, 2003, ARTHRITIS RHEUM-US, V48, P1708, DOI 10.1002/art.11016; Addo A, 2005, SCAND J RHEUMATOL, V34, P198, DOI 10.1080/03009740510018561; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2004, ARTHRITIS RHEUM, V50, P748, DOI 10.1002/art.20118; Barton A, 2003, GENES IMMUN, V4, P487, DOI 10.1038/sj.gene.6364014; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Barton A, 2001, ARTHRITIS RHEUM, V44, P61, DOI 10.1002/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO;2-Q; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bombardier C, 2002, ARTHRITIS RHEUM-US, V46, pS344; Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Chae SC, 2004, BIOCHEM BIOPH RES CO, V315, P971, DOI 10.1016/j.bbrc.2004.01.154; Dahlqvist SR, 2002, ARTHRITIS RHEUM, V46, P3096, DOI 10.1002/art.10592; Daly MJ, 2004, INFLAMM BOWEL DIS, V10, P312, DOI 10.1097/00054725-200405000-00020; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Dieude P, 2002, ARTHRITIS RHEUM, V46, P2039, DOI 10.1002/art.10101; Fabris M, 2002, J RHEUMATOL, V29, P1847; Ferreiros-Vidal I, 2003, RHEUMATOLOGY, V42, P1380, DOI 10.1093/rheumatology/keg383; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabriel SE, 1999, ARTHRITIS RHEUM-US, V42, P415, DOI 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hall FC, 1996, QJM-MON J ASSOC PHYS, V89, P821, DOI 10.1093/qjmed/89.11.821; Helm-van Mil AHMV, 2004, RHEUMATOLOGY, V43, P1232, DOI 10.1093/rheumatology/keh314; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang RF, 2004, J PROPUL POWER, V20, P871, DOI 10.2514/1.9431; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6; Kuiper S, 2001, J RHEUMATOL, V28, P1809; Kyogoku C, 2003, ARTHRITIS RHEUM-US, V48, P273, DOI 10.1002/art.10600; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Lei C, 2005, EUR J HUM GENET, V13, P823, DOI 10.1038/sj.ejhg.5201423; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maksymowych WP, 2002, J RHEUMATOL, V29, P2319; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; Meng HC, 2004, ARTHRITIS RHEUM-US, V50, P2695, DOI 10.1002/art.20366; Miterski B, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-2; Newman B, 2005, ARTHRITIS RHEUM-US, V52, P425, DOI 10.1002/art.20854; Newton JL, 2004, ARTHRITIS RHEUM-US, V50, P2122, DOI 10.1002/art.20358; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Orozco G, 2004, TISSUE ANTIGENS, V64, P667, DOI 10.1111/j.1399-0039.2004.00318.x; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Park Y, 2005, NAT GENET, V37, P112, DOI 10.1038/ng0205-112a; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Prokunina L, 2004, ARTHRITIS RHEUM-US, V50, P1770, DOI 10.1002/art.20280; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Qu HQ, 2005, NAT GENET, V37, P111, DOI 10.1038/ng0205-111; Remmers EF, 2002, ARTHRITIS RHEUM, V46, P2225, DOI 10.1002/art.10439; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rodriguez MR, 2002, HUM IMMUNOL, V63, P76, DOI 10.1016/S0198-8859(01)00358-5; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; STASTNY P, 1977, TRANSPL P, V9, P1863; Steer S, 2005, ARTHRITIS RHEUM, V52, P358, DOI 10.1002/art.20737; Steer S, 2003, RHEUMATOLOGY, V42, P304, DOI 10.1093/rheumatology/keg091; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tengstrand B, 2004, J RHEUMATOL, V31, P214; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vaidya B, 2002, RHEUMATOLOGY, V41, P180, DOI 10.1093/rheumatology/41.2.180; van Jaarsveld CHM, 1999, CLIN EXP RHEUMATOL, V17, P689; VANZEBEN D, 1992, ANN RHEUM DIS, V51, P1029, DOI 10.1136/ard.51.9.1029; Viken MK, 2005, GENES IMMUN, V6, P271, DOI 10.1038/sj.gene.6364178; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weyand CM, 1998, ARTHRITIS RHEUM, V41, P817, DOI 10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wolfe F, 2003, ARTHRITIS RHEUM, V48, P1530, DOI 10.1002/art.11024; Yamada R, 2005, MUTAT RES-FUND MOL M, V573, P136, DOI 10.1016/j.mrfmmm.2004.06.061; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789; Yen JH, 2003, J RHEUMATOL, V30, P438; Zhernakova A, 2005, GENES IMMUN, V6, P459, DOI 10.1038/sj.gene.6364220	92	404	422	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1044	1060		10.1086/498651	http://dx.doi.org/10.1086/498651			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380915	Green Published, Bronze			2022-12-18	WOS:000233241200013
J	Saillard, J; Forster, P; Lynnerup, N; Bandelt, HJ; Norby, S				Saillard, J; Forster, P; Lynnerup, N; Bandelt, HJ; Norby, S			mtDNA variation among Greenland Eskimos: The edge of the Beringian expansion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEW-WORLD; POPULATION; DNA; SEQUENCES; AMERICA; EUROPE; ORIGIN; REGION	The Eskimo-Aleut language phylum is distributed from coastal Siberia across Alaska and Canada to Greenland and is well distinguished from the neighboring Na Dene languages. Genetically, however, the distinction between Na Dene and Eskimo-Aleut speakers is less clear. In order to improve the genetic characterization of Eskimos in general and Greenlanders in particular, we have sequenced hypervariable segment I (HVS-I) of the mitochondrial DNA (mtDNA) control region and typed relevant RFLP sites in the mtDNA of 82 Eskimos from Greenland. A comparison of our data with published sequences demonstrates major mtDNA types shared between Na Dene and Eskimo, indicating a common Beringian history within the Holocene. We further confirm the presence of an Eskimo-specific mtDNA subgroup characterized by nucleotide position 16265G within mtDNA group A2. This subgroup is found in all Eskimo groups analyzed so far and is estimated to have originated <3,000 years ago. A founder analysis of all Eskimo and Chukchi A2 types indicates that the Siberian and Greenland ancestral mtDNA pools separated around the time when the Neo-Eskimo culture emerged. The Greenland mtDNA types are a subset of the Alaskan mtDNA variation they lack the groups D2 and D3 found in Siberia and Alaska and are exclusively A2 but at the same time lack the A2 root type. The data are in agreement with the view that the present Greenland Eskimos essentially descend from Alaskan Neo-Eskimos. European mtDNA types are absent in our Eskimo sample.	Univ Copenhagen, Panum Inst, Antropol Lab, DK-2200 Copenhagen N, Denmark; Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; Univ Hamburg, Dept Math, Hamburg, Germany	University of Copenhagen; University of Cambridge; University of Hamburg	Norby, S (corresponding author), Univ Copenhagen, Panum Inst, Antropol Lab, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.							Ackerman R.E., 1984, HDB N AM INDIANS, V5, P106; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BERTHELSEN C, 1992, KALAALLIT NUNAAT ATL; Bjorck S, 1996, SCIENCE, V274, P1155, DOI 10.1126/science.274.5290.1155; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Fitzhugh W. W, 1984, HDB N AM INDIANS, V5, P528; Forster P, 1996, AM J HUM GENET, V59, P935; Fortescue Michael, 1998, LANGUAGE RELATIONS B; Goddard Ives, 1984, HDB N AM INDIANS, V5, P5; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Gullov H.C., 1997, ARCHAEOLOGICAL ETHNO; Harritt R. K., 1998, ETUD INUIT, V22, P61; Haskell J. Loring, 1987, SO ATHAPASKAN MIGRAT; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; HOSLEY EH, 1981, HDB N AM INDIANS, V6, P546; Jordan R.H., 1984, HDB N AM INDIANS, V5, P540; Kleivan Inge, 1984, HDB N AM INDIANS, V5, P549; KUNZ ML, 1994, SCIENCE, V263, P660, DOI 10.1126/science.263.5147.660; LYNNERUP N, 1998, GREENLAND NORSE MEDD, V24; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mathiassen Therkel, 1927, ARCHAEOLOGY CENTRAL, V4; MERRIWETHER DA, 1994, EXPERIENTIA, V50, P592, DOI 10.1007/BF01921730; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Pringle H, 1997, SCIENCE, V275, P924, DOI 10.1126/science.275.5302.924; Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1990, THESIS U CALIFORNIA; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; Wood P.J., 1984, CARBOHYD POLYM, V4, P49, DOI [10.1016/0144-8617(84)90044-4, DOI 10.1016/0144-8617(84)90044-4]; [No title captured]	39	402	410	1	16	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					718	726		10.1086/303038	http://dx.doi.org/10.1086/303038			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10924403	Green Published, Bronze			2022-12-18	WOS:000089002300017
J	TERWILLIGER, JD				TERWILLIGER, JD			A POWERFUL LIKELIHOOD METHOD FOR THE ANALYSIS OF LINKAGE DISEQUILIBRIUM BETWEEN TRAIT LOCI AND ONE OR MORE POLYMORPHIC MARKER LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE	Historically, most methods for detecting linkage disequilibrium were designed for use with diallelic marker loci, for which the analysis is straightforward. With the advent of polymorphic markers with many alleles, the normal approach to their analysis has been either to extend the methodology for two-allele systems (leading to an increase in df and to a corresponding loss of power) or to select the allele believed to be associated and then collapse the other alleles, reducing, in a biased way, the locus to a diallelic system. I propose a likelihood-based approach to testing for linkage disequilibrium, an approach that becomes more conservative as the number of alleles increases, and as the number of markers considered jointly increases in a multipoint test for linkage disequilibrium, while maintaining high power. Properties of this method for detecting associations and fine mapping the location of disease traits are investigated. It is found to be, in general, more powerful than conventional methods, and it provides a tractable framework for the fine mapping of new disease loci. Application to the cystic fibrosis data of Kerem et al. is included to illustrate the method.			TERWILLIGER, JD (corresponding author), UNIV OXFORD,WELLCOME CTR HUMAN GENET,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.				NHGRI NIH HHS [HG0008] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON TW, 1986, STATISTICHESKII ANAL; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; CHOW Y. S., 1988, PROBABILITY THEORY; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILL WG, 1994, AM J HUM GENET, V54, P705; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; NIKALI K, 1995, IN PRESS AM J HUM GE, V56; Ott J., 1991, ANAL HUMAN GENETIC L; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI	12	402	409	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					777	787						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887434				2022-12-18	WOS:A1995QK91800029
J	Mignot, E; Lin, L; Rogers, W; Honda, Y; Qiu, XH; Lin, XY; Okun, M; Hohjoh, H; Miki, T; Hsu, SH; Leffell, MS; Grumet, FC; Fernandez-Vina, M; Honda, M; Risch, N				Mignot, E; Lin, L; Rogers, W; Honda, Y; Qiu, XH; Lin, XY; Okun, M; Hohjoh, H; Miki, T; Hsu, SH; Leffell, MS; Grumet, FC; Fernandez-Vina, M; Honda, M; Risch, N			Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II; DIABETES-MELLITUS; GENE; DQB1-ASTERISK-0602; SUSCEPTIBILITY; ASSOCIATION; HAPLOTYPE; DISEASE	Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602. Few studies have investigated the influence that additional HLA class II alleles have on susceptibility to this disease. In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed. As reported elsewhere, almost all narcoleptic subjects were positive for both HLA-DQA1*0102 and -DQB1*0602. A strong predisposing effect was observed in DQB1*0602 homozygotes, across all ethnic groups. Relative risks for narcolepsy were next calculated for heterozygous DQB1*0602/other HLA class II allelic combinations. Nine HLA class II alleles carried in trans with DQB1*0602 were found to influence disease predisposition. Significantly higher relative risks were observed for heterozygote combinations including DQB1*0301, DQA1*06, DRB1*04, DRB1*08, DRB1*11, and DRB1*12. Three alleles-DQB1*0601, DQB1*0501, and DQA1*01 (non-DQA1*0102)-were found to be protective. The genetic contribution of HLA-DQ to narcolepsy susceptibility was also estimated by use of lambda statistics. Results indicate that complex HLA-DR and -DQ interactions contribute to the genetic predisposition to human narcolepsy but that additional susceptibility loci are also most likely involved. Together with the recent hypocretin discoveries, these findings are consistent with an immunologically mediated destruction of hypocretin-containing cells in human narcolepsy-cataplexy.	Stanford Univ, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Med Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Dept Pathol, Histocompatibil, Med Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Med Ctr, Dept Genet, Palo Alto, CA 94304 USA; Univ Tokyo, Seiwa Hosp, Neuropsychiat Res Inst, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Genet, Tokyo, Japan; Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; Ehime Univ, Sch Med, Dept Gerontol, Matsuyama, Ehime 790, Japan; Musser Blood Ctr, Philadelphia, PA USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; Univ Maryland, Sch Med, Natl Histocompatibil Lab, Amer Red Cross, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	Stanford University; Stanford University; Stanford University; University of Tokyo; University of Tokyo; Ehime University; Johns Hopkins University; American Red Cross; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Mignot, E (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Med Ctr, 1201 Welch Rd,P114, Palo Alto, CA 94304 USA.	mignot@leland.stanford.edu		Fernandez-Vina, Marcelo A./0000-0002-5707-2588	NIAID NIH HHS [N0 I-AI-82514] Funding Source: Medline; NINDS NIH HHS [R37 NS033797, NS33797] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI082514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033797, R01NS033797] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allcock RJN, 1999, HUM IMMUNOL, V60, P1266, DOI 10.1016/S0198-8859(99)00127-5; Carlander B., 1993, Neurophysiologie Clinique, V23, P15, DOI 10.1016/S0987-7053(05)80279-5; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Ellis MC, 1997, IMMUNOGENETICS, V46, P410, DOI 10.1007/s002510050295; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Friday RP, 1999, DIABETES NUTR METAB, V12, P3; Hohjoh H, 1999, TISSUE ANTIGENS, V54, P138, DOI 10.1034/j.1399-0039.1999.540204.x; Honda Y, 1983, SLEEP WAKE DISORDERS, P187; Honda Y., 1997, SLEEP SLEEP DISORDER, P341; KRISHNASWAMY S, 2000, MOL TYPING 2000 TECH, P1; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lin L, 1997, TISSUE ANTIGENS, V50, P507, DOI 10.1111/j.1399-0039.1997.tb02907.x; MATSUKI K, 1985, J CLIN INVEST, V76, P2078, DOI 10.1172/JCI112211; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Matsuki K, 1988, HLA NARCOLEPSY, P150, DOI DOI 10.1007/978-3-642-83387-8_13; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Mignot E, 1997, SLEEP, V20, P1012; MIGNOT E, 1994, SLEEP, V17, pS60, DOI 10.1093/sleep/17.suppl_8.S60; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 1997, TISSUE ANTIGENS, V49, P329, DOI 10.1111/j.1399-0039.1997.tb02761.x; Nakayama J, 2000, GENOMICS, V65, P84, DOI 10.1006/geno.2000.6143; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Pelin Z, 1998, TISSUE ANTIGENS, V51, P96, DOI 10.1111/j.1399-0039.1998.tb02952.x; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; RISCH N, 1987, AM J HUM GENET, V40, P1; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; THOMSON G, 1985, TISSUE ANTIGENS, V26, P201; Wen L, 2000, J EXP MED, V191, P97, DOI 10.1084/jem.191.1.97; Yasunaga S, 1996, TISSUE ANTIGENS, V47, P37, DOI 10.1111/j.1399-0039.1996.tb02512.x	30	401	423	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					686	699		10.1086/318799	http://dx.doi.org/10.1086/318799			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179016	Green Published, Bronze			2022-12-18	WOS:000166994200013
J	Rioux, JD; Silverberg, MS; Daly, MJ; Steinhart, AH; McLeod, RS; Griffiths, AM; Green, T; Brettin, TS; Stone, V; Bull, SB; Bitton, A; Williams, CN; Greenberg, GR; Cohen, Z; Lander, ES; Hudson, TJ; Siminovitch, KA				Rioux, JD; Silverberg, MS; Daly, MJ; Steinhart, AH; McLeod, RS; Griffiths, AM; Green, T; Brettin, TS; Stone, V; Bull, SB; Bitton, A; Williams, CN; Greenberg, GR; Cohen, Z; Lander, ES; Hudson, TJ; Siminovitch, KA			Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CROHNS-DISEASE; GENETIC-ANALYSIS; PROVIDES EVIDENCE; COMPLEX TRAITS; WIDE SEARCH; LINKAGE; CHROMOSOME-16; ASSOCIATION; DISSECTION; COLITIS	The chronic inflammatory bowel diseases (IBDs)-Crohn disease (CD) and ulcerative colitis (UC)-are idiopathic, inflammatory disorders of the gastrointestinal tract. These conditions have a peak incidence in early adulthood and a combined prevalence of similar to 100-200/100,000. Although the etiology of IBD is multifactorial, a significant genetic contribution to disease susceptibility is implied by epidemiological data revealing a sibling risk of similar to 35-fold for CD and similar to 15-fold for UC. To elucidate the genetic basis for these disorders, we undertook a genomewide scan in 158 Canadian sib-pair families and identified three regions of suggestive linkage (Sp, 5q31-33, and Gp) and one region of significant linkage to 19p13 (LOD score 4.6). Higher-density mapping in the 5q31-q33 region revealed a locus of genomewide significance (LOD score 3.9) that contributes to CD susceptibility in families with early-onset disease. Both of these genomic regions contain numerous genes that are important to the immune and inflammatory systems and that provide good targets for future candidate-gene studies.	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Immunol & Mol Genet, Toronto, ON, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; McGill Univ, Ctr Hlth, Montreal, PQ, Canada; Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Dept Med, Halifax, NS, Canada	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Rioux, JD (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.	rioux@genome.wi.mit.edu; ksimin@mshri.on.ca	Daly, Mark J/B-2453-2017; Greenberg, Gordon/C-4620-2015; McLeod, Robin/K-1476-2013; Siminovitch, Katherine/K-1475-2013; Bull, Shelley B/A-1920-2013; Silverberg, Mark/B-4183-2008; Rioux, John D/A-9599-2015	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326				Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; ELMGREEN J, 1984, ACTA MED SCAND, V215, P375; HALL JM, 1992, AM J HUM GENET, V50, P1235; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; HAWKEY CJ, 1992, AGENTS ACTIONS, pC22; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kmiez Zbigniew, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P143; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; McLeod RS, 1997, DIS COLON RECTUM, V40, P553, DOI 10.1007/BF02055377; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Onishi M, 1998, Int Rev Immunol, V16, P617, DOI 10.3109/08830189809043011; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Rioux JD, 1998, GASTROENTEROLOGY, V115, P1062, DOI 10.1016/S0016-5085(98)70074-5; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Spielman RS, 1996, AM J HUM GENET, V59, P983; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; SUAREZ BK, 1979, CLIN GENET, V15, P126; TAKAO T, 1997, DIGESTION, V58, P476; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517; YANG HY, 1995, GASTROENTEROLOGY, V109, P440, DOI 10.1016/0016-5085(95)90331-3	33	400	415	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1863	1870		10.1086/302913	http://dx.doi.org/10.1086/302913			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10777714	Green Published, Bronze			2022-12-18	WOS:000088373800014
J	Bork, JM; Peters, LM; Riazuddin, S; Bernstein, SL; Ahmed, ZM; Ness, SL; Polomeno, R; Ramesh, A; Schloss, M; Srisailpathy, CRS; Wayne, S; Bellman, S; Desmukh, D; Ahmed, Z; Khan, SN; Kaloustian, VMD; Li, XC; Lalwani, A; Riazuddin, S; Bitner-Glindzicz, M; Nance, WE; Liu, XZ; Wistow, G; Smith, RJH; Griffith, AJ; Wilcox, ER; Friedman, TB; Morell, RJ				Bork, JM; Peters, LM; Riazuddin, S; Bernstein, SL; Ahmed, ZM; Ness, SL; Polomeno, R; Ramesh, A; Schloss, M; Srisailpathy, CRS; Wayne, S; Bellman, S; Desmukh, D; Ahmed, Z; Khan, SN; Kaloustian, VMD; Li, XC; Lalwani, A; Riazuddin, S; Bitner-Glindzicz, M; Nance, WE; Liu, XZ; Wistow, G; Smith, RJH; Griffith, AJ; Wilcox, ER; Friedman, TB; Morell, RJ			Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; MYOSIN-VIIA GENE; HEARING IMPAIRMENT; LINKAGE ANALYSIS; MAPS; CHROMOSOME-10; LOCALIZATION; ENCODES; LOCUS; FAT	Genes causing nonsyndromic autosomal recessive deafness (DFNB12) and deafness associated with retinitis pigmentosa and vestibular dysfunction (USH1D) were previously mapped to overlapping regions of chromosome 10q21-q22. Seven highly consanguineous families segregating nonsyndromic autosomal recessive dearness were analyzed to refine the DFNB12 locus. In a single family, a critical region was defined between D10S1694 and D1OS173 7, similar to0.55 cM apart. Eighteen candidate genes in the region were sequenced. Mutations in a novel cadherin-like gene, CDH23, were found both in families with DFNB12 and in families with USH1D. Six missense mutations were found in five families with DFNB12, and two nonsense and two frameshift mutations were found in four families with USH1D. A northern blot analysis of CDH23 showed a 9.5-kb transcript expressed primarily in the retina. CDH23 is also expressed in the cochlea, as is demonstrated by polymerase chain reaction amplification from cochlear cDNA.	Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Neurootol Branch, NIH, Rockville, MD 20850 USA; Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; Univ Maryland, Sch Med, Dept Ophthalmol, Baltimore, MD 21201 USA; Mt Sinai Med Ctr, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Pediat, New York, NY 10029 USA; McGill Univ, Dept Ophthalmol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Otolaryngol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Pediat & Human Genet, Montreal, PQ H3A 2T5, Canada; Univ Iowa, Dept Otolaryngol, Iowa City, IA USA; Univ Madras, Dept Genet, Madras, Tamil Nadu, India; Great Ormond St Hosp Sick Children, Dept Audiol Med, London WC1N 3JH, England; Inst Child Hlth, Unit Clin & Mol Genet, London, England; Rotary Deaf Sch, Ichalkaranji Tilawani, Maharashtra, India; Epstein Labs, Lab Mol Otol, San Francisco, CA USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; NEI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; McGill University; McGill University; McGill University; University of Iowa; University of Madras; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Morell, RJ (corresponding author), Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, 5 Res Court, Rockville, MD 20850 USA.	morellr@helix.nih.gov	Bitner-Glindzicz, Maria/A-4231-2009; Nasim Khan, Shaheen/F-2135-2015; Morell, Robert James/Q-2042-2019; Peters, Linda/P-5370-2018	Morell, Robert/0000-0003-1537-7356; Peters, Linda/0000-0002-9961-4293	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, R01DC002842, T32DC000035, R01DC002530, R03DC004530, R01DC005575] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DC000039] Funding Source: Medline; NIDCD NIH HHS [R03 DC04530, R01 DC012115, R01-DC02530, R01-DC02842, R03 DC004530, R01 DC005575, T32 DC000035, R01 DC002842] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alagramam KN, 2000, HEARING RES, V148, P181, DOI 10.1016/S0378-5955(00)00152-0; Astuto LM, 2000, AM J HUM GENET, V67, P1569, DOI 10.1086/316889; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; CORREAROTTER R, 1992, BIOTECHNIQUES, V12, P154; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Lalwani AK, 1999, AM J HUM GENET, V64, P318, DOI 10.1086/302216; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MORELL RJ, 1999, CURRENT OPINION OTOL, V7, P259; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Wayne S, 1997, AM J HUM GENET, V61, pA300; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILLEMS PJ, 1997, NEW ENGL J MED, V342, P1101; Zbar RIS, 1998, OTOLARYNG HEAD NECK, V118, P333, DOI 10.1016/S0194-5998(98)70311-0	37	399	421	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					26	37		10.1086/316954	http://dx.doi.org/10.1086/316954			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11090341	Green Published, Bronze			2022-12-18	WOS:000166399900003
J	Tiranti, V; Hoertnagel, K; Carrozzo, R; Galimberti, C; Munaro, M; Granatiero, M; Zelante, L; Gasparini, P; Marzella, R; Rocchi, M; Bayona-Bafaluy, MP; Enriquez, JA; Uziel, G; Bertini, E; Dionisi-Vici, C; Franco, B; Meitinger, T; Zeviani, M				Tiranti, V; Hoertnagel, K; Carrozzo, R; Galimberti, C; Munaro, M; Granatiero, M; Zelante, L; Gasparini, P; Marzella, R; Rocchi, M; Bayona-Bafaluy, MP; Enriquez, JA; Uziel, G; Bertini, E; Dionisi-Vici, C; Franco, B; Meitinger, T; Zeviani, M			Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; INSITU HYBRIDIZATION; COMPLEMENTATION; ORGANIZATION; GENES; CONSERVATION; RESPIRATION; SEQUENCE; HYBRIDS; PROBES	Leigh disease associated with cytochrome c oxidase deficiency (LD[COX-]) is one of the most common disorders of the mitochondrial respiratory chain, in infancy and childhood. No mutations in any of the genes encoding the COX-protein subunits have been identified in LD(COX-) patients. Using complementation assays based on the fusion of LD(COX-) cell lines with several rodent/human rho(0) hybrids, we demonstrated that the COX phenotype was rescued by the presence of a normal human chromosome 9. Linkage analysis restricted the disease locus to the subtelomeric region of chromosome 9q, within the 7-cM interval between markers D9S1847 and D9S1826. Candidate genes within this region include SURF-1, the yeast homologue (SHY-1) of which encodes a mitochondrial protein necessary for the maintenance of COX activity and respiration. Sequence analysis of SURF-1 revealed mutations in numerous DNA samples from LD(COX-) patients, indicating that this gene is responsible for the major complementation group in this important mitochondrial disorder.	Ist Nazl Neurol Carlo Besta, Div Biochim & Genet, I-20133 Milan, Italy; Telethon Inst Genet & Med, Milan, Italy; Univ Munich, Abt Med Genet, Kinderklin, Munich, Germany; Osped Pediat Bambino Gesu, Rome, Italy; Casa Sollievo Sofferenza, S Giovanni Rotondo, Italy; Univ Bari, Bari, Italy; Univ Zaragoza, Zaragoza, Spain	IRCCS Istituto Neurologico Besta; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Munich; IRCCS Bambino Gesu; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; University of Zaragoza	Zeviani, M (corresponding author), Ist Nazl Neurol Carlo Besta, Div Biochim & Genet, Via Celoria 11, I-20133 Milan, Italy.	zeviani@tin.it	Bertini, Enrico/A-2284-2014; Gasparini, Paolo/B-6173-2014; Carrozzo, Rosalba/A-2808-2014; Tiranti, Valeria/J-8233-2016; Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014; Meitinger, Thomas/O-1318-2015; Enríquez, J.A./M-8468-2016; Tiranti, Valeria/AFN-5783-2022; Bertini, Enrico/ABG-1278-2020; Dionisi-Vici, Carlo/K-2045-2018; FRANCO, Brunella/S-2882-2018	Bertini, Enrico/0000-0001-9276-4590; Carrozzo, Rosalba/0000-0002-3327-4054; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Enríquez, J.A./0000-0002-3671-2961; Tiranti, Valeria/0000-0002-3584-7338; Dionisi-Vici, Carlo/0000-0002-0007-3379; Meitinger, Thomas/0000-0002-8838-8403; FRANCO, Brunella/0000-0001-5588-4569	Telethon [767, TGM00Z11, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BREEN GAM, 1986, J BIOL CHEM, V261, P1680; Brown RM, 1996, J INHERIT METAB DIS, V19, P752, DOI 10.1007/BF01799168; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; COLOMBO P, 1992, P NATL ACAD SCI USA, V89, P6358, DOI 10.1073/pnas.89.14.6358; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; Grossman LI, 1997, BBA-GENE STRUCT EXPR, V1352, P174, DOI 10.1016/S0167-4781(97)00025-0; Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895; KILLARY AM, 1995, METHOD ENZYMOL, V254, P133; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LENNARD A, 1994, DNA CELL BIOL, V13, P1117, DOI 10.1089/dna.1994.13.1117; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LIU P, 1993, CANCER GENET CYTOGEN, V65, P93, DOI 10.1016/0165-4608(93)90213-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OTT J, 1991, ANAL HUMAN GENETIC L, P203; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; ROBINSON BH, 1986, J CLIN INVEST, V77, P1422, DOI 10.1172/JCI112453; ROCCHI M, 1991, GENOMICS, V9, P517, DOI 10.1016/0888-7543(91)90419-F; ROCCHI M, 1986, HUM GENET, V74, P30; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017; Zeviani M, 1996, J INHERIT METAB DIS, V19, P504, DOI 10.1007/BF01799111	31	399	413	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1609	1621		10.1086/302150	http://dx.doi.org/10.1086/302150			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837813	Green Published, Bronze			2022-12-18	WOS:000077707700006
J	Bakkaloglu, B; O'Roak, BJ; Louvi, A; Gupta, AR; Abelson, JE; Morgan, TM; Chawarska, K; Klin, A; Ercan-Sencicek, AG; Stillman, AA; Tanriover, G; Abrahams, BS; Duvall, JA; Robbins, EM; Geschwind, DH; Biederer, T; Gunel, M; Lifton, RP; State, MW				Bakkaloglu, Betul; O'Roak, Brian J.; Louvi, Angeliki; Gupta, Abha R.; Abelson, Jesse E.; Morgan, Thomas M.; Chawarska, Katarzyna; Klin, Ami; Ercan-Sencicek, A. Gulhan; Stillman, Althea A.; Tanriover, Gamze; Abrahams, Brett S.; Duvall, Jackie A.; Robbins, Elissa M.; Geschwind, Daniel H.; Biederer, Thomas; Gunel, Murat; Lifton, Richard P.; State, Matthew W.			Molecular cytogenetic analysis and resequencing of Contactin Associated Protein-Like 2 in autism spectrum disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROLIGIN GENES; MUTATIONS; CNTNAP2; ASSOCIATION; NLGN4; DISRUPTION; EXPRESSION; LINKAGE; FAMILY; CASPR2	Autism spectrum disorders (ASD) are a group of related neurodevelopmental syndromes with complex genetic etiology.(1) We identified a de novo chromosome 7q inversion disrupting Autism susceptibility candidate 2 (AUTS2) and Contactin Associated Protein-Like 2 (CNTNAP2) in a child with cognitive and social delay. We focused our initial analysis on CNTNAP2 based on our demonstration of disruption of Contactin 4 (CNTN4) in a patient with ASD;(2) the recent finding of rare homozygous mutations in CNTNAP2 leading to intractable seizures and autism;3 and in situ and biochemical analyses reported herein that confirm expression in relevant brain regions and demonstrate the presence of CNTNAP2 in the synaptic plasma membrane fraction of rat forebrain lysates. We comprehensively resequenced CNTNAP2 in 635 patients and 942 controls. Among patients, we identified a total of 27 nonsynonymous changes; 13 were rare and unique to patients and 8 of these were predicted to be deleterious by bioinformatic approaches and/or altered residues conserved across all species. One variant at a highly conserved position, 1869T, was inherited by four affected children in three unrelated families, but was not found in 4010 control chromosomes (p = 0.014). Overall, this resequencing data demonstrated a modest nonsignificant increase in the burden of rare variants in cases versus controls. Nonethless, when viewed in light of two independent studies published in this issue of AJHG showing a relationship between ASD and common CNTNAP2 alleles,(4,5) the cytogenetic and mutation screening data suggest that rare variants may also contribute to the pathophysiology of ASD, but place limits on the magnitude of this contribution.	[Bakkaloglu, Betul; Louvi, Angeliki; Biederer, Thomas; Gunel, Murat; State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06520 USA; [Bakkaloglu, Betul; O'Roak, Brian J.; Abelson, Jesse E.; Ercan-Sencicek, A. Gulhan; Stillman, Althea A.; Lifton, Richard P.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Louvi, Angeliki; Tanriover, Gamze; Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Gupta, Abha R.; Abelson, Jesse E.; Chawarska, Katarzyna; Klin, Ami; Ercan-Sencicek, A. Gulhan; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Robbins, Elissa M.; Biederer, Thomas] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Bakkaloglu, Betul] Hacettepe Univ, Fac Med, Dept Child & Adolescent Psychiat, TR-06100 Ankara, Turkey; [Morgan, Thomas M.] Washington Univ, Sch Med, Dept Human Genet, St Louis, MO 63110 USA; [Abrahams, Brett S.; Duvall, Jackie A.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ctr Autism Res & Treatment, Semel Inst Neurosci, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Duvall, Jackie A.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Los Angeles, CA 90095 USA; [Duvall, Jackie A.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Duvall, Jackie A.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Genet, Los Angeles, CA 90095 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Hacettepe University; Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	State, MW (corresponding author), Yale Univ, Sch Med, Program Neurogenet, 333 Cedar St, New Haven, CT 06520 USA.	matthew.state@yale.edu	State, Matthew/W-2256-2019; Morgan, Tom/C-3478-2012; Tanriover, Gamze/A-3196-2012; Biederer, Thomas/AAZ-6133-2021; MAZLUM, BETÜL/X-5853-2018	Tanriover, Gamze/0000-0002-8002-5544; Biederer, Thomas/0000-0003-0912-1514; State, Matthew/0000-0003-1624-8302; O'Roak, Brian/0000-0002-4141-0095; Robbins, Elissa/0000-0003-1737-3228	NCRR NIH HHS [K23 RR16118-04, K23 RR016118] Funding Source: Medline; NIDA NIH HHS [R01 DA018928] Funding Source: Medline; NIMH NIH HHS [R01 MH 64547, R01 MH064547] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018928] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Belloso JM, 2007, EUR J HUM GENET, V15, P711, DOI 10.1038/sj.ejhg.5201824; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BLASI F, 2006, GENET, V141, P220; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; DRACOPOLI NC, 2005, CURRENT PROTOCOLS HU; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Gauthier J, 2005, AM J MED GENET B, V132B, P74, DOI 10.1002/ajmg.b.30066; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Talebizadeh Z, 2004, J AUTISM DEV DISORD, V34, P735, DOI 10.1007/s10803-004-5295-x; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vincent JB, 2004, AM J MED GENET B, V129B, P82, DOI 10.1002/ajmg.b.30069; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	33	398	419	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					165	173		10.1016/j.ajhg.2007.09.017	http://dx.doi.org/10.1016/j.ajhg.2007.09.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179895	Green Published, Bronze			2022-12-18	WOS:000253223800017
J	GRANDY, DK; LITT, M; ALLEN, L; BUNZOW, JR; MARCHIONNI, M; MAKAM, H; REED, L; MAGENIS, RE; CIVELLI, O				GRANDY, DK; LITT, M; ALLEN, L; BUNZOW, JR; MARCHIONNI, M; MAKAM, H; REED, L; MAGENIS, RE; CIVELLI, O			THE HUMAN DOPAMINE-D2 RECEPTOR GENE IS LOCATED ON CHROMOSOME-II AT Q22-Q23 AND IDENTIFIES A TAQL RFLP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDREN,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT CELL BIOL & ANAT,PORTLAND,OR 97201; CAMBRIDGE NEUROSCI RES INC,CAMBRIDGE,MA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University			Civelli, Olivier/A-8392-2012		NIDA NIH HHS [DA05289] Funding Source: Medline; PHS HHS [S22518, M32500] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA005289] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARNES DM, 1988, SCIENCE, V241, P415, DOI 10.1126/science.3393909; BOYD CD, 1988, AM J HUM GENET, V42, P309; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CARLSSON A, 1975, CHEMICAL TOOLS CATEC, V2, P219; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GROOVES PM, 1975, SCIENCE, V190, P522; Harnden DG, 1985, INT SYSTEM HUMAN CYT; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HESS EJ, 1987, DOPAMINE RECEPTORS R, V8, P1; JAHNWAR SC, 1983, P NATL ACAD SCI USA, V80, P4794; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LACHELIN GCL, 1977, J CLIN ENDOCR METAB, V44, P1163, DOI 10.1210/jcem-44-6-1163; LEE T, 1978, NATURE, V273, P59, DOI 10.1038/273059a0; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; PEROUTKA SJ, 1980, AM J PSYCHIAT, V137, P1518; SAWIN VL, 1978, HISTOCHEMISTRY, V59, P1, DOI 10.1007/BF00506472; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SEEMAN P, 1984, SCIENCE, V225, P728, DOI 10.1126/science.6147018; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; TOMB DA, 1988, PSYCHIATRY HOUSE OFF, P17; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; WEINER RI, 1978, PHYSIOL REV, V58, P905, DOI 10.1152/physrev.1978.58.4.905; WEINER RI, 1984, PITUITARY HYPERFUNCT, P99	27	398	409	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					778	785						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2573278				2022-12-18	WOS:A1989AZ04900014
J	Lin, PI; Vance, JM; Pericak-Vance, MA; Martin, ER				Lin, Ping-I; Vance, Jeffery M.; Pericak-Vance, Margaret A.; Martin, Eden R.			No gene is an island: The flip-flop phenomenon	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEROTONIN TRANSPORTER GENE; S-TRANSFERASE OMEGA-1; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; COMT GENE; SCHIZOPHRENIA; ASSOCIATION; POLYMORPHISM; AUTISM; METAANALYSIS	An increasing number of publications are replicating a previously reported disease-marker association but with the risk allele reversed from the previous report. Do such "flip-flop" associations confirm or refute the previous association findings? We hypothesized that these associations may indeed be confirmations but that multilocus effects and variation in interlocus correlations contribute to this flip-flop phenomenon. We used theoretical modeling to demonstrate that flip-flop associations can occur when the investigated variant is correlated, through interactive effects or linkage disequilibrium, with a causal variant at another locus, and we show how these findings could explain previous reports of flip-flop associations.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA	Duke University	Martin, ER (corresponding author), Univ Miami, Miller Sch Med, 2015-B Sewell Bldg,LC M-860, Miami, FL 33136 USA.	emartin1@med.miami.edu	Lin, Ping-I (Daniel)/O-2613-2015	Lin, Ping-I/0000-0002-9739-7184; Vance, Jeffery/0000-0003-3815-8199	NIA NIH HHS [AG021547, AG20135, R01 AG019757, R01 AG021547, R01 AG020135, AG05128, P50 AG005128, AG19757] Funding Source: Medline; NINDS NIH HHS [NS311530] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG019757, R01AG020135, R01AG021547] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Betancur C, 2002, MOL PSYCHIATR, V7, P67, DOI 10.1038/sj/mp/4000923; Chen X, 2004, MOL PSYCHIATR, V9, P962, DOI 10.1038/sj.mp.4001519; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Fan JB, 2005, BIOL PSYCHIAT, V57, P139, DOI 10.1016/j.biopsych.2004.10.018; Faraone SV, 2002, AM J MED GENET, V114, P598, DOI 10.1002/ajmg.10601; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lin PI, 2006, NEUROLOGY, V67, P64, DOI 10.1212/01.wnl.0000223438.90113.4e; Maestrini E, 1999, AM J MED GENET, V88, P492, DOI 10.1002/(SICI)1096-8628(19991015)88:5<492::AID-AJMG11>3.0.CO;2-X; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; Mullerova J, 2004, NEWS PHYSIOL SCI, V19, P105, DOI 10.1152/nips.01512.2003; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Palmatier MA, 2004, MOL PSYCHIATR, V9, P859, DOI 10.1038/sj.mp.4001496; Park TW, 2002, EUR NEUROPSYCHOPHARM, V12, P299, DOI 10.1016/S0924-977X(02)00030-5; Patsopoulos NA, 2005, PHARMACOGENET GENOM, V15, P151, DOI 10.1097/01213011-200503000-00003; Sanders AR, 2005, MOL PSYCHIATR, V10, P353, DOI 10.1038/sj.mp.4001586; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tan EK, 2003, NEUROSCI LETT, V336, P70, DOI 10.1016/S0304-3940(02)01178-3; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; Wonodi I, 2003, AM J MED GENET B, V120B, P47, DOI 10.1002/ajmg.b.20037; Yirmiya N, 2001, AM J MED GENET, V105, P381, DOI 10.1002/ajmg.1365; [No title captured]	28	397	402	0	17	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					531	538		10.1086/512133	http://dx.doi.org/10.1086/512133			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273975	Bronze, Green Published			2022-12-18	WOS:000244403300015
J	SPENCE, JE; PERCIACCANTE, RG; GREIG, GM; WILLARD, HF; LEDBETTER, DH; HEJTMANCIK, JF; POLLACK, MS; OBRIEN, WE; BEAUDET, AL				SPENCE, JE; PERCIACCANTE, RG; GREIG, GM; WILLARD, HF; LEDBETTER, DH; HEJTMANCIK, JF; POLLACK, MS; OBRIEN, WE; BEAUDET, AL			UNIPARENTAL DISOMY AS A MECHANISM FOR HUMAN GENETIC-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,HOWARD HUGHES MED INST,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030; MERCY HOSP,WATERTOWN,NY; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; University of Toronto								ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COX DM, 1976, CYTOGENET CELL GENET, V17, P18, DOI 10.1159/000130683; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; EPSTEIN CJ, 1986, CONSEQUENCES CHROMOS, P207; ESTIVILL X, 1986, HUM GENET, V74, P320; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; EVES EM, 1983, SOMAT CELL GENET, V9, P771, DOI 10.1007/BF01539479; HASSOLD T, 1982, HUM GENET, V61, P31, DOI 10.1007/BF00291327; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HEJTMANCIK JF, 1986, NEUROLOGY, V36, P1553, DOI 10.1212/WNL.36.12.1553; HUBBARD VS, 1980, AM J DIS CHILD, V134, P317, DOI 10.1001/archpedi.1980.02130150071018; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LUSHER JM, 1969, J PEDIATR, V74, P265, DOI 10.1016/S0022-3476(69)80075-2; LYON MF, 1983, RAD INDUCED CHROMOSO, P327; MANIATIS T, 1982, MOL CLONING LABORATO; MEISLER MH, 1987, CYTOGENET CELL GENET, V44, P175, DOI 10.1159/000132367; MYERS JC, 1981, P NATL ACAD SCI-BIOL, V78, P3516, DOI 10.1073/pnas.78.6.3516; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEUFELD EF, 1977, AM J HUM GENET, V29, P455; NIIKAWA N, 1984, AM J HUM GENET, V36, P123; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P1345, DOI 10.1093/nar/15.3.1345; PALMER CG, 1980, CLIN GENET, V17, P418; ROTWEIN P, 1986, AM J HUM GENET, V39, P291; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; SEARLE AG, 1985, ANEUPLOIDY ETIOLOGY, P363; SPENCE JE, 1986, AM J HUM GENET, V39, P729; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WAYE JS, 1987, MOL CELL BIOL, V7, P349, DOI 10.1128/MCB.7.1.349; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; WRAMSBY H, 1987, NEW ENGL J MED, V316, P121, DOI 10.1056/NEJM198701153160301; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; [No title captured]	40	397	405	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					217	226						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2893543				2022-12-18	WOS:A1988M313300002
J	Stephens, JC; Reich, DE; Goldstein, DB; Shin, HD; Smith, MW; Carrington, M; Winkler, C; Huttley, GA; Allikmets, R; Schriml, L; Gerrard, B; Malasky, M; Ramos, MD; Morlot, S; Tzetis, M; Oddoux, C; di Giovine, FS; Nasioulas, G; Chandler, D; Aseev, M; Hanson, M; Kalaydjieva, L; Glavac, D; Gasparini, P; Kanavakis, E; Claustres, M; Kambouris, M; Ostrer, H; Duff, G; Baranov, V; Sibul, H; Metspalu, A; Goldman, D; Martin, N; Duffy, D; Schmidtke, J; Estivill, X; O'Brien, SJ; Dean, M				Stephens, JC; Reich, DE; Goldstein, DB; Shin, HD; Smith, MW; Carrington, M; Winkler, C; Huttley, GA; Allikmets, R; Schriml, L; Gerrard, B; Malasky, M; Ramos, MD; Morlot, S; Tzetis, M; Oddoux, C; di Giovine, FS; Nasioulas, G; Chandler, D; Aseev, M; Hanson, M; Kalaydjieva, L; Glavac, D; Gasparini, P; Kanavakis, E; Claustres, M; Kambouris, M; Ostrer, H; Duff, G; Baranov, V; Sibul, H; Metspalu, A; Goldman, D; Martin, N; Duffy, D; Schmidtke, J; Estivill, X; O'Brien, SJ; Dean, M			Dating the origin of the CCR5-Delta 32 AIDS-resistance allele by the coalescence of haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS MUTATION; CHEMOKINE RECEPTOR GENE; MITOCHONDRIAL-DNA; HIV-1 INFECTION; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; MODERN HUMANS; HUMAN GENOME; POPULATIONS; MIP-1-ALPHA	The CCR5-Delta 32 deletion obliterates the CCR5 chemokine and the human immunodeficiency virus (HIV)-1 coreceptor on lymphoid cells, leading to strong resistance against HIV-1 infection and AIDS. A genotype survey of 4,166 individuals revealed a dine of CCR5-Delta 32 allele frequencies of 0%-14% across Eurasia, whereas the variant is absent among native African, American Indian, and East Asian ethnic groups. Haplotype analysis of 192 Caucasian chromosomes revealed strong linkage disequilibrium between CCR5 and two microsatellite loci. By use of coalescence theory to interpret modern haplotype genealogy, we estimate the origin of the CCR5-Delta 32-containing ancestral haplotype to be similar to 700 years ago, with an estimated range of 275-1,875 years. The geographic dine of CCR5-Delta 32 frequencies and its recent emergence are consistent with a historic strong selective event (e.g., an epidemic of a pathogen that, like HIV-1, utilizes CCR5), driving its frequency upward in ancestral Caucasian populations.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; NCI, Intramural Res Support Program, Sci Applicat Int Corp, Frederick, MD 21702 USA; Hosp Duran Reynals, IRO, Dept Mol Genet, Barcelona, Spain; Med Hsch Hannover, Inst Humangenet, Hannover, Germany; Univ Athens, St Sophias Childrens Hosp, Dept Pediat 1, GR-10679 Athens, Greece; Univ Athens, Sch Med, Dept Hyg & Epidemiol, Natl Retrovirus Reference Ctr, GR-10679 Athens, Greece; NYU, Med Ctr, Human Genet Program, Dept Pediat, New York, NY 10016 USA; Univ Sheffield, Dept Mol & Med Genet, Sheffield, S Yorkshire, England; Edith Cowan Univ, Ctr Human Genet, Perth, WA, Australia; Russian Acad Med Sci, Inst Obstet & Gynecol, St Petersburg, Russia; Univ Ljubljana, Lab Mol Pathol, Ljubljana, Slovenia; IRCCS, CSS Hosp, Natl Med Genet Serv, San Giovanni Rotondo, Italy; CNRS, UPR 9008, Biochim Genet Lab, F-9008 Montpellier, France; King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; Tartu State Univ, Estonian Bioctr, EE-202400 Tartu, Estonia; Tartu State Univ, Childrens Hosp, EE-202400 Tartu, Estonia; NIAAA, Neurogenet Lab, Rockville, MD 20852 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Royal Brisband Hosp, Queensland Inst Med Res, Herston, Qld, Australia	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Hannover Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; New York University; University of Sheffield; Edith Cowan University; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; University of Ljubljana; IRCCS Casa Sollievo Della Sofferenza; Centre National de la Recherche Scientifique (CNRS); King Faisal Specialist Hospital & Research Center; Estonian Biocentre; University of Tartu; University of Tartu; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Oxford; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@ncifcrf.gov	Baranov, Vladislav/AAB-4953-2020; Allikmets, Rando/ABD-4533-2021; Majid, Salma/AAT-2616-2020; Schriml, Lynn/AFO-9472-2022; Huttley, Gavin A/G-5169-2015; Duffy, David L/B-7392-2013; Goldstein, David/AAY-8125-2020; Dean, Michael C/G-8172-2012; Smith, Michael/B-5341-2012; Tzetis, Maria/K-5220-2012; Gasparini, Paolo/B-6173-2014; Goldman, David/F-9772-2010; Dean, Michael/R-7501-2019; Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012; OBRIEN, STEPHEN/ABD-1346-2020	Baranov, Vladislav/0000-0002-6518-1207; Majid, Salma/0000-0002-1724-5405; Huttley, Gavin A/0000-0001-7224-2074; Duffy, David L/0000-0001-7227-632X; Dean, Michael C/0000-0003-2234-0631; Tzetis, Maria/0000-0002-6810-2922; Goldman, David/0000-0002-1724-5405; Estivill, Xavier/0000-0002-0723-2256; Schriml, Lynn/0000-0001-8910-9851; Martin, Nicholas/0000-0003-4069-8020; OBRIEN, STEPHEN/0000-0001-7857-0757				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; AnsariLari MA, 1997, NAT GENET, V16, P221, DOI 10.1038/ng0797-221; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P188, DOI 10.1006/mpev.1996.0013; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fisher R., 1930, P ROY SOC EDINB, V50, P205; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Garrett L., 1994, COMING PLAGUE; GELPI AP, 1976, HUM GENET, V32, P65, DOI 10.1007/BF00569977; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Hartl D. L., 1989, PRINCIPLES POPULATIO; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1986, GENETICS, V113, P1057; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; KAPLAN NL, 1994, NAT GENET, V8, P216, DOI 10.1038/ng1194-216a; KIMURA M, 1973, GENETICS, V75, P199; Kimura M., 1971, THEORETICAL ASPECTS; LENSKI RE, 1988, NATURE, V334, P473, DOI 10.1038/334473a0; Li W.H., 1997, MOL EVOLUTION; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Macek M, 1997, HUM GENET, V99, P565, DOI 10.1007/s004390050407; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; MCEVEDY C, 1988, SCI AM, V258, P118, DOI 10.1038/scientificamerican0288-118; MCNEIL WH, 1976, PLAGUES PEOPLE; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; O'BRIEN S J, 1991, Current Biology, V1, P209, DOI 10.1016/0960-9822(91)90058-5; OBrien SJ, 1997, SCI AM, V277, P44, DOI 10.1038/scientificamerican0997-44; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; REICH D, IN PRESS MICROSATELL; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; SLATKIN M, 1991, GENETICS, V129, P555; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; TAKAHATA N, 1992, GENETICS, V130, P925; Theodorou I, 1997, LANCET, V349, P1219; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Vogel F., 1997, HUMAN GENETICS PROBL; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	64	395	417	1	63	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1507	1515		10.1086/301867	http://dx.doi.org/10.1086/301867			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585595	Green Published, hybrid			2022-12-18	WOS:000074174700029
J	Maraganore, DM; de Andrade, M; Lesnick, TG; Strain, KJ; Farrer, MJ; Rocca, WA; Pant, PVK; Frazer, KA; Cox, DR; Ballinger, DG				Maraganore, DM; de Andrade, M; Lesnick, TG; Strain, KJ; Farrer, MJ; Rocca, WA; Pant, PVK; Frazer, KA; Cox, DR; Ballinger, DG			High-resolution whole-genome association study of Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE-DISEQUILIBRIUM; ALPHA-SYNUCLEIN; SUSCEPTIBILITY GENE; NEURONAL APOPTOSIS; WIDE ASSOCIATION; ONSET; MUTATIONS; HUMAN-CHROMOSOME-21; POPULATIONS	We performed a two-tiered, whole-genome association study of Parkinson disease (PD). For tier 1, we individually genotyped 198,345 uniformly spaced and informative single-nucleotide polymorphisms ( SNPs) in 443 sibling pairs discordant for PD. For tier 2a, we individually genotyped 1,793 PD-associated SNPs ( in tier 1) and 300 P < .01 genomic control SNPs in 332 matched case - unrelated control pairs. We identified 11 SNPs that were associated with PD (P < .01) in both tier 1 and tier 2 samples and had the same direction of effect. For these SNPs, we combined P < .01 data from the case-unaffected sibling pair (tier 1) and case - unrelated control pair (tier 2) samples and employed a liberalization of the sibling transmission/disequilibrium test to calculate odds ratios, 95% confidence intervals, and P values. A SNP within the semaphorin 5A gene (SEMA5A) had the lowest combined P value (P = 7.62 x 10(-6)). The protein encoded by this gene plays an important role in neurogenesis and in neuronal apoptosis, which is consistent with existing hypotheses regarding PD pathogenesis. A second SNP tagged the PARK11 late-onset PD susceptibility locus (P = 1.70 x 10(-5)). In tier 2b, we also selected for genotyping additional SNPs that were borderline significant (P < .05) in tier 1 but that tested a priori biological and genetic hypotheses regarding susceptibility to PD (SNPs). In analysis of the combined tier 1 and tier 2b data, the two SNPs with the lowest n p 941 P values (P = 9.07 x 10(-6); P = 2.96 x 10(-5) ) tagged the PARK10 late-onset PD susceptibility locus. Independent replication across populations will clarify the role of the genomic loci tagged by these SNPs in conferring PD susceptibility.	Perlegen Sci Inc, Mountain View, CA 94040 USA; Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Ballinger, DG (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94040 USA.	dballinger@perlegen.com	Rocca, Walter/Z-5335-2019	Farrer, Matthew/0000-0003-1159-5321; Frazer, Kelly/0000-0002-6060-8902; de Andrade, Mariza/0000-0003-2329-2686	NIEHS NIH HHS [ES10751, ES10751-S1, R01 ES010751] Funding Source: Medline; NINDS NIH HHS [NS40256, P01 NS040256, R01 NS033978, NS33978, P50 NS040256] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040256, P50NS040256, R01NS033978] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Barzilai A, 2000, ADV RES NEURODEGENER, V8, P59; Benedetti MD, 2001, MOVEMENT DISORD, V16, P830, DOI 10.1002/mds.1170; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Elbaz A, 2005, MOVEMENT DISORD, V20, P719, DOI 10.1002/mds.20401; Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hirsch E, 1999, BRAIN RES, V823, P67, DOI 10.1016/S0006-8993(99)01103-8; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Mamah CE, 2005, ANN NEUROL, V57, P439, DOI 10.1002/ana.20387; Maraganore DM, 2005, NEUROLOGY, V64, P408, DOI 10.1212/01.WNL.0000152585.76852.9C; Maraganore DM, 2004, ANN NEUROL, V55, P512, DOI 10.1002/ana.20017; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Olivier M, 2001, GENOMICS, V78, P64, DOI 10.1006/geno.2001.6646; Pankratz N, 2003, AM J HUM GENET, V72, P1053, DOI 10.1086/374383; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prestel J, 2005, EUR J HUM GENET, V13, P193, DOI 10.1038/sj.ejhg.5201317; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rocca WA, 2004, ANN NEUROL, V56, P495, DOI 10.1002/ana.20228; Rocca WA, 1998, J CLIN EPIDEMIOL, V51, P517, DOI 10.1016/S0895-4356(98)00017-1; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Shirvan A, 2000, MOL BRAIN RES, V83, P81, DOI 10.1016/S0169-328X(00)00198-4; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Simmons AD, 1998, BIOCHEM BIOPH RES CO, V242, P685, DOI 10.1006/bbrc.1997.8027; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; West AB, 2002, HUM MOL GENET, V11, P2787, DOI 10.1093/hmg/11.22.2787; Wirdefeldt K, 2004, NEUROLOGY, V63, P305, DOI 10.1212/01.WNL.0000129841.30587.9D; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	52	394	407	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					685	693		10.1086/496902	http://dx.doi.org/10.1086/496902			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252231	Green Published, Bronze			2022-12-18	WOS:000232569600001
J	Novelli, G; Muchir, A; Sangiuolo, F; Helbling-Leclerc, A; D'Apice, MR; Massart, C; Capon, F; Sbraccia, P; Federici, M; Lauro, R; Tudisco, C; Pallotta, R; Scarano, G; Dallapiccola, B; Merlini, L; Bonne, G				Novelli, G; Muchir, A; Sangiuolo, F; Helbling-Leclerc, A; D'Apice, MR; Massart, C; Capon, F; Sbraccia, P; Federici, M; Lauro, R; Tudisco, C; Pallotta, R; Scarano, G; Dallapiccola, B; Merlini, L; Bonne, G			Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL PARTIAL LIPODYSTROPHY; DREIFUSS MUSCULAR-DYSTROPHY; CAUSE AUTOSOMAL-DOMINANT; MISSENSE MUTATIONS; CONDUCTION-SYSTEM; GENE; DISEASE; DOMAIN	Mandibuloacral dysplasia (MAD) is a rare autosomal recessive disorder, characterized by postnatal growth retardation, craniofacial anomalies, skeletal malformations, and mottled cutaneous pigmentation. The LMNA gene encoding two nuclear envelope proteins (lamins A and C [lamin A/C]) maps to chromosome 1q21 and has been associated with five distinct pathologies, including Dunnigan-type familial partial lipodystrophy, a condition that is characterized by subcutaneous fat loss and is invariably associated with insulin resistance and diabetes. Since patients with MAD frequently have partial lipodystrophy and insulin resistance, we hypothesized that the disease may be caused by mutations in the LMNA gene. We analyzed five consanguineous Italian families and demonstrated linkage of MAD to chromosome 1q21, by use of homozygosity mapping. We then sequenced the LMNA gene and identified a homozygous missense mutation (R527H) that was shared by all affected patients. Patient skin fibroblasts showed nuclei that presented abnormal lamin A/C distribution and a dysmorphic envelope, thus demonstrating the pathogenic effect of the R527H LMNA mutation.	Univ Roma Tor Vergata, Fac Med & Chirurg, Dept Biopathol & Diagnost Imaging, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Surg, I-00133 Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; CSS Mendel Inst, Rome, Italy; Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U523, F-75634 Paris, France; Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy; Hosp Benevento, Div Med Genet, Benevento, Italy; Rizzoli Orthopaed Inst, Neuromuscular Unit, Bologna, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; G d'Annunzio University of Chieti-Pescara; IRCCS Istituto Ortopedico Rizzoli	Novelli, G (corresponding author), Univ Roma Tor Vergata, Fac Med & Chirurg, Dept Biopathol & Diagnost Imaging, Via Montpellier 1, I-00133 Rome, Italy.	novelli@med.uniroma2.it	sangiuolo, federica/I-4392-2019; Federici, Massimo/G-9940-2012; Bonne, Gisèle/G-3121-2013; Novelli, Giuseppe/A-5195-2013; Merlini, Luciano/N-6478-2019; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Capon, Francesca/F-4763-2011; Dallapiccola, Bruno/K-8692-2016	sangiuolo, federica/0000-0002-6227-4248; Federici, Massimo/0000-0003-4989-5194; Bonne, Gisèle/0000-0002-2516-3258; Novelli, Giuseppe/0000-0002-7781-602X; Merlini, Luciano/0000-0002-1108-1198; Novelli, Giuseppe/0000-0002-7781-602X; Capon, Francesca/0000-0003-2432-5793; Muchir, Antoine/0000-0002-4780-9275; Dallapiccola, Bruno/0000-0002-5031-1013; D'Apice, Maria Rosaria/0000-0002-8467-5667; HELBLING-LECLERC, Anne/0000-0002-2686-2798				Becane HM, 2000, PACE, V23, P1661, DOI 10.1046/j.1460-9592.2000.01661.x; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; CAVALLAZZI C, 1960, RIV CLIN PEDIATR, V65, P313; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; DUNNIGAN MG, 1974, Q J MED, V43, P33; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FREIDENBERG GR, 1992, AM J DIS CHILD, V146, P93, DOI 10.1001/archpedi.1992.02160130095028; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LIN F, 1993, J BIOL CHEM, V268, P16321; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Simha V, 2002, J CLIN ENDOCR METAB, V87, P776, DOI 10.1210/jc.87.2.776; Speckman RA, 2000, AM J HUM GENET, V66, P1192, DOI 10.1086/302836; Stenoien DL, 2000, J CELL BIOCHEM, P99; TENCONI R, 1986, AM J MED GENET, V24, P357, DOI 10.1002/ajmg.1320240215; Tudisco C, 2000, AM J MED GENET, V94, P237, DOI 10.1002/1096-8628(20000918)94:3<237::AID-AJMG10>3.0.CO;2-9; van Bokhoven H, 2002, TRENDS MOL MED, V8, P133, DOI 10.1016/S1471-4914(01)02260-2; VANDERKOOI AJ, IN PRESS NEUROLOGY; Vigouroux C, 2000, DIABETES, V49, P1958, DOI 10.2337/diabetes.49.11.1958; Vigouroux C, 2001, J CELL SCI, V114, P4459; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; YOUNG L W, 1971, Birth Defects Original Article Series, V7, P291	28	394	413	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					426	431		10.1086/341908	http://dx.doi.org/10.1086/341908			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12075506	Green Published, Bronze			2022-12-18	WOS:000176977700022
J	Chong, JX; Buckingham, KJ; Jhangiani, SN; Boehm, C; Sobreira, N; Smith, JD; Harrell, TM; McMillin, MJ; Wiszniewski, W; Gambin, T; Akdemir, ZHC; Doheny, K; Scott, AF; Avramopoulos, D; Chakravarti, A; Hoover-Fong, J; Mathews, D; Witmer, PD; Ling, H; Hetrick, K; Watkins, L; Patterson, KE; Reinier, F; Blue, E; Muzny, D; Kircher, M; Bilguvar, K; Lopez-Giraez, F; Sutton, VR; Tabor, HK; Lea, SM; Gune, M; Mane, S; Gibbs, RA; Boerwinkle, E; Hamosh, A; Shendure, J; Lupski, JR; Lifton, RP; Valle, D; Nickerson, DA; Bamshad, MJ				Chong, Jessica X.; Buckingham, Kati J.; Jhangiani, Shalini N.; Boehm, Corinne; Sobreira, Nara; Smith, Joshua D.; Harrell, Tanya M.; McMillin, Margaret J.; Wiszniewski, Wojciech; Gambin, Tomasz; Akdemir, Zeynep H. Coban; Doheny, Kimberly; Scott, Alan F.; Avramopoulos, Dimitri; Chakravarti, Aravinda; Hoover-Fong, Julie; Mathews, Debra; Witmer, P. Dane; Ling, Hua; Hetrick, Kurt; Watkins, Lee; Patterson, Karynne E.; Reinier, Frederic; Blue, Elizabeth; Muzny, Donna; Kircher, Martin; Bilguvar, Kaya; Lopez-Giraldez, Francesc; Sutton, V. Reid; Tabor, Holly K.; Lea, Suzanne M.; Gune, Murat; Mane, Shrikant; Gibbs, Richard A.; Boerwinkle, Eric; Hamosh, Ada; Shendure, Jay; Lupski, James R.; Lifton, Richard P.; Valle, David; Nickerson, Deborah A.; Bamshad, Michael J.		Ctr Mendelian Genomics	The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							DE-NOVO MUTATIONS; CONGENITAL HEART-DISEASE; WEB-BASED TOOL; SACCHAROMYCES-CEREVISIAE; HUMAN GENOME; MISSING HERITABILITY; PRECISION MEDICINE; FILAMENTOUS GROWTH; COMPLEX DISEASE; RARE DISEASES	Discovering the genetic basis of a Mendelian phenotype establishes a causal link between genotype and phenotype, making possible carrier and population screening and direct diagnosis. Such discoveries also contribute to our knowledge of gene function, gene regulation, development, and biological mechanisms that can be used for developing new therapeutics. As of February 2015, 2,937 genes underlying 4,163 Mendelian phenotypes have been discovered, but the genes underlying similar to 50% (i.e., 3,152) of all known Mendelian phenotypes are still unknown, and many more Mendelian conditions have yet to be recognized. This is a formidable gap in biomedical knowledge. Accordingly, in December 2011, the NIH established the Centers for Mendelian Genomics (CMGs) to provide the collaborative framework and infrastructure necessary for undertaking large-scale whole-exome sequencing and discovery of the genetic variants responsible for Mendelian phenotypes. In partnership with 529 investigators from 261 institutions in 36 countries, the CMGs assessed 18,863 samples from 8,838 families representing 579 known and 470 novel Mendelian phenotypes as of January 2015. This collaborative effort has identified 956 genes, including 375 not previously associated with human health, that underlie a Mendelian phenotype. These results provide insight into study design and analytical strategies, identify novel mechanisms of disease, and reveal the extensive clinical variability of Mendelian phenotypes. Discovering the gene underlying every Mendelian phenotype will require tackling challenges such as worldwide ascertainment and phenotypic characterization of families affected by Mendelian conditions, improvement in sequencing and analytical techniques, and pervasive sharing of phenotypic and genomic data among researchers, clinicians, and families.	[Chong, Jessica X.; Buckingham, Kati J.; Harrell, Tanya M.; McMillin, Margaret J.; Tabor, Holly K.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jhangiani, Shalini N.; Muzny, Donna; Gibbs, Richard A.; Boerwinkle, Eric; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Boehm, Corinne; Sobreira, Nara; Doheny, Kimberly; Scott, Alan F.; Hamosh, Ada; Valle, David] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Boehm, Corinne; Sobreira, Nara; Hoover-Fong, Julie; Hetrick, Kurt; Hamosh, Ada; Valle, David] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Smith, Joshua D.; Patterson, Karynne E.; Reinier, Frederic; Kircher, Martin; Tabor, Holly K.; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wiszniewski, Wojciech; Gambin, Tomasz; Akdemir, Zeynep H. Coban; Sutton, V. Reid; Lea, Suzanne M.; Gibbs, Richard A.; Shendure, Jay; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Doheny, Kimberly; Witmer, P. Dane; Ling, Hua; Hetrick, Kurt; Watkins, Lee] Johns Hopkins Univ, Sch Med, Ctr Inherited Dis Res, Baltimore, MD 21205 USA; [Mathews, Debra] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Blue, Elizabeth] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Bilguvar, Kaya; Lopez-Giraldez, Francesc; Gune, Murat; Gibbs, Richard A.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Lopez-Giraldez, Francesc; Gibbs, Richard A.; Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Tabor, Holly K.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Lea, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lifton, Richard P.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bamshad, Michael J.] Seattle Childrens Hosp, Div Genet Med, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; Yale University; Yale University; Seattle Children's Hospital; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Howard Hughes Medical Institute; Seattle Children's Hospital	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@uw.edu	Wang, Guilin/G-8794-2018; Chong, Jessica/GZH-1625-2022; Kircher, Martin/HDL-9392-2022; Kircher, Martin/H-6909-2019; Shendure, Jay/AAU-3684-2021; López-Giráldez, Francesc/A-5251-2011; Gambin, Tomasz/HDN-5840-2022	Kircher, Martin/0000-0001-9278-5471; López-Giráldez, Francesc/0000-0001-7476-9822; Gambin, Tomasz/0000-0002-0941-4571; Blue, Elizabeth/0000-0002-0633-0305; Chong, Jessica/0000-0002-1616-2448; Mathews, Debra/0000-0002-4897-7617; Hoover-Fong, Julie/0000-0002-1242-5626	National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI) [HG006504, HG006542, HG006493]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, UM1HG006504, U54HG006542, UM1HG006493, U54HG006504, U54HG006493] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all the families, clinicians, and investigators for their participation and support and the staff of Gene Reviews and OMIM for assistance and access to data. We thank Colleen Davis, Seema Jamal, Kathryn Shively, and Colby Marvin for helpful discussion and technical assistance. This work was supported in part by National Human Genome Research Institute (NHGRI) and National Heart, Lung, and Blood Institute (NHLBI) grants HG006504 (to the Yale Center for Mendelian Disorders), HG006542 (to the Baylor-Hopkins Center for Mendelian Genomics), and HG006493 (to the University of Washington Center for Mendelian Genomics). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI and NHLBI of the NIH. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen Inc., is a member of the Scientific Advisory Board of Baylor Miraca Genetics Laboratories, and is a co-inventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine (D.M. and J.R.L.) derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered in the Baylor Miraca Genetics Laboratory (http://www.bmgl.com/BMGL/Default.aspx).	Al-Sayed MD, 2013, AM J HUM GENET, V93, P721, DOI 10.1016/j.ajhg.2013.08.001; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Angelis A, 2015, HEALTH POLICY, V119, P964, DOI 10.1016/j.healthpol.2014.12.016; [Anonymous], 2013, NAT GENET, V45, P1411, DOI 10.1038/ng.2845; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Baynam G, 2015, J PAEDIATR CHILD H, V51, P381, DOI 10.1111/jpc.12705; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Bjornsson HT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009278; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Blakemore AIF, 2010, ANN NY ACAD SCI, V1214, P180, DOI 10.1111/j.1749-6632.2010.05880.x; Brunham LR, 2013, HUM GENET, V132, P603, DOI 10.1007/s00439-013-1286-3; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Christianson A., 2006, GLOBAL REPORT BIRTH; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Eurordis   Rare Diseases Europe, 2007, SURV DEL DIAGN 8 RAR; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Food and Drug Administration, 2004, CHALL OPP REP; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Garcia ML, 2014, CURR OPIN PHARMACOL, V15, P1, DOI 10.1016/j.coph.2013.11.005; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Glessner JT, 2014, CIRC RES, V115, P884, DOI 10.1161/CIRCRESAHA.115.304458; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Harper AR, 2012, NAT BIOTECHNOL, V30, P1117, DOI 10.1038/nbt.2424; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; Hennekam RCM, 2011, SEMIN FETAL NEONAT M, V16, P109, DOI 10.1016/j.siny.2010.12.002; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Hilpert H, 2013, J MED CHEM, V56, P3980, DOI 10.1021/jm400225m; Kaiser J, 2010, SCIENCE, V330, P903, DOI 10.1126/science.330.6006.903; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Li XS, 2014, GENETICS, V197, P611, DOI 10.1534/genetics.114.161307; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu HP, 1996, GENETICS, V144, P967; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Makrythanasis P, 2013, CLIN GENET, V84, P422, DOI 10.1111/cge.12272; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McDermott DH, 2015, CELL, V160, P686, DOI 10.1016/j.cell.2015.01.014; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rehman AU, 2015, EUR J HUM GENET, V23, P1207, DOI 10.1038/ejhg.2014.266; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Rosenblatt DS, 2011, J MED GENET, V48, P577, DOI 10.1136/jmedgenet-2011-100227; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Smith JD, 2014, AM J HUM GENET, V95, P235, DOI 10.1016/j.ajhg.2014.07.008; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yu L, 2014, J MED GENET, V51, P197, DOI 10.1136/jmedgenet-2013-101989; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	105	393	400	6	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					199	215		10.1016/j.ajhg.2015.06.009	http://dx.doi.org/10.1016/j.ajhg.2015.06.009			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26166479	Bronze, Green Published			2022-12-18	WOS:000359328800001
J	Torroni, A; Petrozzi, M; DUrbano, L; Sellitto, D; Zeviani, M; Carrara, F; Carducci, C; Leuzzi, V; Carelli, V; Barboni, P; DeNegri, A; Scozzari, R				Torroni, A; Petrozzi, M; DUrbano, L; Sellitto, D; Zeviani, M; Carrara, F; Carducci, C; Leuzzi, V; Carelli, V; Barboni, P; DeNegri, A; Scozzari, R			Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATIONS; 9-BP DELETION; COMPLEX-I; AFFINITIES; SEQUENCE; GENE; NEURORETINOPATHY; IDENTIFICATION; POPULATIONS; HAPLOGROUPS	mtDNAs from 37 Italian subjects affected by Leber hereditary optic neuropathy (LHON) (28 were 11778 positive, 7 were 3460 positive, and 2 were 14484 positive) and from 99 Italian controls were screened for most of the mutations that currently are associated with LHON. High-resolution restriction-endonuclease analysis also was performed on all subjects, in order to define the phylogenetic relationships between the mtDNA haplotypes and the LHON mutations observed in patients and in controls. This analysis shows that the putative secondary/intermediate LHON mutations 4216, 4917, 13708, 15257, and 15812 are ancient polymorphisms, are associated in specific combinations, and define two common Caucasoid-specific haplotype groupings (haplogroups J and T). On the contrary, the same analysis shows that the primary mutations 11778, 3460, and 14484 are recent and are due to multiple mutational events. However, phylogenetic analysis also reveals a different evolutionary pattern for the three primary mutations. The 3460 mutations are distributed randomly along the phylogenetic trees, without any preferential association with the nine haplogroups (H, I, J, K, T, U, V, W, and X) that characterize European populations, whereas the 11778 and 14484 mutations show a strong preferential association with haplogroup J. This finding suggests that one ancient combination of haplogroup J-specific mutations increases both the penetrance of the two primary mutations 11778 and 14484 and the risk of disease expression.	UNIV ROMA LA SAPIENZA, CTR GENET EVOLUZIONIST, I-00185 ROME, ITALY; UNIV ROMA LA SAPIENZA, DIPARTIMENTO MED SPERIMENTALE, I-00185 ROME, ITALY; UNIV ROMA LA SAPIENZA, DIPARTIMENTO SCI NEUROL & PSCHIATR EVOLUT, I-00185 ROME, ITALY; UNIV ROMA LA SAPIENZA, IST OCULIST, I-00185 ROME, ITALY; OSPED PEDIAT BAMBINO GESU, ROME, ITALY; IST NEUROCHIRURG C BESTA, MILAN, ITALY; UNIV BOLOGNA, IST CLIN NEUROL, BOLOGNA, ITALY; UNIV BOLOGNA, DIPARTIMENTO OCULIST, BOLOGNA, ITALY	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna	Torroni, A (corresponding author), UNIV ROMA LA SAPIENZA, DIPARTIMENTO GENET & BIOL MOL, PLE ALDO MORO 5, I-00185 ROME, ITALY.		Barboni, Piero/AAA-9936-2020; Torroni, Antonio/E-1557-2011; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021	Barboni, Piero/0000-0002-0118-4177; Torroni, Antonio/0000-0002-4163-4478; Zeviani, Massimo/0000-0002-9067-5508; Leuzzi, Vincenzo/0000-0002-2314-6139; CARELLI, VALERIO/0000-0003-4923-6404	Telethon [E.0069] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1994, CLIN NEUROSCI, V2, P138; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; CHEN YS, 1995, AM J HUM GENET, V57, P133; Ghosh SS, 1996, AM J HUM GENET, V58, P325; HORAI S, 1990, AM J HUM GENET, V46, P828; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1993, GENETICS, V133, P133; HOWELL N, 1993, AM J HUM GENET, V53, P959; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; ISHIKAWA S, 1995, MUSCLE NERVE, pS85; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; JOHNS DR, 1993, OPHTHALMOLOGY, V100, P981; LAMMINEN T, 1995, AM J HUM GENET, V56, P1238; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Mackey DA, 1996, AM J HUM GENET, V59, P481; MACKEY DA, 1994, CLIN NEUROSCI, V2, P162; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; NEI M, 1983, GENETICS, V105, P207; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8; OOSTRA RJ, 1994, HUM GENET, V94, P265, DOI 10.1007/BF00208281; PASSARINO G, 1993, AM J HUM GENET, V53, P609; Richards M, 1996, AM J HUM GENET, V59, P185; RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81; SAVONTAUS ML, 1995, BBA-MOL BASIS DIS, V1271, P261, DOI 10.1016/0925-4439(95)00037-5; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Swofford D, 1993, PHYLOGENETIC ANAL US; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1995, AM J HUM GENET, V57, P507; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 1996, AM J HUM GENET, V59, P248; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1995, HUMAN GENE MAPPING 1, P910	50	391	412	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1107	1121						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150158				2022-12-18	WOS:A1997WX76000011
J	Qin, ZHS; Niu, TH; Liu, JS				Qin, ZHS; Niu, TH; Liu, JS			Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE DISEQUILIBRIUM; DIVERSITY; REGION; GENE		Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Liu, JS (corresponding author), Harvard Univ, Dept Stat, 1 Oxford St, Cambridge, MA 02138 USA.		Qin, Zhaohui/Q-3133-2019; Qin, Zhaohui S/E-8196-2011	Qin, Zhaohui/0000-0002-1583-146X; Qin, Zhaohui S/0000-0002-1583-146X	NHGRI NIH HHS [R01 HG002518, R01 HG02518-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; NEALE MC, 1999, MX STAT MODELING; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	16	390	426	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1242	1247		10.1086/344207	http://dx.doi.org/10.1086/344207			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12452179	Green Published, Bronze			2022-12-18	WOS:000178884300030
J	Hanson, RL; Ehm, MG; Pettitt, DJ; Prochazka, M; Thompson, DB; Timberlake, D; Foroud, T; Kobes, S; Baler, L; Burns, DK; Almasy, L; Blangero, J; Garvey, WT; Bennett, PH; Knowler, WC				Hanson, RL; Ehm, MG; Pettitt, DJ; Prochazka, M; Thompson, DB; Timberlake, D; Foroud, T; Kobes, S; Baler, L; Burns, DK; Almasy, L; Blangero, J; Garvey, WT; Bennett, PH; Knowler, WC			An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; QUANTITATIVE TRAIT LOCI; SIB-PAIR ANALYSIS; COMPONENTS MODELS; PEDIGREE ANALYSIS; WIDE SEARCH; SUSCEPTIBILITY; OBESITY; NIDDM; EXTENSIONS	Genetic factors influence the development of type II diabetes mellitus, but genetic loci for the most common forms of diabetes have not been identified. A genomic scan was conducted to identify loci linked to diabetes and body-mass index (BMI) in Pima Indians, a Native American population with a high prevalence of type II diabetes. Among 264 nuclear families containing 966 siblings, 516 autosomal markers with a median distance between adjacent markers of 6.4 cM were genotyped. Variance-components methods were used to test for linkage with an age-adjusted diabetes score and with BMI. In multipoint analyses, the strongest evidence for linkage with age-adjusted diabetes (LOD = 1.7) was on chromosome 11q, in the region that was also linked most strongly with BMI (LOD = 3.6). Bivariate linkage analyses strongly rejected both the null hypothesis of no linkage with either trait and the null hypothesis of no contribution of the locus to the covariation among the two traits. Sib-pair analyses suggest additional potential diabetes-susceptibility loci on chromosomes Iq and 7q.	NIDDKD, Diabet & Arthritis Epidemiol Sect, NIH, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ 85014 USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Sequana Therapeut Inc, Dept Stat Genet, La Jolla, CA USA; Indiana Univ, Sch Med, Dept Med Genet, Indianapolis, IN USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); GlaxoSmithKline; Indiana University System; Indiana University-Purdue University Indianapolis; Texas Biomedical Research Institute; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hanson, RL (corresponding author), NIDDKD, Diabet & Arthritis Epidemiol Sect, NIH, Phoenix Epidemiol & Clin Res Branch, 1550 E Indian Sch Rd, Phoenix, AZ 85014 USA.		Blangero, John/ABA-7175-2021; Baier, Leslie/F-9008-2013; Hanson, Robert L/O-3238-2015; Bennett, Peter/AAH-9605-2021; Almasy, Laura/V-3156-2019	Hanson, Robert L/0000-0002-4252-7068; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018897] Funding Source: NIH RePORTER; NCRR NIH HHS [1P41 RR03655] Funding Source: Medline; NIDDK NIH HHS [DK-47461] Funding Source: Medline; NIGMS NIH HHS [GM-18897] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; BENNETT PH, 1971, LANCET, V2, P125; BOGARDUS C, 1992, J CELL BIOCHEM, V48, P337, DOI 10.1002/jcb.240480402; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; Elbein SC, 1998, DIABETES, V47, pA15; Elston R C, 1984, Genet Epidemiol, V1, P175, DOI 10.1002/gepi.1370010210; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FULKER DW, 1995, AM J HUM GENET, V56, P1224; FULKER DW, 1994, AM J HUM GENET, V54, P1092; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; Haldane JBS, 1919, J GENET, V8, P299; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HANSON RL, 1995, DIABETES, V44, P418, DOI 10.2337/diabetes.44.4.418; HANSON RL, 1995, AM J HUM GENET, V57, P160; Hanson RL, 1998, GENET EPIDEMIOL, V15, P299, DOI 10.1002/(SICI)1098-2272(1998)15:3<299::AID-GEPI7>3.0.CO;2-#; Hanson RL, 1997, AM J HUM GENET, V61, pA278; Hanson RL, 1997, DIABETES S1, V46, pA51; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079; KNOWLER WC, 1991, AM J CLIN NUTR, V53, pS1543, DOI 10.1093/ajcn/53.6.1543S; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LANGE K, 1976, ANN HUM GENET, V46, P373; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Norman RA, 1997, AM J HUM GENET, V60, P166; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; PRICE RA, 1994, HUM BIOL, V66, P251; Pugh EW, 1997, GENET EPIDEMIOL, V14, P867, DOI 10.1002/(SICI)1098-2272(1997)14:6<867::AID-GEPI51>3.0.CO;2-K; *SAGE, 1994, STAT AN GEN EP REL 2; SCHWENGEL DA, 1994, GENOMICS, V22, P46, DOI 10.1006/geno.1994.1344; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; TUOMILEHTOWOLF E, 1993, BRIT MED J, V307, P155, DOI 10.1136/bmj.307.6897.155; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; WHO Study Group on Diabetes Mellitus & World Health Organization, 1985, WHO TECH REP SER, V727; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644; Yamada T, 1996, POLYM REACT ENG, V4, P1; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	55	390	408	0	12	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1130	1138		10.1086/302061	http://dx.doi.org/10.1086/302061			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758619	Green Published, Bronze			2022-12-18	WOS:000076577800027
J	HAMMOND, HA; JIN, L; ZHONG, Y; CASKEY, CT; CHAKRABORTY, R				HAMMOND, HA; JIN, L; ZHONG, Y; CASKEY, CT; CHAKRABORTY, R			EVALUATION OF 13 SHORT TANDEM REPEAT LOCI FOR USE IN PERSONAL IDENTIFICATION APPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN DNA; LENGTH POLYMORPHISM; HYPERVARIABLE LOCI; HPRT LOCUS; GENE; ALLELES; SEQUENCES; AMPLIFICATION; MARKERS; POPULATIONS	Personal identification by using DNA typing methodologies has been an issue in the popular and scientific press for several years. We present a PCR-based DNA-typing method using 13 unlinked short tandem repeat (STR) loci. Validation of the loci and methodology has been performed to meet standards set by the forensic community and the accrediting organization for parentage testing. Extensive statistical analysis has addressed the issues surrounding the presentation of ''match'' statistics. We have found STR loci to provide a rapid, sensitive, and reliable method of DNA typing for parentage testing, forensic identification, and medical diagnostics. Valid statistical analysis is generally simpler than similar analysis of RFLP-VNTR results and provides powerful statistical evidence of the low frequency of random multilocus genotype matching.	BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA; UNIV TEXAS, GRAD SCH BIOMED SCI, CTR DEMOG & POPULAT GENET, HOUSTON, TX USA	Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System	HAMMOND, HA (corresponding author), BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, 1 BAYLOR PLAZA, ROOM T809, HOUSTON, TX 77030 USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; 				AHN YI, 1992, HUM GENET, V90, P184; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BOYLAN KB, 1990, GENOMICS, V6, P16, DOI 10.1016/0888-7543(90)90443-X; BROWN AHD, 1980, GENETICS, V96, P523; CALLEN DF, 1993, AM J HUM GENET, V52, P922; CASKEY CT, 1992, ADV FORENSIC HAEMOGE, P18; CHAKRABORTY R, 1991, SCIENCE, V254, P1735, DOI 10.1126/science.1763323; CHAKRABORTY R, 1984, GENETICS, V108, P719; CHAKRABORTY R, 1993, GENETICS, V134, P953; CHAKRABORTY R, 1989, P NATL ACAD SCI USA, V86, P9407, DOI 10.1073/pnas.86.23.9407; CHAKRABORTY R, 1991, EXPER SUPPL, V58, P127; CHAKRABORTY R, 1994, IN PRESS AM J HUM GE, V55; Chakraborty Ranajit, 1993, P179; CHAKRAVARTI A, 1983, INCLUSION PROBABILIT, P411; DEKA R, 1991, GENOMICS, V11, P83, DOI 10.1016/0888-7543(91)90104-M; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; EDWARDS MC, 1991, NUCLEIC ACIDS RES, V19, P4791, DOI 10.1093/nar/19.17.4791-a; GART JJ, 1984, BIOMETRICS, V40, P887, DOI 10.2307/2531140; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HEARNE CM, 1991, NUCLEIC ACIDS RES, V19, P5450; HUANG THM, 1991, AM J HUM GENET, V49, P1312; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KOOREY DJ, 1993, HUM MOL GENET, V2, P289, DOI 10.1093/hmg/2.3.289; LITT M, 1989, AM J HUM GENET, V44, P397; MILKMAN R, 1970, BIOL BULL, V139, P430; MORTON NE, 1993, P NATL ACAD SCI USA, V90, P1892, DOI 10.1073/pnas.90.5.1892; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PANZER SW, 1993, HUM MOL GENET, V2, P1511; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P195, DOI 10.1093/nar/19.1.195; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P3753, DOI 10.1093/nar/19.13.3753; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V18, P7198; PUERS C, 1993, AM J HUM GENET, V53, P953; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844; ROEWER L, 1992, FORENSIC SCI INT, V53, P163, DOI 10.1016/0379-0738(92)90193-Z; Sensabaugh G.F., 1982, FORENSIC SCI HDB, P338; SHRIVER MD, 1993, GENETICS, V134, P983; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; Sokal Robert R., 1969, BIOMETRY; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; Weir B.S., 1991, GENETIC DATA ANAL; YASUDA N, 1968, BIOMETRICS, V24, P915, DOI 10.2307/2528880; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4958, DOI 10.1093/nar/18.16.4958-a; 1991, CRIME LAB DIG, V18, P44; 1990, STANDARDS PARENTAGE	54	389	446	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					175	189						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912887				2022-12-18	WOS:A1994NW46100024
J	Tang, H; Quertermous, T; Rodriguez, B; Kardia, SLR; Zhu, XF; Brown, A; Pankow, JS; Province, MA; Hunt, SC; Boerwinkle, E; Schork, NJ; Risch, NJ				Tang, H; Quertermous, T; Rodriguez, B; Kardia, SLR; Zhu, XF; Brown, A; Pankow, JS; Province, MA; Hunt, SC; Boerwinkle, E; Schork, NJ; Risch, NJ			Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION STRATIFICATION; POLYMORPHISMS; INFERENCE; RACE	We have analyzed genetic data for 326 microsatellite markers that were typed uniformly in a large multiethnic population-based sample of individuals as part of a study of the genetics of hypertension (Family Blood Pressure Program). Subjects identified themselves as belonging to one of four major racial/ethnic groups (white, African American, East Asian, and Hispanic) and were recruited from 15 different geographic locales within the United States and Taiwan. Genetic cluster analysis of the microsatellite markers produced four major clusters, which showed near-perfect correspondence with the four self-reported race/ethnicity categories. Of 3,636 subjects of varying race/ ethnicity, only 5 (0.14%) showed genetic cluster membership different from their self-identified race/ ethnicity. On the other hand, we detected only modest genetic differentiation between different current geographic locales within each race/ ethnicity group. Thus, ancient geographic ancestry, which is highly correlated with self-identified race/ethnicity-as opposed to current residence-is the major determinant of genetic structure in the U.S. population. Implications of this genetic structure for case-control association studies are discussed.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; Univ Hawaii Manoa, Dept Publ Hlth Sci & Epidemiol, Honolulu, HI 96822 USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Univ Calif San Diego, Dept Psychiat, Polymorphism Res Lab, San Diego, CA 92103 USA; Kaiser Permanente, Div Res, Oakland, CA USA	Stanford University; Fred Hutchinson Cancer Center; Stanford University; University of Hawaii System; University of Hawaii Manoa; University of Michigan System; University of Michigan; Loyola University Chicago; University of Mississippi; University of Mississippi Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego; Kaiser Permanente	Risch, NJ (corresponding author), Stanford Univ, Sch Med, Dept Genet, M322, Stanford, CA 94305 USA.	risch@lahmed.stanford.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X; Quertermous, Thomas/0000-0002-7645-9067; Pankow, James/0000-0001-7076-483X; Schork, Nicholas/0000-0003-0920-5013				Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Boerwinkle E, 2002, HYPERTENSION, V39, P3; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Haga SB, 2003, SCIENCE, V301, P466, DOI 10.1126/science.1087004; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Mardia K.V, 1980, MULTIVARIATE ANAL; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, GENETICS, V155, P945; REYNOLDS J, 1983, GENETICS, V105, P767; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	22	388	409	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					268	275		10.1086/427888	http://dx.doi.org/10.1086/427888			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15625622	Green Published, Bronze			2022-12-18	WOS:000226215100012
J	Hoggart, CJ; Parra, EJ; Shriver, MD; Bonilla, C; Kittles, RA; Clayton, DG; McKeigue, PM				Hoggart, CJ; Parra, EJ; Shriver, MD; Bonilla, C; Kittles, RA; Clayton, DG; McKeigue, PM			Control of confounding of genetic associations in stratified populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXED POPULATIONS; TRANSMISSION/DISEQUILIBRIUM TEST; HAPLOTYPE FREQUENCIES; ETHNIC-DIFFERENCES; AFRICAN-AMERICANS; MAPPING GENES; DISEASE RISK; ADMIXTURE; LINKAGE; DISEQUILIBRIUM	To control for hidden population stratification in genetic-association studies, statistical methods that use marker genotype data to infer population structure have been proposed as a possible alternative to family-based designs. In principle, it is possible to infer population structure from associations between marker loci and from associations of markers with the trait, even when no information about the demographic background of the population is available. In a model in which the total population is formed by admixture between two or more subpopulations, confounding can be estimated and controlled. Current implementations of this approach have limitations, the most serious of which is that they do not allow for uncertainty in estimations of individual admixture proportions or for lack of identifiability of subpopulations in the model. We describe methods that overcome these limitations by a combination of Bayesian and classical approaches, and we demonstrate the methods by using data from three admixed populations-African American, African Caribbean, and Hispanic American-in which there is extreme confounding of trait-genotype associations because the trait under study (skin pigmentation) varies with admixture proportions. In these data sets, as many as one-third of marker loci show crude associations with the trait. Control for confounding by population stratification eliminates these associations, except at loci that are linked to candidate genes for the trait. With only 32 markers informative for ancestry, the efficiency of the analysis is similar to70%. These methods can deal with both confounding and selection bias in genetic-association studies, making family-based designs unnecessary.	Univ London London Sch Hyg & Trop Med, Epidemiol Unit, London WC1E 7HT, England; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Fdn,Wellcome Trust, Diabet & Inflammat Lab, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard University; University of Cambridge; Wellcome Trust Sanger Institute	Hoggart, CJ (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol Unit, Keppel St, London WC1E 7HT, England.		Bonilla, Carolina/U-9263-2018; Parra, Esteban J/A-4957-2008	Bonilla, Carolina/0000-0002-9972-6383; parra, esteban J/0000-0002-2057-8577; Shriver, Mark/0000-0003-0006-0479	NHGRI NIH HHS [R01 HG002154, HG-02154] Funding Source: Medline; NIDDK NIH HHS [DK53958, R01 DK053958] Funding Source: Medline; NIMH NIH HHS [MH60343] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060343] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; Allison DB, 1997, AM J HUM GENET, V60, P676; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAKRABORTY R, 1975, AM J PHYS ANTHROPOL, V42, P507, DOI 10.1002/ajpa.1330420319; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELSTON RC, 1971, ANN HUM GENET, V35, P9, DOI 10.1111/j.1469-1809.1956.tb01373.x; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Gelman A, 2013, BAYESIAN DATA ANAL; Greenland S, 1998, MODERN EPIDEMIOLOGY; Kirk KM, 2002, EUR J HUM GENET, V10, P616, DOI 10.1038/sj.ejhg.5200855; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Little RJ, 1987, STAT ANAL MISSING DA; McKeigue PM, 2000, AM J HUM GENET, V67, P1626, DOI 10.1086/316912; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schaid DJ, 2002, GENET EPIDEMIOL, V23, P426, DOI 10.1002/gepi.10184; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; THOMSON G, 1995, AM J HUM GENET, V57, P487; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xu CF, 2002, HUM GENET, V110, P148, DOI 10.1007/s00439-001-0656-4; 1999, NAT GENET, V22, P1	40	386	398	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1492	1504		10.1086/375613	http://dx.doi.org/10.1086/375613			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12817591	Green Published, Bronze			2022-12-18	WOS:000183275500012
J	Kelley, PM; Harris, DJ; Comer, BC; Askew, JW; Fowler, T; Smith, SD; Kimberling, WJ				Kelley, PM; Harris, DJ; Comer, BC; Askew, JW; Fowler, T; Smith, SD; Kimberling, WJ			Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAP-JUNCTIONS; PROTEINS; COMMUNICATION; CHANNEL	Mutations in the connexin 26 (Cx26) gene (GJB2) are associated with the type of autosomal recessive nonsyndromic neurosensory deafness known as "DFNB1." Studies indicate that DFNB1 (13q11-12) causes 20% of all childhood deafness and may have a carrier rate as high as 2.8%. This study describes the analysis of 58 multiplex families each having at least two affected children diagnosed with autosomal recessive nonsyndromic deafness. Twenty of the 58 families were observed to have mutations in both alleles of Cx26. Thirty-three of 116 chromosomes contained a 30delG allele, for a frequency of .284. This mutation was observed in 2 of 192 control chromosomes, for an estimated gene frequency of .01 +/- .007. The homozygous frequency of the 30delG allele is then estimated at .0001, or 1/10,000. Given that the frequency of all childhood hearing impairment is 1/1,000 and that half of that is genetic, the specific mutation 30delG is responsible for 10% of all childhood hearing loss and for 20% of all childhood hereditary hearing loss. Six novel mutations were also observed in the affected population. The deletions detected cause frameshifts that would severely disrupt the protein structure. Three novel missense mutations, Val84Met, Val95Met, and Ser113Pro, were observed. The missense mutation 101T-->C has been reported to be a dominant allele of DFNA3, a dominant nonsyndromic hearing loss. Data further supporting the finding that this mutation does not cause dominant hearing loss are presented. This allele was found in a recessive family segregating independently from the hearing-loss phenotype and in 3 of 192 control chromosomes. These results indicate that 101T-->C is not sufficient to cause hearing loss.	Boys Town Natl Res Hosp, Ctr Study Hereditary Hearing Loss, Omaha, NE 68131 USA	Boys Town National Research Hospital	Kelley, PM (corresponding author), Boys Town Natl Res Hosp, Ctr Study Hereditary Hearing Loss, 555 N 30th St, Omaha, NE 68131 USA.				NIDCD NIH HHS [P01 DC01813-05, R01 DC02942-02] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002942, P01DC001813] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRUZZONE R, 1994, NEURON, V13, P1253, DOI 10.1016/0896-6273(94)90063-9; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; Cooper D. N., 1993, HUMAN GENE MUTATION; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; EK JF, 1994, CIRC RES, V74, P1058, DOI 10.1161/01.RES.74.6.1058; Katz Lawrence C., 1995, Seminars in Developmental Biology, V6, P117, DOI 10.1016/S1044-5781(06)80021-6; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kumar N M, 1992, Semin Cell Biol, V3, P3; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 1996, J BIOENERG BIOMEMBR, V28, P311, DOI 10.1007/BF02110107; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; PAUL DL, 1995, CURR OPIN CELL BIOL, V7, P665, DOI 10.1016/0955-0674(95)80108-1; RUBIN JB, 1992, P NATL ACAD SCI USA, V89, P3820, DOI 10.1073/pnas.89.9.3820; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; VanCamp G, 1997, AM J HUM GENET, V60, P758; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; WHITE TW, 1995, KIDNEY INT, V48, P1148, DOI 10.1038/ki.1995.398; White TW, 1996, J BIOENERG BIOMEMBR, V28, P339, DOI 10.1007/BF02110110; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; ZHANG JT, 1994, J MEMBRANE BIOL, V139, P15	26	386	453	0	11	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					792	799		10.1086/301807	http://dx.doi.org/10.1086/301807			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529365	Green Published, Bronze			2022-12-18	WOS:000073514400009
J	Altmuller, J; Palmer, LJ; Fischer, G; Scherb, H; Wjst, M				Altmuller, J; Palmer, LJ; Fischer, G; Scherb, H; Wjst, M			Genomewide scans of complex human diseases: True linkage is hard to find	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							DEPENDENT DIABETES-MELLITUS; MAJOR SUSCEPTIBILITY LOCUS; INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BIPOLAR AFFECTIVE-DISORDER; QUANTITATIVE-TRAIT LOCI; AUTOSOMAL GENOMIC SCAN; AFRICAN-AMERICAN PEDIGREES; BONE-MINERAL DENSITY; OLD ORDER AMISH	Many "complex" human diseases, which involve multiple genetic and environmental determinants, have increased in incidence during the past 2 decades. During the same time period, considerable effort and expense have been expended in whole-genome screens aimed at detection of genetic loci contributing to the susceptibility to complex human diseases. However, the success of positional cloning attempts based on whole-genome screens has been limited, and many of the fundamental questions relating to the genetic epidemiology of complex human disease remain unanswered. Both to review the success of the positional cloning paradigm as applied to complex human disease and to investigate the characteristics of the whole-genome scans undertaken to date, we created a database of 101 studies of complex human disease, which were found by a systematic Medline search (current as of December 2000). We compared these studies, concerning 31 different human complex diseases, with regard to design, methods, and results. The "significance" categorizations proposed by Lander and Kruglyak were used as criteria for the "success" of a study. Most (66.3% [n=67]) of the studies did not show "significant" linkage when the criteria of Lander and Kruglyak (1995) were used, and the results of studies of the same disease were often inconsistent. Our analyses suggest that no single study design consistently produces more-significant results. Multivariate analysis suggests that the only factors independently associated with increased study success are (a) an increase in the number of individuals studied and (b) study of a sample drawn from only one ethnic group. Positional cloning based on whole-genome screens in complex human disease has proved more difficult than originally had been envisioned; detection of linkage and positional cloning of specific disease-susceptibility loci remains elusive.	Natl Res Ct Environm Hlth, Inst Epidemiol, Neuherberg, Germany; Natl Res Ctr Environm & Hlth, Inst Biomathemat & Biometr, Neuherberg, Germany; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University	Altmuller, J (corresponding author), Ingolstadter Landstr 1, D-85764 Oberschleissheim, Germany.		Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Scherb, Hagen/0000-0002-2730-5619; Altmuller, Janine/0000-0003-4372-1521				Adams LJ, 1998, AM J HUM GENET, V62, P1084, DOI 10.1086/301826; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; Aouizerat BE, 1999, AM J HUM GENET, V65, P397, DOI 10.1086/302490; Armitage P, 1994, METHODS MED RES; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Badner JA, 1999, GENET EPIDEMIOL, V17, pS485; Bailey A, 1998, HUM MOL GENET, V7, P571; Bellamy R, 2000, CLIN SCI, V98, P245, DOI 10.1042/CS19990228; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brown MA, 1998, ARTHRITIS RHEUM, V41, P588, DOI 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; COON H, 1993, AM J HUM GENET, V52, P1234; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Farrer Lindsay A., 1998, P93; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Friddle C, 2000, AM J HUM GENET, V66, P205, DOI 10.1086/302697; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Ginns EI, 1998, P NATL ACAD SCI USA, V95, P15531, DOI 10.1073/pnas.95.26.15531; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; Gu C, 1998, GENET EPIDEMIOL, V15, P609, DOI 10.1002/(SICI)1098-2272(1998)15:6<609::AID-GEPI5>3.0.CO;2-N; Guerra R, 1999, GENET EPIDEMIOL, V17, pS605; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Harrison GA, 1997, AM J HUM GENET, V60, P1158; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hegele RA, 1999, J HUM GENET, V44, P10, DOI 10.1007/s100380050097; Hopper J L, 1999, J Natl Cancer Inst Monogr, P95; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEAHY MG, 1995, HUM MOL GENET, V4, P1551, DOI 10.1093/hmg/4.9.1551; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Lonjou C, 1999, P NATL ACAD SCI USA, V96, P1621, DOI 10.1073/pnas.96.4.1621; LUO DF, 1995, AM J HUM GENET, V57, P911; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Marsh DG, 1997, NAT GENET, V15, P389; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; Mehta C R, 1994, Stat Methods Med Res, V3, P135, DOI 10.1177/096228029400300203; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; MORTON NE, 1995, CLIN EXP ALLERGY, V25, P110, DOI 10.1111/j.1365-2222.1995.tb00436.x; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Niu TH, 1999, HUM GENET, V104, P226, DOI 10.1007/s004390050940; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Ober C, 1999, CLIN EXP ALLERGY, V29, P11; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Palmer LJ, 2001, CLIN EXP ALLERGY, V31, P152; Palmer LJ, 2001, GENET EPIDEMIOL, V20, P356, DOI 10.1002/gepi.6; Palmer LJ, 2001, HUM MOL GENET, V10, P891, DOI 10.1093/hmg/10.8.891; Palmer LJ, 2000, AM J RESP CRIT CARE, V161, P1836, DOI 10.1164/ajrccm.161.6.9805104; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; Pericak-Vance MA, 2001, MULT SCLER, V7, P3; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Rao DC, 2001, ADV GENET, V42, P13, DOI 10.1016/S0065-2660(01)42012-8; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Rice JP, 1997, AM J MED GENET, V74, P112, DOI 10.1002/(SICI)1096-8628(19970221)74:1<112::AID-AJMG22>3.0.CO;2-T; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Samuelsson L, 1999, HUM GENET, V105, P523, DOI 10.1007/s004390051141; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Sharma P, 2000, HYPERTENSION, V35, P1291, DOI 10.1161/01.HYP.35.6.1291; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Susol E, 2000, ARTHRITIS RHEUM-US, V43, P1641, DOI 10.1002/1529-0131(200007)43:7<1641::AID-ANR30>3.0.CO;2-Y; Terwilliger JD, 2000, HUM BIOL, V72, P63; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729; Wise LH, 1999, GENET EPIDEMIOL, V17, pS767; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Xu J, 1998, CLIN EXP ALLERGY, V28, P1; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201; ZEGER SL, 1991, J AM STAT ASSOC, V86, P79, DOI 10.2307/2289717; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	135	385	400	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					936	950		10.1086/324069	http://dx.doi.org/10.1086/324069			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11565063	Green Published, Bronze			2022-12-18	WOS:000171413400002
J	Wan, MM; Lee, SSJ; Zhang, XY; Houwink-Manville, I; Song, HR; Amir, RE; Budden, S; Naidu, S; Pereira, JLP; Lo, IFM; Zoghbi, HY; Schanen, NC; Francke, U				Wan, MM; Lee, SSJ; Zhang, XY; Houwink-Manville, I; Song, HR; Amir, RE; Budden, S; Naidu, S; Pereira, JLP; Lo, IFM; Zoghbi, HY; Schanen, NC; Francke, U			Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING-PROTEIN MECP2; X-LINKED INHERITANCE; DNA METHYLATION; INCONTINENTIA PIGMENTI; HISTONE DEACETYLASE; CHROMOSOMAL PROTEIN; CHROMATIN STRUCTURE; LINKAGE ANALYSIS; EXCLUSION MAP; GENE	Rett syndrome (RTT) is a neurodevelopmental disorder characterized by loss of acquired skills after a period of normal development in infant girls. The responsible gene, encoding methyl-CpG binding protein 2 (MeCP2), was recently discovered. Here we explore the spectrum of phenotypes resulting from MECP2 mutations. Both nonsense (R168X and R255X) and missense (R106W and R306C) mutations have been found, with multiple recurrences. R168X mutations were identified in six unrelated sporadic cases, as well as in two affected sisters and their normal mother. The missense mutations were de novo and affect conserved domains of MeCP2. All of the nucleotide substitutions involve C-->T transitions at CpG hotspots. A single nucleotide deletion, at codon 137, that creates a L138X stop codon within the methyl-binding domain was found in an individual with features of RTT and incontinentia pigmenti. An 806delG deletion causing a V288X stop in the transcription-repression domain was identified in a woman with motor-coordination problems, mild learning disability, and skewed X inactivation; in her sister and daughter, who were affected with classic RTT; and in her hemizygous son, who died from congenital encephalopathy. Thus, some males with RTT-causing MECP2 mutations may survive to birth, and female heterozygotes with favorably skewed X-inactivation patterns may have little or no involvement. Therefore, MECP2 mutations are not limited to RTT and may be implicated in a much broader phenotypic spectrum.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; Oregon Hlth & Sci Univ, Child Dev & Rehabil Ctr, Portland, OR 97201 USA; Johns Hopkins Med Inst, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Univ Fed Parana, Hosp Gen Portao, Curitiba, Parana, Brazil; Univ Fed Parana, Dept Psychiat, Curitiba, Parana, Brazil; Dept Hlth, Clin Genet Serv, Hong Kong, Peoples R China; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Universidade Federal do Parana; Universidade Federal do Parana; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Francke, U (corresponding author), Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA.	francke@cmgm.stanford.edu		Zoghbi, Huda/0000-0002-0700-3349; Houwink, Isa/0000-0002-9927-7266; Lo, Ivan/0000-0001-9059-4962	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD034610] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00052, M01 RR000052] Funding Source: Medline; NICHD NIH HHS [HD24234, K12 HD034610, P01 HD024448, HD24448] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; AMIR RE, IN PRESS AM J MED GE; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BUSCHHAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177, DOI 10.1073/pnas.84.5.1177; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; ELLISON KA, 1992, AM J HUM GENET, V50, P278; Fan F, 1999, AM J HUM GENET, V65, pA294; HAGBERG B, 1995, NEUROPEDIATRICS, V26, P62, DOI 10.1055/s-2007-979723; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hendrich B, 1999, MAMM GENOME, V10, P906, DOI 10.1007/s003359901112; Hofferbert S, 1997, NEUROPEDIATRICS, V28, P179, DOI 10.1055/s-2007-973697; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; Krawczak M, 1996, HUM MUTAT, V8, P23; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LINDSAY S, 1985, ANN HUM GENET, V49, P115, DOI 10.1111/j.1469-1809.1985.tb01683.x; Lo I. F. M., 1997, American Journal of Human Genetics, V61, pA105; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MARTINHO PS, 1990, HUM GENET, V86, P131; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MIGEON BR, 1989, AM J HUM GENET, V44, P100; MIGEON BR, 1995, AM J HUM GENET, V56, P647; MONK M, 1987, DEVELOPMENT, V99, P371; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, CIBA F SYMP, V214, P6; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rett A, 1966, Wien Med Wochenschr, V116, P723; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507; Schanen NC, 1997, AM J HUM GENET, V61, P634, DOI 10.1086/515525; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Thomas GH, 1996, AM J HUM GENET, V58, P1364; TREVATHAN E, 1988, ANN NEUROL, V23, P425; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wan MH, 1998, AM J MED GENET, V78, P169, DOI 10.1002/(SICI)1096-8628(19980630)78:2<169::AID-AJMG14>3.3.CO;2-D; Webb T, 1998, J MED GENET, V35, P997, DOI 10.1136/jmg.35.12.997	54	385	397	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1520	1529		10.1086/302690	http://dx.doi.org/10.1086/302690			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577905	Green Published, Bronze			2022-12-18	WOS:000084282500006
J	Richards, M; CorteReal, H; Forster, P; Macaulay, V; WilkinsonHerbots, H; Demaine, A; Papiha, S; Hedges, R; Bandelt, HJ; Sykes, B				Richards, M; CorteReal, H; Forster, P; Macaulay, V; WilkinsonHerbots, H; Demaine, A; Papiha, S; Hedges, R; Bandelt, HJ; Sykes, B			Paleolithic and neolithic lineages in the European mitochondrial gene pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA CONTROL REGION; HUMAN-EVOLUTION; HUMAN ORIGINS; DNA; SEQUENCE; POPULATIONS; IDENTIFICATION; HYPOTHESES; COALESCENT; EXPANSIONS	Phylogenetic and diversity analysis of the mtDNA control region sequence variation of 821 individuals from Europe and the Middle East distinguishes five major lineage groups with different internal diversities and divergence times. Consideration of the diversities and geographic distribution of these groups within Europe and the Middle East leads to the conclusion that ancestors of the great majority of modern, extant lineages entered Europe during the Upper Paleolithic. A further set of lineages arrived from the Middle East much later, and their age and geographic distribution within Europe correlates well with archaeological evidence for two culturally and geographically distinct Neolithic colonization events that are associated with the spread of agriculture. It follows from this interpretation that the major extant lineages throughout Europe predate the Neolithic expansion and that the spread of agriculture was a substantially indigenous development accompanied by only a relatively minor component of contemporary Middle Eastern agriculturalists. There is no evidence of any surviving Neanderthal lineages among modern Europeans.	UNIV OXFORD, INST MOL MED, DEPT CELLULAR SCI, OXFORD, ENGLAND; UNIV OXFORD, RES LAB ARCHAEOL, OXFORD, ENGLAND; UNIV HAMBURG, HEINRICH PETTE INST EXPT VIROL & IMMUNOL, D-2000 HAMBURG, GERMANY; UNIV HAMBURG, MATH SEMINAR, D-2000 HAMBURG, GERMANY; UCL, DEPT STAT SCI, LONDON, ENGLAND; UNIV PLYMOUTH, DEPT MED, PLYMOUTH PL4 8AA, DEVON, ENGLAND; UNIV NEWCASTLE UPON TYNE, DIV HUMAN GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND	University of Oxford; University of Oxford; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University of London; University College London; University of Plymouth; Newcastle University - UK			Klein, Richard G/B-5910-2009	RICHARDS, MARTIN/0000-0003-3118-0967; Herbots, Hilde/0000-0002-8538-882X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMMERMANAJ, 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; BARBUJANI G, 1995, AM J PHYS ANTHROPOL, V96, P109, DOI 10.1002/ajpa.1330960202; BENDALL KE, 1995, AM J HUM GENET, V57, P248; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bodmer W. F., 1976, GENETICS EVOLUTION M; Bodmer WF, 1993, P BR ACAD, V82, P37; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Dennell R., 1983, EUROPEAN EC PREHISTO; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GAMBLE C, 1986, PALAECOLITHIC SETTLE; GOLDMAN N, 1992, NATURE, V357, P440, DOI 10.1038/357440a0; Goudet J., 2001, CLADISTICS; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HORAI S, 1990, AM J HUM GENET, V46, P828; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; MACAULAY VA, 1995, MACPAIRWISE 5 0; MELLARS PA, 1992, PHILOS T ROY SOC B, V337, P225, DOI 10.1098/rstb.1992.0100; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nei M., 1987, MOL EVOLUTIONARY GEN; NERURKAR VR, 1993, VIROLOGY, V196, P506, DOI 10.1006/viro.1993.1506; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SHERRY ST, 1994, HUM BIOL, V66, P761; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SOKAL RR, 1991, ANNU REV ANTHROPOL, V20, P119, DOI 10.1146/annurev.an.20.100191.001003; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; STONEKING M, 1991, AM J HUM GENET, V48, P370; STRINGER C, 1993, NATURE, V362, P501, DOI 10.1038/362501a0; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; SYKES B, 1995, AM J HUM GENET, V57, P1463; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TORRONI A, 1994, AM J HUM GENET, V55, P760; VANANDEL TH, 1995, ANTIQUITY, V69, P481, DOI 10.1017/S0003598X00081886; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WHITTLE A, 1985, NEOLITHIC EUROPE SUR; Willis K. J., 1994, HOLOCENE, V4, P326, DOI DOI 10.1177/095968369400400313; Zvelebil M, 1986, HUNTERS TRANSITION M, P5	50	385	390	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					185	203						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659525				2022-12-18	WOS:A1996VL45500026
J	WARBURTON, D; FRASER, FC				WARBURTON, D; FRASER, FC			SPONTANEOUS ABORTION RISKS IN MAN - DATA FROM REPRODUCTIVE HISTORIES COLLECTED IN MEDICAL GENETICS UNIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASHTON GC, 1959, NATURE, V183, P404, DOI 10.1038/183404a0; BISHOP PMF, 1937, GUYS HOSP REP, V87, P362; BODMER WF, 1961, NATURE, V190, P1134, DOI 10.1038/1901134a0; BOOK JA, 1950, AM J HUM GENET, V2, P61; BOOK JA, 1957, ANN HUM GENET, V21, P191; CHUNG CS, 1961, AM J HUM GENET, V13, P9; COFFEY V P, 1958, Ir J Med Sci, V393, P391; DOUGLAS GW, 1959, AM J OBSTET GYNECOL, V78, P960, DOI 10.1016/S0002-9378(16)36649-2; EASTMAN NJ, 1956, WILLIAMS OBSTETRICS, pCH21; ERHARDT CL, 1956, AM J PUBLIC HEALTH N, V46, P828, DOI 10.2105/AJPH.46.7.828; FALCONER DS, 1960, J CELL COMPAR PHYSL, V56, P153, DOI 10.1002/jcp.1030560414; FINNEY DJ, 1952, STATISTICAL METHOD B, P458; GRAY JD, 1958, AM J OBSTET GYNECOL, V75, P43, DOI 10.1016/0002-9378(58)90549-0; Hogben L., 1931, GENETIC PRINCIPLES M; HOLLANDER WF, 1959, P SOC EXP BIOL MED, V101, P425, DOI 10.3181/00379727-101-24966; HULKA JF, 1961, NATURE, V191, P510, DOI 10.1038/191510a0; JAMES WH, 1963, AM J OBSTET GYNECOL, V85, P38; JAMES WH, 1962, J OBSTET GYN BR COMM, V69, P606; JAMES WH, 1961, ANN HUM GENET, V25, P207; JAMES WH, AMER J HUM GENET, V15, P223; JAVERT CT, 1949, AM J OBSTET GYNECOL, V57, P878, DOI 10.1016/0002-9378(49)90643-2; KARN MN, 1950, ANN HUM GYNET, V15, P306; KING AG, 1953, OBSTET GYNECOL, V1, P104; LASH AF, 1950, AM J OBSTET GYNECOL, V59, P68, DOI 10.1016/0002-9378(50)90342-5; LEVENE HOWARD, 1961, PROGR MED GENET, V1, P120; MALPAS P, 1938, J OBSTET GYN BR COMM, V45, P932; MANN EC, 1956, OBSTET GYNECOL, V7, P589; MATSUNAGA E, 1958, ANN HUM GENET, V22, P111; MCDONALD AD, 1958, NEW ENGL J MED, V258, P767, DOI 10.1056/NEJM195804172581601; METRAKOS JD, 1961, NEUROLOGY MINNEAP, V11, P474; MILLIS J, 1958, ANN HUM GENET, V22, P362, DOI 10.1111/j.1469-1809.1958.tb01430.x; MORTON NE, 1959, AM J HUM GENET, V11, P1; NEEL JV, 1956, 461 NAT ACAD SCI PUB; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; PENROSE L S, 1956, Acta Genet Stat Med, V6, P169; REED T. EDWARD, 1958, ANN HUMAN GENETICS, V22, P165; RUCKER M P, 1952, J Int Coll Surg, V17, P328; SLATIS HM, 1958, AM J HUM GENET, V10, P446; SLIZYNSKI BM, 1960, GENET RES, V1, P477, DOI 10.1017/S0016672300000446; SPEERT H, 1954, AM J OBSTET GYNECOL, V68, P665, DOI 10.1016/S0002-9378(16)38253-9; STEINBERG AG, 1959, J MED EDUC, V34, P315; STEVENSON AC, 1959, ANN HUM GENET, V23, P395, DOI 10.1111/j.1469-1809.1959.tb01482.x; TIETZE C, 1950, JAMA-J AM MED ASSOC, V142, P1348, DOI 10.1001/jama.1950.02910350018006; TIETZE C, 1957, POP STUD-J DEMOG, V11, P170, DOI 10.2307/2172112; TUPPER C, 1962, AM J OBSTET GYNECOL, V83, P421, DOI 10.1016/0002-9378(62)90574-4; WARBURTON D, 1961, J OBSTET GYN BR COMM, V68, P784; WHITEHOUSE F, 1929, P ROY SOC MED, V23, P241	47	385	387	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2971A	14131871				2022-12-18	WOS:A19642971A00006
J	Gicquel, C; Gaston, V; Mandelbaum, J; Siffroi, JP; Flahault, A; Le Bouc, Y				Gicquel, C; Gaston, V; Mandelbaum, J; Siffroi, JP; Flahault, A; Le Bouc, Y			In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCNQ1OT gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DEFECTS; METHYLATION; H19; TRANSCRIPT; KVLQT1; GENOME; SHEEP; LIT1; MICE; ICSI		Hosp Armand Trousseau, Lab Explorat Fonct Endocriniennes, F-75012 Paris, France; Hosp Armand Trousseau, INSERM, U515, Paris, France; Hop Tenon, Assistance Publ Hop Paris, Serv Histol Biol Reprod & Cytogenet, F-75970 Paris, France; Hop Tenon, Assistance Publ Hop Paris, UPRES EA 1533, F-75970 Paris, France; Hop Tenon, Assistance Publ Hop Paris, INSERM,U444, Unite Biostat, F-75970 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Gicquel, C (corresponding author), Hosp Armand Trousseau, Lab Explorat Fonct Endocriniennes, 26 Ave Arnold Netter, F-75012 Paris, France.	christine.gicquel@trs.ap-hop-paris.fr						Bliek J, 2001, HUM MOL GENET, V10, P467, DOI 10.1093/hmg/10.5.467; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Gaston V, 2000, HORM RES, V54, P1; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Manning M, 2000, MOL HUM REPROD, V6, P1049, DOI 10.1093/molehr/6.11.1049; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Olivennes F, 2001, HUM REPROD, V16, P1588, DOI 10.1093/humrep/16.8.1588; Orstavik KH, 2003, AM J HUM GENET, V72, P218, DOI 10.1086/346030; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/ror.0.0030155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	23	384	407	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1338	1341		10.1086/374824	http://dx.doi.org/10.1086/374824			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12772698	Green Published, Bronze			2022-12-18	WOS:000182474400028
J	Palmer, JS; Duffy, DL; Box, NF; Aitken, JF; O'Gorman, LE; Green, AC; Hayward, NK; Martin, NG; Sturm, RA				Palmer, JS; Duffy, DL; Box, NF; Aitken, JF; O'Gorman, LE; Green, AC; Hayward, NK; Martin, NG; Sturm, RA			Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CUTANEOUS MELANOMA; MELANOCYTIC NEVI; RED HAIR; SKIN; GENE; MELANOGENESIS; SENSITIVITY; POPULATION; REGISTRY; VARIANTS	Risk of cutaneous malignant melanoma (CMM) is increased in sun-exposed whites, particularly those with a pale complexion. This study was designed to investigate the relationship of the melanocortin-1 receptor (MC1R) genotype to CMM risk, controlled for pigmentation phenotype. We report the occurrence of five common MC1R variants in an Australian population-based sample of 460 individuals with familial and sporadic CMM and 339 control individuals-and their relationship to such other risk factors as skin, hair, and eye color; freckling; and nevus count. There was a strong relationship between MC1R variants and hair color and skin type. Moreover, MC1R variants were found in 72% of the individuals with CMM, whereas only 56% of the control individuals carried at least one variant (P < .001), a finding independent of strength of family history of melanoma. Three active alleles (Arg151Cys, Arg160Trp, and Asp294His), previously associated with red hair, doubled CMM risk for each additional allele carried (odds ratio 2.0; 95% confidence interval 1.6-2.6). No such independent association could be demonstrated with the Val60Leu and Asp84Glu variants. Among pale-skinned individuals alone, this association between CMM and MC1R variants was absent, but it persisted among those reporting a medium or olive/dark complexion. We conclude that the effect that MC1R variant alleles have on CMM is partly mediated via determination of pigmentation phenotype and that these alleles may also negate the protection normally afforded by darker skin coloring in some members of this white population.	Univ Queensland, Ctr Cellular & Mol Biol, Brisbane, Qld 4072, Australia; Univ Queensland, Queensland Inst Med Res, Brisbane, Qld 4072, Australia; Univ Queensland, Joint Genet Program, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Sturm, RA (corresponding author), Univ Queensland, Ctr Cellular & Mol Biol, Brisbane, Qld 4072, Australia.		Duffy, David L/B-7392-2013; Green, Adele C/P-2736-2014; Green, Adele C/B-5324-2011; Sturm, Richard A/C-9943-2009; Box, Neil/F-3591-2010; Aitken, Joanne F/C-5289-2009; hayward, nicholas k/C-1367-2015; hayward, nick/AAV-8802-2020	Duffy, David L/0000-0001-7227-632X; Green, Adele C/0000-0002-2753-4841; Sturm, Richard A/0000-0003-1301-0294; Box, Neil/0000-0002-3486-0346; hayward, nicholas k/0000-0003-4760-1033; Martin, Nicholas/0000-0003-4069-8020; Aitken, Joanne Frances/0000-0001-6859-2186				Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; AITKEN JF, 1994, AM J EPIDEMIOL, V140, P961, DOI 10.1093/oxfordjournals.aje.a117203; Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; AITKEN JF, 1993, BRIT J CANCER, V67, P1036, DOI 10.1038/bjc.1993.190; [Anonymous], 1992, GASTROENTEROL INT; Balch CM, 1992, CUTANEOUS MELANOMA; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Breitbart M, 1997, ACTA DERM-VENEREOL, V77, P374; COUGHLIN SR, 1994, CURR OPIN CELL BIOL, V6, P191, DOI 10.1016/0955-0674(94)90135-X; ENGLISH DR, 1994, AM J EPIDEMIOL, V139, P390, DOI 10.1093/oxfordjournals.aje.a117011; Frants R. R., 1996, American Journal of Human Genetics, V59, pA67; GARBE C, 1994, J INVEST DERMATOL, V102, P695, DOI 10.1111/1523-1747.ep12374280; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; GRANGE F, 1995, ARCH DERMATOL, V131, P1154, DOI 10.1001/archderm.131.10.1154; GREEN A, 1990, BRIT J DERMATOL, V123, P77, DOI 10.1111/j.1365-2133.1990.tb01826.x; Grulich AE, 1996, INT J CANCER, V67, P485, DOI 10.1002/(SICI)1097-0215(19960807)67:4<485::AID-IJC4>3.0.CO;2-O; Hayward Nicholas K., 1996, Current Opinion in Oncology, V8, P136, DOI 10.1097/00001622-199603000-00011; Healy E, 1999, J INVEST DERMATOL, V112, P512, DOI 10.1046/j.1523-1747.1999.00554.x; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hill HZ, 1997, PIGM CELL RES, V10, P158, DOI 10.1111/j.1600-0749.1997.tb00478.x; Ichii-Jones F, 1998, J INVEST DERMATOL, V111, P218, DOI 10.1046/j.1523-1747.1998.00287.x; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell P, 1998, OPHTHALMOLOGY, V105, P1359, DOI 10.1016/S0161-6420(98)98013-7; OTT J, 1996, ASSOCIATE 2 33 COMPU; PAWELEK JM, 1992, PIGM CELL RES, V5, P348, DOI 10.1111/j.1600-0749.1992.tb00561.x; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; *SAS I, 1998, SAS 6 11 COMP PROGR; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; SLOMINSKI A, 1993, MOL CELL ENDOCRINOL, V93, pC1, DOI 10.1016/0303-7207(93)90131-3; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Strange RC, 1999, J INVEST DERMATOL, V112, P513, DOI 10.1046/j.1523-1747.1999.00555.x; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 1998, MUTAT RES-FUND MOL M, V422, P69, DOI 10.1016/S0027-5107(98)00176-6; SWERDLOW AJ, 1987, BRIT J DERMATOL, V117, P137, DOI 10.1111/j.1365-2133.1987.tb04109.x; TILGEN W, 1993, RECENT RES CANCER, V128, P59; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vincensi MR, 1998, MELANOMA RES, V8, P53, DOI 10.1097/00008390-199802000-00009; Weir BS, 1996, SINAUER ASS SUNDERL; Whiteman DC, 1998, INT J CANCER, V77, P843, DOI 10.1002/(SICI)1097-0215(19980911)77:6<843::AID-IJC8>3.0.CO;2-U; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	45	384	400	1	25	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					176	186		10.1086/302711	http://dx.doi.org/10.1086/302711			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631149	Green Published, Bronze			2022-12-18	WOS:000085033600020
J	COMINGS, DE				COMINGS, DE			RATIONALE FOR AN ORDERED ARRANGEMENT OF CHROMATIN IN INTERPHASE NUCLEUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ATKINS L, 1964, HEREDITAS, V51, P67; AUSTIN CR, 1966, SEX CHROMATIN; BARGMANN W, 1960, 4 P INT C EL MICR ED, V2, P230; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BARTON DE, 1964, ANN HUM GENET, V28, P123, DOI 10.1111/j.1469-1809.1964.tb00467.x; BELAR K, 1929, Z ZELLFORSCH MIKROSK, V10, P73; BENNETT D, 1966, CYTOLOGIA, V31, P411, DOI 10.1508/cytologia.31.411; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BISHUN NP, 1966, EXPERIENTIA, V22, P223, DOI 10.1007/BF01900921; BOSS J, 1954, EXP CELL RES, V7, P215, DOI 10.1016/0014-4827(54)90056-7; BOSS J M, 1955, Tex Rep Biol Med, V13, P213; Boveri T, 1909, ARCH EXP ZELLFORSCH, V3, P181; BRACHET J, 1961, CELL              ED, V3, P1; BRACHET J, 1961, CELL              ED, V3, P77; BREGA A, 1968, J CELL BIOL, V36, P485, DOI 10.1083/jcb.36.3.485; BRENNER S, 1953, EXP CELL RES, V5, P257, DOI 10.1016/0014-4827(53)90113-X; BUCK CLAYTON A., 1967, CURR MOD BIOL, V1, P9; CAIRNS J, 1966, J MOL BIOL, V15, P372, DOI 10.1016/S0022-2836(66)80233-4; COHEN MM, 1964, J CELL BIOL, V23, P386, DOI 10.1083/jcb.23.2.386; COMINGS DE, 1968, J MOL BIOL, V33, P225, DOI 10.1016/0022-2836(68)90290-8; COMINGS DE, 1967, CYTOGENETICS, V6, P20, DOI 10.1159/000129927; COMINGS DE, 1967, J CELL BIOL, V35, P699, DOI 10.1083/jcb.35.3.699; CUMMINS JE, 1966, SCIENCE, V154, P1343, DOI 10.1126/science.154.3754.1343; CUZIN F, 1965, CR HEBD ACAD SCI, V260, P5411; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; Dearing WH, 1934, J MORPHOL, V56, P157, DOI 10.1002/jmor.1050560108; DEMARS R, 1962, SCIENCE, V138, P980, DOI 10.1126/science.138.3544.980; DUPRAW EJ, 1965, P NATL ACAD SCI USA, V53, P161, DOI 10.1073/pnas.53.1.161; DUPRAW EJ, 1965, NATURE, V206, P338, DOI 10.1038/206338a0; EVANS HJ, 1961, GENETICS, V46, P257; EVANS HJ, 1961, GENETICS, V46, P277; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; FELDMAN M, 1966, P NATL ACAD SCI USA, V55, P1447, DOI 10.1073/pnas.55.6.1447; FERGUS.MA, 1961, LANCET, V1, P638, DOI 10.1016/S0140-6736(61)91655-5; FERGUSONSMITH MA, 1963, ANN HUM GENET, V27, P143, DOI 10.1111/j.1469-1809.1963.tb00207.x; FOX DP, 1966, CHROMOSOMA, V20, P173, DOI 10.1007/BF00335206; FRITZJAMES PC, 1965, BACTERIOL REV, V29, P293; FROLAND A, 1964, HEREDITAS-GENETISK A, V52, P248; GANESAN AT, 1965, BIOCHEM BIOPH RES CO, V18, P824, DOI 10.1016/0006-291X(65)90859-4; Gates RR, 1938, NATURE, V142, P156, DOI 10.1038/142156b0; GERMAN J, 1964, J CELL BIOL, V20, P37, DOI 10.1083/jcb.20.1.37; GRAVES JAM, 1967, EXP CELL RES, V46, P37; GROPP A, 1963, EXP CELL RES, V30, P577, DOI 10.1016/0014-4827(63)90333-1; GRUMBACH MM, 1963, P NATL ACAD SCI USA, V49, P581, DOI 10.1073/pnas.49.5.581; GRUNEBERG H, 1966, GENET RES, V7, P58, DOI 10.1017/S0016672300009472; HANAWALT PC, 1961, J MOL BIOL, V3, P156, DOI 10.1016/S0022-2836(61)80042-9; HEDDLE JA, 1967, SCIENCE, V158, P929, DOI 10.1126/science.158.3803.929; HEITZ E, 1931, ARCH WISS BOT, V12, P775; HERREROS B, 1967, NATURE, V216, P286, DOI 10.1038/216286a0; HOLLIDAY R, 1964, GENETICS, V50, P323; HSU TC, 1964, J CELL BIOL, V23, P53, DOI 10.1083/jcb.23.1.53; HUBERMAN JA, IN PRESS; Huettner AF, 1924, J MORPHOL PHYSIOL, V39, P249, DOI 10.1002/jmor.1050390108; HUNGERFORD DA, 1964, MAMMALIAN CYTOGENETI, P133; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; JACOB F, 1966, PROC R SOC SER B-BIO, V164, P267, DOI 10.1098/rspb.1966.0029; KASHA KJ, 1965, CAN J GENET CYTOL, V7, P620, DOI 10.1139/g65-082; KATO H, 1968, J NATL CANCER I, V40, P165; KINSEY JD, 1967, GENETICS, V55, P337; KITANI Y, 1964, JPN J GENET, V38, P244, DOI 10.1266/jjg.38.244; KOWARZYK H, 1966, B ACAD POL SCI BIOL, V14, P541; KOWARZYK H, 1965, B ACAD POL SCI BIOL, V13, P321; KRISHAN A, 1965, J CELL BIOL, V24, P433, DOI 10.1083/jcb.24.3.433; KUMAR S, 1966, NATURE, V209, P796, DOI 10.1038/209796a0; LARK C, 1964, J MOL BIOL, V10, P120, DOI 10.1016/S0022-2836(64)80032-2; LARK KG, 1966, BACTERIOL REV, V30, P3, DOI 10.1128/MMBR.30.1.3-32.1966; LARK KG, 1967, P NATL ACAD SCI USA, V58, P352, DOI 10.1073/pnas.58.1.352; LARK KG, 1966, SCIENCE, V154, P1202, DOI 10.1126/science.154.3753.1202; LITTLEFIELD JW, 1965, BIOCHIM BIOPHYS ACTA, V108, P652, DOI 10.1016/0005-2787(65)90061-4; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MAALOE O, 1961, J MOL BIOL, V3, P144, DOI 10.1016/S0022-2836(61)80041-7; MAGUIRE MP, 1967, CHROMOSOMA, V21, P221, DOI 10.1007/BF00329547; MAZIA D, 1961, CELL, V3, P77; MCLEISH J, 1953, HEREDITY           S, V6, P125; MCLINTOCK B, 1934, Z ZELLFORSCH, V21, P294; MERRINGTON M, 1964, ANN HUM GENET, V27, P257, DOI 10.1111/j.1469-1809.1963.tb00792.x; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; MILLER O. J., 1963, CYTOGENETICS [BASEL], V2, P152, DOI 10.1159/000129776; MILLER O. J., 1963, CYTOGENETICS [BASEL], V2, P1, DOI 10.1159/000129760; MITRA J, 1961, AM J BOT, V48, P358, DOI 10.2307/2439327; MOORE KL, 1966, SEX CHROMATIN     ED; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; MOSES MJ, 1960, 4 P INT C EL MICR BE, V2, P230; MUELLER GC, 1962, CANCER RES, V22, P1084; MUELLER GC, 1966, BIOCHIM BIOPHYS ACTA, V114, P108, DOI 10.1016/0005-2787(66)90258-9; MULDAL S, 1963, LANCET, V1, P861; MURRAY RG, 1965, J CELL BIOL, V26, P601, DOI 10.1083/jcb.26.2.601; NICHOLS WW, 1965, HEREDITAS-GENETISK A, V54, P213; OCKEY CH, 1966, HEREDITAS-GENETISK A, V54, P277; OHNO S, 1961, LANCET, V2, P123; PAINTER RB, 1964, NATURE, V201, P162, DOI 10.1038/201162a0; PAINTER RB, 1966, J MOL BIOL, V17, P47, DOI 10.1016/S0022-2836(66)80093-1; PAVAN C, 1964, MAMMALIAN CYTOGEN ED, P133; Peacock W J, 1965, Natl Cancer Inst Monogr, V18, P101; PEACOCK WJ, 1963, P NATL ACAD SCI USA, V49, P793, DOI 10.1073/pnas.49.6.793; PLAUT W, 1966, J MOL BIOL, V16, P85, DOI 10.1016/S0022-2836(66)80264-4; PORTER KR, 1960, J BIOPHYS BIOCHEM CY, V7, P167, DOI 10.1083/jcb.7.1.167; PUSA K, 1963, 11 P INT C GEN HAG, V1, P110; RACKER E, 1968, SCI AM, V218, P32, DOI 10.1038/scientificamerican0268-32; RAO RN, 1967, GENETICS, V57, P821; REVELL SH, 1953, HEREDITY           S, V6, P107; RHODES MM, 1961, CELL, V3, P1; RIEGER R, 1959, CHROMOSOMA, V10, P163, DOI 10.1007/BF00396569; RIS H, 1966, PROC R SOC SER B-BIO, V164, P246, DOI 10.1098/rspb.1966.0027; ROTH LE, 1962, J CELL BIOL, V12, P57, DOI 10.1083/jcb.12.1.57; ROTH LE, 1967, J CELL BIOL, V34, P47, DOI 10.1083/jcb.34.1.47; RUDDLE FH, 1960, THESIS U CALIFORNIA; RYTER A, 1966, ANN I PASTEUR PARIS, V110, P801; RYTER A, 1963, CR HEBD ACAD SCI, V257, P3060; SASAKI MS, 1966, EXP CELL RES, V44, P642, DOI 10.1016/0014-4827(66)90474-5; Sax K, 1940, GENETICS, V25, P41; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SCHNEIDERMAN LJ, 1962, NATURE, V195, P1229, DOI 10.1038/1951229a0; Schrader Franz, 1953, MITOSIS MOVEMENTS CH, V2nd; SCHWARZA.HG, 1966, NATURE, V209, P107, DOI 10.1038/209107a0; SHAW MW, 1965, GENETICS, V51, P181; SHAW MW, 1961, LANCET, V1, P1351; SINHA AK, 1967, EXP CELL RES, V47, P443, DOI 10.1016/0014-4827(67)90002-X; SMITH STANLEY G., 1942, CANADIAN JOUR RES SECT D ZOOL SCI, V20, P221; SOLARI AJ, 1967, J ULTRA MOL STRUCT R, V17, P421, DOI 10.1016/S0022-5320(67)80133-3; SPARROW AH, 1951, ANN NY ACAD SCI, V51, P1508, DOI 10.1111/j.1749-6632.1951.tb30076.x; Stern C, 1936, GENETICS, V21, P625; STEVENS BJ, 1965, J CELL BIOL, V24, P349, DOI 10.1083/jcb.24.3.349; STOREY WB, 1968, SCIENCE, V159, P648, DOI 10.1126/science.159.3815.648; STOREY WB, IN PRESS; SVED JA, 1966, GENETICS, V53, P747; TAYLOR EW, 1965, EXP CELL RES, V40, P316, DOI 10.1016/0014-4827(65)90265-X; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TAYLOR JH, 1958, GENETICS, V43, P515; TEPLITZ RL, 1968, CLIN RES, V16, P121; THORLEY J, 1967, EXP CELL RES, V47, P663, DOI 10.1016/0014-4827(67)90033-X; TOBEY RA, 1966, BIOPHYS J, V6, P567, DOI 10.1016/S0006-3495(66)86678-X; VANDERLYN L, 1948, BOT REV, V14, P270, DOI 10.1007/BF02861742; WALEN KH, 1965, GENETICS, V51, P915; WESTERGAARD M, 1964, COMPT REND TRAV LAB, V34, P395; Wilson EB, 1912, J EXP ZOOL, V13, P345, DOI 10.1002/jez.1400130302; WILSON EB, 1925, CELL DEVELOPMENT HER; WOLFF S, 1964, MUTAT RES, V1, P337, DOI 10.1016/0027-5107(64)90026-0; WOLFF SHELDON, 1959, RADIATION RES SUPPL, V1, P453, DOI 10.2307/3583658; WOOLLAM DHM, 1967, NATURE, V213, P298, DOI 10.1038/213298a0; YOTSUYANAGI Y, 1966, CR ACAD SCI D NAT, V262, P1348; YOUNG CW, 1966, MOL PHARMACOL, V2, P50	142	380	385	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1968	20	5					440	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8383	5701616				2022-12-18	WOS:A1968B838300004
J	KRISTIDIS, P; BOZON, D; COREY, M; MARKIEWICZ, D; ROMMENS, J; TSUI, LC; DURIE, P				KRISTIDIS, P; BOZON, D; COREY, M; MARKIEWICZ, D; ROMMENS, J; TSUI, LC; DURIE, P			GENETIC DETERMINATION OF EXOCRINE PANCREATIC FUNCTION IN CYSTIC-FIBROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION; MUTATIONS; SECRETION; CFTR; DNA	We showed elsewhere that the pancreatic function status of cystic fibrosis (CF) patients could be correlated to mutations in the CF transmembrane conductance regulator (CFTR) gene. Although the majority of CF mutations-including the most common, DELTA-F508-strongly correlated with pancreatic insufficiency (PI), approximately 10% of the mutant alleles may confer pancreatic sufficiency (PS). To extend this observation, genomic DNA of 538 CF patients with well-documented pancreatic function status were analyzed for a series of known mutations in their CFTR genes. Only 20 of the 25 mutations tested were found in this population. They accounted for 84% of the CF chromosomes, with DELTA-F508 being the most frequent (71%), and the other mutations accounted for less than 5% each. A total of 30 different, complete genotypes could be determined in 394 (73%) of the patients. The data showed that each genotype was associated only with PI or only with PS, but not with both. This result is thus consistent with the hypothesis that PI and PS in CF are predisposed by the genotype at the CFTR locus; the PS phenotype occurs in patients who have one or two mild CFTR mutations, such as R117H, R334W, R347P, A455E, and P574H, whereas the PI phenotype occurs in patients with two severe alleles, such as DELTA-F508, DELTA-1507, Q493X, G542X, R553X, W1282X, 621 + 1G --> T, 1717-1G --> A, 556delA, 3659delC, 1148T, G480C, V520F, G551D, and R560T.	UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DIV GASTROENTEROL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto			Tsui, Lap-chee/A-1081-2010		NIDDK NIH HHS [DK-41980] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK041980] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BEAUDET AL, 1990, NEW ENGL J MED, V323, P70; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; COREY M, 1984, Journal of Pediatric Gastroenterology and Nutrition, V3, pS99, DOI 10.1097/00005176-198400031-00016; CUPPENS H, 1990, J MED GENET, V27, P717, DOI 10.1136/jmg.27.11.717; CUPPENS H, 1990, PEDIATR PULM S, V5, P203; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DISANTAGNESE PA, 1955, PEDIATRICS, V15, P683; DURIE P, 1988, 10TH P INT CYST FIBR, P161; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; GASKIN KJ, 1982, J CLIN INVEST, V69, P427, DOI 10.1172/JCI110466; GASPARINI P, 1991, GENOMICS, V10, P193, DOI 10.1016/0888-7543(91)90500-E; GIBBS GE, 1950, J PEDIATR-US, V37, P320, DOI 10.1016/S0022-3476(50)80150-6; GILBERT F, 1990, AM J HUM GENET, V46, P394; JONES CT, 1991, PEDIATR PULMONOL S6, V11, P239; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, 1989, AM J HUM GENET, V44, P827; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KOPELMAN H, 1985, NEW ENGL J MED, V312, P329, DOI 10.1056/NEJM198502073120601; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; OSBORNE L, 1991, AM J HUM GENET, V48, P608; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1991, P NATL ACAD SCI USA, V88, P7500, DOI 10.1073/pnas.88.17.7500; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SANTIS G, 1990, LANCET, V335, P1426, DOI 10.1016/0140-6736(90)91448-J; STRONG T, 1991, PEDIATR PULM S, V6, P244; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WATERS DL, 1990, NEW ENGL J MED, V322, P303, DOI 10.1056/NEJM199002013220505; WHITE MB, 1991, GENOMICS, V10, P266, DOI 10.1016/0888-7543(91)90510-L; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	40	379	385	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1178	1184						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1376016				2022-12-18	WOS:A1992HY65400004
J	Franke, L; van Bakel, H; Fokkens, L; de Jong, ED; Egmont-Petersen, M; Wijmenga, C				Franke, Lude; van Bakel, Harm; Fokkens, Like; de Jong, Edwin D.; Egmont-Petersen, Michael; Wijmenga, Cisca			Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-INTERACTION MAP; TRANSCRIPTIONAL RESPONSES; EXPRESSION; EXCLUSION; DATABASE; KNOWLEDGEBASE; CONFIDENCE; RADIATION; RESOURCE; DISEASE	Most common genetic disorders have a complex inheritance and may result from variants in many genes, each contributing only weak effects to the disease. Pinpointing these disease genes within the myriad of susceptibility loci identified in linkage studies is difficult because these loci may contain hundreds of genes. However, in any disorder, most of the disease genes will be involved in only a few different molecular pathways. If we know something about the relationships between the genes, we can assess whether some genes (which may reside in different loci) functionally interact with each other, indicating a joint basis for the disease etiology. There are various repositories of information on pathway relationships. To consolidate this information, we developed a functional human gene network that integrates information on genes and the functional relationships between genes, based on data from the Kyoto Encyclopedia of Genes and Genomes, the Biomolecular Interaction Network Database, Reactome, the Human Protein Reference Database, the Gene Ontology database, predicted protein-protein interactions, human yeast two-hybrid interactions, and microarray coexpressions. We applied this network to interrelate positional candidate genes from different disease loci and then tested 96 heritable disorders for which the Online Mendelian Inheritance in Man database reported at least three disease genes. Artificial susceptibility loci, each containing 100 genes, were constructed around each disease gene, and we used the network to rank these genes on the basis of their functional interactions. By following up the top five genes per artificial locus, we were able to detect at least one known disease gene in 54% of the loci studied, representing a 2.8-fold increase over random selection. This suggests that our method can significantly reduce the cost and effort of pinpointing true disease genes in analyses of disorders for which numerous loci have been reported but for which most of the genes are unknown.	Univ Utrecht, Med Ctr, Dept Med Genet, Complex Genet Sect,DBG, NL-3508 AB Utrecht, Netherlands; Univ Utrecht, Large Distributed Databases Grp, Inst Informat & Comp Sci, NL-3508 AB Utrecht, Netherlands; Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Utrecht University; Utrecht University; Radboud University Nijmegen	Wijmenga, C (corresponding author), Univ Utrecht, Med Ctr, Dept Med Genet, Complex Genet Sect,DBG, Stratenum 2-117,POB 85060, NL-3508 AB Utrecht, Netherlands.	t.n.wijmenga@med.uu.nl	van Bakel, Harm/N-9561-2017; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Franke, Lude/P-7036-2016	van Bakel, Harm/0000-0002-1376-6916; Wijmenga, Cisca/0000-0002-5635-1614; Fokkens, Like/0000-0001-6696-4409; Franke, Lude/0000-0002-5159-8802				Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Egmont-Petersen M, 2005, COMPUT STAT DATA AN, V49, P998, DOI 10.1016/j.csda.2004.06.018; EGMONTPETERSEN M, 2004, P 8 EUR C PRINC PRAC, P149; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Franke L, 2004, EUR J HUM GENET, V12, P633, DOI 10.1038/sj.ejhg.5201215; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jacobi FK, 2000, HUM GENET, V107, P89, DOI 10.1007/s004390050017; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Malik R, 2005, LECT NOTES ARTIF INT, V3808, P248, DOI 10.1007/11595014_25; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rieger KE, 2004, P NATL ACAD SCI USA, V101, P6635, DOI 10.1073/pnas.0307761101; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seri M, 1999, HUM GENET, V104, P108, DOI 10.1007/s004390050919; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tumer Z, 2002, GENE, V288, P179, DOI 10.1016/S0378-1119(02)00478-X; Turner FS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r75; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; WALLER WG, 1978, IEEE T INFORM THEORY, V24, P392, DOI 10.1109/TIT.1978.1055877; Walpole SM, 1999, HUM GENET, V104, P410, DOI 10.1007/s004390050976; Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085; Yandell MD, 2002, NAT REV GENET, V3, P601, DOI 10.1038/nrg861; Zatz M, 2003, NEUROMUSCULAR DISORD, V13, P532, DOI 10.1016/S0960-8966(03)00100-7	58	378	399	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1011	1025		10.1086/504300	http://dx.doi.org/10.1086/504300			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685651	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000237553800010
J	Grigorenko, EL; Wood, FB; Meyer, MS; Hart, LA; Speed, WC; Shuster, A; Pauls, DL				Grigorenko, EL; Wood, FB; Meyer, MS; Hart, LA; Speed, WC; Shuster, A; Pauls, DL			Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; MULTILOCUS LINKAGE ANALYSIS; PEDIGREE-MEMBER METHOD; READING-DISABILITY; VULNERABILITY LOCUS; GENETIC-LINKAGE; LOD SCORE; RETARDATION; CHILDREN; TRAIT	Six extended dyslexic families with at least four affected individuals were genotyped with markers in three chromosomal regions: 6p23-p21.3, 15pter-qter, and 16pter-qter. Five theoretically derived phenotypes were used in the linkage analyses: (1) phonological awareness; (2) phonological decoding; (3) rapid automatized naming; (4) single-word reading; and (5) discrepancy between intelligence and reading performance, an empirically derived, commonly used phenotype. Two-point and multipoint allele-sharing analyses of chromosome 6 markers revealed significant evidence (P < 10(-6)) for linkage of the phonological awareness phenotype to five adjacent markers (D6S109, D6S461, D6S299, D6S464, and D6S306). The least compelling results were obtained with single-word reading. In contrast, with chromosome 15 markers, a LOD score of 3.15 was obtained for marker D15S143 at theta = 0.0 with single-word reading. Multipoint analyses with markers adjacent to D15S143 (D15S126, D15S132, D15S214, and D15S128) were positive, but none reached acceptable significance levels. Chromosome 15 analyses with the phonological awareness phenotype were negative. Parametric and nonparametric linkage analyses with chromosome 16 markers were negative. The most intriguing aspect of the current findings is that two very distinct reading-related phenotypes, reflecting different levels in the hierarchy of reading-related skills, each contributing to different processes, appear to be linked to two different chromosomal regions.	YALE UNIV,CTR CHILD STUDY,SCH MED,NEW HAVEN,CT 06520; YALE UNIV,DEPT PSYCHOL,SCH MED,NEW HAVEN,CT 06520; YALE UNIV,DEPT GENET,SCH MED,NEW HAVEN,CT 06520; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT NEUROL,SECT NEUROPSYCHOL,WINSTON SALEM,NC 27103	Yale University; Yale University; Yale University; Wake Forest University; Wake Forest Baptist Medical Center			Grigorenko, Elena/V-2418-2019	Hart, Lesley/0000-0002-5404-6659	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD021887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039239, R01MH039239] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21887] Funding Source: Medline; NIMH NIH HHS [MH00508, MH39239] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARON MC, 1993, GENET EPIDEMIOL, V10, P389; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BISGAARD ML, 1987, CLIN GENET, V32, P118; BLACHMAN BA, 1994, J LEARN DISABIL, V27, P287, DOI 10.1177/002221949402700504; BODER E, 1973, DEV MED CHILD NEUROL, V15, P663; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CHILDS B, 1983, DEV PSYCHIAT, P507; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CORNWALL A, 1992, J LEARN DISABIL, V25, P532, DOI 10.1177/002221949202500808; DECKER SN, 1988, BRAIN LANG, V33, P197, DOI 10.1016/0093-934X(88)90064-8; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; Dunn L. M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; EDEN GF, 1995, CORTEX, V31, P451, DOI 10.1016/S0010-9452(13)80059-7; EDEN GF, 1995, J LEARN DISABIL, V28, P5; FELTON RH, 1990, READ WRIT, V2, P39, DOI 10.1007/BF00383373; FELTON RH, 1990, BRAIN LANG, V39, P485, DOI 10.1016/0093-934X(90)90157-C; FELTON RH, 1992, J LEARN DISABIL, V25, P318, DOI 10.1177/002221949202500506; FELTON RH, 1994, TOP LANG DISORD, V14, P42; FELTON RH, 1989, J LEARN DISABIL, V1, P3; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hallgren B., 1950, ACTA PSYCHIAT NEUROL, V65, P2; JORM AF, 1983, BRIT J PSYCHOL, V74, P311, DOI 10.1111/j.2044-8295.1983.tb01865.x; KNAPP M, 1993, GENET EPIDEMIOL, V10, P413, DOI 10.1002/gepi.1370100614; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LANGE K, 1989, AM J HUM GENET, V45, P959; LANGE K, 1991, AM J HUM GENET, V49, P959; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWITTER FI, 1980, BEHAV GENET, V10, P9, DOI 10.1007/BF01067316; LINDAMOOD CH, 1971, LINDAMOND AUDITORY C; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; LUBS HA, 1991, READING BRAIN BIOL B, P89; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; LYON GR, 1991, HDB ASSESSMENT LEARN, P60; MEYER M, IN PRESS J LEARNING; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; PENNINGTON BF, 1987, ANN DYSLEXIA, V37, P62, DOI 10.1007/BF02648060; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; PENNINGTON BF, 1990, J CHILD PSYCHOL PSYC, V31, P193, DOI 10.1111/j.1469-7610.1990.tb01561.x; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; RICHARDSON E, 1985, DECODING SKILLS; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; Rosner J., 1979, TEST AUDITORY ANAL S; RUMSEY JM, 1992, JAMA-J AM MED ASSOC, V19, P912; RUTTER M, 1975, J CHILD PSYCHOL PSYC, V16, P181, DOI 10.1111/j.1469-7610.1975.tb01269.x; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; SHARE DL, 1987, BRIT J DEV PSYCHOL, V5, P35, DOI 10.1111/j.2044-835X.1987.tb01039.x; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; SIEGEL LS, 1989, J LEARN DISABIL-US, V22, P469, DOI 10.1177/002221948902200803; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; SOBEL E, 1995, GENETIC MAPPING DNA; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; STEVENSON J, 1991, READ WRIT INTERDISC, V219, P1345; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; TORGESEN JK, 1994, J LEARN DISABIL, V27, P276, DOI 10.1177/002221949402700503; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WOLF M, COGNITIVE LINGUISTIC; Woodcock R.W., 1977, WOODCOCK JOHNSON PSY	72	377	384	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					27	39						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WA818	8981944				2022-12-18	WOS:A1997WA81800007
J	RISCH, N				RISCH, N			LINKAGE STRATEGIES FOR GENETICALLY COMPLEX TRAITS .3. THE EFFECT OF MARKER POLYMORPHISM ON ANALYSIS OF AFFECTED RELATIVE PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHS [GM 39812] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; LANGE K, 1986, AM J HUM GENET, V39, P148; MORTON NE, 1955, AM J HUM GENET, V7, P277; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1989, GENET EPIDEMIOL, V6, P143, DOI 10.1002/gepi.1370060127; THOMSON G, 1986, AM J HUM GENET, V39, P207; WEEKS DE, 1988, AM J HUM GENET, V42, P315	9	377	382	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					242	253						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301394				2022-12-18	WOS:A1990CM93800004
J	Estivill, X; Govea, N; Barcelo, A; Perello, E; Badenas, C; Romero, E; Moral, L; Scozzari, R; D'Urbano, L; Zeviani, M; Torroni, A				Estivill, X; Govea, N; Barcelo, A; Perello, E; Badenas, C; Romero, E; Moral, L; Scozzari, R; D'Urbano, L; Zeviani, M; Torroni, A			Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-SYNDROMIC DEAFNESS; RIBOSOMAL-RNA GENE; HEARING-LOSS; POINT MUTATION; HAPLOGROUPS; PEDIGREE; ANCIENT; HOMOLOG	Hearing loss involves both genetic and environmental factors. A mutation (A1555G) in the mtDNA has been associated with aminoglycoside-induced and nonsyndromic sensorineural deafness. The pathological significance of this mutation in Caucasoid families has not been established, and its relationship with antibiotic treatment is not well understood. We studied 70 Spanish families with sensorineural deafness (36 congenital and 34 late onset) for the mtDNA A1555G mutation. The A1555G mutation was found in 12 families with maternally transmitted deafness but not in the other 51 families or in 200 control subjects. In 12 families all the patients with. the A1555G mutation who received aminoglycosides became deaf, representing 30.3% of the deaf patients in these families. None of the deaf patients from seven other families received aminoglycosides. Overall, only 17.7% of the patients with deafness and the A1555G mutation had been treated with aminoglycosides. The age at onset of deafness was lower (median age 5 years, range 1-52 years) in those treated with aminoglycosides than in those who did not receive antibiotics (median age 20 years, range 1-65 years) (P < .001). The mtDNA of these families belongs to haplotypes common in Europeans. These data indicate that the A1555G mutation accounts for a large proportion of the Spanish families with late-onset sensorineural deafness, that the A1555G mutation has an age-dependent penetrance for deafness (enhanced by treatment with aminoglycosides), and that mtDNA backgrounds probably do not play a major role in disease expression.	Hosp Duran & Reynals, IRO, Med & Mol Genet Ctr, Barcelona 08907, Spain; Hosp Clin Barcelona, Serv Genet, Barcelona, Spain; Hosp Clin Barcelona, Serv Otorrinolaringol, Barcelona, Spain; Hosp Badalona Germans Trias & Pujol, Serv Otorrinolaringol, Badalona, Spain; Ctr Salud Ciudad Jardin, Alicante, Spain; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Childrens Hosp, Mol Med Unit, Rome, Italy; Ist Nazl Neurol Carlo Besta, Div Biochem & Genet, Milan, Italy	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Hospital Germans Trias i Pujol; Sapienza University Rome; IRCCS Istituto Neurologico Besta	Estivill, X (corresponding author), Hosp Duran & Reynals, IRO, Med & Mol Genet Ctr, Barcelona 08907, Spain.	estivill@iro.es	Zeviani, Massimo/AAU-2632-2021; Estivill, Xavier/A-3125-2013; Zeviani, Massimo/K-2891-2014; Badenas, Celia/ABH-5480-2020; Estivill, Xavier/E-2957-2012; Torroni, Antonio/E-1557-2011; barcelo, anna/K-2383-2014	Zeviani, Massimo/0000-0002-9067-5508; Estivill, Xavier/0000-0002-0723-2256; Badenas, Celia/0000-0002-0621-0477; Torroni, Antonio/0000-0002-4163-4478; Moral Gil, Luis/0000-0002-7066-6073	Telethon [E.0069] Funding Source: Medline	Telethon(Fondazione Telethon)		Basile AS, 1996, NAT MED, V2, P1338, DOI 10.1038/nm1296-1338; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BROWN KS, 1969, MED CLIN N AM, V53, P741, DOI 10.1016/S0025-7125(16)32731-6; CHEN YS, 1995, AM J HUM GENET, V57, P133; Cohen M. M., 1995, HEREDITARY HEARING L, P9; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; ElSchahawi M, 1997, NEUROLOGY, V48, P453, DOI 10.1212/WNL.48.2.453; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L; GORLIN RJ, 1995, HEREDITARY HEARING L, P43; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; Hawkins JE, 1976, HDB SENSORY PHYSL, P707; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KONIGSMARK BW, 1969, NEW ENGL J MED, V281, P713, DOI 10.1056/NEJM196909252811306; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; NADOL JB, 1993, NEW ENGL J MED, V329, P1092, DOI 10.1056/NEJM199310073291507; NANCE WE, 1975, OTOLARYNG CLIN N AM, V8, P19; Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; STEEL KP, 1994, TRENDS GENET, V10, P428, DOI 10.1016/0168-9525(94)90113-9; Swofford D, 1993, PHYLOGENETIC ANAL US; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; Usami S, 1997, LARYNGOSCOPE, V107, P483, DOI 10.1097/00005537-199704000-00011; VanCamp G, 1997, AM J HUM GENET, V60, P758; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	37	376	421	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					27	35		10.1086/301676	http://dx.doi.org/10.1086/301676			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9490575	Green Published, Bronze			2022-12-18	WOS:000072127900007
J	Deardorff, MA; Kaur, M; Yaeger, D; Rampuria, A; Korolev, S; Pie, J; Gil-Rodriguez, C; Arnedo, M; Loeys, B; Kline, AD; Wilson, M; Lillquist, K; Siu, V; Ramos, FJ; Musio, A; Jackson, LS; Dorsett, D; Krantz, ID				Deardorff, Matthew A.; Kaur, Maninder; Yaeger, Dinah; Rampuria, Abhinav; Korolev, Sergey; Pie, Juan; Gil-Rodriguez, Concepcion; Arnedo, Maria; Loeys, Bart; Kline, Antonie D.; Wilson, Meredith; Lillquist, Kaj; Siu, Victoria; Ramos, Feliciano J.; Musio, Antonio; Jackson, Laird S.; Dorsett, Dale; Krantz, Ian D.			Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of Cornelia de Lange syndrome with predominant mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRACHMANN-DELANGE SYNDROME; SISTER-CHROMATID COHESION; NIPPED-B; ROBERTS-SYNDROME; ATP HYDROLYSIS; HUMAN HOMOLOG; CUT GENE; PROTEINS; PHENOTYPE; CHROMOSOME	Mutations in the cohesin regulators NIPBL and ESCO2 are causative of the Cornelia de Lange syndrome (CdLS) and Roberts or SC phocomelia syndrome, respectively. Recently, mutations in the cohesin complex structural component SMC1A have been identified in two probands with features of CdLS. Here, we report the identification of a mutation in the gene encoding the complementary subunit of the cohesin heterodimer, SMC3, and 14 additional SMC1A mutations. All mutations are predicted to retain an open reading frame, and no truncating mutations were identified. Structural analysis of the mutant SMC3 and SMC1A proteins indicate that all are likely to produce functional cohesin complexes, but we posit that they may alter their chromosome binding dynamics. Our data indicate that SMC3 and SMC1A mutations ( 1) contribute to similar to 5% of cases of CdLS, ( 2) result in a consistently mild phenotype with absence of major structural anomalies typically associated with CdLS, and ( 3) in some instances, result in a phenotype that approaches that of apparently nonsyndromic mental retardation.	Childrens Hosp Philadelphia, Div Human & Mol Genet, Abramson Res Ctr 1002, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Drexel Univ, Sch Med, Div Obstet & Gynecol, Philadelphia, PA 19104 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63103 USA; Univ Zaragoza, Fac Med, Grp Genet Clin & Genom Funct, Zaragoza, Spain; Ghent Univ Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; Harvey Inst Human Genet, Baltimore, MD USA; Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; Sygehus Vendsyssel, Dept Pediat, Hjorring, Denmark; Childrens Hosp Western Ontario, London, England; CNR, Inst Biomed Technol, Human Genome Dept, Segrate, Italy	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Drexel University; Saint Louis University; University of Zaragoza; Ghent University; Ghent University Hospital; University of Sydney; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Krantz, ID (corresponding author), Childrens Hosp Philadelphia, Div Human & Mol Genet, Abramson Res Ctr 1002, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ian2@mail.med.upenn.edu	Dorsett, Dale/A-8197-2009; Loeys, Bart/B-3236-2017; Musio, Antonio/GRO-1712-2022; Arnedo, Maria/ABF-8821-2020; Ramos, Feliciano J./ABH-8920-2020; Korolev, Sergey/ABA-7517-2020	Loeys, Bart/0000-0003-3703-9518; Arnedo, Maria/0000-0001-9962-2157; Ramos, Feliciano J./0000-0002-5732-2209; Korolev, Sergey/0000-0001-9313-7126; MUSIO, ANTONIO/0000-0001-7701-6543; Dorsett, Dale/0000-0002-0507-2762; Pie Juste, Juan/0000-0003-3203-6254	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837, R01GM055683] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD052860-010003, R01 HD39323, R01 HD039323, P01 HD052860] Funding Source: Medline; NIGMS NIH HHS [R01 GM055683-09, R01 GM073837, R01 GM055683] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allanson JE, 1997, J MED GENET, V34, P645, DOI 10.1136/jmg.34.8.645; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bhuiyan ZA, 2006, J MED GENET, V43, P568, DOI 10.1136/jmg.2005.038240; BROWN CJ, 1995, HUM MOL GENET, V4, P251, DOI 10.1093/hmg/4.2.251; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; IRELAND M, 1993, AM J MED GENET, V47, P959, DOI 10.1002/ajmg.1320470705; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; KLINE AD, 1993, AM J MED GENET, V47, P1042, DOI 10.1002/ajmg.1320470722; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kuczmarski RJ, 2000, Adv Data, P1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; SAUL RA, 1993, AM J MED GENET, V47, P999, DOI 10.1002/ajmg.1320470712; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; VANALLEN MI, 1993, AM J MED GENET, V47, P947, DOI 10.1002/ajmg.1320470704; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Yan J, 2006, AM J MED GENET A, V140A, P1531, DOI 10.1002/ajmg.a.31305	30	375	388	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					485	494		10.1086/511888	http://dx.doi.org/10.1086/511888			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273969	Green Published, Bronze			2022-12-18	WOS:000244403300009
J	Elliott, HR; Samuels, DC; Eden, JA; Relton, CL; Chinnery, PF				Elliott, Hannah R.; Samuels, David C.; Eden, James A.; Relton, Caroline L.; Chinnery, Patrick F.			Pathogenic mitochondrial DNA mutations are common in the general population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; DIABETES-MELLITUS; PREVALENCE; EPIDEMIOLOGY; DISEASE; SEGREGATION; EXPRESSION; CHILDREN; A3243G	Mitochondrial DNA (mtDNA) mutations are a major cause of genetic disease, but their prevalence in the general population is not known. We determined the frequency of ten mitochondrial point mutations in 3168 neonatal-cord-blood samples from sequential live births, analyzing matched maternal-blood samples to estimate the de novo mutation rate. mtDNA mutations were detected in 15 offspring (0.54%, 95% CI = 0.30-0.89%). Of these live births, 0.00107% (95% CI = 0.00087-0.0127) harbored a mutation not detected in the mother's blood, providing an estimate of the de novo mutation rate. The most common mutation was m.3243A -> G. m.14484T -> C was only found on sub-branches of mtDNA haplogroup J. In conclusion, at least one in 200 healthy humans harbors a pathogenic mtDNA mutation that potentially causes disease in the offspring of female carriers. The exclusive detection of m.14484T -> C on haplogroup J implicates the background mtDNA haplotype in mutagenesis. These findings emphasize the importance of developing new approaches to prevent transmission.	[Elliott, Hannah R.; Chinnery, Patrick F.] Univ Newcastle, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Samuels, David C.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Eden, James A.; Relton, Caroline L.; Chinnery, Patrick F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Virginia Polytechnic Institute & State University; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Samuels, David/AHC-8381-2022; Relton, Caroline/AAC-5904-2019; Elliott, Hannah/AAP-3170-2021; Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008	Samuels, David/0000-0003-3529-7791; Elliott, Hannah/0000-0002-1500-3533; Samuels, David C/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617; Relton, Caroline/0000-0003-2052-4840	United Mitochondrial Diseases Foundation; EU FP6 program; EUmitocombat; MITOCIRCLE; Parkinsons Disease Society (UK); Medical Research Council (UK)	United Mitochondrial Diseases Foundation; EU FP6 program(European Commission); EUmitocombat; MITOCIRCLE; Parkinsons Disease Society (UK)(Parkinson's UK); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was principally funded by the United Mitochondrial Diseases Foundation, with additional support from the Association Francaise contre les Myopathies. P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science who also receives funding from the EU FP6 program, EUmitocombat and MITOCIRCLE, the Parkinsons Disease Society (UK), and the Medical Research Council (UK). The authors are grateful for technical assistance from Jocelyn Davies and expert advice given by Simon Pearce and John Burn.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Armitage P., 2002, STAT METHODS MED RES; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G; Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75; Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Ji LN, 2001, DIABETES RES CLIN PR, V54, pS35, DOI 10.1016/S0168-8227(01)00333-3; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; Klemm T, 2001, EXP CLIN ENDOCR DIAB, V109, P283, DOI 10.1055/s-2001-16348; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.3.CO;2-N; ODAWARA M, 1995, J CLIN ENDOCR METAB, V80, P1290, DOI 10.1210/jc.80.4.1290; Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109; Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007; Relton CL, 2004, MUTAT RES-FUND MOL M, V545, P49, DOI 10.1016/j.mrfmmm.2003.09.007; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Samuels DC, 2003, NUCLEIC ACIDS RES, V31, P6043, DOI 10.1093/nar/gkg784; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; tHart LM, 1996, HUM MUTAT, V7, P193; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196	31	374	386	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					254	260		10.1016/j.ajhg.2008.07.004	http://dx.doi.org/10.1016/j.ajhg.2008.07.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18674747	Green Published, hybrid			2022-12-18	WOS:000258418200010
J	Hagerman, PJ; Hagerman, RJ				Hagerman, PJ; Hagerman, RJ			The fragile-X premutation: A maturing perspective	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CEREBELLAR TREMOR/ATAXIA SYNDROME; INTRANUCLEAR INCLUSION DISEASE; RAPID ANTIBODY-TEST; FMR1 MESSENGER-RNA; CGG-REPEAT; TRINUCLEOTIDE REPEAT; SPINOCEREBELLAR ATAXIAS; HEREDITARY ATAXIAS; FULL MUTATION; AFRICAN-AMERICANS	Carriers of premutation alleles (55-200 CGG repeats) of the fragile-X mental retardation 1 (FMR1) gene are often regarded as being clinically uninvolved. However, it is now apparent that such individuals can present with one ( or more) of three distinct clinical disorders: mild cognitive and/or behavioral deficits on the fragile-X spectrum; premature ovarian failure; and a newly described, neurodegenerative disorder of older adult carriers, fragile-X-associated tremor/ataxia syndrome (FXTAS). Awareness of these clinical presentations is important for proper diagnosis and therapeutic intervention, not only among families with known cases of fragile-X syndrome but also more broadly for adults with tremor, gait ataxia, and parkinsonism who are seen in movement-disorders clinics.	Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; Univ Calif Davis, Med Ctr, Med Invest Neurodev Disorders Inst, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hagerman, PJ (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, 4303 Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.	pjhagerman@ucdavis.edu			NICHD NIH HHS [HD36071, R01 HD036071, R01 HD040661, HD40661] Funding Source: Medline; NINDS NIH HHS [NS43532, R01 NS043532] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043532] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Arocena DG, 2003, HUM GENET, V113, P371, DOI 10.1007/s00439-003-0982-9; Aziz M, 2003, AM J MED GENET B, V121B, P119, DOI 10.1002/ajmg.b.20030; Beilina A, 2004, HUM MOL GENET, V13, P543, DOI 10.1093/hmg/ddh053; Bennetto L, 2001, NEUROPSYCHOLOGY, V15, P290, DOI 10.1037/0894-4105.15.2.291; Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522; Brin MF, 1998, MOVEMENT DISORD, V13, P55; Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; Crawford DC, 2000, HUM MOL GENET, V9, P1759, DOI 10.1093/hmg/9.12.1759; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DIMARIA E, 2003, AM SOC HUM GEN 53 AN; Dogu O, 2003, NEUROLOGY, V61, P1804, DOI 10.1212/01.WNL.0000099075.19951.8C; Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FILLA A, 1992, J NEUROL, V239, P351, DOI 10.1007/BF00867594; Finsterer J, 2002, EUR J NEUROL, V9, P441, DOI 10.1046/j.1468-1331.2002.00453.x; Franke P, 1998, PSYCHIAT RES, V80, P113, DOI 10.1016/S0165-1781(98)00055-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GANE LW, 2002, FRAGILE X SYNDROME D, P251; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Hagerman Paul J., 2003, Neurology, V60, pA469; Hagerman PJ, 2003, CYTOGENET GENOME RES, V100, P206, DOI 10.1159/000072856; Hagerman R., 2002, FRAGILE X SYNDROME D, P287; Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hundscheid RDL, 2001, HUM REPROD, V16, P457, DOI 10.1093/humrep/16.3.457; Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Johnston C, 2001, AM J MED GENET, V103, P314, DOI 10.1002/ajmg.1561; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kimber TE, 1998, J NEUROL SCI, V160, P33, DOI 10.1016/S0022-510X(98)00169-5; Leehey MA, 2003, ARCH NEUROL-CHICAGO, V60, P117, DOI 10.1001/archneur.60.1.117; LEONE M, 1995, ACTA NEUROL SCAND, V91, P183; Loesch DZ, 2003, AM J MED GENET A, V122A, P13, DOI 10.1002/ajmg.a.20214; Loesch DZ, 2003, AM J MED GENET A, V118A, P127, DOI 10.1002/ajmg.a.10099; LOESCH DZ, 1994, AM J MED GENET, V51, P392, DOI 10.1002/ajmg.1320510418; LOUIS ED, 1995, ARCH NEUROL-CHICAGO, V52, P1201, DOI 10.1001/archneur.1995.00540360079019; Macpherson J, 2003, HUM GENET, V112, P619, DOI 10.1007/s00439-003-0939-z; Maddalena Anne, 2001, Genetics in Medicine, V3, P200, DOI 10.1097/00125817-200105000-00010; Mankodi A, 2002, CURR OPIN NEUROL, V15, P545, DOI 10.1097/00019052-200210000-00005; Marozzi A, 2000, HUM REPROD, V15, P197, DOI 10.1093/humrep/15.1.197; MICHAUD J, 1981, ACTA NEUROPATHOL, V54, P113, DOI 10.1007/BF00689403; Mori M, 2001, NEUROEPIDEMIOLOGY, V20, P144, DOI 10.1159/000054775; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; Primerano B, 2002, RNA, V8, P1482, DOI 10.1017/s1355838202020642; Pujana MA, 1999, HUM GENET, V104, P516, DOI 10.1007/s004390050997; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; REISS AL, 1993, AM J HUM GENET, V52, P884; Riddle JE, 1998, AM J MENT RETARD, V102, P590; Rogers C, 2003, CLIN GENET, V64, P54, DOI 10.1034/j.1399-0004.2003.00089.x; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Schenck A, 2002, NEUROBIOL DIS, V11, P53, DOI 10.1006/nbdi.2002.0510; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; SMITS A, 2002, 8 INT FRAG X C CHIC; SOBESKY WE, 1996, FRAGILE X SYNDROME D, P332; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tassone F, 2000, AM J MED GENET, V94, P232, DOI 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H; Tassone F, 2003, CYTOGENET GENOME RES, V100, P124, DOI 10.1159/000072846; Tassone F, 2000, AM J MED GENET, V91, P144, DOI 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2001, J MED GENET, V38, P453, DOI 10.1136/jmg.38.7.453; Tassone F, 2000, AM J MED GENET, V97, P195, DOI 10.1002/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R; van de Warrenburg BPC, 2002, NEUROLOGY, V58, P702, DOI 10.1212/WNL.58.5.702; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; Willemsen R, 1997, J MED GENET, V34, P250, DOI 10.1136/jmg.34.3.250; Zannolli R, 2002, ARCH NEUROL-CHICAGO, V59, P1319, DOI 10.1001/archneur.59.8.1319; ZHONG N, 1995, AM J HUM GENET, V57, P351; Zhong N, 1996, AM J MED GENET, V64, P261, DOI 10.1002/(SICI)1096-8628(19960809)64:2<261::AID-AJMG5>3.0.CO;2-X	80	374	384	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					805	816		10.1086/386296	http://dx.doi.org/10.1086/386296			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15052536	Green Published, Bronze			2022-12-18	WOS:000220926100003
J	Reid, E; Kloos, M; Ashley-Koch, A; Hughes, L; Bevan, S; Svenson, IK; Graham, FL; Gaskell, PC; Dearlove, A; Pericak-Vance, MA; Rubinsztein, DC; Marchuk, DA				Reid, E; Kloos, M; Ashley-Koch, A; Hughes, L; Bevan, S; Svenson, IK; Graham, FL; Gaskell, PC; Dearlove, A; Pericak-Vance, MA; Rubinsztein, DC; Marchuk, DA			A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; NUCLEOTIDE-BINDING; AXONAL-TRANSPORT; DISEASE; DROSOPHILA; MECHANISM; PROTEINS; NEURONS; ELEGANS; ATPASE	We have identified a missense mutation in the motor domain of the neuronal kinesin heavy chain gene KIF5A, in a family with hereditary spastic paraplegia. The mutation occurs in the family in which the SPG10 locus was originally identified, at an invariant asparagine residue that, when mutated in orthologous kinesin heavy chain motor proteins, prevents stimulation of the motor ATPase by microtubule-binding. Mutation of kinesin orthologues in various species leads to phenotypes resembling hereditary spastic paraplegia. The conventional kinesin motor powers intracellular movement of membranous organelles and other macromolecular cargo from the neuronal cell body to the distal tip of the axon. This finding suggests that the underlying pathology of SPG10 and possibly of other forms of hereditary spastic paraplegia may involve perturbation of neuronal anterograde (or retrograde) axoplasmic flow, leading to axonal degeneration, especially in the longest axons of the central nervous system.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; Babraham Bioincubator, MRC, UK Human Genome Mapping Project Resource Ctr, Cambridge, England	Duke University; Duke University; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Marchuk, DA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.		Rubinsztein, David C/C-3472-2011; Reid, Evan/F-3250-2010	Reid, Evan/0000-0003-1623-7304; Marchuk, Douglas/0000-0002-3110-6671; Ashley-Koch, Allison/0000-0001-5409-9155	NINDS NIH HHS [P01 NS026630, P01 NS 26630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashley-Koch A, 2001, NEUROGENETICS, V3, P91, DOI 10.1007/s100480000098; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Fink JK, 2002, ANN NEUROL, V51, P669, DOI 10.1002/ana.10258; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOYT MA, 1993, GENETICS, V135, P35; Hurd DD, 1996, GENETICS, V144, P1075; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; PATEL N, 1993, P NATL ACAD SCI USA, V90, P9181, DOI 10.1073/pnas.90.19.9181; Reid E, 1999, J NEUROL, V246, P995, DOI 10.1007/s004150050503; Reid E, 1999, AM J HUM GENET, V65, P757, DOI 10.1086/302555; Reid E, 2001, J MED GENET, V38, P65, DOI 10.1136/jmg.38.1.65; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	27	374	393	0	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1189	1194		10.1086/344210	http://dx.doi.org/10.1086/344210			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12355402	Green Published, Bronze			2022-12-18	WOS:000178884300017
J	Goring, HHH; Terwilliger, JD; Blangero, J				Goring, HHH; Terwilliger, JD; Blangero, J			Large upward bias in estimation of locus-specific effects from genomewide scans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; LINKAGE ANALYSIS; VARIANCE-COMPONENTS; RECOMBINATION FRACTIONS; PEDIGREE ANALYSIS; INFERENCE; ASCERTAINMENT; EXTENSIONS; FAMILIES; PROBANDS	The primary goal of a genomewide scan is to estimate the genomic locations of genes influencing a trait of interest. It is sometimes said that a secondary goal is to estimate the phenotypic effects of each identified locus. Here, it is shown that these two objectives cannot be met reliably by use of a single data set of a currently realistic size. Simulation and analytical results, based on variance-components linkage analysis as an example, demonstrate that estimates of locus-specific effect size at genomewide LOD score peaks tend to be grossly inflated and can even be virtually independent of the true effect size, even for studies on large samples when the true effect size is small. However, the bias diminishes asymptotically. The explanation for the bias is that the LOD score is a function of the locus-specific effect-size estimate, such that there is a high correlation between the observed statistical significance and the effect-size estimate. When the LOD score is maximized over the many pointwise tests being conducted throughout the genome, the locus-specific effect-size estimate is therefore effectively maximized as well. We argue that attempts at bias correction give unsatisfactory results, and that pointwise estimation in an independent data set may be the only way of obtaining reliable estimates of locus-specific effect-and then only if one does not condition on statistical significance being obtained. We further show that the same factors causing this bias are responsible for frequent failures to replicate initial claims of linkage or association for complex traits, even when the initial localization is, in fact, correct. The findings of this study have wide-ranging implications, as they apply to all statistical methods of gene localization. It is hoped that, by keeping this bias in mind, we will more realistically interpret and extrapolate from the results of genomewide scans.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Texas Biomedical Research Institute; Columbia University; Columbia University; New York State Psychiatry Institute	Goring, HHH (corresponding author), SW Fdn Biomed Res, Dept Genet, POB 760549, San Antonio, TX 78245 USA.	hgoring@darwin.sfbr.org	Blangero, John/ABA-7175-2021		NHLBI NIH HHS [P01 HL028972, HL45522, HL28972, P01 HL045522] Funding Source: Medline; NIGMS NIH HHS [R01 GM031575, GM31575] Funding Source: Medline; NIMH NIH HHS [MH63749, R01 MH059490, R37 MH059490, R01 MH063749, MH59490] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522, P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490, R01MH063749] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; BEATY TH, 1987, GENET EPIDEMIOL, V4, P203, DOI 10.1002/gepi.1370040305; Beavis William D., 1998, P145; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 2000, HUM BIOL, V72, P35; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BOEHNKE M, 1984, AM J HUM GENET, V36, P1298; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; EDWARDS JH, 1976, CYTOGENET CELL GENET, V16, P289, DOI 10.1159/000130612; Falconer DS, 1996, INTRO QUANTITATIVE G; Faraway JJ, 1992, J COMPUTATIONAL GRAP, V1, P213; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; GEORGES M, 1995, GENETICS, V139, P907; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; GORING HHH, 2000, THESIS COLUMBIA U NE; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; JONES DR, 1982, INT J EPIDEMIOL, V11, P276, DOI 10.1093/ije/11.3.276; Kearsey MJ, 1998, HEREDITY, V80, P137, DOI 10.1046/j.1365-2540.1998.00500.x; LANDE R, 1990, GENETICS, V124, P743; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; LINDSAY RM, 1993, AM STAT, V47, P217, DOI 10.2307/2684982; Melchinger AE, 1998, GENETICS, V149, P383; Miller A., 1990, SUBSET SELECTION REG; MORTON NE, 1955, AM J HUM GENET, V7, P277; Mukhopadhyay N, 2000, AM J HUM GENET, V67, P235; RAO DC, 1988, AM J HUM GENET, V42, P506; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Stuart A., 1991, KENDALLS ADV THEORY, V2; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 2000, HUM BIOL, V72, P63; TERWILLIGER JD, IN PRESS SHENGMING K; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; UTZ HF, 1994, BIOMETRICS IN PLANT BREEDING: APPLICATIONS OF MOLECULAR MARKERS, P195; Utz HF, 2000, GENETICS, V154, P1839; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; [No title captured]	48	374	382	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1357	1369		10.1086/324471	http://dx.doi.org/10.1086/324471			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11593451	Bronze, Green Published			2022-12-18	WOS:000172086900019
J	Hua, YM; Vickers, TA; Okunola, HL; Bennett, CF; Krainer, AR				Hua, Yimin; Vickers, Timothy A.; Okunola, Hazeem L.; Bennett, C. Frank; Krainer, Adrian R.			Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MESSENGER-RNA; EXON-7 INCLUSION; SINGLE NUCLEOTIDE; BINDING-SITES; A/B PROTEINS; GENE; A1; ELEMENT	survival of motor neuron 2, centromeric (SMN2) is a gene that modifies the severity of spinal muscular atrophy (SMA), a motor-neuron disease that is the leading genetic cause of infant mortality. Increasing inclusion of SMN2 exon 7, which is predominantly skipped, holds promise to treat or possibly cure SMA; one practical strategy is the disruption of splicing silencers that impair exon 7 recognition. By using an antisense oligonucleotide (ASO)-tiling method, we systematically screened the proximal intronic regions flanking exon 7 and identified two intronic splicing silencers (ISSs): one in intron 6 and a recently described one in intron 7. We analyzed the intron 7 ISS by mutagenesis, coupled with splicing assays, RNA-affinity chromatography, and protein overexpression, and found two tandem hnRNP A1/A2 motifs within the ISS that are responsible for its inhibitory character. Mutations in these two motifs, or ASOs that block them, promote very efficient exon 7 inclusion. We screened 31 ASOs in this region and selected two optimal ones to test in human SMN2 transgenic mice. Both ASOs strongly increased hSMN2 exon 7 inclusion in the liver and kidney of the transgenic animals. Our results show that the high-resolution ASO-tiling approach can identify cis-elements that modulate splicing positively or negatively. Most importantly, our results highlight the therapeutic potential of some of these ASOs in the context of SMA.	[Hua, Yimin; Okunola, Hazeem L.; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Vickers, Timothy A.; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	krainer@cshl.edu	Hua, Yimin/U-6911-2018	Hua, Yimin/0000-0003-0905-7989; Krainer, Adrian/0000-0001-9024-9501	NIGMS NIH HHS [R37 GM042699, GM42699, R01 GM042699] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699, R37GM042699] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AbdulManan N, 1996, NUCLEIC ACIDS RES, V24, P4063, DOI 10.1093/nar/24.20.4063; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Coady TH, 2007, MOL THER, V15, P1471, DOI 10.1038/sj.mt.6300222; Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; Dean NM, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P319; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Geary RS, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P119; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hua Y, 2004, CELL MOL LIFE SCI, V61, P2658, DOI 10.1007/s00018-004-4300-z; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hutchison S, 2002, J BIOL CHEM, V277, P29745, DOI 10.1074/jbc.M203633200; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Miyajima H, 2002, J BIOL CHEM, V277, P23271, DOI 10.1074/jbc.M200851200; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scholl R, 2007, RNA BIOL, V4, P34, DOI 10.4161/rna.4.1.4534; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; Si ZH, 1998, MOL CELL BIOL, V18, P5404, DOI 10.1128/MCB.18.9.5404; Sierakowska H, 1996, P NATL ACAD SCI USA, V93, P12840, DOI 10.1073/pnas.93.23.12840; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Wirth B, 2006, PROG MOLEC, V44, P109; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	77	373	410	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					834	848		10.1016/j.ajhg.2008.01.014	http://dx.doi.org/10.1016/j.ajhg.2008.01.014			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18371932	Bronze, Green Published			2022-12-18	WOS:000255103900003
J	Fromer, M; Moran, JL; Chambert, K; Banks, E; Bergen, SE; Ruderfer, DM; Handsaker, RE; McCarroll, SA; O'Donovan, MC; Owen, MJ; Kirov, G; Sullivan, PF; Hultman, CM; Sklar, P; Purcell, SM				Fromer, Menachem; Moran, Jennifer L.; Chambert, Kimberly; Banks, Eric; Bergen, Sarah E.; Ruderfer, Douglas M.; Handsaker, Robert E.; McCarroll, Steven A.; O'Donovan, Michael C.; Owen, Michael J.; Kirov, George; Sullivan, Patrick F.; Hultman, Christina M.; Sklar, Pamela; Purcell, Shaun M.			Discovery and Statistical Genotyping of Copy-Number Variation from Whole-Exome Sequencing Depth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION-SCALE; SCHIZOPHRENIA; ACCURATE; IDENTIFICATION; DUPLICATIONS; CNV	Sequencing of gene-coding regions (the exome) is increasingly used for studying human disease, for which copy-number variants (CNVs) are a critical genetic component. However, detecting copy number from exome sequencing is challenging because of the noncontiguous nature of the captured exons. This is compounded by the complex relationship between read depth and copy number; this results from biases in targeted genomic hybridization, sequence factors such as GC content, and batching of samples during collection and sequencing. We present a statistical tool (exome hidden Markov model [XHMM]) that uses principal-component analysis (PCA) to normalize exome read depth and a hidden Markov model (HMM) to discover exon-resolution CNV and genotype variation across samples. We evaluate performance on 90 schizophrenia trios and 1,017 case-control samples. X HMM detects a median of two rare (<1%) CNVs per individual (one deletion and one duplication) and has 79% sensitivity to similarly rare CNVs overlapping three or more exons discovered with microarrays. With sensitivity similar to state-of-the-art methods, XHMM achieves higher specificity by assigning quality metrics to the CNV calls to filter out bad ones, as well as to statistically genotype the discovered CNV in all individuals, yielding a trio call set with Mendelian-inheritance properties highly consistent with expectation. We also show that XHMM breakpoint quality scores enable researchers to explicitly search for novel classes of structural variation. For example, we apply XHMM to extract those CNVs that are highly likely to disrupt (delete or duplicate) only a portion of a gene.	[Fromer, Menachem; Ruderfer, Douglas M.; Sklar, Pamela; Purcell, Shaun M.] Mt Sinai Sch Med, Div Psychiat Genom, New York, NY 10029 USA; [Fromer, Menachem; Moran, Jennifer L.; Chambert, Kimberly; Bergen, Sarah E.; Ruderfer, Douglas M.; McCarroll, Steven A.; Purcell, Shaun M.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Fromer, Menachem; Banks, Eric; Handsaker, Robert E.; McCarroll, Steven A.; Purcell, Shaun M.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Fromer, Menachem; Banks, Eric; Handsaker, Robert E.; McCarroll, Steven A.; Purcell, Shaun M.] MIT, Cambridge, MA 02142 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Fromer, Menachem; Bergen, Sarah E.; Ruderfer, Douglas M.; Purcell, Shaun M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [O'Donovan, Michael C.; Owen, Michael J.; Kirov, George] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Sch Med,Dept Psychol Med & Neurol, Med Res Council,Ctr Neuropsychiat Genet & Genom, Cardiff CF14 4XN, S Glam, Wales; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden	Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cardiff University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	Fromer, M (corresponding author), Mt Sinai Sch Med, Div Psychiat Genom, New York, NY 10029 USA.	menachem.fromer@mssm.edu; shaun.purcell@mssm.edu	Handsaker, Bob/AAX-9095-2021; O'Donovan, Michael C/P-7005-2018; Ruderfer, Douglas M/M-5795-2016; Bergen, Sarah/I-8313-2012; Fromer, Menachem/G-2116-2012	Handsaker, Bob/0000-0002-3128-3547; O'Donovan, Michael C/0000-0001-7073-2379; Ruderfer, Douglas M/0000-0002-2365-386X; Bergen, Sarah/0000-0002-5888-0034; Moran, Jennifer/0000-0002-5664-4716; Kirov, George/0000-0002-3427-3950; Fromer, Menachem/0000-0003-3749-4342	National Institute of Health [RC2MH089905, R01HG005827]; Sylvan Herman Foundation; Medical Research Council [G0801418B] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095034, RC2MH089905] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sylvan Herman Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Mark DePristo, Joeseph Buxbaum, and Edward Scolnick for their helpful discussions. This work was supported by National Institute of Health grants RC2MH089905 (to principal investigators S.M.P. and P.S.) and R01HG005827 (to S.M.P.) and by the Sylvan Herman Foundation.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; EVERITT B.S., 1992, APPL MULTIVARIATE DA, DOI [10.1002/9781118887486, DOI 10.1002/9781118887486]; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Karakoc E, 2012, NAT METHODS, V9, P176, DOI [10.1038/NMETH.1810, 10.1038/nmeth.1810]; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1732; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nord AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-184; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Smit AFA, 2010, REPEATMASKER OPEN 3; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	34	371	387	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					597	607		10.1016/j.ajhg.2012.08.005	http://dx.doi.org/10.1016/j.ajhg.2012.08.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23040492	Green Published, Bronze			2022-12-18	WOS:000309568500002
J	Rubinsztein, DC; Leggo, J; Coles, R; Almqvist, E; Biancalana, V; Cassiman, JJ; Chotai, K; Connarty, M; Craufurd, D; Curtis, A; Curtis, D; Davidson, MJ; Differ, AM; Dode, C; Dodge, A; Frontali, M; Ranen, NG; Stine, OC; Sherr, M; Abbott, MH; Franz, ML; Graham, CA; Harper, PS; Hedreen, JC; Jackson, A; Kaplan, JC; Losekoot, M; MacMillan, JC; Morrison, P; Trottier, Y; Novelletto, A; Simpson, SA; Theilmann, J; Whittaker, JL; Folstein, SE; Ross, CA; Hayden, MR				Rubinsztein, DC; Leggo, J; Coles, R; Almqvist, E; Biancalana, V; Cassiman, JJ; Chotai, K; Connarty, M; Craufurd, D; Curtis, A; Curtis, D; Davidson, MJ; Differ, AM; Dode, C; Dodge, A; Frontali, M; Ranen, NG; Stine, OC; Sherr, M; Abbott, MH; Franz, ML; Graham, CA; Harper, PS; Hedreen, JC; Jackson, A; Kaplan, JC; Losekoot, M; MacMillan, JC; Morrison, P; Trottier, Y; Novelletto, A; Simpson, SA; Theilmann, J; Whittaker, JL; Folstein, SE; Ross, CA; Hayden, MR			Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGE-OF-ONSET; TRINUCLEOTIDE REPEAT; CLINICAL-FEATURES; LENGTH; INSTABILITY; POLYMORPHISM; CHROMOSOMES; POPULATION; EXPANSIONS; FAMILIES	Abnormal CAG expansions in the IT-15 gene are associated with Huntington disease (HD). In the diagnostic setting it is necessary to define the limits of the CAG size ranges on normal and HD-associated chromosomes. Most large analyses that defined the limits of the normal and pathological size ranges employed PCR assays, which included the CAG repeats and a CCG repeat tract that was thought to be invariant. Many of these experiments found an overlap between the normal and disease size ranges. Subsequent findings that the CCG repeats vary by 8 trinucleotide lengths suggested that the limits of the normal and disease size ranges should be reevaluated with assays that exclude the CCG polymorphism. Since patients with between 30 and 40 repeats are rare, a consortium was assembled to collect such individuals. AU 178 samples were reanalyzed in Cambridge by using assays specific for the CAG repeats. We have optimized methods for reliable sizing of CAG repeats and show cases that demonstrate the dangers of using PCR assays that include both the CAG and CCG polymorphisms. Seven HD patients had 36 repeats, which confirms that this allele is associated with disease. Individuals without apparent symptoms or signs of PID were found at 36 repeats (aged 74, 78, 79, and 87 years), 37 repeats (aged 69 years), 38 repeats (aged 69 and 90 years), and 39 repeats (aged 67, 90, and 95 years). The detailed case histories of an exceptional case from this series will be presented: a 95-year-old man with 39 repeats who did not have classical features of HD. The apparently healthy survival into old age of some individuals with 36-39 repeats suggests that the HD mutation may not always be fully penetrant.	UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1TN,ENGLAND; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V5Z 1M9,CANADA; INSERM,CNRS,INST GENET & BIOL MOL & CELLULAIRE,ILLKIRCH GRAFFENS,FRANCE; CHRU,STRASBOURG,FRANCE; UNIV LOUVAIN,CTR HUMAN GENET,LOUVAIN,BELGIUM; NORTHWICK PK HOSP & CLIN RES CTR,KENNEDY GALTON CTR,HARROW HA1 3UJ,MIDDX,ENGLAND; SALISBURY DIST HOSP,WESSEX REG GENET SERV,SALISBURY,WILTS,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; NO GENET SERV,MOL GENET LAB,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; GUYS HOSP,DIV MED & MOL GENET,LONDON SE1 9RT,ENGLAND; HOP COCHIN,BIOCHIM GENET LAB,F-75674 PARIS,FRANCE; TUFTS UNIV,NEW ENGLAND MED CTR,DEPT PSYCHIAT,BOSTON,MA 02111; TUFTS UNIV,NEW ENGLAND MED CTR,DEPT PSYCHIAT & PATHOL,BOSTON,MA 02111; BELFAST CITY HOSP,DEPT MED GENET,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND; UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; JOHNS HOPKINS UNIV,DEPT NEUROSCI,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT PSYCHIAT,BALTIMORE,MD 21218; LEIDEN UNIV,DEPT HUMAN GENET,NL-2300 RA LEIDEN,NETHERLANDS; UNIV ROMA TOR VERGATA,DIPARTIMENTO BIOL,I-00173 ROME,ITALY; CNR,INST EXPT MED,ROME,ITALY; UNIV ABERDEEN,SCH MED,DEPT MED GENET,ABERDEEN AB9 2ZD,SCOTLAND; CTR HUMAN GENET,SHEFFIELD,S YORKSHIRE,ENGLAND; KAROLINSKA INST,DEPT MOL MED & GERIATR MED,S-10401 STOCKHOLM,SWEDEN	University of Cambridge; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; Imperial College London; Salisbury District Hospital; University of Manchester; Newcastle University - UK; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Belfast City Hospital; Cardiff University; Johns Hopkins University; Johns Hopkins University; Leiden University; Leiden University - Excl LUMC; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); University of Aberdeen; Karolinska Institutet	Rubinsztein, DC (corresponding author), ADDENBROOKES NHS TRUST,E ANGLIAN MED GENET SERV,MOL GENET LAB,HILLS RD,BOX 158,CAMBRIDGE CB2 2QQ,ENGLAND.		Rubinsztein, David C/C-3472-2011; Losekoot, Monique/AAC-2182-2022; Trottier, Yvon/H-8852-2016; Craufurd, David/G-5277-2013; Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Trottier, Yvon/0000-0001-7230-4810	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029484, P01NS016375, P50NS016375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 16375, NS 29484] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BRITTON JW, 1995, NEUROLOGY, V45, P443, DOI 10.1212/WNL.45.3.443; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FOLSTEIN SE, 1985, SCIENCE, V229, P776, DOI 10.1126/science.2992086; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; HEDREEN JC, 1995, J NEUROPATH EXP NEUR, V54, P105, DOI 10.1097/00005072-199501000-00013; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Legius Eric, 1994, European Journal of Human Genetics, V2, P44; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; QUAN F, 1995, HUM MOL GENET, V4, P2411, DOI 10.1093/hmg/4.12.2411; QUARREL O, 1991, HUNTINGTONS DISEASE, P37; REISS O, 1993, HUM MOL GENET, V2, P637; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; RUBINSZTEIN DC, 1994, J MED GENET, V31, P690, DOI 10.1136/jmg.31.9.690; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; 1993, CELL, V72, P97	26	371	382	1	16	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					16	22						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659522				2022-12-18	WOS:A1996VL45500004
J	ENGBERSEN, AMT; FRANKEN, DG; BOERS, GHJ; STEVENS, EMB; TRIJBELS, FJM; BLOM, HJ				ENGBERSEN, AMT; FRANKEN, DG; BOERS, GHJ; STEVENS, EMB; TRIJBELS, FJM; BLOM, HJ			THERMOLABILE 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE AS A CAUSE OF MILD HYPERHOMOCYSTEINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; METHYLENETETRAHYDROFOLATE REDUCTASE; RISK FACTOR; CULTURED FIBROBLASTS; VASCULAR-DISEASE; HOMOCYSTINURIA; DEFICIENCY; HETEROZYGOSITY; CELLS	Thermolability of 5,10-methylenetetrahydrofolate reductase (MTHFR) was examined as a possible cause of mild hyperhomocysteinemia in patients with premature vascular disease. Control subjects and vascular patients with mild hyperhomocysteinemia and with normohomocysteinemia were studied. The mean (+/-SD) specific MTHFR activity in lymphocytes of 22 control subjects was 15.6 (+/-4.7) nmol CH2O/mg protein/h (range: 9.1-26.6), and the residual activity (+/-SD) after heat inactivation for 5 min at 46 degrees C was 55.3 (+/-12.0)% (range: 35.9-78.3). By measurement of MTHFR activity, two distinct subgroups of hyperhomocysteinemic patients became evident. One group (n = 11) had thermolabile MTHFR with a mean (+/-SD) specific activity of 8.7 (+/-2.1) nmol CH2O/mg protein/h (range: 5.5-12.7) and a residual activity, after heat inactivation, ranging from 0% to 33%. The other group (n = 28) had normal specific activity (+/-SD) of 21.5 (+/-7.2) nmol CH2O/mg protein/h (range: 10.0-39.0) and a normal residual activity (+/-SD) of 53.8 (+/-9.2)% (range: 33.1-71.5) after heat inactivation. The mean (+/-SD) specific activity of 29 normohomocysteinemic patients was 20.7 (+/-6.5) nmol CH2O/mg protein/h (range: 9.4-33.8), and the mean (+/-SD) residual activity after heat inactivation was 58.2 (+/-10.2)% (range: 43.0-82.0). Thus, in 28% of the hyperhomocysteinemic patients with premature vascular disease, abnormal homocysteine metabolism could be attributed to thermolabile MTHFR.	UNIV NIJMEGEN HOSP,DEPT PEDIAT,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT MED,DIV ENDOCRINOL,6500 HB NIJMEGEN,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen				Blom, Henk/0000-0001-5202-9241				BENEVENGA NJ, 1984, NEW ENGL J MED, V310, P265; BLOM HJ, 1994, FIBRINOLYSIS, V8, P86, DOI 10.1016/0268-9499(94)90257-7; BOERS GHJ, 1985, HUM GENET, V69, P164, DOI 10.1007/BF00293290; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BRATTSTROM L, 1992, NEUROL RES, V14, P81, DOI 10.1080/01616412.1992.11740017; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DALY L, 1993, Q J MED, V86, P685, DOI 10.1093/qjmed/86.10.685; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; FOWLER B, 1978, J CLIN INVEST, V61, P645, DOI 10.1172/JCI108976; FRANKEN DG, 1994, ARTERIOSCLER THROMB, V14, P465, DOI 10.1161/01.ATV.14.3.465; HARPEY JP, 1981, J PEDIATR-US, V98, P275, DOI 10.1016/S0022-3476(81)80660-9; HYLAND K, 1988, NEUROLOGY, V38, P459, DOI 10.1212/WNL.38.3.459; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; KANG SS, 1991, AM J HUM GENET, V48, P546; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MUDD SH, 1981, AM J HUM GENET, V33, P883; ROSENBLATT DS, 1977, PEDIATR RES, V11, P1141, DOI 10.1203/00006450-197711000-00005; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; RUYTER IE, 1980, ACTA ODONTOL SCAND, V38, P17, DOI 10.3109/00016358008997715; TEPOELEPOTHOFF MTW, IN PRESS ANN CLIN BI; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183; Wada Y, 1978, Monogr Hum Genet, V9, P140; WENDEL U, 1983, J PEDIATR-US, V102, P938, DOI 10.1016/S0022-3476(83)80029-8; WENDEL U, 1984, EUR J PEDIATR, V142, P147, DOI 10.1007/BF00445602	28	370	394	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					142	150						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825569				2022-12-18	WOS:A1995QC10100018
J	Speed, D; Hemani, G; Johnson, MR; Balding, DJ				Speed, Doug; Hemani, Gibran; Johnson, Michael R.; Balding, David J.			Improved Heritability Estimation from Genome-wide SNPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-STRUCTURE; ASSOCIATION; ARCHITECTURE; SUSCEPTIBILITY; PROPORTION	Estimation of narrow-sense heritability, h(2), from genome-wide SNPs genotyped in unrelated individuals has recently attracted interest and offers several advantages over traditional pedigree-based methods. With the use of this approach, it has been estimated that over half the heritability of human height can be attributed to the similar to 300,000 SNPs on a genome-wide genotyping array. In comparison, only 5%-10% can be explained by SNPs reaching genome-wide significance. We investigated via simulation the validity of several key assumptions underpinning the mixed-model analysis used in SNP-based h(2) estimation. Although we found that the method is reasonably robust to violations of four key assumptions, it can be highly sensitive to uneven linkage disequilibrium (LD) between SNPs: contributions to h(2) are overestimated from causal variants in regions of high LD and are underestimated in regions of low LD. The overall direction of the bias can be up or down depending on the genetic architecture of the trait, but it can be substantial in realistic scenarios. We propose a modified kinship matrix in which SNPs are weighted according to local LD. We show that this correction greatly reduces the bias and increases the precision of h(2) estimates. We demonstrate the impact of our method on the first seven diseases studied by the Wellcome Trust Case Control Consortium. Our LD adjustment revises downward the h(2) estimate for immune-related diseases, as expected because of high LD in the major-histocompatibility region, but increases it for some nonimmune diseases. To calculate our revised kinship matrix, we developed LDAK, software for computing LD-adjusted kinships.	[Speed, Doug; Balding, David J.] UCL, Univ Coll London Genet Inst, London WC1E 6BT, England; [Hemani, Gibran] Univ Queensland, Diamantina Inst, Brisbane, Qld 4102, Australia; [Johnson, Michael R.] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London W6 8RF, England	University of London; University College London; University of Queensland; Imperial College London	Speed, D (corresponding author), UCL, Univ Coll London Genet Inst, Mortimer St, London WC1E 6BT, England.	doug.speed@ucl.ac.uk	Balding, David/G-9898-2011; Speed, Doug/AAM-1032-2021	Balding, David/0000-0002-1480-6115; Speed, Doug/0000-0002-0096-9765; Hemani, Gibran/0000-0003-0920-1055	UK Medical Research Council [G0901388]; MRC [G0901388] Funding Source: UKRI; Medical Research Council [G0901388] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Will Astle and Vincent Plagnol for fruitful discussions, as well as the two anonymous reviewers for helpful comments. Access to Wellcome Trust data was authorized as work related to the project "Genome-wide association study of susceptibility and clinical phenotypes in epilepsy." This work is funded by the UK Medical Research Council under grant G0901388.	Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; DEMPSTER ER, 1950, GENETICS, V35, P212; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson GK., 1991, STAT SCI, V6, P15, DOI [10.1214/ss/1177011926, DOI 10.1214/SS/1177011926]; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706	25	369	371	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1011	1021		10.1016/j.ajhg.2012.10.010	http://dx.doi.org/10.1016/j.ajhg.2012.10.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23217325	hybrid, Green Published			2022-12-18	WOS:000312417400004
J	Zonana, J; Elder, ME; Schneider, LC; Orlow, SJ; Moss, C; Golabi, M; Shapira, SK; Farndon, PA; Wara, DW; Emmal, SA; Ferguson, BM				Zonana, J; Elder, ME; Schneider, LC; Orlow, SJ; Moss, C; Golabi, M; Shapira, SK; Farndon, PA; Wara, DW; Emmal, SA; Ferguson, BM			A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; SUBUNIT; NEMO; IMMUNODEFICIENCY; OSTEOCLAST; ACTIVATION; HOMOLOG; COMPLEX; PROTEIN; FORM	Hypohidrotic ectodermal dysplasia (HED), a congenital disorder of teeth, hair, and eccrine sweat glands, is usually inherited as an X-linked recessive trait, although rarer autosomal dominant and recessive forms exist. We have studied males from four families with HED and immunodeficiency (HED-ID), in which the disorder segregates as an X-linked recessive trait. Affected males manifest dysgammaglobulinemia and, despite therapy, have significant morbidity and mortality from recurrent infections. Recently, mutations in IKK-gamma (NEMO) have been shown to cause familial incontinentia pigmenti (LP). Unlike HED-ID, IP affects females and, with few exceptions, causes male prenatal lethality. Wt-gamma is required for the activation of the transcription factor known as "nuclear factor kappa B" and plays an important role in T and B cell function. We hypothesize that "milder" mutations at this locus may cause HED-ID. In all four families, sequence analysis reveals exon 10 mutations affecting the carboxy-terminal end of the IKK-gamma protein, a domain believed to connect the IKK signalsome complex to upstream activators. The findings define a new X-linked recessive immunodeficiency syndrome, distinct from other types of HED and immunodeficiency syndromes. The data provide further evidence that the development of ectodermal appendages is mediated through a tumor necrosis factor/tumor necrosis factor receptor-like signaling pathway, with the IKK signalsome complex playing a significant role.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97221 USA; Univ Calif San Francisco, Dept Pediat, Div Immunol Allergy Rheumatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Immunol, Boston, MA USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; NYU, Sch Med, Dept Dermatol & Cell Biol, New York, NY USA; Childrens Hosp, Dept Pediat Dermatol, Birmingham B16 8ET, W Midlands, England; Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England; Univ Texas, Hlth Sci Ctr, Dept Pediat, San Antonio, TX 78284 USA	Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; New York University; Birmingham Women's Hospital; University of Texas System; University of Texas Health San Antonio	Zonana, J (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, L103,3181 SW Sam Jackson Pk Rd, Portland, OR 97221 USA.	zonanaj@ohsu.edu		Orlow, Seth/0000-0003-2548-7380	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011311] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR001271, M01 RR01271] Funding Source: Medline; NIDCR NIH HHS [DE11311, R01 DE011311] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abinun M, 1996, EUR J PEDIATR, V155, P146, DOI 10.1007/s004310050395; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; CONLEY ME, 1994, CURR OPIN GENET DEV, V4, P401, DOI 10.1016/0959-437X(94)90028-0; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Freire-Maia N, 1988, Birth Defects Orig Artic Ser, V24, P3; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jin DY, 1999, J BIOMED SCI, V6, P115, DOI 10.1007/BF02256442; Kaufman CK, 2000, J CELL BIOL, V149, P999, DOI 10.1083/jcb.149.5.999; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Munoz F, 1997, AM J HUM GENET, V61, P94; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; PUCK JM, 1994, J CLIN IMMUNOL, V14, P81, DOI 10.1007/BF01541340; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schweizer P, 1999, KLIN PADIATR, V211, P459, DOI 10.1055/s-2008-1043834; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Smahi A, 2000, NATURE, V405, P466; Smart Brian A., 1997, Current Opinion in Pediatrics, V9, P570, DOI 10.1097/00008480-199712000-00004; Smythe WR, 2000, ANN THORAC SURG, V70, P654, DOI 10.1016/S0003-4975(00)01571-X; THOMAS J, 1993, BEHAV SOC SCI LIBR, V12, P1, DOI 10.1300/J103v12n01_01; XIAO G, 2000, J BIOL CHEM, P275; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	33	369	382	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1555	1562		10.1086/316914	http://dx.doi.org/10.1086/316914			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11047757	Green Published, Bronze			2022-12-18	WOS:000165607600019
J	Palferman, S; Matthews, N; Turner, M; Moore, J; Hervas, A; Aubin, A; Wallace, S; Michelotti, J; Wainhouse, C; Paul, A; Thompson, E; Gupta, R; Garner, C; Murin, M; Freitag, C; Ryder, N; Cottington, E; Parr, J; Pickles, A; Rutter, M; Bailey, A; Barnby, G; Lamb, JA; Marlow, A; Scudder, P; Monaco, AP; Baird, G; Cox, A; Docherty, Z; Warburton, P; Green, EP; Abbs, SJ; Le Couteur, A; McConachie, HR; Berney, T; Kelly, TP; De Vries, PJ; Bolton, PF; Green, J; Gilchrist, A; Whittacker, J; Bolton, B; Packer, R; Maestrini, E; Blasi, F; Van Engeland, H; De Jonge, MV; Kemner, C; Klauck, SM; Beyer, KS; Epp, S; Poustka, A; Benner, A; Goethe, JW; Poustka, F; Ruhl, D; Schmotzer, G; Boolte, S; Feineis-Matthews, S; Fombonne, E; Rogee, B; Fremolle-Kruck, J; Pienkowski, C; Tauber, MT; Pedersen, L; Nielsen, KB; Eriksen, G; Haracopos, D; Cotterill, RMJ; Tsiantis, J; Papanikolaou, K; Lord, C; Corsello, C; Guter, S; Leventhal, B; Cook, E; Smalley, SL; Bailey, J; McGough, J; Levitt, J; Pauls, D; Volkmar, F; Weeks, DE				Palferman, S; Matthews, N; Turner, M; Moore, J; Hervas, A; Aubin, A; Wallace, S; Michelotti, J; Wainhouse, C; Paul, A; Thompson, E; Gupta, R; Garner, C; Murin, M; Freitag, C; Ryder, N; Cottington, E; Parr, J; Pickles, A; Rutter, M; Bailey, A; Barnby, G; Lamb, JA; Marlow, A; Scudder, P; Monaco, AP; Baird, G; Cox, A; Docherty, Z; Warburton, P; Green, EP; Abbs, SJ; Le Couteur, A; McConachie, HR; Berney, T; Kelly, TP; De Vries, PJ; Bolton, PF; Green, J; Gilchrist, A; Whittacker, J; Bolton, B; Packer, R; Maestrini, E; Blasi, F; Van Engeland, H; De Jonge, MV; Kemner, C; Klauck, SM; Beyer, KS; Epp, S; Poustka, A; Benner, A; Goethe, JW; Poustka, F; Ruhl, D; Schmotzer, G; Boolte, S; Feineis-Matthews, S; Fombonne, E; Rogee, B; Fremolle-Kruck, J; Pienkowski, C; Tauber, MT; Pedersen, L; Nielsen, KB; Eriksen, G; Haracopos, D; Cotterill, RMJ; Tsiantis, J; Papanikolaou, K; Lord, C; Corsello, C; Guter, S; Leventhal, B; Cook, E; Smalley, SL; Bailey, J; McGough, J; Levitt, J; Pauls, D; Volkmar, F; Weeks, DE		Int Mol Genetic Study Autism Cons	A genomewide screen for autism: Strong evidence for linkage to chromosomes 2q, 7q, and 16p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; TRANSMISSION-RATIO DISTORTION; SEROTONIN TRANSPORTER 5-HTT; SIB-PAIR LINKAGE; INFANTILE-AUTISM; COMPLEX TRAITS; X-CHROMOSOME; GENE; REGION; DISEQUILIBRIUM	Autism is characterized by impairments in reciprocal communication and social interaction and by repetitive and stereotyped patterns of activities and interests. Evidence for a strong underlying genetic predisposition comes from twin and family studies, although susceptibility genes have not yet been identified. A whole-genome screen for linkage, using 83 sib pairs with autism, has been completed, and 119 markers have been genotyped in 13 candidate regions in a further 69 sib pairs. The addition of new families and markers provides further support for previous reports of linkages on chromosomes 7q and 16p. Two new regions of linkage have also been identified on chromosomes 2q and 17q. The most significant finding was a multipoint maximum LOD score (MLS) of 3.74 at marker D2S2188 on chromosome 2; this MLS increased to 4.80 when only sib pairs fulfilling strict diagnostic criteria were included. The susceptibility region on chromosome 7 was the next most significant, generating a multipoint MLS of 3.20 at marker D7S477. Chromosome 16 generated a multipoint MLS of 2.93 at D16S3102, whereas chromosome 17 generated a multipoint MLS of 2.34 at HTTINT2. With the addition of new families, there was no increased allele sharing at a number of other loci originally showing some evidence of linkage. These results support the continuing collection of multiplex sib-pair families to identify autism-susceptibility genes.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Inst Psychiat, Ctr Social Genet & Dev Psychiat, London, England; Inst Psychiat, Dept Child & Adolescent Psychiat, London, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Guys Hosp, Newcomer Ctr, London SE1 9RT, England; Guys Hosp, Reg Genet Ctr, Div Med & Mol Genet, London SE1 9RT, England; Flemming Nuffield Unit, Newcastle Upon Tyne, Tyne & Wear, England; Newcastle Gen Hosp, Neuropsychol Dept, Newcastle Upon Tyne, Tyne & Wear, England; Univ Cambridge, Sch Clin, Dev Psychiat Sect, Cambridge CB2 1TN, England; Booth Hall Childrens Hosp, Manchester, Lancs, England; European Ctr Collect Anim Cell Cultures, Salisbury, Wilts, England; Univ Bologna, Dipartimento Biol, I-40126 Bologna, Italy; AZU, Dept Child & Adolescent Psychiat, Utrecht, Netherlands; Deutsch Krebsforschungszentrum, Dresden, Germany; Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat, D-6000 Frankfurt, Germany; Hop Grave Toulouse, Unite Diagnost & Evaluat Autisme, Toulouse, France; Danish Tech Univ, Copenhagen, Denmark; Agia Sophia Childrens Hosp, Dept Psychol Paediat, Athens, Greece; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA	University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Newcastle General Hospital; University of Cambridge; Royal Manchester Children's Hospital; University of Bologna; Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; CHU de Toulouse; CHU Lyon; Technical University of Denmark; The Aghia Sophia Children's Hospital; University of Chicago; University of California System; University of California Los Angeles; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Volkmar, Fred/AEB-0666-2022; Papanikolaou, Katerina/AAB-4771-2020; Bailey, Anthony/J-2860-2014; Weeks, Daniel E/B-2995-2012; Rutter, Michael/C-8570-2013; Maestrini, Elena/K-7508-2012; Turner, Martha/C-1867-2008; Fombonne, Eric/M-4893-2018; Monaco, Anthony P/A-4495-2010; Pickles, Andrew/A-9625-2011	Bailey, Anthony/0000-0003-4257-972X; Weeks, Daniel E/0000-0001-9410-7228; Maestrini, Elena/0000-0001-5924-3179; Fombonne, Eric/0000-0002-8605-3538; Monaco, Anthony P/0000-0001-7480-3197; Pickles, Andrew/0000-0003-1283-0346; Green, Jonathan/0000-0002-0143-181X; Lamb, Janine/0000-0002-7248-0539; Rutter, Michael Llewellyn/0000-0003-1577-7405	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH001196, K02MH001389] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR06022, M01 RR006022] Funding Source: Medline; NICHD NIH HHS [5-P01-HD-35482, P01 HD035482] Funding Source: Medline; NIMH NIH HHS [K05 MH01196, K02 MH01389] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashley-Koch A, 2000, AM J HUM GENET, V67, P46; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bass MP, 2000, NEUROGENETICS, V2, P219, DOI 10.1007/s100489900081; Blagitko N, 1999, HUM MOL GENET, V8, P2387, DOI 10.1093/hmg/8.13.2387; Burn TC, 1996, GENOME RES, V6, P525, DOI 10.1101/gr.6.6.525; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Cook EH, 1997, MOL PSYCHIATR, V2, P247; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Dunn L.M., 1982, BRIT PICTURE VOCABUL; Dunn L. M., 1997, BRIT PICTURE VOCABUL; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Gilbert JR, 2000, HUM HERED, V50, P151, DOI 10.1159/000022905; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Greenwood CMT, 2000, AM J HUM GENET, V66, P2001, DOI 10.1086/302918; Hallmayer J, 1996, ARCH GEN PSYCHIAT, V53, P985; HALLMAYER J, 1994, AM J HUM GENET, V55, P951; Hayashida S, 2000, GENOMICS, V66, P221, DOI 10.1006/geno.2000.6206; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Klauck SM, 1997, HUM MOL GENET, V6, P2233, DOI 10.1093/hmg/6.13.2233; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Lamb JA, 2000, HUM MOL GENET, V9, P1461; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LIM HH, 1992, BIOCHEM J, V287, P415, DOI 10.1042/bj2870415; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestrini E, 1999, AM J MED GENET, V88, P492, DOI 10.1002/(SICI)1096-8628(19991015)88:5<492::AID-AJMG11>3.0.CO;2-X; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Mbarek O, 1999, AM J MED GENET, V88, P729, DOI 10.1002/(SICI)1096-8628(19991215)88:6<729::AID-AJMG26>3.3.CO;2-H; Mukhopadhyay N, 1999, AM J HUM GENET, V65, pA436; Mullen E.M., 1995, MULLENS SCALES EARLY; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; MURRELL J, 1995, GENOMICS, V25, P59, DOI 10.1016/0888-7543(95)80109-Y; Palferman S, 2001, HUM MOL GENET, V10, P973; Paterson AD, 1999, AM J MED GENET, V88, P657, DOI 10.1002/(SICI)1096-8628(19991215)88:6<657::AID-AJMG15>3.3.CO;2-R; Persico AM, 2000, AM J MED GENET, V96, P123, DOI 10.1002/(SICI)1096-8628(20000207)96:1<123::AID-AJMG24>3.0.CO;2-N; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; PICKLES A, 1995, AM J HUM GENET, V57, P717; RAVEN J, 1989, STANDARD PROGRESSIVE; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Salmon B, 1999, AM J MED GENET, V88, P551, DOI 10.1002/(SICI)1096-8628(19991015)88:5<551::AID-AJMG21>3.3.CO;2-R; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Smalley SL, 1998, J AUTISM DEV DISORD, V28, P407, DOI 10.1023/A:1026052421693; Sparrow SS, 1984, VINELAND ADAPTIVE BE; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEFFENBURG S, 1991, DEV MED CHILD NEUROL, V33, P495; Sutcliffe JS, 2000, AM J HUM GENET, V67, P46; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; Turner M, 2000, MOL MED TODAY, V6, P238, DOI 10.1016/S1357-4310(00)01712-3; VanRaay TJ, 1997, GENOMICS, V41, P279, DOI 10.1006/geno.1997.4659; Veenstra-VanderWeele J, 1999, MOL PSYCHIATR, V4, P64, DOI 10.1038/sj.mp.4000472; Vicente AM, 2000, AM J HUM GENET, V67, P303; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhang H, 2000, AM J HUM GENET, V67, P359; Zhong N, 1999, NEUROGENETICS, V2, P129, DOI 10.1007/s100480050064	73	367	375	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					570	581						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11481586				2022-12-18	WOS:000170271400009
J	BEGGS, AH; HOFFMAN, EP; SNYDER, JR; ARAHATA, K; SPECHT, L; SHAPIRO, F; ANGELINI, C; SUGITA, H; KUNKEL, LM				BEGGS, AH; HOFFMAN, EP; SNYDER, JR; ARAHATA, K; SPECHT, L; SHAPIRO, F; ANGELINI, C; SUGITA, H; KUNKEL, LM			EXPLORING THE MOLECULAR-BASIS FOR VARIABILITY AMONG PATIENTS WITH BECKER MUSCULAR-DYSTROPHY - DYSTROPHIN GENE AND PROTEIN STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLYCEROL KINASE-DEFICIENCY; DMD GENE; DUCHENNE; DELETION; MYOPATHY; MUSCLE; LOCUS; ABNORMALITIES; FREQUENCY; DIAGNOSIS	Becker muscular dystrophy (BMD) often results from in-frame mutations of the dystrophin gene that allow production of an altered but partially functional protein. To address potential structure-function relationships for the various domains of dystrophin, we examined both the dystrophin gene and protein in 68 patients with abnormal dystrophin. Eighty-six percent of BMD patients with dystrophin of altered size have deletions or duplications, and the observed sizes of dystrophin fit well with predictions based on DNA data. Deletions within the amino-terminal domain I tended to result in low levels of dystrophin and a more severe phenotype. The phenotypes of patients with deletions or duplications in the central rod domain were more variable. This region can be divided into three portions based on differences in clinical presentations of patients. Deletions around exons 4553 were most common and generally caused typical BMD; however, phenotypic variability among patients with similar mutations suggests that epigenetic and/or environmental factors play an important role in determining the clinical progression. In contrast, deletions or duplications in the proximal portion of this domain tended to cause severe cramps and myalgia. Finally, loss of the middle of this region probably causes a very mild phenotype, as only one such patient was found and his only symptom was elevated serum creatine phosphokinase levels.	HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DEPT NEUROL,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DEPT ORTHOPED SURG,BOSTON,MA 02115; NATL CTR NEUROL & PSYCHIAT,NATL INST NEUROSCI,KODAIRA,TOKYO,JAPAN; UNIV PADUA,NEUROL CLIN,I-35100 PADUA,ITALY	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; National Center for Neurology & Psychiatry - Japan; University of Padua	BEGGS, AH (corresponding author), CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115, USA.		Angelini, Corrado I/J-3655-2019	Angelini, Corrado I/0000-0002-9554-8794; Beggs, Alan/0000-0001-8818-0568; Hoffman, Eric/0000-0001-6470-5139	Telethon [1321] Funding Source: Medline	Telethon(Fondazione Telethon)		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANGELINI C, 1990, NEUROLOGY, V40, P808, DOI 10.1212/WNL.40.5.808; ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BEGGS AH, 1990, HUM GENET, V86, P45; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BROOKE MH, 1986, CLIN VIEW NEUROMUSCU; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chamberlain J.S., 1990, PCR PROTOCOLS GUIDE, P272; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; DARRAS BT, 1988, AM J HUM GENET, V43, P126; DAVISON MD, 1988, CELL, V52, P159, DOI 10.1016/0092-8674(88)90503-X; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Emery A, 1988, DUCHENNE MUSCULAR DY; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GOSPE SM, 1989, NEUROLOGY, V39, P1277, DOI 10.1212/WNL.39.10.1277; HAMMONDS RG, 1987, CELL, V51, P1, DOI 10.1016/0092-8674(87)90002-X; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1989, LANCET, V2, P1211; HU XY, 1988, J MED GENET, V25, P369, DOI 10.1136/jmg.25.6.369; HU XY, 1990, AM J HUM GENET, V46, P682; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUHN E, 1979, NEUROLOGY, V29, P1144, DOI 10.1212/WNL.29.8.1144; KUNKEL LM, INPRESS ETIOLOGY HUM; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MCCABE ERB, 1989, J CLIN INVEST, V83, P95, DOI 10.1172/JCI113890; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Morrow JS, 1989, CURR OPIN CELL BIOL, V1, P23, DOI 10.1016/S0955-0674(89)80032-8; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; RINGEL SP, 1977, ARCH NEUROL-CHICAGO, V34, P408, DOI 10.1001/archneur.1977.00500190042006; SKLAR RM, 1990, NEUROLOGY, V40, P1854, DOI 10.1212/WNL.40.12.1854; SUNOHARA N, 1990, ANN NEUROL, V28, P634, DOI 10.1002/ana.410280506; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	45	367	383	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					54	67						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063877				2022-12-18	WOS:A1991FW51100008
J	Faivre, L; Collod-Beroud, G; Loeys, BL; Child, A; Binquet, C; Gautier, E; Callewaert, B; Arbustini, E; Mayer, K; Arslan-Kirchner, M; Kiotsekoglou, A; Comeglio, P; Marziliano, N; Dietz, HC; Halliday, D; Beroud, C; Bonithon-Kopp, C; Claustres, M; Muti, C; Plauchu, H; Robinson, PN; Ades, LC; Biggin, A; Benetts, B; Brett, M; Holman, KJ; De Backer, J; Coucke, P; Francke, U; De Paepe, A; Jondeau, G; Boileau, C				Faivre, L.; Collod-Beroud, G.; Loeys, B. L.; Child, A.; Binquet, C.; Gautier, E.; Callewaert, B.; Arbustini, E.; Mayer, K.; Arslan-Kirchner, M.; Kiotsekoglou, A.; Comeglio, P.; Marziliano, N.; Dietz, H. C.; Halliday, D.; Beroud, C.; Bonithon-Kopp, C.; Claustres, M.; Muti, C.; Plauchu, H.; Robinson, P. N.; Ades, L. C.; Biggin, A.; Benetts, B.; Brett, M.; Holman, K. J.; De Backer, J.; Coucke, P.; Francke, U.; De Paepe, A.; Jondeau, G.; Boileau, C.			Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: An international study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-LIKE DOMAINS; FIBRILLIN-1 FBN1; CALCIUM-BINDING; GENE FBN1; PROTEIN; PATHOGENESIS; EXPRESSION; DISORDERS; GENOTYPE; FIBRILLINOPATHIES	Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onset and the wide range of severity of aortic features. The factors that modulate phenotypical severity, both among and within families, remain to be determined. The availability of international FBNI mutation Universal Mutation Database (UMD-FBN1) has allowed us to perform the largest collaborative study ever reported, to investigate the correlation between the FBNI genotype and the nature and severity of the clinical phenotype. A range of qualitative and quantitative clinical parameters (skeletal, cardiovascular, ophthalmologic, skin, pulmonary, and dural) was compared for different classes of mutation (types and locations) in 1,013 probands with a pathogenic FBNI mutation. A higher probability of ectopia lentis was found for patients with a missense mutation substituting or producing a cysteine, when compared with other missense mutations. Patients with an FBN1 premature termination codon had a more severe skeletal and skin phenotype than did patients with an inframe mutation. Mutations in exons 24-32 were associated with a more severe and complete phenotype, including younger age at diagnosis of type I fibrillinopathy and higher probability of developing ectopia lentis, ascending aortic dilatation, aortic surgery, mitral valve abnormalities, scoliosis, and shorter survival; the majority of these results were replicated even when cases of neonatal MFS were excluded. These correlations, found between different mutation types and clinical manifestations, might be explained by different underlying genetic mechanisms (dominant negative versus haploinsufficiency) and by consideration of the two main physiological functions of fibrillin-1 (structural versus mediator of TGF beta signalling). Exon 24-32 mutations define a high-risk group for cardiac manifestations associated with severe prognosis at all ages.	CHU, Ctr Genet, Dijon, France; Ctr Invest Clin, Epidemiol Clin, Essais Clin, Dijon, France; INSERM CIE1, Dijon, France; Univ Montpellier, INSERM, U827, F-34059 Montpellier, France; CHU Montpellier, Genet Mol Lab, Hop Arnault Villeneuve, F-34059 Montpellier, France; Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; St George Hosp, Dept Cardiol Sci, London, England; Fdn IRCCS Policlin San Matteo, Ctr Inherited Cardiovasc Dis, Pavia, Italy; Ctr Human Genet & Lab Med, Martinsried, Germany; Hannover Med Sch, Inst Human Genet, D-3000 Hannover, Germany; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Versailles St Quentin & Yvelines, AP HP, Assistance Publ Hop Paris, Hop Ambroise Pare, Boulogne, France; Univ Versailles St Quentin & Yvelines, AP HP, Assistance Publ Hop Paris, Mol Genet Lab, Boulogne, France; Serv Genet Hotel, Lyon, France; Univ Med Charite, Inst Med Genet, Berlin, Germany; Childrens Hosp Westmead, Marfan Res Grp, Sydney, NSW, Australia; Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; Childrens Hosp Westmead, Dept Mol Genet, Sydney, NSW, Australia; Childrens Hosp Westmead, Dept Discipline Paediat & Child Hlth, Sydney, NSW, Australia; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA; Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Ghent University; Ghent University Hospital; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; St Georges University London; IRCCS Fondazione San Matteo; Hannover Medical School; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Stanford University; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Faivre, L (corresponding author), Hop Enfants, Ctr Genet, 10 Blvd Marechal Delattre da Tassigny, F-21034 Dijon, France.	laurence.faivre@chu-dijon.fr	Loeys, Bart/B-3236-2017; De Backer, Julie/B-2897-2014; Binquet, Christine/E-8953-2018; COLLOD-BEROUD, Gwenaëlle/A-8342-2008; Kiotsekoglou, Anatoli/AAM-9685-2020; Coucke, Paul J/AAO-2954-2020; Callewaert, Bert/J-6357-2014; boileau, catherine/M-4482-2017; BEROUD, Christophe/A-8381-2008; Arbustini, Eloisa/K-8174-2016	Loeys, Bart/0000-0003-3703-9518; De Backer, Julie/0000-0001-8878-1507; Binquet, Christine/0000-0002-9417-5754; COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; Coucke, Paul J/0000-0001-7119-586X; Callewaert, Bert/0000-0002-9743-4205; boileau, catherine/0000-0002-0371-7539; BEROUD, Christophe/0000-0003-2986-8738; Arbustini, Eloisa/0000-0003-2948-7994; Biggin, Andrew/0000-0002-3443-9359; Robinson, Peter/0000-0002-0736-9199; Faivre, Laurence/0000-0001-9770-444X				Arbustini Eloisa, 2005, Hum Mutat, V26, P494, DOI 10.1002/humu.9377; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210; Biggin Andrew, 2004, Hum Mutat, V23, P99, DOI 10.1002/humu.9207; Booms P, 1999, CLIN GENET, V55, P110, DOI 10.1034/j.1399-0004.1999.550207.x; BRESLOW N, 1987, STAT METHODS CANC SE, V2; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; ELDADAH ZA, 1995, J CLIN INVEST, V95, P874, DOI 10.1172/JCI117737; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9; HAYWARD C, 1994, MOL CELL PROBE, V8, P325, DOI 10.1006/mcpr.1994.1045; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katzke S, 2002, HUM MUTAT, V20, P197, DOI 10.1002/humu.10112; Korkko J, 2002, J MED GENET, V39, P34, DOI 10.1136/jmg.39.1.34; Liu WG, 1996, HUM MOL GENET, V5, P1581, DOI 10.1093/hmg/5.10.1581; Loeys B, 2004, HUM MUTAT, V24, P140, DOI 10.1002/humu.20070; Loeys B, 2001, ARCH INTERN MED, V161, P2447, DOI 10.1001/archinte.161.20.2447; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; Lonnqvist L, 1996, GENOMICS, V36, P468, DOI 10.1006/geno.1996.0492; MANTEL N, 1959, J NATL CANCER I, V22, P719; Milewicz DM, 1996, CIRCULATION, V94, P2708, DOI 10.1161/01.CIR.94.11.2708; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Nemet AY, 2006, SURV OPHTHALMOL, V51, P561, DOI 10.1016/j.survophthal.2006.08.008; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Pyeritz R E, 1993, Semin Thorac Cardiovasc Surg, V5, P11; Robinson PN, 2002, HUM MUTAT, V20, P153, DOI 10.1002/humu.10113; Rommel K, 2005, HUM MUTAT, V26, P529, DOI 10.1002/humu.20239; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Whiteman P, 2003, HUM MOL GENET, V12, P727, DOI 10.1093/hmg/ddg081	49	366	377	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					454	466		10.1086/520125	http://dx.doi.org/10.1086/520125			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701892	Green Published, Bronze			2022-12-18	WOS:000249128200003
J	Snoeckx, RL; Huygen, PLM; Feldmann, D; Marlin, S; Denoyelle, F; Waligora, J; Mueller-Malesinska, M; Pollak, A; Ploski, R; Murgia, A; Orzan, E; Castorina, P; Ambrosetti, U; Nowakowska-Szyrwinska, E; Bal, J; Wiszniewski, W; Janecke, AR; Nekahm-Heis, DN; Seeman, P; Bendova, O; Kenna, MA; Frangulov, A; Rehm, HL; Tekin, M; Incesulu, A; Dahl, HHM; du Sart, D; Jenkins, L; Lucas, D; Glindzicz, MB; Avraham, KB; Brownstein, Z; del Castillo, I; Moreno, F; Blin, N; Pfister, M; Sziklai, I; Toth, T; Kelley, PM; Cohn, ES; Van Maldergem, L; Hilbert, P; Roux, AF; Mondain, M; Hoefsloot, LH; Cremers, CWRJ; Lopponen, T; Lopponen, H; Parving, A; Gronskov, K; Schrijver, I; Roberson, J; Gualandi, F; Martini, A; Lina-Granade, G; Pallares-Ruiz, N; Correia, C; Fialho, G; Cryns, K; Hilgert, N; Van de Heyning, P; Nishimura, CJ; Smith, RJH; Van Camp, G				Snoeckx, RL; Huygen, PLM; Feldmann, D; Marlin, S; Denoyelle, F; Waligora, J; Mueller-Malesinska, M; Pollak, A; Ploski, R; Murgia, A; Orzan, E; Castorina, P; Ambrosetti, U; Nowakowska-Szyrwinska, E; Bal, J; Wiszniewski, W; Janecke, AR; Nekahm-Heis, DN; Seeman, P; Bendova, O; Kenna, MA; Frangulov, A; Rehm, HL; Tekin, M; Incesulu, A; Dahl, HHM; du Sart, D; Jenkins, L; Lucas, D; Glindzicz, MB; Avraham, KB; Brownstein, Z; del Castillo, I; Moreno, F; Blin, N; Pfister, M; Sziklai, I; Toth, T; Kelley, PM; Cohn, ES; Van Maldergem, L; Hilbert, P; Roux, AF; Mondain, M; Hoefsloot, LH; Cremers, CWRJ; Lopponen, T; Lopponen, H; Parving, A; Gronskov, K; Schrijver, I; Roberson, J; Gualandi, F; Martini, A; Lina-Granade, G; Pallares-Ruiz, N; Correia, C; Fialho, G; Cryns, K; Hilgert, N; Van de Heyning, P; Nishimura, CJ; Smith, RJH; Van Camp, G			GJB2 mutations and degree of hearing loss: A multicenter study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONNEXIN 26 GENE; CHILDHOOD DEAFNESS; HIGH-FREQUENCY; GAP-JUNCTIONS; M34T VARIANT; DFNB1; FORM; POPULATION; IDENTIFICATION; PERMEABILITY	Hearing impairment (HI) affects 1 in 650 newborns, which makes it the most common congenital sensory impairment. Despite extraordinary genetic heterogeneity, mutations in one gene, GJB2, which encodes the connexin 26 protein and is involved in inner ear homeostasis, are found in up to 50% of patients with autosomal recessive nonsyndromic hearing loss. Because of the high frequency of GJB2 mutations, mutation analysis of this gene is widely available as a diagnostic test. In this study, we assessed the association between genotype and degree of hearing loss in persons with HI and biallelic GJB2 mutations. We performed cross-sectional analyses of GJB2 genotype and audiometric data from 1,531 persons, from 16 different countries, with autosomal recessive, mild-to-profound nonsyndromic HI. The median age of all participants was 8 years; 90% of persons were within the age range of 0-26 years. Of the 83 different mutations identified, 47 were classified as nontruncating, and 36 as truncating. A total of 153 different genotypes were found, of which 56 were homozygous truncating (T/T), 30 were homozygous nontruncating (NT/NT), and 67 were compound heterozygous truncating/ nontruncating (T/NT). The degree of HI associated with biallelic truncating mutations was significantly more severe than the HI associated with biallelic nontruncating mutations (P < .0001). The HI of 48 different genotypes was less severe than that of 35delG homozygotes. Several common mutations (M34T, V37I, and L90P) were associated with mild to moderate HI (median 25-40 dB). Two genotypes-35delG/R143W (median 105 dB) and 35delG/dela(GJB6-D13S1830) (median 108 dB)-had significantly more-severe HI than that of 35delG homozygotes.	Univ Instelling Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium	University of Antwerp	Van Camp, G (corresponding author), Univ Instelling Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	guy.vancamp@ua.ac.be	Gualandi, Francesca/K-7513-2016; Huygen, P.L.M./L-4401-2015; Tekin, Mustafa/ABG-7627-2020; Heyning, Paul H Vande/I-8278-2017; Van Maldergem, Lionel/O-3242-2019; Janecke, Andreas/AAA-5227-2019; Orzan, Eva/AAC-7814-2022; ROUX, Anne-Francoise/B-4953-2008; Van Camp, Guy/F-3386-2013; Bal, Jerzy/V-1129-2019; Bitner-Glindzicz, Maria/A-4231-2009; Van Maldergem, Lionel/G-9849-2017; Cremers, C.W.R.J./L-4254-2015; del Castillo, Ignacio/B-4314-2013; Ambrosetti, Umberto/C-3818-2017; Martini, Alessandro/K-2513-2018	Gualandi, Francesca/0000-0001-9551-057X; Heyning, Paul H Vande/0000-0002-8424-3717; Van Maldergem, Lionel/0000-0001-8880-5214; Orzan, Eva/0000-0001-7465-1066; Van Camp, Guy/0000-0001-5105-9000; Bal, Jerzy/0000-0001-7638-5128; Van Maldergem, Lionel/0000-0001-8880-5214; del Castillo, Ignacio/0000-0003-1188-3665; Gronskov, Karen/0000-0002-2341-1326; Denoyelle, Francoise/0000-0003-4338-9258; Ambrosetti, Umberto/0000-0002-4445-910X; marlin, sandrine/0000-0002-4115-9806; Martini, Alessandro/0000-0002-2003-6348; Janecke, Andreas/0000-0001-7155-0315; Rehm, Heidi L./0000-0002-6025-0015; Pollak, Agnieszka/0000-0002-2847-1782; Smith, Richard/0000-0003-1201-6731; Fialho, Graca/0000-0001-9696-6448; Ploski, Rafal/0000-0001-6286-5526; Tekin, Mustafa/0000-0002-3525-7960; Avraham, Karen B/0000-0002-4913-251X	NIDCD NIH HHS [DC005248, R01 DC005248, R01 DC002842, R01-DC02842] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842, R01DC005248] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Alvarez A, 2003, AM J MED GENET A, V117A, P89, DOI 10.1002/ajmg.a.10851; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Choudhry R, 1997, DEV DYNAM, V210, P417, DOI 10.1002/(SICI)1097-0177(199712)210:4<417::AID-AJA6>3.3.CO;2-0; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; D'Andrea P, 2002, BIOCHEM BIOPH RES CO, V296, P685, DOI 10.1016/S0006-291X(02)00891-4; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Feldmann D, 2004, EUR J HUM GENET, V12, P279, DOI 10.1038/sj.ejhg.5201147; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Griffith AJ, 2000, AM J HUM GENET, V67, P745, DOI 10.1086/303045; Harris AL, 2001, METH MOL B, V154, P357; Heathcote K, 2000, J MED GENET, V37, P50, DOI 10.1136/jmg.37.1.50; Houseman MJ, 2001, J MED GENET, V38, P20, DOI 10.1136/jmg.38.1.20; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kenna MA, 2001, ARCH OTOLARYNGOL, V127, P1037, DOI 10.1001/archotol.127.9.1037; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Lin D, 2001, HUM MUTAT, V18, P42, DOI 10.1002/humu.1148; Loffler J, 2001, EUR J HUM GENET, V9, P226, DOI 10.1038/sj.ejhg.5200607; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Marlin S, 2001, ARCH OTOLARYNGOL, V127, P927, DOI 10.1001/archotol.127.8.927; Mehl AL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e7; Minarik G, 2003, GEN PHYSIOL BIOPHYS, V22, P549; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Murgia A, 1999, J MED GENET, V36, P829; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Orzan E, 1999, BRIT J AUDIOL, V33, P291, DOI 10.3109/03005369909090112; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; Seeman P, 2004, CLIN GENET, V66, P152, DOI 10.1111/j.1399-0004.2004.00283.x; Shahin H, 2002, HUM GENET, V110, P284, DOI 10.1007/s00439-001-0674-2; Skerrett IM, 2004, FASEB J, V18, P860, DOI 10.1096/fj.03-0763fje; SMITH RJH, 2005, DEAFNESS HEREDITARY; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; Storm K, 1999, HUM MUTAT, V14, P263, DOI 10.1002/(SICI)1098-1004(1999)14:3<263::AID-HUMU10>3.0.CO;2-X; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wu BL, 2002, GENET MED, V4, P279, DOI 10.1097/00125817-200207000-00006; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	52	366	407	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					945	957		10.1086/497996	http://dx.doi.org/10.1086/497996			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380907	Bronze, Green Published			2022-12-18	WOS:000233241200005
J	Wang, G; van der Walt, JM; Mayhew, G; Li, YJ; Zuchner, S; Scott, WK; Martin, ER; Vance, JM				Wang, Gaofeng; van der Walt, Joelle M.; Mayhew, Gregory; Li, Yi-Ju; Zuechner, Stephan; Scott, William K.; Martin, Eden R.; Vance, Jeffery M.			Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE DISEQUILIBRIUM TEST; DOPAMINERGIC-NEURONS; ASSOCIATION; LINKAGE; SYSTEM; LOCUS; DUPLICATION; FAMILIES; MUTATION	Parkinson disease (PD) is a common neurodegenerative disorder caused by environmental and genetic factors. We have previously shown linkage of PD to chromosome 8p. Subsequently, fibroblast growth factor 20 (FGF20) at 8p21.3-22 was identified as a risk factor in several association studies. To identify the risk-conferring polymorphism in FGF20, we performed genetic and functional analysis of single-nucleotide polymorphisms within the gene. In a sample of 729 nuclear families with 1089 affected and 1165 unaffected individuals, the strongest evidence of association came from rs12720208 in the 3' untranstated region of FGF20. We show in several functional assays that the risk allele for rs12720208 disrupts a binding site for microRNA-433, increasing translation of FGF20 in vitro and in vivo. In a cell-based system and in PD brains, this increase in translation of FGF20 is correlated with increased a-synuclein expression, which has previously been shown to cause PD through both overexpression and point mutations. We suggest a novel mechanism of action for PD risk in which the modulation of the susceptibility gene's translation by common variations interfere with the regulation mechanisms of microRNA. We propose this is likely to be a common mechanism of genetic modulation of individual susceptibility to complex disease.	[Wang, Gaofeng; van der Walt, Joelle M.; Mayhew, Gregory; Li, Yi-Ju; Zuechner, Stephan; Scott, William K.; Martin, Eden R.; Vance, Jeffery M.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA	Duke University	Vance, JM (corresponding author), Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA.	jvance@med.miami.edu	Scott, William/A-7593-2009	Li, Yi-Ju/0000-0001-6996-4834	NIA NIH HHS [1R01-AG-20135-01, R01 AG020135] Funding Source: Medline; NINDS NIH HHS [P01 NS026630, 2 P50 NS39764-03, P50 NS039764, P01 NS26630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Clarimon J, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-11; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dekker MCJ, 2003, BRAIN, V126, P1722, DOI 10.1093/brain/awg172; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Leng Y, 2001, J BIOL CHEM, V276, P28212, DOI 10.1074/jbc.M011121200; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Murase S, 2006, J NEUROSCI, V26, P9750, DOI 10.1523/JNEUROSCI.2745-06.2006; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Ohmachi S, 2003, J NEUROSCI RES, V72, P436, DOI 10.1002/jnr.10592; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; van der Walt JM, 2004, AM J HUM GENET, V74, P1121, DOI 10.1086/421052; Zhou WB, 2002, BRAIN RES, V926, P42, DOI 10.1016/S0006-8993(01)03292-9	33	365	390	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					283	289		10.1016/j.ajhg.2007.09.021	http://dx.doi.org/10.1016/j.ajhg.2007.09.021			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252210	Green Published, Bronze			2022-12-18	WOS:000253223900002
J	Bruder, CEG; Piotrowski, A; Gijsbers, AACJ; Andersson, R; Erickson, S; de Stahl, TD; Menzel, U; Sandgren, J; von Tell, D; Poplawski, A; Crowley, M; Crasto, C; Partridge, EC; Tiwari, H; Allison, DB; Komorowski, J; van Ommen, GJB; Boomsma, DI; Pedersen, NL; den Dunnen, JT; Wirdefeldt, K; Dumanski, JP				Bruder, Carl E. G.; Piotrowski, Arkadiusz; Gijsbers, Antoinet A. C. J.; Andersson, Robin; Erickson, Stephen; de Stahl, Teresita Diaz; Menzel, Uwe; Sandgren, Johanna; von Tell, Desiree; Poplawski, Andrzej; Crowley, Michael; Crasto, Chiquito; Partridge, E. Christopher; Tiwari, Hemant; Allison, David B.; Komorowski, Jan; van Ommen, Gert-Jan B.; Boomsma, Dorret I.; Pedersen, Nancy L.; den Dunnen, Johan T.; Wirdefeldt, Karin; Dumanski, Jan P.			Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGMENTAL DUPLICATIONS; SOMATIC MOSAICISM; GENE; MICROARRAY; MECHANISMS; COVERAGE; MUTATION	The exploration of copy-number variation (CNV), notably of somatic cells, is an understudied aspect of genome biology. Any differences in the genetic makeup between twins derived from the same zygote represent an irrefutable example of somatic mosaicism. We studied 19 pairs of monozygotic twins with either concordant or discordant phenotype by using two platforms for genome-wide CNV analyses and showed that CNVs exist within pairs in both groups. These findings have an impact on our views of genotypic and phenotypic diversity in monozygotic twins and suggest that CNV analysis in phenotypically discordant monozygotic twins may provide a powerful tool for identifying disease-predisposition loci. Our results also imply that caution should be exercised when interpreting disease causality of de novo CNVs found in patients based on analysis of a single tissue in routine disease-related DNA diagnostics.	[Bruder, Carl E. G.; Piotrowski, Arkadiusz; von Tell, Desiree; Poplawski, Andrzej; Crowley, Michael; Crasto, Chiquito; Partridge, E. Christopher; Allison, David B.; Dumanski, Jan P.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Gijsbers, Antoinet A. C. J.; van Ommen, Gert-Jan B.; den Dunnen, Johan T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Gijsbers, Antoinet A. C. J.; van Ommen, Gert-Jan B.; den Dunnen, Johan T.] Ctr Med Syst Biol, NL-2300 RA Leiden, Netherlands; [Andersson, Robin; Komorowski, Jan] Uppsala Univ, Linnaeus Ctr Bioinformat, SE-75124 Uppsala, Sweden; [Erickson, Stephen; Tiwari, Hemant; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [de Stahl, Teresita Diaz; Menzel, Uwe; Dumanski, Jan P.] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala Acad Hosp, SE-75185 Uppsala, Sweden; [Sandgren, Johanna] Uppsala Univ, Uppsala Acad Hosp, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Pedersen, Nancy L.; Wirdefeldt, Karin] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden	University of Alabama System; University of Alabama Birmingham; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University; University of Alabama System; University of Alabama Birmingham; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Vrije Universiteit Amsterdam; Karolinska Institutet	Bruder, CEG (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.	cbruder@genetics.uab.edu	Boomsma, Dorret I/AAX-4470-2020; dunnen, johan den/ABH-4228-2020; Komorowski, Jan/A-9175-2010; Komorowski, Jan/M-2667-2013; Komorowski, Jan/AAP-1685-2020; Piotrowski, Arkadiusz/A-5484-2010; Andersson, Robin/B-5311-2009	dunnen, johan den/0000-0002-6304-1710; Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Piotrowski, Arkadiusz/0000-0002-0823-0607; Andersson, Robin/0000-0003-1516-879X; Diaz de Stahl, Teresita/0000-0001-5933-6623; Dumanski, Jan Piotr/0000-0002-1489-1452; Allison, David/0000-0003-3566-9399	NHLBI NIH HHS [5T32HL072757-04, T32 HL072757] Funding Source: Medline; NIDDK NIH HHS [3P30DK056336-05S2, P30 DK056336] Funding Source: Medline; NIEHS NIH HHS [ES10758, R01 ES010758, 5R01ES009912-08, R01 ES009912] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010758, R01ES009912] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ameur A, 2006, BIOINFORMATICS, V22, P1024, DOI 10.1093/bioinformatics/btl036; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/twin.9.6.849; Buckley PG, 2002, HUM MOL GENET, V11, P3221, DOI 10.1093/hmg/11.25.3221; Busjahn A, 2006, TWIN RES HUM GENET, V9, P705, DOI 10.1375/183242706779462714; de Bustos C, 2006, GENOMICS, V88, P152, DOI 10.1016/j.ygeno.2006.03.016; DESTAHL DT, 2007, IN PRESS HUM MUTAT; Elbaz A, 2006, LANCET NEUROL, V5, P917, DOI 10.1016/S1474-4422(06)70579-8; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; Gringras P, 2001, EARLY HUM DEV, V64, P105, DOI 10.1016/S0378-3782(01)00171-2; Helderman-van den Enden ATJM, 2003, NEUROMUSCULAR DISORD, V13, P317, DOI 10.1016/S0960-8966(02)00285-7; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; Mantripragada KK, 2006, J MED GENET, V43, P28, DOI 10.1136/jmg.2005.033795; Mantripragada KK, 2003, J MOL MED-JMM, V81, P443, DOI 10.1007/s00109-003-0458-3; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Petronis A, 2006, TRENDS GENET, V22, P347, DOI 10.1016/j.tig.2006.04.010; *R DEV COR TEAM, 2006, LANG ENV STAT COMP V; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ripolles L, 2006, CANCER GENET CYTOGEN, V171, P57, DOI 10.1016/j.cancergencyto.2006.07.006; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, NAT GENET, V39, pS3, DOI 10.1038/ng2095; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Summersgill B, 2002, LEUKEMIA, V16, P1229, DOI 10.1038/sj.leu.2402321; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; WIRDEFELDT K, 2007, INPRESS NEUROBIOL AG; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	34	364	375	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					763	771		10.1016/j.ajhg.2007.12.011	http://dx.doi.org/10.1016/j.ajhg.2007.12.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304490	Green Published, Bronze			2022-12-18	WOS:000254067800021
J	Salas, A; Richards, M; De la Fe, T; Lareu, MV; Sobrino, B; Sanchez-Diz, P; Macaulay, V; Carracedo, A				Salas, A; Richards, M; De la Fe, T; Lareu, MV; Sobrino, B; Sanchez-Diz, P; Macaulay, V; Carracedo, A			The making of the African mtDNA landscape	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISMS; Y-CHROMOSOME POLYMORPHISMS; CONTROL-REGION SEQUENCE; HUMAN-POPULATIONS; IBERIAN PENINSULA; GENETIC DIVERSITY; SOUTHERN AFRICA; NEAR-EASTERN; EVOLUTION; ORIGINS	Africa presents the most complex genetic picture of any continent, with a time depth for mitochondrial DNA (mtDNA) lineages 1 100,000 years. The most recent widespread demographic shift within the continent was most probably the Bantu dispersals, which archaeological and linguistic evidence suggest originated in West Africa 3,000-4, 000 years ago, spreading both east and south. Here, we have carried out a thorough phylogeographic analysis of mtDNA variation in a total of 2,847 samples from throughout the continent, including 307 new sequences from southeast African Bantu speakers. The results suggest that the southeast Bantu speakers have a composite origin on the maternal line of descent, with similar to44% of lineages deriving from West Africa, similar to21% from either West or Central Africa, similar to30% from East Africa, and similar to5% from southern African Khoisan-speaking groups. The ages of the major founder types of both West and East African origin are consistent with the likely timing of Bantu dispersals, with those from the west somewhat predating those from the east. Despite this composite picture, the southeastern African Bantu groups are indistinguishable from each other with respect to their mtDNA, suggesting that they either had a common origin at the point of entry into southeastern Africa or have undergone very extensive gene flow since.	Univ Santiago de Compostela, Unidad Genet Forense, Santiago De Compostela, Galicia, Spain; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Universidade de Santiago de Compostela; University of Huddersfield; University of Oxford	Salas, A (corresponding author), Univ Santiago de Compostela, Unidad Genet Forense, Santiago De Compostela, Galicia, Spain.		Lareu, Maviky/E-4909-2013; Carracedo, Angel/D-4257-2012; Salas, Antonio/E-3977-2012; Rey, Beatriz Sobrino/ABB-8518-2020	Lareu, Maviky/0000-0002-6165-9795; Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Sobrino Rey, Beatriz/0000-0002-6605-9377; RICHARDS, MARTIN/0000-0003-3118-0967				Adams J.M., 1997, REV ATLAS PALAEOVEGE; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAKEL M, 1981, CURR ANTH, V22, P688; Bandelt HJ, 1997, AM J HUM GENET, V61, P980, DOI 10.1086/514878; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2001, ANN HUM GENET, V65, P549, DOI 10.1017/S0003480001008892; BLENCH, 1993, ARCHAEOLOGY AFRICA F; Bortolini MC, 1997, HUM BIOL, V69, P141; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; CLARK JD, 1994, HIST HUMANITY, V1, P191; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Eggert M. K. H., 1993, ARCHAEOLOGY AFRICA F, P289; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; GREENBERG JH, 1972, J AFR HIST, V13, P189, DOI 10.1017/S0021853700011427; GREENBERG JH, 1963, LANGUAGES AFRICA; GRUN R, 1991, ARCHAEOMETRY, V33, P153, DOI 10.1111/j.1475-4754.1991.tb00696.x; Guthrie M., 1970, LANGUAGE HIST AFRICA, P20; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HIERNAUX J, 1968, J AFR HIST, V9, P505, DOI 10.1017/S0021853700009014; Hiernaux J., 1975, PEOPLE AFRICA; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; HUFFMAN TN, 1982, ANNU REV ANTHROPOL, V11, P133, DOI 10.1146/annurev.an.11.100182.001025; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JOHNSTON HH, 1913, J R ANTHR I, V43, P345; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; KUPER A, 1978, AFRICA, V48, P335, DOI 10.2307/1158800; LWANGALUNYIIGO S, 1976, CURR ANTHROPOL, V17, P282, DOI 10.1086/201717; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MacEachern S, 2000, CURR ANTHROPOL, V41, P357, DOI 10.1086/300144; Maley J., 1993, ARCHAEOLOGY AFRICA F, P43; MARTI R, 2001, INVESTIGACION CIENCI, V303, P30; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; Monsalve MV, 1997, P ROY SOC B-BIOL SCI, V264, P1217, DOI 10.1098/rspb.1997.0168; Newman J. L., 1995, PEOPLING AFRICA; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Phillipson DW, 1993, AFRICAN ARCHAEOLOGY; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; RICHARDS M, 2000, ARCHAEOGENETICS DNA, P139; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSRA; STINE OC, 1992, J MOL EVOL, V34, P336; TAJIMA F, 1989, GENETICS, V123, P585; Thomas H., 1997, SLAVE TRADE STORY AT; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VANSINA J, 1995, J AFR HIST, V36, P173, DOI 10.1017/S0021853700034101; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VOGEL JO, 1994, ENCY PRECOLONIAL AFR, P435; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Watson E, 1996, AM J HUM GENET, V59, P437; WHITELAW G, 1994, ENCY PRECOLONIAL AFR, P444; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907	88	364	371	2	23	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1082	1111		10.1086/344348	http://dx.doi.org/10.1086/344348			30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12395296	Green Published, Bronze			2022-12-18	WOS:000178884300008
J	Clark, AG; Weiss, KM; Nickerson, DA; Taylor, SL; Buchanan, A; Stengard, J; Salomaa, V; Vartiainen, E; Perola, M; Boerwinkle, E; Sing, CF				Clark, AG; Weiss, KM; Nickerson, DA; Taylor, SL; Buchanan, A; Stengard, J; Salomaa, V; Vartiainen, E; Perola, M; Boerwinkle, E; Sing, CF			Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISM HAPLOTYPES; FAMILIAL CHYLOMICRONEMIA; LINKAGE DISEQUILIBRIUM; DROSOPHILA-MELANOGASTER; MYOCARDIAL-INFARCTION; RECOMBINATION EVENTS; STATISTICAL TESTS; MUTATION; CLUSTER; SITES	Allelic variation in 3.7 kb of genomic DNA sequence from the human lipoprotein lipase gene (LPL) was scored in 71 healthy individuals (142 chromosomes) from three populations: African Americans (24) from Jackson, MS; Finns (24) from North Karelia, Finland; and non-Hispanic Whites (23) from Rochester, MN. The sequences had a total of 88 variable sites, with a nucleotide diversity (site-specific heterozygosity) of .002 +/- .001 across this 9.7-kb region. The frequency spectrum of nucleotide variation exhibited a slight excess of heterozygosity, but, in general, the data fit expectations of the infinite-sites model of mutation and genetic drift. Allele-specific PCR helped resolve linkage phases, and a total of 88 distinct haplotypes were identified. For 1,410 (64%) of the 2,211 site pairs, all four possible gametes were present in these haplotypes, reflecting a rich history of past recombination. Despite the strong evidence for recombination, extensive linkage disequilibrium was observed. The number of haplotypes generally is much greater than the number expected under the infinite-sites model, but there was sufficient multisite linkage disequilibrium to reveal two major clades, which appear to be very old. Variation in this region of LPL may depart from the variation expected under a simple, neutral model, owing to complex historical patterns of population founding, drift, selection, and recombination. These data suggest that the design and interpretation of disease-association studies may not be as straightforward as often is assumed.	Penn State Univ, Dept Biol, Inst Mol Evolut Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Clark, AG (corresponding author), Penn State Univ, Dept Biol, Inst Mol Evolut Genet, University Pk, PA 16802 USA.			Sing, Charles/0000-0001-5872-7956; Clark, Andrew/0000-0001-7159-8511	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107, R01HL058239, R01HL058238] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58238, HL39107, HL58239] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Betran E, 1997, GENETICS, V146, P89; BROWN AHD, 1980, GENETICS, V96, P523; Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; CAVALLISFORZA LL, 1994, CHAM; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Chakravarti A, 1996, HUM MOL GENET, V5, P303; CHAMBERLAIN JC, 1989, ATHEROSCLEROSIS, V79, P85, DOI 10.1016/0021-9150(89)90037-3; Clark AG, 1997, J EVOLUTION BIOL, V10, P663; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; CRANDALL LA, 1998, EVOLUTION HIV IMPLIC; CURTIS D, 1989, GENETICS, V122, P653; Ewens W.J., 1979, MATH POPULATION GENE; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FU YX, 1993, GENETICS, V133, P693; Gagne C, 1995, Union Med Can, V124, P61; GARROD AE, 1902, LANCET, V11, P1616; GOTODA T, 1991, J CLIN INVEST, V88, P1856, DOI 10.1172/JCI115507; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hartl DL, 1997, PRINCIPLES POPULATIO; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HEGELE RA, 1994, ARTERIOSCLER THROMB, V14, P671, DOI 10.1161/01.ATV.14.5.671; HEIZMANN C, 1991, HUM GENET, V86, P578; Hey J, 1997, GENETICS, V145, P833; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Jakobsen IB, 1997, MOL BIOL EVOL, V14, P474, DOI 10.1093/oxfordjournals.molbev.a025784; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; KIMURA M, 1969, GENETICS, V61, P893; KREITMAN M, 1991, GENETICS, V127, P565; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LEWONTIN RC, 1995, GENETICS, V140, P377; LI WH, 1991, GENETICS, V129, P513; MA YH, 1991, NEW ENGL J MED, V324, P1761, DOI 10.1056/NEJM199106203242502; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Murthy V, 1996, PHARMACOL THERAPEUT, V70, P101, DOI 10.1016/0163-7258(96)00005-8; NACHMAN MW, IN PRESS GENETICS; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; NORMAND T, 1992, HUM GENET, V89, P671, DOI 10.1007/BF00221960; PEACOCK RE, 1992, ATHEROSCLEROSIS, V97, P171, DOI 10.1016/0021-9150(92)90130-9; Peltonen Leena, 1996, Methods (Orlando), V9, P129, DOI 10.1006/meth.1996.0017; REINA M, 1992, J LIPID RES, V33, P1823; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Richter B, 1997, GENETICS, V145, P311; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santamarina-Fojo S., 1992, CURR OPIN LIPIDOL, V3, P186; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SCHAEFFER SW, 1993, GENETICS, V135, P541; SINNOCK P, 1972, AM J HUM GENET, V24, P393; SLATKIN M, 1991, GENETICS, V129, P555; STEPHENS JC, 1985, MOL BIOL EVOL, V2, P539; STOCKS J, 1992, J LIPID RES, V33, P853; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHASHI N, 1995, ARZNEIMITTEL-FORSCH, V45-1, P195; TAKAHATA N, 1995, ANNU REV ECOL SYST, V26, P343, DOI 10.1146/annurev.es.26.110195.002015; Tavare S, 1997, GENETICS, V145, P505; TEMPLETON AR, 1996, VARIATION HUMAN GENO, P259; TEMPLETON AR, 1987, RATES EVOLUTION; THORN JA, 1990, ATHEROSCLEROSIS, V85, P55, DOI 10.1016/0021-9150(90)90182-I; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wakeley J, 1997, GENET RES, V69, P45, DOI 10.1017/S0016672396002571; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir B., 1996, GENETIC DATA ANAL; Wiebusch H, 1996, HUM MUTAT, V8, P392; Wright S, 1931, GENETICS, V16, P0097; YANG WS, 1995, P NATL ACAD SCI USA, V92, P4462, DOI 10.1073/pnas.92.10.4462; ZERBA KE, 1991, GENETICS, V129, P525; ZERBA KE, IN PRESS HUM GENET	83	364	387	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					595	612		10.1086/301977	http://dx.doi.org/10.1086/301977			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683608	Bronze, Green Published			2022-12-18	WOS:000075360800036
J	DRISCOLL, DA; BUDARF, ML; EMANUEL, BS				DRISCOLL, DA; BUDARF, ML; EMANUEL, BS			A GENETIC ETIOLOGY FOR DIGEORGE SYNDROME - CONSISTENT DELETIONS AND MICRODELETIONS OF 22QII	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARTIAL MONOSOMY; LINKAGE MAP; CHROMOSOME-22; DEFICIENCY; FEATURES; 22Q11	DiGeorge syndrome (DGS), a developmental field defect of the third and fourth pharyngeal pouches, is characterized by aplasia or hypoplasia of the thymus and parathyroid glands and by conotruncal cardiac malformations. Cytogenetic studies support the presence of a DGS critical region in band 22q11. In the present study, we report the results of clinical, cytogenetic, and molecular studies of 14 patients with DGS. Chromosome analysis, utilizing high-resolution banding techniques, detected interstitial deletions in five probands and was inconclusive for a deletion in three probands. The remaining six patients had normal karyotypes. In contrast, molecular analysis detected DNA deletions in all 14 probands. Two of 10 loci tested, D22S75 and D22S259, are deleted in all 14 patients. A third locus, D22S66, is deleted in the eight DGS probands tested. Physical mapping using somatic cell hybrids places D22S66 between D22S75 and D22S259, suggesting that it should be deleted in the remaining six cases. Parent-of-origin studies were performed in five families. Four probands failed to inherit a maternal allele, and one failed to inherit a paternal allele. On the basis of these families, and of six maternally and five paternally derived unbalanced-translocation DGS probands in the literature, parent of origin or imprinting does not appear to play an important role in the pathogenesis of DGS. Deletion of the same three loci in all 14 DGS probands begins to delineate the region of chromosome 22 critical for DGS and confirms the hypothesis that submicroscopic deletions of 22q11 are etiologic in the vast majority of cases.	UNIV PENN, SCH MED, DEPT OBSTET & GYNECOL, PHILADELPHIA, PA 19104 USA; CHILDRENS HOSP, DIV HUMAN GENET & MOLEC BIOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT PEDIAT, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT HUMAN GENET, PHILADELPHIA, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania					NIGMS NIH HHS [GM07939, GM07215, GM05876] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BACK E, 1980, ANN GENET-PARIS, V23, P244; BOWEN P, 1986, CLIN GENET, V29, P174; BUDARF M, 1988, Genomics, V3, P168, DOI 10.1016/0888-7543(88)90149-8; BUDARF ML, 1991, GENOMICS, V10, P996, DOI 10.1016/0888-7543(91)90190-P; CROCE CM, 1987, P NATL ACAD SCI USA, V84, P7174, DOI 10.1073/pnas.84.20.7174; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRISCOLL DA, 1991, LANCET, V338, P1390, DOI 10.1016/0140-6736(91)92264-3; DRISCOLL DA, 1991, AM J HUM GENET, V49, pA86; DRISCOLL DA, 1990, AM J HUM GENET, V47, pA215; ELFOULY MH, 1991, AM J MED GENET, V38, P569, DOI 10.1002/ajmg.1320380415; EMANUEL BS, 1991, CYTOGENET CELL GENET, V58, P1; FAED MJW, 1987, J MED GENET, V24, P225, DOI 10.1136/jmg.24.4.225; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIBISON WJ, 1990, AM J HUM GENET, V46, P888; FIBISON WJ, 1990, AM J HUM GENET, V47, pA178; GOLDBERG R, 1985, American Journal of Human Genetics, V37, pA54; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GREENBERG F, 1984, HUM GENET, V65, P317, DOI 10.1007/BF00291554; KAN YW, 1986, AM J HUM GENET, V38, P4; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KUWANO A, 1991, AM J HUM GENET, V49, P707; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MASCARELLO JT, 1989, AM J MED GENET, V32, P112, DOI 10.1002/ajmg.1320320124; MCDERMID HE, 1989, GENOMICS, V5, P1, DOI 10.1016/0888-7543(89)90079-7; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; PIVNICK EK, 1990, AM J MED GENET, V37, P92, DOI 10.1002/ajmg.1320370121; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SHPRINTZEN R J, 1985, American Journal of Human Genetics, V37, pA77; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEVENS CA, 1990, PEDIATRICS, V85, P526	35	364	371	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					924	933						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1349199				2022-12-18	WOS:A1992HR47300006
J	ALDRIDGE, J; KUNKEL, L; BRUNS, G; TANTRAVAHI, U; LALANDE, M; BREWSTER, T; MOREAU, E; WILSON, M; BROMLEY, W; RODERICK, T; LATT, SA				ALDRIDGE, J; KUNKEL, L; BRUNS, G; TANTRAVAHI, U; LALANDE, M; BREWSTER, T; MOREAU, E; WILSON, M; BROMLEY, W; RODERICK, T; LATT, SA			A STRATEGY TO REVEAL HIGH-FREQUENCY RFLPS ALONG THE HUMAN X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP MED CTR, DIV GENET, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, MENTAL RETARDAT RES CTR, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; FDN BLOOD RES, SCARBOROUGH, ME 04074 USA; CTR HUMAN GENET, BAR HARBOR, ME USA; MUSCULAR DYSTROPHY ASSOC, PORTLAND, ME USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Foundation for Blood Research (FBR)					NICHD NIH HHS [HD04807, HD18658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALPERN M, 1971, J PHYSIOL-LONDON, V212, P211, DOI 10.1113/jphysiol.1971.sp009318; APPEL S, 1983, METABOLIC BASIS INHE, P1471; BISHOP DT, 1983, AM J HUM GENET, V35, P795; BOEHM CD, 1983, NEW ENGL J MED, V308, P1054, DOI 10.1056/NEJM198305053081803; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; BRUNS G, 1982, ADV EXP MED BIOL, V154, P60; BUSSLINGER M, 1983, NUCLEIC ACIDS RES, V11, P3559, DOI 10.1093/nar/11.11.3559; Conneally P M, 1980, Adv Hum Genet, V10, P209; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DESNICK RJ, 1983, METABOLIC BASIS INHE, P906; DRYJA T, UNPUB CHROMOSOME 13; FASMAN G, 1980, HDB BIOCH MOL BIOL, P273; FORGET BG, 1976, CELL, V7, P323, DOI 10.1016/0092-8674(76)90161-6; HARPER PS, 1983, J MED GENET, V20, P252, DOI 10.1136/jmg.20.4.252; KESHET E, 1983, NUCLEIC ACIDS RES, V11, P3571, DOI 10.1093/nar/11.11.3571; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; MEYER S, 1975, DATA ANAL SCI ENG, P260; OFARRELL P, 1981, FOCUS, V3, P1; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SINGER J, 1979, SCIENCE, V203, P1019, DOI 10.1126/science.424726; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P58, DOI 10.1159/000131687; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SNEIDER TW, 1980, NUCLEIC ACIDS RES, V8, P3829, DOI 10.1093/nar/8.17.3829; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X	29	364	365	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					546	564						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6328976				2022-12-18	WOS:A1984SY11900005
J	Lefevre, C; Jobard, F; Caux, F; Bouadjar, B; Karaduman, A; Heilig, R; Lakhdar, H; Wollenberg, A; Verret, JL; Weissenbach, J; Ozguc, M; Lathrop, M; Prud'homme, JF; Fischer, J				Lefevre, C; Jobard, F; Caux, F; Bouadjar, B; Karaduman, A; Heilig, R; Lakhdar, H; Wollenberg, A; Verret, JL; Weissenbach, J; Ozguc, M; Lathrop, M; Prud'homme, JF; Fischer, J			Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPID STORAGE DISEASE; ICHTHYOSIS; TRIACYLGLYCEROL; DEHYDROGENASE; DISORDER; LINKAGE; LIPASES	Chanarin-Dorfman syndrome (CDS) is a rare autosomal recessive form of nonbullous congenital ichthyosiform erythroderma (NCIE) that is characterized by the presence of intracellular lipid droplets in most tissues. We previously localized a gene for a subset of NCIE to chromosome 3 (designated "the NCIE2 locus"), in six families. Lipid droplets were found in five of these six families, suggesting a diagnosis of CDS. Four additional families selected on the basis of a confirmed diagnosis of CDS also showed linkage to the NCIE2 locus. Linkage-disequilibrium analysis of these families, all from the Mediterranean basin, allowed us to refine the NCIE2 locus to an similar to1.3-Mb region. Candidate genes from the interval were screened, and eight distinct mutations in the recently identified CGI-58 gene were found in 13 patients from these nine families. The spectrum of gene variants included insertion, deletion, splice-site, and point mutations. The CGI-58 protein belongs to a large family of proteins characterized by an alpha/beta hydrolase fold. CGI-58 contains three sequence motifs that correspond to a catalytic triad found in the esterase/lipase/thioesterase subfamily. Interestingly, CGI-58 differs from other members of the esterase/lipase/thioesterase subfamily in that its putative catalytic triad contains an asparagine in place of the usual serine residue.	Ctr Natl Genotypage, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Univ Paris 13, Unite Propre Rech Enseignement Superieur Equipe A, Immunol Lab, Bobigny, France; Univ Paris 13, Dept Dermatol, Bobigny, France; Bab El Oued Hosp, Dept Dermatol, Algiers, Algeria; Hacettepe Univ, DNA Cell Bank Tubiak, Ankara, Turkey; Hacettepe Univ, Dept Dermatol, Ankara, Turkey; Ibnou Rochd, Dept Dermatol, Casablanca, Morocco; Univ Munich, Dept Dermatol, D-8000 Munich, Germany; CHU Angers, Dept Dermatol, Angers, France; Genethon, Evry, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Universite Paris 13; Universite Paris 13; Hacettepe University; Hacettepe University; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca; University of Munich; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Fischer, J (corresponding author), Ctr Natl Genotypage, 2 Rue Gaston Cremieux, F-91057 Evry, France.	fischer@cng.fr	Fischer, Judith/E-6327-2016	Fischer, Judith/0000-0002-8580-8118; OZGUC, Meral/0000-0003-4577-8759				AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; Braverman N, 1999, NAT GENET, V22, P291, DOI 10.1038/10357; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; CYGLER M, 1993, PROTEIN SCI, V2, P366; DeLaurenzi V, 1996, NAT GENET, V12, P52; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Fischer J, 2000, AM J HUM GENET, V66, P904, DOI 10.1086/302814; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Grange DK, 2000, AM J MED GENET, V90, P328, DOI 10.1002/(SICI)1096-8628(20000214)90:4<328::AID-AJMG13>3.0.CO;2-F; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; HILAIRE N, 1995, J BIOL CHEM, V270, P27027, DOI 10.1074/jbc.270.45.27027; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Igal RA, 1998, J LIPID RES, V39, P31; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; JORDANS GHW, 1953, ACTA MED SCAND, V145, P419; Kaassis C, 1998, ANN DERMATOL VENER, V125, P317; Konig A, 2000, AM J MED GENET, V90, P339; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MELNICK B, 1989, ICHTHYOSES GUIDE CLI, P14; MIRANDA A, 1979, MUSCLE NERVE, V2, P1, DOI 10.1002/mus.880020102; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; ROZENSZAJN L, 1966, BLOOD-J HEMATOL, V28, P258, DOI 10.1182/blood.V28.2.258.258; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; SHAPIRO LJ, 1978, LANCET, V1, P70; Traupe H., 1989, ICHTHYOSES GUIDE CLI; VENENCIE PY, 1988, PEDIATR DERMATOL, V5, P173, DOI 10.1111/j.1525-1470.1988.tb01165.x; Weir BS, 1990, GENETIC DATA ANAL; WILLIAMS ML, 1988, J INHERIT METAB DIS, V11, P131, DOI 10.1007/BF01799862; Wollenberg A, 2000, ACTA DERM-VENEREOL, V80, P39; Zhang L, 1998, FOLD DES, V3, P535, DOI 10.1016/S1359-0278(98)00069-8	37	363	380	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1002	1012		10.1086/324121	http://dx.doi.org/10.1086/324121			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590543	Bronze, Green Published			2022-12-18	WOS:000171413400008
J	Smith, MW; Patterson, N; Lautenberger, JA; Truelove, AL; McDonald, GJ; Waliszewska, A; Kessing, BD; Malasky, MJ; Scafe, C; Le, E; De Jager, PL; Mignault, AA; Yi, Z; de The, G; Essex, M; Sankale, JL; Moore, JH; Poku, K; Phair, JP; Goedert, JJ; Vlahov, D; Williams, SM; Tishkoff, SA; Winkler, CA; De La Vega, FM; Woodage, T; Sninsky, JJ; Hafler, DA; Altshuler, D; Gilbert, DA; O'Brien, SJ; Reich, D				Smith, MW; Patterson, N; Lautenberger, JA; Truelove, AL; McDonald, GJ; Waliszewska, A; Kessing, BD; Malasky, MJ; Scafe, C; Le, E; De Jager, PL; Mignault, AA; Yi, Z; de The, G; Essex, M; Sankale, JL; Moore, JH; Poku, K; Phair, JP; Goedert, JJ; Vlahov, D; Williams, SM; Tishkoff, SA; Winkler, CA; De La Vega, FM; Woodage, T; Sninsky, JJ; Hafler, DA; Altshuler, D; Gilbert, DA; O'Brien, SJ; Reich, D			A high-density admixture map for disease gene discovery in African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; LINKAGE-DISEQUILIBRIUM; POPULATION-STRUCTURE; ADMIXED POPULATIONS; ADMIRED POPULATIONS; ETHNIC-DIFFERENCES; MAPPING GENES; HUMAN GENOME; ASSOCIATION; MARKERS	Admixture mapping ( also known as "mapping by admixture linkage disequilibrium," or MALD) provides a way of localizing genes that cause disease, in admixed ethnic groups such as African Americans, with similar to100 times fewer markers than are required for whole-genome haplotype scans. However, it has not been possible to perform powerful scans with admixture mapping because the method requires a dense map of validated markers known to have large frequency differences between Europeans and Africans. To create such a map, we screened through databases containing similar to450,000 single-nucleotide polymorphisms (SNPs) for which frequencies had been estimated in African and European population samples. We experimentally confirmed the frequencies of the most promising SNPs in a multiethnic panel of unrelated samples and identified 3,011 as a MALD map (1.2 cM average spacing). We estimate that this map is similar to70% informative in differentiating African versus European origins of chromosomal segments. This map provides a practical and powerful tool, which is freely available without restriction, for screening for disease genes in African American patient cohorts. The map is especially appropriate for those diseases that differ in incidence between the parental African and European populations.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; NCI, Lab Genom Divers, Frederick, MD 21701 USA; NCI, Basic Res Program, Sci Applicat Int Corp, Frederick, MD 21701 USA; Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; Harvard Univ, Sch Med, Lab Mol Immunol, Boston, MA USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Harvard AIDS Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Appl Biosyst Inc, Foster City, CA 94404 USA; Chinese Acad Prevent Med, Inst Virol, Beijing 100052, Peoples R China; Inst Pasteur, CNRS, Dept Viral Oncol Epidemiol, Paris, France; Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Nashville, TN USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN USA; Univ Ghana, Sch Adm, Legon, Ghana; Northwestern Univ, Howard Brown Hlth Ctr, Chicago, IL 60611 USA; Northwestern Univ, Dept Med, Chicago, IL 60611 USA; NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Celera Diagnost, Alameda, CA USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Thermo Fisher Scientific; Applied Biosystems; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Ghana; Northwestern University; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York Academy of Medicine; University System of Maryland; University of Maryland College Park	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	reich@receptor.med.harvard.edu	Williams, Scott/Q-4812-2019; Williams, Scott/B-9491-2012; Altshuler, David M/A-4476-2009; OBRIEN, STEPHEN/ABD-1346-2020; Smith, Michael/B-5341-2012; Moore, Jason H./AAV-9645-2021	Williams, Scott/0000-0002-4835-9544; Altshuler, David M/0000-0002-7250-4107; Moore, Jason H./0000-0002-5015-1099; OBRIEN, STEPHEN/0000-0001-7857-0757	DIVISION OF BASIC SCIENCES - NCI [Z01BC005681] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010176, Z01BC005800, Z01BC010270] Funding Source: NIH RePORTER; NCI NIH HHS [N01CO12400] Funding Source: Medline; NHGRI NIH HHS [K-01 HG002758-01, K01 HG002758] Funding Source: Medline; NHLBI NIH HHS [HL-65234, R01 HL065234] Funding Source: Medline; NIAID NIH HHS [U19-AI50864, U19 AI050864] Funding Source: Medline; NINDS NIH HHS [K08 NS046341] Funding Source: Medline; PHS HHS [N01-C0-12400] Funding Source: Medline	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams MD, 2002, AM J HUM GENET, V71, P203; BRISCOE D, 1994, J HERED, V85, P59; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chen M.H., 2000, MONTE CARLO METHODS; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; DELAVEGA FM, 2002, BIOTECHNIQUES, V32, pS48; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Falush D, 2003, GENETICS, V164, P1567; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goedert JJ, 2002, BLOOD, V100, P1584; Halder Indrani, 2003, Human Genomics, V1, P52; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hollenbach JA, 2001, HUM IMMUNOL, V62, P378, DOI 10.1016/S0198-8859(01)00212-9; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lopes A A, 1999, Rev Assoc Med Bras (1992), V45, P115, DOI 10.1590/S0104-42301999000200005; MCELIECE RJ, 2002, THEORY INFORMATION C; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; NEI M, 1982, EVOL BIOL, V14, P1; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Novitsky V, 2001, J VIROL, V75, P9210, DOI 10.1128/JVI.75.19.9210-9228.2001; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pfaff CL, 2002, GENET EPIDEMIOL, V22, P196, DOI 10.1002/gepi.0126; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Risch NJ, 1992, AM J HUM GENET S, V51, P13; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tess BH, 1998, AIDS, V12, P513, DOI 10.1097/00002030-199805000-00013; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	52	362	389	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1001	1013		10.1086/420856	http://dx.doi.org/10.1086/420856			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15088270	Green Published, Bronze			2022-12-18	WOS:000220926100018
J	Vissers, LELM; de Vries, BBA; Osoegawa, K; Janssen, IM; Feuth, T; Choy, CO; Straatman, H; van der Vliet, W; Huys, EHLPG; van Rijk, A; Smeets, D; van Ravenswaaij-Arts, CMA; Knoers, NV; van der Burgt, I; de Jong, PJ; Brunner, HG; van Kessel, AG; Schoenmakers, EFPM; Veltman, JA				Vissers, LELM; de Vries, BBA; Osoegawa, K; Janssen, IM; Feuth, T; Choy, CO; Straatman, H; van der Vliet, W; Huys, EHLPG; van Rijk, A; Smeets, D; van Ravenswaaij-Arts, CMA; Knoers, NV; van der Burgt, I; de Jong, PJ; Brunner, HG; van Kessel, AG; Schoenmakers, EFPM; Veltman, JA			Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA COPY NUMBER; WILLIAMS-SYNDROME; MENTAL-RETARDATION; REARRANGEMENTS; MICROARRAYS; DELETION; REGION; GENE; POLYMORPHISM; DUPLICATION	Microdeletions and microduplications, not visible by routine chromosome analysis, are a major cause of human malformation and mental retardation. Novel high-resolution, whole-genome technologies can improve the diagnostic detection rate of these small chromosomal abnormalities. Array-based comparative genomic hybridization allows such a high-resolution screening by hybridizing differentially labeled test and reference DNAs to arrays consisting of thousands of genomic clones. In this study, we tested the diagnostic capacity of this technology using similar to3,500 flourescent in situ hybridization-verified clones selected to cover the genome with an average of 1 clone per megabase (Mb). The sensitivity and specificity of the technology were tested in normal-versus-normal control experiments and through the screening of patients with known microdeletion syndromes. Subsequently, a series of 20 cytogenetically normal patients with mental retardation and dysmorphisms suggestive of a chromosomal abnormality were analyzed. In this series, three microdeletions and two microduplications were identified and validated. Two of these genomic changes were identified also in one of the parents, indicating that these are large-scale genomic polymorphisms. Deletions and duplications as small as 1 Mb could be reliably detected by our approach. The percentage of false-positive results was reduced to a minimum by use of a dye-swap-replicate analysis, all but eliminating the need for laborious validation experiments and facilitating implementation in a routine diagnostic setting. This high-resolution assay will facilitate the identification of novel genes involved in human mental retardation and/or malformation syndromes and will provide insight into the flexibility and plasticity of the human genome.	Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Childrens Hosp Oakland, Res Inst, BACPAC Resources Ctr, Oakland, CA 94609 USA	Radboud University Nijmegen; Radboud University Nijmegen; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Veltman, JA (corresponding author), Univ Med Ctr Nijmegen, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.		van Kessel, Ad Geurts/A-2810-2010; Smeets, D.F.C.M./L-4653-2015; Veltman, Joris A/F-5128-2010; Brunner, Han/C-9928-2013; Vissers, Lisenka ELM/A-2598-2015; Janssen, Irene M/V-3667-2018	Veltman, Joris A/0000-0002-3218-8250; Vissers, Lisenka ELM/0000-0001-6470-5497; 				Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Anderson G, 1996, P GREENWOOD GENET CT, V15, P32; Ballif BC, 2000, AM J HUM GENET, V67, P1356; Barber JCK, 1998, J MED GENET, V35, P491, DOI 10.1136/jmg.35.6.491; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Biesecker LG, 2002, AM J MED GENET, V107, P263, DOI 10.1002/ajmg.10160.abs; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; de Bruijn DRH, 2001, CYTOGENET CELL GENET, V92, P310, DOI 10.1159/000056920; de Vries BBA, 2003, J MED GENET, V40, P385, DOI 10.1136/jmg.40.6.385; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Der-Sarkissian H, 2002, GENOME RES, V12, P1673, DOI 10.1101/gr.322802; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; Engelen JJM, 2000, AM J MED GENET, V91, P18, DOI 10.1002/(SICI)1096-8628(20000306)91:1<18::AID-AJMG3>3.3.CO;2-V; Eronen M, 2002, J MED GENET, V39, P554, DOI 10.1136/jmg.39.8.554; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; FRYDMAN M, 1986, AM J MED GENET, V25, P245, DOI 10.1002/ajmg.1320250208; KAMBOH MI, 1991, AM J HUM GENET, V49, P1063; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Linardopoulou E, 2001, HUM MOL GENET, V10, P2373, DOI 10.1093/hmg/10.21.2373; Mizugishi K, 1998, J HUM GENET, V43, P178, DOI 10.1007/s100380050064; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Robinson SW, 2003, AM J HUM GENET, V72, P1047, DOI 10.1086/374319; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Schinzel A., 2001, CATALOGUE UNBALANCED; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; VALENTINE H, 1977, P261; Veltman JA, 2003, CANCER RES, V63, P2872; Veltman JA, 2003, AM J HUM GENET, V72, P1578, DOI 10.1086/375695; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Wessendorf S, 2003, ONCOGENE, V22, P1425, DOI 10.1038/sj.onc.1206297; Wu YQ, 1999, J MED GENET, V36, P928; Zafarana G, 2003, ONCOGENE, V22, P7695, DOI 10.1038/sj.onc.1207011	40	362	398	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1261	1270		10.1086/379977	http://dx.doi.org/10.1086/379977			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14628292	Bronze, Green Published			2022-12-18	WOS:000187491100004
J	Ruiz-Pesini, E; Lapena, AC; Diez-Sanchez, C; Perez-Martos, A; Montoya, J; Alvarez, E; Diaz, M; Urrieis, A; Montoro, L; Lopez-Perez, MJ; Enriquez, JA				Ruiz-Pesini, E; Lapena, AC; Diez-Sanchez, C; Perez-Martos, A; Montoya, J; Alvarez, E; Diaz, M; Urrieis, A; Montoro, L; Lopez-Perez, MJ; Enriquez, JA			Human mtDNA haplogroups associated with high or reduced spermatozoa motility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-DNA MUTATIONS; WOLFRAM DIDMOAD SYNDROME; RIBOSOMAL-RNA MUTATION; MULTIPLE-SCLEROSIS; SPERM MOTILITY; DEAFNESS; GENE; DISEASE; PHENOTYPE	A variety of mtDNA mutations responsible for human diseases have been associated with molecular defects in the OXPHOS system. It has been proposed that mtDNA genetic alterations can also be responsible for sperm dysfunction. In addition, it was suggested that if sperm dysfunction is the main phenotypic consequence, these mutations could be fixed as stable mtDNA variants, because mtDNA is maternally inherited. To test this possibility, we have performed an extensive analysis of the distribution of mtDNA haplogroups in white men having fertility problems. We have found that asthenozoospermia, but not oligozoospermia, is associated with mtDNA haplogroups in whites. Thus, haplogroups H and T are significantly more abundant in nonasthenozoospermic and asthenozoospermic populations, respectively, and show significant differences in their OXPHOS performance.	Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain; Hosp 12 Octubre, Unidad Androl, E-28041 Madrid, Spain; Clin Ginecol, Zaragoza, Spain; Nueva Clin Quiron, Zaragoza, Spain; Hosp Principe Asturias, Lab Reprod Humana, Alcala De Henares, Madrid, Spain	University of Zaragoza; Hospital Universitario 12 de Octubre; Prince of Asturias University Hospital	Enriquez, JA (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.	enriquez@postla.unizar.es	Enríquez, J.A./M-8468-2016	Enríquez, J.A./0000-0002-3671-2961				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; BAKER HWG, 1994, REPROD FERT DEVELOP, V6, P9, DOI 10.1071/RD9940009; Brown MD, 1997, AM J HUM GENET, V60, P381; Cummins JM, 1998, INT J ANDROL, V21, P47; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; FISCHELGHODSIAN N, 1995, AM J OTOLARYNG, V16, P403, DOI 10.1016/0196-0709(95)90078-0; FOLGERO T, 1993, HUM REPROD, V8, P1863, DOI 10.1093/oxfordjournals.humrep.a137950; FORD WCL, 1981, J REPROD FERTIL, V63, P271; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; HALANGK W, 1985, BIOCHIM BIOPHYS ACTA, V808, P316, DOI 10.1016/0005-2728(85)90014-3; Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474; Hofmann S, 1997, MOL CELL BIOCHEM, V174, P209, DOI 10.1023/A:1006856407698; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2; Howell N, 1999, INT REV CYTOL, V186, P49; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; John JCS, 1997, NAT MED, V3, P124, DOI 10.1038/nm0297-124c; Kalman B, 1995, Mult Scler, V1, P32; KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X; MARZUKI S, 1991, HUM GENET, V88, P139; MayrWohlfart U, 1996, ACTA NEUROL SCAND, V94, P167, DOI 10.1111/j.1600-0404.1996.tb07048.x; Ohlenbusch A, 1998, NEUROPEDIATRICS, V29, P175, DOI 10.1055/s-2007-973557; Pascual ML, 1996, BIOSCIENCE REP, V16, P35, DOI 10.1007/BF01200999; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Richards M, 1996, AM J HUM GENET, V59, P185; RODRIGUEZSEGADE S, 1985, CLIN CHEM, V31, P754; ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; WALLACE DC, 1995, AM J HUM GENET, V57, P201; World Health Organization, 1992, WHO LAB MAN EX HUM S, V3rd; Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133	45	362	380	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					682	696		10.1086/303040	http://dx.doi.org/10.1086/303040			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10936107	Green Published, Bronze			2022-12-18	WOS:000089002300015
J	McMahon, FJ; Buervenich, S; Charney, D; Lipsky, R; Rush, AJ; Wilson, AF; Sorant, AJM; Papanicolaou, GJ; Laje, G; Fava, M; Trivedi, MH; Wisniewski, SR; Manji, H				McMahon, FJ; Buervenich, S; Charney, D; Lipsky, R; Rush, AJ; Wilson, AF; Sorant, AJM; Papanicolaou, GJ; Laje, G; Fava, M; Trivedi, MH; Wisniewski, SR; Manji, H			Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; STAR-ASTERISK-D; REPORT QIDS-SR; DEPRESSIVE SYMPTOMATOLOGY; QUICK INVENTORY; MESSENGER-RNA; GLOBAL BURDEN; PHARMACOGENETICS; NEUROBIOLOGY; TRANSPORTER	Depressive disorders account for a large and increasing global burden of disease. Although the condition of many patients improves with medication, only a minority experience full remission, and patients whose condition responds to one medication may not have a response to others. Individual variation in antidepressant treatment outcome is, at present, unpredictable but may have a partial genetic basis. We searched for genetic predictors of treatment outcome in 1,953 patients with major depressive disorder who were treated with the antidepressant citalopram in the Sequenced Treatment Alternatives for Depression (STAR*D) study and were prospectively assessed. In a split-sample design, a selection of 68 candidate genes was genotyped, with 768 single-nucleotide-polymorphism markers chosen to detect common genetic variation. We detected significant and reproducible association between treatment outcome and a marker in HTR2A (P range 1 x 10(-6) to 3.7 x 10(-5) in the total sample). Other markers in HTR2A also showed evidence of association with treatment outcome in the total sample. HTR2A encodes the serotonin 2A receptor, which is downregulated by citalopram. Participants who were homozygous for the A allele had an 18% reduction in absolute risk of having no response to treatment, compared with those homozygous for the other allele. The A allele was over six times more frequent in white than in black participants, and treatment was less effective among black participants. The A allele may contribute to racial differences in outcomes of antidepressant treatment. Taken together with prior neurobiological findings, these new genetic data make a compelling case for a key role of HTR2A in the mechanism of antidepressant action.	NIMH, Mol Pathophysiol Lab, Mood & Anxiety Program, NIH,DHHS, Bethesda, MD 20892 USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY USA; NIAAA, Mol Genet Sect, Neurogenet Lab, NIH,DHHS, Rockville, MD 20852 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX USA; NHGRI, Genometr Sect, Inherited Dis Res Branch, NIH,DHHS, Baltimore, MD USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McMahon, FJ (corresponding author), NIMH, Mol Pathophysiol Lab, Mood & Anxiety Program, NIH,DHHS, 35 Convent Dr,Room 1A202, Bethesda, MD 20892 USA.	mcmahonf@intra.nimh.nih.gov	Laje, Gonzalo/L-2654-2014; McMahon, Francis J/A-7290-2009; Fava, Maurizio/AAH-3548-2020; Trivedi, Madhukar/A-9029-2013; anand, amit/A-7222-2009; Wilson, Alexander F./Q-6910-2019; Wilson, Alexander/C-2320-2009	Laje, Gonzalo/0000-0003-2763-3329; McMahon, Francis J/0000-0002-9469-305X; Trivedi, Madhukar/0000-0002-2983-1110; Lipsky, Robert/0000-0001-7753-1473; Rush, Augustus/0000-0003-2004-2382; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457, Z01MH002844, N01MH090003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000326, Z01AA000301] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anguelova M, 2003, MOL PSYCHIATR, V8, P574, DOI 10.1038/sj.mp.4001328; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Bray NJ, 2004, MOL PSYCHIATR, V9, P109, DOI 10.1038/sj.mp.4001366; Brown C, 1999, J AFFECT DISORDERS, V53, P185, DOI 10.1016/S0165-0327(98)00120-7; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Cassano Paolo, 2004, Ann Clin Psychiatry, V16, P15, DOI 10.1080/10401230490281618; Choi MJ, 2005, NEUROPSYCHOBIOLOGY, V52, P155, DOI 10.1159/000087847; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Cusin C, 2002, INT J NEUROPSYCHOPH, V5, P27, DOI 10.1017/S1461145701002711; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Erdmann J, 1996, HUM GENET, V97, P614, DOI 10.1007/s004390050104; Fava M, 2002, PSYCHOTHER PSYCHOSOM, V71, P195, DOI 10.1159/000063644; Franchini L, 1998, J PSYCHIAT RES, V32, P255, DOI 10.1016/S0022-3956(98)00004-1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Hahn MK, 2005, MOL PHARMACOL, V68, P457, DOI 10.1124/mol.105.011270; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HUMPHREY PPA, 1993, TRENDS PHARMACOL SCI, V14, P233, DOI 10.1016/0165-6147(93)90016-D; JAESCHKE R, 2002, USERS GUIDES MED LIT, P351; Kraemer HC, 1987, MANY SUBJECTS STAT P; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Malhotra AK, 2004, AM J PSYCHIAT, V161, P780, DOI 10.1176/appi.ajp.161.5.780; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; MANN JJ, 2005, BASIC NEUROCHEMISTRY, P887; Marangell LB, 2001, J CLIN PSYCHIAT, V62, P12; Minov C, 2001, NEUROSCI LETT, V303, P119, DOI 10.1016/S0304-3940(01)01704-9; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Norton N, 2005, ANN MED, V37, P121, DOI 10.1080/07853890510037347; Papolos DF, 1996, PSYCHIAT RES, V63, P197, DOI 10.1016/0165-1781(96)02935-6; Parsons MJ, 2004, BIOL PSYCHIAT, V56, P406, DOI 10.1016/j.biopsych.2004.06.020; Peremans K, 2005, EUR J NUCL MED MOL I, V32, P708, DOI 10.1007/s00259-005-1772-5; Peters EJ, 2004, MOL PSYCHIATR, V9, P879, DOI 10.1038/sj.mp.4001502; Pritchard JK, 2000, GENETICS, V155, P945; REMILLARD AJ, 1994, HOSP COMMUNITY PSYCH, V45, P359; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Serretti A, 2005, PHARMACOGENET GENOM, V15, P61, DOI 10.1097/01213011-200502000-00001; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; STERN SL, 1980, AM J PSYCHIAT, V137, P545; Strome EM, 2005, BIOL PSYCHIAT, V57, P1004, DOI 10.1016/j.biopsych.2005.01.025; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Vaidya VA, 1997, J NEUROSCI, V17, P2785; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507	53	360	388	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					804	814		10.1086/503820	http://dx.doi.org/10.1086/503820			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642436	Bronze, Green Published			2022-12-18	WOS:000236756200007
J	Thompson, D; Easton, D				Thompson, D; Easton, D		Breast Canc Linkage Consortium	Variation in cancer risks, by mutation position, in BRCA2 mutation carriers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWISH WOMEN; BREAST-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; FREQUENCY; LOCALIZATION; FAMILY; RAD51; PENETRANCE; PREVALENCE	Cancer occurrence in 164 families with breast/ovarian cancer and germline BRCA2 mutations was studied to evaluate the evidence for genotype-phenotype correlations. Mutations in a central portion of the gene (the "ovarian cancer cluster region" [OCCR]) were associated with a significantly higher ratio of cases of ovarian: breast cancer in female carriers than were mutations 50 or 30 of this region (P < .0001), extending previous observations. The optimal definition of the OCCR, as judged on the basis of deviance statistics, was bounded by nucleotides 3059-4075 and 6503-6629. The relative and absolute risks of breast and ovarian cancer associated with OCCR and non-OCCR mutations were estimated by a conditional likelihood approach, conditioning on the set of mutations observed in the families. OCCR mutations were associated both with a highly significantly lower risk of breast cancer (relative risk [RR] 0.63; 95% confidence interval (95% CI) 0.46-0.84; P = .0012) and with a significantly higher risk of ovarian cancer (RR = 1.88; 95% CI = 1.08-3.33; P = .026). No other differences in breast or ovarian cancer risk, by mutation position, were apparent. There was some evidence for a lower risk of prostate cancer in carriers of an OCCR mutation (RR = 0.52; 95% CI = 0.24-1.00; P = .05), but there was no evidence of a difference in breast cancer risk in males. By age 80 years, the cumulative risk of breast cancer in male carriers of a BRCA2 mutation was estimated as 6.92% (95% CI = 1.20%-38.57%). Possible mechanisms for the variation in cancer risk are suggested by the coincidence of the OCCR with the RAD51-binding domain.	CRC, Genet Epidemiol Unit, Strangeways Res Lab, Cambridge, England; Univ Aberdeen, Aberdeen AB9 1FX, Scotland; Kantonsspital, CH-4031 Basel, Switzerland; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Ctr Jean Perrin, Clermont Ferrand, France; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; Univ Wurzburg, Wurzburg, Germany; Ctr Nacl Invest Oncol, Madrid, Spain; Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; Creighton Univ, Omaha, NE 68178 USA; Int Agcy Res Canc, F-69372 Lyon, France; Inst Curie, Paris, France; Univ Hosp Iceland, Reykjavik, Iceland; Icelandic Canc Soc, Reykjavik, Iceland; Imperial Canc Res Fund, Leeds, W Yorkshire, England; Lund Univ, S-22100 Lund, Sweden; McGill Univ, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ H3C 3J7, Canada; Univ Penn, Philadelphia, PA 19104 USA; Leiden Univ, NL-2300 RA Leiden, Netherlands; Fdn Detect Hereditary Tumours, Leiden, Netherlands; Erasmus MC, Rotterdam, Netherlands; Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands; Univ Toronto, Toronto, ON, Canada; Univ Utah, Salt Lake City, UT 84112 USA	University of Aberdeen; Kantonsspital Aarau AG (KSA); University of Basel; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UNICANCER; Centre Jean Perrin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Creighton University; World Health Organization; International Agency for Research on Cancer (IARC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Landspitali National University Hospital; Lund University; McGill University; Universite de Montreal; University of Pennsylvania; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Toronto; Utah System of Higher Education; University of Utah	Easton, D (corresponding author), CRC, Genet Epidemiol Unit, Strangeways Res Lab, Worts Causeway, Cambridge, England.	douglas@srl.cam.ac.uk			NATIONAL CANCER INSTITUTE [R01CA077415, R01CA027632] Funding Source: NIH RePORTER; NCI NIH HHS [CA77415, R01 CA27632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Bertwistle D, 1997, CANCER RES, V57, P5485; Bieche I, 1999, CANCER RES, V59, P2546; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Csokay B, 1999, CANCER RES, V59, P995; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1998, DIS MARKERS, V14, P1; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Haraldsson K, 1998, CANCER RES, V58, P1367; Johannesdottir G, 1996, CANCER RES, V56, P3663; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lu ML, 1996, CANCER RES, V56, P4578; Mavraki E, 1997, BRIT J CANCER, V76, P1428, DOI 10.1038/bjc.1997.574; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; MUIR CS, 1987, IARC SCI PUBL, V88; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; PARKIN DM, 1992, IEARC SCI PUBL, V120; PARKIN DM, 1997, IEARC SCI PUBL, V143; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; TONIN P, 1995, J MED GENET, V32, P982, DOI 10.1136/jmg.32.12.982; VENKITARAMAN AR, 2000, BIOCHIM BIOPHYS ACTA, V1470, P41; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; WATERHOUSE J, 1982, CANC INCIDENCE 5 CON, V4; Waterhouse J, 1976, IARC SCI PUBL, VIII; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	39	359	362	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					410	419		10.1086/318181	http://dx.doi.org/10.1086/318181			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170890	Green Published, Bronze			2022-12-18	WOS:000166524800011
J	HOLMANS, P				HOLMANS, P			ASYMPTOTIC PROPERTIES OF AFFECTED-SIB-PAIR LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; FRAGMENT-LENGTH-POLYMORPHISMS; MULTIPLE-SCLEROSIS; MARKER POLYMORPHISM; MYASTHENIA-GRAVIS; STRATEGIES; GENES; SUSCEPTIBILITY; HAPLOTYPES	The likelihood-ratio method for affected-sib-pair analysis, introduced by Risch, is a powerful method for detecting linkage when the marker is not perfectly polymorphic, as is often the case. The power of this method can be improved by restricting maximization to the set of possible haplotype-sharing probabilities-denoted the ''possible triangle'' method. The asymptotic distributions of the resulting distributions are derived, enabling test criteria to be found for any required test size (i.e., the probability of falsely detecting linkage when none exists) and enabling p values to be assigned to results. The criteria were found to be approximately constant when the PIC of the marker varies, making them applicable to any marker. The asymptotic power approximations were used to investigate the relative performance of pairs with typed parents, relative to those without, by comparing the sample sizes necessary for a given power. Under certain circumstances, typing the parents proved to be inefficient, even when PIC was low.			HOLMANS, P (corresponding author), UNIV CAMBRIDGE,INST PUBL HLTH,MRC,BIOSTAT UNIT,FORVIE SITE,ROBINSON WAY,CAMBRIDGE CB2 2SR,ENGLAND.		Holmans, Peter/F-4518-2015	Holmans, Peter/0000-0003-0870-9412				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; BEALL SS, 1989, NEUROEPIDEMIOL, V22, P59; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHARMLEY P, 1990, P NATL ACAD SCI USA, V87, P4823, DOI 10.1073/pnas.87.12.4823; COX DR, 1974, THEORETICAL STATISTI, P279; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; FUGGER L, 1990, IMMUNOGENETICS, V31, P278; GREEN JR, 1983, ANN HUM GENET, V47, P73, DOI 10.1111/j.1469-1809.1983.tb00972.x; GREEN JR, 1991, ANN HUM GENET, V55, P243, DOI 10.1111/j.1469-1809.1991.tb00419.x; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; LANGE K, 1986, AM J HUM GENET, V39, P148; OKSENBERG JR, 1988, HUM IMMUNOL, V22, P111, DOI 10.1016/0198-8859(88)90041-9; OKSENBERG JR, 1989, P NATL ACAD SCI USA, V86, P988, DOI 10.1073/pnas.86.3.988; PAYAMI H, 1985, ANN HUM GENET, V49, P303, DOI 10.1111/j.1469-1809.1985.tb01706.x; PENROSE LS, 1953, ANN EUGENIC, V18, P120; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1992, AM J HUM GENET, V51, P673; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SPIELMAN RS, 1982, EPIDEMIOL REV, V4, P45, DOI 10.1093/oxfordjournals.epirev.a036251; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x	24	359	363	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					362	374						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430697				2022-12-18	WOS:A1993KN27500015
J	HOWELL, N; BINDOFF, LA; MCCULLOUGH, DA; KUBACKA, I; POULTON, J; MACKEY, D; TAYLOR, L; TURNBULL, DM				HOWELL, N; BINDOFF, LA; MCCULLOUGH, DA; KUBACKA, I; POULTON, J; MACKEY, D; TAYLOR, L; TURNBULL, DM			LEBER HEREDITARY OPTIC NEUROPATHY - IDENTIFICATION OF THE SAME MITOCHONDRIAL NDI MUTATION IN 6 PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE ORGANIZATION; NADH DEHYDROGENASE; ELECTROSTATIC INTERACTIONS; SECONDARY STRUCTURE; PROTEIN STABILITY; RESPIRATORY-CHAIN; GLOBULAR-PROTEINS; READING FRAMES; DNA MUTATION	Biochemical and molecular genetic evidence is presented that in six independent pedigrees the development of Leber hereditary optic neuropathy (LHON) is due to the same primary mutation in the mitochondrial ND1 gene. A LHON family from the Newcastle area of Great Britain was analyzed in depth to determine the mitochondrial genetic etiology of their disease. Biochemical assays of mitochondrial electron transport in organelles isolated from the platelet/white-blood-cell fraction have established that the members of this family have a substantial and specific lowering of flux through complex I (NADH-ubiquinone oxidoreductase). To determine the site of the primary mitochondrial gene mutation in this pedigree, all seven mitochondrial complex I genes were sequenced, in their entirety, from two family members. The primary mutation was identified as a homoplasmic transition at nucleotide 3460, which results in the substitution of threonine for alanine at position 52 of the ND1 protein. This residue occurs within a very highly conserved hydrophilic loop, is invariantly alanine or glycine in all ND1 proteins, and is adjacent to an invariant aspartic acid residue. This is only the second instance in which both a biochemical abnormality and a mitochondrial gene mutation have been identified in an LHON pedigree. The sequence analysis of the ND1 gene was extended to a further 11, unrelated LHON pedigrees that had been screened previously and found not to carry the mitochondrial ND4/R340H mutation. The ND1/A52T mutation at nucleotide 3460 was found in five of these 11 pedigrees. In contrast, this sequence change was not found in any of the 47 non-LHON controls. The possible role of secondary complex I mutations in the etiology of LHON is also addressed in these studies.	UNIV NEWCASTLE UPON TYNE,SCH MED,DIV CLIN NEUROSCI,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND; ROYAL CHILDRENS HOSP,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA	Newcastle University - UK; University of Oxford; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL,GALVESTON,TX 77550, USA.		Mackey, David A/H-5340-2014; Poulton, Joanna/AAB-4828-2021	Mackey, David A/0000-0001-7914-4709; Poulton, Joanna/0000-0002-2460-5587; Bindoff, Laurence/0000-0003-0988-276X	NICHD NIH HHS [P01 HD 08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKKE M, 1990, PROTEINS, V8, P23, DOI 10.1002/prot.340080106; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; BOER PH, 1988, EMBO J, V7, P3501, DOI 10.1002/j.1460-2075.1988.tb03226.x; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BROWN TA, 1983, EMBO J, V2, P427, DOI 10.1002/j.1460-2075.1983.tb01440.x; BURGER G, 1985, J MOL BIOL, V186, P231, DOI 10.1016/0022-2836(85)90100-7; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CUMMINGS DJ, 1988, CURR GENET, V14, P263; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FRIEDRICH T, 1990, FEBS LETT, V265, P37, DOI 10.1016/0014-5793(90)80878-M; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GASCUEL O, 1988, COMPUT APPL BIOSCI, V4, P357; HENSGENS LAM, 1984, NUCLEIC ACIDS RES, V12, P7327, DOI 10.1093/nar/12.19.7327; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1990, AM J HUM GENET, V47, P629; HOWELL N, 1988, J MOL BIOL, V203, P618; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; KLEIN P, 1985, BIOCHIM BIOPHYS ACTA, V815, P468, DOI 10.1016/0005-2736(85)90375-X; KLER RS, IN PRESS J BIOL CHEM; KOHCHI T, 1988, J MOL BIOL, V203, P353, DOI 10.1016/0022-2836(88)90004-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; LUNDSGARD R, 1944, ACTA OPHTHALMOL S3, V21, P3; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; PEDERSON GL, 1977, ANAL BIOCHEM, V83, P346; POULTON J, IN PRESS J MED GENET; PRITCHARD AE, 1990, NUCLEIC ACIDS RES, V18, P163, DOI 10.1093/nar/18.1.163; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; ROE BA, 1985, J BIOL CHEM, V260, P9759; SAQI MAS, 1990, PROTEIN ENG, V3, P419, DOI 10.1093/protein/3.5.419; SCHAPIRA AHV, 1990, BRAIN, V113, P419, DOI 10.1093/brain/113.2.419; Schwartz RM, 1978, ATLAS PROTEIN SEQ S3, P353; SEEDORFF T, 1970, ACTA OPHTHALMOL, V163, P133; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	53	359	372	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					939	950						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928099				2022-12-18	WOS:A1991GM87300004
J	FRASER, FC				FRASER, FC			GENETICS OF CLEFT LIP AND CLEFT PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ADAMS MS, 1967, GENET RES, V10, P313, DOI 10.1017/S0016672300011071; ALTEMUS LA, 1965, PEDIATRICS, V36, P56; Burdi A R, 1969, Cleft Palate J, V6, P1; CARTER C. O., 1965, PROGR MED GENET, V4, P59; Carter C O, 1964, Clin Orthop Relat Res, V33, P119; CARTER CO, 1967, LANCET, V1, P306; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; Carter CO, 1964, 2 INT C CONG MALF, P306; CERVENKA J, 1967, AM J HUM GENET, V19, P416; CHUNG CS, 1968, AM J HUM GENET, V20, P44; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; DRILLIEN CM, 1966, CAUSES NATURAL HISTO; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fogh-Andersen, 1942, INHERITANCE HARELIP; FOGH-ANDERSEN P., 1961, ACTA CHIR SCAND, V122, P106; FOGHANDERSON P, 1943, SAERTRYLE TANDLAEGEB, V47, P411; FRASER F C, 1964, Plast Reconstr Surg, V33, P395, DOI 10.1097/00006534-196404000-00009; FRASER FC, 1957, PEDIATRICS, V19, P782; FRASER FC, 1954, AM J SURG, V87, P656, DOI 10.1016/0002-9610(54)90161-0; FRASER FC, 1963, 2 P INT C HUM GEN, V3, P1852; FRASER GR, 1961, ARCH DIS CHILD, V36, P420, DOI 10.1136/adc.36.188.420; FUJINO HIROSHI, 1963, KYUSHU J MED SCI, V14, P317; FUJINO HIROSHI, 1967, JAP J HUM GENET, V12, P62; FUKUHARA T, 1965, J DENT RES, V44, P259, DOI 10.1177/00220345650440012101; GREENE JC, 1964, J AM DENT ASSOC, V68, P387, DOI 10.14219/jada.archive.1964.0079; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; Kobayasi Y., 1958, JPN J HUM GENET, V3, P73; LOWRY R B, 1969, Journal of Medical Genetics, V6, P67; Meskin L H, 1968, Cleft Palate J, V5, P23; Meskin L H, 1968, Acta Chir Plast, V10, P249; MESKIN LH, 1967, J DENT RES, V46, P1456, DOI 10.1177/00220345670460065001; MESKIN LH, 1963, THESIS U MINNESOTA; MESKIN LH, IN PRESS; METRAKOS J D, 1958, Plast Reconstr Surg Transplant Bull, V22, P109, DOI 10.1097/00006534-195808000-00003; MILLS LF, 1968, ANGLE ORTHOD, V38, P199; MORTON NE, 1967, GENETICS INTERRACIAL; NEEL JV, 1958, AM J HUM GENET, V10, P398; NEWCOMBE HB, 1963, CONGENITAL MALFORMAT, P345; NISWANDER JD, 1968, ACTA GENET STAT MED, V18, P229; NISWANDER JD, 1968, ARCH ORAL BIOL, V13, P1019, DOI 10.1016/0003-9969(68)90017-4; NISWANDER JD, 1967, PUBLIC HEALTH REP, V82, P807, DOI 10.2307/4593135; NORA JJ, 1967, CIRCULATION, V35, P448, DOI 10.1161/01.CIR.35.3.448; PASHAYAN H, 1969, TERATOLOGY, V2, P267; PRUZANSKY S, 1966, 3 INT C HUM GEN CHIC, P80; PRUZANSKY S, 1969, 1 INT S TWIN STUD RO; RANK BK, 1960, MED J AUSTRALIA, V2, P681; Rusconi L, 1966, Minerva Stomatol, V15, P548; Schull WJ, 1965, EFFECTS INBREEDING J; SLATIS HM, 1958, AM J HUM GENET, V10, P446; STEVENSON AC, 1966, B WHO              S, V34; Sutter J, 1954, POPULATION, V9, P425, DOI 10.2307/1524555; TANAKA K, 1967, Japanese Journal of Human Genetics, V12, P141; TRASLER DG, 1968, TERATOLOGY, V1, P33, DOI 10.1002/tera.1420010106; TRASLER DG, 1963, DEV BIOL, V6, P45, DOI 10.1016/0012-1606(63)90004-6; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244; WOOLF C M, 1964, Plast Reconstr Surg, V34, P11, DOI 10.1097/00006534-196407000-00002; WOOLF C M, 1965, Plast Reconstr Surg, V35, P543, DOI 10.1097/00006534-196505000-00011; WOOLF CM, 1963, AM J HUM GENET, V15, P389; WOOLF CM, 1963, AM J HUM GENET, V15, P209	61	358	360	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	3					336	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G6436	4910698				2022-12-18	WOS:A1970G643600009
J	BILLINGS, PR; KOHN, MA; DECUEVAS, M; BECKWITH, J; ALPER, JS; NATOWICZ, MR				BILLINGS, PR; KOHN, MA; DECUEVAS, M; BECKWITH, J; ALPER, JS; NATOWICZ, MR			DISCRIMINATION AS A CONSEQUENCE OF GENETIC TESTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE; LINKAGE MAP; IMPACT	Genetic discrimination refers to discrimination directed against an individual or family based solely on an apparent or perceived genetic variation from the "normal" human genotype. We describe here the results of a case history study designed to assess whether or not genetic discrimination exists. Using the above definition of genetic discrimination and applying stringent criteria for case selection, we find that genetic discrimination exists and is manifested in many social institutions, especially in the health and life insurance industries. Stigmatization, and denial of services or entitlements to individuals who have a genetic diagnosis but who are asymptomatic or who will never become significantly impaired, is noted. Follow-up comprehensive studies on the significance and varieties of genetic discrimination are needed. In order to avoid creating a new social underclass based on genetic discrimination (the "asymptomatic ill"), existing and future genetic testing or screening programs need review by medical, scientific, legal, and social policy experts, as well as the public, and may require modification.	HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; UNIV MASSACHUSETTS, DEPT CHEM, AMHERST, MA 01003 USA; MASSACHUSETTS GEN HOSP, MASSACHUSETTS EYE & EAR INFIRM, DEPT PATHOL, BOSTON, MA 02114 USA; SHRIVER CTR MENTAL RETARDAT, DIV MED GENET, WALTHAM, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Massachusetts Eye & Ear Infirmary; Massachusetts General Hospital	BILLINGS, PR (corresponding author), CALIF PACIFIC MED CTR, DEPT MED, DIV GENET MED, POB 7999, SAN FRANCISCO, CA 94120 USA.		de Cuevas, Margaret/GXV-8365-2022					BECKWITH J, 1991, AM J LAW MED, V17, P1; BILLINGS P, 1988, AM J HUM GENET, V43, P225; BILLINGS P, 1990, BANBURY C, V33; BILLINGS P, 1989, TECHNOL REV, V6, P75; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; DEGORGEY A, 1990, AM J LAW MED, V16, P381; DEZELL M, 1984, BOSTON BUSINESS J, V4, P12; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DSUSEK V, 1987, SCI PEOPLE, V19, P163; EVERSKIEBOOMS G, 1979, CLIN GENET, V15, P465; HAMPTON ML, 1974, AM J DIS CHILD, V128, P58, DOI 10.1001/archpedi.1974.02110260060010; HEWITT M, 1988, COMMERCIAL DEV TESTS; HOLTZMAN NA, 1988, AM J HUM GENET, V42, P624; HOLTZMAN NA, 1989, PROCEED CAUTION PRED; KENEN RH, 1978, AM J PUBLIC HEALTH, V68, P1116, DOI 10.2105/AJPH.68.11.1116; Kevles D, 1985, NAME EUGENICS GENETI; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; MARX GT, 1986, TECHNOL REV, V89, P62; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; MOTULSKY AG, 1983, SCIENCE, V219, P135, DOI 10.1126/science.6336852; MOTULSKY AG, 1974, SCIENCE, V185, P653, DOI 10.1126/science.185.4152.653; MURRAY TH, 1983, HASTINGS CENT REP, V13, P5, DOI 10.2307/3561543; MURRAY TH, 1991, FASEB J, V5, P55, DOI 10.1096/fasebj.5.1.1825074; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; NATOWICZ MR, IN PRESS J PUBLIC HL; Nelkin D., 1989, DANGEROUS DIAGNOSTIC; NORTON C, 1989, HIPPOCRATES, V2, P53; PHILLIPS JA, 1988, MOL GENETICS MED, P68; RUSSELLEINHORN M, 1989, CURRENT ISSUES STRAT; SCOTT J, 1987, BMJ-BRIT MED J, V295, P769, DOI 10.1136/bmj.295.6601.769; SUZUKI D, 1989, GENETHICS; UZYCH L, 1986, Journal of Public Health Policy, V7, P37, DOI 10.2307/3342124; 1990, GENETIC MONITORING S	35	357	358	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					476	482						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539589				2022-12-18	WOS:A1992HH97400004
J	Weaving, LS; Christodoulou, J; Williamson, SL; Friend, KL; McKenzie, OLD; Archer, H; Evans, J; Clarke, A; Pelka, GJ; Tam, PPL; Watson, C; Lahooti, H; Ellaway, CJ; Bennetts, B; Leonard, H; Gecz, J				Weaving, LS; Christodoulou, J; Williamson, SL; Friend, KL; McKenzie, OLD; Archer, H; Evans, J; Clarke, A; Pelka, GJ; Tam, PPL; Watson, C; Lahooti, H; Ellaway, CJ; Bennetts, B; Leonard, H; Gecz, J			Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME-INACTIVATION; CPG-BINDING PROTEIN-2; ARX GENE MUTATION; RETT-SYNDROME; MECP2 MUTATIONS; MOLECULAR FINDINGS; HOMEOBOX GENE; MOUSE EMBRYO; PHENOTYPE; PREVALENCE	Rett syndrome (RTT) is a severe neurodevelopmental disorder caused, in most classic cases, by mutations in the X-linked methyl-CpG-binding protein 2 gene (MECP2). A large degree of phenotypic variation has been observed in patients with RTT, both those with and without MECP2 mutations. We describe a family consisting of a proband with a phenotype that showed considerable overlap with that of RTT, her identical twin sister with autistic disorder and mild-to-moderate intellectual disability, and a brother with profound intellectual disability and seizures. No pathogenic MECP2 mutations were found in this family, and the Xq28 region that contains the MECP2 gene was not shared by the affected siblings. Three other candidate regions were identified by microsatellite mapping, including 10.3 Mb at Xp22.31-pter between Xpter and DXS1135, 19.7 Mb at Xp22.12-p22.11 between DXS1135 and DXS1214, and 16.4 Mb at Xq21.33 between DXS1196 and DXS1191. The ARX and CDKL5 genes, both of which are located within the Xp22 region, were sequenced in the affected family members, and a deletion of nucleotide 183 of the coding sequence (c.183delT) was identified in CDKL5 in the affected family members. In a screen of 44 RTT cases, a single splice-site mutation, IVS13-1G-->A, was identified in a girl with a severe phenotype overlapping RTT. In the mouse brain, Cdkl5 expression overlaps - but is not identical to - that of Mecp2, and its expression is unaffected by the loss of Mecp2. These findings confirm CDKL5 as another locus associated with epilepsy and X-linked mental retardation. These results also suggest that mutations in CDKL5 can lead to a clinical phenotype that overlaps RTT. However, it remains to be determined whether CDKL5 mutations are more prevalent in specific clinical subgroups of RTT or in other clinical presentations.	Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW 2145, Australia; Univ Sydney, Sch Paediat & Child Hlth, Sydney, NSW 2006, Australia; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Wales Coll Med, Dept Med Genet, Cardiff CF4 4XN, S Glam, Wales; Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia; Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia	University of Sydney; University of Sydney; Womens & Childrens Hospital Australia; University of Adelaide; Cardiff University; Children's Medical Research Institute - Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia	Christodoulou, J (corresponding author), Childrens Hosp Westmead, Western Sydney Genet Program, Locked Bag 4001, Westmead, NSW 2145, Australia.	johnc@chw.edu.au	Gecz, Jozef/X-3469-2019; Leonard, Helen/A-1010-2013; Christodoulou, John/M-3628-2019; Christodoulou, John/E-5866-2015	Gecz, Jozef/0000-0002-7884-6861; Leonard, Helen/0000-0001-6405-5834; Christodoulou, John/0000-0002-8431-0641; 				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Ben Zeev B, 2002, J CHILD NEUROL, V17, P20, DOI 10.1177/088307380201700105; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Brunner B, 1999, GENOME RES, V9, P437; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Carrel L, 1996, AM J MED GENET, V64, P27, DOI 10.1002/(SICI)1096-8628(19960712)64:1<27::AID-AJMG3>3.0.CO;2-O; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Davidson BP, 1999, DEV BIOL, V211, P11, DOI 10.1006/dbio.1999.9276; ELLAWAY CJ, 2001, THESIS U SYDNEY WEST; Frints SGM, 2002, AM J MED GENET, V112, P427, DOI 10.1002/ajmg.10629; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Gill H, 2003, J MED GENET, V40, P380, DOI 10.1136/jmg.40.5.380; GOUTIERES F, 1987, BRAIN DEV-JPN, V9, P502, DOI 10.1016/S0387-7604(87)80073-6; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1986, AM J MED GENET, V24, P175; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372, DOI 10.1016/S0387-7604(85)80048-6; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; Hagberg Bengt, 2002, Eur J Paediatr Neurol, V6, P293, DOI 10.1053/ejpn.2002.0612; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; Hoffbuhr KC, 2002, MENT RETARD DEV D R, V8, P99, DOI 10.1002/mrdd.10026; Huopaniemi L, 2000, HUM MUTAT, V16, P307, DOI 10.1002/1098-1004(200010)16:4<307::AID-HUMU3>3.0.CO;2-L; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; Ishii T, 2001, BRAIN DEV-JPN, V23, pS161, DOI 10.1016/S0387-7604(01)00344-8; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Krepischi ACV, 1998, HUM GENET, V102, P319; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Kuramoto N, 2003, BRAIN RES, V981, P78, DOI 10.1016/S0006-8993(03)02968-8; Laccone F, 2004, HUM MUTAT, V23, P234, DOI 10.1002/humu.20004; Leonard H, 1997, EUR CHILD ADOLES PSY, V6, P8; Leonard H, 2001, J CHILD NEUROL, V16, P333, DOI 10.2310/7010.2001.17195; MIGEON BR, 1995, AM J HUM GENET, V56, P647; Miyamoto A, 1997, BRAIN DEV-JPN, V19, P492, DOI 10.1016/S0387-7604(97)00052-1; MNATZAKANIAN GN, 2004, NAT GENET, V36, P1; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Partington MW, 2004, CLIN GENET, V66, P39, DOI 10.1111/j.0009-9163.2004.00268.x; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Sambrook J, 1989, MOL CLONING LAB MANU, V3; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Simonic I, 1997, AM J MED GENET, V74, P331, DOI 10.1002/(SICI)1096-8628(19970531)74:3<331::AID-AJMG16>3.3.CO;2-1; Skjeldal OH, 1997, BRAIN DEV-JPN, V19, P258, DOI 10.1016/S0387-7604(97)00572-X; Steffenburg U, 2001, ACTA PAEDIATR, V90, P34; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; TALVIK T, 1995, ACTA PAEDIATR, V84, P1070, DOI 10.1111/j.1651-2227.1995.tb13827.x; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; TERAI K, 1995, BRAIN DEV-JPN, V17, P153, DOI 10.1016/0387-7604(95)00002-S; Turner G, 2002, AM J MED GENET, V112, P405, DOI 10.1002/ajmg.10714; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Villard L, 2001, J MED GENET, V38, P435, DOI 10.1136/jmg.38.7.435; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Weaving LS, 2003, AM J MED GENET A, V118A, P103, DOI 10.1002/ajmg.a.10053; Webb T, 2001, J MED GENET, V38, P217, DOI 10.1136/jmg.38.4.217; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228; Zappella M, 1997, EUR CHILD ADOLES PSY, V6, P23; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X; ZOGHBI HY, 1990, AM J MED GENET, V35, P148, DOI 10.1002/ajmg.1320350131	66	356	365	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1079	1093		10.1086/426462	http://dx.doi.org/10.1086/426462			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15492925	Green Published, Bronze			2022-12-18	WOS:000224866400012
J	Achilli, A; Rengo, C; Magri, C; Battaglia, V; Olivieri, A; Scozzari, R; Cruciani, F; Zeviani, M; Briem, E; Carelli, V; Moral, P; Dugoujon, JM; Roostalu, U; Loogvali, EL; Kivisild, T; Bandelt, HJ; Richards, M; Villems, R; Santachiara-Benerecetti, AS; Semino, O; Torroni, A				Achilli, A; Rengo, C; Magri, C; Battaglia, V; Olivieri, A; Scozzari, R; Cruciani, F; Zeviani, M; Briem, E; Carelli, V; Moral, P; Dugoujon, JM; Roostalu, U; Loogvali, EL; Kivisild, T; Bandelt, HJ; Richards, M; Villems, R; Santachiara-Benerecetti, AS; Semino, O; Torroni, A			The molecular dissection of mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the European gene pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTROL-REGION SEQUENCES; MITOCHONDRIAL-DNA; WEST; REVEALS; NETWORK; SNPS	Complete sequencing of 62 mitochondrial DNAs (mtDNAs) belonging (or very closely related) to haplogroup H revealed that this mtDNA haplogroup - by far the most common in Europe - is subdivided into numerous sub-haplogroups, with at least 15 of them (H1-H15) identifiable by characteristic mutations. All the haplogroup H mtDNAs found in 5,743 subjects from 43 populations were then screened for diagnostic markers of subhaplogroups H1 and H3. This survey showed that both subhaplogroups display frequency peaks, centered in Iberia and surrounding areas, with distributions declining toward the northeast and southeast - a pattern extremely similar to that previously reported for mtDNA haplogroup V. Furthermore, the coalescence ages of H1 and H3 (similar to11,000 years) are close to that previously reported for V. These findings have major implications for the origin of Europeans, since they attest that the Franco-Cantabrian refuge area was indeed the source of late-glacial expansions of hunter-gatherers that repopulated much of Central and Northern Europe from similar to15,000 years ago. This has also some implications for disease studies. For instance, the high occurrence of H1 and H3 in Iberia led us to re-evaluate the haplogroup distribution in 50 Spanish families affected by nonsyndromic sensorineural deafness due to the A1555G mutation. The survey revealed that the previously reported excess of H among these families is caused entirely by H3 and is due to a major, probably nonrecent, founder event.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; CNR, Ist Biol & Patol Mol, Rome, Italy; Natl Neurol Inst Carlo Besta, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy; Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; Univ Barcelona, Dept Biol Anim, Barcelona, Spain; Ctr Anthropol, UMR 8555, Toulouse, France; Univ Tartu, Dept Evolutionary Biol, Tartu, Estonia; Estonian Bioctr, Tartu, Estonia; Univ Hamburg, Fachbereich Math, Hamburg, Germany; Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; Univ Leeds, Sch Comp, Leeds, W Yorkshire, England	University of Pavia; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituto Neurologico Besta; University of Bologna; University of Barcelona; University of Tartu; Estonian Biocentre; University of Hamburg; University of Leeds; University of Leeds	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	Cruciani, Fulvio/G-6105-2012; OLIVIERI, ANNA/I-9235-2012; Zeviani, Massimo/AAU-2632-2021; Torroni, Antonio/E-1557-2011; Kivisild, Toomas/P-5889-2017; Moral, Pedro/K-9587-2014; Battaglia, Vincenza/F-6950-2017; Magri, Chiara/I-4691-2017; Roostalu, Urmas/B-8421-2011; Zeviani, Massimo/K-2891-2014; Achilli, Alessandro/I-9236-2012	OLIVIERI, ANNA/0000-0002-3941-8098; Zeviani, Massimo/0000-0002-9067-5508; Torroni, Antonio/0000-0002-4163-4478; Kivisild, Toomas/0000-0002-6297-7808; Moral, Pedro/0000-0001-5072-5892; Magri, Chiara/0000-0001-9933-8666; Achilli, Alessandro/0000-0001-6871-3451; RICHARDS, MARTIN/0000-0003-3118-0967; Roostalu, Urmas/0000-0002-7849-2055; SEMINO, Ornella/0000-0002-9675-9403; Cruciani, Fulvio/0000-0002-6900-024X; CARELLI, VALERIO/0000-0003-4923-6404				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Baasner A, 1998, FORENSIC SCI INT, V98, P169, DOI 10.1016/S0379-0738(98)00163-7; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brandstatter A, 2003, INT J LEGAL MED, V117, P291, DOI 10.1007/s00414-003-0395-2; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Herrnstadt, 2002, AM J HUM GENET, V71, P448; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; LOOGVALI EL, 2004, IN PRESS MOL BIOL EV; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; Pfeiffer H, 2001, INT J LEGAL MED, V114, P169, DOI 10.1007/s004140000165; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; ROBERTS N, 1998, HOLOCENE ENV HIST; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Torroni A, 1999, AM J HUM GENET, V65, P1349, DOI 10.1086/302642; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485	40	356	364	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					910	918		10.1086/425590	http://dx.doi.org/10.1086/425590			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15382008	Green Published, Bronze			2022-12-18	WOS:000224303500018
J	Maples, BK; Gravel, S; Kenny, EE; Bustamante, CD				Maples, Brian K.; Gravel, Simon; Kenny, Eimear E.; Bustamante, Carlos D.			RFMix: A Discriminative Modeling Approach for Rapid and Robust Local-Ancestry Inference	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXTURE; POPULATION; ASSOCIATION; DISEASE; ORIGIN	Local-ancestry inference is an important step in the genetic analysis of fully sequenced human genomes. Current methods can only detect continental-level ancestry (i.e., European versus African versus Asian) accurately even when using millions of markers. Here, we present RFMix, a powerful discriminative modeling approach that is faster (similar to 30x) and more accurate than existing methods. We accomplish this by using a conditional random field parameterized by random forests trained on reference panels. RFMix is capable of learning from the admixed samples themselves to boost performance and autocorrect phasing errors. RFMix shows high sensitivity and specificity in simulated Hispanics/Latinos and African Americans and admixed Europeans, Africans, and Asians. Finally, we demonstrate that African Americans in HapMap contain modest (but nonzero) levels of Native American ancestry (similar to 0.4%).	[Maples, Brian K.; Gravel, Simon; Kenny, Eimear E.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Maples, Brian K.] Stanford Univ, Biomed Informat Training Program, Stanford, CA 94305 USA; [Gravel, Simon] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Genet & Genome Sci, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA	Stanford University; Stanford University; McGill University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu		Bustamante, Carlos D./0000-0002-4187-7920; Kenny, Eimear/0000-0001-9198-759X	National Science Foundation (NSF) [DGE-1147470]; National Library of Medicine [LM007033]; National Human Genome Research Institute [2R01HG003229]; NSF Division of Mathematical Sciences [1201234]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF Division of Mathematical Sciences(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Andres Moreno for providing data and Fouad Zakharia and Suyash Shringarpure for helpful comments. This work was supported by National Science Foundation (NSF) Graduate Research Fellowship grant DGE-1147470, National Library of Medicine training grant LM007033, National Human Genome Research Institute grant 2R01HG003229, and NSF Division of Mathematical Sciences grant 1201234. C.D.B. consults for Personalis, Inc., Ancestry.com, Invitae (formerly Locus Development), and the 23andMe.com project "Roots into the Future." None of these entities played any role in the design of the research or interpretation of results presented here.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cann HM, 2002, SCIENCE, V296, P261; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Goncalves VF, 2007, GENET MOL RES, V6, P256; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Lafferty J., 2001, P INT C MACH LEARN, V2001, P282; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Ng AY, 2002, ADV NEUR IN, V14, P841; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Omberg L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-49; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Sundquist A, 2008, GENOME RES, V18, P676, DOI 10.1101/gr.072850.107; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Wang XX, 2011, BIOINFORMATICS, V27, P670, DOI 10.1093/bioinformatics/btq709; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763	33	355	364	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					278	288		10.1016/j.ajhg.2013.06.020	http://dx.doi.org/10.1016/j.ajhg.2013.06.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23910464	Green Published, Bronze			2022-12-18	WOS:000323186200007
J	Kichaev, G; Bhatia, G; Loh, PR; Gazal, S; Burch, K; Freund, MK; Schoech, A; Pasaniuc, B; Price, AL				Kichaev, Gleb; Bhatia, Gaurav; Loh, Po-Ru; Gazal, Steven; Burch, Kathryn; Freund, Malika K.; Schoech, Armin; Pasaniuc, Bogdan; Price, Alkes L.			Leveraging Polygenic Functional Enrichment to Improve GWAS Power	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY CONTROL; PARTITIONING HERITABILITY; MISSING HERITABILITY; VARIANTS; INFORMATION	Functional genomics data has the potential to increase GWAS power by identifying SNPs that have a higher prior probability of association. Here, we introduce a method that leverages polygenic functional enrichment to incorporate coding, conserved, regulatory, and LD-related genomic annotations into association analyses. We show via simulations with real genotypes that the method, functionally informed novel discovery of risk loci (FINDOR), correctly controls the false-positive rate at null loci and attains a 9%-38% increase in the number of independent associations detected at causal loci, depending on trait polygenicity and sample size. We applied FINDOR to 27 independent complex traits and diseases from the interim UK Biobank release (average N = 130K). Averaged across traits, we attained a 13% increase in genome-wide significant loci detected (including a 20% increase for disease traits) compared to unweighted raw p values that do not use functional data. We replicated the additional loci in independent UK Biobank and non-UK Biobank data, yielding a highly statistically significant replication slope (0.66-0.69) in each case. Finally, we applied FINDOR to the full UK Biobank release (average N = 416K), attaining smaller relative improvements (consistent with simulations) but larger absolute improvements, detecting an additional 583 GWAS loci. In conclusion, leveraging functional enrichment using our method robustly increases GWAS power.	[Kichaev, Gleb; Burch, Kathryn; Pasaniuc, Bogdan] Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA 90095 USA; [Bhatia, Gaurav; Loh, Po-Ru; Gazal, Steven; Schoech, Armin; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Loh, Po-Ru; Gazal, Steven; Schoech, Armin; Price, Alkes L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Freund, Malika K.; Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health	Kichaev, G (corresponding author), Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA 90095 USA.; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Price, AL (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	gkichaev@ucla.edu; aprice@hsph.harvard.edu	Gazal, Steven/AAK-3764-2020		NIH [U01 HG009379, R01 MH101244, R01 MH107649, R01 HG009120, 16549]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009120, U01HG009379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107649, T32MH073526, R01MH101244] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to Yakir Reshef, Farhad Hormorzdiari, and Ruth Johnson for helpful discussions. This research was funded by NIH grants U01 HG009379, R01 MH101244, R01 MH107649, and R01 HG009120. This research was conducted using the UK Biobank resource under Application 16549.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eskin E, 2008, GENOME RES, V18, P653, DOI 10.1101/gr.072785.107; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Gusev A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10979; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI [10.1038/NMETH.3885, 10.1038/nmeth.3885]; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu QS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006933; Lu QS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005947; Lu QS, 2016, BIOINFORMATICS, V32, P542, DOI 10.1093/bioinformatics/btv610; Lu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10576; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Palmer C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006916; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Schoech A, 2017, BIORXIV, DOI [10.1101/188086, DOI 10.1101/188086]; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wen XQ, 2016, AM J HUM GENET, V98, P1114, DOI 10.1016/j.ajhg.2016.03.029; Won HH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005622; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang JJ, 2017, AM J HUM GENET, V101, P404, DOI 10.1016/j.ajhg.2017.08.002; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373; Zeng J., 2017, BIORXIV, DOI DOI 10.1101/145755	50	354	358	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					65	75		10.1016/j.ajhg.2018.11.008	http://dx.doi.org/10.1016/j.ajhg.2018.11.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30595370	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000454775500009
J	Mavaddat, N; Michailidou, K; Dennis, J; Lush, M; Fachal, L; Lee, A; Tyrer, JP; Chen, TH; Wang, Q; Bolla, MK; Yang, X; Adank, MA; Ahearn, T; Aittomaki, K; Allen, J; Andrulis, IL; Anton-Culver, H; Antonenkova, NN; Arndt, V; Aronson, KJ; Auer, PL; Auvinen, P; Barrdahl, M; Freeman, LEB; Beckmann, MW; Behrens, S; Benitez, J; Bermisheva, M; Bernstein, L; Blomqvist, C; Bogdanova, NV; Bojesen, SE; Bonanni, B; Borresen-Dale, AL; Brauch, H; Bremer, M; Brenner, H; Brentnall, A; Brock, IW; Brooks-Wilson, A; Brucker, SY; Bruning, T; Burwinkel, B; Campa, D; Carter, BD; Castelao, JE; Chanock, SJ; Chlebowski, R; Christiansen, H; Clarke, CL; Collee, JM; Cordina-Duverger, E; Cornelissen, S; Couch, FJ; Cox, A; Cross, SS; Czene, K; Daly, MB; Devilee, P; Dork, T; dos-Santos-Silva, I; Dumont, M; Durcan, L; Dwek, M; Eccles, DM; Ekici, AB; Eliassen, AH; Ellberg, C; Engel, C; Eriksson, M; Evans, DG; Fasching, PA; Figueroa, J; Fletcher, O; Flyger, H; Forsti, A; Fritschi, L; Gabrielson, M; Gago-Dominguez, M; Gapstur, SM; Garcia-Saenz, JA; Gaudet, MM; Georgoulias, V; Giles, GG; Gilyazova, IR; Glendon, G; Goldberg, MS; Goldgar, DE; Gonzalez-Neira, A; Alnaes, GIG; Grip, M; Gronwald, J; Grundy, A; Guenel, P; Haeberle, L; Hahnen, E; Haiman, CA; Hakansson, N; Hamann, U; Hankinson, SE; Harkness, EF; Hart, SN; He, W; Hein, A; Heyworth, J; Hillemanns, P; Hollestelle, A; Hooning, MJ; Hoover, RN; Hopper, JL; Howell, A; Huang, GMQ; Humphreys, K; Hunter, DJ; Jakimovska, M; Jakubowska, A; Janni, W; John, EM; Johnson, N; Jones, ME; Jukkola-Vuorinen, A; Jung, A; Kaaks, R; Kaczmarek, K; Kataja, V; Keeman, R; Kerin, MJ; Khusnutdinova, E; Kiiski, JI; Knight, JA; Ko, YD; Kosma, VM; Koutros, S; Kristensen, VN; Kruger, U; Kuhl, T; Lambrechts, D; Le Marchand, L; Lee, E; Lejbkowicz, F; Lilyquist, J; Lindblom, A; Lindstrom, S; Lissowska, J; Lo, WY; Loibl, S; Long, JR; Lubinski, J; Lux, MP; MacInnis, RJ; Maishman, T; Makalic, E; Kostovska, IM; Mannermaa, A; Manoukian, S; Margolin, S; Martens, JWM; Martinez, ME; Mavroudis, D; McLean, C; Meindl, A; Menon, U; Middha, P; Miller, N; Moreno, F; Mulligan, AM; Mulot, C; Munoz-Garzon, VM; Neuhausen, SL; Nevanlinna, H; Neven, P; Newman, WG; Nielsen, SF; Nordestgaard, BG; Norman, A; Offit, K; Olson, JE; Olsson, H; Orr, N; Pankratz, VS; Park-Simon, TW; Perez, JIA; Perez-Barrios, C; Peterlongo, P; Peto, J; Pinchev, M; Plaseska-Karanfilska, D; Polley, EC; Prentice, R; Presneau, N; Prokofyeva, D; Purrington, K; Pylkas, K; Rack, B; Radice, P; Rau-Murthy, R; Rennert, G; Rennert, HS; Rhenius, V; Robson, M; Romero, A; Ruddy, KJ; Ruebner, M; Saloustros, E; Sandler, DP; Sawyer, EJ; Schmidt, DF; Schmutzler, RK; Schneeweiss, A; Schoemaker, MJ; Schumacher, F; Schurmann, P; Schwentner, L; Scott, C; Scott, RJ; Seynaeve, C; Shah, M; Sherman, ME; Shrubsole, MJ; Shu, XO; Slager, S; Smeets, A; Sohn, C; Soucy, P; Southey, MC; Spinelli, JJ; Stegmaier, C; Stone, J; Swerdlow, AJ; Tamimi, RM; Tapper, WJ; Taylor, JA; Terry, MB; Thone, K; Tollenaar, RAEM; Tomlinson, I; Truong, T; Tzardi, M; Ulmer, HU; Untch, M; Vachon, CM; van Veen, EM; Vijai, J; Weinberg, CR; Wendt, C; Whittemore, AS; Wildiers, H; Willett, W; Winqvist, R; Wolk, A; Yang, XHR; Yannoukakos, D; Zhang, Y; Zheng, W; Ziogas, A; Clarke, C; Balleine, R; Baxter, R; Braye, S; Carpenter, J; Dahlstrom, J; Forbes, J; Lee, CS; Marsh, D; Morey, A; Pathmanathan, N; Scott, R; Simpson, P; Spigelman, A; Wilcken, N; Yip, D; Zeps, N; Sexton, A; Dobrovic, A; Christian, A; Trainer, A; Fellows, A; Shelling, A; De Fazio, A; Blackburn, A; Crook, A; Meiser, B; Patterson, B; Clarke, C; Saunders, C; Hunt, C; Scott, C; Amor, D; Ortega, DG; Marsh, D; Edkins, E; Salisbury, E; Haan, E; Macrea, F; Farshid, G; Lindeman, G; Trench, G; Mann, G; Giles, G; Gill, G; Thorne, H; Campbell, I; Hickie, I; Caldon, L; Winship, I; Cui, J; Flanagan, J; Kollias, J; Visvader, J; Taylor, J; Burke, J; Saunus, J; Forbs, J; Hopper, J; Beesley, J; Kirk, J; French, J; Tucker, K; Wu, K; Phillips, K; Forrest, L; Lipton, L; Andrews, L; Lobb, L; Walker, L; Kentwell, M; Spurdle, M; Cummings, M; Gleeson, M; Harris, M; Jenkins, M; Young, MA; Delatycki, M; Wallis, M; Burgess, M; Brown, M; Southey, M; Bogwitz, M; Field, M; Friedlander, M; Gattas, M; Saleh, M; Aghmesheh, M; Hayward, N; Pachter, N; Cohen, P; Duijf, P; James, P; Simpson, P; Fong, P; Butow, P; Williams, R; Kefford, R; Simard, J; Balleine, RM; Dawson, SJ; Lok, S; O'connell, S; Greening, S; Nightingale, S; Edwards, S; Fox, S; McLachlan, SA; Lakhani, S; Dudding, T; Antill, Y; Sahlberg, KK; Ottestad, L; Karesen, R; Schlichting, E; Holmen, MM; Sauer, T; Haakensen, V; Engebraten, O; Naume, B; Fossa, A; Kiserud, CE; Reinertsen, KV; Helland, A; Riis, M; Geisler, J; Dunning, AM; Thompson, DJ; Chenevix-Trench, G; Chang-Claude, J; Schmidt, MK; Hall, P; Milne, RL; Pharoah, PDP; Antoniou, AC; Chatterjee, N; Kraft, P; Garcia-Closas, M; Easton, DF				Mavaddat, Nasim; Michailidou, Kyriaki; Dennis, Joe; Lush, Michael; Fachal, Laura; Lee, Andrew; Tyrer, Jonathan P.; Chen, Ting-Huei; Wang, Qin; Bolla, Manjeet K.; Yang, Xin; Adank, Muriel A.; Ahearn, Thomas; Aittomaki, Kristiina; Allen, Jamie; Andrulis, Irene L.; Anton-Culver, Hoda; Antonenkova, Natalia N.; Arndt, Volker; Aronson, Kristan J.; Auer, Paul L.; Auvinen, Paivi; Barrdahl, Myrto; Freeman, Laura E. Beane; Beckmann, Matthias W.; Behrens, Sabine; Benitez, Javier; Bermisheva, Marina; Bernstein, Leslie; Blomqvist, Carl; Bogdanova, Natalia, V; Bojesen, Stig E.; Bonanni, Bernardo; Borresen-Dale, Anne-Lise; Brauch, Hiltrud; Bremer, Michael; Brenner, Hermann; Brentnall, Adam; Brock, Ian W.; Brooks-Wilson, Angela; Brucker, Sara Y.; Bruening, Thomas; Burwinkel, Barbara; Campa, Daniele; Carter, Brian D.; Castelao, Jose E.; Chanock, Stephen J.; Chlebowski, Rowan; Christiansen, Hans; Clarke, Christine L.; Collee, J. Margriet; Cordina-Duverger, Emilie; Cornelissen, Sten; Couch, Fergus J.; Cox, Angela; Cross, Simon S.; Czene, Kamila; Daly, Mary B.; Devilee, Peter; Doerk, Thilo; dos-Santos-Silva, Isabel; Dumont, Martine; Durcan, Lorraine; Dwek, Miriam; Eccles, Diana M.; Ekici, Arif B.; Eliassen, A. Heather; Ellberg, Carolina; Engel, Christoph; Eriksson, Mikael; Evans, D. Gareth; Fasching, Peter A.; Figueroa, Jonine; Fletcher, Olivia; Flyger, Henrik; Foersti, Asta; Fritschi, Lin; Gabrielson, Marike; Gago-Dominguez, Manuela; Gapstur, Susan M.; Garcia-Saenz, Jose A.; Gaudet, Mia M.; Georgoulias, Vassilios; Giles, Graham G.; Gilyazova, Irina R.; Glendon, Gord; Goldberg, Mark S.; Goldgar, David E.; Gonzalez-Neira, Anna; Alnaes, Grethe I. Grenaker; Grip, Mervi; Gronwald, Jacek; Grundy, Anne; Guenel, Pascal; Haeberle, Lothar; Hahnen, Eric; Haiman, Christopher A.; Hakansson, Niclas; Hamann, Ute; Hankinson, Susan E.; Harkness, Elaine F.; Hart, Steven N.; He, Wei; Hein, Alexander; Heyworth, Jane; Hillemanns, Peter; Hollestelle, Antoinette; Hooning, Maartje J.; Hoover, Robert N.; Hopper, John L.; Howell, Anthony; Huang, Guanmengqian; Humphreys, Keith; Hunter, David J.; Jakimovska, Milena; Jakubowska, Anna; Janni, Wolfgang; John, Esther M.; Johnson, Nichola; Jones, Michael E.; Jukkola-Vuorinen, Arja; Jung, Audrey; Kaaks, Rudolf; Kaczmarek, Katarzyna; Kataja, Vesa; Keeman, Renske; Kerin, Michael J.; Khusnutdinova, Elza; Kiiski, Johanna, I; Knight, Julia A.; Ko, Yon-Dschun; Kosma, Veli-Matti; Koutros, Stella; Kristensen, Vessela N.; Kruger, Ute; Kuehl, Tabea; Lambrechts, Diether; Le Marchand, Loic; Lee, Eunjung; Lejbkowicz, Flavio; Lilyquist, Jenna; Lindblom, Annika; Lindstrom, Sara; Lissowska, Jolanta; Lo, Wing-Yee; Loibl, Sibylle; Long, Jirong; Lubinski, Jan; Lux, Michael P.; MacInnis, Robert J.; Maishman, Tom; Makalic, Enes; Kostovska, Ivana Maleva; Mannermaa, Arto; Manoukian, Siranoush; Margolin, Sara; Martens, John W. M.; Martinez, Maria Elena; Mavroudis, Dimitrios; McLean, Catriona; Meindl, Alfons; Menon, Usha; Middha, Pooja; Miller, Nicola; Moreno, Fernando; Mulligan, Anna Marie; Mulot, Claire; Munoz-Garzon, Victor M.; Neuhausen, Susan L.; Nevanlinna, Heli; Neven, Patrick; Newman, William G.; Nielsen, Sune F.; Nordestgaard, Borge G.; Norman, Aaron; Offit, Kenneth; Olson, Janet E.; Olsson, Hakan; Orr, Nick; Pankratz, V. Shane; Park-Simon, Tjoung-Won; Perez, Jose I. A.; Perez-Barrios, Clara; Peterlongo, Paolo; Peto, Julian; Pinchev, Mila; Plaseska-Karanfilska, Dijana; Polley, Eric C.; Prentice, Ross; Presneau, Nadege; Prokofyeva, Darya; Purrington, Kristen; Pylkas, Katri; Rack, Brigitte; Radice, Paolo; Rau-Murthy, Rohini; Rennert, Gad; Rennert, Hedy S.; Rhenius, Valerie; Robson, Mark; Romero, Atocha; Ruddy, Kathryn J.; Ruebner, Matthias; Saloustros, Emmanouil; Sandler, Dale P.; Sawyer, Elinor J.; Schmidt, Daniel F.; Schmutzler, Rita K.; Schneeweiss, Andreas; Schoemaker, Minouk J.; Schumacher, Fredrick; Schuermann, Peter; Schwentner, Lukas; Scott, Christopher; Scott, Rodney J.; Seynaeve, Caroline; Shah, Mitul; Sherman, Mark E.; Shrubsole, Martha J.; Shu, Xiao-Ou; Slager, Susan; Smeets, Ann; Sohn, Christof; Soucy, Penny; Southey, Melissa C.; Spinelli, John J.; Stegmaier, Christa; Stone, Jennifer; Swerdlow, Anthony J.; Tamimi, Rulla M.; Tapper, William J.; Taylor, Jack A.; Terry, Mary Beth; Thoene, Kathrin; Tollenaar, Rob A. E. M.; Tomlinson, Ian; Truong, Therese; Tzardi, Maria; Ulmer, Hans-Ulrich; Untch, Michael; Vachon, Celine M.; van Veen, Elke M.; Vijai, Joseph; Weinberg, Clarice R.; Wendt, Camilla; Whittemore, Alice S.; Wildiers, Hans; Willett, Walter; Winqvist, Robert; Wolk, Alicja; Yang, Xiaohong R.; Yannoukakos, Drakoulis; Zhang, Yan; Zheng, Wei; Ziogas, Argyrios; Clarke, Christine; Balleine, Rosemary; Baxter, Robert; Braye, Stephen; Carpenter, Jane; Dahlstrom, Jane; Forbes, John; Lee, C. Soon; Marsh, Deborah; Morey, Adrienne; Pathmanathan, Nirmala; Scott, Rodney; Simpson, Peter; Spigelman, Allan; Wilcken, Nicholas; Yip, Desmond; Zeps, Nikolajs; Sexton, Adrienne; Dobrovic, Alex; Christian, Alice; Trainer, Alison; Fellows, Andrew; Shelling, Andrew; De Fazio, Anna; Blackburn, Anneke; Crook, Ashley; Meiser, Bettina; Patterson, Briony; Clarke, Christobel; Saunders, Christobel; Hunt, Clare; Scott, Clare; Amor, David; Ortega, David Gallego; Marsh, Deb; Edkins, Edward; Salisbury, Elizabeth; Haan, Eric; Macrea, Finlay; Farshid, Gelareh; Lindeman, Geoff; Trench, Georgia; Mann, Graham; Giles, Graham; Gill, Grantley; Thorne, Heather; Campbell, Ian; Hickie, Ian; Caldon, Liz; Winship, Ingrid; Cui, James; Flanagan, James; Kollias, James; Visvader, Jane; Taylor, Jessica; Burke, Jo; Saunus, Jodi; Forbs, John; Hopper, John; Beesley, Jonathan; Kirk, Judy; French, Juliet; Tucker, Kathy; Wu, Kathy; Phillips, Kelly; Forrest, Laura; Lipton, Lara; Andrews, Leslie; Lobb, Lizz; Walker, Logan; Kentwell, Maira; Spurdle, Mandy; Cummings, Margaret; Gleeson, Margaret; Harris, Marion; Jenkins, Mark; Young, Mary Anne; Delatycki, Martin; Wallis, Mathew; Burgess, Matthew; Brown, Melissa; Southey, Melissa; Bogwitz, Michael; Field, Michael; Friedlander, Michael; Gattas, Michael; Saleh, Mona; Aghmesheh, Morteza; Hayward, Nick; Pachter, Nick; Cohen, Paul; Duijf, Pascal; James, Paul; Simpson, Pete; Fong, Peter; Butow, Phyllis; Williams, Rachael; Kefford, Rick; Simard, Jacques; Balleine, Rose-Mary; Dawson, Sarah-Jane; Lok, Sheau; O'connell, Shona; Greening, Sian; Nightingale, Sophie; Edwards, Stacey; Fox, Stephen; McLachlan, Sue-Anne; Lakhani, Sunil; Dudding, Tracy; Antill, Yoland; Sahlberg, Kristine K.; Ottestad, Lars; Karesen, Rolf; Schlichting, Ellen; Holmen, Marit Muri; Sauer, Toril; Haakensen, Vilde; Engebraten, Olav; Naume, Bjorn; Fossa, Alexander; Kiserud, Cecile E.; Reinertsen, Kristin, V; Helland, Aslaug; Riis, Margit; Geisler, Juergen; Dunning, Alison M.; Thompson, Deborah J.; Chenevix-Trench, Georgia; Chang-Claude, Jenny; Schmidt, Marjanka K.; Hall, Per; Milne, Roger L.; Pharoah, Paul D. P.; Antoniou, Antonis C.; Chatterjee, Nilanjan; Kraft, Peter; Garcia-Closas, Montserrat; Easton, Douglas F.		ABCTB Investigators; kConFab AOCS Investigators; NBCS Collaborators	Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FUNCTIONAL VARIANTS; PROSTATE-CANCER; SUSCEPTIBILITY; SHRINKAGE; MODELS; LOCUS; WOMEN	Stratification of women according to their risk of breast cancer based on polygenic risk scores (PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, optimized for prediction of estrogen receptor (ER)-specific disease, from the largest available genome-wide association dataset and to empirically validate the PRSs in prospective studies. The development dataset comprised 94,075 case subjects and 75,017 control subjects of European ancestry from 69 studies, divided into training and validation sets. Samples were genotyped using genome-wide arrays, and single-nucleotide polymorphisms (SNPs) were selected by stepwise regression or lasso penalized regression. The best performing PRSs were validated in an independent test set comprising 11,428 case subjects and 18,323 control subjects from 10 prospective studies and 190,040 women from UK Biobank (3,215 incident breast cancers). For the best PRSs (313 SNPs), the odds ratio for overall disease per 1 standard deviation in ten prospective studies was 1.61 (95%CI: 1.57-1.65) with area under receiver-operator curve (AUC) = 0.630 (95%CI: 0.628-0.651). The lifetime risk of overall breast cancer in the top centile of the PRSs was 32.6%. Compared with women in the middle quintile, those in the highest 1% of risk had 4.37- and 2.78-fold risks, and those in the lowest 1% of risk had 0.16- and 0.27-fold risks, of developing ER-positive and ER-negative disease, respectively. Goodness-of-fit tests indicated that this PRS was well calibrated and predicts disease risk accurately in the tails of the distribution. This PRS is a powerful and reliable predictor of breast cancer risk that may improve breast cancer prevention programs.	[Mavaddat, Nasim; Michailidou, Kyriaki; Dennis, Joe; Lush, Michael; Lee, Andrew; Wang, Qin; Bolla, Manjeet K.; Yang, Xin; Allen, Jamie; Thompson, Deborah J.; Pharoah, Paul D. P.; Antoniou, Antonis C.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Michailidou, Kyriaki] Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, CY-1683 Nicosia, Cyprus; [Fachal, Laura; Tyrer, Jonathan P.; Rhenius, Valerie; Shah, Mitul; Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England; [Chen, Ting-Huei] Laval Univ, Dept Math & Stat, Quebec City, PQ G1V 0A6, Canada; [Adank, Muriel A.] Antoni van Leeuwenhoek hosp, Netherlands Canc Inst, Family Canc Clin, NL-1066 CX Amsterdam, Netherlands; [Ahearn, Thomas; Freeman, Laura E. Beane; Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Koutros, Stella; Yang, Xiaohong R.; Chatterjee, Nilanjan; Garcia-Closas, Montserrat] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20850 USA; [Aittomaki, Kristiina] Univ Helsinki, Helsinki Univ Hosp, Dept Clin Genet, FIN-00290 Helsinki, Finland; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Genet Epidemiol Res Inst, Irvine, CA 92617 USA; [Antonenkova, Natalia N.; Bogdanova, Natalia, V] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk 223040, BELARUS; [Arndt, Volker; Brenner, Hermann; Zhang, Yan] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Aronson, Kristan J.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON K7L 3N6, Canada; [Aronson, Kristan J.] Queens Univ, Canc Res Inst, Kingston, ON K7L 3N6, Canada; [Auer, Paul L.; Prentice, Ross] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98109 USA; [Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53205 USA; [Auvinen, Paivi] Kuopio Univ Hosp, Canc Ctr, SF-70210 Kuopio, Finland; [Auvinen, Paivi] Univ Eastern Finland, Inst Clin Med, Oncol, Kuopio 70210, Finland; [Auvinen, Paivi; Kataja, Vesa; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Translat Canc Res Area, Kuopio 70210, Finland; [Barrdahl, Myrto; Behrens, Sabine; Campa, Daniele; Jung, Audrey; Kaaks, Rudolf; Middha, Pooja; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Beckmann, Matthias W.; Fasching, Peter A.; Haeberle, Lothar; Hein, Alexander; Lux, Michael P.; Ruebner, Matthias] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Dept Gynecol & Obstet, D-91054 Erlangen, Germany; [Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Programme, Madrid 28029, Spain; [Benitez, Javier] Biomed Network Rare Dis CIBERER, Madrid 28029, Spain; [Bermisheva, Marina; Gilyazova, Irina R.; Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Bernstein, Leslie; Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA 91010 USA; [Blomqvist, Carl] Univ Helsinki, Helsinki Univ Hosp, Dept Oncol, FIN-00290 Helsinki, Finland; [Blomqvist, Carl] Orebro Univ Hosp, Dept Oncol, S-70185 Orebro, Sweden; [Bogdanova, Natalia, V; Bremer, Michael; Christiansen, Hans] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Bogdanova, Natalia, V; Doerk, Thilo; Hillemanns, Peter; Park-Simon, Tjoung-Won; Schuermann, Peter] Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany; [Bojesen, Stig E.; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study Herlev & Gentofte Ho, DK-2730 Herlev, Denmark; [Bojesen, Stig E.; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Bonanni, Bernardo] European Inst Oncol IRCCS, IEO, Div Canc Prevent & Genet, I-20141 Milan, Italy; [Borresen-Dale, Anne-Lise; Alnaes, Grethe I. Grenaker; Kristensen, Vessela N.] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Canc Genet, N-0379 Oslo, Norway; [Borresen-Dale, Anne-Lise; Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Med, N-0450 Oslo, Norway; [Brauch, Hiltrud; Lo, Wing-Yee] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Brauch, Hiltrud; Lo, Wing-Yee] Univ Tubingen, D-72074 Tubingen, Germany; [Brauch, Hiltrud; Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Brentnall, Adam] Queen Mary Univ London, Ctr Canc Prevent, Wolfson Inst Prevent Med, London EC1M 6BQ, England; [Brock, Ian W.; Cox, Angela] Univ Sheffield, Sheffield Inst Nucle Acids SInFoNiA, Dept Oncol & Metab, Sheffield S10 2TN, S Yorkshire, England; [Brooks-Wilson, Angela] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Brucker, Sara Y.] Univ Tubingen, Dept Gynecol & Obstet, D-72076 Tubingen, Germany; [Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, D-44789 Bochum, Germany; [Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, D-69120 Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, C080, Mol Epidemiol Grp, D-69120 Heidelberg, Germany; [Campa, Daniele] Univ Pisa, Dept Biol, I-56126 Pisa, Italy; [Carter, Brian D.; Gapstur, Susan M.; Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Castelao, Jose E.] IISGS, Oncol & Genet Unit, Xerencia Xest Integrada Vigo SERGAS, Vigo 36312, Spain; [Chlebowski, Rowan] Univ Calif Los Angeles, Div Med Oncol & Hematol, Los Angeles, CA 90024 USA; [Clarke, Christine L.] Univ Sydney, Westmead Inst Med Res, Sydney, NSW 2145, Australia; [Collee, J. Margriet] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3015 CN Rotterdam, Netherlands; [Cordina-Duverger, Emilie; Guenel, Pascal; Truong, Therese] Univ Paris Saclay, Univ Paris Sud, INSERM, Canc & Environm Grp,Ctr Res Epidemiol & Populat H, F-94805 Villejuif, France; [Cornelissen, Sten; Keeman, Renske; Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield S10 2TN, S Yorkshire, England; [Czene, Kamila; Eriksson, Mikael; Gabrielson, Marike; He, Wei; Humphreys, Keith; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17165 Stockholm, Sweden; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Clin Genet, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Devilee, Peter] Leiden Univ, Dept Pathol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2333 ZA Leiden, Netherlands; [dos-Santos-Silva, Isabel; Peto, Julian] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Dumont, Martine; Soucy, Penny; Simard, Jacques] Univ Laval, Univ Laval Res Ctr, Ctr Hosp Univ Quebec, Genom Ctr, Quebec City, PQ G1V 4G2, Canada; [Durcan, Lorraine; Maishman, Tom] Univ Southampton, Fac Med, Southampton Clin Trials Unit, Southampton SO17 6YD, Hants, England; [Durcan, Lorraine; Eccles, Diana M.; Maishman, Tom] Univ Southampton, Canc Sci Acad Unit, Fac Med, Southampton SO17 6YD, Hants, England; [Dwek, Miriam; Presneau, Nadege] Univ Westminster, Sch Life Sci, London W1B 2HW, England; [Ekici, Arif B.] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Inst Human Genet, D-91054 Erlangen, Germany; [Eliassen, A. Heather; Tamimi, Rulla M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Eliassen, A. Heather; Hunter, David J.; Tamimi, Rulla M.; Willett, Walter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ellberg, Carolina; Kruger, Ute; Olsson, Hakan] Lund Univ, Dept Canc Epidemiol, Clin Sci, S-22242 Lund, Sweden; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany; [Engel, Christoph] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04103 Leipzig, Germany; [Evans, D. Gareth; Newman, William G.; van Veen, Elke M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Evolut & Genom Sci,Sch Biol Sci, Manchester M13 9WL, Lancs, England; [Evans, D. Gareth; Newman, William G.; van Veen, Elke M.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, North West Genom Lab Hub,Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Figueroa, Jonine] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Med Sch, Edinburgh EH16 4TJ, Midlothian, Scotland; [Figueroa, Jonine] Canc Res UK Edinburgh Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Fletcher, Olivia; Johnson, Nichola] Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, London SW7 3RP, England; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; [Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Clin Res Ctr, S-20502 Malmo, Sweden; [Fritschi, Lin] Curtin Univ, Sch Publ Hlth, Perth, WA 6102, Australia; [Gago-Dominguez, Manuela] Complejo Hosp Univ Santiago, SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Genom Med Grp,Galician Fdn Genom Med, Santiago De Compostela 15706, Spain; [Gago-Dominguez, Manuela; Martinez, Maria Elena] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Garcia-Saenz, Jose A.; Moreno, Fernando] Ctr Invest Biomed Red Canc CIBERONC, IdISSC, Hosp Clin San Carlos, Med Oncol Dept, Madrid 28040, Spain; [Georgoulias, Vassilios; Mavroudis, Dimitrios] Univ Hosp Heraklion, Dept Med Oncol, Iraklion 71110, Greece; [Giles, Graham G.; MacInnis, Robert J.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic 3004, Australia; [Giles, Graham G.; Hopper, John L.; MacInnis, Robert J.; Makalic, Enes; Schmidt, Daniel F.; Stone, Jennifer; Milne, Roger L.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Giles, Graham G.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gilyazova, Irina R.; Khusnutdinova, Elza; Prokofyeva, Darya] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450076, Russia; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H4A 3J1, Canada; [Goldgar, David E.] Univ Utah, Dept Dermatol, Sch Med, Salt Lake City, UT 84112 USA; [Goldgar, David E.] Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT 84112 USA; [Grip, Mervi] Univ Oulu, Oulu Univ Hosp, Dept Surg, SF-90220 Oulu, Finland; [Gronwald, Jacek; Jakubowska, Anna; Kaczmarek, Katarzyna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, PL-71252 Szczecin, Poland; [Grundy, Anne] Univ Montreal, CHUM, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Hahnen, Eric; Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Hereditary Breast & Ovarian Canc, D-50937 Cologne, Germany; [Hahnen, Eric; Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Haiman, Christopher A.; Lee, Eunjung] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hakansson, Niclas; Wolk, Alicja] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Hamann, Ute; Huang, Guanmengqian] German Canc Res Ctr, Mol Genet Breast Canc, D-69120 Heidelberg, Germany; [Hankinson, Susan E.] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Harkness, Elaine F.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Informat Imaging & Data Sci, Manchester M13 9PT, Lancs, England; [Harkness, Elaine F.] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Nightingale Breast Screening Ctr, Manchester M23 9LT, Lancs, England; [Harkness, Elaine F.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester M13 9WL, Lancs, England; [Hart, Steven N.; Lilyquist, Jenna; Norman, Aaron; Olson, Janet E.; Polley, Eric C.; Scott, Christopher; Slager, Susan; Vachon, Celine M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Heyworth, Jane] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA 6009, Australia; [Hollestelle, Antoinette; Hooning, Maartje J.; Martens, John W. M.; Seynaeve, Caroline] Erasmus MC Canc Inst, Dept Med Oncol, Family Canc Clin, NL-3015 CN Rotterdam, Netherlands; [Howell, Anthony] Univ Manchester, Div Canc Sci, Manchester M13 9PL, Lancs, England; [Hunter, David J.; Tamimi, Rulla M.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Hunter, David J.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Jakimovska, Milena; Kostovska, Ivana Maleva; Plaseska-Karanfilska, Dijana] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje 1000, Macedonia; [Jakubowska, Anna] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, PL-71252 Szczecin, Poland; [Janni, Wolfgang; Rack, Brigitte; Schwentner, Lukas] Univ Hosp Ulm, Dept Gynecol & Obstet, D-89075 Ulm, Germany; [John, Esther M.] Stanford Univ, Stanford Canc Inst, Dept Med, Div Oncol,Sch Med, Stanford, CA 94304 USA; [Jones, Michael E.; Schoemaker, Minouk J.; Swerdlow, Anthony J.] Inst Canc Res, Div Genet & Epidemiol, London SM2 5NG, England; [Jukkola-Vuorinen, Arja] Tampere Univ Hosp, Dept Oncol, Box 2000, Tampere 33521, Finland; [Kataja, Vesa] Jyvaskyla Cent Hosp, Cent Finland Hlth Care Dist, Jyvaskyla 40620, Finland; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Sch Med, Surg, Galway H91 TK33, Ireland; [Kiiski, Johanna, I; Nevanlinna, Heli] Univ Helsinki, Helsinki Univ Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Knight, Julia A.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Populat Hlth Res, Toronto, ON M5T 3L9, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, D-53177 Bonn, Germany; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio 70210, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, Dept Clin Pathol, Kuopio 70210, Finland; [Kuehl, Tabea; Thoene, Kathrin; Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, UCCH, Canc Epidemiol Grp, D-20246 Hamburg, Germany; [Lambrechts, Diether] VIB, VIB Ctr Canc Biol, B-3000 Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Human Genet, Lab Translat Genet, B-3000 Leuven, Belgium; [Le Marchand, Loic] Univ Hawaii, Epidemiol Program, Canc Ctr, Honolulu, HI 96813 USA; [Lejbkowicz, Flavio; Pinchev, Mila; Rennert, Gad; Rennert, Hedy S.] Carmel Hosp, Clalit Natl Canc Control Ctr, IL-35254 Haifa, Israel; [Lejbkowicz, Flavio; Pinchev, Mila; Rennert, Gad; Rennert, Hedy S.] Technion Fac Med, IL-35254 Haifa, Israel; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Lindblom, Annika] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Lindstrom, Sara] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Lindstrom, Sara] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr Oncol Inst, Dept Canc Epidemiol & Prevent, PL-02034 Warsaw, Poland; [Loibl, Sibylle] German Breast Grp GmbH, D-63263 Neu Isenburg, Germany; [Long, Jirong; Shrubsole, Martha J.; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr,Div Epidemiol, Nashville, TN 37232 USA; [Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori INT, Dept Med Oncol & Hematol, Unit Med Genet, I-20133 Milan, Italy; [Margolin, Sara; Wendt, Camilla] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, S-11883 Stockholm, Sweden; [Margolin, Sara; Wendt, Camilla; Hall, Per] Soder Sjukhuset, Dept Oncol, S-11883 Stockholm, Sweden; [Martinez, Maria Elena] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [McLean, Catriona] Alfred Hosp, Anat Pathol, Melbourne, Vic 3004, Australia; [Meindl, Alfons] Ludwig Maximilian Univ Munich, Dept Gynecol & Obstet, D-80336 Munich, Germany; [Menon, Usha] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, London WC1V 6LJ, England; [Middha, Pooja] Heidelberg Univ, Fac Med, D-69120 Heidelberg, Germany; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON M5G 2C4, Canada; [Mulot, Claire] Univ Paris Sorbonne Cite, INSEAM UMR 51147, F-75270 Paris, France; [Munoz-Garzon, Victor M.] Hosp Meixoeiro XXI Vigo, Radiat Oncol, Vigo 36214, Spain; [Neven, Patrick; Smeets, Ann; Wildiers, Hans] Univ Hosp Leuven, Leuven Multidisciplinary Breast Ctr, Leuven Canc Inst, Dept Oncol, B-3000 Leuven, Belgium; [Offit, Kenneth; Vijai, Joseph] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Clin Genet Res Lab, New York, NY 10065 USA; [Offit, Kenneth; Rau-Murthy, Rohini; Robson, Mark; Vijai, Joseph] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10065 USA; [Orr, Nick] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT7 1NN, Antrim, North Ireland; [Pankratz, V. Shane] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Perez, Jose I. A.] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo 33012, Spain; [Perez-Barrios, Clara; Romero, Atocha] Hosp Univ Puerta Hierro, Med Oncol Dept, Madrid 28222, Spain; [Peterlongo, Paolo] IFOM FIRC Italian Fdn Canc Res Inst Mol Oncol, Genome Diagnost Program, I-20139 Milan, Italy; [Purrington, Kristen] Wayne State Univ, Dept Oncol, Sch Med, Detroit, MI 48201 USA; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Bioctr Oulu, Canc & Translat Med Res Unit, Lab Canc Genet & Tumor Biol, SF-90220 Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Northern Finland Lab Ctr Oulu, Lab Canc Genet & Tumor Biol, Oulu 90220, Finland; [Radice, Paolo] Fdn IRCCS Ist Nazl Tumori INT, Dept Res, Unit Mol Bases Genet Risk & Genet Testing, I-20133 Milan, Italy; [Ruddy, Kathryn J.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Saloustros, Emmanouil] Univ Hosp Larissa, Dept Oncol, Larisa 71110, Greece; [Sandler, Dale P.; Taylor, Jack A.] NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Res Oncol, London SE1 9RT, England; [Schmidt, Daniel F.] Monash Univ, Fac Informat Technol, Melbourne, Vic 3800, Australia; [Schneeweiss, Andreas; Sohn, Christof] Univ Hosp, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Schneeweiss, Andreas; Sohn, Christof] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Schumacher, Fredrick] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Scott, Rodney J.] John Hunter Hosp, Div Mol Med, Pathol North, Newcastle, NSW 2305, Australia; [Scott, Rodney J.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Discipline Med Genet, Callaghan, NSW 2308, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Med Res Inst, Newcastle, NSW 2305, Australia; [Sherman, Mark E.] Mayo Clin, Dept Hlth Sci Res, Coll Med, Jacksonville, FL 32224 USA; [Southey, Melissa C.; Milne, Roger L.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic 3168, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Clin Pathol, Melbourne, Vic 3010, Australia; [Spinelli, John J.] BC Canc, Populat Oncol, Vancouver, BC V5Z 1G1, Canada; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z4, Canada; [Stegmaier, Christa] Saarland Canc Registry, D-66119 Saarbrucken, Germany; [Stone, Jennifer] Curtin Univ, Curtin UWA Ctr Genet Origins Hlth & Dis, Perth, WA 6000, Australia; [Stone, Jennifer] Univ Western Australia, Perth, WA 6000, Australia; [Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, London SW7 3RP, England; [Tapper, William J.] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England; [Taylor, Jack A.] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Terry, Mary Beth] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Tollenaar, Rob A. E. M.] Leiden Univ, Dept Surg, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Tomlinson, Ian] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tomlinson, Ian] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford OX3 7BN, England; [Tzardi, Maria] Univ Hosp Heraklion, Dept Pathol, Iraklion 71110, Greece; [Ulmer, Hans-Ulrich] Frauenklin Stadtklin Baden Baden, D-76532 Baden Baden, Germany; [Untch, Michael] Helios Clin Berlin Buch, Dept Gynecol & Obstet, D-13125 Berlin, Germany; [Weinberg, Clarice R.] NIEHS, Biostat & Computat Biol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Willett, Walter] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Willett, Walter] Harvard Med Sch, Boston, MA 02115 USA; [Wolk, Alicja] Uppsala Univ, Dept Surg Sci, S-75105 Uppsala, Sweden; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, INRASTES, Athens 15310, Greece; [ABCTB Investigators] Univ Sydney, Westmead Inst Med Res, Australian Breast Canc Tissue Bank, Sydney, NSW 2145, Australia; [kConFab AOCS Investigators] Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; Vestre Viken Hosp, Dept Res, N-3019 Drammen, Norway; Vestre Viken Hosp, Dept Canc Genet, N-3019 Drammen, Norway; Oslo Univ Hosp Ulleval, Div Surg Canc & Transplantat Med, Dept Canc, Sect Breast & Endocrine Surg, N-0450 Oslo, Norway; Oslo Univ Hosp, Dept Radiol & Nucl Med, N-0379 Oslo, Norway; Akershus Univ Hosp, Dept Pathol, N-1478 Lorenskog, Norway; Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, N-0379 Oslo, Norway; Oslo Univ Hosp Radiumhosp, Div Surg Canc & Transplantat Med, Dept Oncol, N-0379 Oslo, Norway; Oslo Univ Hosp Radiumhosp, Natl Advisory Unit Late Effects Canc Treatment, N-0379 Oslo, Norway; Akershus Univ Hosp, Dept Oncol, N-1478 Lorenskog, Norway; [NBCS Collaborators] Oslo Univ Hosp, Breast Canc Res Consortium, N-0379 Oslo, Norway; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld 4006, Australia; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands; [Chatterjee, Nilanjan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Chatterjee, Nilanjan] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	University of Cambridge; University of Cambridge; Laval University; Netherlands Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); Queens University - Canada; Queens University - Canada; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; City of Hope; Beckman Research Institute of City of Hope; University of Helsinki; Helsinki University Central Hospital; Orebro University; Hannover Medical School; Hannover Medical School; University of Copenhagen; University of Copenhagen; University of Copenhagen; IRCCS European Institute of Oncology (IEO); University of Oslo; University of Oslo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of London; Queen Mary University London; University of Sheffield; British Columbia Cancer Agency; Simon Fraser University; Eberhard Karls University of Tubingen; Ruhr University Bochum; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Pisa; American Cancer Society; University of California System; University of California Los Angeles; University of Sydney; Westmead Institute for Medical Research; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Netherlands Cancer Institute; Mayo Clinic; University of Sheffield; Karolinska Institutet; Fox Chase Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; London School of Hygiene & Tropical Medicine; Laval University; University of Southampton; University of Southampton; University of Westminster; University of Erlangen Nuremberg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Lund University; Leipzig University; Leipzig University; University of Manchester; University of Manchester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Edinburgh; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Copenhagen; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Curtin University; Complexo Hospitalario Universitario de Santiago de Compostela; University of California System; University of California San Diego; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos; University Hospital of Heraklion; Cancer Council Victoria; University of Melbourne; Monash University; Bashkir State University; McGill University; McGill University; Royal Victoria Hospital; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Oulu; Pomeranian Medical University; Universite de Montreal; University of Cologne; University of Cologne; University of Southern California; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); University of Massachusetts System; University of Massachusetts Amherst; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Mayo Clinic; University of Western Australia; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Manchester; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Pomeranian Medical University; Ulm University; Stanford Cancer Institute; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Tampere University; Tampere University Hospital; Central Finland Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Hamburg; University Medical Center Hamburg-Eppendorf; Flanders Institute for Biotechnology (VIB); KU Leuven; Cancer Research Center of Hawaii; University of Hawaii System; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; German Breast Group; Vanderbilt University; Fondazione IRCCS Istituto Nazionale Tumori Milan; Karolinska Institutet; Sodersjukhuset Hospital; Sodersjukhuset Hospital; University of California System; University of California San Diego; Florey Institute of Neuroscience & Mental Health; University of Munich; Medical Research Council Clinical Trials Unit; University of London; University College London; Ruprecht Karls University Heidelberg; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; KU Leuven; University Hospital Leuven; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Queens University Belfast; University of New Mexico; University of New Mexico's Health Sciences Center; Hospital Puerta de Hierro-Majadahonda; IFOM - FIRC Institute of Molecular Oncology; Wayne State University; University of Oulu; Fondazione IRCCS Istituto Nazionale Tumori Milan; Mayo Clinic; General University Hospital of Larissa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Monash University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Case Western Reserve University; John Hunter Hospital; University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; Mayo Clinic; Monash University; University of Melbourne; University of British Columbia; Curtin University; University of Western Australia; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Southampton; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University Hospital of Heraklion; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Stanford University; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Uppsala University; National Centre of Scientific Research "Demokritos"; University of Sydney; Westmead Institute for Medical Research; Peter Maccallum Cancer Center; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; QIMR Berghofer Medical Research Institute; Netherlands Cancer Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Mavaddat, N (corresponding author), Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	nm274@medschl.cam.ac.uk	Auer, Paul/AAC-5060-2019; Koutros, Stella/W-5788-2019; Brüning, Thomas/G-8120-2015; Hickie, Ian B/K-8975-2015; smeets, ann/AAP-9191-2020; taylor, jack a/C-7154-2019; Schumacher, Fredrick/R-6043-2019; Hart, Steven/AAI-4761-2021; van Veen, Elke/ABA-3250-2021; Figueroa, Jonine/AFK-2752-2022; Evans, D Gareth/AAB-4308-2022; Brooks-Wilson, Angela/E-9399-2012; Helland, Åslaug/H-3910-2015; Arndt, Volker/AAI-7282-2020; Chenevix-Trench, Georgia/AAV-2014-2020; Michailidou, Kyriaki/ABD-5122-2020; Saloustros, Emmanouil/AAC-8235-2020; Saunus, Jodi M/C-6657-2011; Romero, Atocha/AAS-2862-2021; Guenel, Pascal/H-3728-2018; Meiser, Bettina/AAG-5480-2021; Fasching, Peter A/ABH-9912-2020; Romero-Alfonso, Atocha/AAC-9879-2021; Flyger, Henrik/AAM-6494-2021; Amor, David J/A-6478-2018; Bonanni, Bernardo/AAM-7928-2020; Hein, Alexander/F-6999-2010; Gago-Dominguez, Manuela/AAP-6611-2021; Nordestgaard, Borge Gronne/ABF-1310-2020; DEVILEE, PETER/ABR-2140-2022; Gonzalez-Neira, Anna/C-5791-2015; Jakubowska, Anna/O-8050-2014; Wallis, Mathew/AAG-7981-2021; Dörk, Thilo/J-8620-2012; Knight, Julia/A-6843-2012; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Zeps, Nikolajs/AAF-3186-2021; wildiers, hans/AAV-8158-2021; Lambrechts, Diether/AAJ-3167-2020; Guenel, Pascal/AAS-7688-2021; Margolin, Sara/AAX-9034-2020; Bogdanova, Natalia V./Y-2205-2019; Peterlongo, Paolo/Q-4717-2018; Ekici, Arif B/C-3971-2013; Devilee, Peter/GXV-8005-2022; Figueroa, Jonine/AAG-1065-2022; Schmidt, Marjanka K/G-9058-2011; Fritschi, Lin/K-2096-2012; Zheng, Wei/GQQ-8951-2022; Garcia-Saenz, Jose Angel/AAW-8662-2020; Figueroa, Jonine/GWD-1322-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; truong, therese/A-2837-2013; Fachal, Laura/N-5560-2014; Kraft, Peter/GQH-8448-2022; Cohen, Paul A/AAC-8199-2022; Purrington, Kristen/AAN-6494-2021; He, Wei/C-8441-2015; Knight, Julia/R-5617-2019; Pharoah, Paul/V-6658-2019; Lissowska, Jolanta/AAH-3252-2020; Stone, Jennifer/AAS-3805-2020; Jenkins, Mark/P-7803-2015; Joseph, Vijai/J-9158-2013; Scott, Rodney/B-2827-2013; benitez, javier/H-5232-2015; Heyworth, Jane/F-2795-2010; Radice, Paolo/O-3119-2013; Hakansson, Niclas/L-7913-2013	Koutros, Stella/0000-0001-5294-5485; Brüning, Thomas/0000-0001-9560-5464; Hickie, Ian B/0000-0001-8832-9895; taylor, jack a/0000-0001-5303-6398; Schumacher, Fredrick/0000-0002-3073-7463; Hart, Steven/0000-0001-7714-2734; van Veen, Elke/0000-0001-8618-2332; Figueroa, Jonine/0000-0002-5100-623X; Evans, D Gareth/0000-0002-8482-5784; Brooks-Wilson, Angela/0000-0003-1009-6408; Helland, Åslaug/0000-0002-5520-0275; Arndt, Volker/0000-0001-9320-8684; Chenevix-Trench, Georgia/0000-0002-1878-2587; Michailidou, Kyriaki/0000-0001-7065-1237; Saloustros, Emmanouil/0000-0002-0485-0120; Saunus, Jodi M/0000-0002-4604-4709; Romero, Atocha/0000-0002-1634-7397; Guenel, Pascal/0000-0002-8359-518X; Fasching, Peter A/0000-0003-4885-8471; Amor, David J/0000-0001-7191-8511; Hein, Alexander/0000-0003-2601-3398; Gonzalez-Neira, Anna/0000-0002-5421-2020; Jakubowska, Anna/0000-0002-5650-0501; Wallis, Mathew/0000-0002-5441-1732; Dörk, Thilo/0000-0002-9458-0282; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Zeps, Nikolajs/0000-0002-6404-6839; Lambrechts, Diether/0000-0002-3429-302X; Guenel, Pascal/0000-0002-8359-518X; Peterlongo, Paolo/0000-0001-6951-6855; Ekici, Arif B/0000-0001-6099-7066; Figueroa, Jonine/0000-0002-5100-623X; Schmidt, Marjanka K/0000-0002-2228-429X; Fritschi, Lin/0000-0002-7692-3560; Garcia-Saenz, Jose Angel/0000-0001-6880-0301; Figueroa, Jonine/0000-0002-5100-623X; Garcia-Closas, Montserrat/0000-0003-1033-2650; truong, therese/0000-0002-2943-6786; Fachal, Laura/0000-0002-7256-9752; Cohen, Paul A/0000-0002-4860-9232; Purrington, Kristen/0000-0002-5710-1692; He, Wei/0000-0003-0161-3274; Knight, Julia/0000-0002-7610-7635; Pharoah, Paul/0000-0001-8494-732X; Lissowska, Jolanta/0000-0003-2695-5799; Dwek, Miriam/0000-0001-7184-2932; Eliassen, A Heather/0000-0002-3961-6609; Olsson, Hakan/0000-0002-8794-9635; Rennert, Gad/0000-0002-8512-068X; Menon, Usha/0000-0003-3708-1732; Margolin, Sara/0000-0002-5526-5570; Nordestgaard, Borge/0000-0002-1954-7220; Swerdlow, Anthony/0000-0001-5550-4159; Gago, Manuela/0000-0001-6713-4351; Eccles, Diana M/0000-0002-9935-3169; Jenkins, Mark/0000-0002-8964-6160; , IIS Galicia Sur/0000-0003-3812-7413; Joseph, Vijai/0000-0002-7933-151X; Stone, Jennifer/0000-0001-5077-0124; Brentnall, Adam/0000-0001-6327-4357; Scott, Rodney/0000-0001-7724-3404; Engel, Christoph/0000-0002-7247-282X; Howell, Anthony/0000-0002-6233-719X; Gabrielson, Marike/0000-0002-3171-1556; Schoemaker, Minouk/0000-0001-8403-2234; Allen, Jamie/0000-0002-8677-2225; Carter, Brian/0000-0003-1166-6521; Kiiski, Johanna I./0000-0002-4089-7209; benitez, javier/0000-0002-0923-7202; Heyworth, Jane/0000-0003-1411-4554; Castelao, Jose E/0000-0001-7110-1376; Radice, Paolo/0000-0001-6298-4111; Cox, Angela/0000-0002-5138-1099; Blomqvist, Carl/0000-0003-3041-1938; Fletcher, Olivia/0000-0001-9387-7116; Middha, Pooja/0000-0001-5503-8215; Sawyer, Elinor/0000-0001-8285-4111; Newman, William/0000-0002-6382-4678; Bialkowska, Katarzyna/0000-0001-8489-6665; Jung, Audrey/0000-0003-0875-6673; Flanagan, James/0000-0003-4955-1383; Ellberg, Carolina/0000-0001-7297-0645; Lee, Eunjung/0000-0002-8287-6131; Tapper, William/0000-0002-5896-1889; Kerin, Michael/0000-0003-4164-5561; Brauch, Hiltrud/0000-0001-7531-2736; Pylkas, Katri/0000-0002-2449-0521; Sandler, Dale/0000-0002-6776-0018; Durocher, Francine/0000-0001-8012-4641; Makalic, Enes/0000-0003-3017-0871; Jones, Michael/0000-0001-7479-3451; Long, Jirong/0000-0002-7433-9766; Presneau, Nadege/0000-0002-2107-6691; Simard, Jacques/0000-0001-6906-3390; Barrdahl, Myrto/0000-0001-8680-8729; Hakansson, Niclas/0000-0001-7673-5554; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Winqvist, Robert/0000-0003-0932-9104; Moreno, Fernando/0000-0001-8933-0687; Kraft, Peter/0000-0002-4472-8103; Kruger, Ute/0000-0001-6140-2001; Weinberg, Clarice/0000-0002-7713-8556; Terry, Mary Beth/0000-0002-4106-5033; Lee, Andrew/0000-0003-0677-0252; Bojesen, Stig/0000-0002-4061-4133	Cancer Research UK [C1287/A10710, C1287/A10118, C1287/A16563]; European Community [223175 (HEALTH-F2-2009-223175)]; European Union [633784, 634935, HEALTH-F2-2009-223175]; Government of Canada through Genome Canada; Canadian Institutes of Health Research [GPH-129344]; Ministere de l'Economie, de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation; NIH [U19 CA148065, X01HG007492]; Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative grant [1 U19 CA 148065]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P50CA116201, R25CA092049, ZIACP010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102245, ZIAES049033, ZIAES044005] Funding Source: NIH RePORTER; MRC [MR/P012930/1, MC_PC_14105, MC_PC_12028] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Community(European Commission); European Union(European Commission); Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Economie, de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Economic Development, Innovation and Export Trade of Quebec; National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BCAC was funded by Cancer Research UK (C1287/A16563) and by the European Community's Seventh Framework Programme under grant agreement no. 223175 (HEALTH-F2-2009-223175) (COGS) and by the European Union's Horizon 2020 Research and Innovation Programme under grant agreements 633784 (B-CAST) and 634935 (BRIDGES). Genotyping of the OncoArray was principally funded by Government of Canada through Genome Canada and the Canadian Institutes of Health Research (grant GPH-129344), the Ministere de l'Economie, de la Science et de l'Innovation du Quebec through Genome Quebec, the Quebec Breast Cancer Foundation; NIH grants U19 CA148065 and X01HG007492; and Cancer Research UK (C1287/A10118 and C1287/A16563). Genotyping of the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710), the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer'' program, and the Ministry of Economic Development, Innovation and Export Trade of Quebec (grant #PSR-SIIRI-701). Combining the GWAS data was supported in part by the National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative grant: No. 1 U19 CA 148065 (DRIVE, part of the GAME-ON initiative). We thank all the individuals who took part in these studies and all researchers, clinicians, technicians, and administrative staff who enabled this work to be carried out. For other acknowledgments and sources of funding, see Supplemental Acknowledgments.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Evans D. G, 2016, NIHR J LIB, V4, DOI [10.3310/pgfar04110, DOI 10.3310/PGFAR04110]; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia-Closas M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju305; Hall P, 2013, BRIT J CANCER, V108, P2202, DOI 10.1038/bjc.2013.257; Holm J, 2016, J CLIN ONCOL, V34, P251, DOI 10.1200/JCO.2015.63.0624; Joshi AD, 2014, AM J EPIDEMIOL, V180, P1018, DOI 10.1093/aje/kwu214; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Lee AJ, 2014, BRIT J CANCER, V110, P535, DOI 10.1038/bjc.2013.730; Li J, 2015, ANN ONCOL, V26, P517, DOI 10.1093/annonc/mdu565; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; MacInnis RJ, 2011, GENET EPIDEMIOL, V35, P549, DOI 10.1002/gepi.20605; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2017, NAT GENET, V49, P1767, DOI 10.1038/ng.3785; Milne RL, 2014, HUM MOL GENET, V23, P1934, DOI 10.1093/hmg/ddt581; O'Connell J, 2016, NAT GENET, V48, P817, DOI 10.1038/ng.3583; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118; Pereira M, 2017, GENET EPIDEMIOL, V41, P320, DOI 10.1002/gepi.22038; Rudolph A, 2018, INT J EPIDEMIOL, V47, P526, DOI 10.1093/ije/dyx242; Shi JX, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006493; Shieh Y, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw290; Song MS, 2015, BIOSTATISTICS, V16, P143, DOI 10.1093/biostatistics/kxu034; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	34	354	359	9	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					21	34		10.1016/j.ajhg.2018.11.002	http://dx.doi.org/10.1016/j.ajhg.2018.11.002			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30554720	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-18	WOS:000454775500005
J	Wan, XA; Yang, C; Yang, QA; Xue, H; Fan, XD; Tang, NLS; Yu, WC				Wan, Xiang; Yang, Can; Yang, Qiang; Xue, Hong; Fan, Xiaodan; Tang, Nelson L. S.; Yu, Weichuan			BOOST: A Fast Approach to Detecting Gene-Gene Interactions in Genome-wide Case-Control Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYPE-1 DIABETES SUSCEPTIBILITY; CLASS-II MOLECULES; EPISTASIS; ASSOCIATION; MODELS	Gene-gene interactions have long been recognized to be fundamentally important for understanding genetic causes of complex disease traits. At present, identifying gene-gene interactions from genome-wide case-control studies is computationally and methodologically challenging. In this paper, we introduce a simple but powerful method, named "BOolean Operation-based Screening and Testing" (BOOST). For the discovery of unknown gene-gene interactions that underlie complex diseases, BOOST allows examination of all pairwise interactions in genome-wide case-control studies in a remarkably fast manner. We have carried out interaction analyses on seven data sets from the Wellcome Trust Case Control Consortium (WTCCC). Each analysis took less than 60 hr to completely evaluate all pairs of roughly 360,000 SNPs on a standard 3.0 GHz desktop with 4G memory running the Windows XP system. The interaction patterns identified from the type 1 diabetes data set display significant difference from those identified from the rheumatoid arthritis data set, although both data sets share a very similar hit region in the WTCCC report. BOOST has also identified some disease-associated interactions between genes in the major histocompatibility complex region in the type 1 diabetes data set. We believe that our method can serve as a computationally and statistically useful tool in the coming era of large-scale interaction mapping in genome-wide case-control studies.	[Wan, Xiang; Yang, Can; Yu, Weichuan] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Yang, Qiang] Hong Kong Univ Sci & Technol, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Fan, Xiaodan] Chinese Univ Hong Kong, Dept Stat, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Lab Genet Dis Susceptibil, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong; Chinese University of Hong Kong	Yu, WC (corresponding author), Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China.	eeyu@ust.hk	YANG, Can/J-8790-2014; yang, qiang/GYJ-0971-2022; Tang, Nelson L/P-5018-2017; yang, can/GXV-5624-2022; Yang, Can/T-6073-2018; Fan, Xiaodan/Q-2208-2018	YANG, Can/0000-0003-3368-3082; Tang, Nelson L/0000-0002-3607-5819; Yang, Can/0000-0002-4407-3055; Fan, Xiaodan/0000-0002-2744-9030; Yu, Weichuan/0000-0002-5510-6916; Xue, Hong/0000-0002-8133-9828; Yang, Qiang/0000-0001-5059-8360	Hong Kong Research Grant Council [GRF621707]; Hong Kong University of Science and Technology [RPC06/07.EG09, RPC07/08.EG25, RPC10EG04]; Sir Michael and Lady Kadoorie Funded Research Into Cancer Genetics	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Hong Kong University of Science and Technology; Sir Michael and Lady Kadoorie Funded Research Into Cancer Genetics	We thank the editor and the anonymous reviewers for their constructive suggestions and comments. This work was partially supported with grant GRF621707 from the Hong Kong Research Grant Council, grants RPC06/07.EG09, RPC07/08.EG25, and RPC10EG04 from the Hong Kong University of Science and Technology, and a grant from Sir Michael and Lady Kadoorie Funded Research Into Cancer Genetics.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; Bateson W., 1909, MENDELS PRINCIPLES H; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Dudek Scott M, 2006, Pac Symp Biocomput, P499, DOI 10.1142/9789812701626_0046; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Husain Z, 2008, J AUTOIMMUN, V30, P266, DOI 10.1016/j.jaut.2007.10.006; LECHLER R, 2000, HLA HLTH DIS; LERNER IM, 1968, HEREDITY EVOLUTION S; LEVY J, 1972, GENETICS, V72, P117; Li J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-44; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Matsuda H, 2000, PHYS REV E, V62, P3096, DOI 10.1103/PhysRevE.62.3096; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rocha N, 2008, EMBO J, V27, P1, DOI 10.1038/sj.emboj.7601945; Schwarz DF, 2010, BIOINFORMATICS, V26, P1752, DOI 10.1093/bioinformatics/btq257; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Villadangos JA, 2001, MOL IMMUNOL, V38, P329, DOI 10.1016/S0161-5890(01)00069-4; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	39	354	368	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					325	340		10.1016/j.ajhg.2010.07.021	http://dx.doi.org/10.1016/j.ajhg.2010.07.021			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20817139	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000281923500002
J	Cybulski, C; Gorski, B; Huzarski, T; Masojc, B; Mierzejewski, M; Debniak, T; Teodorczyk, U; Byrski, T; Gronwald, J; Matyjasik, J; Zlowocka, E; Lenner, M; Grabowska, E; Nej, K; Castaneda, J; Medrek, K; Szymanska, A; Szymanska, J; Kurzawski, G; Suchy, J; Oszurek, O; Witek, A; Narod, SA; Lubinski, J				Cybulski, C; Gorski, B; Huzarski, T; Masojc, B; Mierzejewski, M; Debniak, T; Teodorczyk, U; Byrski, T; Gronwald, J; Matyjasik, J; Zlowocka, E; Lenner, M; Grabowska, E; Nej, K; Castaneda, J; Medrek, K; Szymanska, A; Szymanska, J; Kurzawski, G; Suchy, J; Oszurek, O; Witek, A; Narod, SA; Lubinski, J			CHEK2 is a multiorgan cancer susceptibility gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; BREAST-CANCER; PROSTATE-CANCER; HEREDITARY BREAST; COLORECTAL-CANCER; MUTATIONS; 1100DELC; CHK2; RISK; CHEK2-ASTERISK-1100DELC	A single founder allele of the CHEK2 gene has been associated with predisposition to breast and prostate cancer in North America and Europe. The CHEK2 protein participates in the DNA damage response in many cell types and is therefore a good candidate for a multisite cancer susceptibility gene. Three founder alleles are present in Poland. Two of these result in a truncated CHEK2 protein, and the other is a missense substitution of an isoleucine for a threonine. We ascertained the prevalence of each of these alleles in 4,008 cancer cases and 4,000 controls, all from Poland. The majority of the common cancer sites were represented. Positive associations with protein-truncating alleles were seen for cancers of the thyroid (odds ratio [OR] 4.9; P = .0006), breast (OR 2.2; P = .02), and prostate (OR 2.2; P = .04). The missense variant I157T was associated with an increased risk of breast cancer (OR 1.4;), colon cancer (OR 2.0; P = .001), kidney cancer (OR 2.1; P = .0006), prostate cancer (OR 1.7; P = .02), and thyroid cancer (OR 1.9; P = .04). The range of cancers associated with mutations of the CHEK2 gene may be much greater than previously thought.	Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; Univ Szczecin, Interuniv Unit Mol Biol, Szczecin, Poland; Med Univ Silesia, Katowice, Poland	Pomeranian Medical University; University of Szczecin; Medical University Silesia	Narod, SA (corresponding author), Ctr Res Womens Hlth, 790 Bay St, Toronto, ON M5G 1N8, Canada.	steven.narod@sw.ca	Gronwald, Jacek/A-4576-2017; Huzarski, Tomasz/AAQ-2161-2021; Szymanska-Pasternak, Jolanta/N-7184-2014; Narod, Steven A/AAA-6112-2022; Trubicka, Joanna/R-1215-2018; BYRSKI, Tomasz/I-2844-2014; Kurzawski, Grzegorz/T-9225-2018	Gronwald, Jacek/0000-0002-3643-2871; Huzarski, Tomasz/0000-0003-3857-4854; Szymanska-Pasternak, Jolanta/0000-0003-1643-6872; Trubicka, Joanna/0000-0002-9848-3674; BYRSKI, Tomasz/0000-0001-9181-5026; Kurzawski, Grzegorz/0000-0002-2414-9868				Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Dufault MR, 2004, INT J CANCER, V110, P320, DOI 10.1002/ijc.20073; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Kilpivaara O, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e110; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Offit Kenneth, 2003, BMC Med Genet, V4, P1, DOI 10.1186/1471-2350-4-1; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Seppala EH, 2003, BRIT J CANCER, V89, P1966, DOI 10.1038/sj.bjc.6601425; Sodha N, 2000, Science, V289, P359; Vahteristo P, 2001, CANCER RES, V61, P5718	18	354	369	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1131	1135		10.1086/426403	http://dx.doi.org/10.1086/426403			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15492928	Bronze, Green Published			2022-12-18	WOS:000224866400018
J	Waldman, ID; Rowe, DC; Abramowitz, A; Kozel, ST; Mohr, JH; Sherman, SL; Cleveland, HH; Sanders, ML; Card, JHC; Stever, C				Waldman, ID; Rowe, DC; Abramowitz, A; Kozel, ST; Mohr, JH; Sherman, SL; Cleveland, HH; Sanders, ML; Card, JHC; Stever, C			Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; PSYCHIATRIC STATUS; NOVELTY SEEKING; RECEPTOR GENE; POLYMORPHISM; POPULATION; CONDUCT; TWINS; DAT1	Attention-deficit hyperactivity disorder (ADHD) affects similar to 3 %-5 % of children in the United States. In the current psychiatric nomenclature, ADHD comprises three subtypes: inattentive, hyperactive-impulsive, and combined. In this study, we used four analytic strategies to examine the association and linkage of the dopamine transporter gene (DAT1) and ADHD. Our sample included 122 children referred to psychiatric clinics for behavioral and learning problems that included but were not limited to ADHD, as well as their parents and siblings. Within-family analyses of linkage disequilibrium, using the transmission disequilibrium test (TDT), confirmed the 480-bp allele as the high-risk allele. In between-family association analyses, levels of hyperactive-impulsive symptoms but not inattentive symptoms were related to the number of DAT1 high-risk alleles. Siblings discordant for the number of DAT1 high-risk alleles differed markedly in their levels of both hyperactive-impulsive and inattentive symptoms, such that the sibling with the higher number of high-risk alleles had much higher symptom levels. Within-family analyses of linkage disequilibrium, using the TDT, suggested association and linkage of ADHD with DAT1 and that this relation was especially strong with the combined but not the inattentive subtype. The relation of DAT1 to ADHD increased monotonically, from low to medium to high levels of symptom severity. Our results replicate and extend previous findings of the association between the DAT1 gene and childhood ADHD. This represents one of the first replicated relations of a candidate gene and a psychiatric disorder in children.	Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA; Emory Univ, Dept Genet & Mol Med, Atlanta, GA 30322 USA; Univ Arizona, Dept Family & Consumer Resources, Tucson, AZ USA; Univ Arizona, Interdisciplinary Program Genet, Tucson, AZ USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Radcliffe Coll, Henry A Murray Res Ctr, Cambridge, MA 02138 USA	Emory University; Emory University; Emory University; University of Arizona; University of Arizona; University of Colorado System; University of Colorado Boulder	Waldman, ID (corresponding author), Emory Univ, Dept Psychol, 532 N Kilgo Circle, Atlanta, GA 30322 USA.							AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BARR CL, 1993, BIOL PSYCHIAT, V34, P204, DOI 10.1016/0006-3223(93)90073-M; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; BIEDERMAN J, 1990, J AM ACAD CHILD PSY, V29, P526, DOI 10.1097/00004583-199007000-00004; COOK EH, 1995, AM J HUM GENET, V56, P993; CURTIS D, 1995, AM J HUM GENET, V56, P811; DOUCETTESTAMM LA, 1995, GENET EPIDEMIOL, V12, P303, DOI 10.1002/gepi.1370120307; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FARAONE SV, 1992, PSYCHIATR GENET, V2, P257, DOI 10.1097/00041444-199210000-00004; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; GILLIS JJ, 1992, J ABNORM CHILD PSYCH, V20, P303, DOI 10.1007/BF00916694; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; LAHOSTE GJ, 1995, ANN M SOC NEUR SAN D; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LILIENFELD SO, 1990, CLIN PSYCHOL REV, V10, P699, DOI 10.1016/0272-7358(90)90076-M; LOEBER R, 1983, PSYCHOL BULL, V94, P68, DOI 10.1037/0033-2909.94.1.68; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; MORRISON JR, 1973, ARCH GEN PSYCHIAT, V28, P888; NEISWANGER K, 1995, AM J MED GENET, V60, P272, DOI 10.1002/ajmg.1320600403; NOTHEN MM, 1993, J MED GENET, V30, P634, DOI 10.1136/jmg.30.8.634; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Rowe DC, 1998, BEHAV GENET, V28, P215, DOI 10.1023/A:1021427314941; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Silberg J, 1996, J CHILD PSYCHOL PSYC, V37, P803, DOI 10.1111/j.1469-7610.1996.tb01476.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THAPAR A, 1995, BEHAV GENET, V25, P537, DOI 10.1007/BF02327577; THOMSON G, 1995, AM J HUM GENET, V57, P487; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Waldman ID, 1997, GENET EPIDEMIOL, V14, P699, DOI 10.1002/(SICI)1098-2272(1997)14:6<699::AID-GEPI25>3.0.CO;2-K; WALDMAN ID, 1997, ANN M BEH GEN ASS TO; WALDMAN ID, 1994, ANN M BEH GEN ASS BA; WILLCUTT EB, 1995, BIENN M SOC RES CHIL	37	354	362	0	19	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1767	1776		10.1086/302132	http://dx.doi.org/10.1086/302132			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	151EL	9837830	Green Published, Bronze			2022-12-18	WOS:000077707700023
J	Gusev, A; Lee, SH; Trynka, G; Finucane, H; Vilhjalmsson, BJ; Xu, H; Zang, CZ; Ripke, S; Bulik-Sullivan, B; Stahl, E; Kahler, AK; Hultman, CM; Purcell, SM; McCarroll, SA; Daly, M; Pasaniuc, B; Sullivan, PF; Neale, BM; Wray, NR; Raychaudhuri, S; Price, AL				Gusev, Alexander; Lee, S. Hong; Trynka, Gosia; Finucane, Hilary; Vilhjalmsson, Bjarni J.; Xu, Han; Zang, Chongzhi; Ripke, Stephan; Bulik-Sullivan, Brendan; Stahl, Eli; Kaehler, Anna K.; Hultman, Christina M.; Purcell, Shaun M.; McCarroll, Steven A.; Daly, Mark; Pasaniuc, Bogdan; Sullivan, Patrick F.; Neale, Benjamin M.; Wray, Naomi R.; Raychaudhuri, Soumya; Price, Alkes L.		Psychiat Genomics Consortium; SWE-SCZ Consortium	Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; PRIOR INFORMATION; GENETIC-VARIATION; DNA ELEMENTS; LARGE-SCALE; SNPS; SCHIZOPHRENIA; LOCI; EXPRESSION	Regulatory and coding variants are known to be enriched with associations identified by genome-wide association studies (GWASs) of complex disease, but their contributions to trait heritability are currently unknown. We applied variance-component methods to imputed genotype data for 11 common diseases to partition the heritability explained by genotyped SNPs (h(g)(2)) across functional categories (while accounting for shared variance due to linkage disequilibrium). Extensive simulations showed that in contrast to current estimates from GWAS summary statistics, the variance-component approach partitions heritability accurately under a wide range of complex-disease architectures. Across the 11 diseases DNaseI hypersensitivity sites (DHSs) from 217 cell types spanned 16% of imputed SNPs (and 24% of genotyped SNPs) but explained an average of 79% (SE = 8%) of h(g)(2) from imputed SNPs (5.1 x enrichment; p = 3.7 x 10(-17)) and 38% (SE = 4%) of h(g)(2) from genotyped SNPs (1.6 x enrichment, p = 1.0 x 10(-4)). Further enrichment was observed at enhancer DHSs and cell-type-specific DHSs. In contrast, coding variants, which span 1% of the genome, explained <10% of h(g)(2) despite having the highest enrichment. We replicated these findings but found no significant contribution from rare coding variants in independent schizophrenia cohorts genotyped on GWAS and exome chips. Our results highlight the value of analyzing components of heritability to unravel the functional architecture of common disease.	[Gusev, Alexander; Vilhjalmsson, Bjarni J.; Xu, Han; Zang, Chongzhi; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lee, S. Hong; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Trynka, Gosia; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Trynka, Gosia; Ripke, Stephan; Bulik-Sullivan, Brendan; Purcell, Shaun M.; Daly, Mark; Neale, Benjamin M.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Trynka, Gosia; Daly, Mark; Neale, Benjamin M.; Raychaudhuri, Soumya; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Finucane, Hilary] MIT, Dept Math, Cambridge, MA 02142 USA; [Xu, Han; Zang, Chongzhi] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ripke, Stephan; Bulik-Sullivan, Brendan; Purcell, Shaun M.; Daly, Mark; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Bulik-Sullivan, Brendan; Purcell, Shaun M.; McCarroll, Steven A.; Daly, Mark; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Stahl, Eli; Purcell, Shaun M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Kaehler, Anna K.; Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of Manchester	Gusev, A (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	agusev@hsph.harvard.edu; aprice@hsph.harvard.edu	Vilhjalmsson, Bjarni/K-3971-2014; Pantelis, Christos/H-7722-2014; Mattheisen, Manuel/S-3725-2019; Lee, Jimmy/ABB-2919-2020; Slominsky, Petr/AAO-1852-2020; van Os, Jim/C-2113-2014; Hammer, Christian/C-5827-2014; Wu, Jingqin/V-9319-2019; Myin-Germeys, Inez/L-5106-2014; Hartmann, Annette/AAS-6331-2021; Andreassen, Ole A./AAY-7531-2020; Slominsky, Petr A/B-4640-2016; Daly, Mark J/B-2453-2017; Domenici, Enrico/K-8194-2016; Vilhjálmsson, Bjarni/ABC-1369-2020; Collier, David A/D-1649-2011; Milani, Lili/N-1097-2019; Zang, Chongzhi/D-1445-2011; Lee, Sang Hong/A-2569-2011; KUČINSKAS, Vaidutis/A-4798-2013; Liu, Jianjun/AAK-4989-2020; Visscher, Peter/ABB-6151-2020; Mortensen, Preben B/D-2358-2015; Zimprich, Fritz/O-1406-2019; Fanous, Ayman H/O-1263-2017; Webb, Bradley T/B-1459-2009; Melle, Ingrid S/B-4858-2011; O'Donovan, Michael C/P-7005-2018; McQuillin, Andrew/C-1623-2008; SCHALL, ULRICH ANDREAS/G-7452-2013; Mattheisen, Manuel/B-4949-2012; Meier, Sandra/AAB-1242-2021; Konte, Bettina/AAT-1142-2021; Roffman, Joshua/G-8228-2012; Stroup, Thomas/AAB-7780-2019; Reichenberg, Abraham/GQB-1227-2022; Zimprich, Fritz/W-1738-2017; Hansen, Thomas Folkmann/O-5965-2014; Mattingsdal, Morten/Q-9367-2016; Bramon, Elvira/HHC-3809-2022; Zai, Clement C/G-7379-2015; O'Neill, Francis A/C-5582-2008; Agerbo, Esben/A-2645-2012; So, Hon-Cheong/I-1100-2016; McIntosh, Andrew M/B-9379-2008; Ruderfer, Douglas M/M-5795-2016; Bergen, Sarah/I-8313-2012; Golimbet, V/E-2328-2016; Wray, Naomi/C-8639-2015; Ripke, Stephan/AAK-5486-2021; McDonald, Colm/C-1430-2009; Franke, Lude/P-7036-2016; Mowry, Bryan/G-5046-2010; Scott, Rodney/B-2827-2013; Grove, Jakob/K-8112-2015; murray, robin/F-8658-2012; Kelly, Brian/G-7755-2013; Sigurdsson, Engilbert/D-2486-2014; Ptackova, Hana/M-9763-2017	Vilhjalmsson, Bjarni/0000-0003-2277-9249; Pantelis, Christos/0000-0002-9565-0238; Mattheisen, Manuel/0000-0002-8442-493X; Lee, Jimmy/0000-0002-7724-7445; Slominsky, Petr/0000-0003-3530-0655; Hammer, Christian/0000-0003-4548-7548; Wu, Jingqin/0000-0002-2052-3875; Slominsky, Petr A/0000-0003-3530-0655; Daly, Mark J/0000-0002-0949-8752; Domenici, Enrico/0000-0001-7436-6919; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Collier, David A/0000-0003-4087-1559; Milani, Lili/0000-0002-5323-3102; Zang, Chongzhi/0000-0003-4812-3627; Lee, Sang Hong/0000-0001-9701-2718; Liu, Jianjun/0000-0002-3255-3019; Visscher, Peter/0000-0002-2143-8760; Mortensen, Preben B/0000-0002-5230-9865; Zimprich, Fritz/0000-0002-6998-5480; Webb, Bradley T/0000-0002-0576-5366; Melle, Ingrid S/0000-0002-9783-548X; O'Donovan, Michael C/0000-0001-7073-2379; McQuillin, Andrew/0000-0003-1567-2240; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Roffman, Joshua/0000-0003-4073-532X; Stroup, Thomas/0000-0002-3123-0672; Zimprich, Fritz/0000-0002-6998-5480; Hansen, Thomas Folkmann/0000-0001-6703-7762; Mattingsdal, Morten/0000-0003-4440-0324; Bramon, Elvira/0000-0003-1369-5983; O'Neill, Francis A/0000-0002-7531-7657; Agerbo, Esben/0000-0002-2849-524X; McIntosh, Andrew M/0000-0002-0198-4588; Ruderfer, Douglas M/0000-0002-2365-386X; Bergen, Sarah/0000-0002-5888-0034; Golimbet, V/0000-0002-9960-7114; Wray, Naomi/0000-0001-7421-3357; McDonald, Colm/0000-0003-1661-5192; Murphy, Kieran/0000-0003-2930-4465; Gopal, Srihari/0000-0001-5254-2192; Franke, Lude/0000-0002-5159-8802; Escott-Price, Valentina/0000-0003-1784-5483; Bacanu, Silviu-Alin/0000-0002-4364-1583; Myin-Germeys, Inez/0000-0002-3731-4930; Dinan, Timothy/0000-0002-2316-7220; Chen, Eric/0000-0002-5247-3593; Lubinski, Jan/0000-0003-2931-3003; Pocklington, Andrew/0000-0002-2137-0452; Golimbet, Vera/0000-0002-0114-4300; TOSATO, Sarah/0000-0002-9665-7538; Jonsson, Erik/0000-0001-8368-6332; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Kirov, George/0000-0002-3427-3950; Joa, Inge/0000-0002-5516-2336; Palotie, Aarno/0000-0002-2527-5874; Mors, Ole/0000-0002-5660-0393; Curtis, David/0000-0002-4089-9183; ripke, stephan/0000-0003-3622-835X; Donohoe, Gary/0000-0003-3037-7426; Mowry, Bryan/0000-0002-4115-5645; Walters, James/0000-0002-6980-4053; Buccola, Nancy/0000-0003-1378-4636; marsal, sara/0000-0001-5515-3854; IWATA, Nakao/0000-0003-3189-6076; Pasaniuc, Bogdan/0000-0002-0227-2056; Milovancevic, Milos/0000-0002-7891-1010; Knight, Joanne/0000-0002-7148-1660; Black, Donald/0000-0001-8038-1971; Quested, Digby/0000-0001-6155-3336; Perkins, Diana/0000-0001-9396-2206; Crowley, James/0000-0001-9051-1557; Tooney, Paul/0000-0003-3745-4367; Corvin, Aiden/0000-0001-6717-4089; Buxbaum, Joseph/0000-0001-8898-8313; Julia Cano, Antonio/0000-0001-6064-3620; Petryshen, Tracey/0000-0002-7972-4612; Ehrenreich, Hannelore/0000-0001-8371-5711; Sim, Kang/0000-0003-3209-9626; Toncheva, Draga/0000-0002-7451-6363; Bruggeman, Richard/0000-0002-3238-8471; /0000-0002-8114-7615; Pers, Tune/0000-0003-0207-4831; Scott, Rodney/0000-0001-7724-3404; Grove, Jakob/0000-0003-2284-5744; murray, robin/0000-0003-0829-0519; Papiol, Sergi/0000-0001-9366-8728; Raychaudhuri, Soumya/0000-0002-1901-8265; Kelly, Brian/0000-0003-4460-1134; Esko, Tonu/0000-0003-1982-6569; Borglum, Anders/0000-0001-8627-7219; Sigurdsson, Engilbert/0000-0001-9404-7982; Suvisaari, Jaana/0000-0001-7167-0990; Legge, Sophie/0000-0001-6617-0289; Adolfsson, Rolf/0000-0001-9785-8473; Demontis, Ditte/0000-0001-9124-2766; Zai, Clement C/0000-0003-0496-7262; Ptackova, Hana/0000-0002-5694-3695; Freedman, Robert/0000-0002-2181-2898; Stogmann, Elisabeth/0000-0003-4688-8482; So, Hon-Cheong/0000-0002-7102-833X; Djurovic, Srdjan/0000-0002-8140-8061; Klovins, Janis/0000-0001-8362-5505; Moran, Jennifer/0000-0002-5664-4716	Wellcome Trust [076113]; NIH [R01 MH101244, R03 HG006731, 1U01HG0070033]; Doris Duke Clinical Scientist Development Award; NIH fellowship [F32 GM106584]; Rubicon grant from the Netherlands Organization for Scientific Research; Fannie and John Hertz Foundation; Australian Research Council [DE130100614, FT0991360]; National Health and Medical Research Council [613602, 1050218]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0800509, MR/L010305/1, G0601635] Funding Source: researchfish; Chief Scientist Office [SCD/12] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG006731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106584, R01GM105857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244, U01MH096296, T32MH020030, U01MH094432] Funding Source: NIH RePORTER; MRC [G0601635, G0800509] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rubicon grant from the Netherlands Organization for Scientific Research; Fannie and John Hertz Foundation; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) and the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the WTCCC data is available at www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. We thank Manolis Kellis, Abhishek Sarkar, Joe Pickrell, X. Shirley Liu, Nick Patterson, Sara Lindstrom, Peter Kraft, and Shamil Sunyaev for helpful discussions and Amy Williams for assistance with HApI-UR. This research was funded by NIH grants R01 MH101244, R03 HG006731, and 1U01HG0070033, the Doris Duke Clinical Scientist Development Award, and NIH fellowship F32 GM106584. G.T. was supported by the Rubicon grant from the Netherlands Organization for Scientific Research. H.F. was supported by the Fannie and John Hertz Foundation. We also acknowledge grant funding from the Australian Research Council (DE130100614 and FT0991360) and the National Health and Medical Research Council (613602 and 1050218).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bulik-Sullivan B., 2014, LD SCORE REGRESSION; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Eskin E, 2008, GENOME RES, V18, P653, DOI 10.1101/gr.072785.107; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fischer TM, 2004, GENET SEL EVOL, V36, P363, DOI 10.1051/gse:2004006; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gagliano SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098122; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Golan D., 2013, ARXIV13055363; Green P, 2013, SCIENCE, V340, DOI 10.1126/science.1233195; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hayeck T., 2014, MIXED MODEL CORRECTI; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Janss L, 2012, GENETICS, V192, P693, DOI 10.1534/genetics.112.141143; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee D, 2013, BIOINFORMATICS, V29, P2925, DOI 10.1093/bioinformatics/btt500; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; Lynch M, 1998, GENETICS ANAL QUANTI; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mudge JM, 2013, GENOME RES, V23, P1961, DOI 10.1101/gr.161315.113; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	80	353	359	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					535	552		10.1016/j.ajhg.2014.10.004	http://dx.doi.org/10.1016/j.ajhg.2014.10.004			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439723	Green Published, Bronze			2022-12-18	WOS:000344845000005
J	Bertram, L; Lange, C; Mullin, K; Parkinson, M; Hsiao, M; Hogan, MF; Schjeide, BMM; Hooli, B; DiVito, J; Ionita, L; Jiang, HY; Laird, N; Moscarillo, T; Ohlsen, KL; Elliott, K; Wang, X; Hu-Lince, D; Ryder, M; Murphy, A; Wagner, SL; Blacker, D; Becker, KD; Tanzi, RE				Bertram, Lars; Lange, Christoph; Mullin, Kristina; Parkinson, Michele; Hsiao, Monica; Hogan, Meghan F.; Schjeide, Brit M. M.; Hooli, Basavaraj; DiVito, Jason; Ionita, Luliana; Jiang, Hongyu; Laird, Nan; Moscarillo, Thomas; Ohlsen, Kari L.; Elliott, Kathryn; Wang, Xin; Hu-Lince, Diane; Ryder, Marie; Murphy, Amy; Wagner, Steven L.; Blacker, Deborah; Becker, K. David; Tanzi, Rudolph E.			Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-BASED ASSOCIATION; MISSENSE MUTATIONS; ONSET; GENE; EPSILON-4; VARIANTS; CLONING; AGE	Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. To date four genes have been established to either Cause early-onset autosomal-dominant AD (APP, PSEN1, and PSEN2(1-4)) or to increase susceptibility for late-onset AD (APOE However, the heritability of late-onset AD is as high as 80%,(6) and much of the phenotypic variance remains unexplained to date. We performed a genome-wide association (GWA) analysis using 484,522 single-nucleotide polymorphisms (SNPs) on a large (1,376 samples from 410 families) sample of AD families of self-reported European descent. We identified five SNPs showing either significant or marginally significant genome-wide association with a multivariate phenotype combining affection status and onset age. One of these signals (p = 5.7 x 10(-14)) was elicited by SNP rs4420638 and probably reflects APOE-epsilon 4, which maps 11 kb proximal (r(2) = 0.78). The other four signals were tested in three additional independent AD family samples composed of nearly 2700 individuals from almost 900 families. Two of these SNPs showed significant association in the replication samples (combined p values 0.007 and 0.00002). The SNP (rs11159647, on chromosome 14q31) with the strongest association signal also showed evidence of association with the same allele in GWA data generated in an independent sample of similar to 1,400 AD cases and controls (p = 0.04). Although the precise identity of the underlying locus(i) remains elusive, our study provides compelling evidence for the existence of at least one previously undescribed AD gene that, like APOE-epsilon 4, primarily acts as a modifier of onset age.	[Bertram, Lars; Mullin, Kristina; Parkinson, Michele; Hsiao, Monica; Hogan, Meghan F.; Schjeide, Brit M. M.; Hooli, Basavaraj; DiVito, Jason; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis MIND, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA; [Lange, Christoph; Ionita, Luliana; Jiang, Hongyu; Laird, Nan; Murphy, Amy] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Blacker, Deborah] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Moscarillo, Thomas; Blacker, Deborah] Massachusetts Gen Hosp, Dept Psychiat, Gerontol Res Unit, Charlestown, MA 02129 USA; [Ohlsen, Kari L.; Elliott, Kathryn; Wang, Xin; Hu-Lince, Diane; Ryder, Marie; Wagner, Steven L.] TorreyPines Therapeut, La Jolla, CA 92037 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis MIND, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Hogan, Meghan/AAD-4425-2020; Bertram, Lars/K-3889-2015; Tanzi, Rudolph/AAE-9622-2019	Bertram, Lars/0000-0002-0108-124X; Tanzi, Rudolph/0000-0002-7032-1454; Elliott, Kathryn/0000-0002-4926-1215; Hogan, Meghan/0000-0002-5767-1599	Cure Alzheimer Fund; NIMH; Extendicare Foundation; Eisai; NATIONAL INSTITUTE ON AGING [U24AG021886] Funding Source: NIH RePORTER	Cure Alzheimer Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Extendicare Foundation; Eisai(Eisai Co Ltd); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to thank all families for participating in this study. This work was sponsored by grants from the Cure Alzheimer Fund (as part of the "Alzheimer Genorne Project"), the NIMH, and the Extendicare Foundation. Work completed at TorreyPines Therapeutics and was funded by Eisai. L.B. and R.E.T. are consultants to, and equity holders in, TorreyPines Therapeutics and Prana Biotechnology. R.E.T is also a consultant to Prana Biotechnology. R.E.T. is a cofounder of both TorreyPines Therapeutics and Prana Biotechnology. K.L.O., K.E., X.W., D.H.-L., M.R., K.D.B., and S.W. are employees of, and hold stock options in, TorreyPines Therapeutics. K.E. and S.W also hold stock in Merck.	Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Chen XN, 1999, GENOME RES, V9, P492; Fisher RA, 1925, STAT METHODS RES WOR; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Ionita-Laza I, 2007, AM J HUM GENET, V81, P607, DOI 10.1086/519748; Jiang HY, 2006, GENET EPIDEMIOL, V30, P124, DOI 10.1002/gepi.20132; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lee JH, 2008, NEUROGENETICS, V9, P51, DOI 10.1007/s10048-007-0103-3; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Orr HT, 2001, HUM MOL GENET, V10, P2307, DOI 10.1093/hmg/10.20.2307; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHJEIDE BMM, 2008, NEUROGENETI IN PRESS, DOI DOI 10.1007/S10048-008-0151-3; SCHJEIDE BMM, 2009, ARCH NEUROL IN PRESS; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; von Gunten S, 2006, FASEB J, V20, P601, DOI 10.1096/fj.05-5401hyp	29	352	367	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					623	632		10.1016/j.ajhg.2008.10.008	http://dx.doi.org/10.1016/j.ajhg.2008.10.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18976728	Bronze, Green Published			2022-12-18	WOS:000261006900009
J	Harding, RM; Fullerton, SM; Griffiths, RC; Bond, J; Cox, MJ; Schneider, JA; Moulin, DS; Clegg, JB				Harding, RM; Fullerton, SM; Griffiths, RC; Bond, J; Cox, MJ; Schneider, JA; Moulin, DS; Clegg, JB			Archaic African and Asian lineages in the genetic ancestry of modern humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLOBIN GENE; INTRAGENIC RECOMBINATION; EVOLUTIONARY TREES; DNA POLYMORPHISMS; HUMAN-POPULATIONS; NEUTRAL ALLELES; SAMPLING THEORY; HUMAN ORIGINS; DIVERSITY; MITOCHONDRIAL	A 3-kb region encompassing the beta-globin gene has been analyzed for allelic sequence polymorphism in nine populations from Africa, Asia, and Europe. A unique gene tree was constructed from 326 sequences of 349 in the total sample. New maximum-likelihood methods for analyzing gene trees on the basis of coalescence theory have been used. The most recent common ancestor of the beta-globin gene tree is a sequence found only in Africa and estimated to have arisen similar to 800,000 years ago. There is no evidence for an exponential expansion out of a bottlenecked founding population, and an effective population size of similar to 10,000 has been maintained. Modest differences in levels of beta-globin diversity between Africa and Asia are better explained by greater African effective population size than by greater time depth. There may have been a reduction of Asian effective population size in recent evolutionary history. Characteristically Asian ancestry is estimated to be older than 200,000 years, suggesting that the ancestral hominid population at this time was widely dispersed across Africa and Asia. Patterns of beta-globin diversity suggest extensive worldwide late Pleistocene gene flow and are not easily reconciled with a unidirectional migration out of Africa 100,000 years ago and total replacement of archaic populations in Asia.	MONASH UNIV,DEPT MATH,CLAYTON,VIC 3168,AUSTRALIA	Monash University	Harding, RM (corresponding author), JOHN RADCLIFFE HOSP,INST MOL MED,MRC,MOL HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.		Schneider, Julie/F-4785-2010; Fullerton, Stephanie Malia/H-8696-2019	Fullerton, Stephanie Malia/0000-0002-0938-6048; Griffiths, Robert/0000-0001-7190-5104	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; [Anonymous], 1984, AM NAT; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROOKFIELD JFY, 1994, CURR BIOL, V4, P651, DOI 10.1016/S0960-9822(00)00145-7; CHEN YS, 1995, AM J HUM GENET, V57, P133; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; DONNELLY P, 1996, VARIATION HUMAN GENO, P25; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FLINT J, 1993, HUM GENET, V91, P91; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; Griffiths R. C., 1987, 163 MON U DEP MATH; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; HALDANE JBS, 1948, HEREDITAS S, V35, P267; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HARDING RM, IN PRESS J MOL EVOL; HARDING RM, 1996, MOL BIOL HUMAN DIVER, P63; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HILL AVS, 1992, P NATL ACAD SCI USA, V89, P2277, DOI 10.1073/pnas.89.6.2277; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; JORDE LB, 1995, AM J HUM GENET, V57, P523; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kingman J.F.C., 1982, EXCHANGEABILITY PROB, P97; Kolman CJ, 1996, GENETICS, V142, P1321; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LI WH, 1991, GENETICS, V129, P513; MARTINSON JJ, 1995, AM J HUM GENET, V57, P1186; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Newman JL., 1995, PEOPLING AFRICA GEOG; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; POPE GG, 1992, YEARB PHYS ANTHROPOL, V35, P243; Rohlf FJ, 1990, NTSYS PC NUMERICAL T; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; SHERRY ST, 1994, HUM BIOL, V66, P761; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; STROBECK C, 1978, GENETICS, V88, P829; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; TAKAHATA N, 1995, ANNU REV ECOL SYST, V26, P343, DOI 10.1146/annurev.es.26.110195.002015; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Templeton AR, 1996, SCIENCE, V272, P1363; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TRABUCHET G, 1991, HUM BIOL, V63, P241; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	60	352	360	0	18	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					772	789						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106523				2022-12-18	WOS:A1997WT61400006
J	Yang, Y; Chung, EK; Wu, YL; Savelli, SL; Nagaraja, HN; Zhou, B; Hebert, M; Jones, KN; Shu, YL; Kitzmiller, K; Blanchong, CA; McBride, KL; Higgins, GC; Rennebohm, RM; Rice, RR; Hackshaw, KV; Roubey, RAS; Grossman, JM; Tsao, BP; Birmingham, DJ; Rovin, BH; Hebert, LA; Yu, CY				Yang, Yan; Chung, Erwin K.; Wu, Yee Ling; Savelli, Stephanie L.; Nagaraja, Haikady N.; Zhou, Bi; Hebert, Maddie; Jones, Karla N.; Shu, Yaoling; Kitzmiller, Kathryn; Blanchong, Carol A.; McBride, Kim L.; Higgins, Gloria C.; Rennebohm, Robert M.; Rice, Robert R.; Hackshaw, Kevin V.; Roubey, Robert A. S.; Grossman, Jennifer M.; Tsao, Betty P.; Birmingham, Daniel J.; Rovin, Brad H.; Hebert, Lee A.; Yu, C. Yung			Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): Low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RP-C4-CYP21-TNX RCCX MODULES; EXON-INTRON STRUCTURE; HUMAN GENOME; STEROID 21-HYDROXYLASE; AUTOIMMUNE-DISEASES; HEMOLYTIC ACTIVITIES; QUANTITATIVE TRAITS; 4TH COMPONENT; 2 PARTS	Interindividual gene copy-number variation (CNV) of complement component C4 and its associated polymorphisms in gene size (long and short) and protein isotypes (C4A and C4B) probably lead to different susceptibilities to autoimmune disease. We investigated the C4 gene CNV in 1,241 European Americans, including patients with systemic lupus erythematosus (SLE), their first-degree relatives, and unrelated healthy subjects, by definitive genotyping and phenotyping techniques. The gene copy number (GCN) varied from 2 to 6 for total C4, from 0 to 5 for C4A, and from 0 to 4 for C4B. Four copies of total C4, two copies of C4A, and two copies of C4B were the most common GCN counts, but each constituted only between one-half and three-quarters of the study populations. Long C4 genes were strongly correlated with C4A (R = 0.695; P < 0.001). Short C4 genes were correlated with C4B (R = 0.437; P < 0.001). In comparison with healthy subjects, patients with SLE clearly had the GCN of total C4 and C4A shifting to the lower side. The risk of SLE disease susceptibility significantly increased among subjects with only two copies of total C4 (patients 9.3%; unrelated controls 1.5%; odds ratio [OR] = 6.514; P = .00002) but decreased in those with >= 5 copies of C4 (patients 5.79% controls 12%; OR = 0.466; P = .016. Both zero copies (OR = 5.267; P = .001) and one copy (OR = 1.613; P = .022) of C4A were risk factors for SLE, whereas >= 3 copies of C4A appeared to be protective (OR = 0.574; P = .012). Family-based association tests suggested that a specific haplotype with a single short C4B in tight linkage disequilibrium with the -308A allele of TNFA was more likely to be transmitted to patients with SLE. This work demonstrates how gene CNV and its related polymorphisms are associated with the susceptibility to a human complex disease.	Columbus Childrens Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; Ohio State Univ, Ohio SLE Study Grp, Columbus, OH 43210 USA; Ohio State Univ, Gen Clin Res Ctr, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol, Columbus, OH 43210 USA; Ohio State Univ, Dept Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; Univ N Carolina, Div Rheumatol Allergy & Immunol, Chapel Hill, NC USA; Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90024 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles	Yu, CY (corresponding author), Columbus Childrens Res Inst, Ctr Mol & Human Genet, 700 Childrens Dr, Columbus, OH 43205 USA.	cyu@chi.osu.edu	McBride, Kim L/A-5879-2008; Yu, Chack-Yung/E-4360-2011	McBride, Kim L/0000-0002-8407-8942; Yu, Chack-Yung/0000-0002-5218-7503; Tsao, Betty/0000-0001-7938-5975	NCRR NIH HHS [M01 RR000046, 1 P41 RR06009, M01 RR000034, RR00046, M01 RR00034, P41 RR006009] Funding Source: Medline; NHLBI NIH HHS [K23 HL070823, K23 HL70823] Funding Source: Medline; NIAMS NIH HHS [N01 AR2248, R01 AR050078, 1 R01 AR050078, R01 AR043814, R01 AR43814, N01AR02248] Funding Source: Medline; NICHD NIH HHS [K12 HD043372, K12 HD43372] Funding Source: Medline; NIDDK NIH HHS [5 P01 DK55546, P01 DK055546] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009, M01RR000034, M01RR000046] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL070823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043814, R01AR050078, N01AR002248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055546] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ANDERSON MJ, 1992, J IMMUNOL, V148, P2795; ATKINSON JP, 2004, SYSTEMIC LUPUS ERYTH, P153; AWDEH ZL, 1983, P NATL ACAD SCI-BIOL, V80, P259, DOI 10.1073/pnas.80.1.259; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; BELT KT, 1985, IMMUNOGENETICS, V21, P173; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CARROLL MC, 1990, P NATL ACAD SCI USA, V87, P6868, DOI 10.1073/pnas.87.17.6868; Check E, 2005, NATURE, V437, P1084, DOI 10.1038/4371084a; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; Chung EK, 2002, AM J HUM GENET, V71, P823, DOI 10.1086/342777; Chung EK, 2002, AM J HUM GENET, V71, P810, DOI 10.1086/342778; Chung EK, 2005, CURRENT PROTOCOLS IM; Cook HT, 2006, NAT CLIN PRACT RHEUM, V2, P330, DOI 10.1038/ncprheum0191; Croker JA, 2005, CURR OPIN RHEUMATOL, V17, P529, DOI 10.1097/01.bor.0000169360.15701.27; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DODDS AW, 1985, EMBO J, V4, P2239, DOI 10.1002/j.1460-2075.1985.tb03920.x; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; Forabosco P, 2006, GENES IMMUN, V7, P609, DOI 10.1038/sj.gene.6364338; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; GLASS D, 1976, J CLIN INVEST, V58, P853, DOI 10.1172/JCI108538; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6; Hart S, 1997, Laterality, V2, P17; HAUPTMANN G, 1974, B I SIEROTER MILAN, V53, P228; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; ISENMAN DE, 1984, J IMMUNOL, V132, P3019; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; LAW SKA, 1984, EMBO J, V3, P1819, DOI 10.1002/j.1460-2075.1984.tb02052.x; Lee YH, 2006, EUR J HUM GENET, V14, P364, DOI 10.1038/sj.ejhg.5201566; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Lewis MJ, 2006, AUTOIMMUNITY, V39, P367, DOI 10.1080/08916930600739233; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Manzi S, 2004, ARTHRITIS RHEUM-US, V50, P3596, DOI 10.1002/art.20561; Mauff G, 1998, EXP CLIN IMMUNOGENET, V15, P249, DOI 10.1159/000019079; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Nadeau JH, 2006, NATURE, V439, P798, DOI 10.1038/439798a; Petri M, 2006, AUTOIMMUNE DISEASES, 4TH EDITION, P351, DOI 10.1016/B978-012595961-2/50030-5; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rus V, 2007, SYSTEMIC LUPUS ERYTH, P109; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Schneider PM, 2001, IMMUNOGENETICS, V53, P1, DOI 10.1007/s002510000288; SCHUR PH, 1968, NEW ENGL J MED, V278, P533, DOI 10.1056/NEJM196803072781004; SCHUR PH, 1977, AM J CLIN PATHOL, V68, P647; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SHEN LM, 1994, J BIOL CHEM, V269, P8466; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Tsokos G, 2007, SYSTEMIC LUPUS ERYTH; Tsuchiya N, 2001, GENES IMMUN, V2, P317, DOI 10.1038/sj.gene.6363783; Vatay A, 2003, HUM IMMUNOL, V64, P543, DOI 10.1016/S0198-8859(03)00036-3; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Wu YL, 2006, ADV EXP MED BIOL, V586, P227; Yang Y, 2004, CURR DIRECT AUTOIMMU, V7, P98; Yang Y, 2003, J IMMUNOL, V171, P2734, DOI 10.4049/jimmunol.171.5.2734; Yang ZY, 1999, J BIOL CHEM, V274, P12147, DOI 10.1074/jbc.274.17.12147; Yu CY, 2004, TRENDS IMMUNOL, V25, P694, DOI 10.1016/j.it.2004.10.006; Yu CY, 2003, PROG NUCLEIC ACID RE, V75, P217; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1988, IMMUNOGENETICS, V27, P399, DOI 10.1007/BF00364425; YU CY, 1991, J IMMUNOL, V146, P1057; Yu CY, 2002, MANUAL CLIN LAB IMMU, V6th, P117; YU CY, 2007, SYSTEMIC LUPUS ERYTH, P203	88	351	374	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1037	1054		10.1086/518257	http://dx.doi.org/10.1086/518257			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503323	Green Published, Bronze			2022-12-18	WOS:000246553800004
J	Fulker, DW; Cherny, SS; Sham, PC; Hewitt, JK				Fulker, DW; Cherny, SS; Sham, PC; Hewitt, JK			Combined linkage and association sib-pair analysis for quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; LOCI	An extension to current maximum-likelihood variance-components procedures for mapping quantitative-trait loci in sib pairs that allows a simultaneous test of allelic association is proposed. The method involves modeling of the allelic means for a test of association, with simultaneous modeling of the sib-pair covariance structure for a test of linkage. By partitioning of the mean effect of a locus into between- and within-sibship components, the method controls for spurious associations due to population stratification and admixture. The power and efficacy of the method are illustrated through simulation of various models of both real and spurious association.	Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Univ London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London, England	University of Colorado System; University of Colorado Boulder; University of London; King's College London	Cherny, SS (corresponding author), Univ Colorado, Inst Behav Genet, Campus Box 447, Boulder, CO 80309 USA.		Cherny, Stacey S/B-3315-2008	Cherny, Stacey S/0000-0002-0269-3352	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010556, R01AA010556, R01AA007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P60DA011015] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-07330, AA-10556] Funding Source: Medline; NIDA NIH HHS [DA-11015] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Allison DB, 1997, AM J HUM GENET, V60, P676; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Chorney MJ, 1998, PSYCHOL SCI, V9, P159, DOI 10.1111/1467-9280.00032; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Falconer D. S., 1989, Introduction to quantitative genetics.; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Sham P, 1997, AM J HUM GENET, V61, P774; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; XU SH, 1995, GENETICS, V141, P1189	20	351	363	1	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					259	267		10.1086/302193	http://dx.doi.org/10.1086/302193			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915965	Green Published, Bronze			2022-12-18	WOS:000078477400031
J	STINE, OC; XU, JF; KOSKELA, R; MCMAHON, FJ; GSCHWEND, M; FRIDDLE, C; CLARK, CD; MCINNIS, MG; SIMPSON, SG; BRESCHEL, TS; VISHIO, E; RISKIN, K; FEILOTTER, H; CHEN, E; SHEN, S; FOLSTEIN, S; MEYERS, DA; BOTSTEIN, D; MARR, TG; DEPAULO, JR				STINE, OC; XU, JF; KOSKELA, R; MCMAHON, FJ; GSCHWEND, M; FRIDDLE, C; CLARK, CD; MCINNIS, MG; SIMPSON, SG; BRESCHEL, TS; VISHIO, E; RISKIN, K; FEILOTTER, H; CHEN, E; SHEN, S; FOLSTEIN, S; MEYERS, DA; BOTSTEIN, D; MARR, TG; DEPAULO, JR			EVIDENCE FOR LINKAGE OF BIPOLAR DISORDER TO CHROMOSOME-18 WITH A PARENT-OF-ORIGIN EFFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; COLOR-BLINDNESS; FAMILIAL BREAST; TRANSMISSION; PEDIGREES; RELATIVES; UNIPOLAR; MARKERS; CANCER; HUMANS	A susceptibility gene on chromosome 18 and a parent-of-origin effect have been suggested for bipolar affective disorder (BPAD). We have studied 28 nuclear families selected for apparent unilineal transmission of the BPAD phenotype, by using 31 polymorphic markers spanning chromosome 18. Evidence for linkage was tested with affected-sib-pair and LOD score methods under two definitions of the affected phenotype. The affected-sib-pair analyses indicated excess allele sharing for markers on 18p within the region reported previously. The greatest sharing was at D18S37: 64% in bipolar and recurrent unipolar (RUP) sib pairs (P = .0006). In addition, excess sharing of the paternally, but not maternally, transmitted alleles was observed at three markers on 18q: at D18S41, 51 bipolar and RUP sib pairs were concordant for paternally transmitted alleles, and 21 pairs were discordant (P = .0004). The evidence for linkage to loci on both 18p and 18q was strongest in the 11 paternal pedigrees, i.e., those in which the father or one of the father's sibs is affected. In these pedigrees, the greatest allele sharing (81%; P = .00002) and the highest LOD score (3.51; theta = 0.0) were observed at D18S41. Our results provide further support for linkage of BPAD to chromosome 18 and the first molecular evidence for a parent-of-origin effect operating in this disorder. The number of loci involved, and their precise location, require further study.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; COLD SPRING HARBOR LAB,DEPT COMPUTAT BIOL,COLD SPRING HARBOR,NY 11724; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; TUFTS UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02111	Johns Hopkins University; Cold Spring Harbor Laboratory; Stanford University; Tufts University			Koskela, Rebecca/M-8666-2014; McInnis, Melvin G/F-6963-2012; McMahon, Francis J/A-7290-2009	Koskela, Rebecca/0000-0002-1157-2798; McInnis, Melvin G/0000-0002-0375-6247; McMahon, Francis J/0000-0002-9469-305X; DePaulo, J Raymond/0000-0001-9221-9226				BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BARON M, 1977, ARCH GEN PSYCHIAT, V34, P721; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BLACKER D, 1993, PSYCHIATR GENET, V3, P5, DOI 10.1097/00041444-199321000-00002; CLARK CD, 1994, CURRENT PROTOCOLS HU, V1; CORYELL W, 1985, AM J PSYCHIAT, V142, P817; CROWE RR, 1977, J PSYCHIATR RES, V13, P273, DOI 10.1016/0022-3956(77)90015-2; EASTON DF, 1993, AM J HUM GENET, V52, P678; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ENDICOTT J, 1985, J AFFECT DISORDERS, V8, P17, DOI 10.1016/0165-0327(85)90068-0; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GANTZ I, 1993, GENOMICS, V18, P166, DOI 10.1006/geno.1993.1448; GERSHON ES, 1979, ARCH GEN PSYCHIAT, V36, P1423; GOLDIN LR, 1983, AM J HUM GENET, V35, P274; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; MCMAHON FJ, 1994, AM J PSYCHIAT, V151, P210; MENDLEWICZ J, 1972, J AMER MED ASSOC, V222, P1624, DOI 10.1001/jama.222.13.1624; MENDLEWICZ J, 1974, AM J HUM GENET, V26, P692; MORTON NE, 1956, AM J HUM GENET, V8, P80; OROURKE DH, 1983, AM J PHYS ANTHROPOL, V62, P51, DOI 10.1002/ajpa.1330620108; Ott J., 1991, ANAL HUMAN GENETIC L; OTT J, 1992, GENETIC RES PSYCHIAT, P245; REICH T, 1969, AM J PSYCHIAT, V125, P1358, DOI 10.1176/ajp.125.10.1358; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SIMPSON SG, 1992, AM J PSYCHIAT, V149, P1660; SPENCE A, 1993, PSYCHIATR GENET, V3, P3; SPITZER RL, 1975, BIOMETRICS RES; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; Tsuang M, 1990, GENETICS MOOD DISORD; WALSH FS, 1990, J NEUROCHEM, V55, P805, DOI 10.1111/j.1471-4159.1990.tb04563.x; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; 1994, STATISTICAL ANAL GEN; [No title captured]; 1993, CELL, V72, P971	48	350	360	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1384	1394						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	TE655	8533768				2022-12-18	WOS:A1995TE65500016
J	Easton, DF; Deffenbaugh, AM; Pruss, D; Frye, C; Wenstrup, RJ; Allen-Brady, K; Tavtigian, SV; Monteiro, ANA; Iversen, ES; Couch, FJ; Goldgar, DE				Easton, Douglas F.; Deffenbaugh, Amie M.; Pruss, Dmitry; Frye, Cynthia; Wenstrup, Richard J.; Allen-Brady, Kristina; Tavtigian, Sean V.; Monteiro, Alvaro N. A.; Iversen, Edwin S.; Couch, Fergus J.; Goldgar, David E.			A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE VARIANTS; TRANSCRIPTIONAL ACTIVATION; EMBRYONIC LETHALITY; FAMILIAL BREAST; RISK ASSESSMENT; MUTATIONS; CLASSIFICATION; ALLELE	Mutation screening of the breast and ovarian cancer - predisposition genes BRCA1 and BRCA2 is becoming an increasingly important part of clinical practice. Classification of rare nontruncating sequence variants in these genes is problematic, because it is not known whether these subtle changes alter function sufficiently to predispose cells to cancer development. Using data from the Myriad Genetic Laboratories database of nearly 70,000 full-sequence tests, we assessed the clinical significance of 1,433 sequence variants of unknown significance ( VUSs) in the BRCA genes. Three independent measures were employed in the assessment: co-occurrence in trans of a VUS with known deleterious mutations; detailed analysis, by logistic regression, of personal and family history of cancer in VUS-carrying probands; and, in a subset of probands, an analysis of cosegregation with disease in pedigrees. For each of these factors, a likelihood ratio was computed under the hypothesis that the VUSs were equivalent to an "average" deleterious mutation, compared with neutral, with respect to risk. The likelihood ratios derived from each component were combined to provide an overall assessment for each VUS. A total of 133 VUSs had odds of at least 100: 1 in favor of neutrality with respect to risk, whereas 43 had odds of at least 20: 1 in favor of being deleterious. VUSs with evidence in favor of causality were those that were predicted to affect splicing, fell at positions that are highly conserved among BRCA orthologs, and were more likely to be located in specific domains of the proteins. In addition to their utility for improved genetics counseling of patients and their families, the global assessment reported here will be invaluable for validation of functional assays, structural models, and in silico analyses.	Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84132 USA; Univ Cambridge, Strangeways Res Labs, Genet Epidemiol Unit, Cambridge, England; Univ Utah, Sch Med, Myriad Genet Labs, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84132 USA; Int Agcy Res Canc, Genet Canc Suscepitibil Grp, F-69372 Lyon, France; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27706 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Utah System of Higher Education; University of Utah; University of Cambridge; Myriad Genetics, Inc; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; World Health Organization; International Agency for Research on Cancer (IARC); H Lee Moffitt Cancer Center & Research Institute; Duke University; Mayo Clinic	Goldgar, DE (corresponding author), Univ Utah, Sch Med, Dept Dermatol, 30 N 1900 E,SOM 4B454, Salt Lake City, UT 84132 USA.	david.goldgar@hsc.utah.edu	Monteiro, Alvaro N. A./A-7566-2009	Monteiro, Alvaro N. A./0000-0002-8448-4801	NCI NIH HHS [P50 CA116201, R01 CA092309, CA92309] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA092309] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Billack B, 2004, CANCER BIOL THER, V3, P458, DOI 10.4161/cbt.3.5.831; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; COLLINS N, 1995, ONCOGENE, V10, P1673; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hohenstein P, 2001, ONCOGENE, V20, P2544, DOI 10.1038/sj.onc.1204363; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Judkins T, 2005, CANCER RES, V65, P10096, DOI 10.1158/0008-5472.CAN-05-1241; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lovelock PK, 2006, J MED GENET, V43, P74, DOI 10.1136/jmg.2005.033258; Lucci-Cordisco Emanuela, 2006, Cancer Biomarkers, V2, P11; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 2006, CANCER RES, V66, P1897, DOI 10.1158/0008-5472.CAN-05-3034; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Osorio A, 2007, HUM MUTAT, V28, P477, DOI 10.1002/humu.20470; Ostrow KL, 2004, CANCER GENET CYTOGEN, V153, P177, DOI 10.1016/j.cancergencyto.2004.01.020; Petersen GM, 1998, AM J HUM GENET, V62, P1516, DOI 10.1086/301871; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; TAVTIGIAN SV, 2004, FAM CANCER, V5, P77; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Wu KJ, 2005, CANCER RES, V65, P417; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Zhou X, 2005, J AM STAT ASSOC, V100, P51, DOI 10.1198/016214504000001817	37	349	352	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					873	883		10.1086/521032	http://dx.doi.org/10.1086/521032			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924331	Green Published, Bronze			2022-12-18	WOS:000250480900001
J	Patterson, N; Hattangadi, N; Lane, B; Lohmueller, KE; Hafler, DA; Oksenberg, JR; Hauser, SL; Smith, MW; O'Brien, SJ; Altshuler, D; Daly, MJ; Reich, D				Patterson, N; Hattangadi, N; Lane, B; Lohmueller, KE; Hafler, DA; Oksenberg, JR; Hauser, SL; Smith, MW; O'Brien, SJ; Altshuler, D; Daly, MJ; Reich, D			Methods for high-density admixture mapping of disease genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFRICAN-AMERICAN POPULATION; FACTOR-V-LEIDEN; LINKAGE-DISEQUILIBRIUM; ADMIXED POPULATIONS; MULTIPLE-SCLEROSIS; ADMIRED POPULATIONS; HAPLOTYPE STRUCTURE; ALLELE FREQUENCIES; ETHNIC-DIFFERENCES; ASSOCIATION	Admixture mapping (also known as "mapping by admixture linkage disequilibrium," or MALD) has been proposed as an efficient approach to localizing disease-causing variants that differ in frequency ( because of either drift or selection) between two historically separated populations. Near a disease gene, patient populations descended from the recent mixing of two or more ethnic groups should have an increased probability of inheriting the alleles derived from the ethnic group that carries more disease-susceptibility alleles. The central attraction of admixture mapping is that, since gene flow has occurred recently in modern populations ( e. g., in African and Hispanic Americans in the past 20 generations), it is expected that admixture-generated linkage disequilibrium should extend for many centimorgans. High-resolution marker sets are now becoming available to test this approach, but progress will require ( a) computational methods to infer ancestral origin at each point in the genome and (b) empirical characterization of the general properties of linkage disequilibrium due to admixture. Here we describe statistical methods to estimate the ancestral origin of a locus on the basis of the composite genotypes of linked markers, and we show that this approach accurately estimates states of ancestral origin along the genome. We apply this approach to show that strong admixture linkage disequilibrium extends, on average, for 17 cM in African Americans. Finally, we present power calculations under varying models of disease risk, sample size, and proportions of ancestry. Studying similar to2,500 markers in similar to2,500 patients should provide power to detect many regions contributing to common disease. A particularly important result is that the power of an admixture mapping study to detect a locus will be nearly the same for a wide range of mixture scenarios: the mixture proportion should be 10%-90% from both ancestral populations.	Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lab Mol Immunol, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Georgetown Univ, Washington, DC USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; NCI, Lab Genom Divers, Frederick, MD 21701 USA; Sci Applicat Int Corp, Basic Res Program, Frederick, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Georgetown University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	reich@receptor.med.harvard.edu	Smith, Michael/B-5341-2012; Peng, Bo/A-6920-2009; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Hauser, Stephen L/J-2978-2016; OBRIEN, STEPHEN/ABD-1346-2020	Peng, Bo/0000-0001-8225-2284; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; OBRIEN, STEPHEN/0000-0001-7857-0757	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG002758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER; NHGRI NIH HHS [K01 HG002758, K-01 HG002758-01] Funding Source: Medline; NIAID NIH HHS [U19 AI50864, U19 AI050864] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bickel PJ, 2001, MATH STAT BASIC IDEA, V1; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BRISCOE D, 1994, J HERED, V85, P59; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chen M.H., 2000, MONTE CARLO METHODS; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Crocq MA, 1996, HUM HERED, V46, P58, DOI 10.1159/000154327; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; Durbin R., 1998, BIOL SEQUENCE ANAL P; Falush D, 2003, GENETICS, V164, P1567; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gelman A, 2013, BAYESIAN DATA ANAL; Giallourakis C, 2003, AM J HUM GENET, V73, P205, DOI 10.1086/376417; GILKS WR, 1992, J R STAT SOC C-APPL, V41, P337; GILKS WR, 1995, J R STAT SOC C-APPL, V44, P455, DOI 10.2307/2986138; Gilks WR, 1996, MARKOV CHAIN MONTE C; Halder Indrani, 2003, Human Genomics, V1, P52; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; Lockwood JR, 2001, GENET EPIDEMIOL, V20, P17, DOI 10.1002/1098-2272(200101)20:1<17::AID-GEPI3>3.0.CO;2-Q; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710; Nakajima T, 2002, AM J HUM GENET, V70, P108, DOI 10.1086/338454; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Osei-Hyiaman D, 2001, DIABETES, V50, P2169, DOI 10.2337/diabetes.50.9.2169; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PERMUTT MA, 1990, DIABETES CARE, V13, P364, DOI 10.2337/diacare.13.3.364; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ripley B.D., 1987, STOCHASTIC SIMULATIO; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Risch NJ, 1992, AM J HUM GENET S, V51, P13; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Rotimi C, 1996, HYPERTENSION, V27, P558, DOI 10.1161/01.HYP.27.3.558; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Soldevila Marta, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9157; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; THOMPSON EA, 1991, IMA J MATH APPL MED, V8, P149; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	69	349	372	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					979	1000		10.1086/420871	http://dx.doi.org/10.1086/420871			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15088269	Green Published, Bronze			2022-12-18	WOS:000220926100017
J	Onuchic, LF; Furu, L; Nagasawa, Y; Hou, XY; Eggermann, T; Ren, ZY; Bergmann, C; Senderek, J; Esquivel, E; Zeltner, R; Rudnik-Schoneborn, S; Mrug, M; Sweeney, W; Avner, ED; Zerres, K; Guay-Woodford, LM; Somlo, S; Germino, GG				Onuchic, LF; Furu, L; Nagasawa, Y; Hou, XY; Eggermann, T; Ren, ZY; Bergmann, C; Senderek, J; Esquivel, E; Zeltner, R; Rudnik-Schoneborn, S; Mrug, M; Sweeney, W; Avner, ED; Zerres, K; Guay-Woodford, LM; Somlo, S; Germino, GG			PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; GENOMIC DNA; PREDICTION; 6P21.1-P12; EXCLUSION; CANDIDATE; SEQUENCES; ARPKD	Autosomal recessive polycystic kidney disease (ARPKD) is a severe form of polycystic kidney disease that presents primarily in infancy and childhood and that is characterized by enlarged kidneys and congenital hepatic fibrosis. We have identified PKHD1, the gene mutated in ARPKD. PKHD1 extends over greater than or equal to469 kb, is primarily expressed in human fetal and adult kidney, and includes a minimum of 86 exons that are variably assembled into a number of alternatively spliced transcripts. The longest continuous open reading frame encodes a 4, 074-amino-acid protein, polyductin, that is predicted to have a single transmembrane (TM)-spanning domain near its carboxyl terminus, immunoglobulin-like plexin-transcription-factor domains, and parallel beta-helix 1 repeats in its amino terminus. Several transcripts encode truncated products that lack the TM and that may be secreted if translated. The PKHD1-gene products are members of a novel class of proteins that share structural features with hepatocyte growth-factor receptor and plexins and that belong to a superfamily of proteins involved in regulation of cell proliferation and of cellular adhesion and repulsion.	Johns Hopkins Univ, Sch Med, Div Nephrol, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Genet, Baltimore, MD USA; Univ Sao Paulo, Dept Med, Sao Paulo, Brazil; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Pediat, Birmingham, AL USA; Rhein Westfal TH Aachen, Inst Human Genet, Aachen, Germany; Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Universidade de Sao Paulo; Yale University; Yale University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; RWTH Aachen University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Germino, GG (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, Dept Med, Ross 958,720 Rutland Ave, Baltimore, MD 21205 USA.		Rudnik-Schöneborn, Sabine/F-8473-2015; Senderek, Jan/F-8405-2015; Onuchic, Luiz Fernando/H-1589-2012; Eggermann, Thomas/F-3807-2014	Senderek, Jan/0000-0002-8263-1783; Onuchic, Luiz Fernando/0000-0002-4053-5419; Germino, Gregory/0000-0002-3609-5588	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051259] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK051259, R01 DK51259] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; Cramer P, 1997, EMBO J, V16, P7078, DOI 10.1093/emboj/16.23.7078; EGGERMANN T, 1993, ANN GENET-PARIS, V36, P214; GUAYWOODFORD IM, 1996, POLYCYSTIC KIDNEY DI, P237; GUAYWOODFORD LM, 1995, AM J HUM GENET, V56, P1101; Hofmann Y, 2000, EUR J HUM GENET, V8, P163, DOI 10.1038/sj.ejhg.5200426; Kawaguchi M, 2001, J IMMUNOL, V167, P4430, DOI 10.4049/jimmunol.167.8.4430; Lens XM, 1997, GENOMICS, V41, P463, DOI 10.1006/geno.1997.4671; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mucher G, 1998, GENOMICS, V48, P40, DOI 10.1006/geno.1997.5145; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nicolau C, 2000, J CLIN ULTRASOUND, V28, P277, DOI 10.1002/1097-0096(200007/08)28:6<277::AID-JCU2>3.0.CO;2-L; Onuchic LF, 1999, MAMM GENOME, V10, P1175, DOI 10.1007/s003359901186; ONUCHIC LF, IN PRESS AM J MED GE; Park J, 1999, J HIGH ENERGY PHYS; REUSS A, 1990, ULTRASOUND MED BIOL, V16, P355, DOI 10.1016/0301-5629(90)90065-K; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott DA, 2000, GENE, V246, P265, DOI 10.1016/S0378-1119(00)00090-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Zerres K, 1996, ACTA PAEDIATR, V85, P437, DOI 10.1111/j.1651-2227.1996.tb14056.x; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429; Zerres K, 1998, AM J MED GENET, V76, P137, DOI 10.1002/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q	30	349	369	1	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1305	1317		10.1086/340448	http://dx.doi.org/10.1086/340448			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11898128	Bronze, Green Published			2022-12-18	WOS:000175012400020
J	Noble, JA; Valdes, AM; Cook, M; Klitz, W; Thomson, G; Erlich, HA				Noble, JA; Valdes, AM; Cook, M; Klitz, W; Thomson, G; Erlich, HA			The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONRADIOACTIVE OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN-REACTION; SEQUENCE POLYMORPHISM; AMPLIFIED DNA; A ANTIGENS; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY GENES; DISEASE ASSOCIATIONS; PARENTAL ORIGIN; ALLELES	We report here our analysis of HLA class II alleles in 180 Caucasian nuclear families with at least two children with insulin-dependent diabetes mellitus (IDDM). DRB1, DQA1, DQB1, and DPB1 genotypes were determined with PCR/sequence-specific oligonucleotide probe typing methods. The data allowed unambiguous determination of four-locus haplotypes in all but three of the families, Consistent with other studies, our data indicate an increase in DR3/DR4, DR3/DR3, and DR4/DR4 genotypes in patients compared to controls. In addition, we found an increase in DR1/DR4, DR1/DR3, and DR4/DR8 genotypes. While the frequency of DQB1*0302 on DR4 haplotypes is dramatically increased in DR3/DR4 patients, DR4 haplotypes in DR1/DR4 patients exhibit frequencies of DQB1*0302 and DQB1*0301 more closely resembling those in control populations. The protective effect of DR2 is evident in this data set and is limited to the common DRB1*1501-DQB1*0602 haplotype. Most DR2(+) patients carry the less common DR2 haplotype DRB1*1601-DQB1*0502, which is not decreased in patients relative to controls. DPB1 also appears to play a role in disease susceptibility. DPB1*0301 is increased in patients (P < .001) and may contribute to the disease risk of a number of different DR-DQ haplotypes. DPB1*0101, found almost exclusively on DR3 haplotypes in patients, is slightly increased, and maternal transmissions of DRB1*0301-DPB1*0101 haplotypes to affected children occur twice as frequently as do paternal transmissions. Transmissions of DR3 haplotypes carrying other DPB1 alleles occur at approximately equal maternal and paternal frequencies. The complex, multigenic nature of HLA class II-associated IDDM susceptibility is evident from these data.	CHILDRENS HOSP OAKLAND,RES INST,OAKLAND,CA 94609; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley	Noble, JA (corresponding author), ROCHE MOL SYST,DEPT HUMAN GENET,1145 ATLANTIC AVE,ALAMEDA,CA 94501, USA.			Valdes, Ana M./0000-0003-1141-4471	NIDDK NIH HHS [DK46622, DK46626] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046622, R01DK046626] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AWATA T, 1992, DIABETOLOGIA, V35, P906; AWATA T, 1992, DIABETOLOGIA, V35, P419, DOI 10.1007/BF02342437; BAIN SC, 1994, DIABETES, V43, P1462, DOI 10.2337/diabetes.43.12.1462; BALDUCCISILANO PL, 1995, AUTOIMMUNITY, V21, P13; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BLACKWELDER WC, 1986, GENET EPIDEMIOL, V3, P379; BODMER JG, 1995, TISSUE ANTIGENS, V46, P1; BUGAWAN TL, 1988, J IMMUNOL, V141, P4024; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; BUGAWAN TL, 1991, IMMUNOGENETICS, V34, P413, DOI 10.1007/BF01787493; CAILLATZUCMAN S, 1992, J CLIN INVEST, V90, P2242, DOI 10.1172/JCI116110; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; CUDWORTH AG, 1974, LANCET, V2, P1153; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEKOSTER HS, 1992, EUR J IMMUNOL, V22, P1531, DOI 10.1002/eji.1830220628; DESCHAMPS I, 1990, DIABETOLOGIA, V33, P425, DOI 10.1007/BF00404094; EASTEAL S, 1990, DIABETES, V39, P855, DOI 10.2337/diabetes.39.7.855; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; ERLICH H, 1993, ARCH PATHOL LAB MED, V117, P482; ERLICH HA, 1991, DIABETES, V40, P478, DOI 10.2337/diabetes.40.4.478; ERLICH HA, 1991, BAILLIERE CLIN ENDOC, V5, P395, DOI 10.1016/S0950-351X(05)80138-7; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; ERLICH HA, 1990, DIABETES, V39, P96, DOI 10.2337/diabetes.39.1.96; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; FOHLMAN J, 1993, ANN MED, V25, P569; HARFOUCH E, 1995, AUTOIMMUNITY, V21, P14; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; HORN GT, 1988, HUM IMMUNOL, V21, P249, DOI 10.1016/0198-8859(88)90034-1; HU CY, 1993, HUM IMMUNOL, V38, P105, DOI 10.1016/0198-8859(93)90526-7; Huang HS, 1995, HUM IMMUNOL, V44, P210, DOI 10.1016/0198-8859(95)00108-5; KLITZ W, 1994, AM J HUM GENET, V54, P497; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; LUO DF, 1995, AM J HUM GENET, V57, P911; MARGARITTEJEANNIN P, 1995, AM J HUM GENET, V56, P1080; NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; NERUP J, 1974, LANCET, V2, P864; OWERBACH D, 1989, DIABETES, V38, P942, DOI 10.2337/diabetes.38.7.942; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; PAYAMI H, 1989, AM J HUM GENET, V45, P541; REIJONEN H, 1995, 9 INT C IMM SAN FRAN; RISCH N, 1987, AM J HUM GENET, V40, P1; RONNINGEN KS, 1991, DIABETES, V40, P759, DOI 10.2337/diabetes.40.6.759; ROSENLICHT JW, 1993, IMMUNOGENETICS, V37, P479; ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SCHROEIJERS WEM, 1992, HUM IMMUNOL, V33, P229, DOI 10.1016/0198-8859(92)90329-L; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; TAIT BD, 1988, DIABETES, V37, P926, DOI 10.2337/diabetes.37.7.926; TAIT BD, 1991, BAILLIERE CLIN ENDOC, V5, P211, DOI 10.1016/S0950-351X(05)80124-7; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1995, AM J HUM GENET, V57, P474; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TRUCCO M, 1995, J PEDIATR ENDOCR MET, V8, P3; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; VADHEIM CM, 1986, NEW ENGL J MED, V315, P1314, DOI 10.1056/NEJM198611203152103; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	76	348	359	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1134	1148						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900244				2022-12-18	WOS:A1996VN90000023
J	Easton, D; McGuffog, L; Thompson, D; Dunning, A; Tee, L; Baynes, C; Healey, C; Pharoah, P; Ponder, B; Seal, S; Barfoot, R; Sodha, N; Eeles, R; Stratton, M; Rahman, N; Peto, J; Spurdle, AB; Chen, XQ; Chenevix-Trench, G; Hopper, JL; Giles, GG; McCredie, MRE; Syrjakoski, K; Holli, K; Kallioniemi, O; Eerola, H; Vahteristo, P; Blomqvist, C; Nevanlinna, H; Kataja, V; Mannermaa, A; Dork, T; Bremer, M; Devilee, P; de Bock, GH; Krol-Warmerdam, EMM; Kroese-Jansema, K; Wijers-Koster, P; Cornelisse, CJ; Tollenaar, RAEM; Meijers-Heijboer, H; Berns, E; Nagel, J; Foekens, J; Klijn, JGM; Schutte, M				Easton, D; McGuffog, L; Thompson, D; Dunning, A; Tee, L; Baynes, C; Healey, C; Pharoah, P; Ponder, B; Seal, S; Barfoot, R; Sodha, N; Eeles, R; Stratton, M; Rahman, N; Peto, J; Spurdle, AB; Chen, XQ; Chenevix-Trench, G; Hopper, JL; Giles, GG; McCredie, MRE; Syrjakoski, K; Holli, K; Kallioniemi, O; Eerola, H; Vahteristo, P; Blomqvist, C; Nevanlinna, H; Kataja, V; Mannermaa, A; Dork, T; Bremer, M; Devilee, P; de Bock, GH; Krol-Warmerdam, EMM; Kroese-Jansema, K; Wijers-Koster, P; Cornelisse, CJ; Tollenaar, RAEM; Meijers-Heijboer, H; Berns, E; Nagel, J; Foekens, J; Klijn, JGM; Schutte, M		CHEK2 Breast Canc Case-Control Cons	CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; BRCA2 MUTATIONS; RISK; POPULATION; PENETRANCE; CHECKPOINT; SERIES; WOMEN; CHEK2; GENE	Previous studies of families with multiple cases of breast cancer have indicated that a frameshift alteration in the CHEK2 gene, 1100delC, is associated with an elevated frequency of breast cancer in such families, but the risk associated with the variant in other situations is uncertain. To evaluate the breast cancer risk associated with this variant, 10,860 breast cancer cases and 9,065 controls from 10 case-control studies in five countries were genotyped. CHEK2*1100delC was found in 201 cases (1.9%) and 64 controls (0.7%) (estimated odds ratio 2.34; 95% CI 1.72-3.20; P=.0000001). There was some evidence of a higher prevalence of CHEK2*1100delC among cases with a first-degree relative affected with breast cancer (odds ratio 1.44; 95% CI 0.93-2.23; P=.10) and of a trend for a higher breast cancer odds ratio at younger ages at diagnosis (P=.002). These results confirm that CHEK2*1100delC confers an increased risk of breast cancer and that this risk is apparent in women unselected for family history. The results are consistent with the hypothesis that CHEK2*1100delC multiplies the risks associated with susceptibility alleles in other genes to increase the risk of breast cancer.	Strangeways Res Lab, Canc Res UK, Genet Epidemiol Unit, Cambridge CB1 8RN, England; Canc Res UK, Human Canc Genet Res Grp, Cambridge, England; Inst Canc Res, London SW3 6JB, England; Queensland Inst Med Res, Canc & Cell Biol Div, Brisbane, Qld 4006, Australia; Univ Melbourne, Ctr Genet Epidemiol, Melbourne, Vic, Australia; Tampere Univ, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; VTT Biotechnol, Turku, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00290 Helsinki, Finland; Univ Kuopio, Dept Oncol, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Forens Med, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, SF-70210 Kuopio, Finland; Hannover Med Sch, Dept Biochem & Tumour Biol, Clin Obstet & Gynecol, D-3000 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; QIMR Berghofer Medical Research Institute; University of Melbourne; Tampere University; Tampere University; Tampere University Hospital; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Hannover Medical School; Hannover Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Easton, D (corresponding author), Strangeways Res Lab, Canc Res UK, Genet Epidemiol Unit, Worts Causeway, Cambridge CB1 8RN, England.	douglas@srl.cam.ac.uk	Pharoah, Paul/V-6658-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Dörk, Thilo/J-8620-2012; de Bock, Geertruida Hendrika/F-6529-2014; Rahman, Nazneen/B-8890-2012; DEVILEE, PETER/ABR-2140-2022; Kallioniemi, Olli P/H-5111-2011; Spurdle, Amanda B/A-4978-2011; Rahman, Nazneen/D-2802-2013	Pharoah, Paul/0000-0001-8494-732X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Dörk, Thilo/0000-0002-9458-0282; de Bock, Geertruida Hendrika/0000-0003-3104-4471; Kallioniemi, Olli P/0000-0002-3231-0332; Spurdle, Amanda B/0000-0003-1337-7897; Rahman, Nazneen/0000-0003-4376-0440; Dunning, Alison Margaret/0000-0001-6651-7166				Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; BERNS EMJJ, 1992, EUR J CANCER, V28A, P697, DOI 10.1016/S0959-8049(05)80129-7; Chang-Claude J, 2000, CANCER CAUSE CONTROL, V11, P687, DOI 10.1023/A:1008907901087; Chehab NH, 2000, GENE DEV, V14, P278; Day N, 1999, BRIT J CANCER, V80, P95; Dork T, 2001, CANCER RES, V61, P7608; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Hopper J L, 1999, J Natl Cancer Inst Monogr, P95; KILPIVAARA O, IN PRESS INT J CANC; Kuschel B, 2003, CANCER EPIDEM BIOMAR, V12, P809; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Mitrunen K, 2001, CANCER EPIDEM BIOMAR, V10, P635; Neuhausen S, 2004, INT J CANCER, V108, P477, DOI 10.1002/ijc.11385; Offit Kenneth, 2003, BMC Med Genet, V4, P1, DOI 10.1186/1471-2350-4-1; Osorio A, 2004, INT J CANCER, V108, P54, DOI 10.1002/ijc.11414; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Spurdle AB, 2002, CANCER EPIDEM BIOMAR, V11, P439; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vahteristo P, 2001, CANCER RES, V61, P5718; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	29	347	358	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1175	1182						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15122511	Green Published, Bronze			2022-12-18	WOS:000221651900010
J	BELLUS, GA; HEFFERON, TW; DELUNA, RIO; HECHT, JT; HORTON, WA; MACHADO, M; KAITILA, I; MCINTOSH, I; FRANCOMANO, CA				BELLUS, GA; HEFFERON, TW; DELUNA, RIO; HECHT, JT; HORTON, WA; MACHADO, M; KAITILA, I; MCINTOSH, I; FRANCOMANO, CA			ACHONDROPLASIA IS DEFINED BY RECURRENT G380R MUTATIONS OF FGFR3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE CONVERSION; GLOBIN GENE; HOMOZYGOUS ACHONDROPLASIA; POINT MUTATIONS; HEMOPHILIA-A; DISEASE; HYPOCHONDROPLASIA; TRANSITIONS; FREQUENCY; FAMILY	Genomic DNA from 154 unrelated individuals with achondroplasia was evaluated for mutations in the fibroblast growth factor receptor 3 (FGFR3) transmembrane domain. AU but one, an atypical case, were found to have a glycine-to-arginine substitution at codon 380. Of these, 150 had a G-to-A transition at nt 1138, and 3 had a G-to-C transversion at this same position. On the basis of estimates of the prevalence of achondroplasia, the mutation rate at the FGFR3 1138 guanosine nucleotide is two to three orders of magnitude higher than that previously reported for tranversions and transitions in CpG dinucleotides. To date, this represents the most mutable single nucleotide reported in the human genome. The homogeneity of mutations in achondroplasia is unprecedented for an autosomal dominant disorder and may explain the relative lack of heterogeneity in the achondroplasia phenotype.	NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892; HOSP INFANTIL MEXICO FED GOMEZ,DEPT GENET,MEXICO CITY,DF,MEXICO; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX; SHRINERS HOSP CRIPPLED CHILDRENS,DEPT RES,PORTLAND,OR 97201; HELSINKI UNIV HOSP,DEPT CLIN GENET,HELSINKI,FINLAND	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hospital Infantil de Mexico Federico Gomez; Johns Hopkins University; University of Texas System; University of Helsinki; Helsinki University Central Hospital				Bellus, Gary/0000-0001-7492-3324	NHGRI NIH HHS [P01HG00373] Funding Source: Medline; NIAMS NIH HHS [R01AR41135] Funding Source: Medline; NICHD NIH HHS [R01HD20691] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020691] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; ANDERSEN PE, 1989, J MED GENET, V27, P37; BRAUN L, 1990, J EXP MED, V171, P129, DOI 10.1084/jem.171.1.129; BULLOCK P, 1985, SCIENCE, V230, P954, DOI 10.1126/science.2997924; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; COLLIER S, 1993, NAT GENET, V3, P260, DOI 10.1038/ng0393-260; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COOPER DN, IN PRESS METABOLIC M; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GARDNER RJM, 1977, CLIN GENET, V11, P31; Gorlin RJ, 1990, PLAST RECONSTR SURG; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; GRUNDY CB, 1992, HUM GENET, V88, P586, DOI 10.1007/BF00219350; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; HECHT JT, 1987, AM J HUM GENET, V41, P454; HECHT JT, 1986, EUR J PEDIATR, V145, P545, DOI 10.1007/BF02429060; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LANGER LO, 1967, AMER J ROENTGENOL RA, V100, P12, DOI 10.2214/ajr.100.1.12; LEMERRER M, 1994, NAT GENET, V6, P318; LOUX N, 1991, HUM GENET, V87, P373; Lyons Jones K., 1988, SMITHS RECOGNIZABLE; MATSUNO Y, 1992, HUM GENET, V88, P357, DOI 10.1007/BF00197277; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MEUNKE M, 1994, NAT GENET, V8, P269; MURDOCH JL, 1970, ANN HUM GENET, V33, P227, DOI 10.1111/j.1469-1809.1970.tb01648.x; NELSON FW, 1988, ANN NEUROL, V24, P89, DOI 10.1002/ana.410240117; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OKANO Y, 1990, AM J HUM GENET, V46, P919; PARTANEN J, 1993, PHILOS T R SOC B, V340, P297, DOI 10.1098/rstb.1993.0071; PATTINSON JK, 1990, BLOOD, V76, P2242; PAULI RM, 1983, AM J MED GENET, V16, P459, DOI 10.1002/ajmg.1320160404; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; REISS J, 1991, HUM GENET, V87, P457; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SORGE J, 1990, J CLIN INVEST, V86, P1137, DOI 10.1172/JCI114818; STEINBERG RA, 1992, MOL CELL BIOL, V12, P767, DOI 10.1128/MCB.12.2.767; STOLL C, 1989, CLIN GENET, V35, P88; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; URABE K, 1990, AM J HUM GENET, V46, P1178; URIOSTE M, 1994, NAT GENET, V6, P334, DOI 10.1038/ng0494-334; VELINOV M, 1994, NAT GENET, V6, P312; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	52	346	377	0	18	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					368	373						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847369				2022-12-18	WOS:A1995QF42300002
J	VERGNAUD, G; PAGE, DC; SIMMLER, MC; BROWN, L; ROUYER, F; NOEL, B; BOTSTEIN, D; DELACHAPELLE, A; WEISSENBACH, J				VERGNAUD, G; PAGE, DC; SIMMLER, MC; BROWN, L; ROUYER, F; NOEL, B; BOTSTEIN, D; DELACHAPELLE, A; WEISSENBACH, J			A DELETION MAP OF THE HUMAN Y-CHROMOSOME BASED ON DNA HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; CTR TRANSFUS SANGUINE, F-73100 CHAMBERY, FRANCE; UNIV HELSINKI, DEPT MED GENET, SF-00290 HELSINKI 29, FINLAND	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Helsinki	VERGNAUD, G (corresponding author), INST PASTEUR, CNRS LAB 271, INSERM U163, UNITE RECOMBINAISON EXPRESS GENET, F-75724 PARIS 15, FRANCE.		Rouyer, François/L-9043-2018; Vergnaud, Gilles/P-1304-2015	Rouyer, François/0000-0001-5641-397X; Vergnaud, Gilles/0000-0003-0913-194X				ALVESALO L, 1981, ANN HUM GENET, V45, P49, DOI 10.1111/j.1469-1809.1981.tb00305.x; BERNHEIM A, 1983, P NATL ACAD SCI-BIOL, V80, P7571, DOI 10.1073/pnas.80.24.7571; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BOSTOCK CJ, 1978, NATURE, V272, P324, DOI 10.1038/272324a0; BUHLER EM, 1980, HUM GENET, V55, P145, DOI 10.1007/BF00291764; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; CHAPELLE ADL, 1978, CELL, V15, P837, DOI 10.1016/0092-8674(78)90268-4; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; COOKE HJ, 1984, NATURE, V311, P259, DOI 10.1038/311259a0; COOKE HJ, 1979, HUM GENET, V50, P39, DOI 10.1007/BF00295587; DAVIS RM, 1981, J MED GENET, V18, P161, DOI 10.1136/jmg.18.3.161; DELACHAPELLE A, 1984, NATURE, V307, P170, DOI 10.1038/307170a0; DELACHAPELLE A, 1964, ACTA MED SCAND, V175, P25; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; DELACHAPELLE A, 1984, ASPECTS HUMAN GENETI, P125; FERGUSONSMITH MA, 1966, LANCET, V2, P475; GELDWERTH D, 1985, EMBO J, V4, P1739, DOI 10.1002/j.1460-2075.1985.tb03844.x; GOODFELLOW P, 1983, NATURE, V302, P346, DOI 10.1038/302346a0; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; KINROSS J, 1978, CYTOGENET CELL GENET, V20, P59, DOI 10.1159/000130840; KOENIG M, 1984, NUCLEIC ACIDS RES, V12, P4097, DOI 10.1093/nar/12.10.4097; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KUNKEL LM, 1983, NUCLEIC ACIDS RES, V11, P7961, DOI 10.1093/nar/11.22.7961; LAMAR EE, 1984, CELL, V37, P171, DOI 10.1016/0092-8674(84)90312-X; MCKAY RDG, 1978, CYTOGENET CELL GENET, V21, P19, DOI 10.1159/000130875; McKusick V.A., 1983, MENDELIAN INHERITANC; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; MORTON NE, 1957, AM J HUM GENET, V9, P55; MOSES MJ, 1975, SCIENCE, V187, P363, DOI 10.1126/science.1111110; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAGE DC, 1984, AM J HUM GENET, V36, P565; PAGE DC, 1985, NATURE, V315, P224, DOI 10.1038/315224a0; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Polani P. E., 1981, MECHANISMS SEX DIFFE, P465; RODERICK TH, 1984, GENETIC MAPS, V3, P343; SCHMIDTKE J, 1980, HUM GENET, V55, P255, DOI 10.1007/BF00291774; SIEBERS JW, 1973, HUMANGENETIK, V19, P57, DOI 10.1007/BF00295235; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SOLARI AJ, 1980, CHROMOSOMA, V81, P315, DOI 10.1007/BF00368145; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VERGNAUD G, 1984, BRIT MED J, V289, P73, DOI 10.1136/bmj.289.6437.73; WOLFE J, 1984, ANN HUM GENET, V48, P253, DOI 10.1111/j.1469-1809.1984.tb01022.x; WOLFE J, 1984, EMBO J, V3, P1997, DOI 10.1002/j.1460-2075.1984.tb02081.x	46	346	355	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					109	124						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3004206				2022-12-18	WOS:A1986A311100001
J	Bryc, K; Durand, EY; Macpherson, JM; Reich, D; Mountain, JL				Bryc, Katarzyna; Durand, Eric Y.; Macpherson, J. Michael; Reich, David; Mountain, Joanna L.			The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; POPULATION-STRUCTURE; ADMIXTURE PROPORTIONS; CAUCASIAN GENES; LOCAL-ANCESTRY; SOUTH-CAROLINA; WIDE PATTERNS; NEGROES; INFERENCE; SELECTION	Over the past 500 years, North America has been the site of ongoing mixing of Native Americans, European settlers, and Africans (brought largely by the trans-Atlantic slave trade), shaping the early history of what became the United States. We studied the genetic ancestry of 5,269 self-described African Americans, 8,663 Latinos, and 148,789 European Americans who are 23andMe customers and show that the legacy of these historical interactions is visible in the genetic ancestry of present-day Americans. We document pervasive mixed ancestry and asymmetrical male and female ancestry contributions in all groups studied. We show that regional ancestry differences reflect historical events, such as early Spanish colonization, waves of immigration from many regions of Europe, and forced relocation of Native Americans within the US. This study sheds light on the fine-scale differences in ancestry within and across the United States and informs our understanding of the relationship between racial and ethnic identities and genetic ancestry.	[Bryc, Katarzyna; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Bryc, Katarzyna; Durand, Eric Y.; Mountain, Joanna L.] 23 & Me Inc, Mountain View, CA 94043 USA; [Macpherson, J. Michael] Chapman Univ, Sch Computat Sci, Orange, CA 92866 USA; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Chapman University System; Chapman University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bryc, K (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kbryc@23andme.com			NIH [2R44HG006981-02, GM100233]; NSF HOMINID [BCS-1032255]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF HOMINID; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the customers of 23andMe who answered surveys and participated in this research. We are grateful to Dr. Jeffrey C. Long at the University of New Mexico, Dr. Claudio Saunt at the University of Georgia, and Sarah Abel at Centre International des Recherches sur les Esclavages, CNRS, Paris for invaluable discussions and comments on a manuscript draft. We thank Nick Patterson and Priya Moorjani for helpful statistical discussions on f statistics. Of course, all mistakes and inaccuracies are our own. Thanks to all the employees of 23andMe, who together have made this research possible, especially Emma Pierson, Robin Smith, Youna Hu, and Scott Hadly. K.B., E.Y.D., and J.L.M. are current employees (and J.M.M. is a former employee) of 23andMe, Inc., and have private equity interest. This work was supported by NIH award 2R44HG006981-02. D.R. was supported by NSF HOMINID award BCS-1032255 and NIH grant GM100233, and D.R. is a Howard Hughes Medical Institute investigator.	ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad M, 2007, CURR OPIN PEDIATR, V19, P613, DOI 10.1097/MOP.0b013e3282f163ca; BLUMBERG BS, 1971, P NATL ACAD SCI USA, V68, P2554, DOI 10.1073/pnas.68.10.2554; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Broyard Bliss, 2007, ONE DROP MY FATHERS; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burma JH, 1946, AM J SOCIOL, V52, P18, DOI 10.1086/219915; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Chakraborty R., 1986, AM J PHYS ANTHROPOL, V29, P1; Davis F. James, 2001, WHO IS BLACK ONE NAT; Dipierri JE, 1998, HUM BIOL, V70, P1001; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Durand E.Y., 2014, ANCESTRY COMPOSITION; Durand EY, 2014, MOL BIOL EVOL, V31, P2212, DOI 10.1093/molbev/msu151; Eriksson N., 2012, FLAVOUR, V1, P22, DOI [10.1186/2044-7248-1-22, DOI 10.1186/2044-7248-1-22]; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fredrickson George, 1982, WHITE SUPREMACY COMP; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; Gonzalez-Andrade F, 2007, HUM BIOL, V79, P51, DOI 10.1353/hub.2007.0024; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Green L, 1978, CHOCTAW REMOVAL REAL, P8; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Halder I, 2009, HUM MUTAT, V30, P1299, DOI 10.1002/humu.21045; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Klimentidis YC, 2009, AM J PHYS ANTHROPOL, V138, P375, DOI 10.1002/ajpa.20945; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lao O, 2010, HUM MUTAT, V31, pE1875, DOI 10.1002/humu.21366; Lemann N., 2011, PROMISED LAND GREAT; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parra EJ, 2007, PHARMACOGENOMICS ADM, P28; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perez AD, 2009, POPUL DEV REV, V35, P1, DOI 10.1111/j.1728-4457.2009.00260.x; Piersen William Dillon, 1996, AFRICA AM AFRICAN AM; POLLITZE.WS, 1964, HUM BIOL, V36, P362; POLLITZER WS, 1993, HIST METHOD, V26, P53, DOI 10.1080/01615440.1993.10594217; POLLITZER WS, 1970, HUM BIOL, V42, P265; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; ROBERTS D. F., 1962, AMER JOUR HUMAN GENET, V14, P261; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Sans M, 2000, HUM BIOL, V72, P155; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; Shriner Daniel, 2013, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0123s76; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Suarez-Kurtz G, 2009, CAD SAUDE PUBLICA, V25, P1650, DOI 10.1590/S0102-311X2009000800001; Sykes B., 2012, DNA USA GENETIC PORT; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; Via M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016513; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wells S.J., 2004, AFTER REMOVAL CHOCTA; Williamson Joel, 1980, NEW PEOPLE MISCEGENA; WORKMAN PL, 1963, AM J HUM GENET, V15, P429; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141	81	345	349	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					37	53		10.1016/j.ajhg.2014.11.010	http://dx.doi.org/10.1016/j.ajhg.2014.11.010			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AY6YE	25529636	Green Published, hybrid			2022-12-18	WOS:000347707800003
J	Klaver, CCW; Kliffen, M; van Duijn, CM; Hofman, A; Cruts, M; Grobbee, DE; van Broeckhoven, C; de Jong, PTVM				Klaver, CCW; Kliffen, M; van Duijn, CM; Hofman, A; Cruts, M; Grobbee, DE; van Broeckhoven, C; de Jong, PTVM			Genetic association of apolipoprotein E with age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; CREUTZFELDT-JAKOB-DISEASE; PERIPHERIN/RDS GENE; ALZHEIMERS-DISEASE; CHOLESTEROL TRANSPORT; RETINITIS-PIGMENTOSA; RETINAL DYSTROPHY; PATTERN DYSTROPHY; E POLYMORPHISM; VISUAL-ACUITY	Age-related macular degeneration (AMD) is the most common geriatric eye disorder leading to blindness and is characterized by degeneration of the neuroepithelium in the macular area of the eye. Apolipoprotein E (apoE), the major apolipoprotein of the CNS and an important regulator of cholesterol and lipid transport, appears to be associated with neurodegeneration. The apoE gene (APOE) polymorphism is a strong risk factor for various neurodegenerative diseases, and the apoE protein has been demonstrated in disease-associated lesions of these disorders. Hypothesizing that variants of APOE act as a potential risk factor for AMD, we performed a genetic-association study among 88 AMD cases and 901 controls derived from the population-based Rotterdam Study in the Netherlands. The APOE polymorphism showed a significant association with the risk for AMD; the APOE epsilon 4 allele was associated with a decreased risk (odds ratio 0.43 [95% confidence interval 0.21-0.88]), and the epsilon 2 allele was associated with a slightly increased risk of AMD (odds ratio 1.5 [95% confidence interval 0.8-2.82]). To investigate whether apoE is directly involved in the pathogenesis of AMD, we studied apoE immunoreactivity in 15 AMD and 10 control maculae and found that apoE staining was consistently present in the disease-associated deposits in AMD-maculae-that is, drusen and basal laminar deposit. Our results suggest that APOE is a susceptibility gene for AMD.	Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Sch Med, Dept Ophthalmol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Sch Med, Dept Pathol, NL-3000 DR Rotterdam, Netherlands; Univ Antwerp VIB, Born Bunge Fdn, Neurogenet Lab, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Biochem, B-2020 Antwerp, Belgium; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam	de Jong, PTVM (corresponding author), Box 12141, NL-1100 AC Amsterdam, Netherlands.	dejong@epib.fgg.eur.nl	Klaver, Caroline C.W./A-2013-2016; Grobbee, Diederick/C-7651-2014; Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017	Grobbee, Diederick/0000-0003-4472-4468; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Klaver, Caroline/0000-0002-2355-5258				AlChalabi A, 1996, LANCET, V347, P159, DOI 10.1016/S0140-6736(96)90343-8; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Amaratunga A, 1996, J BIOL CHEM, V271, P5628, DOI 10.1074/jbc.271.10.5628; AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Gregory CY, 1996, HUM MOL GENET, V5, P1055, DOI 10.1093/hmg/5.7.1055; GRINDLE CFJ, 1978, T OPHTHAL SOC UK, V98, P172; Guillaume D, 1996, J NEUROCHEM, V66, P2410; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hoyng CB, 1996, AM J OPHTHALMOL, V121, P623, DOI 10.1016/S0002-9394(14)70627-0; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; KEEN TJ, 1994, HUM MOL GENET, V3, P367, DOI 10.1093/hmg/3.2.367; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; KLAVER CCW, 1997, INVEST OPHTH VIS SCI, V38, pS967; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Kliffen M, 1997, MICROSC RES TECHNIQ, V36, P106, DOI 10.1002/(SICI)1097-0029(19970115)36:2<106::AID-JEMT4>3.3.CO;2-E; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Kuhrt H, 1997, J BRAIN RES, V38, P223; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; NAKAZAWA M, 1994, HUM MOL GENET, V3, P1195, DOI 10.1093/hmg/3.7.1195; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Poirier J, 1995, ANN MED, V27, P663, DOI 10.3109/07853899509019253; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SMALL KW, 1992, GENOMICS, V13, P681, DOI 10.1016/0888-7543(92)90141-E; Small KW, 1996, AM J OPHTHALMOL, V121, P13, DOI 10.1016/S0002-9394(14)70529-X; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; UTERMANN G, 1985, ADV EXP MED BIOL, V183, P173; VANDERSCHAFT TL, 1992, OPHTHALMOLOGY, V99, P278; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C	54	345	365	0	17	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					200	206		10.1086/301901	http://dx.doi.org/10.1086/301901			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634502	Green Published, Bronze			2022-12-18	WOS:000074761000028
J	Han, B; Eskin, E				Han, Buhm; Eskin, Eleazar			Random-Effects Model Aimed at Discovering Associations in Meta-Analysis of Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; HETEROGENEITY; RISK; REPLICATION; UNCERTAINTY; RATIO	Meta-analysis is an increasingly popular tool for combining multiple different genome-wide association studies (GWASs) in a single aggregate analysis in order to identify associations with very small effect sizes. Because the data of a meta-analysis can be heterogeneous, referring to the differences in effect sizes between the collected studies, what is often done in the literature is to apply both the fixed-effects model (FE) under an assumption of the same effect size between studies and the random-effects model (RE) under an assumption of varying effect size between studies. However, surprisingly, RE gives less significant p values than FE at variants that actually show varying effect sizes between studies. This is ironic because RE is designed specifically for the case in which there is heterogeneity. As a result, usually, RE does not discover any associations that FE did not discover. In this paper, we show that the underlying reason for this phenomenon is that RE implicitly assumes a markedly conservative null-hypothesis model, and we present a new random-effects model that relaxes the conservative assumption. Unlike the traditional RE, the new method is shown to achieve higher statistical power than FE when there is heterogeneity, indicating that the new method has practical utility for discovering associations in the meta-analysis of GWASs.	[Han, Buhm; Eskin, Eleazar] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Eskin, Eleazar] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eskin, E (corresponding author), Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA.	eeskin@cs.ucla.edu	Han, Buhm/AAQ-9672-2020; Eskin, Eleazar/J-9187-2012	Eskin, Eleazar/0000-0003-1149-4758	National Science Foundation [0513612, 0731455, 0729049, 0916676]; National Institutes of Health [K25-HL080079, U01-DA024417]; Samsung; National Toxicology Program [N01-ES-45530]; National Institute of Environmental Health Sciences to Perlegen Sciences; Direct For Computer & Info Scie & Enginr [0916676] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL080079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung(Samsung); National Toxicology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences to Perlegen Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	B.H. and E.E. are supported by National Science Foundation grants 0513612, 0731455, 0729049, and 0916676 and National Institutes of Health grants K25-HL080079 and U01-DA024417. B.H. is supported by the Samsung Scholarship. This research was supported in part by the University of California, Los Angeles subcontract of contract N01-ES-45530 from the National Toxicology Program and National Institute of Environmental Health Sciences to Perlegen Sciences.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barroso I, 2008, DIABETES, V57, P3161, DOI 10.2337/db08-0719; Biggerstaff BJ, 1997, STAT MED, V16, P753, DOI 10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G; BIRCH MW, 1964, J ROY STAT SOC B, V26, P313; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Field AP, 2003, UNDERSTANDING STAT, V2, P77, DOI [10.1207/s15328031us0202_02, DOI 10.1207/S15328031US0202_02]; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Lebrec JJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1503; Lee KJ, 2008, STAT MED, V27, P418, DOI 10.1002/sim.2897; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Tang H, 2006, NAT GENET, V38, P13, DOI 10.1038/ng0106-13; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wasserman L., 2003, ALL STAT CONCISE COU; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	50	344	345	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					586	598		10.1016/j.ajhg.2011.04.014	http://dx.doi.org/10.1016/j.ajhg.2011.04.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21565292	Bronze, Green Published			2022-12-18	WOS:000290832100006
J	Chen, CC; Lu, RB; Chen, YC; Wang, MF; Chang, YC; Li, TK; Yin, SJ				Chen, CC; Lu, RB; Chen, YC; Wang, MF; Chang, YC; Li, TK; Yin, SJ			Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; DIAGNOSTIC INTERVIEW SCHEDULE; HUMAN-LIVER; KINETIC CHARACTERIZATION; JAPANESE ALCOHOLICS; ATAYAL NATIVES; GENOTYPES; ALLELE; ALDH2; CHINESE	The genes that encode the major enzymes of alcohol metabolism, alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), exhibit functional polymorphism. The variant alleles ADH2*2 and ADH3*1, which encode high-activity ADH isoforms, and the ALDH2*2 allele, which encodes the low-activity form of ALDH2, protect against alcoholism in East Asians. To investigate possible interactions among these protective genes, we genotyped 340 alcoholic and 545 control Han Chinese living in Taiwan at the ADH2, ADH3, and ALDH2 loci. After the influence of ALDH2*2 was controlled for, multiple logistic regression analysis indicated that allelic variation at ADH3 exerts no significant effect on the risk of alcoholism. This can be accounted for by linkage disequlibrium between ADH3*1 and ADH2*2 ALDH2*2 homozygosity, regardless of the ADH2 genotypes, was fully protective against alcoholism; no individual showing such homozygosity was found among the alcoholics. Logistic regression analyses of the remaining six combinatorial genotypes of the polymorphic ADH2 and ALDH2 loci indicated that individuals carrying one or two copies of ADH2*2 and a single copy of ALDH2*2 had the lowest risk (ORs 0.04-0.05) for alcoholism, as compared with the ADH2*1/*1 and ALDH2*1/*1 genotype. The disease risk associated with the ADH2*2/*2-ALDH2*1/*1 genotype appeared to be about half of that associated with the ADH2*2/*2-ALDH2*1/*1 genotype. The results suggest that protection afforded by the ADH2*2 allele may be independent of that afforded by ALDH2*2.	Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; Natl Def Med Ctr, Grad Inst Med Sci, Taipei 10764, Taiwan; Taipei City Psychiat Ctr, Dept Adult Psychiat, Taipei, Taiwan; Taipei Med Coll, Dept Psychiat, Taipei, Taiwan; Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan; Tamkang Univ, Dept Math, Tamsui, Taiwan; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	National Defense Medical Center; National Defense Medical Center; Taipei Medical University; Tri-Service General Hospital; Tamkang University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Yin, SJ (corresponding author), Natl Def Med Ctr, Dept Biochem, POB 90048, Taipei 10764, Taiwan.	yinsj@tpts5.seed.net.tw			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA007611, P50AA007611, R37AA002342, R01AA002342] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA02342, AA07611] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AGARWAL DP, 1992, PHARMACOGENETICS, V2, P48, DOI 10.1097/00008571-199204000-00002; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017; BURNELL JC, 1989, BIOCHEMISTRY-US, V28, P6810, DOI 10.1021/bi00443a005; Carr LG, 1996, ALCOHOL CLIN EXP RES, V20, P43, DOI 10.1111/j.1530-0277.1996.tb01041.x; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chen WJ, 1997, BIOL PSYCHIAT, V41, P703, DOI 10.1016/S0006-3223(96)00072-8; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CONSALVI V, 1986, BIOCHEM BIOPH RES CO, V139, P1009, DOI 10.1016/S0006-291X(86)80278-9; COUZIGOU P, 1990, ALCOHOL ALCOHOLISM, V25, P623, DOI 10.1093/oxfordjournals.alcalc.a045058; Crabb D, 1995, GENETICS ALCOHOLISM, P202; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; DANDRE F, 1995, MOL CELL PROBE, V9, P189, DOI 10.1006/mcpr.1995.0030; EDENBERG HJ, 1997, COMPREHENSIVE TOXICO, V3, P119; EDMAN K, 1992, HUM GENET, V90, P395; EKLUND H, 1987, EUR J BIOCHEM, V167, P185, DOI 10.1111/j.1432-1033.1987.tb13322.x; FARRES J, 1994, J BIOL CHEM, V269, P13854; GILDER FJ, 1993, ADDICTION, V88, P383, DOI 10.1111/j.1360-0443.1993.tb00825.x; Goldman D, 1993, Recent Dev Alcohol, V11, P231; Han CL, 1998, EUR J BIOCHEM, V254, P25, DOI 10.1046/j.1432-1327.1998.2540025.x; HARADA S, 1981, LANCET, V2, P982; HELZER JE, 1990, ARCH GEN PSYCHIAT, V47, P313; Higuchi S, 1996, HUM GENET, V97, P431; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; HSU LC, 1986, AM J HUM GENET, V38, P641; HURLEY TD, 1994, J MOL BIOL, V239, P415, DOI 10.1006/jmbi.1994.1382; HWU HG, 1990, ACTA PSYCHIAT SCAND, V82, P374, DOI 10.1111/j.1600-0447.1990.tb01404.x; IWAHASHI K, 1995, ALCOHOL CLIN EXP RES, V19, P564, DOI 10.1111/j.1530-0277.1995.tb01549.x; JORNVALL H, 1995, ALCOHOL ALCOHOLISM, V30, P153; Kalant H., 1996, PHARM ALCOHOL ALCOHO, P15; LI TK, 1977, P NATL ACAD SCI USA, V74, P4378, DOI 10.1073/pnas.74.10.4378; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; MARDH G, 1985, P NATL ACAD SCI USA, V82, P4979, DOI 10.1073/pnas.82.15.4979; MARDH G, 1986, P NATL ACAD SCI USA, V83, P8908, DOI 10.1073/pnas.83.23.8908; MARDH G, 1986, BIOCHEMISTRY-US, V25, P7279, DOI 10.1021/bi00371a005; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; MIZOI Y, 1979, PHARMACOL BIOCHEM BE, V10, P303, DOI 10.1016/0091-3057(79)90105-9; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Nielsen DA, 1998, ARCH GEN PSYCHIAT, V55, P593, DOI 10.1001/archpsyc.55.7.593; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; PARES X, 1994, ALCOHOL ALCOHOLISM, V29, P701; PENG GS, IN PRESS PHARMACOGEN; PIETRUSZKO R, 1983, ISOZYMES-CURR T BIOL, V8, P195; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; SELLERS EM, 1981, NEW ENGL J MED, V305, P1255; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; SINGH S, 1989, HUM GENET, V83, P119, DOI 10.1007/BF00286702; SMITH M, 1986, ADV HUM GENET, V15, P249; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; STONE CL, 1993, J BIOL CHEM, V268, P892; SVENSSON S, 1999, EUR J BIOCHEM, V261, P1; TAKASE S, 1989, HEPATOLOGY, V9, P704, DOI 10.1002/hep.1840090508; Tanaka F, 1997, ALCOHOL CLIN EXP RES, V21, P596, DOI 10.1111/j.1530-0277.1997.tb03808.x; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Valdes AM, 1997, AM J HUM GENET, V60, P703; Wang XP, 1996, J BIOL CHEM, V271, P31172, DOI 10.1074/jbc.271.49.31172; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; Xiao Q, 1996, J CLIN INVEST, V98, P2027, DOI 10.1172/JCI119007; XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272; YASUNAMI M, 1990, GENOMICS, V7, P152, DOI 10.1016/0888-7543(90)90535-3; YIN SJ, 1995, ADV EXP MED BIOL, V372, P9; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; YIN SJ, 1994, ALCOHOL ALCOHOL S2, V29, P113; YIN SJ, 1994, ADV EXP MED BIOL, V463, P265; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; YOSHIDA A, 1983, AM J HUM GENET, V35, P1107; Zimatkin SM, 1997, ADDICT BIOL, V2, P387, DOI 10.1080/13556219772444	76	343	355	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					795	807		10.1086/302540	http://dx.doi.org/10.1086/302540			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441588	Green Published, Bronze			2022-12-18	WOS:000082426400026
J	Onoufriadis, A; Simpson, MA; Pink, AE; Di Meglio, P; Smith, CH; Pullabhatla, V; Knight, J; Spain, SL; Nestle, FO; Burden, AD; Capon, F; Trembath, RC; Barker, JN				Onoufriadis, Alexandros; Simpson, Michael A.; Pink, Andrew E.; Di Meglio, Paola; Smith, Catherine H.; Pullabhatla, Venu; Knight, Jo; Spain, Sarah L.; Nestle, Frank O.; Burden, A. David; Capon, Francesca; Trembath, Richard C.; Barker, Jonathan N.			Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERLEUKIN-1-RECEPTOR ANTAGONIST; AUTOINFLAMMATORY DISEASE; SUSCEPTIBILITY; ARTHRITIS; VARIANTS	Generalized pustular psoriasis (GPP) is a rare and yet potentially lethal clinical variant of psoriasis, characterized by the formation of sterile cutaneous pustules, neutrophilia, fever and features of systemic inflammation. We sequenced the exomes of five unrelated individuals diagnosed with GPP. Nonsynonymous, splice-site, insertion, and deletion variants with an estimated population frequency of <0.01 were considered as candidate pathogenic mutations. A homozygous c.338C>T (p.Ser113Leu) missense substitution of IL36RN was identified in two individuals, with a third subject found to be a compound heterozygote for c.338C>T (p.Ser113Leu) and a c.142C>T (p.Arg48Trp) missense substitution. IL36RN (previously known as IL1F5) encodes an IL-1 family receptor antagonist, which opposes the activity of the IL-36A and IL-36G innate cytokines. Homology searches revealed that GPP mutations alter evolutionarily conserved residues. Homozygosity for the c.338C>T (p.Ser113Leu) variant is associated with an elevated proinflamrnatory response following ex vivo stimulation with IL36A. These findings suggest loss of function of IL36RN as the genetic basis of GPP and implicate innate immune dysregulation in this severe episodic inflammatory disease, thereby highlighting IL-1 signaling as a potential target for therapeutic intervention.	[Onoufriadis, Alexandros; Simpson, Michael A.; Pullabhatla, Venu; Knight, Jo; Spain, Sarah L.; Capon, Francesca; Trembath, Richard C.] Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England; [Pink, Andrew E.; Di Meglio, Paola; Smith, Catherine H.; Nestle, Frank O.; Barker, Jonathan N.] Kings Coll London, Sch Med, Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England; [Burden, A. David] Univ Glasgow, Dept Dermatol, Glasgow G11 6NT, Lanark, Scotland	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Glasgow	Trembath, RC (corresponding author), Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England.	richard.trembath@kcl.ac.uk; jonathan.barker@kcl.ac.uk	Smith, Catherine H./G-5268-2012; Knight, Jo/F-4946-2011; Capon, Francesca/F-4763-2011; Simpson, Michael/F-4737-2011; Spain, Sarah/G-1968-2010	Smith, Catherine H./0000-0001-9918-1144; Capon, Francesca/0000-0003-2432-5793; Simpson, Michael/0000-0002-8539-8753; Pink, Andrew/0000-0001-5151-5539; Spain, Sarah/0000-0002-7591-8364; Knight, Joanne/0000-0002-7148-1660; Trembath, Richard/0000-0003-0550-3400; Di Meglio, Paola/0000-0002-2066-7780; Barker, Jonathan/0000-0002-9030-183X	MRC [G0601387]; Wellcome Trust [GR07873MA]; British Skin Foundation [1006]; The Generation Trust; MRC/BAD/BSF; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Guy's & St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Medical Research Council [G0601387, G0600698B, G1000342] Funding Source: researchfish; National Institute for Health Research [ACF-2008-17-009, NF-SI-0507-10379] Funding Source: researchfish; MRC [G1000342] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); British Skin Foundation; The Generation Trust; MRC/BAD/BSF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)US-Israel Binational Science Foundation); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's & St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors express their gratitude to the families for participating in this study. This work was supported by an MRC Programme grant to R.C.T., F.O.N., and J.N.B. (G0601387), a Wellcome Trust Programme grant to F.O.N. (GR07873MA), and a British Skin Foundation award to F.C. (1006). A.O. is supported by a studentship funded by The Generation Trust. A.E.P. is supported by an MRC/BAD/BSF Clinical Research Training Fellowship. The authors acknowledge the use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We acknowledge technical assistance from Anna Bertoni and Christian Hundhausen.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Dunn EF, 2003, BIOCHEMISTRY-US, V42, P10938, DOI 10.1021/bi0341197; Griffiths C., 2010, ROOKS TXB DERMATOLOG, V8th; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Viguier M, 2010, ANN INTERN MED, V153, P66, DOI 10.7326/0003-4819-153-1-201007060-00030; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	16	342	360	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					432	437		10.1016/j.ajhg.2011.07.022	http://dx.doi.org/10.1016/j.ajhg.2011.07.022			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21839423	Bronze, Green Published			2022-12-18	WOS:000294939800008
J	Wang, K; Zhou, B; Kuo, YM; Zemansky, J; Gitschier, J				Wang, K; Zhou, B; Kuo, YM; Zemansky, J; Gitschier, J			A novel member of a zinc transporter family is defective in acrodermatitis enteropathica	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ABSORPTION; PREDICTION; EXPRESSION; GENE	The rare inherited condition acrodermatitis enteropathica (AE) results from a defect in the absorption of dietary zinc. Recently, we used homozygosity mapping in consanguineous Middle Eastern kindreds to localize the AE gene to an similar to3.5-cM region on 8q24. In this article, we identify a gene, SLC39A4, located in the candidate region and, in patients with AE, document mutations that likely lead to the disease. The gene encodes a histidine-rich protein, which we refer to as "hZIP4," which is a member of a large family of transmembrane proteins, some of which are known to serve as zinc-uptake proteins. We show that Slc39A4 is abundantly expressed in mouse enterocytes and that the protein resides in the apical membrane of these cells. These findings suggest that the hZIP4 transporter is responsible for intestinal absorption of zinc.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Gitschier, J (corresponding author), Univ Calif San Francisco, Dept Med, U-286,Box 0794,3rd & Parnassus Ave, San Francisco, CA 94143 USA.	gitschi@itsa.ucsf.edu						BARNES PM, 1973, P ROY SOC MED, V66, P327, DOI 10.1177/003591577306600411; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Goudet J., 2001, CLADISTICS; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hall T.A., 1999, NUCLC ACIDS S, V41, P95, DOI citeulike-article-id:691774; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kuo YM, 1997, HUM MOL GENET, V6, P1043, DOI 10.1093/hmg/6.7.1043; LOMBECK I, 1975, LANCET, V1, P855; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEEL L, 1985, AM J PHYSIOL, V248, pG46; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDENHAMER CJA, 1985, TRACE ELEMENTS MAN A, V5, P689; Wang K, 2001, AM J HUM GENET, V68, P1055, DOI 10.1086/319514; WEISMANN K, 1979, BRIT J DERMATOL, V101, P573, DOI 10.1111/j.1365-2133.1979.tb11889.x	21	342	359	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					66	73		10.1086/341125	http://dx.doi.org/10.1086/341125			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12032886	Bronze, Green Published			2022-12-18	WOS:000176307700007
J	Harkin, LA; Bowser, DN; Dibbens, LM; Singh, R; Phillips, F; Wallace, RH; Richards, MC; Williams, DA; Mulley, JC; Berkovic, SF; Scheffer, IE; Petrou, S				Harkin, LA; Bowser, DN; Dibbens, LM; Singh, R; Phillips, F; Wallace, RH; Richards, MC; Williams, DA; Mulley, JC; Berkovic, SF; Scheffer, IE; Petrou, S			Truncation of the GABA(A)-receptor gamma 2 subunit in a family with generalized epilepsy with febrile seizures plus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION; RECEPTORS; SUBTYPES; CHANNEL	Recent findings from studies of two families have shown that mutations in the GABA(A)-receptor gamma2 subunit are associated with generalized epilepsies and febrile seizures. Here we describe a family that has generalized epilepsy with febrile seizures plus (GEFS(+)), including an individual with severe myoclonic epilepsy of infancy, in whom a third GABA(A)-receptor gamma2-subunit mutation was found. This mutation lies in the intracellular loop between the third and fourth transmembrane domains of the GABA(A)-receptor gamma2 subunit and introduces a premature stop codon at Q351 in the mature protein. GABA sensitivity in Xenopus laevis oocytes expressing the mutant gamma2(Q351X) subunit is completely abolished, and fluorescent-microscopy studies have shown that receptors containing GFP-labeled gamma2(Q351X) protein are retained in the lumen of the endoplasmic reticulum. This finding reinforces the involvement of GABA(A) receptors in epilepsy.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; Univ Melbourne, Epilepsy Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Dept Med Neurol, Melbourne, Vic, Australia; Royal Childrens Hosp, Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; Monash Med Ctr, Dept Neurosci, Melbourne, Vic, Australia	Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; University of Melbourne; University of Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Monash University	Harkin, LA (corresponding author), Womens & Childrens Hosp Bion Ltd, Dept Cytogenet & Mol Genet, 28 Dalgleish St, Thebarton, SA 5031, Australia.		Petrou, Steven/M-8332-2013; Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022	Scheffer, Ingrid E/0000-0002-2311-2174; Wallace, Robyn/0000-0001-6141-3317; Berkovic, Samuel/0000-0003-4580-841X; Bowser, David/0000-0002-8974-9442; Petrou, Steven/0000-0002-4960-6375; Dibbens, Leanne/0000-0002-5824-3342				Alekov AK, 2001, EUR J NEUROSCI, V13, P2171, DOI 10.1046/j.0953-816x.2001.01590.x; Barnard EA, 1998, PHARMACOL REV, V50, P291; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Olsen R W, 1999, Adv Neurol, V79, P499; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Schwartzkroin PA, 1998, NAT MED, V4, P1115, DOI 10.1038/2608; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Singh R, 2001, EPILEPSIA, V42, P837, DOI 10.1046/j.1528-1157.2001.042007837.x; Stuhmer W, 1998, METHOD ENZYMOL, V293, P280; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	22	342	379	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					530	536		10.1086/338710	http://dx.doi.org/10.1086/338710			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11748509	Green Published, Bronze			2022-12-18	WOS:000173254300024
J	GARDNER, EJ				GARDNER, EJ			A GENETIC AND CLINICAL STUDY OF INTESTINAL POLYPOSIS, A PREDISPOSING FACTOR FOR CARCINOMA OF THE COLON AND RECTUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOEHME EJ, 1950, ANN SURG, V131, P519, DOI 10.1097/00000658-195004000-00006; DUKES C, 1925, BRIT J SURG, V13, P720; DUKES CUTHBERT, 1930, CANCER REV, V5, P241; ESTES WL, 1948, ANN SURG, V127, P1035, DOI 10.1097/00000658-194805000-00022; Falk VS, 1942, ARCH SURG-CHICAGO, V45, P123, DOI 10.1001/archsurg.1942.01220010126008; GARDNER CM, 1948, ARCH SURG-CHICAGO, V56, P75, DOI 10.1001/archsurg.1948.01240010078009; GARDNER EJ, 1950, AM J HUM GENET, V2, P41; HOXWORTH PI, 1948, SURGERY, V24, P188; Hullsick HE, 1928, SURG GYNECOL OBSTET, V47, P346; Lockhart-Mummery JP, 1939, LANCET, V2, P586; LOCKHARTMUMMERY JP, 1934, DISEASES RECTUM COLO, P234; McKenney DC, 1936, J AMER MED ASSOC, V107, P1871, DOI 10.1001/jama.1936.02770490025008; Niemack J, 1902, ANN SURG, V36, P104, DOI 10.1097/00000658-190207000-00012; PFEIFFER DB, 1945, ANN SURG, V122, P606, DOI 10.1097/00000658-194510000-00009	14	342	349	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	2					167	176						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS393	14902760				2022-12-18	WOS:A1951XS39300005
J	Wallace, C; Newhouse, SJ; Braund, P; Zhang, F; Tobin, M; Falchi, M; Ahmadi, K; Dobson, RJ; Maracano, ACB; Hajat, C; Burton, P; Deloukas, P; Brown, M; Connell, JM; Dominiczak, A; Lathrop, GM; Webster, J; Farrall, M; Spector, T; Samani, NJ; Caulfield, MJ; Munroe, PB				Wallace, Chris; Newhouse, Stephen J.; Braund, Peter; Zhang, Feng; Tobin, Martin; Falchi, Mario; Ahmadi, Kourosh; Dobson, Richard J.; Maracano, Ana Carolina B.; Hajat, Cother; Burton, Paul; Deloukas, Panagiotis; Brown, Morris; Connell, John M.; Dominiczak, Anna; Lathrop, G. Mark; Webster, John; Farrall, Martin; Spector, Tim; Samani, Nilesh J.; Caulfield, Mark J.; Munroe, Patricia B.		Wellcome Trust Case Control	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: Serum urate and dyslipiclemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URIC-ACID; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK; HYPERTENSION; LOCI; CHOLESTEROL; MORTALITY; GLUCOSE	Many common diseases are accompanied by disturbances in biochemical traits. Identifying the genetic determinants could provide novel insights into disease mechanisms and reveal avenues for developing new therapies. Here, we report a genome-wide association analysis for commonly measured serum and urine biochemical traits. As part of the WTCCC, 500,000 SNPs genome wide were geno-typed in 1955 hypertensive individuals characterized for 25 serum and urine biochemical traits. For each trait, we assessed association with individual SNPs, adjusting for age, sex, and BMI. Lipid measurements were further examined in a meta-analysis of genome-wide data from a type 2 diabetes scan. The most promising associations were examined in two epidemiological cohorts. We discovered association between serum urate and SLC2A9, a glucose transporter (p 2 x 10-(15)) and confirmed this in two independent cohorts, GRAPHIC study (p = 9 x 10(-15)) and TwinsUK (p = 8 x 10(-19)). The odds ratio for hyperuricaemia (defined as urate >0.4 mMol/l) is 1.89 (95% CI 1.36-2.61) per copy of common allele. We also replicated many genes previously associated with serum lipids and found previously recognized association between LDL levels and SNPs close to genes encoding PSRCI and CELSR2 (p = 1 x 10(-7)). The common allele was associated with a 6% increase in nonfasting serum LDL. This region showed increased association in the meta-analysis (p = 4 x 10(-14)). This finding provides a potential biological mechanism for the recent association of this same allele of the same SNP with increased risk of coronary disease.	[Wallace, Chris; Newhouse, Stephen J.; Dobson, Richard J.; Maracano, Ana Carolina B.; Caulfield, Mark J.; Munroe, Patricia B.] Barts & London Queen Marys Sch Med & Dent, Barts & London, Clin Pharmacol & Genome Ctr, London EC1M 6BQ, England; [Braund, Peter; Hajat, Cother; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England; [Zhang, Feng; Falchi, Mario; Ahmadi, Kourosh; Spector, Tim] Kings Coll London, Sch Med, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; [Tobin, Martin; Burton, Paul] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Tobin, Martin; Burton, Paul] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Deloukas, Panagiotis] Sanger Ctr, Cambridge CB10 1SA, England; [Brown, Morris] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Connell, John M.; Dominiczak, Anna] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Lathrop, G. Mark] Ctr Natl Genotypage, F-91057 Evry, France; [Webster, John] Aberdeen Royal Infirm, Aberdeen AB9 2ZB, Scotland; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of London; Queen Mary University London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; King's College London; University of Leicester; University of Leicester; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Glasgow; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Aberdeen; University of Oxford; Wellcome Centre for Human Genetics	Munroe, PB (corresponding author), Barts & London Queen Marys Sch Med & Dent, Barts & London, Clin Pharmacol & Genome Ctr, London EC1M 6BQ, England.	p.b.munroe@qmul.ac.uk	Falchi, Mario/F-5956-2013; Dobson, Richard j/C-9269-2011; Spector, Tim D/F-6533-2012; Burton, Paul R/H-7527-2016; Newhouse, Stephen J/C-9330-2011; Dominiczak, Anna F/P-9390-2017; Deloukas, Panos/B-2922-2013; Dominiczak, Anna F/D-2262-2009	Dobson, Richard j/0000-0003-4224-9245; Newhouse, Stephen J/0000-0002-1843-9842; Dominiczak, Anna F/0000-0003-4913-3608; Deloukas, Panos/0000-0001-9251-070X; Caulfield, Mark/0000-0001-9295-3594; s, hema/0000-0002-3440-9475; Falchi, Mario/0000-0002-5646-1004; Wallace, Chris/0000-0001-9755-1703; Munroe, Patricia/0000-0002-4176-2947; Hajat, Cother/0000-0002-1763-3010; Tobin, Martin/0000-0002-3596-7874	MRC [G0400874, G106/1216, G0501942] Funding Source: UKRI; Medical Research Council [G106/1216, G0400874, G0501942] Funding Source: Medline; Wellcome Trust [076113/B/04/Z] Funding Source: Medline; Medical Research Council [G9817803B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Burton PR, 1999, GENET EPIDEMIOL, V17, P118, DOI 10.1002/(SICI)1098-2272(1999)17:2<118::AID-GEPI3>3.0.CO;2-V; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lo PK, 1999, ONCOGENE, V18, P7765, DOI 10.1038/sj.onc.1203167; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; ORRELL DH, 1971, CLIN CHIM ACTA, V35, P483, DOI 10.1016/0009-8981(71)90224-5; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; SPIELGELHALTER D, 2003, WINBUGS VERSION 4 US; STAURT A, 1999, KENDALLS ADV THEORY, P486; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; TEAM RDC, 2007, R LANGUAGE ENV STAT; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Vincent JB, 2000, DNA RES, V7, P233, DOI 10.1093/dnares/7.3.233; *WHO, 2002, RED RISKS PROM HLTH, P58; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	41	340	355	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					139	149		10.1016/j.ajhg.2007.11.001	http://dx.doi.org/10.1016/j.ajhg.2007.11.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179892	Green Published, Bronze			2022-12-18	WOS:000253223800014
J	Cordell, HJ; Clayton, DG				Cordell, HJ; Clayton, DG			A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE-PREDISPOSING VARIANTS; TRANSMISSION/DISEQUILIBRIUM TEST; MAXIMUM-LIKELIHOOD; ASSOCIATION; REGION; RISK; MELLITUS; COMPLEX; MODELS; MHC	A stepwise logistic-regression procedure is proposed for evaluation of the relative importance of variants at different sites within a small genetic region. By fitting statistical models with main effects, rather than modeling the full haplotype effects, we generate tests, with few degrees of freedom, that are likely to be powerful for detecting primary etiological determinants. The approach is applicable to either case/control or nuclear-family data, with case/control data modeled via unconditional and family data via conditional logistic regression. Four different conditioning strategies are proposed for evaluation of effects at multiple, closely linked loci when family data are used. The first strategy results in a likelihood that is equivalent to analysis of a matched case/control study with each affected offspring matched to three pseudocontrols, whereas the second strategy is equivalent to matching each affected offspring with between one and three pseudocontrols. Both of these strategies require parental phase (i.e., those haplotypes present in the parents) to be inferable. Families in which phase cannot be determined must be discarded, which can considerably reduce the effective size of a data set, particularly when large numbers of loci that are not very polymorphic are being considered. Therefore, a third strategy is proposed in which knowledge of parental phase is not required, which allows those families with ambiguous phase to be included in the analysis. The fourth and final strategy is to use conditioning method 2 when parental phase can be inferred and to use conditioning method 3 otherwise. The methods are illustrated using nuclear-family data to evaluate the contribution of loci in the HLA region to the development of type 1 diabetes.	Univ Cambridge, Addenbrookes Hosp, Dept Med Genet,Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Cordell, HJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet,Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Hills Rd, Cambridge CB2 2XY, England.			Cordell, Heather/0000-0002-1879-5572				Beck S, 1999, IMMUNOL REV, V167, P201, DOI 10.1111/j.1600-065X.1999.tb01393.x; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cucca F, 2001, DIABETES, V50, P1200, DOI 10.2337/diabetes.50.5.1200; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gambelunghe G, 1999, J CLIN ENDOCR METAB, V84, P3701, DOI 10.1210/jc.84.10.3701; HIRJI KF, 1987, J AM STAT ASSOC, V82, P1110, DOI 10.2307/2289388; HIRJI KF, 1988, BIOMETRICS, V44, P804; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Koeleman BPC, 2000, ANN HUM GENET, V64, P207, DOI 10.1017/S0003480000008095; Li H, 2001, ANN HUM GENET, V65, P189, DOI 10.1017/S0003480001008491; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ota M, 1999, AM J HUM GENET, V64, P1406, DOI 10.1086/302364; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; Schafer J.L., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; THOMAS D, 1995, GENET EPIDEMIOL, V12, P455, DOI 10.1002/gepi.1370120503; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1995, AM J HUM GENET, V57, P487; Valdes AM, 1997, AM J HUM GENET, V60, P703; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Zavattari P, 2001, HUM MOL GENET, V10, P881, DOI 10.1093/hmg/10.8.881; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; [No title captured]	32	340	347	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					124	141		10.1086/338007	http://dx.doi.org/10.1086/338007			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11719900	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000172571900012
J	Jones, AC; Shyamsundar, MM; Thomas, MW; Maynard, J; Idziaszczyk, S; Tomkins, S; Sampson, JR; Cheadle, JP				Jones, AC; Shyamsundar, MM; Thomas, MW; Maynard, J; Idziaszczyk, S; Tomkins, S; Sampson, JR; Cheadle, JP			Comprehensive mutation analysis of TSC1 and TSC2 - and phenotypic correlations in 150 families with tuberous sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; SPLICE-SITE MUTATION; GENE-2 PRODUCT; PROTEIN; IDENTIFICATION; DELETION; HETEROZYGOSITY; HAMARTIN; COMPLEX; DOMAIN	Tuberous sclerosis (TSC [MIM 191090 and MIM 191100]) is an autosomal dominant disorder characterized by hamartomas in many organs. Two thirds of cases are sporadic and are thought to represent new mutations. TSC is caused by mutations affecting either of the presumed tumor-suppressor genes, TSC1 and TSC2. Both appear to function as tumor suppressors, because somatic loss or intragenic mutation of the corresponding wild-type allele is seen in the associated hamartomas. Here we report the first comprehensive mutation analysis of TSC1 and TSC2 in a cohort of 150 unrelated TSC patients and their families, using heteroduplex and SSCP analysis of all coding exons and using pulsed-field gel electrophoresis and conventional Southern blot analysis and long PCR to screen for large rearrangements. Mutations were characterized in 120 (80%) of the 150 cases, affecting TSC1 in 22 cases and TSC2 in 38 cases. TSC1 mutations were significantly underrepresented in sporadic cases (P = .000185). Twenty-two patients had TSC2 missense mutations that were found predominantly in the GAP-related domain (eight cases) and in a small region encoded in exons 16 and 17, between nucleotides 1849 and 1859 (eight cases), consistent with the presence of residues performing key functions at these sites. In contrast, all TSC1 mutations were predicted to be truncating, consistent with a structural or adapter role for the encoded protein, Intellectual disability was significantly more frequent in TSC2 sporadic cases than in TSC1 sporadic cases (P = .0145). These data provide the first representative picture of the distribution and spectrum of mutations across the TSC1 and TSC2 loci in clinically ascertained TSC and support a difference in severity of TSC1- and TSC2-associated disease.	Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	Cardiff University	Sampson, JR (corresponding author), Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales.	wmgjrs@cardiff.ac.uk	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880				Ali JBM, 1998, J MED GENET, V35, P969, DOI 10.1136/jmg.35.12.969; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Beauchamp RL, 1998, HUM MUTAT, V12, P408, DOI 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.3.CO;2-G; Beaudet AL, 1996, HUM MUTAT, V8, P197; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Cooper D. N., 1993, HUMAN GENE MUTATION; Fleury P, 1980, Brain Dev, V2, P107; Gomez MR, 1988, TUBEROUS SCLEROSIS; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Henske EP, 1996, AM J HUM GENET, V59, P400; Jobert S, 1997, EUR J HUM GENET, V5, P280, DOI 10.1159/000484778; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P3990, DOI 10.1073/pnas.94.8.3990; KUMAR A, 1995, HUM MOL GENET, V4, P2295, DOI 10.1093/hmg/4.12.2295; Kumar A, 1997, HUM MUTAT, V9, P64; KUMAR A, 1995, HUM MOL GENET, V4, P1471, DOI 10.1093/hmg/4.8.1471; Kwiatkowska J, 1998, ANN HUM GENET, V62, P277, DOI 10.1046/j.1469-1809.1998.6240277.x; Longa L, 1997, NEPHROL DIAL TRANSPL, V12, P1900, DOI 10.1093/ndt/12.9.1900; Maheshwar MM, 1996, HUM MOL GENET, V5, P131, DOI 10.1093/hmg/5.1.131; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; NELLIST M, 1993, CELL, V75, P1305; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Plank TL, 1998, CANCER RES, V58, P4766; POVEY S, 1994, ANN HUM GENET, V58, P107, DOI 10.1111/j.1469-1809.1994.tb01881.x; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; SAMPSON JR, 1992, J MED GENET, V29, P861, DOI 10.1136/jmg.29.12.861; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Soucek T, 1998, ONCOGENE, V16, P2197, DOI 10.1038/sj.onc.1201743; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; van den Ouweland AMW, 1997, AM J HUM GENET, V61, pA349; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanBakel I, 1997, HUM MOL GENET, V6, P1409, DOI 10.1093/hmg/6.9.1409; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; VANSLEGTENHORST M, IN PRESS J MED GENET; Verhoef S, 1998, HUM MUTAT, pS85; Vrtel R, 1996, J MED GENET, V33, P47, DOI 10.1136/jmg.33.1.47; Wang Q, 1998, HUM MUTAT, V11, P331; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Wilson PJ, 1996, HUM MOL GENET, V5, P249, DOI 10.1093/hmg/5.2.249; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Young JM, 1998, ANN HUM GENET, V62, P203, DOI 10.1046/j.1469-1809.1998.6230203.x	47	340	371	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1305	1315		10.1086/302381	http://dx.doi.org/10.1086/302381			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205261	Bronze, Green Published			2022-12-18	WOS:000080093000008
J	Weinberg, CR; Wilcox, AJ; Lie, RT				Weinberg, CR; Wilcox, AJ; Lie, RT			A log-linear approach to case-parent-triad data: Assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-ASSOCIATED RISKS; LINKAGE DISEQUILIBRIUM; FINNISH POPULATION; RELATIVE RISKS; TESTS	We describe a log-linear method for analysis of case-parent-triad data, based on maximum likelihood with stratification on parental mating type. The method leads to estimates of association parameters, such as relative risks, for a single allele, and also to likelihood ratio chi(2) tests (LRTs) of linkage disequilibrium. Hardy-Weinberg equilibrium need not be assumed. Our simulations suggest that the LRT has power similar to that of the chi(2) "score" test proposed by Schaid and Sommer and that both can outperform the transmission/disequilibrium test (TDT), although the TDT can perform better under an additive model of inheritance. Because a restricted version of the LRT is asymptotically equivalent to the TDT, the proposed test can be regarded as a generalization of the TDT. The method that we describe generalizes easily to accommodate maternal effects on risk and, in fact, produces powerful and orthogonal tests of the contribution of fetal versus maternal genetic factors. We further generalize the model to allow for effects of parental imprinting. Imprinting effects can be fitted by a simple, iterative procedure that relies on the expectation-maximization algorithm and that uses standard statistical software for the maximization steps. Simulations reveal that LRT tests for detection of imprinting have very good operating characteristics. When a single allele is under study, the proposed method can yield powerful tests for detection of linkage disequilibrium and is applicable to a broader array of causal scenarios than is the TDT.	NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; Univ Bergen, Sect Med Stat, Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen	Weinberg, CR (corresponding author), NIEHS, Biostat Branch, MD A3-03,POB 12233, Res Triangle Pk, NC 27709 USA.		Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311; Weinberg, Clarice/0000-0002-7713-8556				Baker R, 1978, GLIM SYSTEM RELEASE; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; LANGHOLZ B, 1995, GENET EPIDEMIOL, V12, P441, DOI 10.1002/gepi.1370120502; Mitchell LE, 1997, AM J HUM GENET, V60, P1006; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMAS D, 1995, GENET EPIDEMIOL, V12, P455, DOI 10.1002/gepi.1370120503; THOMSON G, 1995, AM J HUM GENET, V57, P487; WILCOX A, IN PRESS AM J EPIDEM	14	340	347	1	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					969	978		10.1086/301802	http://dx.doi.org/10.1086/301802			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529360	Bronze, Green Published			2022-12-18	WOS:000073514400029
J	Di Pasquale, E; Beck-Peccoz, P; Persani, L				Di Pasquale, E; Beck-Peccoz, P; Persani, L			Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; INCREASED OVULATION RATE; INFERTILITY; SECRETION; OOCYTES; REGION; WOMEN; SHEEP; CELLS	Hypergonadotropic ovarian failure is a common cause of female infertility. It is a heterogeneous disorder that, in the most severe forms, is a result of ovarian dysgenesis (OD). Most OD cases are associated with major X-chromosome abnormalities, but the pathogenesis of this disorder is still largely undefined in patients with a normal karyotype. Animal models showed the important role in female reproduction played by the product of a gene located at Xp11.2 in humans (BMP15). BMP15 is an oocyte-specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth. We report two sisters with a normal karyotype who are affected with hypergonadotropic ovarian failure due to OD. The familial presentation suggested a genetic origin, and candidate genes were screened for mutations. A heterozygous nonconservative substitution in the pro region of BMP15 (Y235C) was identified in both sisters but not in 210 control alleles. This mutation was inherited from the father. Mutant BMP15 appears to be processed abnormally, is associated with reduced GC growth, and antagonizes the stimulatory activity of wild-type protein on GC proliferation. In conclusion, the first natural mutation in human BMP15 is associated with familial OD, indicating that the action of BMP15 is required for the progression of human folliculogenesis. This condition represents an exceptional example of X-linked human disease exclusively affecting heterozygous females who inherited the genetic alteration from the unaffected father. BMP15 defects are involved in the pathogenesis of hypergonadotropic ovarian failure in humans.	Univ Milan, Inst Endocrine Sci, Ist Auxol Italiano, IRCCS, I-20095 Cusano Milanino, MI, Italy; Osped Maggiore, IRCCS, Milan, Italy	IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Persani, L (corresponding author), Univ Milan, Inst Endocrine Sci, Ist Auxol Italiano, IRCCS, Via Zucchi 18, I-20095 Cusano Milanino, MI, Italy.	luca.persani@unimi.it	Di Pasquale, Elisa/ABI-6210-2020; Di Pasquale, Elisa/ABI-6252-2020; Persani, Luca/B-6543-2008	Di Pasquale, Elisa/0000-0003-2373-5635; Persani, Luca/0000-0003-2068-9581				Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Layman LC, 1998, FERTIL STERIL, V69, P300, DOI 10.1016/S0015-0282(97)00480-9; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Otsuka F, 2002, ENDOCRINOLOGY, V143, P4938, DOI 10.1210/en.2002-220929; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; SCHULZ E, 1994, ACROS CHIMICA ACTA, V1, P1; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; Takebayashi K, 2000, FERTIL STERIL, V74, P976, DOI 10.1016/S0015-0282(00)01539-9; TAPANAINEN J, 1987, FERTIL STERIL, V48, P576; THOMPSON DR, 1997, CLIN EFFECTIVENESS N, V1, P64; Timmreck LS, 2003, OBSTET GYN CLIN N AM, V30, P287, DOI 10.1016/S0889-8545(03)00027-5; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152	26	338	360	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					106	111		10.1086/422103	http://dx.doi.org/10.1086/422103			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15136966	Green Published, Bronze			2022-12-18	WOS:000222031300013
J	Verhoeven, K; De Jonghe, P; Coen, K; Verpoorten, N; Auer-Grumbach, M; Kwon, JM; FitzPatrick, D; Schmedding, E; De Vriendt, E; Jacobs, A; Van Gerwen, V; Wagner, K; Hartung, HP; Timmerman, V				Verhoeven, K; De Jonghe, P; Coen, K; Verpoorten, N; Auer-Grumbach, M; Kwon, JM; FitzPatrick, D; Schmedding, E; De Vriendt, E; Jacobs, A; Van Gerwen, V; Wagner, K; Hartung, HP; Timmerman, V			Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY SENSORY NEUROPATHY; TRANSPORT; FAMILY; SPTLC1; LOCUS; RILP	Charcot-Marie-Tooth type 2B (CMT2B) is clinically characterized by marked distal muscle weakness and wasting and a high frequency of foot ulcers, infections, and amputations of the toes because of recurrent infections. CMT2B maps to chromosome 3q13-q22. We refined the CMT2B locus to a 2.5-cM region and report two missense mutations (Leu129Phe and Val162Met) in the small GTP-ase late endosomal protein RAB7 which causes the CMT2B phenotype in three extended families and in three patients with a positive family history. The alignment of RAB7 orthologs shows that both missense mutations target highly conserved amino acid residues. RAB7 is ubiquitously expressed, and we found expression in sensory and motor neurons.	Univ Antwerp VIB, Dept Mol Genet, Born Bunge Fdn, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Karl Franzens Univ Graz, Inst Med Biol & Human Genet, Graz, Austria; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Hosp Brussels, Dept Neurol, Brussels, Belgium; Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Graz; Washington University (WUSTL); University of Edinburgh; University Hospital Brussels; Heinrich Heine University Dusseldorf	Timmerman, V (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008; Timmerman, Vincent/O-7283-2019	Timmerman, Vincent/0000-0002-2162-0933; FitzPatrick, David R./0000-0003-4861-969X				Auer-Grumbach M, 2000, NEUROLOGY, V55, P1552, DOI 10.1212/WNL.55.10.1552; Auer-Grumbach M, 2000, NEUROLOGY, V54, P45, DOI 10.1212/WNL.54.1.45; AUERGRUMBACH M, IN PRESS ARCH NEUROL; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bellone E, 2002, NEUROMUSCULAR DISORD, V12, P286, DOI 10.1016/S0960-8966(01)00282-6; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; De Jonghe P, 1997, J NEUROL NEUROSUR PS, V62, P570, DOI 10.1136/jnnp.62.6.570; DEJONGHE P, 2000, NEUROMUSCULAR DIS BA; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; KWON JM, 1995, AM J HUM GENET, V57, P853; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Vitelli R, 1996, BIOCHEM BIOPH RES CO, V229, P887, DOI 10.1006/bbrc.1996.1897	21	338	355	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					722	727		10.1086/367847	http://dx.doi.org/10.1086/367847			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12545426	Green Published, Bronze			2022-12-18	WOS:000181152600022
J	Vahteristo, P; Bartkova, J; Eerola, H; Syrjakoski, K; Ojala, S; Kilpivaara, O; Tamminen, A; Kononen, J; Aittomaki, K; Heikkila, P; Holli, K; Blomqvist, C; Bartek, J; Kallioniemi, OP; Nevanlinna, H				Vahteristo, P; Bartkova, J; Eerola, H; Syrjakoski, K; Ojala, S; Kilpivaara, O; Tamminen, A; Kononen, J; Aittomaki, K; Heikkila, P; Holli, K; Blomqvist, C; Bartek, J; Kallioniemi, OP; Nevanlinna, H			A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; DNA-DAMAGE CHECKPOINT; BRCA2 MUTATIONS; SUSCEPTIBILITY GENES; IN-VIVO; CHK2; KINASE; P53; PROTEIN; FINLAND	CHEK2 (previously known as "CHK2") is a cell-cycle-checkpoint kinase that phosphorylates p53 and BRCA1 in response to DNA damage. A protein-truncating mutation, 1100delC in exon 10, which abolishes the kinase function of CHEK2, has been found in families with Li-Fraumeni syndrome (LFS) and in those with a cancer phenotype that is suggestive of LFS, including breast cancer. In the present study, we found that the frequency of 1100delC was 2.0% among an unselected population-based cohort of 1,035 patients with breast cancer. This was slightly, but not significantly (P=.182), higher than the 1.4% frequency found among 1,885 population control subjects. However, a significantly elevated frequency was found among those 358 patients with a positive family history (11/358 [3.1%]; odds ratio [OR] 2.27; 95% confidence interval [CI] 1.11-4.63;, P=.021, compared with population controls). Furthermore, patients with bilateral breast cancer were sixfold more likely to be 1100delC carriers than were patients with unilateral cancer (95% CI 1.87-20.32; P=.007). Analysis of the 1100delC variant in an independent set of 507 patients with familial breast cancer with no BRCA1 and BRCA2 mutations confirmed a significantly elevated frequency of 1100delC (28/507 [5.5%]; OR 4.2; 95% CI 2.4-7.2; P=.0001), compared with controls, with a high frequency also seen in patients with only a single affected first-degree relative (18/291 [6.2%]). Finally, tissue microarray analysis indicated that breast tumors from patients with 1100delC mutations show reduced CHEK2 immunostaining. The results suggest that CHEK2 acts as a low-penetrance tumor-suppressor gene in breast cancer and that it makes a significant contribution to familial clustering of breast cancer-including families with only two affected relatives, which are more common than families that include larger numbers of affected women.	Univ Helsinki, Cent Hosp, Biomedicum Helsinki B406B, Dept Obstet & Gynecol, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Clin Genet, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Pathol, FIN-00029 Helsinki, Finland; Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; Tampere Univ, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland; Tampere Univ, Dept Oncol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA; Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Danish Cancer Society; Tampere University; Tampere University; Tampere University; Tampere University Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Uppsala University; Uppsala University Hospital	Nevanlinna, H (corresponding author), Univ Helsinki, Cent Hosp, Biomedicum Helsinki B406B, Dept Obstet & Gynecol, Haartmaninkatu 8,POB 700, FIN-00029 Helsinki, Finland.		Bartek, Jiri/G-5870-2014; Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Nevanlinna, Heli/0000-0002-0916-2976; Kononen, Juha/0000-0002-0157-2137; Blomqvist, Carl/0000-0003-3041-1938				Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartkova J, 2001, ONCOGENE, V20, P5897, DOI 10.1038/sj.onc.1204746; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chehab NH, 2000, GENE DEV, V14, P278; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Eerola H, 2000, EUR J CANCER, V36, P1143, DOI 10.1016/S0959-8049(00)00093-9; Eerola H, 2001, CANCER CAUSE CONTROL, V12, P739, DOI 10.1023/A:1011272919982; Haruki N, 2000, CANCER RES, V60, P4689; Hofmann WK, 2001, LEUKEMIA RES, V25, P333, DOI 10.1016/S0145-2126(00)00130-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Lukas C, 2001, CANCER RES, V61, P4990; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Miller CW, 2002, GENE CHROMOSOME CANC, V33, P17, DOI 10.1002/gcc.1207; Shieh SY, 2000, GENE DEV, V14, P289; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; Tavor S, 2001, LEUKEMIA LYMPHOMA, V42, P517, DOI 10.3109/10428190109064610; Vahteristo P, 2001, CANCER RES, V61, P5718; Vahteristo P, 2001, BRIT J CANCER, V84, P704, DOI 10.1054/bjoc.2000.1626; Vehmanen P, 1997, HUM MOL GENET, V6, P2309, DOI 10.1093/hmg/6.13.2309; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	338	349	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					432	438		10.1086/341943	http://dx.doi.org/10.1086/341943			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12094328	Green Published, Bronze			2022-12-18	WOS:000176977700023
J	Valente, EM; Bentivoglio, AR; Dixon, PH; Ferraris, A; Ialongo, T; Frontali, M; Albanese, A; Wood, NW				Valente, EM; Bentivoglio, AR; Dixon, PH; Ferraris, A; Ialongo, T; Frontali, M; Albanese, A; Wood, NW			Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE PARKINSONISM; JAPANESE FAMILIES; GENE; DISEASE; MUTATIONS; DELETIONS; HOMOZYGOSITY; PROTEIN	The cause of Parkinson disease (PD) is still unknown, but genetic factors have recently been implicated in the etiology of the disease. So far, four loci responsible for autosomal dominant PD have been identified. Autosomal recessive juvenile parkinsonism (ARJP) is a clinically and genetically distinct entity; typical PD features are associated with early onset, sustained response to levodopa, and early occurrence of levodopa-induced dyskinesias, which are often severe. To date, only one ARJP gene, Parkin, has been identified, and multiple mutations have been detected both in families with autosomal recessive parkinsonism and in sporadic cases. The Parkin-associated phenotype is broad, and some cases are indistinguishable from idiopathic PD. In greater than or equal to 50% of families with ARJP that have been analyzed, no mutations could be detected in the Parkin gene. We identified a large Sicilian family with four definitely affected members (the Marsala kindred). The phenotype was characterized by early-onset (range 32-48 years) parkinsonism, with slow progression and sustained response to levodopa. Linkage of the disease to the Parkin gene was excluded. A genomewide homozygosity screen was performed in the family. Linkage analysis and haplotype construction allowed identification of a single region of homozygosity shared by all the affected members, spanning 12.5 cM on the short arm of chromosome 1. This region contains a novel locus for autosomal recessive early-onset parkinsonism, PARK6. A maximum LOD score 4.01 at recombination fraction .00 was obtained for marker D1S199.	Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England; Catholic Univ, Dept Neurol, Rome, Italy; CNR, Inst Expt Med, Rome, Italy; Natl Neurol Inst Carlo Besta, Milan, Italy	University of London; University College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituto Neurologico Besta	Wood, NW (corresponding author), Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucl.ac.uk	Ferraris, Alessandro/AHC-2875-2022; Ferraris, Alessandro/E-4392-2013; Albanese, Alberto/K-7396-2016; Wood, Nicholas W/C-2505-2009; Bentivoglio, Anna Rita/K-3752-2018; Valente, Enza Maria/G-2942-2017	Albanese, Alberto/0000-0002-5864-0006; Wood, Nicholas W/0000-0002-9500-3348; Valente, Enza Maria/0000-0002-0600-6820; Bentivoglio, Anna Rita/0000-0002-9663-095X; Ferraris, Alessandro/0000-0003-2947-9572; Dixon, Peter/0000-0002-0197-2632	Telethon [E.1165, C.38] Funding Source: Medline	Telethon(Fondazione Telethon)		Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DWARKADAS S, 1994, HUM HERED, V44, P127, DOI 10.1159/000154205; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leroy E, 1998, HUM GENET, V103, P424, DOI 10.1007/s004390050845; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsumine H, 1997, AM J HUM GENET, V60, P588; Nisipeanu P, 1999, NEUROLOGY, V53, P1602, DOI 10.1212/WNL.53.7.1602; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; VALENTE EM, 1999, J NEUROL S1, V246, P166; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239	26	338	355	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					895	900		10.1086/319522	http://dx.doi.org/10.1086/319522			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254447	Bronze, Green Published			2022-12-18	WOS:000167666000011
J	Waite, KA; Eng, C				Waite, KA; Eng, C			Protean PTEN: Form and function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							TUMOR-SUPPRESSOR PTEN; RILEY-RUVALCABA-SYNDROME; LIPID PHOSPHATASE-ACTIVITY; BANNAYAN-ZONANA-SYNDROME; PEUTZ-JEGHERS-SYNDROME; GERM-LINE MUTATIONS; CELL-CYCLE ARREST; COWDEN-SYNDROME; BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE	Germline mutations distributed across the PTEN tumor-suppressor gene have been found to result in a wide spectrum of phenotypic features. Originally shown to be a major susceptibility gene for both Cowden syndrome (CS), which is characterized by multiple hamartomas and an increased risk of breast, thyroid, and endometrial cancers, and Bannayan-Riley-Ruvalcaba syndrome, which is characterized by lipomatosis, macrocephaly, and speckled penis, the PTEN hamartoma tumor syndrome spectrum has broadened to include Proteus syndrome and Proteus-like syndromes. Exon 5, which encodes the core motif, is a hotspot for mutations likely due to the biology of the protein. PTEN is a major lipid 3-phosphatase, which signals down the PI3 kinase/AKT proapoptotic pathway. Furthermore, PTEN is a protein phosphatase, with the ability to dephosphorylate both serine and threonine residues. The protein-phosphatase activity has also been shown to regulate various cell-survival pathways, such as the mitogen-activated kinase (MAPK) pathway. Although it is well established that PTEN's lipid-phosphatase activity, via the PI3K/AKT pathway, mediates growth suppression, there is accumulating evidence that the protein-phosphatase/MAPK pathway is equally important in the mediation of growth arrest and other crucial cellular functions.	Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eng, C (corresponding author), Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, 420 W 12th Ave,Suite 690TMRF, Columbus, OH 43210 USA.	eng-1@medctr.osu.edu	Waite, Kristin/AAB-1031-2021	Eng, Charis/0000-0002-3693-5145	NICHD NIH HHS [R01 HD039058, R01 HD 39058] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahmed SF, 1999, J CLIN ENDOCR METAB, V84, P4665, DOI 10.1210/jc.84.12.4665; Arch EM, 1997, AM J MED GENET, V71, P489, DOI 10.1002/(SICI)1096-8628(19970905)71:4<489::AID-AJMG24>3.0.CO;2-B; Barker K, 2001, J MED GENET, V38, P480, DOI 10.1136/jmg.38.7.480; Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Carethers JM, 1998, CANCER RES, V58, P2724; Celebi JT, 1999, J MED GENET, V36, P360; Cheyney IW, 1999, CANCER RES, V59, P2318; D'Santos CS, 1998, BBA-MOL CELL BIOL L, V1436, P201, DOI 10.1016/S0005-2760(98)00146-5; Dahia PM, 2000, J MED GENET, V37, P715, DOI 10.1136/jmg.37.9.715; Dasouki MJ, 2001, AM J HUM GENET, V69, P280; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 1998, CANCER RES, V58, P5285; De Vivo I, 2000, J MED GENET, V37, P336, DOI 10.1136/jmg.37.5.336; DEVRIENDT K, 1995, GENET COUNSEL, V6, P361; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dong ZG, 1999, ANTICANCER RES, V19, P3743; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Eng C, 1997, J Genet Couns, V6, P181, DOI 10.1023/A:1025664119494; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Eng C, 1998, INT J ONCOL, V12, P701; Eng C, 2001, J MED GENET, V38, P824, DOI 10.1136/jmg.38.12.824; Eng C, 2001, NAT GENET, V28, P105, DOI 10.1038/88802; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Fackenthal JD, 2001, J MED GENET, V38, P159, DOI 10.1136/jmg.38.3.159; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gimm O, 2000, HUM MOL GENET, V9, P1633, DOI 10.1093/hmg/9.11.1633; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Han SY, 2000, CANCER RES, V60, P3147; HANSSEN AMN, 1995, J MED GENET, V32, P117, DOI 10.1136/jmg.32.2.117; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Hong TM, 2000, AM J RESP CELL MOL, V23, P355, DOI 10.1165/ajrcmb.23.3.4002; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Howes LG, 1998, DRUG SAFETY, V18, P1, DOI 10.2165/00002018-199818010-00001; Huang SC, 2000, CANCER RES, V60, P6882; IAFOLLA AK, 1991, AM J MED GENET, V38, P46, DOI 10.1002/ajmg.1320380112; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; JOSEPH JL, 1998, P NATL ACAD SCI USA, V85, P7164; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kurose K, 1999, AM J HUM GENET, V64, P308, DOI 10.1086/302207; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li DM, 1997, CANCER RES, V57, P2124; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Longy M, 1998, J MED GENET, V35, P886, DOI 10.1136/jmg.35.11.886; Longy M, 1996, ANN GENET-PARIS, V39, P35; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MALLORY SB, 1995, DERMATOL CLIN, V13, P27, DOI 10.1016/S0733-8635(18)30103-7; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, CANCER RES, V57, P5017; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Martelli AM, 1999, PROG LIPID RES, V38, P273, DOI 10.1016/S0163-7827(99)00009-0; Matsushima-Nishiu M, 2001, CANCER RES, V61, P3741; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Metjian A, 1999, J BIOL CHEM, V274, P27943, DOI 10.1074/jbc.274.39.27943; Mills GB, 2001, P NATL ACAD SCI USA, V98, P10031, DOI 10.1073/pnas.191379498; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Mosser VA, 2001, BIOCHEM BIOPH RES CO, V288, P1011, DOI 10.1006/bbrc.2001.5876; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; National Comprehensive Cancer Network, 1999, ONCOLOGY, V13, P161; Nelen MR, 1999, EUR J HUM GENET, V7, P267, DOI 10.1038/sj.ejhg.5200289; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Reardon W, 2001, J MED GENET, V38, P820, DOI 10.1136/jmg.38.12.820; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SIMPSON L, IN PRESS MOL CELL BI; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stambolic V, 2000, CANCER RES, V60, P3605; STARINK TM, 1986, CLIN GENET, V29, P222; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tsou HC, 1997, AM J HUM GENET, V61, P1036, DOI 10.1086/301607; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wanner M, 2001, J AM ACAD DERMATOL, V44, P183, DOI 10.1067/mjd.2001.110390; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Weng LP, 1999, CANCER RES, V59, P5808; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; WHITEMAN DC, IN PRESS INT J CANC; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703; Zori RT, 1998, AM J MED GENET, V80, P399, DOI 10.1002/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.0.CO;2-O	118	336	374	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					829	844		10.1086/340026	http://dx.doi.org/10.1086/340026			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11875759	Green Published, Bronze			2022-12-18	WOS:000174252100001
J	Rizzu, P; Van Swieten, JC; Joosse, M; Hasegawa, M; Stevens, M; Tibben, A; Niermeijer, MF; Hillebrand, M; Ravid, R; Oostra, BA; Goedert, M; van Duijn, CM; Heutink, P				Rizzu, P; Van Swieten, JC; Joosse, M; Hasegawa, M; Stevens, M; Tibben, A; Niermeijer, MF; Hillebrand, M; Ravid, R; Oostra, BA; Goedert, M; van Duijn, CM; Heutink, P			High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTAL-LOBE DEGENERATION; MULTIPLE-SYSTEM TAUOPATHY; NON-ALZHEIMER TYPE; PRE-MESSENGER-RNA; PRESENILE-DEMENTIA; NEUROFIBRILLARY PATHOLOGY; DISEASE; CHROMOSOME-17; LOCALIZATION; PARKINSONISM	Mutations in microtubule-associated protein tau recently have been identified in familial cases of frontotemporal dementia (FTD). We report the frequency of tart mutations in a large population-based study of FTD carried out in the Netherlands from January 1994 to June 1998. Thirty-seven patients had greater than or equal to 1 first-degree relative with dementia. A mutation in the taut gene was found in 17.8% of the group of patients with FTD and in 43% of patients with FTD who also had a positive family history of FTD. Three distinct missense mutations (G272V, P301L, R406W accounted for 15.6% of the mutations. These three missense mutations, and a single amino acid deletion (Delta K280) that was detected in one patient, strongly reduce the ability of tau to promote microtubule assembly. We also found an intronic mutation at position +33 after exon 9, which is likely to affect the alternative splicing of tau. Tau mutations are responsible for a large proportion of familial FTD cases; however, there are also families with FTD in which no mutations in tau have been found, which indicates locus and/or allelic heterogeneity, The different tart mutations may result in disturbances in the interactions of the protein tau with microtubules, resulting in hyperphosphorylation of tau protein, assembly into filaments, and subsequent cell death.	Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands; Netherlands Brain Bank, Amsterdam, Netherlands; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; MRC Laboratory Molecular Biology	Heutink, P (corresponding author), Erasmus Univ, Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	heutink@kgen.fgg.eur.nl	Tibben, Aad/A-9540-2008	van Swieten, John/0000-0001-6278-6844; Heutink, Peter/0000-0001-5218-1737; Tibben, Aad/0000-0002-4560-1710				ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Baker M, 1997, ANN NEUROL, V42, P794, DOI 10.1002/ana.410420516; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; BRUN A, 1987, ARCH GERONTOL GERIAT, V6, P193, DOI 10.1016/0167-4943(87)90021-5; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Froelich S, 1997, AM J MED GENET, V74, P380, DOI 10.1002/(SICI)1096-8628(19970725)74:4<380::AID-AJMG8>3.0.CO;2-T; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GUSTAFSON L, 1987, ARCH GERONTOL GERIAT, V6, P209, DOI 10.1016/0167-4943(87)90022-7; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; HASEGAWA M, 1997, J BIOL CHEM, V272, P33111; Heutink P, 1997, ANN NEUROL, V41, P150, DOI 10.1002/ana.410410205; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; KNOPMAN DS, 1990, NEUROLOGY, V40, P251, DOI 10.1212/WNL.40.2.251; Lendon CL, 1998, NEUROLOGY, V50, P1546, DOI 10.1212/WNL.50.6.1546; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murrell JR, 1997, AM J HUM GENET, V61, P1131, DOI 10.1086/301594; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; PETERSEN RB, 1995, NEUROLOGY, V45, P1062, DOI 10.1212/WNL.45.6.1062; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Spillantini MG, 1996, ACTA NEUROPATHOL, V92, P42, DOI 10.1007/s004010050487; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Wijker M, 1996, HUM MOL GENET, V5, P151, DOI 10.1093/hmg/5.1.151; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Yamaoka LH, 1996, AM J HUM GENET, V59, P1306; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	41	336	347	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					414	421		10.1086/302256	http://dx.doi.org/10.1086/302256			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973279	Green Published, Bronze			2022-12-18	WOS:000078740600011
J	Hodgkinson, CA; Goldman, D; Jaeger, J; Persaud, S; Kane, JM; Lipsky, RH; Malhotra, AK				Hodgkinson, CA; Goldman, D; Jaeger, J; Persaud, S; Kane, JM; Lipsky, RH; Malhotra, AK			Disrupted in Schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SCAN METAANALYSIS; AMINO-ACID OXIDASE; SUSCEPTIBILITY LOCI; HAPLOTYPE RECONSTRUCTION; TRANSLOCATION; DISRUPTED-IN-SCHIZOPHRENIA-1; GENETICS; FAMILY; GENES; NUDEL	Schizophrenia, schizoaffective disorder, and bipolar disorder are common psychiatric disorders with high heritabilities and variable phenotypes. The Disrupted in Schizophrenia 1 (DISC1) gene, on chromosome 1q42, was originally discovered and linked to schizophrenia in a Scottish kindred carrying a balanced translocation that disrupts DISC1 and DISC2. More recently, DISC1 was linked to schizophrenia, broadly defined, in the general Finnish population, through the undertransmission to affected women of a common haplotype from the region of intron 1/exon 2. We present data from a case-control study of a North American white population, confirming the underrepresentation of a common haplotype of the intron 1/exon 2 region in individuals with schizoaffective disorder. Multiple haplotypes contained within four haplotype blocks extending between exon 1 and exon 9 are associated with schizophrenia, schizoaffective disorder, and bipolar disorder. We also find overrepresentation of the exon 9 missense allele Phe607 in schizoaffective disorder. These data support the idea that these apparently distinct disorders have at least a partially convergent etiology and that variation at the DISC1 locus predisposes individuals to a variety of psychiatric disorders.	NIAAA, Sect Human Neurogenet, Rockville, MD USA; NIAAA, Neurogenet Lab, Rockville, MD USA; Zucker Hillside Hosp, Glen Oaks, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Northwell Health	Hodgkinson, CA (corresponding author), Pk 5 Bldg,Room 451,MSC8110,12420 Parklawn Dr, Rockville, MD 20852 USA.	chodg@mail.nih.gov	Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Hodgkinson, Colin/0000-0002-5365-8119; Lipsky, Robert/0000-0001-7753-1473	NIMH NIH HHS [K23 MH001760] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000302] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adler CM, 2003, PSYCHIAT CLIN N AM, V26, P1, DOI 10.1016/S0193-953X(02)00085-0; AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P178; Als TD, 2004, MOL PSYCHIATR, V9, P93, DOI 10.1038/sj.mp.4001393; ARNOLD SE, 1991, ARCH GEN PSYCHIAT, V48, P625; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bailer U, 2002, BIOL PSYCHIAT, V52, P40, DOI 10.1016/S0006-3223(02)01320-3; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Berrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; BLACKER D, 1992, AM J PSYCHIAT, V149, P1473; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Chen YS, 2004, MOL PSYCHIATR, V9, P87, DOI 10.1038/sj.mp.4001453; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Devon RS, 2001, PSYCHIATR GENET, V11, P71, DOI 10.1097/00041444-200106000-00003; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Foroud T, 2000, AM J MED GENET, V96, P18, DOI 10.1002/(SICI)1096-8628(20000207)96:1<18::AID-AJMG6>3.3.CO;2-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Ophoff RA, 2002, AM J HUM GENET, V71, P565, DOI 10.1086/342291; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Schwartz DG, 2000, INTERNET RES, V10, P5; Schweiker W, 1998, ANNU SOC CHRIST ETH, V18, P63; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Sklar P, 2002, ANNU REV GENOM HUM G, V3, P371, DOI 10.1146/annurev.genom.3.022502.103141; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; Sundram S, 2003, CURR MOL MED, V3, P393, DOI 10.2174/1566524033479708; Taylor MS, 2003, GENOMICS, V81, P67, DOI 10.1016/S0888-7543(02)00026-5; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C	49	335	348	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					862	872		10.1086/425586	http://dx.doi.org/10.1086/425586			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15386212	Green Published, Bronze			2022-12-18	WOS:000224303500011
J	Dipple, KM; McCabe, ERB				Dipple, KM; McCabe, ERB			Phenotypes of patients with "simple" mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HETEROCELLULAR HEREDITARY PERSISTENCE; SEX-INFLUENCED MODIFIER; BETA-GLOBIN HAPLOTYPES; OPTIC-NERVE COLOBOMAS; SICKLE-CELL DISEASE; FETAL HEMOGLOBIN; DROSOPHILA-MELANOGASTER; VESICOURETERAL REFLUX; PREDICT PHENOTYPE; GAUCHERS-DISEASE		Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McCabe, ERB (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	emccabe@mednet.ucla.edu			NICHD NIH HHS [R01 HD22563] Funding Source: Medline; NIGMS NIH HHS [T32-GM8243-12] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackerman MJ, 1998, MAYO CLIN PROC, V73, P250, DOI 10.4065/73.3.250; Benevolenskaya EV, 1998, MOL GEN GENET, V260, P131, DOI 10.1007/s004380050879; Bhadra U, 1997, MOL GEN GENET, V254, P621, DOI 10.1007/s004380050460; Bhadra U, 1997, GENETICS, V146, P903; Bhadra U, 1996, MOL GEN GENET, V250, P601; Brand MD, 1997, J EXP BIOL, V200, P193; CAPECCHI MR, 1974, P NATL ACAD SCI USA, V71, P4732, DOI 10.1073/pnas.71.12.4732; Carlson AD, 1999, J STEROID BIOCHEM, V69, P19, DOI 10.1016/S0960-0760(99)00059-X; CHANG YC, 1995, BLOOD, V85, P1111, DOI 10.1182/blood.V85.4.1111.bloodjournal8541111; Chang YPC, 1997, BRIT J HAEMATOL, V96, P806, DOI 10.1046/j.1365-2141.1997.d01-2094.x; Choy FYM, 1999, AM J MED GENET, V84, P484, DOI 10.1002/(SICI)1096-8628(19990611)84:5<484::AID-AJMG14>3.0.CO;2-W; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; DONALD JA, 1988, HUM GENET, V80, P69, DOI 10.1007/BF00451459; DOVER GJ, 1992, BLOOD, V80, P816; Enns GM, 1999, PEDIATR RES, V46, P594, DOI 10.1203/00006450-199911000-00017; GEFFNER ME, 1993, J CLIN INVEST, V91, P538, DOI 10.1172/JCI116233; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; Gurakan F, 1999, J INHERIT METAB DIS, V22, P947, DOI 10.1023/A:1005668230365; Hahn AF, 1999, ANN NY ACAD SCI, V883, P366, DOI 10.1111/j.1749-6632.1999.tb08598.x; HAITES NE, 1998, 3 WORKSH EUR CMT CON, V8, P591; Harder A, 1999, AM J MED GENET, V87, P311, DOI 10.1002/(SICI)1096-8628(19991203)87:4<311::AID-AJMG6>3.0.CO;2-5; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hatton CE, 1997, ARCH DIS CHILD, V77, P17, DOI 10.1136/adc.77.1.17; Ho PJ, 1998, ANN NY ACAD SCI, V850, P436, DOI 10.1111/j.1749-6632.1998.tb10514.x; Ho PJ, 1998, BRIT J HAEMATOL, V100, P70; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; Kim JW, 1996, HUM MUTAT, V7, P214, DOI 10.1002/(SICI)1098-1004(1996)7:3<214::AID-HUMU5>3.0.CO;2-A; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Krauss S, 1996, J THEOR BIOL, V182, P381, DOI 10.1006/jtbi.1996.0177; Michalski JC, 1999, BBA-MOL BASIS DIS, V1455, P69, DOI 10.1016/S0925-4439(99)00077-0; NAO SQ, 1995, J BIOL CHEM, V270, P6815, DOI 10.1074/jbc.270.12.6815; Ohsumi Y, 1999, PHILOS T ROY SOC B, V354, P1577, DOI 10.1098/rstb.1999.0501; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Ramirez F, 1999, ANN MED, V31, P202, DOI 10.3109/07853899909115979; Rees DC, 1998, ANN NY ACAD SCI, V850, P334, DOI 10.1111/j.1749-6632.1998.tb10490.x; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k; SCHIMMENTI LA, 1995, AM J MED GENET, V59, P204, DOI 10.1002/ajmg.1320590217; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; STAMATOYANNOPOULOS G, 1975, BLOOD, V46, P683; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THEIN SL, 1994, AM J HUM GENET, V54, P214; Vilain E, 1998, MOL GENET METAB, V65, P74, DOI 10.1006/mgme.1998.2749; VILAIN E, 1992, AM J HUM GENET, V50, P1008; Waters PJ, 1998, HUM MUTAT, V12, P344, DOI 10.1002/(SICI)1098-1004(1998)12:5<344::AID-HUMU8>3.0.CO;2-D; Weatherall DJ, 1998, ANN NY ACAD SCI, V850, P1, DOI 10.1111/j.1749-6632.1998.tb10456.x; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P2322, DOI 10.1210/jc.80.8.2322	49	335	338	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1729	1735		10.1086/302938	http://dx.doi.org/10.1086/302938			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10793008	Bronze, Green Published			2022-12-18	WOS:000088373800001
J	THOMSON, G; ROBINSON, WP; KUHNER, MK; JOE, S; MACDONALD, MJ; GOTTSCHALL, JL; BARBOSA, J; RICH, SS; BERTRAMS, J; BAUR, MP; PARTANEN, J; TAIT, BD; SCHOBER, E; MAYR, WR; LUDVIGSSON, J; LINDBLOM, B; FARID, NR; THOMPSON, C; DESCHAMPS, I				THOMSON, G; ROBINSON, WP; KUHNER, MK; JOE, S; MACDONALD, MJ; GOTTSCHALL, JL; BARBOSA, J; RICH, SS; BERTRAMS, J; BAUR, MP; PARTANEN, J; TAIT, BD; SCHOBER, E; MAYR, WR; LUDVIGSSON, J; LINDBLOM, B; FARID, NR; THOMPSON, C; DESCHAMPS, I			GENETIC-HETEROGENEITY, MODES OF INHERITANCE, AND RISK ESTIMATES FOR A JOINT STUDY OF CAUCASIANS WITH INSULIN-DEPENDENT DIABETES-MELLITUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN, SCH MED, DEPT PEDIAT, MADISON, WI 53706 USA; BLOOD CTR SE WISCONSIN, MILWAUKEE, WI USA; UNIV MINNESOTA, DEPT MED, DIV ENDOCRINOL & METAB, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA; ST ELISABETH HOSP, DEPT LAB MED, ESSEN, GERMANY; UNIV BONN, DEPT MED STAT, D-5300 BONN, GERMANY; BLOODTRANSFUS SERV, TISSUE TYPING LAB, HELSINKI, FINLAND; ROYAL MELBOURNE HOSP, PARKVILLE, VIC 3050, AUSTRALIA; VIENNA UNIV, KINDERKLIN, A-1090 VIENNA, AUSTRIA; RHEIN WESTFAL TH AACHEN, INST TRANSFUS MED, D-5100 AACHEN, GERMANY; LINKOPING UNIV, FAC HLTH SCI, DEPT PEDIAT, S-58183 LINKOPING, SWEDEN; STATE INST BLOOD GRP SEROL, LINKOPING, SWEDEN; MEM UNIV NEWFOUNDLAND, DIV ENDOCRINOL & METAB, St John A1C 5S7, NEWFOUNDLAND, CANADA; HOP ROBERT DEVRE, SERV ENDOCRINOL DIABET, PARIS, FRANCE	University of Wisconsin System; University of Wisconsin Madison; Versiti Blood Center of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Bonn; Royal Melbourne Hospital; University of Vienna; RWTH Aachen University; Linkoping University; Memorial University Newfoundland	THOMSON, G (corresponding author), UNIV CALIF BERKELEY, DEPT GENET, BERKELEY, CA 94720 USA.		Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020; Partanen, Jukka/B-7207-2014; Ludvigsson, Johnny/AAI-2051-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; Partanen, Jukka/0000-0001-6681-4734; Ludvigsson, Johnny/0000-0003-1695-5234; Rich, Stephen/0000-0003-3872-7793	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-400] Funding Source: Medline; NIADDK NIH HHS [AM20729] Funding Source: Medline; NICHD NIH HHS [HD12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACH FH, 1985, HUM IMMUNOL, V12, P59, DOI 10.1016/0198-8859(85)90343-X; BARBOSA J, 1982, DIABETES, V31, P585, DOI 10.2337/diab.31.7.585; BAUR MP, 1986, GENET EPIDEMIOL, P299; BAUR MP, 1984, HISTOCOMPATIBILITY T, P677; BELL G I, 1985, American Journal of Human Genetics, V37, pA188; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BERTRAMS J, 1984, HISTOCOMPATIBILITY T, P348; BOHME J, 1986, J IMMUNOL, V137, P941; CAMBONTHOMSEN A, IN PRESS FORENSIC HE; CHERN MM, 1982, DIABETES, V31, P1115, DOI 10.2337/diabetes.31.12.1115; CLERGETDARPOUX F, 1986, GENET EPIDEMIOL, P313; COHEN D, 1984, P NATL ACAD SCI-BIOL, V81, P1774, DOI 10.1073/pnas.81.6.1774; COHEN N, 1986, IMMUNOGENETICS, V23, P84, DOI 10.1007/BF00377966; COHENHAGUENAUER O, 1985, P NATL ACAD SCI USA, V82, P3335, DOI 10.1073/pnas.82.10.3335; CONTU L, 1982, TISSUE ANTIGENS, V20, P123; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DEGNBOL B, 1978, ANN HUM GENET, V42, P25, DOI 10.1111/j.1469-1809.1978.tb00929.x; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; DUNSWORTH TS, 1982, CLIN GENET, V21, P233; FARID NR, 1986, MOL BIOL MED, V3, P85; FARID NR, 1979, DIABETES, V28, P552, DOI 10.2337/diabetes.28.6.552; FESTENSTEIN H, 1986, NATURE, V322, P64, DOI 10.1038/322064a0; FIELD LL, 1986, GENET EPIDEMIOL, P323; FIELD LL, IN PRESS GENET EPIDE; GAMBLE DR, 1980, DIABETOLOGIA, V19, P341, DOI 10.1007/BF00280517; GORSUCH AN, 1982, DIABETES, V31, P862, DOI 10.2337/diabetes.31.10.862; HITMAN GA, 1986, IMMUNOGENETICS, V23, P47, DOI 10.1007/BF00376521; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; KLITZ W, 1988, NATURE, V333, P402, DOI 10.1038/333402c0; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; LOUIS EJ, 1984, HISTOCOMPATIBILITY T, P662; LOUIS EJ, 1986, THESIS U CALIFORNIA; LUDVIGSSON J, 1984, PEDIATR RES, V18, P1239, DOI 10.1203/00006450-198412000-00002; LUDVIGSSON J, 1986, DIABETOLOGIA, V29, P207, DOI 10.1007/BF00454876; MACDONALD MJ, 1980, DIABETES, V29, P110, DOI 10.2337/diab.29.2.110; MACDONALD MJ, 1986, P NATL ACAD SCI USA, V83, P7049, DOI 10.1073/pnas.83.18.7049; MACDONALD MJ, 1986, ANN NY ACAD SCI, V475, P356, DOI 10.1111/j.1749-6632.1986.tb20892.x; MOREL PA, IN PRESS P NATL ACAD; MORTON NE, 1983, AM J HUM GENET, V35, P201; MURPHY CC, 1983, CLIN GENET, V23, P405; NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114; NEPOM BS, 1986, J EXP MED, V164, P345, DOI 10.1084/jem.164.1.345; ODUM N, 1988, TISSUE ANTIGENS, V31, P235, DOI 10.1111/j.1399-0039.1988.tb02088.x; PARTANEN J, 1986, TISSUE ANTIGENS, V27, P291; PAYAMI H, 1985, ANN HUM GENET, V49, P303, DOI 10.1111/j.1469-1809.1985.tb01706.x; PLATZ P, 1981, DIABETOLOGIA, V21, P108; RICH SS, 1984, AM J HUM GENET, V36, P1015; RICH SS, 1986, GENET EPIDEMIOL, P341; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, IN PRESS GENET EPIDE; ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169; ROTTER JI, 1980, DIABETES, V29, P115, DOI 10.2337/diabetes.29.2.115; SCHOBER E, 1981, ARCH DIS CHILD, V56, P227, DOI 10.1136/adc.56.3.227; SEGALL M, 1986, HUM IMMUNOL, V17, P61, DOI 10.1016/0198-8859(86)90075-3; SHEEHY MJ, 1985, DIABETOLOGIA, V28, P891, DOI 10.1007/BF00703131; SHEEHY MJ, 1985, DIABETES, V34, P942, DOI 10.2337/diabetes.34.9.942; SHEEHY MJ, 1988, DIABETES, V37, pA91; SKANES VM, 1986, MOL BIOL MED, V3, P143; SOLOW H, 1979, DIABETES, V28, P1, DOI 10.2337/diabetes.28.1.1; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SPIELMAN RS, IN PRESS GENET EPIDE; SUCIUFOCA N, 1979, TRANSPLANT P, V11, P1309; SVEJGAARD A, 1981, ANN HUM GENET, V45, P293, DOI 10.1111/j.1469-1809.1981.tb00340.x; SVEJGAARD A, 1986, TISSUE ANTIGENS, V28, P237; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; SVEJGAARRD A, 1975, TRANSPLANT REV, V22, P1; TAIT BD, 1988, DIABETES, V37, P926, DOI 10.2337/diabetes.37.7.926; TAIT BD, 1986, TISSUE ANTIGENS, V28, P65; TARN AC, 1988, LANCET, V1, P845; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1986, GENET EPIDEMIOL, P363; THOMSON G, 1984, AM J HUM GENET, V36, P1309; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; THOMSON G, 1977, MEASURING SELECTION, P545; THOMSON G, IN PRESS GENET EPIDE; THOMSON G, 1977, HLA DISEASE, P280; TILLIL H, 1987, DIABETES, V36, P93, DOI 10.2337/diabetes.36.1.93; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; TODD JA, 1988, TRENDS GENET, V4, P129, DOI 10.1016/0168-9525(88)90135-7; TOSI R, 1986, DIABETOLOGIA, V29, P430, DOI 10.1007/BF00506534; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; WOLF E, 1983, DIABETOLOGIA, V24, P224	86	335	335	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					799	816						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3057885				2022-12-18	WOS:A1988R344900002
J	PICKLES, A; BOLTON, P; MACDONALD, H; BAILEY, A; LECOUTEUR, A; SIM, CH; RUTTER, M				PICKLES, A; BOLTON, P; MACDONALD, H; BAILEY, A; LECOUTEUR, A; SIM, CH; RUTTER, M			LATENT-CLASS ANALYSIS OF RECURRENCE RISKS FOR COMPLEX PHENOTYPES WITH SELECTION AND MEASUREMENT ERROR - A TWIN AND FAMILY HISTORY STUDY OF AUTISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PSYCHIATRIC-DISORDERS; INDIVIDUALS; DISEASE; MODELS; RELATIVES	The use of the family history method to examine the pattern of recurrence risks for complex disorders such as autism is not straightforward. Problems such as uncertain phenotypic definition, unreliable measurement with increased error rates for more distant relatives, and selection due to reduced fertility all complicate the estimation of risk ratios. Using data from a recent family history study of autism, and a similar study of twins, this paper shows how a latent-class approach can be used to tackle these problems. New findings are presented supporting a multiple-locus model of inheritance, with three loci giving the best fit.			PICKLES, A (corresponding author), INST PSYCHIAT,MRC,CHILD PSYCHIAT UNIT,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.		Pickles, Andrew/A-9625-2011; Bailey, Anthony/J-2860-2014; Rutter, Michael/C-8570-2013	Pickles, Andrew/0000-0003-1283-0346; Bailey, Anthony/0000-0003-4257-972X; 				AITKIN M, 1981, J ROY STAT SOC A STA, V144, P419, DOI 10.2307/2981826; ANDREASEN NC, 1986, ARCH GEN PSYCHIAT, V43, P421; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DELONG GR, 1988, J AUTISM DEV DISORD, V18, P593; ESSEN-MOLLER E, 1955, Acta Genet Stat Med, V5, P334; FARRALL M, 1992, AM J HUM GENET, V50, P270; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; GATH A, 1986, BRIT J PSYCHIAT, V149, P161, DOI 10.1192/bjp.149.2.161; HODGE SE, 1981, AM J HUM GENET, V33, P381; JORDE LB, 1991, AM J HUM GENET, V49, P932; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LITTLE R, 1987, STATISTICAL ANAL MIS; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Majumder P P, 1983, Stat Med, V2, P13, DOI 10.1002/sim.4780020103; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; PIVEN J, 1990, J AM ACAD CHILD PSY, V29, P177, DOI 10.1097/00004583-199003000-00004; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; RISCH N, 1983, BEHAV GENET, V13, P441, DOI 10.1007/BF01065920; RISCH N, 1990, AM J HUM GENET, V46, P222; RUTTER M, 1994, J CHILD PSYCHOL PSYC, V35, P311, DOI 10.1111/j.1469-7610.1994.tb01164.x; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; THOMPSON WD, 1982, ARCH GEN PSYCHIAT, V39, P53; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X; ZOCCOLILLO M, 1992, PSYCHOL MED, V22, P971, DOI 10.1017/S003329170003854X; 1987, DIAGNOSTIC STATISTIC; [No title captured]; [No title captured]; [No title captured]; 1991, NAG FORTRAN LIBRARY	32	334	349	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					717	726						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RR605	7668301				2022-12-18	WOS:A1995RR60500022
J	Konrad, M; Schaller, A; Seelow, D; Pandey, AV; Waldegger, S; Lesslauer, A; Vitzthum, H; Suzuki, Y; Luk, JM; Becker, C; Schlingmann, KP; Schmid, M; Rodriguez-Soriano, J; Ariceta, G; Cano, F; Enriquez, R; Juppner, H; Bakkaloglu, SA; Hediger, MA; Gallati, S; Neuhauss, SCF; Nurnberg, P; Weber, S				Konrad, Martin; Schaller, Andre; Seelow, Dominik; Pandey, Amit V.; Waldegger, Siegfried; Lesslauer, Annegret; Vitzthum, Helga; Suzuki, Yoshiro; Luk, John M.; Becker, Christian; Schlingmann, Karl P.; Schmid, Marcel; Rodriguez-Soriano, Juan; Ariceta, Gema; Cano, Francisco; Enriquez, Ricardo; Jueppner, Harald; Bakkaloglu, Sevcan A.; Hediger, Matthias A.; Gallati, Sabina; Neuhauss, Stephan C. F.; Nuernberg, Peter; Weber, Stefanie			Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOMAGNESEMIA-HYPERCALCIURIA; FAMILIAL HYPOMAGNESEMIA; PROTEIN STRUCTURES; LINKAGE ANALYSIS; PARACELLIN-1; CELLS	Claudins are major components of tight junctions and contribute to the epithelial-barrier function by restricting free diffusion of solutes through the paracellular pathway. We have mapped a new locus for recessive renal magnesium loss on chromosome 1p34.2 and have identified mutations in CLDN19, a member of the claudin multigene family, in patients affected by hypomagnesemia, renal failure, and severe ocular abnormalities. CLDN19 encodes the tight-junction protein claudin-19, and we demonstrate high expression of CLDN19 in renal tubules and the retina. The identified mutations interfere severely with either cell-membrane trafficking or the assembly of the claudin-19 protein. The identification of CLDN19 mutations in patients with chronic renal failure and severe visual impairment supports the fundamental role of claudin-19 for normal renal tubular function and undisturbed organization and development of the retina.	Univ Bern, Childrens Hosp, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, Theodor Kocher Inst, CH-3010 Bern, Switzerland; Univ Bern, Inst Biochem & Mol Med, CH-3010 Bern, Switzerland; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; Univ Cologne, Genet Inst, Cologne, Germany; Deutsch Ressourcenzentrum Genomforsch GmbH, Berlin, Germany; Univ Marburg, Childrens Hosp, Marburg, Germany; Univ Zurich, Inst Zool, Zurich, Switzerland; Univ Hamburg, Inst Vegetat Physiol & Pathophysiol, Hamburg, Germany; Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Reg Hosp Santa Maria, Visp, Switzerland; Spain Reg Hosp, Hosp Cruces, Dept Pediat, Bilbao, Spain; Gen Hosp Elche, Nephrol Sect, Elche, Spain; Univ Chile, Dept Pediat Nephrol, Santiago, Chile; Massachusetts Gen Hosp Children, Dept Pediat Nephrol, Boston, MA USA; Gazi Univ Hosp, Dept Pediat Nephrol, Ankara, Turkey; Univ Heidelberg, Childrens Hosp, D-6900 Heidelberg, Germany	University of Bern; University of Bern; University of Bern; University of Cologne; University of Cologne; Philipps University Marburg; University of Zurich; University of Hamburg; University of Hong Kong; Hospital Universitario Cruces; Universidad de Chile; Gazi University; Ruprecht Karls University Heidelberg	Konrad, M (corresponding author), Univ Bern, Childrens Hosp, Inselspital, Freiburgstr 10, CH-3010 Bern, Switzerland.	martin.konrad@insel.ch	Neuhauss, Stephan/AAX-9915-2020; Schaller, André/L-4174-2018; Seelow, Dominik/HGB-3124-2022; Ariceta, Gema/J-4100-2012; Luk, John/A-4085-2008; Pandey, Amit V/A-7223-2008; Pandey, Amit V/AAO-6442-2020; Bakkaloglu, Sevcan/AAE-9884-2021	Neuhauss, Stephan/0000-0002-9615-480X; Schaller, André/0000-0001-5174-5764; Seelow, Dominik/0000-0002-9746-4412; Luk, John/0000-0002-6323-7940; Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902; SUZUKI, YOSHIRO/0000-0003-0010-1867; Hediger, Matthias/0000-0003-1946-027X				Benigno V, 2000, NEPHROL DIAL TRANSPL, V15, P605, DOI 10.1093/ndt/15.5.605; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lee NPY, 2006, FEBS LETT, V580, P923, DOI 10.1016/j.febslet.2006.01.019; MEIER W, 1979, HELV PAEDIATR ACTA, V34, P257; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Rahner C, 2004, J CELL SCI, V117, P3307, DOI 10.1242/jcs.01181; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RODRIGUEZSORIANO J, 1994, PEDIATR NEPHROL, V8, P431, DOI 10.1007/BF00856522; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Weber S, 2001, J AM SOC NEPHROL, V12, P1872, DOI 10.1681/ASN.V1291872	23	333	345	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					949	957		10.1086/508617	http://dx.doi.org/10.1086/508617			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033971	Bronze, Green Published			2022-12-18	WOS:000241667400016
J	Wang, N; Akey, JM; Zhang, K; Chakraborty, R; Jin, L				Wang, N; Akey, JM; Zhang, K; Chakraborty, R; Jin, L			Distribution of recombination crossovers and the origin of haplotype blocks: The interplay of population history, recombination, and mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; COMMON DISEASE GENES; LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; HUMAN GENOME; HUMAN-CHROMOSOME-21; PROSPECTS; LOCUS	Recent studies suggest that haplotypes are arranged into discrete blocklike structures throughout the human genome. Here, we present an alternative haplotype block definition that assumes no recombination within each block but allows for recombination between blocks, and we use it to study the combined effects of demographic history and various population genetic parameters on haplotype block characteristics. Through extensive coalescent simulations and analysis of published haplotype data on chromosome 21, we find that (1) the combined effects of population demographic history, recombination, and mutation dictate haplotype block characteristics and (2) haplotype blocks can arise in the absence of recombination hot spots. Finally, we provide practical guidelines for designing and interpreting studies investigating haplotype block structure.	Univ Cincinnati, Ctr Genome Informat, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Jin, L (corresponding author), Univ Cincinnati, Ctr Genome Informat, Dept Environm Hlth, 3223 Eden Ave, Cincinnati, OH 45267 USA.		Jin, Li/C-1468-2009; Zhang, Kun/ABE-6349-2020; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Zhang, Kun/0000-0002-7596-5224; Akey, Joshua/0000-0002-4411-1330				Bogart K., 2000, INTRO COMBINATORICS; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fu YX, 1999, THEOR POPUL BIOL, V56, P1, DOI 10.1006/tpbi.1999.1421; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; SATTA Y, 1993, P NATL ACAD SCI USA, V90, P7480, DOI 10.1073/pnas.90.16.7480; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1	18	333	352	1	19	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1227	1234		10.1086/344398	http://dx.doi.org/10.1086/344398			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12384857	Bronze, Green Published			2022-12-18	WOS:000178884300023
J	Jorde, LB; Watkins, WS; Bamshad, MJ; Dixon, ME; Ricker, CE; Seielstad, MT; Batzer, MA				Jorde, LB; Watkins, WS; Bamshad, MJ; Dixon, ME; Ricker, CE; Seielstad, MT; Batzer, MA			The distribution of human genetic diversity: A comparison of mitochondrial, autosomal, and Y-chromosome data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMAN ORIGINS; DNA-SEQUENCE DIVERSITY; TANDEM REPEAT LOCI; HUMAN-EVOLUTION; POPULATION EXPANSION; ASIAN POPULATIONS; HIGH-RESOLUTION; X-CHROMOSOME; POLYMORPHISMS; PATTERNS	We report a comparison of worldwide genetic variation among 255 individuals by using autosomal, mitochondrial, and Y-chromosome polymorphisms. Variation is assessed by use of 30 autosomal restriction-site polymorphisms (RSPs), 60 autosomal short-tandem-repeat polymorphisms (STRPs), 13 Alu-insertion polymorphisms and one LINE-1: element, 611 bp of mitochondrial control-region sequence, and 10 Y-chromosome polymorphisms. Analysis of these data reveals substantial congruity among this diverse array of genetic systems. With the exception of the autosomal RSPs, in which an ascertainment bias exists, all systems show greater gene diversity in Africans than in either Europeans or Asians. Africans also have the largest total number of alleles, as well as the largest number of unique alleles, for most systems. G(ST) values are 11%-18% for the autosomal systems and are two to three times higher for the mtDNA sequence and Y-chromosome RSPs. This difference is expected because of the lower effective population size of mtDNA and Y chromosomes. A lower value is seen for Y-chromosome STRs, reflecting a relative lack of continental population structure, as a result of rapid mutation and genetic drift. Africa has higher G(ST) values than does either Europe or Asia for all systems except the Y-chromosome STRs and Alus. All systems except the Y-chromosome STRs show less variation between populations within continents than between continents. These results are reassuring in their consistency and offer broad support for an African origin of modern human populations.	Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT 84112 USA; Harvard Sch Publ Hlth, Program Populat Genet, Boston, MA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Pathol, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biometry & Genet, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biochem, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biol Mol, New Orleans, LA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard T.H. Chan School of Public Health; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Jorde, LB (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu	Seielstad, Mark/T-7841-2019	Seielstad, Mark/0000-0001-5783-1401	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00064, M01 RR000064] Funding Source: Medline; NIGMS NIH HHS [GM-52290] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arcot SS, 1996, GENOME RES, V6, P1084, DOI 10.1101/gr.6.11.1084; Arcot SS, 1997, MUTAT RES-GENOMICS, V382, P5, DOI 10.1016/S1383-5726(97)00002-2; Arcot SS, 1998, J MOL BIOL, V281, P843, DOI 10.1006/jmbi.1998.1984; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza LL, 1998, TRENDS GENET, V14, P60, DOI 10.1016/S0168-9525(97)01327-9; CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; DEKA R, 1995, ELECTROPHORESIS, V16, P1659, DOI 10.1002/elps.11501601275; Deka R, 1999, MOL BIOL EVOL, V16, P1166, DOI 10.1093/oxfordjournals.molbev.a026207; DEKA R, 1995, AM J HUM GENET, V56, P461; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EXCOFFIER L, 1992, GENETICS, V131, P479; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hammer MF, 1997, GENETICS, V145, P787; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kimmel M, 1998, GENETICS, V148, P1921; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LI WH, 1991, GENETICS, V129, P513; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; Merriwether DA, 1997, AM J PHYS ANTHROPOL, V102, P153, DOI 10.1002/(SICI)1096-8644(199702)102:2<153::AID-AJPA1>3.0.CO;2-#; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Meyer S, 1999, GENETICS, V152, P1103; Milewicz DM, 1996, J MOL EVOL, V42, P117, DOI 10.1007/BF02198836; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; National Research Council, 1996, EV FOR DNA EV; NEI M, 1990, POPULATION BIOL GENE, P251; Nei Masatoshi, 1993, P239; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Quintana-Murci L, 1999, ANN HUM GENET, V63, P153, DOI 10.1046/j.1469-1809.1999.6320153.x; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Relethford John H., 1995, Evolutionary Anthropology, V4, P53, DOI 10.1002/evan.1360040207; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Rogers AR, 1996, AM J HUM GENET, V58, P1033; ROGERS AR, 1995, HUM BIOL, V67, P1; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; Seielstad M, 1999, GENOME RES, V9, P558; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Shriver MD, 1997, GENOME RES, V7, P586, DOI 10.1101/gr.7.6.586; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	75	332	341	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					979	988		10.1086/302825	http://dx.doi.org/10.1086/302825			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712212	Bronze, Green Published			2022-12-18	WOS:000088373200020
J	Segurado, R; Detera-Wadleigh, SD; Levinson, DF; Lewis, CM; Gill, M; Nurnberg, JI; Craddock, N; DePaulo, JR; Baron, M; Gershon, ES; Ekholm, J; Cichon, S; Turecki, G; Claes, S; Kelsoe, JR; Schofield, PR; Badenhop, RF; Morissette, J; Coon, H; Blackwood, D; McInnes, LA; Foroud, T; Edenberg, HJ; Reich, T; Rice, JP; Goate, A; McInnis, MG; McMahon, FJ; Badner, JA; Goldin, LR; Bennett, P; Willour, VL; Zandi, PP; Liu, JJ; Gilliam, C; Juo, SH; Berrettini, WH; Yoshikawa, T; Peltonen, L; Lonnqvist, J; Nothen, MM; Schumacher, J; Windemuth, C; Rietschel, M; Propping, P; Maier, W; Alda, M; Grof, P; Rouleau, GA; Del-Favero, J; Van Broeckhoven, C; Mendlewicz, J; Adolfsson, R; Spence, MA; Luebbert, H; Adams, LJ; Donald, JA; Mitchell, PB; Barden, N; Shink, E; Byerley, W; Muir, W; Visscher, PM; Macgregor, S; Gurling, H; Kalsi, G; McQuillin, A; Escamilla, MA; Reus, VI; Leon, P; Freimer, NB; Ewald, H; Kruse, TA; Mors, O; Radhakrishna, U; Blouin, JL; Antonarakis, SE; Akarsu, N				Segurado, R; Detera-Wadleigh, SD; Levinson, DF; Lewis, CM; Gill, M; Nurnberg, JI; Craddock, N; DePaulo, JR; Baron, M; Gershon, ES; Ekholm, J; Cichon, S; Turecki, G; Claes, S; Kelsoe, JR; Schofield, PR; Badenhop, RF; Morissette, J; Coon, H; Blackwood, D; McInnes, LA; Foroud, T; Edenberg, HJ; Reich, T; Rice, JP; Goate, A; McInnis, MG; McMahon, FJ; Badner, JA; Goldin, LR; Bennett, P; Willour, VL; Zandi, PP; Liu, JJ; Gilliam, C; Juo, SH; Berrettini, WH; Yoshikawa, T; Peltonen, L; Lonnqvist, J; Nothen, MM; Schumacher, J; Windemuth, C; Rietschel, M; Propping, P; Maier, W; Alda, M; Grof, P; Rouleau, GA; Del-Favero, J; Van Broeckhoven, C; Mendlewicz, J; Adolfsson, R; Spence, MA; Luebbert, H; Adams, LJ; Donald, JA; Mitchell, PB; Barden, N; Shink, E; Byerley, W; Muir, W; Visscher, PM; Macgregor, S; Gurling, H; Kalsi, G; McQuillin, A; Escamilla, MA; Reus, VI; Leon, P; Freimer, NB; Ewald, H; Kruse, TA; Mors, O; Radhakrishna, U; Blouin, JL; Antonarakis, SE; Akarsu, N			Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLD-ORDER AMISH; SUSCEPTIBILITY LOCUS; GENETIC-LINKAGE; WIDE SEARCH; CHROMOSOME 12Q23-Q24; CONTROLLED FAMILY; MANIC-DEPRESSION; COMPLEX TRAITS; POTENTIAL LOCI; DNA MARKERS	Genome scans of bipolar disorder (BPD) have not produced consistent evidence for linkage. The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD genome scan data sets in an effort to identify regions with significant support for linkage in the combined data. The two primary analyses considered available linkage data for "very narrow" (i.e., BP-I and schizoaffective disorder - BP) and "narrow" (i.e., adding BP-II disorder) disease models, with the ranks weighted for sample size. A "broad" model (i.e., adding recurrent major depression) and unweighted analyses were also performed. No region achieved genomewide statistical significance by several simulation-based criteria. The most significant P values (<.01) were observed on chromosomes 9p22.3-21.1 ( very narrow), 10q11.21-22.1 ( very narrow), and 14q24.1-32.12 ( narrow). Nominally significant P values were observed in adjacent bins on chromosomes 9p and 18p-q, across all three disease models on chromosomes 14q and 18p-q, and across two models on chromosome 8q. Relatively few BPD pedigrees have been studied under narrow disease models relative to the schizophrenia GSMA data set, which produced more significant results. There was no overlap of the highest-ranked regions for the two disorders. The present results for the very narrow model are promising but suggest that more and larger data sets are needed. Alternatively, linkage might be detected in certain populations or subsets of pedigrees. The narrow and broad data sets had considerable power, according to simulation studies, but did not produce more highly significant evidence for linkage. We note that meta-analysis can sometimes provide support for linkage but cannot disprove linkage in any candidate region.	Univ Dublin Trinity Coll, Dept Genet, Neuropsychiat Genet Unit, Dublin 2, Ireland; St James Hosp, Dept Psychiat, Trinity Ctr Hlth Sci, Dublin 8, Ireland; NIMH, Mood & Anxiety Disorders Program, NIH, Bethesda, MD 20892 USA; NCI, Genet Epidemiol Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; UCL, Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci,Mol Psychiat Lab, Windeyer Inst Med Sci, London WC1E 6BT, England; UCL, Guys Kings & St Thomas Sch Med, Div Genet & Dev, London WC1E 6BT, England; Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; Univ Birmingham, Queen Elizabeth Psychiat Hosp, Div Neurosci, Mol Psychait Grp, Birmingham, W Midlands, England; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Columbia Univ, New York State Psychiat Inst, Dept Med Genet, Div Psychiat Genet, New York, NY USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth, Helsinki, Finland; Flanders Interuniv Inst Biotechnol, Dept Mol Genet, Antwerp, Belgium; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Psychiat, B-2020 Antwerp, Belgium; McGill Univ, Montreal Gen Hosp, Res Inst, Dept Psychiat, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Gen Hosp, Res Inst, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; Univ Calif San Diego, Dept Psychiat, Lab Psychiat Genom, La Jolla, CA 92093 USA; Univ New S Wales, Garvan Inst Med Res, Sydney, NSW, Australia; Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia; Prince Wales Hosp, Mood Disorders Unit, Sydney, NSW, Australia; Univ Laval, Quebec City, PQ, Canada; Ctr Hosp Univ Laval, Res Ctr, Ctr Neurosci, Quebec City, PQ, Canada; Univ Utah, Salt Lake City, UT USA; Univ Edinburgh, Edinburgh, Midlothian, Scotland; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; RIKEN, Inst Phys & Chem Res, Lab Mol Psychiat, Brain Sci Inst, Saitama, Japan; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; Univ Brussels, Erasme Hosp, Dept Psychiat, Brussels, Belgium; Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; Biofrontera Pharmaceut, Leverkusen, Germany; Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Costa Rica, Escuela Med, San Jose, Costa Rica; Univ Costa Rica, Ctr Biol Mol & Celular, San Jose, Costa Rica; Aarhus Univ Hosp, Inst Basic Psychiat Res, Risskov, Denmark; Odense Univ Hosp, Dept Clin Biochem & Genet, DK-5000 Odense, Denmark; Univ Geneva, Sch Med, Dept Med Genet, CH-1211 Geneva, Switzerland; Univ Hosp, Geneva, Switzerland; Univ Hacettepe, Dept Pediat, TR-06100 Ankara, Turkey	Trinity College Dublin; Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Pennsylvania Medicine; University of London; University College London; University of London; King's College London; University College London; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Birmingham; Johns Hopkins University; Columbia University; New York State Psychiatry Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Chicago; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Antwerp; University of Antwerp; McGill University; McGill University; University of California System; University of California San Diego; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University; Laval University; Laval University; Utah System of Higher Education; University of Utah; University of Edinburgh; Washington University (WUSTL); RIKEN; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Bonn; University of Bonn; University of Bonn; Central Institute of Mental Health; Dalhousie University; University of Ottawa; Universite Libre de Bruxelles; Umea University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Francisco; Universidad Costa Rica; Universidad Costa Rica; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Geneva; University of Geneva; Hacettepe University	Segurado, R (corresponding author), Univ Dublin Trinity Coll, Dept Genet, Neuropsychiat Genet Unit, Dublin 2, Ireland.	seguradr@tcd.ie	Schumacher, Johannes/F-4970-2015; Yoshikawa, Takeo/F-9599-2019; Alda, Martin/F-5812-2010; Cichon, Sven/B-9618-2014; McInnis, Melvin G/F-6963-2012; Macgregor, Stuart/C-6442-2009; Cichon, Sven/H-8803-2013; reus, victor i/I-7923-2015; Turecki, Gustavo/K-5100-2015; Akarsu, Nurten/E-9758-2013; Lewis, Cathryn/M-8766-2019; Van Broeckhoven, Christine/M-7853-2019; Antonarakis, Stylianos E/N-8866-2014; Van Broeckhoven, Christine/G-8362-2017; Liu, Jianjun/AAK-4989-2020; McMahon, Francis J/A-7290-2009; Visscher, Peter/ABB-6151-2020; Juo, Suh-Hang/C-9545-2009; Juo, Suh-Hang/A-1765-2010; Lewis, Cathryn M/A-5225-2010; McQuillin, Andrew/C-1623-2008; Gurling, Hugh M/A-5029-2010; Nöthen, Markus/B-2027-2009; Schofield, Peter/C-9669-2011; Segurado, Ricardo/K-6116-2014	Schumacher, Johannes/0000-0001-9217-6457; Alda, Martin/0000-0001-9544-3944; Cichon, Sven/0000-0002-9475-086X; McInnis, Melvin G/0000-0002-0375-6247; Macgregor, Stuart/0000-0001-6731-8142; Cichon, Sven/0000-0002-9475-086X; reus, victor i/0000-0002-8193-5697; Akarsu, Nurten/0000-0001-5432-0032; Lewis, Cathryn/0000-0002-8249-8476; Van Broeckhoven, Christine/0000-0003-0183-7665; Antonarakis, Stylianos E/0000-0001-8907-5823; Van Broeckhoven, Christine/0000-0003-0183-7665; Liu, Jianjun/0000-0002-3255-3019; McMahon, Francis J/0000-0002-9469-305X; Visscher, Peter/0000-0002-2143-8760; Lewis, Cathryn M/0000-0002-8249-8476; McQuillin, Andrew/0000-0003-1567-2240; Nöthen, Markus/0000-0002-8770-2464; Mitchell, Philip/0000-0002-7954-5235; Nurnberger, John/0000-0002-7674-1767; Turecki, Gustavo/0000-0003-4075-2736; Claes, Stephan/0000-0002-1175-492X; Edenberg, Howard/0000-0003-0344-9690; Adolfsson, Rolf/0000-0001-9785-8473; Willour, Virginia/0000-0002-6639-487X; Mors, Ole/0000-0002-5660-0393; Del Favero, jurgen/0000-0002-7427-7489; Gill, Michael/0000-0003-0206-5337; Schofield, Peter/0000-0003-2967-9662; DePaulo, J Raymond/0000-0001-9221-9226; Donald, Jennifer/0000-0002-2732-1379; Segurado, Ricardo/0000-0002-3547-6733; Goate, Alison/0000-0002-0576-2472	MRC [G9810900, G9309834] Funding Source: UKRI; Medical Research Council [G9810900, G9309834] Funding Source: Medline; NCRR NIH HHS [M01 RR 00827, M01 RR000827] Funding Source: Medline; NHGRI NIH HHS [N01 HG 65493] Funding Source: Medline; NIMH NIH HHS [MH 43979, U01 MH 46280, 1R01 MH 3448, MH 00176, R01 MH059545, R01 MH063876, MH 42535, MH 59567, R01 MH 59545, MH 42243, R01 MH 042463, MH 01099, U01 MH 46274, R01 MH062276, U01 MH 54794, MH 59553, R01 MH 49499, R01 MH 62276, MH 47612, K24 MH 064197, R01 MH042243, R01 MH059567, K24 MH064197, U01 MH 54701, U01 MH 54723, U01 MH 46282, MH 63876, R01 MH059553, R01 MH 42643, R01 MH049499, K02 MH 01089] Funding Source: Medline; NINDS NIH HHS [R01 NS 37484, R01 NS037484] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046280, Z01MH002810, R01MH059545, R01MH049499, Z01MH002842, U01MH046274, R01MH062276, U01MH054701, U01MH054794, K24MH064197, R01MH059553, R01MH059567, R01MH063876, U01MH054723, K02MH001089, R29MH047612, R01MH042535, U01MH046282, R01MH043979, R01MH042243, R01MH042643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037484] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams LJ, 1998, AM J HUM GENET, V62, P1084, DOI 10.1086/301826; Badenhop R, 2002, MOL PSYCHIATR, V7, P851, DOI 10.1038/sj.mp.4001114; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; Baron M, 2002, MOL PSYCHIATR, V7, P342, DOI 10.1038/sj.mp.4000998; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; Berrettini WH, 1997, ARCH GEN PSYCHIAT, V54, P27; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blacker D, 1996, AM J MED GENET, V67, P445, DOI 10.1002/(SICI)1096-8628(19960920)67:5<445::AID-AJMG2>3.0.CO;2-J; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; COON H, 1993, AM J HUM GENET, V52, P1234; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; DETERAWADLEIGH SD, 1994, AM J MED GENET, V54, P206, DOI 10.1002/ajmg.1320540307; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Ekholm J, 2002, MOL PSYCHIATR, V7, P453, DOI 10.1038/sj.mp.4001104; ENDICOTT J, 1985, J AFFECT DISORDERS, V8, P17, DOI 10.1016/0165-0327(85)90068-0; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; GERHARD DS, 1994, AM J MED GENET, V54, P398, DOI 10.1002/ajmg.1320540421; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; Grigoroiu-Serbanescu M, 1998, AM J MED GENET, V81, P397, DOI 10.1002/(SICI)1096-8628(19980907)81:5<397::AID-AJMG8>3.0.CO;2-Q; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HEUN R, 1993, ACTA PSYCHIAT SCAND, V87, P279, DOI 10.1111/j.1600-0447.1993.tb03372.x; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; LaBuda MC, 1996, AM J HUM GENET, V59, P1343; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEBOYER M, 1991, EUR ARCH PSY CLIN N, V241, P165, DOI 10.1007/BF02219716; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; McMahon FJ, 2001, ARCH GEN PSYCHIAT, V58, P1025, DOI 10.1001/archpsyc.58.11.1025; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Merikangas KR, 2002, BIOL PSYCHIAT, V52, P457, DOI 10.1016/S0006-3223(02)01471-3; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; Polymeropoulos MH, 1996, MOL PSYCHIATR, V1, P404; Radhakrishna U, 2001, EUR J HUM GENET, V9, P39, DOI 10.1038/sj.ejhg.5200584; RICE JP, 1986, PSYCHIAT RES, V19, P285, DOI 10.1016/0165-1781(86)90121-6; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Segurado R, 2001, AM J MED GENET, V105, P580; Simpson SG, 2002, ARCH GEN PSYCHIAT, V59, P736, DOI 10.1001/archpsyc.59.8.736; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; Taylor Levi, 2002, Curr Psychiatry Rep, V4, P130, DOI 10.1007/s11920-002-0046-1; Todd Richard D, 2002, Curr Psychiatry Rep, V4, P141, DOI 10.1007/s11920-002-0048-z; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x	55	331	337	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					49	62		10.1086/376547	http://dx.doi.org/10.1086/376547			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12802785	Bronze, Green Published			2022-12-18	WOS:000183904900005
J	Anderson, SL; Coli, R; Daly, IW; Kichula, EA; Rork, MJ; Volpi, SA; Ekstein, J; Rubin, BY				Anderson, SL; Coli, R; Daly, IW; Kichula, EA; Rork, MJ; Volpi, SA; Ekstein, J; Rubin, BY			Familial dysautonomia is caused by mutations of the IKAP gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVE GROWTH-FACTOR	The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded identification. We identified and characterized the RNAs encoded by this region of chromosome 9 in cell lines derived from individuals homozygous for the major FD haplotype, and we observed that the RNA encoding the I kappaB kinase complex-associated protein (IKAP) lacks exon 20 and, as a result of a frameshift, encodes a truncated protein. Sequence analysis reveals a T-->C transition in the donor splice site of intron 20. In individuals bearing a minor FD haplotype, a missense mutation in exon 19 disrupts a consensus serine/threonine kinase phosphorylation site. This mutation results in defective phosphorylation of IKAP. These mutations were observed to be present in a random sample of Ashkenazi Jewish individuals, at approximately the predicted carrier frequency of FD. These findings demonstrate that mutations in the gene encoding IKAP are responsible for FD.	Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; Comm Prevent Jewish Dis, Brooklyn, NY USA	Fordham University	Rubin, BY (corresponding author), Fordham Univ, Dept Biol Sci, Larkin Hall 160, Bronx, NY 10458 USA.							Axelrod F B, 1974, Adv Pediatr, V21, P75; Axelrod FB, 1996, PRIMER AUTONOMIC NER, P242; Blumenfeld A, 1999, AM J HUM GENET, V64, P1110, DOI 10.1086/302339; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; BREAKEFIELD XO, 1986, MOL BIOL MED, V3, P483; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; MAAYAN C, 1987, CLIN GENET, V32, P106; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; RILEY CM, 1949, PEDIATRICS, V3, P468; RUBIN BY, 1988, J IMMUNOL, V141, P1180; Yajima H, 1997, BIOSCI BIOTECH BIOCH, V61, P704, DOI 10.1271/bbb.61.704	13	331	340	1	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					753	758		10.1086/318808	http://dx.doi.org/10.1086/318808			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179021	Bronze, Green Published			2022-12-18	WOS:000166994200018
J	HAMMER, MF; HORAI, S				HAMMER, MF; HORAI, S			Y-CHROMOSOMAL DNA VARIATION AND THE PEOPLING OF JAPAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; EVOLUTIONARY RELATIONSHIPS; GENETIC-DISTANCE; POLYMORPHISMS; HAPLOTYPES; SEQUENCES; HISTORY; ORIGINS; ASIA	Four loci mapping to the nonrecombining portion of the Y chromosome were genotyped in Japanese populations from Okinawa, the southernmost island of Japan; Shizuoka and Aomori on the main island of Honshu; and a small sample of Taiwanese. The Y Alu polymorphic (YAP) element is present in 42% of the Japanese and absent in the Taiwanese, confirming the irregular distribution of this polymorphism in Asia. Data from the four loci were used to determine genetic distances among populations, construct Y chromosome haplotypes, and estimate the degree of genetic diversity in each population and on different Y chromosome haplotypes. Evolutionary analysis of Y haplotypes suggests that polymorphisms at the YAP (DYS287) and DXYS5Y loci originated a single time, whereas restriction patterns at the DYS1 locus and microsatellite alleles at the DYS19 locus arose more than once. Genetic distance analysis indicated that the Okinawans are differentiated from Japanese living on Honshu. The data support the hypotheses that modern Japanese populations have resulted from distinctive genetic contributions involving the ancient Jomon people and Yayoi immigrants from Korea or mainland China, with Okinawans experiencing the least amount of admixture with the Yayoi. It is suggested that YAP(+) chromosomes migrated to Japan with the Jomon people >10,000 years ago and that a large infusion of YAP(-) chromosomes entered Japan with the Yayoi migration starting 2,300 years ago. Different degrees of genetic diversity carried by these two ancient chromosomal lineages may be explained by the different lifestyles (hunter-gatherer versus agriculturalist). of the migrant groups, the size of the founding populations, and the antiquities of the founding events.	NATL INST GENET, DEPT HUMAN GENET, MISHIMA, SHIZUOKA 411, JAPAN	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	HAMMER, MF (corresponding author), UNIV ARIZONA, MOLEC SYSTEMAT & EVOLUT LAB, BIOSCI W, TUCSON, AZ 85721 USA.							AKAISHI S, 1975, JIBP SYNTHESIS ANTHR, P77; BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chard C.S., 1974, NE ASIA PREHISTORY; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOMOLKA M, 1994, HUM GENET, V93, P592; GUERIN P, 1988, NUCLEIC ACIDS RES, V16, P7759, DOI 10.1093/nar/16.15.7759; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1993, MOL BIOL EVOL, V10, P971; HANIHARA K, 1984, Acta Anthropogenetica, V8, P149; HANIHARA K, 1992, HUM EVOL, V7, P85; HANIHARA T, 1991, J ANTHROPOL SOC NIP, V99, P399; HARIHARA S, 1992, HUM BIOL, V64, P161; HORAI S, 1991, PHILOS T ROY SOC B, V333, P409, DOI 10.1098/rstb.1991.0091; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1991, NEW ASPECTS GENETICS, P135; HORAI S, 1987, HUM GENET, P177; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; KOZINTSEV AG, 1993, HOMO, V44, P105; LI WH, 1977, GENETICS, V85, P331; LIN SJ, 1994, JPN J HUM GENET, V39, P299, DOI 10.1007/BF01874048; Lucotte G, 1990, Gene Geogr, V4, P21; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MISAWA S, 1974, Journal of the Anthropological Society of Nippon, V82, P135; Mizoguchi Y., 1986, PREHISTORIC HUNTER G, P107; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; MULLER S, 1994, HUM HERED, V44, P298, DOI 10.1159/000154233; NAKAGOME Y, 1992, ANN HUM GENET, V56, P311, DOI 10.1111/j.1469-1809.1992.tb01158.x; NAKAHORI Y, 1989, NUCLEIC ACIDS RES, V17, P2152, DOI 10.1093/nar/17.5.2152; NAKANAGA M, 1991, HUM BIOL, V63, P187; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, IN PRESS ORIGINAL PA; NGO KY, 1986, AM J HUM GENET, V38, P407; OMOTO K, 1976, ORIGIN AUSTR, P365; OSSENBERGN, 1986, PREHISTORIC HUNTER G, P199; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; REYNOLDS J, 1983, GENETICS, V105, P767; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROEWER L, 1992, HUM GENET, V89, P389; ROGERS AR, 1995, HUM BIOL, V67, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTOS FR, 1993, HUM GENET, V90, P655; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE AB, 1994, ANN HUM GENET, V58, P251, DOI 10.1111/j.1469-1809.1994.tb01889.x; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Suzuki H, 1981, RASSENGESCHICHTE MEN, P7; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TORRONI A, 1990, ANN HUM GENET, V54, P287; TSUCHIDA S, 1989, HUM HERED, V39, P61, DOI 10.1159/000153836; TURNER CG, 1976, SCIENCE, V193, P911; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WILSON EO, 1977, PRIMER POPULATION BI; YAMAGUCHI B, 1982, J ANTHROPOL SOC NIP, V90, P77; [No title captured]	65	331	343	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					951	962						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717406				2022-12-18	WOS:A1995QP66300017
J	Guo, DC; Papke, CL; Tran-Fadulu, V; Regalado, ES; Avidan, N; Johnson, RJ; Kim, DH; Pannu, H; Willing, MC; Sparks, E; Pyeritz, RE; Singh, MN; Dalman, RL; Grotta, JC; Marian, AJ; Boerwinkle, EA; Frazier, LQ; LeMaire, SA; Coselli, JS; Estrera, AL; Safi, HJ; Veeraraghavan, S; Muzny, DM; Wheeler, DA; Willerson, JT; Yu, RK; Shete, SS; Scherer, SE; Raman, CS; Buja, LM; Milewicz, DM				Guo, Dong-Chuan; Papke, Christina L.; Tran-Fadulu, Van; Regalado, Ellen S.; Avidan, Nili; Johnson, Ralph Jay; Kim, Dong H.; Pannu, Hariyadarshi; Willing, Marcia C.; Sparks, Elizabeth; Pyeritz, Reed E.; Singh, Michael N.; Dalman, Ronald L.; Grotta, James C.; Marian, Ali J.; Boerwinkle, Eric A.; Frazier, Lorraine Q.; LeMaire, Scott A.; Coselli, Joseph S.; Estrera, Anthony L.; Safi, Hazim J.; Veeraraghavan, Sudha; Muzny, Donna M.; Wheeler, David A.; Willerson, James T.; Yu, Robert K.; Shete, Sanjay S.; Scherer, Steven E.; Raman, C. S.; Buja, L. Maximilian; Milewicz, Dianna M.			Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-BETA; SERUM RESPONSE FACTOR; MYOCARDIAL-INFARCTION; DISSECTIONS; ANEURYSMS; MYOFIBROBLASTS; TRANSCRIPTION; CHILDREN; FEATURES; DELETION	The vascular smooth muscle cell (SMC)-specific isoform of of.-actin (ACTA2) is a major component of the contractile apparatus in SMCs located throughout the arterial system. Heterozygous ACTA2 mutations cause familial thoracic aortic aneurysms and dissections (TAAD), but only half of mutation carriers have aortic disease. Linkage analysis and association studies of individuals in 20 families with ACTA2 mutations indicate that mutation carriers can have a diversity of vascular diseases, including premature onset of coronary artery disease (CAD) and premature ischemic strokes (including Moyamoya disease [MMD]), as well as previously defined TAAD. Sequencing of DNA from patients with nonfamilial TAAD and from premature-onset CAD patients independently identified ACTA2 mutations in these patients and premature onset strokes in family members with ACTA2 mutations. Vascular pathology and analysis of explanted SMCs and myofibroblasts from patients harboring ACTA2 suggested that increased proliferation of SMCs contributed to occlusive diseases. These results indicate that heterozygous ACTA2 mutations predispose patients to a variety of diffuse and diverse vascular diseases, including TAAD, premature CAD, ischemic strokes, and MMD. These data demonstrate that diffuse vascular diseases resulting from either occluded or enlarged arteries can be caused by mutations in a single gene and have direct implications for clinical management and research on familial vascular diseases.	[Guo, Dong-Chuan; Papke, Christina L.; Tran-Fadulu, Van; Regalado, Ellen S.; Avidan, Nili; Johnson, Ralph Jay; Kim, Dong H.; Pannu, Hariyadarshi; Grotta, James C.; Marian, Ali J.; Boerwinkle, Eric A.; Frazier, Lorraine Q.; Estrera, Anthony L.; Safi, Hazim J.; Veeraraghavan, Sudha; Raman, C. S.; Buja, L. Maximilian; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Willing, Marcia C.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Sparks, Elizabeth] Harvard Univ, Sch Med, Boston, MA 02446 USA; [Pyeritz, Reed E.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Singh, Michael N.] Brigham & Womens Hosp, Childrens Hosp Boston, Boston, MA 02115 USA; [Dalman, Ronald L.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Marian, Ali J.; Boerwinkle, Eric A.; LeMaire, Scott A.; Coselli, Joseph S.; Willerson, James T.; Milewicz, Dianna M.] Texas Heart Inst, Houston, TX 77030 USA; [LeMaire, Scott A.; Coselli, Joseph S.; Muzny, Donna M.; Wheeler, David A.; Scherer, Steven E.] Baylor Coll Med, Houston, TX 77030 USA; [Yu, Robert K.; Shete, Sanjay S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Iowa; Harvard University; Harvard Medical School; University of Pennsylvania; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Stanford University; Texas Heart Institute; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Grotta, James/AAH-7423-2021; Estrera, Anthony/ABG-4175-2021; Wheeler, David A/M-9740-2018	Wheeler, David A/0000-0002-9056-6299; Buja, Louis Maximilian/0000-0001-8386-7029; Regalado, Ellen/0000-0002-5859-218X; Marian, AJ/0000-0002-1252-7120; Kim, Dong/0000-0002-1523-6396; LeMaire, Scott/0000-0002-8736-4266; Raman, C. S./0000-0002-1036-3193	INSERM; Programme National de Recherche Cardiovasculaire; Vivian L. Smith Foundation; TexGen Foundation;  [P50HL083794-01];  [R01 HL62594];  [UL1 RR024148];  [P50NS044227]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, P50HL083794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS044227] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Programme National de Recherche Cardiovasculaire; Vivian L. Smith Foundation; TexGen Foundation; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are extremely grateful to the families and their physicians involved in this study. The authors also wish to acknowledge Richard Gibbs (Director) and Chris Akers for the excellent graphic assistance. The following sources provided funding for these studies: P50HL083794-01 (D.M.M.), R01 HL62594 (D.M.M.), UL1 RR024148 (CTSA), P50NS044227 O.C.G.), INSERM and Programme National de Recherche Cardiovasculaire (X.J.), the Vivian L. Smith Foundation, and the TexGen Foundation. D.M.M. is a Doris Duke Distinguished Clinical Scientist, C.S.R. is a Pew Scholar, and C.L.P. is a Schissler Fellow.	Arora PD, 1999, AM J PATHOL, V155, P2087, DOI 10.1016/S0002-9440(10)65527-7; Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DeLano WL, 2002, PYMOL USERS MANUAL; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Fukui M, 2000, NEUROPATHOLOGY, V20, pS61, DOI 10.1046/j.1440-1789.2000.00300.x; Guo DC, 2001, CIRCULATION, V103, P2461; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; HUMPHREY JD, 2002, CARDIOVASCULAR SOLID, P249; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KITAHARA T, 1979, J NEUROL NEUROSUR PS, V42, P208, DOI 10.1136/jnnp.42.3.208; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Scott RM, 2004, J NEUROSURG, V100, P142, DOI 10.3171/ped.2004.100.2.0142; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Tomasek JJ, 2006, INVEST OPHTH VIS SCI, V47, P2693, DOI 10.1167/iovs.05-1297; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	33	329	345	5	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					617	627		10.1016/j.ajhg.2009.04.007	http://dx.doi.org/10.1016/j.ajhg.2009.04.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409525	Green Published, Bronze			2022-12-18	WOS:000266338800006
J	Chen, WM; Abecasis, GR				Chen, Wei-Min; Abecasis, Goncalo R.			Family-based association tests for genomewide association scans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENE-EXPRESSION; WIDE ASSOCIATION; PEDIGREE ANALYSIS; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAITS; MISSING GENOTYPES; NUCLEAR FAMILIES; MODELS; MAP; STRATIFICATION	With millions of single-nucleotide polymorphisms (SNPs) identified and characterized, genomewide association studies have begun to identify susceptibility genes for complex traits and diseases. These studies involve the characterization and analysis of very-high-resolution SNP genotype data for hundreds or thousands of individuals. We describe a computationally efficient approach to testing association between SNPs and quantitative phenotypes, which can be applied to whole-genome association scans. In addition to observed genotypes, our approach allows estimation of missing genotypes, resulting in substantial increases in power when genotyping resources are limited. We estimate missing genotypes probabilistically using the Lander-Green or Elston-Stewart algorithms and combine high-resolution SNP genotypes for a subset of individuals in each pedigree with sparser marker data for the remaining individuals. We show that power is increased whenever phenotype information for ungenotyped individuals is included in analyses and that high-density genotyping of just three carefully selected individuals in a nuclear family can recover >90% of the information available if every individual were genotyped, for a fraction of the cost and experimental effort. To aid in study design, we evaluate the power of strategies that genotype different subsets of individuals in each pedigree and make recommendations about which individuals should be genotyped at a high density. To illustrate our method, we performed genomewide association analysis for 27 gene-expression phenotypes in 3-generation families (Centre d'Etude du Polymorphisme Humain pedigrees), in which genotypes for similar to 860,000 SNPs in 90 grandparents and parents are complemented by genotypes for similar to 6,700 SNPs in a total of 168 individuals. In addition to increasing the evidence of association at 15 previously identified cis-acting associated alleles, our genotype-inference algorithm allowed us to identify associated alleles at 4 cis-acting loci that were missed when analysis was restricted to individuals with the high-density SNP data. Our genotype-inference algorithm and the proposed association tests are implemented in software that is available for free.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chen, WM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Heights, Ann Arbor, MI 48109 USA.	wmchen@virginia.edu	Abecasis, Goncalo R/B-7840-2010; Chen, Wei-Min/A-8469-2009	Abecasis, Goncalo/0000-0003-1509-1825				Abecasis GR, 2005, HUM HERED, V59, P118, DOI 10.1159/000085226; Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AMOS CI, 1994, AM J HUM GENET, V54, P535; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DIXON AL, IN PRESS NAT GENET; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LANGE K, 1987, AM J HUM GENET, V40, P250; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sobel E, 1996, AM J HUM GENET, V58, P1323; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Visscher PM, 2006, GENET EPIDEMIOL, V30, P30, DOI 10.1002/gepi.20124; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	44	329	338	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					913	926		10.1086/521580	http://dx.doi.org/10.1086/521580			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924335	Bronze, Green Published			2022-12-18	WOS:000250480900005
J	Kurek, KC; Luks, VL; Ayturk, UM; Alomari, AI; Fishman, SJ; Spencer, SA; Mulliken, JB; Bowen, ME; Yamamoto, GL; Kozakewich, HPW; Warman, ML				Kurek, Kyle C.; Luks, Valerie L.; Ayturk, Ugur M.; Alomari, Ahmad I.; Fishman, Steven J.; Spencer, Samantha A.; Mulliken, John B.; Bowen, Margot E.; Yamamoto, Guilherme L.; Kozakewich, Harry P. W.; Warman, Matthew L.			Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMATOPOIETIC STEM; OVERGROWTH; CANCER	Congenital lipomatous overgrowth with vascular, epidermal, and skeletal anomalies (CLOVES) is a sporadically occurring, nonhereditary disorder characterized by asymmetric somatic hypertrophy and anomalies in multiple organs. We hypothesized that CLOVES syndrome would be caused by a somatic mutation arising during early embryonic development. Therefore, we employed massively parallel sequencing to search for somatic mosaic mutations in fresh, frozen, or fixed archival tissue from six affected individuals. We identified mutations in PIK3CA in all six individuals, and mutant allele frequencies ranged from 3% to 30% in affected tissue from multiple embryonic lineages. Interestingly, these same mutations have been identified in cancer cells, in which they increase phosphoinositide-3-kinase activity. We conclude that CLOVES is caused by postzygotic activating mutations in PIK3CA. The application of similar sequencing strategies will probably identify additional genetic causes for sporadically occurring, nonheritable malformations.	[Luks, Valerie L.; Ayturk, Ugur M.; Spencer, Samantha A.; Bowen, Margot E.; Warman, Matthew L.] Boston Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Ayturk, Ugur M.; Bowen, Margot E.; Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kurek, Kyle C.; Kozakewich, Harry P. W.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Alomari, Ahmad I.] Boston Childrens Hosp, Dept Vasc & Intervent Radiol, Boston, MA 02115 USA; [Fishman, Steven J.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Mulliken, John B.] Boston Childrens Hosp, Dept Plast Surg, Boston, MA 02115 USA; [Alomari, Ahmad I.; Fishman, Steven J.; Kozakewich, Harry P. W.; Warman, Matthew L.] Boston Childrens Hosp, Vasc Anomalies Ctr, Boston, MA 02115 USA; [Yamamoto, Guilherme L.] Univ Sao Paulo, Fac Med, Dept Genet, BR-01246903 Sao Paulo, Brazil; [Warman, Matthew L.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Universidade de Sao Paulo; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Warman, ML (corresponding author), Boston Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu	Yamamoto, Guilherme/C-9973-2010; Alomari, Ahmad I./AAU-8236-2020	Yamamoto, Guilherme/0000-0002-0490-8257; Alomari, Ahmad I./0000-0002-9404-0489; Neff, Ryan/0000-0003-1870-7031; Bowen, Margot/0000-0001-6391-5775	Manton Center for Orphan Disease Research [94824-01]; Boston Children's Hospital; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053237]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237] Funding Source: NIH RePORTER	Manton Center for Orphan Disease Research; Boston Children's Hospital; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful for the active support of the CLOVES syndrome community (www.clovessyndrome.org and www.clovesfoundation.org) and to the individuals and families that participated in this study. We also acknowledge Cameron Trenor III, Arin Greene, Joseph Upton III, Rebecca Fevurly, Denise Adams, and all of the members of the Vascular Anomalies Center, Boston Children's Hospital for their dedication to the care of individuals with CLOVES and other vascular problems. We thank Mr. Ryan Neff for providing computation assistance, and we thank Joseph Gleeson and colleagues, who shared information about similar findings in individuals with hemimegalencephaly. This work was funded in part by the Manton Center for Orphan Disease Research (pilot grant 94824-01 to K.C.K.) and the Stuart and Jane Weitzman Family Vascular Anomalies Fund at Boston Children's Hospital, the National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR053237, and the Howard Hughes Medical Institute.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Alomari AI, 2011, AM J NEURORADIOL, V32, P1812, DOI 10.3174/ajnr.A2349; Alomari AI, 2010, J THORAC CARDIOV SUR, V140, P459, DOI 10.1016/j.jtcvs.2010.04.023; Alomari AI, 2009, CLIN DYSMORPHOL, V18, P1, DOI 10.1097/MCD.0b013e328317a716; Alomari AI, 2009, AM J MED GENET A, V149A, P294, DOI 10.1002/ajmg.a.32632; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Chen YW, 2012, J CELL PHYSIOL, V227, P2818, DOI 10.1002/jcp.23038; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Cohen MM, 2000, AM J MED GENET, V93, P171, DOI 10.1002/1096-8628(20000731)93:3<171::AID-AJMG1>3.0.CO;2-K; Diaz A, 2007, J PEDIATR ENDOCR MET, V20, P853; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Kurek KC, 2012, AM J SURG PATHOL, V36, P671, DOI 10.1097/PAS.0b013e31824dd86c; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sapp JC, 2007, AM J MED GENET A, V143A, P2944, DOI 10.1002/ajmg.a.32023; Tan MH, 2011, AM J HUM GENET, V88, P42, DOI 10.1016/j.ajhg.2010.11.013; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yuan W., 2012, ONCOGENE; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	25	328	335	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1108	1115		10.1016/j.ajhg.2012.05.006	http://dx.doi.org/10.1016/j.ajhg.2012.05.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22658544	Green Published, Bronze			2022-12-18	WOS:000305262600016
J	Reich, D; Patterson, N; Kircher, M; Delfin, F; Nandineni, MR; Pugach, I; Ko, AMS; Ko, YC; Jinam, TA; Phipps, ME; Saitou, N; Wollstein, A; Kayser, M; Paabo, S; Stoneking, M				Reich, David; Patterson, Nick; Kircher, Martin; Delfin, Frederick; Nandineni, Madhusudan R.; Pugach, Irina; Ko, Albert Min-Shan; Ko, Ying-Chin; Jinam, Timothy A.; Phipps, Maude E.; Saitou, Naruya; Wollstein, Andreas; Kayser, Manfred; Paeaebo, Svante; Stoneking, Mark			Denisova Admixture and the First Modern Human Dispersals into Southeast Asia and Oceania	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; NEW-GUINEA; GENETIC DIVERSITY; MTDNA; COLONIZATION; AUSTRALIANS; SETTLEMENT; JACKKNIFE; PACIFIC; ORIGINS	It has recently been shown that ancestors of New Guineans and Bougainville Islanders have inherited a proportion of their ancestry from Denisovans, an archaic hominin group from Siberia. However, only a sparse sampling of populations from Southeast Asia and Oceania were analyzed. Here, we quantify Denisova admixture in 33 additional populations from Asia and Oceania. Aboriginal Australians, Near Oceanians, Polynesians, Fijians, east Indonesians, and Mamanwa (a "Negrito" group from the Philippines) have all inherited genetic material from Denisovans, but mainland East Asians, western Indonesians, Jehai (a Negrito group from Malaysia), and Onge (a Negrito group from the Andaman Islands) have not. These results indicate that Denisova gene flow occurred into the common ancestors of New Guineans, Australians, and Mamanwa but not into the ancestors of the Jehai and Onge and suggest that relatives of present-day East Asians were not in Southeast Asia when the Denisova gene flow occurred. Our finding that descendants of the earliest inhabitants of Southeast Asia do not all harbor Denisova admixture is inconsistent with a history in which the Denisova interbreeding occurred in mainland Asia and then spread over Southeast Asia, leading to all its earliest modern human inhabitants. Instead, the data can be most parsimoniously explained if the Denisova gene flow occurred in Southeast Asia itself. Thus, archaic Denisovans must have lived over an extraordinarily broad geographic and ecological range, from Siberia to tropical Asia.	[Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Kircher, Martin; Delfin, Frederick; Nandineni, Madhusudan R.; Pugach, Irina; Ko, Albert Min-Shan; Paeaebo, Svante; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost, Lab DNA Fingerprinting, Hyderabad 500001, Andhra Pradesh, India; [Ko, Ying-Chin] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan; [Jinam, Timothy A.; Saitou, Naruya] Natl Inst Genet, Div Populat Genet, Mishima, Shizuoka 4118540, Japan; [Phipps, Maude E.] Monash Univ, Sch Med & Hlth Sci, Selangor 46150, Malaysia; [Wollstein, Andreas] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Wollstein, Andreas; Kayser, Manfred] Erasmus MC Univ Med Ctr Rotterdam, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Kaohsiung Medical University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Monash University; Monash University Sunway; University of Cologne; Erasmus University Rotterdam; Erasmus MC	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; stoneking@eva.mpg.de	Kircher, Martin/H-6909-2019; Kircher, Martin/HDL-9392-2022; Phipps, Maude/F-7590-2012	Kircher, Martin/0000-0001-9278-5471; Phipps, Maude/0000-0001-8314-068X; Delfin, Frederick/0000-0002-8201-0661; Ko, Albert Min-Shan/0000-0002-2096-1330; Nandineni, Madhusudan Reddy/0000-0002-8933-4503; Jinam, Timothy/0000-0003-4757-096X	SOKENDAI Graduate Student Overseas Travel Fund; Max Planck Society; National Science Foundation [1032255]	SOKENDAI Graduate Student Overseas Travel Fund; Max Planck Society(Max Planck SocietyFoundation CELLEX); National Science Foundation(National Science Foundation (NSF))	We thank the volunteers who donated DNA samples. We acknowledge F.A. Almeda Jr., J.P. Erazo, D. Gil, the late J. Kuhl, E.S. Larase, I. Motinola, G. Patagan, W. Sinco, A. Sofro, U. Tadmor, and R. Trent for assistance with sample collections. We thank M. Meyer for preparing DNA libraries for high-throughput sequencing; A. Batik and P. Nurenberg for assistance with genotyping; and O. Bar-Yosef, K. Bryc, R.E. Green, J.-J. Hublin, J. Kelso, D. Lieberman, B. Pakendorf, M. Slatkin, and B. Viola for comments on the manuscript. T.A. Jinam was supported by a grant from the SOKENDAI Graduate Student Overseas Travel Fund. This work was supported by the Max Planck Society and by a National Science Foundation HOMINID grant (1032255).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cann HM, 2002, SCIENCE, V296, P261; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cordaux R, 2003, AM J HUM GENET, V72, P1586, DOI 10.1086/375407; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; KUNSCH HR, 1989, ANN STAT, V17, P1217, DOI 10.1214/aos/1176347265; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MATSUMOTO H, 1979, AM J HUM GENET, V31, P70; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mona S, 2009, MOL BIOL EVOL, V26, P1865, DOI 10.1093/molbev/msp097; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040	34	327	342	5	184	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					516	528		10.1016/j.ajhg.2011.09.005	http://dx.doi.org/10.1016/j.ajhg.2011.09.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	834HV	21944045	Green Published, Bronze			2022-12-18	WOS:000295951300006
J	Merner, ND; Hodgkinson, KA; Haywood, AFM; Connors, S; French, VM; Drenckhahn, JD; Kupprion, C; Ramadanova, K; Thierfelder, L; McKenna, W; Gallagher, B; Morris-Larkin, L; Bassett, AS; Parfrey, PS; Young, TL				Merner, Nancy D.; Hodgkinson, Kathy A.; Haywood, Annika F. M.; Connors, Sean; French, Vanessa M.; Drenckhahn, Joerg-Detlef; Kupprion, Christine; Ramadanova, Kalina; Thierfelder, Ludwig; McKenna, William; Gallagher, Barry; Morris-Larkin, Lynn; Bassett, Anne S.; Parfrey, Patrick S.; Young, Terry-Lynn			Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERM FOLLOW-UP; ECHOCARDIOGRAPHIC MEASUREMENTS; DYSPLASIA; DYSPLASIA/CARDIOMYOPATHY; INVOLVEMENT; FAMILIES; IDENTIFICATION; NEWFOUNDLAND; ASSOCIATION; POPULATION	Autosomal-dominant arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) causes sudden cardiac death and is characterized by clinical and genetic heterogeneity. Fifteen unrelated ARVC families with a disease-associated haplotype on chromosome 3p (ARVD5) were ascertained from a genetically isolated population. Identification of key recombination events reduced the disease region to a 2.36 Mb interval containing 20 annotated genes. Bidirectional resequencing showed one rare variant in transmembrane protein 43 (TMEM43 1073C -> T, S358L), was carried on all recombinant ARVD5 ancestral haplotypes from affected subjects and not found in population controls. The mutation occurs in a highly conserved transmembrane domain of TMEM43 and is predicted to be deleterious. Clinical outcomes in 257 affected and 151 unaffected subjects were compared, and penetrance was determined. We concluded that ARVC at locus ARVD5 is a lethal, fully penetrant, sex-influenced morbid disorder. Median life expectancy was 41 years in affected males compared to 71 years in affected females (relative risk 6.8, 95% CI 1.3-10.9). Heart failure was a late manifestation in survivors. Although little is known about the function of the TMEM43 gene, it contains a response element for PPAR gamma (an adipogenic transcription factor), which may explain the fibrofatty replacement of the myocardium, a characteristic pathological finding in ARVC.	[Merner, Nancy D.; Hodgkinson, Kathy A.; Haywood, Annika F. M.; Connors, Sean; French, Vanessa M.; Morris-Larkin, Lynn; Parfrey, Patrick S.; Young, Terry-Lynn] Mem Univ Newfoundland, Fac Med, St John, NF A1B 3V6, Canada; [Drenckhahn, Joerg-Detlef; Kupprion, Christine; Ramadanova, Kalina; Thierfelder, Ludwig] Max Delbruck Ctr Mol Med, Max Delbruck Zentrum, D-13122 Berlin, Germany; [McKenna, William] Heart Hosp, London W1G 8PH, England; [Gallagher, Barry] James Paton Mem Reg Hlth Ctr, Dept Pathol, Gander, NF A1V 1P7, Canada; [Bassett, Anne S.] Univ Toronto, Clin Genet Res Program, Ctr Addict & Mental Hlth, Toronto, ON M6J 1H4, Canada	Memorial University Newfoundland; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University College London Hospitals NHS Foundation Trust; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Young, TL (corresponding author), Mem Univ Newfoundland, Fac Med, St John, NF A1B 3V6, Canada.	tlyoung@mun.ca	McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Merner, Nancy/0000-0002-8954-0155; Drenckhahn, Jorg-Detlef/0000-0001-8347-7696; Young, Terry-Lynn/0000-0003-4673-6470				Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; BLOMSTROMLUNDQVIST C, 1987, BRIT HEART J, V58, P477; BREITHARDT G, 1991, J AM COLL CARDIOL, V17, P999, DOI 10.1016/0735-1097(91)90822-Q; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corrado D, 2000, HEART, V83, P588, DOI 10.1136/heart.83.5.588; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dokuparti MVN, 2005, J HUM GENET, V50, P375, DOI 10.1007/s10038-005-0273-5; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; GUIRAUDON GM, 1983, CIRCULATION, V67, P463, DOI 10.1161/01.CIR.67.2.463; Hamid MS, 2002, J AM COLL CARDIOL, V40, P1445, DOI 10.1016/S0735-1097(02)02307-0; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; HENRY WL, 1978, CIRCULATION, V57, P278, DOI 10.1161/01.CIR.57.2.278; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hodgkinson KA, 2005, J AM COLL CARDIOL, V45, P400, DOI 10.1016/j.jacc.2004.08.068; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lindstrom L, 2005, CLIN PHYSIOL FUNCT I, V25, P171, DOI 10.1111/j.1475-097X.2005.00607.x; Lobo FV, 1999, CAN J CARDIOL, V15, P1239; MacRae CA, 2006, J CLIN INVEST, V116, P1825, DOI 10.1172/JCI29174; Mannion John, 1977, PEOPLING NEWFOUNDLAN; MARSHALL W, 1988, NEW ENGL J MED, V319, P174; Matsuo Shinro, 2007, Int J Cardiol, V115, pe129, DOI 10.1016/j.ijcard.2006.09.012; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Nava A, 2000, J AM COLL CARDIOL, V36, P2226, DOI 10.1016/S0735-1097(00)00997-9; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; *NYHA CC, 1964, NOMENCLATURE CRITERI, P114; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pinamonti B, 1998, CIRCULATION, V98, P1943, DOI 10.1161/01.CIR.98.18.1943; Protonotarios N, 2001, J AM COLL CARDIOL, V38, P1477, DOI 10.1016/S0735-1097(01)01568-6; Rahman P, 2003, HUM MOL GENET, V12, pR167, DOI 10.1093/hmg/ddg257; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Wlodarska EK, 2005, INT J CARDIOL, V105, P126, DOI 10.1016/j.ijcard.2004.11.016; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	45	327	339	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					809	821		10.1016/j.ajhg.2008.01.010	http://dx.doi.org/10.1016/j.ajhg.2008.01.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18313022	Green Published, Bronze			2022-12-18	WOS:000255103900001
J	Mersiyanova, IV; Perepelov, AV; Polyakov, AV; Sitnikov, VF; Dadali, EL; Oparin, RB; Petrin, AN; Evgrafov, OV				Mersiyanova, IV; Perepelov, AV; Polyakov, AV; Sitnikov, VF; Dadali, EL; Oparin, RB; Petrin, AN; Evgrafov, OV			A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL MYELIN PROTEIN; TREMBLER-J MOUSE; HEREDITARY MOTOR; AXONAL-TRANSPORT; TRANSGENIC MICE; POINT MUTATION; SCHWANN-CELLS; LEWY BODIES; HEAVY GENE	Charcot-Marie-Tooth (CMT) disease is the most common inherited motor and sensory neuropathy. The axonal form of the disease is designated as "CMT type 2" (CMT2). Although four loci known to be implicated in autosomal dominant CMT2 have been mapped thus far (on 1p35-p36, 3q13.1, 3q13-q22, and 7p14), no one causative gene is yet known. A large Russian family with CMT2 was found in the Mordovian Republic (Russia). Affected members had the typical CMT2 phenotype. Additionally, several patients suffered from hyperkeratosis, although the association, if any, between the two disorders is not clear. Linkage with the CMT loci already known (CMT1A, CMT1B, CMT2A, CMT2B, CMT2D, and a number of other CMT-related loci) was excluded. Genomewide screening pinpointed the disease locus in this family to chromosome 8p21, within a 16-cM interval between markers D8S136 and D8S1769. A maximum two-point LOD score of 5.93 was yielded by a microsatellite from the 5' region of the neurofilament-light gene (NF-L). Neurofilament proteins play an important role in axonal structure and are implicated in several neuronal disorders. Screening of affected family members for mutations in the NF-L gene and in the tightly linked neurofilament-medium gene (NF-M) revealed the only DNA alteration linked with the disease: a A998C transversion in the first exon of NF-L, which converts a conserved Gln333 amino acid to proline. This alteration was not found in 180 normal chromosomes. Twenty unrelated CMT2 patients, as well as 26 others with an undetermined form of CMT, also were screened for mutations in NF-L, but no additional mutations were found. It is suggested that Gln33SPro represents a rare disease-causing mutation, which results in the CMT2 phenotype.	Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; Russian State Med Univ, Moscow 117437, Russia; Res Ctr Dermatol & Venerol, Moscow, Russia; Mordovian NP Ogarev State Univ, Saransk, Russia	Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Pirogov Russian National Research Medical University; Mordovian State University	Mersiyanova, IV (corresponding author), Russian Acad Med Sci, Med Genet Res Ctr, Moskvorechie 1, Moscow 115478, Russia.	imers@mail.ru						ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; BENOTHMANE K, 1993, GENOMICS, V17, P370; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Birouk N, 1998, NEUROLOGY, V50, P1074, DOI 10.1212/WNL.50.4.1074; Carpenter DA, 1996, J CELL SCI, V109, P2493; Cleveland DW, 1996, NEUROLOGY, V47, pS54, DOI 10.1212/WNL.47.4_Suppl_2.54S; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; De Jonghe P, 1997, J Peripher Nerv Syst, V2, P370; De Jonghe P, 1997, J NEUROL NEUROSUR PS, V62, P570, DOI 10.1136/jnnp.62.6.570; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dyck P.J, 1993, PNP, P1094; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; EVGRAFOV OV, 1997, J PERIPHER NERV SYST, V2, P392; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Flanigan KM, 1998, ANN NEUROL, V43, P143, DOI 10.1002/ana.410430126; GEISLER N, 1981, J MOL BIOL, V151, P565, DOI 10.1016/0022-2836(81)90011-5; GOLDMAN JE, 1983, SCIENCE, V221, P1082, DOI 10.1126/science.6308771; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HIRANO A, 1991, ADV NEUROL, V56, P91; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Julien JP, 1995, BIOCHEM CELL BIOL, V73, P593, DOI 10.1139/o95-064; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; KWON JM, 1995, AM J HUM GENET, V57, P853; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Magyar JP, 1996, J NEUROSCI, V16, P5351; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; POLLANEN MS, 1994, ACTA NEUROPATHOL, V88, P1, DOI 10.1007/BF00294352; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Rooke K, 1996, NEUROLOGY, V46, P789, DOI 10.1212/WNL.46.3.789; Sahenk Z, 1999, ANN NEUROL, V45, P16, DOI 10.1002/1531-8249(199901)45:1<16::AID-ART5>3.0.CO;2-F; SCHMIDT ML, 1991, LAB INVEST, V64, P352; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; SKRE H, 1974, CLIN GENET, V6, P98; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Takashima H, 1997, ANN NEUROL, V41, P771, DOI 10.1002/ana.410410613; Takashima H, 1999, NEUROMUSCULAR DISORD, V9, P368, DOI 10.1016/S0960-8966(99)00021-8; Thomas PK, 1997, BRAIN, V120, P465, DOI 10.1093/brain/120.3.465; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; Timmerman V, 1996, NEUROLOGY, V46, P1311, DOI 10.1212/WNL.46.5.1311; Tomkins J, 1998, NEUROREPORT, V9, P3967, DOI 10.1097/00001756-199812010-00036; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; Vechio JD, 1996, ANN NEUROL, V40, P603, DOI 10.1002/ana.410400410; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; VOGEL P, 1985, ANN NEUROL, V17, P455, DOI 10.1002/ana.410170507; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Xu ZS, 1996, J CELL BIOL, V133, P1061, DOI 10.1083/jcb.133.5.1061; XU ZS, 1993, J CELL SCI, P101; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	62	327	352	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					37	46		10.1086/302962	http://dx.doi.org/10.1086/302962			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10841809	Green Published, Bronze			2022-12-18	WOS:000088926900007
J	Smith, KR; Damiano, J; Franceschetti, S; Carpenter, S; Canafoglia, L; Morbin, M; Rossi, G; Pareyson, D; Mole, SE; Staropoli, JF; Sims, KB; Lewis, J; Lin, WL; Dickson, DW; Dahl, HH; Bahlo, M; Berkovic, SF				Smith, Katherine R.; Damiano, John; Franceschetti, Silvana; Carpenter, Stirling; Canafoglia, Laura; Morbin, Michela; Rossi, Giacomina; Pareyson, Davide; Mole, Sara E.; Staropoli, John F.; Sims, Katherine B.; Lewis, Jada; Lin, Wen-Lang; Dickson, Dennis W.; Dahl, Hans-Henrik; Bahlo, Melanie; Berkovic, Samuel F.			Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; NEURONAL CEROID-LIPOFUSCINOSIS; INBREEDING COEFFICIENT; SEQUENCING DATA; KUFS-DISEASE; GENE; HOMOZYGOSITY; VARIABILITY; DISORDERS; DEMENTIA	We performed hypothesis-free linkage analysis and exome sequencing in a family with two siblings who had neuronal ceroid lipofuscinosis (NCL). Two linkage peaks with maximum LOD scores of 3.07 and 2.97 were found on chromosomes 7 and 17, respectively. Unexpectedly, we found these siblings to be homozygous for a c.813_816del (p.Thr272Serfs(star)10) mutation in the progranulin gene (GRN, granulin precursor) in the latter peak. Heterozygous mutations in GRN are a major cause of frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP), the second most common early-onset dementia. Reexamination of progranulin-deficient mice revealed rectilinear profiles typical of NCL. The age-at-onset and neuropathology of FTLD-TDP and NCL are markedly different. Our findings reveal an unanticipated link between a rare and a common neurological disorder and illustrate pleiotropic effects of a mutation in the heterozygous or homozygous states.	[Smith, Katherine R.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Smith, Katherine R.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Damiano, John; Dahl, Hans-Henrik; Berkovic, Samuel F.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg West, Vic 3081, Australia; [Franceschetti, Silvana; Canafoglia, Laura] IRCCS Fdn, Unit Neurophysiopathol, Carlo Besta Neurol Inst, I-20133 Milan, Italy; [Carpenter, Stirling] Hosp Sao Joao, Serv Anat Patol, P-4200319 Oporto, Portugal; [Morbin, Michela; Rossi, Giacomina] IRCCS Fdn, Div Neuropathol & Neurol 5, Carlo Besta Neurol Inst, I-20133 Milan, Italy; [Pareyson, Davide] IRCCS Fdn, Clin Cent, Carlo Besta Neurol Inst, I-20133 Milan, Italy; [Pareyson, Davide] IRCCS Fdn, Carlo Besta Neurol Inst, Dept Clin Neurosci, Peripheral Degenerat Neuropathies Unit, I-20133 Milan, Italy; [Mole, Sara E.] UCL, Med Res Council Lab Mol Cell Biol, Inst Child Hlth, Mol Med Unit, London WC1E 6BT, England; [Mole, Sara E.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Staropoli, John F.; Sims, Katherine B.] Massachusetts Gen Hosp, Neurogenet DNA Diagnost Lab, Ctr Human Genet Res, Boston, MA 02114 USA; [Lewis, Jada] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Lewis, Jada] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Lin, Wen-Lang; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Sao Joao Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of London; University College London; University of London; University College London; Harvard University; Massachusetts General Hospital; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; University of Melbourne	Bahlo, M (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, 1G Royal Parade, Parkville, Vic 3052, Australia.	bahlo@wehi.edu.au; s.berkovic@unimelb.edu.au	jiang, yu/HGU-0029-2022; Canafoglia, Laura/K-4787-2016; Pareyson, Davide/K-5890-2016; Rossi, Giacomina/I-2783-2012; Franceschetti, Silvana/K-3438-2016	Canafoglia, Laura/0000-0002-5385-761X; Pareyson, Davide/0000-0001-6854-765X; Rossi, Giacomina/0000-0001-6680-2725; Franceschetti, Silvana/0000-0002-1921-6755; Dickson, Dennis W/0000-0001-7189-7917; Berkovic, Samuel/0000-0003-4580-841X; Morbin, Michela/0000-0001-8034-3123; Bahlo, Melanie/0000-0001-5132-0774; Mole, Sara/0000-0003-4385-4957	Pratt Foundation; National Health and Medical Research Council (NHMRC) Australia; NHMRC; Australian Research Council (ARC); Medical Research Council; Batten Disease Support and Research Association	Pratt Foundation; National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Batten Disease Support and Research Association	K.R.S. is supported by a PhD scholarship funded by the Pratt Foundation. S.F.B. is supported by a National Health and Medical Research Council (NHMRC) Australia Fellowship and an NHMRC Program Grant. M.B. is supported by an Australian Research Council (ARC) Future Fellowship and an NHMRC Program Grant. S.E.M. is supported by the Medical Research Council. The Batten Disease Support and Research Association supported S.E.M., J.S., and K.S. We thank Pawan Mann and Olivia Galante for technical assistance; Danya years, Robyn Ferguson, and Karen Oliver for technical support; the Rare NCL Gene Consortium for encouraging collaborative research on variant NCL cases; and the families and physicians for providing samples.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anders G., 2011, NEURONAL CEROID LIPO, P35; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Benussi L, 2008, NEUROBIOL AGING, V29, P427, DOI 10.1016/j.neurobiolaging.2006.10.028; Benussi L, 2009, NEUROBIOL DIS, V33, P379, DOI 10.1016/j.nbd.2008.11.008; Bruni AC, 2007, NEUROLOGY, V69, P140, DOI 10.1212/01.wnl.0000265220.64396.b4; CARPENTER S, 1977, BRAIN, V100, P137, DOI 10.1093/brain/100.1.137; Ghidoni R, 2012, NEURODEGENER DIS, V9, P121, DOI 10.1159/000333132; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mole S.E., 2010, GENEREVIEWS; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yu CE, 2010, ARCH NEUROL-CHICAGO, V67, P161, DOI 10.1001/archneurol.2009.328; Zlotogora J, 1997, AM J MED GENET, V68, P412, DOI 10.1002/(SICI)1096-8628(19970211)68:4<412::AID-AJMG8>3.0.CO;2-N	32	326	335	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1102	1107		10.1016/j.ajhg.2012.04.021	http://dx.doi.org/10.1016/j.ajhg.2012.04.021			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22608501	Green Published, hybrid			2022-12-18	WOS:000305262600015
J	Sivakumaran, S; Agakov, F; Theodoratou, E; Prendergast, JG; Zgaga, L; Manolio, T; Rudan, I; McKeigue, P; Wilson, JF; Campbell, H				Sivakumaran, Shanya; Agakov, Felix; Theodoratou, Evropi; Prendergast, James G.; Zgaga, Lina; Manolio, Teri; Rudan, Igor; McKeigue, Paul; Wilson, James F.; Campbell, Harry			Abundant Pleiotropy in Human Complex Diseases and Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-ANALYSIS; ANGIOTENSIN-II; CHOLESTEROL; SCHIZOPHRENIA; ALLOPURINOL; DEFICIENCY; SELECTIN; LOCI; SCAN	We present a systematic review of pleiotropy among SNPs and genes reported to show genome-wide association with common complex diseases and traits. We find abundant evidence of pleiotropy; 233 (16.9%) genes and 77 (4.6%) SNPs show pleiotropic effects. SNP pleiotropic status was associated with gene location (p = 0.024; pleiotropic SNPs more often exonic 114.5% versus 4.9% for nonpleiotropic, trait-associated SNPs] and less often intergenic [15.8% versus 23.6%]), "predicted transcript consequence" (p = 0.001; pleiotropic SNPs more often predicted to be structurally deleterious [5% versus 0.4%] but not more often in regulatory sequences), and certain disease classes. We develop a method to calculate the likelihood that pleiotropic links between traits occurred more often than expected and demonstrate that this approach can identify etiological links that are already known (such as between fetal hemoglobin and malaria risk) and those that are not yet established (e.g., between plasma campesterol levels and gallstones risk; and between immunoglobulin A and juvenile idiopathic arthritis). Examples of pleiotropy will accumulate over time, but it is already clear that pleiotropy is a common property of genes and SNPs associated with disease traits, and this will have implications for identification of molecular targets for drug development, future genetic risk-profiling, and classification of diseases.	[Sivakumaran, Shanya; Agakov, Felix; Theodoratou, Evropi; Zgaga, Lina; Rudan, Igor; McKeigue, Paul; Wilson, James F.; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Agakov, Felix] Pharmatics Ltd, Edinburgh EH15 3LZ, Midlothian, Scotland; [Prendergast, James G.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia; [Manolio, Teri] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA	University of Edinburgh; University of Edinburgh; University of Zagreb; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Campbell, H (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	harry.campbell@ed.ac.uk	Zgaga, Lina/Q-9415-2018; Wilson, James F/A-5704-2009; Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010; Theodoratou, Evropi/C-3430-2014	Zgaga, Lina/0000-0003-4089-9703; Wilson, James F/0000-0001-5751-9178; Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Theodoratou, Evropi/0000-0001-5887-9132; Prendergast, James/0000-0001-8916-018X; Agakov, Felix/0000-0003-4280-9062	Cancer Research UK [C31250/A10107]; Medical Research Council [G0800604] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; MRC [G0800604] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	E.T. is funded by Cancer Research UK Fellowship C31250/A10107.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, MED HYPOTHESES, V62, P309, DOI 10.1016/S0306-9877(03)00332-3; Bishop C., 2006, PATTERN RECOGNITION; BISHOP CM, 1994, IEE P-VIS IMAGE SIGN, V141, P217, DOI 10.1049/ip-vis:19941330; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Buie LW, 2006, ANN PHARMACOTHER, V40, P2200, DOI 10.1345/aph.1H222; Cooper Zachary N, 2006, IRB, V28, P1; Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101; Das UN, 2005, MED SCI MONITOR, V11, pRA155; De la Herran-Arita Alberto K, 2011, Front Neurol, V2, P26, DOI 10.3389/fneur.2011.00026; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dickerson FB, 2009, SCHIZOPHR RES, V109, P66, DOI 10.1016/j.schres.2008.12.028; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilliam BE, 2008, CLIN EXP RHEUMATOL, V26, P492; Gruneberg H, 1938, PROC R SOC SER B-BIO, V125, P123, DOI 10.1098/rspb.1938.0017; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; Huang WH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S68; Hudson M, 2008, J AUTOIMMUN, V31, P156, DOI 10.1016/j.jaut.2008.05.002; HUGO Gene Nomenclature Committee, 2011, HGNC DAT; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Jakulj L, 2010, J LIPID RES, V51, P3016, DOI 10.1194/jlr.M008128; Jing Gao, 2006, Applied Computing 2006. 21st Annual ACM Symposium on Applied Computing, P635; Jones R, 2005, PAEDIATR PERINAT EP, V19, P264, DOI 10.1111/j.1365-3016.2005.00664.x; Karasik D, 2010, BONE, V46, P1226, DOI 10.1016/j.bone.2010.01.382; Koivusalo AI, 2010, DIGEST LIVER DIS, V42, P61, DOI 10.1016/j.dld.2009.06.006; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Leroy Annick M., 1996, ROBUST REGRESSION OU; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI 10.1016/j.sigpro.2003.07.018; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McEliece R. J., 1977, THEORY INFORM CODING; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; McGrath J, 2011, SCHIZOPHRENIA BULL, V37, P272, DOI 10.1093/schbul/sbq121; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; National Human Genome Research Institute, CAT GEN WID ASS STUD; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; PASVOL G, 1976, LANCET, V1, P1269; Peirce B., 1852, ASTRON J, V2, P161, DOI [10.1086/100259, DOI 10.1086/100259]; Peirce B., 1877, P AM ACAD ARTS SCI, V13, P348, DOI DOI 10.2307/25138498; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Shear HL, 1998, BLOOD, V92, P2520, DOI 10.1182/blood.V92.7.2520.2520_2520_2526; Sorensen Holger J, 2011, Schizophr Bull, V37, P982, DOI 10.1093/schbul/sbp167; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Sudhop T, 2002, GUT, V51, P860, DOI 10.1136/gut.51.6.860; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tarassenko L., 1995, Fourth International Conference on `Artificial Neural Networks' (Conf. Publ. No.409), P442, DOI 10.1049/cp:19950597; Valdes AM, 2008, RHEUM DIS CLIN N AM, V34, P581, DOI 10.1016/j.rdc.2008.04.008; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wachbroit R, 1998, KENNEDY INST ETHIC J, V8, P131, DOI 10.1353/ken.1998.0013; Wade CH, 2006, AM J MED GENET C, V142C, P284, DOI 10.1002/ajmg.c.30110; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Wright S, 1968, EVOLUTION GENETICS P, V1; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yildiz B, 2007, EUR J PEDIATR, V166, P1179, DOI 10.1007/s00431-006-0360-4; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	76	326	333	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					607	618		10.1016/j.ajhg.2011.10.004	http://dx.doi.org/10.1016/j.ajhg.2011.10.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22077970	Green Published, Bronze			2022-12-18	WOS:000297090100002
J	Conneely, KN; Boehnke, M				Conneely, Karen N.; Boehnke, Michael			So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CLINICAL-TRIALS; ASSOCIATION; GENES; DISTRIBUTIONS; PROBABILITIES; COMPUTATION; SIMULATION; DISEASE	Contemporary genetic association studies may test hundreds of thousands of genetic variants for association, often with multiple binary and continuous traits or under more than one model of inheritance. Many of these association tests may be correlated with one another because of linkage disequilibrium between nearby markers and correlation between traits and models. Permutation tests and simulation-based methods are often employed to adjust groups of correlated tests for multiple testing, since conventional methods such as Bonferroni correction are overly conservative when tests are correlated. We present here a method of computing P values adjusted for correlated tests (P-ACT) that attains the accuracy of permutation or simulation-based tests in much less computation time, and we show that our method applies to many common association tests that are based on multiple traits, markers, and genetic models. Simulation demonstrates that P-ACT attains the power of permutation testing and provides a valid adjustment for hundreds of correlated association tests. In data analyzed as part of the Finland-United States Investigation of NIDDM Genetics (FUSION) study, we observe a near one-to-one relationship (r(2) > .999) between P-ACT and the corresponding permutation-based P values, achieving the same precision as permutation testing but thousands of times faster.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA	Emory University; University of Michigan System; University of Michigan	Conneely, KN (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St,Suite 301, Atlanta, GA 30322 USA.	kconneely@genetics.emory.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376, R01HG000376, Z01HG000040, T32HG000040] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000040] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040, HG00376, R01 HG000376] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 1932, STAT METHODS RES WOR; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cox DR., 1974, THEORETICAL STAT; Cram?r H., 1946, MATH METHODS STAT; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Genz A, 2002, J COMPUT GRAPH STAT, V11, P950, DOI 10.1198/106186002394; GENZ A, 2007, MVTNORM MULTIVARIATE; Genz A, 1992, J COMPUTATIONAL GRAP, V1, P141, DOI [10.2307/1390838, DOI 10.2307/1390838]; GENZ A, 2000, MVTDST SET FORTRAN S; Genz A, 1993, COMPUTING SCI STAT, V25, P400; HOLM S, 1979, SCAND J STAT, V6, P65; JAMES S, 1991, STAT MED, V10, P1123, DOI 10.1002/sim.4780100712; Kimmel G, 2006, AM J HUM GENET, V79, P481, DOI 10.1086/507317; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin DY, 2005, AM J HUM GENET, V77, P513, DOI 10.1086/432817; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; R Development Core Team, 2007, R LANG ENV STAT COMP; Salyakina D, 2005, HUM HERED, V60, P19, DOI 10.1159/000087540; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Seaman SR, 2005, AM J HUM GENET, V76, P399, DOI 10.1086/428140; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wei LJ, 1997, STAT MED, V16, P833, DOI 10.1002/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	32	326	329	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1158	1168		10.1086/522036	http://dx.doi.org/10.1086/522036			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17966093	Green Published, Bronze			2022-12-18	WOS:000251098800004
J	BADNER, JA; SIEBER, WK; GARVER, KL; CHAKRAVARTI, A				BADNER, JA; SIEBER, WK; GARVER, KL; CHAKRAVARTI, A			A GENETIC-STUDY OF HIRSCHSPRUNG DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,A310 CRABTREE HALL,130 DESOTO ST,PITTSBURGH,PA 15261; CHILDRENS HOSP PITTSBURGH,DEPT PEDIAT SURG,PITTSBURGH,PA; WESTERN PENN HOSP,DEPT MED GENET,PITTSBURGH,PA 15224	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; West Penn Hospital					NICHD NIH HHS [HD00774] Funding Source: Medline; NIGMS NIH HHS [GM33771] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGAZALI LI, 1988, J MED GENET, V25, P758, DOI 10.1136/jmg.25.11.758; ARIAS S, 1984, CYTOGENET CELL GENET, V37, P401; BADNER JA, 1988, THESIS U PITTSBURGH; BADNER JA, IN PRESS AM J MED GE; BEEDGEN B, 1986, EUR J PEDIATR, V145, P229, DOI 10.1007/BF00446075; BESSON WT, 1986, CIRCULATION, V73, P360, DOI 10.1161/01.CIR.73.2.360; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; CARMI R, 1982, BIRTH DEFECTS-ORIG, V18, P187; CARTER CO, 1981, J MED GENET, V18, P87, DOI 10.1136/jmg.18.2.87; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; FABIA J, 1970, PEDIATRICS, V45, P60; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; FERRELL RE, 1980, P NATL ACAD SCI-BIOL, V77, P1580, DOI 10.1073/pnas.77.3.1580; GARVER KL, 1985, CLIN GENET, V28, P503; GOLDBERG EL, 1984, INT J EPIDEMIOL, V13, P479, DOI 10.1093/ije/13.4.479; HALL JG, 1988, AM J HUM GENET, V43, P355; HAMILTON J, 1989, J MED GENET, V26, P272, DOI 10.1136/jmg.26.4.272; Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123; HURST JA, 1988, J MED GENET, V25, P494, DOI 10.1136/jmg.25.7.494; JACOBSCOHEN RJ, 1987, J COMP NEUROL, V255, P425, DOI 10.1002/cne.902550309; JARMAS AL, 1983, AM J MED GENET, V16, P163, DOI 10.1002/ajmg.1320160205; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LAMONT MA, 1989, J MED GENET, V26, P100, DOI 10.1136/jmg.26.2.100; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Langman J., 1981, MED EMBRYOLOGY; LAURENCE KM, 1975, J MED GENET, V12, P334, DOI 10.1136/jmg.12.4.334; LEWANDOWSKI RC, 1977, NEW CHROMOSOMAL SYND, P369; LIPSON AH, 1987, CLIN GENET, V32, P175; MAGENIS RE, 1988, AM J MED GENET, V29, P9, DOI 10.1002/ajmg.1320290103; MAHAKRISHNAN A, 1980, ARCH DERMATOL, V116, P1102, DOI 10.1001/archderm.1980.01640340012007; MAHBOUBI S, 1984, PEDIATR RADIOL, V14, P441, DOI 10.1007/BF02343439; MCKUSICK VA, 1965, B JOHNS HOPKINS HOSP, V116, P285; MORTON NE, 1974, AM J HUM GENET, V26, P489; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; PASSARGE E, 1972, Birth Defects Original Article Series, V8, P63; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PRIER L, 1981, Z KINDERCHIR, V32, P69; PUESCHEL SM, 1983, NY STATE J MED, V66, P3067; RAO CR, 1965, LINEAR STATISTICAL I; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; REYNOLDS JF, 1983, PEDIATRICS, V71, P246; SANTOS H, 1988, J MED GENET, V25, P204, DOI 10.1136/jmg.25.3.204; SEARLE A G, 1987, Genomics, V1, P3, DOI 10.1016/0888-7543(87)90099-1; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; SPARKES RS, 1984, HUM GENET, V68, P258, DOI 10.1007/BF00418397; SPOUGE D, 1985, TERATOLOGY, V32, P171, DOI 10.1002/tera.1420320204; VERDY M, 1982, J PEDIATR GASTR NUTR, V1, P603, DOI 10.1097/00005176-198212000-00027; WEBB GC, 1988, J MED GENET, V25, P125, DOI 10.1136/jmg.25.2.125; WEBSTER W, 1973, J EMBRYOL EXP MORPH, V30, P573; WRIGHT TC, 1984, P NATL ACAD SCI-BIOL, V81, P2426, DOI 10.1073/pnas.81.8.2426	54	326	334	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					568	580						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309705				2022-12-18	WOS:A1990CT66800021
J	Yuan, X; Waterworth, D; Perry, JRB; Lim, N; Song, K; Chambers, JC; Zhang, W; Vollenweider, P; Stirnadel, H; Johnson, T; Bergmann, S; Beckmann, ND; Li, Y; Ferrucci, L; Melzer, D; Hernandez, D; Singleton, A; Scott, J; Elliott, P; Waeber, G; Cardon, L; Frayling, TM; Kooner, JS; Mooser, V				Yuan, Xin; Waterworth, Dawn; Perry, John R. B.; Lim, Noha; Song, Kijoung; Chambers, John C.; Zhang, Weihua; Vollenweider, Peter; Stirnadel, Heide; Johnson, Toby; Bergmann, Sven; Beckmann, Noam D.; Li, Yun; Ferrucci, Luigi; Melzer, David; Hernandez, Dena; Singleton, Andrew; Scott, James; Elliott, Paul; Waeber, Gerard; Cardon, Lon; Frayling, Timothy M.; Kooner, Jaspal S.; Mooser, Vincent			Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; CARBOXYPEPTIDASE-N; ADIPONUTRIN GENE; RISK-FACTORS; PROTEINS; DISEASE; HEMOCHROMATOSIS; EXPRESSION; MUTATIONS; MEMBRANE	Plasma liver-enzyme tests are widely used in the clinic for the diagnosis of liver diseases and for monitoring the response to drug treatment. There is considerable evidence that human genetic variation influences plasma levels of liver enzymes. However, such genetic variation has not been systematically assessed. In the present Study, we performed a genome-wide association study of plasma liver-enzyme levels in three populations (total n = 7715) with replication in three additional cohorts (total n 4704). We identified two loci influencing plasma levels of alanine-aminotransferase (ALT) (CPN1-ERLIN1-CHUK on chromosome 10 and PNPLA3-SAMM50 on chromosome 22), one locus influencing gamma-glutamyl transferase (GGT) levels (HNF1A on chromosome 12), and three loci for alkaline phosphatase (ALP) levels (ALPL on chromosome 1, GPLD1 on chromosome 6, and JMJD1C-REEP3 on chromosome 10). In addition, we confirmed the associations between the GGTI locus and GGT levels and between the ABO locus and ALP levels. None of the ALP-associated SNPs were associated with other liver tests, suggesting intestine and/or bone specificity. The mechanisms underlying the associations may involve cis- or trans-transcriptional effects (some of the identified variants were associated with mRNA transcription in human liver or lymphoblastoid cells), dysfunction of the encoded proteins (caused by missense variations at the functional domains), or other unknown pathways. These findings may help in the interpretation of liver-enzyme tests and provide candidate genes for liver diseases of viral, metabolic, autoimmune, or toxic origin. The specific associations with ALP levels may point to genes for bone or intestinal diseases.	[Yuan, Xin; Waterworth, Dawn; Lim, Noha; Song, Kijoung; Cardon, Lon; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA 19406 USA; [Stirnadel, Heide; Li, Yun] GlaxoSmithKline, Worldwide Epidemiol, Harlow EX2 5DW, Essex, England; [Perry, John R. B.; Melzer, David; Frayling, Timothy M.] Univ Exeter, Penn Coll Med & Dent, Inst Biomed & Clin Sci, Exeter CM19 5AW, Devon, England; [Chambers, John C.; Zhang, Weihua; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 11G, England; [Vollenweider, Peter; Waeber, Gerard] CHUV Univ Hosp, Dept Med, CH-1011 Lausanne, Switzerland; [Johnson, Toby; Bergmann, Sven; Beckmann, Noam D.] CHUV Univ Hosp, Div Med Genet, CH-1011 Lausanne, Switzerland; [Johnson, Toby] CHUV Univ Hosp, Inst Social & Preventat Med, CH-1011 Lausanne, Switzerland; [Johnson, Toby; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Ferrucci, Luigi] NIA, Gerontol Res Ctr, Clin Res Branch, Longitudinal Studies Sect, Baltimore, MD 21224 USA; [Hernandez, Dena; Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Li, Yun] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	GlaxoSmithKline; GlaxoSmithKline; University of Exeter; Imperial College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Imperial College London; University of Michigan System; University of Michigan	Mooser, V (corresponding author), GlaxoSmithKline, Div Genet, King Of Prussia, PA 19406 USA.	vincent.2.mooser@gsk.com	Lim, Noha/ABA-2509-2020; Colaus, PsyColaus/K-6607-2013; Singleton, Andrew B/C-3010-2009	Melzer, David/0000-0002-0170-3838; Waeber, Gerard/0000-0003-4193-788X; Elliott, Paul/0000-0002-7511-5684; Johnson, Toby/0000-0002-5998-3270; Bergmann, Sven/0000-0002-6785-9034; Frayling, Timothy/0000-0001-8362-2603	GlaxoSmithKline; National Institute on Aging, National Institutes of Health, and Department of Health and Human Services [1 Z01 AG000965-02]; British Heart Foundation [SP/04/002]; Medical Research Council [G0601966, G0700931] Funding Source: researchfish; MRC [G0601966, G0700931] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [Z01AG000965] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); National Institute on Aging, National Institutes of Health, and Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The CoLaus study was sponsored in part by GlaxoSmithKline, a pharmaceutical company. X.Y., D.W., N.L., K.S., H.S., L.C., and V.M. are full-time employees of GlaxoSmithKhne. The InCHIANTI study was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, and Department of Health and Human Services, project number 1 Z01 AG000965-02. LOLIPOP was supported by the British Heart Foundation Grant SP/04/002. We thank the individuals who volunteered to participate in the CoLaus Study, as well as the staff at Lausanne University Hospital and within GlaxoSmithKline who made this collection possible. The computations for CoLaus imputation were performed in part at the Vital-IT center for high performance computing of the Swiss Institute of Bioinformatics. We thank Jacques Beckmann for his comments.	Adams PC, 2007, LANCET, V370, P1855, DOI 10.1016/S0140-6736(07)61782-6; Bathum L, 2001, CLIN CHEM, V47, P81; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brun-Heath I, 2007, EUR J MED GENET, V50, P367, DOI 10.1016/j.ejmg.2007.06.005; CEREGHINI S, 1990, EMBO J, V9, P2257, DOI 10.1002/j.1460-2075.1990.tb07396.x; Chalasani N, 2006, J CLIN ENDOCR METAB, V91, P2279, DOI 10.1210/jc.2006-0075; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Foreman JE, 2005, PHYSIOL GENOMICS, V23, P295, DOI 10.1152/physiolgenomics.00062.2005; Forlani G, 2008, J ENDOCRINOL INVEST, V31, P146, DOI 10.1007/BF03345581; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Johansson LE, 2006, DIABETES, V55, P826, DOI 10.2337/diabetes.55.03.06.db05-1075; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moldes M, 2006, EUR J ENDOCRINOL, V155, P461, DOI 10.1530/eje.1.02229; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; SKIDGEL RA, 1988, BIOCHEM BIOPH RES CO, V154, P1323, DOI 10.1016/0006-291X(88)90284-7; Stepec S, 2008, ANN HEMATOL, V87, P667, DOI 10.1007/s00277-008-0463-2; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; WALKER BA, 1971, CLIN CHIM ACTA, V35, P433, DOI 10.1016/0009-8981(71)90218-X; Whitfield JB, 2002, CLIN CHEM, V48, P1426; WHITFIELD JB, 1983, AM J HUM GENET, V35, P978; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	44	323	333	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					520	528		10.1016/j.ajhg.2008.09.012	http://dx.doi.org/10.1016/j.ajhg.2008.09.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940312	Green Published, Bronze			2022-12-18	WOS:000260239200010
J	Pickrell, JK				Pickrell, Joseph K.			Joint Analysis of Functional Genomic Data and Genome-wide Association Studies of 18 Human Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; LOCI; RISK; ARCHITECTURE; REVEALS	Annotations of gene structures and regulatory elements can inform genome-wide association studies (GWASs). However, choosing the relevant annotations for interpreting an association study of a given trait remains challenging. I describe a statistical model that uses association statistics computed across the genome to identify classes of genomic elements that are enriched with or depleted of loci influencing a trait. The model naturally incorporates multiple types of annotations. I applied the model to GWASs of 18 human traits, including red blood cell traits, platelet traits, glucose levels, lipid levels, height, body mass index, and Crohn disease. For each trait, I used the model to evaluate the relevance of 450 different genomic annotations, including protein-coding genes, enhancers, and DNase-I hypersensitive sites in over 100 tissues and cell lines. The fraction of phenotype-associated SNPs influencing protein sequence ranged from around 2% (for platelet volume) up to around 20% (for low-density lipoprotein cholesterol), repressed chromatin was significantly depleted for SNPs associated with several traits, and cell-type-specific DNase-I hypersensitive sites were enriched with SNPs associated with several traits (for example, the spleen in platelet volume). Finally, reweighting each GWAS by using information from functional genomics increased the number of loci with high-confidence associations by around 5%.	[Pickrell, Joseph K.] New York Genome Ctr, New York, NY 10013 USA; [Pickrell, Joseph K.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Pickrell, JK (corresponding author), New York Genome Ctr, New York, NY 10013 USA.	jkpickrell@nygenome.org			NIH [GM103098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank David Reich, Nick Patterson, Alkes Price, and Po-Ru Loh for helpful discussions and suggestions and Jonathan Pritchard, Graham Coop, Graham McVicker, Anil Raj, and two anonymous reviewers for comments on a previous version of this manuscript. I also thank Nicole Soranzo for providing access to the platelet studies and Luke Jostins for assistance in obtaining the Crohn disease data. This work was supported by NIH postdoctoral fellowship GM103098 to J.K.P.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gagliano S. A., 2013, BAYESIAN METHOD INCO; Gerasimova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054359; Giambartolomei C., 2013, ARXIV13054022; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Heron EA, 2011, BIOSTATISTICS, V12, P445, DOI 10.1093/biostatistics/kxq072; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kindt ASD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-108; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lewinger JP, 2007, GENET EPIDEMIOL, V31, P871, DOI 10.1002/gepi.20248; Lui JLC, 2012, HUM MOL GENET, V21, P5193, DOI 10.1093/hmg/dds347; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasaniuc B., 2013, ARXIV13093258; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	52	322	325	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					559	573		10.1016/j.ajhg.2014.03.004	http://dx.doi.org/10.1016/j.ajhg.2014.03.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24702953	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000333765300007
J	Lopez-Herrera, G; Tampella, G; Pan-Hammarstrom, Q; Herholz, P; Trujillo-Vargas, CM; Phadwal, K; Simon, AK; Moutschen, M; Etzioni, A; Mory, A; Srugo, I; Melamed, D; Hultenby, K; Liu, CH; Baronio, M; Vitali, M; Philippet, P; Dideberg, V; Aghamohammadi, A; Rezaei, N; Enright, V; Du, LK; Salzer, U; Eibel, H; Pfeifer, D; Veelken, H; Stauss, H; Lougaris, V; Plebani, A; Gertz, EM; Schaffer, AA; Hammarstrom, L; Grimbacher, B				Lopez-Herrera, Gabriela; Tampella, Giacomo; Pan-Hammarstrom, Qiang; Herholz, Peer; Trujillo-Vargas, Claudia M.; Phadwal, Kanchan; Simon, Anna Katharina; Moutschen, Michel; Etzioni, Amos; Mory, Adi; Srugo, Izhak; Melamed, Doron; Hultenby, Kjell; Liu, Chonghai; Baronio, Manuela; Vitali, Massimiliano; Philippet, Pierre; Dideberg, Vinciane; Aghamohammadi, Asghar; Rezaei, Nima; Enright, Victoria; Du, Likun; Salzer, Ulrich; Eibel, Hermann; Pfeifer, Dietmar; Veelken, Hendrik; Stauss, Hans; Lougaris, Vassilios; Plebani, Alessandro; Gertz, E. Michael; Schaeffer, Alejandro A.; Hammarstrom, Lennart; Grimbacher, Bodo			Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; X-LINKED AGAMMAGLOBULINEMIA; SELECTIVE IGA DEFICIENCY; LARGE COHORT; AUTOPHAGY; PROTEIN; GENE; FAMILY; PATHOGENESIS; LINKAGE	Most autosomal genetic causes of childhood-onset hypogammaglobulinemia are currently not well understood. Most affected individuals are simplex cases, but both autosomal-dominant and autosomal-recessive inheritance have been described. We performed genetic linkage analysis in consanguineous families affected by hypogammaglobulinemia. Four consanguineous families with childhood-onset humoral immune deficiency and features of autoimmunity shared genotype evidence for a linkage interval on chromosome 4q. Sequencing of positional candidate genes revealed that in each family, affected individuals had a distinct homozygous mutation in LRBA (lipopolysaccharide responsive beige-like anchor protein). All LRBA mutations segregated with the disease because homozygous individuals showed hypogammaglobulinemia and autoimmunity, whereas heterozygous individuals were healthy. These mutations were absent in healthy controls. Individuals with homozygous LRBA mutations had no LRBA, had disturbed B cell development, defective in vitro B cell activation, plasmablast formation, and immunoglobulin secretion, and had low proliferative responses. We conclude that mutations in LRBA cause an immune deficiency characterized by defects in B cell activation and autophagy and by susceptibility to apoptosis, all of which are associated with a clinical phenotype of hypogammaglobulinemia and autoimmunity.	[Lopez-Herrera, Gabriela; Trujillo-Vargas, Claudia M.; Enright, Victoria; Stauss, Hans; Grimbacher, Bodo] UCL, Royal Free Hosp, Div Infect & Immun, Dept Immunol, London NW3 2QG, England; [Lopez-Herrera, Gabriela] Natl Inst Pediat, Immunodeficiency Res Unit, Mexico City 04530, DF, Mexico; [Tampella, Giacomo; Baronio, Manuela; Vitali, Massimiliano; Lougaris, Vassilios; Plebani, Alessandro] Univ Brescia, Pediat Clin, Spedali Civili Brescia, I-25123 Brescia, Italy; [Tampella, Giacomo; Baronio, Manuela; Vitali, Massimiliano; Lougaris, Vassilios; Plebani, Alessandro] Univ Brescia, Inst Mol Med A Novicelli, Spedali Civili Brescia, I-25123 Brescia, Italy; [Pan-Hammarstrom, Qiang; Hultenby, Kjell; Liu, Chonghai; Du, Likun; Hammarstrom, Lennart] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, SE-14186 Stockholm, Sweden; [Herholz, Peer; Salzer, Ulrich; Eibel, Hermann; Grimbacher, Bodo] Univ Med Ctr, Ctr Chron Immunodeficiency, D-79108 Freiburg, Germany; [Trujillo-Vargas, Claudia M.] Univ Antioquia, Grp Primary Immunodeficiencies, Medellin 1226, Colombia; [Phadwal, Kanchan; Simon, Anna Katharina] Univ Oxford, Biomed Res Ctr Translat Immunol Lab, Natl Inst Hlth Res, Nuffield Dept Med,John Radcliffe Hosp, Oxford OX3 9DS, England; [Simon, Anna Katharina] Univ Oxford, Medcial Res Council Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Moutschen, Michel] Univ Liege, Ctr Immunol, Lab Immunoendocrinol, Inst Pathol, B-4000 Liege, Belgium; [Etzioni, Amos; Mory, Adi; Srugo, Izhak; Melamed, Doron] Technion Israel Inst Technol, Rappaport Sch Med, Div Pediat & Immunol, IL-31096 Haifa, Israel; [Liu, Chonghai] N Sichuan Med Coll, Affiliated Hosp, Dept Pediat, Nanchong 637000, Sichuan, Peoples R China; [Philippet, Pierre] Ctr Hosp Chretien Esperance, Dept Pediat, B-4420 Montegnee, Belgium; [Dideberg, Vinciane] Univ Liege, Ctr Human Genet, B-4000 Liege, Belgium; [Aghamohammadi, Asghar] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Res Ctr Immunodeficiencies, Tehran 14194, Iran; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Mol Immunol Res Ctr, Tehran 14194, Iran; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran 14194, Iran; [Pfeifer, Dietmar] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Hematol, NL-2300 RC Leiden, Netherlands; [Gertz, E. Michael; Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20894 USA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Brescia; University of Brescia; Karolinska Institutet; Karolinska University Hospital; University of Freiburg; Universidad de Antioquia; University of Oxford; University of Oxford; University of Liege; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; North Sichuan Medical University; University of Liege; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA	Grimbacher, B (corresponding author), UCL, Royal Free Hosp, Div Infect & Immun, Dept Immunol, London NW3 2QG, England.	bodo.grimbacher@uniklinik-freiburg.de	HERRERA, GABRIELA/AAL-1781-2021; hammarstrom, qiang pan/ABA-4589-2021; Rezaei, Nima/B-4245-2008; Lopez-Herrera, Gabriela/HHN-1429-2022; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012	Rezaei, Nima/0000-0002-3836-1827; Lopez-Herrera, Gabriela/0000-0002-5498-6739; Veelken, Hendrik/0000-0002-9108-3125; Simon, Anna Katharina/0000-0002-4077-7995; Du, Likun/0000-0002-8448-2187; pan-hammarstrom, qiang/0000-0003-1990-8804; Aghamohammadi, Asghar/0000-0002-9454-1603; Salzer, Ulrich/0000-0002-1769-1157; Phadwal, Kanchan/0000-0001-6745-9818; Gertz, E. Michael/0000-0001-8390-4387; Moutschen, Michel/0000-0002-6405-1785	German Federal Ministry of Education and Research [BMBF 01 EO 0803]; European Community [HEALTH-F2-2008-201549, Health-F5-2008-223292]; Marie Curie Excellence Grant [MEXT-CT-2006-042316]; European Research Council [24511-ImmunoSwitch]; Swedish Research Council; Swedish Cancer Society; Glaxo-Smith-Kline; Fondazione C. Golgi, Brescia; Associazione Italiana Immunodeficienze Primitive; National Institutes of Health, National Library of Medicine, USA; CONACyT, Mexico [93910]; Leukaemia and Lymphoma Research UK; Medical Research Council; National Institute for Health Research Biomedical Research Centre, Oxford, UK; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G021422/1] Funding Source: researchfish; Medical Research Council [G0900950B, G0900950] Funding Source: researchfish; BBSRC [BB/G021422/1] Funding Source: UKRI; MRC [G0900950] Funding Source: UKRI	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); Marie Curie Excellence Grant(European Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Glaxo-Smith-Kline(GlaxoSmithKline); Fondazione C. Golgi, Brescia; Associazione Italiana Immunodeficienze Primitive; National Institutes of Health, National Library of Medicine, USA; CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Leukaemia and Lymphoma Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre, Oxford, UK(National Institute for Health Research (NIHR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to thank Sary Workman, Astrid Petersen, Fariba Tahami, Eira Rawlings, Judy Levin, Charlotte Holden, and Francisco Espinosa Rosales for their assistance. This study was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803). The research was funded in part by the European Community's 6th and 7th Framework Programmes FP7/2007-2013 under grant agreements HEALTH-F2-2008-201549 (EURO-PADnet) and Health-F5-2008-223292 (Euro Gene Scan) and by a Marie Curie Excellence Grant to B.G. (MEXT-CT-2006-042316, MC-PIAID); European Research Council starting grant (24511-ImmunoSwitch); grants from the Swedish Research Council and Swedish Cancer Society; a Glaxo-Smith-Kline grant managed by the Primary Immunodeficiency Association UK; and a grant from the Fondazione C. Golgi, Brescia, and Associazione Italiana Immunodeficienze Primitive. This research is also supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, USA. Gabriela Lopez-Herrera received partial scholarship 93910 from CONACyT, Mexico. Giacomo Tampella is a PhD student of a joint PhD program of the Universities of Brescia and Trieste, Italy. Hans Stauss was supported by grants from Leukaemia and Lymphoma Research UK and from the Medical Research Council. Kanchan Phadwal and Anna Katharina Simon were supported by the National Institute for Health Research Biomedical Research Centre, Oxford, UK.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Aghamohammadi A, 2008, INT ARCH ALLERGY IMM, V147, P87, DOI 10.1159/000135694; Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Ballabio A, 2009, INT J CLIN PHARM TH, V47, pS34; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Conley ME, 2005, IMMUNOL REV, V203, P216, DOI 10.1111/j.0105-2896.2005.00233.x; Cuervo AM, 2010, NAT CELL BIOL, V12, P735, DOI 10.1038/ncb0810-735; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; De Lozanne A, 2003, TRAFFIC, V4, P6, DOI 10.1034/j.1600-0854.2003.40102.x; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Dyomin VG, 2002, GENOMICS, V80, P158, DOI 10.1006/geno.2002.6822; Ehrlich M, 2008, AUTOIMMUNITY, V41, P253, DOI 10.1080/08916930802024202; ELIN RJ, 1974, INFECT IMMUN, V10, P88, DOI 10.1128/IAI.10.1.88-91.1974; Farhoudi Abolhasan, 2003, Iran J Allergy Asthma Immunol, V2, P189; FEUCHTER AE, 1992, GENOMICS, V13, P1237, DOI 10.1016/0888-7543(92)90041-P; Finck A, 2006, EUR J HUM GENET, V14, P867, DOI 10.1038/sj.ejhg.5201634; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim A, 2009, J NEUROSCI, V29, P951, DOI 10.1523/JNEUROSCI.2582-08.2009; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Phadwal K, 2012, AUTOPHAGY, V8, P677, DOI 10.4161/auto.18935; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Plebani A, 2002, CLIN IMMUNOL, V104, P221, DOI 10.1006/clim.2002.5241; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Schaffer AA, 2006, HUM GENET, V118, P725, DOI 10.1007/s00439-005-0101-1; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Segui B, 1999, J BIOL CHEM, V274, P37251, DOI 10.1074/jbc.274.52.37251; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tsang WH, 2009, GENOMICS, V94, P177, DOI 10.1016/j.ygeno.2009.05.009; van der Burg M, 2011, EUR J PEDIATR, V170, P561, DOI 10.1007/s00431-011-1452-3; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; Wang JW, 2004, ONCOGENE, V23, P4089, DOI 10.1038/sj.onc.1207567; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; Wang XL, 2000, J NEUROSCI, V20, P8551; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Warren HS, 2011, J IMMUNOL METHODS, V370, P86, DOI 10.1016/j.jim.2011.06.002; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7	75	322	339	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					986	1001		10.1016/j.ajhg.2012.04.015	http://dx.doi.org/10.1016/j.ajhg.2012.04.015			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22608502	hybrid, Green Published			2022-12-18	WOS:000305262600005
J	KNUDSON, AG; STRONG, LC				KNUDSON, AG; STRONG, LC			MUTATION AND CANCER - NEUROBLASTOMA AND PHEOCHROMOCYTOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDT VA, 1960, ZBL ALLG PATH, V101, P243; Arnould G, 1967, Presse Med, V75, P2115; Aubert L, 1967, Bull Mem Soc Med Hop Paris, V118, P1155; BARNARD RO, 1964, J NEUROSURG, V21, P506, DOI 10.3171/jns.1964.21.6.0506; BARRETT A F, 1963, Clin Radiol, V14, P33, DOI 10.1016/S0009-9260(63)80008-2; BARTLETT RC, 1971, ORAL SURG ORAL MED O, V31, P206, DOI 10.1016/0030-4220(71)90075-2; BAUM JL, 1971, NEW ENGL J MED, V284, P963, DOI 10.1056/NEJM197104292841709; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Bill A H Jr, 1968, J Pediatr Surg, V3, P103, DOI 10.1016/0022-3468(68)90988-3; BLOCK MA, 1968, ARCH SURG-CHICAGO, V96, P521; BOLANDE RP, 1970, CANCER-AM CANCER SOC, V26, P162, DOI 10.1002/1097-0142(197007)26:1<162::AID-CNCR2820260122>3.0.CO;2-Y; BRODY H, 1950, AM J HUM GENET, V2, P371; CAMPBELL CB, 1968, AUSTRALAS ANN MED, V17, P331; CHAPMAN RC, 1959, AM J MED, V26, P883, DOI 10.1016/0002-9343(59)90210-4; CHARACHE H, 1954, AM J SURG, V87, P545, DOI 10.1016/0002-9610(54)90416-X; CHATTEN J, 1967, NEW ENGL J MED, V277, P1230, DOI 10.1056/NEJM196712072772304; COCHRAN W, 1963, Ulster Med J, V32, P82; CONE TE, 1957, PEDIATRICS, V19, P44; CROWE FW, 1956, MULTIPLE NEUROFIBROM; CUSHMAN P, 1962, AM J MED, V32, P352, DOI 10.1016/0002-9343(62)90126-2; DAVISON LM, 1967, BRIT J RADIOL, V40, P549, DOI 10.1259/0007-1285-40-475-549; DEGRAFF J, 1964, ACTA MED SCAND, V176, P583; Dodge HJBM, 1945, ROCKY MT MED J, V42, P35; Edmunds L H Jr, 1966, Ann Thorac Surg, V2, P742; FERNANDO PB, 1951, AMA ARCH PATHOL, V52, P182; FLETCHER J R, 1970, Archives of Surgery, V100, P257; Franssila K, 1968, Duodecim, V84, P615; FREEMAN D, 1965, ARCH PATHOL, V80, P575; GALERA H, 1968, Revista Clinica Espanola, V111, P165; Gibbons J., 1967, BR J CLIN PRACT, V21, P360; GORLIN RJ, 1968, CANCER, V22, P293, DOI 10.1002/1097-0142(196808)22:2<293::AID-CNCR2820220206>3.0.CO;2-R; GREENFIELD LJ, 1965, JNCI-J NATL CANCER I, V35, P215, DOI 10.1093/jnci/35.1.215; GRIFFIN ME, 1969, PEDIATRICS, V43, P377; Gunby PC, 1920, AM J MED SCI, V160, P207; GUSHIEN AS, 1953, AM J MED, V14, P318; HELSON L, 1969, Clinical Research, V17, P614; HERMANN H, 1964, HUMAN TUMOURS SECRET; HOTCHKISS RS, 1967, ANN SURG, V166, P1021, DOI 10.1097/00000658-196712000-00023; HUANG SN, 1968, CANCER, V21, P302, DOI 10.1002/1097-0142(196802)21:2<302::AID-CNCR2820210220>3.0.CO;2-R; HUMBLE RM, 1967, ANAESTHESIA, V22, P296, DOI 10.1111/j.1365-2044.1967.tb02731.x; HUME DM, 1960, AM J SURG, V99, P458, DOI 10.1016/0002-9610(60)90141-0; IBANEZ MI, 1967, CANCER, V20, P706, DOI 10.1002/1097-0142(1967)20:5<706::AID-CNCR2820200523>3.0.CO;2-M; KAYE ROGER H., 1964, J MOUNT SINAI HOSP, V31, P476; KERZNER MS, 1968, ARCH INTERN MED, V121, P91, DOI 10.1001/archinte.121.1.91; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1966, CANCER, V19, P1032, DOI 10.1002/1097-0142(196607)19:7<1032::AID-CNCR2820190719>3.0.CO;2-7; LEE C M Jr, 1953, Am Surg, V19, P803; LEE HY, 1970, OHIO MED J, V99, P583; LEVY M, 1970, ARCH FR PEDIATR, V27, P561; LIMA JB, 1971, AM J SURG, V121, P732, DOI 10.1016/0002-9610(71)90058-4; LJUNGBERG O, 1967, BMJ-BRIT MED J, V1, P279, DOI 10.1136/bmj.1.5535.279; LORIMIER AA, 1969, AM J DIS CHILD, V118, P441; LULU DJ, 1969, ARCH SURG-CHICAGO, V99, P641; LYNCH HT, 1968, AM J DIS CHILD, V115, P723, DOI 10.1001/archpedi.1968.02100010725016; MASHETER HC, 1963, BRIT MED J, P1518; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; MELVIN KEW, 1968, P NATL ACAD SCI USA, V59, P1216, DOI 10.1073/pnas.59.4.1216; MILES RM, 1960, ARCH SURG-CHICAGO, V80, P283, DOI 10.1001/archsurg.1960.01290190103019; MILLER RW, 1971, J NATL CANCER I, V46, P203; MILLER RW, 1968, AM J DIS CHILD, V115, P253, DOI 10.1001/archpedi.1968.02100010255015; MINNO AM, 1954, NEW ENGL J MED, V251, P959, DOI 10.1056/NEJM195412092512401; MULHOLLAND SG, 1969, J AMER MED ASSOC, V207, P1709, DOI 10.1001/jama.207.9.1709; NANKIN H, 1970, Journal of Medical Genetics, V7, P374, DOI 10.1136/jmg.7.4.374; NIBBELIN DW, 1969, NEUROLOGY, V19, P455, DOI 10.1212/WNL.19.5.455; NICHOLLS EM, 1969, HUM HERED, V19, P473, DOI 10.1159/000152255; PALOYAN E, 1970, J AMER MED ASSOC, V214, P1443, DOI 10.1001/jama.214.8.1443; Potter FL, 1942, AM J PATHOL, V18, P141; ROBERTS AH, 1967, BRIT J SURG, V54, P78, DOI 10.1002/bjs.1800540118; RUPPERT RD, 1966, METABOLIS, V15, P537, DOI 10.1016/0026-0495(66)90114-4; SAROSI G, 1968, ANN INTERN MED, V68, P1305, DOI 10.7326/0003-4819-68-6-1305; SATO T, 1967, JPN HEART J, V8, P433; SAXENA KM, 1970, AM J DIS CHILD, V120, P265, DOI 10.1001/archpedi.1970.02100080149020; SCHIMKE RN, 1968, NEW ENGL J MED, V279, P1, DOI 10.1056/NEJM196807042790101; SCHLEGEL G C, 1960, Schweiz Med Wochenschr, V90, P31; SCHNEIDE.KM, 1965, PEDIATRICS, V36, P359; SCHWEISGUTH O, 1968, J PEDIATR SURG, V3, P135; SHANKLIN DR, 1969, BIOL NEONATORUM, V14, P286; SHARP WV, 1971, ANGIOLOGY, V22, P141, DOI 10.1177/000331977102200305; SHELL FM, 1959, AM J OBSTET GYNECOL, V78, P434, DOI 10.1016/0002-9378(59)90199-1; SIPPLE JH, 1961, NEW ENGL J MED, V31, P163; SLAVOTINEK A, 1968, AUSTRALAS ANN MED, V17, P320; SMID AC, 1955, AMA AM J DIS CHILD, V90, P81, DOI 10.1001/archpedi.1955.04030010083013; SMITS M, 1961, ACTA GENET STAT MED, V11, P137; STADLER HE, 1955, J PEDIATR-US, V47, P485, DOI 10.1016/S0022-3476(55)80061-3; STEINER AL, 1968, MEDICINE, V47, P371, DOI 10.1097/00005792-196809000-00001; TISHERMAN SE, 1962, JAMA-J AM MED ASSOC, V182, P152, DOI 10.1001/jama.1962.03050410048010; URBANSKI FX, 1967, J CHRON DIS, V20, P627, DOI 10.1016/0021-9681(67)90040-9; Vries J, 1967, Ned Tijdschr Geneeskd, V111, P1509; Wahl HR, 1914, J MED RES, V30, P205; WILLIAMS CR, 1969, BRIT J SURG, V56, P437, DOI 10.1002/bjs.1800560610; WILLIAMS ED, 1966, J PATHOL BACTERIOL, V91, P71, DOI 10.1002/path.1700910109; WILLIAMS ED, 1966, J CLIN PATHOL, V19, P103, DOI 10.1136/jcp.19.2.103; WILLIAMS ED, 1968, J CLIN PATHOL, V21, P129, DOI 10.1136/jcp.21.2.129; WISE KS, 1971, BRIT MED J, V1, P441, DOI 10.1136/bmj.1.5746.441; WONG KY, 1971, AM J DIS CHILD, V121, P415, DOI 10.1001/archpedi.1971.02100160085010; Zimmermann G, 1968, Munch Med Wochenschr, V110, P333; ZIMMERMANN NJ, 1951, BEITR PATHOL ANAT, V111, P355; 1968, BRIT MED J, V2, P690	98	322	322	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	5					514	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N4590	4340974				2022-12-18	WOS:A1972N459000003
J	Carella, M; DAmbrosio, L; Totaro, A; Grifa, A; Valentino, MA; Piperno, A; Girelli, D; Roetto, A; Franco, B; Gasparini, P; Camaschella, C				Carella, M; DAmbrosio, L; Totaro, A; Grifa, A; Valentino, MA; Piperno, A; Girelli, D; Roetto, A; Franco, B; Gasparini, P; Camaschella, C			Mutation analysis of the HLA-H gene in Italian hemochromatosis patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-DONORS; LINKAGE DISEQUILIBRIUM; PREVALENCE	Hemochromatosis (HH) is an inborn error of iron metabolism, frequent among Caucasians, characterized by progressive iron loading that, if untreated, causes high morbidity and death. HLA-H, a putative HH gene, has recently been isolated. The large majority of patients so far studied are homozygous for a single mutation, which results in a cysteine-to-tyrosine substitution at amino acid 282 of the protein. A second, less frequent, variant, His63Asp, has an undefined role in the pathogenesis of the disease. Here we report that the Cys282Tyr change accounts for 69% of HH chromosomes in a series of 75 unrelated Italian patients who fulfilled well-defined criteria for HH diagnosis. Sixty-four percent of patients were Cys282Tyr homozygous, 10% were heterozygous, and 21% carried the normal allele. The same mutation was rare in normal controls. The His63Asp variant was less frequent but had a similar frequency among affected and normal chromosomes. Subjects without two copies of the Cys282Tyr change were both isolated patients and individuals from families with a Gp-linked disease. Mutation analysis of the HLA-H gene, carried out by RNA-SSCP in the latter patients, did not reveal any significant nucleotide abnormality in coding sequences and intron-exon boundaries. The absence of mutations in HLA-H gene was confirmed in three cases by direct sequencing. Major deletions or rearrangements of the gene were excluded by Southern blotting. The existence of patients with clinical and histological features of HH, but without mutations in HLA-H gene, suggests that in Italy the disease is more heterogeneous than reported in northern Europe.	IRCCS,CSS SAN GIOVANNI ROTONDO,FOGGIA,ITALY; AZIENDA OSPED S GERADO,IST SCI BIOMED,DIV MED 1,MONZA,ITALY; UNIV VERONA,MED CLIN,I-37100 VERONA,ITALY; UNIV TURIN,SEZ CLIN,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,TURIN,ITALY; TELETHON INST GENET & MED,MILAN,ITALY	IRCCS Casa Sollievo Della Sofferenza; University of Verona; University of Turin; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)			Roetto, Antonella/K-4731-2016; Camaschella, Clara/A-3289-2015; Carella, Massimo/A-2804-2014; Girelli, Domenico/B-1183-2008; Gasparini, Paolo/B-6173-2014; FRANCO, Brunella/S-2882-2018	Carella, Massimo/0000-0002-6830-6829; Girelli, Domenico/0000-0001-9684-1899; FRANCO, Brunella/0000-0001-5588-4569; ROETTO, Antonella/0000-0003-1188-7375; Piperno, Alberto/0000-0002-0343-0204	Telethon [TGM06S01, E.0149, E.0537] Funding Source: Medline	Telethon(Fondazione Telethon)		ADAMS PC, 1995, GASTROENTEROLOGY, V109, P177, DOI 10.1016/0016-5085(95)90283-X; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; BISCEGLIA L, 1994, HUM MUTAT, V4, P136, DOI 10.1002/humu.1380040208; BOROT N, IN PRESS IMMUNOGENET; Camaschella C, 1996, HUM GENET, V97, P476; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; DIANZANI I, 1994, AM J HUM GENET, V55, P851; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; Piperno A, 1996, HEPATOLOGY, V24, P43, DOI 10.1002/hep.510240109; POWELL LW, 1988, ANN NY ACAD SCI, V836, P24; Powell W.L., 1994, IRON METABOLISM HLTH; Rothenberg BE, 1996, P NATL ACAD SCI USA, V93, P1529, DOI 10.1073/pnas.93.4.1529; SAARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; STONE C, 1994, HUM MOL GENET, V3, P2043; VELATI C, 1990, HAEMATOLOGICA, V75, P309	21	321	329	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					828	832						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106528				2022-12-18	WOS:A1997WT61400011
J	Rasmussen, SA; Yang, QH; Friedman, JM				Rasmussen, SA; Yang, QH; Friedman, JM			Mortality in neurofibromatosis 1: An analysis using US death certificates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIPHERAL-NERVE SHEATH; TYPE-1 NEUROFIBROMATOSIS; MOYAMOYA-DISEASE; FOLLOW-UP; NF1; TUMORS; RATIO	Although neurofibromatosis 1 (NF1) is a relatively common autosomal dominant condition, information about its effect on mortality is limited. We used Multiple-Cause Mortality Files, compiled from U.S. death certificates by the National Center for Health Statistics, for 1983 through 1997. We identified 3,770 cases of presumed NF1 among 32,722,122 deaths in the United States, a frequency of 1/8,700, which is one-third to one-half the estimated prevalence. Mean and median ages at death for persons with NF1 were 54.4 and 59 years, respectively, compared with 70.1 and 74 years in the general population. Results of proportionate mortality ratio (PMR) analyses showed that persons with NF1 were 34 times more likely (PMR = 34.3, 95% confidence interval [CI] 30.8-38.0) to have a malignant connective or other soft-tissue neoplasm listed on their death certificates than were persons without NF1. Overall, persons with NF1 were 1.2 times more likely than expected (PMR = 1.21, 95% CI 1.14-1.28) to have a malignant neoplasm listed on their death certificates, but the PMR was 6.07 (95% CI 4.88-7.45) for persons who died at 10-19 years of age and was 4.93 (95% CI 4.14-5.82) for those who died at 20-29 years of age. Similarly, vascular disease was recorded more often than expected on death certificates of persons with NF1 who died at <30 years of age (PMR = 3.26, 95% CI 1.31-6.71 at age <10 years; PMR = 2.68, 95% CI 1.38-4.68 at age 10-19 years; and PMR = 2.25, 95% CI 1.46-3.32 at 20-29 years) but not in older persons. This study PMR supports previous findings of decreased life expectancy for persons with NF1 and, within the limitations of death certificates, provides population-based data about NF1 morbidity and mortality that are useful to clinicians caring for patients with NF1.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	Centers for Disease Control & Prevention - USA; University of British Columbia	Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway NE,MS F-45, Atlanta, GA 30341 USA.			Rasmussen, Sonja/0000-0002-0574-4928; Friedman, Jan/0000-0002-7482-9570				Ahlbom A, 1993, BIOSTATISTICS EPIDEM; Airewele GE, 2001, GENET EPIDEMIOL, V20, P75, DOI 10.1002/1098-2272(200101)20:1<75::AID-GEPI7>3.3.CO;2-Q; DECOUFLE P, 1980, AM J EPIDEMIOL, V111, P263, DOI 10.1093/oxfordjournals.aje.a112895; Fossali E, 2000, PEDIATR NEPHROL, V14, P806, DOI 10.1007/s004679900260; Hattori S, 1998, PATHOL RES PRACT, V194, P363, DOI 10.1016/S0344-0338(98)80061-7; Hennekens CR, 1987, EPIDEMIOLOGY MED, P85; Hess JL, 1996, AM J CLIN PATHOL, V105, P238; Imaizumi Yoko, 1995, Journal of Dermatology (Tokyo), V22, P191; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; JENSEN LN, 1998, AM J HUM GENET, V63, pA114; King AA, 2000, AM J MED GENET, V93, P388, DOI 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#; KUPPER LL, 1978, J CHRON DIS, V31, P15, DOI 10.1016/0021-9681(78)90077-2; Kwong KL, 1999, J PAEDIATR CHILD H, V35, P108; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; McGaughran JM, 1999, J MED GENET, V36, P197; MIETTINEN OS, 1981, AM J EPIDEMIOL, V114, P144, DOI 10.1093/oxfordjournals.aje.a113161; MUHONEN MG, 1991, SURG NEUROL, V36, P470, DOI 10.1016/0090-3019(91)90163-4; Poyhonen M, 2000, J MED GENET, V37, P632, DOI 10.1136/jmg.37.8.632; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; ROMAN E, 1984, STAT MED, V3, P7, DOI 10.1002/sim.4780030103; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P225; Shen MH, 1996, J MED GENET, V33, P2, DOI 10.1136/jmg.33.1.2; SIRKEN MG, 1987, AM J PUBLIC HEALTH, V77, P137, DOI 10.2105/AJPH.77.2.137; SOBATA E, 1988, NEUROSURGERY, V22, P544, DOI 10.1227/00006123-198803000-00016; SORENSEN SA, 1986, NEW ENGL J MED, V314, P1010, DOI 10.1056/NEJM198604173141603; Woodruff JM, 1999, AM J MED GENET, V89, P23, DOI 10.1002/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#; ZOLLER M, 1995, ACTA DERM-VENEREOL, V75, P136	27	319	332	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1110	1118		10.1086/320121	http://dx.doi.org/10.1086/320121			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283797	Green Published, Bronze			2022-12-18	WOS:000168171200005
J	Gallagher, MD; Chen-Plotkin, AS				Gallagher, Michael D.; Chen-Plotkin, Alice S.			The Post-GWAS Era: From Association to Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							FRONTOTEMPORAL LOBAR DEGENERATION; BREAST-CANCER RISK; FACTOR-H POLYMORPHISM; ALPHA-SYNUCLEIN; TRANSCRIPTION FACTOR; REGULATORY VARIATION; GENETIC-VARIATION; FETAL-HEMOGLOBIN; COMPLEX TRAITS; VARIANTS	During the past 12 years, genome-wide association studies (GWASs) have uncovered thousands of genetic variants that influence risk for complex human traits and diseases. Yet functional studies aimed at delineating the causal genetic variants and biological mechanisms underlying the observed statistical associations with disease risk have lagged. In this review, we highlight key advances in the field of functional genomics that may facilitate the derivation of biological meaning post-GWAS. We highlight the evidence suggesting that causal variants underlying disease risk often function through regulatory effects on the expression of target genes and that these expression effects might be modest and cell-type specific. We moreover discuss specific studies as proof-of-principle examples for current statistical, bioinformatic, and empirical bench-based approaches to downstream elucidation of GWAS-identified disease risk loci.	[Gallagher, Michael D.; Chen-Plotkin, Alice S.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Gallagher, Michael D.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	University of Pennsylvania; Pennsylvania Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute	Chen-Plotkin, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	chenplot@pennmedicine.upenn.edu	Gallagher, Michael Dane/G-7113-2015	Gallagher, Michael Dane/0000-0002-2109-1293	NIH [F31 NS090892, R01 NS082265, UO1 NS097056, P30 AG010124]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS097056, F31NS090892, R01NS082265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	M.D.G. was supported by the NIH (F31 NS090892), and A.S.C.-P. is supported by the NIH (R01 NS082265, UO1 NS097056, P30 AG010124) and the Alzheimer's Association. We thank Christopher D. Brown for many helpful discussions.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Busch JI, 2016, HUM MOL GENET, V25, P2681, DOI 10.1093/hmg/ddw127; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004798; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Engel KL, 2016, SEMIN CELL DEV BIOL, V57, P40, DOI 10.1016/j.semcdb.2016.05.014; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gaj T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023754; Gallagher MD, 2017, AM J HUM GENET, V101, P643, DOI 10.1016/j.ajhg.2017.09.004; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Ghosh S, 1996, ANNU REV MED, V47, P333; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hause RJ, 2014, AM J HUM GENET, V95, P194, DOI 10.1016/j.ajhg.2014.07.005; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hirschhorn JN, 2005, PEDIATR RES, V57, p74R, DOI 10.1203/01.PDR.0000159574.98964.87; Holwerda SJB, 2013, NUCLEIC ACIDS RES, V41, P6905, DOI 10.1093/nar/gkt491; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Johnson GCL, 2000, CURR OPIN GENET DEV, V10, P330, DOI 10.1016/S0959-437X(00)00075-7; Kaplow IM, 2015, GENOME RES, V25, P907, DOI 10.1101/gr.183749.114; Kapoor A, 2014, AM J HUM GENET, V94, P854, DOI 10.1016/j.ajhg.2014.05.001; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Lettre G, 2016, LANCET, V387, P2554, DOI 10.1016/S0140-6736(15)01341-0; Lu QS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006933; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pai AA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004857; Paraboschi EM, 2014, HUM MOL GENET, V23, P6746, DOI 10.1093/hmg/ddu392; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Stagi M, 2014, MOL CELL NEUROSCI, V61, P226, DOI 10.1016/j.mcn.2014.07.006; Stead JA, 2006, MOL CELL PROTEOMICS, V5, P1697, DOI 10.1074/mcp.T600027-MCP200; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tehranchi AK, 2016, CELL, V165, P730, DOI 10.1016/j.cell.2016.03.041; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Vicente CT, 2015, AM J HUM GENET, V97, P329, DOI 10.1016/j.ajhg.2015.06.010; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Wang DX, 2014, HUM MOL GENET, V23, P268, DOI 10.1093/hmg/ddt417; Wang XC, 2016, ELIFE, V5, DOI 10.7554/eLife.10557; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White CC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002287; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Wu Y, 2014, HUM MOL GENET, V23, P1108, DOI 10.1093/hmg/ddt488; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108	107	318	321	7	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					717	730		10.1016/j.ajhg.2018.04.002	http://dx.doi.org/10.1016/j.ajhg.2018.04.002			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727686	Green Published, Bronze			2022-12-18	WOS:000432440100001
J	Fallin, D; Schork, NJ				Fallin, D; Schork, NJ			Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; PCR	Haplotype analyses have become increasingly common in genetic studies of human disease because of their ability to identify unique chromosomal segments likely to harbor disease-predisposing genes. The study of haplotypes is also used to investigate many population processes, such as migration and immigration rates, linkage-disequilibrium strength, and the relatedness of populations. Unfortunately, many haplotype-analysis methods require phase information that can be difficult to obtain from samples of nonhaploid species. There are, however, strategies for estimating haplotype frequencies from unphased diploid genotype data collected on a sample of individuals that make use of the expectation-maximization (EM) algorithm to overcome the missing phase information. The accuracy of such strategies, compared with other phase-determination methods, must be assessed before their use can be advocated. In this study we consider and explore sources of error between EM-derived haplotype frequency estimates and their population parameters, noting that much of this error is due to sampling error, which is inherent in all studies, even when phase can be determined. In light of this, we focus on the additional error between haplotype frequencies within a sample data set and EM-derived haplotype frequency estimates incurred by the estimation procedure. We assess the accuracy of haplotype frequency estimation as a function of a number of factors, including sample size, number of loci studied, allele frequencies, and locus-specific alellic departures from Hardy-Weinberg and linkage equilibrium. We point out the relative impacts of sampling error and estimation error, calling attention to the pronounced accuracy of EM estimates once sampling error has been accounted for. We also suggest that many factors that may influence accuracy can be assessed empirically within a data set-a fact that can be used to Create "diagnostics" that a user can turn to for assessing potential inaccuracies in estimation.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA	Case Western Reserve University; Jackson Laboratory; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Fallin, D (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Campus,2500 Metrohlth Dr,Rammelkamp, Cleveland, OH 44109 USA.			Schork, Nicholas/0000-0003-0920-5013	NHLBI NIH HHS [HL94011, P50 HL054998, HL54998-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054998] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CLARK AG, 1990, MOL BIOL EVOL, V7, P111; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; LEWONTIN RC, 1964, GENETICS, V49, P49; LONG JC, 1995, AM J HUM GENET, V56, P799; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; SCHORK N, 2000, UNPUB GENOME RES; WEIR BS, 1996, GENETIC DATA ANAL, pR2	10	318	339	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					947	959		10.1086/303069	http://dx.doi.org/10.1086/303069			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10954684	Green Published, Bronze			2022-12-18	WOS:000089651100016
J	Wassif, CA; Maslen, C; Kachilele-Linjewile, S; Lin, D; Linck, LM; Connor, WE; Steiner, RD; Porter, FD				Wassif, CA; Maslen, C; Kachilele-Linjewile, S; Lin, D; Linck, LM; Connor, WE; Steiner, RD; Porter, FD			Mutations in the human sterol Delta(7)-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE CHOLESTEROL-BIOSYNTHESIS; PLASMA; YEAST	The Smith-Lemli-Opitz syndrome (SLOS; also known as "RSH syndrome" [MIM 270400]) is an autosomal recessive multiple malformation syndrome due to a defect in cholesterol biosynthesis. Children with SLOS have elevated serum 7-dehydrocholesterol (7-DHC) levels and typically have low serum cholesterol levels. On the basis of this biochemical abnormality, it has been proposed that mutations in the human sterol Delta(7)-reductase (7-DHC reductase; E.C.1.3.1.21) gene cause SLOS. However, one could also propose a defect in a gene that encodes a protein necessary for either the expression or normal function of sterol Delta(7)-reductase. We cloned cDNA encoding a human sterol Delta(7)-reductase (DHCR7) on the basis of its homology with the sterol Delta(7)-reductase from Arabidopsis thaliana, and we confirmed the enzymatic function of the human gene product by expression in SLOS fibroblasts. SLOS fibroblasts transfected with human sterol Delta(7)-reductase cDNA showed a significant reduction in 7-DHC levels, compared with those in SLOS fibroblasts transfected with the vector alone. Using radiation-hybrid mapping, we show that the DHCR7 gene is encoded at chromosome 11q12-13. To establish that defects in this gene cause SLOS, we sequenced cDNA clones from SLOS patients. In three unrelated patients we have identified four different mutant alleles. Our results demonstrate both that the cDNA that we have identified encodes the human sterol Delta(7)-reductase and that mutations in DHCR7 are responsible for at least some cases of SLOS.	NICHHD, Heritable Disorders Branch, NIH, Unit Mol Dysmorphol, Bethesda, MD 20892 USA; Oregon Hlth Sci Univ, Congenital Heart Res Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Med, Div Endocrinol Diabet Clin Nutr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Doembecher Childrens Hosp, Child Dev & Rehabil Ctr, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Doembecher Childrens Hosp, Child Dev & Rehabil Ctr, Dept Mol & Med Genet, Portland, OR 97201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Porter, FD (corresponding author), NICHHD, Heritable Disorders Branch, NIH, Unit Mol Dysmorphol, Bldg 10,Room 9S241,10 Ctr Dr, Bethesda, MD 20892 USA.		Steiner, Robert D./AAJ-5756-2020	Steiner, Robert D./0000-0003-4177-4590; Wassif, Christopher/0000-0002-2524-1420	NCRR NIH HHS [5 M01 RR 00334] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000334] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALLEY TL, 1995, AM J HUM GENET, V56, P1411; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BERRY R, 1989, AM J MED GENET, V34, P358, DOI 10.1002/ajmg.1320340312; BIALER MG, 1987, AM J MED GENET, V28, P723, DOI 10.1002/ajmg.1320280320; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.3.CO;2-5; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; Dehart DB, 1997, AM J MED GENET, V68, P328, DOI 10.1002/(SICI)1096-8628(19970131)68:3<328::AID-AJMG15>3.0.CO;2-V; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORLIN RJ, 1990, OXFORD MONOGRAMS MED, V19, P890; IRONS M, 1993, LANCET, V341, P1414, DOI 10.1016/0140-6736(93)90983-N; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; LEI KJ, 1992, MOL ENDOCRINOL, V6, P703, DOI 10.1210/me.6.5.703; LIN DS, 1993, J LIPID RES, V34, P491; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; NATOWICZ MR, 1994, AM J MED GENET, V50, P364, DOI 10.1002/ajmg.1320500413; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; ROUX C, 1980, J NUTR, V110, P2310, DOI 10.1093/jn/110.11.2310; Scherer SW, 1997, GENOMICS, V44, P232, DOI 10.1006/geno.1997.4842; SHEFER S, 1995, J CLIN INVEST, V96, P1779, DOI 10.1172/JCI118223; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; TINT GS, 1995, J PEDIATR-US, V127, P82, DOI 10.1016/S0022-3476(95)70261-X; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205	27	318	327	0	10	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					55	62		10.1086/301936	http://dx.doi.org/10.1086/301936			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634533	Green Published, Bronze			2022-12-18	WOS:000074761000010
J	Wilcox, WR; Banikazemi, M; Guffon, N; Waldek, S; Lee, P; Linthorst, GE; Desnick, RJ; Germain, DP				Wilcox, WR; Banikazemi, M; Guffon, N; Waldek, S; Lee, P; Linthorst, GE; Desnick, RJ; Germain, DP		Int Fabry Dis Study Grp	Long-term safety and efficacy of enzyme replacement therapy for Fabry disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-GALACTOSIDASE; GLOBOTRIAOSYLCERAMIDE; INFUSION	Elsewhere, we reported the safety and efficacy results of a multicenter phase 3 trial of recombinant human alpha-galactosidase A (rh-alphaGalA) replacement in patients with Fabry disease. All 58 patients who were enrolled in the 20-wk phase 3 double-blind, randomized, and placebo-controlled study received subsequently 1 mg/kg of rh-alphaGalA ( agalsidase beta, Fabrazyme, Genzyme Corporation) biweekly in an ongoing open-label extension study. Evidence of long-term efficacy, even in patients who developed IgG antibodies against rh-alphaGalA, included the continuously normal mean plasma globotriaosylceramide (GL-3) levels during 30 mo of the extension study and the sustained capillary endothelial GL-3 clearance in 98% (39/40) of patients who had a skin biopsy taken after treatment for 30 mo (original placebo group) or 36 mo (original enzyme-treated group). The mean serum creatinine level and estimated glomerular filtration rate also remained stable after 30-36 mo of treatment. Infusion-associated reactions decreased over time, as did anti-rh-alphaGalA IgG antibody titers. Among seroconverted patients, after 30-36 mo of treatment, seven patients tolerized (no detectable IgG antibody), and 59% had greater than or equal to4-fold reductions in antibody titers. As of 30 mo into the extension trial, three patients were withdrawn from the study because of positive serum IgE or skin tests; however, all have been rechallenged successfully at the time of this report. Thus, enzyme replacement therapy for 30-36 mo with agalsidase beta resulted in continuously decreased plasma GL-3 levels, sustained endothelial GL-3 clearance, stable kidney function, and a favorable safety profile.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Cedars Sinai Burns & Allen Res Inst, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Hop Edouard Herriot, Lyon, France; Hope Hosp, Manchester, Lancs, England; UCL Hosp, London, England; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Hop Europeen Georges Pompidou, Paris, France	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU Lyon; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, 5th Ave & 100th St, New York, NY 10029 USA.	rjdesnick@mssm.edu	GERMAIN, Dominique P./AAD-6747-2020	GERMAIN, Dominique/0000-0002-8355-007X				[Anonymous], 2014, METABOLIC MOL BASES; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; COLOMBI A, 1967, HELV MED ACTA, V34, P67; De Schoenmakere G, 2003, NEPHROL DIAL TRANSPL, V18, P33, DOI 10.1093/ndt/18.1.33; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Gandek, 1997, SF 36 HLTH SURVEY MA; GUFFON N, IN PRESS J INHERIT M; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; RICHARDS SM, 1993, BLOOD, V82, P1402; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Waldek S, 2003, NEW ENGL J MED, V348, P1186, DOI 10.1056/NEJM200303203481224; Weidemann F, 2003, CIRCULATION, V108, P1299, DOI 10.1161/01.CIR.0000091253.71282.04; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	20	317	339	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					65	74		10.1086/422366	http://dx.doi.org/10.1086/422366			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15154115	Bronze, Green Published			2022-12-18	WOS:000222031300008
J	Allison, DB				Allison, DB			Transmission-disequilibrium tests for quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; STATISTICAL POWER; GENETIC-LINKAGE; SIB PAIRS; LOCI; ASSOCIATIONS; GUIDELINES; MARKERS; ADMIXTURE; PROGRAM	The transmission-disequilibrium test (TDT) of Spielman et al. is a family-based linkage-disequilibrium test that offers a powerful way to test for linkage between alleles and phenotypes that is either causal (i.e., the marker locus is the disease/trait allele) or due to linkage disequilibrium. The TDT is equivalent to a randomized experiment and, therefore, is resistant to confounding. When the marker is extremely close to the disease locus or is the disease locus itself, tests such as the TDT can be far more powerful than conventional linkage tests, To date, the TDT and most other family-based association tests have been applied only to dichotomous traits. This paper develops five TDT-type tests for use with quantitative traits. These tests accommodate either unselected sampling or sampling based on selection of phenotypically extreme offspring. Power calculations are provided and show that, when a candidate gene is available (1) these TDT-type tests are at least an order of magnitude more efficient than two common sib-pair tests of linkage; (2) extreme sampling results in substantial increases in power; and (3) if the most extreme 20% of the phenotypic distribution is selectively sampled, across a wide variety of plausible genetic models, quantitative-trait loci explaining as little as 5% of the phenotypic variation can be detected at the .0001 alpha level with <300 observations.			Allison, DB (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, ST LUKES ROOSEVELT HOSP, OBES RES CTR, 1111 AMSTERDAM AVE, NEW YORK, NY 10025 USA.			Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051716, P30DK026687, R29DK047256] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIKE LS, 1991, MULTIPLE REGRESSION; ALF EF, 1975, PSYCHOMETRIKA, V40, P563, DOI 10.1007/BF02291557; ALLISON DB, 1995, J CONSULT CLIN PSYCH, V63, P339; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; Boomsma DI, 1996, BEHAV GENET, V26, P161, DOI 10.1007/BF02359893; Bryk AS, 1992, HIERARCHICAL LINEAR; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; COCKETT NE, 1994, P NATL ACAD SCI USA, V91, P3019, DOI 10.1073/pnas.91.8.3019; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CURTIS D, 1995, AM J HUM GENET, V56, P811; DRAPER NR, 1966, APPLIED REGRESSION A; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; EWENS WJ, 1995, AM J HUM GENET, V57, P455; GORMAN BS, 1995, EDUC PSYCHOL MEAS, V55, P773, DOI 10.1177/0013164495055005009; Grice DE, 1996, AM J HUM GENET, V59, P644; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hays WL, 1988, STATISTICS; HOGG RV, 1978, INTRO MATH STATISTIC; ITA GG, 1994, AM STAT, V48, P324; JIANG CJ, 1995, GENETICS, V140, P1111; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; KNAPP M, 1993, AM J HUM GENET, V52, P1085; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LITTLE RJA, 1990, MODERN METHODS DATA, P374; Longford NT., 1993, RANDOM COEFFICIENT M; Marascuilo L.A., 1977, NONPARAMETRIC DISTRI; Markel P. D., 1994, Psychiatric Genetics, V4, P205, DOI 10.1097/00041444-199400440-00003; Moldin SO, 1995, GENET EPIDEMIOL, V12, P801, DOI 10.1002/gepi.1370120645; MURPHY EA, 1982, BIOSTATISTICS MED; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEALE MC, 1995, STAT MODELING MX MED; Nicholls RD, 1996, PENN CTR N, V5, P560; NICK TG, 1995, GENET EPIDEMIOL, V12, P145, DOI 10.1002/gepi.1370120204; NICKERSON DA, 1992, GENOMICS, V12, P377, DOI 10.1016/0888-7543(92)90388-9; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; Petersen R.G., 1985, DESIGN ANAL EXPT; RICE J, 1979, BIOMETRICS, V35, P451, DOI 10.2307/2530347; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; ROTHSTEIN HR, 1990, EDUC PSYCHOL MEAS, V50, P819, DOI 10.1177/0013164490504009; RUBIN DB, 1991, BIOMETRICS, V47, P1213, DOI 10.2307/2532381; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SPIELMAN RS, 1994, AM J HUM GENET, V54, P559; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; St Jean P., 1996, American Journal of Human Genetics, V59, pA237; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; *SUDAAN STAT SOFTW, 1995, SUDAAN; SWIFT M, 1990, AM J HUM GENET, V47, P266; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1995, AM J HUM GENET, V57, P487	57	317	341	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					676	690						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042929				2022-12-18	WOS:A1997WK40300026
J	HALL, JG				HALL, JG			REVIEW AND HYPOTHESES - SOMATIC MOSAICISM - OBSERVATIONS RELATED TO CLINICAL GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											HALL, JG (corresponding author), UNIV BRITISH COLUMBIA, GRACE HOSP, CLIN GENET UNIT, 4490 OAK ST, VANCOUVER V6H 3V5, BC, CANADA.			Hall, Judith G./0000-0001-5062-491X				ADAMSON ED, 1983, BIOL BASIS REPRODUCT, P307; ALLANSON JE, 1986, CLIN GENET, V29, P429; BECH-HANSEN N T, 1987, American Journal of Human Genetics, V41, pA93; BOWEN P, 1974, Birth Defects Original Article Series, V10, P31; BRADLEY TB, 1980, JOHNS HOPKINS MED J, V146, P236; BRUSILOW S, 1987, PEDIATR RES, V21, pA289, DOI 10.1203/00006450-198704010-00729; BYERS PH, 1988, AM J HUM GENET, V42, P237; CAVENEE WK, 1986, TRENDS GENET, V2, P299, DOI 10.1016/0168-9525(86)90278-7; CHILCOTE RR, 1987, BLOOD, V69, P156; CONNOR JM, 1986, LANCET, V2, P1275; CRANE JP, 1988, PRENATAL DIAG, V8, P119, DOI 10.1002/pd.1970080206; DARRAS B T, 1987, American Journal of Human Genetics, V41, pA95; DAVID TJ, 1972, J MED GENET, V9, P316, DOI 10.1136/jmg.9.3.316; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; DONNAI D, 1986, LANCET, V1, P1443; DONNENFELD AE, 1987, AM J MED GENET, V27, P159, DOI 10.1002/ajmg.1320270117; EDWARDS JH, 1986, J MED GENET, V23, P521, DOI 10.1136/jmg.23.6.521; FIALKOW PJ, 1987, NEW ENGL J MED, V317, P468, DOI 10.1056/NEJM198708203170802; FRYNS JP, 1983, CLIN GENET, V24, P156; GARDNER RJM, 1988, J MED GENET, V25, P113, DOI 10.1136/jmg.25.2.113; GARDNER RL, 1983, BIOL BASIS REPRODUCT, P31; GARTLER SM, 1975, AM J HUM GENET, V27, P218; GOODSHIP J, 1988, LANCET, V1, P729; GRIDLEY T, 1987, TRENDS GENET, V3, P162, DOI 10.1016/0168-9525(87)90218-6; Hall J G, 1975, Birth Defects Orig Artic Ser, V11, P187; HALL J G, 1969, Birth Defects Original Article Series, V5, P24; HALL JG, 1987, LANCET, V1, P751; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; HAPPLE R, 1986, CLIN GENET, V29, P321; HECHT F, 1983, CLIN GENET, V24, P177; HOYME HE, 1986, P GREENWOOD GENET CT, V6, P126; HUNTER AGW, 1985, CLIN GENET, V28, P47; JENKINS ME, 1971, AM J DIS CHILD, V122, P80, DOI 10.1001/archpedi.1971.02110010116024; JUBERG R C, 1988, Pediatric Research, V23, p330A; KALOUSEK D K, 1987, American Journal of Human Genetics, V41, pA278; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; KALOUSEK DK, 1987, HUM GENET, V77, P163, DOI 10.1007/BF00272385; KIMMEL CB, 1988, TRENDS GENET, V4, P68, DOI 10.1016/0168-9525(88)90043-1; KRAJEWSKAWALASEK M, 1987, AM J MED GENET, V27, P153, DOI 10.1002/ajmg.1320270116; LEBEAU MM, 1986, ADV HUM GENET, V15, P1; LENZ W, 1975, AM J HUM GENET, V27, P690; LILFORD RJ, 1987, LANCET, V1, P1415; LUCKETT WP, 1978, AM J ANAT, V152, P59, DOI 10.1002/aja.1001520106; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MADDALENA A, 1987, American Journal of Human Genetics, V41, pA227; MIGEON B R, 1987, American Journal of Human Genetics, V41, pA103; MIGEON BR, 1970, BIOCHEM GENET, V4, P377, DOI 10.1007/BF00485754; MINTZ B, 1973, DEV BIOL, V31, P195, DOI 10.1016/0012-1606(73)90331-X; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; NIELSEN KG, 1988, HUM GENET, V78, P103, DOI 10.1007/BF00291249; NISS R, 1976, J MED GENET, V13, P229, DOI 10.1136/jmg.13.3.229; OPITZ JM, 1984, AM J MED GENET, V19, P251, DOI 10.1002/ajmg.1320190207; PAGON RA, 1979, AM J HUM GENET, V31, P54; PELTOMAKI P, 1987, CLIN GENET, V31, P399; POSTLETHWAIT JH, 1978, GENETICS BIOL DROS C, V2, P359; RASMUSSEN SA, 1988, CLIN GENET, V33, P5; REED TE, 1955, AM J HUM GENET, V7, P28; REISER CA, 1984, AM J MED GENET, V19, P245, DOI 10.1002/ajmg.1320190206; RICCARDI VM, 1988, AM J HUM GENET, V42, P284; RIMOIN DL, 1969, BIRTH DEFECTS, V4, P17; ROBERTSON EJ, 1986, TRENDS GENET, V2, P9, DOI 10.1016/0168-9525(86)90161-7; ROLLNICK BR, 1988, CLIN GENET, V33, P145; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SEARLE AG, 1978, GENETIC MOSAICS CHIM, V12, P209; SHUNSHIN M, 1954, J BONE JOINT SURG BR, V36, P268, DOI 10.1302/0301-620X.36B2.268; Snyder LH, 1944, J LAB CLIN MED, V29, P1211; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; SPENCE JE, 1988, AM J HUM GENET, V42, P217; STRAUSS M, 1981, HUM GENET, V57, P185; SWIFT M, 1974, AM J HUM GENET, V26, P304; THOMAS IT, 1986, P GREENWOOD CTR, V6, P105; TURLEAU C, 1986, HUM GENET, V74, P185, DOI 10.1007/BF00282090; WARBURTON D, 1988, AM J HUM GENET, V42, P215; WEST JD, 1978, GENETIC MOSAICS CHIM, V12, P435; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WILKINS RJ, 1988, LANCET, V1, P329; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677; YOUSSOUFIAN H, 1987, American Journal of Human Genetics, V41, pA249	79	317	319	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					355	363						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3052049				2022-12-18	WOS:A1988Q473600001
J	Wittke-Thompson, JK; Pluzhnikov, A; Cox, NJ				Wittke-Thompson, JK; Pluzhnikov, A; Cox, NJ			Rational inferences about departures from Hardy-Weinberg equilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE DISTRIBUTIONS; PROSTATE-CANCER; CROHNS-DISEASE; ASSOCIATION; SUSCEPTIBILITY; GENE; POLYMORPHISMS; POPULATION; SELECTION; MUTATION	Previous studies have explored the use of departure from Hardy-Weinberg equilibrium (DHW) for fine mapping Mendelian disorders and for general fine mapping. Other studies have used Hardy-Weinberg tests for genotyping quality control. To enable investigators to make rational decisions about whether DHW is due to genotyping error or to underlying biology, we developed an analytic framework and software to determine the parameter values for which DHW might be expected for common diseases. We show analytically that, for a general disease model, the difference between population and Hardy-Weinberg-expected genotypic frequencies (Delta) at the susceptibility locus is a function of the susceptibility-allele frequency (q), heterozygote relative risk (beta), and homozygote relative risk (gamma). For unaffected control samples, Delta is a function of risk in nonsusceptible homozygotes (alpha), the population prevalence of disease (K-p), q, beta, and gamma. We used these analytic functions to calculate D and the number of cases or controls needed to detect DHW for a range of genetic models consistent with common diseases (1.1 <= gamma <= 10 and 0.005 <= K-p <= 0.2). Results suggest that significant DHW can be expected in relatively small samples of patients over a range of genetic models. We also propose a goodness-of-fit test to aid investigators in determining whether a DHW observed in the context of a case-control study is consistent with a genetic disease model. We illustrate how the analytic framework and software can be used to help investigators interpret DHW in the context of association studies of common diseases.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cox, NJ (corresponding author), Univ Chicago, Dept Human Genet, 507H CLSC,920 E 58th St, Chicago, IL 60637 USA.	ncox@genetics.bsd.uchicago.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889, U01DK058026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-58026, R01 DK055889, DK-55889, U01 DK058026] Funding Source: Medline; NIGMS NIH HHS [U01 GM061393, U01-GM61393] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Castle WE, 1903, P AM ACAD ARTS SCI, V39, P223, DOI 10.2307/20021870; Cram?r H., 1946, MATH METHODS STAT; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; Gyorffy B, 2004, GUT, V53, P614; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Kocsis I, 2004, KIDNEY INT, V65, P1956, DOI 10.1111/j.1523-1755.2004.00596.x; Kocsis I, 2004, NEUROLOGY, V63, P357, DOI 10.1212/01.WNL.0000130248.66159.92; Levecque C, 2003, HUM MOL GENET, V12, P79, DOI 10.1093/hmg/ddg009; LI CC, 1967, AM J HUM GENET, V19, P70; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Nejentsev S, 2003, HUM IMMUNOL, V64, P345, DOI 10.1016/S0198-8859(02)00825-X; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; RISCH N, 1990, AM J HUM GENET, V46, P222; Wang LZ, 2003, CANCER LETT, V202, P53, DOI 10.1016/j.canlet.2003.08.001; WEINBERG W, 2005, PAPERS HUMAN GENETIC; Weir SB, 1996, GENETIC DATA ANAL, P91; Xu J, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y	24	316	325	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					967	986		10.1086/430507	http://dx.doi.org/10.1086/430507			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15834813	Green Published, Bronze			2022-12-18	WOS:000229047900005
J	Matsumine, H; Saito, M; ShimodaMatsubayashi, S; Tanaka, H; Ishikawa, A; NakagawaHattori, Y; Yokochi, M; Kobayashi, T; Igarashi, S; Takano, H; Sanpei, K; Koike, R; Mori, H; Kondo, T; Mizutani, Y; Schaffer, AA; Yamamura, Y; Nakamura, S; Kuzuhara, S; Tsuji, S; Mizuno, Y				Matsumine, H; Saito, M; ShimodaMatsubayashi, S; Tanaka, H; Ishikawa, A; NakagawaHattori, Y; Yokochi, M; Kobayashi, T; Igarashi, S; Takano, H; Sanpei, K; Koike, R; Mori, H; Kondo, T; Mizutani, Y; Schaffer, AA; Yamamura, Y; Nakamura, S; Kuzuhara, S; Tsuji, S; Mizuno, Y			Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANGANESE-SUPEROXIDE-DISMUTASE; LINKAGE ANALYSIS; COMPLEX-I; DISEASE; TRAITS; DNA; MAP	An autosomal recessive form of juvenile Parkinsonism (AR-JP) (MIM 600116) is a levodopa-responsive Parkinsonism whose pathological finding is a highly selective degeneration of dopaminergic neurons in the zona compacta of the substantia nigra. By linkage analysis of diallelic polymorphism of the Mn-superoxide dismutase gene (SOD2), we found a family with AR-JP showing perfect segregation of the disease with the SOD2 locus. By extending the linkage analysis to 13 families with AR-JP, we discovered strong evidence for the localization of the AR-JP gene at chromosome 6q25.2-27, including the SOD2 locus, with the maximal cumulative pairwise LOD scores of 7.26 and 7.71 at DGS305 (theta=.03) and D6S253 (theta=.02), respectively. Observation of obligate recombination events, as well as multipoint linkage analysis, placed the AR-JP gene in a 17-cM interval between D6S437 and D6S264. Delineation of the AR-JP gene will be an important step toward our understanding of the molecular mechanism underlying selective degeneration of the nigral neurons.	JUNTENDO UNIV,SCH MED,DEPT NEUROL,TOKYO 113,JAPAN; TOKYO METROPOLITAN EBARA HOSP,DEPT NEUROL,TOKYO,JAPAN; TOKYO METROPOLITAN MATSUZAWA HOSP,DEPT CLIN PATHOL,TOKYO,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; NISHI OJIYA NATL HOSP,DEPT NEUROL,NIIGATA,JAPAN; RICE UNIV,DEPT COMP SCI,HOUSTON,TX 77251; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; HIROSHIMA UNIV,SCH MED,DEPT HLTH SCI,HIROSHIMA,JAPAN; HIROSHIMA UNIV,SCH MED,DEPT INTERNAL MED 3,HIROSHIMA,JAPAN; MIE UNIV,SCH MED,DEPT NEUROL,TSU,MIE,JAPAN	Juntendo University; Niigata University; Rice University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hiroshima University; Hiroshima University; Mie University			Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Mizutani, Yasuhisa/B-3809-2009					BECK Y, 1987, NUCLEIC ACIDS RES, V15, P9076, DOI 10.1093/nar/15.21.9076; BOVERIS A, 1977, ADV EXP BIOL MED, V10, P161; BUTLER RM, 1994, PARALLEL COMPUT, V20, P547, DOI 10.1016/0167-8191(94)90028-0; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHURCH SL, 1992, GENOMICS, V14, P823, DOI 10.1016/S0888-7543(05)80202-2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; GIBB WRG, 1993, PARKINSONS DIS MOVEM, P253; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARTMAN JR, 1988, Patent No. 284105; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; HASSAN HM, 1988, FREE RADICAL BIO MED, V5, P377, DOI 10.1016/0891-5849(88)90111-6; HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409; HECKL K, 1988, NUCLEIC ACIDS RES, V16, P6224, DOI 10.1093/nar/16.13.6224; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; KONDO T, 1990, MOV DISORD S, V5, P29; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; MIZUNO Y, 1987, BIOCHEM BIOPH RES CO, V143, P294, DOI 10.1016/0006-291X(87)90664-4; MIZUTANI Y, 1988, CLIN NEUROL, V28, P1542; Mizutani Y, 1993, GENDAIIRYOU TOKYO, V25, P11; Ott J., 1991, ANAL HUMAN GENETIC L; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Sambrook J, 1989, MOL CLONING LAB MANU; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Takubo Hideki, 1996, Brain and Nerve (Tokyo), V48, P587; TANAKA H, 1991, NEUROLOGY, V41, P719, DOI 10.1212/WNL.41.5.719; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239; YAMAMURA Y, 1993, CLIN NEUROL, V33, P491; ZIEGLER A, 1993, GENOME PRIORITY REPO, V1, P269	39	315	337	1	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					588	596						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042918				2022-12-18	WOS:A1997WK40300015
J	GARDNER, EJ				GARDNER, EJ			FOLLOW-UP STUDY OF A FAMILY GROUP EXHIBITING DOMINANT INHERITANCE FOR A SYNDROME INCLUDING INTESTINAL POLYPS, OSTEOMAS, FIBROMAS AND EPIDERMAL CYSTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CURTH HO, 1955, ARCH DERMATOL, V71, P95, DOI 10.1001/archderm.1955.01540250097018; DEVIC, 1912, ARCH MAL APPAR DIG, V6, P278; DUKES C E, 1958, Dis Colon Rectum, V1, P413; DUKES CE, 1952, ANN EUGENIC, V17, P1; DUKES CUTHBERT, 1930, CANCER REV, V5, P241; FADER M, 1962, Oral Surg Oral Med Oral Pathol, V15, P153, DOI 10.1016/0030-4220(62)90004-X; FITZGERALD GM, 1943, J AM DENT ASSOC, V30, P1408; GARDNER EJ, 1952, CANCER, V5, P695, DOI 10.1002/1097-0142(195207)5:4<695::AID-CNCR2820050407>3.0.CO;2-5; GARDNER EJ, 1953, AM J HUM GENET, V5, P139; GARDNER EJ, 1950, AM J HUM GENET, V2, P41; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GARDNER EJ, 1952, AM J HUM GENET, V4, P31; GARDNER EJ, 1955, NOVANT ANNI LEGGI ME, P321; Gottesman J, 1930, AM J MED SCI, V179, P370; GUMPEL RC, 1956, ANN INTERN MED, V45, P1045, DOI 10.7326/0003-4819-45-6-1045; HELWIG EB, 1947, SURG GYNECOL OBSTET, V84, P36; JEGHERS H, 1949, NEW ENGL J MED, V241, P1031, DOI 10.1056/NEJM194912292412601; JEGHERS H, 1949, NEW ENGL J MED, V241, P993, DOI 10.1056/NEJM194912222412501; JOHNSON LC, 1953, B NEW YORK ACAD MED, V29, P164; LABERGE MY, 1958, P MAYO CLINIC, V32, P749; LAZAR HP, 1957, ARCH INTERN MED, V100, P290, DOI 10.1001/archinte.1957.00260080116023; LEUCHTENBERGER C, 1954, LAB INVEST, V3, P132; LOCKHARTMUMMERY JP, 1934, DISEASES RECTUM COLO; MCKITTRICK LS, 1935, NEW ENGL J MED, V212, P263; Miller RH, 1937, ANN SURG, V105, P511; O'BRIEN J P, 1955, N Y State J Med, V55, P1877; OLDFIELD MC, 1954, BRIT J SURG, V41, P534, DOI 10.1002/bjs.18004116917; PLENK HP, 1954, RADIOLOGY, V62, P830, DOI 10.1148/62.6.830; REED TE, 1955, AM J HUM GENET, V7, P236; SMITH W G, 1958, Dis Colon Rectum, V1, P323, DOI 10.1007/BF02616659; THOMA KH, 1936, INT J ORTHOD ORAL, V22, P1177; WEINER RS, 1955, NEW ENGL J MED, V253, P795, DOI 10.1056/NEJM195511102531901; WOOLF CM, 1955, CANCER, V8, P403, DOI 10.1002/1097-0142(1955)8:2<403::AID-CNCR2820080220>3.0.CO;2-E	33	315	317	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					376	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13946545				2022-12-18	WOS:A19622965A00001
J	Jacquemont, S; Coe, BP; Hersch, M; Duyzend, MH; Krumm, N; Bergmann, S; Beckmann, JS; Rosenfeld, JA; Eichler, EE				Jacquemont, Sebastien; Coe, Bradley P.; Hersch, Micha; Duyzend, Michael H.; Krumm, Niklas; Bergmann, Sven; Beckmann, Jacques S.; Rosenfeld, Jill A.; Eichler, Evan E.			A Higher Mutational Burden in Females Supports a "Female Protective Model" in Neurodevelopmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; AUTISM SPECTRUM DISORDERS; DE-NOVO MUTATIONS; CLINICAL-SIGNIFICANCE; CNVS; IDENTIFICATION; MICRODELETION; VARIANTS; CHILDREN; BEHAVIOR	Increased male prevalence has been repeatedly reported in several neurodevelopmental disorders (NDs), leading to the concept of a "female protective model." We investigated the molecular basis of this sex-based difference in liability and demonstrated an excess of deleterious autosomal copy-number variants (CNVs) in females compared to males (odds ratio [OR] = 1.46, p = 8 x 10(-10)) in a cohort of 15,585 probands ascertained for NDs. In an independent autism spectrum disorder (ASD) cohort of 762 families, we found a 3-fold increase in deleterious autosomal CNVs (p = 7 x 10(-4)) and an excess of private deleterious single-nucleotide variants (SNVs) in female compared to male probands (OR = 1.34, p = 0.03). We also showed that the deleteriousness of autosomal SNVs was significantly higher in female probands (p = 0.0006). A similar bias was observed in parents of probands ascertained for NDs. Deleterious CNVs (>400 kb) were maternally inherited more often (up to 64%, p = 10(-15)) than small CNVs < 400 kb (OR = 1.45, p = 0.0003). In the ASD cohort, increased maternal transmission was also observed for deleterious CNVs and SNVs. Although ASD females showed higher mutational burden and lower cognition, the excess mutational burden remained, even after adjustment for those cognitive differences. These results strongly suggest that females have an increased etiological burden unlinked to rare deleterious variants on the X chromosome. Carefully phenotyped and genotyped cohorts will be required for identifying the symptoms, which show gender-specific liability to mutational burden.	[Jacquemont, Sebastien] Univ Lausanne, Univ Lausanne Hosp, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Coe, Bradley P.; Duyzend, Michael H.; Krumm, Niklas; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Hersch, Micha; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Hersch, Micha; Bergmann, Sven; Beckmann, Jacques S.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs LLC, Spokane, WA 99207 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle; University of Lausanne; Swiss Institute of Bioinformatics; Howard Hughes Medical Institute	Jacquemont, S (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Serv Med Genet, CH-1011 Lausanne, Switzerland.	sebastien.jacquemont@chuv.ch; eee@gs.washington.edu	Beckmann, Jacques S/A-9772-2008; Jacquemont, Sebastien/AAS-5060-2021; Coe, Bradley/A-2878-2009	Beckmann, Jacques S/0000-0002-9741-1900; Jacquemont, Sebastien/0000-0001-6838-8767; Duyzend, Michael/0000-0002-3941-6447; Coe, Bradley/0000-0001-8471-4016; Bergmann, Sven/0000-0002-6785-9034	Fond de Releve Academique, Universitede Lausanne; Swiss National Science Foundation [PP00P3_144902]; Simons Foundation Autism Research Initiative [137578, 191889]; National Institutes of Health [MH101221]; Novartis Pharma AG; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	Fond de Releve Academique, Universitede Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Pharma AG; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Fond de Releve Academique, Universitede Lausanne (S.J.), Swiss National Science Foundation (PP00P3_144902), Simons Foundation Autism Research Initiative (137578 and 191889 to E. E. E.), and National Institutes of Health MH101221 (E. E. E.). E. E. E. is an investigator of the Howard Hughes Medical Institute, is on the scientific advisory board (SAB) of SynapDx Corp., and was an SAB member of Pacific Biosciences Inc. (2009-2013) and DNAnexus Inc. (2011-2013). J.R. is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer Inc. S.J. has acted as a consultant for Novartis Pharma AG and has received grants for the clinical investigation of mavoglurant. We thank all families at the participating Simons Simplex Collection (SSC) sites and the principal investigators (A. Beaudet, R. B., J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We acknowledge M. State and the SSC Genetics Consortium for providing Illumina genotyping and T. Lehner and the Autism Sequencing Consortium for data exchange among the participating groups. This study used data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to data generation is available at http://www.wtccc.org.uk/. We are grateful for manuscript preparation from T. Brown and helpful discussion from M. Kircher and Eichler lab members.	Abikoff HB, 2002, J ABNORM CHILD PSYCH, V30, P349, DOI 10.1023/A:1015713807297; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Goin-Kochel RP, 2007, AUTISM, V11, P279, DOI 10.1177/1362361307076857; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kircher M, 2014, NAT GENET; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mandel JL, 2004, EUR J HUM GENET, V12, P689, DOI 10.1038/sj.ejhg.5201247; Moller RS, 2014, HUM GENET, V133, P625, DOI 10.1007/s00439-013-1403-3; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Russell G, 2011, SOC PSYCH PSYCH EPID, V46, P1283, DOI 10.1007/s00127-010-0294-z; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Stankiewicz P, 2005, AM J MED GENET A, V138A, P11, DOI 10.1002/ajmg.a.30910; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; STEVENSON R.E., 2000, X LINKED MENTAL RETA; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203; Zwaigenbaum L, 2012, J AUTISM DEV DISORD, V42, P2585, DOI 10.1007/s10803-012-1515-y	39	314	322	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					415	425		10.1016/j.ajhg.2014.02.001	http://dx.doi.org/10.1016/j.ajhg.2014.02.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24581740	Bronze, Green Published			2022-12-18	WOS:000332611400015
J	Kallberg, H; Padyukov, L; Plenge, RM; Ronnelid, J; Gregersen, PK; van der Helm-van Mil, AHM; Toes, REM; Huizinga, TW; Klareskog, L; Alfredsson, L				Kallberg, Henrik; Padyukov, Leonid; Plenge, Robert M.; Ronnelid, Johan; Gregersen, Peter K.; van der Helm-van Mil, Annette H. M.; Toes, Rene E. M.; Huizinga, Tom W.; Klareskog, Lars; Alfredsson, Lars		Epidemiological Investigation	Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED EPITOPE; CITRULLINATED PROTEINS; SWEDISH EIRA; RISK; SUSCEPTIBILITY; POLYMORPHISM; REPLICATION; ASSOCIATION; ANTIBODIES; FAMILIES	Gene-gene and gene-environment interactions are key features in the development of rheumatoid arthritis ( RA) and other complex diseases. The aim of this study was to use and compare three different definitions of interaction between the two major genetic risk factors of RA - the HLA-DRB1 shared epitope ( SE) alleles and the PTPN22 R620W allele - in three large case-control studies: the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study, the North American RA Consortium (NARAC) study, and the Dutch Leiden Early Arthritis Clinic study ( in total, 1,977 cases and 2,405 controls). The EIRA study was also used to analyze interactions between smoking and the two genes. "Interaction" was defined either as a departure from additivity, as interaction in a multiplicative model, or in terms of linkage disequilibrium - for example, deviation from independence of penetrance of two unlinked loci. Consistent interaction, defined as departure from additivity, between HLA- DRB1 SE alleles and the A allele of PTPN22 R620W was seen in all three studies regarding anti-CCP-positive RA. Testing for multiplicative interactions demonstrated an interaction between the two genes only when the three studies were pooled. The linkage disequilibrium approach indicated a gene-gene interaction in EIRA and NARAC, as well as in the pooled analysis. No interaction was seen between smoking and PTPN22 R620W. A new pattern of interactions is described between the two major known genetic risk factors and the major environmental risk factor concerning the risk of developing anti-CCP - positive RA. The data extend the basis for a pathogenetic hypothesis for RA involving genetic and environmental factors. The study also raises and illustrates principal questions concerning ways to define interactions in complex diseases.	Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; Karolinska Hosp, Karolinska Inst, Rheumatol Unit, Dept Med, S-10401 Stockholm, Sweden; Stockholm Cty Council, Stockholm Ctr Publ Hlth, Stockholm, Sweden; Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; Univ Uppsala, Unit Clin Immunol, S-75105 Uppsala, Sweden; N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stockholm County Council; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Uppsala University; Northwell Health; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kallberg, H (corresponding author), Karolinska Inst, Inst Environm Med, Box 210, S-17177 Stockholm, Sweden.	henrik.kallberg@ki.se	Alfredsson, Lars/AAC-9007-2019; Ronnelid, Johan/O-2077-2019; Padyukov, Leonid/A-4890-2009	Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Toes, Rene/0000-0002-9618-6414; Klareskog, Lars/0000-0001-9601-6186; van der Helm - van Mil, Annette/0000-0001-8572-1437	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, N01AR022263] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR44422, N01-AR-2-2263, R01 AR044422] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bengtsson C, 2005, ANN RHEUM DIS, V64, P1588, DOI 10.1136/ard.2004.031666; Gregersen PK, 2005, ARTHRITIS RHEUM-US, V52, P1952, DOI 10.1002/art.21125; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, ARTHRITIS RHEUM, V48, pS348; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Stolt P, 2005, ANN RHEUM DIS, V64, P582, DOI 10.1136/ard.2004.022053; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; van Aken J, 2003, CLIN EXP RHEUMATOL, V21, pS100; vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	27	314	324	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					867	875		10.1086/516736	http://dx.doi.org/10.1086/516736			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436241	Green Published, Bronze			2022-12-18	WOS:000245973200005
J	Zerjal, T; Xue, YL; Bertorelle, G; Wells, RS; Bao, WD; Zhu, SL; Qamar, R; Ayub, Q; Mohyuddin, A; Fu, SB; Li, P; Yuldasheva, N; Ruzibakiev, R; Xu, JJ; Shu, QF; Du, RF; Yang, HM; Hurles, ME; Robinson, E; Gerelsaikhan, T; Dashnyam, B; Mehdi, SQ; Tyler-Smith, C				Zerjal, T; Xue, YL; Bertorelle, G; Wells, RS; Bao, WD; Zhu, SL; Qamar, R; Ayub, Q; Mohyuddin, A; Fu, SB; Li, P; Yuldasheva, N; Ruzibakiev, R; Xu, JJ; Shu, QF; Du, RF; Yang, HM; Hurles, ME; Robinson, E; Gerelsaikhan, T; Dashnyam, B; Mehdi, SQ; Tyler-Smith, C			The genetic legacy of the mongols	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPES; SELECTION; ORIGIN	We have identified a Y-chromosomal lineage with several unusual features. It was found in 16 populations throughout a large region of Asia, stretching from the Pacific to the Caspian Sea, and was present at high frequency: similar to8% of the men in this region carry it, and it thus makes up similar to0.5% of the world total. The pattern of variation within the lineage suggested that it originated in Mongolia similar to1,000 years ago. Such a rapid spread cannot have occurred by chance; it must have been a result of selection. The lineage is carried by likely male-line descendants of Genghis Khan, and we therefore propose that it has spread by a novel form of social selection resulting from their behavior.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Harbin Med Univ, Dept Med Biol, Harbin, Peoples R China; Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy; Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; Chinese Acad Sci, Inst Genet, Beijing, Peoples R China; Biomed & Genet Engn Labs, Islamabad, Pakistan; Uzbek Acad Sci, Inst Immunol, Tashkent 700135, Uzbekistan; Univ Cambridge, McDonald Inst, Cambridge, England; Mongolian Acad Sci, Inst Biotechnol, Ulaanbaatar, Mongolia	University of Oxford; Harbin Medical University; University of Ferrara; University of Oxford; Wellcome Centre for Human Genetics; Chinese Academy of Sciences; Academy of Sciences of Uzbekistan; University of Cambridge; Mongolian Academy of Sciences	Tyler-Smith, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	chris@bioch.ox.ac.uk	zerjal, tatiana/AAO-9473-2020; Mehdi, Syed Qasim/L-2385-2015; qamar, raheel/D-4543-2012; Qamar, Raheel/G-3355-2015; Bertorelle, Giorgio/AAE-9078-2022; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Ayub, Qasim/0000-0003-3291-0917; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Bertorelle, Giorgio/0000-0002-2498-2702				Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; EDLESTON RS, 1865, ENTOMOLOGIST, V2, P150; Ellis N, 2002, GENOME RES, V12, P339; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Mohyuddin A, 2001, FORENSIC SCI INT, V118, P141, DOI 10.1016/S0379-0738(01)00382-6; Morgan D., 1986, MONGOLS; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Mousavi Sayed Askar, 1998, HAZARAS AFGHANISTAN; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Slatkin M, 2001, GENETICS, V158, P865; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; WILSON DS, 1994, BEHAV BRAIN SCI, V17, P585, DOI 10.1017/S0140525X00036104; Wilson IJ, 1998, GENETICS, V150, P499; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096	15	314	327	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					717	721		10.1086/367774	http://dx.doi.org/10.1086/367774			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12592608	Green Published, Bronze			2022-12-18	WOS:000181152600021
J	Jiang, YH; Yuen, RKC; Wang, MB; Jin, X; Chen, N; Wu, XL; Ju, J; Mei, JP; Shi, YJ; He, MZ; Wang, GB; Liang, JQ; Wang, Z; Cao, DD; Carter, MT; Chrysler, C; Drmic, IE; Howe, JL; Lau, L; Marshall, CR; Merico, D; Nalpathamkalam, T; Thiruvahindrapuram, B; Thompson, A; Uddin, M; Walker, S; Luo, J; Anagnostou, E; Zwaigenbaum, L; Ring, RH; Wang, J; Lajonchere, C; Wang, J; Shih, A; Szatmari, P; Yang, HM; Dawson, G; Li, YR; Scherer, SW				Jiang, Yong-hui; Yuen, Ryan K. C.; Wang, Mingbang; Jin, Xin; Chen, Nong; Wu, Xueli; Ju, Jia; Mei, Junpu; Shi, Yujian; He, Mingze; Wang, Guangbiao; Liang, Jieqin; Wang, Zhe; Cao, Dandan; Carter, Melissa T.; Chrysler, Christina; Drmic, Irene E.; Howe, Jennifer L.; Lau, Lynette; Marshall, Christian R.; Merico, Daniele; Nalpathamkalam, Thomas; Thiruvahindrapuram, Bhooma; Thompson, Ann; Uddin, Mohammed; Walker, Susan; Luo, Jun; Anagnostou, Evdokia; Zwaigenbaum, Lonnie; Ring, Robert H.; Wang, Jian; Lajonchere, Clara; Wang, Jun; Shih, Andy; Szatmari, Peter; Yang, Huanming; Dawson, Geraldine; Li, Yingrui; Scherer, Stephen W.			Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; COPY NUMBER VARIATIONS; INTELLECTUAL DISABILITY; STRUCTURAL VARIATION; FUNCTIONAL IMPACT; KALLMANN-SYNDROME; CHARGE SYNDROME; LARGE-SCALE; EXOME; RISK	Autism Spectrum Disorder (ASD) demonstrates high heritability and familial clustering, yet the genetic causes remain only partially understood as a result of extensive clinical and genomic heterogeneity. Whole-genome sequencing (WGS) shows promise as a tool for identifying ASD risk genes as well as unreported mutations in known loci, but an assessment of its full utility in an ASD group has not been performed. We used WGS to examine 32 families with ASD to detect de novo or rare inherited genetic variants predicted to be deleterious (loss-of-function and damaging missense mutations). Among ASD probands, we identified deleterious de novo mutations in six of 32 (19%) families and X-linked or autosomal inherited alterations in ten of 32 (31%) families (some had combinations of mutations). The proportion of families identified with such putative mutations was larger than has been previously reported; this yield was in part due to the comprehensive and uniform coverage afforded by WGS. Deleterious variants were found in four unrecognized, nine known, and eight candidate ASD risk genes. Examples include CAPRIN1 and AFF2 (both linked to FMR1, which is involved in fragile X syndrome), VIP (involved in social-cognitive deficits), and other genes such as SCN2A and KCNQ2 (linked to epilepsy), NRXN1, and CHD7, which causes ASD-associated CHARGE syndrome. Taken together, these results suggest that WGS and thorough bioinformatic analyses for de novo and rare inherited mutations will improve the detection of genetic variants likely to be associated with ASD or its accompanying clinical symptoms.	[Jiang, Yong-hui] Duke Univ, Sch Med, Dept Paediat & Neurobiol, Durham, NC 27710 USA; [Yuen, Ryan K. C.; Howe, Jennifer L.; Lau, Lynette; Marshall, Christian R.; Merico, Daniele; Nalpathamkalam, Thomas; Thiruvahindrapuram, Bhooma; Uddin, Mohammed; Walker, Susan; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G IL7, Canada; [Jin, Xin; Chen, Nong; Wu, Xueli; Ju, Jia; Mei, Junpu; Shi, Yujian; He, Mingze; Wang, Guangbiao; Liang, Jieqin; Wang, Zhe; Cao, Dandan; Wang, Jian; Wang, Jun; Yang, Huanming; Li, Yingrui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Jin, Xin] Childrens Hosp Philadelphia, BGI CHOP, Philadelphia, PA 19104 USA; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Carter, Melissa T.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON MSG 2L3, Canada; [Chrysler, Christina; Drmic, Irene E.; Thompson, Ann; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4K1, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S IA1, Canada; [Luo, Jun] Natl Supercomp Ctr Tianjin, Tianjin 300457, Peoples R China; [Anagnostou, Evdokia] Univ Toronto, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T5G 0B7, Canada; [Ring, Robert H.; Lajonchere, Clara; Shih, Andy; Dawson, Geraldine] Autism Speaks, New York, NY 10016 USA; [Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia; [Wang, Jun] Aarhus Univ, Ctr iSequencing, DK-8000 Aarhus C, Denmark; [Dawson, Geraldine] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27510 USA	Duke University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Beijing Genomics Institute (BGI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; South China University of Technology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; University of Toronto; University of Alberta; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; King Abdulaziz University; Aarhus University; University of North Carolina; University of North Carolina Chapel Hill	Li, YR (corresponding author), BGI Shenzhen, Bei Shan Rd, Shenzhen 518083, Peoples R China.	liyr@genomics.cn; stephen.scherer@sickkids.ca	Jin, Xin/ABF-1329-2020; Ring, Robert/M-1238-2016; Scherer, Stephen W./B-3785-2013; Yuen, Ryan K. C./J-4876-2012; Wang, Jun/A-7261-2013; Wang, Mingbang/F-4457-2018; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Ring, Robert/0000-0002-7037-4409; Scherer, Stephen W./0000-0002-8326-1999; Yuen, Ryan K. C./0000-0001-7273-4968; Wang, Mingbang/0000-0002-5989-5377; Uddin, Mohammed/0000-0001-6867-5803; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Dawson, Geraldine/0000-0003-1410-2764; Merico, Daniele/0000-0002-3728-4401; CAO, Dandan/0000-0003-2899-8813; He, Mingze/0000-0002-8164-2480	Autism Speaks; Autism Speaks Canada; National Institutes of Health [NIMH R01MH098114-01]; National Science and Technology Ministry Project 973 program [2011CB809200]; National Science and Technology Ministry Project 863 program [2012AA02A201]; National Natural Science Foundation of China Major Program [30890032]; Shenzhen Municipal Government of China [CXB201108250094A, CXB201108250096A, ZYC200903240080A, ZYC201105170397A, ZYC201105170394A]; Enterprise Key Laboratory; Guangdong Province (the Guangdong Enterprise Key Laboratory of Human Disease Genomics); Shenzhen Key Laboratory of Gene Bank for National Life Science (National Gene Bank Project of China); NeuroDevNet; Canadian Institutes for Advanced Research; University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics Institute; government of Ontario; Canadian Institutes of Health Research; Hospital for Sick Children Foundation; Autism Speaks Postdoctoral Fellowship in Translational Research; Novartis; Seaside Therapeutics; Sanofi Canada; SynaptDx; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098114] Funding Source: NIH RePORTER	Autism Speaks; Autism Speaks Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Ministry Project 973 program; National Science and Technology Ministry Project 863 program; National Natural Science Foundation of China Major Program; Shenzhen Municipal Government of China; Enterprise Key Laboratory; Guangdong Province (the Guangdong Enterprise Key Laboratory of Human Disease Genomics); Shenzhen Key Laboratory of Gene Bank for National Life Science (National Gene Bank Project of China); NeuroDevNet; Canadian Institutes for Advanced Research; University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics Institute(Genome Canada); government of Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children Foundation; Autism Speaks Postdoctoral Fellowship in Translational Research; Novartis(Novartis); Seaside Therapeutics; Sanofi Canada(Sanofi-Aventis); SynaptDx; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Bernie Devlin for guidance in study design, the families for their participation, The Centre for Applied Genomics, and BGI-Shenzhen This work was supported by Autism Speaks, Autism Speaks Canada, the National Institutes of Health (NIMH R01MH098114-01), the National Science and Technology Ministry Project 973 program (2011CB809200), the National Science and Technology Ministry Project 863 program (2012AA02A201), the National Natural Science Foundation of China Major Program (30890032), the Shenzhen Municipal Government of China (CXB201108250094A, CXB201108250096A, ZYC200903240080A, ZYC201105170397A, and ZYC201105170394A), the Enterprise Key Laboratory supported by Guangdong Province (the Guangdong Enterprise Key Laboratory of Human Disease Genomics), Shenzhen Key Laboratory of Gene Bank for National Life Science (National Gene Bank Project of China), NeuroDevNet, the Canadian Institutes for Advanced Research, the University of Toronto McLaughlin Centre, Genome Canada/Ontario Genomics Institute, the government of Ontario, the Canadian Institutes of Health Research, and The Hospital for Sick Children Foundation. R.K.C.Y. holds an Autism Speaks Postdoctoral Fellowship in Translational Research. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children. S.W.S. is on the Scientific Advisory Board of Population Diagnositics (a US Company) and is a founding scientist of YouNique Genomics, both of which could use data from this study. E.A. has received consultation fees from Novartis and Seaside Therapeutics. She has also received an unrestricted grant from Sanofi Canada and has received research funding from SynaptDx. G.D. is on the Professional Advisory Board for Integragen Inc.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chaudhury D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-63; Chu A, 2010, MOL PHARMACOL, V77, P95, DOI 10.1124/mol.109.060137; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; EDWARDS BM, 1995, INT J PEDIATR OTORHI, V33, P23, DOI 10.1016/0165-5876(95)01188-H; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; GeneReviews Pallais J.C., 2011, KALLMANN SYNDROME; Gillberg C, 2006, J AUTISM DEV DISORD, V36, P429, DOI 10.1007/s10803-006-0081-6; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; HARDELIN JP, 1993, HUM MOL GENET, V2, P373, DOI 10.1093/hmg/2.4.373; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johansson M, 2010, RES DEV DISABIL, V31, P9, DOI 10.1016/j.ridd.2009.07.011; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mosca-Boidron AL, 2013, AM J MED GENET A, V161A, P1505, DOI 10.1002/ajmg.a.35878; Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rogers SJ, 2012, J AM ACAD CHILD PSY, V51, P1052, DOI 10.1016/j.jaac.2012.08.003; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Trider CL, 2012, INT J PEDIATR OTORHI, V76, P947, DOI 10.1016/j.ijporl.2012.02.061; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Vervloed MPJ, 2006, AM J MED GENET A, V140A, P851, DOI 10.1002/ajmg.a.31193; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wisniowiecka-Kowalnik B, 2010, AM J MED GENET B, V153B, P983, DOI 10.1002/ajmg.b.31064; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	90	313	323	0	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					249	263		10.1016/j.ajhg.2013.06.012	http://dx.doi.org/10.1016/j.ajhg.2013.06.012			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23849776	Green Published, hybrid			2022-12-18	WOS:000323186200005
J	Bassett, JHD; Forbes, SA; Pannett, AAJ; Lloyd, SE; Christie, PT; Wooding, C; Edwards, CR; Monson, JP; Sampson, J; Wass, JAH; Harding, B; Besser, GM; Wheeler, MH; Thakker, RV				Bassett, JHD; Forbes, SA; Pannett, AAJ; Lloyd, SE; Christie, PT; Wooding, C; Edwards, CR; Monson, JP; Sampson, J; Wass, JAH; Harding, B; Besser, GM; Wheeler, MH; Thakker, RV			Characterization of mutations in patients with multiple endocrine neoplasia type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY RETINOBLASTOMA; MOLECULAR-GENETICS; CHROMOSOME-11; SPECTRUM; MUTAGENESIS; ASSOCIATION; MECHANISMS; DISEASE; ALLELES	Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by turners of the parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene, on chromosome 11q13, has recently been cloned, and mutations have been identified. We have characterized such MEN1 mutations, assessed the reliability of SSCP analysis for the detection of these mutations, and estimated the age-related penetrance for MEN1. Sixty-three unrelated MEN1 kindreds (195 affected and 396 unaffected members) were investigated for mutations in the 2,790-bp coding region and splice sites, by SSCP and DNA sequence analysis. We identified 47 mutations (12 nonsense mutations, 21 deletions, 7 insertions, 1 donor splice-site mutation, and 6 missense mutations), that were scattered throughout the coding region, together with six polymorphisms that had heterozygosity frequencies of 2%-44%. More than 10% of the mutations arose de novo, and four mutation hot spots accounted for > 25% of the mutations. SSCP was found to be a sensitive and specific mutational screening method that detected > 85% of the mutations, Two hundred and one MEN1 mutant-gene carriers (155 affected and 46 unaffected) were identified, and these helped to define the age-related penetrance of MEN1 as 7%, 52%, 87%, 95%, 99%, and 100% at 10, 20, 30, 40, 50, and 60 years of age, respectively. These results provide the basis for a molecular-generic screening approach that will supplement the clinical evaluation and genetic counseling of members of MEN1 families.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC,Clin Sci Ctr,Mol Endocrinol Grp, London W12 0NN, England; St Bartholomews Hosp, Dept Endocrinol, London, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, London, England; Univ Wales Hosp, Inst Med Genet, Cardiff, S Glam, Wales; Cardiff Royal Infirm, Dept Surg, Cardiff, S Glam, Wales; Radcliffe Infirm, Dept Endocrinol, Oxford OX2 6HE, England	Imperial College London; University of London; Queen Mary University London; Imperial College London; Cardiff University; Cardiff Royal Infirmary; Radcliffe Infirmary	Thakker, RV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC,Clin Sci Ctr,Mol Endocrinol Grp, Du Cane Rd, London W12 0NN, England.	rthakker@rpms.ac.uk		Thakker, Rajesh/0000-0002-1438-3220				Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Bassett JHD, 1997, HUM GENET, V100, P657, DOI 10.1007/s004390050569; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; Brown MA, 1997, TRENDS GENET, V13, P202, DOI 10.1016/S0168-9525(97)01132-3; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; COOPER DN, 1991, HUM GENET, V87, P409; Courseaux A, 1996, GENOMICS, V37, P354, DOI 10.1006/geno.1996.0570; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; KRAWCZAK M, 1991, HUM GENET, V86, P425; LARSSON C, 1992, J CLIN INVEST, V89, P1344, DOI 10.1172/JCI115720; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LARSSON C, 1995, J INTERN MED, V238, P239, DOI 10.1111/j.1365-2796.1995.tb00929.x; Lemmens I, 1997, GENOMICS, V44, P94, DOI 10.1006/geno.1997.4872; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Pang JT, 1996, HUM GENET, V97, P732; PANG JT, 1994, EUR J CANCER, V30A, P1961, DOI 10.1016/0959-8049(94)00387-K; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; RIPLEY LS, 1986, J MOL BIOL, V191, P601, DOI 10.1016/0022-2836(86)90448-1; Stock JL, 1997, J CLIN ENDOCR METAB, V82, P486, DOI 10.1210/jc.82.2.486; THAKKER RV, 1993, J CLIN INVEST, V91, P2815, DOI 10.1172/JCI116524; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; THAKKER RV, 1993, CLIN ENDOCRINOL, V38, P1, DOI 10.1111/j.1365-2265.1993.tb00964.x; Thakker RV, 1995, ENDOCRINOLOGY, P2815; Trump D, 1996, QJM-INT J MED, V89, P653; VARMUS HE, 1984, ANNU REV GENET, V18, P553; WERMER P, 1954, AM J MED, V16, P363, DOI 10.1016/0002-9343(54)90353-8	29	313	318	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					232	244		10.1086/301729	http://dx.doi.org/10.1086/301729			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463336	Green Published, Bronze			2022-12-18	WOS:000072416000005
J	WILHELMSEN, KC; LYNCH, T; PAVLOU, E; HIGGINS, M; NYGAARD, TG				WILHELMSEN, KC; LYNCH, T; PAVLOU, E; HIGGINS, M; NYGAARD, TG			LOCALIZATION OF DISINHIBITION-DEMENTIA-PARKINSONISM-AMYATROPHY COMPLEX TO 17Q21-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ONSET ALZHEIMERS-DISEASE; MOTOR NEURON DISEASE; PRECURSOR PROTEIN GENE; X-CHROMOSOME MARKERS; NERVE GROWTH-FACTOR; LINKAGE ANALYSIS; SUPEROXIDE-DISMUTASE; RADIATION HYBRID; HUMAN GENOME	Disinhibition-dementia-parkinsonism-amyotrophy complex (DDPAC) is defined by familial adult-onset behavioral disturbance, followed by frontal lobe dementia, parkinsonism, and amyotrophy in variable proportions. A genetic etiology of DDPAC was suspected because of the familial clustering in family Mo, despite their wide geographic distribution. We have mapped the DDPAC locus to a 12-cM (sex averaged) region between D17S800 and D17S787 on chromosome 17q21-22. The basis for the variability of the clinical findings and pathology in DDPAC is unknown but suggests that the DDPAC locus should be screened as a candidate locus in family studies of conditions with behavioral abnormalities and neurological degeneration.			WILHELMSEN, KC (corresponding author), COLUMBIA PRESBYTERIAN MED CTR, INST NEUROL, DEPT NEUROL, 710 W 168TH ST, NEW YORK, NY 10032 USA.							ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; Acampora D, 1991, Oxf Surv Eukaryot Genes, V7, P1; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BENTLEY KL, 1989, CYTOGENET CELL GENET, V51, P961; BONDUELLE M, 1968, J NEUROL SCI, V6, P315, DOI 10.1016/0022-510X(68)90099-3; Bonduelle M, 1975, HDB CLIN NEUROLOGY, V22, P313; BOUDOURESQUES J, 1967, REV NEUROL-FRANCE, V116, P693; BRUN A, 1987, ARCH GERONTOL GERIAT, V6, P193, DOI 10.1016/0167-4943(87)90021-5; BURNSTEIN MH, 1981, PSYCHOSOMATICS, V22, P151; CAIDAS M, 1966, ACTA NEUROL PSYCHIAT, V66, P125; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUMMINGS JL, 1981, NEUROLOGY, V31, P1415, DOI 10.1212/WNL.31.11.1415; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DEINARD AS, 1992, NUCLEIC ACIDS RES, V20, P1171, DOI 10.1093/nar/20.5.1171-a; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; GILBERT JJ, 1988, ANN NEUROL, V24, P688, DOI 10.1002/ana.410240518; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GREEN P, 1992, CYTOGENET CELL GENET, V59, P122, DOI 10.1159/000133221; Haberlandt W. F., 1964, AMYOTROPHISCHE LATER; HOROUPIAN DS, 1984, ANN NEUROL, V16, P305, DOI 10.1002/ana.410160306; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; HUDSON AJ, 1981, BRAIN, V104, P217, DOI 10.1093/brain/104.2.217; HUGHES CP, 1973, NEUROLOGY, V23, P344; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KORMANNBORTOLOTTO MH, 1992, MECH AGEING DEV, V65, P9, DOI 10.1016/0047-6374(92)90122-T; KOSIK KS, 1990, MOL NEUROBIOL, V4, P171, DOI 10.1007/BF02780339; LASSER DM, 1993, GENOMICS, V16, P785, DOI 10.1006/geno.1993.1269; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LAW A, 1992, HUM GENET, V88, P562, DOI 10.1007/BF00219345; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; MATA M, 1983, NEUROLOGY, V33, P1439, DOI 10.1212/WNL.33.11.1439; MITSUYAMA Y, 1985, EUR ARCH PSY CLIN N, V235, P1, DOI 10.1007/BF00380961; MORITA K, 1987, ARCH GERONTOL GERIAT, V6, P263, DOI 10.1016/0167-4943(87)90026-4; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RAFFIONI S, 1993, ANNU REV BIOCHEM, V62, P823; RODGERSJOHNSON P, 1986, NEUROLOGY, V36, P7, DOI 10.1212/WNL.36.1.7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROSENBERG RN, 1989, ANN NEUROL, V25, P152, DOI 10.1002/ana.410250208; SCHMITT HP, 1984, ANN NEUROL, V16, P642, DOI 10.1002/ana.410160604; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shiraki H, 1975, HDB CLIN NEUROLOGY, P353; SIDDIQUE T, 1989, NEUROLOGY, V39, P919, DOI 10.1212/WNL.39.7.919; STEWART SS, 1988, ANNU REV MED, V39, P193, DOI 10.1146/annurev.med.39.1.193; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STOFFEL M, 1992, NUCLEIC ACIDS RES, V20, P1172, DOI 10.1093/nar/20.5.1172; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203; Yoshida M, 1992, Rinsho Shinkeigaku, V32, P1193	64	313	315	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1159	1165						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977375				2022-12-18	WOS:A1994QB68400012
J	Wang, Y; Kuan, PJ; Xing, C; Cronkhite, JT; Torres, F; Rosenblatt, RL; DiMaio, JM; Kinch, LN; Grishin, NV; Garcia, CK				Wang, Yongyu; Kuan, Phillip J.; Xing, Chao; Cronkhite, Jennifer T.; Torres, Fernando; Rosenblatt, Randall L.; DiMaio, J. Michael; Kinch, Lisa N.; Grishin, Nick V.; Garcia, Christine Kim			Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; CARBOHYDRATE-RECOGNITION; MUTATION; TELOMERASE; DISEASE; ALVEOLITIS; DOMAINS; HEALTH; MICE	Idiopathic pulmonary fibrosis (IPF) is a lethal scarring lung disease that affects older adults. Heterozygous rare mutations in the genes encoding telomerase are found in -15% of familial cases. We have used linkage to map another disease-causing gene in a large family with IPF and adenocarcinoma of the lung to a 15.7 Mb region on chromosome 10. We identified a rare missense mutation in a candidate gene, SFTPA2, within the interval encoding surfactant protein A2 (SP-A2). Another rare mutation in SFTPA2 was identified in another family with IPF and lung cancer. Both mutations involve invariant residues in the highly conserved carbohydrate-recognition domain of the protein and are predicted to disrupt protein structure. Recombinant proteins carrying these mutations are retained in the endoplasmic reticulum and are not secreted. These data are consistent with SFTPA2 germline mutations that interfere with protein trafficking and cause familial IPF and lung cancer.	[Wang, Yongyu; Kuan, Phillip J.; Xing, Chao; Cronkhite, Jennifer T.; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kuan, Phillip J.; Torres, Fernando; Rosenblatt, Randall L.; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [DiMaio, J. Michael] Univ Texas SW Med Ctr Dallas, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	christine.garcia@utsouthwestern.edu	Wang, Yongyu/F-9039-2011	Wang, Yongyu/0000-0002-8804-3472; Wang, Yongyu/0000-0002-6088-8887; Kinch, Lisa/0000-0003-3041-2615; Xing, Chao/0000-0002-1838-0502	General Clinical Research Center [M01-RR000633]; National Institutes of Health [K23-RR02063202]; Doris Duke Charitable Foundation Clinical Scientist Development Award; institutional funds; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER	General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); institutional funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank the affected individuals and their families for their participation in this study, L. Miller, M. Nolasco, T. Hyatt, and A. Cook for excellent technical assistance, R. Barnes for assistance with the linkage analysis and sequence alignment, H. Hobbs for the analysis of the Dallas Heart Study, and M. Brown, J. Goldstein, L. Terada, and H. Hobbs for helpful comments. This work was supported by the General Clinical Research Center (M01-RR000633), the National Institutes of Health (K23-RR02063202 to C.K.G.), the Doris Duke Charitable Foundation Clinical Scientist Development Award (C.K.G.), and institutional funds.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; BEAUMONT F, 1981, THORAX, V36, P252, DOI 10.1136/thx.36.4.252; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; GAZDAR AF, 1990, CANCER RES, V50, P5481; Gupta G, 2007, BIOESSAYS, V29, P452, DOI 10.1002/bies.20573; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; JONES A W, 1970, British Journal of Diseases of the Chest, V64, P78, DOI 10.1016/S0007-0971(70)80032-8; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Korfhagen TR, 1998, BBA-MOL BASIS DIS, V1408, P296, DOI 10.1016/S0925-4439(98)00075-1; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; MCCORMICK SM, 1994, AM J PHYSIOL, V266, pL367, DOI 10.1152/ajplung.1994.266.4.L367; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WHITSETT JA, 1985, J BIOL CHEM, V260, P5273; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	31	312	323	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					52	59		10.1016/j.ajhg.2008.11.010	http://dx.doi.org/10.1016/j.ajhg.2008.11.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19100526	Green Published, Bronze			2022-12-18	WOS:000262679500006
J	Fallin, MD; Lasseter, VK; Avramopoulos, D; Nicodemus, KK; Wolyniec, PS; McGrath, JA; Steel, G; Nestadt, G; Liang, KY; Huganir, RL; Valle, D; Pulver, AE				Fallin, MD; Lasseter, VK; Avramopoulos, D; Nicodemus, KK; Wolyniec, PS; McGrath, JA; Steel, G; Nestadt, G; Liang, KY; Huganir, RL; Valle, D; Pulver, AE			Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							FAMILY-BASED ASSOCIATION; CARDIO-FACIAL SYNDROME; DIGEORGE CHROMOSOMAL REGION; GENOME SCAN METAANALYSIS; RECEPTOR PERIPHERAL GENE; 2 MISSENSE VARIATIONS; D-ASPARTATE RECEPTOR; AMINO-ACID OXIDASE; SYNTHASE NOS1 GENE; SUSCEPTIBILITY GENE	Bipolar, schizophrenia, and schizoaffective disorders are common, highly heritable psychiatric disorders, for which familial coaggregation, as well as epidemiological and genetic evidence, suggests overlapping etiologies. No definitive susceptibility genes have yet been identified for any of these disorders. Genetic heterogeneity, combined with phenotypic imprecision and poor marker coverage, has contributed to the difficulty in defining risk variants. We focused on families of Ashkenazi Jewish descent, to reduce genetic heterogeneity, and, as a precursor to genomewide association studies, we undertook a single-nucleotide polymorphism (SNP) genotyping screen of 64 candidate genes (440 SNPs) chosen on the basis of previous linkage or of association and/or biological relevance. We genotyped an average of 6.9 SNPs per gene, with an average density of 1 SNP per 11.9 kb in 323 bipolar I disorder and 274 schizophrenia or schizoaffective Ashkenazi case-parent trios. Using single-SNP and haplotype-based transmission/disequilibrium tests, we ranked genes on the basis of strength of association (P < .01). Six genes (DAO, GRM3, GRM4, GRIN2B, IL2RB, and TUBA8) met this criterion for bipolar I disorder; only DAO has been previously associated with bipolar disorder. Six genes (RGS4, SCA1, GRM4, DPYSL2, NOS1, and GRID1) met this criterion for schizophrenia or schizoaffective disorder; five replicate previous associations, and one, GRID1, shows a novel association with schizophrenia. In addition, six genes (DPYSL2, DTNBP1, G30/G72, GRID1, GRM4, and NOS1) showed overlapping suggestive evidence of association in both disorders. These results may help to prioritize candidate genes for future study from among the many suspected/proposed for schizophrenia and bipolar disorders. They provide further support for shared genetic susceptibility between these two disorders that involve glutamatesignaling pathways.	Johns Hopkins Univ, Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Behav Sci, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21231 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Pulver, AE (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 1820 Lancaster St,Suite 300, Baltimore, MD 21231 USA.	aepulver@jhmi.edu	Liang, Kung-Yee/F-8299-2011; Avramopoulos, Dimitrios/J-4392-2012	McGrath, John A./0000-0002-9756-7892	NIMH NIH HHS [R01 MH058153, R01MH58153, R01MH057314] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058153, R01MH057314] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdolmaleky HM, 2004, SCHIZOPHR RES, V67, P53, DOI 10.1016/S0920-9964(03)00183-X; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berti L, 2001, GENOMICS, V74, P320, DOI 10.1006/geno.2001.6566; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Bishop JR, 2005, SCHIZOPHR RES, V77, P253, DOI 10.1016/j.schres.2005.04.001; Blaveri E, 2001, EUR J HUM GENET, V9, P469, DOI 10.1038/sj.ejhg.5200646; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brzustowicz LM, 2002, HUM HERED, V54, P199, DOI 10.1159/000070665; Buckland PR, 2004, BBA-MOL BASIS DIS, V1690, P238, DOI 10.1016/j.bbadis.2004.06.023; Buttenschon HN, 2004, AM J MED GENET B, V124B, P73, DOI 10.1002/ajmg.b.20040; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Cardno AG, 2001, BRIT J PSYCHIAT, V179, P39, DOI 10.1192/bjp.179.1.39; Chakravarti A, 2002, P NATL ACAD SCI USA, V99, P4755, DOI 10.1073/pnas.092158299; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CICHON S, 1994, BIOL PSYCHIAT, V36, P850, DOI 10.1016/0006-3223(94)90597-5; Cichon S, 1996, AM J MED GENET, V67, P424, DOI 10.1002/(SICI)1096-8628(19960726)67:4<424::AID-AJMG21>3.0.CO;2-K; Clark DA, 2005, BIOL PSYCHIAT, V58, P435, DOI 10.1016/j.biopsych.2005.04.051; Cordeiro Q, 2005, GENES BRAIN BEHAV, V4, P45, DOI 10.1111/j.1601-183x.2004.00096.x; De Luca A, 2003, AM J MED GENET B, V116B, P32, DOI 10.1002/ajmg.b.10008; De Luca A, 2001, AM J MED GENET, V105, P529, DOI 10.1002/ajmg.1489; Devaney JM, 2002, MOL PSYCHIATR, V7, P419, DOI 10.1038/sj.mp.4001022; Di Maria E, 2004, AM J MED GENET B, V128B, P27, DOI 10.1002/ajmg.b.30028; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; Duan SW, 2005, NEUROSCI LETT, V379, P32, DOI 10.1016/j.neulet.2004.12.040; Dubertret C, 2004, SCHIZOPHR RES, V67, P75, DOI 10.1016/S0920-9964(03)00220-2; Dunayevich E, 2000, Curr Psychiatry Rep, V2, P286, DOI 10.1007/s11920-000-0069-4; Durner M, 1999, AM J HUM GENET, V64, P1411, DOI 10.1086/302371; Eastwood SL, 2005, BIOL PSYCHIAT, V57, P702, DOI 10.1016/j.biopsych.2004.12.029; Ebstein RP, 1997, HUM HERED, V47, P6, DOI 10.1159/000154382; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 2001, GENOME RES, V11, P208, DOI 10.1101/gr.GR-1431R; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Fallin MD, 2004, AM J HUM GENET, V75, P204, DOI 10.1086/422474; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fujii Y, 2003, PSYCHIAT GENET, V13, P71, DOI 10.1097/01.ypg.0000056682.82896.b0; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; GELERNTER J, 1992, GENOMICS, V13, P208, DOI 10.1016/0888-7543(92)90222-E; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Goodwin F.K., 1990, MANIC DEPRESSIVE ILL; Gottlieb S, 1997, AM J HUM GENET, V60, P1194; Harrison PJ, 2005, MOL PSYCHIATR, V10, P804, DOI 10.1038/sj.mp.4001686; Hashimoto R, 2005, J NEURAL TRANSM, V112, P303, DOI 10.1007/s00702-004-0264-2; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; HENNAH W, 2004, WORLD C PSYCH GEN DU; HOLLMANN M, 1994, RENAL PHYSIOL BIOCH, V17, P182; Hong CJ, 2004, NEUROREPORT, V15, P1965, DOI 10.1097/00001756-200408260-00026; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Jamain S, 2001, GENOMICS, V74, P36, DOI 10.1006/geno.2001.6535; Jonsson EG, 2004, PSYCHIAT GENET, V14, P9, DOI 10.1097/01.ypg.0000084943.07075.6b; Jonsson EG, 2003, SCHIZOPHR RES, V61, P111, DOI 10.1016/S0920-9964(02)00287-6; Joo EJ, 1999, PSYCHIATR GENET, V9, P7, DOI 10.1097/00041444-199903000-00002; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kawashima N, 2002, BRAIN RES, V949, P71, DOI 10.1016/S0006-8993(02)02966-9; Kempf L, 2005, INT REV PSYCHIATR, V17, P9, DOI 10.1080/09540260500064959; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KOROSTISHEVSKY M, 2005, AM J MED GENET B; KOYAMA K, 1994, GENOMICS, V21, P460, DOI 10.1006/geno.1994.1300; Kurumaji A, 2001, AM J MED GENET, V105, P172, DOI 10.1002/ajmg.1194; Kurumaji A, 2000, J NEURAL TRANSM, V107, P491, DOI 10.1007/s007020070090; Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Leegwater PAJ, 2002, MOL PSYCHIATR, V7, P1037, DOI 10.1038/sj.mp.4001142; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Liu XM, 2004, NEUROSCI LETT, V369, P228, DOI 10.1016/j.neulet.2004.07.078; Lohoff FW, 2005, PSYCHIAT RES, V135, P171, DOI 10.1016/j.psychres.2005.04.004; Macgregor S, 2004, MOL PSYCHIATR, V9, P1083, DOI 10.1038/sj.mp.4001544; Maheshwari M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-30; Maier W, 2003, PHARMACOPSYCHIATRY, V36, pS195; Masellis M, 2001, SCHIZOPHR RES, V47, P49, DOI 10.1016/S0920-9964(00)00016-5; MATTHYSS.S, 1972, AM J PSYCHIAT, V128, P1310, DOI 10.1176/ajp.128.10.1310; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; MCGUE M, 1991, EUR ARCH PSY CLIN N, V240, P174, DOI 10.1007/BF02190760; Meyer J, 2001, MOL PSYCHIATR, V6, P302, DOI 10.1038/sj.mp.4000869; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Morris DW, 2004, AM J MED GENET B, V125B, P50, DOI 10.1002/ajmg.b.20109; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Muglia P, 2002, MOL PSYCHIATR, V7, P860, DOI 10.1038/sj.mp.4001098; Munafo MR, 2005, MOL PSYCHIATR, V10, P765, DOI 10.1038/sj.mp.4001664; Nakata K, 2003, NEUROSCI LETT, V349, P171, DOI 10.1016/S0304-3940(03)00824-3; Nakata K, 2003, BIOL PSYCHIAT, V53, P571, DOI 10.1016/S0006-3223(02)01729-8; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; NICODEMUS KK, 2004, GEN AN WORKSH 14 NOO; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; Norton N, 2005, ANN MED, V37, P121, DOI 10.1080/07853890510037347; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogura H, 2001, BEHAV GENET, V31, P317, DOI 10.1023/A:1012235510600; Ohtsuki T, 2001, PSYCHIATR GENET, V11, P79, DOI 10.1097/00041444-200106000-00004; Ohtsuki T, 2001, MOL PSYCHIATR, V6, P211, DOI 10.1038/sj.mp.4000808; Owen MJ, 2005, BRIT MED J, V330, P158, DOI 10.1136/bmj.330.7484.158; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; PEREZ DE CASTRO I, 1995, J MED GENET, V32, P131, DOI 10.1136/jmg.32.2.131; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pizzuti A, 1997, HUM MOL GENET, V6, P259, DOI 10.1093/hmg/6.2.259; Porter K, 2005, EUR J NEUROSCI, V21, P351, DOI 10.1111/j.1460-9568.2005.03874.x; Potash JB, 2001, AM J PSYCHIAT, V158, P1258, DOI 10.1176/appi.ajp.158.8.1258; Preisig M, 2005, AM J PHARMACOGENOMIC, V5, P45, DOI 10.2165/00129785-200505010-00004; PULVER AE, 1994, AM J MED GENET, V54, P44, DOI 10.1002/ajmg.1320540109; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Ranade SS, 2003, AM J MED GENET B, V121B, P28, DOI 10.1002/ajmg.b.20070; Ravassard P, 1999, GENOMICS, V62, P82, DOI 10.1006/geno.1999.5982; Raybould R, 2005, BIOL PSYCHIAT, V57, P696, DOI 10.1016/j.biopsych.2005.01.018; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Rossi J, 2000, EUR J NEUROSCI, V12, P3944, DOI 10.1046/j.1460-9568.2000.00292.x; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Saito T, 2003, AM J MED GENET B, V116B, P77, DOI 10.1002/ajmg.b.10042; Saito T, 2001, MOL PSYCHIATR, V6, P193, DOI 10.1038/sj.mp.4000825; Sandhu HK, 2004, PSYCHIAT GENET, V14, P169, DOI 10.1097/00041444-200409000-00010; Saugstad JA, 1998, J NEUROSCI, V18, P905; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; SCHWAB SG, 1995, AM J MED GENET, V60, P436, DOI 10.1002/ajmg.1320600515; Schwartz R, 2003, J COMPUT BIOL, V10, P13, DOI 10.1089/106652703763255642; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Selimi F, 2003, NEURON, V37, P813, DOI 10.1016/S0896-6273(03)00093-X; Severino G, 2005, AM J MED GENET B, V134B, P37, DOI 10.1002/ajmg.b.30116; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Shinkai T, 2002, MOL PSYCHIATR, V7, P560, DOI 10.1038/sj.mp.4001041; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; Spurlock G, 1998, AM J MED GENET, V81, P24, DOI 10.1002/(SICI)1096-8628(19980207)81:1<24::AID-AJMG5>3.0.CO;2-N; Stanchi F, 2000, BIOCHEM BIOPH RES CO, V270, P1111, DOI 10.1006/bbrc.2000.2571; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stern HS, 2001, GASTROENTEROLOGY, V120, P392, DOI 10.1053/gast.2001.21170; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848; Takase K, 2001, SCHIZOPHR RES, V52, P161, DOI 10.1016/S0920-9964(00)00191-2; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Tosato S, 2005, SCHIZOPHRENIA BULL, V31, P613, DOI 10.1093/schbul/sbi043; Treadaway J, 1998, GENOMICS, V54, P359, DOI 10.1006/geno.1998.5599; Tsuang M, 1990, GENETICS MOOD DISORD; TSUANG MT, 1991, SCHIZOPHR RES, V4, P157, DOI 10.1016/0920-9964(91)90031-L; Vincent JB, 1999, AM J PSYCHIAT, V156, P136, DOI 10.1176/ajp.156.1.136; Wang MG, 1996, CYTOGENET CELL GENET, V72, P236, DOI 10.1159/000134198; Wang SB, 1996, AM J HUM GENET, V59, P731; Wang Y, 2003, EUR J NEUROSCI, V17, P1581, DOI 10.1046/j.1460-9568.2003.02595.x; Williams NM, 2004, BIOL PSYCHIAT, V55, P192, DOI 10.1016/j.biopsych.2003.11.002; Williams NM, 2002, MOL PSYCHIATR, V7, P1092, DOI 10.1038/sj.mp.4001188; Wonodi I, 2005, SCHIZOPHR RES, V78, P339, DOI 10.1016/j.schres.2005.03.023; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	165	312	324	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					918	936		10.1086/497703	http://dx.doi.org/10.1086/497703			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380905	Green Published, Bronze			2022-12-18	WOS:000233241200003
J	Nielsen, DM; Ehm, MG; Weir, BS				Nielsen, DM; Ehm, MG; Weir, BS			Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; POSITIONAL CLONING; GENE; RESOLUTION; FAMILIES; REGION	We review and extend a recent suggestion that line-scale localization of a disease-susceptibility locus for a complex disease be done on the basis of deviations from Hardy-Weinberg equilibrium among affected individuals. This deviation is driven by linkage disequilibrium between disease and marker loci in the whole population and requires a heterogeneous genetic basis for the disease. A finding of marker-locus Hardy-Weinberg disequilibrium therefore implies disease heterogeneity and marker-disease linkage disequilibrium, Although a lack of departure of Hardy-Weinberg disequilibrium at marker loci implies that disease susceptibility-weighted linkage disequilibria are zero, given disease heterogeneity, it does not follow that the usual measures of linkage disequilibrium are zero. For disease-susceptibility loci with more than two alleles, therefore, care is needed in the drawing of inferences from marker Hardy-Wreinberg disequilibria.	Glaxo Wellcome Inc, Bioinformat Dept, Res Triangle Pk, NC 27709 USA; N Carolina State Univ, Dept Stat, Program Stat Genet, Raleigh, NC 27695 USA	GlaxoSmithKline; University of North Carolina; North Carolina State University	Ehm, MG (corresponding author), Glaxo Wellcome Inc, Bioinformat Dept, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.			Nielsen, Dahlia/0000-0003-0123-6085	NIGMS NIH HHS [GM45344] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; GLASER B, 1995, HUM MOL GENET, V4, P879, DOI 10.1093/hmg/4.5.879; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Kaplan NL, 1997, AM J HUM GENET, V60, P691; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MENG RC, 1966, J AM STAT ASSOC, V61, P965, DOI 10.2307/2283192; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Tregouet DA, 1997, AM J HUM GENET, V61, P189, DOI 10.1086/513895; Weir B., 1996, GENETIC DATA ANAL	16	312	327	1	16	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1531	1540		10.1086/302114	http://dx.doi.org/10.1086/302114			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9867708	Green Published, Bronze			2022-12-18	WOS:000076985200029
J	Bergametti, F; Denier, C; Labauge, P; Arnoult, M; Boetto, S; Clanet, M; Coubes, P; Echenne, B; Ibrahim, R; Irthum, B; Jacquet, G; Lonjon, M; Moreau, JJ; Neau, JP; Parker, F; Tremoulet, M; Tournier-Lasserve, E				Bergametti, F; Denier, C; Labauge, P; Arnoult, M; Boetto, S; Clanet, M; Coubes, P; Echenne, B; Ibrahim, R; Irthum, B; Jacquet, G; Lonjon, M; Moreau, JJ; Neau, JP; Parker, F; Tremoulet, M; Tournier-Lasserve, E		Soc Francaise Neurochirurgie	Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING-PROTEIN; KRIT1; ASSOCIATION; CCM1	Cerebral cavernous malformations (CCMs) are hamartomatous vascular malformations characterized by abnormally enlarged capillary cavities without intervening brain parenchyma. They cause seizures and cerebral hemorrhages, which can result in focal neurological deficits. Three CCM loci have been mapped, and loss-of-function mutations were identified in the KRIT1 (CCM1) and MGC4607 (CCM2) genes. We report herein the identification of PDCD10 ( programmed cell death 10) as the CCM3 gene. The CCM3 locus has been previously mapped to 3q26-27 within a 22-cM interval that is bracketed by D3S1763 and D3S1262. We hypothesized that genomic deletions might occur at the CCM3 locus, as reported previously to occur at the CCM2 locus. Through high-density microsatellite genotyping of 20 families, we identified, in one family, null alleles that resulted from a deletion within a 4-Mb interval flanked by markers D3S3668 and D3S1614. This de novo deletion encompassed D3S1763, which strongly suggests that the CCM3 gene lies within a 970-kb region bracketed by D3S1763 and D3S1614. Six additional distinct deleterious mutations within PDCD10, one of the five known genes mapped within this interval, were identified in seven families. Three of these mutations were nonsense mutations, and two led to an aberrant splicing of exon 9, with a frameshift and a longer open reading frame within exon 10. The last of the six mutations led to an aberrant splicing of exon 5, without frameshift. Three of these mutations occurred de novo. All of them cosegregated with the disease in the families and were not observed in 200 control chromosomes. PDCD10, also called "TFAR15," had been initially identified through a screening for genes differentially expressed during the induction of apoptosis in the TF-1 premyeloid cell line. It is highly conserved in both vertebrates and invertebrates. Its implication in cerebral cavernous malformations strongly suggests that it is a new player in vascular morphogenesis and/or remodeling.	Fac Med Lariboisiere, INSERM E365, F-75010 Paris, France; Hop Lariboisiere, Lab Cytogenet & Genet Mol, Assistance Publ Hop Paris, F-75475 Paris, France; Serv Neurol, Nimes, France; Serv Neurochirurg, Toulouse, France; Serv Neurol, Toulouse, France; Serv Neurochirurg, Montpellier, France; Serv Neuropediat, Montpellier, France; Serv Neurochirurg, Nantes, France; Serv Neurochirurg, Limoges, France; Serv Neurochirurg, Besancon, France; Serv Neurochirurg, Nice, France; Serv Neurochirurg, Poitiers, France; Serv Neurochirurg, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Poitiers	Tournier-Lasserve, E (corresponding author), Fac Med Lariboisiere, INSERM E365, 10 Ave Verdun, F-75010 Paris, France.	tournier-lasserve@paris7.jussieu.fr	Tournier-Lasserve, Elisabeth/N-7134-2017	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677				Busch CR, 2004, GENE, V329, P1, DOI 10.1016/j.gene.2004.01.004; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Denier C, 2002, MECH DEVELOP, V117, P363, DOI 10.1016/S0925-4773(02)00209-5; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Guzeloglu-Kayisli O, 2004, NEUROSURGERY, V54, P943, DOI 10.1227/01.NEU.0000114512.59624.A5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Labauge P, 1998, LANCET, V352, P1892, DOI 10.1016/S0140-6736(98)03011-6; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; NELLIST M, 1993, CELL, V75, P1305; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Verhoef S, 1999, AM J HUM GENET, V64, P1632, DOI 10.1086/302412; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Wang ZQ, 1999, PALAEONTOLOGY, V42, P329; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953	25	311	326	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					42	51		10.1086/426952	http://dx.doi.org/10.1086/426952			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15543491	Green Published, Bronze			2022-12-18	WOS:000225643600004
J	Jackson, AP; Eastwood, H; Bell, SM; Adu, J; Toomes, C; Carr, IM; Roberts, E; Hampshire, DJ; Crow, YJ; Mighell, AJ; Karbani, G; Jafri, H; Rashid, Y; Mueller, RF; Markham, AF; Woods, CG				Jackson, AP; Eastwood, H; Bell, SM; Adu, J; Toomes, C; Carr, IM; Roberts, E; Hampshire, DJ; Crow, YJ; Mighell, AJ; Karbani, G; Jafri, H; Rashid, Y; Mueller, RF; Markham, AF; Woods, CG			Identification of microcephalin, a protein implicated in determining the size of the human brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAPS; LOCUS; HYBRIDIZATION; SEQUENCE	Primary microcephaly (MIM 251200) is an autosomal recessive neurodevelopmental condition in which there is a global reduction in cerebral cortex volume, to a size comparable with that of early hominids. We previously mapped the MCPH1 locus, for primary microcephaly, to chromosome 8p23, and here we report that a gene within this interval, encoding a BRCA1 C-terminal domain-containing protein, is mutated in MCPH1 families sharing an ancestral 8p23 haplotype. This gene, microcephalin, is expressed in the developing cerebral cortex of the fetal brain. Further study of this and related genes may provide important new insights into neocortical development and evolution.	Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, St James Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Genetec Lab, Lahore, Pakistan	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds	Jackson, AP (corresponding author), Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England.		Jackson, Andrew P/D-3442-2009; Adu, Jimi/R-8434-2019; woods, christopher g/A-1361-2010; Hampshire, Daniel/Q-3540-2019; Crow, Yanick J/N-6120-2014	Jackson, Andrew P/0000-0002-8739-2646; Crow, Yanick J/0000-0001-7211-7564; Bell, Sandra/0000-0002-3022-9864; Adu, Jimi/0000-0002-7838-9699; Toomes, Carmel/0000-0001-8373-9545				ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BUNDEY S, 1992, GENETICS NEUROLOGY G, P20; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; Dixon J, 1997, HUM MOL GENET, V6, P727, DOI 10.1093/hmg/6.5.727; GIBBONS IR, 1991, P NATL ACAD SCI USA, V88, P8563, DOI 10.1073/pnas.88.19.8563; Grosios K, 1999, CYTOGENET CELL GENET, V84, P118, DOI 10.1159/000015235; Hiel JA, 2000, ARCH DIS CHILD, V82, P400; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; KOMAI T, 1955, AM J HUM GENET, V7, P51; Kornack DR, 2000, BRAIN BEHAV EVOLUT, V55, P336, DOI 10.1159/000006668; McCreary BD, 1996, J INTELL DISABIL RES, V40, P66, DOI 10.1111/j.1365-2788.1996.tb00604.x; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Ross JJ, 1977, HDB CLIN NEUROLOGY, V30, P507; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65	22	311	322	1	23	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					136	142		10.1086/341283	http://dx.doi.org/10.1086/341283			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12046007	Green Published, Bronze			2022-12-18	WOS:000176307700013
J	Brophy, VH; Jampsa, RL; Clendenning, JB; McKinstry, LA; Jarvik, GP; Furlong, CE				Brophy, VH; Jampsa, RL; Clendenning, JB; McKinstry, LA; Jarvik, GP; Furlong, CE			Effects of 5 ' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM PARAOXONASE; HIGH-DENSITY-LIPOPROTEIN; BOVINE PLASMA ARYLESTERASE; CORONARY-ARTERY DISEASE; E-DEFICIENT MICE; DIABETES-MELLITUS; ESTERASE-ACTIVITY; MOLECULAR-BASIS; STATUS REQUIRES; MOUSE MODEL	Human HDL-associated paraoxonase (PON1) hydrolyzes a number of toxic organophosphorous compounds and reduces oxidation of LDLs and HDLs. These properties of PON1 account for its ability to protect against pesticide poisonings and atherosclerosis. PON1 also hydrolyzes a number of lactone and cyclic-carbonate drugs. Among individuals in a population, PON1 levels vary widely. We previously identified three polymorphisms in the PON1 regulatory region that affect expression levels in cultured human hepatocytes. In this study, we determined the genotypes of three regulatory-region polymorphisms for 376 white individuals and examined their effect on plasma-PON1 levels, determined by rates of phenylacetate hydrolysis. The -108 polymorphism had a significant effect on PON1-activity level, whereas the -162 polymorphism had a lesser effect. The -909 polymorphism, which is in linkage disequilibrium with the other sites, appears to have little or no independent effect on PON1-activity level in vivo. Other studies have found that the L55M polymorphism in the PON1-coding region is associated with differences in both PON1-mRNA and PON1-activity levels. The results presented here indicate that the L55M effect of lowered activity is not due to the amino acid change but is, rather, largely due to linkage disequilibrium with the -108 regulatory-region polymorphism. The codon 55 polymorphism marginally appeared to account for 15.3% of the variance in PON1 activity, but this dropped to 5% after adjustments for the effects of the -108 and Q192R polymorphisms were made. The -108C/T polymorphism accounted for 22.8% of the observed variability in PON1-expression levels, which was much greater than that attributable to the other PON1 polymorphisms. We also identified four sequence differences in the 3' UTR of the PON1 mRNA.	Univ Washington, Dept Genet, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Furlong, CE (corresponding author), Univ Washington, Dept Genet, Div Med Genet, Box 357360, Seattle, WA 98195 USA.		Jarvik, Gail P/N-6476-2014; Brophy, Victoria/V-8964-2019	Jarvik, Gail P/0000-0002-6710-8708; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009601, P30ES007033, R01ES009883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000057, T32 AG 00057-22] Funding Source: Medline; NIEHS NIH HHS [ES09883, 1 PO1 ES09601, P30 ES007033, R01 ES009883, P30 ES07033] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADKINS S, 1993, AM J HUM GENET, V52, P598; ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; Aviram M, 1998, ARTERIOSCL THROM VAS, V18, P1617, DOI 10.1161/01.ATV.18.10.1617; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Aviram M, 2000, AM J CLIN NUTR, V71, P1062; Biggadike K, 2000, J MED CHEM, V43, P19, DOI 10.1021/jm990436t; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Blatter Garin Marie-Claude, 1997, Journal of Clinical Investigation, V99, P62; Brophy VH, 2000, PHARMACOGENETICS, V10, P453, DOI 10.1097/00008571-200007000-00008; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Cao HB, 1999, J LIPID RES, V40, P133; Cascorbi I, 1999, PHARMACOGENETICS, V9, P755, DOI 10.1097/00008571-199912000-00010; Costa L. G., 1987, TOXICOLOGY PESTICIDE, P263; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; DON MM, 1975, BIOCHEM J, V151, P625, DOI 10.1042/bj1510625; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Furlong CE, 1998, NEUROTOXICOLOGY, V19, P645; FURLONG CE, 1989, ANAL BIOCHEM, V180, P242, DOI 10.1016/0003-2697(89)90424-7; FURLONG CE, 1993, CHEM-BIOL INTERACT, V87, P35, DOI 10.1016/0009-2797(93)90023-R; FURLONG CE, 1988, AM J HUM GENET, V43, P230; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; Hedrick CC, 2000, ARTERIOSCL THROM VAS, V20, P1946, DOI 10.1161/01.ATV.20.8.1946; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Imai Y, 2000, ATHEROSCLEROSIS, V149, P435, DOI 10.1016/S0021-9150(99)00340-8; James RW, 2000, DIABETES, V49, P1390, DOI 10.2337/diabetes.49.8.1390; James RW, 2000, CIRCULATION, V101, P2252, DOI 10.1161/01.CIR.101.19.2252; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; La Du B N, 1986, Prog Clin Biol Res, V214, P87; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Leviev I, 1997, ARTERIOSCL THROM VAS, V17, P2935, DOI 10.1161/01.ATV.17.11.2935; LI WF, 1993, J TOXICOL ENV HEALTH, V40, P337, DOI 10.1080/15287399309531798; LI WF, 1995, TOXICOL LETT, V76, P219, DOI 10.1016/0378-4274(95)80006-Y; Li WF, 2000, PHARMACOGENETICS, V10, P767, DOI 10.1097/00008571-200012000-00002; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mackness B, 1998, ATHEROSCLEROSIS, V139, P341, DOI 10.1016/S0021-9150(98)00095-1; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7; MACKNESS MI, 1985, COMP BIOCHEM PHYS B, V82, P675, DOI 10.1016/0305-0491(85)90506-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nishio E, 1997, BIOCHEM BIOPH RES CO, V236, P289, DOI 10.1006/bbrc.1997.6961; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; Ray A, 2000, J IMMUNOL, V165, P3411, DOI 10.4049/jimmunol.165.6.3411; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Sakai T, 1998, INTERNAL MED, V37, P581, DOI 10.2169/internalmedicine.37.581; Schmidt H, 1998, STROKE, V29, P2043, DOI 10.1161/01.STR.29.10.2043; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; Tomas M, 2000, ARTERIOSCL THROM VAS, V20, P2113, DOI 10.1161/01.ATV.20.9.2113; Tougou K, 1998, DRUG METAB DISPOS, V26, P355; van der Gaag MS, 1999, ATHEROSCLEROSIS, V147, P405, DOI 10.1016/S0021-9150(99)00243-9; Van Lenten BJ, 2001, J BIOL CHEM, V276, P1923, DOI 10.1074/jbc.M004074200; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359	56	311	343	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1428	1436		10.1086/320600	http://dx.doi.org/10.1086/320600			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11335891	Bronze, Green Published			2022-12-18	WOS:000169094600013
J	Eng, CM; Banikazemi, M; Gordon, RE; Goldman, M; Phelps, R; Kim, L; Gass, A; Winston, J; Dikman, S; Fallon, JT; Brodie, S; Stacy, CB; Mehta, D; Parsons, R; Norton, K; O'Callaghan, M; Desnick, RJ				Eng, CM; Banikazemi, M; Gordon, RE; Goldman, M; Phelps, R; Kim, L; Gass, A; Winston, J; Dikman, S; Fallon, JT; Brodie, S; Stacy, CB; Mehta, D; Parsons, R; Norton, K; O'Callaghan, M; Desnick, RJ			A phase 1/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-GALACTOSIDASE-A; THERAPY	Fabry disease results from deficient alpha -galactosidase A (alpha -Gal A) activity and the pathologic accumulation of the globotriaosylceramide (GL-3) and related glycosphingolipids, primarily in vascular endothelial lysosomes. Treatment is currently palliative, and affected patients generally die in their 40s or 50s. Preclinical studies of recombinant human alpha -Gal A (r-h alpha GalA) infusions in knockout mice demonstrated reduction of GL-3 in tissues and plasma, providing rationale for a phase 1/2 clinical trial. Here, we report a single-center, open-label, dose-ranging study of r-h alpha GalA treatment in 15 patients, each of whom received five infusions at one of five dose regimens. Intravenously administered r-h alpha GalA was cleared from the circulation in a dose-dependent manner, via both saturable and non-saturable pathways. Rapid and marked reductions in plasma and tissue GL-3 were observed biochemically, histologically, and/or ultrastructurally. Clearance of plasma GL-3 was dose-dependent. In patients with pre- and posttreatment biopsies, mean GL-3 content decreased 84% in liver (n = 13), was markedly reduced in kidney in four of five patients, and after five doses was modestly lowered in the endomyocardium of four of seven patients. GL-3 deposits were cleared to near normal or were markedly reduced in the vascular endothelium of liver, skin, heart, and kidney, on the basis of light- and electron-microscopic evaluation. In addition, patients reported less pain, increased ability to sweat, and improved quality-of-life measures. Infusions were well tolerated; four patients experienced mild-to-moderate reactions, suggestive of hypersensitivity, that were managed conservatively. Of 15 patients, 8 (53%) developed IgG antibodies to r-h alpha GalA; however, the antibodies were not neutralizing, as indicated by unchanged pharmacokinetic values for infusions 1 and 5. This study provides the basis for a phase 3 trial of enzyme-replacement therapy for Fabry disease.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA; Genzyme Corp, Cambridge, MA USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Sanofi-Aventis; Genzyme Corporation	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.			Fallon, John/0000-0002-7677-4868	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000071, 5 M01 RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [R37 DK034045, 5 R37 DK34045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2014, METABOLIC MOL BASES; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; COLOMBI A, 1967, HELV MED ACTA, V34, P67; Desnick R J, 1980, Birth Defects Orig Artic Ser, V16, P393; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; DESNICK RJ, 1979, P NATL ACAD SCI USA, V76, P5326, DOI 10.1073/pnas.76.10.5326; Desnick RJ., 1995, METABOLIC MOL BASES, P2741; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; ENG CM, 1993, AM J HUM GENET, V53, P1186; Gandek, 1997, SF 36 HLTH SURVEY MA; Grabowski GA, 1998, BLOOD REV, V12, P115, DOI 10.1016/S0268-960X(98)90023-6; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; MAPES CA, 1970, SCIENCE, V169, P987, DOI 10.1126/science.169.3949.987; Matsuura F, 1998, GLYCOBIOLOGY, V8, P329, DOI 10.1093/glycob/8.4.329; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mistry Pramod K., 1999, Journal of Hepatology, V30, P1; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; VANSCHEIDT W, 1991, NEW ENGL J MED, V324, P395; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	22	311	330	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					711	722		10.1086/318809	http://dx.doi.org/10.1086/318809			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179018	Green Published, Bronze			2022-12-18	WOS:000166994200015
J	SCHURR, TG; BALLINGER, SW; GAN, YY; HODGE, JA; MERRIWETHER, DA; LAWRENCE, DN; KNOWLER, WC; WEISS, KM; WALLACE, DC				SCHURR, TG; BALLINGER, SW; GAN, YY; HODGE, JA; MERRIWETHER, DA; LAWRENCE, DN; KNOWLER, WC; WEISS, KM; WALLACE, DC			AMERINDIAN MITOCHONDRIAL DNAS HAVE RARE ASIAN MUTATIONS AT HIGH-FREQUENCIES, SUGGESTING THEY DERIVED FROM 4 PRIMARY MATERNAL LINEAGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									EMORY UNIV, SCH MED, DEPT BIOCHEM, 109 WOODRUFF MEM BLDG, ATLANTA, GA 30322 USA; EMORY UNIV, SCH MED, DEPT ANTHROPOL, ATLANTA, GA 30322 USA; CTR DIS CONTROL, CTR INFECT DIS, DIV HOST FACTORS, ATLANTA, GA 30333 USA; UNIV AGR MALAYSIA, DEPT BIOTECHNOL, SERDANG, MALAYSIA; PENN STATE UNIV, DEPT BIOL, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, GRAD PROGRAM GENET, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, DEPT ANTHROPOL, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, GRAD PROGRAM GENET, UNIVERSITY PK, PA 16802 USA; NIDDKD, DIABET & ARTHRIT EPIDEMIOL SECT, PHOENIX, AZ USA	Emory University; Emory University; Centers for Disease Control & Prevention - USA; Universiti Putra Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Schurr, Theodore G/A-1336-2007					ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BADA JL, 1984, NATURE, V312, P442, DOI 10.1038/312442a0; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; BLANC H, 1983, AM J HUM GENET, V35, P167; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, P485; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1982, THESIS U CALIFORNIA; CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DILLEHAY TD, 1982, J FIELD ARCHAEOL, V9, P547; DORAN GH, 1986, NATURE, V323, P803, DOI 10.1038/323803a0; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GUIDON N, 1986, NATURE, V321, P769, DOI 10.1038/321769a0; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; Haury Emil W., 1976, HOHOKAM DESERT FARME; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; LAMPL M, 1979, 1ST AM ORIGINS AFFIN, P7; LAWRENCE DN, 1980, TISSUE ANTIGENS, V16, P152, DOI 10.1111/j.1399-0039.1980.tb00596.x; MacNeish Richard S., 1983, EARLY MAN NEW WORLD, P125; MATSON GA, 1968, AM J PHYS ANTHROPOL, V29, P311, DOI 10.1002/ajpa.1330290308; Maxam A M, 1980, Methods Enzymol, V65, P499; MESTRINER MA, 1980, AM J PHYS ANTHROPOL, V52, P95, DOI 10.1002/ajpa.1330520112; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; Mourant AE, 1976, DISTRIBUTION HUMAN B; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JV, 1986, AM J HUM GENET, V38, P649; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; NEEL JV, 1980, POPULATION STRUCTURE, P173; NELSON DE, 1986, SCIENCE, V232, P749, DOI 10.1126/science.232.4751.749; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; OWEN RC, 1984, ORIGINS MODERN HUMAN, P517; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SALZANO FM, 1980, J HUM EVOL, V9, P179, DOI 10.1016/0047-2484(80)90018-4; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214; SALZANO FM, 1978, HUM BIOL, V50, P121; Santachiara Benerecetti A S, 1988, Ann Hum Genet, V52, P39; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; Shutler, 1983, EARLY MAN NEW WORLD, P163; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STONEKING M, 1986, GENETIC VARIATION IT, P87; Szathmary E., 1985, OUT ASIA PEOPLING AM, P79; TANIS RJ, 1977, AM J HUM GENET, V29, P419; TAYLOR RE, 1985, AM ANTIQUITY, V50, P136, DOI 10.2307/280638; Turner II C. G., 1983, EARLY MAN NEW WORLD, P147; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; YU MS, 1988, SCI CHINA SER B, V31, P860; [No title captured]; [No title captured]; [No title captured]	80	311	318	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					613	623						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1968708				2022-12-18	WOS:A1990CT66800026
J	Su, B; Xiao, JH; Underhill, P; Deka, R; Zhang, WL; Akey, J; Huang, W; Shen, D; Lu, D; Luo, JC; Chu, JY; Tan, JZ; Shen, PD; Davis, R; Cavalli-Sforza, L; Chakraborty, R; Xiong, MM; Du, RF; Oefner, P; Chen, Z; Jin, L				Su, B; Xiao, JH; Underhill, P; Deka, R; Zhang, WL; Akey, J; Huang, W; Shen, D; Lu, D; Luo, JC; Chu, JY; Tan, JZ; Shen, PD; Davis, R; Cavalli-Sforza, L; Chakraborty, R; Xiong, MM; Du, RF; Oefner, P; Chen, Z; Jin, L			Y-chromosome evidence for a northward migration of modern humans into eastern Asia during the last Ice Age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-EVOLUTION; MITOCHONDRIAL-DNA; FOSSIL EVIDENCE; POPULATIONS; CHINA	The timing and nature of the arrival and the subsequent expansion of modern humans into eastern Asia remains controversial. Using Y-chromosome biallelic markers, we investigated the ancient human-migration patterns in eastern Asia. Our data indicate that southern populations in eastern Asia are much more polymorphic than northern populations, which have only a subset of the southern haplotypes. This pattern indicates that the first settlement of modern humans in eastern Asia occurred in mainland Southeast Asia during the last Ice Age, coinciding with the absence of human fossils in eastern Asia, 50,000-100,000 years ago. After the initial peopling, a great northward migration extended into northern China and Siberia.	Univ Texas, Ctr Human Genet, Houston, TX 77030 USA; Fudan Univ, Morgan Tan Int Ctr Life Sci, Shanghai 200433, Peoples R China; Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China; Natl Human Genome Ctr, Shanghai, Peoples R China; Shanghai Second Med Univ, Rui Jin Hosp, Shanghai, Peoples R China; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; Chinese Acad Sci, Inst Genet, Beijing, Peoples R China	University of Texas System; Fudan University; Fudan University; Shanghai Jiao Tong University; Stanford University; Stanford University; University System of Ohio; University of Cincinnati; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Sciences	Jin, L (corresponding author), Univ Texas, Ctr Human Genet, 6901 Bertner, Houston, TX 77030 USA.		Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; Akey, Joshua/0000-0002-4411-1330				BALLINGER SW, 1992, GENETICS, V130, P139; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; BROOKS AS, 1990, NATURE, V344, P288, DOI 10.1038/344288a0; BROWN P, 1992, PHILOS T ROY SOC B, V337, P235, DOI 10.1098/rstb.1992.0101; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Dawson A.G., 1992, ICE AGE EARTH LATE Q; Etler DA, 1996, ANNU REV ANTHROPOL, V25, P275, DOI 10.1146/annurev.anthro.25.1.275; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; LI TY, 1992, NATURE, V357, P404; Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Turner CG, 1993, ORIGIN PAST MODERN H, P216; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 1997, AM J HUM GENET, V61, pA18; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; Weng Z, 1989, ACTA ANTHR SIN, V8, P261; WILSON AC, 1992, SCI AM, V266, P68; Wolpoff MH, 1996, SCIENCE, V274, P704; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; ZHAO T, 1986, ACTA ANTHR SIN, V6, P1	30	310	376	2	35	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1718	1724		10.1086/302680	http://dx.doi.org/10.1086/302680			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577926	Green Published, Bronze			2022-12-18	WOS:000084282500027
J	BOARD, PG				BOARD, PG			BIOCHEMICAL GENETICS OF GLUTATHIONE-S-TRANSFERASE IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOARD, PG (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DEPT HUMAN BIOL,CANBERRA,ACT 2601,AUSTRALIA.							BOARD PG, ANAL BIOCH; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; GUTHENBERG C, 1979, ACTA CHEM SCAND B, V33, P595, DOI 10.3891/acta.chem.scand.33b-0595; HABIG WH, 1976, GLUTATHIONE METABOLI, P225; JAKOBY WB, 1976, GLUTATHIONE METABOLI, P213; KAMISAKA K, 1975, EUR J BIOCHEM, V60, P153, DOI 10.1111/j.1432-1033.1975.tb20987.x; KETTERER B, 1976, GLUTATHIONE METABOLI, P243; KOSKELO K, 1980, SCAND J CLIN LAB INV, V40, P179, DOI 10.3109/00365518009093023; MARCUS CJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P287, DOI 10.1016/S0003-9861(78)80011-3; STENERSEN J, 1979, BIOCHEM J, V181, P47, DOI 10.1042/bj1810047; TAKAHATA N, 1979, P NATL ACAD SCI USA, V76, P4521, DOI 10.1073/pnas.76.9.4521	11	310	314	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					36	43						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	7468592				2022-12-18	WOS:A1981LA93000004
J	Zhang, DD; Cheng, LJ; Badner, JA; Chen, C; Chen, Q; Luo, W; Craig, DW; Redman, M; Gershon, ES; Liu, CY				Zhang, Dandan; Cheng, Lijun; Badner, Judith A.; Chen, Chao; Chen, Qi; Luo, Wei; Craig, David W.; Redman, Margot; Gershon, Elliot S.; Liu, Chunyu			Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; NEUROPATHOLOGY CONSORTIUM; LINKAGE DISEQUILIBRIUM; GENOME; METHYLTRANSFERASE; EXPRESSION; ASSOCIATION; POPULATION; SIGNATURES; METHYLOME	We have observed extensive interindividual differences in DNA methylation of 8590 CpG sites of 6229 genes in 153 human adult cerebellum samples, enriched in CpG island "shores" and at further distances from CpG islands. To search for genetic factors that regulate this variation, we performed a genome-wide association study (GWAS) mapping of methylation quantitative trait loci (mQTLs) for the 8590 testable CpG sites. cis association refers to correlation of methylation with SNPs within 1 Mb of a CpG site. 736 CpG sites showed phenotype-wide significant cis association with 2878 SNPs (after permutation correction for all tested markers and methylation phenotypes). In trans analysis of methylation, which tests for distant regulation effects, associations of 12 CpG sites and 38 SNPs remained significant after phenotype-wide correction. To examine the functional effects of mQTLs, we analyzed 85 genes that were with genetically regulated methylation we observed and for which we had quality gene expression data. Ten genes showed SNP-methylation-expression three-way associations-the same SNP simultaneously showed significant association with both DNA methylation and gene expression, while DNA methylation was significantly correlated with gene expression. Thus, we demonstrated that DNA methylation is frequently a heritable continuous quantitatively variable trait in human brain. Unlike allele-specific methylation, genetic polymorphisms mark both cis- and trans-regulatory genetic sites at measurable distances from their CpG sites. Some of the genetically regulated DNA methylation is directly connected with genetically regulated gene expression variation.	[Zhang, Dandan; Cheng, Lijun; Badner, Judith A.; Chen, Chao; Chen, Qi; Luo, Wei; Gershon, Elliot S.; Liu, Chunyu] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Gershon, Elliot S.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Craig, David W.; Redman, Margot] Translat Genom Res Inst, Phoenix, AZ 85004 USA	University of Chicago; University of Chicago; Translational Genomics Research Institute	Liu, CY (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	cliu@yoda.bsd.uchicago.edu	Liu, chunyu/Q-3901-2017; Liu, Chunyu/G-7561-2012; Craig, David Wesley/K-6961-2019	Liu, Chunyu/0000-0002-5986-4415; Craig, David Wesley/0000-0003-2040-1955; zhang, dandan/0000-0001-5305-9856	NARSAD Distinguished Investigator Awards; Brain Research Foundation at the University of Chicago; NIH [MHO80425, 51101 MH61613]; Geraldi Norton Foundation; Eklund Family; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061613, R01MH080425] Funding Source: NIH RePORTER	NARSAD Distinguished Investigator Awards; Brain Research Foundation at the University of Chicago(University of Chicago); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geraldi Norton Foundation; Eklund Family; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the families of the individuals involved in this study. The Stanley Medical Research Institute and its Collaborators, Drs. Elashoff, Torrey, and Webster, generously gave us access to their sample collections. This work was Supported by NARSAD Distinguished Investigator Awards (to E.S.G.), the Brain Research Foundation at the University of Chicago (to C.L.), NIH MHO80425 (to C.L.), and NIH 51101 MH61613 (to E.S.G.). Support from the Geraldi Norton Foundation and the Eklund Family is also gratefully acknowledged. We declare no conflict of interest.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, DOI [10.1176/appi.books.9780890423349., DOI 10.1176/APPI.BOOKS.9780890423349]; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Oates NA, 2006, AM J HUM GENET, V79, P155, DOI 10.1086/505031; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Storey John D, 2003, Methods Mol Biol, V224, P149; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019	36	309	311	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					411	419		10.1016/j.ajhg.2010.02.005	http://dx.doi.org/10.1016/j.ajhg.2010.02.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20215007	Bronze, Green Published			2022-12-18	WOS:000275678800012
J	Quintana-Murci, L; Chaix, R; Wells, RS; Behar, DM; Sayar, H; Scozzari, R; Rengo, C; Al-Zahery, N; Semino, O; Santachiara-Benerecetti, AS; Coppa, A; Ayub, Q; Mohyuddin, A; Tyler-Smith, C; Mehdi, SQ; Torroni, A; McElreavey, K				Quintana-Murci, L; Chaix, R; Wells, RS; Behar, DM; Sayar, H; Scozzari, R; Rengo, C; Al-Zahery, N; Semino, O; Santachiara-Benerecetti, AS; Coppa, A; Ayub, Q; Mohyuddin, A; Tyler-Smith, C; Mehdi, SQ; Torroni, A; McElreavey, K			Where west meets east: The complex mtDNA landscape of the southwest and Central Asian corridor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL-REGION SEQUENCE; EUROPEAN POPULATIONS; GEOGRAPHIC-VARIATION; AFRICAN POPULATIONS; EVOLUTIONARY TREE; CASTE POPULATIONS; GENETIC-EVIDENCE; SLAVE-TRADE; NEW-WORLD	The southwestern and Central Asian corridor has played a pivotal role in the history of humankind, witnessing numerous waves of migration of different peoples at different times. To evaluate the effects of these population movements on the current genetic landscape of the Iranian plateau, the Indus Valley, and Central Asia, we have analyzed 910 mitochondrial DNAs (mtDNAs) from 23 populations of the region. This study has allowed a refinement of the phylogenetic relationships of some lineages and the identification of new haplogroups in the southwestern and Central Asian mtDNA tree. Both lineage geographical distribution and spatial analysis of molecular variance showed that populations located west of the Indus Valley mainly harbor mtDNAs of western Eurasian origin, whereas those inhabiting the Indo-Gangetic region and Central Asia present substantial proportions of lineages that can be allocated to three different genetic components of western Eurasian, eastern Eurasian, and south Asian origin. In addition to the overall composite picture of lineage clusters of different origin, we observed a number of deep-rooting lineages, whose relative clustering and coalescent ages suggest an autochthonous origin in the southwestern Asian corridor during the Pleistocene. The comparison with Y-chromosome data revealed a highly complex genetic and demographic history of the region, which includes sexually asymmetrical mating patterns, founder effects, and female-specific traces of the East African slave trade.	Inst Pasteur, CNRS, URA 1961, F-75724 Paris 15, France; Inst Pasteur, Unit Mol Prevent & Therapy Human Dis, Paris, France; Inst Pasteur, Unit Reprod Fertil & Populat, Paris, France; Musee Homme Paris, Paris, France; Wellcome Trust Ctr Human Genet, Headington, England; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Rambam Med Ctr, Haifa, Israel; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, Rome, Italy; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Dr AQ Khan Res Labs, Biomed & Genet Engn Div, Islamabad, Pakistan; Wellcome Trust Sanger Inst, Hinxton, England; Univ Arizona, Dept Med, Tucson, AZ USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Museum National d'Histoire Naturelle (MNHN); University of Oxford; Wellcome Centre for Human Genetics; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Sapienza University Rome; Sapienza University Rome; University of Pavia; Wellcome Trust Sanger Institute; University of Arizona	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS, URA 1961, 25 Rue Dr Roux, F-75724 Paris 15, France.	quintana@pasteur.fr	Al-Zahery, Nadia/AAV-5878-2020; Torroni, Antonio/E-1557-2011; Quintana-Murci, Lluis/AAB-7468-2022; Mehdi, Syed Qasim/L-2385-2015	Torroni, Antonio/0000-0002-4163-4478; coppa, alfredo/0000-0002-7708-2484; Chaix, Raphaelle/0000-0001-5160-1293; Ayub, Qasim/0000-0003-3291-0917; Quintana-Murci, Lluis/0000-0003-2429-6320; SEMINO, Ornella/0000-0002-9675-9403	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Ayub Q, 2003, AM J PHYS ANTHROPOL, V122, P259, DOI 10.1002/ajpa.10234; BALLINGER SW, 1992, GENETICS, V130, P139; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bandelt HJ, 1997, AM J HUM GENET, V61, P980, DOI 10.1086/514878; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA, 1996, ORIGINS SPREAD AGR P, P51; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clarence-Smith WilliamGervase., 1989, EC INDIAN OCEAN SLAV; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; Comas D, 2000, AM J PHYS ANTHROPOL, V112, P5, DOI 10.1002/(SICI)1096-8644(200005)112:1<5::AID-AJPA2>3.0.CO;2-Z; Decker K. D., 1992, SOCIOLINGUISTIC SURV, V5; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; EXCOFFIER L, 1992, GENETICS, V131, P479; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 1996, AM J HUM GENET, V59, P935; Fu YX, 1997, GENETICS, V147, P915; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Horai S, 1996, AM J HUM GENET, V59, P579; Hughes-Buller R., 1991, IMPERIAL GAZETTEER I; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kolman CJ, 1996, GENETICS, V142, P1321; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lovejoy PE, 2000, TRANSFORMATIONS SLAV, Vxxii; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; MCALPIN DW, 1974, LANGUAGE, V50, P89, DOI 10.2307/412012; MCALPIN DW, 1981, T AM PHILOS SOC, V71, P3; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; NANAVUTTY P, 1997, PARSIS; Nasidze I, 2001, P ROY SOC B-BIOL SCI, V268, P1197, DOI 10.1098/rspb.2001.1610; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Renfrew C., 1996, ORIGINS SPREAD AGR P, P70; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Robertson GS, 1896, KAFIRS HINDU KUSH; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schneider S., 2000, ARLEQUIN VER 2 0 SOF; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Soodyall H, 1996, AM J HUM GENET, V58, P595; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; STONEKING M, 1990, GENETICS, V124, P717; SULTANA F, 1995, MARGINALITY MODERNIT, P28; TAJIMA F, 1989, GENETICS, V123, P585; Tambets K., 2000, ARCHAEOGENETICS DNA, P219; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P591; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zvelebil M., 1980, CAMBRIDGE ENCY ARCHA, P252	93	309	329	0	33	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					827	845		10.1086/383236	http://dx.doi.org/10.1086/383236			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077202	Green Published, Bronze			2022-12-18	WOS:000220926100005
J	Bailey, JA; Liu, G; Eichler, EE				Bailey, JA; Liu, G; Eichler, EE			An Alu transposition model for the origin and expansion of human segmental duplications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-GENOME; INTRACHROMOSOMAL RECOMBINATION; DNA-SEQUENCE; EVOLUTION; REPEATS; ORGANIZATION; MECHANISMS; REGION; GENES; ALIGNMENTS	Relative to genomes of other sequenced organisms, the human genome appears particularly enriched for large, highly homologous segmental duplications (greater than or equal to90% sequence identity and greater than or equal to10 kbp in length). The molecular basis for this enrichment is unknown. We sought to gain insight into the mechanism of origin, by systematically examining sequence features at the junctions of duplications. We analyzed 9,464 junctions within regions of high-quality finished sequence from a genomewide set of 2,366 duplication alignments. We observed a highly significant (P < .0001) enrichment of Alu short interspersed element (SINE) sequences near or within the junction. Twenty-seven percent of all segmental duplications terminated within an Alu repeat. The Alu junction enrichment was most pronounced for interspersed segmental duplications separated by >= 1 Mb of intervening sequence. Alu elements at the junctions showed higher levels of divergence, consistent with Alu-Alu-mediated recombination events. When we classified Alu elements into major subfamilies, younger elements (AluY and AluS) accounted for the enrichment, whereas the oldest primate family (AluJ) showed no enrichment. We propose that the primate-specific burst of Alu retroposition activity (which occurred 35-40 million years ago) sensitized the ancestral human genome for Alu-Alu-mediated recombination events, which, in turn, initiated the expansion of gene-rich segmental duplications and their subsequent role in nonallelic homologous recombination.	Case Western Reserve Univ, Sch Med, Dept Genet, Ctr Computat Genom, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Ctr Computat Genom, BRB720,10900 Euclid Ave, Cleveland, OH 44106 USA.	eee@cwru.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815, T32GM007250] Funding Source: NIH RePORTER; NCI NIH HHS [CA094816] Funding Source: Medline; NHGRI NIH HHS [R01 HG002318, HG002318] Funding Source: Medline; NICHD NIH HHS [HD07518-05, T32 HD007518] Funding Source: Medline; NIGMS NIH HHS [R01 GM058815, T32 GM007250, GM58815] Funding Source: Medline; PHS HHS [ER62862] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; CALABRETTA B, 1982, NATURE, V296, P219, DOI 10.1038/296219a0; Crosier M, 2002, GENOME RES, V12, P67, DOI 10.1101/gr.213702; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Guy J, 2000, HUM MOL GENET, V9, P2029, DOI 10.1093/hmg/9.13.2029; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; Kapitonov V, 1996, J MOL EVOL, V42, P59, DOI 10.1007/BF00163212; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; SHEN MR, 1991, J MOL EVOL, V33, P311; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; WALDMAN AS, 1987, P NATL ACAD SCI USA, V84, P5340, DOI 10.1073/pnas.84.15.5340; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	37	309	321	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					823	834		10.1086/378594	http://dx.doi.org/10.1086/378594			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14505274	Green Published, Bronze			2022-12-18	WOS:000185676100010
J	Man, PYW; Griffiths, PG; Brown, DT; Howell, N; Turnbull, DM; Chinnery, PF				Man, PYW; Griffiths, PG; Brown, DT; Howell, N; Turnbull, DM; Chinnery, PF			The epidemiology of Leber hereditary optic neuropathy in the North East of England	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; FRENCH-CANADIAN FAMILIES; MTDNA MUTATIONS; CLINICAL MANIFESTATIONS; PEDIGREE ANALYSIS; FOLLOW-UP; HETEROPLASMY; DISEASE; INHERITANCE; EXPRESSION	We performed the first population-based clinical and molecular genetic study of Leber hereditary optic neuropathy (LHON) in a population of 2,173,800 individuals in the North East of England. We identified 16 genealogically unrelated families who harbor one of the three primary mitochondrial DNA (mtDNA) mutations that cause LHON. Two of these families were found to be linked genetically to a common maternal founder. A de novo mtDNA mutation (G3460A) was identified in one family. The minimum point prevalence of visual failure due to LHON within this population was 3.22 per 100,000 (95% CI 2.47-3.97 per 100,000), and the minimum point prevalence for mtDNA LHON mutations was 11.82 per 100,000 (95% CI 10.38-13.27 per 100,000). These results indicate that LHON is not rare but has a population prevalence similar to autosomally inherited neurological disorders. The majority of individuals harbored only mutant mtDNA (homoplasmy), but heteroplasmy was detected in 12% of individuals. Overall, however, 33% of families with LHON had at least one heteroplasmic individual. The high incidence of heteroplasmy in pedigrees with LHON raises the possibility that a closely related maternal relative of an index case may not harbor the mtDNA mutation, highlighting the importance of molecular genetic testing for each maternal family member seeking advice about their risks of visual failure.	Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Ophthalmol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Mitokor, San Diego, CA USA	Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.			Chinnery, Patrick/0000-0002-7065-6617	Medical Research Council [G0701386, G1002570, MC_UP_1501/2] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altman DG, 1991, PRACTICAL STAT MED R; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Biousse V, 1997, NEUROLOGY, V49, P1136, DOI 10.1212/WNL.49.4.1136; Black GCM, 1996, BRIT J OPHTHALMOL, V80, P915, DOI 10.1136/bjo.80.10.915; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G; Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Fahy E, 1997, NUCLEIC ACIDS RES, V25, P3102, DOI 10.1093/nar/25.15.3102; HARDING AE, 1995, AM J HUM GENET, V57, P77; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; Howell N, 1999, INT REV CYTOL, V186, P49; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3; Leber T., 1871, GRAEFES ARCH OPHTHAL, V17, P249, DOI 10.1007/BF01694557; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Mackey DA, 1996, AM J HUM GENET, V59, P481; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417; Macmillan C, 2000, AM J HUM GENET, V66, P332, DOI 10.1086/302716; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Mashima Y, 1998, CURR EYE RES, V17, P403, DOI 10.1080/02713689808951221; Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006; MATHESON J, 2000, REGIONAL TRENDS, V35, P49; MORRISON PJ, 1995, J MED GENET, V32, P524, DOI 10.1136/jmg.32.7.524; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; SEEDORFF T, 1985, ACTA OPHTHALMOL, V63, P135; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	37	309	336	1	16	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					333	339		10.1086/346066	http://dx.doi.org/10.1086/346066			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12518276	Green Published, Bronze			2022-12-18	WOS:000180680000013
J	CASCORBI, I; DRAKOULIS, N; BROCKMOLLER, J; MAURER, A; SPERLING, K; ROOTS, I				CASCORBI, I; DRAKOULIS, N; BROCKMOLLER, J; MAURER, A; SPERLING, K; ROOTS, I			ARYLAMINE N-ACETYLTRANSFERASE (NAT2) MUTATIONS AND THEIR ALLELIC LINKAGE IN UNRELATED CAUCASIAN INDIVIDUALS - CORRELATION WITH PHENOTYPIC ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEBRISOQUINE HYDROXYLATION; ACETYLATION POLYMORPHISM; HUMAN LIVER; GENOTYPE; CAFFEINE; GENE; CARCINOGENS; POPULATION; EXPRESSION; CANCER	The polymorphic arylamine N-acetyltransferase (NAT2; EC 2.3.1.5) is supposed to be a susceptibility factor for several drug side effects and certain malignancies. A group of 844 unrelated German subjects was genotyped for their acetylation type, and 563 of them were also phenotyped. Seven mutations of the NAT2 gene were evaluated by allele-specific PCR (mutation 341C to T) and PCR-RFLP for mutations at nt positions 191, 282, 481, 590, 803, and 857. From the mutation pattern eight different alleles, including the wild type coding for rapid acetylation and seven alleles coding for slow phenotype, were determined. Four hundred ninety-seven subjects had a genotype of slow acetylation (58.9%; 95% confidence limits 55.5%-62.2%). Phenotypic acetylation capacity was expressed as the ratio of 5-acetylamino-6-formylamino-3-methyluracil and 1-methylxanthine in urine after caffeine intake. Some 6.7% of the cases deviated in genotype and phenotype, but sequencing DNA of these probands revealed no new mutations. Furthermore, linkage pattern of the mutations was always confirmed, as tested in 533 subjects. In vivo acetylation capacity of homozygous wild-type subjects (NAT2*4/*4) was significantly higher than in heterozygous genotypes (P = .001). All mutant alleles showed low in vivo acetylation capacities, including the previously not-yet-defined alleles *5A, *5C, and *13. Moreover, distinct slow genotypes differed significantly among each other, as reflected in lower acetylation capacity of *6A, *7B, and *13 alleles than the group of *5 alleles. The study demonstrated differential phenotypic activity of various NAT2 genes and gives a solid basis for clinical and molecular-epidemiological investigations.	HUMBOLDT UNIV BERLIN,CLIN CHARITE,INST KLIN PHARMAKOL,D-10098 BERLIN,GERMANY; HUMBOLDT UNIV BERLIN,UNIV CLIN VIRCHOW,INST HUMAN GENET,BERLIN,GERMANY	Humboldt University of Berlin; Humboldt University of Berlin			Cascorbi, Ingolf/A-4519-2009; Cascorbi, Ingolf/AAT-1927-2021	Cascorbi, Ingolf/0000-0002-2182-9534; Drakoulis, Nikolaos/0000-0002-7545-8089				AGUNDEZ JAG, 1994, CLIN PHARMACOL THER, V56, P202, DOI 10.1038/clpt.1994.124; BECHTEL YC, 1993, CLIN PHARMACOL THER, V54, P134, DOI 10.1038/clpt.1993.124; BELL DA, 1993, CARCINOGENESIS, V14, P1689, DOI 10.1093/carcin/14.8.1689; BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; CRIBB AE, 1994, PHARMACOGENETICS, V4, P166, DOI 10.1097/00008571-199406000-00009; DEGUCHI T, 1990, J BIOL CHEM, V265, P12757; DIXON WJ, 1992, BMDP STATISTICAL SOF; Evans D., 1992, Protein engineering: Proceedings of an AFRC conference on protein engineering in the agricultural and food industry, Selwyn College, Cambridge, 16-17 September 1991., P95; EVANS DAP, 1964, J LAB CLIN MED, V63, P394; FERGUSON RJ, 1994, DRUG METAB DISPOS, V22, P371; GRAF T, 1992, EUR J CLIN PHARMACOL, V43, P399, DOI 10.1007/BF02220616; GRANT DM, 1984, BRIT J CLIN PHARMACO, V17, P459, DOI 10.1111/j.1365-2125.1984.tb02372.x; GRANT DM, 1989, NUCLEIC ACIDS RES, V17, P3978, DOI 10.1093/nar/17.10.3978; HASHIGUCHI M, 1992, CLIN PHARMACOL THER, V52, P274, DOI 10.1038/clpt.1992.141; HAYES RB, 1993, CARCINOGENESIS, V14, P675, DOI 10.1093/carcin/14.4.675; HEIN DW, 1994, HUM MOL GENET, V3, P729; HEIN DW, 1993, CARCINOGENESIS, V14, P1633, DOI 10.1093/carcin/14.8.1633; HICKMAN D, 1994, BIOCHEM J, V297, P441, DOI 10.1042/bj2970441; HICKMAN D, 1991, BIOCHEM PHARMACOL, V42, P1007, DOI 10.1016/0006-2952(91)90282-A; LIN HJ, 1993, AM J HUM GENET, V52, P827; LIN HJ, 1994, PHARMACOGENETICS, V4, P125, DOI 10.1097/00008571-199406000-00003; MASHIMO M, 1992, HUM GENET, V90, P139; MROZIKIEWICZ PM, 1994, CLIN PHARMACOL THER, V56, P626, DOI 10.1038/clpt.1994.187; OHSAKO S, 1990, J BIOL CHEM, V265, P4630; RELLING MV, 1992, CLIN PHARMACOL THER, V52, P643, DOI 10.1038/clpt.1992.203; ROOTS I, 1988, KLIN WOCHENSCHR, V66, P87; Roots I, 1992, PHARMACOGENETICS DRU, P815; ROOTS I, 1989, XENOBIOTIC METABOLIS, P499; ROTHMAN N, 1993, PHARMACOGENETICS, V3, P250, DOI 10.1097/00008571-199310000-00004; Sambrook J., 1989, MOL CLONING LAB MANU; VATSIS KP, 1991, P NATL ACAD SCI USA, V88, P6333, DOI 10.1073/pnas.88.14.6333; VATSIS KP, 1995, PHARMACOGENETICS, V5, P1, DOI 10.1097/00008571-199502000-00001; WEBER WW, 1993, PHARMACOGENETICS, V3, P209, DOI 10.1097/00008571-199308000-00006	34	309	318	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					581	592						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668286				2022-12-18	WOS:A1995RR60500007
J	HOLMQUIST, GP				HOLMQUIST, GP			CHROMOSOME BANDS, THEIR CHROMATIN FLAVORS, AND THEIR FUNCTIONAL FEATURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							HIGH-RESOLUTION; HUMAN GENOME; DNA-REPLICATION; FRAGILE SITES; MULTIGENE FAMILIES; MITOTIC CHIASMATA; MISMATCH REPAIR; MAMMALIAN-CELLS; MOLECULAR DRIVE; 1250-BAND LEVEL	To show that the input pattern of chromosomal mutations is highly organized relative to the band patterns along human chromosomes, a new term, "metaphase chromatin flavor," is introduced. Five different flavors of euchromatic metaphase bands are cytologically identified along a human ideogram. These are G-bands and, based upon combinations of extreme Alu richness and GC richness, four different R-band flavors. The two flavors with extremely GC-rich components, traditionally called "T-bands," represent only 15% of all bands. However, they contain 65% of mapped genes, 19 of 25 mapped oncogenes, most cancer-associated rearrangements, evolutionary rearrangements, meiotic chiasmata, and X-ray-induced breaks. Flavors with extremely Alu-rich flavors are also involved in melphalan-induced rearrangements, pachytene stretching, and mitotic chiasmata. Frequencies of CpG islands, CCGCCC boxes, retroposon families, and genes are characteristic to each chromatin flavor and will facilitate alignment of genome sequences onto ideograms of chromatin flavor. The influence of chromatin flavor on the evolution of a gene's sequence is so strong that one can infer the flavor of the band in which a gene resides from the sequence of the gene itself. Correlation coefficients for many pairs of mapped genetic variables, while globally high, are quite low within bands of one flavor, implicating a concerted mode of evolution for bands of one chromatin flavor.			HOLMQUIST, GP (corresponding author), CITY HOPE NATL MED CTR, DEPT BIOL, DUARTE, CA 91010 USA.							AMBROS PF, 1987, CYTOGENET CELL GENET, V44, P223, DOI 10.1159/000132375; [Anonymous], 1979, PLANT STRATEGIES VEG; ASHLEY T, 1990, GENETICA, V83, P1; BARRIOS L, 1989, CANCER GENET CYTOGEN, V41, P61, DOI 10.1016/0165-4608(89)90108-8; BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BICKMORE WA, 1989, TRENDS GENET, V5, P144, DOI 10.1016/0168-9525(89)90055-3; BOBROW M, 1973, CYTOGENET CELL GENET, V12, P145, DOI 10.1159/000130450; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; BUCKTON KE, 1976, INT J RADIAT BIOL, V29, P475, DOI 10.1080/09553007614550571; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CUNY G, 1981, EUR J BIOCHEM, V115, P227, DOI 10.1111/j.1432-1033.1981.tb05227.x; DEMARINI DM, 1989, MUTAT RES, V220, P11, DOI 10.1016/0165-1110(89)90006-7; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; DROUIN R, 1985, CAN J GENET CYTOL, V27, P83, DOI 10.1139/g85-014; DROUIN R, 1991, HEREDITAS, V114, P65, DOI 10.1111/j.1601-5223.1991.tb00554.x; DROUIN R, 1988, CYTOBIOS, V56, P107; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; DROUIN R, 1989, GENOME, V32, P425, DOI 10.1139/g89-466; DROUIN R, 1991, CYTOGENET CELL GENET, V57, P91, DOI 10.1159/000133121; DUBOS C, 1978, MUTAT RES, V49, P127, DOI 10.1016/0027-5107(78)90084-2; DUTRILLAUX B, 1974, EXP CELL RES, V85, P143, DOI 10.1016/0014-4827(74)90224-9; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; DUTRILLAUX B, 1977, HUM GENET, V37, P65, DOI 10.1007/BF00293773; DUTRILLAUX B, 1976, CHROMOSOMA, V58, P51, DOI 10.1007/BF00293440; DUTRILLAUX B, 1973, CHROMOSOMA, V41, P395, DOI 10.1007/BF00396497; DUTRILLAUX B, 1977, MOL STRUCTURE HUMAN, P233; FANG JS, 1988, CYTOGENET CELL GENET, V47, P52, DOI 10.1159/000132505; FILIPSKI J, 1988, J THEOR BIOL, V134, P159, DOI 10.1016/S0022-5193(88)80199-1; FILIPSKI J, 1989, ADV MUTAGENESIS RES, P1; GARDINER K, 1990, EMBO J, V9, P1853, DOI 10.1002/j.1460-2075.1990.tb08310.x; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; HANAWALT PC, 1990, BIOTECHNOL HUM GENET, V3, P135; HEIM S, 1987, HUM GENET, V75, P70; HOLMBERG M, 1973, HEREDITAS, V74, P57; HOLMQUIST GP, 1986, BIOCHIM BIOPHYS ACTA, V868, P164, DOI 10.1016/0167-4781(86)90019-9; HOLMQUIST GP, 1989, J MOL EVOL, V28, P469, DOI 10.1007/BF02602928; HOLMQUIST GP, 1989, CHROMOSOMES TODAY, P21; HOLMQUIST GP, 1988, CHROMOSOMES CHROMATI, P76; HOLMQUIST GP, 1990, ADV MUTAGENESIS RES, P95; IKEMURA T, 1990, GENOMICS, V8, P207, DOI 10.1016/0888-7543(90)90273-W; IKEMURA T, 1991, NUCLEIC ACIDS RES, V19, P4333, DOI 10.1093/nar/19.16.4333; IKEMURA T, 1988, J MOL BIOL, V203, P1, DOI 10.1016/0022-2836(88)90086-1; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KOOTSTRA A, 1989, MOL CARCINOGEN, V1, P239, DOI 10.1002/mc.2940010406; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KORENBERG JR, 1978, P NATL ACAD SCI USA, V75, P3382, DOI 10.1073/pnas.75.7.3382; KUHN EM, 1976, CHROMOSOMA, V57, P1, DOI 10.1007/BF00292945; KUHN EM, 1985, HUM GENET, V70, P1, DOI 10.1007/BF00389448; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LEMIEUX N, 1990, HUM GENET, V85, P261; LIMADEFARIA A, 1976, HEREDITAS, V83, P175; LIMADEFARIA A, 1975, HEREDITAS, V81, P249; LUCIANI JM, 1988, CHROMOSOMA, V97, P19, DOI 10.1007/BF00331791; MACAYA G, 1976, J MOL BIOL, V108, P237, DOI 10.1016/S0022-2836(76)80105-2; MAMURIS Z, 1989, CANCER GENET CYTOGEN, V37, P65, DOI 10.1016/0165-4608(89)90076-9; MANUELIDIS L, 1984, CHROMOSOMA, V91, P28, DOI 10.1007/BF00286482; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; MIRO R, 1987, HUM GENET, V75, P345, DOI 10.1007/BF00284105; MOUCHIROUD D, 1988, J MOL EVOL, V27, P311, DOI 10.1007/BF02101193; NAKAYASU H, 1991, J CELL BIOL, V1008, P1; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; OHNO S, 1972, MODERN ASPECTS CYTOG, P169; OHTA T, 1983, P NATL ACAD SCI-BIOL, V80, P4079, DOI 10.1073/pnas.80.13.4079; OHTA T, 1990, POPULATION BIOL GENE, P169; OKADA TA, 1974, CHROMOSOMA, V48, P65, DOI 10.1007/BF00284867; OLIVERO OA, 1990, MOL CARCINOGEN, V3, P37, DOI 10.1002/mc.2940030109; PERRIN P, 1987, J MOL EVOL, V26, P301, DOI 10.1007/BF02101148; PFEIFER GP, 1991, P NATL ACAD SCI USA, V88, P1374, DOI 10.1073/pnas.88.4.1374; PORFIRIO B, 1989, MUTAT RES, V213, P117, DOI 10.1016/0027-5107(89)90142-5; RADMAN M, 1988, GENETIC RECOMBINATIO, P169; SAVAGE JRK, 1977, NATURE, V270, P513, DOI 10.1038/270513a0; SCHAAPER RM, 1989, EMBO J, V8, P3511, DOI 10.1002/j.1460-2075.1989.tb08516.x; SCHWEIZER D, 1981, HUM GENET, V57, P1; Schweizer D, 1987, CHROMOSOMES TODAY, V9, P61, DOI [10.1007/978-94-010-9166-4_7, DOI 10.1007/978-94-010-9166-4_7]; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Sumner A. T, 1990, CHROMOSOME BANDING; SUTHERLAND GR, 1989, CYTOGENET CELL GENET, V51, P452, DOI 10.1159/000132804; THREADGILL DS, 1991, P NATL ACAD SCI USA, V88, P154, DOI 10.1073/pnas.88.1.154; TRENT JM, 1989, CYTOGENET CELL GENET, V51, P533, DOI 10.1159/000132807; VANZEELAND AA, 1990, PROG CLIN BIOL RES, V340, P249; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VONKIEL K, 1985, CHROMOSOMA, V93, P69, DOI 10.1007/BF01259448; WIENBERG J, 1990, GENOMICS, V8, P347, DOI 10.1016/0888-7543(90)90292-3; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; YUNIS JJ, 1981, HUM GENET, V56, P293, DOI 10.1007/BF00274682; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; ZERIAL M, 1986, EUR J BIOCHEM, V160, P479, DOI 10.1111/j.1432-1033.1986.tb10064.x; ZUCKERKANDL E, 1986, J MOL EVOL, V24, P12, DOI 10.1007/BF02099947; 1972, BIRTH DEFECTS, V8	98	309	312	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					17	37						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609794				2022-12-18	WOS:A1992JA46700004
J	Holmans, P; Green, EK; Pahwa, JS; Ferreira, MAR; Purcell, SM; Sklar, P; Owen, MJ; O'Donovan, MC; Craddock, N				Holmans, Peter; Green, Elaine K.; Pahwa, Jaspreet Singh; Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela; Owen, Michael J.; O'Donovan, Michael C.; Craddock, Nick		Wellcome Trust Case Control Consor	Gene Ontology Analysis of GWA Study Data Sets Provides Insights into the Biology of Bipolar Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; LINKS; PRIORITIZATION; SCHIZOPHRENIA; VARIANTS; PROTEIN; RISK; LOCI; AXIS	We present a method for testing overrepresentation of biological pathways, indexed by gene-ontology terms, in lists of significant SNPs from genome-wide association studies. This method corrects for linkage disequilibrium between SNPs, variable gene size, and multiple testing of nonindependent pathways. The method was applied to the Wellcome Trust Case-Control Consortium Crohn disease (CD) data set. At a general level, the biological basis of CD is relatively well known for a complex genetic trait, and it thus acted as a test of the method. The method, known as ALIGATOR (Association LIst Go AnnoTatOR), successfully detected biological pathways implicated in CD. The method was also applied to a meta-analysis of bipolar disorder, and it implicated the modulation of transcription and cellular activity, including that which occurs via hormonal action, as an important player in pathogenesis.	[Holmans, Peter; Green, Elaine K.; Pahwa, Jaspreet Singh; Owen, Michael J.; O'Donovan, Michael C.; Craddock, Nick] Sch Med, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF23 6BQ, S Glam, Wales; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Ferreira, Manuel A. R.] Genet Epidemiol Queensland Inst Med Res, Brisbane, Qld 4029, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; QIMR Berghofer Medical Research Institute	Holmans, P (corresponding author), Sch Med, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF23 6BQ, S Glam, Wales.	holmanspa@cardiff.ac.uk	Holmans, Peter/F-4518-2015; O'Donovan, Michael C/P-7005-2018; Ferreira, Manuel A R/D-3609-2013	Holmans, Peter/0000-0003-0870-9412; O'Donovan, Michael C/0000-0001-7073-2379; Ferreira, Manuel A R/0000-0001-9059-1825	MRC [G0801418] Funding Source: UKRI; Medical Research Council [G0801418] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Alterovitz G, 2007, NUCLEIC ACIDS RES, V35, pD322, DOI 10.1093/nar/gkl799; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Cariappa A, 1998, GUT, V43, P210, DOI 10.1136/gut.43.2.210; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; Craddock N, 2009, SCHIZOPHRENIA BULL, V35, P482, DOI 10.1093/schbul/sbp020; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Forcione DG, 1996, P NATL ACAD SCI USA, V93, P5094, DOI 10.1073/pnas.93.10.5094; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; GOODWIN J, 2007, MANIC DEPRESSIVE ILL; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; HAMSHERE ML, 2009, BR J PSYCHI IN PRESS; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hendrick V, 1998, PSYCHIAT CLIN N AM, V21, P277, DOI 10.1016/S0193-953X(05)70005-8; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lazarus JH, 1998, THYROID, V8, P909, DOI 10.1089/thy.1998.8.909; Lee Vivian, 2005, In Silico Biology, V5, P5; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Sakiyarna T, 2008, INFLAMM BOWEL DIS, V14, P310, DOI 10.1002/ibd.20328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Young EA, 2002, ENDOCRIN METAB CLIN, V31, P63, DOI 10.1016/S0889-8529(01)00002-0; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	308	315	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					13	24		10.1016/j.ajhg.2009.05.011	http://dx.doi.org/10.1016/j.ajhg.2009.05.011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19539887	Bronze, Green Published			2022-12-18	WOS:000267997600004
J	Woods, CG; Bond, J; Enard, W				Woods, CG; Bond, J; Enard, W			Autosomal recessive primary microcephaly (MCPH): A review of clinical, molecular, and evolutionary findings	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CEREBRAL CORTICAL SIZE; ABNORMAL SPINDLE PROTEIN; HUMAN BRAIN SIZE; MITOTIC SPINDLE; CELL-DIVISION; MENTAL-RETARDATION; MAJOR DETERMINANT; CHROMOSOME CONDENSATION; HEAD CIRCUMFERENCE; ASPM GENE	Autosomal recessive primary microcephaly (MCPH) is a neurodevelopmental disorder. It is characterized by two principal features, microcephaly present at birth and nonprogressive mental retardation. The microcephaly is the consequence of a small but architecturally normal brain, and it is the cerebral cortex that shows the greatest size reduction. There are at least seven MCPH loci, and four of the genes have been identified: MCPH1, encoding Microcephalin; MCPH3, encoding CDK5RAP2; MCPH5, encoding ASPM; and MCPH6, encoding CENPJ. These findings are starting to have an impact on the clinical management of families affected with MCPH. Present data suggest that MCPH is the consequence of deficient neurogenesis within the neurogenic epithelium. Evolutionary interest in MCPH has been sparked by the suggestion that changes in the MCPH genes might also be responsible for the increase in brain size during human evolution. Indeed, evolutionary analyses of Microcephalin and ASPM reveal evidence for positive selection during human and great ape evolution. So an understanding of this rare genetic disorder may offer us significant insights into neurogenic mitosis and the evolution of the most striking differences between us and our closest living relatives: brain size and cognitive ability.	Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; Univ Leeds, Mol Med Unit, Leeds, W Yorkshire, England; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	University of Cambridge; University of Leeds; Max Planck Society	Woods, CG (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 2XY, England.	cw347@cam.ac.uk	Enard, Wolfgang/K-3483-2014; woods, christopher g/A-1361-2010					Aicardi J, 1998, DIS NERVOUS SYSTEM C, P90; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; ARMSTRONG E, 1985, AM J PHYS ANTHROPOL, V66, P263, DOI 10.1002/ajpa.1330660303; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; BABSON SG, 1976, J PEDIATR-US, V89, P814, DOI 10.1016/S0022-3476(76)80815-3; Baraitser B, 1990, GENETICS NEUROLOGICA, V18, P26; Barkovich AJ, 2001, CURR OPIN NEUROL, V14, P145, DOI 10.1097/00019052-200104000-00002; Book JA, 1953, AM J MENT DEF, V57, P637; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; BRAND S, 1979, NEUROSCIENCE, V4, P767, DOI 10.1016/0306-4522(79)90005-8; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; BUNDEY S, 1997, EMERY RIMOINS PRINCI, P730; Bundey Sarah, 1993, European Journal of Human Genetics, V1, P206; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; COWIE V, 1960, J MENT DEFIC RES, V4, P42; Craig R, 1998, J CELL SCI, V111, P3609; Dobyns WB, 2002, AM J MED GENET, V112, P315, DOI 10.1002/ajmg.10580; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; FREIRE-MAIA N, 1990, Revista Brasileira de Biologia, V50, P863; GONZALEZ C, 1990, J CELL SCI, V96, P605; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; GROSS SJ, 1983, PEDIATRICS, V71, P70; HARVEY PH, 1990, SCIENCE, V249, P140, DOI 10.1126/science.2196673; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jerison HJ., 1973, EVOLUTION BRAIN INTE, V1; KLOEPFER H. WARNER, 1964, J GENET HUMAINE, V13, P52; KOMAI T, 1955, AM J HUM GENET, V7, P51; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Kumar A, 2004, CLIN GENET, V66, P341, DOI 10.1111/j.1399-0004.2004.00304.x; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Marino L, 1998, BRAIN BEHAV EVOLUT, V51, P230, DOI 10.1159/000006540; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MCHENRY HM, 1994, P NATL ACAD SCI USA, V91, P6780, DOI 10.1073/pnas.91.15.6780; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; MUELLER RF, 1993, J MED GENET, V30, P798, DOI 10.1136/jmg.30.9.798; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; NELLHAUS G, 1968, PEDIATRICS, V41, P106; OPITZ JM, 1992, J CRANIOFAC GENET DE, V10, P175; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Pichon B, 2004, EUR J HUM GENET, V12, P419, DOI 10.1038/sj.ejhg.5201169; PREUSS TM, 2004, COGNITIVE NEUROSCIEN, V3; Przeworski M, 2002, GENETICS, V160, P1179; QAZI QH, 1975, CLIN GENET, V7, P85; QAZI QH, 1973, CLIN GENET, V4, P46; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Riparbelli MG, 2002, J CELL SCI, V115, P913; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; ROCHE AF, 1987, PEDIATRICS, V79, P706; Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948; ROSS JJ, 1977, CONGENTIAL MALFORM 1, V30, P507; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; SELLS CJ, 1977, PEDIATRICS, V59, P262; SHEN J, 2005, IN PRESS J MED GENET; SHER PK, 1975, DEV MED CHILD NEUROL, V17, P705; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stephan H., 1988, P1; SUJATHA M, 1989, HUM GENET, V81, P388, DOI 10.1007/BF00283699; TEEBI AS, 1987, AM J MED GENET, V26, P355, DOI 10.1002/ajmg.1320260214; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; TOLMIE JL, 1987, AM J MED GENET, V27, P583, DOI 10.1002/ajmg.1320270311; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Tuncbilek E, 2001, TURKISH J PEDIATR, V43, P277; VANDENBOSCH J, 1958, ANN HUM GENET, V23, P91; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Walls GL, 1939, J MORPHOL, V64, P67, DOI 10.1002/jmor.1050640106; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; WARKANY J, 1981, MENTAL RETARDATION C, P13; WINTER R, 1998, WBDB WINTER BARAITSE; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang JZ, 2003, GENETICS, V165, P2063	101	308	320	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					717	728		10.1086/429930	http://dx.doi.org/10.1086/429930			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15806441	Bronze, Green Published			2022-12-18	WOS:000228198300001
J	HARLEY, HG; RUNDLE, SA; MACMILLAN, JC; MYRING, J; BROOK, JD; CROW, S; REARDON, W; FENTON, I; SHAW, DJ; HARPER, PS				HARLEY, HG; RUNDLE, SA; MACMILLAN, JC; MYRING, J; BROOK, JD; CROW, S; REARDON, W; FENTON, I; SHAW, DJ; HARPER, PS			SIZE OF THE UNSTABLE CTG REPEAT SEQUENCE IN RELATION TO PHENOTYPE AND PARENTAL TRANSMISSION IN MYOTONIC-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA	A clinical and molecular analysis of 439 individuals affected with myotonic dystrophy, from 101 kindreds, has shown that the size of the unstable CTG repeat detected in nearly all cases of myotonic dystrophy is related both to age at onset of the disorder and to the severity of the phenotype. The largest repeat sizes (1.5-6.0 kb) are seen in patients with congenital myotonic dystrophy, while the minimally affected patients have repeat sizes of <0.5 kb. Comparison of parent-child pairs has shown that most offspring have an earlier age at onset and a larger repeat size than their parents, with only 4 of 182 showing a definite decrease in repeat size, accompanied by a later age at onset or less severe phenotype. Increase in repeat size from parent to child is similar for both paternal and maternal transmissions when the increase is expressed as a proportion of the parental repeat size. Analysis of congenitally affected cases shows not only that they have, on average, the largest repeat sizes but also that their mothers have larger mean repeat sizes, supporting previous suggestions that a maternal effect is involved in the pathogenesis of this form of the disorder.			HARLEY, HG (corresponding author), UNIV WALES COLL MED,INST MED GENET,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.		MacMillan, John C/C-9591-2011	Brook, John David/0000-0002-5946-6740	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BELL J, 1947, TREASURY HUMAN INHER, V4, P343; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1991, BRAIN, V114, P2303, DOI 10.1093/brain/114.5.2303; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KOCH MC, 1991, AM J HUM GENET, V48, P1084; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PENROSE LS, 1948, ANN EUGENIC, V14, P125; REARDON W, 1992, J MED GENET, V29, P770, DOI 10.1136/jmg.29.11.770; REARDON W, 1992, AM J MED GENET, V43, P1006, DOI 10.1002/ajmg.1320430618; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	23	308	313	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1164	1174						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503448				2022-12-18	WOS:A1993LG13300018
J	Sevenet, N; Sheridan, E; Amram, D; Schneider, P; Handgretinger, R; Delattre, O				Sevenet, N; Sheridan, E; Amram, D; Schneider, P; Handgretinger, R; Delattre, O			Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTRAL-NERVOUS-SYSTEM; MALIGNANT RHABDOID TUMOR; LI-FRAUMENI-SYNDROME; MOLECULAR ANALYSIS; GERMLINE MUTATIONS; PARENTAL ORIGIN; INFANCY; MEDULLOBLASTOMA; CHILDHOOD; RETINOBLASTOMA	Biallelic, truncating mutations of the hSNF5/INI1 gene have recently been documented in malignant rhabdoid tumor (MRT), one of the most aggressive human cancers. This finding suggests that hSNF5/INI1 is a new tumor-suppressor gene for which germline mutations might predispose to cancer. We now report the presence of loss-of-function mutations of this gene in the constitutional DNA from affected members but not from healthy relatives in cancer-prone families. Furthermore, a constitutional mutation is documented in a patient with two successive primary cancers. In agreement with the two-hit model, the wild-type hSNF5/INI1 allele is deleted in the tumor DNA from mutation carriers. In all tested cases, DNA from parents demonstrated normal hSNF5/INI1 sequences, therefore indicating the de novo occurrence of the mutation, which was shown to involve the maternal allele in one case and the paternal allele in two other cases. These data indicate that constitutional mutation of the hSNF5/INI1 gene defines a new hereditary syndrome predisposing to renal or extrarenal MRT and to a variety of tumors of the CNS, including choroid plexus carcinoma, medulloblastoma, and central primitive neuroectodermal tumor. This condition, which we propose to term "rhabdoid predisposition syndrome," may account for previous observations of familial and multifocal cases of the aforementioned tumor types. It could also provide the molecular basis for cases of Li-Fraumeni syndrome without p53 germline mutations.	Inst Curie, INSERM, Lab Pathol Mol Canc, U509, F-75248 Paris 05, France; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Hop Caremeau, Nimes, France; Hop Charles Nicolle, Rouen, France; Univ Tubingen, Kinderklin, D-7400 Tubingen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Saint James's University Hospital; Universite de Montpellier; CHU de Nimes; CHU de Rouen; Eberhard Karls University of Tubingen	Delattre, O (corresponding author), Inst Curie, INSERM, Lab Pathol Mol Canc, U509, 26 Rue Ulm, F-75248 Paris 05, France.	delattre@curie.fr		delattre, olivier/0000-0002-8730-2276				BECKWITH JB, 1978, CANCER-AM CANCER SOC, V41, P1937, DOI 10.1002/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U; BIEGEL JA, 1992, GENE CHROMOSOME CANC, V5, P104, DOI 10.1002/gcc.2870050203; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Biegel JA, 1999, CANCER RES, V59, P74; BONNIN JM, 1984, CANCER-AM CANCER SOC, V54, P2137, DOI 10.1002/1097-0142(19841115)54:10<2137::AID-CNCR2820541014>3.0.CO;2-D; Burger PC, 1998, AM J SURG PATHOL, V22, P1083, DOI 10.1097/00000478-199809000-00007; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Chidambaram B, 1998, CHILD NERV SYST, V14, P421, DOI 10.1007/s003810050254; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOUGLASS EC, 1990, GENE CHROMOSOME CANC, V2, P210, DOI 10.1002/gcc.2870020308; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; FORT DW, 1994, GENE CHROMOSOME CANC, V11, P146, DOI 10.1002/gcc.2870110303; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kleihues P, 1997, AM J PATHOL, V150, P1; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; LYNCH HT, 1983, CANCER-AM CANCER SOC, V52, P290, DOI 10.1002/1097-0142(19830715)52:2<290::AID-CNCR2820520216>3.0.CO;2-L; Matsumura Hirotaka, 1997, Neurologia Medico-Chirurgica, V37, P916, DOI 10.2176/nmc.37.916; Moschovi M, 1998, PEDIATR HEMAT ONCOL, V15, P421, DOI 10.3109/08880019809016570; MUCHARDT C, 1995, NUCLEIC ACIDS RES, V23, P1127, DOI 10.1093/nar/23.7.1127; Parellada JA, 1998, EUR J RADIOL, V28, P219, DOI 10.1016/S0720-048X(98)00123-5; PARHAM DM, 1994, AM J SURG PATHOL, V18, P1010, DOI 10.1097/00000478-199410000-00005; Raila FA, 1998, SOUTH MED J, V91, P1159, DOI 10.1097/00007611-199812000-00013; RICHARDS FM, 1995, HUM MOL GENET, V4, P2139, DOI 10.1093/hmg/4.11.2139; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; Rosty C, 1998, GENE CHROMOSOME CANC, V21, P82, DOI 10.1002/(SICI)1098-2264(199802)21:2<82::AID-GCC2>3.0.CO;2-3; Schofield DE, 1996, GENE CHROMOSOME CANC, V15, P10, DOI 10.1002/(SICI)1098-2264(199601)15:1<10::AID-GCC2>3.3.CO;2-1; Schuffenecker I, 1997, AM J HUM GENET, V60, P233; SEVENET N, IN PRESS HUM MOL GEN; Tijssen C C, 1991, Surg Neurol, V36, P234, DOI 10.1016/0090-3019(91)90120-X; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wade PA, 1999, CURR BIOL, V9, pR221, DOI 10.1016/S0960-9822(99)80134-1; White FV, 1999, AM J SURG PATHOL, V23, P249, DOI 10.1097/00000478-199903000-00001; WICK MR, 1995, SEMIN DIAGN PATHOL, V12, P233; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	38	307	312	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1342	1348		10.1086/302639	http://dx.doi.org/10.1086/302639			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521299	Green Published, Bronze			2022-12-18	WOS:000083531000015
J	Roelfsema, JH; White, SJ; Ariyurek, Y; Bartholdi, D; Niedrist, D; Papadia, F; Bacino, CA; den Dunnen, JT; van Ommen, GJB; Breuning, MH; Hennekam, RC; Peters, DJM				Roelfsema, JH; White, SJ; Ariyurek, Y; Bartholdi, D; Niedrist, D; Papadia, F; Bacino, CA; den Dunnen, JT; van Ommen, GJB; Breuning, MH; Hennekam, RC; Peters, DJM			Genetic heterogeneity in Rubinstein-Taybi syndrome: Mutations in both the CBP and EP300 genes cause disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTIONAL COACTIVATOR CBP; HISTONE ACETYLTRANSFERASE ACTIVITY; DEPENDENT PROBE AMPLIFICATION; MOLECULAR ANALYSIS; P300; BINDING; DIFFERENTIATION; ACETYLATION; 16P13.3; LACKING	CREB-binding protein and p300 function as transcriptional coactivators in the regulation of gene expression through various signal-transduction pathways. Both are potent histone acetyl transferases. A certain level of CREB-binding protein is essential for normal development, since inactivation of one allele causes Rubinstein-Taybi syndrome (RSTS). There is a direct link between loss of acetyl transferase activity and RSTS, which indicates that the disorder is caused by aberrant chromatin regulation. We screened the entire CREB-binding protein gene (CBP) for mutations in patients with RSTS by using methods that find point mutations and larger rearrangements. In 92 patients, we were able to identify a total of 36 mutations in CBP. By using multiple ligation-dependent probe amplification, we found not only several deletions but also the first reported intragenic duplication in a patient with RSTS. We extended the search for mutations to the EP300 gene and showed that mutations in EP300 also cause this disorder. These are the first mutations identified in EP300 for a congenital disorder.	Leiden Univ, Med Ctr, Sylvius Lab, Ctr Human & Clin Genet, NL-2333 AL Leiden, Netherlands; Univ Zurich, Inst Med Genet, Zurich, Switzerland; Pediat Hosp Giovanni XXIII, Dept Metab Dis & Clin Genet, Bari, Italy; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich; Baylor College of Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Peters, DJM (corresponding author), Leiden Univ, Med Ctr, Sylvius Lab, Ctr Human & Clin Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	d.j.m.peters@lumc.nl	Breuning, Martijn H/E-3429-2010; Peters, Dorien/AFH-8507-2022; dunnen, johan den/ABH-4228-2020	Peters, Dorien/0000-0001-6974-7143; dunnen, johan den/0000-0002-6304-1710				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bartsch O, 1999, EUR J HUM GENET, V7, P748, DOI 10.1038/sj.ejhg.5200378; Bartsch O, 2002, J MED GENET, V39, P496, DOI 10.1136/jmg.39.7.496; Blough RI, 2000, AM J MED GENET, V90, P29, DOI 10.1002/(SICI)1096-8628(20000103)90:1<29::AID-AJMG6>3.0.CO;2-Z; Coupry I, 2002, J MED GENET, V39, P415, DOI 10.1136/jmg.39.6.415; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Giles RH, 1997, GENOMICS, V42, P96, DOI 10.1006/geno.1997.4699; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Kalkhoven E, 2003, HUM MOL GENET, V12, P441, DOI 10.1093/hmg/ddg039; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; Partanen M, 1999, INT J DEV BIOL, V43, P487; Petrij F, 2000, J MED GENET, V37, P168, DOI 10.1136/jmg.37.3.168; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Ugai H, 1999, J MOL MED, V77, P481, DOI 10.1007/s001099900021; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Winter J, 2003, HUM GENET, V112, P249, DOI 10.1007/s00439-002-0901-5; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	28	305	318	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					572	580		10.1086/429130	http://dx.doi.org/10.1086/429130			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15706485	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000227516000004
J	Zhivotovsky, LA; Underhill, PA; Cinnioglu, C; Kayser, M; Morar, B; Kivisild, T; Scozzari, R; Cruciani, F; Destro-Bisol, G; Spedini, G; Chambers, GK; Herrera, RJ; Yong, KK; Gresham, D; Tournev, I; Feldman, MW; Kalaydjieva, L				Zhivotovsky, LA; Underhill, PA; Cinnioglu, C; Kayser, M; Morar, B; Kivisild, T; Scozzari, R; Cruciani, F; Destro-Bisol, G; Spedini, G; Chambers, GK; Herrera, RJ; Yong, KK; Gresham, D; Tournev, I; Feldman, MW; Kalaydjieva, L			The effective mutation rate at Y chromosome short tandem repeats, with application to human population-divergence time	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-ROOTING PEDIGREES; MICROSATELLITE LOCI; GENETIC DISTANCES; HAPLOTYPES; HISTORY; ORIGINS; DIVERSITY; RESOLUTION; MARKERS; FREQUENCIES	We estimate an effective mutation rate at an average Y chromosome short-tandem repeat locus as 6.9 x 10(-4) per 25 years, with a standard deviation across loci of 5.7 x 10(-4), using data on microsatellite variation within chromosome haplogroups defined by unique-event polymorphisms in populations with documented short-term histories, as well as comparative data on worldwide populations at both the Y chromosome and various autosomal loci. This value is used to estimate the times of the African Bantu expansion, the divergence of Polynesian populations (the Maoris, Cook Islanders, and Samoans), and the origin of Gypsy populations from Bulgaria.	Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; Univ Western Australia, Western Australian Inst Med Res, Perth, WA, Australia; Estonian Bioctr, Tartu, Estonia; Univ Roma La Sapienza, Dept Genet & Mol Biol, Rome, Italy; Univ Roma La Sapienza, Dept Human & Anim Biol, Sect Anthropol, Rome, Italy; Victoria Univ Wellington, Sch Biol Sci, Inst Mol Systemat, Wellington, New Zealand; Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Fdn Hlth Problems Ethn Minorities, Sofia, Bulgaria	Russian Academy of Sciences; Vavilov Institute of General Genetics; Stanford University; Stanford University; Max Planck Society; University of Western Australia; University of Western Australia; Estonian Biocentre; Sapienza University Rome; Sapienza University Rome; Victoria University Wellington; State University System of Florida; Florida International University; Medical University Sofia	Zhivotovsky, LA (corresponding author), Inst Gen Genet, 3 Gubkin St, Moscow 119991, Russia.		Zhivotovsky, Lev A/A-1351-2012; Morar, Bharti/O-8697-2014; Cruciani, Fulvio/G-6105-2012; Kivisild, Toomas/P-5889-2017	Morar, Bharti/0000-0003-3897-1403; Kivisild, Toomas/0000-0002-6297-7808; Cruciani, Fulvio/0000-0002-6900-024X; Chambers, Geoffrey/0000-0003-1019-6855; Destro Bisol, Giovanni/0000-0002-4232-9715	FIC NIH HHS [R03 TW005540] Funding Source: Medline; NIGMS NIH HHS [P01 GM028428, GM28428, GM28016, R01 GM107466, R01 GM028016] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW005540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428, R01GM028016] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bosch E, 2002, FORENSIC SCI INT, V125, P42, DOI 10.1016/S0379-0738(01)00627-2; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Di Rienzo A, 1998, GENETICS, V148, P1269; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Fraser A., 1992, GYPSIES; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hancock I, 2000, SCHOLARSHIP GYPSY ST; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Holtkemper U, 2001, HUM MOL GENET, V10, P629, DOI 10.1093/hmg/10.6.629; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Irwin G., 1992, PREHISTORIC EXPLORAT; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; MARUSHIAKOVA E, 1997, STUDIUM TSIGANOLOGIE, V18; MCFADGEN BG, 1994, RADIOCARBON, V36, P221, DOI 10.1017/S0033822200040510; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; Nebel A, 2001, EUR J HUM GENET, V9, P22, DOI 10.1038/sj.ejhg.5200577; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SLATKIN M, 1995, GENETICS, V139, P457; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; SUTTON DG, 1994, ORIGINS 1 NZ, P243; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; VANSINA J, 1984, J AFR HIST, V25, P129, DOI 10.1017/S0021853700022829; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZHIVOTOVSKY LA, 1995, P NATL ACAD SCI USA, V92, P11549, DOI 10.1073/pnas.92.25.11549; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P2141, DOI 10.1093/oxfordjournals.molbev.a003759; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	59	305	320	0	22	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					50	61		10.1086/380911	http://dx.doi.org/10.1086/380911			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14691732	Green Published, Bronze			2022-12-18	WOS:000187723500005
J	Villavicencio, EH; Walterhouse, DO; Iannaccone, PM				Villavicencio, EH; Walterhouse, DO; Iannaccone, PM			The Sonic hedgehog-Patched-Gli pathway in human development and disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							BASAL-CELL CARCINOMA; SAETHRE-CHOTZEN-SYNDROME; RUBINSTEIN-TAYBI SYNDROME; PALLISTER-HALL SYNDROME; KINESIN-RELATED PROTEIN; IN-SITU HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; LEMLI-OPITZ-SYNDROME; ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR		Northwestern Univ, Sch Med, Dept Pediat, Chicago, IL 60614 USA; Childrens Mem Inst Educ & Res, Chicago, IL USA	Northwestern University	Iannaccone, PM (corresponding author), Northwestern Univ, Sch Med, Dept Pediat, 2300 Childrens Plaza 204, Chicago, IL 60614 USA.	pmi@nwu.edu						Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; ARHEDEN K, 1989, HUM GENET, V82, P1, DOI 10.1007/BF00288260; BALE SJ, 1991, AM J MED GENET, V40, P206, DOI 10.1002/ajmg.1320400217; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Blough RI, 2000, AM J MED GENET, V90, P29, DOI 10.1002/(SICI)1096-8628(20000103)90:1<29::AID-AJMG6>3.0.CO;2-Z; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DONNAI D, 1987, AM J MED GENET, V28, P741, DOI 10.1002/ajmg.1320280323; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; ElGhouzzi V, 1997, NAT GENET, V15, P42; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jones K. L., 1997, SMITHS RECOGNIZABLE; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kas K, 1996, CYTOGENET CELL GENET, V72, P297, DOI 10.1159/000134207; Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; King T, 1999, NATURE, V401, P222, DOI 10.1038/45698; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee J, 1997, DEVELOPMENT, V124, P2537; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Matsumoto N, 1996, GENOMICS, V36, P220, DOI 10.1006/geno.1996.0454; McGarvey TW, 1998, ONCOGENE, V17, P1167, DOI 10.1038/sj.onc.1202045; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Park HL, 2000, DEVELOPMENT, V127, P1593; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; ROBERTS WM, 1989, CANCER RES, V49, P5407; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 1997, HUM GENET, V100, P172, DOI 10.1007/s004390050486; RUBINSTEIN JH, 1990, AM J MED GENET, P3; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Stein U, 1999, CANCER RES, V59, P1890; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Stone DM, 1999, J CELL SCI, V112, P4437; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Vorechovsky I, 1997, CANCER RES, V57, P4677; VORTKAMP A, 1995, DNA CELL BIOL, V14, P629, DOI 10.1089/dna.1995.14.629; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WALTERHOUSE D, 1993, DEV DYNAM, V196, P91, DOI 10.1002/aja.1001960203; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Werner CA, 1997, AM J PATHOL, V151, P335; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Williams KP, 1999, J CELL SCI, V112, P4405; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang JT, 1997, MOL MED, V3, P826, DOI 10.1007/BF03401719; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496	78	305	324	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1047	1054		10.1016/S0002-9297(07)62934-6	http://dx.doi.org/10.1016/S0002-9297(07)62934-6			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11001584	Green Published, Bronze			2022-12-18	WOS:000165091600001
J	THOMSON, G				THOMSON, G			MAPPING DISEASE GENES - FAMILY-BASED ASSOCIATION STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; HAPLOTYPE-RELATIVE-RISK; LINKAGE DISEQUILIBRIUM; HLA; IDDM; MARKER; INHERITANCE; STRENGTH; ANTIGENS; COMPLEX	With recent rapid advances in mapping of the human genome, including highly polymorphic and closely linked markers, studies of marker associations with disease are increasingly relevant for mapping disease genes. The use of nuclear-family data in association studies was initially developed to avoid possible ethnic mismatching between patients and randomly ascertained controls. The parental marker alleles not transmitted to an affected child or never transmitted to an affected sib pair form the so-called AFBAC (affected family-based controls) population. In this paper, the theoretical foundation of the AFBAC method is proved for any single-locus model of disease and for any nuclear family-based ascertainment scheme. In a random-mating population, when there is a marker association with disease, the AFBAC population provides an unbiased estimate of the overall population (control) marker alleles when the recombination fraction (theta) between the marker and disease genes is sufficiently small that it can be taken as zero (theta = 0). With population stratification, only marker associations present in the subpopulations will be detected with family-based analyses. Of more importance, however, is the fact that, when theta not equal 0, differences between transmitted parental (patient) marker allele frequencies and non- or never-transmitted parental marker allele frequencies (implying a marker association with disease) can only be observed for marker genes linked to a disease gene (theta < 1/2). Thus, associations of unlinked marker loci with disease at the population level, caused by population stratification, migration, or admixture, are eliminated. This validates the use of family-based association tests as an appropriate strategy for mapping disease genes.			THOMSON, G (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,3060 VALLEY LIFE SCI BLDG,BERKELEY,CA 94720, USA.				NICHD NIH HHS [HD12731] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Breslow N, 1980, STATISTICAL METHODS, V32; COX NJ, 1988, AM J HUM GENET, V42, P167; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEAN M, 1994, AM J HUM GENET, V55, P788; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FALK CT, 1989, GENET EPIDEMIOL, V6, P95, DOI 10.1002/gepi.1370060118; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; FIELD LL, 1986, GENET EPIDEMIOL S, V1, P323; HILL WG, 1994, AM J HUM GENET, V54, P705; HODGE SE, 1993, AM J HUM GENET, V53, P367; HODGE SE, 1994, AM J HUM GENET, V54, P560; JIN K, 1994, BIOMETRICS, V50, P1189, DOI 10.2307/2533457; JORDE LB, 1994, AM J HUM GENET, V54, P884; KHOURY MJ, 1994, AM J HUM GENET, V55, P414; KLITZ W, 1992, EVOL BIOL, V26, P35; KNAPP M, 1993, AM J HUM GENET, V52, P1085; LECHLER R, 1994, HLA DISEASE; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; MAXWELL AE, 1970, BRIT J PSYCHIAT, V116, P651, DOI 10.1192/bjp.116.535.651; MOTRO U, 1985, GENETICS, V110, P525; NEI M, 1973, GENETICS, V75, P213; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Risch N., 1992, American Journal of Human Genetics, V51, pA13; Rothman K, 1986, MODERN EPIDEMIOLOGY; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1994, AM J HUM GENET, V54, P559; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; SPIELMAN RS, 1993, AM J HUM GENET, V53, P863; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; SUAREZ BK, 1994, AM J HUM GENET, V54, P554; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1993, GENET EPIDEMIOL, V10, P289, DOI 10.1002/gepi.1370100503; THOMSON G, 1977, GENETICS, V85, P753; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1991, IMMUNOGENETICS AUTOI, V1, P188; THOMSON G, 1995, AM J HUM GENET, V57; THOMSON G, 1976, POPULATION GENETICS, P465; TIRET I, 1993, ANN HUM GENET, V57, P141, DOI 10.1111/j.1469-1809.1993.tb00895.x; TIWARI JL, 1985, HLA DISEASE ASS	52	305	309	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					487	498						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668275				2022-12-18	WOS:A1995RL77100032
J	Ahmed, ZM; Riazuddin, S; Bernstein, SL; Ahmed, Z; Khan, S; Griffith, AJ; Morell, RJ; Friedman, TB; Riazuddin, S; Wilcox, ER				Ahmed, ZM; Riazuddin, S; Bernstein, SL; Ahmed, Z; Khan, S; Griffith, AJ; Morell, RJ; Friedman, TB; Riazuddin, S; Wilcox, ER			Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN-VIIA GENE; SYNDROME TYPE-I; SYNDROME TYPE 1D; HEARING-LOSS; GENOMIC DNA; CADHERIN SUPERFAMILY; RECESSIVE DEAFNESS; WALTZER; CDH23; MAPS	Human chromosome 10q21-22 harbors USH1F in a region of conserved synteny to mouse chromosome 10. This region of mouse chromosome 10 contains Pcdh15, encoding a protocadherin gene that is mutated in ames waltzer and causes deafness and vestibular dysfunction. Here we report two mutations of protocadherin 15 (PCDH15) found in two families segregating Usher syndrome type 1F. A Northern blot probed with the PCDH15 cytoplasmic domain showed expression in the retina, consistent with its pathogenetic role in the retinitis pigmentosa associated with USH1F.	Natl Inst Deafness & Other Commun Disorders, Genet Mol Lab, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Neurootol Branch, NIH, Rockville, MD 20850 USA; Univ Maryland, Sch Med, Dept Ophthalmol, Baltimore, MD 21201 USA; Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University System of Maryland; University of Maryland Baltimore; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Wilcox, ER (corresponding author), Natl Inst Deafness & Other Commun Disorders, Genet Mol Lab, NIH, 5 Res Court,2A-19, Rockville, MD 20850 USA.	wilcoxe@nidcd.nih.gov	Morell, Robert James/Q-2042-2019	Morell, Robert/0000-0003-1537-7356	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000035, Z01DC000039, T32DC000035, Z01DC000064, Z01DC000060, Z01DC000048] Funding Source: NIH RePORTER; NIDCD NIH HHS [Z01 DC00035, T32 DC000035] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Angst BD, 2001, J CELL SCI, V114, P629; Astuto LM, 2000, AM J HUM GENET, V67, P1569, DOI 10.1086/316889; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; CORREAROTTER R, 1992, BIOTECHNIQUES, V12, P154; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Friedman T, 2000, CURR OPIN NEUROBIOL, V10, P487, DOI 10.1016/S0959-4388(00)00120-3; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; GRONDAHL J, 1987, CLIN GENET, V31, P255; HALLGREN B, 1959, ACTA PSYCHIAT SCAND, V138, P1; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KIMBERLING WJ, 1991, ANN NY ACAD SCI, V630, P167, DOI 10.1111/j.1749-6632.1991.tb19585.x; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Libby RT, 2001, INVEST OPHTH VIS SCI, V42, P770; Liu X, 2001, EXP EYE RES, V72, P351, DOI 10.1006/exer.2000.0963; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NUUTILA A, 1970, J GENET HUM, V18, P57; Raphael Y, 2001, HEARING RES, V151, P237, DOI 10.1016/S0378-5955(00)00233-1; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SCHAIBLE RH, 1956, MOUSE NEWS LETT, V15, P29; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Solovyev V, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P294; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Wayne S, 1997, AM J HUM GENET, V61, pA300; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986	52	304	315	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					25	34		10.1086/321277	http://dx.doi.org/10.1086/321277			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11398101	Bronze, Green Published			2022-12-18	WOS:000170108100003
J	Gurling, HMD; Kalsi, G; Brynjolfson, J; Sigmundsson, T; Sherrington, R; Mankoo, BS; Read, T; Murphy, P; Blaveri, E; McQuillin, A; Petursson, H; Curtis, D				Gurling, HMD; Kalsi, G; Brynjolfson, J; Sigmundsson, T; Sherrington, R; Mankoo, BS; Read, T; Murphy, P; Blaveri, E; McQuillin, A; Petursson, H; Curtis, D			Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VULNERABILITY LOCUS; WIDE SCAN; FAMILIAL SCHIZOPHRENIA; SUGGESTIVE EVIDENCE; COMPLEX TRAITS; RECEPTOR GENE; DNA MARKERS; SHORT ARM; TRANSLOCATION; REGION	We have performed genetic linkage analysis in 13 large multiply affected families, to test the hypothesis that there is extensive heterogeneity of linkage for genetic subtypes of schizophrenia. Our strategy consisted of selecting 13 kindreds containing multiple affected cases in three or more generations, an absence of bipolar affective disorder, and a single progenitor source of schizophrenia with unilineal transmission into the branch of the kindred sampled. DNA samples from these families were genotyped with 365 microsatellite markers spaced at similar to 10-cM intervals across the whole genome. We observed LOD scores >3.0 at five distinct loci, either in the sample as a whole or within single families, strongly suggesting etiological heterogeneity. Heterogeneity LOD scores >3.0 in the sample as a whole were found at 1q33.2 (LOD score 3.2; P = .0003), 5q33.2 (LOD score 3.6; P = .0001), 8p22.1-22 (LOD score 3.6; P = .0001), and 11q21 (LOD score 3.1; P = .0004). LOD scores >3.0 within single pedigrees were found at 4q13-31 (LOD score 3.2; P = .0003) and at 11q23.3-24 (LOD score 3.2; P = .0003). A LOD score of 2.9 was also found at 20q12.1-11.23 within in a single family. The fact that other studies have also detected LOD scores >3.0 at 1q33.2, 5q33.2, 8p21-22 and 11q21 suggests that these regions do indeed harbor schizophrenia-susceptibility loci. We believe that the weight of evidence for linkage to the chromosome 1q22, 5q33.2, and 8p21-22 loci is now sufficient to justify intensive investigation of these regions by methods based on linkage disequilibrium. Such studies will soon allow the identification of mutations having a direct effect on susceptibility to schizophrenia.	UCL, Royal Free & Univ Coll London Med Sch, Windeyer Inst Med Sci,Dept Psychiat & Behav Sci, Mol Psychiat Lab, London W1T 4JF, England; St Bartholomews & Royal London Sch Med & Dent, Dept Psychol Med, London, England; Univ Hosp, Landspitali, Dept Psychiat, Reykjavik, Iceland	University of London; University College London; University of London; Queen Mary University London; Landspitali National University Hospital	Gurling, HMD (corresponding author), UCL, Royal Free & Univ Coll London Med Sch, Windeyer Inst Med Sci,Dept Psychiat & Behav Sci, Mol Psychiat Lab, 46 Cleveland St, London W1T 4JF, England.	h.gurling@ucl.ac.uk	Gurling, Hugh M/A-5029-2010; McQuillin, Andrew/C-1623-2008; Curtis, David/HGB-3921-2022	McQuillin, Andrew/0000-0003-1567-2240; Curtis, David/0000-0002-4089-9183				ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; BARON M, 1986, BIOL PSYCHIAT, V21, P1051, DOI 10.1016/0006-3223(86)90286-6; Blackwood D, 1998, AM J MED GENET, V81, P532; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; Byerley W, 1999, MOL PSYCHIATR, V4, pS4; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Cheng HF, 1997, J FOOD DRUG ANAL, V5, P41; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curtis D, 1999, GENET EPIDEMIOL, V17, pS115; CURTIS D, 1995, AM J HUM GENET, V57, P703; CURTIS D, 1995, NAT GENET, V9, P13, DOI 10.1038/ng0195-13; Devon RS, 1997, AM J MED GENET, V74, P82, DOI 10.1002/(SICI)1096-8628(19970221)74:1<82::AID-AJMG17>3.0.CO;2-N; Devon RS, 1997, PSYCHIATR GENET, V7, P165; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Ekelund J, 1997, AM J MED GENET, V74, P559; Ekelund J, 1999, MOL PSYCHIATR, V4, pS3; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Garver DL, 1998, AM J MED GENET, V81, P454; GILL M, 1993, PSYCHOL MED, V23, P27, DOI 10.1017/S0033291700038824; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GURLING H, 1995, NAT GENET, V11, P234, DOI 10.1038/ng1195-234; GURLING H, 1996, BAILLIERES CLIN PSYC, V2, P15; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kalsi G, 1996, AM J PSYCHIAT, V153, P107; Kalsi G., 1996, American Journal of Human Genetics, V59, pA384; KALSI G, 1995, AM J MED GENET, V60, P298, DOI 10.1002/ajmg.1320600407; KALSI G, 1995, BRIT J PSYCHIAT, V167, P390, DOI 10.1192/bjp.167.3.390; Kalsi G, 1999, ANN HUM GENET, V63, P235, DOI 10.1046/j.1469-1809.1999.6330235.x; KALSI G, 1995, PSYCHOL MED, V25, P531, DOI 10.1017/S0033291700033456; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; King N, 1997, AM J MED GENET, V74, P472, DOI 10.1002/(SICI)1096-8628(19970919)74:5<472::AID-AJMG2>3.0.CO;2-Q; KOSOWER NS, 1995, AM J MED GENET, V60, P133, DOI 10.1002/ajmg.1320600209; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Levinson DF, 1999, AM J HUM GENET, V65, pA259; Lin HK, 1997, ACTA PHYS-CHIM SIN, V13, P417, DOI 10.3866/PKU.WHXB19970507; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.3.CO;2-C; Maziade M, 1995, AM J MED GENET, V60, P522, DOI 10.1002/ajmg.1320600607; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MORTON NE, 1988, ANN HUM GENET, V52, P309, DOI 10.1111/j.1469-1809.1988.tb01110.x; MULCRONE J, 1995, AM J MED GENET, V60, P103, DOI 10.1002/ajmg.1320600204; NANKO S, 1992, JPN J PSYCHIAT NEUR, V46, P155; Nurnberger J, 1998, PSYCHIATR GENET, V8, P128; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Paunio T, 2000, AM J MED GENET, V96, P460; Pritchard DJ, 1996, ANN HUM GENET, V60, P105, DOI 10.1111/j.1469-1809.1996.tb01182.x; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1990, AM J HUM GENET, V46, P222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SHERRINGTON R, 1993, HUM HERED, V43, P197, DOI 10.1159/000154177; Silverman JM, 1996, AM J MED GENET, V67, P162, DOI 10.1002/(SICI)1096-8628(19960409)67:2<162::AID-AJMG6>3.0.CO;2-U; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; Spitzer RL, 1978, RES DIAGNOSTIC CRITE; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Straub RE, 1997, AM J MED GENET, V74, P558; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; TSUANG M, 1999, AM J MED GENET, V88, P215; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Wang SB, 1996, AM J HUM GENET, V59, P731; WANG ZW, 1993, ARCH GEN PSYCHIAT, V50, P212; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	81	304	319	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					661	673		10.1086/318788	http://dx.doi.org/10.1086/318788			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179014	Green Published, Bronze			2022-12-18	WOS:000166994200011
J	ZANNIS, VI; JUST, PW; BRESLOW, JL				ZANNIS, VI; JUST, PW; BRESLOW, JL			HUMAN APOLIPOPROTEIN-E ISOPROTEIN SUBCLASSES ARE GENETICALLY-DETERMINED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	ZANNIS, VI (corresponding author), CHILDRENS HOSP,MED CTR,BOSTON,MA 02115, USA.		Breslow, Jan L/B-7544-2008		NHLBI NIH HHS [HL-15895] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1978, METABOLISM, V27, P479, DOI 10.1016/0026-0495(78)90102-6; BRESLOW JL, 1977, J BIOL CHEM, V252, P2726; CAREW TE, 1976, LANCET, V1, P1315; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CURRY MD, 1976, BIOCHIM BIOPHYS ACTA, V439, P413, DOI 10.1016/0005-2795(76)90078-7; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Fredrickson D. S., 1978, METABOLIC BASIS INHE, P604; FREDRICKSON DS, 1975, ANN INTERN MED, V82, P150, DOI 10.7326/0003-4819-82-2-150; GOLDBOURT U, 1979, AM J EPIDEMIOL, V109, P296, DOI 10.1093/oxfordjournals.aje.a112683; GORDON T, 1977, ANN INTERN MED, V87, P393, DOI 10.7326/0003-4819-87-4-393; GORDON T, 1977, JAMA-J AM MED ASSOC, V238, P497, DOI 10.1001/jama.238.6.497; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HAVEL RJ, 1973, P NATL ACAD SCI USA, V70, P2015, DOI 10.1073/pnas.70.7.2015; HAZZARD WR, 1972, METABOLISM, V21, P1009, DOI 10.1016/0026-0495(72)90031-5; JAIN RS, 1979, LIFE SCI, V25, P1315, DOI 10.1016/0024-3205(79)90397-7; KUSHWAHA RS, 1978, BIOCHIM BIOPHYS ACTA, V528, P176, DOI 10.1016/0005-2760(78)90192-3; KUSHWAHA RS, 1977, ANN INTERN MED, V86, P509; MAHLEY R W, 1978, P181; MAHLEY RW, 1976, BIOCHEMISTRY-US, V15, P2979, DOI 10.1021/bi00659a007; MAHLEY RW, 1977, J LIPID RES, V18, P314; MAHLEY RW, 1975, BIOCHEMISTRY-US, V14, P2817, DOI 10.1021/bi00684a005; MARCEL YL, 1979, BIOCHIM BIOPHYS ACTA, V573, P175, DOI 10.1016/0005-2760(79)90184-X; MILLER GJ, 1975, LANCET, V1, P16; MISHKEL MA, 1975, CLIN CHIM ACTA, V58, P121, DOI 10.1016/S0009-8981(75)80004-0; NOEL SP, 1979, J CLIN INVEST, V64, P674, DOI 10.1172/JCI109508; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PAGNAN A, 1977, J LIPID RES, V18, P613; PEARSON TA, 1979, AM J EPIDEMIOL, V109, P285, DOI 10.1093/oxfordjournals.aje.a112682; RODRIGUEZ JL, 1976, ATHEROSCLEROSIS, V23, P73, DOI 10.1016/0021-9150(76)90119-2; RUDEL LL, 1979, J LIPID RES, V20, P55; SHELBURNE FA, 1974, J BIOL CHEM, V249, P1428; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; STUDIER FW, 1973, J MOL BIOL, V79, P237, DOI 10.1016/0022-2836(73)90003-X; UTERMANN G, 1979, CLIN GENET, V15, P37; UTERMANN G, 1977, CLIN GENET, V12, P139, DOI 10.1111/j.1399-0004.1977.tb00917.x; UTERMANN G, 1975, FEBS LETT, V56, P352, DOI 10.1016/0014-5793(75)81125-2; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, FEBS LETT, V101, P21, DOI 10.1016/0014-5793(79)81286-7; UTERMANN G, 1978, PROTIDES BIOL FLUIDS, P285; WARNICK GR, 1979, CLIN CHEM, V25, P279; WEIDMAN SW, 1979, J LAB CLIN MED, V93, P549; WEISGRABER KH, 1978, J BIOL CHEM, V253, P6281; ZANNIS V, 1978, J BIOL CHEM, V253, P504; ZANNIS VI, 1980, J BIOL CHEM, V255, P1759; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473; 1974, DHEW75 PUBL; 1972, TECHNICON AUTO ANAL	47	304	312	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					11	24						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	7468588				2022-12-18	WOS:A1981LA93000002
J	Abeliovich, D; Kaduri, L; Lerer, I; Weinberg, N; Amir, G; Sagi, M; Zlotogora, J; Heching, N; Peretz, T				Abeliovich, D; Kaduri, L; Lerer, I; Weinberg, N; Amir, G; Sagi, M; Zlotogora, J; Heching, N; Peretz, T			The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON MUTATIONS; FAMILIES; GENE; FREQUENCY	The mutations 185delAG, 188del11, and 5382insC in the BRCA1 gene and G174delT in the BRCA2 gene were analyzed in 199 Ashkenazi and 44 non-Ashkenazi Jewish unrelated patients with breast and/or ovarian cancer. Of the Jewish Ashkenazi women with ovarian cancer, 62% (13/21) had one of the target mutations, as did 30% (13/43) of women with breast cancer alone diagnosed before the age 40 years and 10% (15/141) of those with breast cancer diagnosed after the age 40 years. Age at ovarian cancer diagnosis was not associated with carrier status. Of 99 Ashkenazi patients with no family history of breast and/or ovarian cancer, 10% carried one of the mutations; in two of them the mutation was proved to be paternally transmitted. One non-Ashkenazi Jewish ovarian cancer patient from Iraq carried the 185delAG mutation. Individual mutation frequencies among breast cancer Ashkenazi patients were 6.7% for 185delAG, 2.2% for 5382insC, and 4.5% for 6174delT, among ovarian cancer patients; 185delAG and G174delT were about equally common (33% and 29%, respectively), but no ovarian cancer patient carried the 5382insC. More mutations responsible for inherited breast and ovarian cancer probably remain to be found in this population, since 79% of high-incidence breast cancer families and 35% of high-incidence breast/ovarian cancer families had none of the three known founder mutations.	HEBREW UNIV JERUSALEM,HADASSAH HOSP,SCH MED,SHARETT INST ONCOL,IL-91120 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH HOSP,SCH MED,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Abeliovich, D (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH HOSP,SCH MED,DEPT HUMAN GENET,POB 12000,IL-91120 JERUSALEM,ISRAEL.			Zlotogora, Joel/0000-0001-6293-2979				BENJAMIN B, 1996, NAT GENET, V14, P185; Berman DB, 1996, AM J HUM GENET, V58, P1166; Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z; FERRIE RM, 1992, AM J HUM GENET, V51, P251; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; LERER I, 1994, AM J MED GENET, V52, P79, DOI 10.1002/ajmg.1320520116; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muto MG, 1996, CANCER RES, V56, P1250; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Sher C, 1996, NEW ENGL J MED, V334, P1199; SHPILBERG O, 1995, BLOOD, V85, P429, DOI 10.1182/blood.V85.2.429.bloodjournal852429; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TAKAHASHI H, 1995, CANCER RES, V55, P2998; TONIN P, 1995, AM J HUM GENET, V57, P189; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; TULINIUS H, 1994, J MED GENET, V31, P618, DOI 10.1136/jmg.31.8.618	25	303	310	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					505	514						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042909				2022-12-18	WOS:A1997WK40300006
J	STONEKING, M; HEDGECOCK, D; HIGUCHI, RG; VIGILANT, L; ERLICH, HA				STONEKING, M; HEDGECOCK, D; HIGUCHI, RG; VIGILANT, L; ERLICH, HA			POPULATION VARIATION OF HUMAN MTDNA CONTROL REGION SEQUENCES DETECTED BY ENZYMATIC AMPLIFICATION AND SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; MATERNAL INHERITANCE; SINGLE HAIRS; EVOLUTION; NUMBER; POLYMORPHISM; GENOME; SITES; CELL	A method of detecting sequence variation of hypervariable segments of the mtDNA control region was developed. The technique uses hybridization of sequence-specific oligonucleotide (SSO) probes to DNA sequences that have been amplified by PCR. The nucleotide sequences of the two hypervariable segments of the mtDNA control region from 52 individuals were determined; these sequences were then used to define nine regions suitable for SSO typing. A total of 23 SSO probes were used to detect sequence variants at these nine regions in 525 individuals from five ethnic groups (African, Asian, Caucasian, Japanese, and Mexican). The SSO typing revealed an enormous amount of variability, with 274 mtDNA types observed among these 525 individuals and with diversity values, for each population, exceeding .95. For each of the nine mtDNA regions significant differences in the frequencies of sequence variants were observed between these five populations. The mtDNA SSO-typing system was successfully applied to a case involving individual identification of skeletal remains; the probability of a random match was approximately 0.7%. The potential useful application of this mtDNA SSO-typing system thus include the analysis of individual identity as well as population genetic studies.	CETUS CORP,DEPT HUMAN GENET,EMERYVILLE,CA 94608; UNIV CALIF,BODEGA MARINE LAB,BODEGA BAY,CA; UNIV CALIF BERKELEY,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley			Hedgecock, Dennis/I-8655-2012	Hedgecock, Dennis/0000-0002-3995-646X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AQUADRO CF, 1983, GENETICS, V103, P287; BALAZS I, 1989, AM J HUM GENET, V44, P182; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; COHEN JE, 1990, AM J HUM GENET, V46, P358; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOEDDE HW, 1989, HUM GENET, V81, P305, DOI 10.1007/BF00283679; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HECHT NB, 1984, DEV BIOL, V102, P452, DOI 10.1016/0012-1606(84)90210-0; HELMUTH R, 1990, AM J HUM GENET, V47, P515; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HORAI S, 1990, AM J HUM GENET, V46, P828; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Orrrego C., 1990, PCR PROTOCOLS, P416; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; Sokal R.R., 1981, BIOMETRY, V2nd ed.; TAJIMA F, 1989, GENETICS, V123, P585; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VONBEROLDINGEN CH, 1989, PCR TECHNOLOGY PRINC, P209; WALBERG MW, 1981, NUCLEIC ACIDS RES, V9, P5411, DOI 10.1093/nar/9.20.5411; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WHITTAM TS, 1986, P NATL ACAD SCI USA, V83, P9611, DOI 10.1073/pnas.83.24.9611	28	303	369	1	27	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					370	382						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990843				2022-12-18	WOS:A1991EV74400022
J	KNOWLER, WC; WILLIAMS, RC; PETTITT, DJ; STEINBERG, AG				KNOWLER, WC; WILLIAMS, RC; PETTITT, DJ; STEINBERG, AG			GM3-5,13,14 AND TYPE-2 DIABETES-MELLITUS - AN ASSOCIATION IN AMERICAN-INDIANS WITH GENETIC ADMIXTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BLOOD SYST INC,HISTOCOMPATIBIL LAB,SCOTTSDALE,AZ; ARIZONA STATE UNIV,DEPT ANTHROPOL,TEMPE,AZ 85287; CASE WESTERN RESERVE UNIV,DEPT BIOL,CLEVELAND,OH 44106	Vitalant; Arizona State University; Arizona State University-Tempe; Case Western Reserve University	KNOWLER, WC (corresponding author), NIDDKD,DIABET & ARTHRITIS EPIDEMIOL SECT,1550 E INDIAN SCH RD,PHOENIX,AZ 85014, USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284				ADAMS DD, 1984, LANCET, V1, P420; BENNETT PH, 1971, LANCET, V2, P125; Berg K, 1967, Diabetologia, V3, P30, DOI 10.1007/BF01269908; Breslow N, 1980, STATISTICAL METHODS, V32; BRIGGS BR, 1980, DIABETES, V29, P68, DOI 10.2337/diabetes.29.1.68; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CHAKRABORTY R, 1986, AM J PHYS ANTHROPOL, V70, P489, DOI 10.1002/ajpa.1330700408; DAUSSET J, 1977, HLA DISEASE; DREVETS C C, 1965, J Okla State Med Assoc, V58, P322; FIELD LL, 1984, LANCET, V1, P1132; GARDNER LI, 1984, DIABETES, V33, P86, DOI 10.2337/diabetes.33.1.86; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KNOWLER WC, 1983, AM J PHYS ANTHROPOL, V62, P107, DOI 10.1002/ajpa.1330620114; MANTEL N, 1959, J NATL CANCER I, V22, P719; NAKAO Y, 1981, NEW ENGL J MED, V304, P407, DOI 10.1056/NEJM198102123040706; REED TE, 1969, AM J HUM GENET, V21, P71; SCHANFIELD MS, 1981, AM J HUM GENET, V33, pA133; SERJEANTSON SW, 1983, DIABETOLOGIA, V25, P13; SERJEANTSON SW, 1981, MED J AUSTRALIA, V1, P462, DOI 10.5694/j.1326-5377.1981.tb135735.x; SMOUSE PE, 1982, BIOMETRICS, V38, P757, DOI 10.2307/2530055; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; STERN MP, 1986, DIABETES, V35, P387, DOI 10.2337/diabetes.35.4.387; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; SVEJGAARD A, 1977, HLA DISEASE, P46; TIWARI JL, 1985, HLA DISEASE ASS; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WILLIAMS RC, 1981, DIABETOLOGIA, V21, P460; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; 1985, WHO TECH REP SER, V727	32	303	317	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					520	526						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177389				2022-12-18	WOS:A1988Q473600020
J	Tan, Z; Randall, G; Fan, J; Camoretti-Mercado, B; Brockman-Schneider, R; Pan, L; Solway, J; Gern, JE; Lemanske, RF; Nicolae, D; Ober, C				Tan, Zheng; Randall, Glenn; Fan, Jihua; Camoretti-Mercado, Blanca; Brockman-Schneider, Rebecca; Pan, Lin; Solway, Julian; Gern, James E.; Lemanske, Robert F., Jr.; Nicolae, Dan; Ober, Carole			Allele-specific targeting of microRNAs to HLA-G and risk of asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRONCHIAL EPITHELIAL-CELLS; SUSCEPTIBILITY GENES; DIFFERENTIATION; SECRETION; REGION	HLA-G is a nonclassic, class I HLA molecule that has important immunomodulatory properties. Previously, we identified HLA-G as an asthma-susceptibility gene and discovered that the risk of asthma in a child was determined by both the child's HLA-G genotype and the mother's affection status. Here we report a SNP in the 3' untranslated region of HLA-G that influences the targeting of three microRNAs (miRNAs) to this gene, and we suggest that allele-specific targeting of these miRNAs accounts, at least in part, for our earlier observations on HLA-G and the risk of asthma.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Wisconsin, Dept Pediat, Madison, WI USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; New York University	Tan, Z (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	tzheng@bsd.uchicago.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530; Nicolae, Dan/0000-0002-0918-4630; Ober, Carole/0000-0003-4626-9809; Randall, Glenn/0000-0001-7417-3615	NHLBI NIH HHS [P01 HL070831, R01 HL072414, HL72414, HL70831] Funding Source: Medline; NICHD NIH HHS [HD21244, R01 HD021244] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831, R01HL072414] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Crestani E, 2004, J ALLERGY CLIN IMMUN, V113, P284, DOI 10.1016/j.jaci.2003.11.009; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hoffjan S, 2005, AM J HUM GENET, V76, P696, DOI 10.1086/429418; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Ober C, 2006, HUM REPROD, V21, P1743, DOI 10.1093/humrep/del036; Ober C, 2005, CURR OPIN IMMUNOL, V17, P670, DOI 10.1016/j.coi.2005.09.009; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Tan Z, 2005, HUM MOL GENET, V14, P3619, DOI 10.1093/hmg/ddi389; Vercelli D, 2006, J ALLERGY CLIN IMMUN, V117, P1303, DOI 10.1016/j.jaci.2006.03.030; Wills-Karp M, 2004, NAT REV GENET, V5, P376, DOI 10.1038/nrg1326; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005	33	302	329	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					829	834		10.1086/521200	http://dx.doi.org/10.1086/521200			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847008	Green Published, Bronze			2022-12-18	WOS:000249307600024
J	Wakefield, J				Wakefield, Jon			A Bayesian measure of the probability of false discovery in genetic epidemiology studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CANCER; RISK	In light of the vast amounts of genomic data that are now being generated, we propose a new measure, the Bayesian false-discovery probability (BFDP), for assessing the noteworthiness of an observed association. BFDP shares the ease of calculation of the recently proposed false-positive report probability (FPRP) but uses more information, has a noteworthy threshold defined naturally in terms of the costs of false discovery and nondiscovery, and has a sound methodological foundation. In addition, in a multiple-testing situation, it is straightforward to estimate the expected numbers of false discoveries and false nondiscoveries. We provide an in-depth discussion of FPRP, including a comparison with the q value, and examine the empirical behavior of these measures, along with BFDF, via simulation. Finally, we use BFDP to assess the association between 131 single-nucleotide polymorphisms and lung cancer in a case-control study.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wakefield, J (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.	jonno@u.washington.edu						Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Freedman ML, 2005, AM J HUM GENET, V76, P82, DOI 10.1086/427224; Genovese C, 2003, BAYESIAN STATISTICS 7, P145; GOODMAN SN, 1993, AM J EPIDEMIOL, V137, P485, DOI 10.1093/oxfordjournals.aje.a116700; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GOPEC Consortium, 2005, AM J HUM GENET, V77, P127; Greenland S, 2000, BIOMETRICS, V56, P915, DOI 10.1111/j.0006-341X.2000.00915.x; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hung RJ, 2005, JNCI-J NATL CANCER I, V97, P567, DOI 10.1093/jnci/dji101; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Muller P, 2004, J AM STAT ASSOC, V99, P990, DOI 10.1198/016214504000001646; Pauler DK, 1999, J AM STAT ASSOC, V94, P1242; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Scott JG, 2006, J STAT PLAN INFER, V136, P2144, DOI 10.1016/j.jspi.2005.08.031; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strange RC, 2004, ANN HUM GENET, V68, P536, DOI 10.1046/j.1529-8817.2004.00132.x; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; TYER J, 2006, GENET EPIDEMIOL, V30, P636; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Whittemore AS, 2005, CANCER EPIDEM BIOMAR, V14, P1359, DOI 10.1158/1055-9965.EPI-05-0403; Witte JS, 1996, STAT MED, V15, P1161, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1161::AID-SIM221>3.0.CO;2-7	34	302	308	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					208	227		10.1086/519024	http://dx.doi.org/10.1086/519024			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668372	Green Published, Bronze			2022-12-18	WOS:000248540400002
J	Yang, YQ; Xia, M; Jin, QF; Bendahhou, S; Shi, JY; Chen, YP; Liang, B; Lin, J; Liu, Y; Liu, B; Zhou, QS; Zhang, DW; Wang, R; Ma, N; Su, XY; Niu, KY; Pei, Y; Xu, WY; Chen, ZP; Wan, HY; Cui, JM; Barhanin, J; Chen, YH				Yang, YQ; Xia, M; Jin, QF; Bendahhou, S; Shi, JY; Chen, YP; Liang, B; Lin, J; Liu, Y; Liu, B; Zhou, QS; Zhang, DW; Wang, R; Ma, N; Su, XY; Niu, KY; Pei, Y; Xu, WY; Chen, ZP; Wan, HY; Cui, JM; Barhanin, J; Chen, YH			Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-QT SYNDROME; SUDDEN CARDIAC DEATH; RADIOFREQUENCY ABLATION; CLINICAL-IMPLICATIONS; POTASSIUM CHANNEL; PULMONARY VEINS; HERG; ARRHYTHMIA; EPIDEMIOLOGY; INITIATION	Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. We first reported an S140G mutation of KCNQ1, an alpha subunit of potassium channels, in one Chinese kindred with AF. However, the molecular defects and cellular mechanisms in most patients with AF remain to be identified. We evaluated 28 unrelated Chinese kindreds with AF and sequenced eight genes of potassium channels (KCNQ1, HERG, KCNE1, KCNE2, KCNE3, KCNE4, KCNE5, and KCNJ2). An arginine-to-cysteine mutation at position 27 (R27C) of KCNE2, the beta subunit of the KCNQ1-KCNE2 channel responsible for a background potassium current, was found in 2 of the 28 probands. The mutation was present in all affected members in the two kindreds and was absent in 462 healthy unrelated Chinese subjects. Similar to KCNQ1 S140G, the mutation had a gain-of-function effect on the KCNQ1-KCNE2 channel; unlike long QT syndrome-associated KCNE2 mutations, it did not alter HERG-KCNE2 current. The mutation did not alter the functions of the HCN channel family either. Thus, KCNE2 R27C is a gain-of-function mutation associated with the initiation and/or maintenance of AF.	Tongji Univ, Inst Med Genet, Shanghai 200065, Peoples R China; Tongji Univ, Dept Cardiol, Shanghai 200065, Peoples R China; Inst Pharmacol Mol & Cellulaire, CNRS, Valbonne, France; Case Western Reserve Univ, Cardiac Bioelect Res & Training Ctr, Cleveland, OH USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA; Case Western Reserve Univ, Univ Hosp Cleveland, Dept Cardiol, Cleveland, OH 44106 USA	Tongji University; Tongji University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Chen, YH (corresponding author), Tongji Univ, Inst Med Genet, 389 Xin Cun Rd, Shanghai 200065, Peoples R China.	yihanchen@mail.tongji.edu.cn	Zhou, Qin-shu/D-4606-2009; Liang, Bo/C-7210-2012					Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Itoh T, 1998, HUM GENET, V102, P435, DOI 10.1007/s004390050717; Jais P, 1997, CIRCULATION, V95, P572, DOI 10.1161/01.CIR.95.3.572; Liu LL, 1997, AM J PHYSIOL-HEART C, V273, pH805, DOI 10.1152/ajpheart.1997.273.2.H805; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; MACKENZIE J, 2004, BRIT MED J, V5, P529; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Nattel S, 2000, ANNU REV PHYSIOL, V62, P51, DOI 10.1146/annurev.physiol.62.1.51; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Ryder KM, 1999, AM J CARDIOL, V84, p131R; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Van Wagoner DR, 2000, J MOL CELL CARDIOL, V32, P1101, DOI 10.1006/jmcc.2000.1147; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; ZIPES DP, 1974, CARDIOVASC RES, V8, P647, DOI 10.1093/cvr/8.5.647	27	302	317	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					899	905		10.1086/425342	http://dx.doi.org/10.1086/425342			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15368194	Green Published, Bronze			2022-12-18	WOS:000224303500016
J	Muenke, M; Gripp, KW; McDonaldMcGinn, DM; Gaudenz, K; Whitaker, LA; Bartlett, SP; Markowitz, RI; Robin, NH; Nwokoro, N; Mulvihill, JJ; Losken, HW; Mulliken, JB; Guttmacher, AE; Wilroy, RS; Clarke, LA; Hollway, G; Ades, LC; Haan, EA; Mulley, JC; Cohen, MM; Bellus, GA; Francomano, CA; Moloney, DM; Wall, SA; Wilkie, AOM; Zackai, EH				Muenke, M; Gripp, KW; McDonaldMcGinn, DM; Gaudenz, K; Whitaker, LA; Bartlett, SP; Markowitz, RI; Robin, NH; Nwokoro, N; Mulvihill, JJ; Losken, HW; Mulliken, JB; Guttmacher, AE; Wilroy, RS; Clarke, LA; Hollway, G; Ades, LC; Haan, EA; Mulley, JC; Cohen, MM; Bellus, GA; Francomano, CA; Moloney, DM; Wall, SA; Wilkie, AOM; Zackai, EH			A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAETHRE-CHOTZEN-SYNDROME; JACKSON-WEISS-SYNDROME; CROUZON-SYNDROME; PFEIFFER-SYNDROME; SYNDROME LOCUS; APERT SYNDROME; HETEROGENEITY; ACHONDROPLASIA; EXCLUSION; DOMAIN	The underlying basis of many forms of syndromic craniosynostosis has been defined on a molecular level. However, many patients with familial or sporadic craniosynostosis do not have the classical findings of those craniosynostosis syndromes. Here we present 61 individuals from 20 unrelated families where coronal synostosis is due to an amino acid substitution (Pro250Arg) that results from a single point mutation in the fibroblast growth factor receptor 3 gene on chromosome 4p. In this instance, a new clinical syndrome is being defined on the basis of the molecular finding. In addition to the skull findings, some patients had abnormalities on radiographs of hands and feet, including thimble-like middle phalanges, coned epiphyses, and carpal and tarsal fusions. Brachydactyly was seen in some cases; none had clinically significant syndactyly or deviation of the great toe. Sensorineural hearing loss was present in some, and developmental delay was seen in a minority. While the radiological findings of hands and feet can be very helpful in diagnosing this syndrome, it is not in all cases clearly distinguishable on a clinical basis from other craniosynostosis syndromes. Therefore, this mutation should be tested for in patients with coronal synostosis.	UNIV PENN,CHILDRENS HOSP PHILADELPHIA,DEPT GENET,PHILADELPHIA,PA 19104; CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH; UNIV PITTSBURGH,PITTSBURGH,PA; HARVARD UNIV,CHILDRENS HOSP,SCH MED,BOSTON,MA 02115; UNIV VERMONT,COLL MED,BURLINGTON,VT; UNIV TENNESSEE,MEMPHIS,TN; UNIV BRITISH COLUMBIA,VANCOUVER,BC V5Z 1M9,CANADA; WOMENS & CHILDRENS HOSP,ADELAIDE,SA,AUSTRALIA; DALHOUSIE UNIV,HALIFAX,NS,CANADA; JOHNS HOPKINS UNIV,NATL CTR HUMAN GENOME RES,NIH,BETHESDA,MD; JOHN RADCLIFFE HOSP,INST MOL MED,OXFORD OX3 9DU,ENGLAND; RADCLIFFE INFIRM,CRANIOFACIAL UNIT,OXFORD OX2 6HE,ENGLAND	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Vermont; University of Tennessee System; University of Tennessee Health Science Center; University of British Columbia; Womens & Childrens Hospital Australia; Dalhousie University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; Radcliffe Infirmary	Muenke, M (corresponding author), UNIV PENN,CHILDRENS HOSP PHILADELPHIA,DEPT PEDIAT,DIV HUMAN GENET & MOL BIOL,34TH & CIV CTR BLVD,PHILADELPHIA,PA 19104, USA.		Wilkie, Andrew/AAC-3820-2020; Hollway, Georgina E/E-6764-2010; McDonald-McGinn, Donna/L-8643-2019	Wilkie, Andrew/0000-0002-2972-5481; Muenke, Maximilian/0000-0002-7719-6545; Clarke, Lorne/0000-0003-0512-7281; Bellus, Gary/0000-0001-7492-3324	NICHD NIH HHS [R29HD28732, R01HD29862] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029862, R29HD028732] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADES LC, 1994, AM J MED GENET, V51, P121, DOI 10.1002/ajmg.1320510208; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; COHEN M M JR, 1986, P413; COHEN MM, 1995, AM J MED GENET, V56, P334, DOI 10.1002/ajmg.1320560327; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; ElGhouzzi V, 1997, NAT GENET, V15, P42; Glass I A, 1994, Clin Dysmorphol, V3, P215; Golla Astrid, 1996, European Journal of Human Genetics, V4, P141; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; HOLLWAY GE, 1995, HUM MOL GENET, V4, P681, DOI 10.1093/hmg/4.4.681; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; HUNTER AGW, 1977, TERATOLOGY, V15, P301, DOI 10.1002/tera.1420150312; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; MA HW, 1995, HUM GENET, V96, P731, DOI 10.1007/BF00210308; MARTSOLF J T, 1971, American Journal of Diseases of Children, V121, P257; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Meyers GA, 1996, AM J HUM GENET, V58, P491; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PFEIFFER R A, 1964, Z Kinderheilkd, V90, P301, DOI 10.1007/BF00447500; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; ROBIN NH, 1994, HUM MOL GENET, V3, P2153, DOI 10.1093/hmg/3.12.2153; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STEINBERGER D, 1995, HUM GENET, V96, P113, DOI 10.1007/BF00214198; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TAVORMINA PL, 1995, HUM MOL GENET, V4, P2174; TSUJI K, 1994, AM J MED GENET, V49, P98, DOI 10.1002/ajmg.1320490119; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; vonGernet S, 1996, AM J MED GENET, V63, P177; Wilkes D, 1996, J MED GENET, V33, P744, DOI 10.1136/jmg.33.9.744; WILKIE AOM, 1995, J MED GENET, V32, P174, DOI 10.1136/jmg.32.3.174; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WILKIE AOM, 1995, CURR BIOL, V5, P500	54	302	314	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					555	564						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042914				2022-12-18	WOS:A1997WK40300011
J	Whittemore, AS; Gong, G; Itnyre, J				Whittemore, AS; Gong, G; Itnyre, J			Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three US population-based case-control studies of ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK	We investigate the familial risks of cancers of the breast and ovary, using data pooled from three populationbased case-control studies of ovarian cancer that were conducted in the United States. We base estimates of the frequency of mutations of BRCA1 (and possibly other genes) on the reported occurrence of breast cancer and ovarian cancer in the mothers and sisters of 922 women with incident ovarian cancer (cases) and in 922 women with no history of ovarian cancer (controls). Segregation analysis and goodness-of-fit testing of genetic models suggest that rare mutations (frequency .0014; 95% confidence interval .0002-.011) account for all the observed aggregation of breast cancer and ovarian cancer in these families. The estimated risk of breast cancer by age 80 years is 73.5% in mutation carriers and 6.8% in noncarriers. The corresponding estimates for ovarian cancer are 27.8% in carriers and 1.8% in noncarriers. For cancer risk in carriers, these estimates are lower than those obtained from families selected for high cancer prevalence. The estimated proportion of all U.S. cancer diagnoses, by age 80 years, that are due to germ-line BRCA1 mutations is 3.0% for breast cancer and 4.4% for ovarian cancer. Aggregation of breast cancer and ovarian cancer was less evident in the families of 163 cases with borderline ovarian cancers than in the families of cases with invasive cancers, Familial aggregation did not differ by the ethnicity of the probands, although the number of non-White and Hispanic cases (N=99) was sparse.			Whittemore, AS (corresponding author), STANFORD UNIV,SCH MED,DEPT HLTH RES & POLICY,REDWOOD BLDG,ROOM T204,STANFORD,CA 94305, USA.				NCI NIH HHS [CA-R29-47448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Auranen A, 1996, AM J EPIDEMIOL, V144, P548, DOI 10.1093/oxfordjournals.aje.a008964; CASAGRANDE JT, 1979, LANCET, V2, P170; *CASH, 1987, NEW ENGL J MED, V316, P650; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1995, AM J HUM GENET, V56, P265; FORD D, 1995, AM J HUM GENET, V57, P1457; KELSEY J, 1996, OBSERVATIONAL EPIDEM; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; NAROD SA, 1995, AM J HUM GENET, V56, P254; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; SCHILDKRAUT JM, 1988, AM J EPIDEMIOL, V128, P456, DOI 10.1093/oxfordjournals.aje.a114994; WHITTEMORE AS, 1988, AM J EPIDEMIOL, V128, P1228, DOI 10.1093/oxfordjournals.aje.a115077; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1175, DOI 10.1093/oxfordjournals.aje.a116426	14	302	304	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					496	504						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042908				2022-12-18	WOS:A1997WK40300005
J	MacDermot, KD; Bonora, E; Sykes, N; Coupe, AM; Lai, CSL; Vernes, SC; Vargha-Khadem, F; McKenzie, F; Smith, RL; Monaco, AP; Fisher, SE				MacDermot, KD; Bonora, E; Sykes, N; Coupe, AM; Lai, CSL; Vernes, SC; Vargha-Khadem, F; McKenzie, F; Smith, RL; Monaco, AP; Fisher, SE			Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTIONAL REPRESSORS; SUSCEPTIBILITY GENE; INHERITED SPEECH; FORKHEAD-DOMAIN; EXPRESSION; DISORDER; BRAIN; IMPAIRMENT; MUTATIONS; EVOLUTION	FOXP2, the first gene to have been implicated in a developmental communication disorder, offers a unique entry point into neuromolecular mechanisms influencing human speech and language acquisition. In multiple members of the well-studied KE family, a heterozygous missense mutation in FOXP2 causes problems in sequencing muscle movements required for articulating speech ( developmental verbal dyspraxia), accompanied by wider deficits in linguistic and grammatical processing. Chromosomal rearrangements involving this locus have also been identified. Analyses of FOXP2 coding sequence in typical forms of specific language impairment (SLI), autism, and dyslexia have not uncovered any etiological variants. However, no previous study has performed mutation screening of children with a primary diagnosis of verbal dyspraxia, the most overt feature of the disorder in affected members of the KE family. Here, we report investigations of the entire coding region of FOXP2, including alternatively spliced exons, in 49 probands affected with verbal dyspraxia. We detected variants that alter FOXP2 protein sequence in three probands. One such variant is a heterozygous nonsense mutation that yields a dramatically truncated protein product and cosegregates with speech and language difficulties in the proband, his affected sibling, and their mother. Our discovery of the first nonsense mutation in FOXP2 now opens the door for detailed investigations of neurodevelopment in people carrying different etiological variants of the gene. This endeavor will be crucial for gaining insight into the role of FOXP2 in human cognition.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ London Imperial Coll Sci & Technol, Dept Med & Community Genet, London, England; UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London, England; John Hunter Childrens Hosp Genet & Neurol, Waratah, Australia	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; University of London; University College London	Fisher, SE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	simon.fisher@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Fisher, Simon E./E-9130-2012; Vernes, Sonja/E-8454-2012; Mckenzie, Fiona/AAB-1456-2021; Vargha-Khadem, Faraneh/C-2558-2008	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; Vernes, Sonja/0000-0003-0305-4584; Bonora, Elena/0000-0001-6132-7734; Simpson, Nuala/0000-0003-3390-9993; vargha-khadem, faraneh/0000-0003-4890-8379	Medical Research Council [G0300117] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0300117] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Flint J, 2003, CURR OPIN GENET DEV, V13, P310, DOI 10.1016/S0959-437X(03)00049-2; Gauthier J, 2003, AM J MED GENET A, V118A, P172, DOI 10.1002/ajmg.a.10105; Griffiths R., 1970, ABILITIES YOUNG CHIL; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Kaminen N, 2003, J MED GENET, V40, P340, DOI 10.1136/jmg.40.5.340; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lewis BA, 2004, J COMMUN DISORD, V37, P157, DOI 10.1016/j.jcomdis.2003.08.003; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; LIEGEOIS FJ, 2001, ABSTR SOC NEUROSCI, V27, P529; Marcus GF, 2003, TRENDS COGN SCI, V7, P257, DOI 10.1016/S1364-6613(03)00104-9; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Saleem RA, 2003, HUM MOL GENET, V12, P2993, DOI 10.1093/hmg/ddg324; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wassink TH, 2002, AM J MED GENET, V114, P566, DOI 10.1002/ajmg.10415; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Webb DM, 2005, J HERED, V96, P212, DOI 10.1093/jhered/esi025; World Health Organization, 1993, ICD 10 CLASS MENT BE; Zhang JZ, 2002, GENETICS, V162, P1825; Zimmerman I., 1992, PRESCHOOL LANGUAGE S	36	300	309	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1074	1080		10.1086/430841	http://dx.doi.org/10.1086/430841			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15877281	Green Published, Bronze			2022-12-18	WOS:000229047900013
J	Repping, S; Skaletsky, H; Lange, J; Silber, S; van der Veen, F; Oates, RD; Page, DC; Rozen, S				Repping, S; Skaletsky, H; Lange, J; Silber, S; van der Veen, F; Oates, RD; Page, DC; Rozen, S			Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTRACHROMOSOMAL RECOMBINATION; MALE-INFERTILITY; DAZ GENES; MICRODELETIONS; REGION; REARRANGEMENTS; AZOOSPERMIA; DUPLICATIONS; LOCALIZATION; REPEATS	It is widely believed that at least three nonoverlapping regions of the human Y chromosome-AZFa, AZFb, and AZFc ("azoospermia factors" a, b, and c)-are essential for normal spermatogenesis. These intervals are defined by interstitial Y-chromosome deletions that impair or extinguish spermatogenesis. Deletion breakpoints, mechanisms, and lengths, as well as inventories of affected genes, have been elucidated for deletions of AZFa and of AZFc but not for deletions of A-ZFb or of AZFb plus AZFc. We studied three deletions of AZFb and eight deletions of AZA plus AZFc, as assayed by the STSs defining these intervals. Guided by Y-chromosome sequence, we localized breakpoints precisely and were able to sequence nine of the deletion junctions. Homologous recombination can explain seven of these deletions but not the remaining two. This fact and our discovery of breakpoint hotspots suggest that factors in addition to homology underlie these deletions. The deletions previously thought to define AZFb were found to extend from palindrome P5 to the proximal arm of palindrome P1, 1.5 Mb within AZZFc. Thus, they do not define a genomic region separate from AZFc. We also found that the deletions of A-ZFb plus AZFc, as assayed by standard STSs heretofore available, in fact extend from PS to the distal arm of P1 and spare distal AZFc. Both classes of deletions are massive: P5/proximal-P1 deletions encompass up to 6.2 Mb and remove 32 genes and transcripts; P5/distal-P1 deletions encompass up to 7.7 Mb and remove 42 genes and transcripts. To our knowledge, these are the largest of all human interstitial deletions for which deletion junctions and complete intervening sequence are available. The restriction of the associated phenotype to spermatogenic failure indicates the remarkable functional specialization of the affected regions of the Y chromosome.	Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, England; Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO USA; Boston Univ, Med Ctr, Dept Urol, Boston, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Amsterdam; Academic Medical Center Amsterdam; Saint Luke's Hospital - Missouri; Boston University	Rozen, S (corresponding author), Whitehead Inst, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	rozen@wi.mit.edu	; Rozen, Steven G./J-5939-2013	Oates, Robert/0000-0003-2330-6697; Repping, Sjoerd/0000-0002-6959-149X; Rozen, Steven G./0000-0002-4288-0056				Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Aradhya S, 2001, HUM MOL GENET, V10, P2557, DOI 10.1093/hmg/10.22.2557; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Brandell RA, 1998, HUM REPROD, V13, P2812, DOI 10.1093/humrep/13.10.2812; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; DAVID G, 1979, FERTIL STERIL, V31, P453; de Vries JWA, 2002, FERTIL STERIL, V77, P68, DOI 10.1016/S0015-0282(01)02935-1; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Elliott DJ, 2000, J ENDOCRINOL INVEST, V23, P652, DOI 10.1007/BF03343789; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Ferlin A, 1999, HUM REPROD, V14, P1710, DOI 10.1093/humrep/14.7.1710; Friel A, 2001, INT J ANDROL, V24, P31, DOI 10.1046/j.1365-2605.2001.00264.x; Girardi SK, 1997, HUM REPROD, V12, P1635, DOI 10.1093/humrep/12.8.1635; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Krausz C, 1999, J CLIN ENDOCR METAB, V84, P3606, DOI 10.1210/jc.84.10.3606; Lin YM, 2000, UROLOGY, V56, P1041, DOI 10.1016/S0090-4295(00)00846-3; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MACLEOD J, 1979, FERTIL STERIL, V31, P103; MACLEOD J, 1951, J UROLOGY, V66, P436, DOI 10.1016/S0022-5347(17)74358-3; Martinez MC, 2000, J ANDROL, V21, P651; Maurer B, 2001, ANDROLOGIA, V33, P27, DOI 10.1046/j.1439-0272.2001.00406.x; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; OATES RD, IN PRESS HUM REPROD; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Rozen S, 2000, Methods Mol Biol, V132, P365; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Simoni M, 1997, FERTIL STERIL, V67, P542, DOI 10.1016/S0015-0282(97)80083-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Van Landuyt L, 2000, MOL HUM REPROD, V6, P291, DOI 10.1093/molehr/6.4.291; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; World Health Organization, 1992, WHO LAB MAN EX HUM S, V3rd; Yen P, 2001, NAT GENET, V29, P243, DOI 10.1038/ng1101-243; Yen PH, 1998, GENOMICS, V54, P5, DOI 10.1006/geno.1998.5526; ZUKERMAN Z, 1977, FERTIL STERIL, V28, P1310	41	300	335	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					906	922		10.1086/342928	http://dx.doi.org/10.1086/342928			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12297986	Green Published, Bronze			2022-12-18	WOS:000178613800017
J	Shiels, A; Mackay, D; Ionides, A; Berry, V; Moore, A; Bhattacharya, S				Shiels, A; Mackay, D; Ionides, A; Berry, V; Moore, A; Bhattacharya, S			A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	47th Annual Meeting of the American-Society-of-Human-Genetics	OCT 28-NOV 01, 1997	BALTIMORE, MARYLAND	Amer Soc Human Genet			CONGENITAL CATARACT; CRYSTALLIN GENE; GAP-JUNCTION; HEREDITARY CATARACT; MOLECULAR-CLONING; LINKAGE ANALYSIS; BETA-CRYSTALLIN; PROTEIN MP70; LOCUS; MOUSE	CZP1, a locus for autosomal dominant "zonular pulveruleut" cataract, previously had been linked with the Duffy blood-group-antigen locus on chromosome Iq, Here we report genetic refinement of the CZP1 locus and show that the underlying mutation is present in GJA8, the gene for connexin50. To mag the CZP1: focus we performed linkage analysis using microsatellite markers on two distantly related branches of the original Ev, pedigree, which now spans eight generations. Significantly positive two-point LOD score (Z) values were obtained for markers D1S2669 (maximum Z [Z(max)] = 4.52; maximum recombination frequency [theta(max)] = 0) and D1S514 (Z(max) = 4.48; theta(max) = 0), Multipoint analysis gave Z(max) = 5.22 (theta(max) = 0) at marker D1S2669. Haplotyping indicated that CZP1 probably lies in the genetic interval D1S2746-(20.6 cM)-D1S2771. Sequence analysis of the entire protein-coding region of the GJA8 gene from the pedigree detected a C-->T transition in codon 88, which introduced a novel MnlI restriction-enzyme site that also cosegregated with the cataract, This missense mutation is predicted so result in the nonconservative substitution of serine for a phylogenetically conserved proline (P88S). These studies provide the first direct evidence that GJA8 plays a vital role in the maintenance of human lens transparency and identify the genetic defect believed to underlie the first inherited disease to be linked to a human autosome.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cataract Res Ctr, St Louis, MO 63110 USA; Inst Ophthalmol, Dept Mol Genet, London, England; Moorfields Eye Hosp, London, England	Washington University (WUSTL); University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cataract Res Ctr, Box 8096, St Louis, MO 63110 USA.	shielsa@am.seer.wustl.edu	Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Mackay, Donna/0000-0002-2499-1203	NATIONAL EYE INSTITUTE [P30EY002687, R01EY011411] Funding Source: NIH RePORTER; NEI NIH HHS [EY11411, EY02687] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams P H, 1942, Br J Ophthalmol, V26, P152, DOI 10.1136/bjo.26.4.152; ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; Bort S, 1997, HUM GENET, V99, P746, DOI 10.1007/s004390050442; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; CHURCH RL, 1995, CURR EYE RES, V14, P215, DOI 10.3109/02713689509033517; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; FRANCOIS J, 1982, OPHTHALMOLOGICA, V184, P61, DOI 10.1159/000309186; Geyer D D, 1997, Mol Vis, V3, P13; Ionides ACW, 1997, HUM MOL GENET, V6, P47, DOI 10.1093/hmg/6.1.47; *J HOPK U, 1997, ONL MEND INH MAN OMI; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KERSCHER S, 1995, GENOMICS, V29, P445, DOI 10.1006/geno.1995.9983; Kramer P, 1996, GENOMICS, V35, P539, DOI 10.1006/geno.1996.0395; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; LUND AM, 1992, CLIN GENET, V41, P65; Mackay D, 1997, AM J HUM GENET, V60, P1474, DOI 10.1086/515468; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; Merin S., 1991, INHERITED EYE DIS, P86; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.0.CO;2-M; Nettleship E., 1909, T OPHTHAL SOC UK, V29, P188; Nettleship E, 1906, T OPHTHAL SOC UK, V26, P191; PADMA T, 1995, AM J HUM GENET, V57, P840; RENWICK J H, 1970, Journal of Medical Genetics, V7, P239, DOI 10.1136/jmg.7.3.239; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; RODRIGUEZ IR, 1992, BIOCHIM BIOPHYS ACTA, V1180, P44, DOI 10.1016/0925-4439(92)90025-I; Rogaev EI, 1996, HUM MOL GENET, V5, P699, DOI 10.1093/hmg/5.5.699; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Steele E C Jr, 1997, Mol Vis, V3, P5; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; WAARDENBURG PJ, 1961, GENET OPHTHALMOL, V1, P863; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1997, MOL BIOL CELL, V8, P93; Yang DI, 1996, CURR EYE RES, V15, P307, DOI 10.3109/02713689609007625; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	49	300	316	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					526	532		10.1086/301762	http://dx.doi.org/10.1086/301762			7	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497259	Green Published, Bronze			2022-12-18	WOS:000072894400005
J	Bianchi, DW; Williams, JM; Sullivan, LM; Hanson, FW; Klinger, KW; Shuber, AP				Bianchi, DW; Williams, JM; Sullivan, LM; Hanson, FW; Klinger, KW; Shuber, AP			PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	46th Annual Meeting of the American-Society-of-Human-Genetics	OCT 29-NOV 02, 1996	SAN FRANCISCO, CA	Amer Soc Human Genet			PRENATAL-DIAGNOSIS; PERIPHERAL-BLOOD; TRISOMY-21; KARYOTYPE	Fetal cells in maternal blood are a noninvasive source of fetal genetic material for prenatal diagnosis. We determined the number of fetal-cell DNA equivalents present in maternal whole-blood samples to deduce whether this number is affected by fetal karyotype. Peripheral blood samples were obtained from 199 women carrying chromosomally normal fetuses and from 31 women with male aneuploid fetuses. Male fetal-cell DNA-equivalent quantitation was determined by PCR amplification of a Y chromosome-specific sequence and was compared with PCR product amplified from known concentrations of male DNA run simultaneously. The mean number of male fetal-cell DNA equivalents detected in 16-ml blood samples from 30 women bearing a 46,XY fetus was 19 (range 0-31). The mean number of male fetal-cell DNA equivalents detected in 109 women bearing a 46,XX fetus was 2 (range 0-24). The mean number of male fetal-cell DNA equivalents detected when the fetus was male compared with when the fetus was female was highly significant (P = .0001). More fetal cells were detected in maternal blood when the fetus was aneuploid. The mean number of male fetal-cell DNA equivalents detected when the fetal karyotype was 47,XY,+21 was 110 (range 0.1-650), which was significantly higher than the number of male fetal-cell DNA equivalents detected in 46,XY fetuses (P = .0001). Fete-maternal transfusion of nucleated cells appears to be influenced by fetal karyotype. The sixfold elevation of fetal cells observed in maternal blood when the fetus had trisomy 21 indicates that noninvasive cytogenetic diagnosis of trisomy 21 should be feasible.	TUFTS UNIV NEW ENGLAND MED CTR,DEPT OBSTET & GYNECOL,BOSTON,MA 02111; TUFTS UNIV,SCH MED,BOSTON,MA 02111; BOSTON MED CTR,GEN INTERNAL MED SECT,RES UNIT,BOSTON,MA; GENZYME CORP,CAMBRIDGE,MA; PRENATAL DIAGNOST & IMAGING CTR,SACRAMENTO,CA; GENZYME GENET,FRAMINGHAM,MA	Tufts Medical Center; Tufts University; Boston Medical Center; Sanofi-Aventis; Genzyme Corporation; Sanofi-Aventis; Genzyme Corporation	Bianchi, DW (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR,DEPT PEDIAT,750 WASHINGTON ST,BOX 394,BOSTON,MA 02111, USA.			Sullivan, Lisa/0000-0003-0726-7149				ALLEN FH, 1982, RH HEMOLYTIC DIS NEW, P1; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1994, AM J OBSTET GYNECOL, V171, P922, DOI 10.1016/S0002-9378(94)70059-1; BIANCHI DW, 1992, HUM GENET, V90, P368; BIANCHI DW, 1995, J PEDIATR-US, V127, P847, DOI 10.1016/S0022-3476(95)70018-8; DELACRUZ F, 1995, AM J OBSTET GYNECOL, V173, P1354, DOI 10.1016/0002-9378(95)91393-9; ELIAS S, 1992, LANCET, V340, P1033, DOI 10.1016/0140-6736(92)93041-K; GANSHIRTAHLERT D, 1993, AM J REPROD IMMUNOL, V30, P194; HAWES CS, 1994, AM J OBSTET GYNECOL, V170, P1297; KUHLMANN RS, 1990, AM J OBSTET GYNECOL, V163, P1264, DOI 10.1016/0002-9378(90)90704-B; LABBE S, 1989, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V18, P989; LUCOTTE G, 1991, MOL CELL PROBE, V5, P359, DOI 10.1016/S0890-8508(06)80007-1; PRICE JO, 1991, AM J OBSTET GYNECOL, V165, P1731, DOI 10.1016/0002-9378(91)90024-L; READING JP, 1995, HUM REPROD, V10, P2510; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; STROBEL SL, 1989, ARCH PATHOL LAB MED, V109, P775; SULLIVAN LM, 1992, J DENT RES, V71, P1938, DOI 10.1177/00220345920710121601; TAKABAYASHI H, 1995, PRENATAL DIAG, V15, P74, DOI 10.1002/pd.1970150116; VERLOES A, 1995, AM J OBSTET GYNECOL, V172, P167, DOI 10.1016/0002-9378(95)90108-6; Wald NJ, 1995, PRENATAL DIAG, V15, P1227, DOI 10.1002/pd.1970151305; WESSMAN M, 1992, PRENATAL DIAG, V12, P993, DOI 10.1002/pd.1970121204; ZHENG YL, 1995, PRENATAL DIAG, V15, P897, DOI 10.1002/pd.1970151004	22	300	352	1	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					822	829		10.1086/514885	http://dx.doi.org/10.1086/514885			8	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382092	Green Published, hybrid			2022-12-18	WOS:A1997YA59100008
J	Bergwitz, C; Roslin, NM; Tieder, M; Loredo-Osti, JC; Bastepe, M; Abu-Zahra, H; Frappier, D; Burkett, K; Carpenter, O; Anderson, D; Garabedian, M; Sermet, I; Fujiwara, TM; Morgan, K; Tenenhouse, HS; Juppner, H				Bergwitz, C; Roslin, NM; Tieder, M; Loredo-Osti, JC; Bastepe, M; Abu-Zahra, H; Frappier, D; Burkett, K; Carpenter, O; Anderson, D; Garabedian, M; Sermet, I; Fujiwara, TM; Morgan, K; Tenenhouse, HS; Juppner, H			SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NA/PI COTRANSPORTER; PARATHYROID-HORMONE; I-COTRANSPORTER; GENE; EXPRESSION; ABLATION; IDENTIFICATION; POLYMORPHISMS; OSTEOMALACIA; LINKAGE	Hereditary hypophosphatemic rickets with hypercalciuria ( HHRH) is a rare disorder of autosomal recessive inheritance that was first described in a large consanguineous Bedouin kindred. HHRH is characterized by the presence of hypophosphatemia secondary to renal phosphate wasting, radiographic and/or histological evidence of rickets, limb deformities, muscle weakness, and bone pain. HHRH is distinct from other forms of hypophosphatemic rickets in that affected individuals present with hypercalciuria due to increased serum 1,25-dihydroxyvitamin D levels and increased intestinal calcium absorption. We performed a genomewide linkage scan combined with homozygosity mapping, using genomic DNA from a large consanguineous Bedouin kindred that included 10 patients who received the diagnosis of HHRH. The disease mapped to a 1.6-Mbp region on chromosome 9q34, which contains SLC34A3, the gene encoding the renal sodium-phosphate cotransporter NaPi-IIc. Nucleotide sequence analysis revealed a homozygous single-nucleotide deletion ( c. 228delC) in this candidate gene in all individuals affected by HHRH. This mutation is predicted to truncate the NaPi-IIc protein in the first membrane-spanning domain and thus likely results in a complete loss of function of this protein in individuals homozygous for c. 228delC. In addition, compound heterozygous missense and deletion mutations were found in three additional unrelated HHRH kindreds, which supports the conclusion that this disease is caused by SLC34A3 mutations affecting both alleles. Individuals of the investigated kindreds who were heterozygous for a SLC34A3 mutation frequently showed hypercalciuria, often in association with mild hypophosphatemia and/or elevations in 1,25-dihydroxyvitamin D levels. We conclude that NaPi-IIc has a key role in the regulation of phosphate homeostasis.	Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Pediat Nephrol, IL-69978 Tel Aviv, Israel; Yale Univ, Sch Med, Dept Pediat Endocrinol, New Haven, CT USA; John Hunter Childrens Hosp, Dept Endocrinol, Newcastle, NSW, Australia; Hop Necker Enfants Malad, Dept Pediat, Paris, France; Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; McGill University; McGill University; McGill University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Simon Fraser University	Bergwitz, C (corresponding author), Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA.	cbergwitz@partners.org	Bastepe, Murat/GQQ-3389-2022	Roslin, Nicole/0000-0002-4609-8299; Bastepe, Murat/0000-0002-2643-3504	NICHD NIH HHS [K24 HD001288, K24-HD-01288] Funding Source: Medline; NIDDK NIH HHS [R01 DK 46718, R03 DK089127, R01 DK046718, K08 DK078361] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089127, K08DK078361, R01DK046718] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bacconi A, 2005, P NATL ACAD SCI USA, V102, P12606, DOI 10.1073/pnas.0505882102; Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; Bastepe M, 2000, MOL CELL PROBE, V14, P261, DOI 10.1006/mcpr.2000.0308; Bastepe M, 1999, MOL CELL PROBE, V13, P449, DOI 10.1006/mcpr.1999.0271; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; GAZIT D, 1991, J CLIN ENDOCR METAB, V72, P229, DOI 10.1210/jcem-72-1-229; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GUPTA M, 2001, J BIOL CHEM, V2, P2; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hilfiker H, 1998, PFLUG ARCH EUR J PHY, V436, P591, DOI 10.1007/s004240050676; Holm IA, 1997, AM J HUM GENET, V60, P790; Jones AO, 2001, J AM SOC NEPHROL, V12, P507, DOI 10.1681/ASN.V123507; Karim-Jimenez Z, 2000, P NATL ACAD SCI USA, V97, P12896, DOI 10.1073/pnas.220394197; Karim-Jimenez Z, 2001, PFLUG ARCH EUR J PHY, V442, P782, DOI 10.1007/s004240100602; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KEMPSON SA, 1995, AM J PHYSIOL-RENAL, V268, pF784, DOI 10.1152/ajprenal.1995.268.4.F784; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KOS CH, 1998, THESIS MCGILL U MONT; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lazarus R, 2002, GENOMICS, V80, P223, DOI 10.1006/geno.2002.6820; Liu SG, 2005, J AM SOC NEPHROL, V16, P1645, DOI 10.1681/ASN.2004121060; Madjdpour C, 2004, PFLUG ARCH EUR J PHY, V448, P402, DOI 10.1007/s00424-004-1253-x; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Miyamoto K, 2002, J AM SOC NEPHROL, V13, p284A; Miyamoto KI, 2004, JPN J PHYSIOL, V54, P93, DOI 10.2170/jjphysiol.54.93; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Ohkido I, 2003, PFLUG ARCH EUR J PHY, V446, P106, DOI 10.1007/s00424-003-1010-6; Pal DK, 2001, EUR J HUM GENET, V9, P855, DOI 10.1038/sj.ejhg.5200724; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Sermet-Gaudelus I, 2001, NEPHRON, V88, P83, DOI 10.1159/000045964; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Tenenhouse HS, 1998, AM J PHYSIOL-RENAL, V275, pF527, DOI 10.1152/ajprenal.1998.275.4.F527; Tenenhouse HS, 2005, ANNU REV NUTR, V25, P197, DOI 10.1146/annurev.nutr.25.050304.092642; Tenenhouse HS, 2004, AM J PHYSIOL-RENAL, V286, pF675, DOI 10.1152/ajprenal.00362.2003; Tenenhouse HS, 2003, AM J PHYSIOL-RENAL, V285, pF1271, DOI 10.1152/ajprenal.00252.2003; TIEDER M, 1993, NEPHRON, V64, P526, DOI 10.1159/000187395; TIEDER M, 1987, NEW ENGL J MED, V316, P125, DOI 10.1056/NEJM198701153160302; van den Heuvel L, 2001, NEPHROL DIAL TRANSPL, V16, P48, DOI 10.1093/ndt/16.1.48; Virkki LV, 2005, AM J PHYSIOL-RENAL, V288, pF969, DOI 10.1152/ajprenal.00293.2004; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664	54	299	316	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					179	192		10.1086/499409	http://dx.doi.org/10.1086/499409			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16358214	Bronze, Green Published			2022-12-18	WOS:000236744900001
J	Hampe, J; Schreiber, S; Shaw, SH; Lau, KF; Bridger, S; Macpherson, AJS; Cardon, LR; Sakul, H; Harris, TJR; Buckler, A; Hall, J; Stokkers, P; van Deventer, SJH; Nurnberg, P; Mirza, MM; Lee, JCW; Lennard-Jones, JE; Mathew, CG; Curran, ME				Hampe, J; Schreiber, S; Shaw, SH; Lau, KF; Bridger, S; Macpherson, AJS; Cardon, LR; Sakul, H; Harris, TJR; Buckler, A; Hall, J; Stokkers, P; van Deventer, SJH; Nurnberg, P; Mirza, MM; Lee, JCW; Lennard-Jones, JE; Mathew, CG; Curran, ME			A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; TURNERS-SYNDROME; CLINICAL CHARACTERISTICS; SUSCEPTIBILITY LOCUS; FAMILIAL OCCURRENCE; HLA ANTIGENS; GENES; RISK	Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, typically starting in early adulthood. IBD is subdivided into two subtypes, on the basis of clinical and histologic features: Crohn disease and ulcerative colitis (UC). Previous genomewide searches identified regions harboring susceptibility loci on chromosomes 1, 3, 4, 7, 12, and 16. To expand our understanding of the genetic risk profile, we performed a 9-cM genomewide search for susceptibility loci in 268 families containing 353 affected sibling pairs. Previous linkages on chromosomes 12 and 16 were replicated, and the chromosome 4 linkage was extended in this sample. New suggestive evidence for autosomal linkages was observed on chromosomes 1, 6, 10, and 22, with LOD scores of 2.08, 2.07, 2.30, and 1.52, respectively. A maximum LOD score of 1.76 was observed on the X chromosome, for UC, which is consistent with the clinical association of IBD with Ullrich-Turner syndrome. The linkage finding on chromosome 6p is of interest, given the possible contribution of human leukocyte antigen and tumor necrosis-factor genes in IBD. This genomewide linkage scan, done with a large family cohort, has confirmed three previous IBD linkages and has provided evidence for five additional regions that may harbor IBD predisposition genes.	Univ Kiel, Dept Med 1, Kiel, Germany; Charite, Berlin, Germany; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Kings Coll London, Sch Med, London SE5 9PJ, England; Guys Hosp, Guys Kings & St Thomass Sch Med, Div Med & Mol Genet, London SE1 9RT, England; St Marks Hosp, Harrow, Middx, England; Axys Pharmaceut Inc, Genet, La Jolla, CA 92037 USA	University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London	Curran, ME (corresponding author), Axys Pharmaceut Inc, Genet, 11099 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mark_curran@axyspharm.com	Mathew, Christopher G/G-3434-2015; Hampe, Jochen/A-2555-2010	Mathew, Christopher G/0000-0003-4178-1838; Hampe, Jochen/0000-0002-2421-6127				ARULANANTHAM K, 1980, PEDIATRICS, V66, P63; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BERGLOONEN EMVD, 1977, J IMMUNOGENET, V4, P167; BIEMOND I, 1986, GUT, V27, P934, DOI 10.1136/gut.27.8.934; Bouma G, 1997, CLIN EXP IMMUNOL, V109, P175, DOI 10.1046/j.1365-2249.1997.4121510.x; Bouma G, 1998, IMMUNOGENETICS, V47, P451, DOI 10.1007/s002510050382; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; DELPRE G, 1980, GASTROENTEROLOGY, V78, P1452; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; FIELDING JF, 1986, J CLIN GASTROENTEROL, V8, P655, DOI 10.1097/00004836-198612000-00013; Forcione DG, 1996, P NATL ACAD SCI USA, V93, P5094, DOI 10.1073/pnas.93.10.5094; FUJITA K, 1984, J CLIN LAB IMMUNOL, V14, P99; Gahmberg CG, 1998, CELL MOL LIFE SCI, V54, P549, DOI 10.1007/s000180050183; GLEESON MH, 1972, GUT, V13, P438, DOI 10.1136/gut.13.6.438; HALL J, 1997, CURRENT PROTOCOLS HU, V2; HAMILTON SR, 1987, INT J COLORECTAL DIS, V2, P113, DOI 10.1007/BF01647703; Hampe J, 1998, INT J COLORECTAL DIS, V13, P260, DOI 10.1007/s003840050173; HAMPE J, IN PRESS HUM HERED; Hayward PAR, 1996, QJM-MON J ASSOC PHYS, V89, P713; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HUGOT JP, 1994, AM J MED GENET, V52, P207, DOI 10.1002/ajmg.1320520216; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Idury RM, 1997, GENOME RES, V7, P1104, DOI 10.1101/gr.7.11.1104; KNUDTZON J, 1988, ACTA PAEDIATR SCAND, V77, P922, DOI 10.1111/j.1651-2227.1988.tb10784.x; KNUDTZON J, 1988, ACTA MED SCAND, V223, P375; KOHLER JA, 1981, BRIT MED J, V282, P950, DOI 10.1136/bmj.282.6268.950; Koutroubakis I, 1996, HEPATO-GASTROENTEROL, V43, P381; Kruglyak L, 1996, AM J HUM GENET, V58, P1092; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KUSTER W, 1989, AM J MED GENET, V32, P105, DOI 10.1002/ajmg.1320320122; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MAYBERRY JF, 1989, INT J COLORECTAL DIS, V4, P59, DOI 10.1007/BF01648555; Mirza MM, 1998, J MED GENET, V35, P218, DOI 10.1136/jmg.35.3.218; NAKAJIMA A, 1995, GASTROENTEROLOGY, V109, P1462, DOI 10.1016/0016-5085(95)90631-2; Naom I, 1996, AM J HUM GENET, V59, P226; NORDGREN S, 1992, INT J COLORECTAL DIS, V7, P214, DOI 10.1007/BF00341224; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; ORHOLM M, 1993, BRIT MED J, V306, P20, DOI 10.1136/bmj.306.6869.20; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Peeters M, 1996, GASTROENTEROLOGY, V111, P597, DOI 10.1053/gast.1996.v111.pm8780562; Perri F, 1998, ITAL J GASTROENTEROL, V30, P56; Plevy SE, 1996, GASTROENTEROLOGY, V110, P1053, DOI 10.1053/gast.1996.v110.pm8612993; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; PRICE WH, 1979, J MED GENET, V16, P263, DOI 10.1136/jmg.16.4.263; Probert CSJ, 1996, INT J COLORECTAL DIS, V11, P25, DOI 10.1007/BF00418851; PURRMANN J, 1985, Z GASTROENTEROL, V23, P432; RISCH N, 1990, AM J HUM GENET, V46, P229; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; RUSSELL AS, 1975, AM J DIG DIS, V20, P359, DOI 10.1007/BF01237793; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Scarpa R, 1996, CLIN EXP RHEUMATOL, V14, P449; Schmid P, 1998, AM J PATHOL, V152, P485; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P21, DOI 10.1016/0016-5085(95)90004-7; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SMOLEN JS, 1982, GASTROENTEROLOGY, V82, P34; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Thompson NP, 1996, BRIT MED J, V312, P95; TOYODA H, 1993, GASTROENTEROLOGY, V104, P741, DOI 10.1016/0016-5085(93)91009-7; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Uyar FA, 1998, EUR J IMMUNOGENET, V25, P293, DOI 10.1046/j.1365-2370.1998.00104.x	69	299	314	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					808	816		10.1086/302294	http://dx.doi.org/10.1086/302294			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053016	Green Published, Bronze			2022-12-18	WOS:000079204700019
J	OTT, J				OTT, J			COMPUTER-PROGRAM FOR LINKAGE ANALYSIS OF GENERAL HUMAN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV WASHINGTON,DIV MED GENET RG20,SEATTLE,WA 98195	University of Washington; University of Washington Seattle								ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1973, AM J HUM GENET, V24, pA57	4	299	304	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					528	529						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	984049				2022-12-18	WOS:A1976CH66100013
J	Sengupta, S; Zhivotovsky, LA; King, R; Mehdi, SQ; Edmonds, CA; Chow, CET; Lin, AA; Mitra, M; Sil, SK; Ramesh, A; Rani, MVU; Thakur, CM; Cavalli-Sforza, LL; Majumder, PP; Underhill, PA				Sengupta, S; Zhivotovsky, LA; King, R; Mehdi, SQ; Edmonds, CA; Chow, CET; Lin, AA; Mitra, M; Sil, SK; Ramesh, A; Rani, MVU; Thakur, CM; Cavalli-Sforza, LL; Majumder, PP; Underhill, PA			Polarity and temporality of high-resolution Y-chromosome distributions in India identify both indigenous and exogenous expansions and reveal minor genetic influence of central Asian pastoralists	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASTE POPULATIONS; DIVERGENCE TIME; MUTATION-RATE; HINDU CASTES; HAPLOGROUP-J; LINEAGES; ORIGINS; FLOW; MITOCHONDRIAL; POLYMORPHISMS	Although considerable cultural impact on social hierarchy and language in South Asia is attributable to the arrival of nomadic Central Asian pastoralists, genetic data ( mitochondrial and Y chromosomal) have yielded dramatically conflicting inferences on the genetic origins of tribes and castes of South Asia. We sought to resolve this conflict, using high-resolution data on 69 informative Y-chromosome binary markers and 10 microsatellite markers from a large set of geographically, socially, and linguistically representative ethnic groups of South Asia. We found that the influence of Central Asia on the pre-existing gene pool was minor. The ages of accumulated microsatellite variation in the majority of Indian haplogroups exceed 10,000 - 15,000 years, which attests to the antiquity of regional differentiation. Therefore, our data do not support models that invoke a pronounced recent genetic input from Central Asia to explain the observed genetic variation in South Asia. R1a1 and R2 haplogroups indicate demographic complexity that is inconsistent with a recent single history. Associated microsatellite analyses of the high-frequency R1a1 haplogroup chromosomes indicate independent recent histories of the Indus Valley and the peninsular Indian region. Our data are also more consistent with a peninsular origin of Dravidian speakers than a source with proximity to the Indus and with significant genetic input resulting from demic diffusion associated with agriculture. Our results underscore the importance of marker ascertainment for distinguishing phylogenetic terminal branches from basal nodes when attributing ancestral composition and temporality to either indigenous or exogenous sources. Our reappraisal indicates that pre-Holocene and Holocene-era-not Indo-European-expansions have shaped the distinctive South Asian Y-chromosome landscape.	Indian Stat Inst, Human Genet Unit, Kolkata 700108, India; Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Dr AQ Khan Res Labs, Biomed & Genet Engn Div, Islamabad, Pakistan; Pandit Ravishankar Shukla Univ, Sch Studies Anthropol, Raipur, Madhya Pradesh, India; Tripura Univ, Agartala, India; Univ Madras, Dept Genet, Madras, Tamil Nadu, India; Bharathiar Univ, Dept Environm Sci, Coimbatore, Tamil Nadu, India; BJ Wadia Hosp Children, Bombay, Maharashtra, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Russian Academy of Sciences; Vavilov Institute of General Genetics; Stanford University; Pt. Ravishankar Shukla University; Tripura University; University of Madras; Bharathiar University	Majumder, PP (corresponding author), Indian Stat Inst, Human Genet Unit, 203 Barrackpore Trunk Rd, Kolkata 700108, India.	ppm@isical.ac.in	Mehdi, Syed Qasim/L-2385-2015; Zhivotovsky, Lev A/A-1351-2012; Sengupta, Sanghamitra/AAW-4300-2021		NIGMS NIH HHS [P01 GM028428] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Barbujani G, 2000, HUM BIOL, V72, P133; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Beekes Robert S. P., 1995, COMP INDOEUROPEAN LI; Blazek Vaclav, 1992, ARCH ORIENT, V60, P16; Cann HM, 2002, SCIENCE, V296, P261; Cauvin J., 2000, BIRTH GODS ORIGINS A; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Delfiner P, 1976, ADV GEOSTATISTICS MI, P49; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Fuller Dorian, 2003, EXAMINING FARMING LA, P203; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; KENNEDY KAR, 2000, GOD APES FOSSIL MEN, P165; Kenoyer J, 1998, ANCIENT CITIES INDUS; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2003, EXAMINING FARMING LA, P215; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Majumder PP, 2001, GENOME RES, V11, P931, DOI 10.1101/gr.192401; Malaspina P, 1997, J MOL EVOL, V44, P652; MCALPIN DW, 1974, LANGUAGE, V50, P89, DOI 10.2307/412012; MCALPIN DW, 1981, T AM PHILOS SOC, V71, P3; Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; Renfrew C., 1996, ORIGINS SPREAD AGR P, P70; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; SANDWELL DT, 1987, GEOPHYS RES LETT, V14, P139, DOI 10.1029/GL014i002p00139; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; TAMBETS K, 2003, EXAMINING FARMING LA, P449; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; UNDERHILL PA, 2001, RECENT ADV HUMAN BIO, V8, P43; Weale ME, 2003, GENETICS, V165, P229; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WITZEL M, 2004, LINGUISTICS ARCHAEOL, P87; Wooding S, 2004, HUM GENET, V115, P221, DOI 10.1007/s00439-004-1130-x; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2005, HUM GENET, V116, P529, DOI 10.1007/s00439-005-1281-4; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	58	298	318	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					202	221		10.1086/499411	http://dx.doi.org/10.1086/499411			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400607	Bronze, Green Published			2022-12-18	WOS:000236744900003
J	Gimenez-Roqueplo, AP; Favier, J; Rustin, P; Mourad, JJ; Plouin, PF; Corvol, P; Rotig, A; Jeunemaitre, X				Gimenez-Roqueplo, AP; Favier, J; Rustin, P; Mourad, JJ; Plouin, PF; Corvol, P; Rotig, A; Jeunemaitre, X			The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT PARAGANGLIOMA; FAMILIAL PARAGANGLIOMAS; GLOMUS TUMORS; CANCER; DEFICIENCY; EXPRESSION; DIAGNOSIS; CODON; CELLS	Hereditary paragangliomas are usually benign tumors of the autonomic nervous system that are composed of cells derived from the primitive neural crest. Even though three genes (SDHD, SDHC, and SDHB), which encode three protein subunits of cytochrome b of complex II in the mitochondrial respiratory chain, have been identified, the molecular mechanisms leading to tumorigenesis are unknown. We studied a family in which the father and his eldest son had bilateral neck paragangliomas, whereas the second son had a left carotid-body paraganglioma and an ectopic mediastinal pheochromocytoma. A nonsense mutation (R22X) in the SDHD gene was found in these three affected subjects. Loss of heterozygosity was observed for the maternal chromosome 11q21-q25 within the tumor but not in peripheral leukocytes. Assessment of the activity of respiratory-chain enzymes showed a complete and selective loss of complex II enzymatic activity in the inherited pheochromocytoma, that was not detected in six sporadic pheochromocytomas. In situ hybridization and immunohistochemistry experiments showed a high level of expression of markers of the angiogenic pathway. Real-time quantitative reverse transcriptase (RT)-PCR measurements confirmed that vascular endothelial growth factor and endothelial PAS domain protein 1 mRNA levels were significantly higher (three-and sixfold, respectively) than those observed in three sporadic benign pheochromocytomas. Thus, inactivation of the SDHD gene in hereditary paraganglioma is associated with a complete loss of mitochondrial complex II activity and with a high expression of angiogenic factors.	Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Mol Genet, F-75015 Paris, France; Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Hypertens Arterielle, F-75015 Paris, France; Hop Enfants Malad, INSERM, U393, Paris, France; Coll France, INSERM, U36, F-75231 Paris, France; Hop St Michel, Serv Med Interne, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Gimenez-Roqueplo, AP (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Mol Genet, 20-40 Rue Leblanc, F-75015 Paris, France.		GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018; Favier, Judith/M-7601-2017; JEUNEMAITRE, Xavier/AAQ-4853-2021; Rötig, Agnès/G-9592-2017	GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; Favier, Judith/0000-0001-8190-5853; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Rötig, Agnès/0000-0003-0589-0703; Mourad, Jean-Jacques/0000-0003-0877-8311				Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Badenhop RF, 2001, GENE CHROMOSOME CANC, V31, P255, DOI 10.1002/gcc.1142; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2001, EUR J HUM GENET, V9, P121, DOI 10.1038/sj.ejhg.5200585; Bikhazi PH, 1999, AM J OTOL, V20, P639; BirchMachin MA, 1996, BIOCHEM BIOPH RES CO, V220, P57, DOI 10.1006/bbrc.1996.0356; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Dannenberg H, 2001, AM J PATHOL, V158, P1937, DOI 10.1016/S0002-9440(10)64662-7; Favier J, 1999, FEBS LETT, V462, P19, DOI 10.1016/S0014-5793(99)01476-3; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Gimm O, 2000, CANCER RES, V60, P6822; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jyung RW, 2000, LARYNGOSCOPE, V110, P161, DOI 10.1097/00005537-200001000-00029; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; Koreth J, 1999, J PATHOL, V187, P28, DOI 10.1002/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R; LEGAULTDEMARE L, 1981, NEUROCHEM INT, V3, P301; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Milunsky J, 1997, AM J MED GENET, V72, P66, DOI 10.1002/(SICI)1096-8628(19971003)72:1<66::AID-AJMG14>3.0.CO;2-S; Milunsky JM, 2001, AM J MED GENET, V100, P311, DOI 10.1002/ajmg.1270; Niemann S, 1999, NEUROGENETICS, V2, P167, DOI 10.1007/s100480050078; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Niemann S, 2001, AM J MED GENET, V98, P32; Oosterwijk JC, 1996, J MED GENET, V33, P379, DOI 10.1136/jmg.33.5.379; PACHECOOJEDA L, 1988, WORLD J SURG, V12, P856, DOI 10.1007/BF01655498; Petropoulos AE, 2000, LARYNGOSCOPE, V110, P1225, DOI 10.1097/00005537-200007000-00030; Pfeifer K, 2000, AM J HUM GENET, V67, P777, DOI 10.1086/303101; Prabhakar NR, 2000, J APPL PHYSIOL, V88, P2287, DOI 10.1152/jappl.2000.88.6.2287; Richard DE, 2000, J BIOL CHEM, V275, P26765; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; SIBONY M, 1995, LAB INVEST, V73, P586; VANDERMEY AGL, 1989, LANCET, V2, P1291; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284	40	298	305	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1186	1197		10.1086/324413	http://dx.doi.org/10.1086/324413			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11605159	Bronze, Green Published			2022-12-18	WOS:000172086900003
J	Kalaydjieva, L; Gresham, D; Gooding, R; Heather, L; Baas, F; de Jonge, R; Blechschmidt, K; Angelicheva, D; Chandler, D; Worsley, P; Rosenthal, A; King, RHM; Thomas, PK				Kalaydjieva, L; Gresham, D; Gooding, R; Heather, L; Baas, F; de Jonge, R; Blechschmidt, K; Angelicheva, D; Chandler, D; Worsley, P; Rosenthal, A; King, RHM; Thomas, PK			N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; PERIPHERAL MYELIN PROTEIN; DIFFERENTIAL DISPLAY ANALYSIS; SCHWANN-CELLS; DEMYELINATING NEUROPATHY; POINT MUTATION; TREMBLER-J; WILD-TYPE; EXPRESSION; GROWTH	Hereditary motor and sensory neuropathies, to which Charcot-Marie-Tooth (CMT) disease belongs, are a common cause of disability in adulthood. Growing awareness that axonal loss, rather than demyelination per se, is responsible for the neurological deficit in demyelinating CMT disease has focused research on the mechanisms of early development, cell differentiation, and cell-cell interactions in the peripheral nervous system. Autosomal recessive peripheral neuropathies are relatively rare but are clinically more severe than autosomal dominant forms of CMT, and understanding their molecular basis may provide a new perspective on these mechanisms. Here we report the identification of the gene responsible for hereditary motor and sensory neuropathy-Lom (HMSNL). HMSNL shows features of Schwann-cell dysfunction and a concomitant early axonal involvement, suggesting that impaired axonglia interactions play a major role in its pathogenesis. The gene was previously mapped to 8q24.3, where conserved disease haplotypes suggested genetic homogeneity and a single founder mutation. We have reduced the HMSNL interval to 200 kb and have characterized it by means of large-scale genomic sequencing. Sequence analysis of two genes located in the critical region identified the founder HMSNL mutation: a premature-termination codon at position 148 of the N-myc downstream-regulated gene 1 (NDRG1). NDRG1 is ubiquitously expressed and has been proposed to play a role in growth arrest and cell differentiation, possibly as a signaling protein shuttling between the cytoplasm and the nucleus. We have studied expression in peripheral nerve and have detected particularly high levels in the Schwann cell. Taken together, these findings point to NDRG1 having a role in the peripheral nervous system, possibly in the Schwann-cell signaling necessary for axonal survival.	Edith Cowan Univ, Ctr Human Genet, Perth, WA 6027, Australia; Western Australian Inst Med Res, Perth, WA, Australia; Univ Amsterdam, Acad Med Ctr, Neurozintuigen Lab, NL-1105 AZ Amsterdam, Netherlands; UCL, Inst Neurol, London, England; Inst Mol Biotechnol, Jena, Germany	Edith Cowan University; University of Western Australia; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London	Kalaydjieva, L (corresponding author), Edith Cowan Univ, Ctr Human Genet, Joondalup Campus, Perth, WA 6027, Australia.	L.Kalaydjieva@cowan.edu.au	Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428				Antonarakis SE, 1998, HUM MUTAT, V11, P1; Baechner D, 1995, J NEUROSCI RES, V42, P733, DOI 10.1002/jnr.490420602; Baethmann M, 1998, NEUROMUSCULAR DISORD, V8, P90, DOI 10.1016/S0960-8966(98)00011-X; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; Bouhouche A, 1999, AM J HUM GENET, V65, P722, DOI 10.1086/302542; Butinar D, 1999, ANN NEUROL, V46, P36, DOI 10.1002/1531-8249(199907)46:1<36::AID-ANA7>3.0.CO;2-J; Casaubon LK, 1996, AM J HUM GENET, V58, P28; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANDLER D, 2000, IN PRESS NEUROMUSCUL; COLOMER J, 2000, IN RPESS NEUROMUSCUL; Garcia A, 1998, NEUROLOGY, V50, P1061, DOI 10.1212/WNL.50.4.1061; Hanemann CO, 1997, ACTA NEUROPATHOL, V94, P310, DOI 10.1007/s004010050712; HARDING AE, 1980, J NEUROL NEUROSUR PS, V43, P669, DOI 10.1136/jnnp.43.8.669; Jessen KR, 1998, MICROSC RES TECHNIQ, V41, P393, DOI 10.1002/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; Keller MP, 1999, SEMIN NEUROL, V19, P353, DOI 10.1055/s-2008-1040850; Killian JM, 1996, MUSCLE NERVE, V19, P74, DOI 10.1002/(SICI)1097-4598(199601)19:1<74::AID-MUS10>3.0.CO;2-3; King RHM, 1999, NEUROPATH APPL NEURO, V25, P306; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; KrauterCanham R, 1997, PLANT SCI, V129, P191, DOI 10.1016/S0168-9452(97)00182-9; Kurdistani SK, 1998, CANCER RES, V58, P4439; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MARDIS ER, 1994, NUCLEIC ACIDS RES, V22, P2173, DOI 10.1093/nar/22.11.2173; Merlini L, 1998, NEUROMUSCULAR DISORD, V8, P182, DOI 10.1016/S0960-8966(98)00023-6; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Naef R, 1998, MICROSC RES TECHNIQ, V41, P359, DOI 10.1002/(SICI)1097-0029(19980601)41:5<359::AID-JEMT3>3.0.CO;2-L; Okuda T, 1999, BIOCHEM BIOPH RES CO, V266, P208, DOI 10.1006/bbrc.1999.1780; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Raap A K, 1994, Methods Mol Biol, V33, P123; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; Robertson AM, 1999, J ANAT, V195, P331, DOI 10.1046/j.1469-7580.1999.19530331.x; Sahenk Z, 1999, ANN NY ACAD SCI, V883, P415, DOI 10.1111/j.1749-6632.1999.tb08602.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Sancho S, 1999, BRAIN, V122, P1563, DOI 10.1093/brain/122.8.1563; Schenone A, 1999, CURR OPIN NEUROL, V12, P603, DOI 10.1097/00019052-199910000-00015; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; SNIPES GJ, 1994, TRENDS NEUROSCI, V17, P399, DOI 10.1016/0166-2236(94)90011-6; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; vanBelzen N, 1997, LAB INVEST, V77, P85; Xu B, 1999, BIOL REPROD, V61, P681, DOI 10.1095/biolreprod61.3.681; Yamauchi Y, 1999, MOL BRAIN RES, V68, P149, DOI 10.1016/S0169-328X(99)00084-4; Zhou DJ, 1998, CANCER RES, V58, P2182; Zoidl G, 1997, CELL TISSUE RES, V287, P459, DOI 10.1007/s004410050770	54	298	323	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					47	58		10.1086/302978	http://dx.doi.org/10.1086/302978			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10831399	Green Published, Bronze			2022-12-18	WOS:000088926900008
J	Shriver, MD; Smith, MW; Jin, L; Marcini, A; Akey, JM; Deka, R; Ferrell, RE				Shriver, MD; Smith, MW; Jin, L; Marcini, A; Akey, JM; Deka, R; Ferrell, RE			Ethnic-affiliation estimation by use of population-specific DNA markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEPWISE MUTATION MODEL; LINKAGE DISEQUILIBRIUM; LOCI; MITOCHONDRIAL; POLYMORPHISMS; FREQUENCY; ORIGINS; RACE	During the past 10 years, DNA analysis has revolutionized the determination of identity in a forensic context. Statements about the biological identity of two human DNA samples now can be made with complete confidence. Although DNA markers are very powerful for distinguishing among individuals, most offer little power to distinguish ethnicity or to support any statement about the physical characteristics of an individual. Through a search of the literature and of unpublished data on allele frequencies we have identified a panel of population-specific genetic markers that enable robust ethnic-affiliation estimation for major U.S. resident populations. In this report, we identify these loci and present their levels of allele-frequency differential between ethnically defined samples, and we demonstrate, using log-likelihood analysis, that this panel of markers provides significant statistical power for ethnic-affiliation estimation. In addition to their use in forensic ethnic-affiliation estimation, population-specific genetic markers are very useful in both population- and individual-level admixture estimation and in mapping genes by use of the linkage disequilibrium created when populations hybridize.	NCI,FREDERICK CANC RES & DEV CTR,SAIC,INTRAMURAL RES SUPPORT PROGRAM,FREDERICK,MD; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Stanford University	Shriver, MD (corresponding author), UNIV PITTSBURGH,DEPT HUMAN GENET,130 DE SOTO ST,PITTSBURGH,PA 15235, USA.		Jin, Li/C-1468-2009; Smith, Michael/B-5341-2012; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Shriver, Mark/0000-0003-0006-0479; Akey, Joshua/0000-0002-4411-1330	NIGMS NIH HHS [GM-45861] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045861] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bowcock A M, 1987, Gene Geogr, V1, P47; Bowcock A M, 1991, Gene Geogr, V5, P151; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRISCOE D, 1994, J HERED, V85, P59; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1991, Ethnicity and Disease, V1, P245; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CONNER A, 1994, J FORENSIC SCI, V39, P1360; DEAN M, 1994, AM J HUM GENET, V55, P788; DEKA R, 1995, AM J HUM GENET, V56, P461; DIBENNARDO R, 1983, AM J PHYS ANTHROPOL, V61, P305, DOI 10.1002/ajpa.1330610305; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; ISCAN MY, 1983, AM J PHYS ANTHROPOL, V62, P205, DOI 10.1002/ajpa.1330620210; JORDE LB, 1995, AM J HUM GENET, V57, P523; KIDD JR, 1991, HUM BIOL, V63, P775; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; Nei M, 1987, MOL POPULATION GENET; REED TE, 1973, NATURE, V244, P575, DOI 10.1038/244575a0; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHRIVER MD, 1993, GENETICS, V134, P983; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	28	298	331	1	31	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					957	964						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106543				2022-12-18	WOS:A1997WT61400026
J	ROUSSEAU, F; ROUILLARD, P; MOREL, ML; KHANDJIAN, EW; MORGAN, K				ROUSSEAU, F; ROUILLARD, P; MOREL, ML; KHANDJIAN, EW; MORGAN, K			PREVALENCE OF CARRIERS OF PREMUTATION-SIZE ALLELES OF THE FMRI GENE AND IMPLICATIONS FOR THE POPULATION-GENETICS OF THE FRAGILE-X SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; FOUNDER CHROMOSOMES; PRENATAL-DIAGNOSIS; CGG REPEAT; DNA; INHERITANCE; MUTATION; IDENTIFICATION; INSTABILITY; EXPRESSION	The fragile X syndrome is the second leading cause of mental retardation after Down syndrome. Fragile X premutations are not associated with any clinical phenotype but are at high risk of expanding to full mutations causing the disease when they are transmitted by a carrier woman. There is no reliable estimate of the prevalence of women who are carriers of fragile X premutations. We have screened 10,624 unselected women by Southern blot for the presence of FMR1 premutation alleles and have confirmed their size by PCR analysis. We found 41 carriers of alleles with 55-101 CGG repeats, a prevalence of 1/259 women (95% confidence interval 1/373-1/198). Thirty percent of these alleles carry an inferred haplotype that corresponds to the most frequent haplotype found in fragile X males and may indeed constitute premutations associated with a significant risk of expansion on transmission by carrier women. We identified another inferred haplotype that is rare in both normal and fragile X chromosomes but that is present on 13 (57%) of 23 chromosomes carrying FMR1! alleles with 53-64 CGG repeats. This suggests either (1) that this haplotype may be stable or (2) that the associated premutation-size alleles have not yet reached equilibrium in this population and that the incidence of fragile X syndrome may increase in the future.	UNIV LAVAL,FAC MED,DEPT BIOCHIM,QUEBEC CITY,PQ G1K 7P4,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MONTREAL GEN HOSP,RES INST,MONTREAL,PQ H3G 1A4,CANADA	Laval University; McGill University; McGill University; McGill University	ROUSSEAU, F (corresponding author), HOP ST FRANCIS ASSISE,CTR RECH,UNITE RECH GENET HUMAINE & MOLEC,10 RUE ESPINAY,QUEBEC CITY,PQ G1L 3L5,CANADA.							BONTHRON D, 1993, LANCET, V341, P769, DOI 10.1016/0140-6736(93)90552-R; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BROWN WT, 1986, AM J MED GENET, V23, P341, DOI 10.1002/ajmg.1320230126; BUNDEY S, 1993, LANCET, V341, P770; Charbonneau H., 1987, HIST ATLAS CANADA, V1; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1994, HUM MOL GENET, V9, P1553; HOWARDPEEBLES PN, 1993, LANCET, V341, P770; JACOBS PA, 1993, J MED GENET, V30, P454, DOI 10.1136/jmg.30.6.454; KOLEHMAINEN K, 1994, AM J MED GENET, V51, P428, DOI 10.1002/ajmg.1320510425; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAIRD CD, 1987, GENETICS, V117, P587; MACPHERSON J, 1992, AM J MED GENET, V43, P905, DOI 10.1002/ajmg.1320430535; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; NUSSBAUM RL, 1989, METABOLIC BASIS INHE, P327; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Oudet C., 1993, European Journal of Human Genetics, V1, P181; OUDET C, 1993, AM J HUM GENET, V52, P297; PALOMAKI GE, 1993, LANCET, V341, P373, DOI 10.1016/0140-6736(93)90176-H; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; ROUSSEAU F, 1992, AM J MED GENET, V43, P197, DOI 10.1002/ajmg.1320430133; ROUSSEAU F, 1994, EUR J CLIN INVEST, V24, P1, DOI 10.1111/j.1365-2362.1994.tb02052.x; ROUSSEAU F, 1994, HUM MUTAT, V4, P51, DOI 10.1002/humu.1380040107; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SHERMAN S, 1991, DIAGNOSIS TREATMENT, P69; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WEIR BS, 1990, GENERIC DATA ANAL ME; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	42	298	302	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1006	1018						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485149				2022-12-18	WOS:A1995TA44900005
J	NEEL, JV				NEEL, JV			STUDY OF MAJOR CONGENITAL DEFECTS IN JAPANESE INFANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARESIN N, 1950, Zentralbl Gynakol, V72, P1329; BAUER KH, 1940, HDB ERBBIOLOGIE MENS, V3, P105; BOOK J. A., 1951, ACTA GENET STATIST MED, V2, P289; BOOK JA, 1950, AM J HUM GENET, V2, P61; BOOK JA, 1957, ANN HUM GENET, V21, P191; CARTER CO, 1950, J OBSTET GYN BRIT EM, V57, P897; COFFEY VP, 1955, IRISH J MED SCI, V344, P30; CROW JF, 1958, AM ANTHROPOL, V60, P1; Davis JS, 1924, ANN SURG, V80, P363, DOI 10.1097/00000658-192409000-00007; DEPORTE JV, 1945, NEW YORK STATE J MED, V45, P1097; DOBZHANSKY T, 1955, COLD SPRING HARB SYM, V20, P1; EHRAT R, 1948, MISSBILDUNGEN NEUGEB; Fogh-Andersen P., 1943, OPERA EX DOMO BIOL HEREDITARIAE HUMANAE UNIV HAFNIENSIS, V4, P1; FRASER FC, 1954, AM J SURG, V87, P656, DOI 10.1016/0002-9610(54)90161-0; Gates Reginald Ruggles, 1946, HUMAN GENETICS; GREENBERG M, 1949, PEDIATRICS, V3, P456; HANDFORTH JR, 1950, ANAT REC, V106, P119, DOI 10.1002/ar.1091060202; HARRIS LE, 1954, PEDIATRICS, V14, P314; HEGNAUER H, 1951, Geburtshilfe Frauenheilkd, V11, P777; HERTIG AT, 1949, AM J OBSTET GYNECOL, V58, P968, DOI 10.1016/0002-9378(49)90203-3; HINDSENIELSEN S, 1938, ACTA CHIR SCAND, V80, P525; HIRST JC, 1945, CYCLOPEDIA MEDICINE, V10, P189; INOUYE E, 1957, AM J HUM GENET, V9, P317; KOMAI T, 1947, PEDIGREES HEREDITARY; KOMAI T, 1937, STUDIES JAPANESE TWI, V1; Komai Taku, 1934, PEDIGREES HEREDITARY; Krantz HC, 1947, J SPEECH DISORD, V12, P267, DOI 10.1044/jshd.1203.267; LANDAUER W, 1957, AM NAT, V91, P79, DOI 10.1086/281965; LANDAUER W, 1956, J EXP ZOOL, V132, P25, DOI 10.1002/jez.1401320103; LANDAUER W, 1955, AM NAT, V89, P35, DOI 10.1086/281859; LANDAUER W, 1947, J EXP ZOOL, V105, P145, DOI 10.1002/jez.1401050202; LANDAUER W, 1953, GENETICS, V38, P216; LANDTMAN B, 1948, ARCH DIS CHILD, V23, P237, DOI 10.1136/adc.23.116.237; Lerner IM, 1954, GENETIC HOMEOSTASIS; LILIENFELD AM, 1951, US PUB HLTH REP, V66, P191; LUCY RE, 1949, J LANCET, P80; MacMahon B, 1951, BR J SOC MED, V5, P254; MacMahon B, 1953, BRIT J PREV SOC MED, V7, P211; Mall FP, 1917, AM J ANAT, V22, P49, DOI 10.1002/aja.1000220104; MALPAS P, 1937, J OBSTET GYN BR COMM, V44, P434; MCINTOSH R, 1954, PEDIATRICS, V14, P505; MCKEOWN T, 1953, AM J HUM GENET, V5, P168; MCKEOWN T, 1951, LANCET, V260, P192; MITANI S, 1943, SANKA TO FUJINKA, V11, P345; MOORE TC, 1952, SURGERY, V32, P352; MOORE TC, 1952, SURG GYNECOL OBSTET, V95, P281; MORTON NE, 1958, AM J HUM GENET, V10, P344; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MURPHY DP, 1947, CONGENITAL MALFORMAT; NAUJOKS, 1938, ARCH GYNAK, V166, P445; NEEL JV, 1957, PEDIATRICS, V19, P749; NEEL JV, 1956, 461 NAT AC SCI NAT R; NEWTON L, 1947, Conn State Med J, V11, P617; NOWAK J, 1950, Zentralbl Gynakol, V72, P1313; OHKURA K, 1956, JPN J HUM GENET, V1, P11; PENROSE L S, 1951, Practitioner, V166, P429; PENROSE LS, 1955, LANCET, V2, P312; PENROSE LS, 1957, J MENT DEFIC RES, V1, P4; PENROSE LS, 1946, ANN EUGENIC, V13, P73, DOI 10.1111/j.1469-1809.1946.tb02344.x; POLMAN A, 1951, GENETICA, V25, P29; PRINDLE RA, 1955, NEW ENGL J MED, V252, P555, DOI 10.1056/NEJM195504072521401; Record RG, 1949, BR J SOC MED, V3, P183; Record RG, 1950, BR J SOC MED, V4, P26; RECORD RG, 1951, ANN EUGENIC, V15, P285; SANDERS J., 1934, GENETICA, V15, P433, DOI 10.1007/BF01507412; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; SJOGREN T, 1949, ACTA PSYCHIAT NE S56; SMITH RL, 1956, J NATL CANCER I, V17, P459; STEVENSON SS, 1950, PEDIATRICS, V6, P37; Sutter J, 1953, POPULATION, V8, P511, DOI 10.2307/1525212; Sutter J, 1952, POPULATION, V7, P249, DOI 10.2307/1524207; VOGEL F, 1956, Z MENSCH VERERB KONS, V33, P470; WALLACE HM, 1953, PEDIATRICS, V12, P525; WARKANY J, 1958, EUGEN QUART, V5, P4, DOI 10.1080/19485565.1958.9987340; WOOLF B, 1946, BRIT MED BULL, V4, P170, DOI 10.1093/oxfordjournals.bmb.a072742; WORM M, 1952, Geburtshilfe Frauenheilkd, V12, P443; 1956, EPIDEM VITAL STAT RE, V9, P410; 1956, 6 US NAT OFF VIT STA, V39	78	298	298	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1958	10	4					398	445						48	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA221	13606117				2022-12-18	WOS:A1958WA22100002
J	Behar, DM; van Oven, M; Rosset, S; Metspalu, M; Loogvali, EL; Silva, NM; Kivisild, T; Torroni, A; Villems, R				Behar, Doron M.; van Oven, Mannis; Rosset, Saharon; Metspalu, Malt; Loogvali, Eva-Liis; Silva, Nuno M.; Kivisild, Toomas; Torroni, Antonio; Villems, Richard			A "Copernican" Reassessment of the Human Mitochondrial DNA Tree from its Root	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC ANCESTRY; MTDNA VARIATION; Y-CHROMOSOME; SEQUENCE; EVOLUTION; SELECTION; REVEALS; HETEROPLASMY; REGION	Mutational events along the human mtDNA phylogeny are traditionally identified relative to the revised Cambridge Reference Sequence, a contemporary European sequence published in 1981. This historical choice is a continuous source of inconsistencies, misinterpretations, and errors in medical, forensic, and population genetic studies. Here, after having refined the human mtDNA phylogeny to an unprecedented level by adding information from 8,216 modern mitogenomes, we propose switching the reference to a Reconstructed Sapiens Reference Sequence, which was identified by considering all available mitogenomes from Homo neanderthalensis. This "Copernican" reassessment of the human mtDNA tree from its deepest root should resolve previous problems and will have a substantial practical and educational influence on the scientific and public perception of human evolution by clarifying the core principles of common ancestry for extant descendants.	[Behar, Doron M.; Metspalu, Malt; Loogvali, Eva-Liis; Kivisild, Toomas; Villems, Richard] Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia; [Behar, Doron M.; Metspalu, Malt; Loogvali, Eva-Liis; Kivisild, Toomas; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Behar, Doron M.] Rambam Hlth Care Campus, Mol Med Lab, IL-31096 Haifa, Israel; [van Oven, Mannis] Univ Med Ctr Rotterdam, Erasmus MC, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands; [Rosset, Saharon] Tel Aviv Univ, Sch Math Sci, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel; [Silva, Nuno M.] Univ Porto, Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal; [Kivisild, Toomas] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 1QH, England; [Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia	Estonian Biocentre; University of Tartu; University of Tartu; Rambam Health Care Campus; Erasmus University Rotterdam; Erasmus MC; Tel Aviv University; Universidade do Porto; University of Cambridge; University of Pavia; Estonian Academy of Sciences	Behar, DM (corresponding author), Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia.	behardm@usernet.com; m.vanoven@erasmusmc.nl	Kivisild, Toomas/P-5889-2017; Metspalu, Mait/G-8671-2015; Torroni, Antonio/E-1557-2011	Kivisild, Toomas/0000-0002-6297-7808; Metspalu, Mait/0000-0003-3099-9161; Torroni, Antonio/0000-0002-4163-4478; van Oven, Mannis/0000-0003-0026-7998	European Commission, Directorate-General for Research [205419]; European Union; Swedish Collegium for Advanced Studies; Estonian Science Foundation [8973]; Fondazione Alma Mater Ticinensis; Italian Ministry of Education, University and Research; Israeli Science Foundation [1227/09]; IBM; FCT, the Portuguese Foundation for Science and Technology [SFRH/BD/69119/2010]; Portuguese Foundation for Science and Technology	European Commission, Directorate-General for Research(European CommissionEuropean Commission Joint Research Centre); European Union(European Commission); Swedish Collegium for Advanced Studies; Estonian Science Foundation; Fondazione Alma Mater Ticinensis; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Israeli Science Foundation(Israel Science Foundation); IBM(International Business Machines (IBM)); FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We thank the genealogical community for donating their privately obtained complete mtDNA sequences for scientific studies and FamilyTreeDNA for compiling the data. We thank FamilyTreeDNA for supporting the establishment of the herein released website. We thank Eileen Krauss-Murphy of FamilyTreeDNA for help with assembly of the database. We thank Rebekah Canada and William R. Hurst for help with the assembly of haplogroup H and K samples, respectively. R.V. and D.M.B. thank the European Commission, Directorate-General for Research for FP7 Ecogene grant 205419. D.M.B. is a shareholder of FamilyTreeDNA and a member of its scientific advisory board. R.V. and M.M. thank the European Union, Regional Development Fund for a Centre of Excellence in Genomics grant, and R.V. thanks the Swedish Collegium for Advanced Studies for support during the initial stage of this study. M.M. thanks Estonian Science Foundation for grant 8973. A.T. received support from Fondazione Alma Mater Ticinensis and the Italian Ministry of Education, University and Research: Progetti Ricerca Interesse Nazionale 2009. S.R. thanks the Israeli Science Foundation for grant 1227/09 and IBM for an Open Collaborative Research grant. FCT, the Portuguese Foundation for Science and Technology, partially supported this work through the personal grant N.M.S. (SFRH/BD/69119/2010). Instituto de Patologia e Imunologia Molecular da Universidade do Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ballantyne KN, 2012, FORENSIC SCI INT-GEN, V6, P425, DOI 10.1016/j.fsigen.2011.08.010; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Baum DA, 2005, SCIENCE, V310, P979, DOI 10.1126/science.1117727; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Darwin C., 1859, NATURAL SELECTION OR; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunnarsdottir ED, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1235; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kivisild T, 2006, NUCL ACID M, V18, P149; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MITOMAP, 2011, HUM MIT GEN DAT; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P13, DOI 10.1016/j.fsigen.2006.11.003; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Richards M, 1996, AM J HUM GENET, V59, P185; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	55	297	302	7	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					675	684		10.1016/j.ajhg.2012.03.002	http://dx.doi.org/10.1016/j.ajhg.2012.03.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22482806	Green Published, Bronze			2022-12-18	WOS:000302833400009
J	Goldgar, DE; Easton, DF; Deffenbaugh, AM; Monteiro, ANA; Tavtigian, SV; Couch, FJ				Goldgar, DE; Easton, DF; Deffenbaugh, AM; Monteiro, ANA; Tavtigian, SV; Couch, FJ		BIC Steering Comm	Integrated evaluation of DNA sequence variants of unknown clinical significance: Application to BRCA1 and BRCA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE MUTATIONS; BREAST-CANCER; EMBRYONIC LETHALITY; GERMLINE MUTATIONS; ALLELE LOSS; GENE; SUSCEPTIBILITY; RECOMBINATION; INACTIVATION; LEADS	Many sequence variants in predisposition genes are of uncertain clinical significance, and classification of these variants into high- or low-risk categories is an important problem in clinical genetics. Classification of such variants can be performed by direct epidemiological observations, including cosegregation with disease in families and degree of family history of the disease, or by indirect measures, including amino acid conservation, severity of amino acid change, and evidence from functional assays. In this study, we have developed an approach to the synthesis of such evidence in a multifactorial likelihood-ratio model. We applied this model to the analysis of three unclassified variants in BRCA1 and three in BRCA2. The evidence strongly suggests that two variants (C1787S in BRCA1 and D2723H in BRCA2) are deleterious, three (R841W in BRCA1 and Y42C and P655R in BRCA2) are neutral, and one (R1699Q in BRCA1) remains of uncertain significance. These results provide a demonstration of the utility of the model.	Int Agcy Res Canc, Unit Genet Epidemiol, F-69008 Lyon, France; Univ Cambridge, Canc Res UK, Genet Epidemiol Unit, Cambridge, England; Myriad Genet Labs, Salt Lake City, UT USA; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Mayo Clin Coll Med, Rochester, MN USA	World Health Organization; International Agency for Research on Cancer (IARC); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Myriad Genetics, Inc; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Mayo Clinic	Goldgar, DE (corresponding author), Int Agcy Res Canc, Unit Genet Epidemiol, 150 Cours Albert Thomas, F-69008 Lyon, France.	goldgar@iarc.fr	Monteiro, Alvaro N. A./A-7566-2009	Monteiro, Alvaro N. A./0000-0002-8448-4801	NCI NIH HHS [R01 CA092309, P01 CA082267] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Barker DF, 1996, GENET EPIDEMIOL, V13, P595; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hohenstein P, 2001, ONCOGENE, V20, P2544, DOI 10.1038/sj.onc.1204363; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Lakhani SR, 1997, LANCET, V349, P1505; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Petersen GM, 1998, AM J HUM GENET, V62, P1516, DOI 10.1086/301871; REBBECK TR, 1994, GENET EPIDEMIOL, V11, P419, DOI 10.1002/gepi.1370110504; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	25	297	307	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					535	544		10.1086/424388	http://dx.doi.org/10.1086/424388			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15290653	Green Published, Bronze			2022-12-18	WOS:000223634100001
J	Semino, O; Magri, C; Benuzzi, G; Lin, AA; Al-Zahery, N; Battaglia, V; Maccioni, L; Triantaphyllidis, C; Shen, PD; Oefner, PJ; Zhivotovsky, LA; King, R; Torroni, A; Cavalli-Sforza, LL; Underhill, PA; Santachiara-Benerecetti, AS				Semino, O; Magri, C; Benuzzi, G; Lin, AA; Al-Zahery, N; Battaglia, V; Maccioni, L; Triantaphyllidis, C; Shen, PD; Oefner, PJ; Zhivotovsky, LA; King, R; Torroni, A; Cavalli-Sforza, LL; Underhill, PA; Santachiara-Benerecetti, AS			Origin, diffusion, and differentiation of Y-chromosome haplogroups E and J: Inferences on the neolithization of Europe and later migratory events in the Mediterranean area	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION ANALYSIS; MUTATION-RATE; MICROSATELLITE; POLYMORPHISMS; POPULATION; HAPLOTYPES; AFRICA; DIVERSITY; LINEAGES; MTDNA	The phylogeography of Y-chromosome haplogroups E (Hg E) and J ( Hg J) was investigated in >2,400 subjects from 29 populations, mainly from Europe and the Mediterranean area but also from Africa and Asia. The observed 501 Hg E and 445 Hg J samples were subtyped using 36 binary markers and eight microsatellite loci. Spatial patterns reveal that ( 1) the two sister clades, J-M267 and J-M172, are distributed differentially within the Near East, North Africa, and Europe; ( 2) J-M267 was spread by two temporally distinct migratory episodes, the most recent one probably associated with the diffusion of Arab people; ( 3) E-M81 is typical of Berbers, and its presence in Iberia and Sicily is due to recent gene flow from North Africa; ( 4) J-M172(xM12) distribution is consistent with a Levantine/Anatolian dispersal route to southeastern Europe and may reflect the spread of Anatolian farmers; and ( 5) E-M78 ( for which microsatellite data suggest an eastern African origin) and, to a lesser extent, J-M12(M102) lineages would trace the subsequent diffusion of people from the southern Balkans to the west. A 7%-22% contribution of Y chromosomes from Greece to southern Italy was estimated by admixture analysis.	Univ Pavia, Dipartimento Genet & Microbiol A Buzzati Traverso, I-27100 Pavia, Italy; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad, Iraq; Univ Cagliari, Ist Clin & Biol Evolut, Cagliari, Italy; Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; Stanford Genome Technol Ctr, Palo Alto, CA USA; Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia	University of Pavia; Stanford University; Stanford University; University of Baghdad; University of Cagliari; Aristotle University of Thessaloniki; Stanford University; Russian Academy of Sciences; Vavilov Institute of General Genetics	Semino, O (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol A Buzzati Traverso, Via Ferrata 1, I-27100 Pavia, Italy.	semino@ipvgen.unipv.it	Torroni, Antonio/E-1557-2011; Al-Zahery, Nadia/AAV-5878-2020; Zhivotovsky, Lev A/A-1351-2012; Magri, Chiara/I-4691-2017; Battaglia, Vincenza/F-6950-2017	Torroni, Antonio/0000-0002-4163-4478; Magri, Chiara/0000-0001-9933-8666; SEMINO, Ornella/0000-0002-9675-9403	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55273, P01 GM028428, GM28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Ammerman A.J., 1984, NEOLITHIC TRANSITION; BANDELT HJ, 1995, GENETICS, V141, P743; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Carvalho-Silva DR, 1999, J MOL EVOL, V49, P204, DOI 10.1007/PL00006543; CAVALLISFORZA L, 2002, EXAMINING FARMING LA, P79; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Delfiner P, 1976, ADV GEOSTATISTICS MI, P49; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Ellis N, 2002, GENOME RES, V12, P339; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Nebel A, 2002, AM J HUM GENET, V70, P1594, DOI 10.1086/340669; Nebel A, 2001, EUR J HUM GENET, V9, P22, DOI 10.1038/sj.ejhg.5200577; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Semino O, 1996, AM J HUM GENET, V59, P964; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; TORRONI A, 1990, INT J ANTHR, V5, P97; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Weale ME, 2003, GENETICS, V165, P229; WHITEHOUSE RD, 1968, ANTIQUITY, V42, P188, DOI 10.1017/S0003598X00034293; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	42	297	311	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1023	1034		10.1086/386295	http://dx.doi.org/10.1086/386295			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15069642	Green Published, Bronze			2022-12-18	WOS:000220926100020
J	MORTON, NE				MORTON, NE			GENETIC TESTS UNDER INCOMPLETE ASCERTAINMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAILEY NTJ, 1951, ANN EUGENIC, V16, P223, DOI 10.1111/j.1469-1809.1951.tb02474.x; FINNEY DJ, 1949, ANN EUGENIC, V14, P319; HALDANE JBS, 1949, ANN EUGENIC, V14, P339; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; Ikin EW, 1939, ANN EUGENIC, V9, P409, DOI 10.1111/j.1469-1809.1939.tb02222.x; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; MORTON NE, 1958, SCIENCE, V127, P79, DOI 10.1126/science.127.3289.79; RACE RR, 1942, ANN EUGEN LOND, V11, P385; RAO CR, 1952, ADV STATISTICAL METH; TAYLOR GL, 1938, ANN EUGEN, V9, P18	10	297	308	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	1					1	16						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF072	13626932				2022-12-18	WOS:A1959WF07200001
J	Behar, DM; Villems, R; Soodyall, H; Blue-Smith, J; Pereira, L; Metspalu, E; Scozzari, R; Makkan, H; Tzur, S; Comas, D; Bertranpetit, J; Quintana-Murci, L; Tyler-Smith, C; Wells, RS; Rosset, S				Behar, Doron M.; Villems, Richard; Soodyall, Himla; Blue-Smith, Jason; Pereira, Luisa; Metspalu, Ene; Scozzari, Rosaria; Makkan, Heeran; Tzur, Shay; Comas, David; Bertranpetit, Jaume; Quintana-Murci, Lluis; Tyler-Smith, Chris; Wells, R. Spencer; Rosset, Saharon		Genographic Consortium	The dawn of human matrilineal diversity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FALSE DISCOVERY RATE; MITOCHONDRIAL-DNA; MTDNA VARIATION; Y-CHROMOSOME; GENE FLOW; AFRICA; POPULATIONS; HAPLOGROUP; TRACES; PHYLOGEOGRAPHY	The quest to explain demographic history during the early part of human evolution has been limited because of the scarce paleoanthropological record from the Middle Stone Age. To shed light on the structure of the mitochondrial DNA (mtDNA) phylogeny at the dawn of Homo sapiens, we constructed a matrilineal tree composed of 624 complete mtDNA genomes from sub-Saharan Hg L lineages. We paid particular attention to the Khoi and San (Khoisan) people of South Africa because they are considered to be a unique relic of hunter-gatherer lifestyle and to carry paternal and maternal lineages belonging to the deepest clades known among modern humans. Both the tree phylogeny and coalescence calculations suggest that Khoisan matrilineal ancestry diverged from the rest of the human mtDNA pool 90,000-150,000 years before present (ybp) and that at least five additional, currently extant maternal lineages existed during this period in parallel. Furthermore, we estimate that a minimum of 40 other evolutionarily successful lineages flourished in sub-Saharan Africa during the period of modern human dispersal out of Africa approximately 60,000-70,000 ybp. Only much later, at the beginning of the Late Stone Age, about 40,000 ybp, did introgression of additional lineages occur into the Khoisan mtDNA pool. This process was further accelerated during the recent Bantu expansions. Our results suggest that the early settlement of humans in Africa was already matrilineally structured and involved small, separately evolving isolated populations.	[Behar, Doron M.; Tzur, Shay] Rambam Hlth Care Campus, Mol Med Lab, IL-31096 Haifa, Israel; [Villems, Richard; Metspalu, Ene] Univ Tartu, Dept Evolut Biol, EE-51010 Tartu, Estonia; [Villems, Richard; Metspalu, Ene] Univ Tartu, Dept Evolut Biol, Estonian Bioctr, EE-51010 Tartu, Estonia; [Soodyall, Himla; Makkan, Heeran] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Soodyall, Himla; Makkan, Heeran] Univ Witwatersrand, Natl Hlth Lab Serv, Div Human Genet, Sch Pathol, ZA-2000 Johannesburg, South Africa; [Blue-Smith, Jason; Wells, R. Spencer] Natl Geog Soc, Mission Program, Washington, DC 20036 USA; [Pereira, Luisa] Univ Porto, Inst Pathol & Immunol Mol, P-4200465 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal; [Scozzari, Rosaria] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Comas, David; Bertranpetit, Jaume] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Evolut Biol Unit, Barcelona 08003, Catalonia, Spain; [Quintana-Murci, Lluis] Inst Pasteur, CNRS, URA 3012, Unit Human Evolut Genet, F-75724 Paris, France; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Rosset, Saharon] IBM Corp, Thomas J Watson Res Ctr, Data Analyt Res Grp, Yorktown Hts, NY 10598 USA; [Rosset, Saharon] Tel Aviv Univ, Sch Math Sci, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel	Rambam Health Care Campus; University of Tartu; Estonian Biocentre; University of Tartu; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; National Geographic Society; Universidade do Porto; Universidade do Porto; Sapienza University Rome; Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; International Business Machines (IBM); Tel Aviv University	Behar, DM (corresponding author), Rambam Hlth Care Campus, Mol Med Lab, IL-31096 Haifa, Israel.	behardm@usernet.com	Makkan, Heeran/GXI-0465-2022; Quintana-Murci, Lluis/AAB-7468-2022; Santos, Fabrício Rodrigues/H-2370-2011; Comas, David/D-5382-2014; Bertranpetit, Jaume/F-8550-2012; Balanovsky, Oleg/G-1549-2014; Cooper, Alan/E-8171-2012; Pereira, Luisa/H-3050-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Comas, David/0000-0002-5075-0956; Bertranpetit, Jaume/0000-0003-0100-0590; Cooper, Alan/0000-0002-7738-7851; Pereira, Luisa/0000-0002-4271-1527; Makkan, Heeran/0000-0002-4737-7804; Quintana-Murci, Lluis/0000-0003-2429-6320; Royyuru, Ajay/0000-0003-4440-4755	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Barnard A., 1992, HUNTERS HERDERS SO A; Batini C, 2007, MOL PHYLOGENET EVOL, V43, P635, DOI 10.1016/j.ympev.2006.09.014; BEHAR DM, 2008, IN PRESS PLOS 1; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Cohen AS, 2007, P NATL ACAD SCI USA, V104, P16422, DOI 10.1073/pnas.0703873104; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; GULDEMANN T, 2007, QUOTATIVE INDEXES AF; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Klein R.G., 1999, HUMAN CAREER; Knight A, 2003, CURR BIOL, V13, P464, DOI 10.1016/S0960-9822(03)00130-1; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; OLIVER R, 1966, J AFR HIST, V7, P361, DOI 10.1017/S0021853700006472; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; TORRONI A, 1993, AM J HUM GENET, V53, P591; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	48	296	305	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1130	1140		10.1016/j.ajhg.2008.04.002	http://dx.doi.org/10.1016/j.ajhg.2008.04.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439549	Green Published, hybrid			2022-12-18	WOS:000255923600012
J	Sutcliffe, JS; Delahanty, RJ; Prasad, HC; McCauley, JL; Han, Q; Jiang, L; Li, C; Folstein, SE; Blakely, RD				Sutcliffe, JS; Delahanty, RJ; Prasad, HC; McCauley, JL; Han, Q; Jiang, L; Li, C; Folstein, SE; Blakely, RD			Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; GENOMIC SCREEN; GENOMEWIDE SCREEN; SEQUENCE VARIANTS; GENE; LINKAGE; ASSOCIATION; POLYMORPHISM; DISEQUILIBRIUM; PREVALENCE	Autism is a spectrum of neurodevelopmental disorders with a primarily genetic etiology exhibiting deficits in ( 1) development of language and ( 2) social relationships and ( 3) patterns of repetitive, restricted behaviors or interests and resistance to change. Elevated platelet serotonin (5-HT) in 20%-25% of cases and efficacy of selective 5-HT reuptake inhibitors ( SSRIs) in treating anxiety, depression, and repetitive behaviors points to the 5-HT transporter (5-HTT; SERT) as a strong candidate gene. Association studies involving the functional insertion/deletion polymorphism in the promoter (5-HTTLPR) and a polymorphism in intron 2 are inconclusive, possibly because of phenotypic heterogeneity. Nonetheless, mounting evidence for genetic linkage of autism to the chromosome 17q11.2 region that harbors the SERT locus (SLC6A4) supports a genetic effect at or near this gene. We confirm recent reports of sex-biased genetic effects in 17q by showing highly significant linkage driven by families with only affected males. Association with common alleles fails to explain observed linkage; therefore, we hypothesized that preferential transmission of multiple alleles does explain it. From 120 families, most contributing to linkage at 17q11.2, we found four coding substitutions at highly conserved positions and 15 other variants in 5' noncoding and other intronic regions transmitted in families exhibiting increased rigid-compulsive behaviors. In the aggregate, these variants show significant linkage to and association with autism. Our data provide strong support for a collection of multiple, often rare, alleles at SLC6A4 as imposing risk of autism.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Johns Hopkins University	Sutcliffe, JS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	james.s.sutcliffe@vanderbilt.edu	Sutcliffe, James S/C-1348-2012; Li, Chun/R-1095-2019; Li, Chun/B-8388-2012	Sutcliffe, James S/0000-0001-5200-6007; Li, Chun/0000-0002-8819-2443; 	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061009, R01MH055135, R01MH064547, R10MH055135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007390] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00095, M01 RR000095] Funding Source: Medline; NIDA NIH HHS [R01 DA007390, DA07390] Funding Source: Medline; NIMH NIH HHS [MH55135, MH64547, R01 MH064547, R01 MH061009, MH61009] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, HUM MOL GENET, V7, P571; Barrett S, 1999, AM J MED GENET, V88, P609; Bolton PF, 1998, PSYCHOL MED, V28, P385, DOI 10.1017/S0033291797006004; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; COOK EH, 1993, LIFE SCI, V52, P2005, DOI 10.1016/0024-3205(93)90685-V; Cook EH, 1997, MOL PSYCHIATR, V2, P247; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; DEVLIN B, IN PRESS MOL PSYCHIA; Faraj BA, 1997, BIOCHEM PHARMACOL, V53, P53, DOI 10.1016/S0006-2952(96)00726-5; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hollander E, 2005, NEUROPSYCHOPHARMACOL, V30, P582, DOI 10.1038/sj.npp.1300627; Holloway JW, 1999, HUM MUTAT, V14, P340, DOI 10.1002/(SICI)1098-1004(199910)14:4<340::AID-HUMU10>3.0.CO;2-Z; JONES MB, 1988, J AUTISM DEV DISORD, V18, P31, DOI 10.1007/BF02211816; Kanner L, 1943, NERV CHILD, V2, P217; Khan NA, 1996, CELL IMMUNOL, V172, P269, DOI 10.1006/cimm.1996.0242; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Kim SJ, 2002, MOL PSYCHIATR, V7, P278, DOI 10.1038/sj.mp.4001033; Klauck SM, 1997, HUM MOL GENET, V6, P2233, DOI 10.1093/hmg/6.13.2233; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li QB, 2002, ELECTROPHORESIS, V23, P1499, DOI 10.1002/1522-2683(200205)23:10<1499::AID-ELPS1499>3.0.CO;2-X; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; Maestrini E, 1999, AM J MED GENET, V88, P492, DOI 10.1002/(SICI)1096-8628(19991015)88:5<492::AID-AJMG11>3.0.CO;2-X; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Nickerson DA, 2001, METH MOL B, V175, P29; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ogilvie AD, 1996, LANCET, V347, P731, DOI 10.1016/S0140-6736(96)90079-3; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Persico AM, 2000, AM J MED GENET, V96, P123, DOI 10.1002/(SICI)1096-8628(20000207)96:1<123::AID-AJMG24>3.0.CO;2-N; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; PRASAD HC, IN PRESS P NATL ACAD; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1989, AM J PSYCHIAT, V146, P194; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; SCHAIN RJ, 1961, J PEDIATR-US, V58, P315, DOI 10.1016/S0022-3476(61)80261-8; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Spielman RS, 1996, AM J HUM GENET, V59, P983; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Tadevosyan-Leyfer O, 2003, J AM ACAD CHILD PSY, V42, P864, DOI 10.1097/01.CHI.0000046870.56865.90; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; VENENSTRAVANDER.J, 2004, ANNU REV GENOM HUM G, V5, P379; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Yirmiya N, 2001, AM J MED GENET, V105, P381, DOI 10.1002/ajmg.1365; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	74	296	305	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					265	279		10.1086/432648	http://dx.doi.org/10.1086/432648			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	943WW	15995945	Bronze, Green Published			2022-12-18	WOS:000230387200008
J	PING, AJ; REEVE, AE; LAW, DJ; YOUNG, MR; BOEHNKE, M; FEINBERG, AP				PING, AJ; REEVE, AE; LAW, DJ; YOUNG, MR; BOEHNKE, M; FEINBERG, AP			GENETIC-LINKAGE OF BECKWITH-WIEDEMANN SYNDROME TO 11P15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,4520 MSRB I,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,BEREICH MOLEC BIOL,ANN ARBOR,MI 48109; UNIV OTAGO,DEPT BIOCHEM,DUNEDIN,NEW ZEALAND	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Otago			Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, R29GM041440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023410] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41440, GM07863] Funding Source: Medline; NINDS NIH HHS [NS23410] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER D, 1984, AM J HUM GENET, V36, P1159; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRESLOW N, 1988, CANCER RES, V48, P1653; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; KRAMER S, 1983, J NATL CANCER I, V70, P49; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MORTON NE, 1955, AM J HUM GENET, V7, P277; OLNEY AH, 1988, AM J MED GENET, V29, P491, DOI 10.1002/ajmg.1320290304; OLSHAN AF, 1986, CANCER GENET CYTOGEN, V21, P303, DOI 10.1016/0165-4608(86)90209-8; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; PUESCHEL SM, 1984, J PEDIATR-US, V104, P484, DOI 10.1016/S0022-3476(84)81127-0; REEVE AE, IN PRESS MOL CELL BI; SCHMUTZ SM, 1986, CLIN GENET, V30, P154; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6	20	296	304	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					720	723						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565083				2022-12-18	WOS:A1989U333800013
J	Kohler, S; Schulz, MH; Krawitz, P; Bauer, S; Dolken, S; Ott, CE; Mundlos, C; Horn, D; Mundlos, S; Robinson, PN				Koehler, Sebastian; Schulz, Marcel H.; Krawitz, Peter; Bauer, Sebastian; Doelken, Sandra; Ott, Claus E.; Mundlos, Christine; Horn, Denise; Mundlos, Stefan; Robinson, Peter N.			Clinical Diagnostics in Human Genetics with Semantic Similarity Searches in Ontologies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; DEVELOPMENTAL DELAY; DECISION-SUPPORT; YIELD; SYSTEM; TOOL	The differential diagnostic process attempts to identify candidate diseases that best explain a set of clinical features. This process can be complicated by the fact that the features can have varying degrees of specificity as well as by the presence of features unrelated to the disease itself. Depending on the experience of the physician and the availability of laboratory tests, clinical abnormalities may be described in greater or lesser detail. We have adapted semantic similarity metrics to measure phenotypic similarity between queries and hereditary diseases annotated with the use of the Human Phenotype Ontology (HPO) and have developed a statistical model to assign 1) values to the resulting similarity scores, which can be used to rank the candidate diseases. We show that our approach outperforms simpler term-matching approaches that do not take the semantic interrelationships between terms into account. The advantage of our approach was greater for queries containing phenotypic noise or imprecise clinical descriptions. The semantic network defined by the HPO can be used to refine the differential diagnosis by suggesting clinical features that, if present, best differentiate among the candidate diagnoses. Thus, semantic similarity searches in ontologies represent a useful way of harnessing the semantic structure of human phenotypic abnormalities to help with the differential diagnosis. We have implemented Our methods in a freely available web application for the field of human Mendelian disorders.	[Koehler, Sebastian; Krawitz, Peter; Bauer, Sebastian; Doelken, Sandra; Ott, Claus E.; Horn, Denise; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Koehler, Sebastian; Krawitz, Peter; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, BCRT, D-13353 Berlin, Germany; [Schulz, Marcel H.; Mundlos, Stefan; Robinson, Peter N.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Schulz, Marcel H.] Int Max Planck Res Sch Computat Biol & Sci Comp, D-14195 Berlin, Germany; [Mundlos, Christine] ACHSE, D-14050 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Max Planck Society	Robinson, PN (corresponding author), Charite Univ Med Berlin, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.robinson@charite.de	Mundlos, Stefan/ABH-9585-2020; Ott, Claus E/G-1936-2011; Köhler, Sebastian/H-3301-2019; Krawitz, Peter M/F-3142-2012; Ott, Claus/U-8226-2019; Köhler, Sebastian/A-2029-2012	Ott, Claus E/0000-0003-3627-3791; Köhler, Sebastian/0000-0002-5316-1399; Krawitz, Peter M/0000-0002-3194-8625; Ott, Claus/0000-0003-3627-3791; Köhler, Sebastian/0000-0002-5316-1399; Mundlos, Stefan/0000-0002-9788-3166; Schulz, Marcel H./0000-0002-1252-3656; Robinson, Peter/0000-0002-0736-9199	Deutsche Forschungsgemeinschaft [DFG RO 2005/4-1, SFB 760]; Bundesministerium fur Bildung und Forschung [0313911]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The authors would like to acknowledge the monumental work of the late Professor Victor McKusick and colleagues at OMIM, without which our own work on the HPO would have been impossible. This work was supported by the Deutsche Forschungsgemeinschaft (DFG RO 2005/4-1, SFB 760) and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) (Bundesministerium fur Bildung und Forschung, project no. 0313911).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayme Segolene, 2003, Soins, P46; BANKIER A, 1989, OPHTHALMIC PAED GEN, V10, P51, DOI 10.3109/13816818909083773; BARNETT GO, 1987, JAMA-J AM MED ASSOC, V258, P67, DOI 10.1001/jama.258.1.67; Battaglia A, 1999, AM J MED GENET, V82, P60, DOI 10.1002/(SICI)1096-8628(19990101)82:1<60::AID-AJMG12>3.3.CO;2-W; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Cover TM., 1991, ELEMENTS INFORM THEO; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Fryns JP, 2002, HUM GENET, V111, P113, DOI 10.1007/s00439-002-0759-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Jiang J. J., 1997, P INT C RES COMP LIN, P19; Jones K. L., 2005, SMITHS RECOGNIZABLE; Lin D., 1998, ICML, V98, P296; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; MILLER R, 1986, M D COMPUT, V3, P34; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Neveol Aurelie, 2006, AMIA Annu Symp Proc, P589; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; RESNIK P, 1995, P 14 INT JOINT C ART, P448; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schurink CAM, 2005, LANCET INFECT DIS, V5, P305, DOI 10.1016/S1473-3099(05)70115-8; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Srour M, 2006, PEDIATRICS, V118, P139, DOI 10.1542/peds.2005-2702; TRACE D, 1990, S COMP APPL MED CAR, P635; van Karnebeek CDM, 2005, EUR J HUM GENET, V13, P6, DOI 10.1038/sj.ejhg.5201279; WARNER HR, 1989, METHOD INFORM MED, V28, P370; Yu HY, 2007, BIOINFORMATICS, V23, P2163, DOI 10.1093/bioinformatics/btm291	29	295	302	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					457	464		10.1016/j.ajhg.2009.09.003	http://dx.doi.org/10.1016/j.ajhg.2009.09.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19800049	Green Published, Bronze			2022-12-18	WOS:000270836000003
J	Hackman, P; Vihola, A; Haravuori, H; Marchand, S; Sarparanta, J; de Seze, J; Labeit, S; Witt, C; Peltonen, L; Richard, I; Udd, B				Hackman, P; Vihola, A; Haravuori, H; Marchand, S; Sarparanta, J; de Seze, J; Labeit, S; Witt, C; Peltonen, L; Richard, I; Udd, B			Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TISSUE-SPECIFIC EXPRESSION; ONSET DISTAL MYOPATHY; KAPPA-B PATHWAY; Z-DISC; CLINICAL PHENOTYPES; MOLECULAR-STRUCTURE; CHROMOSOME 2Q31; CANDIDATE GENE; KINASE DOMAIN; ALPHA-ACTININ	Tibial muscular dystrophy (TMD) is an autosomal dominant late-onset distal myopathy linked to chromosome 2q31. The linked region includes the giant TTN gene, which encodes the central sarcomeric protein, titin. We have previously shown a secondary calpain-3 defect to be associated with TMD, which further underscored that titin is the candidate. We now report the first mutations in TTN to cause a human skeletal-muscle disease, TMD. In Mex6, the last exon of TTN, a unique 11-bp deletion/insertion mutation, changing four amino acid residues, completely cosegregated with all tested 81 Finnish patients with TMD in 12 unrelated families. The mutation was not found in 216 Finnish control samples. In a French family with TMD, a Leu-->Pro mutation at position 293,357 in Mex6 was discovered. Mex6 is adjacent to the known calpain-3 binding site Mex5 of M-line titin. Immunohistochemical analysis using two exon-specific antibodies directed to the M-line region of titin demonstrated the specific loss of carboxy-terminal titin epitopes in the TMD muscle samples that we studied, thus implicating a functional defect of the M-line titin in the genesis of the TMD disease phenotype.	Vasa Cent Hosp, Dept Neurol, FIN-65130 Vaasa, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Biomedicum Helsinki, Helsinki, Finland; Genethon, Evry, France; Ctr Hosp Reg Univ Lille, Dept Neurol, Lille, France; Klinikum Mannheim, Dept Anesthesiol, Mannheim, Germany; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA	Vaasa Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Universite de Lille - ISITE; CHU Lille; University of California System; University of California Los Angeles	Udd, B (corresponding author), Vasa Cent Hosp, Dept Neurol, FIN-65130 Vaasa, Finland.	bjarne.udd@vshp.fi	De Seze, Jerome/M-8316-2016; Richard, isabelle/J-8298-2013; Sarparanta, Jaakko/AAQ-1713-2020	De Seze, Jerome/0000-0002-7197-7578; Sarparanta, Jaakko/0000-0002-5497-5255; Haravuori, Henna/0000-0002-4080-7779				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chadwick RB, 1996, BIOTECHNIQUES, V20, P676; de Seze J, 1998, NEUROLOGY, V51, P1746, DOI 10.1212/WNL.51.6.1746; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Fardeau M, 1996, NEUROMUSCULAR DISORD, V6, P447, DOI 10.1016/S0960-8966(96)00387-2; Fougerousse F, 2000, NEUROMUSCULAR DISORD, V10, P251, DOI 10.1016/S0960-8966(99)00107-8; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Gautel M, 1996, J CELL SCI, V109, P2747; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; MULLERSEITZ M, 1993, GENOMICS, V18, P559, DOI 10.1016/S0888-7543(05)80356-8; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; SIRACUSA LD, 1990, GENOMICS, V6, P491, DOI 10.1016/0888-7543(90)90479-E; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; TRINICK J, 1994, TRENDS BIOCHEM SCI, V19, P405, DOI 10.1016/0968-0004(94)90088-4; UDD B, 1991, MUSCLE NERVE, V14, P1050, DOI 10.1002/mus.880141103; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; UDD B, 1992, J NEUROL SCI, V113, P214, DOI 10.1016/0022-510X(92)90249-K; VIDALPUIG A, 1994, BIOTECHNIQUES, V17, P490; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614	39	295	304	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					492	500		10.1086/342380	http://dx.doi.org/10.1086/342380			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145747	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000177489600004
J	Monnier, N; Procaccio, V; Stieglitz, P; Lunardi, J				Monnier, N; Procaccio, V; Stieglitz, P; Lunardi, J			Malignant-hyperthermia susceptibility is associated with a mutation of the alpha(1)-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; RYANODINE RECEPTOR; ALPHA-1 SUBUNIT; GAMMA-SUBUNIT; CA2+ CHANNEL; BETA-SUBUNIT; GENE; LOCALIZATION; LOCUS; CHROMOSOME-17Q	Malignant hyperthermia susceptibility (MHS) is characterized by genetic heterogeneity. However, except for the MHS1 locus, which corresponds to the skeletal muscle ryanodine receptor (RYR1) and for which several mutations have been described, no direct molecular evidence for a mutation in another gene has been reported so far. In this study we show that the CACNL1A3 gene encoding the alpha 1-subunit of the human skeletal muscle dihydropyridine-sensitive L-type voltage-dependent calcium channel (VDCC) represents a new MHS locus and is responsible for the disease in a large French family. Linkage analysis performed with an intragenic polymorphic microsatellite marker of the CACLN1A3 gene generated a two-point LOD score of 4.38 at a recombinant fraction of 0. Sequence analysis of the coding region of the CACLN1A3 gene showed the presence of an Arg-His substitution at residue 1086, resulting from the transition of A for G3333, which segregates perfectly with the MHS phenotype in the family. The mutation is localized in a very different part of the al-subunit of the human skeletal muscle VDCC, compared with previously reported mutations found in patients with hypokalemic periodic paralysis, and these two diseases might be discussed in terms of allelic diseases. This report is the first direct evidence that the skeletal muscle VDCC is involved in MHS, and it suggests a direct interaction between the skeletal muscle VDCC and the ryanodine receptor in the skeletal muscle sarcoplasmic reticulum.	CEA,DBMS,LAB BECP,EA UJF 2019,F-38054 GRENOBLE 09,FRANCE; ADN,BIOCHIM LAB,GRENOBLE,FRANCE; CHU GRENOBLE,DEPT ANESTHESIE,F-38043 GRENOBLE,FRANCE	CEA; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)				procaccio, Vincent/0000-0002-1537-4684				BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; *EUR MAL HYP GROUP, 1984, BRIT J ANAESTH, V56, P1267; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GRABNER M, 1991, P NATL ACAD SCI USA, V88, P727, DOI 10.1073/pnas.88.3.727; GREGG R, 1993, GENOMICS, V15, P186; GREGG RG, 1993, GENOMICS, V15, P107, DOI 10.1006/geno.1993.1017; Hogan K, 1996, GENOMICS, V31, P392, DOI 10.1006/geno.1996.0066; HOGAN K, 1994, GENOMICS, V24, P608, DOI 10.1006/geno.1994.1677; ILES DE, 1993, HUM MOL GENET, V2, P863; ILES DE, 1992, GENOMICS, V14, P749, DOI 10.1016/S0888-7543(05)80179-X; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; ILES DE, 1994, GENOMICS, V19, P561; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; JURKATROTT K, 1994, HUM MOL GENET, V3, P914; KALASZ H, 1993, FEBS LETT, V331, P177, DOI 10.1016/0014-5793(93)80321-K; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; LAMBERT C, 1994, ANESTH ANALG, V79, P1012; LARACH MG, 1989, ANESTH ANALG, V69, P511; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEHMANNHORN F, 1990, BRIT J ANAESTH, V65, P692, DOI 10.1093/bja/65.5.692; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MALOUF NN, 1992, NEURON, V8, P899, DOI 10.1016/0896-6273(92)90204-Q; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; McKusick VA, 1990, MENDELIAN INHERITANC; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; OLCKERS A, 1992, GENOMICS, V14, P829, DOI 10.1016/S0888-7543(05)80206-X; POWERS PA, 1993, J BIOL CHEM, V268, P9275; POWERS PA, 1994, GENOMICS, V19, P192, DOI 10.1006/geno.1994.1044; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; PTACEK LJ, 1994, CELL, V77, P863; QUANE KA, 1994, GENOMICS, V23, P236, DOI 10.1006/geno.1994.1483; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; QUANE KA, 1994, HUM MOL GENET, V3, P471, DOI 10.1093/hmg/3.3.471; SUDBRAK R, 1993, HUM MOL GENET, V2, P857, DOI 10.1093/hmg/2.7.857; SUDBRAK R, 1995, AM J HUM GENET, V56, P684; SUNADA Y, 1995, CURR OPIN NEUROL, V8, P379, DOI 10.1097/00019052-199510000-00010; TAKEKURA H, 1994, BIOPHYS J, V67, P793, DOI 10.1016/S0006-3495(94)80539-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; ZHENG W, 1995, J NEUROSCI, V15, P1132	52	295	305	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1316	1325		10.1086/515454	http://dx.doi.org/10.1086/515454			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199552	Green Published, Bronze			2022-12-18	WOS:A1997XE29400009
J	KELLERMA.G; LUYTENKE.M; SHAW, CR				KELLERMA.G; LUYTENKE.M; SHAW, CR			GENETIC-VARIATION OF ARYL HYDROCARBON HYDROXYLASE IN HUMAN LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV TEXAS,DEPT BIOL,SECT MED GENET,HOUSTON,TX 77025; MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77025	University of Texas System; University of Texas System; UTMD Anderson Cancer Center								BUSBEE D L, 1972, Science (Washington D C), V178, P315, DOI 10.1126/science.178.4058.315; CANTRELL ET, IN PRESS; CONNEY AH, 1967, PHARMACOL REV, V19, P317; GIELEN JE, 1971, SCIENCE, V172, P167, DOI 10.1126/science.172.3979.167; GROVER PL, 1971, P NATL ACAD SCI USA, V68, P1098, DOI 10.1073/pnas.68.6.1098; GROVER PL, 1972, BIOCHEM PHARMACOL, V21, P2713, DOI 10.1016/0006-2952(72)90020-2; HUBERMAN E, 1972, CANCER RES, V32, P1391; KELLERMANN G, TO BE PUBLISHED; LU AYH, 1972, ARCH BIOCHEM BIOPHYS, V152, P457, DOI 10.1016/0003-9861(72)90239-1; MARQUARDT H, 1972, CANCER RES, V32, P716; MASON HS, 1957, ADV ENZYMOL REL S BI, V19, P79; NEBERT DW, 1970, J BIOL CHEM, V245, P519; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; NEBERT DW, 1972, FED PROC, V31, P1315; NEBERT DW, 1968, J BIOL CHEM, V243, P6250; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; THOMAS PE, 1972, BIOCHEM GENET, V6, P157, DOI 10.1007/BF00486400; TOKUHATA GK, 1964, AM J PUBLIC HEALTH N, V54, P24, DOI 10.2105/AJPH.54.1.24	18	295	297	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					327	331						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704864				2022-12-18	WOS:A1973P918200014
J	Lenkkeri, U; Mannikko, M; McCready, P; Lamerdin, J; Gribouval, O; Niaudet, P; Antignac, C; Kashtan, CE; Holmberg, C; Olsen, A; Kestila, M; Tryggvason, K				Lenkkeri, U; Mannikko, M; McCready, P; Lamerdin, J; Gribouval, O; Niaudet, P; Antignac, C; Kashtan, CE; Holmberg, C; Olsen, A; Kestila, M; Tryggvason, K			Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL-TRANSPLANTATION; PRENATAL-DIAGNOSIS; HAPLOTYPE ANALYSIS; ALPHA-FETOPROTEIN; DNA-SEQUENCES; GENOMIC DNA; ORGANIZATION; EVOLUTION; POPULATION; MANAGEMENT	Congenital nephrotic syndrome of the Finnish type (NPHS1) is an autosomal recessive disorder that is caused by mutations in the recently discovered nephrin gene, NPHS1 (AF035835). The disease, which belongs to the Finnish disease heritage, exists predominantly in Finland, but many cases have been observed else:where in Europe and North America. The nephrin gene consists of 29 exons spanning 26 kb in the chromosomal region 19q13.1. In the present study, the genomic structure of the nephrin gene was analyzed, and 35 NPHS1 patients were screened for the presence of mutations in the gene. A total of 32 novel mutations, including deletions; insertions; nonsense, missense, and splicing mutations; and two common polymorphisms were found. Only two Swedish and four Finnish patients had the typical Finnish mutations: a 2-bp deletion in exon 2 (Fin(major)) or a nonsense mutation in exon 26 (Fin(minor)). In seven cases, no mutations were found in the coding region of the NPHS1 gene or in the immediate 5'-flanking region. These patients may have mutations elsewhere in the promoter, in intron areas, or in a gene encoding another protein that interacts with nephrin.	Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; Oulu Univ, Bioctr Oulu, Oulu, Finland; Oulu Univ, Dept Biochem, Oulu, Finland; Lawrence Livermore Natl Lab, Livermore, CA USA; Hop Necker Enfants Malad, Serv Nephrol Pediat, Paris, France; Univ Minnesota, Dept Pediat, Minneapolis, MN USA; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden	Karolinska Institutet; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Minnesota System; University of Minnesota Twin Cities; University of Helsinki; Karolinska Institutet	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden.	karl.tryggvason@mbb.ki.se	ANTIGNAC, Corinne/H-8945-2017; Mannikko, Minna/C-5877-2008; Gribouval, Olivier/A-7689-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Mannikko, Minna/0000-0002-6857-6423; Gribouval, Olivier/0000-0003-0238-8224	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010704, R01AI010704] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00400] Funding Source: Medline; NIAID NIH HHS [AI-10704-36] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBRIGHT SG, 1990, OBSTET GYNECOL, V76, P969; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CYBULSKY MI, 1991, P NATL ACAD SCI USA, V88, P7859, DOI 10.1073/pnas.88.17.7859; Fuchshuber A, 1996, PEDIATR NEPHROL, V10, P135; HALLMAN N, 1956, ANN PEDIATR FENN, V2, P227; HOLMBERG C, 1995, PEDIATR NEPHROL, V9, P87, DOI 10.1007/BF00858984; HOLMBERG C, 1991, TRANSPLANT P, V23, P1378; HUTTUNEN NP, 1976, ARCH DIS CHILD, V51, P344, DOI 10.1136/adc.51.5.344; KESTILA M, 1994, AM J HUM GENET, V54, P757; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; MAHAN JD, 1984, J PEDIATR-US, V105, P549, DOI 10.1016/S0022-3476(84)80418-7; Mannikko M, 1997, KIDNEY INT, V51, P868, DOI 10.1038/ki.1997.122; Mannikko M, 1996, J AM SOC NEPHROL, V7, P2700; MANNIKKO M, 1995, AM J HUM GENET, V57, P1377; MAUCH D, 1994, PEDIAT NEPHROLOGY, P788; NAKANO R, 1991, BIOCHEM BIOPH RES CO, V178, P282, DOI 10.1016/0006-291X(91)91811-P; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NORIO R, 1966, ANN PAEDIATR FENN S, V12, P27; OWENS GC, 1987, P NATL ACAD SCI USA, V84, P294, DOI 10.1073/pnas.84.1.294; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SEPPALA M, 1976, LANCET, V2, P123; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164	30	294	316	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					51	61		10.1086/302182	http://dx.doi.org/10.1086/302182			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915943	Green Published, Bronze			2022-12-18	WOS:000078477400009
J	Ionita-Laza, I; Lee, S; Makarov, V; Buxbaum, JD; Lin, XH				Ionita-Laza, Iuliana; Lee, Seunggeun; Makarov, Vlad; Buxbaum, Joseph D.; Lin, Xihong			Sequence Kernel Association Tests for the Combined Effect of Rare and Common Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE ASSOCIATION; GENETIC-VARIANTS; GENOME; FRAMEWORK; SET; PROPORTION; RISK; SNPS	Recent developments in sequencing technologies have made it possible to uncover both rare and common genetic variants. Genome-wide association studies (GWASs) can test for the effect of common variants, whereas sequence-based association studies can evaluate the cumulative effect of both rare and common variants on disease risk. Many groupwise association tests, including burden tests and variance-component tests, have been proposed for this purpose. Although such tests do not exclude common variants from their evaluation, they focus mostly on testing the effect of rare variants by upweighting rare-variant effects and downweighting common-variant effects and can therefore lose substantial power when both rare and common genetic variants in a region influence trait susceptibility. There is increasing evidence that the allelic spectrum of risk variants at a given locus might include novel, rare, low-frequency, and common genetic variants. Here, we introduce several sequence kernel association tests to evaluate the cumulative effect of rare and common variants. The proposed tests are computationally efficient and are applicable to both binary and continuous traits. Furthermore, they can readily combine GWAS and whole-exome-sequencing data on the same individuals, when available, and are also applicable to deep-resequencing data of GWAS loci. We evaluate these tests on data simulated under comprehensive scenarios and show that compared with the most commonly used tests, including the burden and variance-component tests, they can achieve substantial increases in power. We next show applications to sequencing studies for Crohn disease and autism spectrum disorders. The proposed tests have been incorporated into the software package SKAT.	[Ionita-Laza, Iuliana; Makarov, Vlad] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Lee, Seunggeun; Lin, Xihong] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat Neurosci & Genet, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Columbia University; Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10032 USA.	ii2135@columbia.edu; xlin@hsph.harvard.edu	Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	National Science Foundation [DMS-1100279]; National Institutes of Health [R01MH095797, 1R03HG005908, K99-HL113164, MH089025, MH100233, R37 CA076404, P01CA134294]; Seaver Foundation; Direct For Mathematical & Physical Scien [1100279] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R37CA076404, P01CA134294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL113164] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG005908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089025, R01MH095797, U01MH100233] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was partially supported by National Science Foundation grant DMS-1100279 and National Institutes of Health grants R01MH095797 and 1R03HG005908 (to I.I.-L.), National Institutes of Health grant K99-HL113164 (to S.L.), a Seaver Foundation grant and National Institutes of Health grants MH089025 and MH100233 (to J.D.B.), and National Institutes of Health grants R37 CA076404 and P01CA134294 (to S.L. and X.L.).	Agresti A., 2003, CATEGORICAL DATA ANA; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Cai TT, 2011, J R STAT SOC B, V73, P629, DOI 10.1111/j.1467-9868.2011.00778.x; Cardin NJ, 2012, GENET EPIDEMIOL, V36, P642, DOI 10.1002/gepi.21659; Chen LS, 2012, AM J HUM GENET, V91, P977, DOI 10.1016/j.ajhg.2012.09.017; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DAVIES RB, 1977, BIOMETRIKA, V64, P247, DOI 10.2307/2335690; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sun L., 2012, ARXIV12054079; Tzeng JY, 2011, AM J HUM GENET, V89, P277, DOI 10.1016/j.ajhg.2011.07.007; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57	45	293	301	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					841	853		10.1016/j.ajhg.2013.04.015	http://dx.doi.org/10.1016/j.ajhg.2013.04.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23684009	Green Published, Bronze			2022-12-18	WOS:000320415300002
J	Schwab, SG; Knapp, M; Mondabon, S; Hallmayer, J; Borrmann-Hassenbach, M; Albus, M; Lerer, B; Rietschel, M; Trixler, M; Maier, W; Wildenauer, DB				Schwab, SG; Knapp, M; Mondabon, S; Hallmayer, J; Borrmann-Hassenbach, M; Albus, M; Lerer, B; Rietschel, M; Trixler, M; Maier, W; Wildenauer, DB			Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 6P; LOCUS; HAPLOTYPE; MUTATIONS	Genetic variants in a gene on 6p22.3, dysbindin, have been shown recently to be associated with schizophrenia (Straub et al. 2002a). There is no doubt that replication in other independent samples would enhance the significance of this finding considerably. Since the gene is located in the center of the linkage peak on chromosome 6p that we reported earlier, we decided to test six of the most positive DNA polymorphisms in a sib-pair sample and in an independently ascertained sample of triads comprising 203 families, including the families for which we detected linkage on chromosome 6p. Evidence for association was observed in the two samples separately as well as in the combined sample (P = .00068 for SNP rs760761). Multilocus haplotype analysis increased the significance further to .00002 for a two-locus haplotype and to .00001 for a three-locus haplotype. Estimation of frequencies for six-locus haplotypes revealed one common haplotype with a frequency of 73.4% in transmitted, and only 57.6% in nontransmitted, parental haplotypes. All other six-locus haplotypes occurring at a frequency of >1% were less often transmitted than nontransmitted. Our results represent a first successful replication of linkage disequilibrium in psychiatric genetics detected in a region with previous evidence of linkage and will encourage the search for causes of schizophrenia by the genetic approach.	Univ Bonn, Dept Psychiat, Mol Genet Lab, D-53111 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; State Mental Hosp, Haar, Germany; Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, Jerusalem, Israel; Zent Inst Seel Gesundheit, D-6800 Mannheim, Germany; Univ Pecs, Dept Psychiat, Pecs, Hungary	University of Bonn; University of Bonn; Stanford University; Hebrew University of Jerusalem; Hadassah University Medical Center; Central Institute of Mental Health; University of Pecs	Wildenauer, DB (corresponding author), Univ Bonn, Dept Psychiat, Mol Genet Lab, Wilhelmstr 31, D-53111 Bonn, Germany.	dieter.wildenauer@ukb.uni-bonn.de						Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; Chen XN, 1999, GENOME RES, V9, P492; Hofmann W, 2002, INT J CANCER, V97, P472, DOI 10.1002/ijc.1626; Hwu HG, 2000, AM J MED GENET, V96, P74, DOI 10.1002/(SICI)1096-8628(20000207)96:1<74::AID-AJMG15>3.0.CO;2-G; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Levinson DF, 1996, AM J MED GENET, V67, P580; LEWONTIN RC, 1988, GENETICS, V120, P849; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Nurnberger JI, 1999, AM J MED GENET, V88, P233, DOI 10.1002/(SICI)1096-8628(19990618)88:3<233::AID-AJMG5>3.0.CO;2-B; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SERETH H, 1993, HUM GENET, V92, P289; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Straub, 2002, AM J HUM GENET, V71, P1007; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; THOMAS GR, 1995, AM J HUM GENET, V56, P1315; THOMAS GR, 1994, AM J HUM GENET, V54, P71; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Weir B., 1996, GENETIC DATA ANAL; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	24	293	302	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					185	190		10.1086/345463	http://dx.doi.org/10.1086/345463			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474144	Green Published, Bronze			2022-12-18	WOS:000180186800019
J	XIE, X; OTT, J				XIE, X; OTT, J			TESTING LINKAGE DISEQUILIBRIUM BETWEEN A DISEASE GENE AND MARKER LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									COLUMBIA UNIV,NEW YORK,NY 10027	Columbia University									0	293	306	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3		S			1107	1107						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LW335					2022-12-18	WOS:A1993LW33501105
J	Bua, E; Johnson, J; Herbst, A; Delong, B; McKenzie, D; Salamat, S; Aiken, JM				Bua, Entela; Johnson, Jody; Herbst, Allen; Delong, Bridget; McKenzie, Debbie; Salamat, Shahriar; Aiken, Judd M.			Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; RHESUS-MONKEYS; TOTAL NUMBER; ABNORMALITIES; SARCOPENIA; ATROPHY; POLYMERASE; IMPAIRMENT; GENOMES; TISSUES	Skeletal muscle - mass loss with age has severe health consequences, yet the molecular basis of the loss remains obscure. Although mitochondrial DNA ( mtDNA) - deletion mutations have been shown to accumulate with age, for these aberrant genomes to be physiologically relevant, they must accumulate to high levels intracellularly and be present in a significant number of cells. We examined mtDNA-deletion mutations in vastus lateralis (VL) muscle of human subjects aged 49 - 93 years, using both histologic and polymerase-chain-reaction (PCR) analyses, to determine the physiological and genomic integrity of mitochondria in aging human muscle. The number of VL muscle fibers exhibiting mitochondrial electrontransport-system (ETS) abnormalities increased from an estimated 6% at age 49 years to 31% at age 92 years. We analyzed the mitochondrial genotype of 48 single ETS-abnormal, cytochrome c oxidase-negative/succinate dehydrogenase-hyperreactive (COX5(-)/SDH++) fibers from normal aging human subjects and identified mtDNA-deletion mutations in all abnormal fibers. Deletion mutations were clonal within a fiber and concomitant to the COX5(-)/SDH++ region. Quantitative PCR analysis of wild-type and deletion-containing mtDNA genomes within ETS-abnormal regions of single fibers demonstrated that these deletion mutations accumulate to detrimental levels (190% of the total mtDNA).	Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Aiken, JM (corresponding author), Univ Wisconsin, Dept Anim Hlth & Biomed Sci, 1656 Linden Dr, Madison, WI 53706 USA.	aiken@svm.vetmed.wisc.edu	McKenzie, Debbie/G-4459-2015	McKenzie, Debbie/0000-0002-9291-6977; Herbst, Allen/0000-0001-6601-1245; Aiken, Judd/0000-0001-6119-4521	NIA NIH HHS [AG11604, R01 AG011604] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011604] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117; Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Cartee GD, 1996, J GERONTOL A-BIOL, V51, pB214, DOI 10.1093/gerona/51A.3.B214; CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Dubowitz V, 1985, MUSCLE BIOPSY PRACTI, P19; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; ISHIHARA A, 1987, BRAIN RES, V435, P355, DOI 10.1016/0006-8993(87)91624-6; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2; McKiernan S, 2004, FASEB J, V18, P580, DOI 10.1096/fj.03-0667fje; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I; MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127; MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049; OVEREND TJ, 1992, CLIN PHYSIOL, V12, P629, DOI 10.1111/j.1475-097X.1992.tb00366.x; Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078; Reimers CD, 1998, J NEUROL SCI, V159, P60, DOI 10.1016/S0022-510X(98)00134-8; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275, DOI 10.1097/00003086-198310000-00042; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	44	292	299	1	20	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					469	480		10.1086/507132	http://dx.doi.org/10.1086/507132			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909385	Bronze, Green Published			2022-12-18	WOS:000239830700009
J	Veeramah, KR; O'Brien, JE; Meisler, MH; Cheng, XY; Dib-Hajj, SD; Waxman, SG; Talwar, D; Girirajan, S; Eichler, EE; Restifo, LL; Erickson, RP; Hammer, MF				Veeramah, Krishna R.; O'Brien, Janelle E.; Meisler, Miriam H.; Cheng, Xiaoyang; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Talwar, Dinesh; Girirajan, Santhosh; Eichler, Evan E.; Restifo, Linda L.; Erickson, Robert P.; Hammer, Michael F.			De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SODIUM-CHANNEL SCN8A; DISEASE-GENE DISCOVERY; FEBRILE SEIZURES-PLUS; COPY NUMBER VARIATION; MENTAL-RETARDATION; SENSORY NEURONS; DRAVET SYNDROME; MOUSE HEART; DISORDERS; MICE	Individuals with severe, sporadic disorders of infantile onset represent an important class of disease for which discovery of the underlying genetic architecture is not amenable to traditional genetic analysis. Full-genome sequencing of affected individuals and their parents provides a powerful alternative strategy for gene discovery. We performed whole-genome sequencing (WGS) on a family quartet containing an affected proband and her unaffected parents and sibling. The 15-year-old female proband had a severe epileptic encephalopathy consisting of early-onset seizures, features of autism, intellectual disability, ataxia, and sudden unexplained death in epilepsy. We discovered a de novo heterozygous missense mutation (c.5302A>G [p.Asn1768Asp]) in the voltage-gated sodium-channel gene SCN8A in the proband. This mutation alters an evolutionarily conserved residue in Nav1.6, one of the most abundant sodium channels in the brain. Analysis of the biophysical properties of the mutant channel demonstrated a dramatic increase in persistent sodium current, incomplete channel inactivation, and a depolarizing shift in the voltage dependence of steady-state fast inactivation. Current-clamp analysis in hippocampal neurons transfected with p.Asn1768Asp channels revealed increased spontaneous firing, paroxysmal-depolarizing-shift-like complexes, and an increased firing frequency, consistent with a dominant gain-of-function phenotype in the heterozygous proband. This work identifies SCN8A as the fifth sodium-channel gene to be mutated in epilepsy and demonstrates the value of WGS for the identification of pathogenic mutations causing severe, sporadic neurological disorders.	[Veeramah, Krishna R.; Hammer, Michael F.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Restifo, Linda L.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Erickson, Robert P.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [O'Brien, Janelle E.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Cheng, Xiaoyang; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Talwar, Dinesh; Erickson, Robert P.] Arizona Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85724 USA; [Talwar, Dinesh; Restifo, Linda L.] Arizona Hlth Sci Ctr, Dept Neurol, Tucson, AZ 85724 USA; [Restifo, Linda L.] Arizona Hlth Sci Ctr, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Talwar, Dinesh] Ctr Neurosci, Tucson, AZ 85718 USA; [Girirajan, Santhosh; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Arizona; University of Arizona; University of Arizona; University of Michigan System; University of Michigan; Yale University; University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Hammer, MF (corresponding author), Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA.	mfh@email.arizona.edu	Cheng, Xiaoyang/N-9970-2019; Waxman, Stephen/Z-2507-2019; Cheng, Xiaoyang/M-1257-2017; Cheng, Xiaoyang/A-1729-2012	Cheng, Xiaoyang/0000-0003-1446-2815; Waxman, Stephen/0000-0001-5718-7177; Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Garrison, Janelle/0000-0002-5031-9234	National Institutes of Health [R01_HG005226, R01_NS34509, T32_GM007544, HD065285]; Veterans Administration Medical Research Service; Rehabilitation Research Service; Simons Foundation Autism Research Initiative; Autism Speaks; Arizona Center for Biology of Complex Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Medical Research Service; Rehabilitation Research Service; Simons Foundation Autism Research Initiative; Autism Speaks; Arizona Center for Biology of Complex Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was provided by the National Institutes of Health to K.R.V. (R01_HG005226), M.H.M. (R01_NS34509), J.E.O. (T32_GM007544), and E.E.E. (HD065285). S.G.W. and S.D.H. are funded by grants from the Veterans Administration Medical Research Service and Rehabilitation Research Service. This work was also supported by the Simons Foundation Autism Research Initiative (E.E.E.). E.E.E. is an investigator of the Howard Hughes Medical Institute. L.L.R. is funded by Autism Speaks and the Arizona Center for Biology of Complex Diseases. We thank Tanya Karafet, Daniel Wolf, and Kimiko Della Croce for the de novo variant validation by PCR and sequencing.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne C., CARPENTIER W KEREN B; Devinsky O, 2011, NEW ENGL J MED, V365, P1801, DOI 10.1056/NEJMra1010481; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Dib-Hajj SD, 2009, NAT PROTOC, V4, P1118, DOI 10.1038/nprot.2009.90; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; Gant JC, 2009, EPILEPSIA, V50, P629, DOI 10.1111/j.1528-1167.2008.01725.x; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Liao Y, 2010, NEUROLOGY, V75, P1454, DOI 10.1212/WNL.0b013e3181f8812e; Lu Y, 2009, NEUROL RES, V31, P135, DOI 10.1179/174313209X393942; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Marini C, 2011, EPILEPSIA, V52, P24, DOI 10.1111/j.1528-1167.2011.02997.x; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Noujaim SF, 2012, FASEB J, V26, P63, DOI 10.1096/fj.10-179770; O'Brien JE, 2012, MOL CELL NEUROSCI, V49, P120, DOI 10.1016/j.mcn.2011.10.005; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Papale LA, 2009, HUM MOL GENET, V18, P1633, DOI 10.1093/hmg/ddp081; Pavone P., 2011, BRAIN DEV IN PRESS; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Ratnapriya R, 2010, HUM GENET, V128, P123, DOI 10.1007/s00439-010-0831-6; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Robinson PN, 2011, CLIN GENET, V80, P127, DOI 10.1111/j.1399-0004.2011.01713.x; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schaller KL, 2000, J COMP NEUROL, V420, P84; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Vanoye CG, 2006, J GEN PHYSIOL, V127, P1, DOI 10.1085/jgp.200509373; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Wu SP, 2007, AM J MED GENET B, V144B, P492, DOI 10.1002/ajmg.b.30495	59	291	314	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					502	510		10.1016/j.ajhg.2012.01.006	http://dx.doi.org/10.1016/j.ajhg.2012.01.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22365152	Green Published, Bronze			2022-12-18	WOS:000301762800016
J	Rice, G; Patrick, T; Parmar, R; Taylor, CF; Aeby, A; Aicardi, J; Artuch, R; Montalto, SA; Bacino, CA; Barroso, B; Baxter, P; Benko, WS; Bergmann, C; Bertini, E; Biancheri, R; Blair, EM; Blau, N; Bonthron, DT; Briggs, T; Brueton, LA; Brunner, HG; Burke, CJ; Carr, IM; Carvalho, DR; Chandler, KE; Christen, HJ; Corry, PC; Cowan, FM; Cox, H; D'Arrigo, S; Dean, J; De Laet, C; De Praeter, C; Dery, C; Ferrie, CD; Flintoff, K; Frints, SGM; Garcia-Cazorla, A; Gener, B; Goizet, C; Goutieres, F; Green, AJ; Guet, A; Hamel, BCJ; Hayward, BE; Heiberg, A; Hennekam, RC; Husson, M; Jackson, AP; Jayatunga, R; Jiang, YH; Kant, SG; Kao, A; King, MD; Kingston, HM; Klepper, J; van der Knaap, MS; Kornberg, AJ; Kotzot, D; Kratzer, W; Lacombe, D; Lagae, L; Landrieu, PG; Lanzi, G; Leitch, A; Lim, MJ; Livingston, JH; Lourenco, CM; Lyall, EGH; Lynch, SA; Lyons, MJ; Marom, D; McClure, JP; McWilliam, R; Melancon, SB; Mewasingh, LD; Moutard, ML; Nischal, KK; Ostergaard, JR; Prendiville, J; Rasmussen, M; Rogers, RC; Roland, D; Rosser, EM; Rostasy, K; Roubertie, A; Sanchis, A; Schiffmann, R; Scholl-Burgi, S; Seal, S; Shalev, SA; Corcoles, CS; Sinha, GP; Soler, D; Spiegel, R; Stephenson, JBP; Tacke, U; Tan, TY; Till, M; Tolmie, JL; Tomlin, P; Vagnarelli, F; Valente, EM; Van Coster, RNA; Van der Aa, N; Vanderver, A; Vles, JSH; Voit, T; Wassmer, E; Weschke, B; Whiteford, ML; Willemsen, MAA; Zankl, A; Zuberi, SM; Orcesi, S; Fazzi, E; Lebon, P; Crow, YJ				Rice, Gillian; Patrick, Teresa; Parmar, Rekha; Taylor, Claire F.; Aeby, Alec; Aicardi, Jean; Artuch, Rafael; Montalto, Simon Attard; Bacino, Carlos A.; Barroso, Bruno; Baxter, Peter; Benko, Willam S.; Bergmann, Carsten; Bertini, Enrico; Biancheri, Roberta; Blair, Edward M.; Blau, Nenad; Bonthron, David T.; Briggs, Tracy; Brueton, Louise A.; Brunner, Han G.; Burke, Christopher J.; Carr, Ian M.; Carvalho, Daniel R.; Chandler, Kate E.; Christen, Hans-Juergen; Corry, Peter C.; Cowan, Frances M.; Cox, Helen; D'Arrigo, Stefano; Dean, John; De laet, Corinne; De Praeter, Claudine; Dery, Catherine; Ferrie, Colin D.; Flintoff, Kim; Frints, Suzanna G. M.; Garcia-Cazorla, Angels; Gener, Blanca; Goizet, Cyril; Goutieres, Francoise; Green, Andrew J.; Gueet, Agnes; Hamel, Ben C. J.; Hayward, Bruce E.; Heiberg, Arvid; Hennekam, Raoul C.; Husson, Marie; Jackson, Andrew P.; Jayatunga, Rasieka; Jiang, Yong-Hui; Kant, Sarina G.; Kao, Amy; King, Mary D.; Kingston, Helen M.; Klepper, Joerg; van der Knaap, Marjo S.; Kornberg, Andrew J.; Kotzot, Dieter; Kratzer, Wilfried; Lacombe, Didier; Lagae, Lieven; Landrieu, Pierre Georges; Lanzi, Giovanni; Leitch, Andrea; Lim, Ming J.; Livingston, John H.; Lourenco, Charles M.; Lyall, E. G. Hermione; Lynch, Sally A.; Lyons, Michael J.; Marom, Daphna; McClure, John P.; McWilliam, Robert; Melancon, Serge B.; Mewasingh, Leena D.; Moutard, Marie-Laure; Nischal, Ken K.; Ostergaard, John R.; Prendiville, Julie; Rasmussen, Magnhild; Rogers, R. Curtis; Roland, Dominique; Rosser, Elisabeth M.; Rostasy, Kevin; Roubertie, Agathe; Sanchis, Amparo; Schiffmann, Raphael; Scholl-Buergi, Sabine; Seal, Sunita; Shalev, Stavit A.; Corcoles, C. Sierra; Sinha, Gyan P.; Soler, Doriette; Spiegel, Ronen; Stephenson, John B. P.; Tacke, Uta; Tan, Tiong Yang; Till, Marianne; Tolmie, John L.; Tomlin, Pam; Vagnarelli, Federica; Valente, Enza Maria; Van Coster, Rudy N. A.; Van der Aa, Nathalie; Vanderver, Adeline; Vles, Johannes S. H.; Voit, Thomas; Wassmer, Evangeline; Weschke, Bernhard; Whiteford, Margo L.; Willemsen, Michel A. A.; Zankl, Andreas; Zuberi, Sameer M.; Orcesi, Simona; Fazzi, Elisa; Lebon, Pierre; Crow, Yanick J.			Clinical and molecular phenotype of Aicardi-Goutieres syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INFECTION-LIKE SYNDROME; PROGRESSIVE FAMILIAL ENCEPHALOPATHY; CEREBROSPINAL-FLUID LYMPHOCYTOSIS; INTERFERON-ALPHA; INTRAUTERINE INFECTION; INTRACRANIAL CALCIFICATION; BASAL GANGLIA; 2 BROTHERS; MUTATIONS	Aicardi-Goutieres syndrome (AGS) is a genetic encephalopathy whose clinical features mimic those of acquired in utero viral infection. AGS exhibits locus heterogeneity, with mutations identified in genes encoding the 3'-> 5' exonuclease TREX1 and the three subunits of the RNASEH2 endonuclease complex. To define the molecular spectrum of AGS, we performed mutation screening in patients, from 127 pedigrees, with a clinical diagnosis of the disease. Biallelic mutations in TREX1, RNASEH2A, RNASEH2B, and RNASEH2C were observed in 31, 3, 47, and 18 families, respectively. In five families, we identified an RNASEH2A or RNASEH2B mutation on one allele only. In one child, the disease occurred because of a de novo heterozygous TREX1 mutation. In 22 families, no mutations were found. Null mutations were common in TREX1, although a specific missense mutation was observed frequently in patients from northern Europe. Almost all mutations in RNASEH2A, RNASEH2B, and RNASEH2C were missense. We identified an RNASEH2C founder mutation in 13 Pakistani families. We also collected clinical data from 123 mutation-positive patients. Two clinical presentations could be delineated: an early-onset neonatal form, highly reminiscent of congenital infection seen particularly with TREX1 mutations, and a later- onset presentation, sometimes occurring after several months of normal development and occasionally associated with remarkably preserved neurological function, most frequently due to RNASEH2B mutations. Mortality was correlated with genotype; 34.3% of patients with TREX1, RNASEH2A, and RNASEH2C mutations versus 8.0% RNASEH2B mutation-positive patients were known to have died (P = .001). Our analysis defines the phenotypic spectrum of AGS and suggests a coherent mutation- screening strategy in this heterogeneous disorder. Additionally, our data indicate that at least one further AGS- causing gene remains to be identified.	St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, DNA Lab, Leeds LS9 7TF, W Yorkshire, England; Canc Res UK, Mutat Detect Facil, Leeds, W Yorkshire, England; Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England; Erasme Univ Hosp, Dept Paediat Neurol, Brussels, Belgium; Childrens Hosp Queen Fabiola, Brussels, Belgium; Hop Trousseau, Serv Neuropediat, F-75571 Paris, France; Hop Trousseau, Dept Paediat Neurol, F-75571 Paris, France; Hop Bicetre, Paediat Neurol Dept, Paris, France; Grp Hosp Pitie Salpetriere, Inst Myol, F-75634 Paris, France; Hop Cochin St Vincent de Paul, Serv Virol, Paris, France; Hosp St Joan Deu Ciberer, Dept Clin Biochem, Barcelona, Spain; Hosp St Joan Deu Ciberer, Dept Barcelona Pediat Neurol, Barcelona, Spain; St Lukes Hosp, Dept Paediat, Guardamangia, Malta; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; Ctr Hosp, Ser Neurol, Pau, France; Sheffield Childrens Hosp, Dept Paediat, Sheffield S10 2TH, S Yorkshire, England; Natl Inst Neurol Disorders & Stroke, Dev & Metab Neurol Branch, Natl Inst Hlth, Bethesda, MD USA; Univ Aachen, Rhein Westfal TH Aachen, Dept Human Genet, D-5100 Aachen, Germany; Bambino Gesu Childrens Res Hosp, Mol Med Unit, Rome, Italy; Mendel Inst Med Genet & Twin Res, IRCCS, Rome, Italy; G Gaslini Inst Children, Muscular & Neurodegeberat Dis Unit, Genoa, Italy; Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Sandwell & W Birmingham NHS Trust, Dept Paediat, Birmingham, W Midlands, England; Birmingham Childrens Hosp, Dept Neurol, Birmingham, W Midlands, England; Radboud Univ Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Pediat Neurol, Nijmegen, Netherlands; Royal Childrens Hosp, Dept Pediat Neurol, Brisbane, Qld, Australia; Royal Childrens Hosp, Genet Hlth Queensland, Brisbane, Qld, Australia; Univ Estadual Sao Paulo, Serv Aconselhamento Genet, Botucatu, SP, Brazil; St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; Kinderkrankenhaus Bult, Hannover, Germany; Bradford Natl Hlth Serv NHS Trust, Dept Paediat, Bradford, W Yorkshire, England; Fdn Ist Neurol C Besta, Dev Neurol Dept, Milan, Italy; Grampian Clin Genet Ctr, Aberdeen, Scotland; State Univ Ghent Hosp, Dept Neonatol, Ghent, Belgium; State Univ Ghent Hosp, Dept Pediat, Ghent, Belgium; Maastricht Univ Hosp, Dept Clin Genet, Maastricht, Netherlands; Maastricht Univ Hosp, Dept Neurol, Maastricht, Netherlands; Great Ormond St Hosp Sick Children, Imperial Coll, Dept Paediat & Imaging Sci, London, England; Great Ormond St Hosp Sick Children, St Marys NHS Trust, London, England; Great Ormond St Hosp Sick Children, Dept Ophthalmol, London, England; Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London, England; Evelina Childrens Hosp, London, England; St Thomas NHS Trust, London, England; Univ Laval, Sch Med, Dept Paediat, Quebec City, PQ, Canada; Hosp Cruces, Clin Genet Unit, Baracaldo, Spain; CHU Pellegrin Enfants, Gen Med Serv, Bordeaux, France; CHU Pellegrin Enfants, Unite Neurol Enfant & Adolescent, Bordeaux, France; Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin, Ireland; Childrens Univ Hosp, Dept Paediat Neurol, Dublin, Ireland; Univ Oslo, Rikshosp, Radiumhosp, Dept Med Genet, N-0027 Oslo, Norway; Univ Oslo, Rikshosp, Radiumhosp, Dept Paediat, N-0027 Oslo, Norway; Vrije Univ Amsterdam, Ctr Med, Dept Child Neurol, Amsterdam, Netherlands; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; Oregon Hlth & Sci Univ, Div Pediat Neurol, Portland, OR 97201 USA; Klinikum Aschaffenburg, Aschaffenburg, Germany; Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; Med Univ Innsbruck, Dept Med Genet, Div Clin Genet, Innsbruck, Austria; Childrens Hosp Innsbruck, Dept Pediat, Div Pediat Neurol & Inborn Errors Metab, Innsbruck, Austria; Klin Kinder & Jugendliche, Constance, Germany; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; IRCCS Casmiro Mondino Inst Neurol, Dept Child Neurol & Psychiat, Pavia, Italy; Univ Sao Paulo, Dept Neurogenet, Ribeirao Preto, Brazil; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Rabin Med Ctr, Raphael Racanati Genet Inst, Petah Tiqwa, Israel; Crosshouse Hosp, Dept Paediat, Ayr, Scotland; Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland; Royal Hosp Sick Children, Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland; Montreal Childrens Hosp, Div Med Genet, Montreal, PQ H3H 1P3, Canada; Univ Hosp Leicester NHS Trust, Dept Paediat Neurol, Leicester, Leics, England; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; British Columbia Childrens Hosp, Div Pediat Dermatol, Vancouver, BC, Canada; Inst Pathol & Genet, Gosselies, Belgium; Gui Chauliac Hosp, Pediat Neurol Dept, Montpellier, France; Hosp Univ Doctor Peset, Serv Pediat, Valencia, Spain; Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; Haemek Med Ctr, Inst Genet, Afula, Israel; Complejo Hosp Jean, Neuropediat Unit, Jean, Spain; Manor Hosp, Dept Paediat, Walsall, W Midlands, England; Univ Hosp, Div Neuropediat, Freiburg, Germany; Royal Childrens Hosp, Genet Hlth Serv Victoria, Brisbane, Qld, Australia; Hop Debrousse, Lyon, France; Lancashire Teaching Hosp Trust, Preston, Lancs, England; Arcispedale Santa Maria Nuova, Neonatal Intens Care Unit, Reggio Emilia, Italy; Ctr Genet Med, Antwerp, Belgium; Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; Humboldt Univ, Dept Neuropediat, Berlin, Germany	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; Cancer Research UK; Leeds General Infirmary; University of Leeds; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Baylor College of Medicine; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); RWTH Aachen University; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Oxford; University Children's Hospital Zurich; Birmingham Women's Hospital; University of Birmingham; University of Birmingham; Radboud University Nijmegen; Radboud University Nijmegen; Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane; Universidade Estadual Paulista; University of Manchester; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Laval University; Hospital Universitario Cruces; CHU Bordeaux; CHU Bordeaux; Our Ladys Children Hospital Crumlin; Childrens University Hospital - Temple Street; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Vrije Universiteit Amsterdam; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Oregon Health & Science University; Royal Children's Hospital Melbourne; Medical University of Innsbruck; KU Leuven; University Hospital Leuven; IRCCS Fondazione Casimiro Mondino; Universidade de Sao Paulo; Greenwood Genetic Center; Rabin Medical Center; University of Glasgow; University of Glasgow; McGill University; University Hospitals of Leicester NHS Trust; University of Leicester; Aarhus University; BC Childrens Hospital; University of British Columbia; Universite de Montpellier; CHU de Montpellier; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Emek Medical Center; Complejo Hospitalario de Jaen; University of Freiburg; Royal Children's Hospital Brisbane; CHU Lyon; IRCCS Arcispedale S. Maria Nuova; Children's National Health System; Humboldt University of Berlin	Crow, YJ (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Level 9,Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England.	Yanickcrow@mac.com	Wassmer, Evangeline/K-5467-2019; Valente, Enza Maria/G-2942-2017; Vanderver, Adeline/CAG-5072-2022; Zankl, Andreas/F-2044-2010; Fazzi, Elisa/J-6076-2016; Bertini, Enrico/ABG-1278-2020; GOIZET, Cyril/M-4576-2014; Kant, Sarina/F-8596-2010; Brunner, Han/C-9928-2013; Rice, Gillian I/G-3128-2015; Tan, Tiong Yang/AAV-6563-2020; Gener, Blanca/E-4310-2012; Jackson, Andrew P/D-3442-2009; Willemsen, Michel A.A.P./H-8119-2014; Crow, Yanick J/N-6120-2014; orcesi, simona/J-6030-2016; Bertini, Enrico/A-2284-2014; Green, Andrew/AAJ-7592-2020; d'arrigo, stefano/K-3640-2016; Lourenço, Charles M/O-2731-2013	Valente, Enza Maria/0000-0002-0600-6820; Zankl, Andreas/0000-0001-8612-1062; Fazzi, Elisa/0000-0003-4805-7906; GOIZET, Cyril/0000-0002-1913-889X; Rice, Gillian I/0000-0002-4223-0571; Tan, Tiong Yang/0000-0001-8455-7778; Jackson, Andrew P/0000-0002-8739-2646; Crow, Yanick J/0000-0001-7211-7564; orcesi, simona/0000-0001-8947-9342; Bertini, Enrico/0000-0001-9276-4590; d'arrigo, stefano/0000-0001-5188-9418; Green, Andrew/0000-0002-1077-7417; Bonthron, David/0000-0001-8132-8179; Lynch, Sally Ann/0000-0003-3540-1333; Burke, Christopher/0000-0001-7609-1146; Aeby, Alec/0000-0002-7516-665X; Briggs, Tracy/0000-0001-5208-2691; Weschke, Bernhard/0000-0003-4533-0743; Scholl-Burgi, Sabine/0000-0002-2529-4231; Kao, Amy/0000-0002-6753-9903; JACKSON, ALAN/0000-0002-1623-0383; Vanderver, Adeline/0000-0002-6290-6751; Blau, Nenad/0000-0003-4347-3230; Lacombe, Didier/0000-0002-8956-2207; Artuch, Rafael/0000-0002-3422-9685; Frints, Suzanna G.M./0000-0002-5027-8364; Dean, John/0000-0003-3841-0841	MRC [MC_U127580972] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER; Medical Research Council [MC_U127580972] Funding Source: Medline; NINDS NIH HHS [K08 NS060695] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Ali M, 2006, J MED GENET, V43, P444, DOI 10.1136/jmg.2005.031880; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; BURN J, 1986, CLIN GENET, V30, P112; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2000, AM J HUM GENET, V67, P213, DOI 10.1086/302955; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Desanges C, 2006, FETAL DIAGN THER, V21, P153, DOI 10.1159/000089067; Gardner RJM, 2005, PRENATAL DIAG, V25, P362, DOI 10.1002/pd.1152; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; HOYERAAL HM, 1970, ACTA PAEDIATR SCAND, V59, P185, DOI 10.1111/j.1651-2227.1970.tb08986.x; Knoblauch H, 2003, AM J MED GENET A, V120A, P261, DOI 10.1002/ajmg.a.20138; Lanzi G, 2005, NEUROLOGY, V64, P1621, DOI 10.1212/01.WNL.0000159864.05826.08; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Lebon Pierre, 2002, Eur J Paediatr Neurol, V6 Suppl A, pA47, DOI 10.1053/ejpn.2002.0574; McEntagart M, 1998, NEUROPEDIATRICS, V29, P163, DOI 10.1055/s-2007-973555; Modlin JF, 2003, NEW ENGL J MED, V349, P691, DOI 10.1056/NEJMcpc030017; Rasmussen M, 2005, NEUROPEDIATRICS, V36, P40, DOI 10.1055/s-2004-830532; REARDON W, 1994, AM J MED GENET, V52, P58, DOI 10.1002/ajmg.1320520112; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; TOLMIE JL, 1995, J MED GENET, V32, P881, DOI 10.1136/jmg.32.11.881; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963	31	291	304	1	38	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					713	725		10.1086/521373	http://dx.doi.org/10.1086/521373			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17846997	Green Published, Bronze			2022-12-18	WOS:000249307600013
J	Gazda, HT; Sheen, MR; Vlachos, A; Choesmel, V; O'Donohue, MF; Schneider, H; Darras, N; Hasman, C; Sieff, CA; Newburger, PE; Ball, SE; Niewiadomska, E; Matysiak, M; Zaucha, JM; Glader, B; Niemeyer, C; Meerpohl, JJ; Atsidaftos, E; Lipton, JM; Gleizes, PE; Beggs, AH				Gazda, Hanna T.; Sheen, Mee Rie; Vlachos, Adrianna; Choesmel, Valerie; O'Donohue, Marie-Francoise; Schneider, Hal; Darras, Natasha; Hasman, Catherine; Sieff, Colin A.; Newburger, Peter E.; Ball, Sarah E.; Niewiadomska, Edyta; Matysiak, Michal; Zaucha, Jan M.; Glader, Bertil; Niemeyer, Charlotte; Meerpohl, Joerg J.; Atsidaftos, Eva; Lipton, Jeffrey M.; Gleizes, Pierre-Emmanuel; Beggs, Alan H.			Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-BASIS; RPS19 PROTEIN; S19 GENE; RNA; INHIBITION; MATURATION; REGISTRY; CELLS; IDENTIFICATION	Diamond-Blackfan anemia (DBA), a congenital bone-marrow-failure syndrome, is characterized by red blood cell aplasia, macrocytic anemia, clinical heterogeneity, and increased risk of malignancy. Although anemia is the most prominent feature of DBA, the disease is also characterized by growth retardation and congenital anomalies that are present in similar to 30%-50% of patients. The disease has been associated with mutations in four ribosomal protein (RP) genes, RPS19, RPS24, RPS17, and RPL35A, in about 30% of patients. However, the genetic basis of the remaining 70% of cases is still unknown. Here, we report the second known mutation in RPS17 and probable pathogenic mutations in three more RP genes, RPL5, RPL11, and RPS7. In addition, we identified rare variants of unknown significance in three other genes, RPL36, RPS15, and RPS27A. Remarkably, careful review of the clinical data showed that mutations in RFL5 are associated with multiple physical abnormalities, including craniofacial, thumb, and heart anomalies, whereas isolated thumb malformations are predominantly present in patients carrying mutations in RPL11. We also demonstrate that mutations of RPL5, RPL11, or RPS7 in DBA cells is associated with diverse defects in the maturation of ribosomal RNAs in the large or the small ribosomal subunit production pathway, expanding the repertoire of ribosomal RNA processing defects associated with DBA.	[Gazda, Hanna T.; Sheen, Mee Rie; Schneider, Hal; Darras, Natasha; Hasman, Catherine; Beggs, Alan H.] Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet, Boston, MA 02115 USA; [Gazda, Hanna T.; Sheen, Mee Rie; Schneider, Hal; Darras, Natasha; Hasman, Catherine; Beggs, Alan H.] Childrens Hosp, Manton Ctr Orphan Dis Res, Program Genom, Boston, MA 02115 USA; [Gazda, Hanna T.; Sieff, Colin A.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Vlachos, Adrianna; Atsidaftos, Eva; Lipton, Jeffrey M.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Vlachos, Adrianna; Atsidaftos, Eva; Lipton, Jeffrey M.] Schneider Childrens Hosp, Albert Einstein Coll Med, New Hyde Pk, NY 11040 USA; [Choesmel, Valerie; O'Donohue, Marie-Francoise; Gleizes, Pierre-Emmanuel] Univ Toulouse, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Choesmel, Valerie; O'Donohue, Marie-Francoise; Gleizes, Pierre-Emmanuel] CNRS, UMR 5099, F-31000 Toulouse, France; [Sieff, Colin A.] Childrens Hosp, Div Pediat Hematol, Boston, MA 02115 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [Ball, Sarah E.] St Georges Univ London, Dept Cellular & Mol Med, London SW17 0RE, England; [Niewiadomska, Edyta; Matysiak, Michal] Med Univ Warsaw, Dept Paediat Haematol Oncol, PL-00576 Warsaw, Poland; [Zaucha, Jan M.] Med Univ Gdansk, Dept Propedeut Oncol, PL-81519 Gdansk, Poland; [Glader, Bertil] Stanford Univ, Sch Med, Div Pediat Hematol Oncol, Palo Alto, CA 94304 USA; [Niemeyer, Charlotte; Meerpohl, Joerg J.] Univ Freiburg, Dept Paediat, Div Paediat Haematol & Oncol, D-79106 Freiburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Northwell Health; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yeshiva University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; St Georges University London; Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Stanford University; University of Freiburg	Gazda, HT (corresponding author), Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet, 300 Longwood Ave, Boston, MA 02115 USA.	hanna.gazda@childrens.harvard.edu	Gleizes, Pierre-Emmanuel/H-3821-2014; Matysiak, Michal J/V-6942-2018; Zaucha, Jan Maciej/AAF-2658-2020; Gleizes, Pierre-Emmanuel/ABB-9653-2021; Meerpohl, Joerg J/J-4224-2013	Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Matysiak, Michal J/0000-0001-8748-7883; Zaucha, Jan Maciej/0000-0002-0986-8936; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Meerpohl, Joerg J/0000-0002-1333-5403; O'Donohue, Marie-Francoise/0000-0002-1204-8285; Newburger, Peter/0000-0002-8615-673X; Niewiadomska, Edyta/0000-0003-2045-6278; Beggs, Alan/0000-0001-8818-0568	NICHD NIH HHS [P30 HD018655, P30 HD18655] Funding Source: Medline; NINDS NIH HHS [P50 NS040828-080003, P50 NS040828] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AASE JM, 1969, J PEDIATR, V74, P471, DOI 10.1016/S0022-3476(69)80208-8; Alter BP, 1998, NATHAN OSKIS HEMATOL, P237; Angelini M, 2007, HUM MOL GENET, V16, P1720, DOI 10.1093/hmg/ddm120; Ball SE, 1996, BRIT J HAEMATOL, V94, P645, DOI 10.1046/j.1365-2141.1996.d01-1839.x; BOMMER UA, 1988, FEBS LETT, V233, P114, DOI 10.1016/0014-5793(88)81366-8; Campagnoli MF, 2004, HAEMATOLOGICA, V89, P480; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Cmejla R, 2000, BLOOD CELL MOL DIS, V26, P124, DOI 10.1006/bcmd.2000.0286; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; DANILOVA N, 2008, BLOOD; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; GLADER BE, 1983, NEW ENGL J MED, V309, P1486, DOI 10.1056/NEJM198312153092404; Gregory LA, 2007, NUCLEIC ACIDS RES, V35, P5913, DOI 10.1093/nar/gkm626; Gripp KW, 2001, AM J MED GENET, V101, P268, DOI 10.1002/ajmg.1329; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Hamaguchi I, 2002, BLOOD, V100, P2724, DOI 10.1182/blood.V100.8.2724; HEYN R, 1974, J PEDIATR-US, V85, P531, DOI 10.1016/S0022-3476(74)80464-6; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kuramitsu M, 2008, BRIT J HAEMATOL, V140, P348, DOI 10.1111/j.1365-2141.2007.06930.x; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; Lipton JM, 2006, PEDIATR BLOOD CANCER, V46, P558, DOI 10.1002/pbc.20642; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; Orfali KA, 2004, BRIT J HAEMATOL, V125, P243, DOI 10.1111/j.1365-2141.2004.04890.x; Ramenghi U, 2000, BLOOD CELL MOL DIS, V26, P417, DOI 10.1006/bcmd.2000.0324; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vlachos A, 2001, J PEDIAT HEMATOL ONC, V23, P377, DOI 10.1097/00043426-200108000-00015; Willig TN, 1999, BLOOD, V94, P4294; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	50	290	308	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					769	780		10.1016/j.ajhg.2008.11.004	http://dx.doi.org/10.1016/j.ajhg.2008.11.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19061985	Green Published, Bronze			2022-12-18	WOS:000261822100012
J	Tai, HL; Krynetski, EY; Yates, CR; Loennechen, T; Fessing, MY; Krynetskaia, NF; Evans, WE				Tai, HL; Krynetski, EY; Yates, CR; Loennechen, T; Fessing, MY; Krynetskaia, NF; Evans, WE			Thiopurine S-methyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AZATHIOPRINE-INDUCED MYELOSUPPRESSION; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEART-TRANSPLANT RECIPIENT; SACCHAROMYCES-CEREVISIAE; ERYTHROCYTE CORRELATION; BIOCHEMICAL-PROPERTIES; PHARMACOGENETICS; 6-MERCAPTOPURINE; TOXICITY; RNA	The autosomal recessive trait of thiopurine S-methyltransferase (TPMT) deficiency is associated with severe hematopoietic toxicity when patients are treated with standard doses of mercaptopurine, azathioprine, or thioguanine. To define the molecular mechanism of this genetic polymorphism, we cloned and characterized the cDNA of a TPMT-deficient patient, which revealed a novel mutant allele (TPMT*3) containing two nucleotide transitions (G(460)-->A and A(719)-->G) producing amino acid changes at codons 154 (Ala-->Thr) and 240 (Tyr-->Cys), differing from the rare mutant TPMT allele we previously identified (i.e., TPMT*2 with only G(238)-->C). Site-directed mutagenesis and heterologous expression established that either TPMT*3 mutation alone leads to a reduction in catalytic activity (G(460)-->A, ninefold reduction; A(719)-->G, 1.4-fold reduction), while the presence of both mutations leads to complete loss of activity. Using mutation specific PCR-RFLP analysis, the TPMT*3 allele was detected in genomic DNA from approximate to 75% of unrelated white subjects with heterozygous phenotypes, indicating that TPMT*3 is the most prevalent mutant allele associated with TPMT-deficiency in Caucasians.	ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT SCI, MEMPHIS, TN 38105 USA; UNIV TENNESSEE, DEPT CLIN PHARM, CTR PEDIAT PHARMACOKINET & THERAPEUT, MEMPHIS, TN USA; UNIV TENNESSEE, DEPT PHARMACEUT, MEMPHIS, TN USA; UNIV TENNESSEE, DEPT PEDIAT, MEMPHIS, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center			Evans, William E./C-2069-2012	Evans, William E./0000-0002-9333-5322; Fessing, Michael/0000-0002-3120-8707	NATIONAL CANCER INSTITUTE [P30CA021765, P01CA020180, R37CA036401] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765, CA20180, R37 CA36401] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECKER DM, 1993, CURRENT PROTOCOLS MO, V2, P1371; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; CULLIN C, 1988, GENE, V65, P203, DOI 10.1016/0378-1119(88)90457-X; DRYNETSKI EY, 1995, MOL PHARMACOL, V47, P1141; DUPRET JM, 1994, J BIOL CHEM, V269, P26830; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; EVANS WE, 1991, J PEDIATR-US, V119, P985, DOI 10.1016/S0022-3476(05)83063-X; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; HOLLANDER AAMJ, 1995, LANCET, V345, P610, DOI 10.1016/S0140-6736(95)90520-0; HONCHEL R, 1993, MOL PHARMACOL, V43, P878; KRYNETSKI EY, 1995, P NATL ACAD SCI USA, V92, P949, DOI 10.1073/pnas.92.4.949; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNARD L, 1993, ARCH DIS CHILD, V69, P577, DOI 10.1136/adc.69.5.577; LENNARD L, 1987, CLIN PHARMACOL THER, V41, P18, DOI 10.1038/clpt.1987.4; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1989, CLIN PHARMACOL THER, V46, P149, DOI 10.1038/clpt.1989.119; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCLEOD HL, 1995, BLOOD, V85, P1897, DOI 10.1182/blood.V85.7.1897.bloodjournal8571897; MCLEOD HL, 1993, LANCET, V341, P1151, DOI 10.1016/0140-6736(93)93168-Z; MCLEOD HL, 1995, PHARMACOGENETICS, V5, P281, DOI 10.1097/00008571-199510000-00003; MCLEOD HL, 1994, CLIN PHARMACOL THER, V55, P15, DOI 10.1038/clpt.1994.4; SAMBROOK J, 1989, MOL CLONING LAB MANU, V2, P740; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHUTZ E, 1993, LANCET, V341, P436, DOI 10.1016/0140-6736(93)93028-Y; SZUMLANSKI CL, 1992, PHARMACOGENETICS, V2, P148, DOI 10.1097/00008571-199208000-00002; VANLOON JA, 1982, BIOCHEM GENET, V20, P637, DOI 10.1007/BF00483962; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; WOODSON LC, 1982, J PHARMACOL EXP THER, V222, P174; [No title captured]	31	290	306	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					694	702						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644731				2022-12-18	WOS:A1996UA38000005
J	Andreassen, OA; Djurovic, S; Thompson, WK; Schork, AJ; Kendler, KS; O'Donovan, MC; Rujescu, D; Werge, T; van de Bunt, M; Morris, AP; McCarthy, MI; Roddey, JC; McEvoy, LK; Desikan, RS; Dale, AM				Andreassen, Ole A.; Djurovic, Srdjan; Thompson, Wesley K.; Schork, Andrew J.; Kendler, Kenneth S.; O'Donovan, Michael C.; Rujescu, Dan; Werge, Thomas; van de Bunt, Martijn; Morris, Andrew P.; McCarthy, Mark I.; Roddey, J. Cooper; McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.		Int Consortium Blood Pressure GWAS; Diabet Genetics Replication; Psychiatric Genomics Consortium	Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; LOCI; HERITABILITY; HYPOTHESIS; MORTALITY; INFERENCE	Several lines of evidence suggest that genome-wide association studies (GWASs) have the potential to explain more of the "missing heritability" of common complex phenotypes. However, reliable methods for identifying a larger proportion of SNPs are currently lacking. Here, we present a genetic-pleiotropy-informed method for improving gene discovery with the use of GWAS summary-statistics data. We applied this methodology to identify additional loci associated with schizophrenia (SCZ), a highly heritable disorder with significant missing heritability. Epidemiological and clinical studies suggest comorbidity between SCZ and cardiovascular-disease (CVD) risk factors, including systolic blood pressure, triglycerides, low- and high-density lipoprotein, body mass index, waist-to-hip ratio, and type 2 diabetes. Using stratified quantile-quantile plots, we show enrichment of SNPs associated with SCZ as a function of the association with several CVD risk factors and a corresponding reduction in false discovery rate (FDR). We validate this "pleiotropic enrichment" by demonstrating increased replication rate across independent SCZ substudies. Applying the stratified FDR method, we identified 25 loci associated with SCZ at a conditional FDR level of 0.01. Of these, ten loci are associated with both SCZ and CVD risk factors, mainly triglycerides and low- and high-density lipoproteins but also waist-to-hip ratio, systolic blood pressure, and body mass index. Together, these findings suggest the feasibility of using genetic-pleiotropy-informed methods for improving gene discovery in SCZ and identifying potential mechanistic relationships with various CVD risk factors.	[Andreassen, Ole A.; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, N-0407 Oslo, Norway; [Andreassen, Ole A.; Djurovic, Srdjan] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0407 Oslo, Norway; [Andreassen, Ole A.; Thompson, Wesley K.; Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; [Schork, Andrew J.; Roddey, J. Cooper; McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92037 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92037 USA; [Schork, Andrew J.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92037 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [O'Donovan, Michael C.] Cardiff Univ, Sch Med, Med Res Council Ctr Neuropsychiat Genet & Genom, Cardiff CF14 4XN, S Glam, Wales; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06112 Halle, Germany; [Werge, Thomas] Univ Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, iPSYCH, DK-4000 Roskilde, Denmark; [van de Bunt, Martijn; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7LJ, England; [McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92037 USA; [Roddey, J. Cooper; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	University of Oslo; University of Oslo; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Virginia Commonwealth University; Cardiff University; Martin Luther University Halle Wittenberg; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California San Diego; University of California System; University of California San Diego	Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, N-0407 Oslo, Norway.	o.a.andreassen@medisin.uio.no; amdale@ucsd.edu	Fanous, Ayman H/O-1263-2017; Cichon, Sven/B-9618-2014; Ruderfer, Douglas M/M-5795-2016; Mattingsdal, Morten/Q-9367-2016; O'Donovan, Michael C/P-7005-2018; Rujescu, Dan/GRS-3875-2022; Hansen, Thomas Folkmann/O-5965-2014; Mattheisen, Manuel/B-4949-2012; Kendler, Kenneth/AAF-2876-2019; Cichon, Sven/H-8803-2013; Andreassen, Ole A./AAY-7531-2020; Mattheisen, Manuel/S-3725-2019; McQuillin, Andrew/C-1623-2008; van Os, Jim/C-2113-2014; Hartmann, Annette/AAS-6331-2021; Melle, Ingrid S/B-4858-2011; Myin-Germeys, Inez/L-5106-2014; Konte, Bettina/AAT-1142-2021; Kähler, Anna K/J-2874-2012; McCarthy, Mark/M-3763-2015; Mowry, Bryan/G-5046-2010	Cichon, Sven/0000-0002-9475-086X; Ruderfer, Douglas M/0000-0002-2365-386X; Mattingsdal, Morten/0000-0003-4440-0324; O'Donovan, Michael C/0000-0001-7073-2379; Hansen, Thomas Folkmann/0000-0001-6703-7762; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; McQuillin, Andrew/0000-0003-1567-2240; Melle, Ingrid S/0000-0002-9783-548X; Konte, Bettina/0000-0001-5287-308X; Myin-Germeys, Inez/0000-0002-3731-4930; Posthuma, Danielle/0000-0001-7582-2365; McCarthy, Mark/0000-0002-4393-0510; Mowry, Bryan/0000-0002-4115-5645; Andreassen, Ole A./0000-0002-4461-3568; van de Bunt, Martijn/0000-0002-6744-6125; Nothen, Markus/0000-0002-8770-2464; KELLER, MATTHEW/0000-0002-6075-9882; Bruggeman, Richard/0000-0002-3238-8471; Agartz, Ingrid/0000-0002-9839-5391; Zammit, Stanley/0000-0002-2647-9211; Djurovic, Srdjan/0000-0002-8140-8061	Kristian Gerhard Jebsen Foundation; Research Council of Norway; South East Norway Health Authority; Unger-Vetlesen Medical Fund; National Institutes of Health (NIH) [T32 EB005970, R01AG031224, R01EB000790, RC2DA29475, RC2DA029475, R01HD061414]; Robert J. Glushko and Pamela Samuelson Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970, R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA029475] Funding Source: NIH RePORTER; Medical Research Council [G0801418B, G0800509] Funding Source: researchfish; MRC [G0800509] Funding Source: UKRI	Kristian Gerhard Jebsen Foundation; Research Council of Norway(Research Council of Norway); South East Norway Health Authority; Unger-Vetlesen Medical Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. Glushko and Pamela Samuelson Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank Terry Jernigan for helpful input on this manuscript. O.A.A. was supported by the Kristian Gerhard Jebsen Foundation, the Research Council of Norway, the South East Norway Health Authority, and the Unger-Vetlesen Medical Fund. R.S.D. was supported by National Institutes of Health (NIH) grant T32 EB005970. A.M.D. was supported by NIH grants R01AG031224, R01EB000790, and RC2DA29475. A.J.S. was supported by NIH grants RC2DA029475 and R01HD061414 and the Robert J. Glushko and Pamela Samuelson Graduate Fellowship.	Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Craiu RV, 2008, STAT SINICA, V18, P861; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B., 2010, LARGE SCALE INFERENC; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Karoutzou G, 2008, MOL PSYCHIATR, V13, P245, DOI 10.1038/sj.mp.4002096; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Mitchell AJ, 2011, SCHIZOPHR B; Murray C.J.L., 1996, HARVARD SCH PUBLIC H; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raphael T, 1921, ARCH NEURO PSYCHIATR, V5, P687, DOI 10.1001/archneurpsyc.1921.02180300052005; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2012, NAT MED, V18, P210, DOI 10.1038/nm.2670; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoo Yun Joo, 2009, BMC Proc, V3 Suppl 7, pS103	48	289	290	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					197	209		10.1016/j.ajhg.2013.01.001	http://dx.doi.org/10.1016/j.ajhg.2013.01.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23375658	Green Published, Bronze			2022-12-18	WOS:000315179600004
J	Monks, SA; Leonardson, A; Zhu, H; Cundiff, P; Pietrusiak, P; Edwards, S; Phillips, JW; Sachs, A; Schadt, EE				Monks, SA; Leonardson, A; Zhu, H; Cundiff, P; Pietrusiak, P; Edwards, S; Phillips, JW; Sachs, A; Schadt, EE			Genetic inheritance of gene expression in human cell lines	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRAIT LINKAGE ANALYSIS; REGULATORY VARIATION; HUMAN GENOME; MICROARRAYS; MOUSE; MAP	Combining genetic inheritance information, for both molecular profiles and complex traits, is a promising strategy not only for detecting quantitative trait loci (QTLs) for complex traits but for understanding which genes, pathways, and biological processes are also under the influence of a given QTL. As a primary step in determining the feasibility of such an approach in humans, we present the largest survey to date, to our knowledge, of the heritability of gene-expression traits in segregating human populations. In particular, we measured expression for 23,499 genes in lymphoblastoid cell lines for members of 15 Centre d'Etude du Polymorphisme Humain ( CEPH) families. Of the total set of genes, 2,340 were found to be expressed, of which 31% had significant heritability when a false-discovery rate of 0.05 was used. QTLs were detected for 33 genes on the basis of at least one P value <.000005. Of these, 13 genes possessed a QTL within 5 Mb of their physical location. Hierarchical clustering was performed on the basis of both Pearson correlation of gene expression and genetic correlation. Both reflected biologically relevant activity taking place in the lymphoblastoid cell lines, with greater coherency represented in Kyoto Encyclopedia of Genes and Genomes database (KEGG) pathways than in Gene Ontology database pathways. However, more pathway coherence was observed in KEGG pathways when clustering was based on genetic correlation than when clustering was based on Pearson correlation. As more expression data in segregating populations are generated, viewing clusters or networks based on genetic correlation measures and shared QTLs will offer potentially novel insights into the relationship among genes that may underlie complex traits.	Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Rosetta Inpharmat LLC, Seattle, WA USA; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; Merck & Co Inc, Merck Res Labs, Rahway, NJ 07065 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Merck & Company; Johns Hopkins University; Merck & Company	Monks, SA (corresponding author), Oklahoma State Univ, Dept Stat, 301G Math Stat & Comp Sci Bldg, Stillwater, OK 74078 USA.	stephanie.monks@okstate.edu	Edwards, Stephen W/G-4482-2011; Santorico, Stephanie/L-7009-2015	Edwards, Stephen/0000-0002-7985-111X; Santorico, Stephanie/0000-0001-7846-0945				Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Belmaker RH, 2002, BIPOLAR DISORD, V4, P67, DOI 10.1034/j.1399-5618.2002.00108.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	24	289	307	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1094	1105		10.1086/426461	http://dx.doi.org/10.1086/426461			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15514893	Green Published, Bronze			2022-12-18	WOS:000224866400013
J	Giglio, S; Broman, KW; Matsumoto, N; Calvari, V; Gimelli, G; Neumann, T; Ohashi, H; Voullaire, L; Larizza, D; Giorda, R; Weber, JL; Ledbetter, DH; Zuffardi, O				Giglio, S; Broman, KW; Matsumoto, N; Calvari, V; Gimelli, G; Neumann, T; Ohashi, H; Voullaire, L; Larizza, D; Giorda, R; Weber, JL; Ledbetter, DH; Zuffardi, O			Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECURRENT CONSTITUTIONAL T(11-22); CONGENITAL HEART-DEFECTS; INVERTED DUPLICATION; DELETION; REGION; 8P; CENTROMERE; MECHANISM; DISORDERS; DISEASE	The olfactory receptor (OR)-gene superfamily is the largest in the mammalian genome. Several of the human OR genes appear in clusters with greater than or equal to 10 members located on almost all human chromosomes, and some chromosomes contain more than one cluster. We demonstrate, by experimental and in silico data, that unequal crossovers between two OR gene clusters in 8p are responsible for the formation of three recurrent chromosome macrorearrangements and a submicroscopic inversion polymorphism. The first two macrorearrangements are the inverted duplication of 8p, inv dup(8p), which is associated with a distinct phenotype, and a supernumerary marker chromosome, +der(8)(8p23.1pter), which is also a recurrent rearrangement and is associated with minor anomalies. We demonstrate that it is the reciprocal of the inv dup(8p). The third macrorearrangment is a recurrent 8p23 interstitial deletion associated with heart defect. Since inv dup(8p)s originate consistently in maternal meiosis, we investigated the maternal chromosomes 8 in eight mothers of subjects with inv dup(8p) and in the mother of one subject with +der(8), by means of probes included between the two 8p-OR gene clusters. All the mothers were heterozygous for an 8p submicroscopic inversion that was delimited by the 8p-OR gene clusters and was present, in heterozygous state, in 26% of a population of European descent. Thus, inversion heterozygosity may cause susceptibility to unequal recombination, leading to the formation of the inv dup(8p) or to its reciprocal product, the +der(8p). After the Yp inversion polymorphism, which is the preferential background for the PRKX/PRKY translocation in XX males and XY females, the OR-8p inversion is the second genomic polymorphism that confers susceptibility to the formation of common chromosome rearrangements. Accordingly, it may be possible to develop a profile of the individual risk of having progeny with chromosome rearrangements.	Univ Pavia, I-27100 Pavia, Italy; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Pediat IRCSS San Matteo, Pavia, Italy; Ist Giannina Gaslini, Lab Citogenet, I-16148 Genoa, Italy; Univ Munster, Inst Humangenet, D-4400 Munster, Germany; Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Murdoch Children Res Inst, Parkville, Vic, Australia; IRCCS E Medea, Bososio Parini, Lecco, Italy	University of Pavia; University of Chicago; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Munster; Nagasaki University; Murdoch Children's Research Institute; IRCCS Eugenio Medea	Zuffardi, O (corresponding author), Univ Pavia, CP 217, I-27100 Pavia, Italy.		Giorda, Roberto/J-1052-2014; Giglio, Sabrina SG/K-9109-2016; Giglio, Sabrina Rita/ABB-1093-2020; Giorda, Roberto/Q-6010-2019	Giorda, Roberto/0000-0001-8175-9606; Giglio, Sabrina SG/0000-0002-3954-326X; Giglio, Sabrina Rita/0000-0002-3954-326X; Giorda, Roberto/0000-0001-8175-9606; Broman, Karl/0000-0002-4914-6671; zuffardi, orsetta/0000-0002-1466-4559				Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; DEDIESMULDERS CEM, 1995, AM J MED GENET, V59, P369, DOI 10.1002/ajmg.1320590318; Devriendt K, 1999, AM J HUM GENET, V64, P1119, DOI 10.1086/302330; FELDMAN GL, 1993, AM J MED GENET, V47, P482, DOI 10.1002/ajmg.1320470410; Floridia G, 1996, AM J HUM GENET, V58, P785; Giglio S, 2000, CIRCULATION, V102, P432; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; GUO WJ, 1995, AM J MED GENET, V58, P230, DOI 10.1002/ajmg.1320580307; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Matsumoto N, 1997, GENOMICS, V45, P11, DOI 10.1006/geno.1997.4897; Mombaerts P, 1999, CURR OPIN GENET DEV, V9, P315, DOI 10.1016/S0959-437X(99)80047-1; Neumann T, 1999, CYTOGENET CELL GENET, V85, P158; OHASHI H, 1994, AM J HUM GENET, V55, P1202; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Rothenmund H, 1997, AM J MED GENET, V72, P339, DOI 10.1002/(SICI)1096-8628(19971031)72:3<339::AID-AJMG17>3.0.CO;2-U; Sambrook J, 1989, MOL CLONING LAB MANU; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Tyler-Smith C, 2000, CELL, V102, P5, DOI 10.1016/S0092-8674(00)00004-0; Wieczorek D, 2000, J MED GENET, V37, P798, DOI 10.1136/jmg.37.10.798	25	289	304	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					874	883		10.1086/319506	http://dx.doi.org/10.1086/319506			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11231899	Green Published, Bronze			2022-12-18	WOS:000167666000009
J	Ober, C; Tsalenko, A; Parry, R; Cox, NJ				Ober, C; Tsalenko, A; Parry, R; Cox, NJ			A second-generation genomewide screen for asthma-susceptibility alleles in a founder population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERUM IMMUNOGLOBULIN-E; LINKAGE DISEQUILIBRIUM; WIDE SEARCH; GENETIC DISSECTION; COMPLEX TRAITS; CHROMOSOME 5Q; IGE LEVELS; MARKERS; POLYMORPHISM; ASSOCIATION	A genomewide screen for asthma- and atopy-susceptibility loci was conducted, using 563 markers, in 693 Hutterites who are members of a single 15-generation pedigree, nearly doubling the sample size from the authors' earlier studies. The resulting increase in power led to the identification of 23 loci in 18 chromosomal regions showing evidence for linkage that is, in general, 10-fold more significant (P < .001 vs. P < .01) than the linkages reported previously in this population. Moreover, linkages to loci in 11 chromosomal regions were identified for the first time in the Hutterites in this report, including five regions (5p, 5q, 8p, 14q, and 16q) showing evidence both of linkage, by the likelihood ratio (LR) chi (2), and of disequilibrium, by the transmission/disequilibrium test. A region on chromosome 19 continues to show evidence for linkage, by both tests, in this study. Studies of 17 candidate genes provide evidence for association with variation in the IL4RA gene (16p12), the HLA class 19 genes (6p21), and the interferon-alpha gene cluster (9p22), but the lack of evidence for linkage in these regions by the LR chi (2) test suggests that these are minor susceptibility loci. A polymorphism in the CD14 gene is in linkage disequilibrium with an as yet unidentified susceptibility allele in the 5q cytokine cluster, a region showing evidence for linkage among the Hutterites. Finally, 10 of the regions showing evidence for linkage in the Hutterites have shown evidence of linkage to related phenotypes in other genome screens, suggesting that these regions may contain common alleles that have relatively large effects on asthma and atopy phenotypes in diverse populations.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ S Dakota, Sch Med, Dept Med, Sioux Falls, SD USA	University of Chicago; University of South Dakota	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	carole@genetics.uchicago.edu			NHLBI NIH HHS [U01 HL049596, HL56399, P50 HL056399] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399, U01HL049596] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; ABNEY M, 2000, IN PRESS AM J HUM S; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CURTIS D, 1995, AM J HUM GENET, V57, P703; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DIAZ MO, 1995, SEMIN VIROL, V6, P143, DOI 10.1006/smvy.1995.0019; DIZIER MH, IN PRESS AM J RESP C; Donfack J, 2000, J ALLERGY CLIN IMMUN, V105, P960, DOI 10.1067/mai.2000.106926; Doull IJM, 1996, AM J RESP CRIT CARE, V153, P1280, DOI 10.1164/ajrccm.153.4.8616554; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; Gao PS, 1999, CLIN GENET, V56, P164; Golovleva I, 1996, AM J HUM GENET, V59, P570; Hall D, 1997, AM J HUM GENET, V61, pA200; Hizawa N, 1998, J ALLERGY CLIN IMMUN, V102, P449, DOI 10.1016/S0091-6749(98)70134-4; Holt PG, 1999, NATURE, V402, pB12; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MANGE AP, 1964, HUM BIOL, V36, P104; Marsh DG, 1997, NAT GENET, V15, P389; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Martinez FD, 1998, AM J RESP CRIT CARE, V158, P1739, DOI 10.1164/ajrccm.158.6.9712040; MATHIAS RA, 2000, IN PRESS GENET EPIDE; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Miterski B, 1999, GENES IMMUN, V1, P37, DOI 10.1038/sj.gene.6363634; Noguchi E, 1997, AM J RESP CRIT CARE, V156, P1390, DOI 10.1164/ajrccm.156.5.9702084; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Ober C, 1999, CLIN EXP ALLERGY, V29, P11; OBER C, 2000, PATHOBIOLOGY ASTHMA, V21, P245; Palmer LJ, 1998, AM J RESP CRIT CARE, V158, P1825, DOI 10.1164/ajrccm.158.6.9804037; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Summerhill E, 2000, AM J RESP CRIT CARE, V162, P599, DOI 10.1164/ajrccm.162.2.9910108; Weitkamp LR, 1999, IMMUNOGENETICS, V49, P491, DOI 10.1007/s002510050525; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Wjst M, 1999, CLIN EXP ALLERGY, V29, P5; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	43	289	293	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1154	1162		10.1016/S0002-9297(07)62946-2	http://dx.doi.org/10.1016/S0002-9297(07)62946-2			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11022011	Green Published, Bronze			2022-12-18	WOS:000165091600013
J	Cannon, TD; Huttunen, MO; Lonnqvist, J; Tuulio-Henriksson, A; Pirkola, T; Glahn, D; Finkelstein, J; Hietanen, M; Kaprio, J; Koskenvuo, M				Cannon, TD; Huttunen, MO; Lonnqvist, J; Tuulio-Henriksson, A; Pirkola, T; Glahn, D; Finkelstein, J; Hietanen, M; Kaprio, J; Koskenvuo, M			The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPSYCHOTIC RELATIVES; GENETIC EPIDEMIOLOGY; PREFRONTAL CORTEX; TEMPORAL-LOBE; MEMORY; BRAIN; RISK; ATTENTION; SIBLINGS; DISEASE	While genetic influences in schizophrenia are substantial, the disorder's molecular genetic basis remains elusive. Progress has been hindered by lack of means to detect nonpenetrant carriers of the predisposing genes and by uncertainties concerning the extent of locus heterogeneity. One approach to solving this complexity is to examine the inheritance of pathophysiological processes mediating between genotype and disease phenotype. Here we evaluate whether deficits in neurocognitive functioning covary with degree of genetic relationship with a proband in the unaffected MZ and DZ co-twins of patients with schizophrenia. Twin pairs discordant for schizophrenia were recruited from a total population cohort and were compared with a demographically balanced sample of control twin pairs, on a comprehensive neuropsychological test battery. The following four neuropsychological functions contributed uniquely to the discrimination of degree of genetic loading for schizophrenia and, when combined, were more highly correlated within MZ pairs than within DZ pairs, in both discordant and control twins: spatial working memory (i.e., remembering a sequence of spatial locations over a brief delay), divided attention (i.e., simultaneous performance of a counting and visual-search task), intrusions during recall of a word list (i.e., "remembering" nonlist items), and choice reaction time to visual targets. Together with evidence from human and animal studies of mediation of these functions by partially distinct brain systems, our findings suggest that there are multiple independently inherited dimensions of neural deficit in schizophrenia and encourage a search for genes contributing to quantitative variation in discrete aspects of disease liability. On tests of verbal and visual episodic memory, but not on the liability-related measures, patients were more impaired than their own MZ co-twins, suggesting a preferential impact of nongenetic influences on long-term memory systems.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Natl Publ Hlth Inst Finland, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; Univ Helsinki, Dept Neurol, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Univ Oulu, Dept Publ Hlth, Oulu, Finland; Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; Univ Turku, Dept Publ Hlth, Turku, Finland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Oulu; University of Pennsylvania; University of Turku	Cannon, TD (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall, Los Angeles, CA 90095 USA.		Kaprio, Jaakko/A-1820-2008	Kaprio, Jaakko/0000-0002-3716-2455	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052857] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH052857, MH52857] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 1994, DSM, VIV; Andreasen N.C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1984, SCALE ASSESSMENT POS; BENSON DF, 1985, DUAL BRAIN; Benton AL, 1976, MULTILINGUAL APHASIA; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Byrne M, 1999, PSYCHOL MED, V29, P1161, DOI 10.1017/S0033291799001002; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P1084, DOI 10.1001/archpsyc.55.12.1084; CANNON TD, 1994, ARCH GEN PSYCHIAT, V51, P651; Cannon TD, 1996, ANN MED, V28, P533, DOI 10.3109/07853899608999117; Censits DM, 1997, SCHIZOPHR RES, V24, P289, DOI 10.1016/S0920-9964(96)00091-6; CHAPMAN LJ, 1989, J ABNORM PSYCHOL, V98, P357, DOI 10.1037/0021-843X.98.4.357; Cliff N., 1987, ANAL MULTIVARIATE DA; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORBETTA M, 1991, J NEUROSCI, V11, P2383; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DELIS D, 1983, CALIFORNIA VERBAL LE; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Farah MJ, 1996, BEHAV BRAIN RES, V76, P181, DOI 10.1016/0166-4328(95)00198-0; Faraone SV, 1999, J ABNORM PSYCHOL, V108, P176, DOI 10.1037/0021-843X.108.1.176; FARAONE SV, 1995, J ABNORM PSYCHOL, V104, P286, DOI 10.1037/0021-843X.104.2.286; FINKELSTIEN J, 1998, THESIS U PENNSYLVANI; FISHER M, 1971, BRIT J PSYCHIAT, V118, P43; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GERLACH J, 1991, SCHIZOPHRENIA BULL, V17, P289, DOI 10.1093/schbul/17.2.289; GOLDBERG TE, 1990, ARCH GEN PSYCHIAT, V47, P1066; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; GUR RC, 1993, INT J NEUROSCI, V72, P31, DOI 10.3109/00207459308991621; Halgren E, 1982, Hum Neurobiol, V1, P251; Halstead WC, 1985, HALSTEADREITAN NEURO; HEATON RK, 1981, WISCONSIN CARD SORTI; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; KAPRIO J, 1990, ACTA GENET MED GEMEL, V39, P427, DOI 10.1017/S0001566000003652; Karayiorgou M, 1997, NEURON, V19, P967, DOI 10.1016/S0896-6273(00)80390-6; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; KREMEN WS, 1994, SCHIZOPHRENIA BULL, V20, P103, DOI 10.1093/schbul/20.1.103; LORANGER AW, 1985, PERSONALITY DISORDER; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Lynch M, 1998, GENETICS ANAL QUANTI; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; ROBERTS GW, 1990, BIOL PSYCHIAT, V28, P127, DOI 10.1016/0006-3223(90)90630-K; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; Sakai K, 2000, J NEUROSCI, V20, P2691; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Spitzer RL, 1989, INSTRUCTION MANUAL S; Squire LR, 1996, COLD SPRING HARB SYM, V61, P185; Stefanis N, 1999, BIOL PSYCHIAT, V46, P697, DOI 10.1016/S0006-3223(99)00089-X; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Wechsler D., 1997, WAIS 3 WECHSLER ADUL	57	289	294	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					369	382		10.1086/303006	http://dx.doi.org/10.1086/303006			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	354YA	10880296	Bronze, Green Published			2022-12-18	WOS:000089357800013
J	Martin, ER; Lai, EH; Gilbert, JR; Rogala, AR; Afshari, AJ; Riley, L; Finch, KL; Stevens, F; Livak, KJ; Slotterbeck, BD; Slifer, SH; Warren, LL; Conneally, PM; Schmechel, DE; Purvis, I; Pericak-Vance, MA; Roses, AD; Vance, JM				Martin, ER; Lai, EH; Gilbert, JR; Rogala, AR; Afshari, AJ; Riley, L; Finch, KL; Stevens, F; Livak, KJ; Slotterbeck, BD; Slifer, SH; Warren, LL; Conneally, PM; Schmechel, DE; Purvis, I; Pericak-Vance, MA; Roses, AD; Vance, JM			SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYLOID-BETA-PEPTIDE; APOLIPOPROTEIN-E; TYPE-4 ALLELE; ONSET; LINKAGE; GENE; ASSOCIATION; FAMILIES; DENSITY; BINDING	There has been great interest in the prospects of using single-nucleotide polymorphisms (SNPs) in the search for complex disease genes, and several initiatives devoted to the identification and mapping of SNPs throughout the human genome are currently underway. However, actual data investigating the use of SNPs for identification of complex disease genes are scarce. To begin to look at issues surrounding the use of SNPs in complex disease studies, we have initiated a collaborative SNP mapping study around APOE, the well-established susceptibility gene for late-onset Alzheimer disease (AD). Sixty SNPs in a 1.5-Mb region surrounding APOE were genotyped in samples of unrelated cases of AD, in controls, and in families with AD. Standard tests were conducted to look for association of SNP alleles with AD, in cases and controls. We also used family-based association analyses, including recently developed methods to look for haplotype association. Evidence of association (P less than or equal to .05) was identified for 7 of 13 SNPs, including the APOE-4 polymorphism, spanning 40 kb on either side of APOE. As expected, very strong evidence for association with AD was seen for the APOE-4 polymorphism, as well as for two other SNPs that lie <16 kb from APOE. Haplotype analysis using family data increased significance over that seen in single-locus tests for some of the markers, and, for these data, improved localization of the gene. Our results demonstrate that associations can be detected at SNPs near a complex disease gene. We found that a high density of markers will be necessary in order to have a good chance of including SNPs with detectable levels of allelic association with the disease mutation, and statistical analysis based on haplotypes can provide additional information with respect to tests of significance and fine localization of complex disease genes.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Bryan Alzheimer Dis Res Ctr, Durham, NC 27710 USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Glaxo Wellcome Inc, London, England; PE Biosyst, Foster City, CA USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Duke University; Duke University; Duke University; GlaxoSmithKline; GlaxoSmithKline; Indiana University System; Indiana University-Purdue University Indianapolis	Martin, ER (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3468, Durham, NC 27710 USA.			Vance, Jeffery/0000-0003-3815-8199	NIA NIH HHS [P50 AG005128, 5 P50 AG05128-16, U24 AG021886] Funding Source: Medline; NINDS NIH HHS [2 P01 NS26630-11A1, R01 NS031153, 5 R01 NS31153-07, P01 NS026630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031153, P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P50AG005128] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Freitas EM, 1998, DNA SEQUENCE, V9, P89, DOI 10.3109/10425179809086433; Gerdes LU, 1996, HUM GENET, V98, P546, DOI 10.1007/s004390050257; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; LATHROP GM, 1984, P NATL ACAD SCI USA, V81, P3446; Marshall E, 1999, SCIENCE, V284, P406, DOI 10.1126/science.284.5413.406; Martin ER, 1999, AM J HUM GENET, V65, pA434; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; RIMMLER J, 1998, AM J HUM GENET S, V63, pA240; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; VANCE JM, 1998, AM J HUM GENET S, V63, pA312; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	30	289	316	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					383	394		10.1086/303003	http://dx.doi.org/10.1086/303003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10869235	Green Published, Bronze			2022-12-18	WOS:000089357800014
J	BOEHNKE, M; LANGE, K; COX, DR				BOEHNKE, M; LANGE, K; COX, DR			STATISTICAL-METHODS FOR MULTIPOINT RADIATION HYBRID MAPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-CHROMOSOMES; GENE TRANSFER; CELL-FUSION; LIKELIHOOD	On the basis of the earlier work of Goss and Harris, Cox et al. introduced radiation hybrid (RH) mapping, a somatic cell genetic technique for constructing fine-structure maps of human chromosomes. Radiation hybrid mapping uses X-ray breakage of chromosomes to order a set of genetic loci and to estimate distances between them. To analyze RH mapping data Cox et al. derived statistical methods that employ information on sets of two and four loci, to build an overall locus order. Here we describe alternative nonparametric and maximum-likelihood methods for the analysis of RHs that use information on many loci simultaneously, including information on partially typed hybrids. Combination of these multipoint methods provides a statistically more efficient solution to the locus-ordering problem. We illustrate our approach by applying it to RH mapping data on 14 markers in 99 radiation hybrids for the proximal long arm of human chromosome 21.	UNIV CALIF LOS ANGELES,COLL MED,DEPT BIOMATH,LOS ANGELES,CA 90024; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco	BOEHNKE, M (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109, USA.				NCI NIH HHS [CA16042] Funding Source: Medline; NHGRI NIH HHS [P30-HG00290, R29-HG00376] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BISHOP DT, IN PRESS CYTOGENET C; BOEHNKE M, IN PRESS CYTOGENET C; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; CHAKRAVARTI A, IN PRESS CYTOGENET C; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Edwards A. W. F., 1964, PHENETIC PHYLOGENETI, P67; FALK CT, 1991, GENOMICS, V9, P120, DOI 10.1016/0888-7543(91)90228-7; FALK CT, IN PRESS CYTOGENET C; GOODMAN E, 1977, INTRO DESIGN ANAL AL; GOSS SJ, 1977, J CELL SCI, V25, P39; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; GOSS SJ, 1977, J CELL SCI, V25, P17; GREEN P, IN PRESS CYTOGENET C; Haldane JBS, 1919, J GENET, V8, P299; Karlin S., 1975, 1 COURSE STOCHASTIC, P45; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LWRENCE S, IN PRESS CYTOGENET C; MENDENHALL W, 1991, INTRO PROBABILITY ST, P305; NIJENHUIS A, 1978, COMBINATORIAL ALGORI, P240; PRESS WH, 1989, NUMERICAL RECIPES AR, P326; THOMPSON EA, 1987, IMA J MATH APPL MED, V4, P93; WEEKS DE, 1989, IMA J MATH APPL MED, V6, P209; WEEKS DE, IN PRESS CYTOGENET C	27	289	300	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1174	1188						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746551				2022-12-18	WOS:A1991GU67200005
J	Chow, CY; Landers, JE; Bergen, SK; Sapp, PC; Grant, AE; Jones, JM; Everett, L; Lenk, GM; McKenna-Yasek, DM; Weisman, LS; Figlewicz, D; Brown, RH; Meisler, MH				Chow, Clement Y.; Landers, John E.; Bergen, Sarah K.; Sapp, Peter C.; Grant, Adrienne E.; Jones, Julie M.; Everett, Lesley; Lenk, Guy M.; McKenna-Yasek, Diane M.; Weisman, Lois S.; Figlewicz, Denise; Brown, Robert H.; Meisler, Miriam H.			Deleterious Variants of FIG4. a Phosphoinositide Phosphatase, in Patients with ALS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN-DISEASE GENES; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; MUTATION PATTERN; EXCHANGE FACTOR; NEURODEGENERATION; GENETICS; PREDICT	Mutations of the lipid phosphatase FIG4 that regulates PI(3,5)P-2 are responsible for the recessive peripheral-nerve disorder CMT4J. We now describe nonsynonymous variants of FIG4 in 2% (9/473) of patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). Heterozygosity for a deleterious allele of FIG4 appears to be a risk factor for ALS and PLS, extending the list of known ALS genes and increasing the clinical spectrum of FIG4-related diseases.	[Chow, Clement Y.; Bergen, Sarah K.; Grant, Adrienne E.; Jones, Julie M.; Everett, Lesley; Lenk, Guy M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Landers, John E.; Sapp, Peter C.; McKenna-Yasek, Diane M.; Brown, Robert H.] Massachusetts Gen Hosp, Day Neuromuscular Res Lab, Boston, MA 02114 USA; [Landers, John E.; Sapp, Peter C.; McKenna-Yasek, Diane M.; Brown, Robert H.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Weisman, Lois S.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Weisman, Lois S.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Figlewicz, Denise] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Sapp, Peter C.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Lenk, Guy M./Q-1226-2016	Lenk, Guy M./0000-0001-8092-1405; Everett, Lesley/0000-0002-7373-2056; Landers, John/0000-0001-8084-5043	National Institutes of Health [GM24872, NS050557, NS050641, T32 GM007544, NS064015]; ALS Association; ALS Therapy Alliance; Angel Fund; Pierre L. de Bourgknecht AUS Research Foundation; Al-Athel ALS Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544, R01GM024872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557, R01NS064015, R01NS050641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; ALS Therapy Alliance; Angel Fund; Pierre L. de Bourgknecht AUS Research Foundation; Al-Athel ALS Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants GM24872-(M.H.M.), NS050557 (R.H.B.), NS050641 (R.H.B.), T32 GM007544 (C.Y.C.), and NS064015 (L.S.W.) and by the ALS Association (M.H.M. and R.H.B.), the ALS Therapy Alliance, Project ALS, the Angel Fund, the Pierre L. de Bourgknecht AUS Research Foundation, and the Al-Athel ALS Foundation. We thank Emily Kauffman for assistance in development of the yeast-vacuole assay. P.S. is supported through the auspices of H. Robert Horvitz, an Investigator of the Howard Hughes Medical Institute. DNA panels from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), as well as clinical data, were used in this study. The submitters that contributed samples are acknowledged in detailed descriptions of each panel: NDPT025, NDPT026, NDPT029, NDPT006, and NDPT009.	Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004; Hughes WE, 2000, BIOCHEM J, V350, P337, DOI 10.1042/0264-6021:3500337; JIN N, 2008, EMBO J; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Volpicelli-Daley L, 2007, NAT MED, V13, P784, DOI 10.1038/nm0707-784; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Zhang XB, 2008, BRAIN, V131, P1990, DOI 10.1093/brain/awn114; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	20	288	301	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					85	88		10.1016/j.ajhg.2008.12.010	http://dx.doi.org/10.1016/j.ajhg.2008.12.010			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19118816	Green Published, hybrid			2022-12-18	WOS:000262679500011
J	Sethupathy, P; Borel, C; Gagnebin, M; Grant, GR; Deutsch, S; Elton, TS; Hatzigeorgiou, AG; Antonarakis, SE				Sethupathy, Praveen; Borel, Christelle; Gagnebin, Maryline; Grant, Gregory R.; Deutsch, Samuel; Elton, Terry S.; Hatzigeorgiou, Artemis G.; Antonarakis, Stylianos E.			Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3 ' untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							II TYPE-1 RECEPTOR; RENIN-ANGIOTENSIN SYSTEM; HONG-KONG CHINESE; GENE POLYMORPHISM; ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; ALDOSTERONE SYSTEM; DOWN-SYNDROME; ASSOCIATION; IDENTIFICATION	Animal microRNAs (miRNAs) regulate gene expression through base pairing to their targets within the 31 untranslated region (UTR) of protein-coding genes. Single-nucleotide polymorphisms (SNPs) located within such target sites can affect miRNA, regulation. We mapped annotated SNPs onto a collection of experimentally supported human miRNA targets. Of the 143 experimentally supported human target sites, 9 contain 12 SNPs. We further experimentally investigated one of these tar,et sites for hsa-miR-155, within the 3' UTR of the human AGTR1 gene that contains SNP rs5186. Using reporter silencing assays, we show that hsa-miR-155 down-regulates the expression of only the 11 66A, and not the 1166C, allele of rs5186. Remarkably, the 1166C allele has been associated with hypertension in many studies. Thus, the 1166C allele may be functionally associated with hypertension by abrogating regulation by hsa-miR-155, thereby elevating AGTR1 levels. Since hsa-miR-155 is on chromosome 21, we hypothesize that the observed lower blood pressure in trisomy 21 is partially caused by the overexpression of hsa-miR-155 leading to allele-specific underexpression of AGTR1. Indeed, we have shown in fibroblasts from monozygotic twins discordant for trisomy 21 that levels of AGTR1 protein are lower in trisomy 21.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; Univ Penn, Sch Engn & Appl Sci, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Geneva; University of Geneva; University System of Ohio; Ohio State University	Hatzigeorgiou, AG (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, 34 Fleming St, Vari 16672, Greece.	artemis@fleming.gr	borel, christelle/AAC-9645-2019; Grant, Gregory Robert/I-3599-2019; Hatzigeorgiou, Artemis/Z-1976-2019; Antonarakis, Stylianos E/N-8866-2014	Grant, Gregory Robert/0000-0002-0139-7658; Antonarakis, Stylianos E/0000-0001-8907-5823; Deutsch, Samuel/0000-0001-9456-7101	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048848, R29HL048848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER; NHLBI NIH HHS [R29 HL048848, HL48848, R01 HL048848] Funding Source: Medline; NIGMS NIH HHS [5T32GM008216, T32 GM008216] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdollahi MR, 2005, J MED GENET, V42, P396, DOI 10.1136/jmg.2004.026716; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Agachan B, 2003, EXP MOL MED, V35, P545, DOI 10.1038/emm.2003.71; Antonio A, 2004, J PROD ANAL, V21, P5; Barbalic M, 2006, AM J HYPERTENS, V19, P837, DOI 10.1016/j.amjhyper.2006.01.004; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berge KE, 1998, CLIN GENET, V53, P214; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burnside S, 2000, J MATER SCI-MATER EL, V11, P355, DOI 10.1023/A:1008989601919; Carswell CI, 2003, DRUGS, V63, P407, DOI 10.2165/00003495-200363040-00006; Castellano M, 1996, HYPERTENSION, V28, P1076, DOI 10.1161/01.HYP.28.6.1076; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Davis AC, 2001, J HIGH ENERGY PHYS; Draheim CC, 2002, AM J MENT RETARD, V107, P201, DOI 10.1352/0895-8017(2002)107<0201:DICDRB>2.0.CO;2; Dzida G, 2001, Med Sci Monit, V7, P1236; Gard M., 2001, DISCOURSE-ABINGDON, V22, P213, DOI [10.1080/01596300120072383, DOI 10.1080/01596300120072383]; Giner V, 2001, MED CLIN-BARCELONA, V117, P525, DOI 10.1016/S0025-7753(01)72167-7; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Henskens LH, 2003, J HYPERTENS, V21, P81, DOI 10.1097/00004872-200301000-00017; Hindorff LA, 2002, AM J HYPERTENS, V15, P1050, DOI 10.1016/S0895-7061(02)03063-7; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jiang ZN, 2001, CHINESE MED J-PEKING, V114, P1249; KAIDASHEV IP, 2005, LIKSPRAVA, V8, P66; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; Kato N, 2000, J HYPERTENS, V18, P1025, DOI 10.1097/00004872-200018080-00006; Katsuya T, 1999, Nihon Ronen Igakkai Zasshi, V36, P547; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobashi G, 2004, J HUM GENET, V49, P182, DOI 10.1007/s10038-004-0129-4; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P292; Liu Ying, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P220; Liyou N, 1999, CLIN EXP PHARMACOL P, V26, P525, DOI 10.1046/j.1440-1681.1999.03066.x; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Morrison RA, 1996, HYPERTENSION, V28, P569, DOI 10.1161/01.HYP.28.4.569; Nalogowska-Glosnicka K, 2000, Med Sci Monit, V6, P523; Ono K, 2003, HYPERTENS RES, V26, P131, DOI 10.1291/hypres.26.131; Petrovic D, 2002, FOLIA BIOL-KRAKOW, V50, P53; Porto PI, 2003, CLIN EXP HYPERTENS, V25, P117, DOI 10.1081/CEH-120017932; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reich H, 2003, KIDNEY INT, V63, P1443, DOI 10.1046/j.1523-1755.2003.00867.x; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schmidt S, 1997, J HYPERTENS, V15, P1385, DOI 10.1097/00004872-199715120-00003; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seremak-Mrozikiewicz A, 2000, Ginekol Pol, V71, P783; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; SIPR K., 1998, SCRIPTA BIOETHICA, V9, P9; Song JC, 2002, CLIN PHARMACOKINET, V41, P207, DOI 10.2165/00003088-200241030-00005; Spiering W, 2005, BLOOD PRESS MONIT, V10, P135, DOI 10.1097/00126097-200506000-00004; Stankovic A, 2003, CLIN CHIM ACTA, V327, P181, DOI 10.1016/S0009-8981(02)00340-6; Sugimoto K, 2004, HYPERTENS RES, V27, P551, DOI 10.1291/hypres.27.551; Takami S, 1998, AM J HYPERTENS, V11, P316, DOI 10.1016/S0895-7061(97)00457-3; Thomas GN, 2001, DIABETES CARE, V24, P356, DOI 10.2337/diacare.24.2.356; Thomas GN, 2000, CLIN EXP HYPERTENS, V22, P87, DOI 10.1081/CEH-100100064; Tiret L, 1998, J HYPERTENS, V16, P37, DOI 10.1097/00004872-199816010-00007; van Geel PP, 2000, HYPERTENSION, V35, P717, DOI 10.1161/01.HYP.35.3.717; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang WYS, 1997, CLIN GENET, V51, P31; Zhang Kui-xing, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P720; Zhu SM, 2006, CLIN CHEM LAB MED, V44, P282, DOI 10.1515/CCLM.2006.048	68	288	318	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					405	413		10.1086/519979	http://dx.doi.org/10.1086/519979			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668390	Green Published, Bronze			2022-12-18	WOS:000248540400020
J	Cook, EH; Courchesne, RY; Cox, NJ; Lord, C; Gonen, D; Guter, SJ; Lincoln, A; Nix, K; Haas, R; Leventhal, BL; Courchesne, E				Cook, EH; Courchesne, RY; Cox, NJ; Lord, C; Gonen, D; Guter, SJ; Lincoln, A; Nix, K; Haas, R; Leventhal, BL; Courchesne, E			Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBUNIT MESSENGER-RNAS; DIAGNOSTIC OBSERVATION SCHEDULE; AMINOBUTYRIC-ACID RECEPTOR; MOLECULAR ANALYSIS; RAT-BRAIN; REGION; GENE; TWIN; INDIVIDUALS; CHROMOSOMES	Autistic disorder is a complex genetic disease. Because of previous reports of individuals with autistic disorder with duplications of the Prader-Willi/Angelman syndrome critical region, we screened several markers across the 15q11-13 region, for linkage disequilibrium. One hundred forty families, consisting predominantly of a child with autistic disorder and both parents, were studied. Genotyping was performed by use of multiplex PCR and capillary electrophoresis, Two children were identified who had interstitial chromosome 15 duplications and were excluded from further linkage-disequilibrium analysis. Use of the multiallelic transmission-disequilibrium test (MTDT), for nine loci on 15q11-13, revealed linkage disequilibrium between autistic disorder and a marker in the gamma-aminobutyric acid, receptor subunit gene, GABRB3 155CA-2 (MTDT 28.63, 10 df, P = .0014). No evidence was found for parent-of-origin effects on allelic transmission. The convergence of GABRB3 as a positional and functional candidate along with the linkage-disequilibrium data suggests the need for further investigation of the role of GABRB3 or adjacent genes in autistic disorder.	Univ Chicago, Dept Psychiat, Lab Dev Neurosci, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Lab Dev Neurosci, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Dev Disorders Clin, Chicago, IL 60637 USA; Univ Chicago, Dept Psychiat, Dev Disorders Clin, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Childrens Hosp, Res Ctr,Lab Res Neurosci Autism, La Jolla, CA 92093 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego; Children's Hospital Los Angeles; University of California System; University of California San Diego	Cook, EH (corresponding author), Univ Chicago, Dept Psychiat, Lab Dev Neurosci, MC 3077,5841 S Maryland Ave, Chicago, IL 60637 USA.	ed@yoda.bsd.uchicago.edu		Guter, Stephen/0000-0002-4476-2045	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001389, R01MH052223, K05MH001196] Funding Source: NIH RePORTER; NIMH NIH HHS [K05 MH01196, 5 K02 MH01389, R01 MH52223] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Bailey A, 1998, HUM MOL GENET, V7, P571; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAKER P, 1994, J AUTISM DEV DISORD, V24, P529, DOI 10.1007/BF02172133; Bauman M.L, 1994, NEUROBIOLOGY AUTISM, P119; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; BUNDEY S, 1994, DEV MED CHILD NEUROL, V36, P736; BYERLEY W, 1995, PSYCHIATR GENET, V5, P23, DOI 10.1097/00041444-199521000-00004; CHANG CCA, 1995, J COMP NEUROL, V356, P615, DOI 10.1002/cne.903560410; Christian SL, 1998, GENOME RES, V8, P146, DOI 10.1101/gr.8.2.146; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; Cook EH, 1997, AM J HUM GENET, V60, P928; Cook EH, 1997, MOL PSYCHIATR, V2, P247; COON H, 1994, PSYCHIAT GENET, V4, P185, DOI 10.1097/00041444-199400430-00009; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; CROLLA JA, 1995, HUM GENET, V95, P161; Crowe RR, 1997, AM J PSYCHIAT, V154, P1096; CULIAT CT, 1994, P NATL ACAD SCI USA, V91, P2815, DOI 10.1073/pnas.91.7.2815; CURTIS D, 1995, AM J HUM GENET, V56, P811; DILAVORE PC, 1995, J AUTISM DEV DISORD, V25, P355, DOI 10.1007/BF02179373; Flejter WL, 1996, AM J MED GENET, V61, P182, DOI 10.1002/(SICI)1096-8628(19960111)61:2<182::AID-AJMG17>3.3.CO;2-K; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; GILLBERG C, 1991, J AM ACAD CHILD PSY, V30, P489, DOI 10.1097/00004583-199105000-00022; GLATT K, 1994, GENOMICS, V19, P157, DOI 10.1006/geno.1994.1027; Glatt K, 1997, GENOMICS, V41, P63, DOI 10.1006/geno.1997.4639; Guipponi M, 1997, AM J MED GENET, V74, P150, DOI 10.1002/(SICI)1096-8628(19970418)74:2<150::AID-AJMG6>3.3.CO;2-H; HERAULT J, 1993, PSYCHIAT RES, V46, P261, DOI 10.1016/0165-1781(93)90094-W; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; HOTOPF M, 1995, J AUTISM DEV DISORD, V25, P41, DOI 10.1007/BF02178166; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; KIRKNESS EF, 1993, J BIOL CHEM, V268, P4420; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Klauck SM, 1997, HUM MOL GENET, V6, P2233, DOI 10.1093/hmg/6.13.2233; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LEANACOX J, 1994, AM J HUM GENET, V54, P748; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Martinsson T, 1996, EUR CHILD ADOLES PSY, V5, P185, DOI 10.1007/BF00538845; NADLER LS, 1994, J NEUROBIOL, V25, P1533, DOI 10.1002/neu.480251206; Pericak-Vance MA, 1997, AM J HUM GENET, V61, pA40; PICKLES A, 1995, AM J HUM GENET, V57, P717; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROBINSON WP, 1995, HUM MOL GENET, V4, P801, DOI 10.1093/hmg/4.5.801; Sander T, 1997, ACTA NEUROL SCAND, V96, P1; SCHINZEL AA, 1994, J MED GENET, V31, P798, DOI 10.1136/jmg.31.10.798; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; SMALLEY SL, 1995, AM J MED GENET, V60, P19, DOI 10.1002/ajmg.1320600105; SMALLEY SL, 1992, J AUTISM DEV DISORD, V22, P339, DOI 10.1007/BF01048239; Sparrow SS., 1984, VINELAND ADAPTIVE BE; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Warren RP, 1996, J NEUROIMMUNOL, V67, P97; WENZ WH, IN PRESS GENOME RES; WISDEN W, 1992, J NEUROSCI, V12, P1040	60	288	300	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1077	1083		10.1086/301832	http://dx.doi.org/10.1086/301832			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ZL922	9545402	Green Published, Bronze			2022-12-18	WOS:000073487000011
J	Torroni, A; Bandelt, HJ; D'Urbano, L; Lahermo, P; Moral, P; Sellitto, D; Rengo, C; Forster, P; Savontaus, ML; Bonne-Tamir, B; Scozzari, R				Torroni, A; Bandelt, HJ; D'Urbano, L; Lahermo, P; Moral, P; Sellitto, D; Rengo, C; Forster, P; Savontaus, ML; Bonne-Tamir, B; Scozzari, R			mtDNA analysis reveals a major late paleolithic population expansion from southwestern to northeastern Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL REGION SEQUENCE; GENETIC-RELATIONSHIP; AFRICAN POPULATIONS; DIVERSITY; ORIGIN; AFFINITIES; EVOLUTION; AMERINDS; LINEAGES	mtDNA sequence variation was studied in 419 individuals from nine Eurasian populations, by high-resolution RFLP analysis, and it was followed by sequencing of the control region of a subset of these mtDNAs and a detailed survey of previously published data from numerous other European populations. This analysis revealed that a major Paleolithic population expansion from the "Atlantic zone" (southwestern Europe) occurred 10,000-15,000 years ago, after the Last Glacial Maximum. As an mtDNA marker for this expansion we identified haplogroup V, an autochthonous European haplogroup, which most likely originated in the northern Iberian peninsula or southwestern France at about the time of the Younger Dryas. Its sister haplogroup, H, which is distributed throughout the entire range of Caucasoid populations and which originated in the Near East similar to 25,000-30,000 years ago, also took part in this expansion, thus rendering it by far the most frequent (40%-60%) haplogroup in western Europe. Subsequent migrations after the Younger Dryas eventually carried those "Atlantic" mtDNAs into central and northern Europe. This scenario, already implied by archaeological records, is given overwhelming support from both the distribution of the autochthonous European Y chromosome type 15, as detected by the probes 49a/f, and the synthetic maps of nuclear data.	Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Roma La Sapienza, Ctr Genet Evoluzionist, I-00185 Rome, Italy; Univ Hamburg, Math Seminar, D-2000 Hamburg, Germany; Univ Turku, Dept Med Genet, Turku, Finland; Univ Barcelona, Dept Biol Anim, Barcelona, Spain; Sackler Fac Med, Dept Human Genet, Ramat Aviv, Israel	Sapienza University Rome; Sapienza University Rome; University of Hamburg; University of Turku; University of Barcelona; Tel Aviv University; Sackler Faculty of Medicine	Torroni, A (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	torroni@axcasp.caspur.it	Moral, Pedro/K-9587-2014; Torroni, Antonio/E-1557-2011	Moral, Pedro/0000-0001-5072-5892; Torroni, Antonio/0000-0002-4163-4478	Telethon [921] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bandelt HJ, 1997, AM J HUM GENET, V61, P980, DOI 10.1086/514878; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bjorck S, 1996, SCIENCE, V274, P1155, DOI 10.1126/science.274.5290.1155; Brown MD, 1997, AM J HUM GENET, V60, P381; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; CHEN YS, 1995, AM J HUM GENET, V57, P133; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Forster P, 1996, AM J HUM GENET, V59, P935; GINTHER C, 1993, EXS, V67, P211; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GUGLIELMINO CR, 1990, AM J PHYS ANTHROPOL, V83, P57, DOI 10.1002/ajpa.1330830107; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; JORDE LB, 1995, AM J HUM GENET, V57, P523; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; Lahermo P, 1996, AM J HUM GENET, V58, P1309; Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777; Lee SD, 1997, FORENSIC SCI INT, V87, P99, DOI 10.1016/S0379-0738(97)02114-2; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; NEI M, 1983, GENETICS, V105, P207; Otte M., 1990, WORLD 18000 BP, P54; Passarino G, 1996, AM J HUM GENET, V59, P927; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; REED AJ, 1995, MOL BIOL EVOL, V12, P604; Richards M, 1996, AM J HUM GENET, V59, P185; RUHLEN MA, 1987, GUIDE WORLD LANGUAGE; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SANTOS M, 1994, HUM BIOL, V66, P963; Scozzari R, 1997, AM J HUM GENET, V60, P241; Semino O, 1996, AM J HUM GENET, V59, P964; Stenico M, 1996, AM J HUM GENET, V59, P1363; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1995, AM J HUM GENET, V57, P201; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Zerjal T, 1997, AM J HUM GENET, V60, P1174	54	288	295	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1137	1152		10.1086/301822	http://dx.doi.org/10.1086/301822			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545392	Bronze, Green Published			2022-12-18	WOS:000073487000020
J	zur Stadt, U; Rohr, J; Seifert, W; Koch, F; Grieve, S; Pagel, J; Strauss, J; Kasper, B; Nurnberg, G; Becker, C; Maul-Pavicic, A; Beutel, K; Janka, G; Griffiths, G; Ehl, S; Hennies, HC				zur Stadt, Udo; Rohr, Jan; Seifert, Wenke; Koch, Florian; Grieve, Samantha; Pagel, Julia; Strauss, Julia; Kasper, Brigitte; Nuernberg, Gudrun; Becker, Christian; Maul-Pavicic, Andrea; Beutel, Karin; Janka, Gritta; Griffiths, Gillian; Ehl, Stephan; Hennies, Hans Christian			Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-KILLER-CELLS; SECRETORY LYSOSOMES; GENOTYPE-PHENOTYPE; GRANULE EXOCYTOSIS; EPITHELIAL-CELLS; CYCLOSPORINE-A; GENE-MUTATIONS; PERFORIN; CYTOTOXICITY; EXPRESSION	Rapid intracellular transport and secretion of cytotoxic granules through the immunological synapse requires a balanced interaction of several proteins. Disturbance of this highly regulated process underlies familial hemophagocytic lymphohistiocytosis (FHL), a genetically heterogeneous autosomal-recessive disorder characterized by a severe hyperinflammatory phenotype. Here, we have assigned FHL-5 to a 1 Mb region on chromosome 19p by using high-resolution SNP genotyping in eight unrelated FHL patients from consanguineous families. Subsequently, we found nine different mutations, either truncating or missense, in STXBP2 in twelve patients from Turkey, Saudi Arabia, and Central Europe. STXBP2 encodes syntaxin binding protein 2 (Munc18-2), involved in the regulation of vesicle transport to the plasma membrane. We have identified syntaxin 11, a SNARE protein mutated in FHL-4, as an interaction partner of STXBP2. This interaction is eliminated by the missense mutations found in our FHL-5 patients, which leads to a decreased stability of both proteins, as shown in patient lymphocytes. Activity of natural killer and cytotoxic T cells was markedly reduced or absent, as determined by CD107 degranulation. Our findings thus identify a key role for STXBP2 in lytic granule exocytosis.	[zur Stadt, Udo; Koch, Florian; Pagel, Julia; Strauss, Julia] Childrens Canc Ctr, Inst Res, D-20251 Hamburg, Germany; [zur Stadt, Udo; Beutel, Karin; Janka, Gritta] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, D-20246 Hamburg, Germany; [Rohr, Jan; Maul-Pavicic, Andrea; Ehl, Stephan] Univ Freiburg, CCI, D-79106 Freiburg, Germany; [Seifert, Wenke; Nuernberg, Gudrun; Becker, Christian; Hennies, Hans Christian] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Seifert, Wenke] Free Univ Berlin, Fac Biol Chem & Pharm, D-14195 Berlin, Germany; [Grieve, Samantha; Griffiths, Gillian] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 OXY, England; [Kasper, Brigitte] Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Cologne; University of Cologne; Free University of Berlin; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Forschungszentrum Borstel	zur Stadt, U (corresponding author), Childrens Canc Ctr, Inst Res, D-20251 Hamburg, Germany.	zurstadt@kinderkrebs-forschung.de	Kasper, Brigitte/B-1675-2009; Ehl, Stephan/AAM-6006-2020; Hennies, Hans C/G-9424-2014; Seifert, Wenke/B-8772-2011	Hennies, Hans C/0000-0001-7210-2389; Seifert, Wenke/0000-0003-1432-9862; Griffiths, Gillian/0000-0003-0434-5842; Ehl, Stephan/0000-0002-9265-2721; Kasper, Brigitte/0000-0002-0320-9614				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Arico M, 1996, LEUKEMIA, V10, P197; Arneson LN, 2007, J IMMUNOL, V179, P3397, DOI 10.4049/jimmunol.179.6.3397; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Beutel K, 2009, PEDIATR BLOOD CANCER, V53, P184, DOI 10.1002/pbc.22037; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Clementi R, 2001, J MED GENET, V38, P643, DOI 10.1136/jmg.38.9.643; Dufourcq-Lagelouse R, 1999, AM J HUM GENET, V64, P172, DOI 10.1086/302194; Ericson KG, 2001, AM J HUM GENET, V68, P590, DOI 10.1086/318796; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Horne A, 2008, BRIT J HAEMATOL, V143, P75, DOI 10.1111/j.1365-2141.2008.07315.x; JANKA GE, 1983, EUR J PEDIATR, V140, P221, DOI 10.1007/BF00443367; Janka GE, 2007, EUR J PEDIATR, V166, P95, DOI 10.1007/s00431-006-0258-1; Kauppi M, 2002, J BIOL CHEM, V277, P43973, DOI 10.1074/jbc.M208315200; Lee SM, 2004, J MED GENET, V41, P137, DOI 10.1136/jmg.2003.011528; LIU CC, 1989, J EXP MED, V170, P2105, DOI 10.1084/jem.170.6.2105; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Menasche G, 2005, IMMUNOL REV, V203, P165, DOI 10.1111/j.0105-2896.2005.00224.x; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Ohadi M, 1999, AM J HUM GENET, V64, P165, DOI 10.1086/302187; Prekeris R, 2000, EUR J CELL BIOL, V79, P771, DOI 10.1078/0171-9335-00109; Riento K, 1996, EUR J BIOCHEM, V239, P638, DOI 10.1111/j.1432-1033.1996.0638u.x; Riento K, 2000, J BIOL CHEM, V275, P13476, DOI 10.1074/jbc.275.18.13476; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rudd E, 2008, J MED GENET, V45, P134, DOI 10.1136/jmg.2007.054288; Rudd E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.035253; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; SALCEDO TW, 1993, J IMMUNOL, V151, P2511; Sparber-Sauer M, 2009, BONE MARROW TRANSPL, V44, P333, DOI 10.1038/bmt.2009.34; Stadt UZ, 2006, HUM MUTAT, V27, P62, DOI 10.1002/humu.20274; STEPHAN JL, 1993, BLOOD, V82, P2319; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Suga N, 2002, BRIT J HAEMATOL, V116, P346, DOI 10.1046/j.1365-2141.2002.03266.x; Tang BL, 1998, BIOCHEM BIOPH RES CO, V245, P627, DOI 10.1006/bbrc.1998.8490; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; TRINCHIERI G, 1984, J EXP MED, V160, P1147, DOI 10.1084/jem.160.4.1147; Trizzino A, 2008, J MED GENET, V45, P15, DOI 10.1136/jmg.2007.052670; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076	49	287	297	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					482	492		10.1016/j.ajhg.2009.09.005	http://dx.doi.org/10.1016/j.ajhg.2009.09.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19804848	Green Published, Bronze			2022-12-18	WOS:000270836000005
J	Ariani, F; Hayek, G; Rondinella, D; Artuso, R; Mencarelli, MA; Spanhol-Rosseto, A; Pollazzon, M; Buoni, S; Spiga, O; Ricciardi, S; Meloni, I; Longo, I; Mari, F; Broccoli, V; Zappella, M; Renieri, A				Ariani, Francesca; Hayek, Giuseppe; Rondinella, Dalila; Artuso, Rosangela; Mencarelli, Maria Antonietta; Spanhol-Rosseto, Ariele; Pollazzon, Marzia; Buoni, Sabrina; Spiga, Ottavia; Ricciardi, Sara; Meloni, Ilaria; Longo, Ilaria; Mari, Francesca; Broccoli, Vania; Zappella, Michele; Renieri, Alessandra			FOXG1 is responsible for the congenital variant of Rett syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGENITOR CELLS; MECP2; PROLIFERATION; TRANSCRIPTION; BRAIN; GENE; BF-1; TELENCEPHALON; RETARDATION; CDKL5/STK9	Rett syndrome is a severe neurodevelopmental disease caused by mutations in the X-linked gene encoding for the methyl-CpG-binding protein MeCP2. Here, we report the identification of FOXG1-truncating mutations in two patients affected by the congenital variant of Rett syndrome. FOXG1 encodes a brain-specific transcriptional repressor that is essential for early development of the telencephalon. Molecular analysis revealed that Foxg1 might also share common molecular mechanisms with MeCP2 during neuronal development, exhibiting partially overlapping expression domain in postnatal cortex and neuronal subnuclear localization.	[Ariani, Francesca; Rondinella, Dalila; Artuso, Rosangela; Mencarelli, Maria Antonietta; Spanhol-Rosseto, Ariele; Pollazzon, Marzia; Meloni, Ilaria; Longo, Ilaria; Mari, Francesca; Renieri, Alessandra] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Hayek, Giuseppe; Buoni, Sabrina; Zappella, Michele] Child Neuropsychiatry Univ Hosp, AOUS, I-53100 Siena, Italy; [Spiga, Ottavia] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Ricciardi, Sara; Broccoli, Vania] Ist Sci San Raffaele, I-20132 Milan, Italy	University of Siena; University of Siena; University Hospital of Siena; University of Siena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Renieri, A (corresponding author), Univ Siena, Dept Mol Biol, Via Laterina 8, I-53100 Siena, Italy.	renieri@unisi.it	Broccoli, Vania/K-3464-2016; Mencarelli, Maria Antonietta/AAC-5615-2022; Ariani, Francesca/A-2956-2014; Artuso, Rosangela/AAB-9701-2019; Mari, Francesca/E-7737-2012; Meloni, Ilaria/R-6627-2018; Renieri, Alessandra/K-5950-2016; Ricciardi, Sara/I-6308-2018	Broccoli, Vania/0000-0003-4050-0926; Mencarelli, Maria Antonietta/0000-0001-5131-3718; Ariani, Francesca/0000-0002-0988-344X; Artuso, Rosangela/0000-0001-9330-1360; Mari, Francesca/0000-0003-1992-1654; Meloni, Ilaria/0000-0002-6255-9761; Renieri, Alessandra/0000-0002-0846-9220; Ricciardi, Sara/0000-0001-8124-432X; Longo, Ilaria/0000-0003-2056-8763; pollazzon, marzia/0000-0002-9865-0751; hayek, joussef/0000-0002-0440-2491	Telethon [GTB07001] Funding Source: Medline	Telethon(Fondazione Telethon)		Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; De Bona C, 2000, EUR J HUM GENET, V8, P325, DOI 10.1038/sj.ejhg.5200473; Erlandson A, 2003, GENET TEST, V7, P329, DOI 10.1089/109065703322783707; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; Hagberg Bengt, 2002, Eur J Paediatr Neurol, V6, P293, DOI 10.1053/ejpn.2002.0612; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2007, J NEUROSCI, V27, P11103, DOI 10.1523/JNEUROSCI.1066-07.2007; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; Livak K. J., 1997, ABI PRISM 7700 SEQUE; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Monros E, 2001, BRAIN DEV-JPN, V23, pS251, DOI 10.1016/S0387-7604(01)00374-6; MURAKAMI JW, 1992, AM J ROENTGENOL, V159, P177, DOI 10.2214/ajr.159.1.1609693; PAPA FT, 2008, AM J MED GE IN PRESS; ROLANDO S, 1985, BRAIN DEV-JPN, V7, P290, DOI 10.1016/S0387-7604(85)80030-9; Sampieri K, 2007, HUM MUTAT, V28, P329, DOI 10.1002/humu.20453; Scala E, 2005, J MED GENET, V42, P103, DOI 10.1136/jmg.2004.026237; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shoichet SA, 2005, HUM GENET, V117, P536, DOI 10.1007/s00439-005-1310-3; Smeets E, 2003, AM J MED GENET A, V122A, P227, DOI 10.1002/ajmg.a.20321; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001	27	287	291	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					89	93		10.1016/j.ajhg.2008.05.015	http://dx.doi.org/10.1016/j.ajhg.2008.05.015			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18571142	Green Published, Bronze			2022-12-18	WOS:000257784000010
J	Watson, E; Forster, P; Richards, M; Bandelt, HJ				Watson, E; Forster, P; Richards, M; Bandelt, HJ			Mitochondrial footprints of human expansions in Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA-SEQUENCE DIVERSITY; CONTROL-REGION SEQUENCE; UPPER SEMLIKI VALLEY; MODERN HUMAN ORIGINS; DNA POLYMORPHISMS; HUMAN-POPULATIONS; HOMO-SAPIENS; BURIAL SITE; ES-SKHUL; EVOLUTION	mtDNA studies support an African origin for modern Eurasians, but expansion events within Africa have not previously been investigated. We have therefore analyzed 407 mtDNA control-region sequences from 13 African ethnic groups. A number of sequences (13%) were highly divergent and coalesced on the ''mitochondrial Eve'' in Africans. The remaining sequences also ultimately coalesced on this sequence but fell into four major clusters whose starlike phylogenies testify to demographic expansions. The oldest of these African expansions dates to similar to 60,000-80,000 years ago. Eurasian sequences are derived from essentially one sequence within this ancient cluster, even though a diverse mitochondrial pool was present in Africa at the time.	UNIV HAMBURG,HEINRICH PETTE INST EXPT VIROL & IMMUNOL,HAMBURG,GERMANY; UNIV HAMBURG,MATH SEMINAR,HAMBURG,GERMANY; UNIV OXFORD,JOHN RADCLIFFE HOSP,DEPT CELLULAR SCI,INST MOL MED,OXFORD OX3 9DU,ENGLAND	Heinrich Pette Institute; University of Hamburg; University of Hamburg; University of Oxford	Watson, E (corresponding author), MASSEY UNIV,SCH BIOL SCI,PALMERSTON NORTH,NEW ZEALAND.			RICHARDS, MARTIN/0000-0003-3118-0967	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDELT HJ, 1997, IN PRESS AM J HUM GE; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BANDELT HJ, 1995, GENETICS, V141, P743; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BRAUER G, 1992, J HUM EVOL, V23, P419, DOI 10.1016/0047-2484(92)90089-R; BRAUER G, 1989, HUMAN REVOLUTION, P123; Brauer G, 1996, J HUM EVOL, V30, P161, DOI 10.1006/jhev.1996.0014; Brauer G., 1992, CONTINUITY REPLACEME, P83; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BROOKS AS, 1995, SCIENCE, V268, P548, DOI 10.1126/science.7725099; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHEN YS, 1995, AM J HUM GENET, V57, P133; CLARK JD, 1989, HUM REVOLUTION BEHAV, P564; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DAY MH, 1982, 1 C INT PAL HUM NIC, P814; Deacon H.J., 1992, CONTINUITY REPLACEME, P121; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; ELLER E, 1996, MOL BIOL EVOL, V13, P1255; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; Forster P, 1996, AM J HUM GENET, V59, P935; Gamble C., 1993, TIMEWALKERS PREHISTO; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GREENBERG JH, 1963, LANGUAGES AFRICA; GRUN R, 1991, ARCHAEOMETRY, V33, P153, DOI 10.1111/j.1475-4754.1991.tb00696.x; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; KLEIN RG, 1989, HUMAN REVOLUTION, P529; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; MELLARS P, 1989, HUMAN REVOLUTION, P1; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; Mithen Steven, 1996, PREHISTORY MIND SEAR; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Noble W., 1996, HUMAN EVOLUTION LANG; PENNY D, 1995, MOL BIOL EVOL, V12, P863; POWER C, 1996, ARCHAEOLOGY HUMAN AN, P306; RIGHTMIRE GP, 1989, HUMAN REVOLUTION, P109; RITTE U, 1993, HUM BIOL, V65, P359; RUVOLO M, 1994, P NATL ACAD SCI USA, V91, P8900, DOI 10.1073/pnas.91.19.8900; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SHERRY ST, 1994, HUM BIOL, V66, P761; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSRA; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; STRINGER C, 1988, NATURE, V331, P565, DOI 10.1038/331565a0; Stringer C., 1996, AFRICAN EXODUS ORIGI; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; TEMPLETON AR, 1995, GENETICS, V140, P767; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALIFORNIA; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WAKELEY J, 1993, J MOL EVOL, V37, P613; Watson E, 1996, AM J HUM GENET, V59, P437; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	65	287	300	1	41	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					691	704		10.1086/515503	http://dx.doi.org/10.1086/515503			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326335	Green Published, Bronze			2022-12-18	WOS:A1997XY52300027
J	TORRONI, A; SUKERNIK, RI; SCHURR, TG; STARIKOVSKAYA, YB; CABELL, MF; CRAWFORD, MH; COMUZZIE, AG; WALLACE, DC				TORRONI, A; SUKERNIK, RI; SCHURR, TG; STARIKOVSKAYA, YB; CABELL, MF; CRAWFORD, MH; COMUZZIE, AG; WALLACE, DC			MTDNA VARIATION OF ABORIGINAL SIBERIANS REVEALS DISTINCT GENETIC AFFINITIES WITH NATIVE-AMERICANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; BASE PAIR RECOGNITION; RED-CELL ENZYMES; PAPUA-NEW-GUINEA; IMMUNOGLOBULIN ALLOTYPES; NORTHEASTERN SIBERIA; RESTRICTION ENZYMES; ASIAN POPULATIONS; LENGTH MUTATIONS; TAIMIR PENINSULA	The mtDNA variation of 411 individuals from 10 aboriginal Siberian populations was analyzed in an effort to delineate the relationships between Siberian and Native American populations. All mtDNAs were characterized by PCR amplification and restriction analysis, and a subset of them was characterized by control region sequencing. The resulting data were then compiled with previous mtDNA data from Native Americans and Asians and were used for phylogenetic analyses and sequence divergence estimations. Aboriginal Siberian populations exhibited mtDNAs from three (A, C, and D) of the four haplogroups observed in Native Americans. However, none of the Siberian populations showed mtDNAs from the fourth haplogroup, group B. The presence of group B deletion haplotypes in East Asian and Native American populations but their absence in Siberians raises the possibility that haplogroup B could represent a migratory event distinct from the one(s) which brought group A, C, and D mtDNAs to the Americas. Our findings support the hypothesis that the first humans to move from Siberia to the Americas carried with them a limited number of founding mtDNAs and that the initial migration occurred between 17,000-34,000 years before present.	EMORY UNIV,DEPT GENET & MOLEC BIOL,ATLANTA,GA 30322; EMORY UNIV,DEPT ANTHROPOL,ATLANTA,GA 30322; RUSSIAN ACAD SCI,INST CYTOL & GENET,HUMAN MOLEC GENET,NOVOSIBIRSK,RUSSIA; UNIV KANSAS,DEPT ANTHROPOL,BIOL ANTHROPOL LAB,LAWRENCE,KS 66045	Emory University; Emory University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Kansas			Starikovskaya, Elena/N-5636-2015; Schurr, Theodore G/A-1336-2007; Sukernik, Rem I/N-6990-2015; Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 46915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BLANC H, 1983, AM J HUM GENET, V35, P167; BOGORAZ VG, 1910, PUBLICATIONS JESSU 1, V3; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN MD, 1992, GENETICS, V130, P163; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; CRAWFORD MH, 1982, CURRENT DEV ANTHR GE, V2, P51; DEBETS GF, 1947, PUBLICATION I ETHNOL, V2; GERSHOWITZ H, 1978, AM J PHYS ANTHROPOL, V49, P289, DOI 10.1002/ajpa.1330490302; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HARIHARA S, 1992, HUM BIOL, V64, P161; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOCHELSON W, 1910, PUBLICATIONS JESSU 1, V9; KARAPHET TM, 1981, AM J PHYS ANTHROPOL, V56, P139, DOI 10.1002/ajpa.1330560205; KIDD JR, 1991, HUM BIOL, V63, P775; Krauss ME, 1988, CROSSROADS CONTINENT, P145; KREYNOVICH EA, 1978, SOVETSKOYE FINNO UGR, V14, P214; Levin MG, 1964, PEOPLES SIBERIA; MATSUMOTO H, 1988, HUM GENET, V80, P207, DOI 10.1007/BF01790088; NEI M, 1983, GENETICS, V105, P207; OSIPOVA LP, 1983, J IMMUNOGENET, V10, P11; POSUKH OL, 1990, HUM BIOL, V62, P457; RYCHKOV YG, 1977, POPULATION STRUCTURE, P47; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHANFIELD MS, 1992, HUM BIOL, V64, P381; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SOKAL RR, 1981, SYST ZOOL, V30, P309, DOI 10.2307/2413252; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; SUKERNIK RI, 1981, AM J PHYS ANTHROPOL, V55, P121, DOI 10.1002/ajpa.1330550116; SUKERNIK RI, 1982, HUM GENET, V61, P148, DOI 10.1007/BF00274206; SUKERNIK RI, 1986, GENETIKA+, V22, P2361; SUKERNIK RI, 1992, EXP CLIN IMMUNOGENET, V9, P15; SUKERNIK RI, 1986, GENETIKA+, V22, P2369; SUKERNIK RI, 1988, EKOLOGIYA AM INDEITS, P19; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; SZATHMARY E J E, 1984, Acta Anthropogenetica, V8, P79; Szathmary E.J.E., 1981, YEARB PHYS ANTHROPOL, V24, P37; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Tugolukov VA, 1979, WHO ARE YOU YUKAGHIR; TUGOLUKOV VA, 1985, TUNGUSIC PEOPLE EVEN; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1992, HUM BIOL, V64, P403; WARD RH, 1991, P NATL ACAD SCI USA, V88, P1; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; [No title captured]	61	287	294	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					591	608						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	LU559	7688933				2022-12-18	WOS:A1993LU55900003
J	EASTON, DF; PONDER, MA; HUSON, SM; PONDER, BAJ				EASTON, DF; PONDER, MA; HUSON, SM; PONDER, BAJ			AN ANALYSIS OF VARIATION IN EXPRESSION OF NEUROFIBROMATOSIS (NF) TYPE-1 (NF1) - EVIDENCE FOR MODIFYING GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Neurofibromatosis (NF) type 1 (NF1) is notable for its variable expression. To determine whether variation in expression has an inherited component, we examined 175 individuals in 48 NF families, including six MZ twin pairs. Three quantitative traits were scored-number of cafe-au-lait patches, number of cutaneous neurofibromas, and head circumference; and five binary traits were scored-the presence or absence of plexiform neurofibromas, optic gliomas, scoliosis, epilepsy, and referral for remedial education. For cafe-au-lait patches and neurofibromas, correlation was highest between MZ twins, less high between first-degree relatives, and lower still between more distant relatives. The high correlation between MZ twins suggests a strong genetic component in variation of expression, but the low correlation between distant relatives suggests that the type of mutation at the NF1 locus itself plays only a minor role. All of the five binary traits, with the exception of plexiform neurofibromas, also showed significant familial clustering. The familial effects for these traits were consistent with polygenic effects, but there were insufficient data to rule out other models, including a significant effect of different NF1 mutations. There was no evidence of any association between the different traits in affected individuals. We conclude that the phenotypic expression of NF1 is to a large extent determined by the genotype at other ''modifying'' loci and that these modifying genes are trait specific.	UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,TENNIS COURT RD,CAMBRIDGE CB2 1QP,ENGLAND; INST CANC RES,EPIDEMIOL SECT,SUTTON SM2 5PX,SURREY,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND	University of Cambridge; University of London; Institute of Cancer Research - UK; University of Oxford								AKESSON HO, 1983, ACTA GENET MED GEMEL, V32, P245, DOI 10.1017/S0001566000005109; ATLAS SW, 1988, AM J NEURORADIOL, V9, P598; BAKER RJ, 1978, GLIM SYSTEM; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRADY WJ, 1962, J NEUROPATHOL EXP NE, V2, P555; Carey J C, 1979, Birth Defects Orig Artic Ser, V15, P271; CRAWFORD MJ, 1983, DEV MED CHILD NEUROL, V25, P367; DIEKMANN L, 1967, Z KINDERHEILKD, V101, P191, DOI 10.1007/BF00438492; DRESNER E, 1949, Q J MED, V18, P93; HALL JG, 1991, AM J MED GENET, V38, P135, DOI 10.1002/ajmg.1320380128; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1989, PEDIGREE ANAL PACKAG; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LENTNER C, 1984, GEIGY SCI TABLES, V3; Loftis EL, 1940, ARCH DERMATOL SYPH, V42, P657, DOI 10.1001/archderm.1940.01490160117017; MORTON NE, 1974, AM J HUM GENET, V26, P489; OPITZ JM, 1985, AM J MED GENET, V21, P477, DOI 10.1002/ajmg.1320210310; Riccardi V M, 1979, Birth Defects Orig Artic Ser, V15, P283; STRUMPH DA, 1987, NIH CONSENSUS DEV C, V6; VAUGHN AJ, 1981, AM J MED GENET, V8, P155, DOI 10.1002/ajmg.1320080205; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	22	287	295	1	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					305	313						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328449				2022-12-18	WOS:A1993LN82000002
J	SWIFT, M; MORRELL, D; CROMARTIE, E; CHAMBERLIN, AR; SKOLNICK, MH; BISHOP, DT				SWIFT, M; MORRELL, D; CROMARTIE, E; CHAMBERLIN, AR; SKOLNICK, MH; BISHOP, DT			THE INCIDENCE AND GENE-FREQUENCY OF ATAXIA-TELANGIECTASIA IN THE UNITED-STATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514; UNIV UTAH,MED CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84132	University of North Carolina; University of North Carolina Chapel Hill; Utah System of Higher Education; University of Utah	SWIFT, M (corresponding author), UNIV N CAROLINA,BIOL SCI RES CTR,220H,CHAPEL HILL,NC 27514, USA.			Bishop, Tim/0000-0002-8752-8785	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA028854, R01CA014235] Funding Source: NIH RePORTER; NCI NIH HHS [CA14235, CA28854] Funding Source: Medline; NICHD NIH HHS [HD03110] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BODER E, 1985, ATAXIA TELANGIECTASI, P1; Cannings C., 1980, CURRENT DEV ANTHR GE, P251; DALY MB, 1978, J CHRON DIS, V31, P625, DOI 10.1016/0021-9681(78)90023-1; EDWARDS AWF, 1972, LIKELIHOOD, V1; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; HASSTEDT SJ, 1979, 13 U UT TECHN REP; HECHT F, 1977, GENETICS HUMAN CANCE, P105; JASPERS NGJ, 1985, ATAXIA TELANGIECTASI, P147; LEHMANN AR, 1982, ATAXIA TELANGIECTASI, P83; LI CC, 1955, POPULATION GENETICS, P229; MCKUSICK VA, 1966, J AMER MED ASSOC, V195, P739, DOI 10.1001/jama.195.9.739; MORRELL D, 1986, J NATL CANCER I, V77, P89; MUDD SH, 1985, AM J HUM GENET, V37, P1; Sedgewick RP, 1972, HDB CLINICAL NEUROLO, V14, P267; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1980, J NATL CANCER I, V65, P863; SWIFT M, 1979, JNCI-J NATL CANCER I, V62, P1415; SWIFT M, 1987, N ENGL J MED; WALDMANN TA, 1972, LANCET, V2, P112	19	287	293	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1986	39	5					573	583						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F3032	3788973				2022-12-18	WOS:A1986F303200003
J	Marshall, OJ; Chueh, AC; Wong, LH; Choo, KHA				Marshall, Owen J.; Chueh, Anderly C.; Wong, Lee H.; Choo, K. H. Andy			Neocentromeres: New insights into centromere structure, disease development, and karyotype evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							SUPERNUMERARY MARKER CHROMOSOME; DETECTABLE ALPHA-SATELLITE; MOLECULAR CYTOGENETIC CHARACTERIZATION; PALLISTER-KILLIAN-SYNDROME; HISTONE H3 VARIANT; CENP-A; MOSAIC TETRASOMY; INTERSTITIAL DELETION; INVERTED DUPLICATION; PRENATAL-DIAGNOSIS	Since the discovery of the first human neocentromere in 1993, these spontaneous, ectopic centromeres have been shown to be an astonishing example of epigenetic change within the genome. Recent research has focused on the role of neocentromeres in evolution and speciation, as well as in disease development and the understanding of the organization and epigenetic maintenance of the centromere. Here, we review recent progress in these areas of research and the significant insights gained.	[Marshall, Owen J.; Chueh, Anderly C.; Wong, Lee H.; Choo, K. H. Andy] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Marshall, Owen J.; Chueh, Anderly C.; Wong, Lee H.; Choo, K. H. Andy] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne	Choo, KHA (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	andy.choo@mcri.edu.au	Marshall, Owen/AAV-8859-2020; Chueh, Anderly/AAF-9375-2022; Chueh, Anderly C./D-8615-2015; Chüeh, Anderly C/AFC-2076-2022; Wong, Lee H/H-9757-2012	Marshall, Owen/0000-0003-1605-3871; Chueh, Anderly C./0000-0003-1140-5516; Chüeh, Anderly C/0000-0003-1140-5516; Wong, Lee H/0000-0002-4005-7330				Abeliovich D, 1996, CANCER GENET CYTOGEN, V89, P1, DOI 10.1016/0165-4608(95)00300-2; ADOLPH KW, 1977, P NATL ACAD SCI USA, V74, P4937, DOI 10.1073/pnas.74.11.4937; Alonso A, 2003, HUM MOL GENET, V12, P2711, DOI 10.1093/hmg/ddg282; Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Amor DJ, 2005, AM J MED GENET A, V133A, P151, DOI 10.1002/ajmg.a.30527; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Assumpcao JG, 2002, AM J MED GENET, V113, P263, DOI 10.1002/ajmg.10701; Barbi G, 2000, AM J MED GENET, V91, P116, DOI 10.1002/(SICI)1096-8628(20000313)91:2<116::AID-AJMG7>3.0.CO;2-Q; Barbi G, 2003, J Med Genet, V40, pe27, DOI 10.1136/jmg.40.3.e27; Barwell J, 2004, AM J MED GENET A, V130A, P295, DOI 10.1002/ajmg.a.30208; Basu J, 2005, NUCLEIC ACIDS RES, V33, P587, DOI 10.1093/nar/gki207; Batanian JR, 2006, CANCER GENET CYTOGEN, V170, P152, DOI 10.1016/j.cancergencyto.2006.06.008; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; BLENNOW E, 1994, AM J HUM GENET, V54, P877; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bukvic N, 1996, HUM GENET, V97, P453; Cardone MF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r91; Chen CP, 2004, PRENATAL DIAG, V24, P767, DOI 10.1002/pd.977; CHOO KH, 1991, NUCLEIC ACIDS RES, V19, P1179, DOI 10.1093/nar/19.6.1179; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Chuang L, 2005, AM J MED GENET A, V133A, P180, DOI 10.1002/ajmg.a.30362; Chueh AC, 2005, HUM MOL GENET, V14, P85, DOI 10.1093/hmg/ddi008; Cockwell AE, 2000, J MED GENET, V37, P807, DOI 10.1136/jmg.37.10.807; Coelho PA, 2003, J CELL SCI, V116, P4763, DOI 10.1242/jcs.00799; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; CONDE C, 2001, AM J HUM GENET S, V69, pA765; Constantinou M, 2005, CHROMOSOME RES, V13, P66; Craig JM, 2003, HUM MOL GENET, V12, P3109, DOI 10.1093/hmg/ddg330; Craig JM, 2003, EMBO J, V22, P2495, DOI 10.1093/emboj/cdg232; Dalpra L, 2005, GENET MED, V7, P620, DOI 10.1097/01.gim.0000182876.57766.2d; Dawe RK, 2004, CHROMOSOME RES, V12, P655, DOI 10.1023/B:CHRO.0000036607.74671.db; de Pater JM, 2005, PRENATAL DIAG, V25, P151, DOI 10.1002/pd.1097; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dufke A, 2001, EUR J HUM GENET, V9, P572, DOI 10.1038/sj.ejhg.5200673; duSart D, 1997, NAT GENET, V16, P144; Eder V, 2003, MOL BIOL EVOL, V20, P1506, DOI 10.1093/molbev/msg165; FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x; Floridia G, 2000, CHROMOSOMA, V109, P318, DOI 10.1007/s004120000081; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Forus A, 2001, CANCER GENET CYTOGEN, V131, P13, DOI 10.1016/S0165-4608(01)00516-7; Fritz B, 2001, J MED GENET, V38, P559, DOI 10.1136/jmg.38.8.559; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gimelli G, 2007, EUR J MED GENET, V50, P264, DOI 10.1016/j.ejmg.2007.04.003; Gimelli G, 2000, CHROMOSOMA, V109, P328, DOI 10.1007/s004120000082; Gisselsson D, 1999, HUM GENET, V104, P315, DOI 10.1007/s004390050960; Grimbacher B, 1999, GENET MED, V1, P213; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Herry A, 2004, AM J MED GENET A, V128A, P33, DOI 10.1002/ajmg.a.30077; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; HIGGINS RR, 2000, AM J HUM GENET S, V67, pA775; Hu J, 2002, AM J MED GENET, V113, P82, DOI 10.1002/ajmg.10708; Huang B, 1998, AM J MED GENET, V80, P368, DOI 10.1002/(SICI)1096-8628(19981204)80:4<368::AID-AJMG12>3.3.CO;2-2; Huang XL, 2005, CLIN GENET, V68, P513, DOI 10.1111/j.1399-0004.2005.00523.x; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Irvine DV, 2004, CHROMOSOME RES, V12, P805, DOI 10.1007/s10577-005-5377-4; Italiano A, 2006, CANCER GENET CYTOGEN, V167, P122, DOI 10.1016/j.cancergencyto.2006.01.004; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; KAISERROGERS KA, 1995, AM J HUM GENET, V57, P658; Kasai F, 2003, CYTOGENET GENOME RES, V102, P326, DOI 10.1159/000075770; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Knegt AC, 2003, PRENATAL DIAG, V23, P215, DOI 10.1002/pd.559; KOSZTOLANYI G, 1987, HUM GENET, V75, P174, DOI 10.1007/BF00591082; KUCEROVA M, 1983, AM J HUM GENET, V35, P91; LAEMMLI UK, 1977, COLD SPRING HARB SYM, V42, P351; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Levy B, 2000, CYTOGENET CELL GENET, V91, P165, DOI 10.1159/000056839; Li MM, 2000, PRENATAL DIAG, V20, P138, DOI 10.1002/(SICI)1097-0223(200002)20:2<138::AID-PD772>3.0.CO;2-2; Li SL, 2002, AM J MED GENET, V110, P258, DOI 10.1002/ajmg.10454; Liehr T, 2004, CYTOGENET GENOME RES, V107, P55, DOI 10.1159/000079572; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maggert KA, 2001, GENETICS, V158, P1615; MAGNANI I, 1993, CLIN GENET, V43, P180; Mahjoubi F, 2005, CYTOGENET GENOME RES, V109, P485, DOI 10.1159/000084207; Maraschio P, 1996, HUM GENET, V97, P382; Masumoto H, 1998, CHROMOSOMA, V107, P406, DOI 10.1007/s004120050324; Montefalcone G, 1999, GENOME RES, V9, P1184, DOI 10.1101/gr.9.12.1184; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Morrissette JJD, 2001, AM J MED GENET, V99, P21, DOI 10.1002/1096-8628(20010215)99:1<21::AID-AJMG1122>3.0.CO;2-X; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nakano M, 2003, J CELL SCI, V116, P4021, DOI 10.1242/jcs.00697; Nasuda S, 2005, P NATL ACAD SCI USA, V102, P9842, DOI 10.1073/pnas.0504235102; Neumann T, 1999, CYTOGENET CELL GENET, V85, P158; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Obado SO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r37; OHASHI H, 1994, AM J HUM GENET, V55, P1202; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okamoto Y, 2007, EMBO J, V26, P1279, DOI 10.1038/sj.emboj.7601584; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PAPENHAUSEN P, 2003, AM J HUM GENET, V73, pA841; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Petit P, 1997, GENET COUNSEL, V8, P341; Pietrzak J, 2007, J APPL GENET, V48, P167, DOI 10.1007/BF03194675; Platero JS, 1998, J CELL BIOL, V140, P1297; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Portnoi MF, 1999, J MED GENET, V36, P246; QIN N, 2005, AM J HUM GENET S, V76, pA829; RAUCH A, 1992, CLIN GENET, V42, P84; Ravnan JB, 1999, AM J HUM GENET, V65, pA356; Reddy KS, 2000, AM J MED GENET, V92, P69, DOI 10.1002/(SICI)1096-8628(20000501)92:1<69::AID-AJMG12>3.0.CO;2-O; Rivera H, 1996, ANN GENET-PARIS, V39, P236; Rivera H, 1999, AM J MED GENET, V85, P385, DOI 10.1002/(SICI)1096-8628(19990806)85:4<385::AID-AJMG15>3.0.CO;2-P; Rooades MM, 1942, P NATL ACAD SCI USA, V28, P433, DOI 10.1073/pnas.28.10.433; Rowe AG, 2000, AM J MED GENET, V93, P393, DOI 10.1002/1096-8628(20000828)93:5<393::AID-AJMG9>3.0.CO;2-Z; Sacchi N, 1996, CYTOGENET CELL GENET, V73, P123, DOI 10.1159/000134322; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; Saffery R, 2001, P NATL ACAD SCI USA, V98, P5705, DOI 10.1073/pnas.091468498; Sala E, 2005, CHROMOSOME RES, V13, P131; Satinover DL, 2001, CHROMOSOMA, V110, P275, DOI 10.1007/s004120100143; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sirvent N, 2000, GENE CHROMOSOME CANC, V29, P117, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1014>3.0.CO;2-Q; Slater HR, 1999, J MED GENET, V36, P914; Spiegel M, 2003, AM J MED GENET A, V116A, P284, DOI 10.1002/ajmg.a.10916; Strissel PL, 1996, CHROMOSOMA, V105, P122, DOI 10.1007/s004120050167; SULCOVA V, 1999, AM J HUM GENET S, V65, pA2026; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; Sullivan CM, 2005, J MED GENET, V42, pS71; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Sumer H, 2004, J BIOL CHEM, V279, P37631, DOI 10.1074/jbc.M401051200; Sumer H, 2003, GENOME RES, V13, P1737, DOI 10.1101/gr.1095903; Szpirer C, 2005, CYTOGENET GENOME RES, V108, P322, DOI 10.1159/000081526; Tabet AC, 2004, PRENATAL DIAG, V24, P733, DOI 10.1002/pd.804; Tavormina PA, 2002, J CELL BIOL, V158, P23, DOI 10.1083/jcb.200202053; Teshima I, 2000, AM J MED GENET, V94, P113, DOI 10.1002/1096-8628(20000911)94:2<113::AID-AJMG3>3.0.CO;2-Q; Tonnies H, 2007, J HISTOCHEM CYTOCHEM, V55, P651, DOI 10.1369/jhc.6A7161.2007; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Tomonaga T, 2003, CANCER RES, V63, P3511; Topennies H, 2006, CYTOGENET GENOME RES, V114, P325, DOI 10.1159/000094221; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vance GH, 1997, AM J MED GENET, V71, P436, DOI 10.1002/(SICI)1096-8628(19970905)71:4<436::AID-AJMG13>3.0.CO;2-H; VandenEnden A, 1996, AM J MED GENET, V63, P482, DOI 10.1002/(SICI)1096-8628(19960614)63:3<482::AID-AJMG13>3.0.CO;2-I; Velinov A, 2004, ANN GENET-PARIS, V47, P199, DOI 10.1016/j.anngen.2004.02.005; Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804; Ventura M, 2003, GENOME RES, V13, P2059, DOI 10.1101/gr.1155103; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Vermeesch JR, 2005, EUR J MED GENET, V48, P319, DOI 10.1016/j.ejmg.2005.04.018; Voullaire L, 1999, AM J MED GENET, V85, P403, DOI 10.1002/(SICI)1096-8628(19990806)85:4<403::AID-AJMG18>3.3.CO;2-I; Voullaire L, 2001, AM J MED GENET, V102, P86, DOI 10.1002/1096-8628(20010722)102:1<86::AID-AJMG1390>3.0.CO;2-T; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; Wandall A, 1998, CHROMOSOMA, V107, P359, DOI 10.1007/s004120050319; Warburton PC, 2003, EUR J HUM GENET, V11, P749, DOI 10.1038/sj.ejhg.5201047; Warburton PE, 2000, AM J HUM GENET, V66, P1794, DOI 10.1086/302924; Warburton PE, 2004, CHROMOSOME RES, V12, P617, DOI 10.1023/B:CHRO.0000036585.44138.4b; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Willard HF, 1991, CURR OPIN GENET DEV, V1, P509, DOI 10.1016/S0959-437X(05)80200-X; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; Wong LH, 2002, GENE THER, V9, P724, DOI 10.1038/sj.gt.3301756; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Yan HH, 2006, PLANT CELL, V18, P2123, DOI 10.1105/tpc.106.043794; YU J, 2004, AM J HUM GENET S, V74, pA982; Yu S, 2007, CYTOGENET GENOME RES, V116, P141, DOI 10.1159/000097434; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	163	286	295	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					261	282		10.1016/j.ajhg.2007.11.009	http://dx.doi.org/10.1016/j.ajhg.2007.11.009			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252209	Green Published, Bronze			2022-12-18	WOS:000253223900001
J	Zareparsi, S; Branham, KEH; Li, MY; Shah, S; Klein, RJ; Ott, J; Hoh, J; Abecasis, GR; Swaroop, A				Zareparsi, S; Branham, KEH; Li, MY; Shah, S; Klein, RJ; Ott, J; Hoh, J; Abecasis, GR; Swaroop, A			Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-REACTIVE PROTEIN; GENOMEWIDE-SCAN; MALATTIA LEVENTINESE; GENETIC ASSOCIATION; APOLIPOPROTEIN-E; DRUSEN FORMATION; LINKAGE; LOCUS; COMMON; POLYMORPHISM	Using a large sample of cases and controls from a single center, we show that a T -> C substitution in exon 9 ( Y402H) of the complement factor H gene is strongly associated with susceptibility to age- related macular degeneration, the most common cause of blindness in the elderly. Frequency of the C allele was 0.61 in cases, versus 0.34 in age-matched controls (P < 1x10(-24)). Genotype frequencies also differ markedly between cases and controls ( x(2)=112.68 [ 2 degrees of freedom]; P < 1x10(-24)). A multiplicative model fits the data well, and we estimate the population frequency of the high- risk C allele to be 0.39 ( 95% confidence interval 0.36 - 0.42) and the genotype relative risk to be 2.44 ( 95% confidence interval 2.08 - 2.83) for TC heterozygotes and 5.93 ( 95% confidence interval 4.33 - 8.02) for CC homozygotes.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rockefeller University; Yale University	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu	Branham, Kari/AAA-8336-2022; Klein, Robert/K-1888-2013; Abecasis, Goncalo R/B-7840-2010	Klein, Robert/0000-0003-3539-5391; Branham, Kari/0000-0002-2492-254X; Swaroop, Anand/0000-0002-1975-1141; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL EYE INSTITUTE [F32EY014085, P30EY007003, R01EY015771] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K25HG000060] Funding Source: NIH RePORTER; NEI NIH HHS [P30-EY007003, F32 EY014085, R01 EY015771, R01-EY15771, F32-EY014085, P30 EY007003] Funding Source: Medline; NHGRI NIH HHS [K25-HG000060, K25 HG000060] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2005, HUM HERED, V59, P118, DOI 10.1159/000085226; Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hayashi M, 2004, Ophthalmic Genet, V25, P111; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; RISCH N, 1990, AM J HUM GENET, V46, P222; Schmidt S, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-18; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2001, HUM MOL GENET, V10, P2285, DOI 10.1093/hmg/10.20.2285; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zareparsi S, 2004, INVEST OPHTH VIS SCI, V45, P1306, DOI 10.1167/iovs.03-1253; ZAREPARSI S, 2005, HUM MOL GENET	35	286	343	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					149	153		10.1086/431426	http://dx.doi.org/10.1086/431426			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15895326	Bronze, Green Published			2022-12-18	WOS:000229794500015
J	Bray, NJ; Buckland, PR; Williams, NM; Williams, HJ; Norton, N; Owen, MJ; O'Donovan, MC				Bray, NJ; Buckland, PR; Williams, NM; Williams, HJ; Norton, N; Owen, MJ; O'Donovan, MC			A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATECHOL-O-METHYLTRANSFERASE; GENE POLYMORPHISM; PRIMER EXTENSION; ALLELE; TRANSMISSION; MECHANISM	The gene encoding catechol-O-methyltransferase ( COMT) is a strong candidate for schizophrenia susceptibility, owing to the role of COMT in dopamine metabolism, and the location of the gene within the deleted region in velocardiofacial syndrome, a disorder associated with high rates of schizophrenia. Recently, a highly significant association was reported between schizophrenia and a COMT haplotype in a large case-control sample (Shifman et al. 2002). In addition to a functional valinermethionine (Val/Met) polymorphism, this haplotype included two noncoding single-nucleotide polymorphisms ( SNPs) at either end of the COMT gene. Given the role of COMT in dopamine catabolism and that deletion of 22q11 ( containing COMT) is associated with schizophrenia, we postulated that the susceptibility COMT haplotype is associated with low COMT expression. To test this hypothesis, we have applied quantitative measures of allele-specific expression using mRNA from human brain. We demonstrate that COMT is subject to allelic differences in expression in human brain and that the COMT haplotype implicated in schizophrenia ( Shifman et al. 2002) is associated with lower expression of COMT mRNA. We also show that the 3' flanking region SNP that gave greatest evidence for association with schizophrenia in that study is transcribed in human brain and exhibits significant differences in allelic expression, with lower relative expression of the associated allele. Our results indicate that COMT variants other than the Val/Met change are of functional importance in human brain and that the haplotype implicated in schizophrenia susceptibility is likely to exert its effect, directly or indirectly, by down-regulating COMT expression.	Cardiff Univ, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	O'Donovan, MC (corresponding author), Cardiff Univ, Dept Psychol Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	odonovanmc@cardiff.ac.uk	O'Donovan, Michael C/P-7005-2018; Williams, Hywel/AAL-2440-2021	O'Donovan, Michael C/0000-0001-7073-2379; Williams, Hywel/0000-0001-7758-0312; Bray, Nicholas/0000-0002-4357-574X	MRC [G9309834, G9810900] Funding Source: UKRI; Medical Research Council [G9810900, G9309834] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AXELROD J, 1958, J BIOL CHEM, V233, P702; CARLSSON A, 1978, PSYCHOPHARMACOLOGY G, P1057; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Daniels JK, 1996, AM J PSYCHIAT, V153, P268; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; GROSSMAN MH, 1985, J NEUROCHEM, V44, P421, DOI 10.1111/j.1471-4159.1985.tb05432.x; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; JEFFERY DR, 1984, J NEUROCHEM, V42, P826, DOI 10.1111/j.1471-4159.1984.tb02755.x; Kunugi H, 1997, PSYCHIAT GENET, V7, P97, DOI 10.1097/00041444-199723000-00001; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Liou YJ, 2001, NEUROPSYCHOBIOLOGY, V43, P11, DOI 10.1159/000054858; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; MORROW B, 1995, AM J HUM GENET, V56, P1391; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Ohmori O, 1998, NEUROSCI LETT, V243, P109, DOI 10.1016/S0304-3940(98)00100-1; Owen MJ, 2002, PSYCHIAT GENETICS GE, P247; Pulver AE, 2000, BIOL PSYCHIAT, V47, P221; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x; VANROSSUM JM, 1966, ARCH INT PHARMACOD T, V160, P492; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	26	286	292	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					152	161		10.1086/376578	http://dx.doi.org/10.1086/376578			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12802784	Green Published, Bronze			2022-12-18	WOS:000183904900013
J	Olson, MV				Olson, MV			When less is more: Gene loss as an engine of evolutionary change	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESTRICTION-MODIFICATION SYSTEMS; MELATONIN; MOUSE; ENDONUCLEASES; EXPRESSION		Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Olson, MV (corresponding author), Univ Washington, Dept Med, Div Med Genet, Box 352145, Seattle, WA 98195 USA.	mvo@u.washington.edu						AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; Ali M, 1998, J MED GENET, V35, P353, DOI 10.1136/jmg.35.5.353; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; BOARD P, 1990, PHARMACOL THERAPEUT, V48, P357, DOI 10.1016/0163-7258(90)90054-6; Broach J.R., 1991, MOL CELLULAR BIOL YE, V1; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; BRONSON FH, 1992, BIOL REPROD, V46, P246, DOI 10.1095/biolreprod46.2.246; CRAWFORD DHG, 1995, AM J HUM GENET, V57, P362; Diamond J., 1997, RUZHYA MIKROBY STALI; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GOEBL MG, 1986, CELL, V46, P983, DOI 10.1016/0092-8674(86)90697-5; GOTO M, 1994, BRAIN RES MOL BRAIN, V21, P249; HALL BG, 1983, MOL BIOL EVOL, V1, P109; HALL BG, 1992, MOL BIOL EVOL, V9, P688; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; JELTSCH A, 1995, GENE, V160, P7, DOI 10.1016/0378-1119(95)00181-5; Karyagina A, 1997, NUCLEIC ACIDS RES, V25, P2114, DOI 10.1093/nar/25.11.2114; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; NEEL JV, 1962, AM J HUM GENET, V14, P353; OhUigin C, 1997, HUM GENET, V101, P141, DOI 10.1007/s004390050603; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAMARKIN L, 1985, SCIENCE, V227, P714, DOI 10.1126/science.3881822; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; VOGEL F, 1996, HUMAN GENETICS PROBL; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101	28	286	294	6	34	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					18	23		10.1086/302219	http://dx.doi.org/10.1086/302219			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915938	Green Published, Bronze			2022-12-18	WOS:000078477400004
J	Wirth, B; Herz, M; Wetter, A; Moskau, S; Hahnen, E; Rudnik-Schoneborn, S; Wienker, T; Zerres, K				Wirth, B; Herz, M; Wetter, A; Moskau, S; Hahnen, E; Rudnik-Schoneborn, S; Wienker, T; Zerres, K			Quantitative analysis of survival motor neuron copies: Identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO; MOLECULAR ANALYSIS; MISSENSE MUTATION; DISEASE SEVERITY; CANDIDATE GENES; SMA PHENOTYPE; DELETIONS; REGION; CONVERSION; PROTEIN	Problems with diagnosis and genetic counseling occur for patients with autosomal recessive proximal spinal muscular atrophy (SMA) who do not show the most common mutation: homozygous absence of at least exon 7 of the telomeric survival motor neuron gene (SMN1). Here we present molecular genetic data for 42 independent nondeleted SMA patients. A nonradioactive quantitative PCR test showed one SMN1 copy in 19 patients (45%). By sequencing cloned reverse-transcription (RT) PCR products or genomic fragments of SMN1, we identified nine different mutations in 18 of the 19 patients, six described for the first time: three missense mutations (Y272C, T274I, S262I), three frameshift mutations in exons 2a, 2b, and 4 (124insT, 241-242ins4, 591delA), one nonsense mutation in exon 1 (Q15X), one Alu-mediated deletion from intron 4 to intron 6, and one donor splice site mutation in intron 7 (c.922+6T-->G). The most frequent mutation, Y272C, was found in 6 (33%) of 18 patients. Each intragenic mutation found in at least two patients occurred on the same haplotype background, indicating founder mutations. Genotype-phenotype correlation allowed inference of the effect of each mutation on the function of the SMN1 protein and the role of the SMN2 copy number in modulating the SMA phenotype. In 14 of 23 SM4 patients with two SMN1 copies, at least one intact SMN1 copy was sequenced, which excludes a 5q-SMA and suggests the existence of further gene(s) responsible for similar to 4%-5% of phenotypes indistinguishable from SMA. We determined the validity of the test, and we discuss its practical implications and limitations.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Dept Genet Epidemiol, D-53111 Bonn, Germany; Rhein Westfal TH Aachen, Dept Human Genet, D-5100 Aachen, Germany	University of Bonn; University of Bonn; RWTH Aachen University	Wirth, B (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Rudnik-Schöneborn, Sabine/F-8473-2015; Wirth, Brunhilde/H-3192-2019	Wirth, Brunhilde/0000-0003-4051-5191				Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burglen L, 1997, AM J HUM GENET, V60, P72; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Burglen L, 1996, 1 C WORLD MUSCL SOC, pS39; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Campbell L, 1998, AM J HUM GENET, V63, P37, DOI 10.1086/301918; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; CHANG JG, 1995, AM J HUM GENET, V57, P1503; Chen QF, 1998, GENOMICS, V48, P121, DOI 10.1006/geno.1997.5141; COBBEN JM, 1995, AM J HUM GENET, V57, P805; COLLIER S, 1993, NAT GENET, V3, P260, DOI 10.1038/ng0393-260; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; Harteveld KL, 1997, HUM GENET, V99, P528, DOI 10.1007/s004390050401; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; LORSON CL, IN PRESS P NATL ACAD; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; Parsons DW, 1998, J MED GENET, V35, P674, DOI 10.1136/jmg.35.8.674; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; Patrinos GP, 1998, HUM GENET, V102, P629, DOI 10.1007/s004390050753; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Raclin V, 1997, J MED GENET, V34, P86, DOI 10.1136/jmg.34.1.86; Rochat B, 1997, PHARMACOGENETICS, V7, P1, DOI 10.1097/00008571-199702000-00001; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; *SAS I, 1996, SAS STAT US GUID; Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Simard LR, 1997, AM J MED GENET, V72, P51, DOI 10.1002/(SICI)1096-8628(19971003)72:1<51::AID-AJMG11>3.0.CO;2-T; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; vanderSteege G, 1996, AM J HUM GENET, V59, P834; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; Wang CH, 1998, NEUROGENETICS, V1, P273; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	52	285	309	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1340	1356		10.1086/302369	http://dx.doi.org/10.1086/302369			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205265	Green Published, Bronze			2022-12-18	WOS:000080093000012
J	Dorschner, MO; Amendola, LM; Turner, EH; Robertson, PD; Shirts, BH; Gallego, CJ; Bennett, RL; Jones, KL; Tokita, MJ; Bennett, JT; Kim, JH; Rosenthal, EA; Kim, DS; Tabor, HK; Bamshad, MJ; Motulsky, AG; Scott, CR; Pritchard, CC; Walsh, T; Burke, W; Raskind, WH; Byers, P; Hisama, FM; Nickerson, DA; Jarvik, GP				Dorschner, Michael O.; Amendola, Laura M.; Turner, Emily H.; Robertson, Peggy D.; Shirts, Brian H.; Gallego, Carlos J.; Bennett, Robin L.; Jones, Kelly L.; Tokita, Mari J.; Bennett, James T.; Kim, Jerry H.; Rosenthal, Elisabeth A.; Kim, Daniel S.; Tabor, Holly K.; Bamshad, Michael J.; Motulsky, Arno G.; Scott, C. Ronald; Pritchard, Colin C.; Walsh, Tom; Burke, Wylie; Raskind, Wendy H.; Byers, Peter; Hisama, Fuld M.; Nickerson, Deborah A.; Jarvik, Gail P.		Natl Heart Lung And Blood Inst; Grand Opportunity Exome Sequencing	Actionable, Pathogenic Incidental Findings in 1,000 Participants' Exomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LI-FRAUMENI-SYNDROME; GERMLINE MUTATIONS; WORKING GROUP; INDIVIDUALS; RECOMMENDATIONS; INSIGHTS; GENES; TP53	The incorporation of genomics into medicine is stimulating interest on the return of incidental findings (IFs) from exome and genome sequencing. However, no large-scale study has yet estimated the number of expected actionable findings per individual; therefore, we classified actionable pathogenic single-nucleotide variants in 500 European- and 500 African-descent participants randomly selected from the National Heart, Lung, and Blood Institute Exome Sequencing Project. The 1,000 individuals were screened for variants in 114 genes selected by an expert panel for their association with medically actionable genetic conditions possibly undiagnosed in adults. Among the 1,000 participants, 585 instances of 239 unique variants were identified as disease causing in the Human Gene Mutation Database (HGMD). The primary literature supporting the variants' pathogenicity was reviewed. Of the identified IFs, only 16 unique autosomal-dominant variants in 17 individuals were assessed to be pathogenic or likely pathogenic, and one participant had two pathogenic variants for an autosomal-recessive disease. Furthermore, one pathogenic and four likely pathogenic variants not listed as disease causing in HGMD were identified. These data can provide an estimate of the frequency (similar to 3.4% for European descent and similar to 1.2% for African descent) of the high-penetrance actionable pathogenic or likely pathogenic variants in adults. The 23 participants with pathogenic or likely pathogenic variants were disproportionately of European (17) versus African (6) descent. The process of classifying these variants underscores the need for a more comprehensive and diverse centralized resource to provide curated information on pathogenicity for clinical use to minimize health disparities in genomic medicine.	[Dorschner, Michael O.; Turner, Emily H.; Robertson, Peggy D.; Kim, Daniel S.; Bamshad, Michael J.; Motulsky, Arno G.; Nickerson, Deborah A.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Amendola, Laura M.; Gallego, Carlos J.; Bennett, Robin L.; Jones, Kelly L.; Tokita, Mari J.; Bennett, James T.; Rosenthal, Elisabeth A.; Motulsky, Arno G.; Scott, C. Ronald; Walsh, Tom; Burke, Wylie; Raskind, Wendy H.; Byers, Peter; Hisama, Fuld M.; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Bennett, James T.; Tabor, Holly K.; Bamshad, Michael J.; Scott, C. Ronald] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Dorschner, Michael O.; Raskind, Wendy H.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Dorschner, Michael O.; Turner, Emily H.; Shirts, Brian H.; Pritchard, Colin C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Tabor, Holly K.; Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Byers, Peter] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kim, Jerry H.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jarvik, GP (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	pair@u.washington.edu	Jarvik, Gail P/N-6476-2014; Bennett, Robin/AAB-3683-2020; Burke, William/C-1203-2012	Jarvik, Gail P/0000-0002-6710-8708; Walsh, Tom/0000-0002-8875-0310; Kim, Daniel Seung/0000-0003-2971-1909; Jones, Kelly/0000-0002-5097-9865; Byers, Peter H./0000-0001-7786-7030; Turner, Emily/0000-0001-9040-9229; Bennett, James/0000-0003-2843-5594; Shirts, brian/0000-0002-7188-6764	National Institutes of Health; National Human Genome Research Institute; National Cancer Institute [U01HG006507, U01HG006375, U01HG007307, 5T32GM007454]; Washington State Life Sciences Discovery Fund [265508]; National Heart, Lung, and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL CANCER INSTITUTE [R01CA175716] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103010, RC2HL102923, RC2HL102924, RC2HL102926, RC2HL102925] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006507, U01HG006375, U01HG007307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Washington State Life Sciences Discovery Fund; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the NEXT Medicine and review teams for development of the actionable gene list and critical review of the manuscript: David Veenstra, S. Malia Fullerton, Donald Patrick, Dean Regier, Peter Tarczy-Hornoch, Patrick Heagerty, Brian Browning, Chris Nefcy, Barbara Evans, Martha Horike-Pyne, Sue Trinidad, Bryan Comstock, David Crosslin, Jane Ranchalis, Josh Smith, Sara Goering, Carrie Bennette, Elizabeth Hopley, Bryan Paeper, Jeff Furlong, Katie Igartua, Debbie Olson, Amber Burt, Sara Eisner, and Adam Gordon. We thank Joshua Akey for sharing his group's ancestry analyses. This work was funded by the National Institutes of Health; National Human Genome Research Institute and National Cancer Institute grants U01HG006507, U01HG006375, U01HG007307, and 5T32GM007454; and the Washington State Life Sciences Discovery Fund (grant 265508 to the Northwest Institute of Genetic Medicine). The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute (NHLBI) and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. Funding for the NHLBI Grand Opportunity (GO) Exome Sequencing Project was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO), and RC2 HL-102924 (Women's Health Initiative Sequencing Project). Exome sequencing was performed through NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO).	Anastasova V, 2013, AM J BIOETHICS, V13, P52, DOI 10.1080/15265161.2012.754066; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Fressart V, 2010, EUROPACE, V12, P861, DOI 10.1093/europace/euq104; Fullerton SM, 2012, GENET MED, V14, P424, DOI 10.1038/gim.2012.15; Garcia-Pavia P, 2011, HEART, V97, P1744, DOI 10.1136/hrt.2011.227967; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Janavicius R, 2010, EPMA J, V1, P397, DOI 10.1007/s13167-010-0037-y; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Laurino M.Y., 2012, MEDSCAPE; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lyon GJ, 2012, PERS MED, V9, P163, DOI [10.2217/pme.11.98, 10.2217/PME.11.98]; Parker LS, 2008, J LAW MED ETHICS, V36, P341, DOI 10.1111/j.1748-720X.2008.00278.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pennington KP, 2013, CANCER-AM CANCER SOC, V119, P332, DOI 10.1002/cncr.27720; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quesnel S, 1999, ONCOGENE, V18, P3970, DOI 10.1038/sj.onc.1202783; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Ramos E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-29; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Van Dijk FS, 2009, EUR J MED GENET, V52, P1, DOI 10.1016/j.ejmg.2008.11.004; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	27	284	289	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					631	640		10.1016/j.ajhg.2013.08.006	http://dx.doi.org/10.1016/j.ajhg.2013.08.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24055113	Green Published, Bronze			2022-12-18	WOS:000326305600005
J	Harding, RM; Healy, E; Ray, AJ; Ellis, NS; Flanagan, N; Todd, C; Dixon, C; Sajantila, A; Jackson, IJ; Birch-Machin, MA; Rees, JL				Harding, RM; Healy, E; Ray, AJ; Ellis, NS; Flanagan, N; Todd, C; Dixon, C; Sajantila, A; Jackson, IJ; Birch-Machin, MA; Rees, JL			Evidence for variable selective pressures at MC1R	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MELANOCORTIN-1 RECEPTOR; HUMAN-EVOLUTION; RED HAIR; SEQUENCE VARIATION; DNA-SEQUENCES; MSH RECEPTOR; X-CHROMOSOME; POPULATION; PIGMENTATION; POLYMORPHISMS	It is widely assumed that genes that influence variation in skin and hair pigmentation are under selection. To date, the melanocortin 1 receptor (MC1R) is the only gene identified that explains substantial phenotypic variance in human pigmentation. Here we investigate MC1R polymorphism in several populations, for evidence of selection. We conclude that MC1R is under strong functional constraint in Africa, where any diversion from eumelanin production (black pigmentation) appears to be evolutionarily deleterious. Although many of the MC1R amino acid variants observed in non-African populations do affect MC1R function and contribute to high levels of MC1R diversity in Europeans, we found no evidence, in either the magnitude or the patterns of diversity, for its enhancement by selection; rather, our analyses show that levels of MC1R polymorphism simply reflect neutral expectations under relaxation of strong functional constraint outside Africa.	Inst Mol Med, Oxford, England; Newcastle Univ, Dept Dermatol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Oxford; Newcastle University - UK; University of Helsinki; University of Edinburgh	Rees, JL (corresponding author), Univ Edinburgh, Royal Infirm, Dept Dermatol, Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.	jonathan.rees@ed.ac.uk	Sajantila, Antti/AAY-9084-2021	Healy, Eugene/0000-0001-5591-6970; Sajantila, Antti/0000-0003-4117-5248; Jackson, Ian/0000-0001-6526-0688				Bodmer W. F., 1976, GENETICS EVOLUTION M; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Di Rienzo A, 1998, GENETICS, V148, P1269; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Flint J, 1999, HUM GENET, V105, P567, DOI 10.1007/s004390051147; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Griffiths R.C., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Harding RM, 1999, P NATL ACAD SCI USA, V96, P2582, DOI 10.1073/pnas.96.6.2582; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HUDSON RR, 1987, GENETICS, V116, P153; Jordan SA, 1998, BIOESSAYS, V20, P603, DOI 10.1002/(SICI)1521-1878(199808)20:8&lt;603::AID-BIES1&gt;3.0.CO;2-J; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; MARJORAM P, 1994, GENETICS, V136, P673; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; Nielsen R, 1998, GENETICS, V148, P929; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Owens K, 1999, SCIENCE, V286, P451, DOI 10.1126/science.286.5439.451; Rana BK, 1999, GENETICS, V151, P1547; Rees JL, 1999, QJM-INT J MED, V92, P125, DOI 10.1093/qjmed/92.3.125; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Schneider S, 1997, ARLEQUIN SOFTWARE PO; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Sokal Robert R., 1969, BIOMETRY; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Tan CP, 1999, FEBS LETT, V451, P137, DOI 10.1016/S0014-5793(99)00525-6; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371; [No title captured]	43	284	293	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1351	1361		10.1086/302863	http://dx.doi.org/10.1086/302863			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10733465	Bronze, Green Published			2022-12-18	WOS:000088373400017
J	Bidichandani, SI; Ashizawa, T; Patel, PI				Bidichandani, SI; Ashizawa, T; Patel, PI			The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOPURINE-HOMOPYRIMIDINE SEQUENCES; CLINICAL-FEATURES; S1 NUCLEASE; H-DNA; REGION; DUPLEX; HELIX; GENE; ELONGATION; PLASMIDS	Friedreich ataxia (FRDA), an autosomal recessive, neurodegenerative disease is the most common inherited ataxia. The vast majority of patients are homozygous for an abnormal expansion of a polymorphic GAA triplet repeat in the first intron of the X25 gene, which encodes a mitochondrial protein, frataxin. Cellular degeneration in FRDA may be caused by mitochondrial dysfunction, possibly due to abnormal iron accumulation, as observed in yeast cells deficient for a frataxin homologue. Using RNase protection assays, we have shown that patients homozygous for the expansion have a marked deficiency of mature X25 mRNA. The mechanism(s) by which the intronic GAA triplet expansion results in this reduction of X25 mRNA is presently unknown. No evidence was found for abnormal splicing of the expanded intron 1. Using cloned repeat sequences from FRDA patients, we show that the GAA repeat per se interferes with in vitro transcription in a length-dependent manner, with both prokaryotic and eukaryotic enzymes. This interference was most pronounced in the physiological orientation of transcription, when synthesis of the GAA-rich transcript was attempted. These results are consistent with the observed negative correlation between triplet-repeat length and the age at onset of disease. Using in vitro chemical probing strategies, we also show that the GAA triplet repeat adopts an unusual DNA structure, demonstrated by hyperreactivity to osmium tetroxide, hydroxylamine, and diethyl pyrocarbonate. These results raise the possibility that the GAA triplet-repeat expansion may result in an unusual yet stable DNA structure that interferes with transcription, ultimately leading to a cellular deficiency of frataxin.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Patel, PI (corresponding author), Baylor Coll Med, Dept Neurol, NB431A,1 Baylor Plaza, Houston, TX 77030 USA.		; Patel, Pragna/H-9129-2017	Bidichandani, Sanjay/0000-0001-6191-6475; Patel, Pragna/0000-0003-3584-1072				Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P526, DOI 10.1017/S0317167100034995; BERNUES J, 1989, EMBO J, V8, P2087, DOI 10.1002/j.1460-2075.1989.tb03617.x; Bidichandani S. I., 1996, American Journal of Human Genetics, V59, pA48; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; BIDICHANDANI SI, 1996, CURRENT NEUROLOGY, P1; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Cossee M, 1997, NAT GENET, V15, P337, DOI 10.1038/ng0497-337; DEMICHELE G, 1994, J NEUROL NEUROSUR PS, V57, P977, DOI 10.1136/jnnp.57.8.977; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Epplen C, 1997, HUM GENET, V99, P834, DOI 10.1007/s004390050458; Escude C, 1996, P NATL ACAD SCI USA, V93, P4365, DOI 10.1073/pnas.93.9.4365; EVANS T, 1986, J BIOL CHEM, V261, P4771; Filla A, 1996, AM J HUM GENET, V59, P554; FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Giovannangeli C, 1996, J MOL BIOL, V261, P386, DOI 10.1006/jmbi.1996.0471; GRABCZYK E, 1995, J BIOL CHEM, V270, P1791, DOI 10.1074/jbc.270.4.1791; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1993, ADV NEUROL, V61, P1; HARTMAN DA, 1992, J BIOL CHEM, V267, P5488; HENTSCHEL CC, 1982, NATURE, V295, P714, DOI 10.1038/295714a0; HTUN H, 1984, P NATL ACAD SCI-BIOL, V81, P7288, DOI 10.1073/pnas.81.23.7288; HTUN H, 1988, SCIENCE, V241, P1791, DOI 10.1126/science.3175620; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; KANG S, 1992, J BIOL CHEM, V267, P19435; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KOHWI Y, 1988, P NATL ACAD SCI USA, V85, P3781, DOI 10.1073/pnas.85.11.3781; Lamarche J., 1993, HDB CEREBELLAR DIS, P453; MCCARTHY JG, 1987, NUCLEIC ACIDS RES, V15, P8069, DOI 10.1093/nar/15.19.8069; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Ohshima K, 1996, J BIOL CHEM, V271, P16784, DOI 10.1074/jbc.271.28.16784; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; PALAU F, 1995, ANN NEUROL, V37, P359, DOI 10.1002/ana.410370312; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; REABAN ME, 1991, NATURE, V351, P448; SEMERAD CL, 1994, NUCLEIC ACIDS RES, V22, P5321, DOI 10.1093/nar/22.24.5321; SKOOG JU, 1993, NUCLEIC ACIDS RES, V21, P2131, DOI 10.1093/nar/21.9.2131; STAVNEZER J, 1991, NATURE, V351, P447, DOI 10.1038/351447b0; VOLOSHIN ON, 1988, NATURE, V333, P475, DOI 10.1038/333475a0; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8	48	284	295	1	23	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					111	121		10.1086/301680	http://dx.doi.org/10.1086/301680			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443873	Green Published, Bronze			2022-12-18	WOS:000072127900016
J	SCHOTT, JJ; CHARPENTIER, F; PELTIER, S; FOLEY, P; DROUIN, E; BOUHOUR, JB; DONNELLY, P; VERGNAUD, G; BACHNER, L; MOISAN, JP; LEMAREC, H; PASCAL, O				SCHOTT, JJ; CHARPENTIER, F; PELTIER, S; FOLEY, P; DROUIN, E; BOUHOUR, JB; DONNELLY, P; VERGNAUD, G; BACHNER, L; MOISAN, JP; LEMAREC, H; PASCAL, O			MAPPING OF A GENE FOR LONG QT SYNDROME TO CHROMOSOME 4Q25-27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; HETEROGENEITY; DYSFUNCTION; ARRHYTHMIA; INTERVALS; FAMILIES; LOCUS	Long QT syndrome (LQTS) is a heterogeneous inherited disorder causing syncope and sudden death from ventricular arrhythmias. A first locus for this disorder was mapped to chromosome 11p15.5. However, locus heterogeneity has been demonstrated in several families, and two other loci have recently been located on chromosomes 7q35-36 and 3p21-24. We used linkage analysis to map the locus in a 65-member family in which LQTS was associated with more marked sinus bradycardia than usual, leading to sinus node dysfunction. Linkage to chromosome 11p15.5, 7q35-36, or 3p21-24 was excluded. Positive linkage was obtained for markers located on chromosome 4q25-27. A maximal LOD score of 7.05 was found for marker D4S402. The identification of a fourth locus for LQTS confirms its genetic heterogeneity. Locus 4q25-27 is associated with a peculiar phenotype within the LQTS entity.	CHU NANTES,PHYSIOPATHOL & PHARMACOL CELLULAIRES & MOLEC LAB,NANTES,FRANCE; CHU NANTES,GENET MOLEC LAB,NANTES,FRANCE; CHU NANTES,GENET ESPECES LAB,NANTES,FRANCE; CHU NANTES,CARDIOL CLIN,CNRS,URA 1340,NANTES,FRANCE; GS INFOBIOGEN,CNRS,INSERM,SERV BIOINFORMAT,VILLEJUIF,FRANCE	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)			Le Marec, Hervé/D-2718-2015; Charpentier, Flavien/D-3586-2015; Schott, jean-Jacques/F-8842-2013; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Le Marec, Hervé/0000-0002-8288-8693; Charpentier, Flavien/0000-0002-5057-0998; Schott, jean-Jacques/0000-0002-9578-9475; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X				BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; BENHORIN J, 1993, SCIENCE, V260, P1960, DOI 10.1126/science.8316839; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURRAN M, 1993, J CLIN INVEST, V92, P799, DOI 10.1172/JCI116653; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DAY CP, 1990, BRIT HEART J, V63, P342; DEAN JCS, 1993, J MED GENET, V30, P947, DOI 10.1136/jmg.30.11.947; ENGLAND J, 1987, NATURE, V325, P783; FULLER CM, 1994, J BIOL CHEM, V269, P26642; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; HENGSTENBERG C, 1994, J MOL CELL CARDIOL, V26, P3, DOI 10.1006/jmcc.1994.1002; HOSODA K, 1992, J BIOL CHEM, V287, P18797; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; KAMB A, 1989, P NATL ACAD SCI USA, V86, P4372, DOI 10.1073/pnas.86.12.4372; KEATING M, 1991, AM J HUM GENET, V49, P1335; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; KUGLER JD, 1991, AM HEART J, V121, P1132, DOI 10.1016/0002-8703(91)90673-6; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEHMANN H, 1978, BRIT HEART J, V40, P1314; LEPPERT M, 1987, HUMAN GENE MAPPING, V9, P648; LIDEREAU R, 1986, JNCI-J NATL CANCER I, V77, P697, DOI 10.1093/jnci/77.3.697; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1992, CIRCULATION, V85, P140; ONO K, 1994, NATURE, V370, P301, DOI 10.1038/370301a0; ONOZUKA M, 1991, NEUROSCI LETT, V124, P35, DOI 10.1016/0304-3940(91)90816-C; PASCAL O, 1993, J CELL BIOCHEM, V17, P202; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SATLER C, 1992, CIRCULATION, V86, P348; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; Taggart R. Thomas, 1993, Journal of the American College of Cardiology, V21, p477A; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; TOWBIN J A, 1992, Pediatric Research, V31, p23A; TOWBIN JA, 1994, CIRCULATION, V90, P2635, DOI 10.1161/01.CIR.90.6.2635; VINCENT GM, 1992, NEW ENGL J MED, V327, P846, DOI 10.1056/NEJM199209173271204; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	42	284	291	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1114	1122						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485162				2022-12-18	WOS:A1995TA44900018
J	BROWN, CJ; GOSS, SJ; LUBAHN, DB; JOSEPH, DR; WILSON, EM; FRENCH, FS; WILLARD, HF				BROWN, CJ; GOSS, SJ; LUBAHN, DB; JOSEPH, DR; WILSON, EM; FRENCH, FS; WILLARD, HF			ANDROGEN RECEPTOR LOCUS ON THE HUMAN X-CHROMOSOME - REGIONAL LOCALIZATION TO XQ11-12 AND DESCRIPTION OF A DNA POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO, DEPT MED GENET, TORONTO M5S 1A8, ONTARIO, CANADA; UNIV OXFORD, SIR WILLIAM DUNN SCH PATHOL, OXFORD OX1 3RE, ENGLAND; UNIV N CAROLINA, REPROD BIOL LAB, CHAPEL HILL, NC 27514 USA	University of Toronto; University of Oxford; University of North Carolina; University of North Carolina Chapel Hill			Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101	NICHD NIH HHS [HD16910, HD21744, HD04466] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD004466, R01HD021744, R37HD004466, R01HD016910] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARVEILER B, 1987, Genomics, V1, P60, DOI 10.1016/0888-7543(87)90105-4; BARLOW DP, 1987, TRENDS GENET, V3, P167, DOI 10.1016/0168-9525(87)90219-8; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; BUCK DW, 1976, CYTOGENET CELL GENET, V16, P99, DOI 10.1159/000130563; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; DAVISSON M T, 1987, Genomics, V1, P213, DOI 10.1016/0888-7543(87)90047-4; Fichman K R, 1980, Adv Hum Genet, V10, P333; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Mahtani MM, 1988, GENOMICS, V2, P294, DOI 10.1016/0888-7543(88)90017-1; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P6339, DOI 10.1073/pnas.78.10.6339; PINSKY L, 1987, ADV HUM GENET, V16, P299; TRAPMAN J, 1988, BIOCHEM BIOPH RES CO, V153, P241, DOI 10.1016/S0006-291X(88)81214-2; WIEACKER P, 1987, HUM GENET, V76, P248; WILLARD HF, 1985, HUM GENET, V71, P138; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606; Wilson J.D., 1983, METABOLIC BASIS INHE, P1001; WILSON JD, 1985, TRENDS GENET, V1, P335, DOI 10.1016/0168-9525(85)90129-5; ZONANA J, 1988, AM J HUM GENET, V43, P75	23	284	299	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					264	269						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2563196				2022-12-18	WOS:A1989R970500012
J	Irrthum, A; Devriendt, K; Chitayat, D; Matthijs, G; Glade, C; Steijlen, PM; Fryns, JP; Van Steensel, MAM; Vikkula, M				Irrthum, A; Devriendt, K; Chitayat, D; Matthijs, G; Glade, C; Steijlen, PM; Fryns, JP; Van Steensel, MAM; Vikkula, M			Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAIR FOLLICLE MORPHOGENESIS; AUTOSOMAL SEX REVERSAL; TUMOR LYMPHANGIOGENESIS; CAMPOMELIC DYSPLASIA; BETA-CATENIN; SRY; EXPRESSION; PROTEINS; PROMOTES; SEQUENCE	Hereditary lymphedema is a developmental disorder characterized by chronic swelling of the extremities due to dysfunction of the lymphatic vessels. Two responsible genes have been identified: the vascular endothelial growth factor receptor 3 (VEGFR3) gene, implicated in congenital lymphedema, or Milroy disease, and the forkhead-related transcription factor gene FOXC2, causing lymphedema-distichiasis. We describe three families with an unusual association of hypotrichosis, lymphedema, and telangiectasia. Using microsatellite analysis, we first excluded both VEGFR3 and FOXC2 as causative genes; we then considered the murine ragged phenotype, caused by mutations in the Sox18 transcription factor, as a likely counterpart to the human disease, because it presents a combination of hair and cardiovascular anomalies, including symptoms of lymphatic dysfunction. Two of the families were consanguineous; in affected members of these families, we identified homozygous missense mutations in the SOX18 gene, located in 20q13. The two amino acid substitutions, W95R and A104P, affect conserved residues in the first alpha helix of the DNA-binding domain of the transcription factor. In the third family, the parents were nonconsanguineous, and both the affected child and his brother, who died in utero with hydrops fetalis, showed a heterozygous nonsense mutation that truncates the SOX18 protein in its transactivation domain; this substitution was not found in genomic DNA from either parent and hence constitutes a de novo germline mutation. Thus, we show that SOX18 mutations in humans cause both recessive and dominant hypotrichosis-lymphedema-telangiectasia, suggesting that, in addition to its established role in hair and blood vessel development, the SOX18 transcription factor plays a role in the development and/or maintenance of lymphatic vessels.	Catholic Univ Louvain, Lab Human Mol Genet, Christian De Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Univ Leuven, Ctr Human Genet, Louvain, Belgium; Univ Toronto, Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; Med Spectrum Twente, Hengelo, Netherlands; Acad Ziekenhuis Maastricht, Dept Dermatol, Maastricht, Netherlands	Universite Catholique Louvain; KU Leuven; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Medical Spectrum Twente; Maastricht University; Maastricht University Medical Centre (MUMC)	Vikkula, M (corresponding author), Catholic Univ Louvain, Lab Human Mol Genet, Christian De Duve Inst Cellular Pathol, Ave Hippocrate 74&5,BP 75-39, B-1200 Brussels, Belgium.	vikkula@bchm.ucl.ac.be	Steijlen, Peter/X-2729-2019; Vikkula, Miikka/Q-1038-2018; van Steensel, Maurice A.M./V-3852-2019	Vikkula, Miikka/0000-0002-6236-338X; Matthijs, Gert/0000-0001-6710-1912; van Steensel, Maurice/0000-0002-7507-2442				BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Boon LM, 1999, AM J HUM GENET, V65, P125, DOI 10.1086/302450; Boucher CA, 2001, J MED GENET, V38, P591, DOI 10.1136/jmg.38.9.591; Bull LN, 2000, AM J HUM GENET, V67, P994, DOI 10.1086/303080; CHITAYAT D, 1989, AM J MED GENET, V33, P352, DOI 10.1002/ajmg.1320330313; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; FEINGOLD M, 1992, AM J MED GENET, V43, P1030, DOI 10.1002/ajmg.1320430623; Finegold DN, 2001, HUM MOL GENET, V10, P1185, DOI 10.1093/hmg/10.11.1185; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Glade C, 2001, EUR J DERMATOL, V11, P515; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hosking BM, 2001, GENE, V262, P239, DOI 10.1016/S0378-1119(00)00525-4; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iljin K, 2001, FASEB J, V15, P1028, DOI 10.1096/fj.00-0383com; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Lukusa T, 2002, GENET COUNSEL, V13, P1; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Pennisi DJ, 2000, MAMM GENOME, V11, P1147, DOI 10.1007/s003350010216; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Plate KH, 2001, NAT MED, V7, P151, DOI 10.1038/84579; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WALLACE ME, 1979, HEREDITY, V43, P9, DOI 10.1038/hdy.1979.54; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; WITT DR, 1987, AM J MED GENET, V27, P841, DOI 10.1002/ajmg.1320270412; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	39	283	296	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1470	1478		10.1086/375614	http://dx.doi.org/10.1086/375614			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12740761	Green Published, Bronze			2022-12-18	WOS:000183275500010
J	Fullerton, SM; Clark, AG; Weiss, KM; Nickerson, DA; Taylor, SL; Stengard, JH; Salomaa, V; Vartiainen, E; Perola, M; Boerwinkle, E; Sing, CF				Fullerton, SM; Clark, AG; Weiss, KM; Nickerson, DA; Taylor, SL; Stengard, JH; Salomaa, V; Vartiainen, E; Perola, M; Boerwinkle, E; Sing, CF			Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEVELOPING ALZHEIMERS-DISEASE; HUMAN LIPOPROTEIN-LIPASE; REGULATORY REGION; STATISTICAL TESTS; E GENE; LINKAGE DISEQUILIBRIUM; POPULATION-GENETICS; AFRICAN-AMERICANS; EPSILON-4 ALLELE; DNA POLYMORPHISM	Three common protein isoforms of apolipoprotein E (apoE), encoded by the (epsilon)2, (epsilon)3, and (epsilon)4 alleles of the APOE gene, differ in their association with cardiovascular and Alzheimer's disease risk. To gain a better understanding of the genetic variation underlying this important polymorphism, we identified sequence haplotype variation in 5.5 kb of genomic DNA encompassing the whole of the APOE locus and adjoining flanking regions in 96 individuals from four populations: blacks from Jackson, MS (n = 48 chromosomes), Mayans from Campeche, Mexico (n 48), Finns from North Karelia, Finland (n = 48), and non-Hispanic whites from Rochester, MN (rt 48). In the region sequenced, 23 sites varied (21 single nucleotide polymorphisms, or SNPs, 1 diallelic indel, and 1 multiallelic indel). The 22 diallelic sites defined 31 distinct haplotypes in the sample. The estimate of nucleotide diversity (site-specific heterozygosity) for the locus was 0.0005 +/- 0.0003. Sequence analysis of the chimpanzee APOE gene showed that it was most closely related to human (epsilon)4-type haplotypes, differing from the human consensus sequence at 67 synonymous (54 substitutions and 13 indels) and 9 nonsynonymous fixed positions. The evolutionary history of allelic divergence within humans was inferred from the pattern of haplotype relationships. This analysis suggests that haplotypes defining the (epsilon)3 and (epsilon)2 alleles are derived from the ancestral (epsilon)4s and that the (epsilon)3 group of haplotypes have increased in frequency, relative to (epsilon)4s, in the past 200,000 years. Substantial heterogeneity exists within all three classes of sequence haplotypes, and there are important interpopulation differences in the sequence variation underlying the protein isoforms that may be relevant to interpreting conflicting reports of phenotypic associations with variation in the common protein isoforms.	Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, KTL, Helsinki, Finland; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Fullerton, SM (corresponding author), Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA.	smf15@psu.edu	Fullerton, Stephanie Malia/H-8696-2019	Fullerton, Stephanie Malia/0000-0002-0938-6048; Perola, Markus/0000-0003-4842-1667; Clark, Andrew/0000-0001-7159-8511; Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [R01 HL039107, HL58238, HL39107, HL58239] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107, R01HL058239, R01HL058238] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Artiga MJ, 1998, HUM MOL GENET, V7, P1887, DOI 10.1093/hmg/7.12.1887; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; BANDELT HJ, 1995, GENETICS, V141, P743; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; CORBO RM, 1995, ANN HUM GENET, V59, P197, DOI 10.1111/j.1469-1809.1995.tb00741.x; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CREWS DE, 1993, HUM BIOL, V65, P211; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAVIGNON J, 1993, NEW HORIZONS CORONAR; DEKNIJFF P, 1994, HUM MUTAT, V4, P178, DOI 10.1002/humu.1380040303; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gerdes LU, 1996, HUM GENET, V98, P239, DOI 10.1007/s004390050200; Gerdes LU, 1996, HUM GENET, V98, P546, DOI 10.1007/s004390050257; Gillespie JH, 2000, GENETICS, V155, P909; GRIFFITHS RC, 1997, PROGR POPULATION GEN, P165; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hartl DL, 1997, PRINCIPLES POPULATIO; Hixson JE, 1988, GENOMICS, V2, P315, DOI 10.1016/0888-7543(88)90020-1; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENETICS, V116, P153; HUI DY, 1984, J BIOL CHEM, V259, P860; Jaruzelska J, 1999, GENETICS, V152, P1091; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; KAMBOH MI, 1995, HUM BIOL, V67, P195; KAPLAN NL, 1989, GENETICS, V123, P887; KAPRIO J, 1991, ARTERIOSCLER THROMB, V11, P1330, DOI 10.1161/01.ATV.11.5.1330; KIDD JR, 1991, HUM BIOL, V63, P775; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; Lambert JC, 1998, HUM MOL GENET, V7, P1511, DOI 10.1093/hmg/7.9.1511; LARSEN F, 1993, HUM MOL GENET, V2, P775, DOI 10.1093/hmg/2.6.775; LEWONTIN RC, 1985, ANNU REV GENET, V19, P81, DOI 10.1146/annurev.ge.19.120185.000501; LI WH, 1991, GENETICS, V129, P513; Lucotte G, 1997, HUM BIOL, V69, P253; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martin GM, 1999, NEUROBIOL AGING, V20, P441, DOI 10.1016/S0197-4580(99)00078-0; Mui S, 1996, NEUROLOGY, V47, P196, DOI 10.1212/WNL.47.1.196; Nei M., 1987, MOL EVOLUTIONARY GEN; NICDKERSON DA, IN PRESS GENOME RES; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; OSUNTOKUN BO, 1995, ANN NEUROL, V38, P463, DOI 10.1002/ana.410380319; RALL SC, 1982, J BIOL CHEM, V257, P4171; Rana BK, 1999, GENETICS, V151, P1547; REILLY SL, 1992, AM J HUM GENET, V51, P1311; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Roks G, 1998, NEUROSCI LETT, V258, P65, DOI 10.1016/S0304-3940(98)00857-X; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sahota A, 1997, ANN NEUROL, V42, P659, DOI 10.1002/ana.410420418; Salomaa V V, 1994, J Cardiovasc Risk, V1, P241; Sayi JG, 1997, E AFR MED J, V74, P668; Scacchi R, 1997, HUM BIOL, V69, P375; Seixas S, 1999, HUM BIOL, V71, P1001; SIMONSEN KL, 1995, GENETICS, V141, P413; SING CF, 1985, AM J HUM GENET, V37, P268; Song YQ, 1998, NEUROSCI LETT, V250, P189, DOI 10.1016/S0304-3940(98)00470-4; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taddei K, 1997, NEUROSCI LETT, V223, P29, DOI 10.1016/S0304-3940(97)13394-8; TAJIMA F, 1989, GENETICS, V123, P585; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Tang MX, 1996, AM J HUM GENET, V58, P574; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Town T, 1998, NEUROSCI LETT, V252, P95, DOI 10.1016/S0304-3940(98)00567-9; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1996, GENETIC DATA ANAL, pR2; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wright S, 1931, GENETICS, V16, P0097; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100; Xu Y, 1999, J LIPID RES, V40, P50; YAMADA T, 1995, J NEUROL SCI, V129, P56, DOI 10.1016/0022-510X(94)00249-N; ZANNIS VI, 1985, J LIPID RES, V26, P1421; Zekraoui L, 1997, HUM BIOL, V69, P575; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	96	283	302	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					881	900		10.1086/303070	http://dx.doi.org/10.1086/303070			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986041	Bronze, Green Published			2022-12-18	WOS:000089651100012
J	Irrthum, A; Karkkainen, MJ; Devriendt, K; Alitalo, K; Vikkula, M				Irrthum, A; Karkkainen, MJ; Devriendt, K; Alitalo, K; Vikkula, M			Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHATIC ENDOTHELIUM; VENOUS MALFORMATIONS; GENE; RECEPTOR-3; LINKAGE; DOMAIN	Hereditary lymphedema is a chronic swelling of limbs due to dysfunction of lymphatic vessels. An autosomal dominant, congenital form of the disease, also known as "Milroy disease," has been mapped to the telomeric part of chromosome 5q, in the region 5q34-q35. This region contains a good candidate gene for the disease, VEGFR3 (FLT4), that encodes a receptor tyrosine kinase specific for lymphatic vessels. To clarify the role of VEGFR3 in the etiology of the disease, we have analyzed a family with hereditary lymphedema. We show linkage of the disease with markers in 5q34-q35, including a VEGFR3 intragenic polymorphism, and we describe an A-->G transition that cosegregates with the disease, corresponding to a histidine-to-arginine substitution in the catalytic loop of the protein. In addition, we show, by in vitro expression, that this mutation inhibits the autophosphorylation of the receptor. Thus, defective VEGFR3 signaling seems to be the cause of congenital hereditary lymphedema linked to 5q34-q35.	Christian de Duve Inst Cellular Pathol, Lab Human Mol Genet, B-1200 Brussels, Belgium; Catholic Univ Louvain, Brussels, Belgium; Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, Mol Canc Biol Lab, Helsinki, Finland; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium	Universite Catholique Louvain; Ludwig Institute for Cancer Research; University of Helsinki; KU Leuven	Vikkula, M (corresponding author), Christian de Duve Inst Cellular Pathol, Lab Human Mol Genet, Ave Hippocrate 75 & 4,BP 75-39, B-1200 Brussels, Belgium.		Vikkula, Miikka/Q-1038-2018; Alitalo, Kari K/J-5013-2014	Vikkula, Miikka/0000-0002-6236-338X; Alitalo, Kari K/0000-0002-7331-0902				Boon LM, 1999, AM J HUM GENET, V65, P125, DOI 10.1086/302450; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; ESTERLY J R, 1965, J Med Genet, V2, P93, DOI 10.1136/jmg.2.2.93; Evans AL, 1999, AM J HUM GENET, V64, P547, DOI 10.1086/302248; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jussila L, 1998, CANCER RES, V58, P1599; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kinmonth JB, 1982, LYMPHATICS DIS INVES, P1; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Mangion J, 1999, AM J HUM GENET, V65, P427, DOI 10.1086/302500; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; OPITZ JM, 1986, AM J MED GENET, V24, P127, DOI 10.1002/ajmg.1320240115; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; SPRITZ RA, 1993, J INVEST DERMATOL, V101, P22, DOI 10.1111/1523-1747.ep12358440; ZHOU MY, 1995, BIOTECHNIQUES, V19, P34	19	283	311	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					295	301		10.1086/303019	http://dx.doi.org/10.1086/303019			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10856194	Bronze, Green Published			2022-12-18	WOS:000089357800006
J	Kayser, M; Roewer, L; Hedman, M; Henke, L; Henke, J; Brauer, S; Kruger, C; Krawczak, M; Nagy, M; Dobosz, T; Szibor, R; de Knijff, P; Stoneking, M; Sajantila, A				Kayser, M; Roewer, L; Hedman, M; Henke, L; Henke, J; Brauer, S; Kruger, C; Krawczak, M; Nagy, M; Dobosz, T; Szibor, R; de Knijff, P; Stoneking, M; Sajantila, A			Characteristics and frequency of germline mutations at microsatellite loci from the human Y chromosome, as revealed by direct observation in father/son pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TANDEM-REPEAT; DROSOPHILA-MELANOGASTER; PROVIDES EVIDENCE; DNA ANALYSIS; NEW-WORLD; POPULATIONS; INSTABILITY; RATES; MODEL; BIAS	A number of applications of analysis of human Y-chromosome microsatellite loci to human evolution and forensic science require reliable estimates of the mutation rate and knowledge of the mutational mechanism. We therefore screened a total of 4,999 meioses from father/son pairs with confirmed paternity (probability greater than or equal to 99.9%) at 15 Y-chromosomal microsatellite loci and identified 14 mutations. The locus-specific mutation-rate estimates were 0-8.58 x 10(-3), and the average mutation rate estimates were 3.17 x 10(-3) (95% confidence interval [CI] 1.89-4.94 x 10(-3)) across 8 tetranucleotide microsatellites and 2.80 x 10(-3) (95% CI 1.72-4.27 x 10(-3)) across all 15 Y-chromosomal microsatellites studied. Our data show a mutational bias toward length increase, on the basis of observation of more repeat gains than losses (10:4). The data are in almost complete agreement with the stepwise-mutation model, with 13 single-repeat changes and 1 double-repeat change. Sequence analysis revealed that all mutations occurred in uninterrupted homogenous arrays of greater than or equal to 11 repeats. We conclude that mutation rates and characteristics of human Y-chromosomal microsatellites are consistent with those of autosomal microsatellites. This indicates that the general mutational mechanism of microsatellites is independent of recombination.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Charite Humboldt Univ Berlin, Inst Rechts Med, Berlin, Germany; Univ Wales Coll Cardiff, Coll Med, Cardiff CF1 3NS, S Glam, Wales; Med Univ Wroclaw, Inst Forens Med, Wroclaw, Poland; Otto Von Guericke Univ, Inst Rechts Med, Magdeburg, Germany; Leiden Univ, Ctr Med, Leicester, Leics, England	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cardiff University; Wroclaw Medical University; Otto von Guericke University	Kayser, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Inselstr 22, D-04103 Leipzig, Germany.	kayser@eva.mpg.de	Krawczak, Michael/A-8964-2010; Dobosz, Tadeusz/ABE-9988-2021; de Knijff, Peter/Y-2519-2018; Sajantila, Antti/AAY-9084-2021; Dobosz, Tadeusz/T-8250-2018	Krawczak, Michael/0000-0003-2603-1502; de Knijff, Peter/0000-0002-0899-771X; Sajantila, Antti/0000-0003-4117-5248; Dobosz, Tadeusz/0000-0003-0413-9109; Roewer, Lutz/0000-0001-9383-4941; Nagy, Marion/0000-0002-7319-8033				Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Amos W, 1996, NAT GENET, V12, P13, DOI 10.1038/ng0196-13; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; BYRD C, 1965, P NATL ACAD SCI USA, V53, P79, DOI 10.1073/pnas.53.1.79; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cooper G, 1999, P NATL ACAD SCI USA, V96, P11916, DOI 10.1073/pnas.96.21.11916; Cooper G, 1998, HUM MOL GENET, V7, P1425, DOI 10.1093/hmg/7.9.1425; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Essen-Moller E., 1938, MITT ANTHR GES, V68, P9; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GOLDSTEIN DB, 1995, NUCLEIC ACIDS RES, V23, P3882, DOI 10.1093/nar/23.19.3882; Gunn PR, 1997, ELECTROPHORESIS, V18, P1650, DOI 10.1002/elps.1150180930; Henke J, 1999, AM J HUM GENET, V64, P1473, DOI 10.1086/302373; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Jobling MA, 1999, HUM MOL GENET, V8, P2117, DOI 10.1093/hmg/8.11.2117; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 1998, INT CONGR SER, V1167, P494; KRAWCZAK M, 1992, ELECTROPHORESIS, V13, P10, DOI 10.1002/elps.1150130104; Lahermo P, 1999, EUR J HUM GENET, V7, P447, DOI 10.1038/sj.ejhg.5200316; Malaspina P, 1997, J MOL EVOL, V44, P652; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Redd AJ, 1997, BIOL CHEM, V378, P923; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Sajantila A, 1999, EUR J HUM GENET, V7, P263, DOI 10.1038/sj.ejhg.5200257; Santos FR, 1996, HUM GENET, V97, P309, DOI 10.1007/BF02185760; Santos FR, 1996, AM J HUM GENET, V58, P1369; Schlotterer C, 1998, MOL BIOL EVOL, V15, P1269, DOI 10.1093/oxfordjournals.molbev.a025855; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schneider PM, 1998, FORENSIC SCI INT, V97, P61, DOI 10.1016/S0379-0738(98)00146-7; TALBOT CC, 1995, HUM MOL GENET, V4, P1193, DOI 10.1093/hmg/4.7.1193; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wierdl M, 1997, GENETICS, V146, P769; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	41	283	308	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1580	1588		10.1086/302905	http://dx.doi.org/10.1086/302905			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762544	Green Published, Bronze			2022-12-18	WOS:000088373700012
J	Hormozdiari, F; van de Bunt, M; Segre, AV; Li, X; Joo, JWJ; Bilow, M; Sul, JH; Sankararaman, S; Pasaniuc, B; Eskin, E				Hormozdiari, Farhad; van de Bunt, Martijn; Segre, Ayellet V.; Li, Xiao; Joo, Jong Wha J.; Bilow, Michael; Sul, Jae Hoon; Sankararaman, Sriram; Pasaniuc, Bogdan; Eskin, Eleazar			Colocalization of GWAS and eQTL Signals Detects Target Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE-TESTING CORRECTION; LINKAGE DISEQUILIBRIUM; INCREASING POWER; CAUSAL VARIANTS; COMMON VARIANTS; EXPRESSION; LOCI; IDENTIFICATION; POPULATIONS	The vast majority of genome-wide association study (GWAS) risk loci fall in non-coding regions of the genome. One possible hypothesis is that these GWAS risk loci alter the individual's disease risk through their effect on gene expression in different tissues. In order to understand the mechanisms driving a GWAS risk locus, it is helpful to determine which gene is affected in specific tissue types. For example, the relevant gene and tissue could play a role in the disease mechanism if the same variant responsible for a GWAS locus also affects gene expression. Identifying whether or not the same variant is causal in both GWASs and expression quantitative trail locus (eQTL) studies is challenging because of the uncertainty induced by linkage disequilibrium and the fact that some loci harbor multiple causal variants. However, current methods that address this problem assume that each locus contains a single causal variant. In this paper, we present eCAVIAR, a probabilistic method that has several key advantages over existing methods. First, our method can account for more than one causal variant in any given locus. Second, it can leverage summary statistics without accessing the individual genotype data. We use both simulated and real datasets to demonstrate the utility of our method. Using publicly available eQTL data on 45 different tissues, we demonstrate that eCAVIAR can prioritize likely relevant tissues and target genes for a set of glucose-and insulin-related trait loci.	[Hormozdiari, Farhad; Joo, Jong Wha J.; Bilow, Michael; Sankararaman, Sriram; Eskin, Eleazar] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [van de Bunt, Martijn] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [van de Bunt, Martijn] Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford OX3 7BN, England; [Segre, Ayellet V.; Li, Xiao] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Sul, Jae Hoon] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Sul, Jae Hoon] Univ Calif Los Angeles, Semel Ctr Informat & Personalized Genom, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Sankararaman, Sriram; Pasaniuc, Bogdan; Eskin, Eleazar] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eskin, E (corresponding author), Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA.; Eskin, E (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	eeskin@cs.ucla.edu		Pasaniuc, Bogdan/0000-0002-0227-2056; van de Bunt, Martijn/0000-0002-6744-6125	National Science Foundation [0513612, 0731455, 0729049, 0916676, 1065276, 1302448, 1320589, 1331176]; NIH [K25-HL080079, U01-DA024417, P01-HL30568, P01-HL28481, R01-GM083198, R01-ES021801, R01-MH101782, R01-ES022282, R00-GM 111744-03]; NIH Big Data to Knowledge (BD2K) award [U54EB020403]; University Of Oxford; Broad Institute [HHSN268201000029C]; National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; Novo Nordisk postdoctoral fellowship; Direct For Computer & Info Scie & Enginr [1320589] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, K25HL080079, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022282, R01ES021801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083198, R00GM111744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Big Data to Knowledge (BD2K) award; University Of Oxford; Broad Institute; National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics; Novo Nordisk postdoctoral fellowship; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	F.H.,J.W.J.J., M.B., and E.E. are supported by National Science Foundation grants 0513612, 0731455, 0729049, 0916676, 1065276, 1302448, 1320589, and 1331176 and NIH grants K25-HL080079, U01-DA024417, P01-HL30568, P01-HL28481, R01-GM083198, R01-ES021801, R01-MH101782, and R01-ES022282. E.E. is supported in part by NIH Big Data to Knowledge (BD2K) award U54EB020403. M.v.d.B. is supported by a Novo Nordisk postdoctoral fellowship run in partnership with the University Of Oxford. A.V.S. and X.L. are supported by contract HHSN268201000029C (Broad Institute). S.S. is supported in part by NIH grant R00-GM 111744-03. We acknowledge support from the National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691).	Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eskin E, 2008, GENOME RES, V18, P653, DOI 10.1101/gr.072785.107; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Hormozdiari F, 2016, AM J HUM GENET, V99, P89, DOI 10.1016/j.ajhg.2016.04.013; Hormozdiari F, 2015, BIOINFORMATICS, V31, P206, DOI 10.1093/bioinformatics/btv240; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Huang YT, 2015, GENET EPIDEMIOL, V39, P347, DOI 10.1002/gepi.21905; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Joo JWJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0903-6; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kostem E, 2011, GENETICS, V188, P449, DOI 10.1534/genetics.111.128595; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Li Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw627; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Matesanz F, 2015, HUM MOL GENET, V24, P5619, DOI 10.1093/hmg/ddv256; Monlong J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5698; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ongen H, 2015, AM J HUM GENET, V97, P567, DOI 10.1016/j.ajhg.2015.09.004; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Sul JH, 2015, AM J HUM GENET, V96, P857, DOI 10.1016/j.ajhg.2015.04.012; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016	49	282	284	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1245	1260		10.1016/j.ajhg.2016.10.003	http://dx.doi.org/10.1016/j.ajhg.2016.10.003			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27866706	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000389148600002
J	Numata, S; Ye, TZ; Hyde, TM; Guitart-Navarro, X; Tao, R; Wininger, M; Colantuoni, C; Weinberger, DR; Kleinman, JE; Lipska, BK				Numata, Shusuke; Ye, Tianzhang; Hyde, Thomas M.; Guitart-Navarro, Xavier; Tao, Ran; Wininger, Michael; Colantuoni, Carlo; Weinberger, Daniel R.; Kleinman, Joel E.; Lipska, Barbara K.			DNA Methylation Signatures in Development and Aging of the Human Prefrontal Cortex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN BRAIN; MONOZYGOTIC TWINS; CPG ISLAND; EPIGENETIC DIFFERENCES; BIPOLAR DISORDER; GENE-EXPRESSION; SCHIZOPHRENIA; GENOME; HYPERMETHYLATION; AGE	The human prefrontal cortex (PFC), a mastermind of the brain, is one of the last brain regions to mature. To investigate the role of epigenetics in the development of PFC, we examined DNA methylation in similar to 14,500 genes at similar to 27,000 CpG loci focused on 5' promoter regions in 108 subjects range in age from fetal to elderly. DNA methylation in the PFC shows unique temporal patterns across life. The fastest changes occur during the prenatal period, slow down markedly after birth and continue to slow further with aging. At the genome level, the transition from fetal to postnatal life is typified by a reversal of direction, from demethylation prenatally to increased methylation postnatally. DNA methylation is strongly associated with genotypic variants and correlates with expression of a subset of genes, including genes involved in brain development and in de novo DNA methylation. Our results indicate that promoter DNA methylation in the human PFC is a highly dynamic process modified by genetic variance and regulating gene transcription. Additional discovery is made possible with a stand-alone application, BrainCloudMethyl.	[Numata, Shusuke; Ye, Tianzhang; Hyde, Thomas M.; Tao, Ran; Wininger, Michael; Colantuoni, Carlo; Weinberger, Daniel R.; Kleinman, Joel E.; Lipska, Barbara K.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Ye, Tianzhang; Hyde, Thomas M.; Colantuoni, Carlo; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Guitart-Navarro, Xavier] NIDA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Colantuoni, Carlo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lipska, BK (corresponding author), NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA.	lipskab@mail.nih.gov	Tao, Ran/C-2662-2013; Lipska, Barbara K/E-4569-2017; Tao, Ran/L-3460-2014; Wininger, Michael/K-8985-2012	Colantuoni, Carlo/0000-0001-6818-6380; Wininger, Michael/0000-0002-7871-3292	National Institute of Mental Health at the National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002399, ZICMH002903] Funding Source: NIH RePORTER	National Institute of Mental Health at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Liqin Wang and Vesna Imamovic for their technical expertise; Mary Herman for her contribution to the Clinical Brain Disorders Branch/National Institute of Mental Health brain collection; Abdel Elkahloun at National Human Genome Research Institute Microarray Core Facility for scanning data; and Ronald Zielke, Robert Johnson, and Robert Vigorito at the NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland School of Medicine, for their collection of brains. We also thank the families of the deceased for the donations of brain tissue and their time and effort devoted to the consent process and interviews. This research was supported by the Intramural Research Program of the National Institute of Mental Health at the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Connor CM, 2008, EPIGENETICS-US, V3, P55, DOI 10.4161/epi.3.2.5938; Cotton AM, 2009, HUM MOL GENET, V18, P3544, DOI 10.1093/hmg/ddp299; Cox T.E., 1994, MULTIDIMENSIONAL SCA, V213; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kleinman JE, 2011, BIOL PSYCHIAT, V69, P140, DOI 10.1016/j.biopsych.2010.10.032; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Need AC, 2009, EUR J HUM GENET, V17, P946, DOI 10.1038/ejhg.2008.264; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102; Weinberger D. R., 2010, SCHIZOPHRENIA; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xin YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011357; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	52	282	285	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					260	272		10.1016/j.ajhg.2011.12.020	http://dx.doi.org/10.1016/j.ajhg.2011.12.020			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22305529	Green Published, Bronze			2022-12-18	WOS:000300742200006
J	Savage, SA; Giri, N; Baerlocher, GM; Orr, N; Lansdorp, PM; Alter, BP				Savage, Sharon A.; Giri, Neelarn; Baerlocher, Gabriela M.; Orr, Nick; Lansdorp, Peter M.; Alter, Blanche P.			TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REVERSE-TRANSCRIPTASE COMPONENT; STEM-CELL TRANSPLANTATION; APLASTIC-ANEMIA; GENETIC-VARIATION; LINKAGE DISEQUILIBRIUM; MUTATIONS; LENGTH; DISEASE; TERT; RETINOPATHY	Patients with dyskeratosis congenita (DC), a heterogeneous inherited bone marrow failure syndrome, have abnormalities in telomere biology, including very short telomeres and germline mutations in DKC1, TERC, TERT, or NOP10, but similar to 60% of DC patients lack an identifiable mutation. With the very short telomere phenotype and a highly penetrant, rare disease model, a linkage scan was performed on a family with autosomal-dominant DC and no mutations in DKC1, TERC, or TERT Evidence favoring linkage was found at 2p24 and 14q11.2, and this led to the identification of TINF2 (14q11.2) mutations, K280E, in the proband and her five affected relatives and TINF2R282H in three additional unrelated DC probands, including one with Revesz syndrome; a fifth DC proband had a R282S mutation. TINF2 mutations were not present in unaffected relatives, DC probands with mutations in DKC1, TERC, or TERT or 298 control subjects. We demonstrate that a fifth gene, TINF2, is mutated in classical DC and, for the first time, in Revesz syndrome. This represents the first shelterin complex mutation linked to human disease and confirms the role of very short telomeres as a diagnostic test for DC.	[Savage, Sharon A.; Giri, Neelarn; Alter, Blanche P.] NCI, Dept Hlth & Human Serv, NIH, Div Canc Epidemiol & Genet,Clin Genet Branch, Bethesda, MD 20892 USA; [Baerlocher, Gabriela M.] Univ Hosp Bern, Dept Hematol, CH-3010 Bern, Switzerland; [Orr, Nick] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Baerlocher, Gabriela M.; Lansdorp, Peter M.] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bern; University Hospital of Bern; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); British Columbia Cancer Agency	Savage, SA (corresponding author), NCI, Dept Hlth & Human Serv, NIH, Div Canc Epidemiol & Genet,Clin Genet Branch, Bethesda, MD 20892 USA.	savagesh@mail.nili.gov	Savage, Sharon A/B-9747-2015; Savage, Sharon/AAB-5160-2019	Savage, Sharon A/0000-0001-6006-0740; Savage, Sharon/0000-0001-6006-0740; Lansdorp, Peter/0000-0001-7435-1071	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N02CP11019] Funding Source: Medline; NIAID NIH HHS [R01 AI029524, AI29524, R21 AI029524] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01CP010190, Z01CP010144] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Al-Rahawan MM, 2006, INT J HEMATOL, V83, P275, DOI 10.1532/IJH97.06030; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Brazzola P, 2005, BONE MARROW TRANSPL, V36, P1103, DOI 10.1038/sj.bmt.1705171; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dror Y, 2003, BONE MARROW TRANSPL, V31, P847, DOI 10.1038/sj.bmt.1703931; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; KAJTAR P, 1994, AM J MED GENET, V49, P374, DOI 10.1002/ajmg.1320490404; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Marrone Anna, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008671; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Ostronoff F, 2007, BIOL BLOOD MARROW TR, V13, P366, DOI 10.1016/j.bbmt.2006.11.015; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; REVESZ T, 1992, J MED GENET, V29, P673, DOI 10.1136/jmg.29.9.673; Savage SA, 2006, EXP HEMATOL, V34, P664, DOI 10.1016/j.exphem.2006.02.008; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Savage SA, 2006, BLOOD CELL MOL DIS, V37, P134, DOI 10.1016/j.bcmd.2006.07.001; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Sznajer Y, 2003, EUR J PEDIATR, V162, P863, DOI 10.1007/s00431-003-1317-5; Tamary H, 2007, PEDIATR HEMAT ONCOL, V24, P87, DOI 10.1080/08880010601123240; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Walne AJ, 2005, INT J HEMATOL, V82, P184, DOI 10.1532/IJH97.05067; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449; Yabe M, 1997, BONE MARROW TRANSPL, V19, P389, DOI 10.1038/sj.bmt.1700674; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhu Y, 2004, CANCER RES, V64, P2251, DOI 10.1158/0008-5472.CAN-03-2800	45	282	296	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					501	509		10.1016/j.ajhg.2007.10.004	http://dx.doi.org/10.1016/j.ajhg.2007.10.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252230	Bronze, Green Published			2022-12-18	WOS:000253223900022
J	Vanharanta, S; Buchta, M; McWhinney, SR; Virta, SK; Peczkowska, M; Morrison, CD; Lehtonen, R; Januszewicz, A; Jarvinen, H; Juhola, M; Mecklin, JP; Pukkala, E; Herva, R; Kiuru, M; Nupponen, NN; Aaltonen, LA; Neumann, HPH; Eng, C				Vanharanta, S; Buchta, M; McWhinney, SR; Virta, SK; Peczkowska, M; Morrison, CD; Lehtonen, R; Januszewicz, A; Jarvinen, H; Juhola, M; Mecklin, JP; Pukkala, E; Herva, R; Kiuru, M; Nupponen, NN; Aaltonen, LA; Neumann, HPH; Eng, C			Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIPPEL-LINDAU-DISEASE; TUMOR-SUPPRESSOR GENE; GERMLINE MUTATIONS; TUBEROUS-SCLEROSIS; IDENTIFICATION; PREVALENCE; DOMAIN	Hereditary paraganglioma syndrome has recently been shown to be caused by germline heterozygous mutations in three (SDHB, SDHC, and SDHD) of the four genes that encode mitochondrial succinate dehydrogenase. Extraparaganglial component neoplasias have never been previously documented. In a population- based registry of symptomatic presentations of phaeochromocytoma/paraganglioma comprising 352 registrants, among whom 16 unrelated registrants were SDHB mutation positive, one family with germline SDHB mutation c. 847-50delTCTC had two members with renal cell carcinoma (RCC), of solid histology, at ages 24 and 26 years. Both also had paraganglioma. A registry of early-onset RCCs revealed a family comprising a son with clear-cell RCC and his mother with a cardiac tumor, both with the germline SDHB R27X mutation. The cardiac tumor proved to be a paraganglioma. All RCCs showed loss of the remaining wild-type allele. Our observations suggest that germline SDHB mutations can predispose to early-onset kidney cancers in addition to paragangliomas and carry implications for medical surveillance.	Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Surg 2, Helsinki, Finland; Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; Jyvaskyla Cent Hosp, Dept Pathol, Jyvaskyla, Finland; Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; Oulu Univ Hosp, Dept Pathol, Oulu, Finland; Univ Freiburg, Div Nephrol & Hypertens, Freiburg, Germany; Inst Cardiol, Warsaw, Poland; Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Univ Cambridge, Canc Res UK, Humcan Canc Genet Res Grp, Cambridge, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finnish Cancer Registry; Central Finland Central Hospital; Central Finland Central Hospital; University of Oulu; University of Freiburg; Institute of Cardiology - Poland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eng, C (corresponding author), Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, 420 W 12th Ave,Suite 690,Tzagournis Med Res Facil, Columbus, OH 43210 USA.	eng-1@medctr.osu.edu	Mecklin, Jukka-Pekka/AAC-9650-2019; Mecklin, Jukka-Pekka/AAB-5378-2020; Aaltonen, Lauri/A-5375-2010	Mecklin, Jukka-Pekka/0000-0003-4895-2249; Aaltonen, Lauri/0000-0001-6839-4286; Eng, Charis/0000-0002-3693-5145; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Kiuru, Maija/0000-0002-7010-5516	NICHD NIH HHS [R01 HD039058, R01HD39058, R01HD39058-02S1] Funding Source: Medline; PHS HHS [NE571/4-1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 2001, ADV CANCER RES, V82, P85, DOI 10.1016/S0065-230X(01)82003-0; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Liu MY, 2003, CANCER RES, V63, P2675; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Matteucci E, 2003, ONCOGENE, V22, P4062, DOI 10.1038/sj.onc.1206519; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Neumann HPH, 1998, J UROLOGY, V160, P1248, DOI 10.1016/S0022-5347(01)62509-6; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; SAMPSON JR, 1995, J MED GENET, V32, P848, DOI 10.1136/jmg.32.11.848; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Tacchini L, 2001, CARCINOGENESIS, V22, P1363, DOI 10.1093/carcin/22.9.1363; Takahashi M, 2002, J MED GENET, V39, P1, DOI 10.1136/jmg.39.1.1; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849	24	282	294	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					153	159		10.1086/381054	http://dx.doi.org/10.1086/381054			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14685938	Green Published, Bronze			2022-12-18	WOS:000187723500014
J	Jawaheer, D; Seldin, MF; Amos, CI; Chen, WV; Shigeta, R; Monteiro, J; Kern, M; Criswell, LA; Albani, S; Nelson, JL; Clegg, DO; Pope, R; Schroeder, HW; Bridges, SL; Pisetsky, DS; Ward, R; Kastner, DL; Wilder, RL; Pincus, T; Callahan, LF; Flemming, D; Wener, MH; Gregersen, PK				Jawaheer, D; Seldin, MF; Amos, CI; Chen, WV; Shigeta, R; Monteiro, J; Kern, M; Criswell, LA; Albani, S; Nelson, JL; Clegg, DO; Pope, R; Schroeder, HW; Bridges, SL; Pisetsky, DS; Ward, R; Kastner, DL; Wilder, RL; Pincus, T; Callahan, LF; Flemming, D; Wener, MH; Gregersen, PK			A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPLEX TRAITS; SUSCEPTIBILITY LOCI; LINKAGE STRATEGIES; AMERICAN PATIENTS; IDENTIFICATION; 1Q	Rheumatoid arthritis (RA) is an autoimmune/inflammatory disorder with a complex genetic component. We report the first major genomewide screen of multiplex families with RA gathered in the United States. The North American Rheumatoid Arthritis Consortium, using well-defined clinical criteria, has collected 257 families containing 301 affected sibling pairs with RA. A genome screen for allele sharing was performed, using 379 microsatellite markers. A nonparametric analysis using SIBPAL confirmed linkage of the HLA locus to RA (P<.00005), with <lambda>(HLA) = HLA. However, the analysis also revealed a number of non-HLA loci on chromosomes 1 (D1S235), 4 (D4S1647), 12 (D12S373), 16 (D16S403), and 17 (D17S1301), with evidence for linkage at a significance level of P<.005. Analysis of X-linked markers using the MLOD method from ASPEX also suggests linkage to the telomeric marker DXS6807. Stratifying the families into white or seropositive subgroups revealed some additional markers that showed improvement in significance over the full data set. Several of the regions that showed evidence for nominal significance (P<.05) in our data set had previously been implicated in RA (D16S516 and D17S1301) or in other diseases of an autoimmune nature, including systemic lupus erythematosus (D1S235), inflammatory bowel disease (D4S1647, D5S1462, and D16S516), multiple sclerosis (D12S1052), and ankylosing spondylitis (D16S516). Therefore, genes in the HLA complex play a major role in RA susceptibility, but several other regions also contribute significantly to overall genetic risk.	N Shore Univ Hosp, Div Biol & Human Genet, Manhasset, NY 11030 USA; Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA; Univ Calif San Diego, Ctr Pediat Rheumatol, La Jolla, CA 92093 USA; Fred Hutchinson Canc Res Ctr, Program Immunogenet, Seattle, WA 98104 USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; Duke Univ, Med Ctr, Med Res Serv,Div Rheumatol Allergy & Clin Immunol, Durham VA Hosp, Durham, NC USA; Univ Oxford, Inst Biol Anthropol, Oxford, England; NIAMS, NIH, Bethesda, MD USA; USN, CDR, MC, Dept Radiol,Natl Naval Med Ctr, Bethesda, MD 20084 USA; Vanderbilt Univ, Dept Med, Nashville, TN USA; Univ N Carolina, Thurston Arthrit Res Ctr, Dept Orthoped & Med, Chapel Hill, NC USA	Northwell Health; North Shore University Hospital; University of California System; University of California Davis; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Diego; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Northwestern University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Duke University; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Defense; United States Navy; Walter Reed National Military Medical Center; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Gregersen, PK (corresponding author), N Shore Univ Hosp, Div Biol & Human Genet, 350 Community Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu	Jawaheer, Damini/AFR-8556-2022; Callahan, Leigh/X-3799-2018; Wener, Mark/ABE-4491-2021	Callahan, Leigh/0000-0001-6362-7220; Schroeder, Harry/0000-0002-3767-6878; Pope, Richard M./0000-0003-2416-8660; Jawaheer, Damini/0000-0003-4954-874X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655, M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR072232, R01AR044422] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655, 5 M01 RR-00079, P41 RR003655, M01 RR000079] Funding Source: Medline; NIAMS NIH HHS [N01-AR-7-2232, R01 AR44222, R01 AR044422] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON SG, 1970, B WORLD HEALTH ORGAN, V42, P311; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2000, ARTHRITIS RHEUM, V43, pS271; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Brown MA, 1998, ARTHRITIS RHEUM, V41, P588, DOI 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; DEIGHTON CM, 1989, CLIN GENET, V36, P178; DUNNETT CW, 1989, APPL STAT-J ROY ST C, V38, P564, DOI 10.2307/2347754; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Gregersen PK, 1998, ARTHRIT CARE RES, V11, P1, DOI 10.1002/art.1790110102; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Holmans P, 1998, HUM BIOL, V70, P1025; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LYNN AH, 1995, AM J HUM GENET, V57, P150; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MCDANIEL DO, 1995, ANN INTERN MED, V123, P181, DOI 10.7326/0003-4819-123-3-199508010-00004; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; OLERUP O, 1993, HDB HLA TYPING TECHN, P149; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SPIEGEL TM, 1987, J RHEUMATOL, V14, P887; Teller K, 1996, J RHEUMATOL, V23, P1363; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Zhao LP, 1999, AM J HUM GENET, V64, P1739, DOI 10.1086/512072	34	282	295	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					927	936		10.1086/319518	http://dx.doi.org/10.1086/319518			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254450	Bronze, Green Published			2022-12-18	WOS:000167666000015
J	Valnot, I; Osmond, S; Gigarel, N; Mehaye, B; Amiel, J; Cormier-Daire, V; Munnich, A; Bonnefont, JP; Rustin, P; Rotig, A				Valnot, I; Osmond, S; Gigarel, N; Mehaye, B; Amiel, J; Cormier-Daire, V; Munnich, A; Bonnefont, JP; Rustin, P; Rotig, A			Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN; LEIGH-SYNDROME; COX DEFICIENCY; HUMAN MTDNA; CODON; YEAST; IDENTIFICATION; MICRODELETION; EXPRESSION; BIOGENESIS	Cytochrome c oxidase (COX) catalyzes both electron transfer from cytochrome c to molecular oxygen and the concomitant vectorial proton pumping across the inner mitochondrial membrane. Studying a large family with multiple cases of neonatal ketoacidotic comas and isolated COX deficiency, we have mapped the disease locus to chromosome 17p13.1, in a region encompassing two candidate genes involved in COX assembly-namely, SCO1 and COX10. Mutation screening revealed compound heterozygosity for SCO1 gene mutations in the patients. The mutated allele, inherited from the father, harbored a 2-bp frameshift deletion (Delta GA; nt 363-364) resulting in both a premature stop codon and a highly unstable mRNA. The maternally inherited mutation (C520T) changed a highly conserved proline into a leucine in the protein (P174L). This proline, adjacent to the CxxxC copper-binding domain of SCO1, is likely to play a crucial role in the tridimentional structure of the domain. Interestingly, the clinical presentation of SCO1-deficient patients markedly differs from that of patients harboring mutations in other COX assembly and/or maturation genes.	Hop Necker Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, F-75743 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rotig, A (corresponding author), Hop Necker Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, 149 Rue de Sevres, F-75743 Paris, France.		Rötig, Agnès/G-9592-2017; amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022; cormier-daire, valerie/H-6520-2017	Rötig, Agnès/0000-0003-0589-0703; amiel, jeanne/0000-0001-5973-4728; BONNEFONT, Jean-Paul/0000-0002-4235-1197; cormier-daire, valerie/0000-0002-2839-9856				Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; BUCHWALD P, 1991, MOL GEN GENET, V229, P413, DOI 10.1007/BF00267464; Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DiMauro S, 1999, J CHILD NEUROL, V14, pS23, DOI 10.1177/0883073899014001051; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910; Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Murakami T, 1997, GENOMICS, V42, P161, DOI 10.1006/geno.1997.4711; Papadopoulou LC, 1999, NAT GENET, V23, P333; Paret C, 1999, FEBS LETT, V447, P65, DOI 10.1016/S0014-5793(99)00266-5; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Rentzsch A, 1999, CURR GENET, V35, P103, DOI 10.1007/s002940050438; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; VONKLEISTRETZOW JC, IN PRESS J MED GENET; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	31	281	286	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1104	1109						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11013136				2022-12-18	WOS:000165091600007
J	CAMBIEN, F; ALHENCGELAS, F; HERBETH, B; ANDRE, JL; RAKOTOVAO, R; GONZALES, MF; ALLEGRINI, J; BLOCH, C				CAMBIEN, F; ALHENCGELAS, F; HERBETH, B; ANDRE, JL; RAKOTOVAO, R; GONZALES, MF; ALLEGRINI, J; BLOCH, C			FAMILIAL RESEMBLANCE OF PLASMA ANGIOTENSIN-CONVERTING ENZYME LEVEL - THE NANCY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INSERM,U36,F-75005 PARIS,FRANCE; CTR MED PREVENT,F-54500 VANDOEUVRE NANCY,FRANCE; INSERM,U115,F-54511 VANDOEUVRE NANCY,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	CAMBIEN, F (corresponding author), HOP BROUSSAIS,INSERM,U258,96 RUE DIDOT,F-75674 PARIS 14,FRANCE.		Cambien, Francois/AAP-9751-2020; Alhenc-Gelas, Francois/F-9511-2017					ALHENCGELAS F, 1983, J LAB CLIN MED, V101, P83; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; DAS M, 1977, J BIOL CHEM, V252, P1316; DONNER A, 1981, AM J EPIDEMIOL, V114, P149, DOI 10.1093/oxfordjournals.aje.a113162; DUX S, 1984, ISRAEL J MED SCI, V20, P1138; ERDOS EG, 1980, TOPICS HYPERTENSION, P21; HAYES LW, 1978, BIOCHEM BIOPH RES CO, V82, P1147, DOI 10.1016/0006-291X(78)90306-6; LALOUEL JM, 1981, 14 U UT DEP BIOPH CO; LEPOGAMP T, 1985, 22ND C EUR DIAL TRAN; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; NAKAMURA Y, 1982, J CLIN ENDOCR METAB, V55, P931, DOI 10.1210/jcem-55-5-931; NEELS HM, 1982, CLIN CHEM, V28, P1352; OKABE T, 1985, Q J MED, V216, P55; RODRIGUEZ GE, 1981, J PEDIATR-US, V99, P68, DOI 10.1016/S0022-3476(81)80959-6; SKEGGS LT, 1956, J EXP MED, V103, P295, DOI 10.1084/jem.103.3.295; WESTGREN U, 1976, ACTA MED SCAND, V200, P493; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; YASUI T, 1983, EUR HEART J, V4, P27, DOI 10.1093/eurheartj/4.suppl_G.27; YOTSUMOTO H, 1982, ANN INTERN MED, V96, P326, DOI 10.7326/0003-4819-96-3-326	20	281	294	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					774	780						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2847529				2022-12-18	WOS:A1988Q933600027
J	Zollner, S; Pritchard, JK				Zollner, Sebastian; Pritchard, Jonathan K.			Overcoming the winner's curse: Estimating penetrance parameters from case-control data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRO12ALA POLYMORPHISM; GENETIC ASSOCIATION; DIABETES-MELLITUS; BIAS; GAMMA; SUBSTITUTION; GENOMEWIDE; OBESITY; RISK	Genomewide association studies are now a widely used approach in the search for loci that affect complex traits. After detection of significant association, estimates of penetrance and allele-frequency parameters for the associated variant indicate the importance of that variant and facilitate the planning of replication studies. However, when these estimates are based on the original data used to detect the variant, the results are affected by an ascertainment bias known as the "winner's curse." The actual genetic effect is typically smaller than its estimate. This overestimation of the genetic effect may cause replication studies to fail because the necessary sample size is underestimated. Here, we present an approach that corrects for the ascertainment bias and generates an estimate of the frequency of a variant and its penetrance parameters. The method produces a point estimate and confidence region for the parameter estimates. We study the performance of this method using simulated data sets and show that it is possible to greatly reduce the bias in the parameter estimates, even when the original association study had low power. The uncertainty of the estimate decreases with increasing sample size, independent of the power of the original test for association. Finally, we show that application of the method to case-control data can improve the design of replication studies considerably.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zollner, S (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	szoellne@umich.edu			NHGRI NIH HHS [R01 HG002772-05, R01 HG002772, R01 HG002772-01, R01 HG002772-04, R01 HG002772-03, R01 HG002772-02, HG002772] Funding Source: Medline; NHLBI NIH HHS [HL084729, U01 HL084729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; CAPEN EC, 1971, J PETROL TECHNOL, V23, P641, DOI 10.2118/2993-PA; Clement K, 2000, INT J OBESITY, V24, P391, DOI 10.1038/sj.ijo.0801191; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mancini FP, 1999, DIABETES, V48, P1466, DOI 10.2337/diabetes.48.7.1466; Meirhaeghe A, 2000, INT J OBESITY, V24, P195, DOI 10.1038/sj.ijo.0801112; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Ringel J, 1999, BIOCHEM BIOPH RES CO, V254, P450, DOI 10.1006/bbrc.1998.9962; RISCH N, 1996, SCIENCE, V273, P1517; Siegmund D, 2002, AM J HUM GENET, V71, P1183, DOI 10.1086/343819; Sun L, 2005, GENET EPIDEMIOL, V28, P352, DOI 10.1002/gepi.20068; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	21	280	285	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					605	615		10.1086/512821	http://dx.doi.org/10.1086/512821			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357068	Green Published, Bronze			2022-12-18	WOS:000245465200003
J	BRUNNER, HG; NELEN, MR; VANZANDVOORT, P; ABELING, NGGM; VANGENNIP, AH; WOLTERS, EC; KUIPER, MA; ROPERS, HH; VANOOST, BA				BRUNNER, HG; NELEN, MR; VANZANDVOORT, P; ABELING, NGGM; VANGENNIP, AH; WOLTERS, EC; KUIPER, MA; ROPERS, HH; VANOOST, BA			X-LINKED BORDERLINE MENTAL-RETARDATION WITH PROMINENT BEHAVIORAL DISTURBANCE - PHENOTYPE, GENETIC LOCALIZATION, AND EVIDENCE FOR DISTURBED MONOAMINE METABOLISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORRIE DISEASE; PRENATAL-DIAGNOSIS; CARRIER DETECTION; DELETION; OXIDASE; AGGRESSION; DNA; CHROMOSOME; FAMILIES; URINE	We have identified a large Dutch kindred with a new form of X-linked nondysmorphic mild mental retardation. All affected males in this family show very characteristic abnormal behavior, in particular aggressive and sometimes violent behavior. Other types of impulsive behavior include arson, attempted rape, and exhibitionism. Attempted suicide has been reported in a single case. The locus for this disorder could be assigned to the Xp11-21 interval between DXS7 and DXS77 by linkage analysis using markers spanning the X chromosome. A maximal multipoint lod score of 3.69 was obtained at the monoamine oxidase type A (MAOA) locus in Xp11.23-11.4. Results of 24-h urine analysis in three affected males indicated a marked disturbance of monoamine metabolism. These data are compatible with a primary defect in the structural gene for MAOA and/or monoamine oxidase type B (MAOB). Normal platelet MAOB activity suggests that the unusual behavior pattern in this family may be caused by isolated MAOA deficiency.	UNIV AMSTERDAM,ACAD MED CTR,DEPT PEDIAT,1105 AZ AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM,DEPT NEUROL,1007 MC AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT CLIN CHEM,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	BRUNNER, HG (corresponding author), UNIV HOSP NIJMEGAN,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Brunner, Han/C-9928-2013; Nelen, Marcel R./L-4542-2015; Kuiper, Michael/AAG-9878-2019	Kuiper, Michael/0000-0001-6201-7332				ABELING NG, 1984, CLIN CHIM ACTA, V137, P211, DOI 10.1016/0009-8981(84)90181-5; BARKER DF, 1991, HUM GENET, V88, P189; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BLACK GCM, 1991, NUCLEIC ACIDS RES, V19, P689; BLEEKERWAGEMAKERS EM, 1988, OPHTHALMIC PAED GEN, V9, P137, DOI 10.3109/13816818809031489; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; CHEN ZY, 1992, NAT GENET, V1, P204, DOI 10.1038/ng0692-204; CHEN ZY, 1992, NUCLEIC ACIDS RES, V19, P4537; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; COLLINS FA, 1992, AM J MED GENET, V42, P127, DOI 10.1002/ajmg.1320420126; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DELACHAPELLE A, 1985, CLIN GENET, V28, P317; Depue R A, 1986, Ann N Y Acad Sci, V487, P47, DOI 10.1111/j.1749-6632.1986.tb27885.x; DEWEERS M, 1992, HUM MOL GENET, V1, P653, DOI 10.1093/hmg/1.8.653; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; HOTAMISLIGIL GS, 1991, AM J HUM GENET, V49, P383; KONINGS CH, 1992, CLIN CHIM ACTA, V205, P145, DOI 10.1016/S0009-8981(05)80009-9; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1992, AM J MED GENET, V43, P415, DOI 10.1002/ajmg.1320430163; MURPHY DL, 1990, J NEUROCHEM, V54, P242, DOI 10.1111/j.1471-4159.1990.tb13307.x; NERI G, 1992, AM J MED GENET, V43, P373, DOI 10.1002/ajmg.1320430158; SAMMANS C, 1991, AM J MED GENET, V38, P224; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; STROOMER AEM, 1990, CLIN CHEM, V36, P1834; VANKEMPEN GMJ, 1985, CLIN CHIM ACTA, V153, P197, DOI 10.1016/0009-8981(85)90352-3; VANOOST BA, 1991, AM J MED GENET, V38, P328, DOI 10.1002/ajmg.1320380232; VANPRAAG HM, 1991, PSYCHOL MED, V21, P15, DOI 10.1017/S0033291700014604; VANPRAAG HM, 1990, BRIT J PSYCHIAT, V157, P723, DOI 10.1192/bjp.157.5.723; VIRKKUNEN M, 1987, ARCH GEN PSYCHIAT, V44, P241; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; WILSON M, 1991, AM J MED GENET, V40, P406, DOI 10.1002/ajmg.1320400405; ZHU DP, 1989, AM J MED GENET, V33, P485, DOI 10.1002/ajmg.1320330415	34	280	287	1	34	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1032	1039						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503438				2022-12-18	WOS:A1993LG13300002
J	SALIDO, EC; YEN, PH; KOPRIVNIKAR, K; YU, LC; SHAPIRO, LJ				SALIDO, EC; YEN, PH; KOPRIVNIKAR, K; YU, LC; SHAPIRO, LJ			THE HUMAN ENAMEL PROTEIN GENE AMELOGENIN IS EXPRESSED FROM BOTH THE X-CHROMOSOMES AND THE Y-CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEVELOPING BOVINE ENAMEL; AMINO-ACID-SEQUENCE; SEX-CHROMOSOMES; MESSENGER-RNA; TOOTH SIZES; DNA; MATRIX; FEMALES; MALES	Amelogenins, a family of extracellular matrix proteins of the dental enamel, are transiently but abundantly expressed by ameloblasts during tooth development. Amelogenins seem to regulate the formation of crystallites during the secretory stage of enamel development, while they are specifically degraded during tooth-bud maturation. In this paper we report the characterization of the AMGX and AMGY genes on the short arms of the human X and Y chromosomes which encode the amelogenins. Our studies on the expression of the amelogenin genes in male developing tooth buds showed that both the AMGX and AMGY genes are transcriptionally active and encode potentially functional proteins. We have isolated genomic and cDNA clones from both the AMGX and AMGY loci and have studied the sequence organization of these two genes. Reverse transcriptase (RT)PCR amplification of the 5' portion of the amelogenin transcripts revealed several alternatively spliced products. The splicing pattern observed in the Y-derived mRNA varies from that of the X-derived mRNA. The promoter regions from both genes and the predicted amelogenin protein sequences are presented. This information will be useful for studying the molecular basis of X-linked amelogenesis imperfecta, for understanding the evolution and regulation of gene expression on the mammalian sex chromosomes, and for investigating the role of amelogenin genes during tooth development.	UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,HOWARD HUGHES MED INST,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT PEDIAT,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT BIOL CHEM,TORRANCE,CA 90509; FAC MED LA LAGUNA,DEPT PATHOL,LA LAGUNA,SPAIN; UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad de la Laguna; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System			Salido, Eduardo C/I-2232-2015	Salido, Eduardo C/0000-0001-9599-9854	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012178] Funding Source: NIH RePORTER; NICHD NIH HHS [HD12178] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALVESALO L, 1979, ANN HUM GENET, V43, P97, DOI 10.1111/j.1469-1809.1979.tb02001.x; ALVESALO L, 1981, ANN HUM GENET, V45, P49, DOI 10.1111/j.1469-1809.1981.tb00305.x; ALVESALO L, 1980, AM J HUM GENET, V32, P736; ALVESALO L, 1980, AM J HUM GENET, V32, P955; ALVESALO L, 1987, HUM GENET, V77, P345, DOI 10.1007/BF00291424; BULUWELA L, 1989, NUCLEIC ACIDS RES, V17, P452, DOI 10.1093/nar/17.1.452; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DEUTSCH D, 1989, ANAT RECORD, V224, P189, DOI 10.1002/ar.1092240209; FARGE P, 1987, ARCH ORAL BIOL, V32, P655, DOI 10.1016/0003-9969(87)90040-9; FINCHAM AG, 1980, ARCH ORAL BIOL, V25, P669, DOI 10.1016/0003-9969(80)90099-0; FINCHAM AG, 1990, CALCIFIED TISSUE INT, V47, P105, DOI 10.1007/BF02555993; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FUKAE M, 1983, JPN J ORAL BIOL S, V25, P29; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; KILLEN PD, 1988, J BIOL CHEM, V263, P12310; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; LAGERSTROM M, 1990, AM J HUM GENET, V46, P120; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NAKAHORI Y, 1991, GENOMICS, V9, P765, DOI 10.1016/0888-7543(91)90373-M; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; Robinson C, 1989, Connect Tissue Res, V22, P93; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHIMOKAWA H, 1987, J BIOL CHEM, V262, P4042; Shimokawa H, 1987, Adv Dent Res, V1, P293; SLAVKIN HC, 1982, J DENT RES, V61, P1457; Snead M L, 1987, Adv Dent Res, V1, P298; SNEAD ML, 1988, DEVELOPMENT, V104, P77; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; STRAWICH E, 1990, EUR J BIOCHEM, V191, P47, DOI 10.1111/j.1432-1033.1990.tb19092.x; TAKAGI T, 1984, BIOCHEM BIOPH RES CO, V121, P592, DOI 10.1016/0006-291X(84)90223-7; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; TRASK BJ, 1991, AM J HUM GENET, V48, P1; WALLACE RB, 1987, METHOD ENZYMOL, V152, P432; WITKOP CJ, 1967, ORAL SURG ORAL MED O, V23, P174, DOI 10.1016/0030-4220(67)90092-8; Young M F, 1987, Adv Dent Res, V1, P289; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	46	280	293	0	58	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					303	316						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734713				2022-12-18	WOS:A1992HD00100007
J	Jarvik, GP; Amendola, LM; Berg, JS; Brothers, K; Clayton, EW; Chung, W; Evans, BJ; Evans, JP; Fullerton, SM; Gallego, CJ; Garrison, NA; Gray, SW; Holm, IA; Kullo, IJ; Lehmann, LS; McCarty, C; Prows, CA; Rehm, HL; Sharp, RR; Salama, J; Sanderson, S; Van Driest, SL; Williams, MS; Wolf, SM; Wolf, WA; Burke, W				Jarvik, Gail P.; Amendola, Laura M.; Berg, Jonathan S.; Brothers, Kyle; Clayton, Ellen W.; Chung, Wendy; Evans, Barbara J.; Evans, James P.; Fullerton, Stephanie M.; Gallego, Carlos J.; Garrison, Nanibaa' A.; Gray, Stacy W.; Holm, Ingrid A.; Kullo, Iftikhar J.; Lehmann, Lisa Soleymani; McCarty, Cathy; Prows, Cynthia A.; Rehm, Heidi L.; Sharp, Richard R.; Salama, Joseph; Sanderson, Saskia; Van Driest, Sara L.; Williams, Marc S.; Wolf, Susan M.; Wolf, Wendy A.; Burke, Wylie		eMERGE Act-ROR Comm; CERC Comm; CSER Act-ROR Working Grp	Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANAGING INCIDENTAL FINDINGS; ACMG RECOMMENDATIONS; CLINICAL GENOMICS; PATIENT AUTONOMY; WORKING GROUP; CHILDREN; EXOME; BREAST; CANCER; ISSUES	As more research studies incorporate next-generation sequencing (including whole-genome or whole-exome sequencing), investigators and institutional review boards face difficult questions regarding which genomic results to return to research participants and how. An American College of Medical Genetics and Genomics 2013 policy paper suggesting that pathogenic mutations in 56 specified genes should be returned in the clinical setting has raised the question of whether comparable recommendations should be considered in research settings. The Clinical Sequencing Exploratory Research (CSER) Consortium and the Electronic Medical Records and Genomics (eMERGE) Network are multisite research programs that aim to develop practical strategies for addressing questions concerning the return of results in genomic research. CSER and eMERGE committees have identified areas of consensus regarding the return of genomic results to research participants. In most circumstances, if results meet an actionability threshold for return and the research participant has consented to return, genomic results, along with referral for appropriate clinical follow-up, should be offered to participants. However, participants have a right to decline the receipt of genomic results, even when doing so might be viewed as a threat to the participants' health. Research investigators should be prepared to return research results and incidental findings discovered in the course of their research and meeting an actionability threshold, but they have no ethical obligation to actively search for such results. These positions are consistent with the recognition that clinical research is distinct from medical care in both its aims and its guiding moral principles.	[Jarvik, Gail P.; Amendola, Laura M.; Gallego, Carlos J.; Salama, Joseph] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Berg, Jonathan S.; Evans, James P.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Brothers, Kyle] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Brothers, Kyle] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Clayton, Ellen W.; Garrison, Nanibaa' A.; Van Driest, Sara L.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37204 USA; [Clayton, Ellen W.; Garrison, Nanibaa' A.; Van Driest, Sara L.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Nashville, TN 37204 USA; [Chung, Wendy] Columbia Univ, New York, NY 10032 USA; [Evans, Barbara J.] Univ Houston, Ctr Law, Houston, TX 77204 USA; [Fullerton, Stephanie M.; Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Gray, Stacy W.; Lehmann, Lisa Soleymani; Rehm, Heidi L.] Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Gray, Stacy W.; Lehmann, Lisa Soleymani; Rehm, Heidi L.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Gray, Stacy W.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Holm, Ingrid A.; Wolf, Wendy A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Holm, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Holm, Ingrid A.; Wolf, Wendy A.] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Holm, Ingrid A.; Wolf, Wendy A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [McCarty, Cathy] Essentia Inst Rural Hlth, Duluth, MN 55805 USA; [Prows, Cynthia A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Prows, Cynthia A.] Cincinnati Childrens Hosp Med Ctr, Div Patient Serv, Cincinnati, OH 45229 USA; [Sharp, Richard R.] Mayo Clin, Biomed Eth Program, Rochester, MN 55905 USA; [Sanderson, Saskia] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Wolf, Susan M.] Univ Minnesota, Sch Med, Law Sch, Minneapolis, MN 55455 USA; [Wolf, Susan M.] Univ Minnesota, Consortium Law & Values Hlth Environm & Life Sci, Minneapolis, MN 55455 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Louisville; Vanderbilt University; Vanderbilt University; Columbia University; University of Houston System; University of Houston; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Mayo Clinic; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Geisinger Health System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jarvik, GP (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	pair@u.washington.edu	Tromp, Gerard/B-2677-2017; Jarvik, Gail P/N-6476-2014; Gray, Stacy/GRF-6833-2022; Fullerton, Stephanie Malia/H-8696-2019; Gray, Stacy/AAJ-2956-2020; Burke, William/C-1203-2012	Tromp, Gerard/0000-0002-7761-0806; Jarvik, Gail P/0000-0002-6710-8708; Fullerton, Stephanie Malia/0000-0002-0938-6048; Gray, Stacy/0000-0001-6948-0143; Rehm, Heidi L./0000-0002-6025-0015; Holm, Ingrid/0000-0003-4712-8821; McCarty, Catherine/0000-0003-1089-0142; Connolly, John/0000-0003-4396-1226; Clayton, Ellen/0000-0002-0308-4110; Lynch, John/0000-0001-6457-620X	NIH [U01HG006507, U01 HG006487, U01 HG007307, U01HG007307, U01HG006500, U01 G006492]; Electronic Medical Records and Genomics (eMERGE) Network [U01HG006375, U01HG006378, U01HG04603, U01HG006828, U01HG006379, U01HG006382]; eMERGE Return of Results awards [R21HG00612, R01 HG006615, R01 HG004500, 1R01CA154517]; Robert Wood Johnson Foundation Investigator Award [69763]; NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425, UL1TR000067] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006487, UM1HG007301, U01HG004603, R01HG006615, U01HG006382, U01HG006375, U01HG007278, U01HG006380, U01HG006828, U01HG007307, U01HG006507, U01HG006378, R01HG004500, U01HG006492, U01HG006379, U01HG006500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Electronic Medical Records and Genomics (eMERGE) Network; eMERGE Return of Results awards; Robert Wood Johnson Foundation Investigator Award(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH Clinical Sequencing Exploratory Research (CSER) awards U01HG006507, U01 HG006487, U01 HG007307, U01HG007307, U01HG006500, and U01 G006492; Electronic Medical Records and Genomics (eMERGE) Network awards U01HG006375, U01HG006378, U01HG04603, U01HG006828, U01HG006379, and U01HG006382; eMERGE Return of Results awards R21HG00612, R01 HG006615, R01 HG004500, and 1R01CA154517; and Robert Wood Johnson Foundation Investigator Award 69763. All views expressed are those of the authors and do not necessarily reflect the views of the funding agencies, the CSER Consortium, or the eMERGE Network. L.A.H., J.M., C.H., K.S., N.L., S.S., and C.C. are members of the NIH CSER staff team, responsible for scientific program management of the CSER program.	Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; American College of Medical and Genetics, 2014, ACMG UPD REC OPT OUT; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Beskow LM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000952; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Botoseneanu A, 2011, HEALTH EDUC BEHAV, V38, P617, DOI 10.1177/1090198110389711; Buchanan AE., 1989, DECIDING OTHERS ETHI; Burke W, 2014, AM J MED GENET C, V166, P105, DOI 10.1002/ajmg.c.31393; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Clayton EW, 2014, AM J BIOETHICS, V14, P3, DOI 10.1080/15265161.2013.879945; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Evans Barbara J, 2014, Univ Pa J Const Law, V16, P549; Evans BJ, 2013, GENET MED, V15, P915, DOI 10.1038/gim.2013.135; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Goldstein J., 1979, BEST INTERESTS CHILD, VII; Graves KD, 2011, PUBLIC HEALTH GENOM, V14, P178, DOI 10.1159/000324703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Haga SB, 2013, ADV GENET, V84, P41, DOI 10.1016/B978-0-12-407703-4.00002-5; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Knoppers BM, 2014, EUR J HUM GENET, V22, P3, DOI 10.1038/ejhg.2013.176; Kohane IS, 2007, SCIENCE, V316, P836, DOI 10.1126/science.1135489; Neumann PJ, 2012, HEALTH ECON, V21, P238, DOI 10.1002/hec.1704; Ormondroyd E, 2007, J Genet Couns, V16, P527, DOI 10.1007/s10897-007-9088-1; P. C. for the Study of Bioethical Issues, 2012, PRIVACY PROGR WHOLE; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Richards MPM, 2003, J MED ETHICS, V29, P93, DOI 10.1136/jme.29.2.93; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Ross LF, 1998, CHILDREN FAMILIES HL; Shalowitz DI, 2008, PLOS MED, V5, P714, DOI 10.1371/journal.pmed.0050091; Townsend A, 2013, GENET MED, V15, P751, DOI 10.1038/gim.2013.105; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wendler D, 2007, AM J MED GENET A, V143A, P1733, DOI 10.1002/ajmg.a.31823; WILFOND BS, 1995, AM J HUM GENET, V57, P1233; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Yu JH, 2013, GENET MED, V15, P684, DOI 10.1038/gim.2013.35	40	279	280	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					818	826		10.1016/j.ajhg.2014.04.009	http://dx.doi.org/10.1016/j.ajhg.2014.04.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24814192	Green Published, Bronze			2022-12-18	WOS:000337331200003
J	Lopez, LC; Schuelke, M; Quinzii, CM; Kanki, T; Rodenburg, RJT; Naini, A; DiMauro, S; Hirano, M				Lopez, Luis Carlos; Schuelke, Markus; Quinzii, Catarina M.; Kanki, Tomotake; Rodenburg, Richard J. T.; Naini, Ali; DiMauro, Salvatore; Hirano, Michio			Leigh syndrome with nephropathy and CoQ(10) deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME Q(10) DEFICIENCY; CEREBELLAR-ATAXIA; MITOCHONDRIAL ENCEPHALOMYOPATHY; MYOPATHY; PROTEIN	Coenzyme Q(10) (CoQ(10)) is a vital lipophilic molecule that transfers electrons from mitochondrial respiratory chain complexes I and II to complex III. Deficiency of CoQ(10) has been associated with diverse clinical phenotypes, but, in most patients, the molecular cause is unknown. The first defect in a CoQ(10) biosynthetic gene, COQ2, was identified in a child with encephalomyopathy and nephrotic syndrome and in a younger sibling with only nephropathy. Here, we describe an infant with severe Leigh syndrome, nephrotic syndrome, and CoQ(10) deficiency in muscle and fibroblasts and compound heterozygous mutations in the PDSS2 gene, which encodes a subunit of decaprenyl diphosphate synthase, the first enzyme of the CoQ(10) biosynthetic pathway. Biochemical assays with radiolabeled substrates indicated a severe defect in decaprenyl diphosphate synthase in the patient's fibroblasts. This is the first description of pathogenic mutations in PDSS2 and confirms the molecular and clinical heterogeneity of primary CoQ(10) deficiency.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Virchow Univ Hosp Berlin, Charite, Dept Neuropediat, Berlin, Germany; Univ Nijmegen, Radboud Med Ctr, Ctr Mitochondrial Disorders, Nijmegen, Netherlands	Columbia University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen	Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,P&S 4-443, New York, NY 10032 USA.	mh29@columbia.edu	Rodenburg, Richard/N-3579-2014; Kanki, Tomotake/H-7250-2012; Lopez, Luis Carlos/L-5129-2014; Lopez, Luis Carlos/AAP-9411-2020	Rodenburg, Richard/0000-0001-5227-3527; Kanki, Tomotake/0000-0001-9646-5379; Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; Schuelke, Markus/0000-0003-2824-3891	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543, P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD032062, R01 HD057543, HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766, P01 NS011766] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artuch R, 2006, J NEUROL SCI, V246, P153, DOI 10.1016/j.jns.2006.01.021; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c; Kawamukai M, 2002, J BIOSCI BIOENG, V94, P511, DOI 10.1016/S1389-1723(02)80188-8; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; Naini A, 2003, BIOFACTORS, V18, P145, DOI 10.1002/biof.5520180217; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371	21	279	292	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1125	1129		10.1086/510023	http://dx.doi.org/10.1086/510023			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186472	Green Published, Bronze			2022-12-18	WOS:000242131600015
J	Culverhouse, R; Suarez, BK; Lin, J; Reich, T				Culverhouse, R; Suarez, BK; Lin, J; Reich, T			A perspective on epistasis: Limits of models displaying no main effect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ECOLOGICAL GENETICS; ABNORMAL-ABDOMEN; LINKAGE DISEQUILIBRIUM; DISEASE; GENES; TRANSMISSION; COMPONENTS; LOCUS; TRAIT	The completion of a draft sequence of the human genome and the promise of rapid single-nucleotide-polymorphism-genotyping technologies have resulted in a call for the abandonment of linkage studies in favor of genome scans for association. However, there exists a large class of genetic models for which this approach will fail: purely epistatic models with no additive or dominance variation at any of the susceptibility loci. As a result, traditional association methods (such as case/control, measured genotype, and transmission/disequilibrium test [TDT]) will have no power if the loci are examined individually. In this article, we examine this class of models, delimiting the range of genetic determination and recurrence risks for two-, three-, and four-locus purely epistatic models. Our study reveals that these models, although giving rise to no additive or dominance variation, do give rise to increased allele sharing between affected sibs. Thus, a genome scan for linkage could detect genomic subregions harboring susceptibility loci. We also discuss some simple multilocus extensions of single-locus analysis methods, including a conditional form of the TDT.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Culverhouse, R (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid St, St Louis, MO 63110 USA.	rob@frodo.wustl.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014677, P50MH031302, P30MH031302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008403] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA08403] Funding Source: Medline; NIMH NIH HHS [MH31302, MH14677, T32 MH014677] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1932, STAT METHODS RES WOR; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BORECKI IB, 1990, AM J HUM GENET, V47, P542; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; DESALLE R, 1986, GENETICS, V112, P877; DIZIER MH, 1986, GENET EPIDEMIOL, V3, P343, DOI 10.1002/gepi.1370030507; DIZIER MH, 1994, AM J HUM GENET, V55, P1042; ELHAZMI MAF, 1992, ACTA HAEMATOL-BASEL, V88, P61; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HOLLOCHER H, 1992, GENETICS, V130, P355; HOLLOCHER H, 1994, GENETICS, V136, P1373; Kempthorne O, 1957, INTRO GENETIC STAT; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MOTZKIN TS, 1953, CONTRIBUTIONS THEORY, V0002, P00051; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; ODENHEIMER DJ, 1983, AM J HUM GENET, V35, P1224; Rice JP, 1995, GENET EPIDEMIOL, V12, P659, DOI 10.1002/gepi.1370120623; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; *SAS I, 1995, SAS REL 6 11; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SING CF, 1985, DISEASES COMPLEX ETI, P39; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1976, ANN HUM GENET, V40, P231, DOI 10.1111/j.1469-1809.1976.tb00186.x; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Tiwari HK, 1997, GENET EPIDEMIOL, V14, P1131, DOI 10.1002/(SICI)1098-2272(1997)14:6<1131::AID-GEPI95>3.3.CO;2-7; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; WRIGHT S, 1923, P 6 INT C GEN, V1, P356; Zubenko GS, 2001, MOL PSYCHIATR, V6, P413, DOI 10.1038/sj.mp.4000900	34	279	288	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					461	471		10.1086/338759	http://dx.doi.org/10.1086/338759			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791213	Green Published, Bronze			2022-12-18	WOS:000173254300017
J	Salomons, GS; van Dooren, SJM; Verhoeven, NM; Cecil, KM; Ball, WS; Degrauw, TJ; Jakobs, C				Salomons, GS; van Dooren, SJM; Verhoeven, NM; Cecil, KM; Ball, WS; Degrauw, TJ; Jakobs, C			X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY; INBORN ERROR; METABOLISM; XQ28; ASSIGNMENT; 16P11.2; CLONING	We report the first X-linked creatine-deficiency syndrome caused by a defective creatine transporter. The male index patient presented with developmental delay and hypotonia. Proton magnetic-resonance spectroscopy of his brain revealed absence of the creatine signal. However, creatine in urine and plasma was increased, and guanidinoacetate levels were normal. In three female relatives of the index patient, mild biochemical abnormalities and learning disabilities were present, to various extents. Fibroblasts from the index patient contained a hemizygous nonsense mutation in the gene SLC6A8 and were defective in creatine uptake. The three female relatives were heterozygous for this mutation in SLC6A8, which has been mapped to Xq28.	VU Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands; Univ Cincinnati, Cincinnati, OH 45221 USA; Childrens Hosp Med Ctr, Imaging Res Ctr, Div Radiol, Cincinnati, OH USA; Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Jakobs, C (corresponding author), VU Med Ctr, Dept Clin Chem, Metab Unit, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.			Cecil, Kim/0000-0001-8233-5485				Bianchi MC, 2000, ANN NEUROL, V47, P511; Cecil KM, 2001, ANN NEUROL, V49, P401, DOI 10.1002/ana.79; GREGOR P, 1995, GENOMICS, V25, P332, DOI 10.1016/0888-7543(95)80155-F; Iyer GS, 1996, GENOMICS, V34, P143, DOI 10.1006/geno.1996.0254; Kaplan L. A., 1989, CLIN CHEM THEORY ANA, V2nd; NASH SR, 1994, RECEPTOR CHANNEL, V2, P165; Sandoval N, 1996, GENOMICS, V35, P383, DOI 10.1006/geno.1996.0373; Schulze A, 1997, J PEDIATR-US, V131, P626, DOI 10.1016/S0022-3476(97)70075-1; SORA I, 1994, BIOCHEM BIOPH RES CO, V204, P419, DOI 10.1006/bbrc.1994.2475; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; Stockler S, 1996, AM J HUM GENET, V58, P914; Struys EA, 1998, J PHARMACEUT BIOMED, V18, P659, DOI 10.1016/S0731-7085(98)00280-5; van der Knaap MS, 2000, ANN NEUROL, V47, P540, DOI 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.0.CO;2-K; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xu W, 1997, CYTOGENET CELL GENET, V76, P19, DOI 10.1159/000134503	16	278	292	2	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1497	1500		10.1086/320595	http://dx.doi.org/10.1086/320595			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11326334	Bronze, Green Published			2022-12-18	WOS:000169094600020
J	Stankovic, T; Kidd, AMJ; Sutcliffe, A; McGuire, GM; Robinson, P; Weber, P; Bedenham, T; Bradwell, AR; Easton, DF; Lennox, GG; Haites, N; Byrd, PJ; Taylor, AMR				Stankovic, T; Kidd, AMJ; Sutcliffe, A; McGuire, GM; Robinson, P; Weber, P; Bedenham, T; Bradwell, AR; Easton, DF; Lennox, GG; Haites, N; Byrd, PJ; Taylor, AMR			ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; FREQUENCY; PATIENT; VARIANT	We report the spectrum of 59 ATM mutations observed in ataxia-telangiectasia (A-T) patients in the British Isles. Of 51 ATM mutations identified in families native to the British Isles, II were founder mutations, and 2 of these 11 conferred a milder clinical phenotype with respect to both cerebellar degeneration and cellular features. We report, in two A-T families, an ATM mutation (7271T --> G) that may be associated with an increased risk of breast cancer in both homozygotes and heterozygotes (relative risk 12.7; P = .0025), although there is a less severe A-T phenotype in terms of the degree of cerebellar degeneration. This mutation (7271T --> G) also allows expression of full-length ATM protein at a level comparable with that in unaffected individuals. In addition, we have studied 18 A-T patients, in 15 families, who developed leukemia, lymphoma, preleukemic T-cell proliferation, or Hodgkin lymphoma, mostly in childhood. A wide variety of ATM mutation types, including missense mutations and in-frame deletions, were seen in these patients. We also show that 25% of all A-T patients carried in-frame deletions or missense mutations, many of which were also associated with expression of mutant ATM protein.	Univ Birmingham, Sch Med, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England; Univ Birmingham, Sch Med, Dept Immunol, Birmingham B15 2TA, W Midlands, England; Aberdeen Royal Infirm, Dept Med Genet, Aberdeen, Scotland; Inst Publ Hlth, CRC, Genet Epidemiol Unit, Cambridge, England; Queens Med Ctr, Div Clin Neurol, Nottingham NG7 2UH, England	University of Birmingham; University of Birmingham; University of Aberdeen; University of Cambridge; University of Nottingham	Taylor, AMR (corresponding author), Univ Birmingham, Sch Med, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England.	A.M.R.Taylor@bham.ac.uk		Stankovic, Tatjana/0000-0002-3780-274X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P1499; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Beaudet AL, 1996, HUM MUTAT, V8, P197; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gardella R, 1996, AM J HUM GENET, V59, P292; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Lakin ND, 1996, ONCOGENE, V13, P2707; LIU Q, 1995, BIOTECHNIQUES, V18, P470; McConville CM, 1996, AM J HUM GENET, V59, P320; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Taylor A. M. R., 1996, P138; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Telatar M, 1996, AM J HUM GENET, V59, P40; UZIEL T, 1996, GENOMICS, V33, P313; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Wright J, 1996, AM J HUM GENET, V59, P839; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; YING KL, 1981, CANCER GENET CYTOGEN, V4, P311, DOI 10.1016/0165-4608(81)90027-3	28	278	284	0	12	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					334	345		10.1086/301706	http://dx.doi.org/10.1086/301706			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463314	Green Published, Bronze			2022-12-18	WOS:000072416000017
J	Cruciani, F; Santolamazza, P; Shen, PD; Macaulay, V; Moral, P; Olckers, A; Modiano, D; Holmes, S; Destro-Bisol, G; Coia, V; Wallace, DC; Oefner, PJ; Torroni, A; Cavalli-Sforza, LL; Scozzari, R; Underhill, PA				Cruciani, F; Santolamazza, P; Shen, PD; Macaulay, V; Moral, P; Olckers, A; Modiano, D; Holmes, S; Destro-Bisol, G; Coia, V; Wallace, DC; Oefner, PJ; Torroni, A; Cavalli-Sforza, LL; Scozzari, R; Underhill, PA			A back migration from Asia to sub-Saharan Africa is supported by high-resolution analysis of human Y-chromosome haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; RECENT COMMON ANCESTRY; HOMO-SAPIENS SAPIENS; MICROSATELLITE LOCI; SEQUENCE VARIATION; HUMAN-POPULATIONS; GEOGRAPHIC-DISTRIBUTION; JEWISH COMMUNITIES; HUMAN-EVOLUTION; ORIGIN	The variation of 77 biallelic sites located in the nonrecombining portion of the Y chromosome was examined in 608 male subjects from 22 African populations. This survey revealed a total of 37 binary haplotypes, which were combined with microsatellite polymorphism data to evaluate internal diversities and to estimate coalescence ages of the binary haplotypes. The majority of binary haplotypes showed a nonuniform distribution across the continent. Analysis of molecular variance detected a high level of interpopulation diversity (Phi(ST)=0.342), which appears to be partially related to the geography (Phi(CT)=0.230). In sub-Saharan Africa, the recent spread of a set of haplotypes partially erased pre-existing diversity, but a high level of population (Phi(ST)=0.332) and geographic (Phi(CT)=0.179) structuring persists. Correspondence analysis shows that three main clusters of populations can be identified: northern, eastern, and sub-Saharan Africans. Among the latter, the Khoisan, the Pygmies, and the northern Cameroonians are clearly distinct from a tight cluster formed by the Niger-Congo-speaking populations from western, central western, and southern Africa. Phylogeographic analyses suggest that a large component of the present Khoisan gene pool is eastern African in origin and that Asia was the source of a back migration to sub-Saharan Africa. Haplogroup IX Y chromosomes appear to have been involved in such a migration, the traces of which can now be observed mostly in northern Cameroon.	Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Roma La Sapienza, Sez Parassitol, I-00185 Rome, Italy; Univ Roma La Sapienza, Sez Antropol, I-00185 Rome, Italy; Univ Cattolica, Ist Med Legale, Rome, Italy; Stanford Genome Technol Ctr, Palo Alto, CA USA; Univ Oxford, Dept Stat, Oxford OX1 2JD, England; Univ Barcelona, Dept Biol Anim, Barcelona, Spain; Potchefstroom Univ Christian Higher Educ, Ctr Genome Res, Pretoria, South Africa; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA USA; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Stanford University; University of Oxford; University of Barcelona; North West University - South Africa; Stanford University; Stanford University; Emory University; University of Pavia	Cruciani, F (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.		Cruciani, Fulvio/G-6105-2012; Torroni, Antonio/E-1557-2011; Moral, Pedro/K-9587-2014; Olckers, Antonel/AAW-8903-2020	Torroni, Antonio/0000-0002-4163-4478; Moral, Pedro/0000-0001-5072-5892; Olckers, Antonel/0000-0002-4974-5666; Holmes, Susan/0000-0002-2208-8168; Cruciani, Fulvio/0000-0002-6900-024X; Destro Bisol, Giovanni/0000-0002-4232-9715	PHS HHS [28428] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Altheide TK, 1997, AM J HUM GENET, V61, P462; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brauer G, 1978, Z Morphol Anthropol, V69, P266; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; EXCOFFIER L, 1992, GENETICS, V131, P479; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gonzalez-Neira A, 2001, FORENSIC SCI INT, V122, P19, DOI 10.1016/S0379-0738(01)00405-4; GREENBERG JH, 1987, STORIA GEN AFRICA, V1, P313; GREENBERG JH, 1963, LANGUAGES AFRICA; Grimes B.F., 2000, ETHNOLOGUE LANGUAGES, V14th ed.; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Hiernaux J., 1974, PEOPLE AFRICA; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Malaspina P, 2001, ANN HUM GENET, V65, P339, DOI 10.1017/S0003480001008727; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; Malaspina P, 1997, J MOL EVOL, V44, P652; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Melton T, 1997, J FORENSIC SCI, V42, P582; NGO KY, 1986, AM J HUM GENET, V38, P407; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; PENNY D, 1995, MOL BIOL EVOL, V12, P863; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; RITTE U, 1993, HUM BIOL, V65, P359; RITTE U, 1993, J MOL EVOL, V37, P435; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schneider S., 2000, ARLEQUIN VER 2000 SO; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Semino O, 1996, AM J HUM GENET, V59, P964; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; SLATKIN M, 1995, GENETICS, V139, P457; Spedini G, 1999, AM J PHYS ANTHROPOL, V110, P143, DOI 10.1002/(SICI)1096-8644(199910)110:2<143::AID-AJPA3>3.3.CO;2-A; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tobias PV, 1978, BUSHMEN SAN HUNTERS; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; UNDERHILL PA, 2001, RECENT ADV HUMAN BIO, V8, P43; Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846; Vandamme AM, 1998, TRENDS MICROBIOL, V6, P477, DOI 10.1016/S0966-842X(98)01406-1; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WADDLE DM, 1994, NATURE, V368, P452, DOI 10.1038/368452a0; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Watson E, 1996, AM J HUM GENET, V59, P437; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	88	277	284	0	29	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1197	1214		10.1086/340257	http://dx.doi.org/10.1086/340257			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11910562	Green Published, Bronze			2022-12-18	WOS:000175012400010
